#Release Date: 2020-2-12
Geneid	Keywords
100009667	ENDOMETRIAL CARCINOMA#0.9166
10000	PROTEIN KINASE B#1.0047;BREAST CANCER#1.0021;PROTEIN KINASE#0.9926;TUMOR SUPPRESSOR#0.9906;CELL PROLIFERATION#0.9890;CELL GROWTH#0.9872;OVARIAN CANCER#0.9869;PROSTATE CANCER#0.9868;APOPTOSIS#0.9858;CANCER CELL#0.9808;SIGNALING PATHWAY#0.9799;CELL CYCLE#0.9797;BREAST CANCER CELL#0.9787;GROWTH FACTOR#0.9783;AUTOPHAGY#0.9743;GENE EXPRESSION#0.9716;OVARIAN#0.9715;AKT SIGNALING#0.9690;THYROID CANCER#0.9681;KINASE ACTIVITY#0.9666;SKELETAL MUSCLE#0.9651;APOPTOTIC#0.9584;ONCOGENIC#0.9542;TUMOR CELLS#0.9527;MICROCEPHALY#0.9454;CELL MIGRATION#0.9454;QUANTITATIVE REAL TIME#0.9451;ENDOTHELIAL CELL#0.9444;CELL DEATH#0.9412;T CELL#0.9402;LUNG CANCER#0.9396;POLYMERASE CHAIN REACTION#0.9338;RAPAMYCIN#0.9338;KINASE INHIBITOR#0.9279;TARGET OF RAPAMYCIN#0.9270;SIGNALING CASCADE#0.9236;GLYCOGEN SYNTHASE KINASE#0.9153;STEM CELL#0.9148;ANGIOGENESIS#0.9057;REVERSE TRANSCRIPTION#0.8998;ADIPOCYTE#0.8975;MITOGEN ACTIVATED PROTEIN#0.8909;HEPATOCELLULAR CARCINOMA#0.8838;PROTEIN SYNTHESIS#0.8746;MACROPHAGE#0.8650;M PHASE#0.8552;NERVOUS SYSTEM#0.8515;POTASSIUM CHANNEL#0.8452;SQUAMOUS CELL CARCINOMA#0.8426;CELL MOTILITY#0.8316;INSULIN-LIKE GROWTH FACTOR#0.8267;EPIDERMAL GROWTH FACTOR#0.8257;ADENOCARCINOMA#0.8239;TRANSCRIPTION FACTOR#0.8235;CELL CYCLE ARREST#0.8186;GLUCOSE UPTAKE#0.8172;GROWTH FACTOR RECEPTOR#0.8163;SIGNAL TRANSDUCTION#0.8010;PLASMA MEMBRANE#0.8009;RIBOSOMAL PROTEIN#0.7980;MUSCLE CELL#0.7955;2-DEOXYGLUCOSE#0.7944;ESTROGEN RECEPTOR#0.7938;SPINAL CORD#0.7936;EPILEPSY#0.7933;DUAL LUCIFERASE REPORTER#0.7892;MAPK SIGNALING#0.7881;INSULIN RECEPTOR#0.7814;RNA INTERFERENCE#0.7808;COLORECTAL CANCER#0.7802;B CELL#0.7739;GLIOBLASTOMA MULTIFORME#0.7655;BRAIN DEVELOPMENT#0.7637;CISPLATIN#0.7610;COLORECTAL#0.7545;HAIR CELL#0.7500;CARDIOMYOCYTE#0.7490;PROGENITOR CELL#0.7393;ENDOTHELIAL GROWTH FACTOR#0.7385;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7385;EPITHELIAL CELL#0.7323;LYMPH NODE#0.7148;INTELLECTUAL DISABILITY#0.7069;TAMOXIFEN#0.7042;DNA REPAIR#0.6858;SENESCENCE#0.6798;ANCHORAGE INDEPENDENT GROWTH#0.6785;MAP KINASE#0.6767;SIGNALLING PATHWAY#0.6755;GLUCOSE HOMEOSTASIS#0.6746;ATHEROSCLEROSIS#0.6670;HUMAN BREAST CANCER#0.6591;INSULIN RECEPTOR SUBSTRATE#0.6528;TUMOR TISSUES#0.6491;BREAST CANCER PATIENTS#0.6484;TYPE 2 DIABETES#0.6442;TOXICITY#0.6430;FOCAL ADHESION#0.6310;EXTRACELLULAR MATRIX#0.6269;DEVELOPMENTAL DELAY#0.6193;PROTEIN KINASE C#0.6165;SMOOTH MUSCLE CELL#0.6164;SMOOTH MUSCLE#0.6148;DRUG RESISTANCE#0.6022;AXON REGENERATION#0.6015;IMMUNE CELL#0.6002
10002	ENHANCED S-CONE SYNDROME#1.0764;PHOTORECEPTOR DEVELOPMENT#1.0406;RETINAL DEGENERATION#1.0346;PHOTORECEPTOR CELL#1.0224;RETINITIS PIGMENTOSA#1.0211;NUCLEAR HORMONE RECEPTOR#1.0201;RETINITIS#1.0149;INDUCED PLURIPOTENT STEM CELL#1.0068;TRANSCRIPTION FACTOR#1.0015;RETINAL DISEASE#0.9975;CARDIOMYOCYTE#0.9965;PLURIPOTENT STEM CELL#0.9909;LIGAND BINDING DOMAIN#0.9901;PROGENITOR CELL#0.9890;GENE EXPRESSION#0.9870;DNA BINDING#0.9864;STEM CELL#0.9736;OPSIN#0.9699;HUMAN EMBRYONIC STEM#0.9670;EMBRYONIC STEM CELL#0.9662;SIGNALING PATHWAY#0.9536;CELL CYCLE#0.9433;NEURAL RETINA#0.9337;POLYMERASE CHAIN REACTION#0.9298;CANCER CELL#0.9249;GROWTH FACTOR#0.9156;OPTICAL COHERENCE TOMOGRAPHY#0.8948;NUCLEAR LAYER#0.8930;CELL DIFFERENTIATION#0.8864;STROMAL CELL#0.8859;MOUSE EMBRYONIC STEM#0.8826;BLINDNESS#0.8741;NEURAL RETINA LEUCINE#0.8703;CELL PROLIFERATION#0.8703;OUTER NUCLEAR LAYER#0.8658;NIGHT BLINDNESS#0.8584;RETINAL DEVELOPMENT#0.8564;MESENCHYMAL STEM CELL#0.8540;CELL SURFACE#0.8494;RETINAL PIGMENT EPITHELIUM#0.8484;ENDOTHELIAL CELL#0.8429;HYPOXIA#0.8415;PHOTOTRANSDUCTION#0.8344;NEURAL STEM CELL#0.8338;HISTONE MODIFICATION#0.8293;TERATOMA#0.8135;BONE MARROW#0.8114;DECIDUALIZATION#0.8101;EXTRACELLULAR MATRIX#0.8094;LEUCINE#0.8024;BREAST CANCER#0.7820;APOPTOSIS#0.7736;REVERSE TRANSCRIPTION#0.7466;EPITHELIAL CELL#0.7449;CELL DEATH#0.7334;NERVOUS SYSTEM#0.7232;REGENERATION#0.7086;RETINOIC ACID#0.7027;STEM CELL DIFFERENTIATION#0.7015;MACROPHAGE#0.6979;ESTROGEN RECEPTOR#0.6860;CELL FATE DETERMINATION#0.6845;DNA METHYLATION#0.6801;PRECURSOR CELL#0.6790;EMBRYOID BODY#0.6747;INNER CELL MASS#0.6715;EPIBLAST#0.6666;FIBROBLAST GROWTH FACTOR#0.6596;NEURAL PROGENITOR CELL#0.6565;GERM CELL#0.6553;BETA CELL#0.6548;NEURAL CELL#0.6518;LYSINE#0.6298;HEMATOPOIETIC CELL#0.6293;NEURONAL CELLS#0.6263;HEPATOCYTE DIFFERENTIATION#0.6164;PARKINSON'S DISEASE#0.6148;GOOD MANUFACTURING PRACTICE#0.6143;TOXICITY#0.6075
100033819	LIVER CANCER#0.9746;STEM CELL#0.9622;CANCER STEM CELL#0.8215;EPITHELIAL BARRIER FUNCTION#0.6391;MESENCHYMAL STEM CELL#0.6170;CANCER CELL#0.6081
100048905	IFN-GAMMA#0.9004
100048912	ANTISENSE RNA#1.0771;CANCER CELL#1.0489;SIGNALING PATHWAY#1.0457;CYCLIN DEPENDENT KINASE INHIBITOR#1.0451;HEPATOCELLULAR CARCINOMA#1.0434;LUNG CANCER#1.0430;CYCLIN DEPENDENT KINASE#1.0405;KINASE INHIBITOR#1.0390;CELL PROLIFERATION#1.0380;POLYMERASE CHAIN REACTION#1.0359;CELL GROWTH#1.0353;PERIODONTITIS#1.0321;CORONARY ARTERY DISEASE#1.0261;APOPTOSIS#1.0254;ARTERY DISEASE#1.0234;QUANTITATIVE REAL TIME#1.0212;CORONARY ARTERY#1.0190;SQUAMOUS CELL CARCINOMA#1.0165;MYOCARDIAL INFARCTION#1.0135;CELL CYCLE#1.0131;OPEN ANGLE GLAUCOMA#1.0123;ATHEROSCLEROSIS#1.0115;ARTERY#1.0099;PRIMARY OPEN ANGLE GLAUCOMA#1.0084;TYPE 2 DIABETES#1.0016;GENE EXPRESSION#1.0009;PERIPHERAL BLOOD#1.0004;ONCOGENIC#0.9952;DNA METHYLATION#0.9927;TRANSCRIPTION FACTOR#0.9926;TUMOR SUPPRESSOR#0.9906;INTRACRANIAL ANEURYSM#0.9709;LUNG ADENOCARCINOMA#0.9692;LYMPH NODE#0.9656;SMOOTH MUSCLE#0.9608;INFLAMMATORY RESPONSE#0.9594;SENESCENCE#0.9550;HEART DISEASE#0.9548;ATHEROSCLEROTIC#0.9498;CORONARY HEART DISEASE#0.9464;COLORECTAL CANCER#0.9459;DUAL LUCIFERASE REPORTER#0.9433;TUMOR TISSUES#0.9288;REVERSE TRANSCRIPTION#0.9218;EPITHELIAL CELL#0.9218;LYMPH NODE METASTASIS#0.9200;CELL CYCLE ARREST#0.9197;ADENOCARCINOMA#0.9183;DIABETES MELLITUS#0.9151;SMOOTH MUSCLE CELL#0.9101;MUSCLE CELL#0.9093;BREAST CANCER#0.9013;HYPOXIA#0.8989;CELL MIGRATION#0.8968;GROWTH FACTOR#0.8959;ADJACENT NORMAL TISSUE#0.8951;CERVICAL CANCER#0.8845;ENDOTHELIAL CELL#0.8842;CEREBRAL INFARCTION#0.8840;OVARIAN CANCER#0.8806;CISPLATIN#0.8797;LIVER CANCER#0.8583;ENDOMETRIOSIS#0.8515;ACUTE MYELOID LEUKEMIA#0.8442;MYELOID LEUKEMIA#0.8424;POLYCOMB REPRESSIVE COMPLEX#0.8396;HYPERTENSION#0.8296;COLORECTAL#0.8208;VASCULAR SMOOTH MUSCLE CELL#0.8045;PROSTATE CANCER#0.7866;NORMAL TENSION GLAUCOMA#0.7688;SQUAMOUS CELL CANCER#0.7672;OVARIAN#0.7616;RETINOBLASTOMA#0.7615;WNT SIGNALING PATHWAY#0.7562;DIABETIC RETINOPATHY#0.7523;HYPOXIA INDUCIBLE FACTOR#0.7485;GLUCOSE METABOLISM#0.7476;ULCERATIVE COLITIS#0.7439;ACUTE MYOCARDIAL INFARCTION#0.7434;CERVICAL#0.7317;URIC ACID#0.7281;G1 PHASE#0.7270;APOPTOTIC#0.7191;AGGRESSIVE PERIODONTITIS#0.7162;TYPE 2 DIABETES MELLITUS#0.7100;2 DIABETES MELLITUS#0.7100;PROTEIN CODING GENE#0.7065;LOW DENSITY LIPOPROTEIN#0.6877;VASCULAR DISEASE#0.6843;OPTIC NERVE#0.6834;C REACTIVE PROTEIN#0.6719;PRO-INFLAMMATORY#0.6674;TUMOR NECROSIS FACTOR#0.6519;T CELL#0.6501;POLYCOMB REPRESSIVE COMPLEX 1#0.6313;STEM CELL#0.6283;PACLITAXEL#0.6280;CELL ADHESION#0.6278;LIPID METABOLISM#0.6263;ANGIOGENESIS#0.6261;NEPHROPATHY#0.6244;GROWTH REGULATOR#0.6206;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.6108;CAROTID ARTERY STENOSIS#0.6101;THYROID CANCER#0.6091;CAROTID ARTERY#0.6083;VSMC PROLIFERATION#0.6044
100049160	INTENTION TO TREAT#0.6962
100049579	CARNITINE#1.0813;CARNITINE TRANSPORTER#1.0250;CARNITINE TRANSPORT#0.8986;L-CARNITINE#0.8253;MAMMARY GLAND#0.7898;ORGANIC CATION TRANSPORTER#0.7572;PEROXISOMAL MEMBRANE#0.6108
100049587	MYELOID CELL#0.9825;LECTIN#0.9397;INFLAMMATORY RESPONSE#0.8850;SIALIC ACID BINDING#0.8713;IMMUNE RESPONSE#0.7966;MONOCYTE#0.7778;GENE CONVERSION#0.7340;NEUTROPHIL#0.6462;PRO-INFLAMMATORY#0.6379
100049615	EPITHELIAL CELL#1.1799
10004	MUTAGENESIS#0.7419
10005	PALMITOYL-COA HYDROLASE ACTIVITY#1.1367;THIOESTERASE II#1.1340;COA HYDROLASE ACTIVITY#1.1117;ACYL COA THIOESTERASE#1.1044;PALMITOYL COA HYDROLASE#1.0966;COA HYDROLASE#1.0867;HYDROLASE ACTIVITY#1.0728;PALMITOYL#1.0723;PEROXISOMAL#1.0614;CARNITINE#1.0137;PEROXISOME#0.9897;COENZYME A#0.9722;L-CARNITINE#0.9239;ENZYME ACTIVITY#0.9124;MAMMARY GLAND#0.9032;ACYL COA HYDROLASE#0.8908;FATTY ACID SYNTHASE#0.8193;MITOCHONDRIA#0.8141;OLEIC ACID#0.8090;CLOFIBRATE#0.7876;COASH#0.7590;BLOOD PLATELETS#0.7002;GLUCOSE 6 PHOSPHATASE#0.6972;NUCLEOSOME#0.6965;ADIPOSE TISSUE#0.6856;PALMITIC ACID#0.6789;MICROSOME#0.6778;ACYLTRANSFERASE ACTIVITY#0.6749;URATE OXIDASE#0.6569;4'-PHOSPHOPANTETHEINE#0.6509;SYNTHETASE ACTIVITY#0.6500;LIPID METABOLISM#0.6416;FATTY ACID OXIDATION#0.6354;DICARBOXYLIC ACID#0.6316;NUCLEOSOME ASSEMBLY#0.6287;HISTONE CHAPERONE#0.6254;INTRACELLULAR LOCALIZATION#0.6077
10006	WAVE COMPLEX#1.0559;ABA SIGNALING#1.0549;ACTIN CYTOSKELETON#1.0207;CANCER CELL#1.0176;SIGNAL TRANSDUCTION#1.0100;COMPLEX I#1.0041;NUCLEOTIDE EXCHANGE FACTOR#1.0038;ACTIN POLYMERIZATION#1.0005;GROWTH FACTOR#0.9994;CELL MIGRATION#0.9987;STOMATAL CLOSURE#0.9685;COLORECTAL CARCINOMA#0.9601;PROTEIN KINASE#0.9592;OVARIAN CANCER#0.9538;SIGNALING PATHWAY#0.9484;CELL ADHESION#0.9349;GUANINE#0.9316;BREAST CANCER#0.9208;ANION CHANNEL#0.9160;GENE EXPRESSION#0.9105;ABA SIGNAL TRANSDUCTION#0.8889;EPIDERMAL GROWTH FACTOR#0.8816;WISKOTT ALDRICH SYNDROME#0.8629;COLORECTAL#0.8557;GERMINATION#0.8515;ACTIN CYTOSKELETON REMODELING#0.8480;DENDRITIC SPINE#0.8281;KINASE ACTIVITY#0.8023;COLORECTAL CANCER#0.8002;PLASMA MEMBRANE#0.7996;OVARIAN#0.7982;SIGNALLING PATHWAY#0.7945;TRANSCRIPTION FACTOR#0.7710;CELL PROLIFERATION#0.7631;BINDING PROTEIN 1#0.7561;GROWTH FACTOR RECEPTOR#0.7529;MORPHOGENESIS#0.7401;RNA INTERFERENCE#0.7277;REGULATION OF MACROPINOCYTOSIS#0.7261;EXTRACELLULAR MATRIX#0.7117;MACROPINOCYTOSIS#0.7037;ONCOGENIC#0.6928;NERVOUS SYSTEM#0.6914;SEED DORMANCY#0.6812;BREAST CANCER CELL#0.6747;RUFFLE#0.6697;RECEPTOR TYROSINE KINASE#0.6675;ENDOCYTOSIS#0.6576;SEED GERMINATION#0.6495;CAMKII#0.6398;PROTEIN COMPLEX#0.6335;TUMOR SUPPRESSOR#0.6287;KINASE INHIBITOR#0.6237;ACTIN FILAMENT#0.6120;DRUG RESISTANCE#0.6110;HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#0.6106;B CELL#0.6065;Y CHROMOSOME#0.6012
100073347	OUTER MEMBRANE#1.0411;TOM COMPLEX#1.0281;TRANSCRIPTION FACTOR#0.9982;DNA BINDING#0.9429;GENE EXPRESSION#0.8753;MITOCHONDRIAL OUTER MEMBRANE#0.8748;CELL CYCLE#0.8597;TRANSACTIVATION#0.8327;MITOCHONDRIA#0.8244;PROMYELOCYTE#0.8143;APOPTOSIS#0.8079;GRANULOCYTE#0.7337;MITOCHONDRIAL MEMBRANE#0.7025;TOB COMPLEX#0.6861;CANCER CELL#0.6852;COMPLEX I#0.6754;SAM COMPLEX#0.6743;T CELL#0.6691;NEUTROPHIL#0.6686;ENHANCER BINDING PROTEIN#0.6452;ENHANCER BINDING#0.6447;ABT-263#0.6423;POLYMORPHONUCLEAR LEUKOCYTES#0.6155;HEMATOPOIETIC CELL#0.6128
10007	GLUCOSAMINE 6-PHOSPHATE#1.0851;GLUCOSAMINE#1.0670;FRUCTOSE -6-PHOSPHATE#1.0427;GLCNAC#1.0135;FRUCTOSE#1.0130;CATABOLISM#0.8588;GLUCOSE-6-PHOSPHATE#0.7863;FERTILIZATION#0.7353;CELL WALL#0.7251;GLYCOSYLATION#0.6709;GLUTAMINE#0.6647;2-DEOXY-D-GLUCOSE#0.6486;SPERMATOZOA#0.6445;PLASMA MEMBRANE#0.6400;OOCYTE#0.6371;ACROSOME REACTION#0.6210;DEAMINASE ACTIVITY#0.6157;N ACETYLGLUCOSAMINE KINASE#0.6124
10008	POTASSIUM CHANNEL#1.0219;PARALYSIS#0.9960;ION CHANNEL#0.9544;ACTION POTENTIAL#0.9001;ARRHYTHMIA#0.8922;SKELETAL MUSCLE#0.8687;EPITHELIAL CELL#0.8635;CHANNEL ACTIVITY#0.8484;OOCYTE#0.8476;ATRIAL FIBRILLATION#0.8178;CYSTIC FIBROSIS#0.7941;INNER EAR#0.7319;LONG QT SYNDROME#0.6967;SMALL INTESTINE#0.6895;BRUGADA SYNDROME#0.6230;LIPID RAFT#0.6067
100093630	CELL PROLIFERATION#0.9502;APOPTOSIS#0.9389;CELL CYCLE#0.8700;CANCER CELL#0.7317;SMALL NUCLEOLAR RNA#0.7166;DUAL LUCIFERASE REPORTER#0.6698;FASTING BLOOD GLUCOSE#0.6683;CELL COUNTING KIT#0.6669;PANCREATIC ADENOCARCINOMA#0.6114;ENDOMETRIAL CARCINOMA#0.6105;CEREBRAL ISCHEMIA#0.6027
10009	LUNG CANCER#1.0825;CANCER CELL#1.0617;ZINC FINGER PROTEIN#1.0590;TRANSCRIPTION FACTOR#1.0521;DNA BINDING#1.0369;BREAST CANCER#1.0363;GENE EXPRESSION#1.0361;CELL CYCLE#1.0265;CELL PROLIFERATION#1.0183;DNA METHYLATION#1.0084;METHYL CPG BINDING#0.9843;ENDOTHELIAL CELL#0.9667;LYMPH NODE#0.9584;BREAST CANCER CELL#0.9311;SIGNALING PATHWAY#0.9218;APOPTOSIS#0.8836;PROSTATE CANCER#0.8554;COLON CANCER#0.8527;CYTOPLASM#0.8370;CELL ADHESION#0.8226;NUCLEAR EXPORT#0.8215;EPITHELIAL CELL#0.7804;NUCLEAR IMPORT#0.7643;LYMPH NODE METASTASES#0.7606;EPITHELIAL MESENCHYMAL TRANSITION#0.7421;HUMAN CORNEAL ENDOTHELIAL#0.7175;CELL MIGRATION#0.7005;5-AZA-2'-DEOXYCYTIDINE#0.6940;2'-DEOXYCYTIDINE#0.6934;ELECTROPHORETIC MOBILITY SHIFT#0.6876;APOPTOTIC#0.6795;TUMOR SUPPRESSOR#0.6695;TRANSCRIPTION REPRESSOR#0.6358;INTESTINAL CANCER#0.6319;P53 BINDING#0.6188;SECRETORY CELL#0.6174;CELL DIFFERENTIATION#0.6158;INVASIVE BREAST CANCER#0.6126;INTESTINAL EPITHELIAL CELL#0.6086;CHRONIC MYELOID LEUKEMIA#0.6053
1000	ADH-1#1.0864;VSMC APOPTOSIS#1.0593;CADHERIN BINDING#1.0572;ZONULA OCCLUDENS 1#1.0518;ZONULA OCCLUDENS#1.0446;OSTEOBLAST DIFFERENTIATION#1.0295;INTERCALATED DISK#1.0260;INTERCALATED DISC#1.0175;CONNEXIN#1.0162;MYOBLAST#1.0160;SCHWANN CELL#1.0158;MYOGENESIS#1.0154;CATENIN COMPLEX#1.0151;NEURONAL MIGRATION#1.0150;OSTEOBLAST#1.0148;PROLIFERATING CELL NUCLEAR ANTIGEN#1.0147;AXON GROWTH#1.0143;SMOOTH MUSCLE ACTIN#1.0134;DENDRITIC SPINE#1.0132;CHONDROGENESIS#1.0127;PERICYTE#1.0110;ENDOCYTOSIS#1.0109;NEURAL CELL#1.0081;MYOBLAST FUSION#1.0073;NEURITE OUTGROWTH#1.0068;CELL AGGREGATION#1.0067;SOMITE#1.0063;GROWTH CONE#1.0060;E BOX BINDING#1.0058;NEURAL RETINA#1.0052;GRANULOSA CELL#1.0049;NEURITE#1.0046;ASTROCYTE#1.0042;CORNEAL ENDOTHELIUM#1.0027;MAP KINASE#1.0023;SMOOTH MUSCLE#1.0022;CELL-CELL ADHESION MOLECULE#1.0018;BONE FORMATION#1.0014;SMOOTH MUSCLE CELL#1.0012;SCIATIC NERVE#1.0009;NEURAL CREST CELL#1.0000;TIGHT JUNCTION PROTEIN#0.9999;NEURAL CREST#0.9996;CARDIOMYOCYTE#0.9987;MUSCLE CELL#0.9980;NEURAL TUBE#0.9980;SYNAPTOGENESIS#0.9979;VASCULAR SMOOTH MUSCLE CELL#0.9976;CELL CELL JUNCTION#0.9975;STEM CELL MARKER#0.9969;CELL MEMBRANE#0.9956;CONTACT SITE#0.9955;ENDOMETRIUM#0.9953;HEMATOPOIETIC STEM CELL#0.9944;GLIAL CELL#0.9944;SERTOLI CELL#0.9941;TROPHOBLAST CELL#0.9933;ACTIN FILAMENT#0.9929;CELL JUNCTION#0.9921;MYOFIBRIL#0.9920;PROTEIN TYROSINE PHOSPHATASE#0.9919;MELANOCYTE#0.9919;ENDOTHELIUM#0.9913;CELL POLARITY#0.9909;RETINAL GANGLION CELL#0.9908;MESENCHYME#0.9906;MESENCHYMAL CELL#0.9899;KERATINOCYTE#0.9892;ENDOTHELIAL GROWTH FACTOR#0.9891;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9891;MESENCHYMAL TO EPITHELIAL TRANSITION#0.9889;SKELETAL MUSCLE#0.9887;ADHERENS JUNCTION#0.9882;BREAST CARCINOMA#0.9878;GAP JUNCTION#0.9878;MYOCYTES#0.9871;CONTACT INHIBITION#0.9870;MYOFIBROBLAST#0.9866;PROTEIN KINASE B#0.9866;FIBROBLAST GROWTH FACTOR#0.9864;SPINAL CORD#0.9857;PLASMA MEMBRANE#0.9856;PROTEIN KINASE C#0.9850;BLOOD TESTIS BARRIER#0.9842;CELL ADHESION MOLECULE#0.9841;CELL SURFACE#0.9840;CLEAVED CASPASE 3#0.9839;CELL MATRIX ADHESION#0.9839;B CELL#0.9833;INTERCELLULAR JUNCTION#0.9832;HEPATOCYTE GROWTH FACTOR#0.9831;DESMOSOME#0.9831;VSMC PROLIFERATION#0.9830;FOCAL ADHESION KINASE#0.9828;GROWTH FACTOR RECEPTOR#0.9828;MESOTHELIAL CELL#0.9825;LUNG ADENOCARCINOMA#0.9821;CELL CELL ADHESION#0.9821;EXCITATORY SYNAPSE#0.9818;STRESS FIBER#0.9813;TIGHT JUNCTION#0.9813;CYCLIN DEPENDENT KINASE#0.9813;GERM CELL#0.9813;BONE MORPHOGENETIC PROTEIN#0.9810;CELL MOTILITY#0.9809;LIPID RAFT#0.9803;MELANOMA CELL LINES#0.9802;NEURAL STEM CELL#0.9797;COLLAGEN TYPE I#0.9789;MESENCHYMAL EPITHELIAL TRANSITION#0.9788;EMBRYONIC STEM CELL#0.9779;FOCAL ADHESION#0.9777;NEURITE GROWTH#0.9774;ANDROGEN RECEPTOR#0.9767;CELL ADHESION#0.9760;HYPOXIA#0.9756;CELL DIVISION#0.9754;BASEMENT MEMBRANE#0.9753;CERVICAL#0.9749;CYTOPLASM#0.9748;CERVICAL CANCER#0.9748;NEURAL PLATE#0.9747;NEURONAL CELLS#0.9746;MICROTUBULE#0.9746;ESTROGEN RECEPTOR#0.9743;TROPHOBLAST#0.9742;MAPK SIGNALING#0.9741;ENDOMETRIAL CARCINOMA#0.9735;NEURITE EXTENSION#0.9734;ACTIN CYTOSKELETON#0.9733;CORNEAL ENDOTHELIAL CELL#0.9732;HYPOXIA INDUCIBLE FACTOR#0.9729;SIGNALING MOLECULE#0.9729;ENDOTHELIAL CELL#0.9724;CELL DIFFERENTIATION#0.9721;MORPHOGENESIS#0.9718;STROMA#0.9715;RECURRENCE FREE SURVIVAL#0.9714;BREAST CANCER PATIENTS#0.9713;HYPOXIC#0.9710;REVERSE TRANSCRIPTION#0.9709;MYOCARDIUM#0.9709;RNA INTERFERENCE#0.9707;PROGENITOR CELL#0.9700;GANGLION CELLS#0.9698;BLOOD VESSEL#0.9696;ENDOPLASMIC RETICULUM#0.9695;CHOLANGIOCARCINOMA#0.9693;SIGNAL TRANSDUCTION#0.9693;TUMOR TISSUES#0.9692;GASTRULATION#0.9688;T CELL#0.9688;QUANTITATIVE REVERSE TRANSCRIPTION#0.9686;RENAL CELL CARCINOMA#0.9684;ORAL SQUAMOUS CELL CARCINOMA#0.9682;SIGNALLING PATHWAY#0.9679;KINASE ACTIVITY#0.9678;LYMPH NODE METASTASES#0.9675;OVARIAN#0.9673;MULTIPLE MYELOMA#0.9672;BONE MARROW#0.9670;MACROPHAGE#0.9669;CEREBRAL CORTEX#0.9667;CENTRAL NERVOUS SYSTEM#0.9666;SIGNALING CASCADE#0.9666;OVARIAN CARCINOMA#0.9662;CARDIOMYOPATHY#0.9661;G1 PHASE#0.9660;TUBE FORMATION#0.9658;PANCREATIC CANCER#0.9653;KINASE INHIBITOR#0.9651;ADJACENT NORMAL TISSUE#0.9650;CISPLATIN#0.9649;AKT SIGNALING#0.9648;COLON CANCER#0.9645;LUNG CARCINOMA#0.9645;STROMAL CELL#0.9641;PROSTATE CANCER#0.9641;RECEPTOR TYROSINE KINASE#0.9637;FOLLICLE STIMULATING HORMONE#0.9636;MESENCHYMAL STEM CELL#0.9632;ALZHEIMER'S DISEASE#0.9629;ANGIOGENESIS#0.9629;OVARIAN CANCER#0.9628;EPIDERMAL GROWTH FACTOR#0.9628;TRANSCRIPTION FACTOR#0.9626;ADENOCARCINOMA#0.9626;S PHASE#0.9623;MITOGEN ACTIVATED PROTEIN#0.9622;APOPTOTIC#0.9620;GENE SILENCING#0.9619;CONNECTIVE TISSUE#0.9618;REGENERATION#0.9615;NERVOUS SYSTEM#0.9612;HUMAN BREAST CANCER#0.9612;B CELL LYMPHOMA#0.9610;CELL MOVEMENT#0.9609;POLYMERASE CHAIN REACTION#0.9609;CELL DEATH#0.9608;SIGNAL TRANSDUCER#0.9607;TRANSFORMING GROWTH FACTOR BETA#0.9602;GENE EXPRESSION#0.9601;CHONDROCYTE#0.9600;PROTEIN KINASE#0.9600;EPITHELIAL CELL#0.9595;WNT SIGNALING PATHWAY#0.9594;NUCLEUS PULPOSUS#0.9594;MAMMARY EPITHELIAL CELL#0.9593;TUMOR NECROSIS FACTOR#0.9593;EXTRACELLULAR MATRIX#0.9590;HEART DEVELOPMENT#0.9589;EPITHELIAL TO MESENCHYMAL#0.9589;MYOTUBE#0.9589;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9589;SPERMATOGENESIS#0.9586;HEPATOCELLULAR CARCINOMA CELL#0.9585;TUMOR CELLS#0.9583;BREAST CANCER CELL#0.9581;COMPLEX I#0.9579;GLYCOGEN SYNTHASE KINASE#0.9577;COLONY FORMATION ASSAY#0.9575;REACTIVE OXYGEN SPECIES#0.9573;GROWTH FACTOR#0.9572;LYMPH NODE METASTASIS#0.9572;AMYLOID PRECURSOR PROTEIN#0.9572;GLYCOSYLATION#0.9570;CANCER STEM CELL#0.9568;LIVER CANCER#0.9565;AUTOPHAGY#0.9565;STEM CELL#0.9564;SQUAMOUS CELL CARCINOMA#0.9563;DRUG RESISTANCE#0.9558;LUNG METASTASIS#0.9557;TRANSFORMING GROWTH FACTOR#0.9552;LYMPH NODE#0.9552;CELL MIGRATION#0.9552;EPITHELIAL MESENCHYMAL TRANSFORMATION#0.9549;QUANTITATIVE REAL TIME#0.9549;BREAST CANCER#0.9547;DUAL LUCIFERASE REPORTER#0.9546;EPITHELIAL MESENCHYMAL TRANSITION#0.9545;CELL GROWTH#0.9534;CELL COUNTING KIT#0.9534;DISEASE FREE SURVIVAL#0.9530;CELL CYCLE ARREST#0.9529;HISTOGENESIS#0.9523;ONCOGENIC#0.9521;ENDOMETRIAL CANCER#0.9516;TOXICITY#0.9508;PROTEOGLYCAN#0.9507;PERIPHERAL NERVE#0.9505;OSTEOGENESIS#0.9500;LUNG CANCER#0.9500;BLADDER CARCINOMA#0.9493;PLURIPOTENT STEM CELL#0.9492;HUMAN PANCREATIC CANCER#0.9492;PROTEIN COMPLEX#0.9491;CELL CYCLE#0.9487;COLORECTAL#0.9487;EPITHELIAL OVARIAN CANCER#0.9485;SYNAPTIC JUNCTION#0.9480;ALKALINE PHOSPHATASE#0.9477;TUMOR SUPPRESSOR#0.9477;COLORECTAL CANCER#0.9476;CANCER RELATED DEATH#0.9474;CANCER CELL#0.9473;APOPTOSIS#0.9472;INSULIN-LIKE GROWTH FACTOR#0.9470;HEPATOCELLULAR CARCINOMA#0.9461;SIGNALING PATHWAY#0.9459;NERVE FIBER#0.9446;PERIPHERAL NERVOUS SYSTEM#0.9444;CELL PROLIFERATION#0.9440;INTRAHEPATIC CHOLANGIOCARCINOMA#0.9437;TRANSCRIPTASE#0.9436;WOUND HEALING#0.9428;RETINAL PIGMENT EPITHELIAL#0.9419;NMDA RECEPTOR#0.9412;RETINOIC ACID#0.9411;NEURULATION#0.9407;TESTOSTERONE#0.9403;PANCREATIC DUCTAL ADENOCARCINOMA#0.9402;ENDOMETRIOSIS#0.9399;LYSINE#0.9394;MOUSE EMBRYONIC STEM#0.9393;AMPA RECEPTOR#0.9382;CYTOTOXICITY#0.9373;NEURAL PROGENITOR CELL#0.9371;NEUROGENESIS#0.9367;TISSUE MORPHOGENESIS#0.9361;HISTONE DEACETYLASE#0.9352;TYROSINE KINASE INHIBITOR#0.9344;RAPAMYCIN#0.9333;ESTRADIOL#0.9330;PULMONARY FIBROSIS#0.9322;TRANSMISSION ELECTRON MICROSCOPY#0.9314;STEM CELL LIKE#0.9310;NEUROBLASTOMA#0.9303;FOREBRAIN#0.9302;ESOPHAGEAL CANCER#0.9297;AGGRESSIVE BEHAVIOR#0.9294;TUBULAR EPITHELIAL CELL#0.9294;GALECTIN#0.9290;PROGESTERONE#0.9290;THYROID CARCINOMA#0.9288;OOCYTE#0.9264;CHEMOKINE RECEPTOR#0.9259;BRAIN DEVELOPMENT#0.9256;PRECURSOR CELL#0.9254;FORMALIN#0.9232;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9220;THYROID CANCER#0.9211;MECHANISM OF ACTION#0.9211;CIRCULATING TUMOR CELL#0.9210;M PHASE#0.9199;OLIGODENDROCYTE#0.9195;CARDIAC MUSCLE#0.9194;TARGET OF RAPAMYCIN#0.9185;ACTIN BINDING#0.9179;NERVE GROWTH FACTOR#0.9169;LONG TERM POTENTIATION#0.9158;MICROVASCULAR ENDOTHELIAL CELL#0.9148;YOLK SAC#0.9145;EXHERIN#0.9143;REPORTER GENE ASSAY#0.9139;CALCIUM CHANNEL#0.9126;CILIARY GANGLION#0.9110;METFORMIN#0.9089;UBIQUITIN#0.9087;DNA BINDING#0.9079;ARRHYTHMIA#0.9071;INDUCED PLURIPOTENT STEM CELL#0.9067;MYELINATION#0.9066;ACTIN-N#0.9065;DILATED CARDIOMYOPATHY#0.9060;BASAL CELL#0.9048;LUCIFERASE ACTIVITY#0.9041;PLATELET-DERIVED GROWTH FACTOR#0.9040;INTERSTITIAL CELL#0.9012;METASTATIC MELANOMA#0.9009;GLUTAMATE RECEPTOR#0.9009;DEDIFFERENTIATION#0.9007;LEYDIG CELL#0.9002;L-LYSINE#0.8999;LUMINAL#0.8997;LOCALISATION#0.8996;MALIGNANT MESOTHELIOMA#0.8995;UMBILICAL CORD#0.8994;BASAL ES#0.8982;ANCHORAGE INDEPENDENT GROWTH#0.8979;MICROFILAMENT#0.8969;PROSTATE CARCINOMA#0.8969;PROTEIN SYNTHESIS#0.8965;GLUTAMATERGIC SYNAPSE#0.8965;SYNAPTIC CLEFT#0.8962;LEUKOCYTE#0.8956;TONGUE SQUAMOUS CELL CARCINOMA#0.8953;INTERMEDIATE FILAMENT#0.8922;IMMUNE RESPONSE#0.8921;RETINAL DEVELOPMENT#0.8913;CELL COMMUNICATION#0.8909;DOMINANT NEGATIVE MUTANT#0.8909;ISCHEMIA#0.8899;MESENCHYMAL STROMAL CELL#0.8884;MEMBRANE RUFFLE#0.8860;METASTATIC BREAST CANCER#0.8851;PERIPHERAL BLOOD#0.8839;SURFACE EPITHELIUM#0.8822;OPTIC NERVE#0.8819;INVASIVE BREAST CANCER#0.8798;CANCER ASSOCIATED FIBROBLASTS#0.8785;GESTATION#0.8771;ARTERY#0.8748;FLOW CYTOMETRY ANALYSIS#0.8740;LECTIN#0.8714;GASTROINTESTINAL STROMAL TUMOR#0.8693;NOTCH SIGNALING PATHWAY#0.8681;PROSTATE SPECIFIC ANTIGEN#0.8677;HEAD AND NECK CANCER#0.8675;NECK CANCER#0.8675;SCANNING ELECTRON MICROSCOPY#0.8674;ANOIKIS#0.8669;EPHRIN#0.8655;NEUROBLAST#0.8651;TRANSACTIVATION#0.8648;HOST CELL#0.8640;TRADITIONAL CHINESE MEDICINE#0.8638;NEUROLIGIN#0.8622;OVARIAN SURFACE EPITHELIAL#0.8619;BLOOD BRAIN BARRIER#0.8612;T CELL FACTOR#0.8609;NEUROEPITHELIAL CELL#0.8606;LENS DEVELOPMENT#0.8597;SYNAPTIC VESICLE#0.8583;HIGH MOBILITY GROUP#0.8574;EPENDYMAL CELL#0.8566;EPITHELIAL STEM CELL#0.8554;ORGANOGENESIS#0.8552;NEUROFILAMENT#0.8549;EPIBLAST#0.8541;MESODERM CELL#0.8532;PIGMENT EPITHELIAL CELL#0.8517;INHIBITION OF CELL MIGRATION#0.8516;PACLITAXEL#0.8507;GLIOBLASTOMA MULTIFORME#0.8500;SPERMATOCYTES#0.8495;N GLYCAN#0.8493;INVASIVE CARCINOMA#0.8488;TO TUMOR PROGRESSION#0.8487;COLORECTAL CARCINOMA#0.8482;GROWTH PATTERN#0.8480;UMBILICAL VEIN#0.8472;EPIBLAST CELL#0.8464;BONE MARROW STROMAL#0.8457;ENDOMETRIAL EPITHELIAL CELLS#0.8449;TRANSDIFFERENTIATION#0.8448;DORSAL ROOT GANGLION#0.8447;CELLULAR LOCALIZATION#0.8440;NUCLEUS PULPOSUS CELL#0.8435;MYOCARDIAL INFARCTION#0.8430;HEMATOPOIESIS#0.8424;RETINAL PIGMENT EPITHELIAL CELLS#0.8406;ACTOMYOSIN#0.8385;LEUKEMIC STEM CELL#0.8384;AXON GUIDANCE#0.8384;HUMAN MESENCHYMAL STEM#0.8371;HUMAN CORNEAL ENDOTHELIAL#0.8369;LOCOMOTION#0.8363;PHOTORECEPTOR CELL#0.8361;HUMAN UMBILICAL VEIN#0.8357;INDUCTION OF APOPTOSIS#0.8355;NUCLEOTIDE EXCHANGE FACTOR#0.8354;TERMINAL DIFFERENTIATION#0.8341;DERMAL FIBROBLAST#0.8338;MARROW STROMAL CELLS#0.8335;BONE MARROW STROMAL CELL#0.8335;NEURON MIGRATION#0.8334;OVARIES#0.8333;CELL ADHESION COMPLEX#0.8327;YEAR SURVIVAL RATE#0.8317;ASTROCYTOMA#0.8316;PLANAR CELL POLARITY#0.8305;MITOCHONDRIA#0.8294;MUTAGENESIS#0.8293;TECTUM#0.8274;ANCHORING#0.8272;AQUAPORIN#0.8270;TERATOMA#0.8259;HISTONE DEACETYLASE INHIBITOR#0.8258;STEM CELL DIFFERENTIATION#0.8256;MYOGENIC CELL#0.8252;RETINOBLASTOMA#0.8239;PHOSPHATASE AND TENSIN HOMOLOG#0.8239;ACTION POTENTIAL#0.8238;OVARIAN SURFACE EPITHELIUM#0.8235;KINESIN#0.8233;ADHERENS JUNCTION FORMATION#0.8229;SODIUM CHANNEL#0.8199;ACTIN POLYMERIZATION#0.8195;UROKINASE#0.8191;DNA METHYLATION#0.8173;EOSIN#0.8171;LEUCINE#0.8164;CORNEAL EPITHELIAL CELL#0.8162;EMBRYONIC HEART#0.8148;EYE DEVELOPMENT#0.8148;PURKINJE CELL#0.8142;GEMCITABINE#0.8123;COLLAGEN TYPE IV#0.8120;COLON CARCINOMA#0.8118;DOXORUBICIN#0.8091;QUIESCENCE#0.8064;RADIAL GLIAL CELL#0.8050;PAPILLARY THYROID CARCINOMA#0.8032;MAMMARY GLAND#0.8017;TUMOR NODE METASTASIS#0.8016;CHONDROCYTE DIFFERENTIATION#0.8012;METASTATIC PROSTATE CANCER#0.8011;KIDNEY DISEASE#0.8005;JUXTAMEMBRANE#0.7993;CELL BODY#0.7990;TISSUE HOMEOSTASIS#0.7986;OVERALL SURVIVAL RATE#0.7980;CELL PERIPHERY#0.7970;OLFACTORY EPITHELIUM#0.7951;PHOSPHATASE ACTIVITY#0.7944;POLY ADP RIBOSE#0.7939;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7938;ENDOCRINE CELL#0.7929;HYALURONAN#0.7918;SPHINGOSINE#0.7910;SKIN CANCER#0.7906;PRO-INFLAMMATORY#0.7903;CELL ELONGATION#0.7895;EPITHELIAL OVARIAN CARCINOMA#0.7890;PROXIMAL TUBULAR EPITHELIAL#0.7867;CARDIAC DEVELOPMENT#0.7861;CELL DEVELOPMENT#0.7851;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY#0.7851;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7843;VASCULAR ENDOTHELIAL CADHERIN#0.7837;LARYNGEAL CARCINOMA#0.7836;HOMOPHILIC CELL ADHESION#0.7833;INFLAMMATORY RESPONSE#0.7830;HEAT SHOCK PROTEIN#0.7828;NON-SMALL CELL LUNG CARCINOMA#0.7828;5-AZA-2'-DEOXYCYTIDINE#0.7825;TOLL LIKE RECEPTOR#0.7825;2'-DEOXYCYTIDINE#0.7821;EMBRYO IMPLANTATION#0.7808;DEPHOSPHORYLATION#0.7801;CANCER STEM-LIKE CELL#0.7794;PANCREATIC CARCINOMA#0.7783;SOMITOGENESIS#0.7778;CORD BLOOD#0.7771;PROGRAMMED CELL DEATH#0.7769;OSTEOARTHRITIS#0.7753;LIVER METASTASIS#0.7750;IMMUNE CELL#0.7742;TISSUE REGENERATION#0.7741;ACTIN BINDING PROTEIN#0.7728;RELAPSE FREE SURVIVAL#0.7726;AXON EXTENSION#0.7720;LEUCINE RICH REPEAT#0.7711;APICAL ES#0.7706;HEPATIC STELLATE CELL#0.7705;QUERCETIN#0.7697;CYTOSKELETON ORGANIZATION#0.7695;INTEGRIN LINKED KINASE#0.7691;SYNAPTIC TRANSMISSION#0.7689;NEURAL FOLD#0.7684;FACTOR I#0.7683;PROTEIN PROTEIN INTERACTION#0.7667;INFLAMMATORY CELL#0.7656;SPERMATOZOA#0.7651;EXOSOME#0.7647;CELL FUSION#0.7639;GUANINE#0.7629;ADENOMATOUS POLYPOSIS COLI#0.7619;BETA CATENIN BINDING#0.7618;FILAMENTOUS ACTIN#0.7608;OLFACTORY BULB#0.7605;EXTRACELLULAR REGION#0.7600;COLLAGEN TYPE II#0.7598;SRC FAMILY KINASE#0.7594;EPITHELIAL TISSUES#0.7584;RESVERATROL#0.7578;EMBRYO DEVELOPMENT#0.7566;HEPATOMA CELLS#0.7558;SPHINGOSINE 1 PHOSPHATE#0.7556;HYALURONIC ACID#0.7546;SENESCENCE#0.7540;NEURAL TUBE CLOSURE#0.7533;TUBE CLOSURE#0.7532;EXTRACELLULAR MATRIX COMPONENT#0.7531;CARDIOMYOCYTE DIFFERENTIATION#0.7527;MALIGNANT GLIOMA#0.7524;HUMAN EMBRYONIC STEM#0.7524;VASCULAR CELL#0.7519;CRANIAL NEURAL CREST#0.7509;72-HOURS#0.7502;PROTEIN TYROSINE KINASE#0.7499;NOTOCHORD#0.7497;ROS GENERATION#0.7495;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.7484;HUMAN MAMMARY EPITHELIAL#0.7479;NITRIC OXIDE#0.7461;CANCER SPECIFIC SURVIVAL#0.7455;ANTISENSE RNA#0.7453;TEMOZOLOMIDE#0.7450;METASTATIC LYMPH NODE#0.7441;HUMAN BRONCHIAL EPITHELIAL#0.7439;NEUROENDOCRINE CARCINOMA#0.7431;DELAMINATION#0.7428;LIMB DEVELOPMENT#0.7428;MONOCYTE#0.7427;CELL CYCLE REGULATOR#0.7424;BRONCHIAL EPITHELIAL CELLS#0.7423;BETA CELL#0.7421;UMBILICAL CORD BLOOD#0.7421;GASTRIC MUCOSA#0.7411;CERVICAL SQUAMOUS CELL CARCINOMA#0.7406;CHOROID PLEXUS#0.7403;CELLULAR PROCESS#0.7402;5 FLUOROURACIL#0.7399;LUNG DISEASE#0.7396;GLUTATHIONE#0.7392;POSTSYNAPTIC DENSITY#0.7382;NEURAL CREST CELL MIGRATION#0.7382;PROTEIN KINASE A#0.7371;YES ASSOCIATED PROTEIN#0.7363;ADULT RAT CARDIOMYOCYTES#0.7363;MUSCLE FIBER#0.7362;RELATED PROTEIN 1#0.7360;GOBLET CELL#0.7342;MYOSIN HEAVY CHAIN#0.7337;ENHANCER BINDING#0.7337;MURAL CELL#0.7331;CAMKII#0.7330;PRIMITIVE STREAK#0.7303;SPECIFIC PROTEIN 1#0.7297;ETHANOL#0.7289;CNS DEVELOPMENT#0.7288;CENTROSOME#0.7281;POSTSYNAPTIC MEMBRANE#0.7277;APOPTOTIC CELL DEATH#0.7268;PHOSPHOLIPASE C#0.7267;RUFFLE#0.7265;MEMBRANE TYPE 1#0.7261;LENS MORPHOGENESIS#0.7253;PRESYNAPTIC TERMINAL#0.7241;ENDOSOME#0.7228;AIRWAY EPITHELIUM#0.7226;LUNG EPITHELIAL CELL#0.7217;17β-ESTRADIOL#0.7216;TO THE PROGRESSION#0.7214;RETINAL PIGMENT EPITHELIUM#0.7209;TYROSINE KINASE RECEPTOR#0.7205;HAIR CELL#0.7201;FLUOROURACIL#0.7194;CARCINOMA IN SITU#0.7193;ADENOSINE#0.7192;TOXICANT#0.7145;IDIOPATHIC PULMONARY FIBROSIS#0.7141;MAST CELL#0.7127;RECEPTOR ANTAGONIST#0.7118;HEART MUSCLE#0.7108;DUCTAL EPITHELIAL CELLS#0.7105;TAMOXIFEN#0.7100;NEPHRON#0.7095;RIBOSE#0.7089;ION CHANNEL#0.7084;ALKALINE PHOSPHATASE ACTIVITY#0.7068;HOMOTYPIC CELL-CELL ADHESION#0.7065;ZONULA ADHERENS#0.7057;CYTOSKELETAL ELEMENT#0.7057;BILE DUCT#0.7051;BIOTIN#0.7051;SYNAPTIC MEMBRANE#0.7051;MICROTUBULE ASSOCIATED PROTEIN#0.7046;BRAIN ENDOTHELIAL CELL#0.7045;MYOBLAST DIFFERENTIATION#0.7035;SYNAPSE DEVELOPMENT#0.7035;OSTEOSARCOMA CELL LINES#0.7033;COLUMNAR#0.7032;CYTOPLASMIC REGION#0.7019;VASCULAR MORPHOGENESIS#0.7012;GEFITINIB#0.7008;CORNEAL EPITHELIUM#0.7002;PAPILLARY THYROID CANCER#0.7002;EMBRYONAL CARCINOMA#0.7000;INVASIVE DUCTAL CARCINOMA#0.6996;ONCOGENESIS#0.6993;LENS VESICLE#0.6989;CLEAR CELL RENAL CELL CARCINOMA#0.6988;BASAL LAMINA#0.6988;PYRAMIDAL CELL#0.6982;MACROPINOSOME#0.6970;METHYLATION SPECIFIC PCR#0.6969;INTERNEURON#0.6967;GONAD#0.6951;ELECTROPHORETIC MOBILITY SHIFT#0.6927;SYSTEM DEVELOPMENT#0.6924;ASCITES#0.6918;LASER SCANNING MICROSCOPY#0.6915;RENAL FIBROSIS#0.6888;GASTRIC EPITHELIAL CELLS#0.6867;NEGATIVE CONTROL GROUP#0.6865;TROPHECTODERM#0.6863;EDEMA#0.6863;TISSUE DEVELOPMENT#0.6859;PROTEASOME#0.6842;ERLOTINIB#0.6839;RNA BINDING#0.6838;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.6824;CELL MORPHOGENESIS#0.6822;ZINC FINGER PROTEIN#0.6821;AXON TERMINAL#0.6819;MOUSE EMBRYONIC FIBROBLAST#0.6817;MESOTHELIOMA CELL#0.6814;ANTISENSE MORPHOLINO OLIGONUCLEOTIDE#0.6808;ENDMT#0.6797;HEMATOPOIETIC CELL#0.6780;ADVANCED GASTRIC CANCER#0.6778;ICI 182,780#0.6775;ESOPHAGEAL CARCINOMA#0.6775;JUNCTIONAL ADHESION MOLECULE#0.6770;EMBRYONIC BRAIN#0.6769;CYTOCHROME C#0.6760;TESTICULAR DEVELOPMENT#0.6756;ARGININE#0.6748;INSULIN SECRETION#0.6736;NEURAL ECTODERM#0.6722;MAMMARY EPITHELIUM#0.6722;PITUITARY ADENOMA#0.6713;ADHESION BELT#0.6712;TISSUE REMODELING#0.6705;IFN-GAMMA#0.6699;N-ACETYLCYSTEINE#0.6689;ADIPOCYTE#0.6686;DIGESTION#0.6686;BUDDING#0.6679;BONE GROWTH#0.6676;ORAL MUCOSA#0.6674;CIGARETTE SMOKE EXTRACT#0.6666;LYSOSOME#0.6644;MYELOID LEUKEMIA#0.6643;ORAL EPITHELIAL CELLS#0.6635;ADULT STEM CELL#0.6634;MONONUCLEAR CELLS#0.6624;ALVEOLAR EPITHELIAL CELL#0.6615;TRYPTOPHAN#0.6589;CHONDROITIN SULFATE PROTEOGLYCAN#0.6582;SURFACE ECTODERM#0.6582;P38 MAPK SIGNALING#0.6572;OVARIAN SURFACE EPITHELIAL CELL#0.6564;INHIBITION OF LOCOMOTION#0.6552;DISCOIDIN DOMAIN RECEPTOR#0.6538;INVASIVE GROWTH#0.6536;IMMUNE SYSTEM#0.6531;VASCULAR ENDOTHELIUM#0.6524;PEROXISOME#0.6511;VASCULAR ENDOTHELIAL CELL#0.6507;GALLBLADDER#0.6505;INHIBITORY SYNAPSE#0.6502;ORGANELLE#0.6482;CELLULAR ADHESION MOLECULE#0.6479;NEUROPROTECTION#0.6475;PATTERN FORMATION#0.6473;DEXAMETHASONE#0.6453;FLOW CYTOMETRY ASSAY#0.6447;SKELETON#0.6447;OVARIAN FOLLICLE#0.6435;ACTIVATING TRANSCRIPTION FACTOR#0.6434;SALIVARY GLAND#0.6431;INTERVERTEBRAL DISC#0.6431;TISSUE GROWTH FACTOR#0.6426;2'-DEOXYURIDINE#0.6418;NICOTINIC ACETYLCHOLINE RECEPTOR#0.6415;INFLAMMATORY BOWEL DISEASE#0.6414;LITHIUM#0.6401;ACETYLCHOLINE RECEPTOR#0.6392;MODE OF ACTION#0.6392;HIPPOCAMPAL MOSSY FIBER#0.6387;TRANSIENT RECEPTOR POTENTIAL#0.6387;EPITHELIAL PROGENITOR CELL#0.6383;ARACHIDONIC ACID#0.6367;COLLAGENASE#0.6354;METASTASIS FREE SURVIVAL#0.6351;HEART DISEASE#0.6351;INFERTILITY#0.6348;FASCIA ADHERENS#0.6335;RETINAL LAMINATION#0.6331;ACETYLCHOLINE#0.6325;GENE EXPRESSION OMNIBUS#0.6318;BASAL ECTOPLASMIC SPECIALIZATION#0.6318;ATHEROSCLEROSIS#0.6313;AIRWAY EPITHELIAL CELL#0.6301;SORAFENIB#0.6298;PROSTATE EPITHELIAL CELL#0.6282;GENISTEIN#0.6278;BONE MARROW MICROENVIRONMENT#0.6276;ENDOMETRIAL ADENOCARCINOMA#0.6273;HUMAN LIMBAL EPITHELIAL#0.6271;OUTFLOW TRACT#0.6268;MECHANISMS OF ACTION#0.6265;CARDIAC TRABECULATION#0.6254;PANCREATIC ADENOCARCINOMA#0.6253;PLANAR CELL POLARITY PATHWAY#0.6251;QUANTITATIVE REVERSE TRANSCRIPTASE#0.6246;INTRACELLULAR SIGNALING PATHWAY#0.6240;ADIPOSE TISSUE#0.6237;STATUS EPILEPTICUS#0.6229;CYCLIN DEPENDENT KINASE INHIBITOR#0.6226;DNA METHYLTRANSFERASE#0.6218;THYROID TRANSCRIPTION FACTOR#0.6217;EARLY TIME POINT#0.6217;DENTATE GYRUS#0.6209;HEMATOPOIETIC PROGENITOR CELL#0.6201;ADENINE#0.6197;HEMORRHAGE#0.6183;FIBROBLAST ACTIVATION#0.6182;EPITHELIAL CARCINOMA#0.6179;INVASIVE BREAST CARCINOMA#0.6177;APICAL CONSTRICTION#0.6166;DIABETES MELLITUS#0.6162;HATCHING#0.6161;POST-TRANSLATIONAL MODIFICATION#0.6159;TUMOR INITIATING CELL#0.6155;ADENOID CYSTIC CARCINOMA#0.6140;AXON PATHFINDING#0.6140;NORMAL BREAST TISSUE#0.6123;PITUITARY GLAND#0.6100;EXTRACELLULAR SPACE#0.6092;LIMBAL EPITHELIAL CELL#0.6080;SARCOMERE#0.6069;AXONAL GROWTH CONE#0.6065;OSELTAMIVIR PHOSPHATE#0.6054;SMOOTH MUSCLE CELL APOPTOSIS#0.6041;CONSTRICTION#0.6039;DIHYDROTESTOSTERONE#0.6039;HEART FORMATION#0.6037;MUSCLE CELL APOPTOSIS#0.6017;BIOLOGICAL PROCESS#0.6004;ATHEROSCLEROTIC#0.6003;SKIN MELANOMA#0.6001
10010	TANK BINDING KINASE#1.0717;NF-KAPPAB ACTIVATION#1.0535;B CELL#1.0191;SIGNALING PATHWAY#1.0066;TOLL LIKE RECEPTOR#0.9965;INTERFERON REGULATORY FACTOR#0.9958;TUMOR NECROSIS FACTOR#0.9954;UBIQUITIN#0.9698;TRANSCRIPTION FACTOR#0.9587;IMMUNE RESPONSE#0.9207;GENE EXPRESSION#0.9055;APOPTOSIS#0.9011;PROTEIN KINASE#0.8804;SIGNAL TRANSDUCTION#0.8226;INNATE IMMUNITY#0.8105;ANTIVIRAL RESPONSE#0.8059;TYPE I IFN PRODUCTION#0.8055;MACROPHAGE#0.7803;INFLAMMATORY RESPONSE#0.7763;VIRAL INFECTION#0.7724;TRAF SIGNALING#0.7604;INNATE IMMUNE RESPONSE#0.7603;CELL PROLIFERATION#0.7322;SIGNALING CASCADE#0.7317;IFN REGULATORY FACTOR#0.6976;LIPID RAFT#0.6916;APOPTOTIC#0.6761;IKK COMPLEX#0.6750;IKAPPAB KINASE#0.6686;EPSTEIN BARR VIRUS#0.6416;B LYMPHOCYTE#0.6408;BONE MARROW#0.6362;CELL DEATH#0.6360;KINASE ACTIVITY#0.6282;ACTIVATION OF NF-KAPPAB#0.6121;IMMUNE SYSTEM#0.6047
100113403	PRO-INFLAMMATORY#0.9008;INFLAMMATORY RESPONSE#0.8993;MACROPHAGE#0.6424
100113407	BREAST CANCER#1.1796
10011	STEROID RECEPTOR COACTIVATOR#1.0573;RNA BINDING#1.0324;SRA BINDING#1.0303;ESTROGEN RECEPTOR ALPHA#1.0225;BREAST CANCER#1.0193;BREAST CANCER CELL#1.0107;THYROID HORMONE RECEPTOR#1.0070;ANDROGEN RECEPTOR#1.0063;PROGESTERONE#1.0044;TRANSCRIPTION FACTOR#1.0015;CANCER CELL#1.0001;ESTROGEN RECEPTOR#0.9995;GENE EXPRESSION#0.9910;SIGNALING PATHWAY#0.9868;TRANSACTIVATION#0.9787;PROTEIN KINASE#0.9700;OVARIAN#0.9648;MAMMARY GLAND#0.9600;PROSTATE CANCER#0.9499;GLUCOCORTICOID RECEPTOR#0.9482;CELL CYCLE#0.9377;CREB BINDING#0.9364;GROWTH FACTOR#0.9195;CELL PROLIFERATION#0.9151;APOPTOSIS#0.9045;NUCLEAR HORMONE RECEPTOR#0.8971;ESTRADIOL#0.8821;POLYMERASE CHAIN REACTION#0.8753;STEROID HORMONE RECEPTOR#0.8719;TAMOXIFEN#0.8635;RNA HELICASE#0.8626;LIGAND BINDING DOMAIN#0.8625;VITAMIN D RECEPTOR#0.8605;CELL MIGRATION#0.8596;DNA BINDING#0.8572;HISTONE ACETYLTRANSFERASE#0.8233;RECEPTOR INTERACTING PROTEIN#0.7980;REVERSE TRANSCRIPTION#0.7859;MITOGEN ACTIVATED PROTEIN#0.7629;ADIPOCYTE#0.7597;ONCOGENIC#0.7447;UBIQUITIN#0.7445;CELL GROWTH#0.7278;STEM CELL#0.7262;PEROXISOME#0.7177;PSEUDOURIDINE SYNTHASE#0.7146;BREAST CANCER PATIENTS#0.7120;TUMOR SUPPRESSOR#0.7044;RNA INTERFERENCE#0.7015;POLYCYSTIC OVARY SYNDROME#0.6792;INSULIN-LIKE GROWTH FACTOR#0.6791;STEROIDOGENESIS#0.6643;PSEUDOURIDYLATION#0.6639;UTERUS#0.6632;RETINOIC ACID#0.6526;OVARIAN CANCER#0.6522;PROTEASOME#0.6375;ENDOMETRIOSIS#0.6336;ADIPOGENESIS#0.6311;TUMOR TISSUES#0.6297;RECEPTOR ACTIVITY#0.6276;QUANTITATIVE REAL TIME#0.6276;CYCLIN DEPENDENT KINASE#0.6234;CYTOPLASM#0.6222;KERATINOCYTE#0.6151;STROMAL CELL#0.6067;ATHEROSCLEROSIS#0.6066;TRIGLYCERIDE LIPASE#0.6031
100124696	SERUM RESPONSE FACTOR#0.6467;RECEPTOR TYROSINE KINASE#0.6290
100124700	OVARIAN CANCER#1.0683;OVARIAN#1.0631;COLON CANCER#1.0627;RNA INTERFERENCE#1.0625;EPITHELIAL MESENCHYMAL TRANSITION#1.0602;RENAL CELL CARCINOMA#1.0593;BREAST CANCER PATIENTS#1.0573;ANTISENSE RNA#1.0551;LYMPH NODE METASTASIS#1.0504;LUNG CANCER#1.0498;CERVICAL CANCER#1.0495;POLYCOMB REPRESSIVE COMPLEX#1.0481;PROSTATE CANCER#1.0463;CERVICAL#1.0461;CELL MIGRATION#1.0461;HEPATOCELLULAR CARCINOMA#1.0458;QUANTITATIVE REAL TIME#1.0455;AUTOPHAGY#1.0453;TUMOR TISSUES#1.0452;LYMPH NODE#1.0452;CISPLATIN#1.0448;COLORECTAL CANCER#1.0448;CANCER STEM CELL#1.0439;COLORECTAL#1.0435;BREAST CANCER CELL#1.0433;LUNG ADENOCARCINOMA#1.0421;PANCREATIC CANCER#1.0392;EPITHELIAL TO MESENCHYMAL TRANSITION#1.0391;EPITHELIAL TO MESENCHYMAL#1.0389;STEM CELL#1.0363;ONCOGENIC#1.0359;ADENOCARCINOMA#1.0344;SQUAMOUS CELL CARCINOMA#1.0337;DRUG RESISTANCE#1.0330;REVERSE TRANSCRIPTION#1.0324;BREAST CANCER#1.0318;CELL GROWTH#1.0317;POLYMERASE CHAIN REACTION#1.0271;CANCER CELL#1.0258;GENE SILENCING#1.0242;GROWTH FACTOR#1.0237;CELL PROLIFERATION#1.0232;APOPTOSIS#1.0221;SIGNALING PATHWAY#1.0218;EXOSOME#1.0217;LIVER CANCER#1.0189;DUAL LUCIFERASE REPORTER#1.0172;CELL CYCLE#1.0137;DNA METHYLATION#1.0133;DISEASE FREE SURVIVAL#1.0122;RNA BINDING#1.0032;LYSINE#0.9959;TUMOR SUPPRESSOR#0.9943;EPITHELIAL CELL#0.9842;GENE EXPRESSION#0.9821;CELL CYCLE ARREST#0.9799;EXTRACELLULAR MATRIX#0.9778;EPITHELIAL OVARIAN CANCER#0.9728;ENDOMETRIAL CANCER#0.9716;ENDOMETRIAL CARCINOMA#0.9672;CHONDROCYTE#0.9657;TRANSCRIPTION FACTOR#0.9656;QUANTITATIVE REVERSE TRANSCRIPTION#0.9651;MYELOID LEUKEMIA#0.9634;G1 PHASE#0.9611;ADJACENT NORMAL TISSUE#0.9540;CARDIOMYOCYTE#0.9524;ENDOTHELIAL CELL#0.9479;COLONY FORMATION ASSAY#0.9466;PERIPHERAL BLOOD#0.9439;NUCLEUS PULPOSUS#0.9296;TUMOR CELLS#0.9243;GASTRIC ADENOCARCINOMA#0.9230;WOUND HEALING#0.9165;CELL COUNTING KIT#0.9139;RHEUMATOID ARTHRITIS#0.9130;ACUTE MYELOID LEUKEMIA#0.9119;GASTROINTESTINAL STROMAL TUMOR#0.9079;WNT SIGNALING PATHWAY#0.9064;THYROID CARCINOMA#0.9052;ESTROGEN RECEPTOR#0.9039;SIGNALLING PATHWAY#0.9007;APOPTOTIC#0.8981;PROTEIN CODING GENE#0.8906;AKT SIGNALING#0.8903;HUMAN BREAST CANCER#0.8896;REPORTER GENE ASSAY#0.8877;RNA BINDING PROTEIN#0.8872;ORAL SQUAMOUS CELL CARCINOMA#0.8831;PARKINSON'S DISEASE#0.8816;HYPOXIA#0.8795;CHROMATIN ORGANIZATION#0.8736;ANGIOGENESIS#0.8649;TUMOR NECROSIS FACTOR#0.8605;HEPATOCELLULAR CARCINOMA CELL#0.8554;TROPHOBLAST#0.8502;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.8494;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.8485;TUMOR NODE METASTASIS#0.8436;CELL MOTILITY#0.8407;THYROID CANCER#0.8400;BONE MARROW#0.8392;ESOPHAGEAL CANCER#0.8381;INFLAMMATORY RESPONSE#0.8321;LUCIFERASE ACTIVITY#0.8263;ENDOTHELIAL GROWTH FACTOR#0.8177;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8177;LUNG METASTASIS#0.8085;PROTEIN KINASE#0.8048;DEMETHYLATION#0.8024;PRC2 COMPLEX#0.7989;OSTEOARTHRITIS#0.7893;CHROMATIN REMODELING#0.7887;MACROPHAGE#0.7838;B CELL#0.7770;ESTRADIOL#0.7700;HISTONE MODIFICATION#0.7656;GROWTH FACTOR RECEPTOR#0.7634;OESOPHAGEAL SQUAMOUS CELL#0.7616;SENESCENCE#0.7543;DOXORUBICIN#0.7527;T CELL#0.7526;CONGENITAL HEART DISEASE#0.7524;MYOCARDIAL INFARCTION#0.7398;REGULATION OF GENE EXPRESSION#0.7397;CELL DEATH#0.7364;HEART DISEASE#0.7360;RAPAMYCIN#0.7336;INSULIN-LIKE GROWTH FACTOR#0.7329;PROPOFOL#0.7226;TARGET OF RAPAMYCIN#0.7213;GENISTEIN#0.7074;MECHANISM OF ACTION#0.7033;CARDIOMYOPATHY#0.7031;ATHEROSCLEROSIS#0.6986;HISTONE METHYLTRANSFERASE#0.6951;B CELL LYMPHOMA#0.6863;CHROMATIN MODIFICATION#0.6854;NUCLEUS PULPOSUS CELL#0.6853;CIGARETTE SMOKE EXTRACT#0.6820;CANCER STEM-LIKE CELL#0.6800;RENAL CARCINOMA#0.6766;OVARIAN CARCINOMA#0.6743;PRIMARY BREAST CANCER#0.6729;SIGNAL TRANSDUCER#0.6464;GASTRIC TISSUE#0.6324;HUMAN BRONCHIAL EPITHELIAL#0.6290;RETINOBLASTOMA#0.6235;MESENCHYMAL STEM CELL#0.6216;ANDROGEN RECEPTOR#0.6173;SQUAMOUS CELL CANCER#0.6147;LIVER METASTASIS#0.6093;RENAL INTERSTITIAL FIBROSIS#0.6053
100125288	GERM CELL#1.0173;GERM CELL DEVELOPMENT#0.8049;ZINC FINGER PROTEIN#0.7940;CELL DEVELOPMENT#0.7881;GONAD#0.6637
100126270	NEURAL PRECURSOR CELL#0.9168;PRECURSOR CELL#0.9020;GENE EXPRESSION#0.6597;FRAGILE X SYNDROME#0.6295
100126299	TUMOR SUPPRESSOR#1.0378;PROTEIN KINASE#0.9772;CANCER CELL#0.9269;CELL PROLIFERATION#0.8787;DNA METHYLATION#0.8740;PROTEIN KINASE R#0.8024;PROSTATE CANCER#0.7949;APOPTOSIS#0.7281;GENE EXPRESSION#0.7067;CELL DEATH#0.7059;T CELL#0.7038;MAJOR VAULT PROTEIN#0.6653;DIFFERENTIALLY METHYLATED REGION#0.6610;DRUG RESISTANCE#0.6229
100126302	BONE FORMATION#0.6774;CELL DIFFERENTIATION#0.6743
100126306	VENOUS BLOOD#0.7630
100126308	CELL PROLIFERATION#0.6570;VSMC PROLIFERATION#0.6148;NEURITE OUTGROWTH#0.6018;LUNG CARCINOMA#0.6002
100126310	APOPTOSIS#0.7275;ENDOTHELIAL CELL APOPTOSIS#0.6846;BREAST CANCER CELL#0.6605;TUMOR SUPPRESSOR#0.6586;CELL GROWTH#0.6574;ENDOTHELIAL CELL#0.6555;BREAST CANCER#0.6553;CANCER CELL#0.6537
100126311	CELL PROLIFERATION#1.0110;COLORECTAL CANCER#0.6651;LYMPH NODE#0.6469;CELL CYCLE#0.6456;LUNG CANCER#0.6317
100126313	CELL PROLIFERATION#0.9759;SIGNALING PATHWAY#0.9682;CANCER CELL#0.9598;CELL GROWTH#0.8278;HEPATOCELLULAR CARCINOMA#0.7738;POLYMERASE CHAIN REACTION#0.7639;GENE EXPRESSION#0.7558;APOPTOSIS#0.7063;REVERSE TRANSCRIPTION#0.6716;ONCOGENIC#0.6559;TUMOR SUPPRESSOR#0.6291;PANCREATIC CANCER#0.6233;CELL MIGRATION#0.6198;EPITHELIAL CELL#0.6161;STEM CELL#0.6156;CELL CYCLE#0.6082
100126314	CELL PROLIFERATION#0.9236;HEPATOCELLULAR CARCINOMA#0.7461;CERVICAL CANCER#0.6169;CANCER CELL#0.6036
100126315	SIGNALING PATHWAY#1.0670;CELL PROLIFERATION#1.0059;APOPTOSIS#0.9973;CELL GROWTH#0.8333;GASTRIC ADENOCARCINOMA#0.8107;STEM CELL#0.7606;REVERSE TRANSCRIPTION#0.7195;ADENOCARCINOMA#0.6636;QUANTITATIVE REVERSE TRANSCRIPTION#0.6408;EPITHELIAL MESENCHYMAL TRANSITION#0.6388;AKT SIGNALING#0.6323;GROWTH FACTOR#0.6205
100126316	CANCER CELL#1.0746;BREAST CANCER#1.0039;BREAST CANCER CELL#0.9495;TUMOR SUPPRESSOR#0.9171;CELL PROLIFERATION#0.8969;APOPTOSIS#0.8118;CARDIOMYOCYTE#0.7577;DUAL LUCIFERASE REPORTER#0.6857;TAMOXIFEN#0.6644;COLORECTAL CANCER#0.6359;CERVICAL CANCER#0.6335;GROWTH FACTOR#0.6310;DRUG RESISTANCE#0.6229;T CELL#0.6219;LUNG CANCER#0.6194
100126317	CELL PROLIFERATION#0.9937;SIGNALING PATHWAY#0.8812;APOPTOSIS#0.8331;DUAL LUCIFERASE REPORTER#0.7251;CANCER CELL#0.6887
100126318	CANCER CELL#1.0112;PROSTATE CANCER#0.9205;CELL PROLIFERATION#0.8902;HYPOXIA#0.7466;APOPTOSIS#0.7336;TUMOR SUPPRESSOR#0.6600;AUTOPHAGY#0.6125
100126319	CELL PROLIFERATION#1.0911;TUMOR SUPPRESSOR#1.0508;CANCER CELL#1.0486;APOPTOSIS#1.0432;DUAL LUCIFERASE REPORTER#1.0375;AUTOPHAGY#1.0324;COLORECTAL CANCER#0.9069;SIGNALING PATHWAY#0.9036;CELL GROWTH#0.8463;ADJACENT NORMAL TISSUE#0.8387;COLORECTAL#0.7973;CELL CYCLE#0.7674;CISPLATIN#0.7460;PANCREATIC CANCER#0.7338;REVERSE TRANSCRIPTION#0.6935;LUNG CANCER#0.6758;POLYMERASE CHAIN REACTION#0.6666;LYMPH NODE#0.6448;PROTEIN KINASE#0.6429;GENE EXPRESSION#0.6304;DRUG RESISTANCE#0.6296;HEPATOCELLULAR CARCINOMA#0.6272;BREAST CANCER#0.6244;LUCIFERASE ACTIVITY#0.6185
100126324	CANCER CELL#0.7176;PROTEIN DEGRADATION#0.6827;BREAST CARCINOMA#0.6789;OVARIAN CANCER#0.6756;CELL GROWTH#0.6711;CELL PROLIFERATION#0.6681
100126325	CELL PROLIFERATION#1.1117;CANCER CELL#0.9925;LUNG CANCER#0.8523;SIGNET RING CELL#0.6397;DUAL LUCIFERASE REPORTER#0.6274;LIVER CANCER#0.6231
100126328	CELL PROLIFERATION#1.0545;CANCER CELL#1.0215;APOPTOSIS#1.0105;POLYMERASE CHAIN REACTION#0.8802;BREAST CANCER#0.8733;HEPATOCELLULAR CARCINOMA#0.7994;CELL CYCLE#0.7965;SIGNALING PATHWAY#0.7818;LYMPH NODE METASTASIS#0.7778;LYMPH NODE#0.7731;QUANTITATIVE REAL TIME#0.7691;EPITHELIAL MESENCHYMAL TRANSITION#0.7067;CERVICAL CANCER#0.7059;LUNG CANCER#0.6540;PANCREATIC CANCER#0.6245;INFLAMMATORY RESPONSE#0.6191;SQUAMOUS CELL CARCINOMA#0.6146;CERVICAL#0.6103;CELL GROWTH#0.6102
100126331	APOPTOSIS#0.8022;CANCER CELL#0.7346;SQUAMOUS CELL CARCINOMA#0.7258;DUAL LUCIFERASE REPORTER#0.6588;COLORECTAL CANCER#0.6474
100126333	LAYER BY LAYER#0.7780;COLORECTAL CARCINOMA#0.7575
100126334	VITAMIN D RECEPTOR#0.6343;CELL DIFFERENTIATION#0.6260;CELL PROLIFERATION#0.6198
100126335	CELL PROLIFERATION#1.0733;CANCER CELL#0.9804;APOPTOSIS#0.9773;COLORECTAL CANCER#0.9438;CELL CYCLE#0.8579;COLORECTAL#0.7993;SIGNALING PATHWAY#0.7867;TUMOR SUPPRESSOR#0.7828;EPITHELIAL MESENCHYMAL TRANSITION#0.7721;LUNG CANCER#0.7667;ENDOMETRIUM#0.6530;DUAL LUCIFERASE REPORTER#0.6370;ESOPHAGEAL CANCER#0.6284;PROSTATE CANCER#0.6125;ENDOMETRIOSIS#0.6066
100126336	MYOCARDIAL INFARCTION#1.0056;SKELETAL MUSCLE#0.9962;MYOSIN HEAVY CHAIN#0.9610;GENE EXPRESSION#0.9287;ACUTE MYOCARDIAL INFARCTION#0.9234;MUSCLE FIBER#0.8243;TRANSCRIPTION FACTOR#0.7579;POLYMERASE CHAIN REACTION#0.7178;MUSCLE CELL#0.6944;CARDIOMYOCYTE#0.6378;QUANTITATIVE REAL TIME#0.6378;REVERSE TRANSCRIPTION#0.6361;LEFT VENTRICULAR REMODELING#0.6347;CELL CYCLE#0.6083
100126338	CANCER CELL#0.9418;DUAL LUCIFERASE REPORTER#0.8858;PERIPHERAL BLOOD#0.8680;BREAST CANCER#0.8676;CELL PROLIFERATION#0.8284;BREAST CANCER CELL#0.6892;LUNG CANCER#0.6872;KAWASAKI DISEASE#0.6553;COLON CANCER#0.6348;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6331;CORONARY ARTERY#0.6320;MONONUCLEAR CELLS#0.6311
100126340	CANCER CELL#1.0586;CELL PROLIFERATION#0.9915;CELL MIGRATION#0.9615;CERVICAL CANCER#0.9404;COLORECTAL CANCER#0.8877;BREAST CANCER#0.8481;CERVICAL#0.7708;APOPTOSIS#0.7681;LUNG CANCER#0.7309;COLORECTAL#0.7221;CELL GROWTH#0.7174;EPITHELIAL MESENCHYMAL TRANSITION#0.6439;POLYMERASE CHAIN REACTION#0.6416;BREAST CANCER CELL#0.6401;CERVICAL CANCER CELL LINES#0.6004
100126343	TUMOR SUPPRESSOR#1.0599;CELL PROLIFERATION#1.0450;APOPTOSIS#0.9996;COLORECTAL CANCER#0.8339;CANCER CELL#0.8296;SIGNALING PATHWAY#0.8169;INFLAMMATORY RESPONSE#0.7847;BREAST CANCER#0.7663;REVERSE TRANSCRIPTION#0.7487;POLYMERASE CHAIN REACTION#0.7462;COLORECTAL#0.6814;DUAL LUCIFERASE REPORTER#0.6391;ADJACENT NORMAL TISSUE#0.6322;SQUAMOUS CELL CARCINOMA#0.6211;LUNG CANCER#0.6138;CELL GROWTH#0.6134;CELL CYCLE#0.6120;GROWTH FACTOR#0.6094
100126345	GRANULOMA FORMATION#0.6378;CERVICAL CANCER#0.6214;LUNG CANCER#0.6124;SIGNALING PATHWAY#0.6086
100126346	BREAST CANCER#1.0083;GENE EXPRESSION#0.7441;CELL PROLIFERATION#0.6654;APOPTOSIS#0.6435;SIGNALING PATHWAY#0.6260;SKELETAL MUSCLE WASTING#0.6097
100126348	CANCER CELL#1.0304;CELL PROLIFERATION#0.9996;COLORECTAL CANCER#0.9945;COLORECTAL#0.9221;BREAST CANCER#0.9129;APOPTOSIS#0.8273;LUNG CANCER#0.7771;BREAST CANCER CELL#0.7245;CELL CYCLE#0.7054;QUANTITATIVE REAL TIME#0.6807;EPITHELIAL MESENCHYMAL TRANSITION#0.6342;OVARIAN CANCER#0.6314;POLYMERASE CHAIN REACTION#0.6146;SENESCENCE#0.6121;CAMP SIGNALLING#0.6028
100126351	CELL PROLIFERATION#0.8995;CANCER CELL#0.8278;APOPTOSIS#0.8230;GENE EXPRESSION#0.7602;OVARIAN CANCER#0.6362;CELL DEATH#0.6311
100126355	LUNG ADENOCARCINOMA#0.6265;LUNG CANCER#0.6176
100126572	GAP JUNCTION#0.9422;CONNEXIN#0.8425;GAP JUNCTION CHANNEL#0.7576
100126791	EOSINOPHIL#0.9685;EOSINOPHIL DEVELOPMENT#0.7805;TUMOR SUPPRESSOR#0.7104;CELL PROLIFERATION#0.7070;BREAST CANCER PATIENTS#0.6640;BREAST CANCER#0.6553
100126794	COLORECTAL#0.9920;ESOPHAGEAL CANCER#0.9200;ADENOCARCINOMA#0.8713;COLORECTAL CANCER#0.8532;SQUAMOUS CELL CARCINOMA#0.8531;COLORECTAL ADENOCARCINOMA#0.7995;CELL PROLIFERATION#0.7814;COLORECTAL CARCINOMA#0.7191;COLON CANCER#0.7138;CANCER CELL#0.6537;GENE EXPRESSION#0.6525;POLYMERASE CHAIN REACTION#0.6090
100127888	COLORECTAL CANCER#1.0453;COLORECTAL#0.8420;CELL PROLIFERATION#0.7788
100128098	BREAST CANCER#0.7599
100128191	CELL PROLIFERATION#0.6980;CELL CYCLE#0.6826;CERVICAL CANCER#0.6559
100128252	CANCER CELL#1.0145;CERVICAL CANCER#0.9225;SQUAMOUS CELL CARCINOMA#0.7224;NORMAL CERVICAL TISSUE#0.7103;CERVICAL#0.6989;ESOPHAGEAL CANCER#0.6858;SPINAL CORD INJURY#0.6831;SPINAL CORD#0.6737;CELL CYCLE#0.6692
100128262	LUNG CANCER#0.8997;CELL PROLIFERATION#0.8960;ANGIOGENESIS#0.6451
100128338	CELL PROLIFERATION#1.0756;CANCER CELL#0.9164;SIGNALING PATHWAY#0.8747;OVARIAN CANCER#0.8435;NOTCH SIGNALING PATHWAY#0.6800;ADJACENT NORMAL TISSUE#0.6753;CELL GROWTH#0.6624;OVARIAN#0.6403;NUCLEUS PULPOSUS#0.6228;COLORECTAL CARCINOMA#0.6113;CERVICAL CANCER#0.6091;CELL MIGRATION#0.6022;HEPATOCELLULAR CARCINOMA#0.6021
100128537	DNA METHYLATION#0.8748;HEMATOPOIETIC STEM CELL#0.6644;STEM CELL#0.6550
100128553	CUTANEOUS T CELL LYMPHOMA#1.2018;T CELL#1.1769
100128590	SIGNALING PATHWAY#1.1785
100128731	GLYCOSYLATION#0.7132
100128750	COPY NUMBER ALTERATION#1.2051
100128881	PROSTATE CANCER#0.7024;CANCER CELL#0.6975;CELL PROLIFERATION#0.6818;CELL CYCLE#0.6444
100128927	SKELETAL MUSCLE#0.8522
100128977	BREAST CANCER#0.8978;METASTATIC LYMPH NODE#0.7363;BREAST CANCER PATIENTS#0.7187;BREAST CANCER CELL#0.7152;LYMPH NODE#0.7122;CELL GROWTH#0.7121;CANCER CELL#0.7084
100129075	CELL PROLIFERATION#0.8960;APOPTOSIS#0.6411
100129080	CHLOROPLAST RIBOSOME#0.7251
100129123	ANGIOTENSIN CONVERTING ENZYME#0.8381;MUSCLE CELL#0.7124;LACTOSE METABOLISM#0.6844;CHORION#0.6437;TRANSCRIPTION FACTOR#0.6298
100129193	MAJOR URINARY PROTEIN#1.0326;URINARY PROTEIN#1.0263;GENE EXPRESSION#0.9165;TESTOSTERONE#0.8829;EXCRETION#0.7877;GROWTH HORMONE#0.7222;ALLERGEN#0.7159;GENE CONVERSION#0.7133;THYMIDINE KINASE#0.7085;PHEROMONE BINDING#0.6962;ODORANT BINDING#0.6783;ISOTHERMAL TITRATION CALORIMETRY#0.6261;MAMMARY GLAND#0.6190;PAROTID GLAND#0.6102
100129339	T LYMPHOCYTE#0.9193;BONE MARROW#0.7715
100129405	HUMAN BRONCHIAL EPITHELIAL#0.8164;BRONCHIAL EPITHELIAL CELLS#0.8147;LUNG CANCER#0.7994;EPITHELIAL CELL#0.7969;CELL PROLIFERATION#0.7958
100129460	CRYPTOCOCCAL MENINGITIS#1.2297;MENINGITIS#0.8585
100129528	HUMAN AIRWAY EPITHELIAL#1.1238;AIRWAY EPITHELIAL CELL#1.1167;POLYMERASE CHAIN REACTION#1.0490;SIGNALING PATHWAY#1.0433;EPITHELIAL CELL#1.0427;GENE EXPRESSION#1.0296;HUMAN NASAL EPITHELIAL#0.9964;REVERSE TRANSCRIPTION#0.8817;PROTEIN KINASE#0.8212;TRANSCRIPTASE#0.8159;CILIATED CELL#0.7880;NASAL EPITHELIUM#0.7732;TOLL LIKE RECEPTOR#0.7579;GROWTH FACTOR#0.7286;MITOGEN ACTIVATED PROTEIN#0.6964;MIDDLE EAR#0.6663;P38 MAPK SIGNALING#0.6431;MAPK SIGNALING#0.6349
100129575	CELL SURFACE#0.7806
100129583	PARKINSON'S DISEASE#0.6896
100129662	BREAST CANCER CELL#1.1848;BREAST CANCER#1.1796;CANCER CELL#1.1780;GLYCOLYSIS#0.8539
100129669	MALE INFERTILITY#0.7640
100129696	VACUOLAR ACIDIFICATION#0.6943
100129827	SIGNALING PATHWAY#1.1785;PACLITAXEL#0.8542
100129973	APOPTOSIS#0.7665;VASCULAR ENDOTHELIAL CELL#0.7612;ENDOTHELIAL CELL#0.7524
100129983	QUANTITATIVE REAL TIME#0.6748;HEPATOCELLULAR CARCINOMA#0.6738;POLYMERASE CHAIN REACTION#0.6707
100130015	URIC ACID#0.8173;URATE OXIDASE#0.7383
100130097	KINESIN#1.1084;MICROTUBULE#0.9450;INTRAFLAGELLAR TRANSPORT#0.8246;MICROTUBULE DYNAMICS#0.6731;KINETOCHORE#0.6412;MITOSIS#0.6122
100130155	ASTROCYTE ACTIVATION#0.9289;AUTOPHAGY#0.6475;ASTROCYTE#0.6472
100130275	CELL CYCLE#0.8971;BREAST CANCER#0.8969;APOPTOSIS#0.6411
100130302	TRANSCRIPTION FACTOR#0.7285
100130535	METALLO BETA LACTAMASE#1.0344;IMIPENEM#0.9989;MEROPENEM#0.9960;CEFTAZIDIME#0.9704;POLYMERASE CHAIN REACTION#0.9580;MINIMUM INHIBITORY CONCENTRATION#0.9573;MYELOID CELL#0.9385;BONE MARROW#0.8834;INTENSIVE CARE UNIT#0.8825;COLISTIN#0.8563;SELECTIN#0.8477;GLCNAC#0.8247;LEUKOCYTE#0.8201;CELL SURFACE#0.8123;AZTREONAM#0.7956;EFFLUX PUMP#0.7898;BLAST CELL#0.7730;OUTER MEMBRANE#0.7635;DRUG RESISTANCE#0.7515;CEFEPIME#0.7362;DIPICOLINIC ACID#0.7226;CHONDROCYTE#0.7181;CONJUGATION#0.6945;PIPERACILLIN#0.6643;GRANULOCYTE#0.6448;ANTIMICROBIAL SUSCEPTIBILITY TESTING#0.6383;ACUTE LEUKEMIA#0.6356;TAZOBACTAM#0.6154;AMIKACIN#0.6119
100130613	CERAMIDE KINASE#0.9564;LEUCINE RICH REPEAT#0.9142;LEUCINE#0.6483
100130733	LEUCINE RICH REPEAT#1.1969;LEUCINE#0.8511
100130776	CELL PROLIFERATION#1.0569;CANCER CELL#0.9348;APOPTOSIS#0.8571;ONCOGENIC#0.8467;LUNG CANCER#0.8199;BREAST CANCER#0.8112;HISTAMINE#0.7891;BREAST CANCER CELL#0.7688;SIGNALING PATHWAY#0.6018
100130889	PSORIASIS#0.8158
100131096	THYROID CANCER#1.0007;SIGNALLING PATHWAY#0.9952;APOPTOSIS#0.9055;PAPILLARY THYROID CANCER#0.7688;ANTISENSE RNA#0.7661;AUTOPHAGY#0.7579
100131137	SEMINAL PLASMA#0.9837;SEMINAL VESICLE#0.9129;SPERM CAPACITATION#0.8419;SPERMATOZOA#0.7435;SEMEN#0.7168;ACROSOME REACTION#0.6974;FERTILIZATION#0.6655;HEPARIN#0.6473;EPIDIDYMIS#0.6290
100131176	HYPOXIA#0.8487
100131187	GLUTATHIONE#0.7109;THIOSULFATE SULFURTRANSFERASE#0.7062;MAJOR DEPRESSIVE EPISODE#0.6710;SPINAL CORD#0.6321
100131439	CELL SURFACE#0.6637
100131726	CELL PROLIFERATION#0.8232;ANTISENSE RNA#0.7326;LUNG ADENOCARCINOMA#0.7216;CELL MIGRATION#0.7148
100131796	COLON CANCER#1.0496;DNA METHYLATION#0.8293;CANCER CELL#0.8214
100131801	CYTOCHROME C OXIDASE#0.9641;CYTOCHROME C#0.9567;CYTOCHROME C OXIDASE ACTIVITY#0.6411
100131827	ZINC FINGER PROTEIN#0.7687
100131897	CELL PROLIFERATION#1.1443;LUNG ADENOCARCINOMA#0.9086;AKT SIGNALING#0.9079;TUMOR TISSUES#0.9069;S PHASE#0.9044;CELL CYCLE#0.8971;SIGNALING PATHWAY#0.8958;ADENOCARCINOMA#0.6456;APOPTOSIS#0.6411
100132074	TRANSCRIPTION FACTOR#1.0268;CANCER CELL#1.0157;CELL PROLIFERATION#0.9964;APOPTOSIS#0.9536;GROWTH FACTOR#0.9092;GLUCOSE METABOLISM#0.8288;CELL CYCLE#0.8219;BREAST CANCER#0.7603;HYPERGLYCEMIA#0.7058;REACTIVE OXYGEN SPECIES#0.6746;BREAST CANCER CELL#0.6269;LYMPH NODE METASTASIS#0.6124;LUNG CANCER#0.6080;LYMPH NODE#0.6076;GLUCONEOGENESIS#0.6033
100132116	LUNG ADENOCARCINOMA#0.7890
100132159	CERVICAL CANCER#0.9086;CELL PROLIFERATION#0.9035;APOPTOSIS#0.6741;CERVICAL#0.6472
100132285	T CELL#0.9966;NATURAL KILLER CELL#0.9934;LEUKOCYTE#0.9672;HUMAN LEUKOCYTE ANTIGEN#0.9465;POLYMERASE CHAIN REACTION#0.9322;SEQUENCE SPECIFIC PRIMER#0.9265;PERIPHERAL BLOOD#0.9044;CELL ACTIVATION#0.8928;CYTOTOXICITY#0.8866;CELL SURFACE#0.8799;STEM CELL#0.8594;NK CELL ACTIVATION#0.8229;IFN-GAMMA#0.8088;STEM CELL TRANSPLANTATION#0.8059;IMMUNE RESPONSE#0.7984;HEMATOPOIETIC STEM CELL#0.7693;MAJOR HISTOCOMPATIBILITY COMPLEX#0.7569;RHEUMATOID ARTHRITIS#0.7549;RECEPTOR LIGAND#0.7306;COLORECTAL CANCER#0.7293;CD4+ T CELL#0.7261;VASCULITIS#0.7221;HEMATOPOIETIC CELL TRANSPLANTATION#0.7004;TYPE 1 DIABETES#0.6981;HEMATOPOIETIC CELL#0.6892;LYSIS#0.6736;HEPATITIS C#0.6559;VIRAL INFECTION#0.6226;HEPATITIS C VIRUS#0.6048;MYELOID LEUKEMIA#0.6038
100132464	CELL PROLIFERATION#1.1787
100132510	GLUTATHIONE#0.9192
100132891	CELL PROLIFERATION#1.0410
100133307	CYTOCHROME P450#0.7967
100133311	CELL CYCLE#0.8208;CELL PROLIFERATION#0.7549;NON-SMALL CELL LUNG CARCINOMA#0.6418;LUNG CARCINOMA#0.6328;DRUG RESISTANCE#0.6284;SIGNALING PATHWAY#0.6195
100133790	CELL DEATH#0.7333;TRANSCRIPTION FACTOR#0.6852
100133941	EPITHELIAL SPECIFIC ANTIGEN#1.0856;TRANSITIONAL B CELL#1.0674;SELECTIN#1.0441;INVASIVE DUCTAL CARCINOMA#1.0307;LYMPH NODE METASTASIS#1.0255;MULTIPLE SCLEROSIS#1.0241;CELL ADHESION MOLECULE#1.0240;DISEASE FREE SURVIVAL#1.0217;GRANULOCYTE#1.0208;CELL SURFACE ANTIGEN#1.0195;BOWMAN'S CAPSULE#1.0166;TUMOR TISSUES#1.0151;TUMOR STEM CELL#1.0144;OVARIAN#1.0110;CELL ASSOCIATED#1.0103;PRIMARY BREAST CANCER#1.0102;FLOW CYTOMETRY ANALYSIS#1.0097;EXOSOME#1.0094;LIPID RAFT#1.0089;REGULATORY B CELL#1.0086;B CELL#1.0075;QUANTITATIVE REAL TIME#1.0074;OVARIAN CANCER#1.0069;PROSTATE CANCER#1.0068;NEUTROPHIL#1.0064;MAMMARY EPITHELIAL CELL#1.0058;CELL ADHESION#1.0052;LUNG CANCER#1.0045;BREAST CARCINOMA#1.0027;CELL SURFACE#1.0020;STEM CELL MARKER#1.0019;PANCREATIC CANCER#1.0017;AUTOIMMUNE DISEASE#1.0014;SQUAMOUS CELL CARCINOMA#0.9995;CANCER INITIATING CELLS#0.9991;CANCER STEM-LIKE CELL#0.9978;LUMINAL#0.9977;COLORECTAL#0.9975;MONOCYTE#0.9972;CERVICAL CANCER#0.9968;COLON CANCER#0.9967;CERVICAL#0.9962;STEM CELL LIKE#0.9958;MAMMARY GLAND#0.9955;PANCREATIC ADENOCARCINOMA#0.9954;TUMOR INITIATING CELL#0.9953;HEPATOCELLULAR CARCINOMA#0.9943;MEMORY B CELL#0.9934;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9934;LUPUS ERYTHEMATOSUS#0.9931;NEURAL CELL#0.9931;MESENCHYMAL STEM CELL#0.9917;B LYMPHOCYTE#0.9906;BREAST CANCER PATIENTS#0.9906;COLORECTAL CANCER#0.9904;LUMINAL PROGENITOR#0.9902;LYMPH NODE#0.9893;PROGESTERONE#0.9893;T LYMPHOCYTE#0.9891;BREAST CANCER#0.9888;CELL MIGRATION#0.9888;GROWTH FACTOR RECEPTOR#0.9885;HYPOXIA#0.9882;ADENOCARCINOMA#0.9882;BREAST CANCER CELL#0.9875;ESTROGEN RECEPTOR#0.9857;CELL DIFFERENTIATION#0.9856;CELL DEATH#0.9853;EPITHELIAL CELL#0.9851;DOXORUBICIN#0.9850;CELL GROWTH#0.9849;PROGENITOR CELL#0.9847;EPIDERMAL GROWTH FACTOR#0.9846;CELL PROLIFERATION#0.9843;OVARIAN CARCINOMA#0.9838;HUMAN BREAST CANCER#0.9830;MONONUCLEAR CELLS#0.9825;PLASMA CELL#0.9821;CELL DEVELOPMENT#0.9819;CISPLATIN#0.9814;LEUKOCYTE#0.9813;CENTRAL NERVOUS SYSTEM#0.9813;HEMATOPOIETIC CELL#0.9810;EMBRYONIC STEM CELL#0.9810;NERVOUS SYSTEM#0.9809;POLYMERASE CHAIN REACTION#0.9808;DENDRITIC CELL#0.9807;STEM CELL#0.9795;TRANSFORMING GROWTH FACTOR#0.9793;CANCER CELL#0.9790;PERIPHERAL BLOOD#0.9789;NUCLEUS PULPOSUS#0.9788;INVASIVE BREAST CARCINOMA#0.9785;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9781;TUMOR CELLS#0.9779;EPITHELIAL TO MESENCHYMAL#0.9777;GEMCITABINE#0.9775;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9774;ORAL SQUAMOUS CELL CARCINOMA#0.9762;APOPTOSIS#0.9760;EPITHELIAL MESENCHYMAL TRANSITION#0.9755;PROTEIN KINASE#0.9751;CANCER STEM CELL#0.9749;STROMAL CELL#0.9744;SMOOTH MUSCLE#0.9741;B CELL DEVELOPMENT#0.9737;CD4+ T CELL#0.9735;T CELL#0.9732;ENDOTHELIAL CELL#0.9730;MACROPHAGE#0.9725;GROWTH FACTOR#0.9722;APOPTOTIC#0.9716;THYMOCYTE#0.9708;SIGNALING PATHWAY#0.9708;CELL CYCLE#0.9705;ANGIOGENESIS#0.9703;IMMUNE RESPONSE#0.9701;DRUG RESISTANCE#0.9700;PANCREATIC DUCTAL ADENOCARCINOMA#0.9697;TRANSCRIPTION FACTOR#0.9695;CELL ACTIVATION#0.9691;CD8+ T CELL#0.9684;B CELL DIFFERENTIATION#0.9683;ANDROGEN RECEPTOR#0.9675;BONE MARROW#0.9674;CYTOPLASM#0.9673;BASAL CELL#0.9673;REGENERATION#0.9672;EPITHELIAL STEM CELL#0.9647;GENE EXPRESSION#0.9645;IMMUNE CELL#0.9617;MESENCHYMAL CELL#0.9608;ADIPOCYTE#0.9608;CYTOTOXICITY#0.9602;NEURAL STEM CELL#0.9601;FAT PAD#0.9601;HUMAN EMBRYONIC STEM#0.9599;TUMOR NECROSIS FACTOR#0.9555;NEUROBLASTOMA#0.9541;ONCOGENIC#0.9539;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.9522;INVASIVE BREAST CANCER#0.9513;PLURIPOTENT STEM CELL#0.9505;SIGNAL TRANSDUCER#0.9501;EXTRACELLULAR MATRIX#0.9494;CELL MATURATION#0.9492;TUMOR SUPPRESSOR#0.9484;TIGHT JUNCTION#0.9481;PACLITAXEL#0.9479;CHOLANGIOCARCINOMA#0.9473;CELL MOTILITY#0.9448;STROMA#0.9441;SIGNAL TRANSDUCTION#0.9427;IMMUNE SYSTEM#0.9417;REACTIVE OXYGEN SPECIES#0.9394;LIVER CANCER#0.9384;METASTASIS FREE SURVIVAL#0.9329;SALIVARY GLAND#0.9302;ALKALINE PHOSPHATASE#0.9271;HEMATOPOIETIC STEM CELL#0.9267;PRECURSOR CELL#0.9251;SMOOTH MUSCLE ACTIN#0.9225;PAROXYSMAL NOCTURNAL HEMOGLOBINURIA#0.9209;CELL MEMBRANE#0.9200;REVERSE TRANSCRIPTION#0.9158;RENAL CELL CARCINOMA#0.9150;LUMINAL CELL#0.9140;INFLAMMATORY RESPONSE#0.9139;ENCEPHALOMYELITIS#0.9131;PLASMA MEMBRANE#0.9127;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9108;RETINOIC ACID#0.9089;ANCHORAGE INDEPENDENT GROWTH#0.9052;LYMPH NODE METASTASES#0.9038;GASTRIC ADENOCARCINOMA#0.9033;KINASE ACTIVITY#0.9028;MITOGEN ACTIVATED PROTEIN#0.9016;GLYCOSYLATION#0.9010;METASTATIC BREAST CANCER#0.9009;HUMAN PANCREATIC CANCER#0.8933;NORMAL BREAST TISSUE#0.8920;LUNG ADENOCARCINOMA#0.8893;MYELOID CELL#0.8887;LYMPHOID CELL#0.8875;5 FLUOROURACIL#0.8875;LYMPH NODE INVOLVEMENT#0.8822;HEDGEHOG SIGNALING PATHWAY#0.8814;GALLBLADDER CARCINOMA#0.8809;ATP BINDING CASSETTE#0.8780;HUMAN MAMMARY EPITHELIAL#0.8777;ATP BINDING#0.8763;INSULIN-LIKE GROWTH FACTOR#0.8754;COLONY FORMATION ASSAY#0.8746;LUNG CARCINOMA#0.8729;TRANSCRIPTASE#0.8728;CIRCULATING TUMOR CELL#0.8724;INFLAMMATORY BOWEL DISEASE#0.8711;SMALL INTESTINE#0.8706;BONE MARROW CELLS#0.8696;RNA INTERFERENCE#0.8689;EPSTEIN BARR VIRUS#0.8684;CLEAR CELL RENAL CELL CARCINOMA#0.8677;ENDOMETRIAL CARCINOMA#0.8657;CARCINOMA IN SITU#0.8648;LECTIN#0.8625;MAMMARY FAT PAD#0.8608;CORD BLOOD#0.8599;HEMOGLOBINURIA#0.8586;DUCTAL CARCINOMA IN SITU#0.8580;TRANSFORMING GROWTH FACTOR BETA#0.8554;AUTOPHAGY#0.8549;NUCLEUS PULPOSUS CELL#0.8500;PRO-INFLAMMATORY#0.8467;ASCITES#0.8465;CHEMOKINE RECEPTOR#0.8453;MYELOID LEUKEMIA#0.8438;DNA METHYLATION#0.8438;ADIPOSE TISSUE#0.8424;WOUND HEALING#0.8369;HYPOXIC#0.8366;ERYTHROCYTE#0.8345;NEURITE OUTGROWTH#0.8323;INVASIVE CARCINOMA#0.8286;INTERVERTEBRAL DISC#0.8259;HEPATOCELLULAR CARCINOMA CELL#0.8241;KINASE INHIBITOR#0.8240;MULTIPLE MYELOMA#0.8229;MAJOR HISTOCOMPATIBILITY COMPLEX#0.8220;REGULATORY T CELL#0.8216;T CELL PROLIFERATION#0.8204;PODOCYTE#0.8191;FLUOROURACIL#0.8169;ANTIGEN PRESENTING CELLS#0.8137;SENESCENCE#0.8104;IFN-GAMMA#0.8097;DOCETAXEL#0.8097;FORMALIN#0.8074;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8070;GALLBLADDER#0.8070;OVAL CELL#0.8058;RHEUMATOID ARTHRITIS#0.8053;CHONDROCYTE#0.8045;CELL CYCLE ARREST#0.8033;IL-10 PRODUCTION#0.8020;LYMPH NODE INVASION#0.8017;CELL FRACTION#0.7976;PLASMABLAST#0.7958;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.7942;AUTOIMMUNITY#0.7923;COLORECTAL CARCINOMA#0.7909;INTRAHEPATIC CHOLANGIOCARCINOMA#0.7906;TAMOXIFEN#0.7886;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7848;ENDOTHELIAL GROWTH FACTOR#0.7847;COLORECTAL ADENOCARCINOMA#0.7840;RITUXIMAB#0.7814;TOLL LIKE RECEPTOR#0.7785;NOTOCHORD#0.7764;HEAT SHOCK PROTEIN#0.7757;T CELL ACTIVATION#0.7739;MAMMARY EPITHELIUM#0.7733;GESTATION#0.7716;NAIVE B CELL#0.7709;CYTOKINE PRODUCTION#0.7694;LEUCINE#0.7693;PERIPHERAL BLOOD LEUKOCYTE#0.7693;TOXICITY#0.7680;ORAL EPITHELIAL CELLS#0.7665;CELL EXPANSION#0.7659;CANCER RELATED DEATH#0.7630;WHITE BLOOD CELL#0.7623;LASER CAPTURE MICRODISSECTION#0.7623;COLON CARCINOMA#0.7609;EPITHELIAL OVARIAN CANCER#0.7598;T CELL DIFFERENTIATION#0.7593;OVERALL SURVIVAL TIME#0.7592;TRASTUZUMAB#0.7588;IMMUNOTOXIN#0.7586;ASTROCYTE#0.7573;MITOCHONDRIAL MEMBRANE#0.7565;CERVICAL SQUAMOUS CELL CARCINOMA#0.7541;DUCTAL BREAST CANCER#0.7538;SIGNALING MOLECULE#0.7529;NEPHRON#0.7500;FETAL KIDNEY#0.7497;METFORMIN#0.7496;EPENDYMAL CELL#0.7493;B CELL RECEPTOR#0.7446;UMBILICAL CORD#0.7439;PROSTATE CARCINOMA#0.7424;S PHASE#0.7407;NON-SMALL CELL LUNG CARCINOMA#0.7403;ULCERATIVE COLITIS#0.7373;CROHN'S DISEASE#0.7368;LYMPHOCYTIC LEUKEMIA#0.7360;PERIODONTAL DISEASE#0.7350;SPINAL CORD#0.7321;TRANSIT AMPLIFYING CELL#0.7281;INTESTINAL STEM CELL#0.7259;LIVER METASTASIS#0.7257;KERATINOCYTE#0.7232;INDUCED PLURIPOTENT STEM CELL#0.7229;ENDOMETRIAL CANCER#0.7197;COLONY-STIMULATING FACTOR#0.7183;SORAFENIB#0.7162;ESOPHAGEAL CANCER#0.7159;HOST CELL#0.7144;ACTIVATED T CELL#0.7139;NORMAL STEM CELLS#0.7137;MESENCHYME#0.7132;DEDIFFERENTIATION#0.7131;MUSCLE FIBER#0.7131;ADIPOGENESIS#0.7128;RED BLOOD CELL#0.7121;BILIARY TRACT#0.7064;TUMOR ASSOCIATED ANTIGEN#0.7030;ABC TRANSPORTER#0.7017;HODGKIN'S LYMPHOMA#0.6990;LYMPHOID TISSUE#0.6982;PHOSPHOLIPASE C#0.6967;STEM CELL ANTIGEN#0.6960;HEPATITIS B#0.6954;DNA REPAIR#0.6943;PANETH CELL#0.6941;PATHOLOGIC COMPLETE RESPONSE#0.6936;METANEPHRIC MESENCHYME#0.6931;ACTIVATED T-CELLS#0.6909;CHRONIC LYMPHOCYTIC LEUKEMIA#0.6892;B CELL ACTIVATION#0.6871;Y CHROMOSOME#0.6859;MICROVESICLE#0.6855;AMNIOTIC FLUID#0.6837;NEURAL CREST#0.6826;NEURITE#0.6822;BILE DUCT#0.6816;MARGINAL ZONE B CELL#0.6779;LUNG METASTASIS#0.6778;MARGINAL ZONE B#0.6775;CROSS PRESENTATION#0.6773;AGGRESSIVE BEHAVIOR#0.6757;MINIMAL RESIDUAL DISEASE#0.6754;GERMINAL CENTER#0.6733;GASTROINTESTINAL TRACT#0.6701;CELLULAR SENESCENCE#0.6695;PERIODONTITIS#0.6665;NEUROGENESIS#0.6641;TIGHT JUNCTION PROTEIN#0.6640;LYSIS#0.6631;MYOEPITHELIAL CELL#0.6626;TRAUMATIC BRAIN INJURY#0.6611;ENDOTHELIUM#0.6607;ALANINE#0.6606;RETINOBLASTOMA#0.6600;BREAST CELL LINES#0.6586;NECK CANCER#0.6572;IMMATURE TRANSITIONAL B CELL#0.6555;GM-CSF#0.6533;FLOW CYTOMETRY ASSAY#0.6502;METAPLASTIC CARCINOMA#0.6466;WHITE ADIPOSE TISSUE#0.6440;ONCOGENESIS#0.6434;FOCAL ADHESION#0.6426;ENDOMETRIUM#0.6421;ACUTE MYELOID LEUKEMIA#0.6416;PROLIFERATING CELL NUCLEAR ANTIGEN#0.6412;BLOOD VESSEL#0.6401;METAPLASIA#0.6308;PRE-B-LYMPHOCYTE#0.6308;RICIN#0.6290;HEMATOPOIESIS#0.6288;RETICULOCYTE#0.6283;TUMOR NODE METASTASIS#0.6257;PANCREATITIS#0.6257;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.6252;M PHASE#0.6247;HYPOXIA INDUCIBLE FACTOR#0.6237;GROWTH FACTOR BINDING#0.6229;SIGNALLING PATHWAY#0.6226;ANTIGEN PRESENTATION#0.6226;FIBROBLAST GROWTH FACTOR#0.6216;MEDULLOBLASTOMA#0.6207;INVASIVE MICROPAPILLARY CARCINOMA#0.6204;QUIESCENCE#0.6196;SIGNALING CASCADE#0.6194;RECURRENCE FREE SURVIVAL#0.6167;UMBILICAL CORD BLOOD#0.6165;YEAR SURVIVAL RATE#0.6153;GRAFT VERSUS HOST#0.6144;PERIPHERAL BLOOD LYMPHOCYTES#0.6138;AQUAPORIN#0.6123;ANEMIA#0.6116;OXALIPLATIN#0.6106;CANINE MAMMARY TUMORS#0.6097;NATURAL KILLER CELL#0.6093;FLUORESCEIN#0.6057;MORPHOGENESIS#0.6054;CYCLOPHOSPHAMIDE#0.6052;BLADDER CARCINOMA#0.6034;DIFFERENTIAL GENE EXPRESSION#0.6015
100133957	COLORECTAL CANCER#1.1841;CELL PROLIFERATION#1.1787;COLORECTAL#0.8485;APOPTOSIS#0.8439
100134229	RESPONSE TO NUTRIENT#0.8306;PANCREATIC CANCER#0.8300;CANCER CELL#0.7951
100134444	PARALYSIS#1.0599;POTASSIUM CHANNEL#1.0305;THYROTOXIC#0.9982;SKELETAL MUSCLE#0.8958;HYPOKALEMIC PERIODIC PARALYSIS#0.8479
100134934	CST COMPLEX#1.0958;TELOMERE#1.0570;TELOMERE MAINTENANCE#1.0074;CDC13-STN1-TEN1 COMPLEX#1.0052;BUDDING#0.9965;COMPLEX I#0.9965;TELOMERE CAPPING#0.9865;DNA BINDING#0.9545;DNA REPLICATION#0.9189;REPLICATION PROTEIN A#0.8840;PROTEIN COMPLEX#0.8809;SSDNA BINDING#0.7317;SUMOYLATION#0.7060;REPLICATION RESTART#0.6838;SINGLE-STRANDED DNA BINDING#0.6531;CELL CYCLE#0.6471;S PHASE#0.6302;TELOMERE BINDING#0.6233;CANCER CELL#0.6163;DNA DAMAGE RESPONSE#0.6155;ENZYME ACTIVITY#0.6030
100135756	PLASMA MEMBRANE#0.6002
100137047	ARGININE#0.6865;HISTONE DEMETHYLASE#0.6023
100137049	PHOSPHOLIPASE A2#0.7875
10013	TUBULIN DEACETYLASE ACTIVITY#1.1211;TUBULIN DEACETYLATION#1.0888;TUBULIN DEACETYLASE#1.0734;UBIQUITIN BINDING#1.0604;AGGRESOME#1.0513;AXONAL TRANSPORT#1.0506;DEACETYLASE ACTIVITY#1.0427;DYNEIN#1.0408;SQUAMOUS CELL CARCINOMA#1.0382;CELL MOTILITY#1.0374;ACUTE KIDNEY INJURY#1.0339;AUTOPHAGOSOME#1.0297;PRO-INFLAMMATORY#1.0294;MICROTUBULE DYNAMICS#1.0258;CISPLATIN#1.0200;CELL MIGRATION#1.0197;AUTOPHAGOSOME-LYSOSOME FUSION#1.0152;MACROPHAGE#1.0134;B CELL#1.0130;CYTOPLASM#1.0119;CATALYTIC ACTIVITY#1.0106;MICROTUBULE#1.0105;GLUCOCORTICOID RECEPTOR#1.0101;STEM CELL#1.0083;MULTIPLE MYELOMA#1.0080;PROTEIN DEGRADATION#1.0080;AUTOPHAGY#1.0076;ZINC BINDING#1.0075;ENDOTHELIAL CELL#1.0061;UBIQUITIN PROTEASOME SYSTEM#1.0060;UBIQUITIN#1.0056;HEAT SHOCK PROTEIN#1.0044;PROSTATE CANCER#1.0043;BORTEZOMIB#1.0037;ONCOGENIC#1.0035;MITOCHONDRIA#1.0032;STRUCTURE ACTIVITY RELATIONSHIP#1.0028;ZINC BINDING GROUP#1.0024;MITOCHONDRIAL TRANSPORT#1.0022;BREAST CANCER#1.0017;LUNG CANCER#1.0009;BREAST CANCER CELL#0.9996;HISTONE DEACETYLASE#0.9995;LYSOSOME#0.9994;EPITHELIAL CELL#0.9984;GROWTH FACTOR#0.9976;GROWTH FACTOR RECEPTOR#0.9972;NEURODEGENERATIVE DISEASE#0.9970;VORINOSTAT#0.9961;HYPOXIA#0.9949;PROTEASOME#0.9949;TUMOR CELLS#0.9942;TUMOR SUPPRESSOR#0.9942;OVARIAN CANCER#0.9924;CELL PROLIFERATION#0.9916;LYSINE#0.9915;SIGNALING PATHWAY#0.9911;T CELL#0.9882;ALZHEIMER'S DISEASE#0.9875;HISTONE ACETYLATION#0.9874;SUBEROYLANILIDE HYDROXAMIC ACID#0.9863;CYTOTOXICITY#0.9857;INFLAMMATORY RESPONSE#0.9850;CELL CYCLE ARREST#0.9839;ENDOPLASMIC RETICULUM#0.9837;CELL DEATH#0.9835;REACTIVE OXYGEN SPECIES#0.9833;CELL GROWTH#0.9830;HUMAN BREAST CANCER#0.9819;PROTEIN KINASE#0.9817;CANCER CELL#0.9811;APOPTOSIS#0.9799;HEPATOCELLULAR CARCINOMA#0.9797;ESTROGEN RECEPTOR#0.9792;CELL CYCLE#0.9789;IMMUNE RESPONSE#0.9777;TRANSCRIPTION FACTOR#0.9777;DNA BINDING#0.9766;CELL ACTIVATION#0.9758;PROTEIN ACETYLATION#0.9754;APOPTOTIC#0.9725;PANCREATIC CANCER#0.9719;PACLITAXEL#0.9717;OVARIAN#0.9695;TOXICITY#0.9695;NERVOUS SYSTEM#0.9688;GENE EXPRESSION#0.9687;BONE MARROW#0.9681;POST-TRANSLATIONAL MODIFICATION#0.9678;B CELL LYMPHOMA#0.9643;HISTONE DEACETYLASE INHIBITOR#0.9609;AMYOTROPHIC LATERAL SCLEROSIS#0.9580;LATERAL SCLEROSIS#0.9580;POLYMERASE CHAIN REACTION#0.9572;ANGIOGENESIS#0.9571;EPIDERMAL GROWTH FACTOR#0.9568;KIDNEY DISEASE#0.9558;PARKINSON'S DISEASE#0.9551;DEXAMETHASONE#0.9539;MICROTUBULE ASSOCIATED PROTEIN#0.9538;QUANTITATIVE REAL TIME#0.9463;ANDROGEN RECEPTOR#0.9435;ORGANELLE#0.9407;DRUG RESISTANCE#0.9380;NEUROPATHY#0.9376;VIRAL INFECTION#0.9322;CILIUM#0.9311;COLON CANCER#0.9235;MICROTUBULE BINDING#0.9220;HYPERTENSION#0.9124;CHAPERONE ACTIVITY#0.9072;SMOOTH MUSCLE#0.9025;OOCYTE#0.9023;NEUROBLASTOMA#0.9008;SKELETAL MUSCLE#0.8982;POSTTRANSLATIONAL MODIFICATION#0.8937;KINASE ACTIVITY#0.8930;CENTROSOME#0.8923;HOST CELL#0.8899;PRIMARY CILIUM#0.8858;HISTONE MODIFICATION#0.8849;T CELL ACTIVATION#0.8848;HISTONE ACETYLTRANSFERASE#0.8795;BREAST CANCER PATIENTS#0.8764;ROS GENERATION#0.8764;DISEASE FREE SURVIVAL#0.8733;INFLUENZA A VIRUS#0.8732;DIFFUSE LARGE B-CELL LYMPHOMA#0.8727;EPITHELIAL MESENCHYMAL TRANSITION#0.8717;DNA REPAIR#0.8688;POLYCYSTIC KIDNEY DISEASE#0.8687;MYELOID LEUKEMIA#0.8680;G1 PHASE#0.8623;CHARCOT-MARIE-TOOTH DISEASE#0.8614;TOOTH DISEASE#0.8613;CHARCOT MARIE TOOTH#0.8594;NEUROPROTECTION#0.8496;COLORECTAL#0.8469;MITOGEN ACTIVATED PROTEIN#0.8451;LIGHT CHAIN 3#0.8426;REGENERATION#0.8421;PROTEIN COMPLEX#0.8412;SIGNALING CASCADE#0.8349;ACUTE MYELOID LEUKEMIA#0.8348;RNA INTERFERENCE#0.8344;INCLUSION BODY#0.8336;MECHANISM OF ACTION#0.8330;HISTONE DEACETYLATION#0.8329;PLASMA MEMBRANE#0.8325;COLORECTAL CANCER#0.8322;CELL ADHESION#0.8316;MICROTUBULE STABILIZATION#0.8295;NADPH OXIDASE#0.8294;CILIOGENESIS#0.8287;DNA METHYLATION#0.8283;ENZYME ACTIVITY#0.8208;TIGHT JUNCTION#0.8184;EMBRYONIC STEM CELL#0.8172;POLYUBIQUITIN#0.8163;HUNTINGTON'S DISEASE#0.8149;ENDOPLASMIC RETICULUM STRESS#0.8125;PLURIPOTENT STEM CELL#0.8118;GLYCOGEN SYNTHASE KINASE#0.8102;PERIPHERAL BLOOD#0.8099;CYTOCHROME C#0.8079;TRANSACTIVATION#0.7997;DOUBLE STRAND BREAK#0.7964;OSTEOBLAST#0.7955;VALPROIC ACID#0.7950;BINDING PROTEIN 1#0.7949;MESENCHYMAL STEM CELL#0.7938;OOCYTE MATURATION#0.7932;MODE OF ACTION#0.7922;CERVICAL CANCER#0.7919;DENDRITIC CELL#0.7911;TUBULAR EPITHELIAL CELL#0.7907;MUSCLE CELL#0.7903;REVERSE TRANSCRIPTION#0.7902;PLATELET ACTIVATION#0.7871;TAMOXIFEN#0.7865;EPITHELIAL TO MESENCHYMAL#0.7832;SELECTIVE AUTOPHAGY#0.7821;CYSTIC FIBROSIS#0.7806;CENTRAL NERVOUS SYSTEM#0.7788;MOUSE EMBRYONIC FIBROBLAST#0.7780;ACTIN CYTOSKELETON#0.7773;ADIPOCYTE#0.7766;NOCODAZOLE#0.7748;RNA BINDING#0.7741;CD8+ T CELL#0.7728;OXYGEN GLUCOSE DEPRIVATION#0.7714;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7681;STRESS GRANULE#0.7679;MICROTUBULE DISASSEMBLY#0.7675;MITOSIS#0.7666;PERIPHERAL NERVE#0.7662;ISCHEMIA#0.7661;FOCAL ADHESION#0.7606;ESTROGEN RECEPTOR ALPHA#0.7596;HEMORRHAGIC#0.7592;NEUROTOXICITY#0.7585;IMMUNE CELL#0.7573;OSTEOCLAST#0.7564;RETINOIC ACID#0.7561;NUCLEAR EXPORT#0.7560;STROMAL CELL#0.7555;BLOOD VESSEL#0.7555;CERVICAL#0.7552;LYMPH NODE#0.7532;DEUBIQUITINATING ENZYME#0.7524;RAPAMYCIN#0.7508;CYTOPLASMIC INCLUSION#0.7507;SIGNAL TRANSDUCTION#0.7500;SIGNALLING PATHWAY#0.7488;NON HODGKIN LYMPHOMA#0.7444;MICROTUBULE DEPOLYMERIZATION#0.7436;CARDIOMYOCYTE#0.7433;CELL FUSION#0.7433;DNA DAMAGE RESPONSE#0.7429;CELL MOVEMENT#0.7420;MANTLE CELL LYMPHOMA#0.7405;MUSCLE WASTING#0.7398;TEMOZOLOMIDE#0.7397;CLEAVED CASPASE 3#0.7396;PROTEASOME PATHWAY#0.7386;ORAL SQUAMOUS CELL CARCINOMA#0.7377;T LYMPHOCYTE#0.7366;REGULATORY T CELL#0.7362;FLOWERING#0.7345;TRANSFORMING GROWTH FACTOR#0.7332;EXTRACELLULAR MATRIX#0.7331;CELL SURFACE#0.7323;HYPOXIC#0.7299;PROTEIN DEACETYLASE#0.7298;INDUCED PLURIPOTENT STEM CELL#0.7253;CHEMOTAXIS#0.7253;ACUTE LUNG INJURY#0.7250;LIPID DROPLET#0.7249;ASTROCYTE#0.7245;NEUTROPHIL#0.7237;HISTONE H3 ACETYLATION#0.7232;ALPHA-TUBULIN ACETYLATION#0.7223;KINESIN#0.7218;SENESCENCE#0.7203;AUTOIMMUNE DISEASE#0.7199;RESPONSE TO STRESS#0.7199;CELL DIFFERENTIATION#0.7194;GENE SILENCING#0.7186;TUMOR NECROSIS FACTOR#0.7176;ADENOCARCINOMA#0.7171;LIVER CANCER#0.7160;CYTOKINE PRODUCTION#0.7132;SMOOTH MUSCLE CELL#0.7122;CHROMATIN REMODELING#0.7122;MECHANISMS OF ACTION#0.7094;MULTIPLE MYELOMA CELLS#0.7083;BASAL BODY#0.7061;EMBRYONIC KIDNEY#0.7019;REGULATION OF MICROTUBULE DYNAMICS#0.7013;DOXORUBICIN#0.6984;TOLL LIKE RECEPTOR#0.6982;OLIGODENDROCYTE#0.6967;GLIAL CYTOPLASMIC INCLUSION#0.6942;RNA BINDING PROTEIN#0.6936;CELL POLARIZATION#0.6928;DEMENTIA#0.6922;ATP BINDING#0.6918;INNATE IMMUNE RESPONSE#0.6820;ENDOTHELIAL GROWTH FACTOR#0.6801;AUTOPHAGOSOME FORMATION#0.6767;INVASIVE DUCTAL CARCINOMA#0.6747;SPERM MOTILITY#0.6743;M PHASE#0.6728;NUCLEAR MATRIX#0.6718;PROTEIN PROTEIN INTERACTION#0.6717;ACUTE LIVER FAILURE#0.6716;CELL CYCLE REGULATION#0.6709;DEFENSE RESPONSE#0.6701;MELANOMA CELL LINES#0.6674;PLATELET-DERIVED GROWTH FACTOR#0.6657;NEURITE#0.6650;KINASE INHIBITOR#0.6589;MICROTUBULE ORGANIZING CENTER#0.6584;WOUND HEALING#0.6526;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6524;ENDOSOME#0.6465;NEUROLOGICAL DISORDER#0.6458;RHEUMATOID ARTHRITIS#0.6456;TARGET OF RAPAMYCIN#0.6435;VASCULAR SMOOTH MUSCLE CELL#0.6421;SUPEROXIDE DISMUTASE#0.6401;ADIPOSE TISSUE#0.6396;MACROAUTOPHAGY#0.6394;DNA METHYLTRANSFERASE#0.6277;MONOCYTE#0.6264;MISMATCH REPAIR#0.6250;MITOCHONDRIAL MEMBRANE#0.6246;MITOPHAGY#0.6245;ESTRADIOL#0.6240;THYROID CANCER#0.6240;HUMAN EMBRYONIC KIDNEY#0.6223;RENAL CELL CARCINOMA#0.6220;TUMOR GROWTH INHIBITION#0.6219;TAXOL#0.6217;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6186;LUPUS ERYTHEMATOSUS#0.6184;BONE MARROW STROMAL#0.6183;AUTOPHAGOSOME MATURATION#0.6161;APOPTOTIC CELL DEATH#0.6145;17-DMAG#0.6145;CD4+ T CELL#0.6114;20S PROTEASOME#0.6106;MONONUCLEAR CELLS#0.6078;SKELETAL MUSCLE WASTING#0.6062;COLITIS#0.6061;LUNG ENDOTHELIAL CELLS#0.6053;RELAPSE FREE SURVIVAL#0.6051;ACUTE LUNG INFLAMMATION#0.6050;AXON INITIAL SEGMENT#0.6042;LUPUS NEPHRITIS#0.6040;MUSCLE ATROPHY#0.6034;CARFILZOMIB#0.6015;PULMONARY FIBROSIS#0.6004
100144434	NOTOCHORD#0.6311
100144632	PHOSPHATE BINDING PROTEIN#1.1505;PHOSPHATE BINDING#1.1447
100144748	BREAST CANCER#1.0349;CELL CYCLE#0.9946;TUMOR SUPPRESSOR#0.9741;APOPTOSIS#0.9661;S PHASE#0.9339;DNA BINDING#0.8921;THYROID CANCER#0.8564;BREAST CARCINOMA#0.8536;DNA REPLICATION#0.7916;CANCER CELL#0.7255;TRANSCRIPTION FACTOR#0.7123;DUAL LUCIFERASE REPORTER#0.6471;DNA SYNTHESIS#0.6392;ANDROGEN RECEPTOR#0.6308;BREAST CANCER CELL#0.6287;PERICENTRIC HETEROCHROMATIN#0.6152;FOLLICULAR THYROID CANCER#0.6076
10014	PROTEIN KINASE D#1.0556;NUCLEAR EXPORT#1.0547;CANCER CELL#1.0247;MYOCYTE ENHANCER FACTOR#1.0229;HISTONE DEACETYLASE#1.0171;AXON REGENERATION#1.0161;PROTEIN KINASE#1.0089;TRANSCRIPTION FACTOR#0.9984;ENDOTHELIAL CELL#0.9982;SKELETAL MUSCLE#0.9978;APOPTOSIS#0.9965;CAMKII#0.9880;BREAST CANCER#0.9874;GENE EXPRESSION#0.9859;HISTONE ACETYLATION#0.9841;SIGNALING PATHWAY#0.9824;NUCLEAR IMPORT#0.9781;T CELL#0.9770;GROWTH FACTOR#0.9691;MYOCYTES#0.9652;CARDIOMYOCYTE#0.9571;CYTOPLASM#0.9488;CELL PROLIFERATION#0.9480;LYSINE#0.9208;MUSCLE CELL#0.9162;SMOOTH MUSCLE#0.8855;CELL GROWTH#0.8619;REGENERATION#0.8589;PROTEIN KINASE C#0.8416;ANGIOGENESIS#0.8372;CAMP RESPONSE ELEMENT#0.8234;SMOOTH MUSCLE CELL#0.8166;HISTONE MODIFICATION#0.8122;CAMP RESPONSE ELEMENT BINDING#0.8101;CD4+ T CELL#0.7935;VASCULAR SMOOTH MUSCLE CELL#0.7899;PRO-INFLAMMATORY#0.7884;KINASE ACTIVITY#0.7808;DEPHOSPHORYLATION#0.7789;STEM CELL#0.7761;HYPOXIA#0.7747;HISTONE DEACETYLASE INHIBITOR#0.7687;POLYMERASE CHAIN REACTION#0.7605;HISTONE ACETYLTRANSFERASE#0.7582;HYPOXIA INDUCIBLE FACTOR#0.7506;CELL DIFFERENTIATION#0.7502;CELL CYCLE#0.7358;PROTEIN KINASE A#0.7312;MITOGEN ACTIVATED PROTEIN#0.7273;MYOCARDIAL INFARCTION#0.7264;INFLAMMATORY RESPONSE#0.7263;MYOBLAST#0.7256;RNA INTERFERENCE#0.7233;OSTEOBLAST#0.7222;TUMOR CELLS#0.7193;ISCHEMIA#0.7180;MYOTUBE#0.7100;EPITHELIAL CELL#0.7024;ADRENERGIC RECEPTOR#0.7019;TRANSACTIVATION#0.6905;GLUCOSE UPTAKE#0.6850;COLORECTAL CANCER#0.6806;B CELL#0.6785;CELL DEATH#0.6781;PROGENITOR CELL#0.6777;HIGH FAT DIET#0.6760;C TERMINAL DOMAIN#0.6740;BREAST CANCER CELL#0.6739;HEPATOCELLULAR CARCINOMA#0.6735;TUMOR SUPPRESSOR#0.6608;TUBULIN DEACETYLATION#0.6537;HUMAN BREAST CANCER#0.6514;QUANTITATIVE REAL TIME#0.6508;OSTEOBLAST DIFFERENTIATION#0.6367;TUBULIN DEACETYLASE#0.6366;ISOPROTERENOL#0.6364;OSTEOCYTE#0.6330;HISTONE H3 ACETYLATION#0.6320;OBESE#0.6275;BONE FORMATION#0.6220;REVERSE TRANSCRIPTION#0.6193;DNA METHYLATION#0.6180;DNA BINDING#0.6159;STRIATUM#0.6148;HEART VALVE FORMATION#0.6142;MYOSIN HEAVY CHAIN#0.6036;PHENYLEPHRINE#0.6020
100151683	SPLICEOSOME#1.0658;SMALL NUCLEAR RNA#0.9432;U6ATAC SNRNP#0.9300;MICROCEPHALY#0.7203;BASE PAIRING#0.7201;U5 SNRNP#0.6622
100151684	SPLICEOSOME#1.0768;U6ATAC SNRNP#1.0478;BASE PAIRING#0.7957;U5 SNRNP#0.6699
10015	ABSCISSION#1.0599;VIRUS BUDDING#1.0506;PROGRAMMED CELL DEATH#1.0454;MIDBODY#1.0402;LATE ENDOSOME#1.0396;CELL DEATH#1.0302;EXOSOME#1.0295;VIRAL BUDDING#1.0270;MULTIVESICULAR BODY#1.0263;BUDDING#1.0179;CYTOKINESIS#1.0174;APOPTOSIS#1.0164;ENDOSOME#1.0124;VIRION#1.0081;UBIQUITIN#1.0050;CYTOKINETIC ABSCISSION#1.0045;GROWTH FACTOR#1.0035;VIRUS LIKE PARTICLE#1.0013;EXOSOME BIOGENESIS#0.9982;EXTRACELLULAR VESICLE#0.9819;PLASMA MEMBRANE#0.9806;HUMAN IMMUNODEFICIENCY VIRUS#0.9781;STEM CELL#0.9720;TRANSMISSION ELECTRON MICROSCOPY#0.9704;HOST CELL#0.9547;NUCLEOCAPSID#0.9540;CELL ADHESION#0.9523;MULTIVESICULAR ENDOSOME#0.9514;ENDOCYTOSIS#0.9470;CELL SURFACE#0.9410;LYSOSOME#0.9356;ACTIN CYTOSKELETON#0.9328;CANCER CELL#0.9118;ESCRT III COMPLEX#0.9079;CELL PROLIFERATION#0.9039;EQUINE INFECTIOUS ANEMIA#0.8958;VESICLE FORMATION#0.8851;ENDOTHELIAL CELL#0.8811;EPIDERMAL GROWTH FACTOR#0.8723;VACUOLAR PROTEIN SORTING#0.8707;RNA INTERFERENCE#0.8687;CELL MEMBRANE#0.8672;EPITHELIAL CELL#0.8623;SIGNALING PATHWAY#0.8588;CYTOPLASM#0.8563;MICROVESICLE#0.8535;MEMBRANE FISSION#0.8523;BREAST CANCER#0.8505;ENDOSOMAL MEMBRANE#0.8435;CELL DIVISION#0.8425;ACTIN FILAMENT#0.8416;T CELL#0.8349;GROWTH FACTOR RECEPTOR#0.8324;ANGIOGENESIS#0.8285;AUTOPHAGY#0.8207;CELL MIGRATION#0.8198;APOPTOTIC#0.8094;CELL CYCLE#0.8014;PROTEIN COMPLEX#0.7874;GLUTATHIONE#0.7833;HEAT SHOCK PROTEIN#0.7791;VACUOLE#0.7611;GALECTIN#0.7559;CELL COMMUNICATION#0.7490;ANEMIA#0.7359;VIRAL REPLICATION#0.7308;PROTEIN TYROSINE PHOSPHATASE#0.7270;ACTIN POLYMERIZATION#0.7142;LIPID RAFT#0.6949;SIGNAL TRANSDUCTION#0.6921;MESENCHYMAL STEM CELL#0.6771;CELLULAR MEMBRANE#0.6677;PROTEIN PROTEIN INTERACTION#0.6625;IMMUNE RESPONSE#0.6573;ASTROCYTE#0.6571;INTERCELLULAR BRIDGE#0.6547;CENTROSOME#0.6399;SIMIAN IMMUNODEFICIENCY VIRUS#0.6381;PROGENITOR CELL#0.6295;MUSCLE CELL#0.6261;SKELETAL MUSCLE#0.6260;ORGANELLE#0.6242;EARLY ENDOSOME#0.6234;MIDBODY RING#0.6232;CONTRACTILE RING#0.6163;TUMOR CELLS#0.6130;GERMLINE STEM CELL#0.6126;ESCRT I COMPLEX#0.6125;MVB BIOGENESIS#0.6102;ESCRT COMPLEX#0.6071;M PHASE#0.6066;EPITHELIAL BARRIER FUNCTION#0.6045
100169750	TETRAHYDROPYRAN#1.0656;ACETAL#0.9790;DNA SYNTHESIS#0.7074;SKELETON#0.6947;DODECANE#0.6148;CANCER CELL#0.6132
10016	PROGRAMMED CELL DEATH#1.0573;APOPTOTIC#1.0448;CELL DEATH#1.0436;APOPTOSIS#1.0425;CANCER CELL#1.0165;ENDOPLASMIC RETICULUM#1.0147;OVARIAN CANCER#0.9920;T CELL#0.9888;CELL PROLIFERATION#0.8972;CYTOPLASM#0.8887;LUNG CANCER#0.8884;ER TO GOLGI TRANSPORT#0.8839;OVARIAN#0.8304;ENDOPLASMIC RETICULUM EXIT SITE#0.8241;ER EXIT SITE#0.8137;ER EXIT#0.8073;COPII VESICLE#0.7980;PLASMA MEMBRANE#0.7946;ENDOSOME#0.7872;SIGNAL TRANSDUCTION#0.7766;CELL CYCLE#0.7720;SIGNALING PATHWAY#0.7476;POLYMERASE CHAIN REACTION#0.7323;BUDDING#0.7205;GLUTATHIONE#0.6952;COPII VESICLE BUDDING#0.6839;MULTIVESICULAR BODY#0.6569;BIOTIN#0.6448;CERVICAL#0.6427;SURFACE PLASMON RESONANCE#0.6391;MICROTUBULE#0.6209;GENE EXPRESSION#0.6192;CELL GROWTH#0.6120;PROTEIN COMPLEX#0.6086;EPITHELIAL OVARIAN CANCER#0.6082;CEREBRAL ISCHEMIA#0.6036;RNA BINDING#0.6027
10017	APOPTOTIC#1.0360;CELL DEATH#1.0350;APOPTOSIS#1.0248;CANCER CELL#0.9507;OOCYTE#0.9276;B CELL#0.8651;OOCYTE MATURATION#0.8163;AUTOPHAGY#0.7740;CELL CYCLE#0.7599;GENE EXPRESSION#0.7464;BONE MARROW#0.7200;MITOCHONDRIA#0.7170;B CELL LYMPHOMA#0.7136;PLASMA CELL#0.6911;RNA INTERFERENCE#0.6887;OVARIAN#0.6625;OVARIES#0.6129;MYELODYSPLASTIC SYNDROME#0.6067;MYELOID LEUKEMIA#0.6024
100187716	APOPTOSIS#0.7532;GENE EXPRESSION#0.7434;CELL PROLIFERATION#0.6315;SIGNALING PATHWAY#0.6313;HIPPO SIGNALING PATHWAY#0.6087;HIPPO SIGNALING#0.6031
100187907	TRIIODOTHYRONINE#0.8505;THYROID HORMONE RECEPTOR#0.7752;RETINOID X RECEPTOR#0.7032;QUADRUPOLE ION TRAP#0.6416;LINEAR ION TRAP#0.6316;ALIZARIN RED S#0.6150
100188011	PNEUMONIA#0.7798;INTERSTITIAL LUNG DISEASE#0.7749;LUNG DISEASE#0.7688;LANGERHANS CELL#0.6524
100188278	BREAST CANCER#0.6913
100188754	PNEUMONIA#0.6685
100188771	CELL SURFACE#0.7485;CELL WALL#0.7401
100188776	TRANSCRIPTION FACTOR#0.9248;SIGNALING PATHWAY#0.6102;ENDOTHELIAL CELL#0.6013
100188785	CHROMATIN REMODELING#0.6821
100188789	T CELL#0.6838;PROSTATE CANCER#0.6292
100188795	GROWTH FACTOR#1.0102;NERVE GROWTH FACTOR#0.9860;ALZHEIMER'S DISEASE#0.9427;CANCER CELL#0.7987;GENE EXPRESSION#0.7727;T CELL#0.7666;TROPISM#0.6946
100188812	RESTLESS LEGS SYNDROME#0.7222
100188813	AGE AT ONSET#0.7278;RESTLESS LEGS SYNDROME#0.6051
100188821	EGG LAYING#0.9286;SIGNALING PATHWAY#0.7837;HETEROTRIMERIC G-PROTEIN#0.7807;COMPLEX I#0.7028;SPINDLE POSITIONING#0.6781;DIACYLGLYCEROL KINASE#0.6484;LOCOMOTION#0.6394;SYNAPTIC TRANSMISSION#0.6276;PROTEIN KINASE#0.6082
100188830	CELL SURFACE#1.0478;DNA METHYLATION#1.0457;MAJOR HISTOCOMPATIBILITY COMPLEX#1.0370;TUMOR CELLS#1.0356;VIRAL GENOME#1.0350;DNA REPLICATION#1.0279;ONCOGENIC#1.0269;VIRION#1.0196;DNA BINDING#1.0024;DNA INTEGRATION#1.0023;GENE EXPRESSION#1.0013;TUMOR ANTIGEN#1.0001;T LYMPHOCYTE#0.9842;HOST CELL#0.9768;DNA SYNTHESIS#0.9736;CYTOTOXIC T-LYMPHOCYTE#0.9708;VIRAL DNA REPLICATION#0.9688;VIRAL REPLICATION#0.9265;LYSIS#0.8805;S PHASE#0.8547;METAPHASE#0.8006;ONCOGENESIS#0.7863;TRANSCRIPTION FACTOR#0.7854;CELL CYCLE#0.7853;CYTOPLASM#0.7792;CARRIE#0.7703;PROTEIN KINASE#0.7401;IFN-GAMMA#0.7213;VIRAL INFECTION#0.6802;RETINOBLASTOMA#0.6768;TRANSACTIVATION#0.6727;T CELL#0.6695;PROTEIN SYNTHESIS#0.6620;HUMAN EMBRYONIC KIDNEY#0.6555;EMBRYONIC KIDNEY#0.6550;CYTOSINE ARABINOSIDE#0.6387;CYTOTOXICITY#0.6325;C-TERMINAL BINDING#0.6285;MHC PROTEIN#0.6203;SMALL NUCLEAR RNA#0.6042;DNA DEGRADATION#0.6033
100188832	AUTISTIC#0.6075
100188839	RESTLESS LEGS SYNDROME#0.7856;RESTLESS#0.6024
100188845	OPTIC DISC#1.0711;OPTIC PIT#0.9942;OPTIC NERVE#0.9235;OPTICAL COHERENCE TOMOGRAPHY#0.6615
100188846	ABBREVIATED INJURY SCALE#0.9240;INSOMNIA#0.8311;INJURY SEVERITY SCORE#0.8017;TRAUMATIC BRAIN INJURY#0.6779
100188848	MESIAL TEMPORAL LOBE#1.1435;TEMPORAL LOBE EPILEPSY#1.1321;TEMPORAL LOBE#1.1279;EPILEPSY#1.0427
100188857	DYNEIN#1.0323;MICROTUBULE#0.7333;ATP HYDROLYSIS#0.6912;MICROTUBULE BINDING#0.6904;NUCLEOTIDE BINDING#0.6826
100188863	XYLANASE#0.9370;CELL SURFACE#0.6943;CELL WALL#0.6746;GLUCOSE HOMEOSTASIS#0.6238
100188864	MEDULLARY SPONGE KIDNEY#1.1186;ANIRIDIA#1.0698;GIGANTISM#1.0676;NEVUS#1.0433;SCOLIOSIS#1.0410;MACROCEPHALY#1.0408;BECKWITH-WIEDEMANN SYNDROME#1.0269;KLIPPEL-TRENAUNAY SYNDROME#1.0258;PROTEUS SYNDROME#1.0254;MENTAL RETARDATION#1.0145;EPIDERMAL NEVUS#0.9915;HEMANGIOMA#0.9729;HYPOGLYCEMIA#0.9692;LIPOMATOSIS#0.9500;HEPATOBLASTOMA#0.9490;OMPHALOCELE#0.9362;VARICOSE VEINS#0.9058;ADRENOCORTICAL CARCINOMA#0.9001;HAMARTOMA#0.8967;DEVELOPMENTAL DELAY#0.8620;CONNECTIVE TISSUE#0.8387;LIPOMA#0.8379;PHEOCHROMOCYTOMA#0.8252;NEPHROBLASTOMA#0.7566;UMBILICAL HERNIA#0.7564;CENTRAL NERVOUS SYSTEM#0.7553;NERVOUS SYSTEM#0.7543;NODULAR#0.7502;RENAL CELL CARCINOMA#0.7427;CRYPTORCHIDISM#0.7122;RHABDOMYOSARCOMA#0.6969;CONGENITAL HEART DISEASE#0.6965;CONGENITAL HEART DEFECTS#0.6872;HEART DISEASE#0.6859;PORT-WINE STAIN#0.6634;CONGENITAL DISORDER#0.6587;MAGNETIC RESONANCE IMAGING#0.6355;ADRENAL CARCINOMA#0.6339;CONGENITAL HIP DISLOCATION#0.6250;POLYDACTYLY#0.6241;SWELLING#0.6214;CLEAR CELL ADENOCARCINOMA#0.6183;DENYS-DRASH SYNDROME#0.6157;PLEXIFORM NEUROFIBROMA#0.6089;NEUROFIBROMA#0.6003
100188881	T CELL#0.9845;POLYMERASE CHAIN REACTION#0.9801;AMPICILLIN#0.8168;TOXICITY#0.7995;CYTOTOXICITY#0.7976;TETRACYCLINE#0.7746;CANCER CELL#0.7663;CEFTAZIDIME#0.7282;APOPTOSIS#0.6968;MINIMUM INHIBITORY CONCENTRATION#0.6882;DYNAMIC LIGHT SCATTERING#0.6833;IMIPENEM#0.6759;CEFOTAXIME#0.6578;BETA-LACTAMASE ACTIVITY#0.6336;CELL WALL#0.6232;MITOCHONDRIA#0.6204;DRUG RESISTANCE#0.6048
100188893	GIP COMPLEX#1.0568;TOM COMPLEX#1.0513;OUTER MEMBRANE#1.0131;MITOCHONDRIA#0.8926;MITOCHONDRIAL OUTER MEMBRANE#0.8380;OUTER MITOCHONDRIAL MEMBRANE#0.6806;MITOCHONDRIAL MEMBRANE#0.6719;PROTEIN IMPORT#0.6091
10018	ANOIKIS#1.0394;HEPATOCYTE APOPTOSIS#1.0297;DYNEIN#1.0281;GEFITINIB#1.0278;CLEAVED CASPASE 3#1.0274;ERLOTINIB#1.0232;ER STRESS-INDUCED APOPTOSIS#1.0206;ACTIVATED T CELL#1.0197;SORAFENIB#1.0196;THYMOCYTE#1.0195;INTRINSIC APOPTOTIC PATHWAY#1.0176;OSTEOCLAST#1.0174;APOPTOSIS INDUCING FACTOR#1.0165;ACTIVATED T-CELLS#1.0145;LYMPHOID CELL#1.0128;PACLITAXEL#1.0122;BETA CELL#1.0090;ABT-263#1.0087;DEPHOSPHORYLATION#1.0076;IMATINIB#1.0070;CD8+ T CELL#1.0069;B LYMPHOCYTE#1.0044;MITOCHONDRIAL TRANSLOCATION#1.0043;PROTEIN KINASE C#1.0042;RNA INTERFERENCE#1.0027;BORTEZOMIB#1.0004;AUTOPHAGY#1.0003;DEXAMETHASONE#0.9994;LUNG ADENOCARCINOMA#0.9993;MEMORY T CELL#0.9988;VORINOSTAT#0.9985;AUTOIMMUNITY#0.9982;CELL KILLING#0.9980;APOPTOTIC#0.9970;INTRINSIC APOPTOSIS#0.9969;T CELL APOPTOSIS#0.9966;MOUSE EMBRYONIC FIBROBLAST#0.9963;CISPLATIN#0.9960;MAP KINASE#0.9960;CYTOCHROME C RELEASE#0.9958;EPSTEIN BARR VIRUS#0.9951;HEMATOPOIETIC CELL#0.9947;DEATH RECEPTOR#0.9946;MICROTUBULE#0.9941;PROTEASOME#0.9939;POLY ADP RIBOSE#0.9938;CD4+ T CELL#0.9931;POLYMERASE CHAIN REACTION#0.9929;SIGNALLING PATHWAY#0.9920;MACROPHAGE#0.9918;MITOCHONDRIAL OUTER MEMBRANE#0.9906;CYCLIN DEPENDENT KINASE#0.9899;B CELL LYMPHOMA#0.9896;MAST CELL#0.9891;PANCREATIC CANCER#0.9889;THYMOCYTE APOPTOSIS#0.9886;OUTER MEMBRANE#0.9885;ISCHEMIA#0.9881;RIBOSE#0.9880;DOXORUBICIN#0.9878;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9873;T CELL#0.9861;B CELL#0.9860;LUNG CANCER#0.9860;HYPOXIA#0.9854;OVARIAN CANCER#0.9853;TYROSINE KINASE INHIBITOR#0.9848;CYTOCHROME C#0.9845;LYMPHOCYTIC LEUKEMIA#0.9842;APOPTOSIS#0.9842;OVARIAN#0.9841;ACTIVATED CASPASE 3#0.9840;CASPASE ACTIVATION#0.9840;DNA FRAGMENTATION#0.9832;ENDOTHELIAL CELL#0.9831;DYNEIN LIGHT CHAIN#0.9827;MYELOID CELL#0.9825;HISTONE DEACETYLASE INHIBITOR#0.9823;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9821;CASPASE-3 ACTIVITY#0.9819;CELL DEATH#0.9813;MITOCHONDRIA#0.9810;SENSITIZATION#0.9810;T LYMPHOCYTE#0.9802;BREAST CANCER CELL#0.9802;PERIPHERAL BLOOD#0.9801;UBIQUITIN#0.9793;CELL DEVELOPMENT#0.9789;SIGNALING CASCADE#0.9789;INDUCTION OF APOPTOSIS#0.9785;MITOCHONDRIAL MEMBRANE#0.9784;CHRONIC MYELOID LEUKEMIA#0.9775;HUMAN BREAST CANCER#0.9772;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9765;EPIDERMAL GROWTH FACTOR#0.9764;KINASE INHIBITOR#0.9762;CELL ACTIVATION#0.9761;DRUG RESISTANCE#0.9761;ADENOCARCINOMA#0.9761;ETOPOSIDE#0.9758;MITOGEN ACTIVATED PROTEIN#0.9751;PROGRAMMED CELL DEATH#0.9748;ONCOGENIC#0.9748;CARDIOMYOCYTE#0.9747;MITOSIS#0.9747;CYTOPLASM#0.9746;TUMOR SUPPRESSOR#0.9745;GROWTH FACTOR RECEPTOR#0.9741;REGULATION OF APOPTOSIS#0.9739;APOPTOTIC CELL DEATH#0.9738;MULTIPLE MYELOMA#0.9736;ENDOPLASMIC RETICULUM STRESS#0.9733;NEURONAL CELLS#0.9728;GRANULOSA CELL#0.9727;HISTONE DEACETYLASE#0.9723;EPITHELIAL CELL#0.9722;AKT SIGNALING#0.9720;RAPAMYCIN#0.9718;BONE MARROW#0.9718;SIGNAL TRANSDUCTION#0.9717;PROGENITOR CELL#0.9717;T CELL ACTIVATION#0.9710;TRANSCRIPTION FACTOR#0.9710;NEUTROPHIL#0.9708;COLORECTAL CANCER#0.9706;COLON CANCER#0.9704;TUMOR NECROSIS FACTOR#0.9704;REVERSE TRANSCRIPTION#0.9703;PROTEIN KINASE#0.9701;BREAST CANCER#0.9701;COLORECTAL#0.9700;MYELOID LEUKEMIA#0.9695;PROSTATE CANCER#0.9693;MITOCHONDRIAL DEPOLARIZATION#0.9691;RESVERATROL#0.9691;ENDOPLASMIC RETICULUM#0.9689;IMMUNE RESPONSE#0.9689;NEURONAL CELL DEATH#0.9688;SQUAMOUS CELL CARCINOMA#0.9666;TARGET OF RAPAMYCIN#0.9665;STEM CELL#0.9661;APOPTOSIS SIGNALING#0.9661;MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION#0.9661;PROTEIN KINASE B#0.9661;ACTIVE CASPASE 3#0.9658;TUMOR CELLS#0.9655;REACTIVE OXYGEN SPECIES#0.9651;RECEPTOR TYROSINE KINASE#0.9650;CYTOTOXICITY#0.9650;OSTEOBLAST#0.9650;PROTEIN PROTEIN INTERACTION#0.9647;TRANSFORMING GROWTH FACTOR#0.9646;TOXICITY#0.9639;GROWTH FACTOR#0.9639;HEPATOCELLULAR CARCINOMA#0.9637;NEURON DEATH#0.9634;GENE EXPRESSION#0.9633;SIGNALING PATHWAY#0.9631;CELL CYCLE ARREST#0.9625;MULTIPLE MYELOMA CELLS#0.9620;M PHASE#0.9615;IMMUNE SYSTEM#0.9615;ACUTE MYELOID LEUKEMIA#0.9614;CANCER CELL#0.9602;MECHANISM OF ACTION#0.9594;CELL CYCLE#0.9586;DNA BINDING#0.9586;CASPASE INHIBITOR#0.9571;LYSINE#0.9565;CELL PROLIFERATION#0.9557;NEUROBLASTOMA#0.9555;CELL GROWTH#0.9547;INHIBITION OF APOPTOSIS#0.9540;MYELOID CELL LEUKEMIA#0.9535;G1 PHASE#0.9535;QUANTITATIVE REAL TIME#0.9491;LYMPH NODE#0.9488;ANGIOGENESIS#0.9464;VIRAL INFECTION#0.9464;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.9449;STROMAL CELL#0.9448;HOST CELL#0.9444;REGULATORY T CELL#0.9437;AUTOIMMUNE DISEASE#0.9426;B CELL RECEPTOR#0.9419;NITRIC OXIDE#0.9398;OUTER MITOCHONDRIAL MEMBRANE#0.9398;SIGNAL TRANSDUCER#0.9378;APOPTOTIC PROGRAM#0.9372;LYMPHOCYTE APOPTOSIS#0.9346;CELL DIFFERENTIATION#0.9340;CELL SURFACE#0.9338;DNA METHYLATION#0.9338;COMPLEX I#0.9325;UNFOLDED PROTEIN RESPONSE#0.9323;PHOSPHATASE 2A#0.9307;T CELL HOMEOSTASIS#0.9301;NEUROPROTECTION#0.9296;CDK INHIBITOR#0.9290;DENDRITIC CELL#0.9280;MELANOMA CELL LINES#0.9269;EXTRACELLULAR MATRIX#0.9264;MELPHALAN#0.9258;PROTEIN SYNTHESIS#0.9247;CERVICAL CANCER#0.9229;CELL MIGRATION#0.9226;ESTROGEN RECEPTOR#0.9212;DEATH RECEPTOR 5#0.9200;KINASE ACTIVITY#0.9196;IMMUNE CELL#0.9182;ISCHEMIA REPERFUSION INJURY#0.9170;INSULIN-LIKE GROWTH FACTOR#0.9154;NERVOUS SYSTEM#0.9127;TUMOR TISSUES#0.9115;TRANSACTIVATION#0.9105;MAPK SIGNALING#0.9081;MANTLE CELL LYMPHOMA#0.9071;TOLL LIKE RECEPTOR#0.9046;EFFECTOR T CELL#0.9045;PROPIDIUM#0.9028;MOLECULAR DYNAMICS SIMULATION#0.8996;TRANSFORMING GROWTH FACTOR BETA#0.8984;COLONY-STIMULATING FACTOR#0.8977;CYCLIN DEPENDENT KINASE INHIBITOR#0.8976;PROTEIN KINASE A#0.8967;MAMMARY GLAND#0.8953;LYMPHOMA CELL LINES#0.8937;RECEPTOR AGONIST#0.8923;ROS GENERATION#0.8910;SEQUESTERING#0.8909;PROTEIN PHOSPHATASE 2A#0.8891;CEREBELLAR GRANULE NEURON#0.8881;PROTEASOME PATHWAY#0.8878;GLYCOGEN SYNTHASE KINASE#0.8866;NERVE GROWTH FACTOR#0.8855;MAMMARY EPITHELIAL CELL#0.8849;GLUCOCORTICOID RECEPTOR#0.8842;LUMINAL#0.8840;ALZHEIMER'S DISEASE#0.8805;S PHASE#0.8805;MAPK ACTIVATION#0.8777;SUPEROXIDE DISMUTASE#0.8733;ANTI APOPTOSIS#0.8730;EXTRINSIC APOPTOSIS#0.8720;PHOSPHATASE AND TENSIN HOMOLOG#0.8719;PRO-INFLAMMATORY#0.8703;GENE SILENCING#0.8674;ACTIVATION-INDUCED CELL DEATH#0.8672;MUTAGENESIS#0.8671;HYPOXIC#0.8665;T CELL DEVELOPMENT#0.8660;BURKITT LYMPHOMA#0.8647;DIFFUSE LARGE B-CELL LYMPHOMA#0.8642;CERVICAL#0.8605;PARKINSON'S DISEASE#0.8589;HEAT SHOCK PROTEIN#0.8558;NITRIC OXIDE SYNTHASE#0.8543;APOPTOTIC PROCESS#0.8538;ADENOSINE#0.8537;MITOCHONDRIAL DAMAGE#0.8533;B CELL DEVELOPMENT#0.8517;OVARIAN CARCINOMA#0.8475;DISEASE CONTROL RATE#0.8462;INFLAMMATORY RESPONSE#0.8461;OBJECTIVE RESPONSE RATE#0.8428;CELL ADHESION#0.8422;PLASMA CELL#0.8419;HISTONE ACETYLATION#0.8359;HYPOXIA INDUCIBLE FACTOR#0.8314;SIGNALING MOLECULE#0.8310;MITOCHONDRIAL TRANSMEMBRANE POTENTIAL#0.8300;NON HODGKIN LYMPHOMA#0.8286;JNK SIGNALING PATHWAY#0.8279;LYSOSOME#0.8278;ARTERY#0.8219;ENHANCER BINDING#0.8209;MITOCHONDRION#0.8208;RECEPTOR ANTAGONIST#0.8203;PROTEIN DEGRADATION#0.8201;HEPATOCELLULAR CARCINOMA CELL#0.8195;MELANOCYTE#0.8187;GLUTATHIONE#0.8184;GERM CELL#0.8178;N-ACETYLCYSTEINE#0.8147;OXYGEN GLUCOSE DEPRIVATION#0.8130;MAST CELL APOPTOSIS#0.8129;RENAL CARCINOMA#0.8112;ARSENIC TRIOXIDE#0.8104;MITOCHONDRIAL MEMBRANE PERMEABILITY#0.8062;DNA REPAIR#0.8045;LEUKOCYTE#0.7990;LAPATINIB#0.7957;EXTRINSIC APOPTOTIC PATHWAY#0.7936;ENDOTHELIAL GROWTH FACTOR#0.7924;CEREBRAL ISCHEMIA#0.7919;ALANINE#0.7901;VINCRISTINE#0.7886;GRANULOCYTE#0.7882;MELATONIN#0.7841;DOCETAXEL#0.7825;NECROPTOSIS#0.7815;DNA DAMAGE RESPONSE#0.7811;HEPATOMA CELLS#0.7805;DASATINIB#0.7790;CYTARABINE#0.7788;OVARIES#0.7786;MITOCHONDRIAL MEMBRANE DEPOLARIZATION#0.7778;ENHANCER BINDING PROTEIN#0.7762;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7755;FOLLICULAR LYMPHOMA#0.7753;SUBEROYLANILIDE HYDROXAMIC ACID#0.7734;LYMPHOCYTIC CHORIOMENINGITIS#0.7729;OOCYTE#0.7728;MECHANISMS OF ACTION#0.7726;APOPTOTIC SIGNALING PATHWAY#0.7726;GM-CSF#0.7698;TYPE 1 DIABETES#0.7697;BELINOSTAT#0.7694;MEMBRANE DEPOLARIZATION#0.7674;TREG CELL#0.7644;RESONANCE ENERGY TRANSFER#0.7637;L-PAM#0.7629;ADRENERGIC RECEPTOR#0.7618;BRAIN ISCHEMIA#0.7616;T CELL PROLIFERATION#0.7615;CELL DIVISION#0.7604;RENAL CELL CARCINOMA#0.7596;CENTRAL NERVOUS SYSTEM#0.7574;VIRAL REPLICATION#0.7572;LIGHT CHAIN 1#0.7571;GRANULOSA CELL APOPTOSIS#0.7559;KIDNEY DISEASE#0.7539;HEMATOPOIESIS#0.7536;5 FLUOROURACIL#0.7515;MONONUCLEAR CELLS#0.7470;PLASMA MEMBRANE#0.7465;FRAGMENT LENGTH POLYMORPHISM#0.7464;OPTIC NERVE#0.7461;MORPHOGENESIS#0.7428;BREAST CARCINOMA#0.7412;EPITHELIAL MESENCHYMAL TRANSITION#0.7412;RETINAL GANGLION CELL#0.7409;BETA ADRENERGIC RECEPTOR#0.7406;LIGHT CHAIN 3#0.7405;MRNA SPLICING#0.7390;LIVER DISEASE#0.7390;COLONY FORMATION ASSAY#0.7379;TRANSCRIPTIONAL CONTROL#0.7369;CYCLIC AMP#0.7363;TYPE 2 DIABETES#0.7360;ADENOSINE MONOPHOSPHATE#0.7358;MEMORY B CELL#0.7355;STATUS EPILEPTICUS#0.7354;ANISOMYCIN#0.7348;GERMINAL CENTER#0.7322;MESOTHELIOMA CELL#0.7315;MONOCYTE#0.7305;METFORMIN#0.7291;GASTRIC EPITHELIAL CELLS#0.7275;GLYCOLYSIS#0.7268;BREAST CANCER PATIENTS#0.7258;CASPASE ACTIVITY#0.7258;NEUROTOXICITY#0.7247;5-AZA-2'-DEOXYCYTIDINE#0.7238;TISSUE HOMEOSTASIS#0.7234;2'-DEOXYCYTIDINE#0.7233;LIPID OXIDATION#0.7232;COLORECTAL ADENOMA#0.7214;COLORECTAL CARCINOMA#0.7207;MICROTUBULE ASSOCIATED PROTEIN#0.7198;TAMOXIFEN#0.7182;INSULIN RECEPTOR#0.7181;CALCINEURIN#0.7179;SEVOFLURANE#0.7146;ACETYLCYSTEINE#0.7144;PI3K SIGNALING#0.7127;PROTEIN BINDING#0.7124;STAUROSPORINE#0.7119;JUN PHOSPHORYLATION#0.7112;NEUTROPHIL APOPTOSIS#0.7085;RHEUMATOID ARTHRITIS#0.7084;LIVER CANCER#0.7077;DAUNORUBICIN#0.7075;PANCREATIC BETA CELL APOPTOSIS#0.7071;POST-TRANSLATIONAL MODIFICATION#0.7066;SENESCENCE#0.7065;PALMITATE#0.7047;FACTOR I#0.7041;LYMPHOCYTE HOMEOSTASIS#0.7030;HISTONE MODIFICATION#0.7012;INHIBITION OF CELL PROLIFERATION#0.7002;GANGLION CELLS#0.6993;REPORTER GENE ASSAY#0.6989;CYTOTOXIC T CELL#0.6973;MIDDLE CEREBRAL ARTERY#0.6965;CEREBRAL ARTERY#0.6963;SENSITIZER#0.6941;NEURODEGENERATIVE DISEASE#0.6936;WOUND HEALING#0.6936;DUAL LUCIFERASE REPORTER#0.6926;MITOCHONDRIAL LOCALIZATION#0.6920;MUSCLE CELL#0.6918;LYMPHOCYTE DEVELOPMENT#0.6904;AUTOPHAGOSOME#0.6901;RECEPTOR LIGAND#0.6897;FLOW CYTOMETRY ANALYSIS#0.6887;OXALIPLATIN#0.6861;MITOTIC SPINDLE#0.6854;HEMATOPOIETIC STEM CELL#0.6799;COLITIS#0.6797;B CELL DIFFERENTIATION#0.6776;MALIGNANT GLIOMA#0.6757;TH1 CELL#0.6743;CEREBRAL ARTERY OCCLUSION#0.6713;NF-KAPPAB ACTIVATION#0.6703;BONE MARROW CELLS#0.6695;CELL CYCLE REGULATOR#0.6685;RETINOBLASTOMA#0.6640;VACCINIA#0.6609;HEAD AND NECK CANCER#0.6600;TUMOR GROWTH INHIBITION#0.6599;NECK CANCER#0.6599;CELL COUNTING KIT#0.6562;HEPATOCYTE GROWTH FACTOR#0.6537;NADPH OXIDASE#0.6531;GENOTOXIC#0.6527;DOPAMINERGIC NEURON#0.6523;HEPATITIS C#0.6513;ENDOTHELIAL CELL APOPTOSIS#0.6511;HEART DISEASE#0.6505;ACTIVATED B CELL#0.6504;ASTROCYTE#0.6490;PHOSPHATIDYLSERINE#0.6469;NAIVE T CELL#0.6464;FLUOROURACIL#0.6458;GLUCOSE REGULATED PROTEIN#0.6456;PRECURSOR CELL#0.6454;ADENYLATE CYCLASE#0.6450;HUNTINGTON'S DISEASE#0.6447;VIRULENCE#0.6444;ANCHORAGE INDEPENDENT GROWTH#0.6438;RESPONSE TO TREATMENT#0.6425;CORD BLOOD#0.6410;CYTOKINE PRODUCTION#0.6386;MEDIATED DRUG RESISTANCE#0.6374;SPINAL CORD#0.6369;LENALIDOMIDE#0.6323;CAMKII#0.6294;SPINDLE ASSEMBLY#0.6289;ACTIVATING TRANSCRIPTION FACTOR#0.6275;SIMVASTATIN#0.6269;BONE MARROW STROMAL CELL#0.6254;BONE MARROW STROMAL#0.6250;ALVEOLAR EPITHELIAL CELL#0.6246;ERYTHROID CELL#0.6237;EARLY GROWTH RESPONSE#0.6231;DOUBLE STRAND BREAK#0.6230;PHAGOCYTOSIS#0.6230;GRAFT VERSUS HOST#0.6230;BERBERINE#0.6225;GLUCOSE METABOLISM#0.6220;HIGH FAT DIET#0.6214;MYOCARDIAL INFARCTION#0.6198;ESTRADIOL#0.6189;T-CELL LEUKEMIA#0.6148;ACTINOMYCIN D#0.6134;HUMAN PANCREATIC CANCER#0.6133;EPITHELIAL TO MESENCHYMAL TRANSITION#0.6133;EPITHELIAL TO MESENCHYMAL#0.6131;B CELL APOPTOSIS#0.6101;IFN-GAMMA#0.6072;ERYTHROPOIESIS#0.6064;FORSKOLIN#0.6039;LYSOSOMAL MEMBRANE#0.6032;LEUCINE#0.6021;UBIQUITIN PROTEASOME PATHWAY#0.6018;RESPONSE TO ER STRESS#0.6012;PHOTORECEPTOR CELL#0.6011;B CELL HOMEOSTASIS#0.6010;RHABDOMYOSARCOMA#0.6005
100190939	CELL PROLIFERATION#0.7283;AKT SIGNALING#0.7209
100192378	HIPPO SIGNALING PATHWAY#1.2153;HIPPO SIGNALING#1.2097;BREAST CANCER#1.1796;SIGNALING PATHWAY#1.1785
10019	ENDOTHELIAL CELL#1.0605;HEMATOPOIETIC CELL#1.0467;CELL PROLIFERATION#1.0396;SIGNALING PATHWAY#1.0361;B CELL#1.0347;T CELL#1.0293;MYELOPROLIFERATIVE NEOPLASM#1.0261;STEM CELL#1.0230;HEMATOPOIETIC STEM CELL#1.0201;BONE MARROW#1.0195;TYPE 1 DIABETES#1.0171;GROWTH FACTOR#1.0092;CYTOKINE RECEPTOR#1.0032;HEMATOPOIESIS#0.9901;PROGENITOR CELL#0.9856;STEM CELL FACTOR#0.9798;AUTOIMMUNE DISEASE#0.9792;CELL GROWTH#0.9762;GENE EXPRESSION#0.9638;APOPTOSIS#0.9610;CELL ADHESION#0.9481;SIGNAL TRANSDUCTION#0.9458;CELIAC DISEASE#0.9372;HYPERTENSION#0.9350;PROTEIN KINASE#0.9170;ESSENTIAL THROMBOCYTHEMIA#0.8591;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8506;INSULIN RECEPTOR#0.8493;MYELOID LEUKEMIA#0.8210;POLYCYTHEMIA VERA#0.8100;TUMOR NECROSIS FACTOR#0.8049;MITOGEN ACTIVATED PROTEIN#0.8027;ANGIOGENESIS#0.7966;MYOCARDIAL INFARCTION#0.7857;IMMUNE RESPONSE#0.7802;MYELOFIBROSIS#0.7651;MAST CELL#0.7521;INSULIN-LIKE GROWTH FACTOR#0.7508;SIGNAL TRANSDUCER#0.7488;VASCULAR CELL#0.7480;TRANSCRIPTION FACTOR#0.7428;CANCER CELL#0.7424;MEGAKARYOCYTE#0.7330;CELL ACTIVATION#0.7275;ONCOGENIC#0.7244;ARTERY#0.7114;PLASMA MEMBRANE#0.7073;POLYCYTHEMIA#0.7064;COLORECTAL#0.6937;T LYMPHOCYTE#0.6912;LEUKOCYTE#0.6806;CORONARY ARTERY#0.6801;CELL DEVELOPMENT#0.6554;ARTERY DISEASE#0.6524;COLORECTAL CANCER#0.6320;CORONARY ARTERY DISEASE#0.6206;PERIPHERAL BLOOD#0.6205;HEMATOPOIETIC PROGENITOR CELL#0.6162;CHRONIC MYELOID LEUKEMIA#0.6148
1001	HYPOTRICHOSIS#1.0887;CELL ADHESION#1.0063;BREAST CANCER#0.9389;CANCER CELL#0.8823;CELL ADHESION MOLECULE#0.8694;BREAST CARCINOMA#0.8170;BREAST CANCER CELL#0.8153;HAIR FOLLICLE#0.7002;EPITHELIAL CELL#0.6986;GENE EXPRESSION#0.6909;ECTODERMAL DYSPLASIA#0.6611;RETINAL PIGMENT EPITHELIUM#0.6456
10020	INCLUSION BODY MYOPATHY#1.0460;GLCNAC#1.0425;MYOPATHY#1.0386;INCLUSION BODY#1.0372;SKELETAL MUSCLE#1.0300;SIALYLATION#1.0286;VACUOLE#1.0192;MUSCLE WEAKNESS#1.0074;QUADRICEPS#1.0057;MUSCLE ATROPHY#0.9290;GLUCOSAMINE#0.9148;CELL SURFACE#0.9143;ENZYME ACTIVITY#0.9033;CELL ADHESION#0.8806;MUSCLE CELL#0.8400;KINASE ACTIVITY#0.8200;GLYCOSYLATION#0.8176;STEM CELL#0.8003;EMBRYONIC STEM CELL#0.7955;URIDINE#0.7758;MYOBLAST#0.7640;LECTIN#0.7571;GLCNAC 2-EPIMERASE ACTIVITY#0.7492;GENE EXPRESSION#0.7240;MUSCLE FIBER#0.6982;APOPTOSIS#0.6912;MUSCULAR DYSTROPHY#0.6859;INCLUSION BODY MYOSITIS#0.6305;DIPHOSPHATE#0.6205;NEURAL CELL#0.6116;CELL ADHESION MOLECULE#0.6089
100216344	DYSTONIA#0.7788
10021	POTASSIUM CHANNEL#1.0475;BRADYCARDIA#1.0288;SICK SINUS SYNDROME#1.0231;CONNEXIN#1.0215;CATION CHANNEL#1.0173;TRANSCRIPTION FACTOR#1.0113;SINOATRIAL NODE CELL#1.0096;CARDIAC CONDUCTION#1.0023;CYCLIC NUCLEOTIDE GATED#0.9970;MYOCYTES#0.9949;STEM CELL#0.9917;ATRIAL FIBRILLATION#0.9913;POLYMERASE CHAIN REACTION#0.9888;GENE EXPRESSION#0.9885;CARDIOMYOCYTE#0.9878;MYOCARDIUM#0.9869;OOCYTE#0.9857;ION CHANNEL#0.9847;ARRHYTHMIA#0.9824;ACTION POTENTIAL#0.9797;SINUS NODE DYSFUNCTION#0.9696;TACHYCARDIA#0.9596;EMBRYONIC STEM CELL#0.9567;CELL MEMBRANE#0.9531;NERVOUS SYSTEM#0.9491;REVERSE TRANSCRIPTION#0.9445;CYCLIC NUCLEOTIDE BINDING#0.9373;PROTEIN KINASE#0.9349;CELL SURFACE#0.9258;CAMP BINDING#0.9234;NUCLEOTIDE BINDING#0.9142;NUCLEOTIDE BINDING DOMAIN#0.9030;ADRENERGIC RECEPTOR#0.9000;GAP JUNCTION#0.8784;HUMAN EMBRYONIC KIDNEY#0.8730;EMBRYONIC KIDNEY#0.8725;MESENCHYMAL STEM CELL#0.8717;BIPOLAR CELL#0.8645;EMBRYONIC HEART#0.8631;EPILEPSY#0.8597;MOUSE EMBRYONIC STEM#0.8496;LEFT VENTRICULAR NONCOMPACTION#0.8489;THALAMUS#0.8267;CARDIOMYOPATHY#0.8239;HEART DISEASE#0.8149;ATRIAL CELL#0.8127;ISOPROTERENOL#0.8093;GROWTH FACTOR#0.7926;CHANNEL ACTIVITY#0.7926;PULMONARY VEIN#0.7846;OUTFLOW TRACT#0.7683;RIGHT ATRIUM#0.7622;PLURIPOTENT STEM CELL#0.7617;GANGLION CELLS#0.7579;SPINAL CORD#0.7550;LIPID RAFT#0.7512;MYOCARDIAL INFARCTION#0.7478;HEART RATE VARIABILITY#0.7385;SMOOTH MUSCLE#0.7174;ISCHEMIA#0.7153;INDUCED PLURIPOTENT STEM CELL#0.7074;CORONARY ARTERY#0.7020;PROGENITOR CELL#0.7019;SODIUM CHANNEL#0.7015;HEART DEVELOPMENT#0.6978;VENA CAVA#0.6977;CAMP BINDING DOMAIN#0.6964;SINUS VENOSUS#0.6904;CALCIUM CHANNEL#0.6904;CELL DIFFERENTIATION#0.6877;CENTRAL NERVOUS SYSTEM#0.6863;DORSAL ROOT GANGLION#0.6811;REDUCED HEART RATE#0.6805;ACTION POTENTIAL DURATION#0.6569;ARTERY#0.6446;BONE MARROW#0.6261;CAVEOLAE#0.6188;BETA ADRENERGIC RECEPTOR#0.6116;RYANODINE RECEPTOR#0.6107;SEPTUM#0.6068;ATRIOVENTRICULAR BLOCK#0.6050
10022	ENTEROENDOCRINE CELL#0.9687;PEPTIDE HORMONE#0.8891;RECEPTOR BINDING#0.8681;COLORECTAL#0.7527;GLUCOSE HOMEOSTASIS#0.7514;INSULIN SECRETION#0.6970;LEUCINE RICH REPEAT#0.6197;SIGNALLING PATHWAY#0.6079
100233209	MACROPHAGE APOPTOSIS#0.9337;APOPTOSIS#0.8714;TUBERCULOSIS#0.6491;AUTOPHAGY#0.6475;MONOCYTE#0.6444;MACROPHAGE#0.6424
100233226	ASPARTIC ACID#0.6710
10023	T CELL#1.0718;SIGNALING PATHWAY#1.0534;CANCER CELL#0.9690;WNT SIGNALING PATHWAY#0.9536;GLYCOGEN SYNTHASE KINASE#0.9129;LUNG CANCER#0.8151;ADENOCARCINOMA#0.7034;APOPTOSIS#0.6679;KINASE ACTIVITY#0.6305;ESOPHAGEAL CANCER#0.6284;CELL GROWTH#0.6109;CELL PROLIFERATION#0.6069
100240731	MALE INFERTILITY#0.9308;INFERTILITY#0.7314
10024	CELL ADHESION#1.0511;EMBRYO IMPLANTATION#0.9662;EPITHELIAL CELL#0.9299;CELL PROLIFERATION#0.8423;HEPATOCELLULAR CARCINOMA#0.8346;CELL CYCLE#0.8226;ENDOMETRIAL EPITHELIAL CELLS#0.8181;CELL ADHESION MOLECULE#0.8129;SPINDLE ASSEMBLY#0.7972;MICROTUBULE#0.7376;TROPHOBLAST#0.6482;POLYMERASE CHAIN REACTION#0.6312
10025	MEDIATOR COMPLEX#1.0515;GENE EXPRESSION#0.9647;IRON HOMEOSTASIS#0.7274
10026	ANCHORING#0.9397;ENDOPLASMIC RETICULUM#0.8987;CELL SURFACE#0.7181;PROTEIN COMPLEX#0.6446;DOPA OXIDASE#0.6194
100270639	HYPERTROPHIC PYLORIC STENOSIS#1.2471;PYLORIC STENOSIS#1.2341
100270680	CANCER CELL#1.1397;CELL PROLIFERATION#1.0806;LUNG CANCER#0.8612;HEPATOCELLULAR CARCINOMA#0.8223;OVARIAN SQUAMOUS CELL CARCINOMA#0.7933;CELL MIGRATION#0.7275;APOPTOSIS#0.7255;SIGNALING PATHWAY#0.7226;COLORECTAL CANCER#0.6703;ADJACENT NORMAL TISSUE#0.6600;DUAL LUCIFERASE REPORTER#0.6598;TUMOR TISSUES#0.6535;EPITHELIAL MESENCHYMAL TRANSITION#0.6535;CELL CYCLE PATHWAY#0.6199;ESOPHAGEAL CARCINOMA#0.6050
100271694	RNA BINDING#0.7579;HEART RATE VARIABILITY#0.7256;VIRUS LIKE PARTICLE#0.6116
100271696	SEX CHROMOSOME#0.6632;X CHROMOSOME#0.6488
100271849	B CELL LYMPHOMA#1.0645;B CELL#1.0521;MYOCYTE ENHANCER FACTOR#1.0467;GERMINAL CENTER#1.0376;TRANSCRIPTION FACTOR#1.0185;DIFFUSE LARGE B-CELL LYMPHOMA#1.0117;DNA BINDING#0.9853;GENE EXPRESSION#0.9380;MANTLE CELL LYMPHOMA#0.8306;SKELETAL MUSCLE#0.8011;SMOOTH MUSCLE#0.7688;CELL GROWTH#0.7520;MUSCLE CELL#0.7234;ENHANCER BINDING#0.6767;NON HODGKIN LYMPHOMA#0.6558;SMOOTH MUSCLE CELL#0.6402;GROWTH FACTOR#0.6307;LYMPHOID TISSUE#0.6237;T CELL#0.6235;TUMOR CELLS#0.6090
100271873	DNA METHYLATION#0.8713;PI3K SIGNALING#0.6203
100287082	TUMOR TISSUES#0.6790;PANCREATIC CANCER#0.6781;POLYMERASE CHAIN REACTION#0.6455;REVERSE TRANSCRIPTION#0.6189
100287226	ZINC FINGER PROTEIN#1.1975
100287301	NODULATION#1.0079;CATALYTIC ACTIVITY#0.7411
100287559	CELL PROLIFERATION#1.0123;APOPTOSIS#0.7665;DUAL LUCIFERASE REPORTER#0.7277;REPORTER GENE ASSAY#0.7268
100287616	CELL PROLIFERATION#1.1250;PROSTATE CANCER#0.8798;CANCER CELL#0.8743;BREAST CANCER#0.8367;APOPTOSIS#0.8311;CELL CYCLE#0.7379;BREAST CANCER CELL#0.6649;ONCOGENIC#0.6418;ATP BINDING CASSETTE TRANSPORTER#0.6236;ATP BINDING CASSETTE#0.6135;ENDOMETRIAL CANCER#0.6132;CELL MIGRATION#0.6092;ATP BINDING#0.6070;PANCREATIC CANCER#0.6064
100287932	TIM23 COMPLEX#1.0853;TIM22 COMPLEX#1.0840;TOM COMPLEX#1.0609;COMPLEX I#1.0482;INNER MITOCHONDRIAL MEMBRANE#1.0407;MITOCHONDRIAL PROTEIN IMPORT#1.0376;MITOCHONDRIAL INNER MEMBRANE#1.0317;MITOCHONDRIAL MATRIX#1.0245;MITOCHONDRIAL MEMBRANE#1.0176;PROTEIN IMPORT#1.0167;MEMBRANE OF MITOCHONDRIA#1.0165;OUTER MEMBRANE#1.0151;MITOCHONDRIA#0.9953;RESPIRATORY CHAIN#0.9517;HEAT SHOCK PROTEIN#0.9209;OUTER MITOCHONDRIAL MEMBRANE#0.8818;MITOCHONDRIAL INTERMEMBRANE SPACE#0.8794;PROTEIN TRANSPORT#0.8703;MITOPHAGY#0.8600;C TERMINAL DOMAIN#0.8558;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8487;MITOCHONDRIAL OUTER MEMBRANE#0.7984;TRANSCRIPTION FACTOR#0.7851;CYTOCHROME C#0.7750;ORGANELLE#0.7668;ATP SYNTHASE#0.7627;CARDIOLIPIN#0.7335;APOPTOSIS#0.7327;CELL DEATH#0.7096;MITOCHONDRIAL DNA#0.6851;PROTEIN COMPLEX#0.6574;AUTOPHAGY#0.6491;GENE EXPRESSION#0.6304;PERIPHERAL MEMBRANE PROTEIN#0.6294;OXIDATIVE PHOSPHORYLATION#0.6249;CHANNEL ACTIVITY#0.6160;CYTOCHROME C OXIDASE#0.6078;CONTACT SITE#0.6038
100288077	AUTOPHAGY#0.6475;ANGIOGENESIS#0.6451
100288139	INFLAMMATORY CELL#0.6045
100288428	ASPIRIN#0.6519
100288687	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY#1.0832;TRANSCRIPTION FACTOR#1.0739;MUSCULAR DYSTROPHY#1.0683;MYOBLAST#0.9289;MUSCLE CELL#0.8567;GENE EXPRESSION#0.7959;EWING SARCOMA#0.7941;SKELETAL MUSCLE#0.6845;MYOTUBE#0.6800;MESENCHYMAL CHONDROSARCOMA#0.6335;DNA BINDING#0.6306;OLFACTORY NEUROBLASTOMA#0.6277;MYOEPITHELIAL CARCINOMA#0.6167;DESMOPLASTIC SMALL ROUND CELL TUMOR#0.6165;NONSENSE MEDIATED DECAY#0.6017;MURINE EMBRYONIC STEM#0.6002
100288711	MYOBLAST#0.9448;MYOTUBE#0.6983;MUSCULAR DYSTROPHY#0.6959;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY#0.6782;REGENERATION#0.6037
100289017	OLFACTION#0.8210
100289019	COLORECTAL CANCER#0.9014;CANCER CELL#0.8953;COLORECTAL#0.6458
100289178	BREAST CANCER#0.7966
100289419	CILIARY NEUROTROPHIC FACTOR#0.9900;LEUKEMIA INHIBITORY FACTOR#0.8470
100289683	CENTRAL NERVOUS SYSTEM#0.6473;NERVOUS SYSTEM#0.6463
1002	CELL ADHESION#0.9928;CELL CELL ADHESION#0.9887;CELL ADHESION MOLECULE#0.9829;RETINAL GANGLION CELL#0.9257;OPTIC NERVE#0.9001;FOREBRAIN#0.8865;MORPHOGENESIS#0.8443;GANGLION CELLS#0.8378;NERVOUS SYSTEM#0.8378;SIGNALING PATHWAY#0.8161;SKELETAL MUSCLE#0.8113;EPITHELIAL CELL#0.8091;CANCER CELL#0.7649;NEURITE#0.7572;SPINAL CORD#0.7534;NEUROBLAST#0.7499;CELL MIGRATION#0.7496;TUMOR SUPPRESSOR#0.7340;STEM CELL#0.6930;SMOOTH MUSCLE#0.6794;CELL PROLIFERATION#0.6775;TRANSCRIPTION FACTOR#0.6527;POLYMERASE CHAIN REACTION#0.6512;ADHERENS JUNCTION#0.6449;CELL-CELL ADHESION MOLECULE#0.6434;CELL SURFACE#0.6338;BREAST CANCER#0.6289;TELENCEPHALON#0.6269;CENTRAL NERVOUS SYSTEM#0.6209;CELL AGGREGATION#0.6154;SYSTEM DEVELOPMENT#0.6154;STRIATED MUSCLE#0.6095;CELL MOTILITY#0.6027
100301525	DYSCHROMATOSIS UNIVERSALIS HEREDITARIA#0.6032
100302112	CANCER CELL#1.0665;CELL PROLIFERATION#0.8633;APOPTOSIS#0.8360;OVARIAN CANCER#0.6723;LUNG CANCER#0.6567;OVERALL SURVIVAL RATE#0.6236;CERVICAL CANCER#0.6169;TUMOR TISSUES#0.6152;SIGNALLING PATHWAY#0.6129;BREAST CANCER CELL#0.6104;COLORECTAL CANCER#0.6096;BREAST CANCER#0.6051;GENE EXPRESSION#0.6024
100302123	CELL PROLIFERATION#0.9003;LUNG CANCER#0.7862;APOPTOSIS#0.7050;CANCER CELL#0.6998;POLYMERASE CHAIN REACTION#0.6957;HEPATOCELLULAR CARCINOMA#0.6818;DUAL LUCIFERASE REPORTER#0.6398;GENE EXPRESSION#0.6169;QUANTITATIVE REAL TIME#0.6135
100302133	HEPATOCELLULAR CARCINOMA#0.6196;COLORECTAL CANCER#0.6193
100302138	BONE FORMATION#0.7184;STEM CELL#0.7096
100302145	CANCER CELL#1.0339;PANCREATIC CANCER#0.8948;TUMOR SUPPRESSOR#0.8486;CELL PROLIFERATION#0.7902;DNA METHYLATION#0.6998;APOPTOSIS#0.6834;LUNG CANCER#0.6483;TRANSCRIPTION FACTOR#0.6300;ECTOPIC PREGNANCY#0.6082
100302150	CELL PROLIFERATION#0.8613;BREAST CANCER#0.7406;CANCER CELL#0.7121;APOPTOSIS#0.6888;BREAST CANCER CELL#0.6679;CELL CYCLE#0.6638;ADJACENT NORMAL TISSUE#0.6191;FATTY LIVER DISEASE#0.6139;FATTY LIVER#0.6119;LIVER DISEASE#0.6068;PROSTATE CANCER#0.6055
100302172	BREAST CANCER#0.9008;CANCER CELL#0.8996;OVARIAN CANCER#0.8733;CELL CYCLE#0.8675;CELL PROLIFERATION#0.8578;APOPTOSIS#0.8154;LUNG CANCER#0.7328;OVARIAN#0.6835;METHYLATION SPECIFIC PCR#0.6666;CELL GROWTH#0.6548;LYMPH NODE#0.6548;LIVER CANCER#0.6015
100302174	OVARIAN CANCER#1.0081;CANCER CELL#0.9500;OVARIAN#0.8981;CELL PROLIFERATION#0.7367;APOPTOSIS#0.6862;BREAST CANCER#0.6493;TERMINAL LOOP#0.6412;FOOT AND MOUTH DISEASE#0.6276;MOUTH DISEASE#0.6270;EPITHELIAL OVARIAN CANCER#0.6147;PROSTATE CANCER#0.6018
100302177	ECTOPIC PREGNANCY#0.7234
100302179	CANCER CELL#0.9063;CELL PROLIFERATION#0.8483;SIGNALING PATHWAY#0.6778;CISPLATIN#0.6349;OSTEOSARCOMA CELL LINES#0.6160;WNT SIGNALING PATHWAY#0.6031
100302181	CELL PROLIFERATION#0.9502;TUMOR SUPPRESSOR#0.8439;ADJACENT NORMAL TISSUE#0.6783;LYMPH NODE METASTASIS#0.6709;SQUAMOUS CELL CARCINOMA#0.6550;LYMPH NODE#0.6535;EPITHELIAL MESENCHYMAL TRANSITION#0.6110
100302187	CELL PROLIFERATION#1.0771;APOPTOSIS#0.9825;CANCER CELL#0.9052;TUMOR SUPPRESSOR#0.8960;SIGNALING PATHWAY#0.8458;CELL GROWTH#0.8425;AKT SIGNALING#0.8152;GERM CELL#0.7815;SQUAMOUS CELL CARCINOMA#0.6856;ADENOCARCINOMA#0.6722;HEPATOCELLULAR CARCINOMA CELL#0.6486;CELL CYCLE#0.6349;HEPATOCELLULAR CARCINOMA#0.6301;HUMAN CERVICAL CARCINOMA#0.6018
100302197	GRANULOSA CELL#0.8095;SIGNALING PATHWAY#0.7955
100302201	CANCER CELL#0.9468;CELL PROLIFERATION#0.8020;APOPTOSIS#0.7314;BREAST CANCER#0.6575;BREAST CANCER CELL#0.6573;CELL GROWTH#0.6442;HEPATOMA CELLS#0.6024
100302202	CELL PROLIFERATION#0.8862;PANCREATIC CANCER#0.6781;PSORIASIS#0.6575;PAPILLARY THYROID CARCINOMA#0.6286;THYROID CARCINOMA#0.6216
100302213	OVARIAN CANCER#0.9035;OVARIAN#0.6451
100302217	WNT SIGNALING PATHWAY#0.9146;SIGNALING PATHWAY#0.8958
100302221	CELL PROLIFERATION#0.9963;CANCER CELL#0.7736;PANCREATIC CANCER#0.6545;CELL CYCLE#0.6473;CELL CYCLE TRANSITION#0.6133;SMALL NUCLEOLAR RNA#0.6129
100302232	CELL DEATH#0.6868
100302235	CANCER CELL#0.8524;BREAST CANCER#0.8301;SIGNALING PATHWAY#0.6545;CELL CYCLE#0.6449;FAMILIAL BREAST CANCER#0.6236;NOTCH SIGNALING PATHWAY#0.6148;LUNG CANCER#0.6045
100302246	CELL PROLIFERATION#0.9719;CELL MIGRATION#0.7324;APOPTOSIS#0.6807;PROSTATE CANCER#0.6545;DISEASE SPECIFIC SURVIVAL#0.6080
100302255	CANCER CELL#0.6257
100302256	SIGNALING PATHWAY#0.9046;CANCER CELL#0.9043;APOPTOSIS#0.8557;CELL PROLIFERATION#0.8555;OVARIAN CANCER#0.8400;HEPATOCELLULAR CARCINOMA#0.7504;GLYCOLYSIS#0.6443;OVARIAN#0.6377;WNT SIGNALING PATHWAY#0.6117;DUAL LUCIFERASE REPORTER#0.6117;PANCREATIC CANCER#0.6031
100302263	CELL PROLIFERATION#0.8888;ADIPOCYTE#0.6044;NF KAPPAB BINDING#0.6007
100302270	STEM CELL#0.9534;MAINTENANCE OF PLURIPOTENCY#0.7144;CELL PROLIFERATION#0.7012;PLURIPOTENT STEM CELL#0.6679;AKT SIGNALING#0.6663;CELL CYCLE#0.6555
100302279	LUNG CANCER#0.7353
100302280	CANCER CELL#0.8953
100302510	CORNEAL DYSTROPHY#0.6768
100302512	CLINICAL GLOBAL IMPRESSION#1.0461;RESTLESS LEGS SYNDROME#1.0261;RESTLESS#0.9824;ROTIGOTINE#0.8290
100302513	HEARING IMPAIRMENT#1.2052
100302650	CELL PROLIFERATION#0.7788;CANCER CELL#0.7782;PROSTATE CARCINOMA#0.7633;CELL GROWTH#0.7457
100302692	X CHROMOSOME#0.9011;X CHROMOSOME INACTIVATION#0.7115;CHROMOSOME INACTIVATION#0.7112;AKT SIGNALING#0.6668;SIGNALING PATHWAY#0.6570
100302739	ANTISENSE RNA#0.7978;COLORECTAL CANCER#0.7480;CANCER CELL#0.7420
100302740	APOPTOSIS#0.8297;CELL DEATH#0.6891;APOPTOTIC#0.6009
100302746	COLORECTAL CANCER#0.8011
100303453	ENDOMETRIAL CARCINOMA#0.7632
100303491	CANCER CELL#1.1144;CELL PROLIFERATION#1.0806;APOPTOSIS#1.0222;ANTISENSE RNA#0.9951;E BOX BINDING#0.9104;COLON CANCER#0.8251;EPITHELIAL MESENCHYMAL TRANSITION#0.7208;NATURAL ANTISENSE TRANSCRIPT#0.6941;COLORECTAL CANCER#0.6490;SQUAMOUS CELL CARCINOMA#0.6489;LUNG CANCER#0.6476;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.6077
100303728	SIGNALLING PATHWAY#0.9046;CELL PROLIFERATION#0.8960;APOPTOSIS#0.6411
100303755	MITOCHONDRIAL DISEASE#0.7397;CYTOCHROME C OXIDASE#0.6304;CYTOCHROME C#0.6248
100306940	FOLLICULAR LYMPHOMA#0.8346
100307118	METASTATIC GASTRIC CANCER#0.6487
100307119	BASAL CELL CARCINOMA#0.8163;BASAL CELL#0.8123
100310785	ACUTE LEUKEMIA#1.0712;ACUTE LYMPHOBLASTIC LEUKEMIA#1.0540;ACUTE MYELOID LEUKEMIA#0.9565;MYELOID LEUKEMIA#0.9552;MIXED LINEAGE LEUKEMIA#0.9494;TRANSCRIPTION FACTOR#0.8797;IRON HOMEOSTASIS#0.7949;MINIMAL RESIDUAL DISEASE#0.7076;TOPOISOMERASE II#0.7028;BONE MARROW#0.6769;TOPOISOMERASE#0.6563;GENE EXPRESSION#0.6444
100312954	GENE EXPRESSION#0.8942
100313780	TUMOR SUPPRESSOR#0.7133;CELL PROLIFERATION#0.7091
100313824	CELL PROLIFERATION#1.0125;CANCER CELL#0.9346;APOPTOSIS#0.8374;DUAL LUCIFERASE REPORTER#0.6566
100313923	CELL PROLIFERATION#0.7431;CANCER CELL#0.6537;DNA METHYLATION#0.6133;CELL GROWTH#0.6073
100316868	CELL CYCLE#1.0826;APOPTOSIS#1.0802;COLORECTAL CANCER#1.0755;PANCREATIC CANCER#1.0715;CELL PROLIFERATION#1.0711;CANCER CELL#1.0697;LYMPH NODE METASTASIS#1.0530;LYMPH NODE#1.0485;CELL GROWTH#1.0405;LUNG CANCER#1.0367;ONCOGENIC#1.0219;POLYMERASE CHAIN REACTION#1.0178;COLORECTAL#1.0080;EPITHELIAL MESENCHYMAL TRANSITION#1.0027;HEPATOCELLULAR CARCINOMA#0.9906;CELL MIGRATION#0.9865;SIGNALING PATHWAY#0.9801;GENE EXPRESSION#0.9619;QUANTITATIVE REAL TIME#0.9612;PROSTATE CANCER#0.9492;ANTISENSE RNA#0.9191;DUAL LUCIFERASE REPORTER#0.9137;RNA INTERFERENCE#0.9093;SQUAMOUS CELL CARCINOMA#0.8807;ADJACENT NORMAL TISSUE#0.8465;LUNG ADENOCARCINOMA#0.8236;OVARIAN CANCER#0.8139;ENDOTHELIAL CELL#0.8081;BREAST CANCER#0.8079;ADENOCARCINOMA#0.8014;LIVER CANCER#0.7893;HEPATIC STELLATE CELL#0.7766;G1 PHASE#0.7751;STEM CELL#0.7376;RENAL CELL CARCINOMA#0.7245;REVERSE TRANSCRIPTION#0.7171;CELL CYCLE ARREST#0.6859;CELL COUNTING KIT#0.6444;EXOSOME#0.6436;CISPLATIN#0.6383;OVARIAN#0.6368;REPORTER GENE ASSAY#0.6253;TONGUE SQUAMOUS CELL CARCINOMA#0.6204;HUMAN PANCREATIC CANCER#0.6170;GLUTAMATE RECEPTOR#0.6082;TUMOR SUPPRESSOR#0.6081;DISEASE FREE SURVIVAL#0.6076;BREAST CANCER CELL#0.6041;ACUTE MYELOID LEUKEMIA#0.6029;MYELOID LEUKEMIA#0.6014
100322879	PARAPLEGIA#0.7005
100329167	AORTIC ANEURYSM#1.0358;DYNEIN#1.0331;ARTERY#0.9776;OPEN AAA REPAIR#0.9665;ATP HYDROLYSIS#0.8668;ILIAC ARTERY#0.8534;MICROTUBULE#0.8338;ATP BINDING#0.7170;CORONARY ARTERY#0.6856;MICROTUBULE BINDING#0.6079
100329168	CHLAMYDIA#0.9174
100359393	CEREBELLAR ATAXIA#0.6988
100359403	PARKINSON'S DISEASE#1.0515
10036	FACTOR I#1.0894;HISTONE CHAPERONE#1.0749;CHROMATIN ASSEMBLY#1.0670;NUCLEOSOME ASSEMBLY#1.0467;NUCLEOSOME#1.0431;DNA REPLICATION#1.0353;S PHASE#1.0191;CELL PROLIFERATION#1.0169;CANCER CELL#0.9436;CAF-1 COMPLEX#0.9278;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9082;DNA REPAIR#0.8880;HETEROCHROMATIN#0.8775;GENE SILENCING#0.8710;CELL CYCLE#0.8253;DNA SYNTHESIS#0.8146;PROTEIN COMPLEX#0.7873;REPLICATION FORK#0.7831;STEM CELL#0.7171;APOPTOSIS#0.6887;CHROMATIN ASSEMBLY COMPLEX#0.6161;EPITHELIAL CELL#0.6138;TRANSCRIPTION FACTOR#0.6128;GENE EXPRESSION#0.6097;LUNG CANCER#0.6011
100379142	CENTRAL NERVOUS SYSTEM#1.1823;NERVOUS SYSTEM#1.1805
100379174	COLORECTAL#0.6458
100379198	EPILEPSY#0.9715;ABSENCE EPILEPSY#0.6252;AGGRESSIVE BEHAVIOR#0.6034
100379199	TYROSINASE ACTIVITY#0.6243;MELANIN SYNTHESIS#0.6077;MELANOCYTE#0.6071
100379249	NATURAL ANTISENSE TRANSCRIPT#0.9568;APOPTOTIC#0.6435;APOPTOSIS#0.6411
100379251	CARDIOMYOCYTE#0.6485
100379571	ALZHEIMER'S DISEASE#0.9435;AMYLOID PRECURSOR PROTEIN#0.7254;PERIPHERAL BLOOD#0.6002
100380873	DNA REPAIR#0.6928;ICL REPAIR#0.6876;FANCONI ANEMIA#0.6486;FOCAL CORTICAL DYSPLASIA#0.6192
100380876	LIPID DROPLET#0.8443;CONTACT SITE#0.6842;METHIONINE SYNTHASE#0.6328;NUCLEAR ENVELOPE#0.6198
100381207	HEARING LOSS#0.7582
100381270	TRANSCRIPTION FACTOR#1.1212;SKELETAL MUSCLE#1.0205;GENE EXPRESSION#0.8545;BETA CELL#0.8337;MYOBLAST#0.8177;CELL PROLIFERATION#0.8001;CELL CYCLE#0.6511;NEURAL CREST STEM CELL#0.6350;NEURAL CREST STEM#0.6343;CELL AGGREGATION#0.6139;CELL JUNCTION#0.6066;NEURAL CREST#0.6001
10038	BASE EXCISION REPAIR#1.0355;SINGLE STRAND BREAK#1.0322;T CELL#1.0288;DNA BINDING#1.0125;DNA DAMAGE RESPONSE#1.0073;DOUBLE STRAND BREAK#1.0048;CELL CYCLE#0.9987;POLY ADP RIBOSE#0.9972;RIBOSE#0.9956;DNA REPAIR#0.9953;HOMOLOGOUS RECOMBINATION#0.9905;CATALYTIC ACTIVITY#0.9892;BREAST CANCER#0.9874;APOPTOSIS#0.9860;CANCER CELL#0.9846;OVARIAN CANCER#0.9811;CELL DEATH#0.9810;OVARIAN#0.9788;GENE EXPRESSION#0.9681;REPLICATION FORK#0.9539;SIGNALING PATHWAY#0.9502;GENOTOXIC#0.9200;APOPTOTIC#0.9055;POSTTRANSLATIONAL MODIFICATION#0.9006;TELOMERE#0.8877;BONE MARROW#0.8615;SINGLE STRAND BREAK REPAIR#0.8580;POST-TRANSLATIONAL MODIFICATION#0.8438;CELL DIFFERENTIATION#0.8410;S PHASE#0.8318;PROSTATE CANCER#0.8302;RNASE P#0.8226;TEMOZOLOMIDE#0.8123;TUMOR CELLS#0.8105;TRANSCRIPTION FACTOR#0.8020;CEREBRAL ISCHEMIA#0.7941;TOXICITY#0.7920;IMMUNE RESPONSE#0.7849;CYTOTOXICITY#0.7577;SKELETAL MUSCLE#0.7529;LUNG CANCER#0.7485;DNA REPLICATION#0.7405;DOUBLE-STRAND BREAK REPAIR#0.7318;TOPOISOMERASE#0.7294;ISCHEMIA#0.7172;PANCREATIC CANCER#0.7103;DNA REPAIR ENZYME#0.7090;SPERMATOGENESIS#0.6945;MUTAGENESIS#0.6908;PROTEIN PROTEIN INTERACTION#0.6761;LIPID METABOLISM#0.6751;CELL DEVELOPMENT#0.6727;ADENINE#0.6724;CISPLATIN#0.6716;BREAST CANCER CELL#0.6615;MOUSE EMBRYONIC FIBROBLAST#0.6564;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.6535;NICOTINAMIDE#0.6514;HYDROXYUREA#0.6433;PROTEIN KINASE#0.6280;THYMOCYTE#0.6279;LYSINE#0.6279;RECURRENT OVARIAN CANCER#0.6165;REPLICATION PROTEIN A#0.6076
10039	DOUBLE STRAND BREAK#1.0633;RIBOSE#1.0333;POLY ADP RIBOSE#1.0297;BREAST CANCER#1.0217;DNA REPAIR#1.0063;CANCER CELL#0.9949;SINGLE STRAND BREAK#0.9946;BREAST CANCER CELL#0.9680;DOUBLE-STRAND BREAK REPAIR#0.9231;GENE EXPRESSION#0.8843;CELL CYCLE#0.8296;CELL DEATH#0.8171;BASE EXCISION REPAIR#0.7337;DNA LIGASE#0.7057;OVARIAN CANCER#0.7038;HOMOLOGOUS RECOMBINATION#0.6482;POST-TRANSLATIONAL MODIFICATION#0.6479;DNA BINDING#0.6334;DNA DAMAGE RESPONSE#0.6331;APOPTOSIS#0.6198;EPITHELIAL TO MESENCHYMAL TRANSITION#0.6156;EPITHELIAL TO MESENCHYMAL#0.6153;OVARIAN#0.6144;TELOMERE#0.6129;CATALYTIC ACTIVITY#0.6067
1003	SOLUBLE VASCULAR ENDOTHELIAL#1.0773;CADHERIN BINDING#1.0567;JUNCTIONAL ADHESION MOLECULE#1.0540;ZONULA OCCLUDENS 1#1.0529;CATENIN COMPLEX#1.0510;ENDOTHELIAL CELL-CELL ADHESION#1.0487;ZONULA OCCLUDENS#1.0415;VASCULAR ENDOTHELIAL CADHERIN#1.0405;ENDOCYTOSIS#1.0353;TIGHT JUNCTION PROTEIN#1.0230;ENDMT#1.0228;CELL PERIPHERY#1.0205;ACTIN FILAMENT#1.0173;SMOOTH MUSCLE ACTIN#1.0160;CELL MEMBRANE#1.0139;FETAL LIVER#1.0114;PROTEIN TYROSINE PHOSPHATASE#1.0100;SELECTIN#1.0071;ADHERENS JUNCTION#1.0071;INTERCELLULAR JUNCTION#1.0067;HYPOXIA INDUCIBLE FACTOR#1.0057;LECTIN#1.0053;ENDOTHELIAL NITRIC OXIDE#1.0050;GROWTH FACTOR RECEPTOR#1.0047;CELL CELL JUNCTION#1.0042;STRESS FIBRE#1.0039;CELL ADHESION MOLECULE#1.0030;TIGHT JUNCTION#1.0022;ACTIN CYTOSKELETON#0.9998;CELL JUNCTION#0.9986;VASCULAR MORPHOGENESIS#0.9986;DEPHOSPHORYLATION#0.9983;NITRIC OXIDE SYNTHASE#0.9982;MATURE ENDOTHELIAL CELL#0.9974;STRESS FIBER#0.9970;CELL SURFACE#0.9963;PLATELET-DERIVED GROWTH FACTOR#0.9951;ENDOTHELIAL CELL MIGRATION#0.9937;CELL CELL ADHESION#0.9934;PLASMA MEMBRANE#0.9925;T CELL#0.9919;HEMATOPOIETIC CELL#0.9910;PERICYTE#0.9910;KINASE INSERT DOMAIN#0.9895;FOCAL ADHESION#0.9892;REVERSE TRANSCRIPTION#0.9889;CELL ADHESION#0.9887;QUANTITATIVE REAL TIME#0.9886;BREAST CANCER CELL#0.9884;YOLK SAC#0.9880;POLYMERASE CHAIN REACTION#0.9877;ENDOTHELIAL MICROPARTICLE#0.9872;LYMPHATIC VESSEL#0.9868;LOW DENSITY LIPOPROTEIN#0.9862;LYMPHATIC ENDOTHELIAL CELL#0.9857;RETINAL ENDOTHELIAL CELLS#0.9854;HISTAMINE#0.9853;TRANSENDOTHELIAL ELECTRICAL RESISTANCE#0.9852;BREAST CANCER#0.9849;SPHINGOSINE 1 PHOSPHATE#0.9849;SMOOTH MUSCLE#0.9839;EPIDERMAL GROWTH FACTOR#0.9839;PROTEIN KINASE C#0.9837;NITRIC OXIDE#0.9835;TRANSFORMING GROWTH FACTOR#0.9826;HYPOXIA#0.9822;MICROPARTICLE#0.9817;MONOCYTE#0.9811;FLUID SHEAR STRESS#0.9808;COMPLEX I#0.9803;BASEMENT MEMBRANE#0.9791;VASCULAR CELL#0.9789;CIRCULATING ENDOTHELIAL CELL#0.9788;NEUTROPHIL#0.9788;FOCAL ADHESION KINASE#0.9784;ADHERENS JUNCTION FORMATION#0.9782;CELL GROWTH#0.9781;MESENCHYMAL CELL#0.9771;VASCULAR ENDOTHELIUM#0.9771;OVARIAN#0.9770;CONTACT INHIBITION#0.9769;LEUKOCYTE#0.9764;TUBE FORMATION#0.9761;MACROPHAGE#0.9758;SPHINGOSINE#0.9742;MORPHOGENESIS#0.9736;TUMOR NECROSIS FACTOR#0.9735;TRANSCRIPTION FACTOR#0.9734;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9731;ENDOMT#0.9729;ENDOTHELIAL GROWTH FACTOR#0.9729;CELL MIGRATION#0.9729;EPITHELIAL CELL#0.9728;HEMATOPOIESIS#0.9728;ATHEROSCLEROTIC#0.9723;BETA CATENIN BINDING#0.9717;VASCULAR ENDOTHELIAL CELL#0.9714;MYOCARDIUM#0.9706;VASCULOGENESIS#0.9701;ENDOTHELIAL CELL#0.9701;PRO-INFLAMMATORY#0.9697;GENE EXPRESSION#0.9696;APOPTOSIS#0.9694;OVARIAN CANCER#0.9694;MONONUCLEAR CELLS#0.9693;DIABETIC RETINOPATHY#0.9690;TUMOR CELLS#0.9686;EPITHELIAL MESENCHYMAL TRANSITION#0.9684;CANCER CELL#0.9681;STROMAL CELL#0.9680;FIBROBLAST GROWTH FACTOR#0.9680;SIMVASTATIN#0.9680;PROTEIN KINASE#0.9675;FETAL LIVER KINASE#0.9675;REACTIVE OXYGEN SPECIES#0.9673;HEMATOPOIETIC STEM CELL#0.9672;MUSCLE CELL#0.9663;SMOOTH MUSCLE CELL#0.9661;GROWTH FACTOR#0.9661;UMBILICAL CORD#0.9649;CELL PROLIFERATION#0.9639;SIGNALING PATHWAY#0.9639;MICROTUBULE#0.9635;FLUORESCEIN#0.9635;FLOW CYTOMETRY ANALYSIS#0.9627;CORONARY ARTERY#0.9626;PULMONARY ARTERY#0.9623;CELL MOTILITY#0.9622;ENDOTHELIUM#0.9620;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9616;BRAIN ENDOTHELIAL CELL#0.9614;CELL DIFFERENTIATION#0.9613;PERIPHERAL BLOOD#0.9609;PLURIPOTENT STEM CELL#0.9608;MICROVASCULAR ENDOTHELIAL CELL#0.9607;ANGIOGENESIS#0.9603;KINASE INHIBITOR#0.9603;UMBILICAL VEIN#0.9596;HUMAN UMBILICAL VEIN#0.9595;HYPOXIC#0.9594;EXTRACELLULAR MATRIX#0.9590;EMBRYONIC STEM CELL#0.9589;MYOCARDIAL INFARCTION#0.9582;ENDOTHELIAL CELL PROLIFERATION#0.9582;BLOOD BRAIN BARRIER#0.9580;MESENCHYMAL STEM CELL#0.9579;HEMORRHAGE#0.9577;EDEMA#0.9575;ACUTE LUNG INJURY#0.9572;VASCULAR DISEASE#0.9572;BLOOD VESSEL#0.9571;ACTOMYOSIN#0.9568;SPECIFIC PROTEIN 1#0.9561;MITOGEN ACTIVATED PROTEIN#0.9560;VENULE#0.9559;LUNG CANCER#0.9559;CORD BLOOD#0.9558;APOPTOTIC#0.9554;ARTERY DISEASE#0.9549;CELL DEATH#0.9545;ATHEROSCLEROSIS#0.9544;ENDOTHELIAL PROGENITOR CELL#0.9543;BONE MARROW#0.9541;TROPHOBLAST#0.9539;ISCHEMIA#0.9537;SIGNAL TRANSDUCTION#0.9536;HEMORRHAGIC#0.9534;DIABETES MELLITUS#0.9531;PROGENITOR CELL#0.9530;PERIAPICAL GRANULOMA#0.9525;CORONARY ARTERY DISEASE#0.9519;ARTERY#0.9519;HYPERTENSION#0.9513;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9510;UMBILICAL CORD BLOOD#0.9508;DIAPEDESIS#0.9506;WOUND HEALING#0.9505;INFLAMMATORY RESPONSE#0.9502;STEM CELL#0.9487;CELL POLARITY#0.9484;CELL-CELL ADHESION MOLECULE#0.9484;TRANSFORMING GROWTH FACTOR BETA#0.9482;INFLAMMATORY CELL#0.9481;REGENERATION#0.9480;LYMPH NODE#0.9480;CELL CYCLE#0.9478;LUNG MICROVASCULAR ENDOTHELIAL#0.9471;INDUCED PLURIPOTENT STEM CELL#0.9453;NERVOUS SYSTEM#0.9440;NADPH OXIDASE#0.9427;COLORECTAL CANCER#0.9427;VEGF SIGNALING#0.9427;SIGNALING MOLECULE#0.9420;BLOOD RETINAL BARRIER#0.9385;STEM CELL MARKER#0.9380;MOUSE EMBRYONIC STEM#0.9368;TOXICITY#0.9336;HUMAN EMBRYONIC STEM#0.9335;ENDOTHELIAL CELL DIFFERENTIATION#0.9327;KINASE ACTIVITY#0.9324;HEPATOCELLULAR CARCINOMA#0.9290;ADIPOSE TISSUE#0.9290;CELL ACTIVATION#0.9285;CENTRAL NERVOUS SYSTEM#0.9268;SPROUTING ANGIOGENESIS#0.9255;ACTIN POLYMERIZATION#0.9247;CONNEXIN#0.9239;CYTOTOXICITY#0.9227;LAMINAR SHEAR STRESS#0.9209;CIRCULATING ENDOTHELIAL PROGENITOR#0.9206;PULMONARY EDEMA#0.9192;IMMUNE CELL#0.9190;COLONY-STIMULATING FACTOR#0.9150;EXOSOME#0.9122;FACTOR VIII#0.9113;LUNG ENDOTHELIAL CELLS#0.9109;TRANSCRIPTASE#0.9101;CELL ELONGATION#0.9080;INTERMEDIATE FILAMENT#0.9078;COLORECTAL#0.9068;VASCULAR SMOOTH MUSCLE CELL#0.9058;TRANSDIFFERENTIATION#0.9042;HEPATOCYTE GROWTH FACTOR#0.9031;HINDLIMB#0.8999;BONE MORPHOGENETIC PROTEIN#0.8998;ACUTE MYOCARDIAL INFARCTION#0.8997;RNA INTERFERENCE#0.8991;LUMINAL#0.8983;PROTEIN COMPLEX#0.8981;IFN-GAMMA#0.8970;HEPARIN#0.8954;AKT SIGNALING#0.8929;SIGNALING CASCADE#0.8867;ENDOTHELIAL CELL ACTIVATION#0.8859;MAP KINASE#0.8858;ISCHEMIA REPERFUSION INJURY#0.8844;RESPIRATORY DISTRESS#0.8842;ANGIOGENIC GROWTH FACTORS#0.8810;NUCLEOTIDE EXCHANGE FACTOR#0.8807;ADIPOCYTE#0.8796;HIGH MOBILITY GROUP#0.8777;ENDOTHELIAL CELL APOPTOSIS#0.8774;GAP JUNCTION#0.8771;BONE MARROW CELLS#0.8765;ACETYLCHOLINE#0.8762;CANCER STEM CELL#0.8744;STREPTOZOTOCIN#0.8736;TROPHOBLAST CELL#0.8732;CORPUS LUTEUM#0.8730;ERYTHROCYTE#0.8730;SUPEROXIDE DISMUTASE#0.8716;SIGNALLING PATHWAY#0.8691;CYTOPLASM#0.8686;TRANSMISSION ELECTRON MICROSCOPY#0.8683;COAGULATION#0.8654;PANCREATIC CANCER#0.8650;SKELETAL MUSCLE#0.8642;HYPERGLYCEMIA#0.8641;LOCALISATION#0.8635;MURAL CELL#0.8632;GRANULOCYTE#0.8620;PROTEIN KINASE A#0.8607;P21 ACTIVATED KINASE#0.8589;MYOFIBROBLAST#0.8588;MYOSIN HEAVY CHAIN#0.8581;INSULIN-LIKE GROWTH FACTOR#0.8577;GENE SILENCING#0.8566;RETINOIC ACID#0.8560;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8542;INSOLUBLE FRACTION#0.8531;CHEMOTAXIS#0.8528;HUMAN MESENCHYMAL STEM#0.8512;PRECURSOR CELL#0.8509;ASTROCYTE#0.8505;INHIBITION OF ANGIOGENESIS#0.8478;OSTEOBLAST#0.8472;ADVANCED GLYCATION END#0.8466;MONOCYTE CHEMOATTRACTANT PROTEIN#0.8449;MAST CELL#0.8427;DEFINITIVE HEMATOPOIESIS#0.8406;CARDIOMYOCYTE#0.8401;CELL FRACTION#0.8388;ADENOSINE#0.8386;AUTOPHAGY#0.8384;CHEMOKINE RECEPTOR#0.8382;RESVERATROL#0.8359;FILAMENTOUS ACTIN#0.8354;SURFACE PLASMON RESONANCE#0.8342;GESTATION#0.8328;VASCULAR TISSUE ENGINEERING#0.8284;ARTERIOLE#0.8277;ANGIOBLASTS#0.8255;TUMOR ENDOTHELIAL CELL#0.8243;TUMOUR NECROSIS FACTOR#0.8232;FOCAL ADHESION FORMATION#0.8228;ADENOCARCINOMA#0.8227;DORSAL AORTA#0.8218;TUBULOGENESIS#0.8215;HUMAN BREAST CANCER#0.8199;ATORVASTATIN#0.8190;FIBRINOGEN#0.8188;HUMAN PULMONARY ARTERY#0.8183;STEM CELL DIFFERENTIATION#0.8178;RECEPTOR TYROSINE KINASE#0.8170;DENDRITIC CELL#0.8147;INTEGRIN ACTIVATION#0.8141;C REACTIVE PROTEIN#0.8137;THROMBOSIS#0.8119;LYMPHANGIOGENESIS#0.8108;DEXAMETHASONE#0.8082;HEMATOPOIETIC PROGENITOR CELL#0.8075;ENDOSOME#0.8065;CARDIOVASCULAR SYSTEM#0.8058;GUANINE#0.8041;TUMOR TISSUES#0.8029;CELL PENETRATING PEPTIDE#0.8014;FACTOR I#0.8014;LEUKOCYTE ADHESION#0.8007;PROTEASE ACTIVATED RECEPTOR#0.8002;PLATELET ACTIVATING FACTOR#0.7995;IMMUNE RESPONSE#0.7993;SENESCENCE#0.7968;VASCULAR PROGENITOR CELL#0.7963;ADIPOSE-DERIVED STEM CELL#0.7962;IMATINIB#0.7960;FORSKOLIN#0.7939;TOLL LIKE RECEPTOR#0.7936;METASTATIC MELANOMA#0.7932;METASTATIC BREAST CANCER#0.7930;EPHRIN#0.7918;PULMONARY HYPERTENSION#0.7897;ROS GENERATION#0.7889;INHIBITION OF CELL GROWTH#0.7874;SRC FAMILY KINASE#0.7847;GOLGI APPARATUS#0.7833;RECEPTOR COMPLEX#0.7788;CONTACT SITE#0.7787;MECHANISM OF ACTION#0.7769;PROSTACYCLIN#0.7754;SERUM ALBUMIN#0.7753;REGULATION OF VASCULAR PERMEABILITY#0.7739;CYTOTROPHOBLAST#0.7719;EOSIN#0.7712;COLONY-FORMING CELL#0.7685;ALKALINE PHOSPHATASE#0.7665;CELL MATRIX ADHESION#0.7664;DNA BINDING#0.7663;TYPE 2 DIABETES#0.7660;SCANNING ELECTRON MICROSCOPY#0.7630;TRANSIENT RECEPTOR POTENTIAL#0.7627;EPITHELIOID SARCOMA#0.7626;CEREBRAL ARTERY#0.7618;ZONULA ADHERENS#0.7614;CELL AGGREGATION#0.7582;MICROVESICLE#0.7580;CEREBRAL ISCHEMIA#0.7569;MESENCHYMAL STROMAL CELL#0.7555;INTIMA MEDIA THICKNESS#0.7536;OVARIAN HYPERSTIMULATION SYNDROME#0.7517;HEART DISEASE#0.7515;TYROSINE KINASE INHIBITOR#0.7491;MYOSIN LIGHT-CHAIN KINASE#0.7462;RETINAL VASCULAR PERMEABILITY#0.7456;CEREBRAL ARTERY OCCLUSION#0.7431;HUMAN CORD BLOOD#0.7426;COLLAGENASE#0.7421;MIDDLE CEREBRAL ARTERY#0.7418;PLASMA PROTEIN#0.7405;CONNECTIVE TISSUE#0.7395;TYROSINE KINASE RECEPTOR#0.7373;PROSTATE CANCER#0.7372;SQUAMOUS CELL CARCINOMA#0.7372;RESPONSE TO TNF#0.7369;HEMANGIOBLAST#0.7364;DIGESTION#0.7326;CORONARY ARTERY ENDOTHELIAL CELLS#0.7325;GLUTATHIONE#0.7286;STROMA#0.7283;L-ARGININE#0.7282;MESONEPHROS#0.7255;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7215;EPITHELIAL TO MESENCHYMAL#0.7213;NEURAL STEM CELL#0.7210;CARDIOVASCULAR RISK FACTOR#0.7198;ENDOTHELIAL CELL DYSFUNCTION#0.7179;CYCLIC AMP#0.7176;OXYGEN INDUCED RETINOPATHY#0.7175;CELL ASSOCIATED#0.7167;CHOROID PLEXUS#0.7159;GM-CSF#0.7158;MELATONIN#0.7101;UROKINASE#0.7080;BRAIN WATER CONTENT#0.7058;EARLY ENDOSOME#0.7018;STRESS FIBRE FORMATION#0.6990;DOXYCYCLINE#0.6979;ENDOTHELIAL CELL DENSITY#0.6938;ANGIOTENSIN CONVERTING ENZYME#0.6932;KIDNEY DISEASE#0.6931;PROTEIN SYNTHESIS#0.6922;LUNG METASTASIS#0.6904;UTERUS#0.6902;ENDOTHELIAL GROWTH MEDIUM#0.6899;TAMOXIFEN#0.6888;PKC ACTIVATION#0.6848;GLIOBLASTOMA MULTIFORME#0.6821;LUNG CARCINOMA#0.6813;PARENCHYMA#0.6809;BREAST CARCINOMA#0.6802;GRANULOCYTE COLONY STIMULATING FACTOR#0.6802;PROTEIN PROTEIN INTERACTION#0.6798;TYPE 2 DIABETES MELLITUS#0.6795;2 DIABETES MELLITUS#0.6795;COLON CANCER#0.6788;TYPE 1 DIABETES#0.6779;QUIESCENCE#0.6733;CAVEOLAE#0.6732;ACTIN BINDING#0.6719;PLATELET ACTIVATION#0.6702;RESPONSE TO LPS#0.6694;RELATED PROTEIN 1#0.6689;VASODILATION#0.6684;LYMPH NODE METASTASIS#0.6679;MEMBRANE FRACTION#0.6662;MRNA TRANSCRIPTION#0.6659;RECEPTOR ANTAGONIST#0.6647;NEUTROPHIL EXTRAVASATION#0.6646;EXTRACELLULAR VESICLE#0.6644;CELL COMMUNICATION#0.6641;ARGININE#0.6638;ENDOTHELIAL PRECURSOR CELL#0.6636;ADULT BONE MARROW#0.6634;GLYCOSYLATION#0.6608;EVANS BLUE EXTRAVASATION#0.6601;CELL MOVEMENT#0.6599;CAROTID ARTERY#0.6594;LUNG DISEASE#0.6593;BRAIN EDEMA#0.6589;METASTATIC MELANOMA CELLS#0.6576;ARACHIDONIC ACID#0.6520;THROMBIN RECEPTOR#0.6476;PHOSPHATIDYLSERINE#0.6455;PROTEIN PHOSPHORYLATION#0.6433;CATION CHANNEL#0.6430;CYTOCHROME P450#0.6421;VASCULAR ENDOTHELIAL DYSFUNCTION#0.6416;POST-TRANSLATIONAL MODIFICATION#0.6401;MAGNETIC RESONANCE IMAGING#0.6380;SPINAL CORD#0.6374;LIMB ISCHEMIA#0.6366;JUXTAMEMBRANE#0.6342;UREMIC TOXIN#0.6318;PULMONARY FIBROSIS#0.6310;ANCHORING#0.6306;GONAD#0.6301;TISSUE DAMAGE#0.6290;AMIODARONE#0.6269;RENAL FIBROSIS#0.6265;SIGNALLING CASCADE#0.6252;FOCAL CEREBRAL ISCHEMIA#0.6246;CELL FUSION#0.6244;TRADITIONAL CHINESE MEDICINE#0.6239;BLOOD COAGULATION#0.6212;UVEAL MELANOMA#0.6202;KERATINOCYTE#0.6197;HEMORRHAGIC FEVER WITH RENAL SYNDROME#0.6193;ACETYLCHOLINE RECEPTOR#0.6193;STEM CELL LIKE#0.6180;OXYGEN GLUCOSE DEPRIVATION#0.6170;LDL RECEPTOR#0.6127;SYSTOLIC BLOOD PRESSURE#0.6102;GINKGOLIDE-B#0.6100;INDUCIBLE NITRIC OXIDE#0.6100;GLYCOGEN SYNTHASE KINASE#0.6093;CELL DEVELOPMENT#0.6078;PHOSPHOLIPASE C#0.6077;HISTONE DEACETYLASE#0.6071;SIGNAL TRANSDUCER#0.6070;CHRONIC KIDNEY DISEASE#0.6070;BRADYKININ RECEPTOR#0.6062;PHOSPHODIESTERASE#0.6031;ALLANTOIS#0.6028;TRYPTOPHAN#0.6025;BLOOD CIRCULATION#0.6018;GREEN TEA CATECHIN#0.6011
10040	SIGNALING MOLECULE#0.9029;KERATINOCYTE#0.8807;GROWTH FACTOR#0.8368;DNA SYNTHESIS#0.8198;BREAST CANCER#0.8116;KERATINOCYTE DIFFERENTIATION#0.8090;SRC FAMILY KINASE#0.7344;ENDOSOME#0.6819;CLATHRIN HEAVY CHAIN#0.6721;MVB FORMATION#0.6676
100420505	GERM CELL#0.9589;ENDOPLASMIC RETICULUM#0.7556
100422496	PRE-MRNA SPLICING#1.0586;MRNA SPLICING#1.0554;SPLICEOSOME#1.0352;NINETEEN COMPLEX#0.8815;LIPID DROPLET#0.8496;COMPLEX I#0.7408;PROTEIN COMPLEX#0.6835
100422824	CELL PROLIFERATION#1.1787
100422833	CELL PROLIFERATION#0.9021;SIGNALING PATHWAY#0.7598;CANCER CELL#0.7573;BREAST CANCER#0.6850;APOPTOSIS#0.6395;TYPE 2 DIABETES#0.6308
100422861	SIGNALING PATHWAY#0.7737;MONOCYTE DERIVED MACROPHAGE#0.6861;CORONARY ARTERY#0.6745
100422876	ERBB SIGNALING PATHWAY#0.8055;ERBB SIGNALING#0.7839;LUCIFERASE ACTIVITY#0.7595;SIGNALING PATHWAY#0.7424
100422896	CELL GROWTH#0.9059
100422908	DUAL LUCIFERASE REPORTER#0.9146
100422943	CELL PROLIFERATION#0.7515;CANCER CELL#0.7084
100422945	TUMOR SUPPRESSOR#0.9002;LUNG CANCER#0.8997;CELL PROLIFERATION#0.8960;CANCER CELL#0.8953
100422948	POLYMERASE CHAIN REACTION#0.6032
100422957	BREAST CANCER#0.7099
100422974	BREAST CANCER#0.8019;CANCER CELL#0.7613;BREAST CANCER CELL#0.6596;G1 PHASE#0.6015
100422979	EPITHELIAL TO MESENCHYMAL TRANSITION#0.6589;EPITHELIAL TO MESENCHYMAL#0.6586
100422981	OVARIAN#0.6451
100422982	APOPTOSIS#0.8319;CELL PROLIFERATION#0.8153;ESOPHAGEAL CARCINOMA#0.6361
100422983	OVARIAN#0.8479
100422991	CANCER CELL#0.8573;CELL PROLIFERATION#0.7953;GENISTEIN#0.6357;SIGNALING PATHWAY#0.6352;RENAL CANCER CELLS#0.6211;VSMC PROLIFERATION#0.6074
100422992	APOPTOSIS#0.8229;ACUTE MYELOID LEUKEMIA#0.7265;MYELOID LEUKEMIA#0.7253;CELL PROLIFERATION#0.7181;CHRONIC LYMPHOCYTIC LEUKEMIA#0.6826;LYMPHOCYTIC LEUKEMIA#0.6813;AKT SIGNALING#0.6799;DNA METHYLATION#0.6772;TUMOR SUPPRESSOR#0.6723
100422995	TUMOR SUPPRESSOR#0.6586;SIGNALING PATHWAY#0.6542
100423001	INFLUENZA A VIRUSES#1.2182;VIRAL REPLICATION#1.1914
100423014	BREAST CANCER#0.6637;CELL PROLIFERATION#0.6487;BREAST CANCER CELL#0.6026;TUMOR SUPPRESSOR#0.6007
100423036	BEVACIZUMAB#0.8570
100423038	EXOSOME#0.6544
100423062	B CELL#1.0111;POLYMERASE CHAIN REACTION#0.8203;T CELL#0.8114;IMMUNE RESPONSE#0.7664;B LYMPHOCYTE#0.7488;B CELL DEVELOPMENT#0.7467;CELL DEVELOPMENT#0.7409;PLASMA CELL#0.7238;B CELL RECEPTOR#0.6648;BONE MARROW#0.6385;ANTIGEN BINDING#0.6268
10042	HIGH MOBILITY GROUP#0.7928;SMOOTH MUSCLE#0.6571
100431172	LECTIN#0.9751;KERATINOCYTE#0.9634;CYTOTOXICITY#0.6499
10043	UBIQUITIN#1.0486;ENDOSOME#1.0071;GENE EXPRESSION#0.8711;CLATHRIN BINDING#0.8185;EARLY ENDOSOME#0.8156;SYNAPTIC VESICLE#0.8106;TRANSCRIPTION FACTOR#0.8070;PROTEIN DEGRADATION#0.8067;SIGNALING PATHWAY#0.7945;AUTOPHAGY#0.7627;CELL CYCLE#0.7556;AUTOPHAGOSOME MATURATION#0.7222;PLASMA MEMBRANE#0.7148;C TERMINAL DOMAIN#0.6911;UBIQUITIN BINDING#0.6859;B CELL#0.6569;RNA REPLICATION#0.6506;SYNAPTIC TRANSMISSION#0.6405;AUTOPHAGOSOME#0.6118;M PHASE#0.6068;GROWTH FACTOR#0.6040;S PHASE#0.6034;RIBOSOMAL PROTEIN#0.6033
10044	POLY-A BINDING#1.0481;RNA BINDING#1.0395;CHIKUNGUNYA#1.0136;EQUINE ENCEPHALITIS#1.0100;VENEZUELAN EQUINE ENCEPHALITIS#1.0046;SEVERE ACUTE RESPIRATORY SYNDROME#1.0006;VIRAL REPLICATION#0.9989;RNA SYNTHESIS#0.9939;RNA REPLICATION#0.9894;HOST CELL#0.9861;GROUP A ROTAVIRUS#0.9825;RIBOSE#0.9800;PROTEIN SYNTHESIS#0.9721;VIRULENCE#0.9691;STRESS GRANULE#0.9490;TRANSLATION INITIATION#0.9470;POLYMERASE CHAIN REACTION#0.9462;GASTROENTERITIS#0.9461;EIF4G BINDING#0.9451;DIARRHEA#0.9432;C TERMINAL DOMAIN#0.9220;REVERSE TRANSCRIPTION#0.9214;RNA BINDING PROTEIN#0.9051;IMMUNE RESPONSE#0.9043;SIGNALING PATHWAY#0.8934;VIRAL INFECTION#0.8700;TRANSLATION INITIATION FACTOR#0.8656;T CELL#0.8556;ENDOPLASMIC RETICULUM#0.8534;ARGININE#0.8436;NUCLEOCAPSID#0.8384;SH3 DOMAIN BINDING#0.8105;CYTOPLASM#0.8102;VIRION#0.8004;NEURONAL CELLS#0.7868;VIRAL GENOME#0.7846;MARGINAL ZONE B#0.7658;MUTAGENESIS#0.7634;TRANSCRIPTASE#0.7507;RNA HELICASE#0.7357;B CELL#0.7197;PROTEIN KINASE#0.7134;EPITHELIAL CELL#0.7000;GENE EXPRESSION#0.6911;PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME#0.6881;OUTER CAPSID#0.6875;BREAST CANCER#0.6827;UBIQUITIN#0.6690;INNATE IMMUNE RESPONSE#0.6677;INTERNEURON#0.6599;CELL MIGRATION#0.6523;SIGNAL TRANSDUCER#0.6487;STRESS GRANULE ASSEMBLY#0.6452;NUCLEIC ACID#0.6317;PROTEASOME#0.6307;HEMATOPOIETIC CELL#0.6257;CELL ADHESION#0.6254;KINASE ACTIVITY#0.6232;VACCINIA#0.6169;CYTOPLASMIC FOCI#0.6167;VIRAL PROTEIN SYNTHESIS#0.6161;NUCLEOTIDE EXCHANGE FACTOR#0.6099;DOUBLE-STRANDED RNA BINDING#0.6072;MARGINAL ZONE B CELL#0.6051;INFECTIOUS BRONCHITIS VIRUS#0.6021;HYDROLASE ACTIVITY#0.6015
10045	PROTEASOME#1.0345;NUCLEAR PORE#1.0310;PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME#1.0218;GENE EXPRESSION#1.0212;SEVERE ACUTE RESPIRATORY SYNDROME#1.0206;METHYLTRANSFERASE ACTIVITY#1.0185;TRANSCRIPTION FACTOR#1.0162;VIRAL REPLICATION#1.0145;RNA REPLICATION#1.0112;VIRULENCE#1.0109;RNA SYNTHESIS#1.0073;PROTEIN SYNTHESIS#1.0060;SIGNALING PATHWAY#1.0002;CHIKUNGUNYA#0.9984;NODULATION#0.9960;IMMUNE RESPONSE#0.9956;MRNA DEGRADATION#0.9947;NUCLEAR PORE COMPLEX#0.9891;PORE COMPLEX#0.9882;MUTAGENESIS#0.9882;GASTROENTERITIS#0.9775;GROUP A ROTAVIRUS#0.9770;HOST CELL#0.9754;EQUINE ENCEPHALITIS#0.9710;UBIQUITIN#0.9666;CYTOPLASM#0.9655;DIARRHEA#0.9591;IFN REGULATORY FACTOR#0.9578;INNATE IMMUNE RESPONSE#0.9576;PLASMA MEMBRANE#0.9485;VENEZUELAN EQUINE ENCEPHALITIS#0.9353;VIRAL GENOME#0.9090;NUCLEAR ENVELOPE#0.9050;NUCLEAR EXPORT#0.8972;ANTIVIRAL RESPONSE#0.8710;INTERFERON REGULATORY FACTOR#0.8651;RNA BINDING#0.8540;MRNA SYNTHESIS#0.8517;IMMUNE EVASION#0.8490;CREB BINDING#0.8474;T CELL#0.8374;MRNA CAPPING#0.8326;SYMBIOSIS#0.8299;OUTER CAPSID#0.8124;RNA CAPPING#0.8063;RIBOSOME#0.8022;PROTEIN PROCESSING#0.7996;VIRAL INFECTION#0.7991;INNATE IMMUNITY#0.7840;VIRION#0.7775;PROTEASE ACTIVITY#0.7765;POLYMERASE CHAIN REACTION#0.7763;ALANINE#0.7715;METHIONINE#0.7713;S-ADENOSYLMETHIONINE#0.7492;NUCLEOCAPSID#0.7410;RNA METHYLTRANSFERASE#0.7146;NODULE FORMATION#0.7140;RIBOSOMAL SUBUNIT#0.7127;40S RIBOSOMAL SUBUNIT#0.7075;GUANINE#0.7073;NUCLEAR PORE COMPLEXES#0.7044;HEPATITIS C#0.6869;INTERFERON PRODUCTION#0.6828;PROTEIN TRANSLATION#0.6815;VACCINIA#0.6706;NUCLEAR TRANSPORT#0.6585;C TERMINAL DOMAIN#0.6299;CULLIN-RING LIGASE#0.6254;APOPTOSIS#0.6244;CYTOPLASMIC TRANSPORT#0.6190;CYSTEINE PROTEASE ACTIVITY#0.6172;DENDRITIC CELL#0.6166;VIRAL GENE EXPRESSION#0.6158;NUCLEAR PERIPHERY#0.6042
100462725	OBESE#0.8494
100463488	RABIES#0.8692
100463489	ERLOTINIB#0.8586;GEFITINIB#0.8581
100463498	SQUAMOUS CELL CARCINOMA#0.9702;CANCER CELL#0.9543;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9398;CELL CYCLE#0.9314;KERATINOCYTE#0.8966;APOPTOSIS#0.8892;ORAL CANCER CELL#0.8058;SIGNALING PATHWAY#0.7834;CISPLATIN#0.7385;HEAD AND NECK CANCER#0.6906;NECK CANCER#0.6906;CYTOTOXIN#0.6740;GROWTH FACTOR#0.6499;DOCETAXEL#0.6270;CYTOTOXICITY#0.6115;LYMPH NODE#0.6114;CELL DEATH#0.6008
100463500	CANCER CELL#0.6415;SQUAMOUS CELL CARCINOMA#0.6161;MITOCHONDRIAL MEMBRANE POTENTIAL#0.6155;MITOCHONDRIAL MEMBRANE#0.6129
10046	HYPOSPADIAS#1.0870;TESTOSTERONE#1.0086;LEYDIG CELL#0.9305;TUMOR CELLS#0.8776;TRANSCRIPTION FACTOR#0.7672;DNA BINDING#0.7498;STEROIDOGENIC FACTOR 1#0.7323;GONADAL DYSGENESIS#0.7278;TRANSACTIVATION#0.6852;FUNCTIONAL LUTEOLYSIS#0.6223
10047	CYSTATIN#1.0998;EPIDIDYMIS#1.0685;SPERMATOZOA#0.9868;GERM CELL#0.9271;PITUITARY GLAND#0.8042;CAPUT#0.7820;ACROSOME#0.7748;ACROSOME REACTION#0.7247;FERTILIZATION#0.6804;LUMINAL#0.6176;EFFERENT DUCT#0.6019;INITIAL SEGMENT#0.6008
10048	RAN-BINDING PROTEIN#1.0955;MICROTUBULE#1.0642;MICROTUBULE ORGANIZING CENTER#1.0599;SIGNALING PATHWAY#1.0458;CANCER CELL#1.0121;GERM CELL#0.9793;UBIQUITIN#0.9416;CELL MIGRATION#0.9348;CELL CYCLE#0.9144;GENE EXPRESSION#0.8910;CYTOPLASM#0.8877;ALZHEIMER'S DISEASE#0.8408;APOPTOSIS#0.8362;PROTEIN COMPLEX#0.8201;TUMOR SUPPRESSOR#0.8125;STEM CELL#0.8109;SIGNAL TRANSDUCTION#0.8091;MICROTUBULE NUCLEATION#0.8053;NERVOUS SYSTEM#0.8032;CELL PROLIFERATION#0.7956;TRANSCRIPTION FACTOR#0.7943;CELL SURFACE#0.7829;TRANSACTIVATION#0.7760;TYROSINE KINASE DOMAIN#0.7756;LUNG CANCER#0.7644;SPERMATOGENESIS#0.7592;CELL ADHESION#0.7559;ANDROGEN RECEPTOR#0.7062;NEUROTROPHIN RECEPTOR#0.7013;CELL DEVELOPMENT#0.6935;AMYLOID PRECURSOR PROTEIN#0.6902;GLUTATHIONE#0.6445;SPERMATOCYTES#0.6379;PROTEIN KINASE#0.6350;CENTROSOME#0.6322;GERM CELL DEVELOPMENT#0.6198;THYROID HORMONE RECEPTOR#0.6179;CELL DEATH#0.6158;M PHASE#0.6108;GLUCOCORTICOID RECEPTOR#0.6048;CELL DIFFERENTIATION#0.6013;NEURITE#0.6012
10049	LIMB-GIRDLE MUSCULAR DYSTROPHY#1.0616;MUSCULAR DYSTROPHY#1.0569;ATP HYDROLYSIS#1.0431;ATPASE ACTIVITY#1.0302;MYOPATHY#1.0189;HEAT SHOCK PROTEIN#1.0131;CHAPERONE ACTIVITY#1.0057;PROTEIN FOLDING#0.9998;GERM CELL#0.9954;NUCLEOTIDE EXCHANGE FACTOR#0.9882;CELL CYCLE#0.9858;RIBOSOME#0.9447;ENDOPLASMIC RETICULUM#0.9359;DNA REPLICATION#0.9289;PEPTIDE BINDING#0.9282;TRANSCRIPTION FACTOR#0.9137;TOXICITY#0.9108;GENE EXPRESSION#0.8966;NEURODEGENERATIVE DISEASE#0.8854;PROTEASOME#0.8633;CHLOROPLAST#0.8568;PARKINSON'S DISEASE#0.8535;CANCER CELL#0.8526;DNA BINDING#0.8452;BREAST CANCER#0.8312;CYTOPLASM#0.8214;PROTEIN DISULFIDE ISOMERASE#0.8163;PROTEIN QUALITY CONTROL#0.8126;SPERMATOZOA#0.8061;TUMOR SUPPRESSOR#0.8017;UBIQUITIN#0.7986;HUNTINGTON'S DISEASE#0.7682;RENATURATION#0.7643;SKELETAL MUSCLE#0.7598;PLACENTAL DEVELOPMENT#0.7593;PROTEIN PROTEIN INTERACTION#0.7443;ACROSOME#0.7411;SPINAL CORD#0.7410;NUCLEAR IMPORT#0.7343;CHAPERONIN#0.7337;LUCIFERASE ACTIVITY#0.7299;CELL DIVISION#0.7252;PROTEIN SYNTHESIS#0.7204;NUCLEOTIDE BINDING#0.7180;APOPTOSIS#0.7126;RNA BINDING#0.7101;SUBSTRATE BINDING DOMAIN#0.7067;MITOCHONDRIA#0.6862;MYOFIBRILLAR MYOPATHY#0.6777;SIGNALING PATHWAY#0.6678;STEM CELL#0.6629;CELL GROWTH#0.6520;POLYMERASE CHAIN REACTION#0.6456;FIBRIL#0.6369;AUTOPHAGY#0.6123;Z DISC#0.6109;AMYLOID FIBRIL FORMATION#0.6108;STRESS GRANULE#0.6018
1004	RENAL CELL CARCINOMA#1.0318;CELL ADHESION MOLECULE#1.0041;CELL ADHESION#1.0031;GENE EXPRESSION#0.9806;CANCER CELL#0.9605;CELL CELL ADHESION#0.9392;NEURAL CREST#0.9369;NERVOUS SYSTEM#0.8966;TUMOR CELLS#0.8751;NEURAL CREST CELL#0.8716;EPITHELIAL CELL#0.8499;OVARIAN#0.8415;POLYMERASE CHAIN REACTION#0.8214;LYMPH NODE#0.8075;TRANSCRIPTION FACTOR#0.8024;GROWTH FACTOR#0.7895;RENAL CELL CANCER#0.7822;LYMPH NODE METASTASIS#0.7634;STROMAL CELL#0.7393;MESENCHYME#0.7027;KIDNEY DEVELOPMENT#0.6962;PERIPHERAL BLOOD#0.6961;CEREBRAL CORTEX#0.6886;FOREBRAIN#0.6592;URETERIC BUD#0.6577;PERIPHERAL NERVOUS SYSTEM#0.6209;RETINAL DEVELOPMENT#0.6207;OVARIAN CANCER#0.6152;KIDNEY CANCER#0.6119;AMACRINE CELL#0.6107;NEURAL TUBE#0.6090;OVARIAN CARCINOMA#0.6070;HINDBRAIN#0.6029
100500809	CELL GROWTH#0.6766;CELL PROLIFERATION#0.6610
100500812	GASTRIC ANTRAL VASCULAR ECTASIA#0.6594;CELL PROLIFERATION#0.6544
100500827	BREAST CANCER CELL#1.1848;BREAST CANCER#1.1796;CELL PROLIFERATION#1.1787;CANCER CELL#1.1780
100500833	EPITHELIAL MESENCHYMAL TRANSITION#0.6653;COLON CANCER#0.6627;CANCER CELL#0.6537
100500840	GEMCITABINE#0.6544
100500843	LYMPHOPROLIFERATIVE DISEASE#1.2052
100500844	LIVER CANCER#1.1930;CANCER CELL#1.1780
100500857	DIABETIC RETINOPATHY#1.1947
100500858	CANCER CELL#0.7084
100500878	OSTEOBLAST#0.8509
100500880	ACUTE MYELOID LEUKEMIA#0.7596;MYELOID LEUKEMIA#0.7579;QUANTITATIVE TRAIT LOCUS#0.7357;HEPATOCELLULAR CARCINOMA#0.7147;LUNG CANCER#0.7127
100500914	HYPOPITUITARISM#0.6629
100500918	SQUAMOUS CELL CANCER#0.6726
100505385	ANTISENSE RNA#0.6668;SURFACE PLASMON RESONANCE#0.6592
100505390	ATP HYDROLYSIS#0.7070;DYNEIN#0.6896;CORPUS STRIATUM#0.6822;NUCLEOTIDE BINDING#0.6106;ATPASE ACTIVITY#0.6083
100505475	CARDIOMYOCYTE#0.8513
100505495	CELL PROLIFERATION#0.9518;PROSTATE CANCER#0.6422;LUNG CANCER#0.6240
100505592	GASTRIC ADENOCARCINOMA#1.0636;CELL MIGRATION#1.0406;CELL PROLIFERATION#0.9801;ADENOCARCINOMA#0.9374;CELL CYCLE#0.8273;COLORECTAL CANCER#0.7341;CANCER CELL#0.7295;LUNG CANCER#0.6553
100505641	CANCER CELL#0.8948;CELL PROLIFERATION#0.8498;COLORECTAL CANCER#0.7114
100505648	DNA REPAIR#0.7850;EPITHELIAL OVARIAN CANCER#0.7609;OVARIAN CANCER#0.7501;CELL CYCLE#0.7437
100505666	CELL PROLIFERATION#0.7427
100505705	PROGENITOR CELL#1.1842;CELL DEATH#1.1799
100505741	BREAST CANCER#0.8730;STORAGE PROTEIN#0.7920;CANCER CELL#0.7538;HUMAN BREAST CANCER#0.7232;BREAST CANCER CELL#0.6882
100505746	BREAST CANCER CELL#0.7152;BREAST CANCER#0.7099;CELL PROLIFERATION#0.7091;CANCER CELL#0.7084
100505806	SMALL NUCLEOLAR RNA#1.2156;MULTIPLE MYELOMA#0.8071;HEPATOCELLULAR CARCINOMA#0.8014;TUMOR SUPPRESSOR#0.7999
100505832	PAPILLARY THYROID CARCINOMA#0.7054;THYROID CANCER#0.6996;THYROID CARCINOMA#0.6983;CANCER CELL#0.6849
100505854	CELL PROLIFERATION#0.7037;PORTAL HYPERTENSION#0.6910;HEPATIC STELLATE CELL#0.6854;PORTAL VEIN#0.6848
100505881	BREAST CANCER#0.9757;CELL PROLIFERATION#0.8681;CANCER CELL#0.8501;BREAST CANCER CELL#0.8325;CELL GROWTH#0.8014;APOPTOSIS#0.7314;ANTISENSE RNA#0.6687;POLYMERASE CHAIN REACTION#0.6546;NON-SMALL CELL LUNG CARCINOMA#0.6092;LUNG CARCINOMA#0.6002
100505994	CELL PROLIFERATION#1.0991;LUNG CANCER#1.0947;CELL CYCLE#1.0580;CANCER CELL#1.0390;APOPTOSIS#1.0271;BREAST CANCER#0.8777;CERVICAL CANCER#0.8001;POLYMERASE CHAIN REACTION#0.7872;SIGNALING PATHWAY#0.7545;DRUG RESISTANCE#0.6376;CELL CYCLE ARREST#0.6360;HEPATOCELLULAR CARCINOMA#0.6192;SQUAMOUS CELL CARCINOMA#0.6189;CELL MIGRATION#0.6150;CARDIOMYOCYTE#0.6070;CERVICAL#0.6055;PRC2 COMPLEX#0.6042
100506013	STEM CELL#1.0215;SIGNALING PATHWAY#1.0211;APOPTOSIS#0.9765;PEPTIDE HORMONE#0.9743;CARDIOVASCULAR SYSTEM#0.9517;EMBRYONIC STEM CELL#0.8819;HYPERTENSION#0.8773;CANCER CELL#0.8621;HEART DEVELOPMENT#0.8328;CARDIAC DEVELOPMENT#0.7888;HUMAN EMBRYONIC STEM#0.7832;PRE-ECLAMPSIA#0.7745;ANGIOGENESIS#0.7650;CELL CYCLE#0.7599;TROPHOBLAST#0.7525;CYTOTOXICITY#0.7461;CARDIOVASCULAR SYSTEM DEVELOPMENT#0.6872;CERVICAL#0.6621;GROWTH FACTOR#0.6394;SYSTEM DEVELOPMENT#0.6216;ECLAMPSIA#0.6190;ARGININE VASOPRESSIN#0.6133;CERVICAL CANCER#0.6130;BLOOD VESSEL#0.6086;CELL GROWTH#0.6052
100506020	DIABETIC NEPHROPATHY#0.9084;NEPHROPATHY#0.6485
100506046	ORAL SUBMUCOUS FIBROSIS#0.7572;LUNG CANCER#0.7127
100506164	INTIMA MEDIA THICKNESS#0.6804;TYPE 1 DIABETES#0.6619;LEFT VENTRICULAR MASS#0.6273;DNA BINDING#0.6092
100506211	COLORECTAL ADENOCARCINOMA#0.6579;INVASIVE BREAST CANCER#0.6540;COLON CANCER#0.6425;HEPATOCELLULAR CARCINOMA#0.6398;BREAST CANCER#0.6350
100506237	LUNG CARCINOMA#0.7557;CELL MIGRATION#0.7484
100506311	CELL PROLIFERATION#1.0513;APOPTOSIS#1.0424;ANTISENSE RNA#0.9387;GENE EXPRESSION#0.8839;ACUTE MYELOID LEUKEMIA#0.8788;MYELOID LEUKEMIA#0.8771;LUNG CANCER#0.8750;CELL CYCLE#0.7890;MYELOID CELL#0.7840;CELL DIFFERENTIATION#0.7063;ACUTE PROMYELOCYTIC LEUKEMIA#0.6416;DRUG RESISTANCE#0.6219
100506365	CLEAR CELL RENAL CELL CARCINOMA#0.7654;RENAL CELL CARCINOMA#0.7534;SIGNALING PATHWAY#0.7424
100506392	LUNG CANCER#1.1823
100506394	CANCER CELL#0.7278;BREAST CANCER#0.7099;SIGNALING PATHWAY#0.7088;APOPTOSIS#0.6905
100506428	CELL PROLIFERATION#1.1195;PROSTATE CANCER#1.0639;APOPTOSIS#1.0392;EPITHELIAL MESENCHYMAL TRANSITION#0.8763;ANDROGEN RECEPTOR#0.8748;CANCER CELL#0.8573;COLORECTAL CANCER#0.7341;CELL CYCLE#0.7308;NORMAL PROSTATE EPITHELIAL#0.6906;PROSTATE EPITHELIAL CELL#0.6742;LYMPH NODE METASTASIS#0.6604;HEPATOCELLULAR CARCINOMA#0.6569;LYMPH NODE#0.6548;EPITHELIAL CELL#0.6429;ACUTE KIDNEY INJURY#0.6027
100506492	BREAST CANCER#1.0654;CELL PROLIFERATION#0.9597;CANCER CELL#0.9445;POLYMERASE CHAIN REACTION#0.7438;TUMOR TISSUES#0.7420;BREAST CANCER CELL#0.6649;QUANTITATIVE REAL TIME#0.6625;COLORECTAL#0.6384;APOPTOSIS#0.6348;COLORECTAL ADENOCARCINOMA#0.6168;INVASIVE DUCTAL CARCINOMA#0.6161;BREAST CANCER PATIENTS#0.6027;OVARIAN CANCER#0.6006
100506495	LEUKEMIA INHIBITORY FACTOR#0.8075;ANTISENSE RNA#0.7181;CELL PROLIFERATION#0.7181;BREAST CANCER CELL#0.6742;CANCER CELL#0.6674
100506658	VASCULAR ENDOTHELIAL CADHERIN#1.0563;SCAVENGER RECEPTOR#1.0455;DEPHOSPHORYLATION#1.0440;INSOLUBLE FRACTION#1.0430;JUNCTIONAL ADHESION MOLECULE#1.0405;ZONULA OCCLUDENS 1#1.0343;ZONULA OCCLUDENS#1.0290;CONNEXIN#1.0283;LIPID RAFT#1.0283;ENDOCYTIC RECYCLING#1.0210;SOLUBLE FRACTION#1.0199;TIGHT JUNCTION ASSEMBLY#1.0196;RETINAL ENDOTHELIAL CELLS#1.0125;C TERMINAL DOMAIN#1.0098;SMOOTH MUSCLE ACTIN#1.0081;TIGHT JUNCTION FORMATION#1.0077;LOCALISATION#1.0073;FOCAL ADHESION KINASE#1.0063;IFN-GAMMA#1.0060;EVANS BLUE EXTRAVASATION#1.0046;MAP KINASE#1.0044;B CELL#1.0033;CELL CELL JUNCTION#1.0012;SQUAMOUS CELL CARCINOMA#1.0007;ENDOCYTOSIS#1.0004;CELL MEMBRANE#1.0003;TIGHT JUNCTION PROTEIN#1.0001;SERTOLI CELL#0.9993;AQUAPORIN#0.9993;INULIN#0.9987;FOCAL ADHESION#0.9971;DIAMINE OXIDASE#0.9953;JEJUNUM#0.9952;CYTOPLASM#0.9948;SMOOTH MUSCLE#0.9943;GLIAL FIBRILLARY ACIDIC PROTEIN#0.9943;GAP JUNCTION#0.9934;MYOSIN LIGHT-CHAIN KINASE#0.9929;B CELL LYMPHOMA#0.9924;PERICYTE#0.9922;DUODENUM#0.9922;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9916;TIGHT JUNCTION#0.9913;PROTEIN COMPLEX#0.9911;ACTIN FILAMENT#0.9905;ETHANOL#0.9903;STRESS FIBER#0.9899;QUANTITATIVE REAL TIME#0.9897;CELL SURFACE#0.9896;LOW DENSITY LIPOPROTEIN#0.9895;REVERSE TRANSCRIPTION#0.9892;INTERCELLULAR SPACE#0.9886;CORNEAL EPITHELIAL CELL#0.9880;ACTIN CYTOSKELETON#0.9867;HEPATITIS C#0.9864;GOBLET CELL#0.9862;LYMPH NODE#0.9862;DESMOSOME#0.9858;KERATINOCYTE#0.9857;CONTACT SITE#0.9855;HYPOXIA#0.9855;BRAIN WATER CONTENT#0.9855;PLASMA MEMBRANE#0.9851;CELL JUNCTION#0.9850;HEPATITIS C VIRUS#0.9846;BILE DUCT#0.9833;SIGNALING MOLECULE#0.9832;VASCULAR ENDOTHELIAL CELL#0.9832;LASER SCANNING MICROSCOPY#0.9828;CEREBRAL CORTEX#0.9828;INTERCELLULAR JUNCTION#0.9827;ESTRADIOL#0.9826;GLIAL CELL#0.9818;NADPH OXIDASE#0.9815;CORNEAL EPITHELIUM#0.9815;BLOOD VESSEL#0.9813;ADHERENS JUNCTION#0.9806;BLOOD TESTIS BARRIER#0.9804;CELL CELL ADHESION#0.9804;EPIDERMAL GROWTH FACTOR#0.9799;SPINAL CORD#0.9799;FOCAL CEREBRAL ISCHEMIA#0.9798;RETINAL PIGMENT EPITHELIAL#0.9797;GROWTH FACTOR RECEPTOR#0.9797;POLYMERASE CHAIN REACTION#0.9796;MANNITOL#0.9795;BRAIN ENDOTHELIAL CELL#0.9794;CELL ADHESION MOLECULE#0.9793;BASEMENT MEMBRANE#0.9792;NEUTROPHIL#0.9788;BREAST CANCER#0.9784;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9779;ENDOTHELIAL GROWTH FACTOR#0.9776;HYPOXIC#0.9775;BASAL LAMINA#0.9771;INTESTINAL MUCOSAL BARRIER#0.9770;SUCROSE#0.9768;NITRIC OXIDE SYNTHASE#0.9763;PROTEIN KINASE C#0.9761;MAST CELL#0.9760;BLOOD RETINAL BARRIER#0.9757;ALVEOLAR EPITHELIAL CELL#0.9756;TOLL LIKE RECEPTOR#0.9755;CERVICAL#0.9753;COLONIC EPITHELIAL CELLS#0.9751;MONOCYTE#0.9741;TRANSFORMING GROWTH FACTOR#0.9740;HOST CELL#0.9738;INDUCIBLE NITRIC OXIDE#0.9737;TRANSENDOTHELIAL ELECTRICAL RESISTANCE#0.9733;AIRWAY EPITHELIAL CELL#0.9732;GERM CELL#0.9727;DEXAMETHASONE#0.9724;CELL MIGRATION#0.9719;T CELL#0.9716;CELL POLARITY#0.9715;HUMAN INTESTINAL EPITHELIAL#0.9715;ENTEROCYTE#0.9714;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9712;UMBILICAL VEIN#0.9711;HUMAN UMBILICAL VEIN#0.9708;GLUTATHIONE PEROXIDASE#0.9703;ADENOCARCINOMA#0.9700;ACUTE PANCREATITIS#0.9699;INTESTINAL MUCOSA#0.9698;EXTRACELLULAR MATRIX#0.9696;SMALL INTESTINE#0.9694;SIGNAL TRANSDUCTION#0.9692;TRANSCRIPTION FACTOR#0.9692;GENE EXPRESSION#0.9690;APOPTOTIC#0.9689;HEAT SHOCK PROTEIN#0.9688;ANGIOGENESIS#0.9686;TRANSCRIPTASE#0.9686;BRAIN EDEMA#0.9685;KINASE INHIBITOR#0.9685;MICROTUBULE#0.9674;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9674;MITOGEN ACTIVATED PROTEIN#0.9673;EPITHELIAL TO MESENCHYMAL#0.9673;LACTULOSE#0.9670;WOUND HEALING#0.9668;ALKALINE PHOSPHATASE#0.9667;BILE DUCT LIGATION#0.9666;CELL ADHESION#0.9661;TRANSEPITHELIAL ELECTRICAL RESISTANCE#0.9659;NITRIC OXIDE#0.9656;LARGE INTESTINE#0.9656;CANCER CELL#0.9652;ASTROCYTE#0.9652;CELL PROLIFERATION#0.9652;OXYGEN GLUCOSE DEPRIVATION#0.9652;BIOTIN#0.9651;LACTIC ACID#0.9650;CYTOTOXICITY#0.9650;ENDOTHELIUM#0.9650;COLITIS#0.9647;PROTEIN KINASE#0.9647;GLUTATHIONE#0.9643;INTESTINAL EPITHELIAL CELL#0.9641;VASCULAR CELL#0.9640;APICAL JUNCTION#0.9638;LUMINAL#0.9638;CAVEOLAE#0.9636;CEREBRAL ISCHEMIA#0.9635;CELL PERIPHERY#0.9634;LEUKOCYTE#0.9626;TARGET OF RAPAMYCIN#0.9626;ENDOTHELIAL CELL#0.9625;TRANSMISSION ELECTRON MICROSCOPY#0.9624;MICROVASCULAR ENDOTHELIAL CELL#0.9624;PRO-INFLAMMATORY#0.9623;ISCHEMIA#0.9620;GROWTH FACTOR#0.9620;CELL DIFFERENTIATION#0.9618;MACROPHAGE#0.9615;PIGMENT EPITHELIAL CELL#0.9615;DIABETIC RETINOPATHY#0.9615;REACTIVE OXYGEN SPECIES#0.9611;SUPEROXIDE DISMUTASE#0.9608;EPITHELIAL BARRIER FUNCTION#0.9607;APOPTOSIS#0.9607;HIGH FAT DIET#0.9607;EPITHELIAL MESENCHYMAL TRANSITION#0.9606;CROHN'S DISEASE#0.9604;SALIVARY GLAND#0.9604;MEMBRANE FRACTION#0.9603;ISCHEMIA REPERFUSION INJURY#0.9599;MAPK SIGNALING#0.9597;D-LACTIC ACID#0.9596;DEXTRAN SULFATE SODIUM#0.9592;DIARRHEA#0.9591;COLORECTAL#0.9591;IRRITABLE BOWEL SYNDROME#0.9590;ULCERATIVE COLITIS#0.9590;RAPAMYCIN#0.9589;WEIGHT LOSS#0.9585;INFLAMMATORY CELL#0.9582;STREPTOZOTOCIN#0.9580;BREAST CANCER CELL#0.9578;MULTIPLE SCLEROSIS#0.9573;FLUORESCEIN#0.9572;CEREBRAL ARTERY OCCLUSION#0.9571;TUMOR NECROSIS FACTOR#0.9569;WEIGHT GAIN#0.9568;STEM CELL#0.9566;CELL CYCLE#0.9560;BASAL CELL#0.9559;CELL DEATH#0.9556;SPERMATOGENESIS#0.9553;LIVER DISEASE#0.9552;EPITHELIAL CELL#0.9549;MESENTERIC LYMPH NODE#0.9548;EDEMA#0.9548;MIDDLE CEREBRAL ARTERY#0.9548;CEREBRAL ARTERY#0.9547;ADVANCED GLYCATION END#0.9544;KINASE ACTIVITY#0.9544;ALZHEIMER'S DISEASE#0.9543;TRAUMATIC BRAIN INJURY#0.9537;MEMBRANE MICRODOMAIN#0.9534;PARENCHYMA#0.9534;HEMORRHAGE#0.9534;GASTROINTESTINAL TRACT#0.9523;TUMOUR NECROSIS FACTOR#0.9517;TOXICITY#0.9510;SIGNALING PATHWAY#0.9505;TESTOSTERONE#0.9501;DEXTRAN SODIUM SULFATE#0.9499;GLUTAMINE#0.9492;HYPOXIA INDUCIBLE FACTOR#0.9491;IMMUNE CELL#0.9485;ALLERGEN#0.9484;BLOOD BRAIN BARRIER#0.9480;EOSIN#0.9479;INFLAMMATORY BOWEL DISEASE#0.9476;GLUCOCORTICOID RECEPTOR#0.9476;ARTERY#0.9470;RETINAL PIGMENT EPITHELIUM#0.9468;CENTRAL NERVOUS SYSTEM#0.9464;IMMUNE SYSTEM#0.9461;INFLAMMATORY RESPONSE#0.9456;PROTEIN KINASE A#0.9456;IMMUNE RESPONSE#0.9456;PROTEIN LOCALIZATION#0.9455;MICROVILLI#0.9455;AUTOPHAGY#0.9453;CELL GROWTH#0.9450;NERVOUS SYSTEM#0.9448;DISEASE ACTIVITY INDEX#0.9444;PANCREATITIS#0.9441;ALANINE#0.9439;RECEPTOR ANTAGONIST#0.9414;BRAIN DAMAGE#0.9413;LUNG CANCER#0.9410;MELATONIN#0.9396;RETINOIC ACID#0.9388;ENDOSOME#0.9383;RETINAL PIGMENT EPITHELIAL CELLS#0.9376;FATTY LIVER#0.9369;IMMUNOGLOBULIN G#0.9365;SIGNALLING PATHWAY#0.9365;ACUTE LUNG INJURY#0.9362;OVARIAN#0.9361;HEMORRHAGIC#0.9359;SPERMATOCYTES#0.9346;MECHANISM OF ACTION#0.9344;ENDOPLASMIC RETICULUM#0.9342;HEPATOCELLULAR CARCINOMA#0.9335;ESTROGEN RECEPTOR#0.9320;AIRWAY EPITHELIUM#0.9317;CLEAVED CASPASE 3#0.9313;PROTEIN DEGRADATION#0.9309;TUMOR CELLS#0.9305;ARGININE#0.9304;CHOROID PLEXUS#0.9303;CELLULAR LOCALIZATION#0.9300;FATTY LIVER DISEASE#0.9255;COLORECTAL CANCER#0.9238;AVERAGE DAILY GAIN#0.9227;PERIPHERAL BLOOD#0.9226;HUMAN NASAL EPITHELIAL#0.9221;MYELOPEROXIDASE ACTIVITY#0.9213;INSULIN-LIKE GROWTH FACTOR#0.9210;PROGESTERONE#0.9205;BRONCHIAL EPITHELIAL CELLS#0.9205;FACTOR I#0.9203;HUMAN AIRWAY EPITHELIAL#0.9198;ADENOSINE#0.9196;DENDRITIC CELL#0.9178;EPIDIDYMIS#0.9177;WATER CHANNEL#0.9172;ACID PHOSPHATASE#0.9163;HYPERGLYCEMIA#0.9149;GENISTEIN#0.9134;TRANSEPITHELIAL ELECTRIC RESISTANCE#0.9134;VASCULAR ENDOTHELIUM#0.9131;HUMAN CORNEAL EPITHELIAL#0.9113;HISTONE DEACETYLASE#0.9110;HUMAN BRONCHIAL EPITHELIAL#0.9101;REGENERATION#0.9100;NEUROPROTECTION#0.9081;INTESTINAL DAMAGE#0.9067;ASPARTATE#0.9036;ATPASE ACTIVITY#0.9032;PULMONARY EDEMA#0.8985;VIRULENCE#0.8967;72-HOURS#0.8936;DIABETES MELLITUS#0.8925;BASAL ECTOPLASMIC SPECIALIZATION#0.8921;L-ARGININE#0.8909;UBIQUITIN#0.8908;17β-ESTRADIOL#0.8907;SERUM ALBUMIN#0.8905;CELIAC DISEASE#0.8890;MAPK ACTIVATION#0.8879;ZONULA ADHERENS#0.8873;RNA INTERFERENCE#0.8868;QUANTITATIVE REVERSE TRANSCRIPTION#0.8864;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.8862;BONE MARROW#0.8850;RESVERATROL#0.8826;SPINAL CORD INJURY#0.8804;TUMOR SUPPRESSOR#0.8791;TUBE FORMATION#0.8771;LIVER DAMAGE#0.8765;MECHANISMS OF ACTION#0.8752;FILAMENTOUS ACTIN#0.8739;MITOCHONDRIA#0.8738;SWELLING#0.8737;BRAIN ISCHEMIA#0.8729;INFERTILITY#0.8713;PROTEIN PHOSPHATASE 2A#0.8703;PHOSPHATASE 2A#0.8700;HYPERSENSITIVITY#0.8697;NORMAL CONTROL GROUP#0.8688;FATTY ACID BINDING#0.8674;TRANSFORMING GROWTH FACTOR BETA#0.8671;HUMAN BREAST CANCER#0.8646;SIGNAL TRANSDUCER#0.8639;CHOLESTASIS#0.8637;OXYGENASE#0.8635;TRYPTOPHAN#0.8626;OBESE#0.8625;BODY WEIGHT GAIN#0.8599;PROTEASOME#0.8593;MORPHOGENESIS#0.8583;MAMMARY EPITHELIAL CELL#0.8559;INTESTINAL TRACT#0.8558;TRADITIONAL CHINESE MEDICINE#0.8551;HISTAMINE#0.8549;ANCHORING#0.8536;PKC ACTIVITY#0.8525;SIGNALING CASCADE#0.8524;RETINAL VASCULAR PERMEABILITY#0.8513;TRANSFERRIN RECEPTOR#0.8512;MESENCHYMAL STEM CELL#0.8507;ROS GENERATION#0.8504;STRIATUM#0.8498;HEPATOCYTE GROWTH FACTOR#0.8497;APICAL JUNCTIONAL COMPLEX#0.8488;BODY WEIGHT LOSS#0.8487;GASTRIC MUCOSA#0.8482;ADIPOSE TISSUE#0.8475;BERBERINE#0.8471;DIGESTION#0.8467;ALCOHOLIC FATTY LIVER#0.8459;TRANSMISSION ELECTRON MICROSCOPE#0.8455;AKT SIGNALING#0.8455;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.8446;INTESTINAL DISEASE#0.8426;SCIATIC NERVE#0.8412;COLON CANCER#0.8404;HEPATOMA CELLS#0.8393;SUBMANDIBULAR GLAND#0.8392;DAILY FEED INTAKE#0.8391;NASAL MUCOSA#0.8390;PSORIASIS#0.8362;FOLLICLE STIMULATING HORMONE#0.8355;GRANULOSA CELL#0.8343;PERIPHERAL NERVE#0.8336;HIGH MOBILITY GROUP#0.8319;HEME OXYGENASE 1#0.8313;STROMAL CELL#0.8306;PKC ACTIVATION#0.8301;FRUCTOSE#0.8300;HYPERTENSION#0.8273;BICELLULAR TIGHT JUNCTION#0.8254;GM6001#0.8234;ACINAR CELL#0.8229;CELL ACTIVATION#0.8208;PHOSPHATASE ACTIVITY#0.8201;ATOPIC DERMATITIS#0.8197;EPITHELIAL CELL APOPTOSIS#0.8188;ACETIC ACID#0.8184;QUERCETIN#0.8176;MAMMARY GLAND#0.8172;RECEPTOR AGONIST#0.8154;MAGNETIC RESONANCE IMAGING#0.8149;SEVERE ACUTE PANCREATITIS#0.8120;TIGHT JUNCTION DISASSEMBLY#0.8116;CELL MOTILITY#0.8110;ENCEPHALOMYELITIS#0.8083;ION TRANSPORT#0.8071;PROTEIN KINASE B#0.8061;INTESTINAL DEVELOPMENT#0.8045;SCANNING ELECTRON MICROSCOPY#0.8037;CEREBRAL INFARCTION#0.8006;PROGENITOR CELL#0.8004;MRNA TRANSCRIPTION#0.8000;LUBIPROSTONE#0.8000;TYPE 2 DIABETES#0.7998;NECROTIZING#0.7997;INFLAMMATORY CELL INFILTRATION#0.7993;VITAMIN D RECEPTOR#0.7965;BRAIN GLIOMA#0.7954;ENDOTHELIAL NITRIC OXIDE#0.7953;DIAMINE OXIDASE ACTIVITY#0.7951;CHLORIDE CHANNEL#0.7941;EPITHELIAL TISSUES#0.7930;EARLY ENDOSOME#0.7923;PROTEIN SYNTHESIS#0.7920;APICAL ES#0.7919;CELLULAR MEMBRANE#0.7908;DERMATITIS#0.7904;SPHINGOSINE 1 PHOSPHATE#0.7898;STATISTICALLY SIGNIFICANT DIFFERENCE#0.7885;CYTOCHROME C#0.7873;L-ARG#0.7866;LIPID METABOLISM#0.7865;POST-TRANSLATIONAL MODIFICATION#0.7861;CYTOKINE PRODUCTION#0.7860;GESTATION#0.7849;PERIPHERAL MEMBRANE PROTEIN#0.7840;EXCRETION#0.7838;HYPERPHOSPHORYLATION#0.7827;NEURONAL CELL DEATH#0.7817;METALLOPROTEINASE INHIBITOR#0.7793;MONOCYTE CHEMOATTRACTANT PROTEIN#0.7790;LATERAL PLASMA MEMBRANE#0.7784;MITOCHONDRIAL MEMBRANE#0.7763;SKIN DISEASE#0.7739;MALE INFERTILITY#0.7736;FEED CONVERSION RATIO#0.7735;MESENCHYMAL EPITHELIAL TRANSITION#0.7732;NEUROLOGICAL DISORDER#0.7726;STEM CELL MARKER#0.7720;T LYMPHOCYTE#0.7720;ISOFLURANE#0.7712;CYSTIC FIBROSIS#0.7711;NASAL EPITHELIUM#0.7703;TOPICAL#0.7699;HYDROCORTISONE#0.7691;UTERUS#0.7678;METFORMIN#0.7655;CORTISOL#0.7648;COLON CARCINOMA#0.7618;OUABAIN#0.7585;COMPLEX I#0.7581;TROPHECTODERM#0.7578;PANCREATIC CANCER#0.7574;GLYCOGEN SYNTHASE KINASE#0.7542;MESENCHYMAL CELL#0.7541;LUNG EPITHELIAL CELL#0.7537;LUNG DISEASE#0.7531;TIGHT JUNCTION ORGANIZATION#0.7530;BLASTOCYST FORMATION#0.7526;LATE ENDOSOME#0.7522;OBSTRUCTIVE JAUNDICE#0.7511;SKELETAL MUSCLE#0.7502;DEMENTIA#0.7497;EARLY BRAIN INJURY#0.7486;LUNG CARCINOMA#0.7454;L-CYSTEINE#0.7433;MACULAR DEGENERATION#0.7426;TH17 CELL#0.7420;ENDOPLASMIC RETICULUM STRESS#0.7417;INHIBIN#0.7415;PROTEIN TYROSINE PHOSPHATASE#0.7405;CATENIN COMPLEX#0.7396;CELL DIVISION#0.7396;MITOCHONDRIAL MEMBRANE POTENTIAL#0.7390;PROTEIN PROTEIN INTERACTION#0.7384;BASAL ES#0.7383;PEROXISOME#0.7381;ORAL MUCOSA#0.7380;KIDNEY DISEASE#0.7378;LACTATION#0.7374;FIBROBLAST GROWTH FACTOR#0.7373;INTRACELLULAR LOCALIZATION#0.7366;GASTRIC TISSUE#0.7358;ASPARTIC ACID#0.7344;CLOSTRIDIUM PERFRINGENS ENTEROTOXIN#0.7321;EXOSOME#0.7314;SPHINGOSINE#0.7303;HIGH DENSITY LIPOPROTEIN#0.7279;CLATHRIN-MEDIATED ENDOCYTOSIS#0.7263;KERATINOCYTE DIFFERENTIATION#0.7263;CELL POLARIZATION#0.7262;ENDOCYTIC VESICLE#0.7253;ENZYME ACTIVITY#0.7247;ACUTE ISCHEMIC STROKE#0.7232;ACTOMYOSIN#0.7226;SPERMATOGENIC CELLS#0.7218;AGE RELATED MACULAR DEGENERATION#0.7211;NEUROTOXIC#0.7207;N-ACETYLCYSTEINE#0.7198;ASPIRIN#0.7197;CHRONIC HEPATITIS C#0.7188;BASAL GANGLIA#0.7188;TISSUE DAMAGE#0.7182;HUMAN IMMUNODEFICIENCY VIRUS#0.7162;OF DIABETIC RATS#0.7160;TYROSINE KINASE INHIBITOR#0.7157;VITAMIN C#0.7135;METHIONINE#0.7123;MYELOID CELL#0.7121;TOXICANT#0.7105;STROMA#0.7095;EOSINOPHIL#0.7093;LYSOZYME ACTIVITY#0.7087;FIBRINOGEN#0.7086;PARKINSON'S DISEASE#0.7073;VIRION#0.7072;BRAIN CORTEX#0.7065;APICAL ECTOPLASMIC SPECIALIZATION#0.7049;PLATELET-DERIVED GROWTH FACTOR#0.7038;SIMVASTATIN#0.7027;COLLAGENASE#0.7024;EICOSAPENTAENOIC ACID#0.6995;NONALCOHOLIC FATTY LIVER DISEASE#0.6977;LEUCINE#0.6965;IRINOTECAN#0.6957;MUTAGENESIS#0.6952;ATHEROSCLEROSIS#0.6951;BRAIN DEVELOPMENT#0.6951;LUNG ADENOCARCINOMA#0.6943;PHOSPHATASE INHIBITOR#0.6927;ANDROGEN RECEPTOR#0.6918;OOCYTE#0.6917;DOXYCYCLINE#0.6916;TROPISM#0.6904;DNA BINDING#0.6895;SENESCENCE#0.6881;BINDING PROTEIN 1#0.6878;CAROTID ARTERY#0.6853;LEPTOTENE#0.6838;WATER CHANNEL PROTEIN#0.6823;PORTAL VEIN#0.6818;ESOPHAGUS#0.6807;TRANSIENT RECEPTOR POTENTIAL#0.6804;LYSINE#0.6801;TUMOR TISSUES#0.6788;MAGUK#0.6778;MONONUCLEAR CELLS#0.6754;ACUTE LIVER FAILURE#0.6748;OVARIAN CANCER#0.6743;EPITHELIAL CELL PROLIFERATION#0.6741;CENTROSOME#0.6732;SKIN BARRIER FUNCTION#0.6724;CEREBROVASCULAR DISEASE#0.6722;MUCOSITIS#0.6717;NEUROEPITHELIAL CELL#0.6713;GENE SILENCING#0.6698;RESPIRATORY DISTRESS#0.6696;REPRODUCTIVE TOXICITY#0.6688;VIRAL INFECTION#0.6665;LYMPH NODE METASTASIS#0.6662;CORPUS LUTEUM#0.6657;ANCHORING JUNCTION#0.6618;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.6599;VASCULAR DISEASE#0.6577;SELECTIN#0.6572;ADENINE#0.6572;DEATH RECEPTOR#0.6566;STRESS FIBRE#0.6552;ACTIN POLYMERIZATION#0.6550;VOCAL FOLD#0.6544;ADENOSINE MONOPHOSPHATE#0.6531;NEUTROPHIL MIGRATION#0.6523;VASCULAR DEMENTIA#0.6521;DUCTAL CELL#0.6494;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6488;INNER EAR#0.6476;VACUOLE#0.6447;RESPONSE TO CORTISOL#0.6441;LECTIN#0.6426;RELATED PROTEIN 1#0.6425;RESONANCE ENERGY TRANSFER#0.6420;DUAL LUCIFERASE REPORTER#0.6419;PROTEIN PHOSPHORYLATION#0.6419;DIABETIC MACULAR EDEMA#0.6411;ENTRY INTO HOST CELL#0.6408;ENTRY INTO HOST#0.6401;NEUROTOXICITY#0.6388;APICAL JUNCTION COMPLEX#0.6386;SENSITIZATION#0.6382;INNATE IMMUNITY#0.6379;FERMENTATION#0.6371;DRUG RESISTANCE#0.6369;EMODIN#0.6355;GLYCINE#0.6344;C REACTIVE PROTEIN#0.6341;BODY SURFACE AREA#0.6329;IMMUNOFLUORESCENCE CONFOCAL MICROSCOPY#0.6319;PHOSPHATE BUFFERED SALINE#0.6304;L-GLUTAMINE#0.6297;LIVER CIRRHOSIS#0.6288;GI TRACT#0.6273;INTESTINAL ABSORPTION#0.6270;EYE DISEASE#0.6270;ENDOTHELIAL CELL PROLIFERATION#0.6262;PROTEOGLYCAN#0.6261;TAUROCHOLATE#0.6258;ANDROGEN BINDING#0.6254;RESPONSE TO LPS#0.6248;DOMINANT NEGATIVE MUTANT#0.6245;EPITHELIAL SPECIFIC ANTIGEN#0.6231;GASTROENTERITIS#0.6215;COLON MUCOSA#0.6211;BREAST CARCINOMA#0.6189;PROPOFOL#0.6185;GASTRIC EPITHELIAL CELLS#0.6181;L-TRYPTOPHAN#0.6181;NEPHRON#0.6178;SURFACE EPITHELIUM#0.6175;INDOMETHACIN#0.6164;MEMBRANE ASSEMBLY#0.6152;MESOTHELIAL CELL#0.6122;RIBOSOMAL PROTEIN#0.6106;GLUCOSE TRANSPORT#0.6100;PROTEASE ACTIVITY#0.6098;MYELOID CELL LEUKEMIA#0.6096;MICROFILAMENT#0.6075;MACROPINOCYTOSIS#0.6070;EMBRYONIC STEM CELL#0.6060;CHRONIC KIDNEY DISEASE#0.6056;HUMAN CORNEAL EPITHELIUM#0.6056;CONTROLLED CORTICAL IMPACT#0.6052;ACETYLCYSTEINE#0.6047;ARTERIOLE#0.6046;FIBRIL#0.6038;NECROTIC#0.6027;P38 MAPK SIGNALING#0.6021
100506660	SISTER CHROMATID COHESION#0.7345;DNA REPLICATION#0.6648
100506668	INTERFERON STIMULATED GENE#0.9237;ANTIVIRAL RESPONSE#0.9207
100506696	CANCER CELL#1.0732;LUNG CANCER#1.0264;CELL PROLIFERATION#0.9650;CELL GROWTH#0.9005;PROSTATE CANCER#0.8695;APOPTOSIS#0.8235;ONCOGENIC#0.7514;ADJACENT NORMAL TISSUE#0.7424;LYMPH NODE METASTASIS#0.7355;LYMPH NODE#0.7304;QUANTITATIVE REAL TIME#0.6755;POLYMERASE CHAIN REACTION#0.6713;WOUND HEALING#0.6567;INTRAHEPATIC CHOLANGIOCARCINOMA#0.6154
100506742	ENHANCER BINDING PROTEIN#1.0358;ENHANCER BINDING#1.0356;TUDCA#1.0353;EUKARYOTIC INITIATION FACTOR#1.0318;CLEAVED CASPASE 3#1.0203;GLUCOSE REGULATED PROTEIN#1.0154;ACTIVATING TRANSCRIPTION FACTOR#1.0148;REVERSE TRANSCRIPTION#1.0129;CASPASE-3 ACTIVITY#1.0121;TRANSLATION INITIATION FACTOR#1.0119;BINDING PROTEIN 1#1.0109;TRANSLATION INITIATION#1.0084;B CELL#1.0058;B CELL LYMPHOMA#1.0034;ER STRESS RESPONSE#0.9999;ER STRESS-INDUCED APOPTOSIS#0.9995;POLYMERASE CHAIN REACTION#0.9964;TRANSCRIPTION FACTOR#0.9962;POLY ADP RIBOSE#0.9946;CYTOCHROME C RELEASE#0.9943;SUPEROXIDE DISMUTASE#0.9912;DNA FRAGMENTATION#0.9902;TUMOR NECROSIS FACTOR#0.9894;SPINAL CORD#0.9883;HEPATOCYTE APOPTOSIS#0.9866;ASPARTATE#0.9863;PROTEIN KINASE#0.9843;CARDIOMYOCYTE#0.9840;APOPTOSIS#0.9840;MYOCARDIUM#0.9839;CEREBRAL ISCHEMIA#0.9831;CYTOCHROME C#0.9816;GENE EXPRESSION#0.9794;CASPASE INHIBITOR#0.9771;AUTOPHAGY#0.9771;DEATH RECEPTOR#0.9769;RIBOSE#0.9769;APOPTOTIC#0.9757;PROTEIN STRUCTURE PREDICTION#0.9753;HYPOXIA#0.9751;INFLAMMATORY RESPONSE#0.9748;APOPTOSIS INDUCING FACTOR#0.9742;GLUTATHIONE#0.9740;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9722;APOPTOTIC CELL DEATH#0.9721;UNFOLDED PROTEIN RESPONSE#0.9721;EPITHELIAL CELL#0.9720;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.9717;ENDOTHELIAL CELL#0.9701;ISCHEMIA REPERFUSION INJURY#0.9697;INDUCTION OF APOPTOSIS#0.9693;MITOCHONDRIAL MEMBRANE#0.9687;TAUROURSODEOXYCHOLIC ACID#0.9674;CELL PROLIFERATION#0.9674;SIGNALING PATHWAY#0.9669;CYTOTOXICITY#0.9666;MITOCHONDRIA#0.9659;ENDOPLASMIC RETICULUM#0.9655;NEUROTOXICITY#0.9650;TOXICITY#0.9648;CELL DEATH#0.9638;NEURONAL CELLS#0.9637;CANCER CELL#0.9622;CISPLATIN#0.9613;REACTIVE OXYGEN SPECIES#0.9595;ENDOPLASMIC RETICULUM STRESS#0.9587;CALPAIN ACTIVITY#0.9587;ARTERY#0.9586;ISCHEMIA#0.9579;GROWTH FACTOR#0.9569;MITOGEN ACTIVATED PROTEIN#0.9557;ALZHEIMER'S DISEASE#0.9551;CELL CYCLE#0.9524;NITRIC OXIDE#0.9506;QUANTITATIVE REAL TIME#0.9494;MIDDLE CEREBRAL ARTERY#0.9486;ACTIVE CASPASE 3#0.9485;CEREBRAL ARTERY#0.9484;NEURODEGENERATIVE DISEASE#0.9483;NEURONAL CELL DEATH#0.9463;TRANSMISSION ELECTRON MICROSCOPY#0.9461;CYTOPLASM#0.9453;PRO-INFLAMMATORY#0.9442;MYOCARDIAL INFARCTION#0.9430;SPINAL CORD INJURY#0.9424;RNA INTERFERENCE#0.9423;ASTROCYTE#0.9405;CASPASE ACTIVATION#0.9395;NEUROPROTECTION#0.9375;EOSIN#0.9360;IMMUNE RESPONSE#0.9324;CEREBRAL ARTERY OCCLUSION#0.9315;MACROPHAGE#0.9279;OLIGODENDROCYTE#0.9262;T CELL#0.9240;NERVOUS SYSTEM#0.9234;PROTEASOME#0.9228;HEAT SHOCK PROTEIN#0.9191;ROS GENERATION#0.9176;ETHANOL#0.9156;BETA CELL#0.9130;BREAST CANCER#0.9108;NEUROBLASTOMA#0.9089;PODOCYTE APOPTOSIS#0.9087;SIGNALING MOLECULE#0.9085;PARKINSON'S DISEASE#0.9084;STREPTOZOTOCIN#0.9061;UBIQUITIN#0.8961;BREAST CANCER CELL#0.8941;APOPTOSIS SIGNALING#0.8924;PROGRAMMED CELL DEATH#0.8806;MORRIS WATER MAZE#0.8799;CELL CYCLE ARREST#0.8752;PROTEIN SYNTHESIS#0.8697;PODOCYTE#0.8696;CARDIOMYOPATHY#0.8625;TUMOR CELLS#0.8608;N-ACETYLCYSTEINE#0.8608;BLOOD UREA NITROGEN#0.8550;ADENOSINE#0.8544;NORMAL CONTROL GROUP#0.8535;DIABETES MELLITUS#0.8534;CELL GROWTH#0.8529;NITRIC OXIDE SYNTHASE#0.8505;HEPATOCELLULAR CARCINOMA#0.8491;NADPH OXIDASE#0.8480;DOXORUBICIN#0.8432;CENTRAL NERVOUS SYSTEM#0.8426;ACTIVATED CASPASE 3#0.8421;NEURON APOPTOSIS#0.8412;MELATONIN#0.8394;OXYGEN GLUCOSE DEPRIVATION#0.8390;SHAM OPERATION GROUP#0.8389;LIVER DISEASE#0.8383;PROTEIN FOLDING#0.8380;CHONDROCYTE#0.8374;ER MEMBRANE#0.8294;OOCYTE#0.8236;ORGANELLE#0.8215;PROTEIN KINASE R#0.8214;CEREBRAL CORTEX#0.8211;MUSCLE CELL#0.8154;SMOOTH MUSCLE#0.8144;MYOCYTES#0.8086;GLUTATHIONE PEROXIDASE#0.8081;MYOBLAST#0.8072;OF DIABETIC RATS#0.8022;PROTEIN DISULFIDE ISOMERASE#0.8018;STEM CELL#0.8012;MITOCHONDRIAL DAMAGE#0.7971;AGEING#0.7897;ENZYME ACTIVITY#0.7877;SKELETAL MUSCLE#0.7871;RETINAL DEGENERATION#0.7867;PROPIDIUM#0.7862;SMOOTH MUSCLE CELL#0.7852;NEUROTOXIC#0.7794;SARCOPLASMIC RETICULUM#0.7793;LUNG CANCER#0.7789;ACETYLCYSTEINE#0.7769;GERM CELL#0.7762;CAMKII#0.7747;SIGNALLING PATHWAY#0.7718;RETINAL PIGMENT EPITHELIAL#0.7697;AKT SIGNALING#0.7541;RAPAMYCIN#0.7473;TRADITIONAL CHINESE MEDICINE#0.7394;APOPTOTIC PROCESS#0.7393;CORONARY ARTERY#0.7338;RESVERATROL#0.7337;CERVICAL CANCER#0.7310;SIGNAL TRANSDUCTION#0.7286;MITOCHONDRIAL PERMEABILITY TRANSITION#0.7284;TRAUMATIC BRAIN INJURY#0.7246;PULMONARY ARTERY#0.7233;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7220;HUMAN UMBILICAL VEIN#0.7216;SIGNALING CASCADE#0.7214;UMBILICAL VEIN#0.7213;LEFT ANTERIOR DESCENDING#0.7181;BONE MARROW#0.7151;AMYOTROPHIC LATERAL SCLEROSIS#0.7135;LATERAL SCLEROSIS#0.7134;HEART DISEASE#0.7118;DOPAMINERGIC NEURON#0.7107;TYPE 2 DIABETES#0.7105;PLASMA MEMBRANE#0.7053;CASPASE ACTIVITY#0.7046;ANTI APOPTOSIS#0.7046;OLIGODENDROCYTE APOPTOSIS#0.7044;FOCAL CEREBRAL ISCHEMIA#0.7039;ALANINE#0.6996;MALARIA#0.6988;HIGH FAT DIET#0.6974;QUANTITATIVE REVERSE TRANSCRIPTION#0.6936;NEURAL CELL#0.6934;NEUROLOGICAL DEFICIT SCORE#0.6918;DEPHOSPHORYLATION#0.6910;CASPASE-8 ACTIVITY#0.6878;MECHANISM OF ACTION#0.6870;HEME OXYGENASE 1#0.6850;EPITHELIAL CELL APOPTOSIS#0.6839;LYSOSOME#0.6822;PERMEABILITY TRANSITION PORE#0.6793;PRION DISEASE#0.6789;IFN-GAMMA#0.6772;L-CYSTEINE#0.6754;NEPHROTOXICITY#0.6729;CREATINE KINASE#0.6728;FATTY LIVER#0.6722;INDUCIBLE NITRIC OXIDE#0.6713;KIDNEY DISEASE#0.6700;ENDOTHELIAL GROWTH FACTOR#0.6680;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6680;CASPASE-9 ACTIVITY#0.6679;ACUTE KIDNEY INJURY#0.6640;FLOW CYTOMETRY ASSAY#0.6637;HYPOXIC#0.6636;OVARIAN#0.6621;HYPERTENSION#0.6606;MEMORY IMPAIRMENT#0.6596;CERVICAL#0.6560;ESTROGEN RECEPTOR#0.6533;PROTEIN KINASE C#0.6532;STEROL REGULATORY ELEMENT#0.6473;MAPK SIGNALING#0.6454;LIVER DAMAGE#0.6447;NEUROLOGICAL DISORDER#0.6443;ER LUMEN#0.6443;INNATE IMMUNE RESPONSE#0.6441;HYPERGLYCEMIA#0.6425;NEONATAL RAT CARDIOMYOCYTES#0.6406;ADIPOCYTE#0.6405;COLORECTAL CANCER#0.6399;APOPTOTIC SIGNALING PATHWAY#0.6367;RETINAL PIGMENT EPITHELIAL CELLS#0.6338;PIGMENT EPITHELIAL CELL#0.6328;ALVEOLAR EPITHELIAL CELL#0.6310;NEPHROPATHY#0.6298;ATORVASTATIN#0.6293;CEREBRAL INFARCTION#0.6289;DIABETIC NEPHROPATHY#0.6263;BIOTIN#0.6248;OXYGENASE#0.6239;TRANSFORMING GROWTH FACTOR#0.6219;TRANSMISSION ELECTRON MICROSCOPE#0.6187;SWELLING#0.6148;GLIAL CELL#0.6099;TRANSCRIPTASE#0.6045;REGENERATION#0.6038;ENDOTHELIAL CELL APOPTOSIS#0.6026;TUBULAR EPITHELIAL CELL#0.6023;BACTERIAL SEPSIS#0.6018
100506776	CELL PROLIFERATION#0.8960
100506779	INFLUENZA A VIRUS#0.6906
100506783	CELL CYCLE#0.7437
100506834	BREAST CANCER#1.1796
100506866	CELL PROLIFERATION#1.0147;LUNG ADENOCARCINOMA#0.9924;EPITHELIAL MESENCHYMAL TRANSITION#0.8726;COLORECTAL CANCER#0.8414;ADENOCARCINOMA#0.7911;APOPTOSIS#0.7855;CELL MIGRATION#0.7415;CANCER CELL#0.7366;POLYMERASE CHAIN REACTION#0.6783;DUAL LUCIFERASE REPORTER#0.6750;ANTISENSE RNA#0.6744;CERVICAL CANCER#0.6701;SQUAMOUS CELL CARCINOMA#0.6642;BREAST CANCER#0.6606;COLORECTAL#0.6410;DRUG RESISTANCE#0.6051;OVARIAN CANCER#0.6039;PROSTATE CANCER#0.6018
100506881	HEPATOCELLULAR CARCINOMA#1.1843
100506897	CHOLESTEROL METABOLISM#0.9158;INFLAMMATORY RESPONSE#0.8993;MACROPHAGE#0.6424
100506898	DNA METHYLATION#1.1878
100507027	SKELETAL MUSCLE#0.9410;LYMPH NODE#0.7230;CELL DIFFERENTIATION#0.6466;SIGNALING PATHWAY#0.6413;SARCOPLASMIC RETICULUM#0.6341;MUSCLE CELL DIFFERENTIATION#0.6101;GENE EXPRESSION#0.6035
100507043	NEURAL CELL#0.6711;SODIUM CHANNEL#0.6597;BLASTOMERE#0.6076
100507056	ADJACENT NORMAL TISSUE#1.0877;HEPATOCELLULAR CARCINOMA#1.0818;ONCOGENIC#1.0709;COLON CANCER#1.0685;CANCER CELL#1.0658;CELL PROLIFERATION#1.0637;APOPTOSIS#1.0527;LYMPH NODE#1.0483;CELL CYCLE#1.0364;COLORECTAL CANCER#1.0298;COLORECTAL#1.0229;CERVICAL CANCER#1.0171;POLYMERASE CHAIN REACTION#0.9933;QUANTITATIVE REAL TIME#0.9757;LYMPH NODE METASTASIS#0.9678;SIGNALING PATHWAY#0.9401;REVERSE TRANSCRIPTION#0.9337;OVARIAN CANCER#0.9238;BREAST CANCER#0.9182;CELL MIGRATION#0.8954;SQUAMOUS CELL CARCINOMA#0.8794;CELL GROWTH#0.8780;ADENOCARCINOMA#0.8720;CERVICAL#0.8659;ACUTE MYELOID LEUKEMIA#0.8550;MYELOID LEUKEMIA#0.8534;ENDOMETRIAL CARCINOMA#0.8240;LUNG CANCER#0.8160;PROSTATE CANCER#0.8102;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7729;EPITHELIAL TO MESENCHYMAL#0.7725;OVARIAN#0.7644;CELL COUNTING KIT#0.7614;AKT SIGNALING#0.7578;PROTEIN KINASE#0.7508;STEM CELL#0.7486;TRANSCRIPTION FACTOR#0.7315;EPITHELIAL MESENCHYMAL TRANSITION#0.7199;TUMOR TISSUES#0.7049;ORAL SQUAMOUS CELL CARCINOMA#0.6939;HEPATOCELLULAR CARCINOMA CELL#0.6922;QUANTITATIVE REVERSE TRANSCRIPTION#0.6647;WOUND HEALING#0.6613;G1 PHASE#0.6396;EPITHELIAL CELL#0.6335;TUMOR SUPPRESSOR#0.6294;CIGARETTE SMOKE EXTRACT#0.6233;TUMOR NODE METASTASIS#0.6188;5 FLUOROURACIL#0.6084;ZINC FINGER PROTEIN#0.6077;LUNG ADENOCARCINOMA#0.6077;COLONY FORMATION ASSAY#0.6067;CYCLIN DEPENDENT KINASE#0.6051;GENE EXPRESSION#0.6040
100507057	COLORECTAL CANCER#0.7558;DUAL LUCIFERASE REPORTER#0.7277;EXTRACELLULAR MATRIX#0.7130;INFLAMMATORY RESPONSE#0.7124;CELL PROLIFERATION#0.7091
100507086	CERVICAL CANCER#0.8083;CANCER CELL#0.7951
100507098	CANCER CELL#0.9308;CELL PROLIFERATION#0.8853;DUAL LUCIFERASE REPORTER#0.7293;APOPTOSIS#0.6655;ANTISENSE RNA#0.6567;TUMOR SUPPRESSOR#0.6397;BREAST CANCER#0.6370
100507246	CANCER CELL#1.1019;SMALL NUCLEOLAR RNA#1.0969;DUAL LUCIFERASE REPORTER#1.0836;CELL PROLIFERATION#1.0739;APOPTOSIS#1.0642;HEPATOCELLULAR CARCINOMA#1.0489;CELL CYCLE#1.0068;QUANTITATIVE REAL TIME#1.0047;ONCOGENIC#0.9860;POLYMERASE CHAIN REACTION#0.9229;TUMOR TISSUES#0.9222;CELL GROWTH#0.9106;COLORECTAL CANCER#0.9078;CELL MIGRATION#0.9051;SIGNALING PATHWAY#0.9032;LUNG CANCER#0.8662;REPORTER GENE ASSAY#0.8333;COLORECTAL#0.8166;LYMPH NODE#0.8034;NEUROBLASTOMA#0.7886;PANCREATIC CANCER#0.7807;EPITHELIAL MESENCHYMAL TRANSITION#0.7715;DISEASE FREE SURVIVAL#0.7665;CERVICAL CANCER#0.7557;LYMPH NODE METASTASIS#0.7457;CELL COUNTING KIT#0.6744;WOUND HEALING#0.6453;LIPID METABOLISM#0.6150;BREAST CANCER#0.6090;SQUAMOUS CELL CARCINOMA#0.6074;SORAFENIB#0.6028
100507249	PROSTATE CANCER#0.7558;BLAST CELL#0.7314;ACUTE LYMPHOBLASTIC LEUKEMIA#0.7210;MONONUCLEAR CELLS#0.7137;BONE MARROW#0.7108;PERIPHERAL BLOOD#0.7103;BREAST CANCER#0.7099;CANCER CELL#0.7084
100507308	DEMETHYLATION#0.7641
100507316	CELL PROLIFERATION#1.0915;HEPATOCELLULAR CARCINOMA#1.0031;CELL CYCLE#0.8549;LUNG CANCER#0.7533;GALLBLADDER CANCER#0.7011;APOPTOSIS#0.6917;CELL CYCLE ARREST#0.6217
100507347	EPITHELIAL MESENCHYMAL TRANSITION#0.7603;ANTISENSE RNA#0.7326;COLORECTAL CANCER#0.7145;GENE EXPRESSION#0.7072;WOUND HEALING#0.6271
100507392	SMOOTH MUSCLE#0.9932;ENDOTHELIAL CELL#0.9902;SMOOTH MUSCLE CELL#0.9203;MUSCLE CELL#0.9195;CORONARY ARTERY#0.6888;CELL MIGRATION#0.6746;VASCULAR CELL#0.6209;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6201;HUMAN UMBILICAL VEIN#0.6192;UMBILICAL VEIN#0.6189;REVERSE TRANSCRIPTION#0.6131
100507410	HEPATOCELLULAR CARCINOMA#1.1501;SIGNALING PATHWAY#1.1440;DUAL LUCIFERASE REPORTER#0.9146;REPORTER GENE ASSAY#0.9137;CELL PROLIFERATION#0.8960;APOPTOSIS#0.6741
100507436	ANTIGEN PROCESSING MACHINERY#1.0458;ANKYLOSING SPONDYLITIS#1.0389;CERVICAL CANCER#1.0369;ANTIGEN PROCESSING#1.0298;ANTIGEN PRESENTATION#1.0298;HEPATITIS C#1.0224;CERVICAL#1.0220;EPITHELIAL CELL#1.0213;ENDOTHELIAL CELL#1.0195;MONOCYTE#1.0189;HEPATOCELLULAR CARCINOMA#1.0160;SQUAMOUS CELL CARCINOMA#1.0141;CHRONIC HEPATITIS C#1.0098;TRANSCRIPTION FACTOR#1.0042;BETA-2#1.0019;HEPATITIS B#1.0009;OVARIAN#1.0008;POLYMERASE CHAIN REACTION#1.0000;CELL ACTIVATION#0.9997;LUNG CANCER#0.9968;HEPATITIS C VIRUS#0.9964;IFN-GAMMA#0.9959;NK CELL MEDIATED CYTOTOXICITY#0.9956;CELL SURFACE#0.9925;CELIAC DISEASE#0.9911;IMMUNE EVASION#0.9911;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9891;CYTOTOXIC T CELL#0.9879;CYTOTOXIC T-LYMPHOCYTE#0.9867;MONONUCLEAR CELLS#0.9852;CYTOLYSIS#0.9844;T LYMPHOCYTE#0.9842;CYTOTOXICITY#0.9841;TUMOR CELLS#0.9831;CD8+ T CELL#0.9827;GROWTH FACTOR#0.9820;HISTONE DEACETYLASE#0.9820;CANCER CELL#0.9817;T CELL#0.9812;B CELL#0.9811;DENDRITIC CELL#0.9805;IMMUNE CELL#0.9799;MELANOMA CELL LINES#0.9783;LYSIS#0.9782;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9776;SEQUENCE SPECIFIC PRIMER#0.9774;CELL RECOGNITION#0.9762;NATURAL KILLER CELL#0.9756;RECEPTOR LIGAND#0.9748;PERIPHERAL BLOOD#0.9743;AUTOIMMUNE DISEASE#0.9742;BREAST CANCER#0.9740;HUMAN LEUKOCYTE ANTIGEN#0.9716;SPONDYLITIS#0.9714;TUMOR ANTIGEN#0.9684;IMMUNE SYSTEM#0.9676;LEUKOCYTE#0.9650;GENE EXPRESSION#0.9624;IMMUNE RESPONSE#0.9622;CELL KILLING#0.9609;LYMPH NODE#0.9601;NK CELL ACTIVATION#0.9600;VIRAL INFECTION#0.9596;RENAL CELL CARCINOMA#0.9569;BONE MARROW#0.9552;CD4+ T CELL#0.9551;APOPTOSIS#0.9549;TUMOR NECROSIS FACTOR#0.9527;OVARIAN CANCER#0.9514;UVEAL MELANOMA#0.9512;HEPATITIS B VIRUS#0.9510;STEM CELL#0.9447;TYPE 1 DIABETES#0.9403;SEQUENCE BASED TYPING#0.9343;ADDISON'S DISEASE#0.9275;MULTIPLE MYELOMA#0.9260;KIDNEY TRANSPLANT RECIPIENTS#0.9231;SIGNALING PATHWAY#0.9223;PSORIASIS#0.9199;TRANSFORMING GROWTH FACTOR#0.9103;PLASMA MEMBRANE#0.9071;KERATINOCYTE#0.9032;COLORECTAL#0.8986;INNATE IMMUNITY#0.8974;HEAT SHOCK PROTEIN#0.8971;CYTOKINE PRODUCTION#0.8961;ENDOPLASMIC RETICULUM#0.8959;DIABETES MELLITUS#0.8940;PLASMA CELL#0.8931;CELL PROLIFERATION#0.8922;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8919;LUPUS ERYTHEMATOSUS#0.8916;GAMMA DELTA T CELL#0.8885;MYELOID LEUKEMIA#0.8874;ANTIGEN PROCESSING AND PRESENTATION#0.8868;RETINOIC ACID#0.8849;HISTONE DEACETYLASE INHIBITOR#0.8746;DISEASE FREE SURVIVAL#0.8725;MACROPHAGE#0.8705;CHRONIC HEPATITIS B#0.8666;INNATE IMMUNE RESPONSE#0.8626;SEQUENCING BASED TYPING#0.8611;EXOSOME#0.8576;TUMOR ASSOCIATED ANTIGEN#0.8549;PROTEIN KINASE#0.8544;ACTIVATED T-CELLS#0.8499;ACTIVATED T CELL#0.8496;RHEUMATOID ARTHRITIS#0.8479;COLORECTAL CANCER#0.8466;OVARIAN CARCINOMA#0.8434;STATIONARY PHASE#0.8416;INNATE IMMUNE SYSTEM#0.8412;PSORIATIC ARTHRITIS#0.8405;ACUTE MYELOID LEUKEMIA#0.8381;PROSTATE CANCER#0.8379;CELL CYCLE#0.8328;EPSTEIN BARR VIRUS#0.8308;VALPROIC ACID#0.8263;HUMAN LEUCOCYTE ANTIGEN#0.8263;ADENOCARCINOMA#0.8261;T CELL ACTIVATION#0.8224;DONOR SPECIFIC ANTIBODIES#0.8184;OUTER MEMBRANE#0.8123;CELL DEATH#0.8108;NEUTROPHIL#0.8094;FORMALIN#0.8070;LECTIN#0.8062;STROMAL CELL#0.8058;IMMUNE SUPPRESSION#0.8049;ULCERATIVE COLITIS#0.7982;LEPROSY#0.7982;ANTIBODY MEDIATED REJECTION#0.7976;BREAST CARCINOMA#0.7966;PANCREATIC CANCER#0.7952;AUTOIMMUNITY#0.7947;T CELL PROLIFERATION#0.7929;GRAFT VERSUS HOST#0.7840;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.7825;SIGNAL TRANSDUCTION#0.7735;CELL MEMBRANE#0.7724;SHORT TANDEM REPEAT#0.7668;HYPOXIA#0.7657;HEMATOPOIETIC STEM CELL#0.7648;MULTIPLE MYELOMA CELLS#0.7643;CELL SURFACE ANTIGEN#0.7634;INFLAMMATORY BOWEL DISEASE#0.7609;BREAST CANCER CELL#0.7559;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.7539;TAKAYASU'S ARTERITIS#0.7532;HEAT SHOCK FACTOR#0.7513;COLITIS#0.7449;ORAL SQUAMOUS CELL CARCINOMA#0.7428;FLOW CYTOMETRY ANALYSIS#0.7411;SENSITIZATION#0.7376;METASTATIC MELANOMA#0.7364;ADAPTIVE IMMUNE RESPONSE#0.7356;CELL GROWTH#0.7293;STEM CELL TRANSPLANTATION#0.7234;PRO-INFLAMMATORY#0.7070;PERIPHERAL BLOOD LYMPHOCYTES#0.7018;BETA CELL#0.7015;CROHN'S DISEASE#0.7000;PROTEIN KINASE C#0.6988;COLON CANCER#0.6986;HEPATOCELLULAR CARCINOMA CELL#0.6970;PROTEASOME#0.6956;LYMPH NODE METASTASIS#0.6923;UVEITIS#0.6911;LIVER DISEASE#0.6905;TROPHOBLAST#0.6864;HEPATOMA CELLS#0.6859;APOPTOTIC#0.6720;REGULATORY T CELL#0.6720;ENDOTHELIAL GROWTH FACTOR#0.6645;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6645;ONCOGENIC#0.6607;HEAD AND NECK CANCER#0.6532;NECK CANCER#0.6531;BREAST CANCER PATIENTS#0.6487;LIVER CANCER#0.6457;TOLL LIKE RECEPTOR#0.6427;EPIDERMAL GROWTH FACTOR#0.6410;GROWTH FACTOR RECEPTOR#0.6410;NKT CELL#0.6315;GEMCITABINE#0.6299;CHRONIC CERVICITIS#0.6297;CYTOPLASM#0.6282;MAXILLARY SINUS SQUAMOUS CELL CARCINOMA#0.6195;LUNG CARCINOMA#0.6164;RNA INTERFERENCE#0.6143;CERVICAL CANCER CELL LINES#0.6137;NATURAL CYTOTOXICITY RECEPTOR#0.6123;GENOTOXIC#0.6096;GRANULOCYTE#0.6048;BINDING PROTEIN 1#0.6014;LYMPHOCYTE ANTIGEN#0.6002
100507488	BREAST CANCER#1.1796
100507500	CELL PROLIFERATION#0.8312;SQUAMOUS CELL CARCINOMA#0.6831;CELL CYCLE#0.6797;PLACENTA TISSUES#0.6787;LUNG CANCER#0.6234;CANCER CELL#0.6191
100507533	CELL PROLIFERATION#0.9416;ANTISENSE RNA#0.7844;APOPTOSIS#0.7635;CERVICAL CANCER#0.7008;CERVICAL#0.6723;WNT SIGNALING PATHWAY#0.6528;HEPATOCELLULAR CARCINOMA#0.6398;SIGNALING PATHWAY#0.6339
100507567	BREAST CANCER CELL#0.8018;BREAST CANCER#0.7966;CANCER CELL#0.7951;APOPTOSIS#0.6131
10051	CONDENSIN COMPLEX#1.0512;CHROMOSOME CONDENSATION#0.9805;CELL CYCLE#0.9788;MITOTIC CHROMOSOME#0.9594;CHROMATID#0.9353;MITOSIS#0.9326;SISTER CHROMATID COHESION#0.9156;GENE EXPRESSION#0.8224;DNA REPAIR#0.7972;COLORECTAL CANCER#0.7679;CHROMOSOME SEGREGATION#0.7579;HEPATOCELLULAR CARCINOMA#0.6904;INTERPHASE#0.6175
100526737	PARASPECKLES#0.6883;ALANINE#0.6459
100526790	T CELL#0.9005;TUBERCULIN SKIN TEST#0.8676;TUBERCULOSIS#0.8507
100526820	COLORECTAL#0.8485
100526823	T CELL#0.8823;TUBERCULIN SKIN TEST#0.7404
100527960	GTPASE ACTIVITY#1.2026;APOPTOSIS#0.8439
100527963	TRANSCRIPTION FACTOR#0.7694
100528023	EPILEPSY#0.7578;FOCAL EPILEPSY#0.6486
100528024	MENTAL RETARDATION#1.0960;WAGR SYNDROME#1.0820;ANIRIDIA#1.0703;FRASER SYNDROME#0.6694
100529141	CELL SURFACE#0.7533
10052	BIPOLAR CELL#1.0183;POLYMERASE CHAIN REACTION#1.0140;SMOOTH MUSCLE#1.0128;MYOCYTES#1.0081;CONNEXIN#1.0073;CARDIOMYOCYTE#1.0072;SMOOTH MUSCLE CELL#1.0028;REVERSE TRANSCRIPTION#0.9984;MUSCLE CELL#0.9966;GAP JUNCTION CHANNEL#0.9958;GAP JUNCTION#0.9924;GENE EXPRESSION#0.9922;ENDOTHELIAL CELL#0.9915;MYOCARDIUM#0.9910;ELECTRICAL SYNAPSE#0.9845;ACTION POTENTIAL#0.9809;STEM CELL#0.9791;CELL COMMUNICATION#0.9766;GROWTH FACTOR#0.9665;ARRHYTHMIA#0.9644;ENDOTHELIUM#0.9619;OOCYTE#0.9499;CONNEXON#0.9428;OLIGODENDROCYTE#0.9423;BLOOD VESSEL#0.9319;EMBRYONIC STEM CELL#0.9231;CARDIAC CONDUCTION#0.9163;ARTERY#0.9122;VASCULAR SMOOTH MUSCLE CELL#0.9116;AMACRINE CELL#0.9099;BLADDER SMOOTH MUSCLE#0.8966;TRANSCRIPTION FACTOR#0.8883;ARTERIOLE#0.8880;PROTEIN KINASE#0.8796;PLASMA MEMBRANE#0.8729;INTERCELLULAR CHANNEL#0.8670;OSTEOBLAST#0.8649;ASTROCYTE#0.8538;PROGENITOR CELL#0.8529;TRANSCRIPTASE#0.8506;INTERCALATED DISC#0.8304;HYPERTENSION#0.8298;ZONULA OCCLUDENS#0.8236;GAP JUNCTION COMMUNICATION#0.8189;MESENCHYMAL STEM CELL#0.8187;CARDIOVASCULAR SYSTEM#0.8178;ZONULA OCCLUDENS 1#0.8171;EMBRYONIC HEART#0.8137;GAP JUNCTION PLAQUE#0.8113;QUANTITATIVE REAL TIME#0.8004;SKELETAL MUSCLE#0.7936;ATRIAL FIBRILLATION#0.7911;CELL SURFACE#0.7820;EPITHELIAL CELL#0.7584;CYCLIC NUCLEOTIDE GATED#0.7553;HEART DISEASE#0.7484;NERVOUS SYSTEM#0.7452;CELL DIFFERENTIATION#0.7450;HEART DEVELOPMENT#0.7369;CELL PROLIFERATION#0.7327;ION CHANNEL#0.7277;CELL MEMBRANE#0.7130;TRANSFORMING GROWTH FACTOR#0.7037;ALKALINE PHOSPHATASE#0.7011;DETRUSOR SMOOTH MUSCLE#0.6970;NEONATAL RAT CARDIOMYOCYTES#0.6921;MESENCHYMAL CELL#0.6916;RIGHT ATRIUM#0.6608;MYOCARDIAL INFARCTION#0.6593;STROMAL CELL#0.6531;POTASSIUM CHANNEL#0.6498;MYOFIBROBLAST#0.6493;APOPTOSIS#0.6473;INTERCALATED DISK#0.6403;GRANULOSA CELL#0.6310;TIGHT JUNCTION#0.6301;FIBROBLAST GROWTH FACTOR#0.6264;BONE MARROW#0.6256;GLIAL CELL#0.6157;ACETYLCHOLINE#0.6100;PDZ BINDING MOTIF#0.6072;GANGLION CELLS#0.6005;BASILAR ARTERY#0.6002
100533619	CERVICAL CANCER#0.9827;CANCER CELL#0.8214;GENE EXPRESSION#0.7939;CERVICAL#0.7546
10053	EPITHELIAL CELL#1.0363;TRANS GOLGI NETWORK#0.8429;PLASMA MEMBRANE#0.8158;CLATHRIN ADAPTOR#0.7467;CYTOKINESIS#0.6689;ADAPTIN#0.6364
10054	SUMO ACTIVATING ENZYME#1.0879;SUMOYLATION#1.0283;CONJUGATION#1.0208;UBIQUITIN#1.0126;CANCER CELL#1.0009;UBIQUITIN ACTIVATING ENZYME#0.9206;CELL CYCLE#0.8747;COLORECTAL CANCER#0.8550;APOPTOSIS#0.7941;GENE EXPRESSION#0.7938;CELL PROLIFERATION#0.7866;IMPORTIN#0.7851;POST-TRANSLATIONAL MODIFICATION#0.7721;NUCLEAR IMPORT#0.7629;LUNG CANCER#0.7587;SIGNALING PATHWAY#0.7347;PROTEIN SUMOYLATION#0.7252;DNA REPAIR#0.6986;CELL DEATH#0.6972;TRANSCRIPTION FACTOR#0.6951;COLORECTAL#0.6885;LYSINE#0.6795;POLYMERASE CHAIN REACTION#0.6561;XERODERMA PIGMENTOSUM#0.6164;RNA BINDING PROTEIN#0.6073;RNA BINDING#0.6012
10055	SUMOYLATION#1.0418;SUMO ACTIVATING ENZYME#1.0127;UBIQUITIN#1.0054;CONJUGATION#0.9708;CELL CYCLE#0.7617;CANCER CELL#0.7531;PROTEIN SUMOYLATION#0.6380;GENE EXPRESSION#0.6255
10056	INTERSTITIAL LUNG DISEASE#0.6741;LUNG DISEASE#0.6663
10057	GEMCITABINE#1.0217;MULTIDRUG RESISTANCE PROTEIN#1.0100;BREAST CANCER#1.0082;ABC TRANSPORTER#1.0048;ATP BINDING CASSETTE TRANSPORTER#1.0009;ATP BINDING CASSETTE#0.9927;ORGANIC ANION TRANSPORTER#0.9924;CANCER CELL#0.9922;ENDOTHELIAL CELL#0.9919;ATP BINDING#0.9912;POLYMERASE CHAIN REACTION#0.9910;GENE EXPRESSION#0.9885;DRUG RESISTANCE#0.9855;GLUTATHIONE#0.9750;LUNG CANCER#0.9736;5 FLUOROURACIL#0.9600;TUMOR CELLS#0.9589;CISPLATIN#0.9574;CYTOTOXICITY#0.9527;PANCREATIC CANCER#0.9496;EFFLUX PUMP#0.9254;BLOOD BRAIN BARRIER#0.9186;STEM CELL#0.9079;DOXORUBICIN#0.9062;METHOTREXATE#0.8861;PLASMA MEMBRANE#0.8860;MUSCLE CELL#0.8813;TOXICITY#0.8773;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8694;EPITHELIAL CELL#0.8652;PHOSPHODIESTERASE#0.8643;FLUOROURACIL#0.8638;APOPTOSIS#0.8616;BREAST CANCER CELL#0.8564;PROBENECID#0.8483;FOLATE#0.8386;CELL PROLIFERATION#0.8249;QUANTITATIVE REAL TIME#0.8173;ERYTHROCYTE#0.8161;ARA-C#0.8123;COLORECTAL#0.8065;MULTI DRUG RESISTANCE#0.8033;ASTROCYTE#0.8028;PANCREATIC CARCINOMA#0.7995;COLORECTAL CANCER#0.7973;MYELOID LEUKEMIA#0.7887;PERIPHERAL BLOOD#0.7866;SMOOTH MUSCLE#0.7857;IRINOTECAN#0.7839;ACUTE MYELOID LEUKEMIA#0.7740;HUMAN EMBRYONIC KIDNEY#0.7538;EMBRYONIC KIDNEY#0.7533;EPILEPSY#0.7509;GUANOSINE#0.7470;SMOOTH MUSCLE CELL#0.7459;CELL MEMBRANE#0.7442;T CELL#0.7394;TRANSCRIPTASE#0.7262;HYALURONAN#0.7184;ADENOSINE#0.7156;RESPONSE TO GEMCITABINE#0.7141;MERCAPTOPURINE#0.7042;CGMP TRANSPORT#0.6999;GS-X PUMP#0.6735;ADENOSINE TRIPHOSPHATE#0.6673;TRANSCRIPTION FACTOR#0.6469;SILDENAFIL#0.6426;ADENINE#0.6388;TROPHOBLAST#0.6296;DRUG TRANSPORT#0.6294;PRIMARY ANGLE-CLOSURE GLAUCOMA#0.6281;DETOXIFICATION#0.6274;PRIMARY ANGLE CLOSURE#0.6260;ADENOCARCINOMA#0.6244;CYSTIC FIBROSIS#0.6234;OVARIAN CANCER#0.6214;ANGLE-CLOSURE GLAUCOMA#0.6208;GROWTH FACTOR#0.6159;REVERSE TRANSCRIPTION#0.6159
10058	MAJOR FACILITATOR SUPERFAMILY#1.0522;ACTIVE TRANSPORTER#1.0270;PEROXISOMAL MEMBRANE#1.0268;PEROXISOMAL#1.0221;MDR PROTEIN#1.0181;SULFONYLUREA RECEPTOR#1.0108;LIPID TRANSPORTER#1.0105;LIPID TRANSPORT#1.0101;MALTOSE#1.0100;DIGESTION#1.0076;MULTI DRUG RESISTANCE#1.0072;ION CHANNEL#1.0071;CYTOCHROME P450#1.0069;TRANSMEMBRANE TRANSPORTER#1.0060;PEPTIDE TRANSPORTER#1.0047;SPINAL CORD#1.0045;ABC TRANSPORTER#1.0019;EFFLUX PUMP#0.9980;CYSTIC FIBROSIS#0.9972;CYTOPLASMIC MEMBRANE#0.9960;ATP BINDING CASSETTE#0.9935;ATP BINDING#0.9933;BREAST CANCER#0.9930;DETOXIFICATION#0.9922;PROTEOGLYCAN#0.9921;ACUTE MYELOID LEUKEMIA#0.9910;MYELOID LEUKEMIA#0.9907;CELL MEMBRANE#0.9902;MULTIDRUG RESISTANCE PROTEIN#0.9896;MEMBRANE TRANSPORT#0.9891;ANTIGEN PROCESSING#0.9889;OVARIAN CANCER#0.9889;DNA REPAIR#0.9888;OUTER MEMBRANE#0.9888;SPINAL CORD INJURY#0.9876;CHOLESTEROL EFFLUX#0.9876;NUCLEOTIDE BINDING DOMAIN#0.9859;HEPATOCELLULAR CARCINOMA#0.9857;CHOLESTEROL TRANSPORTER#0.9854;TRANSPORTER ACTIVITY#0.9850;CHOLESTEROL TRANSPORT#0.9848;ADENOSINE#0.9845;REVERSE CHOLESTEROL TRANSPORT#0.9844;DRUG TRANSPORT#0.9841;BLOOD BRAIN BARRIER#0.9837;HUMAN BREAST CANCER#0.9832;MITOCHONDRIA#0.9830;CELLULAR MEMBRANE#0.9828;ATP HYDROLYSIS#0.9826;SCAVENGER RECEPTOR#0.9823;NUCLEOTIDE BINDING#0.9817;MITOXANTRONE#0.9815;ATP BINDING CASSETTE TRANSPORTER#0.9810;TUBERCULOSIS#0.9805;BREAST CANCER CELL#0.9795;PEROXISOME#0.9782;DRUG BINDING#0.9778;CELLULAR DETOXIFICATION#0.9770;GLYCINE#0.9767;EXCRETION#0.9764;CANCER STEM CELL#0.9763;TUMOR CELLS#0.9760;VIRULENCE#0.9759;QUANTITATIVE REAL TIME#0.9755;SIGNALING PATHWAY#0.9748;MACROPHAGE#0.9743;ENDOTHELIAL CELL#0.9743;DRUG RESISTANCE#0.9741;TRANSMEMBRANE TRANSPORT#0.9726;REVERSE TRANSCRIPTION#0.9716;VERAPAMIL#0.9715;GLUTATHIONE#0.9713;KINASE INHIBITOR#0.9711;CHOLESTEROL HOMEOSTASIS#0.9696;VACUOLE#0.9694;OVARIAN#0.9691;CANCER CELL#0.9689;LIVER X RECEPTOR#0.9689;POTASSIUM CHANNEL#0.9688;REGENERATION#0.9686;EPITHELIAL CELL#0.9681;CENTRAL NERVOUS SYSTEM#0.9668;STEM CELL#0.9665;ATHEROSCLEROSIS#0.9663;BONE MARROW#0.9659;CYTOPLASM#0.9658;ENDOPLASMIC RETICULUM#0.9654;CELL WALL#0.9649;PLASMA MEMBRANE#0.9648;GROWTH FACTOR#0.9647;NERVOUS SYSTEM#0.9643;TRANSCRIPTION FACTOR#0.9640;CELL CYCLE#0.9631;POLYMERASE CHAIN REACTION#0.9629;DOXORUBICIN#0.9625;HIGH DENSITY LIPOPROTEIN#0.9619;LUNG CANCER#0.9616;C TERMINAL DOMAIN#0.9611;GENE EXPRESSION#0.9610;CELL SURFACE#0.9609;CELL GROWTH#0.9600;ATPASE ACTIVITY#0.9596;PACLITAXEL#0.9592;PROTEIN KINASE#0.9583;TOXICITY#0.9582;TYROSINE KINASE INHIBITOR#0.9582;APOPTOSIS#0.9579;MECHANISM OF ACTION#0.9570;CISPLATIN#0.9568;SIGNAL TRANSDUCTION#0.9564;LIPID METABOLISM#0.9557;MUTAGENESIS#0.9555;SITOSTEROLEMIA#0.9548;CHONDROITIN SULFATE PROTEOGLYCAN#0.9529;CYTOTOXICITY#0.9526;GLIBENCLAMIDE#0.9508;ADENOSINE TRIPHOSPHATE#0.9502;PREGNANE X RECEPTOR#0.9499;REACTIVE OXYGEN SPECIES#0.9496;COLORECTAL#0.9484;MITOCHONDRIAL MEMBRANE#0.9483;COLORECTAL CANCER#0.9471;CELL PROLIFERATION#0.9467;ERYTHROCYTE#0.9465;LOW DENSITY LIPOPROTEIN#0.9462;RIBOSOME#0.9449;ADENYLATE KINASE#0.9438;DYSCHROMATOSIS UNIVERSALIS HEREDITARIA#0.9424;SMALL INTESTINE#0.9423;SIGNALING MOLECULE#0.9408;GLYCOSYLATION#0.9398;HISTIDINE#0.9394;FLUCONAZOLE#0.9391;APOPTOTIC#0.9357;CHANNEL ACTIVITY#0.9335;IVERMECTIN#0.9334;LYSOSOME#0.9331;CHLORIDE CHANNEL#0.9325;CELL DEATH#0.9316;ORGANELLE#0.9312;TOPOTECAN#0.9307;MEMBRANE FUSION#0.9283;DNA BINDING#0.9282;ATHEROSCLEROTIC#0.9281;DAUNORUBICIN#0.9276;MEDIATED DRUG RESISTANCE#0.9270;HYPOXIA#0.9253;GENETIC DISEASE#0.9239;ORGANIC ANION TRANSPORTER#0.9232;RED BLOOD CELL#0.9225;PROGENITOR CELL#0.9202;VINBLASTINE#0.9189;CHOLESTEROL METABOLISM#0.9163;IRINOTECAN#0.9161;RNA INTERFERENCE#0.9157;VINCRISTINE#0.9137;ANION CHANNEL#0.9130;AUXIN TRANSPORT#0.9127;IRON HOMEOSTASIS#0.9100;DRUG METABOLISM#0.9099;KINASE ACTIVITY#0.9086;STRUCTURE ACTIVITY RELATIONSHIP#0.9075;SIDEROPHORE#0.9056;OTHER ORGANISM#0.9041;METHOTREXATE#0.9041;ALZHEIMER'S DISEASE#0.9026;TIGHT JUNCTION#0.9020;LIPID HOMEOSTASIS#0.9007;T CELL#0.8996;MONOCYTE#0.8972;GROWTH FACTOR RECEPTOR#0.8955;LUMINAL#0.8945;SIGNAL PEPTIDE#0.8942;EXTRACELLULAR MATRIX#0.8917;CELL DIVISION#0.8917;PROTEIN SYNTHESIS#0.8893;LYSINE#0.8858;NUTRIENT UPTAKE#0.8849;ADENYLATE#0.8843;COMPLEX I#0.8829;CYCLOSPORIN A#0.8813;CELLULAR LOCALIZATION#0.8780;IMATINIB#0.8768;ADENINE#0.8758;IMMUNE RESPONSE#0.8756;STEROL REGULATORY ELEMENT#0.8743;MALARIA#0.8736;TRANSCRIPTASE#0.8732;EPIDERMAL GROWTH FACTOR#0.8725;ESTROGEN RECEPTOR#0.8723;SUPEROXIDE DISMUTASE#0.8718;MODE OF ACTION#0.8685;SUCROSE#0.8666;MALTOSE BINDING#0.8662;HOST CELL#0.8653;CATABOLISM#0.8645;NEURODEGENERATIVE DISEASE#0.8638;STEROL TRANSPORTER#0.8633;TRANSLATION INITIATION#0.8582;PROTEIN PROTEIN INTERACTION#0.8567;MALTOSE TRANSPORT#0.8550;SIDE-POPULATION CELL#0.8541;ASTROCYTE#0.8537;STARGARDT DISEASE#0.8505;RHODAMINE 6G#0.8464;ENDOCYTOSIS#0.8403;HYALURONIDASE#0.8369;VACUOLAR MEMBRANE#0.8361;PORPHYRIN SYNTHESIS#0.8354;PROBENECID#0.8352;PERIPLASM#0.8351;CHOLESTASIS#0.8336;PERIPHERAL BLOOD#0.8326;HEME ACQUISITION#0.8324;HEAT SHOCK PROTEIN#0.8316;GLIAL CELL#0.8310;GEFITINIB#0.8297;LIVER DISEASE#0.8295;METAL BINDING#0.8241;PROTEIN COMPLEX#0.8210;HEME BIOSYNTHESIS#0.8176;ENTEROCYTE#0.8115;CHOROID PLEXUS#0.8113;MECHANISMS OF ACTION#0.8111;EXTRACELLULAR SPACE#0.8101;LIPID RAFT#0.8095;ESTRADIOL#0.8086;ARGININE#0.8080;CYCLOSPORIN#0.8018;NODULATION#0.7980;RIBOSE#0.7967;ANGIOGENESIS#0.7961;ADENYLATE KINASE ACTIVITY#0.7952;MAJOR HISTOCOMPATIBILITY COMPLEX#0.7949;ADENOCARCINOMA#0.7938;ENDOSOME#0.7924;SUGAR BINDING#0.7914;B CELL#0.7905;CYCLOSPORINE#0.7890;QUANTITATIVE REVERSE TRANSCRIPTION#0.7884;RIBOSOMAL PROTEIN#0.7880;5 FLUOROURACIL#0.7878;TANGIER DISEASE#0.7864;BLOOD GROUP ANTIGEN#0.7841;FATTY ACID METABOLISM#0.7832;HYALURONAN#0.7825;HUMAN EMBRYONIC KIDNEY#0.7819;EMBRYONIC KIDNEY#0.7815;ALANINE#0.7776;ARSENITE#0.7773;HEPARIN#0.7756;IRON ACQUISITION#0.7745;GLUTAMINE#0.7737;ATRIAL FIBRILLATION#0.7735;COLON CANCER#0.7705;NEUROBLASTOMA#0.7705;METHIONINE#0.7703;PROTEASOME#0.7702;ETHANOL#0.7696;ADENOSINE 5'-TRIPHOSPHATE#0.7693;IMMUNE SYSTEM#0.7685;ASPARTATE#0.7679;TRYPTOPHAN#0.7643;DIPHOSPHATE#0.7642;HEME SYNTHESIS#0.7621;INSULIN SECRETION#0.7600;SUGAR TRANSPORT#0.7577;PRIMARY ACTIVE TRANSPORTER#0.7574;CARCINOGEN#0.7567;RELATED PROTEIN 1#0.7565;TOXICANT#0.7553;PUMP ACTIVITY#0.7539;OOCYTE#0.7511;CELL DIFFERENTIATION#0.7505;TRANSMISSION ELECTRON MICROSCOPY#0.7501;ANEMIA#0.7480;CHOLESTEROL SYNTHESIS#0.7457;ERYTHROID PRECURSOR#0.7453;TOPOISOMERASE#0.7453;CAMPTOTHECIN#0.7452;ADRIAMYCIN#0.7442;OUTER MITOCHONDRIAL MEMBRANE#0.7436;AXON REGENERATION#0.7436;GOLGI APPARATUS#0.7431;ORGANIC CATION TRANSPORTER#0.7427;MULTIDRUG RESISTANT PROTEIN#0.7393;ETOPOSIDE#0.7389;FOAM CELL FORMATION#0.7363;MONONUCLEAR CELLS#0.7363;CHOLINE#0.7321;PORPHYRIN BIOSYNTHESIS#0.7309;ELECTROPHORETIC MOBILITY SHIFT#0.7292;PSEUDOXANTHOMA ELASTICUM#0.7289;HEME BINDING#0.7288;VESICULAR TRANSPORT#0.7270;PROTOPORPHYRIN IX#0.7255;INTESTINAL ABSORPTION#0.7249;NITRIC OXIDE#0.7236;GESTATION#0.7220;IRON SULFUR CLUSTER#0.7218;IRON TRANSPORT#0.7214;ARYL HYDROCARBON RECEPTOR#0.7209;HEMATOPOIETIC STEM CELL#0.7181;ENDOTHELIUM#0.7178;CHONDROITIN SULPHATE PROTEOGLYCAN#0.7174;HEME BINDING PROTEIN#0.7171;CYTOCHROME C#0.7158;MITOCHONDRIAL INNER MEMBRANE#0.7144;LACTIC ACID#0.7134;IMMUNE CELL#0.7134;CARRIE#0.7125;ERWINIA CHRYSANTHEMI#0.7121;PROTEIN PHOSPHORYLATION#0.7111;GERMINATION#0.7105;LECTIN#0.7100;COENZYME A#0.7059;RAPAMYCIN#0.7049;SIGNALLING PATHWAY#0.7039;DIABETES MELLITUS#0.7014;PHOSPHATE BINDING#0.6999;EPILEPSY#0.6982;MAMMARY GLAND#0.6953;GASTROINTESTINAL TRACT#0.6945;EMBRYONIC STEM CELL#0.6942;CALCIUM CHANNEL#0.6940;PROSTATE CANCER#0.6916;COLCHICINE#0.6903;SIDEROBLASTIC ANEMIA#0.6881;ARTERY#0.6879;FLUOROURACIL#0.6878;SENSITIZATION#0.6865;LEUCINE#0.6856;ELACRIDAR#0.6856;CELLULAR HOMEOSTASIS#0.6842;MULTIPLE SEQUENCE ALIGNMENT#0.6798;CATALYTIC ACTIVITY#0.6796;BINDING PROTEIN 1#0.6781;CELL ADHESION#0.6764;FLIPPASE#0.6755;NILOTINIB#0.6731;PHASE II METABOLISM#0.6731;VITAMIN B12#0.6730;INTRACELLULAR LOCALIZATION#0.6729;DIFFERENTIAL GENE EXPRESSION#0.6727;URIC ACID#0.6689;TRANSPORTER COMPLEX#0.6666;TUMOR SUPPRESSOR#0.6656;HYPOXIC#0.6652;NEUROLOGICAL DISORDER#0.6649;ALKALINE PHOSPHATASE#0.6647;TYPE 2 DIABETES#0.6646;TETRACYCLINE#0.6646;UBIQUITIN#0.6642;RESVERATROL#0.6637;ITRACONAZOLE#0.6606;MOLECULAR DYNAMICS SIMULATION#0.6596;DNA METHYLATION#0.6594;PROTEIN SECRETION#0.6563;ENZYME ACTIVITY#0.6554;ADRENAL GLAND#0.6536;HORIZONTAL GENE TRANSFER#0.6522;CELL MIGRATION#0.6492;BIOTIN#0.6478;BERBERINE#0.6475;SEQUESTERING#0.6450;SORAFENIB#0.6433;TONOPLAST#0.6429;INDOLE#0.6421;HYALURONIC ACID#0.6419;GENETIC DISORDER#0.6409;VASCULAR ENDOTHELIAL CELL#0.6404;PEPTIDOGLYCAN#0.6404;PEPTIDE TRANSPORT#0.6403;OLFACTORY ENSHEATHING GLIA#0.6395;PANCREATIC CANCER#0.6393;TARGET OF RAPAMYCIN#0.6392;PERIPHERAL NERVE#0.6392;GENISTEIN#0.6387;CARNITINE#0.6385;BETA CELL#0.6384;CELL ENVELOPE#0.6373;BLOOD TESTIS BARRIER#0.6364;RIFAMPICIN#0.6330;INTRAHEPATIC CHOLESTASIS#0.6316;MACULAR DEGENERATION#0.6308;LOCALISATION#0.6298;AMINOLEVULINIC ACID#0.6297;INTRACELLULAR MEMBRANE#0.6292;DIGOXIN#0.6279;HEME TRANSPORTER#0.6269;GLYBURIDE#0.6260;COLON ADENOCARCINOMA#0.6251;CHRONIC MYELOID LEUKEMIA#0.6246;COLICIN#0.6244;POLYCYCLIC AROMATIC HYDROCARBON#0.6232;ISCHEMIA#0.6231;FRUCTOSE#0.6218;PRAZOSIN#0.6207;FACTOR I#0.6199;MITOGEN ACTIVATED PROTEIN#0.6184;INFLAMMATORY RESPONSE#0.6177;ER MEMBRANE#0.6175;STEROL TRANSPORT#0.6172;SCHWANN CELL#0.6168;PROTEIN TRANSPORTER#0.6159;INTESTINAL EPITHELIAL CELL#0.6121;MELANOCYTE#0.6121;LEISHMANIASIS#0.6115;RECEPTOR TYROSINE KINASE#0.6091;GENE SILENCING#0.6080;GERM CELL#0.6070;SIGNALING CASCADE#0.6067;BLOOD VESSEL#0.6052;TOLL LIKE RECEPTOR#0.6049;SMOOTH MUSCLE#0.6029;BACITRACIN#0.6016;CHOLESTEROL UPTAKE#0.6015
10059	MEMBRANE FISSION#1.0684;MITOCHONDRIAL TRANSLOCATION#1.0610;GTPASE ACTIVITY#1.0568;DEPHOSPHORYLATION#1.0553;GTP HYDROLYSIS#1.0545;CALCINEURIN#1.0518;DOMINANT NEGATIVE MUTANT#1.0442;SUMOYLATION#1.0436;RELATED PROTEIN 1#1.0380;OPTIC ATROPHY#1.0336;MITOCHONDRIAL DIVISION#1.0324;CONSTRICTION#1.0321;MITOCHONDRIAL OUTER MEMBRANE#1.0263;BREAST CANCER CELL#1.0251;ENDOCYTOSIS#1.0231;PEROXISOMAL#1.0228;GTP BINDING#1.0225;MITOCHONDRIAL FISSION#1.0220;CAMKII#1.0218;BREAST CANCER#1.0198;NECROPTOSIS#1.0192;REGULATION OF MITOCHONDRIAL FISSION#1.0192;CYCLIN DEPENDENT KINASE#1.0157;MITOCHONDRIAL DEPOLARIZATION#1.0151;OUTER MEMBRANE#1.0137;PEROXISOME#1.0101;LUNG CANCER#1.0085;CARDIAC ARREST#1.0078;CYTOPLASM#1.0068;OUTER MITOCHONDRIAL MEMBRANE#1.0062;CYTOCHROME C RELEASE#1.0058;VACUOLE#1.0056;MITOCHONDRIAL LOCALIZATION#1.0043;NEURONAL CELL DEATH#1.0043;CEREBRAL ISCHEMIA#1.0032;GENE EXPRESSION#1.0021;POST-TRANSLATIONAL MODIFICATION#1.0012;MITOCHONDRIAL FUSION#1.0007;MICROTUBULE#0.9999;MELATONIN#0.9996;PROTEIN KINASE A#0.9995;ENDOSOME#0.9995;CARDIOMYOPATHY#0.9980;MEMBRANE FUSION#0.9974;NEURONAL CELLS#0.9964;MITOPHAGY#0.9953;UBIQUITIN#0.9946;DILATED CARDIOMYOPATHY#0.9946;MITOCHONDRIAL PERMEABILITY TRANSITION#0.9938;MICROTUBULE ASSOCIATED PROTEIN#0.9932;STEM CELL#0.9925;CARDIOMYOCYTE#0.9919;NLRP3 INFLAMMASOME ACTIVATION#0.9919;PERMEABILITY TRANSITION PORE#0.9918;CISPLATIN#0.9908;CELL CYCLE#0.9904;GLYCOLYSIS#0.9903;CRISTAE#0.9902;CANCER CELL#0.9901;ISCHEMIA REPERFUSION INJURY#0.9892;ENDOPLASMIC RETICULUM#0.9885;T CELL#0.9884;HYPERGLYCEMIA#0.9880;ACTIN FILAMENT#0.9876;HYPOXIA#0.9867;APOPTOTIC CELL DEATH#0.9866;ROS GENERATION#0.9854;PROTEIN KINASE#0.9852;TRANSCRIPTION FACTOR#0.9850;ENDOTHELIAL CELL#0.9850;CYTOCHROME C#0.9846;HUNTINGTON'S DISEASE#0.9842;ISCHEMIA#0.9839;SIGNALING PATHWAY#0.9835;AUTOPHAGY#0.9831;ELECTRON TRANSPORT#0.9824;COMPLEX I#0.9821;RESPIRATION#0.9819;CELL PROLIFERATION#0.9818;ACTIN POLYMERIZATION#0.9810;MITOCHONDRIA#0.9807;ELECTRON TRANSPORT CHAIN#0.9796;LIGHT CHAIN 3#0.9796;OXIDATIVE PHOSPHORYLATION#0.9789;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9785;APOPTOSIS#0.9782;PLASMA MEMBRANE#0.9782;MITOCHONDRIAL MEMBRANE#0.9780;MTDNA#0.9780;CARDIOLIPIN#0.9774;SUPEROXIDE DISMUTASE#0.9767;EPITHELIAL CELL#0.9765;MUSCLE CELL#0.9761;CELL DEATH#0.9759;NITRIC OXIDE#0.9748;OXYGEN GLUCOSE DEPRIVATION#0.9747;ALZHEIMER'S DISEASE#0.9745;AUTOPHAGOSOME#0.9745;SKELETAL MUSCLE#0.9741;TOXICITY#0.9735;SMOOTH MUSCLE#0.9730;MITOCHONDRIAL DAMAGE#0.9720;PARKINSON'S DISEASE#0.9706;RESPIRATORY CHAIN#0.9702;MITOCHONDRIAL DNA#0.9702;APOPTOTIC#0.9692;MITOCHONDRIAL DISTRIBUTION#0.9677;RNA INTERFERENCE#0.9675;ARTERY#0.9656;NEURODEGENERATIVE DISEASE#0.9647;PODOCYTE#0.9638;HYPOXIC#0.9635;NERVOUS SYSTEM#0.9626;MYOCYTES#0.9625;SENESCENCE#0.9622;PEROXISOME DIVISION#0.9621;TRANSMISSION ELECTRON MICROSCOPY#0.9620;REACTIVE OXYGEN SPECIES#0.9618;MITOCHONDRIAL TRANSCRIPTION#0.9616;CELL MIGRATION#0.9615;B CELL#0.9613;ADENOSINE TRIPHOSPHATE#0.9607;CYTOCHROME C OXIDASE#0.9592;GROWTH FACTOR#0.9589;ORGANELLE#0.9588;PROGRAMMED CELL DEATH#0.9558;NEUROTOXICITY#0.9538;STATUS EPILEPTICUS#0.9520;DISTRIBUTION OF MITOCHONDRIA#0.9494;SMOOTH MUSCLE CELL#0.9493;BETA CELL#0.9488;INFLAMMATORY RESPONSE#0.9480;MOUSE EMBRYONIC FIBROBLAST#0.9480;MORPHOGENESIS#0.9450;LYSOSOME#0.9429;PALMITATE#0.9428;ADENOSINE#0.9415;NEUROPROTECTION#0.9393;LATE GOLGI#0.9387;HEPATOTOXICITY#0.9379;PROTEASOME#0.9340;HIGH FAT DIET#0.9334;MITOCHONDRION#0.9314;INSULIN SECRETION#0.9300;SWELLING#0.9271;GUANOSINE#0.9262;PRO-INFLAMMATORY#0.9246;HYPERTENSION#0.9191;NEUROBLASTOMA#0.9186;OVARIAN CANCER#0.9185;TYPE 2 DIABETES#0.9160;TUMOR NECROSIS FACTOR#0.9144;CYTOTOXICITY#0.9120;MIDDLE CEREBRAL ARTERY#0.9103;CEREBRAL ARTERY#0.9100;RECEPTOR INTERACTING PROTEIN#0.9099;NUCLEAR RESPIRATORY FACTOR#0.9092;POSTTRANSLATIONAL MODIFICATION#0.9075;CASPASE ACTIVATION#0.9058;INNER MITOCHONDRIAL MEMBRANE#0.9032;MYOCARDIAL INFARCTION#0.8999;DOPAMINERGIC NEURON#0.8985;MITOSIS#0.8982;OBESE#0.8956;SPINAL CORD#0.8940;CLEAVED CASPASE 3#0.8903;MACROPHAGE#0.8871;ATP SYNTHESIS#0.8869;VACUOLAR PROTEIN SORTING#0.8863;STAUROSPORINE#0.8840;CEREBRAL ARTERY OCCLUSION#0.8824;TUMOR CELLS#0.8819;BRAIN DAMAGE#0.8819;ENDOCYTIC VESICLE#0.8739;RETINAL GANGLION CELL#0.8726;CENTRAL NERVOUS SYSTEM#0.8719;ASTROCYTE#0.8693;TARGET OF RAPAMYCIN#0.8678;MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION#0.8666;INTRINSIC APOPTOSIS#0.8618;NEURITE#0.8618;MIXED LINEAGE KINASE#0.8611;HEART DISEASE#0.8610;PEROXISOMAL MEMBRANE#0.8606;DNA FRAGMENTATION#0.8586;ENDOTHELIUM#0.8568;RAPAMYCIN#0.8506;MITOCHONDRIAL INNER MEMBRANE#0.8466;B CELL LYMPHOMA#0.8459;NITRIC OXIDE SYNTHASE#0.8433;MITOCHONDRIAL MATRIX#0.8415;MYOCARDIUM#0.8368;DOXORUBICIN#0.8328;ACTIN BINDING#0.8320;ATP SYNTHASE#0.8301;EMBRYONIC STEM CELL#0.8273;CELLULAR HOMEOSTASIS#0.8270;MITOCHONDRIAL TRANSPORT#0.8261;VASCULAR SMOOTH MUSCLE CELL#0.8259;OVARIAN#0.8257;PROTEIN DISULFIDE ISOMERASE#0.8253;LATERAL SCLEROSIS#0.8229;ENDOPLASMIC RETICULUM STRESS#0.8227;SIGNALLING PATHWAY#0.8218;AXONAL TRANSPORT#0.8162;MEMBRANE SCISSION#0.8150;GLUTATHIONE#0.8099;AMYOTROPHIC LATERAL SCLEROSIS#0.8082;BLOOD BRAIN BARRIER#0.8079;NEUROLOGICAL DISORDER#0.8074;S PHASE#0.8072;POLYMERASE CHAIN REACTION#0.8027;STREPTOZOTOCIN#0.8023;UNFOLDED PROTEIN RESPONSE#0.8018;NECROTIC#0.8006;NEPHROPATHY#0.7985;MYOBLAST#0.7960;MITOCHONDRIAL CRISTAE#0.7957;ADENOCARCINOMA#0.7954;PYRUVATE#0.7942;GLUCOSE METABOLISM#0.7930;GLYCOGEN SYNTHASE KINASE#0.7917;ACTIN CYTOSKELETON#0.7904;LUNG ADENOCARCINOMA#0.7903;MYOTUBE#0.7899;CELL GROWTH#0.7876;NEUROPATHY#0.7865;SUCCINATE#0.7857;ACUTE KIDNEY INJURY#0.7842;MYOCARDIAL INFARCT SIZE#0.7838;PRIMARY CORTICAL NEURON#0.7834;SUBSTANTIA NIGRA#0.7825;HEPATOCELLULAR CARCINOMA#0.7787;DOPAMINE#0.7782;DENDRITIC SPINE#0.7776;DESUMOYLATION#0.7743;PHOSPHOGLYCERATE MUTASE#0.7743;PROTEIN KINASE C#0.7695;MITOGEN ACTIVATED PROTEIN#0.7689;FATTY ACID OXIDATION#0.7663;BRAIN EDEMA#0.7662;DOMINANT OPTIC ATROPHY#0.7631;ANION CHANNEL#0.7626;CYTOKINESIS#0.7612;CELL DIFFERENTIATION#0.7595;PODOCYTE APOPTOSIS#0.7553;KINASE ACTIVITY#0.7541;APOPTOSIS INDUCING FACTOR#0.7502;ADIPOSE TISSUE#0.7471;ANCHORING#0.7461;EPILEPSY#0.7431;SYNAPTIC TRANSMISSION#0.7417;ADIPOCYTE#0.7413;QUANTITATIVE REAL TIME#0.7409;MECHANISM OF ACTION#0.7407;PROGRAMMED NECROSIS#0.7406;DEVELOPMENTAL DELAY#0.7401;L-CYSTEINE#0.7396;LEUCINE RICH REPEAT#0.7353;CORONARY ARTERY#0.7328;PROGENITOR CELL#0.7328;ATHEROSCLEROSIS#0.7327;IMMUNE RESPONSE#0.7301;METFORMIN#0.7277;AUTOPHAGOSOME FORMATION#0.7230;BUDDING#0.7204;HEPATOMA CELLS#0.7196;DRUG RESISTANCE#0.7195;HUMAN BREAST CANCER#0.7192;HEAT SHOCK PROTEIN#0.7187;TUBULAR EPITHELIAL CELL#0.7182;CASPASE-3 ACTIVITY#0.7162;GENE SILENCING#0.7151;PULMONARY ARTERIAL HYPERTENSION#0.7136;INDUCTION OF APOPTOSIS#0.7135;ACTIVATION OF APOPTOSIS#0.7102;COLON CANCER#0.7089;DIABETIC NEPHROPATHY#0.7089;PEROXISOME MEMBRANE#0.7078;CONTACT SITE#0.7051;TRANS GOLGI NETWORK#0.7049;CHARCOT MARIE TOOTH#0.7041;SKIN FIBROBLASTS#0.7035;N-ACETYLCYSTEINE#0.7002;COATED VESICLE#0.7000;NUCLEOID#0.6992;ONCOGENIC#0.6989;PLURIPOTENT STEM CELL#0.6982;NEUROGENESIS#0.6970;SIGNALING CASCADE#0.6964;CELL PLATE#0.6959;LIVER DISEASE#0.6951;COLORECTAL CANCER#0.6944;MEMBRANE CURVATURE#0.6881;HOST CELL#0.6873;SYNAPTIC VESICLE#0.6840;NEURITE OUTGROWTH#0.6828;CELL DIVISION#0.6823;ACTIVATED CASPASE 3#0.6804;PANCREATIC CANCER#0.6797;LIPID METABOLISM#0.6790;UBIQUITIN PROTEASOME SYSTEM#0.6763;TRANSIENT RECEPTOR POTENTIAL#0.6749;OPTIC NERVE#0.6739;TRAUMATIC BRAIN INJURY#0.6732;LATE ENDOSOME#0.6731;PHOSPHATASE 2A#0.6717;EDEMA#0.6712;CELL CYCLE ARREST#0.6691;BRAIN DEVELOPMENT#0.6687;NEURAL CELL#0.6679;LEUCINE#0.6677;MITOCHONDRIAL ELECTRON TRANSPORT CHAIN#0.6670;MITOCHONDRIAL MEMBRANE FUSION#0.6663;MITOCHONDRIAL ELECTRON TRANSPORT#0.6647;CELL ACTIVATION#0.6614;SIGNALING MOLECULE#0.6602;ANGIOGENESIS#0.6548;RESPIRATORY CHAIN COMPLEX#0.6544;INTRINSIC APOPTOTIC PATHWAY#0.6535;UBIQUITIN PROTEIN LIGASE#0.6529;RENAL ISCHEMIA REPERFUSION#0.6521;REACTIVE OXYGEN SPECIES GENERATION#0.6508;NULL CELL#0.6489;NEUROTOXIC#0.6483;COLORECTAL#0.6483;INTERPHASE#0.6479;ISOPROTERENOL#0.6464;PULMONARY HYPERTENSION#0.6454;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.6450;LYSINE#0.6437;FOREBRAIN#0.6419;MULTIPLE SCLEROSIS#0.6417;ENZYME ACTIVITY#0.6400;PROSTATE CANCER#0.6398;REGULATION OF APOPTOSIS#0.6367;DNA COPY NUMBER#0.6329;NEUROTOXIN#0.6326;PROXIMAL TUBULAR CELL#0.6314;KIDNEY DISEASE#0.6290;RESVERATROL#0.6287;SELECTIVE AUTOPHAGY#0.6272;PULMONARY ARTERY#0.6265;PEROXISOME PROLIFERATION#0.6261;IRON OVERLOAD#0.6223;CLATHRIN-MEDIATED ENDOCYTOSIS#0.6221;CARNITINE#0.6179;SQUAMOUS CELL CARCINOMA#0.6171;MITOCHONDRIAL RESPIRATORY CHAIN#0.6167;NEURAL STEM CELL#0.6156;MUSCLE ATROPHY#0.6147;LEFT ANTERIOR DESCENDING#0.6140;POLY ADP RIBOSE#0.6133;GANGLION CELLS#0.6117;KINESIN#0.6099;REVERSE TRANSCRIPTION#0.6094;LACTIC ACIDOSIS#0.6091;CONJUGATION#0.6075;HEMORRHAGE#0.6057;STRIATUM#0.6045;OOCYTE#0.6038;MORRIS WATER MAZE#0.6005
1005	NEURAL CREST CELL#1.0169;NEURAL CREST#1.0121;CELL ADHESION#0.9729;CELL MIGRATION#0.8976;CELL CELL ADHESION#0.7820;NERVOUS SYSTEM#0.7631;SPINAL CORD#0.7524;NEURAL TUBE#0.7317;BASAL PLATE#0.6548;CENTRAL NERVOUS SYSTEM#0.6278
10060	SULFONYLUREA RECEPTOR#1.0342;SMOOTH MUSCLE#1.0182;ABC TRANSPORTER#1.0113;GLIBENCLAMIDE#1.0065;POTASSIUM CHANNEL#1.0047;ATP BINDING CASSETTE#1.0000;DIAZOXIDE#0.9993;ATP BINDING#0.9982;SKELETAL MUSCLE#0.9926;POLYMERASE CHAIN REACTION#0.9909;NUCLEOTIDE BINDING#0.9514;ARTERY#0.9447;GENE EXPRESSION#0.9401;CHANNEL ACTIVITY#0.9396;REVERSE TRANSCRIPTION#0.9362;ADENOSINE TRIPHOSPHATE#0.9312;BETA CELL#0.9145;MITOCHONDRIA#0.9040;HYPERTRICHOSIS#0.8951;CORONARY ARTERY#0.8789;ADENOSINE#0.8773;ALZHEIMER'S DISEASE#0.8673;CARDIOMYOCYTE#0.8634;SMOOTH MUSCLE CELL#0.8333;MUSCLE CELL#0.8326;PLASMA MEMBRANE#0.8289;NUCLEOTIDE BINDING DOMAIN#0.8110;CELL PROLIFERATION#0.8093;MYOCYTES#0.8051;MYOCARDIAL INFARCTION#0.7698;DILATED CARDIOMYOPATHY#0.7693;ISCHEMIA#0.7684;TOLBUTAMIDE#0.7670;ION CHANNEL#0.7552;HYPERTENSION#0.7534;ASTROCYTE#0.7242;HYPOXIA#0.7108;CARDIOMYOPATHY#0.7101;INSULIN SECRETION#0.7087;EPITHELIAL CELL#0.6739;CORONARY ARTERY VASOSPASM#0.6585;AUXIN HOMEOSTASIS#0.6424;VASODILATION#0.6420;CALCIUM CHANNEL#0.6356;ARRHYTHMIA#0.6275;SPINAL CORD#0.6227;MYOCARDIUM#0.6173;CYSTIC FIBROSIS#0.6118;MESENTERIC ARTERY#0.6045;OXIDATIVE METABOLISM#0.6024
100616115	BREAST CANCER#1.1452
100616119	PARKINSON'S DISEASE#0.9644
100616142	CELL PROLIFERATION#0.9257;LUNG CANCER#0.8713;CANCER CELL#0.8678;BREAST CANCER#0.7472;COLON CANCER#0.6767;CELL GROWTH#0.6596;APOPTOSIS#0.6285;BREAST CANCER CELL#0.6149
100616170	NOT OTHERWISE SPECIFIED#0.6740;PERIPHERAL T-CELL LYMPHOMA#0.6726;ANAPLASTIC LARGE CELL LYMPHOMA#0.6665;BONE MORPHOGENETIC PROTEIN#0.6538;T CELL#0.6416
100616200	CANCER CELL#1.1780
100616224	APOPTOSIS#0.6411
100616258	KERATINOCYTE#0.6131;APOPTOSIS#0.6058
100616312	SOLUBLE LEPTIN RECEPTOR#0.7329;CELL PROLIFERATION#0.6856
100616327	BREAST CANCER#0.6707
100616353	INSULIN SECRETION#0.6440
100616364	OVARIAN#0.6451
100616379	HEMATURIA#0.6593
100616388	PROSTATE CANCER#1.1840;CANCER CELL#1.1780
100616407	BREAST CANCER#0.8653;CANCER CELL#0.7053;T CELL#0.6648;LIVER METASTASIS#0.6247;CD4+ T CELL#0.6099
100616448	EPITHELIAL MESENCHYMAL TRANSITION#0.7535
100616454	TUMOR TISSUES#0.7200
100616467	APOPTOSIS#0.9055;VASCULAR ENDOTHELIAL CELL#0.6468;ENDOTHELIAL CELL#0.6406
100616469	EPITHELIAL MESENCHYMAL TRANSITION#0.6653;POLYMERASE CHAIN REACTION#0.6546
100616481	AIRWAY EPITHELIUM#1.2019;LUNG CANCER#1.1823;EPITHELIAL CELL#1.1799
100616489	CELL PROLIFERATION#0.6434
100616496	VIRION#1.0128;PROVIRUS#1.0123;TRANSCRIPTASE#0.9988;VIRAL GENOME#0.9870;HUMAN IMMUNODEFICIENCY VIRUS#0.9868;GENE EXPRESSION#0.9833;T CELL#0.9820;PERIPHERAL BLOOD#0.9683;T-CELL LEUKEMIA#0.9472;AVIAN LEUKOSIS#0.9393;CANCER CELL#0.9382;MULTIPLE SCLEROSIS#0.9009;MONONUCLEAR CELLS#0.8901;REVERSE TRANSCRIPTION#0.8732;ONCOGENIC#0.8708;NUCLEIC ACID#0.8631;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8532;VIRUS LIKE PARTICLE#0.8512;REVERSE TRANSCRIPTASE ACTIVITY#0.8225;MILLION YEARS AGO#0.7795;HOST CELL#0.7689;BUDDING#0.7685;RNA INTERFERENCE#0.7580;TRANSCRIPTION FACTOR#0.7566;KIDNEY TRANSPLANT RECIPIENTS#0.7560;TRANSPOSITION#0.7502;HERPES SIMPLEX VIRUS#0.7456;HERPES SIMPLEX#0.7449;GENE SILENCING#0.7290;NUCLEOCAPSID#0.6846;MUTAGENESIS#0.6744;NERVOUS SYSTEM#0.6722;IFN-GAMMA#0.6683;DNA METHYLATION#0.6587;QUANTITATIVE REAL TIME#0.6462;ADULT T-CELL LEUKEMIA#0.6100
100616497	PEPTIDE TRANSPORTER#0.9982;PEPTIDE TRANSPORT#0.9172;OLIGOPEPTIDE TRANSPORTER#0.8855;DNA BINDING#0.8381;UBIQUITIN#0.7305
100616498	LUNG ADENOCARCINOMA#0.7552
10061	ABC TRANSPORTER#0.9989;ATP BINDING CASSETTE#0.9370;ATP BINDING#0.9354;CLEAR CELL ADENOCARCINOMA#0.9133;BREAST CANCER#0.8461;ADENOCARCINOMA#0.8317;OVARIAN#0.8228;CANCER CELL#0.7697;OVARIAN CANCER#0.7624;GENE EXPRESSION#0.7287;HOST CELL#0.6399;ENDOMETRIAL CANCER#0.6389;EPITHELIAL CELL#0.6263;STEM CELL#0.6258;TUMOR CELLS#0.6202;PROGESTERONE#0.6160
100628315	CELL PROLIFERATION#0.6547;PULMONARY FIBROSIS#0.6060;DNA DAMAGE RESPONSE#0.6040;TUMOR TISSUES#0.6009
10062	FARNESOID X RECEPTOR#1.0401;LIVER X RECEPTOR#1.0398;RETINOID X RECEPTOR#1.0310;NUCLEAR HORMONE RECEPTOR#1.0288;FATTY ACID SYNTHASE#1.0219;SCAVENGER RECEPTOR#1.0209;CHOLESTEROL HOMEOSTASIS#1.0095;PEROXISOME#1.0076;TRANSCRIPTION FACTOR#1.0055;STEROL REGULATORY ELEMENT#1.0045;ATP BINDING CASSETTE TRANSPORTER#1.0033;NUCLEAR RECEPTOR SUPERFAMILY#0.9997;CHOLESTEROL EFFLUX#0.9982;PREGNANE X RECEPTOR#0.9958;ATP BINDING CASSETTE#0.9953;ATP BINDING#0.9943;MACROPHAGE#0.9940;LIPOGENESIS#0.9899;LIPID METABOLISM#0.9886;ADIPOSE TISSUE#0.9859;LOW DENSITY LIPOPROTEIN#0.9835;POLYMERASE CHAIN REACTION#0.9828;CHOLESTEROL METABOLISM#0.9826;SIGNALING PATHWAY#0.9823;LIPID HOMEOSTASIS#0.9814;REVERSE CHOLESTEROL TRANSPORT#0.9777;CHOLESTEROL TRANSPORT#0.9777;ADIPOCYTE#0.9734;GENE EXPRESSION#0.9709;HIGH DENSITY LIPOPROTEIN#0.9700;ATHEROSCLEROSIS#0.9669;PROTEIN KINASE#0.9586;COENZYME A#0.9559;EXCRETION#0.9522;MULTIPLE SCLEROSIS#0.9501;ATHEROSCLEROTIC#0.9447;HIGH FAT DIET#0.9399;TRANSACTIVATION#0.9343;FATTY LIVER#0.9331;STEAROYL COA DESATURASE#0.9272;LIVER DISEASE#0.9253;MONOCYTE#0.9238;FATTY ACID SYNTHESIS#0.9150;BINDING PROTEIN 1#0.9126;ADENOSINE TRIPHOSPHATE#0.9096;BILE ACID SYNTHESIS#0.9055;FOAM CELL FORMATION#0.9020;GLUCOSE METABOLISM#0.9018;ADENOSINE#0.8932;INFLAMMATORY RESPONSE#0.8919;TYPE 2 DIABETES#0.8845;ACETYL COA CARBOXYLASE#0.8810;MONONUCLEAR CELLS#0.8717;FATTY LIVER DISEASE#0.8673;TUMOR NECROSIS FACTOR#0.8614;REVERSE TRANSCRIPTION#0.8609;LDL RECEPTOR#0.8558;CHOLESTEROL UPTAKE#0.8551;HIGH CHOLESTEROL DIET#0.8530;FATTY ACID METABOLISM#0.8468;CHOLESTEROL TRANSPORTER#0.8464;FATTY ACID OXIDATION#0.8432;CONSTITUTIVE ANDROSTANE RECEPTOR#0.8402;ENHANCER BINDING PROTEIN#0.8314;ENHANCER BINDING#0.8309;REGULATION OF LIPID METABOLISM#0.8284;CELL PROLIFERATION#0.8271;OBESE#0.8260;DNA BINDING#0.8102;PERIPHERAL BLOOD#0.8100;ADIPOGENESIS#0.8087;DNA METHYLATION#0.8079;RETINOIC ACID#0.7979;GROWTH FACTOR#0.7918;FATTY ACID BINDING#0.7648;SMALL HETERODIMER PARTNER#0.7600;LIPID DROPLET#0.7527;KUPFFER CELL#0.7503;HYPERCHOLESTEROLEMIA#0.7460;CYTOCHROME P450#0.7407;ABC TRANSPORTER#0.7403;ATORVASTATIN#0.7402;GLUCOSE HOMEOSTASIS#0.7297;EPITHELIAL CELL#0.7226;APOPTOSIS#0.7225;GLUCOCORTICOID RECEPTOR#0.7208;CHOLESTEROL SYNTHESIS#0.7196;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7184;SKELETAL MUSCLE#0.7171;RECEPTOR AGONIST#0.7125;NONALCOHOLIC FATTY LIVER DISEASE#0.7096;ADIPOCYTE DIFFERENTIATION#0.7076;CATABOLISM#0.7074;VITAMIN D RECEPTOR#0.6996;DE NOVO LIPOGENESIS#0.6851;CHOLESTEROL BIOSYNTHESIS#0.6837;CANCER CELL#0.6828;LIGAND BINDING DOMAIN#0.6703;BILE ACID METABOLISM#0.6614;SMALL INTESTINE#0.6606;ESTROGEN RECEPTOR#0.6467;PRO-INFLAMMATORY#0.6447;INNATE IMMUNITY#0.6307;CARBOHYDRATE RESPONSE ELEMENT BINDING#0.6299;HEPATOMA CELLS#0.6180;T CELL#0.6095
10063	COPPER CHAPERONE#1.0814;CYTOCHROME C OXIDASE#1.0434;CYTOCHROME C#1.0380;COPPER BINDING#1.0167;MITOCHONDRIA#1.0055;SUPEROXIDE DISMUTASE#0.9501;METAL BINDING#0.8982;MITOCHONDRIAL INTERMEMBRANE SPACE#0.8758;CISPLATIN#0.8313;MRNA DECAY#0.8269;GENE EXPRESSION#0.8239;COPPER HOMEOSTASIS#0.7677;MICOS COMPLEX#0.7519;RESPIRATORY CHAIN#0.7460;MITOCHONDRION#0.7098;CYTOPLASM#0.6771;RESPIRATION#0.6472;REACTIVE OXYGEN SPECIES#0.6412;MITOCHONDRIAL INNER MEMBRANE#0.6332;GLUTATHIONE#0.6229;FETAL LIVER#0.6147
100642175	EPITHELIAL MESENCHYMAL TRANSITION#1.1006;CANCER CELL#1.0928;CELL PROLIFERATION#1.0896;BREAST CANCER#1.0798;APOPTOSIS#1.0635;CELL GROWTH#1.0427;SQUAMOUS CELL CARCINOMA#0.9396;CELL MIGRATION#0.9378;HEPATOCELLULAR CARCINOMA#0.9377;QUANTITATIVE REAL TIME#0.9375;BREAST CANCER CELL#0.9200;LYMPH NODE METASTASIS#0.8993;LYMPH NODE#0.8950;LUNG CANCER#0.8809;OVARIAN CANCER#0.8624;ONCOGENIC#0.8586;COLORECTAL CANCER#0.8210;CELL CYCLE#0.8014;POLYMERASE CHAIN REACTION#0.7948;COLORECTAL#0.7465;EPITHELIAL CELL#0.7130;OVARIAN#0.6995;TUMOR TISSUES#0.6988;TRANSCRIPTION FACTOR#0.6873;TUMOR NODE METASTASIS#0.6786;COLONY FORMATION ASSAY#0.6516;ADJACENT NORMAL TISSUE#0.6510;RNA BINDING PROTEIN#0.6290;RNA BINDING#0.6276;DISEASE FREE SURVIVAL#0.6269;SIGNALING PATHWAY#0.6202;TROPHOBLAST CELL#0.6171;BREAST CANCER PATIENTS#0.6096
100652748	TRANSCRIPTION FACTOR#1.1783
100652772	LUNG CANCER#1.0624;CELL PROLIFERATION#1.0615;CANCER CELL#1.0093;NICOTINAMIDE#0.9066;CELL CYCLE#0.8606;BREAST CANCER#0.8301;SIGNALING PATHWAY#0.8289;APOPTOSIS#0.7975;ANTISENSE RNA#0.7565;TUMOR TISSUES#0.6628;POLYMERASE CHAIN REACTION#0.6563;CERVICAL CANCER#0.6026;EPITHELIAL MESENCHYMAL TRANSITION#0.6009
100653366	CHOLANGITIS#0.9271;SCLEROSING CHOLANGITIS#0.8733;CHOLANGIOCARCINOMA#0.7955;BILE DUCT#0.6292
100653377	Y CHROMOSOME#1.0130;SERTOLI CELL#1.0000;AZOOSPERMIA#0.9958;SERTOLI CELL-ONLY SYNDROME#0.9935;GERM CELL#0.9836;INFERTILE#0.9831;MALE INFERTILITY#0.9813;SEMEN#0.9789;INFERTILITY#0.9748;SPERMATOGENESIS#0.9738;SPERMATOZOA#0.9633;SEX CHROMOSOME#0.9623;POLYMERASE CHAIN REACTION#0.9585;GENE EXPRESSION#0.9321;MEIOSIS#0.9315;X CHROMOSOME#0.9146;STEM CELL#0.9066;TESTOSTERONE#0.9036;SPERMATOCYTES#0.8633;COPY NUMBER VARIATION#0.8109;AUTOSOME#0.8090;LEYDIG CELL#0.7918;FOLLICLE STIMULATING HORMONE#0.7833;ANDROGEN RECEPTOR#0.7750;GERM CELL DEVELOPMENT#0.7743;CELL DEVELOPMENT#0.7632;PACHYTENE#0.7610;STERILITY#0.7601;HOMOLOGOUS RECOMBINATION#0.7546;CRYPTORCHIDISM#0.7460;OLIGOSPERMIA#0.6667;PERIPHERAL BLOOD#0.6655;SPERMATOGONIAL STEM CELL#0.6623;INHIBIN#0.6434;SPERM MOTILITY#0.6406;APOPTOSIS#0.6374;SEMINAL PLASMA#0.6303;FERTILIZATION#0.6072
100653382	CHRONIC LYMPHOCYTIC LEUKEMIA#0.8395;LYMPHOCYTIC LEUKEMIA#0.8388;LYMPH NODE#0.7347;B CELL#0.6663
100653385	3P- SYNDROME#1.1608
10066	CELL SURFACE#1.0092;EXOCYTOSIS#0.9745;PLASMA MEMBRANE#0.9522;DENSE CORE VESICLE#0.7571;DENSE CORE VESICLE EXOCYTOSIS#0.6988;VESICLE EXOCYTOSIS#0.6624;RECYCLING ENDOSOME#0.6551;SECRETORY VESICLE#0.6517;TRANSPORTER ACTIVITY#0.6068
10067	ENDOSOME#0.8271;MULTIVESICULAR ENDOSOME#0.6337;FEED FORWARD LOOP#0.6164;RECEPTOR DEGRADATION#0.6138
10068	INTERLEUKIN 18 BINDING#1.0851;IL-1RA#1.0653;IL-18 BINDING#1.0466;IFN-GAMMA#1.0304;RHEUMATOID ARTHRITIS#1.0105;PRO-INFLAMMATORY#1.0062;T CELL#1.0033;MACROPHAGE#1.0011;PERIPHERAL BLOOD#1.0005;POLYMERASE CHAIN REACTION#0.9872;ISCHEMIA#0.9843;IMMUNE RESPONSE#0.9794;TUMOR NECROSIS FACTOR#0.9782;GENE EXPRESSION#0.9708;MONONUCLEAR CELLS#0.9597;GROWTH FACTOR#0.9413;AUTOIMMUNE DISEASE#0.9317;RECEPTOR ANTAGONIST#0.9302;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9280;EPITHELIAL CELL#0.9072;SPINAL CORD#0.8950;MONOCYTE#0.8604;CELL SURFACE#0.8603;INFLAMMATORY RESPONSE#0.8539;NEUTROPHIL#0.8350;INFLAMMATORY BOWEL DISEASE#0.8231;COLITIS#0.8098;APOPTOSIS#0.7985;LIVER DISEASE#0.7897;TRANSFORMING GROWTH FACTOR#0.7870;ACUTE KIDNEY INJURY#0.7804;CANCER CELL#0.7694;QUANTITATIVE REAL TIME#0.7657;INTERFERON REGULATORY FACTOR#0.7586;KERATINOCYTE#0.7554;IL-18 PRODUCTION#0.7523;MAST CELL#0.7323;PROSTATE CANCER#0.7296;STEM CELL#0.7259;SIGNAL TRANSDUCTION#0.7229;ATHEROSCLEROTIC#0.7122;PURPURA#0.6926;RENAL FIBROSIS#0.6879;ARTERY#0.6776;OVARIAN#0.6681;LUPUS ERYTHEMATOSUS#0.6664;NATURAL KILLER CELL#0.6554;INFLAMMATORY CELL#0.6530;MUTAGENESIS#0.6501;ADULT-ONSET STILL'S DISEASE#0.6456;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6362;BONE MARROW#0.6316;FERTILIZATION#0.6302;EOSINOPHIL#0.6295;OXIDATIVE STRESS INDEX#0.6294;TRANSFORMING GROWTH FACTOR BETA#0.6290;C REACTIVE PROTEIN#0.6212;MOLLUSCUM CONTAGIOSUM#0.6203;VACCINIA#0.6058;ISCHEMIA REPERFUSION INJURY#0.6035;TOLL LIKE RECEPTOR#0.6012;LYMPHOCYTE ACTIVATION#0.6012
1006	CELL ADHESION#0.9276;CELL ADHESION MOLECULE#0.7578;SUPERIOR COLLICULUS#0.7135;AUTISM SPECTRUM DISORDER#0.7039;STRIATUM#0.6569;NERVOUS SYSTEM#0.6481
10071	COLORECTAL CANCER#0.7585;REVERSE TRANSCRIPTION#0.7345;COLORECTAL#0.7117;GENE EXPRESSION#0.7113;POLYMERASE CHAIN REACTION#0.6437;EPITHELIAL CELL#0.6031
10072	DIPEPTIDYL PEPTIDASE#1.0582;ZINC BINDING#1.0005;ENZYME ACTIVITY#0.9510;FARNESOL#0.8972;CARBOXYPEPTIDASE A#0.8369;ERYTHROCYTE#0.8087;ANGIOTENSIN CONVERTING ENZYME#0.7174;TRANSCRIPTION FACTOR#0.6872;LEUCINE#0.6624;MUTAGENESIS#0.6224;OVARIAN#0.6207
10073	NUCLEAR IMPORT#1.0620;IMPORTIN#0.9730;U1 SNRNP#0.8623;NUCLEAR EXPORT#0.8537
100750225	PROSTATE CANCER#1.0833;CELL PROLIFERATION#1.0825;CANCER CELL#1.0713;APOPTOSIS#1.0681;SIGNALING PATHWAY#1.0035;ONCOGENIC#0.9997;QUANTITATIVE REAL TIME#0.9888;POLYMERASE CHAIN REACTION#0.9866;CELL GROWTH#0.9859;OVARIAN CANCER#0.9757;HEPATOCELLULAR CARCINOMA#0.9429;COLORECTAL CANCER#0.9283;CELL CYCLE#0.9241;TUMOR TISSUES#0.8793;LYMPH NODE#0.8666;SQUAMOUS CELL CARCINOMA#0.8324;LUNG CANCER#0.8215;OVARIAN#0.8166;REVERSE TRANSCRIPTION#0.8048;ENDOMETRIAL CARCINOMA#0.7926;COLORECTAL#0.7856;CELL MIGRATION#0.7798;LYMPH NODE METASTASIS#0.7669;STEM CELL#0.7599;CISPLATIN#0.7435;WOUND HEALING#0.6272;DUAL LUCIFERASE REPORTER#0.6242;HOMOLOGOUS RECOMBINATION#0.6196;DRUG RESISTANCE#0.6161;SIGNALLING PATHWAY#0.6161;TUMOR SUPPRESSOR#0.6059;BREAST CANCER#0.6051
100750246	ANTISENSE RNA#0.9770;APOPTOSIS#0.9590;VASCULAR SMOOTH MUSCLE CELL#0.7533;HYPOXIA INDUCIBLE FACTOR#0.7503;SMOOTH MUSCLE CELL#0.7503;MUSCLE CELL#0.7496;SMOOTH MUSCLE#0.7484;AORTIC ANEURYSM#0.6879;ENDOTHELIAL CELL#0.6471;CELL PROLIFERATION#0.6463;INTRACRANIAL ANEURYSM#0.6281;VSMC PROLIFERATION#0.6207;COLORECTAL CARCINOMA#0.6079;VASCULAR ENDOTHELIAL CELL#0.6051
100750247	CELL PROLIFERATION#1.0729;ANTISENSE RNA#1.0287;HYPOXIA INDUCIBLE FACTOR#1.0197;HYPOXIA#0.9906;CELL MIGRATION#0.9189;APOPTOSIS#0.6838;BREAST CANCER#0.6614;CELL CYCLE#0.6580;CANCER CELL#0.6458;ADIPOSE-DERIVED STEM CELL#0.6174;AKT SIGNALING#0.6049
100750329	HEARING LOSS#0.6225
10075	UBIQUITIN PROTEIN LIGASE#1.0667;INTELLECTUAL DISABILITY#1.0523;UBIQUITIN#1.0417;BREAST CANCER#1.0395;CANCER CELL#1.0385;TUMOR SUPPRESSOR#1.0169;APOPTOSIS#1.0118;PROTEASOME#1.0067;DNA DAMAGE RESPONSE#1.0046;CELL PROLIFERATION#0.9795;SIGNALING PATHWAY#0.9703;STEM CELL#0.9698;DNA REPAIR#0.9474;CELL CYCLE#0.9395;B CELL#0.9385;APOPTOTIC#0.9311;BREAST CANCER CELL#0.9229;LUNG CANCER#0.9211;GENE EXPRESSION#0.8670;UBIQUITIN PROTEASOME SYSTEM#0.8492;COPY NUMBER GAIN#0.8276;CELL DEATH#0.8242;OXYGEN GLUCOSE DEPRIVATION#0.8185;BASE EXCISION REPAIR#0.8054;LYSINE#0.7707;UBIQUITIN PROTEASOME PATHWAY#0.7602;PROTEASOME PATHWAY#0.7583;COLORECTAL CANCER#0.7525;EPITHELIAL CELL#0.7273;DNA REPLICATION#0.7066;RNA INTERFERENCE#0.7060;BINDING PROTEIN 1#0.7003;PROSTATE CANCER#0.6956;COLORECTAL#0.6870;TRANSCRIPTION FACTOR#0.6796;HECT E3#0.6674;SPERMATOGENESIS#0.6601;MITOPHAGY#0.6416;DEUBIQUITINATING ENZYME#0.6385;GENOTOXIC#0.6354;CELLULAR DNA DAMAGE RESPONSE#0.6353;B LYMPHOCYTE HOMEOSTASIS#0.6254;NEUROGENESIS#0.6218;OXIDATIVE STRESS RESPONSE#0.6086;CELL DEVELOPMENT#0.6001
10076	PROTEIN TYROSINE PHOSPHATASE#1.0523;SECRETORY VESICLE#0.9419;STEM CELL#0.9170;T CELL#0.9145;SIGNALING PATHWAY#0.9106;TUMOR SUPPRESSOR#0.8364;GENE EXPRESSION#0.7441;PROTEIN KINASE#0.7256;CANCER CELL#0.7069;PERIPHERAL BLOOD#0.6939;MONONUCLEAR CELLS#0.6931;CELL ADHESION#0.6923;PROTEIN TYROSINE KINASE#0.6839;DRG DEVELOPMENT#0.6709;OSTEOCLAST#0.6570;EXTRACELLULAR REGION#0.6382;VESICLE FUSION#0.6350;JUXTAMEMBRANE#0.6275;B CELL#0.6234;SECRETORY VESICLE MEMBRANE#0.6208;FOCAL ADHESION#0.6190;MAST CELL#0.6165;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6148;BONE MARROW#0.6107;MITOGEN ACTIVATED PROTEIN#0.6080
100775105	BREAST CANCER#1.0351;SIGNAL PEPTIDE#1.0256;CANCER CELL#1.0178;VACCINIA#1.0074;MODIFIED VACCINIA ANKARA#1.0049;IFN-GAMMA#0.9945;CELL SURFACE#0.9928;VIRUS LIKE PARTICLE#0.9901;CIRCULATING RECOMBINANT FORM#0.9890;TROPISM#0.9886;MULTIPLE SCLEROSIS#0.9881;VIRAL GENOME#0.9877;POLYMERASE CHAIN REACTION#0.9873;LYMPH NODE#0.9867;SIMIAN IMMUNODEFICIENCY VIRUS#0.9853;VIRION#0.9851;PROVIRUS#0.9848;AVIAN LEUKOSIS#0.9846;REVERSE TRANSCRIPTION#0.9829;VIRAL ENVELOPE#0.9827;CD8+ T CELL#0.9822;GLYCOSYLATION#0.9805;HUMAN BREAST CANCER#0.9798;B CELL#0.9768;ADULT T-CELL LEUKEMIA#0.9743;HOST CELL#0.9730;TRANSCRIPTASE#0.9728;MONONUCLEAR CELLS#0.9725;DRUG RESISTANCE#0.9722;EPSTEIN BARR VIRUS#0.9721;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9717;GENE EXPRESSION#0.9715;T-CELL LEUKEMIA#0.9713;VIRAL REPLICATION#0.9707;CD4+ T CELL#0.9704;CYTOTOXIC T-LYMPHOCYTE#0.9700;HUMORAL IMMUNE RESPONSE#0.9687;VISNA#0.9658;MONOCYTE#0.9656;PERIPHERAL BLOOD#0.9655;T CELL#0.9652;MACROPHAGE#0.9641;NUCLEIC ACID#0.9635;T LYMPHOCYTE#0.9631;CELLULAR IMMUNE RESPONSE#0.9631;HUMAN IMMUNODEFICIENCY VIRUS#0.9620;IMMUNE RESPONSE#0.9569;NERVOUS SYSTEM#0.9552;CENTRAL NERVOUS SYSTEM#0.9491;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9485;IMMUNE SYSTEM#0.9479;CYTOPLASM#0.9478;VIRAL INFECTION#0.9394;PERIPHERAL BLOOD LYMPHOCYTES#0.9348;DENDRITIC CELL#0.9280;INTRACELLULAR CYTOKINE STAINING#0.9259;REVERSE TRANSCRIPTASE ACTIVITY#0.9251;ONCOGENIC#0.9221;VESICULAR STOMATITIS VIRUS#0.9141;APOPTOSIS#0.9124;BUDDING#0.9049;HERPES SIMPLEX#0.9025;NORMAL BREAST TISSUE#0.9021;TROPICAL SPASTIC PARAPARESIS#0.8927;CYTOTOXIC T CELL#0.8908;ANEMIA#0.8897;LEUKOCYTE#0.8877;PLASMA MEMBRANE#0.8825;ACQUIRED IMMUNODEFICIENCY SYNDROME#0.8801;TRANSACTIVATION#0.8793;TYPE 1 DIABETES#0.8757;BONE MARROW#0.8755;CELL-MEDIATED IMMUNE RESPONSE#0.8741;TUMOR CELLS#0.8722;CELL PROLIFERATION#0.8711;HOMOLOGOUS RECOMBINATION#0.8706;ENDOPLASMIC RETICULUM#0.8659;HERPES SIMPLEX VIRUS#0.8647;EQUINE INFECTIOUS ANEMIA#0.8585;MUTAGENESIS#0.8562;LYMPHOID CELL#0.8526;BREAST CANCER CELL#0.8461;CELL MEMBRANE#0.8447;CELL FUSION#0.8415;NUCLEAR EXPORT#0.8402;CYTOTOXICITY#0.8389;LYMPHOID TISSUE#0.8367;B LYMPHOCYTE#0.8344;STOMATITIS#0.8335;PROTEIN SYNTHESIS#0.8302;REVERSE TRANSCRIPTASE INHIBITOR#0.8279;SYNCYTIUM FORMATION#0.8222;VIRAL GLYCOPROTEIN#0.8197;TRANSCRIPTION FACTOR#0.8131;ZIDOVUDINE#0.8084;LYSIS#0.8062;MILLION YEARS AGO#0.7985;ENFUVIRTIDE#0.7984;CELL ASSOCIATED#0.7947;NUCLEOCAPSID#0.7840;ANTISENSE RNA#0.7832;GERM CELL#0.7804;DIGESTION#0.7787;ENDOTHELIAL CELL#0.7751;AUTOIMMUNE DISEASE#0.7662;BREAST CANCER PATIENTS#0.7614;METHIONINE#0.7582;FRAGMENT LENGTH POLYMORPHISM#0.7546;RECEPTOR BINDING#0.7524;TROPHOBLAST#0.7520;VIRAL TRANSCRIPTION#0.7485;SYNCYTIOTROPHOBLAST#0.7482;RHEUMATOID ARTHRITIS#0.7444;DNA SYNTHESIS#0.7291;QUANTITATIVE REAL TIME#0.7127;CELL ACTIVATION#0.7046;APOPTOTIC#0.7031;SALIVARY GLAND#0.6970;INNATE IMMUNE RESPONSE#0.6958;PROTEIN KINASE#0.6906;MAMMARY GLAND#0.6823;CARRIE#0.6822;NEOMYCIN#0.6762;ERYTHROPOIETIN RECEPTOR#0.6744;CELL-MEDIATED IMMUNITY#0.6736;AUTOIMMUNITY#0.6711;FOWLPOX#0.6703;ANTIGEN PRESENTING CELLS#0.6701;TUMOR TISSUES#0.6696;LUNG CANCER#0.6673;PARALYSIS#0.6671;SIGNALING PATHWAY#0.6636;VIRAL ASSEMBLY#0.6627;COLON CANCER#0.6613;MEMORY T CELL#0.6567;VIRAL GENE EXPRESSION#0.6499;PLASMA VIRAL LOAD#0.6409;VIRULENCE#0.6284;AIDS RELATED COMPLEX#0.6276;ACUTE LEUKEMIA#0.6265;ANTIGEN PRESENTATION#0.6257;CUTANEOUS T CELL LYMPHOMA#0.6149;THYMOCYTE#0.6139;PLACENTATION#0.6134;RNA BINDING#0.6091;DNA METHYLATION#0.6079;EPITHELIAL CELL#0.6039
100775107	CANCER STEM-LIKE CELL#0.9250;COLON CANCER#0.9044
10077	T CELL#1.0412;HEMATOPOIETIC CELL#0.7283;SKELETAL MUSCLE#0.7232;IMMUNE RESPONSE#0.7213;COLON CARCINOMA#0.6544;MULTIPLE SCLEROSIS#0.6486;APOPTOSIS#0.6182
1007	CELL ADHESION#0.7451
10081	COLICIN#0.8068;OUTER MEMBRANE#0.7531;CELL DEATH#0.6261
100820829	INTERCALATED DISC#0.7841;SERUM RESPONSE FACTOR#0.7644;ZONULA OCCLUDENS 1#0.6850;ZONULA OCCLUDENS#0.6829;CARDIOMYOPATHY#0.6363
10082	PROTEOGLYCAN#0.9508;CELL SURFACE#0.8978;GROWTH FACTOR#0.8483;CANCER CELL#0.6972;OVARIAN CANCER#0.6551;FIBROBLAST GROWTH FACTOR#0.6524;GENE EXPRESSION#0.6376
10083	HAIR CELL#1.0359;USHER SYNDROME#1.0238;INNER EAR#1.0159;HEARING LOSS#0.9946;USHER SYNDROME TYPE 1#0.9877;RETINITIS PIGMENTOSA#0.9845;RETINITIS#0.9584;BLINDNESS#0.9451;HEARING IMPAIRMENT#0.9144;RETINAL DEGENERATION#0.9128;PHOTORECEPTOR CELL#0.8838;PDZ BINDING MOTIF#0.8269;BRUSH BORDER#0.7752;COLON CANCER#0.7575;SENSORINEURAL HEARING LOSS#0.7210;MICROVILLI#0.7062;PTC124#0.6886;EPITHELIAL CELL#0.6868;OUTER HAIR CELL#0.6707;ACTIN BUNDLING#0.6515;PROTEIN COMPLEX#0.6315;CYTOPLASMIC REGION#0.6122;PROTEIN PROTEIN INTERACTION#0.6080
100847001	DIPEPTIDYL PEPTIDASE 4#1.1984;DIPEPTIDYL PEPTIDASE#1.1936;VASCULAR ENDOTHELIAL CELL#1.1907;ENDOTHELIAL CELL#1.1798;PROTEIN KINASE#1.1787;AUTOPHAGY#0.8503;APOPTOSIS#0.8439
100847081	CANCER CELL#0.7566;OVARIAN#0.6451
10084	RENPENNING SYNDROME#1.1508;BINDING PROTEIN 1#1.0843;INTELLECTUAL DISABILITY#1.0640;MENTAL RETARDATION#1.0578;MRNA SPLICING#1.0308;PRE-MRNA SPLICING#0.9993;X CHROMOSOME#0.9910;MICROCEPHALY#0.9874;C TERMINAL DOMAIN#0.9425;GENE EXPRESSION#0.9012;STEM CELL#0.8587;CELL DEATH#0.8010;INTRINSICALLY DISORDERED PROTEIN#0.7802;NEURAL STEM PROGENITOR#0.7698;NEURODEGENERATIVE DISEASE#0.7603;TRANSCRIPTION FACTOR#0.7595;PROGENITOR CELL#0.7445;NEURONAL RNA GRANULE#0.6644;RNA GRANULE#0.6451
100859927	DYNEIN#0.8704;MICROTUBULE BINDING#0.7814;MICROTUBULE#0.7436;ATP HYDROLYSIS#0.6836;NUCLEOTIDE BINDING#0.6795
100859930	CELL PROLIFERATION#1.0437;HEPATOCELLULAR CARCINOMA#0.8939;APOPTOSIS#0.7920;CANCER CELL#0.6783;HEPATOCELLULAR CARCINOMA CELL#0.6377;ENDOMETRIAL CANCER#0.6365;HEPATOMA CELLS#0.6350;MAPK SIGNALING#0.6335;TUMOR TISSUES#0.6307;LUNG CANCER#0.6234;QUANTITATIVE REAL TIME#0.6229;BREAST CANCER#0.6206;SIGNALING PATHWAY#0.6195
10085	LEUKOCYTE#1.0662;KNEE JOINT#1.0604;EPIDERMAL GROWTH FACTOR#1.0578;GROWTH FACTOR#1.0568;ENDOTHELIAL CELL#1.0558;BREAST CANCER#1.0495;EXTRACELLULAR MATRIX#1.0479;ANGIOGENESIS#1.0466;LEUKOCYTE ADHESION#1.0065;CANCER CELL#0.9985;NEUTROPHIL#0.9949;APOPTOSIS#0.9705;TUMOR CELLS#0.9595;MACROPHAGE#0.9222;GENE EXPRESSION#0.9160;PERIODONTITIS#0.8981;BONE MARROW#0.8935;BLOOD VESSEL#0.8918;STEM CELL#0.8871;TRANSCRIPTION FACTOR#0.8686;CHONDROCYTE#0.8580;INFLAMMATORY CELL#0.8484;BREAST CANCER CELL#0.8467;WOUND HEALING#0.8301;OSTEOARTHRITIS#0.8200;ENDOTHELIAL GROWTH FACTOR#0.8051;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8051;ENDOTHELIUM#0.7941;MESENCHYMAL STEM CELL#0.7923;INTEGRIN BINDING#0.7656;CELL PROLIFERATION#0.7624;INTERMITTENT CLAUDICATION#0.7586;SALIVARY GLAND#0.7581;CELL CYCLE#0.7487;PERIPHERAL ARTERIAL DISEASE#0.7477;SIGNALING PATHWAY#0.7435;CELL MIGRATION#0.7319;ANOIKIS#0.7296;ISCHEMIA#0.7129;FIBROBLAST GROWTH FACTOR#0.7125;EXTRACELLULAR VESICLE#0.6865;LUNG CARCINOMA#0.6790;EPITHELIAL MESENCHYMAL TRANSITION#0.6774;HYPOXIA#0.6607;APOPTOTIC#0.6588;INFLAMMATORY RESPONSE#0.6520;VASCULAR MORPHOGENESIS#0.6370;INTEGRIN LIGAND#0.6287;SMOOTH MUSCLE#0.6271;CHONDROGENESIS#0.6248;PROTEOGLYCAN#0.6165;EARLY BREAST CANCER#0.6067;MORPHOGENESIS#0.6021
100861412	FIBRINOGEN#0.6803
100861440	HEARING IMPAIRMENT#1.2052
100861514	MACROPHAGE#0.8452
100861540	ACETAMINOPHEN#0.6570
100861550	URINARY TRACT OBSTRUCTION#0.7890;LOWER URINARY TRACT#0.7686
100862684	GERM CELL TUMORS#0.6005
10086	TERATOCARCINOMA#0.9046
100873790	PHOTOTOXICITY#0.6383
100874009	PHENYLALANINE AMMONIA LYASE#0.8548;GENE EXPRESSION#0.7470;TRANSCRIPTION FACTOR#0.6697
100874011	COLON CANCER#1.1871
100874028	BREAST CANCER#0.8969
100874041	CELL PROLIFERATION#0.7515;PANCREATIC CARCINOMA#0.7317;CELL GROWTH#0.7305;RNA BINDING PROTEIN#0.7230;RNA BINDING#0.7205;HEPATOCELLULAR CARCINOMA#0.7147;CANCER CELL#0.7084
100874054	CELL PROLIFERATION#1.1262;CANCER CELL#1.0820;CELL CYCLE#1.0751;ONCOGENIC#1.0459;SQUAMOUS CELL CARCINOMA#0.8894;QUANTITATIVE REAL TIME#0.8540;AKT SIGNALING#0.8515;ESOPHAGEAL CANCER#0.8152;ENDOTHELIAL CELL#0.7981;APOPTOSIS#0.7975;SIGNALING PATHWAY#0.7967;POLYMERASE CHAIN REACTION#0.7220;DUAL LUCIFERASE REPORTER#0.6443;TUMOR TISSUES#0.6381;RNA HELICASE#0.6380;EXOSOME#0.6209
100874074	LYMPH NODE METASTASIS#1.1886;COLORECTAL CANCER#1.1841;LYMPH NODE#1.1818;COLORECTAL#0.8485
100874075	CERVICAL CANCER#0.8083;CELL MIGRATION#0.8014;SIGNALING PATHWAY#0.7955
100874207	AKT SIGNALING#0.9079;COLORECTAL CANCER#0.9014;SIALYLATION#0.6621;COLORECTAL#0.6458
100874323	LUNG ADENOCARCINOMA#0.7216;STEM CELL#0.7096
100874345	PARATHYROID HORMONE#1.1854;OSTEOGENESIS#0.8559;OSTEOPOROSIS#0.8524;PARATHYROID#0.8500
100874366	CELL PROLIFERATION#0.9518;ANTISENSE RNA#0.7430;BREAST CANCER CELL#0.7152;BREAST CANCER#0.7099;CANCER CELL#0.7084;HEPATOCELLULAR CARCINOMA#0.6254
100874433	CELL CYCLE#1.1798
10087	GOLGI APPARATUS#1.0405;ENDOPLASMIC RETICULUM#1.0375;GOLGI MEMBRANE#0.9814;OXYSTEROL BINDING#0.9746;CONTACT SITE#0.9553;CERAMIDE TRANSPORT#0.9265;PROTEIN KINASE D#0.9224;GOLGI COMPLEX#0.9127;PROTEIN KINASE#0.9067;CHLAMYDIA#0.8022;PLASMA MEMBRANE#0.7967;ANTIGEN BINDING#0.7874;VESICULAR TRANSPORT#0.7800;HOST CELL#0.7783;TRANS GOLGI NETWORK#0.7684;BREAST CANCER#0.7435;SPHINGOSINE#0.7267;SPHINGOMYELIN SYNTHESIS#0.7055;CANCER CELL#0.7027;SPHINGOLIPID METABOLISM#0.6934;PHOSPHOINOSITIDE BINDING#0.6435;LIPID METABOLISM#0.6361;CELL DEATH#0.6323;APOPTOTIC#0.6252;T- PA#0.6186;GOLGI DISASSEMBLY#0.6183;CERAMIDE BINDING#0.6093
100885775	CELL PROLIFERATION#1.0817;CANCER CELL#1.0774;APOPTOSIS#1.0719;SIGNALING PATHWAY#1.0645;LYMPH NODE METASTASIS#1.0164;LYMPH NODE#1.0116;CELL MIGRATION#0.9924;POLYMERASE CHAIN REACTION#0.9561;COLORECTAL CANCER#0.9525;TUMOR TISSUES#0.9500;LUNG CANCER#0.9491;THYROID CANCER#0.9482;EPITHELIAL CELL#0.9389;ADJACENT NORMAL TISSUE#0.9254;CELL GROWTH#0.9057;THYROID CARCINOMA#0.8533;CELL CYCLE#0.8353;MAPK SIGNALING#0.8341;COLORECTAL#0.8272;SQUAMOUS CELL CARCINOMA#0.8264;REVERSE TRANSCRIPTION#0.7932;DIABETIC RETINOPATHY#0.7918;HEPATOCELLULAR CARCINOMA#0.7712;EPITHELIAL MESENCHYMAL TRANSITION#0.7155;PIGMENT EPITHELIAL CELL#0.7128;RETINAL PIGMENT EPITHELIAL#0.7108;ONCOGENIC#0.7108;PAPILLARY THYROID CARCINOMA#0.7029;TUMOR SUPPRESSOR#0.6694;RETINAL PIGMENT EPITHELIAL CELLS#0.6339;CELL CYCLE ARREST#0.6290;RETINOBLASTOMA#0.6214;BREAST CANCER#0.6129
100885779	CANCER CELL#1.0906;CELL PROLIFERATION#1.0775;STEM CELL#1.0757;BREAST CANCER#1.0621;APOPTOSIS#1.0469;PANCREATIC CANCER#1.0221;LYMPH NODE#1.0087;SIGNALING PATHWAY#1.0081;EPITHELIAL MESENCHYMAL TRANSITION#0.9886;POLYMERASE CHAIN REACTION#0.9828;SQUAMOUS CELL CARCINOMA#0.9583;TUMOR TISSUES#0.9422;CANCER STEM CELL#0.9422;LYMPH NODE METASTASIS#0.9258;LUNG CANCER#0.9136;BREAST CANCER CELL#0.9042;QUANTITATIVE REAL TIME#0.9032;EMBRYONIC STEM CELL#0.8974;EPITHELIAL TO MESENCHYMAL#0.8717;HYPOXIA#0.8645;PLURIPOTENT STEM CELL#0.8470;DUAL LUCIFERASE REPORTER#0.8279;EPITHELIAL TO MESENCHYMAL TRANSITION#0.8268;TRANSCRIPTION FACTOR#0.8250;COLORECTAL CANCER#0.8175;INDUCED PLURIPOTENT STEM CELL#0.8083;COLON CANCER#0.7737;OVARIAN CANCER#0.7728;TUMOR CELLS#0.7229;ADJACENT NORMAL TISSUE#0.7143;HEPATOCELLULAR CARCINOMA#0.7067;REVERSE TRANSCRIPTION#0.7051;GENE EXPRESSION#0.6996;OVARIAN#0.6947;CELL MIGRATION#0.6645;COLORECTAL#0.6496;EXOSOME#0.6476;NEGATIVE CONTROL GROUP#0.6262;DISEASE FREE SURVIVAL#0.6246;EXTRACELLULAR VESICLE#0.6163;RNA INTERFERENCE#0.6116;DNA REPAIR#0.6103
100885789	T CELL#1.0743;TH1 CELL#0.7859;TRANSCRIPTION FACTOR#0.6752;IMMUNE RESPONSE#0.6139
100886964	THYROID CARCINOMA#1.0987;PAPILLARY THYROID CARCINOMA#1.0886;CANCER CELL#1.0512;CELL PROLIFERATION#1.0452;THYROID CANCER#1.0278;TUMOR SUPPRESSOR#0.8589;TUMOR TISSUES#0.8348;CELL CYCLE#0.7291;STEM CELL#0.6406;CERVICAL#0.6333;PERIODONTAL LIGAMENT STEM CELL#0.6274;APOPTOSIS#0.6266;ANAPLASTIC THYROID CANCER#0.6230;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.6145;PERIODONTAL LIGAMENT#0.6056
100887755	CELL MIGRATION#0.7773;EPITHELIAL MESENCHYMAL TRANSITION#0.7069;HEPATOMA CELLS#0.6586;COLORECTAL CANCER#0.6487
10089	POTASSIUM CHANNEL#0.8996;ION CHANNEL#0.8088;SPINAL CORD#0.7927;ANESTHETIC#0.7901;GENE EXPRESSION#0.6698;EPITHELIAL CELL#0.6646;PROTEIN KINASE#0.6447
1008	CELL ADHESION#0.8013;NERVOUS SYSTEM#0.7375;PROSTATE CANCER#0.6336
10090	SULFATION#0.8121;CELL MIGRATION#0.6676;ACETYLGALACTOSAMINE-4-SULFATE#0.6114
10092	ACTIN RELATED PROTEIN#1.0468;ACTIN CYTOSKELETON#0.6221
10093	ACTIN RELATED PROTEIN#1.0460;ACTIN CYTOSKELETON#0.8373;ACTIN FILAMENT#0.7528;CELL MIGRATION#0.7162;CANCER CELL#0.7129
10094	ACTIN RELATED PROTEIN#0.9774;ACTIN NUCLEATION#0.7756;ACTIN FILAMENT#0.7057;ACTIN CYTOSKELETON#0.7023;PROTEIN COMPLEX#0.6771;COMPLEX I#0.6594;ACTIN POLYMERIZATION#0.6082
10095	ACTIN RELATED PROTEIN#0.9234;T CELL#0.8201;ACTIN FILAMENT#0.7409;ACTIN POLYMERIZATION#0.6939;CD8+ T CELL#0.6286
10096	ACTIN FILAMENT NUCLEATION#1.0654;WAVE COMPLEX#1.0454;F-ACTIN BINDING#1.0399;LAMELLIPODIUM#1.0291;PROTEIN COMPLEX#1.0256;ACTIN NUCLEATION#1.0252;ACTIN RELATED PROTEIN#1.0240;WISKOTT ALDRICH SYNDROME#1.0214;COMPLEX I#1.0210;ACTIN POLYMERIZATION#1.0064;ACTIN FILAMENT#1.0049;ACTIN FILAMENT BUNDLE#0.9981;SIGNALING PATHWAY#0.9981;SCAR COMPLEX#0.9980;WAVE REGULATORY COMPLEX#0.9971;ACTIN BINDING PROTEIN#0.9941;MORPHOGENESIS#0.9923;ACTIN BINDING#0.9922;ENDOCYTOSIS#0.9912;PODOSOME#0.9885;MICROTUBULE#0.9875;CYTOKINESIS#0.9866;FILAMENTOUS ACTIN#0.9864;OOCYTE#0.9856;HOST CELL#0.9856;CELL MOTILITY#0.9847;PHAGOCYTOSIS#0.9821;CANCER CELL#0.9816;GROWTH FACTOR#0.9815;PLASMA MEMBRANE#0.9808;CELL MIGRATION#0.9790;ACTIN CYTOSKELETON#0.9775;FOCAL ADHESION#0.9773;ACTIN FILAMENT BRANCHING#0.9759;T CELL#0.9740;CELL MORPHOGENESIS#0.9687;CELL ADHESION#0.9670;CELL POLARITY#0.9655;DENDRITIC SPINE#0.9639;CELL SURFACE#0.9637;CYTOPLASM#0.9637;ATP BINDING#0.9622;EPITHELIAL CELL#0.9604;ENDOTHELIAL CELL#0.9569;SMOOTH MUSCLE#0.9511;EXTRACELLULAR MATRIX#0.9498;EPIDERMAL GROWTH FACTOR#0.9477;GROWTH CONE#0.9414;NUCLEOTIDE BINDING#0.9413;PROTEIN KINASE#0.9303;RUFFLE#0.9220;GENE EXPRESSION#0.9206;ACTIN PATCH#0.9199;FILOPODIA FORMATION#0.9158;MACROPHAGE#0.9103;RNA INTERFERENCE#0.9060;ENDOSOME#0.9048;CELL PERIPHERY#0.9002;CELL MOVEMENT#0.8988;CELL MEMBRANE#0.8970;ACTIN DEPOLYMERIZING FACTOR#0.8940;CLATHRIN-MEDIATED ENDOCYTOSIS#0.8917;CELL DIVISION#0.8912;GROWTH FACTOR RECEPTOR#0.8851;GOLGI MEMBRANE#0.8756;ATP HYDROLYSIS#0.8737;MYOBLAST FUSION#0.8720;MICROFILAMENT#0.8715;CELL CORTEX#0.8699;STRESS FIBER#0.8684;MEMBRANE RUFFLING#0.8671;CELL CYCLE#0.8650;ACTOMYOSIN#0.8616;WASP INTERACTING PROTEIN#0.8583;MEMBRANE RUFFLE#0.8536;ORGANELLE#0.8532;VACCINIA#0.8504;CELL JUNCTION#0.8502;LAMELLIPODIUM FORMATION#0.8497;BREAST CANCER#0.8490;SIGNAL TRANSDUCTION#0.8488;STEM CELL#0.8452;TOTAL INTERNAL REFLECTION#0.8375;CHEMOTAXIS#0.8365;AXON DEVELOPMENT#0.8347;LOCOMOTION#0.8299;MYOBLAST#0.8219;CELL ACTIVATION#0.8215;CELL LEADING EDGE#0.8200;NEUTROPHIL#0.8187;CELL GROWTH#0.8081;NERVOUS SYSTEM#0.8058;SIGNALING CASCADE#0.8018;VASODILATOR#0.8014;SERTOLI CELL#0.7992;ENDOCYTIC VESICLE#0.7977;ACTIN BUNDLING#0.7931;BUDDING#0.7920;APICAL ES#0.7871;ADHERENS JUNCTION#0.7841;INVADOPODIUM FORMATION#0.7832;CELL LOCOMOTION#0.7796;VESICLE TRAFFICKING#0.7726;ACTIN CABLE#0.7673;PHAGOCYTIC CUP#0.7646;MUSCLE CELL#0.7635;ACTIN CAP#0.7598;INVADOPODIUM#0.7587;SIGNALLING PATHWAY#0.7549;WASH COMPLEX#0.7548;ACTIN MONOMER BINDING#0.7526;ACTIN FILAMENT BINDING#0.7485;PHAGOSOME#0.7454;C TERMINAL DOMAIN#0.7425;FILOPODIUM FORMATION#0.7377;MEIOSIS#0.7278;DOMINANT NEGATIVE MUTANT#0.7219;CELL CELL ADHESION#0.7157;P21 ACTIVATED KINASE#0.7116;MOLECULAR DYNAMICS SIMULATION#0.7060;SRC FAMILY KINASE#0.7060;FOCAL ADHESION KINASE#0.7047;MITOSIS#0.7042;RESONANCE ENERGY TRANSFER#0.7035;NEURONAL CELLS#0.7025;CORTICAL ACTIN CYTOSKELETON#0.6970;FILOPODIUM#0.6796;NEURITE#0.6777;TIGHT JUNCTION#0.6750;CELL EXPANSION#0.6746;BLOOD TESTIS BARRIER#0.6732;MICROTUBULE CYTOSKELETON#0.6713;OOCYTE MATURATION#0.6637;T CELL ACTIVATION#0.6635;MICROSPIKE FORMATION#0.6581;WOUND HEALING#0.6568;CELL BODY#0.6518;PROTEIN KINASE C#0.6480;SIGNALING MOLECULE#0.6458;KINASE ACTIVITY#0.6431;TUMOR CELLS#0.6407;IMMUNOLOGICAL SYNAPSE#0.6393;MICROVILLI#0.6363;EARLY ENDOSOME#0.6339;GUANINE#0.6329;BRUSH BORDER ASSEMBLY#0.6324;NUCLEOTIDE EXCHANGE FACTOR#0.6314;G ACTIN BINDING#0.6272;ZONULA ADHERENS#0.6211;OSTEOCLAST#0.6184;ASTROCYTE#0.6160;BASAL ES#0.6147;ACTIN CYTOSKELETON REMODELING#0.6146;ENDOPLASMIC RETICULUM#0.6135;CELL CELL JUNCTION#0.6115;NUCLEAR MIGRATION#0.6102;HOMOLOGY-DIRECTED REPAIR#0.6099;LYMPH NODE#0.6092;PSEUDOPOD#0.6084;REGULATION OF ACTIN POLYMERIZATION#0.6076;INTRACELLULAR TRANSPORT#0.6015
10097	ACTIN FILAMENT NUCLEATION#1.0661;ACTIN FILAMENT BRANCHING#1.0595;F-ACTIN BINDING#1.0436;WAVE COMPLEX#1.0422;LAMELLIPODIUM#1.0351;COMPLEX I#1.0322;PROTEIN COMPLEX#1.0321;ACTIN NUCLEATION#1.0267;PODOSOME#1.0262;ACTIN RELATED PROTEIN#1.0224;SCAR COMPLEX#1.0211;WISKOTT ALDRICH SYNDROME#1.0204;OOCYTE#1.0154;ACTIN POLYMERIZATION#1.0080;ACTIN FILAMENT#1.0056;FILOPODIA FORMATION#1.0020;SIGNALING PATHWAY#0.9977;MORPHOGENESIS#0.9976;ENDOCYTOSIS#0.9975;FILAMENTOUS ACTIN#0.9972;FOCAL ADHESION#0.9961;ACTIN BINDING#0.9925;ACTIN PATCH#0.9921;GROWTH CONE#0.9914;ACTIN BINDING PROTEIN#0.9914;MICROTUBULE#0.9912;CANCER CELL#0.9901;T CELL#0.9891;GROWTH FACTOR#0.9885;HOST CELL#0.9838;CELL MOTILITY#0.9807;CYTOKINESIS#0.9807;CELL MORPHOGENESIS#0.9790;PLASMA MEMBRANE#0.9784;CELL MIGRATION#0.9784;CELL ADHESION#0.9773;RUFFLE#0.9765;DENDRITIC SPINE#0.9764;STRESS FIBER#0.9727;ACTIN CYTOSKELETON#0.9704;ENDOTHELIAL CELL#0.9693;CELL SURFACE#0.9690;CYTOPLASM#0.9675;PHAGOCYTOSIS#0.9631;EPITHELIAL CELL#0.9625;EXTRACELLULAR MATRIX#0.9611;VACCINIA#0.9554;EPIDERMAL GROWTH FACTOR#0.9545;CLATHRIN-MEDIATED ENDOCYTOSIS#0.9539;CELL POLARITY#0.9523;RNA INTERFERENCE#0.9509;ATP HYDROLYSIS#0.9474;ATP BINDING#0.9469;ACTOMYOSIN#0.9444;MACROPHAGE#0.9398;MEMBRANE RUFFLE#0.9371;MEMBRANE RUFFLING#0.9339;LOCOMOTION#0.9326;CELL DIVISION#0.9310;ACTIN CABLE#0.9271;TOTAL INTERNAL REFLECTION#0.9240;SMOOTH MUSCLE#0.9236;ACTIN FILAMENT BUNDLE#0.9136;CELL LOCOMOTION#0.9132;ADHERENS JUNCTION#0.9126;CELL CORTEX#0.9122;ENDOSOME#0.9119;LAMELLIPODIUM FORMATION#0.9098;CELL PERIPHERY#0.9074;CELL MEMBRANE#0.9040;ORGANELLE#0.9015;WAVE REGULATORY COMPLEX#0.8999;ACTIN DEPOLYMERIZING FACTOR#0.8932;VESICLE TRAFFICKING#0.8925;SIGNAL TRANSDUCTION#0.8860;CELL MOVEMENT#0.8803;MUSCLE CELL#0.8792;CELL JUNCTION#0.8749;WASH COMPLEX#0.8714;ACTIN CYTOSKELETON REMODELING#0.8713;MYOBLAST FUSION#0.8712;GENE EXPRESSION#0.8662;BUDDING#0.8639;SIGNALLING PATHWAY#0.8598;STEM CELL#0.8555;MICROFILAMENT#0.8545;CORTICAL ACTIN CYTOSKELETON#0.8506;ACTIN MONOMER BINDING#0.8500;MYOBLAST#0.8412;NEUTROPHIL#0.8367;AXON DEVELOPMENT#0.8335;SIGNALING CASCADE#0.8259;NUCLEOTIDE BINDING#0.8212;C TERMINAL DOMAIN#0.8207;GROWTH FACTOR RECEPTOR#0.8195;MITOSIS#0.8191;NUCLEAR MIGRATION#0.8182;CENTROSOME#0.8125;BREAST CANCER#0.8098;ENDOCYTIC VESICLE#0.8084;ACTIVIN RECEPTOR#0.8026;ACTIN CAP#0.8014;BRISTLE DEVELOPMENT#0.7967;CHEMOTAXIS#0.7966;NERVOUS SYSTEM#0.7963;OOCYTE MATURATION#0.7902;CONTRACTILE RING#0.7846;INVADOPODIUM FORMATION#0.7824;COATED PIT#0.7767;CELL LEADING EDGE#0.7732;CLATHRIN-COATED PIT#0.7645;CELL CYCLE#0.7611;PROTEIN KINASE#0.7589;INVADOPODIUM#0.7580;KINASE ACTIVITY#0.7571;MOLECULAR DYNAMICS SIMULATION#0.7547;WASP INTERACTING PROTEIN#0.7542;GOLGI MEMBRANE#0.7533;HEALTHY CONTROL GROUP#0.7484;MEIOSIS#0.7440;REGULATION OF ACTIN POLYMERIZATION#0.7428;VASODILATOR#0.7344;WOUND HEALING#0.7326;SPINE HEAD#0.7292;FILOPODIUM#0.7279;CELL CELL ADHESION#0.7278;CELL GROWTH#0.7275;MEMBRANE INVAGINATION#0.7129;OSTEOCLAST#0.7000;ZONULA ADHERENS#0.6996;ACTIN BUNDLING#0.6986;T LYMPHOCYTE#0.6957;CELL EXPANSION#0.6890;P21 ACTIVATED KINASE#0.6863;G ACTIN BINDING#0.6797;TUMOR CELLS#0.6785;ACTIN FILAMENT BINDING#0.6751;VIRULENCE#0.6710;PHAGOCYTIC CUP#0.6696;AUTOPHAGY#0.6656;AUTOPHAGOSOME#0.6652;CD4+ T CELL#0.6645;CELL CELL JUNCTION#0.6612;MICROTUBULE CYTOSKELETON#0.6592;FOCAL ADHESION KINASE#0.6535;APOPTOSIS#0.6535;LYMPH NODE#0.6535;CELL BODY#0.6511;DOMINANT NEGATIVE MUTANT#0.6497;RESONANCE ENERGY TRANSFER#0.6489;SIGNALING MOLECULE#0.6451;RECEPTOR TYROSINE KINASE#0.6435;ENDOPLASMIC RETICULUM#0.6426;SMOOTH MUSCLE CELL#0.6417;INTRACELLULAR TRANSPORT#0.6338;EARLY ENDOSOME#0.6332;CELL FUSION#0.6327;NEURITE#0.6324;AXON GUIDANCE#0.6316;BRUSH BORDER ASSEMBLY#0.6311;MUTAGENESIS#0.6306;EMBRYO DEVELOPMENT#0.6300;IMMUNOLOGICAL SYNAPSE#0.6277;NEURONAL CELLS#0.6249;MICROVILLI#0.6248;APICAL ES#0.6228;FILOPODIUM FORMATION#0.6217;NUCLEOTIDE EXCHANGE FACTOR#0.6158;PLATELET-DERIVED GROWTH FACTOR#0.6122;HOMOLOGY-DIRECTED REPAIR#0.6089;CELL PROLIFERATION#0.6070
10098	ENDOPLASMIC RETICULUM#0.6835;TROPHOBLAST#0.6220;OSTEOCLAST#0.6194
100996301	ANTISENSE RNA#0.6974;CELL PROLIFERATION#0.6831;LUNG EPITHELIAL CELL#0.6544;THYROID CANCER#0.6481;BREAST CANCER CELL#0.6403;EPITHELIAL CELL#0.6353;SIGNALING PATHWAY#0.6339
100996348	COLORECTAL CANCER#0.9014;COLORECTAL#0.6458;APOPTOSIS#0.6411
100996569	T CELL#0.7409
100996949	PYRUVATE#1.0433;PYRUVATE DEHYDROGENASE COMPLEX#1.0029;DEHYDROGENASE COMPLEX#0.9995;DNA BINDING#0.7734;VIRULENCE#0.6599;ANTHER DEVELOPMENT#0.6165
10099	FIBRONECTIN BINDING#0.6175
1009	NEURAL CREST#1.0658;MYOFIBROBLAST#1.0497;STROMAL CELL#1.0406;NEURAL CREST CELL#1.0388;SMOOTH MUSCLE#1.0362;PROSTATE CANCER#1.0357;FIBROBLAST LIKE SYNOVIOCYTES#1.0353;OSTEOBLAST#1.0326;MESENCHYMAL CELL#1.0322;AORTIC VALVE#1.0197;BREAST CANCER CELL#1.0195;TUMOR SUPPRESSOR#1.0165;SYNOVIUM#1.0161;CELL CELL ADHESION#1.0144;CELL MIGRATION#1.0115;POLYMERASE CHAIN REACTION#1.0112;BREAST CANCER#1.0107;RHEUMATOID ARTHRITIS#1.0096;SMOOTH MUSCLE ACTIN#1.0094;EPITHELIAL CELL#1.0093;CELL ADHESION MOLECULE#1.0083;CELL SURFACE#1.0070;CANCER CELL#1.0062;EPITHELIAL TO MESENCHYMAL#1.0059;MACROPHAGE#1.0039;GROWTH FACTOR#1.0006;CELL ADHESION#0.9998;TRANSFORMING GROWTH FACTOR#0.9932;STEM CELL#0.9924;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9907;EXTRACELLULAR MATRIX#0.9859;TRANSCRIPTION FACTOR#0.9843;ADHERENS JUNCTION#0.9805;CELL PROLIFERATION#0.9791;GENE EXPRESSION#0.9789;MESENCHYMAL STEM CELL#0.9630;BONE MARROW#0.9521;CELL DIFFERENTIATION#0.9498;REVERSE TRANSCRIPTION#0.9413;MUSCLE CELL#0.9365;TROPHOBLAST#0.9301;CRANIAL NEURAL CREST#0.9279;CELL-CELL ADHESION MOLECULE#0.9264;TUMOR NECROSIS FACTOR#0.9218;SMOOTH MUSCLE CELL#0.9203;MESENCHYME#0.9195;FOCAL ADHESION#0.9188;STROMA#0.9162;EPITHELIAL MESENCHYMAL TRANSITION#0.9127;AORTIC VALVE DISEASE#0.9068;MORPHOGENESIS#0.9008;SIGNALING PATHWAY#0.8974;LYMPH NODE#0.8939;ENDOMETRIUM#0.8894;CELL MOTILITY#0.8876;MENSTRUAL CYCLE#0.8853;DETRUSOR SMOOTH MUSCLE#0.8771;OSTEOBLAST DIFFERENTIATION#0.8704;GROWTH FACTOR RECEPTOR#0.8656;ALKALINE PHOSPHATASE#0.8638;PULMONARY FIBROSIS#0.8476;ESTRADIOL#0.8440;PROGENITOR CELL#0.8422;PERIPHERAL BLOOD#0.8418;RETINOBLASTOMA#0.8366;BONE FORMATION#0.8365;OSTEOARTHRITIS#0.8335;CELL JUNCTION#0.8253;INTERSTITIAL CELL#0.8230;ENDOTHELIAL CELL#0.8197;TUMOR CELLS#0.8126;CYTOTROPHOBLAST#0.8016;TROPHOBLAST CELL#0.7982;HUMAN BREAST CANCER#0.7883;PROGESTERONE#0.7812;CELL CELL JUNCTION#0.7790;ONCOGENIC#0.7777;CONNEXIN#0.7610;SYNOVITIS#0.7606;SPINAL CORD#0.7564;PLASMA MEMBRANE#0.7473;QUANTITATIVE REAL TIME#0.7471;TERMINAL DIFFERENTIATION#0.7452;APOPTOSIS#0.7380;DNA METHYLATION#0.7290;OSTEOGENESIS#0.7246;NODULE FORMATION#0.7219;CELL AGGREGATION#0.7216;PLATELET-DERIVED GROWTH FACTOR#0.7092;CELL GROWTH#0.7010;INVASIVE BREAST CANCER#0.6803;ACTIN CYTOSKELETON#0.6760;RNA INTERFERENCE#0.6743;NERVOUS SYSTEM#0.6741;CHONDROCYTE#0.6723;CANCER STEM CELL#0.6721;EMBRYONIC STEM CELL#0.6629;WOUND HEALING#0.6615;TRANSFORMING GROWTH FACTOR BETA#0.6600;PROTEIN KINASE#0.6573;TRANSCRIPTASE#0.6557;BLOOD VESSEL#0.6544;VASCULAR CELL#0.6511;ADENOCARCINOMA#0.6463;REGENERATION#0.6393;CONNECTIVE TISSUE#0.6319;SIGNALLING PATHWAY#0.6291;MYOBLAST#0.6278;CELL MEMBRANE#0.6243;ANGIOGENESIS#0.6225;FIBROBLAST GROWTH FACTOR#0.6191;KERATINOCYTE#0.6124;OVARIAN#0.6101;AKT SIGNALING#0.6076;SYSTEM DEVELOPMENT#0.6073;DERMAL FIBROBLAST#0.6040;ALKALINE PHOSPHATASE ACTIVITY#0.6030;IL-11#0.6017;PHOSPHATASE ACTIVITY#0.6004
100	ADENOSINE AMINOHYDROLASE#1.0911;ADENOSINE DEAMINASE#1.0703;ADENOSINE#1.0452;ERYTHROCYTE#1.0257;HISTONE ACETYLTRANSFERASE#1.0064;ADENINE#0.9855;DEOXYADENOSINE#0.9430;TUBERCULOSIS#0.9236;ACETYLTRANSFERASE COMPLEX#0.9212;SAGA COMPLEX#0.9110;SEVERE COMBINED IMMUNODEFICIENCY#0.8976;T CELL#0.8733;COMPLEX I#0.8282;DIABETES MELLITUS#0.8169;PLEURISY#0.8155;INTESTINAL MUCOSA#0.8088;DEOXYCOFORMYCIN#0.8029;HISTONE ACETYLTRANSFERASE COMPLEX#0.7467;LYMPHOBLAST#0.7465;TOXICITY#0.7342;INOSINE#0.7270;PULMONARY TUBERCULOSIS#0.7089;HISTONE ACETYLATION#0.7067;LYSINE#0.6901;ADENOSINE DEAMINASE DEFICIENCY#0.6824;GLUCOCORTICOID RECEPTOR#0.6743;TYPE 2 DIABETES#0.6621;PLASMA PROTEIN#0.6535;B CELL#0.6305;PYRIMIDINE METABOLISM#0.6249;IMMUNE RESPONSE#0.6149;SPUTUM#0.6039
10100	GENE EXPRESSION#0.9114;CELL MOTILITY#0.6327;MIGRAINE#0.6305;LUNG CANCER#0.6244;SMOOTH MUSCLE#0.6237;LARGE EXTRACELLULAR LOOP#0.6116
10101	NUCLEOTIDE BINDING#1.0726;NEUROBLASTOMA#1.0684;IRON SULFUR CLUSTER#0.8948;PROTEASOME#0.8737;CELL DEATH#0.7086;IRON-SULFUR CLUSTER ASSEMBLY#0.6960;VITAMIN E#0.6747;SUCCINATE#0.6130;APOPTOSIS#0.6117;CYCLIC AMP#0.6103
10102	NUCLEOTIDE EXCHANGE FACTOR#1.0643;GUANINE#1.0518;TRANSLATION ELONGATION FACTOR#1.0467;TRANSLATION ELONGATION#1.0433;RIBOSOMAL PROTEIN#1.0346;PROTEIN SYNTHESIS#1.0159;RIBOSOME#0.9994;PROTEIN SYNTHESIS ELONGATION#0.9975;MITOCHONDRIAL TRANSLATION#0.9897;MITOCHONDRIAL TRANSLATION ELONGATION#0.9528;GTP HYDROLYSIS#0.9312;NUCLEOTIDE BINDING#0.8960;GTPASE ACTIVITY#0.8706;COMPLEX I#0.8492;GUANOSINE#0.7720;TRANSLATIONAL ELONGATION#0.7361;PROTEIN BIOSYNTHESIS#0.7226;RNA REPLICATION#0.6987;MITOCHONDRIA#0.6561;CHLOROPLAST#0.6470;TRNA BINDING#0.6219;RENATURATION#0.6068;RIBOSOMAL SUBUNIT#0.6040
10103	CANCER CELL#1.0533;CELL SURFACE#1.0178;CELL MIGRATION#0.9906;GENE EXPRESSION#0.9198;CELL CYCLE#0.9041;PANCREATIC CANCER#0.8992;CELL PROLIFERATION#0.8940;CELL MOTILITY#0.8180;APOPTOSIS#0.8030;PLASMA MEMBRANE#0.7831;EPITHELIAL CELL#0.7830;PULMONARY FIBROSIS#0.7495;POLYMERASE CHAIN REACTION#0.7304;SQUAMOUS CELL CARCINOMA#0.7029;REVERSE TRANSCRIPTION#0.6851;ADENOCARCINOMA#0.6781;CELL ADHESION#0.6723;T CELL#0.6689;SIGNAL TRANSDUCTION#0.6602;LYMPH NODE#0.6601;WOUND HEALING#0.6437;COLON CANCER#0.6198;PROSTATE CANCER#0.6178;HUMAN PANCREATIC CANCER#0.6175;ALVEOLAR EPITHELIAL CELL#0.6170;EPITHELIAL TO MESENCHYMAL TRANSITION#0.6123;EPITHELIAL TO MESENCHYMAL#0.6121;LEUKOCYTE#0.6060;HEPATOCELLULAR CARCINOMA#0.6042
101054525	CONN'S SYNDROME#0.6095
10105	ADENINE NUCLEOTIDE TRANSLOCASE#1.0618;ANION CHANNEL#1.0541;CYCLOPHILIN#1.0471;CYCLOSPORINE#1.0388;ADENINE#1.0376;MITOCHONDRIAL MATRIX#1.0376;CYCLOSPORIN A#1.0182;CYCLOSPORIN#1.0172;ATP SYNTHASE#1.0166;SKELETAL MUSCLE#1.0133;CANCER CELL#1.0113;CYTOCHROME C#1.0055;MITOCHONDRIAL MEMBRANE POTENTIAL#1.0026;CELL DEATH#1.0015;MITOCHONDRIAL PERMEABILITY TRANSITION#0.9984;PERMEABILITY TRANSITION PORE#0.9976;ISCHEMIA#0.9969;APOPTOTIC#0.9949;APOPTOSIS#0.9948;MITOCHONDRIAL MEMBRANE#0.9945;REACTIVE OXYGEN SPECIES#0.9851;MITOCHONDRIA#0.9843;SWELLING#0.9840;ISCHEMIA REPERFUSION INJURY#0.9816;INNER MITOCHONDRIAL MEMBRANE#0.9780;ISOMERASE ACTIVITY#0.9728;CARDIOMYOCYTE#0.9702;NECROTIC#0.9664;NECROPTOSIS#0.9567;ALZHEIMER'S DISEASE#0.9468;NECROTIC CELL DEATH#0.9383;PHOSPHATE CARRIER#0.9326;GENE EXPRESSION#0.9161;CYTOCHROME C RELEASE#0.9093;PROGRAMMED NECROSIS#0.8819;MITOCHONDRIAL INNER MEMBRANE#0.8787;MITOCHONDRIAL DEPOLARIZATION#0.8735;CYTOTOXICITY#0.8718;PANCREATIC CANCER#0.8452;SIGNALING PATHWAY#0.8401;OUTER MEMBRANE#0.8397;CIS-TRANS ISOMERASE ACTIVITY#0.8333;RESPIRATION#0.8273;GLUTATHIONE#0.8140;PROTEIN KINASE#0.8101;COMPLEX I#0.8072;MITOCHONDRIAL MEMBRANE PERMEABILITY#0.7902;TOXICITY#0.7635;PPIASE ACTIVITY#0.7634;T CELL#0.7530;CALCINEURIN#0.7297;LUNG CANCER#0.7251;APOPTOTIC CELL DEATH#0.7249;OXYGEN GLUCOSE DEPRIVATION#0.7232;SUPEROXIDE DISMUTASE#0.7142;AUTOPHAGY#0.7097;GLYCOGEN SYNTHASE KINASE#0.7089;PROGRAMMED CELL DEATH#0.7070;MITOCHONDRIAL DAMAGE#0.6989;ARTERY#0.6887;HIGH FAT DIET#0.6760;CEREBRAL ISCHEMIA#0.6744;MYOCYTES#0.6734;MITOCHONDRIAL MEMBRANE PERMEABILITY TRANSITION#0.6691;REGULATED NECROSIS#0.6633;MEMBRANE PERMEABILITY TRANSITION#0.6620;OXIDATIVE PHOSPHORYLATION#0.6537;SIGNAL TRANSDUCTION#0.6492;MYOCARDIAL INFARCTION#0.6487;TRANSCRIPTION FACTOR#0.6469;MYOCARDIAL INFARCT SIZE#0.6447;MYOCARDIUM#0.6384;ROS GENERATION#0.6359;MUSCULAR DYSTROPHY#0.6336;COMPOUND 19#0.6282;ETHANOL#0.6248;NEUROTOXICITY#0.6159;MITOCHONDRION#0.6120;KREBS CYCLE#0.6085;MITOCHONDRIAL TRANSCRIPTION#0.6027
101060264	TUMOR TISSUES#0.6790;HEPATOCELLULAR CARCINOMA#0.6737;ANTISENSE RNA#0.6105;APOPTOSIS#0.6095;QUANTITATIVE REAL TIME#0.6012
10106	STEROL CARRIER PROTEIN#1.0606;C TERMINAL DOMAIN#0.7881;CELL CYCLE#0.6750;GENE EXPRESSION#0.6466;PLASMA MEMBRANE#0.6459;PHOSPHATASE ACTIVITY#0.6328
10107	TRANSCRIPTION FACTOR#0.9327;GENE EXPRESSION#0.8272;ERYTHROID CELL#0.6267;TERMINAL DIFFERENTIATION#0.6172
10109	ACTIN RELATED PROTEIN#1.0797;BREAST CANCER#0.9231;CANCER CELL#0.9045;CELL MIGRATION#0.8079;ACTIN FILAMENT#0.7638;CELL GROWTH#0.7535;ACTIN NUCLEATION#0.7248;ACTIN CYTOSKELETON#0.7027;ACTIN POLYMERIZATION#0.6887;COMPLEX I#0.6579;ACTIN BINDING#0.6551;REGULATORY LIGHT CHAIN#0.6415;MUSCLE CELL#0.6288;SMOOTH MUSCLE#0.6277;WISKOTT ALDRICH SYNDROME#0.6236;SMOOTH MUSCLE CELL#0.6126
1010	CELL ADHESION#0.7994;COLORECTAL CANCER#0.7692;NERVOUS SYSTEM#0.6894;CENTRAL NERVOUS SYSTEM#0.6609;CANCER CELL#0.6593;COLORECTAL#0.6579;ADENOID CYSTIC CARCINOMA#0.6497;TUBE FORMATION#0.6397;COLORECTAL CARCINOMA#0.6389
101101692	TROPHOBLAST#0.8549
10110	OOCYTE#0.9039;PROTEIN KINASE#0.8623;PROTEIN KINASE B#0.8288
10111	RAD50 COMPLEX#1.0972;DNA REPAIR COMPLEX#1.0881;MRX COMPLEX#1.0693;PROTEIN COMPLEX#1.0442;ATP BINDING#1.0384;MRE11 COMPLEX#1.0365;MRN COMPLEX#1.0351;DNA LIGASE#1.0285;ATP HYDROLYSIS#1.0252;RECOMBINATIONAL REPAIR#1.0221;TELOMERE MAINTENANCE#1.0207;DNA REPAIR PROTEIN#1.0127;COMPLEX I#1.0105;S-PHASE CHECKPOINT#1.0046;TELOMERE#1.0041;DOUBLE-STRAND BREAK REPAIR#1.0028;REPLICATION PROTEIN A#1.0026;DNA DAMAGE CHECKPOINT#0.9992;NUCLEASE ACTIVITY#0.9982;MISMATCH REPAIR#0.9963;ATAXIA TELANGIECTASIA MUTATED#0.9960;HOMOLOGOUS RECOMBINATION REPAIR#0.9959;DNA BINDING#0.9946;NIJMEGEN BREAKAGE SYNDROME#0.9931;REPLICATION FORK#0.9921;CELL CYCLE CHECKPOINT#0.9920;BREAST CANCER#0.9904;MEIOSIS#0.9897;OVARIAN CANCER#0.9865;BUDDING#0.9850;DNA REPAIR#0.9848;S PHASE#0.9845;TOPOISOMERASE#0.9841;PROTEIN KINASE#0.9836;EXONUCLEASE ACTIVITY#0.9827;ATAXIA TELANGIECTASIA#0.9826;CELL CYCLE ARREST#0.9818;COLORECTAL#0.9814;DOUBLE STRAND BREAK#0.9810;CELLULAR DNA DAMAGE RESPONSE#0.9807;CHROMATID#0.9806;COLORECTAL CANCER#0.9805;DNA DAMAGE RESPONSE#0.9787;HOMOLOGOUS RECOMBINATION#0.9783;TUMOR SUPPRESSOR#0.9779;KINASE ACTIVITY#0.9766;DNA REPLICATION#0.9722;OVARIAN#0.9717;CELL CYCLE#0.9716;CANCER CELL#0.9704;APOPTOSIS#0.9703;MITOTIC RECOMBINATION#0.9690;GENE EXPRESSION#0.9688;SIGNALING PATHWAY#0.9674;ATPASE ACTIVITY#0.9650;GENE CONVERSION#0.9621;CELL DEATH#0.9593;TRANSCRIPTION FACTOR#0.9587;DNA SYNTHESIS#0.9545;GENOTOXIC#0.9520;HYPERSENSITIVITY#0.9486;ENDONUCLEASE ACTIVITY#0.9481;CISPLATIN#0.9460;POLY ADP RIBOSE#0.9388;DNA HELICASE#0.9346;CELL CYCLE CONTROL#0.9298;RESPONSE TO IONIZING RADIATION#0.9257;VIRAL REPLICATION#0.9253;ADENYLATE KINASE#0.9251;VIRAL DNA REPLICATION#0.9177;TUMOR CELLS#0.9163;FANCONI ANEMIA#0.9137;MITOSIS#0.9120;ATP BINDING CASSETTE#0.9110;NUCLEOTIDE EXCISION REPAIR#0.9089;V-D-J RECOMBINATION#0.9067;CYTOTOXICITY#0.9023;TELOMERASE ACTIVITY#0.9004;RIBOSE#0.8998;HEREDITARY BREAST CANCER#0.8980;T CELL#0.8979;C TERMINAL DOMAIN#0.8971;G2 PHASE#0.8950;CELL PROLIFERATION#0.8911;PERIPHERAL BLOOD#0.8825;PROPHASE#0.8825;SENESCENCE#0.8783;BASE EXCISION REPAIR#0.8753;CHROMATIN REMODELING#0.8748;CAMPTOTHECIN#0.8655;SYNAPTONEMAL COMPLEX#0.8645;POLYMERASE CHAIN REACTION#0.8640;APOPTOTIC#0.8633;GENETIC DISORDER#0.8606;STEM CELL#0.8589;VIRAL GENOME#0.8537;BREAST CANCER PATIENTS#0.8482;LUNG CANCER#0.8482;UBIQUITIN#0.8461;GERM CELL#0.8404;SINGLE STRAND ANNEALING#0.8375;CYTOPLASM#0.8365;DNA RECOMBINATION#0.8363;SYNAPSIS#0.8322;B CELL#0.8301;CELL DIVISION#0.8291;DNA UNWINDING#0.8277;PROSTATE CANCER#0.8248;CYCLIN DEPENDENT KINASE#0.8239;ANEMIA#0.8217;CELL GROWTH#0.8111;NUCLEOTIDE BINDING#0.8086;BREAST CANCER CELL#0.8075;DNA METHYLATION#0.8060;ADENYLATE#0.8024;MUTAGENESIS#0.8017;MEIOTIC CHROMOSOME#0.7952;ADENYLATE KINASE ACTIVITY#0.7947;TH2 CELL#0.7943;TELOMERE CAPPING#0.7922;ONCOGENIC#0.7894;SPORULATION#0.7840;PROTEIN PROTEIN INTERACTION#0.7826;HOMOLOGY-DIRECTED REPAIR#0.7774;FAMILIAL BREAST CANCER#0.7742;POST-TRANSLATIONAL MODIFICATION#0.7652;CHROMOSOME SEGREGATION#0.7587;ABC TRANSPORTER#0.7586;CELL CYCLE REGULATION#0.7571;DNASE I#0.7457;MICROCEPHALY#0.7430;ARGININE#0.7412;BONE MARROW#0.7392;M PHASE#0.7336;NUCLEOTIDE BINDING DOMAIN#0.7232;HISTONE DEACETYLASE#0.7217;TUMOR TISSUES#0.7176;EPITHELIAL CELL#0.7168;REACTIVE OXYGEN SPECIES#0.7102;SIGNAL TRANSDUCTION#0.7057;ATPASE COMPLEX#0.7041;DNA TOPOISOMERASE#0.7039;MITOMYCIN C#0.7037;GROWTH FACTOR#0.7022;RNA INTERFERENCE#0.6973;CLASS SWITCH RECOMBINATION#0.6937;BREAST CARCINOMA#0.6921;HYDROXYUREA#0.6881;DNASE#0.6872;CELL KILLING#0.6861;DNA METABOLISM#0.6854;SISTER CHROMATID COHESION#0.6847;PROLIFERATING CELL NUCLEAR ANTIGEN#0.6845;TOXICITY#0.6823;HEMATOPOIETIC CELL#0.6821;PROTEASOME#0.6817;SINGLE-STRANDED DNA BINDING#0.6814;LYSINE#0.6809;HOMOLOGOUS RECOMBINATIONAL REPAIR#0.6759;MAINTENANCE OF GENOME INTEGRITY#0.6742;NUCLEOSOME#0.6726;CYSTIC FIBROSIS#0.6724;ETOPOSIDE#0.6721;SSDNA BINDING#0.6710;KINASE INHIBITOR#0.6690;SINGLE STRAND BREAK#0.6652;TELOMERE BINDING#0.6621;HEAD AND NECK CANCER#0.6578;AXIAL ELEMENT#0.6577;NECK CANCER#0.6577;IMMUNE RESPONSE#0.6569;IONIZING RADIATION-INDUCED FOCI#0.6540;BINDING PROTEIN 1#0.6455;CHROMOSOME BREAKAGE#0.6454;DNA METABOLIC#0.6437;ENDOTHELIAL CELL#0.6426;5'-EXONUCLEASE ACTIVITY#0.6348;SYNAPTONEMAL COMPLEX FORMATION#0.6287;SIGNALING CASCADE#0.6255;DNA FRAGMENTATION#0.6247;DNA REPAIR ENZYME#0.6223;DISEASE FREE SURVIVAL#0.6220;SUMOYLATION#0.6219;DNA END BINDING#0.6141;ENDOPLASMIC RETICULUM#0.6112;DNA INTEGRATION#0.6062
10112	CENTRAL SPINDLE#1.1054;PANCREATIC CANCER#1.0825;KINESIN#1.0645;CANCER CELL#1.0614;CYTOKINESIS#1.0547;CELL PROLIFERATION#1.0240;MICROTUBULE#1.0146;CELL CYCLE#1.0124;ANAPHASE#0.9659;GENE EXPRESSION#0.9500;CELL DIVISION#0.9415;MITOSIS#0.9411;APOPTOSIS#0.8967;BREAST CANCER#0.8820;T CELL#0.8630;HEPATOCELLULAR CARCINOMA#0.8465;ADVANCED PANCREATIC CANCER#0.8257;SIGNALING PATHWAY#0.8225;SPINDLE MIDZONE#0.8173;MITOTIC SPINDLE#0.8148;SPINDLE ORGANIZATION#0.8088;FURROW#0.7776;CENTROMERE#0.7414;EPITHELIAL CELL#0.7173;PROTEIN PROTEIN INTERACTION#0.7166;SPINDLE ASSEMBLY#0.7137;OVARIAN#0.7017;CERVICAL CANCER#0.6919;LYMPH NODE METASTASIS#0.6900;CLEAVAGE FURROW#0.6897;METAPHASE#0.6866;LUNG CANCER#0.6856;LYMPH NODE#0.6852;MIDBODY#0.6818;GROWTH FACTOR#0.6799;GENE EXPRESSION OMNIBUS#0.6663;SPINDLE FORMATION#0.6519;GENISTEIN#0.6450;OOCYTE#0.6394;PERIPHERAL BLOOD#0.6338;CHROMOSOMAL PASSENGER COMPLEX#0.6251;CELL CORTEX#0.6201;DISEASE FREE SURVIVAL#0.6200;OVARIAN CANCER#0.6178;OOCYTE MATURATION#0.6151;RECURRENCE FREE SURVIVAL#0.6081;PROGENITOR CELL#0.6023;SQUAMOUS CELL CARCINOMA#0.6022
10113	NUCLEOTIDE EXCHANGE FACTOR#1.0433;GUANINE#1.0218;ER EXIT#1.0143;ENDOPLASMIC RETICULUM#1.0066;ER EXIT SITE#0.9764;TRANSPORT VESICLE#0.9548;BUDDING#0.9476;TRANSCRIPTION FACTOR#0.9181;VESICLE BUDDING#0.9119;ER MEMBRANE#0.8883;GOLGI APPARATUS#0.8818;PROTEIN TRANSPORT#0.8718;COPII VESICLE#0.8589;GENE EXPRESSION#0.8541;VESICLE FORMATION#0.8463;RESPONSE TO GLUCOSE#0.7925;GTP BINDING#0.7857;ADRENAL GLAND#0.7824;ADIPOSE TISSUE#0.7736;SECRETORY PATHWAY#0.7507;ER TO GOLGI TRANSPORT#0.6914;ADENOSINE 5'-MONOPHOSPHATE#0.6365;PROTEIN COMPLEX#0.6343;TRANSITIONAL ER#0.6284;BETA CELL#0.6143;PLASMA MEMBRANE#0.6124
10114	PROTEIN KINASE#1.0387;CELL CYCLE#0.9490;APOPTOSIS#0.9443;CELL PROLIFERATION#0.9240;TRANSCRIPTION FACTOR#0.9239;SIGNALING PATHWAY#0.9176;KINASE ACTIVITY#0.9017;GENE EXPRESSION#0.8847;LUNG CANCER#0.8567;CELL GROWTH#0.8254;CANCER CELL#0.8213;JUN PHOSPHORYLATION#0.7988;PROTEIN KINASE A#0.7783;INSULIN SECRETION#0.7689;EPITHELIAL CELL#0.6080;POLYMERASE CHAIN REACTION#0.6075;CELL DEATH#0.6066;AMILORIDE#0.6060;TYPE 2 DIABETES#0.6026;QUANTITATIVE REAL TIME#0.6010
101154753	CELL PROLIFERATION#1.0431;APOPTOSIS#1.0360;COLORECTAL CANCER#1.0252;CANCER CELL#0.9724;CELL CYCLE#0.9425;TRANSCRIPTION FACTOR#0.9363;COLORECTAL#0.9220;POLYMERASE CHAIN REACTION#0.9130;SIROLIMUS ELUTING STENT#0.9114;LYMPH NODE#0.8662;RIBOSOMAL PROTEIN#0.8440;BREAST CANCER#0.8377;SERTRALINE#0.8300;GENE REGULATORY NETWORK#0.8293;QUANTITATIVE REAL TIME#0.8167;PERIPHERAL BLOOD#0.8112;LYMPH NODE METASTASIS#0.8026;GENE EXPRESSION#0.7788;CELL GROWTH#0.7709;SENESCENCE#0.7684;ONCOGENIC#0.7584;EPITHELIAL MESENCHYMAL TRANSITION#0.7438;SIROLIMUS#0.7435;HEPATOCELLULAR CARCINOMA#0.7399;RANDOMISED CONTROLLED TRIAL#0.6803;ADJACENT NORMAL TISSUE#0.6793;TUMOR SUPPRESSOR#0.6732;PROTEIN KINASE C#0.6495;PROTEIN KINASE#0.6461;RENAL CELL CARCINOMA#0.6286;LUNG CANCER#0.6244;MYOCARDIAL INFARCTION#0.6207;DEPRESSIVE SYMPTOMS#0.6140;TUMOR TISSUES#0.6091;SIGNALING PATHWAY#0.6007
10116	APOPTOSIS#0.9939;SEX DETERMINATION#0.9493;CANCER CELL#0.8863;INSULIN SECRETION#0.8093;COLON CANCER#0.8078;APOPTOTIC#0.8071;UBIQUITIN#0.7062;GENE EXPRESSION#0.6385
10117	AMELOGENESIS IMPERFECTA#1.0256;AUTOIMMUNE HEPATITIS#1.0223;AMELOGENESIS#1.0116;ENAMEL FORMATION#1.0112;TOOTH DEVELOPMENT#1.0032;MINERALIZATION#0.9915;EXTRACELLULAR MATRIX#0.9893;SMOOTH MUSCLE#0.9884;MOLAR#0.9870;HEPATITIS C#0.9748;GENE EXPRESSION#0.9727;ENAMEL ORGAN#0.9613;ENAMEL DEVELOPMENT#0.9504;INCISORS#0.9387;POLYMERASE CHAIN REACTION#0.9265;LIVER DISEASE#0.9114;ENAMEL MINERALIZATION#0.8927;T CELL#0.8863;CHRONIC HEPATITIS C#0.8755;CYTOCHROME P450#0.8701;EPITHELIAL CELL#0.8551;DENTAL CARIES#0.8455;TRANSCRIPTION FACTOR#0.8394;BIOMINERALIZATION#0.8285;IMMUNE RESPONSE#0.7873;SCANNING ELECTRON MICROSCOPY#0.7562;TRANSLATION INITIATION#0.7478;ODONTOGENESIS#0.7425;HEPATITIS C VIRUS#0.7251;CD8+ T CELL#0.7251;SCLEROSING CHOLANGITIS#0.7183;MANDIBLE#0.6939;DYNAMIC LIGHT SCATTERING#0.6841;CELL PROLIFERATION#0.6789;MICROSOME#0.6706;MORPHOGENESIS#0.6512;ALKALINE PHOSPHATASE#0.6324;DENTIN MATRIX PROTEIN#0.6076;HUMAN LEUKOCYTE ANTIGEN#0.6043
101180900	SCHWANN CELL#0.9012;MYELINATION#0.6076
101180976	CHRONIC HEPATITIS C#1.0314;RIBAVIRIN#1.0287;HEPATITIS C#1.0200;HEPATITIS C VIRUS#1.0090;GENE EXPRESSION#1.0041;INTERFERON STIMULATED GENE#0.9583;HEPATITIS B#0.9549;SUSTAINED VIROLOGICAL RESPONSE#0.9480;LIVER DISEASE#0.8669;SUSTAINED VIROLOGIC RESPONSE#0.8587;HEPATITIS B VIRUS#0.7632;IMMUNE RESPONSE#0.7208;T CELL#0.6963;PERIPHERAL BLOOD#0.6690;CHRONIC HEPATITIS B#0.6362;INNATE IMMUNITY#0.6061
10121	ACTIN RELATED PROTEIN#1.0851;DYNACTIN COMPLEX#1.0716;DYNEIN#1.0439;MICROTUBULE#1.0161;SPECTRIN#0.8925;CENTROSOME#0.8914;NUCLEAR MIGRATION#0.7004;MICROTUBULE BASED#0.6829;CHAPERONIN#0.6579;MITOTIC SPINDLE#0.6545;COMPLEX I#0.6383;ORGANELLE#0.6062;MICROTUBULE END#0.6007
101234261	CELL PROLIFERATION#1.0097;OVARIAN CANCER#0.9609;CANCER CELL#0.8641;ONCOGENIC#0.8339;SIGNALING PATHWAY#0.7995;OVARIAN#0.7892;CELL MIGRATION#0.6645;BREAST CANCER#0.6493;APOPTOSIS#0.6368;ENDOMETRIAL CARCINOMA#0.6170;DIFFERENTIAL GENE EXPRESSION#0.6165;LUNG CANCER#0.6001
10123	CANCER CELL#0.9400;LUNG CANCER#0.8840;CHOLESTEROL EFFLUX#0.8406;GROWTH FACTOR#0.8012;GTP BINDING#0.7811;COLORECTAL CANCER#0.7106;FILOPODIUM FORMATION#0.6895;COLORECTAL#0.6567;VESICULAR TRANSPORT#0.6479;PLASMA MEMBRANE#0.6375;OVARIAN CANCER#0.6314;GENE EXPRESSION#0.6035
101241892	CELL PROLIFERATION#0.8672;CANCER CELL#0.8056;APOPTOSIS#0.7622;HYPOXIA#0.6909;HEPATOCELLULAR CARCINOMA#0.6645;HISTONE ACETYLATION#0.6149
101241897	TUBERCULOSIS#0.8374
101241900	MUSCULAR ATROPHY#0.7415;AMYOTROPHIC LATERAL SCLEROSIS#0.6449;LATERAL SCLEROSIS#0.6448;SPINAL MUSCULAR ATROPHY#0.6344
10125	THYMOCYTE#1.0467;B CELL#1.0453;NUCLEOTIDE EXCHANGE FACTOR#1.0408;GUANINE#1.0395;PLASMA MEMBRANE#1.0379;CELL DEVELOPMENT#1.0303;T CELL#1.0258;PROTEIN KINASE C#1.0245;PROTEIN KINASE#1.0210;PHOSPHOLIPASE C#0.9970;T CELL DEVELOPMENT#0.9949;SIGNALING PATHWAY#0.9856;GENE EXPRESSION#0.9815;CD4+ T CELL#0.9457;SIGNAL TRANSDUCTION#0.9442;KERATINOCYTE#0.9413;DIACYLGLYCEROL BINDING#0.9312;T LYMPHOCYTE#0.9211;MITOGEN ACTIVATED PROTEIN#0.9166;AUTOIMMUNITY#0.8896;CELL PROLIFERATION#0.8843;CELL ACTIVATION#0.8816;T CELL ACTIVATION#0.8731;MAP KINASE#0.8687;DIACYLGLYCEROL KINASE#0.8499;CD8+ T CELL#0.8494;GUANINE EXCHANGE FACTOR#0.8470;GROWTH FACTOR#0.8356;APOPTOSIS#0.8326;B CELL RECEPTOR#0.8025;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7812;LUPUS ERYTHEMATOSUS#0.7810;GERMINAL CENTER#0.7643;ONCOGENIC#0.7579;BONE MARROW#0.7462;IMMUNE RESPONSE#0.7061;MAST CELL#0.6971;GOLGI APPARATUS#0.6932;STRIATUM#0.6891;NEUTROPHIL#0.6272;B CELL PROLIFERATION#0.6101;LEUKOCYTE#0.6096;TYPE 2 DIABETES#0.6092;CYTOKINE RECEPTOR#0.6042;CELL DIFFERENTIATION#0.6033
10126	SPERM MOTILITY#0.7082
10127	TRANSCRIPTION FACTOR#0.9027
10128	LEUCINE#1.0724;PROSTATE CANCER#1.0557;CYTOCHROME C OXIDASE#1.0467;RNA BINDING#1.0434;MITOCHONDRIA#1.0413;CYTOCHROME C#1.0408;MITOCHONDRIAL TRANSCRIPTION#1.0027;GENE EXPRESSION#0.9887;AUTOPHAGY#0.9825;RNA BINDING PROTEIN#0.9385;SKELETAL MUSCLE#0.9040;APOPTOSIS#0.9017;MTDNA#0.8570;CANCER CELL#0.8558;MITOCHONDRIAL GENE EXPRESSION#0.8343;MITOCHONDRIAL DNA#0.8307;OXIDATIVE PHOSPHORYLATION#0.8300;MITOCHONDRIAL TRANSLATION#0.8192;MITOCHONDRION#0.8054;MITOCHONDRIAL DISEASE#0.7763;MITOPHAGY#0.7737;ATP SYNTHASE#0.7535;LUNG ADENOCARCINOMA#0.7446;ADENOCARCINOMA#0.7427;TRANSCRIPTION FACTOR#0.7287;FATTY ACID OXIDATION#0.7090;COMPLEX I#0.7032;MICROTUBULE#0.7002;STEM CELL#0.6982;DNA BINDING#0.6595;VACCINIA#0.6437;CELL CYCLE#0.6336;RIBONUCLEOPROTEIN COMPLEX#0.6280;IL-11#0.6192;PARKINSON'S DISEASE#0.6089;CANCER STEM CELL#0.6082
10129	MITOTIC SPINDLE#0.7885;TUBULIN DEACETYLASE ACTIVITY#0.7790;TUBULIN DEACETYLASE#0.7523;POLO BOX DOMAIN#0.7093;SPINDLE POLE#0.6815;MITOTIC CHROMOSOME#0.6768;DEACETYLASE ACTIVITY#0.6742
1012	ADIPONECTIN BINDING#1.1237;SMOOTH MUSCLE CELL#1.0626;MUSCLE CELL#1.0620;CELL SURFACE#1.0613;SMOOTH MUSCLE#1.0606;LYMPH NODE#1.0423;ENDOTHELIAL CELL#1.0382;CELL PROLIFERATION#1.0376;ANGIOGENESIS#1.0320;VASCULAR CELL#1.0298;METHYLATION SPECIFIC POLYMERASE#1.0250;COLORECTAL CANCER#1.0250;GROWTH FACTOR#1.0249;CELL ADHESION MOLECULE#1.0230;METHYLATION SPECIFIC PCR#1.0227;BREAST CANCER#1.0213;LIPOPROTEIN BINDING#1.0203;CELL ADHESION#1.0171;POLYMERASE CHAIN REACTION#1.0166;SQUAMOUS CELL CARCINOMA#1.0164;APOPTOSIS#1.0159;CANCER CELL#1.0127;CERVICAL CANCER#1.0125;CERVICAL#1.0117;SIGNALING PATHWAY#1.0076;LUNG CANCER#1.0043;CELL CYCLE#1.0026;LOW DENSITY LIPOPROTEIN#0.9984;TUMOR SUPPRESSOR#0.9966;COLORECTAL#0.9942;TRANSITIONAL CELL CARCINOMA#0.9891;2'-DEOXYCYTIDINE#0.9882;GENE EXPRESSION#0.9817;CELL GROWTH#0.9802;DNA METHYLATION#0.9777;5-AZA-2'-DEOXYCYTIDINE#0.9760;KERATINOCYTE#0.9754;ATHEROSCLEROSIS#0.9731;CELL MIGRATION#0.9728;BASAL CELL#0.9718;ADIPOSE TISSUE#0.9638;CARDIOVASCULAR SYSTEM#0.9635;LDL BINDING#0.9627;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.9623;PROSTATE CANCER#0.9564;VASCULAR SMOOTH MUSCLE CELL#0.9547;CYCLIN DEPENDENT KINASE#0.9509;ADENOCARCINOMA#0.9456;SIGNAL TRANSDUCTION#0.9428;HEPATOCELLULAR CARCINOMA#0.9421;CELL CELL ADHESION#0.9379;CELL MEMBRANE#0.9367;OVARIAN#0.9366;ATHEROSCLEROTIC#0.9336;TRANSCRIPTION FACTOR#0.9320;KINASE INHIBITOR#0.9314;BLOOD VESSEL#0.9300;PROTEIN KINASE#0.9216;HYPERACTIVITY#0.9185;ADIPOCYTE#0.9158;PLASMA MEMBRANE#0.9125;EPIDERMAL GROWTH FACTOR#0.9096;CORONARY ARTERY#0.9006;REVERSE TRANSCRIPTION#0.8955;ARTERY#0.8950;EPITHELIAL CELL#0.8904;INSULIN-LIKE GROWTH FACTOR#0.8885;NEURITE#0.8873;TUMOR TISSUES#0.8838;DNA METHYLTRANSFERASE#0.8779;TUMOR CELLS#0.8727;VASCULAR ENDOTHELIAL CELL#0.8697;MYELOID LEUKEMIA#0.8615;CYCLIN DEPENDENT KINASE INHIBITOR#0.8562;LUNG CARCINOMA#0.8561;CORONARY ARTERY DISEASE#0.8533;ARTERY DISEASE#0.8531;OVARIAN CANCER#0.8523;EXTRACELLULAR MATRIX#0.8496;HUMAN UMBILICAL VEIN#0.8463;UMBILICAL VEIN#0.8461;LIPID RAFT#0.8286;ESTROGEN RECEPTOR#0.8252;LYMPH NODE METASTASIS#0.8235;DISEASE FREE SURVIVAL#0.8162;ENDOMETRIAL CANCER#0.8135;COLON CANCER#0.8077;NEURITE OUTGROWTH#0.8067;DNA HYPERMETHYLATION#0.8063;ENDOTHELIUM#0.8007;UMBILICAL VEIN ENDOTHELIAL CELLS#0.8000;M PHASE#0.7998;NERVE GROWTH FACTOR#0.7975;SKELETAL MUSCLE#0.7931;CHRONIC MYELOID LEUKEMIA#0.7895;STROMAL CELL#0.7861;TYPE 2 DIABETES#0.7839;ADENOMATOUS POLYPOSIS COLI#0.7797;RETINOIC ACID RECEPTOR#0.7750;RETINOIC ACID#0.7689;GALLBLADDER CANCER#0.7659;PERIPHERAL BLOOD#0.7579;HYPERTENSION#0.7539;BONE MARROW#0.7511;CELL RECOGNITION#0.7505;ESOPHAGEAL CANCER#0.7501;BREAST CARCINOMA#0.7473;NERVOUS SYSTEM#0.7447;S PHASE#0.7435;PHOSPHOLIPASE C#0.7238;ALZHEIMER'S DISEASE#0.7205;TRANSCRIPTASE#0.7194;OBESE#0.7147;AORTIC SMOOTH MUSCLE CELLS#0.7119;HUMAN BREAST CANCER#0.7071;TRANSFORMING GROWTH FACTOR#0.7006;APOPTOTIC#0.6992;STEM CELL#0.6990;QUANTITATIVE REAL TIME#0.6958;GROWTH FACTOR RECEPTOR#0.6936;EPITHELIAL TISSUES#0.6787;GENE SILENCING#0.6782;ADJACENT NORMAL TISSUE#0.6781;VASCULAR ENDOTHELIUM#0.6760;CELL MOTILITY#0.6751;DILATED CARDIOMYOPATHY#0.6738;BETA-2#0.6720;SPINAL CORD#0.6642;ENDOMETRIAL CARCINOMA#0.6607;BREAST CANCER PATIENTS#0.6594;LUNG ADENOCARCINOMA#0.6489;3-OST-2#0.6470;GROWTH REGULATOR#0.6369;PROGESTERONE#0.6319;VASCULAR DISEASE#0.6293;FOCAL ADHESION#0.6292;CPG ISLAND METHYLATION#0.6281;HIGH DENSITY LIPOPROTEIN#0.6276;B CELL#0.6229;RETINOBLASTOMA#0.6146;BINDING PROTEIN 3#0.6096;MACROPHAGE#0.6071;NEURAL CELL#0.6056;MAMMARY GLAND#0.6048;ACTIN CYTOSKELETON#0.6047;CONTACT INHIBITION#0.6031;WEIGHT LOSS#0.6024
10130	PROTEIN DISULFIDE ISOMERASE#1.0585;ENDOPLASMIC RETICULUM#1.0216;CELL SURFACE#0.9174;CANCER CELL#0.8523;PROTEIN FOLDING#0.8338;UNFOLDED PROTEIN RESPONSE#0.7839;SIGNALING PATHWAY#0.7522;APOPTOSIS#0.7430;THROMBOSIS#0.6853;ENDOTHELIAL CELL#0.6414;GENE EXPRESSION#0.6247;BREAST CANCER#0.6169;ER STRESS RESPONSE#0.6139;LYMPH NODE#0.6047
10131	COLORECTAL CARCINOMA#1.0815;COLORECTAL#1.0629;TUMOR NECROSIS FACTOR#1.0562;ENDOPLASMIC RETICULUM#1.0454;COLORECTAL CANCER#1.0297;MITOCHONDRIA#1.0271;CANCER CELL#1.0254;APOPTOSIS#1.0231;DRUG RESISTANCE#1.0205;TUMOR CELLS#1.0202;CELL DEATH#1.0200;HEAT SHOCK PROTEIN#1.0193;LYMPH NODE#1.0112;MITOCHONDRIAL MEMBRANE POTENTIAL#1.0017;MITOCHONDRIAL MEMBRANE#0.9979;REACTIVE OXYGEN SPECIES#0.9899;CELL CYCLE#0.9844;OVARIAN CANCER#0.9814;CELL PROLIFERATION#0.9721;GENE EXPRESSION#0.9636;APOPTOTIC#0.9555;CARDIOMYOCYTE#0.9472;PROSTATE CANCER#0.9438;OVARIAN#0.9047;MITOCHONDRIAL PERMEABILITY TRANSITION#0.9046;PERMEABILITY TRANSITION PORE#0.9009;SUCCINATE DEHYDROGENASE#0.8974;LYMPH NODE METASTASIS#0.8928;EPITHELIAL CELL#0.8830;TRANSCRIPTION FACTOR#0.8818;SIGNALING PATHWAY#0.8800;CELL MOTILITY#0.8608;PROTEIN SYNTHESIS#0.8472;ATPASE ACTIVITY#0.8464;STEM CELL#0.8399;ATP HYDROLYSIS#0.8394;LUNG CANCER#0.8346;MITOCHONDRIAL MATRIX#0.8245;5 FLUOROURACIL#0.8084;BREAST CARCINOMA#0.8063;SUCCINATE#0.8061;CYTOCHROME C#0.8033;VACTERL ASSOCIATION#0.8023;CELL MIGRATION#0.7779;OXIDATIVE PHOSPHORYLATION#0.7744;HYPOXIC#0.7725;HYPOXIA#0.7678;AUTOPHAGY#0.7638;BREAST CANCER#0.7570;PROTEIN FOLDING#0.7551;UNFOLDED PROTEIN RESPONSE#0.7405;MITOCHONDRIAL LOCALIZATION#0.7310;CYTOPLASM#0.7257;GLUCOSE REGULATED PROTEIN#0.7054;POLYMERASE CHAIN REACTION#0.7000;ONCOGENIC#0.6947;CISPLATIN#0.6858;PARKINSON'S DISEASE#0.6664;COMPLEX I#0.6626;RESPIRATION#0.6599;ADENOCARCINOMA#0.6537;CELL GROWTH#0.6533;PROTEIN KINASE#0.6516;ORGANELLE#0.6512;PROTEIN QUALITY CONTROL#0.6451;ISCHEMIA#0.6383;FLUOROURACIL#0.6348;TUMOUR NECROSIS FACTOR#0.6327;SPORE DIFFERENTIATION#0.6310;TUMOR SUPPRESSOR#0.6295;ATP BINDING#0.6275;GLYCOLYSIS#0.6210;PROTEASOME#0.6191;MITOCHONDRIAL FUSION#0.6147;CELL MEMBRANE#0.6106;METASTATIC PROSTATE CANCER#0.6100;OXIDATIVE METABOLISM#0.6055;CYCLOPHILIN#0.6028;TOXICITY#0.6022;TUBULAR EPITHELIAL CELL#0.6005;EPITHELIAL OVARIAN CANCER#0.6004
10133	UBIQUITIN BINDING#1.0619;SELECTIVE AUTOPHAGY#1.0589;NORMAL TENSION GLAUCOMA#1.0568;TANK BINDING KINASE#1.0490;AUTOPHAGOSOME FORMATION#1.0489;MITOPHAGY#1.0431;TUMOR NECROSIS FACTOR#1.0417;AUTOPHAGY#1.0384;APOPTOSIS#1.0335;TRANSFERRIN RECEPTOR#1.0315;VESICLE TRAFFICKING#1.0307;CELL DEATH#1.0301;RETINAL GANGLION CELL#1.0297;MITOCHONDRIA#1.0286;AUTOPHAGOSOME#1.0280;PRIMARY OPEN ANGLE GLAUCOMA#1.0235;GOLGI APPARATUS#1.0232;UBIQUITIN#1.0210;GANGLION CELLS#1.0208;OPEN ANGLE GLAUCOMA#1.0204;PAGET'S DISEASE OF BONE#1.0195;TRANSCRIPTION FACTOR#1.0128;NEURODEGENERATIVE DISEASE#1.0086;AMYOTROPHIC LATERAL SCLEROSIS#1.0080;LATERAL SCLEROSIS#1.0080;LIGHT CHAIN 3#1.0066;LYSOSOME#1.0009;GENE EXPRESSION#1.0007;PLASMA MEMBRANE#1.0007;MICROTUBULE ASSOCIATED PROTEIN#1.0006;MICROTUBULE#0.9993;POLYMERASE CHAIN REACTION#0.9938;CYTOPLASM#0.9863;EPITHELIAL CELL#0.9598;SPINAL CORD#0.9555;GOLGI COMPLEX#0.9487;PROTEIN KINASE#0.9456;DEMENTIA#0.9408;FRONTOTEMPORAL DEMENTIA#0.9275;OPTIC NERVE#0.9253;DNA BINDING#0.9224;NEURONAL CELLS#0.9165;BLINDNESS#0.8978;MACROPHAGE#0.8740;SIGNAL TRANSDUCTION#0.8738;NF-KAPPAB ACTIVATION#0.8695;MITOCHONDRIAL MEMBRANE#0.8681;PARKINSON'S DISEASE#0.8642;RAPAMYCIN#0.8574;REACTIVE OXYGEN SPECIES#0.8380;ENDOSOME#0.8313;ENDOPLASMIC RETICULUM#0.8260;IMMUNE RESPONSE#0.8258;SIGNALING PATHWAY#0.8253;INCLUSION BODY#0.8251;POLYUBIQUITIN#0.8137;BONE MARROW#0.8085;COMPLEX I#0.8044;TOLL LIKE RECEPTOR#0.7985;OSTEOCLAST#0.7983;APOPTOTIC#0.7976;ALZHEIMER'S DISEASE#0.7968;NEUROPATHY#0.7941;SUPEROXIDE DISMUTASE#0.7939;CYTOPLASMIC INCLUSION#0.7937;HUNTINGTON'S DISEASE#0.7932;STEM CELL#0.7922;CELLULAR MORPHOGENESIS#0.7763;PROTEASOME#0.7755;MOTOR NEURON DISEASE#0.7716;CELL SURFACE#0.7675;PHAGOPHORE#0.7636;RNA INTERFERENCE#0.7581;OSTEOCLAST DIFFERENTIATION#0.7533;CELL CYCLE#0.7521;LEUCINE#0.7500;GROWTH FACTOR#0.7496;HUMAN TRABECULAR MESHWORK#0.7486;CANCER CELL#0.7376;PHOTORECEPTOR CELL#0.7324;XENOPHAGY#0.7225;RECYCLING ENDOSOME#0.7099;NEURONAL INTRANUCLEAR INCLUSIONS#0.7074;T CELL#0.7008;INNATE IMMUNITY#0.6989;CYTOCHROME P450#0.6970;MITOCHONDRIAL DAMAGE#0.6967;RECEPTOR DEGRADATION#0.6906;IMMUNE CELL#0.6871;SECRETORY VESICLE#0.6807;ORGANELLE#0.6707;EXOCYTOSIS#0.6604;NEURITE#0.6585;MORPHOGENESIS#0.6581;NERVOUS SYSTEM#0.6577;POLYUBIQUITIN BINDING#0.6505;ENDOCYTOSIS#0.6486;INTERFERON REGULATORY FACTOR#0.6355;OUTER MITOCHONDRIAL MEMBRANE#0.6355;INNATE IMMUNE RESPONSE#0.6323;REGULATION OF AUTOPHAGY#0.6323;UBIQUITIN PROTEIN LIGASE#0.6310;LOW TENSION GLAUCOMA#0.6305;BONE DISEASE#0.6246;ENDOCYTIC RECYCLING#0.6245;PROTEIN DEGRADATION#0.6230;ASTROCYTE#0.6213;CELL DIVISION#0.6061
10134	B CELL RECEPTOR#1.0976;B CELL#1.0653;ER MEMBRANE#1.0650;MITOCHONDRIA#1.0357;APOPTOSIS#1.0281;ENDOPLASMIC RETICULUM#1.0226;CELL SURFACE#1.0205;APOPTOTIC#1.0171;CYTOCHROME C#1.0129;CELL DEATH#0.9992;ENDOPLASMIC RETICULUM STRESS#0.8470;CANCER CELL#0.8375;ENDOPLASMIC RETICULUM MEMBRANE#0.8353;EPITHELIAL CELL#0.8332;CYTOCHROME C RELEASE#0.8178;CELL ASSOCIATED#0.8031;DYSTONIA#0.7680;STEM CELL#0.7663;GOLGI APPARATUS#0.7657;CERVICAL CANCER#0.7436;SECRETORY PATHWAY#0.7420;PLASMA MEMBRANE#0.7150;EMBRYONIC STEM CELL#0.7034;MITOCHONDRIAL FISSION#0.6978;ER STRESS RESPONSE#0.6964;C TERMINAL DOMAIN#0.6879;CASPASE ACTIVATION#0.6655;T CELL#0.6614;UBIQUITIN#0.6613;ER-GOLGI INTERMEDIATE COMPARTMENT#0.6474;CREATINE TRANSPORTER#0.6443;UNFOLDED PROTEIN RESPONSE#0.6423;EXTRINSIC APOPTOSIS#0.6296;CELL ADHESION#0.6007;COMPLEX I#0.6003
10135	GINGIVAL CREVICULAR FLUID#1.0805;NAD BIOSYNTHETIC#1.0797;NAD SALVAGE PATHWAY#1.0706;CORD BLOOD#1.0640;CEREBRAL ISCHEMIA#1.0609;NAD SALVAGE#1.0608;DIABETIC NEPHROPATHY#1.0563;NAD SYNTHESIS#1.0562;BREAST CANCER CELL#1.0554;FATTY ACID BINDING#1.0492;NAD METABOLISM#1.0489;RETINOL BINDING#1.0483;SOLUBLE LEPTIN RECEPTOR#1.0474;MONOCYTE CHEMOATTRACTANT PROTEIN#1.0467;RETINOL#1.0466;ACUTE LUNG INJURY#1.0445;NEPHROPATHY#1.0445;NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE#1.0436;PERIODONTITIS#1.0434;UMBILICAL VEIN#1.0434;ENDOTHELIAL GROWTH FACTOR#1.0428;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0428;NAD BIOSYNTHESIS#1.0385;ISCHEMIA#1.0369;CHONDROCYTE#1.0368;METFORMIN#1.0358;INSULIN RESISTANCE INDEX#1.0358;BREAST CANCER#1.0353;B CELL#1.0348;PSORIASIS#1.0340;FASTING BLOOD GLUCOSE#1.0336;NICOTINAMIDE#1.0330;AKT SIGNALING#1.0327;COLORECTAL#1.0322;NEUTROPHIL#1.0321;NICOTINAMIDE MONONUCLEOTIDE#1.0318;COLORECTAL CANCER#1.0317;HUMAN BREAST CANCER#1.0314;TUMOUR NECROSIS FACTOR#1.0311;EPITHELIAL CELL#1.0307;ENDOMETRIAL CANCER#1.0285;MYOCARDIAL INFARCTION#1.0275;FASTING PLASMA GLUCOSE#1.0273;ENDOTHELIAL CELL#1.0269;GESTATIONAL DIABETES#1.0267;SENESCENCE#1.0267;VISCERAL ADIPOSE TISSUE#1.0259;CORONARY ARTERY DISEASE#1.0253;ARTERY DISEASE#1.0251;LYMPH NODE#1.0245;CARDIOMYOCYTE#1.0241;HYPOXIA#1.0241;GESTATIONAL DIABETES MELLITUS#1.0237;UMBILICAL VEIN ENDOTHELIAL CELLS#1.0233;MONOCYTE#1.0231;HUMAN UMBILICAL VEIN#1.0228;SUBCUTANEOUS ADIPOSE TISSUE#1.0224;FIBROBLAST GROWTH FACTOR#1.0217;CORONARY ARTERY#1.0211;C REACTIVE PROTEIN#1.0209;APOPTOTIC#1.0205;MULTIPLE REGRESSION ANALYSIS#1.0201;FACTOR I#1.0199;PERIODONTAL DISEASE#1.0194;GLUCOSE HOMEOSTASIS#1.0192;TUMOR NECROSIS FACTOR#1.0190;NICOTINIC ACID#1.0190;CELL PROLIFERATION#1.0187;ANGIOGENESIS#1.0181;INSULIN RECEPTOR#1.0168;ROSIGLITAZONE#1.0165;QUANTITATIVE REAL TIME#1.0165;BONE MINERAL DENSITY#1.0162;ATHEROSCLEROTIC#1.0162;RESVERATROL#1.0159;SYNOVIAL FLUID#1.0158;LINEAR REGRESSION ANALYSIS#1.0157;GLUCOSE UPTAKE#1.0156;LEUKOCYTE#1.0151;RHEUMATOID ARTHRITIS#1.0142;MACROPHAGE#1.0138;AUTOPHAGY#1.0138;WAIST HIP RATIO#1.0137;WEIGHT LOSS#1.0130;POLYCYSTIC OVARY SYNDROME#1.0118;CELL GROWTH#1.0116;INSULIN SECRETION#1.0116;CANCER CELL#1.0114;PRE-ECLAMPSIA#1.0110;OVARIAN#1.0108;REVERSE TRANSCRIPTION#1.0108;BETA CELL#1.0106;ALCOHOLIC FATTY LIVER#1.0105;SKELETAL MUSCLE#1.0101;KIDNEY DISEASE#1.0100;CELL DEATH#1.0090;TYPE 2 DIABETIC#1.0090;TESTOSTERONE#1.0089;NONALCOHOLIC FATTY LIVER DISEASE#1.0081;HYPOXIA INDUCIBLE FACTOR#1.0078;BONE MARROW#1.0074;CHRONIC KIDNEY DISEASE#1.0071;CARDIOVASCULAR RISK FACTOR#1.0068;GROWTH FACTOR#1.0068;SIGNALING PATHWAY#1.0063;POLYMERASE CHAIN REACTION#1.0056;SIGNALLING PATHWAY#1.0054;MUSCLE CELL#1.0042;FATTY LIVER DISEASE#1.0039;NITRIC OXIDE#1.0030;TYPE 2 DIABETES MELLITUS#1.0019;2 DIABETES MELLITUS#1.0019;GLUCOSE METABOLISM#1.0017;ARTERY#1.0014;PROTEIN KINASE#1.0012;PRO-INFLAMMATORY#1.0008;PANCREATIC CANCER#1.0002;TUBE FORMATION#1.0001;LIPID METABOLISM#0.9999;LIVER DISEASE#0.9999;PEROXISOME#0.9999;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.9989;APOPTOSIS#0.9989;MITOGEN ACTIVATED PROTEIN#0.9988;OSTEOARTHRITIS#0.9983;FATTY LIVER#0.9982;SMOOTH MUSCLE#0.9980;PROTEIN DEACETYLASE#0.9977;LOW DENSITY LIPOPROTEIN#0.9975;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9973;STEM CELL#0.9970;T CELL#0.9968;TRANSCRIPTION FACTOR#0.9966;CELLULAR METABOLISM#0.9966;AND BODY COMPOSITION#0.9962;ADENINE#0.9960;GESTATION#0.9955;PERIPHERAL BLOOD#0.9949;GLUCOSE TOLERANCE TEST#0.9944;ADIPOCYTE#0.9938;HIGH DENSITY LIPOPROTEIN#0.9936;GLYCOLYSIS#0.9934;PALMITATE#0.9931;ATHEROSCLEROSIS#0.9919;PROGENITOR CELL#0.9919;OBESE#0.9917;GENE EXPRESSION#0.9913;INFLAMMATORY RESPONSE#0.9912;MONONUCLEAR CELLS#0.9908;ORAL GLUCOSE TOLERANCE#0.9899;REACTIVE OXYGEN SPECIES#0.9895;HIGH FAT DIET#0.9894;DIABETES MELLITUS#0.9893;CELL CYCLE#0.9886;POLY ADP RIBOSE#0.9884;PREADIPOCYTE#0.9870;PROGESTERONE#0.9867;HEPATITIS C#0.9864;ADIPOCYTE DIFFERENTIATION#0.9854;STEROIDOGENESIS#0.9850;ENDOTHELIUM#0.9849;TYPE 2 DIABETES#0.9842;EXTRACELLULAR MATRIX#0.9831;HYPERTENSION#0.9809;ADIPOSE TISSUE#0.9800;TUMOR CELLS#0.9796;CYTOTOXICITY#0.9789;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9783;CELL ADHESION#0.9779;INFLAMMATORY CELL#0.9768;RIBOSE#0.9766;HYPERTHYROIDISM#0.9763;SMOOTH MUSCLE CELL#0.9759;VENOUS BLOOD#0.9756;SYSTOLIC BLOOD PRESSURE#0.9740;GLUCOSE INTOLERANCE#0.9734;LUNG CANCER#0.9728;WEIGHT GAIN#0.9709;HYPERGLYCEMIA#0.9678;VASCULAR CELL#0.9675;WHITE ADIPOSE TISSUE#0.9675;G-CSF#0.9674;BODY FAT MASS#0.9665;IMMUNE RESPONSE#0.9645;ENDOTHELIAL PROGENITOR CELL#0.9637;TYPE 1 DIABETES#0.9605;ACUTE PANCREATITIS#0.9598;MULTIPLE LINEAR REGRESSION#0.9594;SUPEROXIDE DISMUTASE#0.9587;OVARIAN CANCER#0.9582;SELECTIN#0.9542;INFLAMMATORY BOWEL DISEASE#0.9534;ENERGY HOMEOSTASIS#0.9518;CHRONIC HEPATITIS C#0.9505;PIOGLITAZONE#0.9499;SKELETAL MUSCLE CELLS#0.9498;TRAUMATIC BRAIN INJURY#0.9497;MITOCHONDRIA#0.9492;CELL ADHESION MOLECULE#0.9492;HISTONE DEACETYLASE#0.9482;CYTOKINE PRODUCTION#0.9472;TOXICITY#0.9453;PROTEIN KINASE B#0.9436;OSTEOBLAST#0.9429;IMMUNE CELL#0.9408;ADENOCARCINOMA#0.9407;IMPAIRED GLUCOSE TOLERANCE#0.9406;IMMUNE SYSTEM#0.9405;ENZYME ACTIVITY#0.9385;WHITE BLOOD CELL#0.9340;GROWTH HORMONE#0.9337;VASCULAR DISEASE#0.9318;INSULIN-LIKE GROWTH FACTOR#0.9315;GLUCOSE TRANSPORT#0.9309;RESPIRATORY DISTRESS#0.9291;MECHANISM OF ACTION#0.9275;CIRCADIAN RHYTHM#0.9270;NICOTINATE PHOSPHORIBOSYLTRANSFERASE#0.9267;HEART DISEASE#0.9260;ACUTE CORONARY SYNDROME#0.9248;NEUTROPHIL APOPTOSIS#0.9237;STROMAL CELL#0.9228;NORMAL GLUCOSE TOLERANCE#0.9223;NEUROPROTECTION#0.9209;MARKERS OF INFLAMMATION#0.9207;ECLAMPSIA#0.9198;NITRIC OXIDE SYNTHASE#0.9184;SERUM ADIPONECTIN LEVELS#0.9183;VASCULAR ENDOTHELIAL CELL#0.9157;AND VISCERAL FAT#0.9133;FAT CELL#0.9121;DNA REPAIR#0.9064;CELLULAR SENESCENCE#0.9062;GLOMERULAR FILTRATION RATE#0.9040;GLOMERULAR FILTRATION#0.9037;FIBRINOGEN#0.9011;RHEUMATIC DISEASE#0.9007;OMENTAL ADIPOSE TISSUE#0.9003;ESTRADIOL#0.8995;DIET INDUCED OBESITY#0.8991;PANCREATIC DUCTAL ADENOCARCINOMA#0.8967;ASYMMETRIC DIMETHYLARGININE#0.8941;MELATONIN#0.8941;ANOREXIA#0.8938;SIMVASTATIN#0.8938;VASCULAR SMOOTH MUSCLE CELL#0.8934;CELL MIGRATION#0.8911;SIGNAL TRANSDUCTION#0.8904;REGENERATION#0.8880;EPIDERMAL GROWTH FACTOR#0.8877;ADENOSINE#0.8861;URIC ACID#0.8856;BLOOD GLUCOSE LEVEL#0.8852;PROSTATE CANCER#0.8842;ONCOGENIC#0.8834;HEPATOCELLULAR CARCINOMA#0.8828;FLOW MEDIATED DILATATION#0.8822;MONOCYTE CHEMOTACTIC PROTEIN#0.8764;ENDOPLASMIC RETICULUM#0.8735;GLUTATHIONE#0.8718;MICROVASCULAR ENDOTHELIAL CELL#0.8716;NADPH OXIDASE#0.8715;COLORECTAL CARCINOMA#0.8712;EUGLYCEMIC HYPERINSULINEMIC CLAMP#0.8698;GRANULOSA CELL#0.8695;VISCERAL FAT MASS#0.8672;CORTISOL#0.8668;OSTEOPOROSIS#0.8654;HYPOXIC#0.8652;INTIMA MEDIA THICKNESS#0.8626;FATTY ACID SYNTHASE#0.8617;LIPOGENESIS#0.8613;DEACETYLASE ACTIVITY#0.8609;LYMPH NODE METASTASIS#0.8588;HEPATIC STELLATE CELL#0.8581;CORONARY HEART DISEASE#0.8576;DEXAMETHASONE#0.8561;LIVER CIRRHOSIS#0.8559;MESENCHYMAL STEM CELL#0.8556;ADIPOGENESIS#0.8525;UMBILICAL CORD#0.8515;PANCREATITIS#0.8502;AUTOIMMUNE DISEASE#0.8493;CISPLATIN#0.8479;HYPERANDROGENISM#0.8471;BRAIN NATRIURETIC PEPTIDE#0.8466;TOLL LIKE RECEPTOR#0.8429;COLORECTAL ADENOMA#0.8419;ALKALINE PHOSPHATASE#0.8418;SERUM LEPTIN LEVEL#0.8327;CHOLESTEROL METABOLISM#0.8321;BLOOD VESSEL#0.8319;PROTEIN SECRETION#0.8317;LEYDIG CELL#0.8298;MESANGIAL CELL#0.8290;ALANINE#0.8289;ULCERATIVE COLITIS#0.8277;STRUCTURE ACTIVITY RELATIONSHIP#0.8266;OXYGEN GLUCOSE DEPRIVATION#0.8265;COLITIS#0.8253;ANOREXIA NERVOSA#0.8222;ASTROCYTE#0.8201;DRUG RESISTANCE#0.8198;DEDIFFERENTIATION#0.8170;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.8165;ACROMEGALY#0.8156;SIGNALING MOLECULE#0.8122;PROTEIN SYNTHESIS#0.8115;MULTIPLE LOGISTIC REGRESSION#0.8106;RECEPTOR ANTAGONIST#0.8105;ALZHEIMER'S DISEASE#0.8090;IL-6 PRODUCTION#0.8084;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8072;LUPUS ERYTHEMATOSUS#0.8070;SIGNAL TRANSDUCER#0.8068;HYPOTHYROIDISM#0.8050;C-LEVEL#0.8050;DNA BINDING#0.8018;ALDOSTERONE#0.8016;VITAMIN B3#0.8005;FATTY ACID OXIDATION#0.8005;ESTROGEN RECEPTOR#0.8001;GLYCERALDEHYDE-3-PHOSPHATE#0.7990;RUPTURE OF MEMBRANES#0.7985;MAMMARY EPITHELIAL CELL#0.7979;PRIMARY HUMAN HEPATOCYTES#0.7979;VASCULAR ENDOTHELIAL FUNCTION#0.7978;ASPARTATE#0.7963;ATP BINDING CASSETTE#0.7955;CEREBROVASCULAR DISEASE#0.7947;ATP BINDING#0.7936;KERATINOCYTE#0.7926;AMNION#0.7925;AMNIOTIC FLUID#0.7921;POLYCYSTIC OVARIAN SYNDROME#0.7909;MULTIPLE MYELOMA#0.7886;REPLICATIVE SENESCENCE#0.7881;FAT FREE MASS#0.7881;SILENT INFORMATION REGULATOR#0.7875;AREA UNDER CURVE#0.7856;OOCYTE#0.7855;SQUAMOUS CELL CARCINOMA#0.7834;MYOCYTES#0.7833;SLEEP APNEA#0.7825;SERUM ALBUMIN#0.7823;CYTOKINE SECRETION#0.7809;OSTEOBLAST DIFFERENTIATION#0.7787;DILATED CARDIOMYOPATHY#0.7787;HYALURONIC ACID#0.7777;EPITHELIAL MESENCHYMAL TRANSITION#0.7775;INNATE IMMUNITY#0.7774;HEPATITIS B#0.7768;MORBID OBESITY#0.7750;CELL DIFFERENTIATION#0.7714;PYRUVATE#0.7690;SERUM AMYLOID A#0.7673;TYPE 1 DIABETES MELLITUS#0.7672;72-HOURS#0.7651;STREPTOZOTOCIN#0.7644;5-PHOSPHORIBOSYL 1-PYROPHOSPHATE#0.7605;CAROTID ARTERY#0.7585;MENISCUS#0.7581;VISCERAL FAT ACCUMULATION#0.7581;CARDIOVASCULAR SYSTEM#0.7578;T LYMPHOCYTE#0.7575;RESPIRATION#0.7570;REGULATION OF GLUCOSE HOMEOSTASIS#0.7554;COLLAGEN INDUCED ARTHRITIS#0.7547;TRANSCRIPTASE#0.7538;MITOCHONDRIAL MEMBRANE#0.7517;TRANSFORMING GROWTH FACTOR#0.7489;WATER TRANSPORT#0.7467;BREAST CANCER PATIENTS#0.7466;KAWASAKI DISEASE#0.7465;OVARIES#0.7454;LYMPHOCYTIC LEUKEMIA#0.7453;MACROPHAGE POLARIZATION#0.7450;PNEUMONIA#0.7423;PI3K SIGNALING#0.7413;ATP BINDING CASSETTE TRANSPORTER#0.7409;EZETIMIBE#0.7402;L-CARNITINE#0.7401;MIDDLE CEREBRAL ARTERY#0.7400;CEREBRAL ARTERY#0.7397;RESPIRATORY BURST#0.7390;LIPOPROTEIN LIPASE#0.7366;LIPID RAFT#0.7350;ANKYLOSING SPONDYLITIS#0.7346;DISEASE FREE SURVIVAL#0.7346;AEROBIC EXERCISE TRAINING#0.7339;UMBILICAL CORD BLOOD#0.7338;NEGATIVE ENERGY BALANCE#0.7338;CAROTID STENOSIS#0.7336;DNA METHYLATION#0.7330;EXCRETION#0.7320;CYTOCHROME C#0.7320;NF-KAPPAB ACTIVATION#0.7306;KINASE INHIBITOR#0.7304;MAP KINASE#0.7275;MYOTUBE#0.7272;LOW BIRTH WEIGHT#0.7263;TYPE 1 DIABETIC#0.7226;FOAM CELL FORMATION#0.7221;CARDIOMYOPATHY#0.7214;FAT SPECIFIC PROTEIN#0.7209;BONE FORMATION#0.7187;DIABETIC RETINOPATHY#0.7185;ADVANCED GLYCATION END#0.7181;HEPATITIS C VIRUS#0.7177;CHOLESTEROL EFFLUX#0.7176;COLON CANCER#0.7168;INSULIN RECEPTOR SUBSTRATE#0.7166;MYELOID LEUKEMIA#0.7165;SYNOVIUM#0.7163;MITOCHONDRIAL MEMBRANE POTENTIAL#0.7149;SCAVENGER RECEPTOR#0.7144;ORAL SQUAMOUS CELL CARCINOMA#0.7136;INDUCTION OF APOPTOSIS#0.7123;GENOTOXIC#0.7116;COAGULATION#0.7115;HEPARIN#0.7109;TUMOR SUPPRESSOR#0.7107;LYSINE#0.7107;TRANSACTIVATION#0.7087;NORMAL GLUCOSE TOLERANT#0.7064;STEROL REGULATORY ELEMENT#0.7034;OLEIC ACID#0.7026;COLLAGEN TYPE I#0.7025;CEREBRAL ARTERY OCCLUSION#0.7015;LUNG DISEASE#0.6993;HEMORRHAGE#0.6982;ACUTE MYOCARDIAL INFARCTION#0.6971;FASTING SERUM INSULIN#0.6966;LUNG ENDOTHELIUM#0.6963;FREE ANDROGEN INDEX#0.6951;IFN-GAMMA#0.6940;CROHN'S DISEASE#0.6905;INDUCES CANCER#0.6846;IMPAIRED FASTING GLUCOSE#0.6839;RAPAMYCIN#0.6810;CONTROLLED OVARIAN STIMULATION#0.6807;SALIVARY GLAND#0.6806;PROTEIN BINDING#0.6799;CYTOPLASM#0.6788;GRANULOCYTE#0.6785;ACUTE MYELOID LEUKEMIA#0.6783;DE NOVO LIPOGENESIS#0.6777;TCA CYCLE#0.6776;JNK SIGNALING PATHWAY#0.6752;DEHYDROEPIANDROSTERONE SULFATE#0.6728;ENDOTHELIAL NITRIC OXIDE#0.6726;TYROSINE KINASE 1#0.6711;ALVEOLAR EPITHELIAL CELL#0.6704;IL-8 SECRETION#0.6704;MECHANISMS OF ACTION#0.6699;NF-KAPPAB INHIBITOR#0.6699;WOUND HEALING#0.6699;TELOMERASE ACTIVITY#0.6688;RECURRENCE FREE SURVIVAL#0.6687;ACTIVATED T LYMPHOCYTES#0.6686;RECEPTOR ACTIVATOR#0.6675;METASTATIC MELANOMA#0.6669;PANCREATIC ISLET#0.6665;DIURNAL#0.6665;CARNITINE#0.6665;LEFT VENTRICULAR MASS#0.6664;ELECTROPHORETIC MOBILITY SHIFT#0.6659;NERVOUS SYSTEM#0.6650;AUTOIMMUNITY#0.6628;CELL SURFACE#0.6600;HEAT SHOCK PROTEIN#0.6542;CELL CYCLE ARREST#0.6521;VIRAL HEPATITIS#0.6521;HUMAN ADIPOSE TISSUE#0.6500;P21 ACTIVATED KINASE#0.6499;INSULIN SIGNALING PATHWAY#0.6493;ADENOSINE MONOPHOSPHATE#0.6482;FAT PAD#0.6478;BODY WEIGHT LOSS#0.6476;OBSTRUCTIVE SLEEP APNEA#0.6475;ATORVASTATIN#0.6469;SATURATED FATTY ACID#0.6468;CATABOLISM#0.6462;GLIAL CELL#0.6447;CELL MATURATION#0.6446;INHIBITION OF NEUTROPHIL APOPTOSIS#0.6407;ISCHEMIA REPERFUSION INJURY#0.6404;PHAGOCYTOSIS#0.6401;INDUCIBLE NITRIC OXIDE#0.6396;S PHASE#0.6387;FASTING BLOOD SUGAR#0.6343;HUMAN PULMONARY ARTERY#0.6328;REGULATION OF METABOLISM#0.6328;LIPOLYSIS#0.6313;DISEASE ACTIVITY SCORE#0.6295;SENSITIZATION#0.6268;ENHANCER BINDING PROTEIN#0.6265;M2 MACROPHAGE#0.6263;ENHANCER BINDING#0.6261;OXIDATIVE PHOSPHORYLATION#0.6260;PROTEINURIA#0.6239;HEALTHY CONTROL GROUP#0.6236;FEEDING BEHAVIOR#0.6233;TOTAL BODY FAT#0.6231;OSTEOCLAST#0.6230;PERIODONTAL LIGAMENT#0.6222;NEURODEGENERATIVE DISEASE#0.6219;ROS GENERATION#0.6214;MAPK SIGNALING#0.6211;CAMKII#0.6197;KIDNEY TRANSPLANT RECIPIENTS#0.6191;DEATH RECEPTOR#0.6189;HIGH MOBILITY GROUP#0.6186;PULMONARY ARTERY#0.6184;RESPONSE TO TREATMENT#0.6184;ESSENTIAL HYPERTENSION#0.6184;HORMONE BINDING#0.6179;LOSARTAN#0.6167;HEPARIN BINDING#0.6150;ENDOPLASMIC RETICULUM STRESS#0.6140;COLONY-STIMULATING FACTOR#0.6134;NEUROPATHY#0.6130;ABNORMAL GLUCOSE METABOLISM#0.6120;GROWTH FACTOR RECEPTOR#0.6119;RNA INTERFERENCE#0.6110;COMPLEX I#0.6109;EPICARDIAL ADIPOSE TISSUE#0.6093;PARTURITION#0.6089;PLASMA MEMBRANE#0.6080;VEGF PRODUCTION#0.6064;MYOBLAST#0.6061;MULTIVARIATE LINEAR REGRESSION#0.6061;SPERMATOGENESIS#0.6058;NLRP3 INFLAMMASOME ACTIVATION#0.6048;DOXORUBICIN#0.6040;PSORIATIC ARTHRITIS#0.6030;ERYTHROCYTE#0.6026;ETHANOL#0.6026
10137	CELL WALL#0.6325;G-CSF#0.6304;MAGNETIC RESONANCE IMAGING#0.6280
10138	APOPTOSIS#0.6715;DNA BINDING#0.6569;STEM CELL#0.6428;TRANSCRIPTION FACTOR#0.6423;P38 MAPK SIGNALING#0.6093
10139	RELATED PROTEIN 1#1.1125;PLASMA MEMBRANE#0.9985;GOLGI MEMBRANE#0.8946;TRANS GOLGI NETWORK#0.8208;ACTIN RELATED PROTEIN#0.8047;ADIPOCYTE#0.7816;EPITHELIAL CELL#0.7639;LIPID DROPLET#0.7597;ENDOSOME#0.7463;LIPOLYSIS#0.7216;CHYLOMICRON#0.7154;GTP BINDING#0.6780;DYNACTIN COMPLEX#0.6587;DYNEIN#0.6418;ADIPOSE TISSUE#0.6298;COATOMER#0.6269;CELL SURFACE#0.6106
1013	CELL ADHESION#0.9420;SKELETAL MUSCLE#0.8557;GENE EXPRESSION#0.7544;FATTY ACID OXIDATION#0.6423;CELL CELL ADHESION#0.6298;MYOBLAST#0.6198
101409257	TRANSFORMING GROWTH FACTOR#0.7996;BREAST CANCER#0.7966;GROWTH FACTOR#0.7931;APOPTOSIS#0.7926;CANCER CELL#0.6701
101409265	DRUG DELIVERY SYSTEM#1.1995
10140	CANCER CELL#1.0549;T CELL#1.0544;TUMOR SUPPRESSOR#1.0518;CELL PROLIFERATION#1.0366;CELL CYCLE#1.0293;BREAST CANCER#1.0156;SIGNALING PATHWAY#1.0148;APOPTOSIS#0.9888;CELL GROWTH#0.9792;GENE EXPRESSION#0.9765;LUNG CANCER#0.9567;TRANSCRIPTION FACTOR#0.9491;B CELL#0.9184;MRNA DEADENYLATION#0.9159;TH17 CELL#0.9036;S PHASE#0.8884;POLY-A BINDING#0.8776;BREAST CANCER CELL#0.8655;BONE FORMATION#0.8600;GROWTH FACTOR#0.8591;UBIQUITIN#0.8391;NUCLEAR EXPORT#0.8192;RNA BINDING PROTEIN#0.8145;RNA BINDING#0.8019;CCR4 NOT COMPLEX#0.7911;PROTEASOME#0.7865;CELL CYCLE REGULATOR#0.7725;CD4+ T CELL#0.7675;NUCLEAR LOCALIZATION SIGNAL#0.7611;CENTRAL NERVOUS SYSTEM#0.7544;STEM CELL#0.7536;NERVOUS SYSTEM#0.7532;CYCLIN DEPENDENT KINASE#0.7350;BONE MORPHOGENETIC PROTEIN#0.7171;FOG 3#0.7143;QUIESCENCE#0.7097;TH1 CELL#0.7065;NUCLEAR EXPORT SIGNAL#0.6992;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6879;POLYMERASE CHAIN REACTION#0.6830;BONE MARROW#0.6812;LYMPH NODE#0.6807;OSTEOBLAST#0.6674;CELL DIFFERENTIATION#0.6582;CELL CYCLE ARREST#0.6395;MRNA DECAY#0.6255;ONCOGENIC#0.6213;GERM CELL#0.6171;CELL MIGRATION#0.6138;SKELETAL MUSCLE#0.6129;HUMAN BRONCHIAL EPITHELIAL#0.6063
10142	T CELL#1.0598;MICROTUBULE NUCLEATION#1.0585;CENTROSOME#1.0510;GOLGI APPARATUS#1.0505;ANCHORING#1.0498;MICROTUBULE#1.0359;PROTEIN KINASE A#1.0228;PROTEIN KINASE#1.0186;NMDA RECEPTOR#0.9871;CELL CYCLE#0.9679;TREATMENT PLANNING SYSTEM#0.9608;POTASSIUM CHANNEL#0.9417;MICROTUBULE DYNAMICS#0.9347;PROTEIN PHOSPHATASE 1#0.9132;LONG QT SYNDROME#0.9078;CELL MIGRATION#0.9077;COLORECTAL CANCER#0.9066;EPITHELIAL CELL#0.8598;CELL PROLIFERATION#0.7979;COLORECTAL#0.7596;MICROTUBULE CYTOSKELETON#0.7500;MACROMOLECULAR COMPLEX#0.7466;INTERPHASE#0.7175;ARRHYTHMIA#0.7071;ION CHANNEL#0.7035;CENTROSOME DUPLICATION#0.7002;ORGANELLE#0.6562;DIGESTION#0.6382;ACTION POTENTIAL#0.6372;LYMPH NODE#0.6304;VOLATILE ORGANIC COMPOUND#0.6141
10143	LECTIN#1.0108;EXTRACELLULAR MATRIX#0.7027;INVASIVE DUCTAL CANCER#0.6968;SEPTIC ARTHRITIS#0.6600;PLASMINOGEN ACTIVATION#0.6465;AKT SIGNALING#0.6316;QUANTITATIVE REAL TIME#0.6271;CELL SURFACE#0.6220;CELL PROLIFERATION#0.6198
101448070	GLUCOSE-6-PHOSPHATE#0.7419
10144	LUNG CANCER#1.0579;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#1.0255;LUNG DISEASE#1.0209;PULMONARY FIBROSIS#0.9630;HEDGEHOG INTERACTING PROTEIN#0.9568;GENE EXPRESSION#0.8932;EPITHELIAL CELL#0.8720;ADIPOSE TISSUE#0.7286;ADIPOCYTE#0.7009;CANCER CELL#0.6080
10146	GTPASE ACTIVATING PROTEIN BINDING#1.1207;SG ASSEMBLY#1.0807;SH3 DOMAIN BINDING#1.0785;STRESS GRANULE ASSEMBLY#1.0778;BINDING PROTEIN 1#1.0662;PROTEIN BINDING#1.0651;CANCER CELL#1.0348;STRESS GRANULE#1.0332;SIGNALING PATHWAY#1.0298;VIRAL REPLICATION#1.0267;BREAST CANCER#1.0240;RNA BINDING#1.0234;RNA BINDING PROTEIN#1.0217;T CELL#1.0173;GALECTIN#1.0058;APOPTOSIS#0.9981;TRANSLATION INITIATION#0.9932;BREAST CANCER CELL#0.9844;RNA GRANULE#0.9781;CAPRIN#0.9720;PROTEIN KINASE#0.9678;VIRAL INFECTION#0.9642;GENE EXPRESSION#0.9498;GROWTH FACTOR#0.9496;LUNG CANCER#0.9384;ARSENITE#0.9297;MRNA BINDING#0.9153;TRANSLATION INITIATION FACTOR#0.9070;HOST CELL#0.8995;POLY-A BINDING#0.8983;CHIKUNGUNYA#0.8921;CELL PROLIFERATION#0.8914;ANTIVIRAL RESPONSE#0.8904;RNA METABOLISM#0.8808;TRANSCRIPTION FACTOR#0.8761;CYTOPLASM#0.8636;PROTEIN SYNTHESIS#0.8379;NUCLEAR TRANSPORT#0.8301;CELL GROWTH#0.8256;PROTEIN KINASE R#0.8056;IMMUNE RESPONSE#0.7996;EUKARYOTIC INITIATION FACTOR#0.7969;CELL CYCLE#0.7886;RNA REPLICATION#0.7806;CYTOPLASMIC STRESS GRANULE#0.7668;ARGININE#0.7650;CELL DEATH#0.7636;NEURODEGENERATIVE DISEASE#0.7631;CYTOPLASMIC FOCI#0.7603;LYMPH NODE#0.7588;HEPATITIS C#0.7520;LYMPH NODE METASTASIS#0.7515;UBIQUITIN#0.7398;RIBOSOMAL SUBUNIT#0.7373;INNATE IMMUNE RESPONSE#0.7270;MOUSE EMBRYONIC FIBROBLAST#0.7156;RIBOSOME#0.7133;CELL ADHESION#0.6912;INNATE IMMUNITY#0.6830;DNA BINDING#0.6762;RESPONSE TO STRESS#0.6760;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6543;LUPUS ERYTHEMATOSUS#0.6541;EPITHELIAL CELL#0.6488;MICROTUBULE#0.6389;MACROPHAGE#0.6329;ESOPHAGEAL SQUAMOUS CARCINOMA#0.6304;FOOT AND MOUTH DISEASE#0.6236;MOUTH DISEASE#0.6232;HUMAN BREAST CANCER#0.6107;S PHASE#0.6087;DNA HELICASE#0.6078
10148	EPSTEIN BARR VIRUS#1.0567;TREG CELL#1.0351;B CELL#1.0226;PERIPHERAL BLOOD MONONUCLEAR CELLS#1.0193;MONONUCLEAR CELLS#1.0147;MACROPHAGE#1.0121;PERIPHERAL BLOOD#1.0113;CD4+ T CELL#1.0080;GENE EXPRESSION#0.9947;REGULATORY T CELL#0.9922;DENDRITIC CELL#0.9900;POLYMERASE CHAIN REACTION#0.9885;LYMPH NODE#0.9879;T CELL#0.9863;IMMUNE RESPONSE#0.9840;SIGNALING PATHWAY#0.9778;TH17 CELL#0.9764;TRANSCRIPTION FACTOR#0.9758;AUTOIMMUNE DISEASE#0.9672;IFN-GAMMA#0.9383;INFLAMMATORY BOWEL DISEASE#0.9035;CELL PROLIFERATION#0.9018;INFLAMMATORY RESPONSE#0.8960;EPITHELIAL CELL#0.8898;CD8+ T CELL#0.8818;PRO-INFLAMMATORY#0.8678;COLITIS#0.8549;ALLERGIC RHINITIS#0.8538;IMMUNE CELL#0.8512;EFFECTOR T CELL#0.8442;TROPHOBLAST#0.8381;IMMUNE SYSTEM#0.8373;CELL DIFFERENTIATION#0.8340;CYTOKINE PRODUCTION#0.8317;MONOCYTE#0.8189;T LYMPHOCYTE#0.8184;TH1 CELL#0.7767;ULCERATIVE COLITIS#0.7744;CELL ACTIVATION#0.7701;PLASMA CELL#0.7655;TUBERCULOSIS#0.7555;QUANTITATIVE REAL TIME#0.7471;IL-27 PRODUCTION#0.7457;TUMOR NECROSIS FACTOR#0.7436;CROHN'S DISEASE#0.7357;ANTIGEN PRESENTING CELLS#0.7339;B CELL LYMPHOMA#0.7337;T CELL PROLIFERATION#0.7211;CELL DEVELOPMENT#0.7150;B LYMPHOCYTE#0.7109;CYTOKINE RECEPTOR#0.7078;APOPTOSIS#0.7072;RHINITIS#0.7014;GROWTH FACTOR#0.6962;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6902;IL-10 PRODUCTION#0.6862;NORMAL CONTROL GROUP#0.6827;CYTOTOXIC T-LYMPHOCYTE#0.6614;T CELL ACTIVATION#0.6549;INFLAMMATORY CELL#0.6539;ENCEPHALOMYELITIS#0.6430;SYNCYTIOTROPHOBLAST#0.6395;EOSINOPHIL#0.6391;TOLL LIKE RECEPTOR#0.6344;REVERSE TRANSCRIPTION#0.6273;DELAYED-TYPE HYPERSENSITIVITY#0.6169;NEUTROPHIL#0.6140;LEUKOCYTE#0.6127;CHAGAS DISEASE#0.6022
10149	EPIDIDYMIS#0.8600;INFERTILITY#0.8310;MALE INFERTILITY#0.7553;SIGNAL TRANSDUCTION#0.6394;CELL ADHESION#0.6253;CYSTIC FIBROSIS#0.6232
1014	EPITHELIAL CELL#1.0335;RENAL CELL CARCINOMA#1.0101;TUBULAR EPITHELIAL CELL#0.9684;NEPHRON#0.9592;CELL ADHESION#0.9366;TRANSCRIPTION FACTOR#0.9082;CHROMOPHOBE RENAL CELL CARCINOMA#0.8699;GENE EXPRESSION#0.7606;CELL ADHESION MOLECULE#0.7233;TUMOR CELLS#0.7019;RENAL ONCOCYTOMA#0.7010;PAPILLARY RENAL CELL CARCINOMA#0.6946;COLLECTING DUCT CARCINOMA#0.6613;URETERIC BUD#0.6279;THYROID CARCINOMA#0.6146
10150	RNA BINDING#0.9667;RNA BINDING PROTEIN#0.9269;GENE EXPRESSION#0.8672;MYOTONIC DYSTROPHY TYPE 1#0.8458;MYOBLAST#0.7860;SKELETAL MUSCLE#0.7221;RNA PROCESSING#0.6244;NERVOUS SYSTEM#0.6141
10151	MULTIPLE ENDOCRINE NEOPLASIA#0.9166
10152	ABA SIGNALING#1.0434;SIGNAL TRANSDUCTION#1.0127;PHOSPHATASE ACTIVITY#0.9976;SIGNALING PATHWAY#0.9878;PROTEIN KINASE#0.9824;GERMINATION#0.9761;ABA SIGNAL TRANSDUCTION#0.9668;SEED GERMINATION#0.9516;TRANSCRIPTION FACTOR#0.9253;GENE EXPRESSION#0.9247;WAVE COMPLEX#0.9038;STOMATAL CLOSURE#0.8917;CELL MIGRATION#0.8663;SIGNALLING PATHWAY#0.8462;PLASMA MEMBRANE#0.7763;ANION CHANNEL#0.7288;ACTIN CYTOSKELETON#0.7094;SEED DORMANCY#0.6308;TUMOR SUPPRESSOR#0.6125;NITRATE TRANSPORT#0.6039
10153	FREEZING TOLERANCE#1.0406;COLD ACCLIMATION#1.0184;TRANSCRIPTION FACTOR#1.0114;DNA BINDING#0.9990;GENE EXPRESSION#0.9863;SIGNALING PATHWAY#0.8453;DEHYDRATION#0.8452;DEHYDRATION RESPONSIVE ELEMENT#0.8406;LEAF SENESCENCE#0.8363;ELECTROPHORETIC MOBILITY SHIFT#0.8243;RESPONSE TO COLD#0.8216;SIGNAL TRANSDUCTION#0.8015;ENHANCER BINDING PROTEIN#0.7598;ENHANCER BINDING#0.7593;CENTROMERE BINDING#0.7388;SENESCENCE#0.7158;TRANSACTIVATION#0.6784;CENTROMERE#0.6630;CELL SURFACE#0.6079
10154	SEMAPHORIN RECEPTOR#1.0562;GROWTH CONE#1.0233;CELL MIGRATION#1.0182;AXON GUIDANCE#1.0138;NERVOUS SYSTEM#1.0061;CELL SURFACE#1.0052;ACTIN CYTOSKELETON#0.9982;SIGNAL TRANSDUCTION#0.9971;CELL ADHESION#0.9890;CYTOPLASMIC REGION#0.9767;ENDOTHELIAL CELL#0.9763;ANGIOGENESIS#0.9739;T CELL#0.9737;GAP ACTIVITY#0.9704;GROWTH CONE COLLAPSE#0.9696;TRANSMEMBRANE RECEPTOR#0.9647;IMMUNE SYSTEM#0.9567;IMMUNE RESPONSE#0.9523;DENDRITIC CELL#0.9471;GROWTH FACTOR#0.9465;SIGNALING PATHWAY#0.9300;TUMOR SUPPRESSOR#0.9201;MELANOCYTE#0.9176;GTPASE BINDING#0.9168;MORPHOGENESIS#0.8903;CELL MOTILITY#0.8751;PROTEIN KINASE#0.8744;RECEPTOR COMPLEX#0.8617;NEURITE#0.8566;TRANSCRIPTION FACTOR#0.8564;CANCER CELL#0.8400;NUCLEOTIDE EXCHANGE FACTOR#0.8120;IMMUNE CELL#0.7827;COMPLEX I#0.7767;RECEPTOR TYROSINE KINASE#0.7678;RHO GTPASE BINDING#0.7608;CELL PROLIFERATION#0.7487;AXON PRUNING#0.7383;SIGNALLING PATHWAY#0.7320;SPINAL CORD#0.7298;EPITHELIAL CELL#0.7274;RHOGEF#0.7264;GUANINE#0.7256;EXTRACELLULAR REGION#0.7202;ACTIN FILAMENT#0.7161;TYROSINE KINASE RECEPTOR#0.7151;NEURITE OUTGROWTH#0.7107;CENTRAL NERVOUS SYSTEM#0.7047;APOPTOSIS#0.6948;ENDOTHELIAL GROWTH FACTOR#0.6905;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6905;NEUTROPHIL#0.6818;RAS GAP ACTIVITY#0.6816;BLOOD VESSEL#0.6807;INFLAMMATORY RESPONSE#0.6695;AXON GUIDANCE RECEPTOR#0.6648;GENE EXPRESSION#0.6463;AXON COLLATERAL#0.6256;CELL ADHESION MOLECULE#0.6080;MIDLINE#0.6054;BREAST CANCER#0.6033
10155	HETEROCHROMATIN PROTEIN 1#1.0645;SUMOYLATION#1.0584;HETEROCHROMATIN#1.0398;GENE SILENCING#1.0372;DNA METHYLATION#1.0364;CELL PROLIFERATION#1.0322;CANCER CELL#1.0293;HISTONE DEACETYLASE#1.0290;ZINC FINGER PROTEIN#1.0268;DNA DAMAGE RESPONSE#1.0201;DNA REPAIR#1.0125;LUNG CANCER#1.0125;EMBRYONIC STEM CELL#1.0120;CHROMATIN REMODELING#1.0076;CELL CYCLE#1.0065;BREAST CANCER#1.0050;STEM CELL#1.0033;TRANSCRIPTION FACTOR#0.9990;DNA BINDING#0.9987;LYSINE#0.9941;DOUBLE STRAND BREAK#0.9925;GENE EXPRESSION#0.9909;T CELL#0.9883;TUMOR SUPPRESSOR#0.9857;APOPTOSIS#0.9843;CELL DIFFERENTIATION#0.9766;HISTONE METHYLTRANSFERASE#0.9751;ATAXIA TELANGIECTASIA#0.9748;ATAXIA TELANGIECTASIA MUTATED#0.9726;UBIQUITIN#0.9617;SIGNALING PATHWAY#0.9615;BREAST CANCER CELL#0.9573;HISTONE MODIFICATION#0.9451;HETEROCHROMATIN FORMATION#0.9320;DNA METHYLTRANSFERASE#0.9269;MOUSE EMBRYONIC STEM#0.9159;POST-TRANSLATIONAL MODIFICATION#0.9114;HEPATOCELLULAR CARCINOMA#0.8801;PROGENITOR CELL#0.8800;B CELL#0.8774;PROTEIN PROTEIN INTERACTION#0.8553;NEURAL PROGENITOR CELL#0.8533;OOCYTE#0.8470;COLORECTAL CANCER#0.8450;CENTROMERIC HETEROCHROMATIN#0.8365;GERM CELL#0.8322;PROTEIN KINASE#0.8085;KAPOSI'S SARCOMA#0.7886;NUCLEOSOME#0.7836;OVARIAN#0.7811;POSTTRANSLATIONAL MODIFICATION#0.7633;TUMOR CELLS#0.7538;TRANSACTIVATION#0.7536;HOMOLOGOUS RECOMBINATION#0.7529;PLURIPOTENT STEM CELL#0.7511;CELL GROWTH#0.7405;OVARIAN CANCER#0.7384;DNA REPLICATION#0.7300;ARGININE#0.7293;CERVICAL CANCER#0.7264;COLORECTAL#0.7021;VIRAL GENOME#0.6976;G1 PHASE#0.6762;SIGNAL TRANSDUCTION#0.6714;CELL MIGRATION#0.6670;AUTOPHAGY#0.6571;PROTEIN COMPLEX#0.6515;RETINOIC ACID#0.6491;NURD COMPLEX#0.6484;EUCHROMATIN#0.6470;DE NOVO DNA METHYLATION#0.6351;ERYTHROPOIESIS#0.6276;CELL DEVELOPMENT#0.6273;GLOBIN#0.6266;TRANSCRIPTION REPRESSOR#0.6239;MDM2 BINDING#0.6219;METHYLTRANSFERASE ACTIVITY#0.6172;DEMETHYLATION#0.6169;CHROMATIN MODIFICATION#0.6104;VIRAL LATENCY#0.6076;COMPLEX I#0.6062;REGULATORY T CELL#0.6049
10156	PLASMA MEMBRANE#1.0071;PROTEIN PROTEIN INTERACTION#0.9769;INFLAMMATORY BOWEL DISEASE#0.9767;PROTEIN COMPLEX#0.8815;PROTEIN-PROTEIN COMPLEX#0.8343;METASTATIC COLORECTAL CANCER#0.7521;COLORECTAL CANCER#0.7414;T CELL#0.7407;IMMUNE RESPONSE#0.7273;ROOT MEAN SQUARE#0.7177;INFERTILITY#0.6632
10157	LYSINE CATABOLISM#1.0991;LYSINE#1.0692;CATABOLISM#1.0450;LYSINE DEGRADATION#0.9961;HYPERLYSINEMIA#0.7035;LYSINE METABOLISM#0.6471
10158	TUMOR CELLS#1.0323;EPITHELIAL CELL#0.9573;PROXIMAL TUBULAR EPITHELIAL#0.8485;REACTIVE OXYGEN SPECIES#0.8470;TUBULAR EPITHELIAL CELL#0.8387;BRUSH BORDER#0.8042;BORTEZOMIB#0.7569;STEM CELL#0.7163;CELL PROLIFERATION#0.7099;CANCER CELL#0.7095;PROTEASOME#0.6520;HEMATOPOIETIC CELL#0.6215;BREAST CANCER#0.6132
10159	HANDLE REGION PEPTIDE#1.0454;END ORGAN DAMAGE#1.0423;PODOCYTE#1.0336;SIGNAL TRANSDUCTION#1.0282;SIGNALING PATHWAY#1.0262;MESANGIAL CELL#1.0230;ALISKIREN#1.0228;DUCT CELL#1.0220;NEPHRON#1.0159;MITOGEN ACTIVATED PROTEIN#1.0146;AUTOPHAGY#1.0136;PROTEIN KINASE#1.0099;NEPHROPATHY#1.0070;ANGIOTENSIN CONVERTING ENZYME#1.0067;SMOOTH MUSCLE#1.0063;CELL PROLIFERATION#1.0051;DIABETIC NEPHROPATHY#1.0031;SMOOTH MUSCLE CELL#1.0023;ALDOSTERONE#1.0019;ENDOTHELIAL CELL#1.0018;MUSCLE CELL#1.0017;APOPTOSIS#0.9993;RENIN ACTIVITY#0.9924;GENE EXPRESSION#0.9923;KIDNEY DISEASE#0.9915;HYPERTENSION#0.9897;DIABETES MELLITUS#0.9891;DIABETIC RETINOPATHY#0.9870;GROWTH FACTOR#0.9832;EXCRETION#0.9822;TRANSFORMING GROWTH FACTOR#0.9802;NERVOUS SYSTEM#0.9791;STEM CELL#0.9710;ATPASE ACTIVITY#0.9680;ADIPOSE TISSUE#0.9676;DIRECT RENIN INHIBITOR#0.9616;ENZYME INHIBITOR#0.9520;PROTON PUMP#0.9486;COLLECTING DUCTS#0.9485;RECEPTOR ANTAGONIST#0.9430;CENTRAL NERVOUS SYSTEM#0.9418;ACIDIFICATION#0.9405;VASCULAR SMOOTH MUSCLE CELL#0.9389;ENDOTHELIAL GROWTH FACTOR#0.9355;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9355;POLYMERASE CHAIN REACTION#0.9285;LOSARTAN#0.9265;CHRONIC KIDNEY DISEASE#0.9212;CELL SURFACE#0.9169;SIGNALLING PATHWAY#0.9119;REACTIVE OXYGEN SPECIES#0.9100;STREPTOZOTOCIN#0.8925;ANGIOTENSIN RECEPTOR#0.8899;PROTEINURIA#0.8897;WNT RECEPTOR#0.8844;GLOMERULAR FILTRATION#0.8834;RENAL FIBROSIS#0.8822;ENDOTHELIUM#0.8775;NADPH OXIDASE#0.8762;LOW DENSITY LIPOPROTEIN#0.8722;VASOPRESSIN#0.8667;V-ATPASE ASSEMBLY#0.8657;INTRACELLULAR SIGNALING PATHWAY#0.8616;GESTATIONAL DIABETES#0.8592;OBSTRUCTIVE SLEEP APNEA#0.8564;SLEEP APNEA#0.8548;VALSARTAN#0.8471;KIDNEY DEVELOPMENT#0.8467;CARDIOMYOPATHY#0.8434;CATALYTIC ACTIVITY#0.8404;BRAIN RENIN-ANGIOTENSIN SYSTEM#0.8338;INFLAMMATORY RESPONSE#0.8297;CANCER CELL#0.8271;SYSTOLIC BLOOD PRESSURE#0.8259;NITRIC OXIDE#0.8245;CELL DEATH#0.8234;TRANSCRIPTION FACTOR#0.8139;RETINAL DEVELOPMENT#0.8110;ZINC FINGER PROTEIN#0.8061;ALCOHOLIC CARDIOMYOPATHY#0.8033;EPITHELIAL CELL#0.7993;SITE 1 PROTEASE#0.7931;CELL POLARITY#0.7913;URINARY PROTEIN#0.7911;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7881;HUMAN UMBILICAL VEIN#0.7874;UMBILICAL VEIN#0.7871;SKELETAL MUSCLE#0.7818;RECEPTOR COMPLEX#0.7816;EXTRACELLULAR MATRIX#0.7816;GESTATIONAL DIABETES MELLITUS#0.7791;MONOCYTE#0.7785;HIGH FAT DIET#0.7644;TISSUE DAMAGE#0.7632;PLASMA MEMBRANE#0.7611;MACROPHAGE#0.7601;EPITHELIAL SODIUM CHANNEL#0.7597;ACE INHIBITOR#0.7509;MENTAL RETARDATION#0.7485;EMBRYONIC STEM CELL#0.7463;TUMOR NECROSIS FACTOR#0.7436;PANCREATIC CANCER#0.7407;PLANAR CELL POLARITY#0.7402;BLOOD PRESSURE REGULATION#0.7353;WNT RECEPTOR COMPLEX#0.7267;SODIUM CHANNEL#0.7247;ENDOPLASMIC RETICULUM#0.7240;CELL MEMBRANE#0.7203;URETERIC BUD#0.7194;OF DIABETIC RATS#0.7138;T CELL#0.7131;CAPTOPRIL#0.7099;STROMAL CELL#0.7044;SLEEP APNEA SYNDROME#0.7037;CARDIOMYOCYTE#0.7026;MAP KINASE#0.7024;SMOOTH MUSCLE ACTIN#0.6970;AORTIC SMOOTH MUSCLE CELLS#0.6952;EXTRACELLULAR SPACE#0.6929;DIABETIC KIDNEY DISEASE#0.6905;MORPHOGENESIS#0.6895;GLOMERULAR FILTRATION RATE#0.6860;PROLIFERATIVE DIABETIC RETINOPATHY#0.6853;ARTERY#0.6839;ISCHEMIA#0.6837;RECEPTOR BINDING#0.6762;MAPK ACTIVATION#0.6726;GESTATION#0.6677;ATPASE COMPLEX#0.6675;C REACTIVE PROTEIN#0.6669;BAFILOMYCIN A1#0.6574;REVERSE TRANSCRIPTION#0.6572;TYPE 2 DIABETES#0.6556;ADENOCARCINOMA#0.6528;BRAIN DEVELOPMENT#0.6512;CARDIOVASCULAR SYSTEM#0.6506;HYPOXIA#0.6443;APOPTOTIC#0.6292;PANCREATIC DUCTAL ADENOCARCINOMA#0.6284;NEUROGENESIS#0.6225;CELL DIFFERENTIATION#0.6213;GLOMERULAR FILTRATION BARRIER#0.6201;BRANCHING MORPHOGENESIS#0.6152;INTELLECTUAL DISABILITY#0.6074;ANGIOGENESIS#0.6073;REGULATION OF BLOOD PRESSURE#0.6070;MALIGNANT HYPERTENSION#0.6066;ADULT HIPPOCAMPAL NEUROGENESIS#0.6020
1015	PEPTIDE TRANSPORTER#1.0699;HEPATOCELLULAR CARCINOMA#1.0417;CANCER CELL#1.0347;COLORECTAL#1.0313;ADENOCARCINOMA#1.0249;LYMPH NODE#1.0197;CELL PROLIFERATION#1.0155;COLORECTAL ADENOCARCINOMA#1.0055;COLORECTAL CANCER#1.0035;GENE EXPRESSION#0.9983;CELL ADHESION#0.9929;APOPTOSIS#0.9888;LYMPH NODE METASTASIS#0.9873;COLON CANCER#0.9818;SIGNALING PATHWAY#0.9508;TRANSCRIPTION FACTOR#0.9345;RNA INTERFERENCE#0.9030;CELL CYCLE#0.8802;EPITHELIAL CELL#0.8726;INTEGRIN ACTIVATION#0.8706;GROWTH FACTOR#0.8703;METASTATIC COLORECTAL ADENOCARCINOMA#0.8672;GASTRIC ADENOCARCINOMA#0.8321;PANCREATIC CANCER#0.8154;METAPLASIA#0.8153;TOCOPHEROL#0.8106;TIGHT JUNCTION#0.7583;NEOPLASTIC TISSUES#0.7529;GASTROINTESTINAL TRACT#0.7528;CELL ADHESION MOLECULE#0.7512;CELL CYCLE ARREST#0.7494;ONCOGENIC#0.7352;POLYMERASE CHAIN REACTION#0.7248;SMALL INTESTINE#0.7071;CLEAVED CASPASE 3#0.6846;COLORECTAL CARCINOMA#0.6844;HYPOXANTHINE#0.6815;TUMOR TISSUES#0.6590;LYMPH NODE MICROMETASTASIS#0.6520;APOPTOTIC#0.6510;LIVER METASTASIS#0.6455;METANEPHRIC ADENOMA#0.6413;GUANINE#0.6405;TUMOR SUPPRESSOR#0.6311;EPIDERMAL GROWTH FACTOR#0.6307;ORGANIC CATION TRANSPORTER#0.6148;ORGANIC ANION TRANSPORTER#0.6134;PROTEIN KINASE#0.6089;HISTIDINE#0.6051;REVERSE TRANSCRIPTION#0.6035;CELL SURFACE#0.6024
10160	NUCLEOTIDE EXCHANGE FACTOR#0.6835;CHONDROCYTE#0.6295;ADVANCED GASTRIC CANCER#0.6036;OVERALL SURVIVAL TIME#0.6033
10161	AUTOSOMAL RECESSIVE HYPOTRICHOSIS#1.1080;HYPOTRICHOSIS#1.0891;HAIR GROWTH#0.9783;HAIR FOLLICLE#0.9445;CANCER CELL#0.8658;ENDOTHELIAL CELL#0.8403;HAIR LOSS#0.8130;CELL PROLIFERATION#0.8100;SIGNALING PATHWAY#0.7908;GENE EXPRESSION#0.7506;SCALP#0.6708;GROWTH FACTOR#0.6376;HEPATOCELLULAR CARCINOMA#0.6373;QUANTITATIVE REAL TIME#0.6322;HAIR FOLLICLE DEVELOPMENT#0.6245;BREAST CANCER#0.6144
10162	ARACHIDONIC ACID#0.9243;MACROPHAGE#0.8452;LIPID METABOLISM#0.7646;SMALL INTESTINE#0.7562;ATHEROSCLEROSIS#0.7384;ENTEROCYTE#0.7379;CHOLESTEROL BIOSYNTHESIS#0.7094;PHOSPHOLIPID HOMEOSTASIS#0.6588;LIVER X RECEPTOR#0.6171;CELL DEATH#0.6118;T CELL#0.6047
10163	T CELL#1.0589;ACTIN RELATED PROTEIN#1.0360;WISKOTT ALDRICH SYNDROME#1.0331;CELL MIGRATION#1.0247;ACTIN POLYMERIZATION#1.0231;CANCER CELL#1.0127;CELL MOTILITY#1.0041;GROWTH FACTOR#1.0011;SIGNALING PATHWAY#1.0010;ACTIN FILAMENT#0.9990;ACTIN CYTOSKELETON#0.9987;ACTIN NUCLEATION#0.9904;WAVE COMPLEX#0.9662;MICROTUBULE#0.9624;BREAST CANCER#0.9612;RUFFLE#0.9470;RNA INTERFERENCE#0.9306;COMPLEX I#0.9041;MACROPHAGE#0.8881;MEMBRANE RUFFLING#0.8819;INSULIN RECEPTOR#0.8633;LAMELLIPODIUM FORMATION#0.8571;CELL MOVEMENT#0.8452;CELL ADHESION#0.8420;CELL PERIPHERY#0.8359;T CELL ACTIVATION#0.8318;LYMPH NODE#0.8297;CELL ACTIVATION#0.8295;MEMBRANE TRANSPORT#0.8212;EPITHELIAL CELL#0.7881;LYMPH NODE METASTASIS#0.7676;OOCYTE#0.7615;INSULIN RECEPTOR SUBSTRATE#0.7614;PANCREATIC CANCER#0.7588;HEPATOCYTE GROWTH FACTOR#0.7580;PLASMA MEMBRANE#0.7547;LAMELLIPODIUM#0.7541;PROTEIN KINASE#0.7309;BINDING PROTEIN 1#0.7011;PROTEIN COMPLEX#0.6836;FILOPODIUM FORMATION#0.6819;CD4+ T CELL#0.6766;KINESIN COMPLEX#0.6741;BREAST CANCER CELL#0.6674;EXTRACELLULAR MATRIX#0.6663;ASYMMETRIC CYTOKINESIS#0.6630;ACTIN BINDING#0.6620;CELL MEMBRANE#0.6557;MEMBRANE RUFFLE#0.6555;IMMUNOLOGICAL SYNAPSE#0.6526;KINESIN#0.6405;ZONULA ADHERENS#0.6390;ENDOTHELIAL CELL#0.6326;MORPHOGENESIS#0.6323;SH3 DOMAIN BINDING#0.6287;NUCLEAR MIGRATION#0.6281;CELL POLARITY#0.6106;REVERSE TRANSCRIPTION#0.6101;WAVE REGULATORY COMPLEX#0.6074;HUMAN BREAST CANCER#0.6060
10164	SELECTIN#1.0421;LYMPHOCYTE HOMING#1.0418;LYMPH NODE#1.0384;GLCNAC#1.0223;SULFATION#1.0095;VENULE#0.9632;ENDOTHELIAL CELL#0.9554;PERIPHERAL LYMPH NODES#0.8677;MUCINOUS ADENOCARCINOMA#0.8516;O GLYCAN#0.8367;ADENOCARCINOMA#0.7540;EPITHELIAL CELL#0.6962;LEUKOCYTE#0.6616;T CELL#0.6473;PAPILLARY SEROUS ADENOCARCINOMA#0.6400;HUMAN UMBILICAL VEIN#0.6206;UMBILICAL VEIN#0.6203;COLITIS#0.6090;B CELL#0.6085;CANCER CELL#0.6067
10165	CITRULLINEMIA#1.0753;INTRAHEPATIC CHOLESTASIS#1.0418;ASPARTATE#1.0414;UREA CYCLE#1.0366;CHOLESTASIS#1.0365;HEPATOCELLULAR CARCINOMA#1.0177;ARGININOSUCCINATE#1.0071;CITRULLINE#1.0068;LIVER DISEASE#0.9724;MALATE ASPARTATE SHUTTLE#0.9607;FATTY LIVER#0.9135;HEPATIC ENCEPHALOPATHY#0.8983;PERIPHERAL BLOOD#0.8799;ARGININE#0.8799;GLYCOLYSIS#0.8536;PYRUVATE#0.8216;MITOCHONDRIA#0.8197;PERIPHERAL BLOOD LYMPHOCYTES#0.8128;AUTOSOMAL RECESSIVE DISEASE#0.8042;BRAIN EDEMA#0.7907;EDEMA#0.7869;METHIONINE#0.7447;FATTY LIVER DISEASE#0.6870;PANCREATITIS#0.6570;BILIARY ATRESIA#0.6528;LACTOSE#0.6153
101669762	CELL PROLIFERATION#1.0901;CANCER CELL#1.0787;LYMPH NODE METASTASIS#0.9702;LYMPH NODE#0.9649;LUNG CANCER#0.9011;ONCOGENIC#0.8845;SIGNALING PATHWAY#0.8822;CERVICAL CANCER#0.8426;COLORECTAL CANCER#0.8372;POLYMERASE CHAIN REACTION#0.8076;ADJACENT NORMAL TISSUE#0.7376;SQUAMOUS CELL CARCINOMA#0.7168;CELL CYCLE#0.7151;COLORECTAL#0.6723;CERVICAL#0.6651;REVERSE TRANSCRIPTION#0.6619;EPITHELIAL MESENCHYMAL TRANSITION#0.6428;APOPTOSIS#0.6407;BREAST CANCER#0.6347;PRC2 COMPLEX#0.6197;NORMAL ADJACENT TISSUE#0.6036
101669763	HISTONE H4 ACETYLATION#1.2243
101669767	PROSTATE CANCER#1.0867;SWI-SNF COMPLEX#0.8776
10166	ORNITHINE#1.0756;UREA CYCLE#1.0480;MITOCHONDRIAL MEMBRANE#0.8438;ARGININE#0.8021;INNER MITOCHONDRIAL MEMBRANE#0.7817;ORNITHINE TRANSPORT#0.7381;UREA CYCLE DISORDER#0.6834;CITRULLINE#0.6007
10167	CYSTIC FIBROSIS#0.8240
10170	3-ALPHA-HSD ACTIVITY#1.1001;RETINOL DEHYDROGENASE#1.0588;RETINOL#1.0426;BETA-HYDROXYSTEROID DEHYDROGENASE#1.0421;ALDO KETO REDUCTASE#1.0184;ANTI INFLAMMATORY DRUGS#1.0148;CHLORDECONE REDUCTASE#1.0127;5.ALPHA.-DIHYDROTESTOSTERONE#1.0072;5ALPHA DIHYDROTESTOSTERONE#0.9995;DIHYDROTESTOSTERONE#0.9986;INDOMETHACIN#0.9909;TESTOSTERONE#0.9855;PROGESTERONE#0.9846;ENZYME ACTIVITY#0.9809;RETINOIC ACID#0.9748;ANDROGEN METABOLISM#0.9407;BILE ACID BINDING#0.9386;EPITHELIAL CELL#0.9273;ANDROGEN RECEPTOR#0.9262;MICROSOME#0.9253;GENE EXPRESSION#0.9202;ASTROCYTE#0.9136;STEROID BINDING#0.8882;ESTRADIOL#0.8828;ALDEHYDE REDUCTASE#0.8741;ANDROSTENEDIONE#0.8674;LEYDIG CELL#0.8601;SUBMANDIBULAR GLAND#0.8479;CHENODEOXYCHOLIC ACID#0.8409;GLIAL CELL#0.8356;OVARIAN#0.8184;CHOLIC ACID#0.8172;MUTAGENESIS#0.8138;ADIPOSE TISSUE#0.8071;NICOTINAMIDE#0.7955;GLYCINE#0.7880;CANCER CELL#0.7832;ESTROGENS#0.7827;PROGESTIN#0.7785;PROSTAGLANDIN F SYNTHASE#0.7655;STEROID METABOLISM#0.7641;PROSTATE CANCER#0.7641;20ALPHA-HYDROXYSTEROID DEHYDROGENASE#0.7602;COFACTOR BINDING#0.7594;TRANSCRIPTION FACTOR#0.7217;MEDROXYPROGESTERONE ACETATE#0.7131;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.7077;NERVOUS SYSTEM#0.6997;OLIGODENDROCYTE#0.6927;ADENINE#0.6812;CENTRAL NERVOUS SYSTEM#0.6747;STROMAL CELL#0.6722;DIHYDRODIOL DEHYDROGENASE ACTIVITY#0.6717;STEROID DEHYDROGENASE#0.6705;3BETA-HYDROXYSTEROID DEHYDROGENASE#0.6639;STEROID 5ALPHA-REDUCTASE#0.6611;GRANULOSA CELL#0.6577;DODECYL SULFATE#0.6382;GLUCOSE-6-PHOSPHATE#0.6296;MACROPHAGE#0.6265;VITAMIN A#0.6243;STROMA#0.6232;OMENTAL ADIPOSE TISSUE#0.6166;OLFACTORY BULB#0.6100;PROGESTERONE METABOLISM#0.6100;GLUTATHIONE#0.6090;SODIUM DODECYL SULFATE#0.6051;POLYCYCLIC AROMATIC HYDROCARBON#0.6040
10171	RRNA PROCESSING#0.7718;SMALL NUCLEOLAR RNA#0.6536;RIBOSOMAL SUBUNIT#0.6363;RIBOSOME#0.6075
10172	TRANSCRIPTIONAL REPRESSOR ACTIVITY#0.8602;CELL PROLIFERATION#0.7958
10174	FOCAL ADHESION#1.0728;CELL ADHESION#1.0501;GROWTH FACTOR#0.9552;GENE EXPRESSION#0.9530;EPIDERMAL GROWTH FACTOR#0.8654;SIGNAL TRANSDUCTION#0.8649;PROTEIN KINASE#0.8647;CELL MIGRATION#0.8448;VINCULIN BINDING#0.8073;DNA METHYLATION#0.6977;CELL GROWTH#0.6902;EXTRACELLULAR MATRIX#0.6359;CAM BINDING#0.6283;CYTOKINETIC ABSCISSION#0.6259;ACTIN CYTOSKELETON#0.6174;GERM CELL#0.6162;ESTROGEN RECEPTOR#0.6073;SKELETAL MUSCLE#0.6061;TUMOR SUPPRESSOR#0.6060;SMOOTH MUSCLE#0.6050
10175	T CELL ACTIVATION#0.6440;CELL ACTIVATION#0.6406;T CELL#0.6324
10178	BREAST CANCER#0.8062;HUMAN BREAST CANCER#0.7161;NOTTINGHAM PROGNOSTIC INDEX#0.6766;LYMPH NODE#0.6694
10179	RNA BINDING#1.0487;EXOSOME#0.9626;RNA SPLICING#0.6247
1017	CYCLIN A1-CDK2 COMPLEX#1.0698;CYCLIN E KINASE ACTIVITY#1.0530;CENTROSOME DUPLICATION#1.0347;OLOMOUCINE#1.0330;FLAVOPIRIDOL#1.0310;PURVALANOL A#1.0310;CYCLIN BINDING#1.0211;DNA POLYMERASE ALPHA#1.0208;CENTROSOME#1.0178;CATALYTIC ACTIVITY#1.0164;S-PHASE CHECKPOINT#1.0099;CENTRIOLE#1.0090;HYPOXIA#1.0073;KINASE INHIBITOR P27#1.0071;THYMOCYTE#1.0060;ATP BINDING#1.0049;MEIOSIS#1.0044;CDC2 KINASE ACTIVITY#1.0033;DOMINANT NEGATIVE MUTANT#1.0030;PROTEIN COMPLEX#1.0025;KINASE ACTIVITY#1.0006;CLEAVED CASPASE 3#0.9993;STAUROSPORINE#0.9984;PROTEIN PHOSPHORYLATION#0.9983;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9978;CYCLIN DEPENDENT KINASE#0.9976;HYPERPHOSPHORYLATION#0.9973;DNA DAMAGE CHECKPOINT#0.9970;IFN-GAMMA#0.9970;DEPHOSPHORYLATION#0.9970;MOLECULAR DYNAMICS SIMULATION#0.9965;CELL DIVISION CYCLE#0.9940;ATAXIA TELANGIECTASIA#0.9927;COMPLEX I#0.9924;OOCYTE#0.9923;INTERPHASE#0.9923;CELL CYCLE TRANSITION#0.9909;CELLULAR SENESCENCE#0.9904;THYMOCYTE APOPTOSIS#0.9903;ENTRY INTO MITOSIS#0.9896;MITOTIC CELL CYCLE#0.9891;HEPATOMA CELLS#0.9874;MAP KINASE#0.9873;LOVASTATIN#0.9873;B CELL LYMPHOMA#0.9864;PROTEIN KINASE ACTIVITY#0.9864;GERM CELL#0.9857;NUCLEAR EXPORT#0.9855;ANAPHASE#0.9849;DEGRADATION OF CYCLIN#0.9848;G2 PHASE#0.9846;MESANGIAL CELL#0.9840;TELOMERE#0.9831;REGULATION OF CELL CYCLE#0.9831;PROGESTERONE#0.9824;MAMMARY EPITHELIAL CELL#0.9818;RETINOBLASTOMA#0.9817;GLYCOGEN SYNTHASE KINASE#0.9817;PROTEIN KINASE B#0.9811;TRANSACTIVATION#0.9810;GENISTEIN#0.9810;CELL CYCLE REGULATOR#0.9802;S PHASE#0.9800;MYOBLAST#0.9799;SENESCENCE#0.9798;ANDROGEN RECEPTOR#0.9789;CELL CYCLE PHASE#0.9787;VSMC PROLIFERATION#0.9786;LIVER CANCER#0.9783;GENOTOXIC#0.9781;CYCLIN D1-CDK4 COMPLEX#0.9781;STRUCTURE ACTIVITY RELATIONSHIP#0.9779;DOUBLE STRAND BREAK#0.9776;FACTOR XA#0.9774;QUIESCENCE#0.9773;C TERMINAL DOMAIN#0.9773;LIVER REGENERATION#0.9771;MOUSE EMBRYONIC FIBROBLAST#0.9768;CYCLIN-DEPENDENT KINASE ACTIVITY#0.9768;DNA REPLICATION#0.9763;DNA DAMAGE RESPONSE#0.9762;PROPHASE#0.9761;CDK INHIBITOR#0.9759;CELL DIFFERENTIATION#0.9757;GRANULOSA CELL#0.9755;SIGNALLING PATHWAY#0.9753;ESTRADIOL#0.9751;ENDOTHELIAL GROWTH FACTOR#0.9743;INHIBITION OF CELL PROLIFERATION#0.9743;PROTEIN KINASE INHIBITOR#0.9740;RAPAMYCIN#0.9740;LYMPH NODE#0.9739;KERATINOCYTE#0.9737;OVARIAN CARCINOMA#0.9737;CISPLATIN#0.9730;TOPOISOMERASE#0.9730;CERVICAL CANCER#0.9730;REVERSE TRANSCRIPTION#0.9729;TUMOR TISSUES#0.9728;ENZYME ACTIVITY#0.9722;LUNG CARCINOMA#0.9722;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9719;PROGENITOR CELL#0.9718;DNA REPAIR#0.9714;CELL CYCLE CHECKPOINT#0.9713;CELL DIVISION#0.9713;QUANTITATIVE REAL TIME#0.9713;CELL ADHESION#0.9712;CENTRIOLE DUPLICATION#0.9708;PYRAZOLE#0.9707;MACROPHAGE#0.9706;PROTEIN KINASE C#0.9705;G1 PHASE#0.9702;MITOSIS#0.9700;VIRAL REPLICATION#0.9699;TAMOXIFEN#0.9699;RNA INTERFERENCE#0.9696;HEPATOCYTE PROLIFERATION#0.9696;HEMATOPOIETIC CELL#0.9694;PURVALANOL#0.9694;TERMINAL DIFFERENTIATION#0.9694;CELL CYCLE#0.9693;ALANINE#0.9692;INSULIN-LIKE GROWTH FACTOR#0.9692;FIBROBLAST GROWTH FACTOR#0.9692;NEUROBLASTOMA#0.9687;OVARIAN CANCER#0.9685;T CELL#0.9685;PANCREATIC CANCER#0.9683;EPITHELIAL MESENCHYMAL TRANSITION#0.9681;CASPASE-3 ACTIVITY#0.9678;B CELL#0.9677;OVARIAN#0.9677;CELL CYCLE CONTROL#0.9676;CARDIOMYOCYTE#0.9673;CYTOPLASM#0.9671;PROTEASOME#0.9671;PACLITAXEL#0.9670;CDK ACTIVITY#0.9670;MAPK SIGNALING#0.9669;GROWTH FACTOR RECEPTOR#0.9669;FACTOR I#0.9669;GLUTATHIONE#0.9668;DNA SYNTHESIS#0.9665;PROTEIN PROTEIN INTERACTION#0.9665;CYCLIN DEPENDENT KINASE INHIBITOR#0.9663;RETINOIC ACID#0.9662;LYMPH NODE METASTASIS#0.9661;UBIQUITIN#0.9659;ESTROGEN RECEPTOR#0.9656;EMBRYONIC STEM CELL#0.9654;BONE MARROW#0.9653;TARGET OF RAPAMYCIN#0.9651;CERVICAL#0.9651;CELL CYCLE ARREST#0.9650;SMOOTH MUSCLE CELL PROLIFERATION#0.9650;TRANSFORMING GROWTH FACTOR BETA#0.9649;PROTEIN KINASE#0.9649;AUTOPHAGY#0.9648;DOXORUBICIN#0.9647;COLORECTAL CANCER#0.9647;MUSCLE CELL PROLIFERATION#0.9647;ANCHORAGE INDEPENDENT GROWTH#0.9645;AKT SIGNALING#0.9643;PLATELET-DERIVED GROWTH FACTOR#0.9642;POLYMERASE CHAIN REACTION#0.9639;OLIGODENDROCYTE#0.9638;INHIBITION OF CELL GROWTH#0.9637;FLOW CYTOMETRY ANALYSIS#0.9632;REGENERATION#0.9632;EPIDERMAL GROWTH FACTOR#0.9632;BREAST CARCINOMA#0.9630;ADENOSINE#0.9630;ORIGIN RECOGNITION COMPLEX#0.9630;CELL CYCLE PATHWAY#0.9629;PROTEIN SYNTHESIS#0.9628;MICROTUBULE#0.9625;T LYMPHOCYTE#0.9623;COLORECTAL#0.9623;ANAPHASE PROMOTING COMPLEX#0.9619;APOPTOTIC CELL DEATH#0.9613;RENAL CELL CARCINOMA#0.9610;ENDOTHELIAL CELL#0.9610;RESVERATROL#0.9608;SIGNALING CASCADE#0.9608;SQUAMOUS CELL CARCINOMA#0.9607;COLON CARCINOMA#0.9602;M PHASE#0.9602;HEPATOCELLULAR CARCINOMA CELL#0.9601;CELL CYCLE REGULATION#0.9600;EPITHELIAL CELL#0.9600;KINASE INHIBITOR#0.9600;DNA BINDING#0.9599;CYTOCHROME C#0.9597;TRANSFORMING GROWTH FACTOR#0.9596;TUMOR NECROSIS FACTOR#0.9593;ENDOMETRIAL CARCINOMA#0.9588;PROTEASOME PATHWAY#0.9587;HOST CELL#0.9586;MOUSE EMBRYO FIBROBLASTS#0.9585;MUTAGENESIS#0.9585;CELL MIGRATION#0.9585;MITOTIC SPINDLE#0.9583;THYMIDINE#0.9583;POLY ADP RIBOSE#0.9581;MECHANISM OF ACTION#0.9579;RIBOSE#0.9576;BREAST CANCER CELL#0.9575;BREAST CANCER#0.9575;SPERMATOCYTES#0.9574;SIGNAL TRANSDUCTION#0.9573;TRANSCRIPTASE#0.9573;CASPASE ACTIVATION#0.9573;MITOGEN ACTIVATED PROTEIN#0.9572;SIGNALING MOLECULE#0.9572;MOUSE EMBRYONIC STEM#0.9568;COLON CANCER#0.9564;TUMOR CELLS#0.9559;ONCOGENIC#0.9559;MYELOID LEUKEMIA#0.9558;ATAXIA TELANGIECTASIA MUTATED#0.9557;CELL SURFACE#0.9556;HUMAN BREAST CANCER#0.9556;RECEPTOR TYROSINE KINASE#0.9551;MECHANISMS OF ACTION#0.9544;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9542;TUMOR SUPPRESSOR#0.9537;EXTRACELLULAR MATRIX#0.9537;COLONY FORMATION ASSAY#0.9537;STEM CELL#0.9535;MITOTIC ENTRY#0.9534;LUNG CANCER#0.9531;HISTONE DEACETYLASE#0.9529;ADENOCARCINOMA#0.9526;REPLICATION FORK#0.9525;SMOOTH MUSCLE#0.9523;PROSTATE CANCER#0.9523;LUNG ADENOCARCINOMA#0.9522;ANGIOGENESIS#0.9521;PROSTATE CARCINOMA#0.9521;VASCULAR SMOOTH MUSCLE CELL#0.9521;TRANSCRIPTION FACTOR#0.9520;SKELETAL MUSCLE#0.9520;DNA FRAGMENTATION#0.9519;NERVOUS SYSTEM#0.9519;GROWTH FACTOR#0.9519;MITOCHONDRIAL MEMBRANE#0.9517;ARTERY#0.9517;CYTOCHROME C RELEASE#0.9512;ACUTE MYELOID LEUKEMIA#0.9512;PROPIDIUM#0.9512;HEPATOCELLULAR CARCINOMA#0.9511;COLORECTAL CARCINOMA#0.9510;LYSINE#0.9510;MUSCLE CELL#0.9508;ASTROCYTE#0.9508;GENE EXPRESSION#0.9507;SMOOTH MUSCLE CELL#0.9506;CELL DEATH#0.9506;MITOCHONDRIA#0.9504;PROTEIN KINASE A#0.9503;ENDOPLASMIC RETICULUM#0.9503;APOPTOSIS#0.9501;INTESTINAL EPITHELIAL CELL#0.9500;INDUCTION OF APOPTOSIS#0.9496;HEAT SHOCK PROTEIN#0.9496;REACTIVE OXYGEN SPECIES#0.9491;APOPTOTIC#0.9490;TOXICITY#0.9487;CANCER CELL#0.9484;CELL GROWTH#0.9480;CYTOTOXICITY#0.9478;WOUND HEALING#0.9476;CELL PROLIFERATION#0.9476;CELL COUNTING KIT#0.9474;MELANOCYTE#0.9467;ROS GENERATION#0.9466;PREADIPOCYTE#0.9463;PERIPHERAL BLOOD#0.9457;SIGNALING PATHWAY#0.9457;FOCAL ADHESION#0.9454;ATHEROSCLEROSIS#0.9452;METAPHASE#0.9446;OOCYTE MATURATION#0.9443;CONTACT INHIBITION#0.9436;PROGRAMMED CELL DEATH#0.9427;ETOPOSIDE#0.9425;DNA LIGASE#0.9412;SIMVASTATIN#0.9409;ENHANCER BINDING PROTEIN#0.9404;RIBOSOMAL PROTEIN#0.9403;TRADITIONAL CHINESE MEDICINE#0.9403;ENHANCER BINDING#0.9400;TOPOISOMERASE II#0.9394;ONCOGENESIS#0.9393;TYROSINE KINASE INHIBITOR#0.9391;MULTIPLE MYELOMA#0.9390;NITRIC OXIDE#0.9368;CELL DEVELOPMENT#0.9361;PEROXISOME#0.9357;LEIOMYOMA#0.9351;ALL TRANS RETINOIC ACID#0.9340;CASPASE INHIBITOR#0.9339;FOCAL ADHESION KINASE#0.9322;DEXAMETHASONE#0.9309;CHROMATIN REMODELING#0.9305;SIGNAL TRANSDUCER#0.9299;CYCLIC AMP#0.9271;NUCLEAR LOCALIZATION SIGNAL#0.9258;IMMUNE RESPONSE#0.9250;MODE OF ACTION#0.9243;HOMOLOGOUS RECOMBINATION#0.9242;MYOTUBE#0.9241;REPLICATIVE SENESCENCE#0.9240;PHOSPHATASE ACTIVITY#0.9234;SEQUESTERING#0.9214;HUMAN PANCREATIC CANCER#0.9203;CENTRAL NERVOUS SYSTEM#0.9200;NUCLEAR IMPORT#0.9200;BREAST CANCER PATIENTS#0.9188;MYELOID CELL#0.9160;EPSTEIN BARR VIRUS#0.9147;DRUG RESISTANCE#0.9135;HYPOXIC#0.9129;FERTILIZATION#0.9125;ARGININE#0.9095;NULL CELL#0.9086;HUMAN MAMMARY EPITHELIAL#0.9054;HYDROXYUREA#0.9040;ALZHEIMER'S DISEASE#0.9031;NUCLEAR ENVELOPE#0.9024;HELICASE ACTIVITY#0.9024;TELOMERASE ACTIVITY#0.9016;INDOLE#0.9016;HEAD AND NECK CANCER#0.9003;NECK CANCER#0.9002;LYMPHOCYTIC LEUKEMIA#0.8992;ADIPOGENESIS#0.8985;PHOSPHOLIPASE C#0.8971;DIHYDROFOLATE REDUCTASE#0.8964;TRASTUZUMAB#0.8956;DEATH RECEPTOR#0.8954;5 FLUOROURACIL#0.8941;PROTEIN BINDING#0.8938;DUAL SPECIFICITY PHOSPHATASE#0.8930;ORAL SQUAMOUS CELL CARCINOMA#0.8910;MAMMARY GLAND#0.8909;FLOW CYTOMETRY ASSAY#0.8906;LEUCINE#0.8897;HUMAN UMBILICAL VEIN#0.8881;CYTOKINESIS#0.8880;UMBILICAL VEIN#0.8879;HUMAN IMMUNODEFICIENCY VIRUS#0.8877;CELL ACTIVATION#0.8862;REPLICATION PROTEIN A#0.8858;ACTINOMYCIN D#0.8849;INSULIN RECEPTOR#0.8825;BUDDING#0.8804;HISTONE DEACETYLASE INHIBITOR#0.8803;UBIQUITIN PROTEASOME PATHWAY#0.8802;ADIPOCYTE#0.8797;PLASMA MEMBRANE#0.8785;HEPATITIS B#0.8781;ADJACENT NORMAL TISSUE#0.8778;MELANOMA CELL LINES#0.8775;NEURODEGENERATIVE DISEASE#0.8771;CELL MEMBRANE#0.8765;PROGESTIN#0.8764;CARCINOGEN#0.8762;G0 PHASE#0.8761;GENE SILENCING#0.8751;72-HOURS#0.8749;MESENCHYMAL STEM CELL#0.8747;ETHANOL#0.8742;CHRONIC LYMPHOCYTIC LEUKEMIA#0.8724;AORTIC SMOOTH MUSCLE CELLS#0.8711;VASCULAR ENDOTHELIAL CELL#0.8710;MONONUCLEAR CELLS#0.8706;CELLULAR GROWTH#0.8697;DUAL LUCIFERASE REPORTER#0.8692;ENDOMETRIAL CANCER#0.8680;2'-DEOXYURIDINE#0.8650;B LYMPHOCYTE#0.8649;CANCER RELATED DEATH#0.8647;CAROTID ARTERY#0.8647;PROTEIN TYROSINE KINASE#0.8599;CD4+ T CELL#0.8594;BINDING PROTEIN 1#0.8590;HEPATOCYTE GROWTH FACTOR#0.8588;TETRACYCLINE#0.8585;CAFFEINE#0.8582;UBIQUITIN LIGASE COMPLEX#0.8581;THYROID CARCINOMA#0.8569;STROMAL CELL#0.8557;PROTEIN DATA BANK#0.8550;LINES OF EVIDENCE#0.8548;PROTEIN TYROSINE PHOSPHATASE#0.8541;ARYL HYDROCARBON RECEPTOR#0.8537;DNA REPLICATION INITIATION#0.8518;SCHWANN CELL#0.8499;MIMOSINE#0.8476;SKIN CANCER#0.8441;P53 SIGNALING PATHWAY#0.8435;TUBE FORMATION#0.8428;MAPK ACTIVATION#0.8393;CANCER STEM CELL#0.8365;LUNG FIBROBLASTS#0.8353;HEPATITIS B VIRUS#0.8350;POST-TRANSLATIONAL MODIFICATION#0.8349;GLOMERULONEPHRITIS#0.8333;MISMATCH REPAIR#0.8322;PROTEASOME DEGRADATION#0.8321;SMOOTH MUSCLE ACTIN#0.8311;OSTEOBLAST#0.8302;EPITHELIAL CELL PROLIFERATION#0.8301;HERPES SIMPLEX VIRUS#0.8299;GUANINE#0.8296;HERPES SIMPLEX#0.8296;SPINDLE ASSEMBLY#0.8295;ELECTROPHORETIC MOBILITY SHIFT#0.8291;NEURAL STEM CELL#0.8283;FLUOROURACIL#0.8271;NEUTROPHIL#0.8267;ADRIAMYCIN#0.8258;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.8257;TUBULAR EPITHELIAL CELL#0.8248;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.8239;REGULATION OF CELL PROLIFERATION#0.8238;RNA BINDING#0.8229;MONOCYTE#0.8222;GASTRIC MUCOSA#0.8217;PHOSPHATASE INHIBITOR#0.8207;ENDOTHELIAL CELL PROLIFERATION#0.8206;ARA-C#0.8189;CAMPTOTHECIN#0.8177;LYMPHOMA CELL LINES#0.8171;NERVE GROWTH FACTOR#0.8141;CHROMOSOME SEGREGATION#0.8128;BERBERINE#0.8115;T CELL PROLIFERATION#0.8087;UMBILICAL VEIN ENDOTHELIAL CELLS#0.8082;CHRONIC MYELOID LEUKEMIA#0.8049;ADIPOCYTE DIFFERENTIATION#0.8045;FIBROBLAST PROLIFERATION#0.8031;HYPOXIA INDUCIBLE FACTOR#0.8029;MYOCYTES#0.8021;MITOTIC CATASTROPHE#0.8020;PLURIPOTENT STEM CELL#0.8012;HEMATOPOIESIS#0.8012;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.7998;LUMINAL#0.7992;NON-SMALL CELL LUNG CARCINOMA#0.7991;IMMUNE SYSTEM#0.7985;POSTTRANSLATIONAL MODIFICATION#0.7960;TROPHOBLAST#0.7958;MCM COMPLEX#0.7951;PROTEIN DEGRADATION#0.7950;GEMCITABINE#0.7933;DNA METHYLATION#0.7903;PROTEIN PHOSPHATASE 2A#0.7896;PHOSPHATASE 2A#0.7893;RECEPTOR ANTAGONIST#0.7891;LUCIFERASE ACTIVITY#0.7874;CELL ADHESION MOLECULE#0.7856;SENSITIZATION#0.7847;NOCODAZOLE#0.7841;ANTI HER2#0.7829;MITOTIC EXIT#0.7829;HISTONE KINASE#0.7823;CASEIN KINASE 2#0.7821;ACUTE LYMPHOBLASTIC LEUKEMIA#0.7821;ADENINE#0.7818;SRC FAMILY KINASE#0.7817;LIGASE ACTIVITY#0.7814;QUERCETIN#0.7810;MEIOSIS I#0.7805;GLIOBLASTOMA MULTIFORME#0.7803;T-CELL LEUKEMIA#0.7803;RETINOIC ACID RECEPTOR#0.7800;RHEUMATOID ARTHRITIS#0.7789;MITOTIC CLONAL EXPANSION#0.7762;HEMATOPOIETIC STEM CELL#0.7759;T CELL ACTIVATION#0.7740;APOPTOSIS INDUCING FACTOR#0.7737;ESTROGENS#0.7729;SUPEROXIDE DISMUTASE#0.7721;ISCHEMIA#0.7715;VITAMIN D3#0.7710;OLIGODENDROCYTE PROGENITOR CELL#0.7704;VIRAL DNA REPLICATION#0.7703;ENDOMETRIUM#0.7701;BONE MORPHOGENETIC PROTEIN#0.7692;PRECURSOR CELL#0.7674;INHIBITION OF GROWTH#0.7663;KERATINOCYTE DIFFERENTIATION#0.7632;EPIGALLOCATECHIN#0.7630;GRANULOCYTE#0.7614;POLY T#0.7610;HYPERTENSION#0.7608;HISTONE KINASE ACTIVITY#0.7595;RNA BINDING PROTEIN#0.7592;SMC PROLIFERATION#0.7587;MEIOTIC PROPHASE I#0.7586;ACTIVATED T CELL#0.7582;THYROID CANCER#0.7581;MICROTUBULE ASSOCIATED PROTEIN#0.7577;APOPTOTIC PROCESS#0.7575;PHOSPHATASE I#0.7573;PROTEIN PHOSPHATASE 1#0.7545;N-ACETYLCYSTEINE#0.7537;CELECOXIB#0.7516;DIFFUSE LARGE B-CELL LYMPHOMA#0.7504;REGULATION OF CENTROSOME DUPLICATION#0.7475;PACHYTENE#0.7474;VITAMIN D RECEPTOR#0.7465;DNA HELICASE#0.7461;ACTIVATED CASPASE 3#0.7446;CHROMATIN BINDING#0.7429;STEROID RECEPTOR COACTIVATOR#0.7418;QUANTITATIVE REVERSE TRANSCRIPTION#0.7391;LYMPHOID CELL#0.7385;DISEASE FREE SURVIVAL#0.7380;PI3K SIGNALING#0.7375;GLIAL CELL#0.7373;GENE EXPRESSION OMNIBUS#0.7361;COLONY-STIMULATING FACTOR#0.7357;ADIPOSE TISSUE#0.7354;7-HYDROXYSTAUROSPORINE#0.7330;SPERMATOGENESIS#0.7330;INFERTILITY#0.7324;BETA GALACTOSIDASE#0.7323;REGULATION OF CELLULAR#0.7321;VASCULAR DISEASE#0.7309;GLIDE#0.7298;TESTOSTERONE#0.7294;ESOPHAGEAL CARCINOMA#0.7246;PODOCYTE#0.7233;VAN DER WAALS#0.7230;PCNA COMPLEX#0.7228;BLADDER CARCINOMA#0.7225;CASPASE ACTIVITY#0.7221;KAPOSI'S SARCOMA#0.7215;PHOSPHATASE AND TENSIN HOMOLOG#0.7209;ENDOSOME#0.7179;HEPARIN#0.7179;CYCLOSOME#0.7177;GLUCOCORTICOID RECEPTOR#0.7162;INHIBITION OF DNA REPLICATION#0.7146;INTERFERON REGULATORY FACTOR#0.7132;PAPILLOMA#0.7131;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7129;TYPE 2 DIABETES#0.7128;GLYCINE#0.7126;PROTEIN INTERACTION NETWORK#0.7110;EMBRYONIC LUNG#0.7091;CENTROSOME CYCLE#0.7077;HUMAN EMBRYONIC STEM#0.7073;THYMIDYLATE SYNTHASE#0.7071;GERM CELL DEVELOPMENT#0.7068;EPITHELIAL OVARIAN CANCER#0.7066;ALKALINE PHOSPHATASE#0.7050;CAJAL BODY#0.7035;CORONARY ARTERY#0.6999;DNA REPAIR PROTEIN#0.6998;HISTONE ACETYLTRANSFERASE#0.6967;HISTONE ACETYLATION#0.6960;THYMIDINE KINASE#0.6959;CELL KILLING#0.6959;ADENOSINE TRIPHOSPHATE#0.6939;NEURAL CELL#0.6934;CORD BLOOD#0.6925;BETA-ESTRADIOL#0.6904;MALIGNANT GLIOMA#0.6873;SPINDLE ASSEMBLY CHECKPOINT#0.6871;CPT-11#0.6870;TRANSCRIPTIONAL CONTROL#0.6860;SUMOYLATION#0.6839;MEIOSIS II#0.6838;TUBEROUS SCLEROSIS#0.6837;INHIBITION OF APOPTOSIS#0.6832;CAK COMPLEX#0.6831;OLOMOUCINE II#0.6826;VIRAL INFECTION#0.6824;GEFITINIB#0.6818;PARKINSON'S DISEASE#0.6812;BLOOD VESSEL#0.6811;INHIBITION OF PHOSPHORYLATION#0.6811;ESOPHAGEAL CANCER#0.6809;METASTATIC MELANOMA#0.6802;CELL MOTILITY#0.6788;NEURONAL CELLS#0.6781;TAXOL#0.6750;RHABDOMYOSARCOMA#0.6746;CHOLANGIOCARCINOMA#0.6740;PREGNANE X RECEPTOR#0.6731;ASPIRIN#0.6725;UBIQUITIN LIGASE ACTIVITY#0.6720;SKELETAL MUSCLE CELLS#0.6714;LUNG EPITHELIAL CELL#0.6704;TROPHOBLAST CELL#0.6703;MEIOTIC CELL CYCLE#0.6698;NEURITE OUTGROWTH#0.6692;ENDOPLASMIC RETICULUM STRESS#0.6677;NEURITE#0.6672;LYMPH NODE METASTASES#0.6639;TRANSFORMING GROWTH FACTOR ALPHA#0.6601;L-CYSTEINE#0.6593;ACETYLCYSTEINE#0.6590;ASTROCYTOMA#0.6587;PREREPLICATION COMPLEX#0.6571;COENZYME A#0.6565;PREINITIATION COMPLEX#0.6562;ENDOMETRIAL EPITHELIAL CELLS#0.6560;ANTI APOPTOSIS#0.6560;ARSENIC TRIOXIDE#0.6544;PRE-MRNA SPLICING#0.6543;ORNITHINE DECARBOXYLASE#0.6539;TROGLITAZONE#0.6534;LOW DENSITY LIPOPROTEIN#0.6518;MRNA SPLICING#0.6517;RESPONSE TO IONIZING RADIATION#0.6517;MITOCHONDRIAL TRANSMEMBRANE POTENTIAL#0.6507;HYPERACTIVE#0.6506;ACTIVATED T-CELLS#0.6505;BASAL CELL#0.6491;BETA CELL#0.6490;FORMALIN#0.6481;NEURAL PROGENITOR CELL#0.6480;ICI 182,780#0.6463;DOUBLE-STRAND BREAK REPAIR#0.6448;GASTRIC ULCER#0.6430;VALPROIC ACID#0.6426;INTRACELLULAR LOCALIZATION#0.6425;PANCREATIC ISLET#0.6424;MELATONIN#0.6422;THYMIDYLATE#0.6414;REPORTER GENE ASSAY#0.6401;MALE MEIOSIS#0.6394;CENTRIOLE AMPLIFICATION#0.6386;DUAL-SPECIFICITY PROTEIN PHOSPHATASE#0.6370;GRANULOSA CELL PROLIFERATION#0.6368;NUCLEIC ACID#0.6366;DERMAL PAPILLA CELL#0.6354;G-CSF#0.6354;HERCEPTIN#0.6348;PROTEIN KINASE COMPLEX#0.6344;NITRIC OXIDE SYNTHASE#0.6337;TUMOR GROWTH INHIBITION#0.6327;SV40 T-ANTIGEN#0.6318;DNA REPLICATION CHECKPOINT#0.6313;CHROMOSOME CONDENSATION#0.6312;DIHYDROTESTOSTERONE#0.6281;P53 BINDING#0.6279;NUCLEOSOME#0.6276;UMBILICAL CORD#0.6274;REGULATION OF DNA REPLICATION#0.6274;CYCLE INHIBITOR P21#0.6272;HISTONE METHYLTRANSFERASE#0.6260;HEPATITIS C VIRUS#0.6253;HEPATITIS C#0.6245;RETINOID X RECEPTOR#0.6242;T CELL DEVELOPMENT#0.6242;GERMLINE STEM CELL#0.6235;MEMBRANE DEPOLARIZATION#0.6232;GLYCOGEN PHOSPHORYLASE#0.6215;SALICYLIC ACID#0.6214;PHOSPHATIDYLSERINE#0.6205;PEMETREXED#0.6204;ACTIN CYTOSKELETON#0.6200;NEUROGENESIS#0.6191;EVEROLIMUS#0.6185;NUCLEAR DIVISION#0.6183;LEYDIG CELL#0.6181;RAD001#0.6149;CELL CYCLE DYSREGULATION#0.6148;EMODIN#0.6132;1α,25-DIHYDROXYVITAMIN D3#0.6126;CENTRIOLAR SATELLITE#0.6125;PARATHYROID#0.6114;BIOTIN#0.6112;ENDOTHELIUM#0.6107;TISSUE HOMEOSTASIS#0.6093;SULFONAMIDE#0.6083;CYTARABINE#0.6079;REGULATION OF GENE EXPRESSION#0.6078;EMBRYONIC KIDNEY#0.6074;MEVASTATIN#0.6074;PROSTATE SPECIFIC ANTIGEN#0.6072;ENDOMETRIOID ENDOMETRIAL CARCINOMA#0.6054;MEGAKARYOCYTE#0.6045;LUPUS ERYTHEMATOSUS#0.6044;CAM BINDING#0.6035;GROWTH OF CELL#0.6034;PHOSPHATE BINDING#0.6032;PARATHYROID HORMONE#0.6027;CEREBELLAR GRANULE NEURON#0.6018;STEM CELL PROLIFERATION#0.6013;CHONDROCYTE#0.6011;MYOBLAST PROLIFERATION#0.6010
101805488	BREAST CANCER#1.0934;SIGNALING PATHWAY#1.0919;CELL PROLIFERATION#1.0868;COLON CANCER#1.0788;CANCER CELL#1.0697;LYMPH NODE#1.0659;LUNG CANCER#1.0642;APOPTOSIS#1.0549;TUMOR TISSUES#1.0458;COLORECTAL CANCER#1.0340;LYMPH NODE METASTASIS#1.0259;ONCOGENIC#1.0231;QUANTITATIVE REAL TIME#1.0182;SQUAMOUS CELL CARCINOMA#1.0045;POLYMERASE CHAIN REACTION#0.9744;COLORECTAL#0.9695;HEPATOCELLULAR CARCINOMA#0.9364;WNT SIGNALING PATHWAY#0.9161;LUNG ADENOCARCINOMA#0.9112;OVARIAN CANCER#0.8974;CELL CYCLE#0.8660;ADENOCARCINOMA#0.8484;ADJACENT NORMAL TISSUE#0.8297;EPITHELIAL MESENCHYMAL TRANSITION#0.8244;CELL GROWTH#0.8180;OVARIAN#0.8137;EPITHELIAL OVARIAN CARCINOMA#0.8020;ORAL SQUAMOUS CELL CARCINOMA#0.7837;OVARIAN CARCINOMA#0.7829;OVERALL SURVIVAL TIME#0.7770;BREAST CANCER CELL#0.7660;CELL MIGRATION#0.7608;G1 PHASE#0.7109;REVERSE TRANSCRIPTION#0.7064;TRANSCRIPTION FACTOR#0.7034;EXOSOME#0.6729;CERVICAL#0.6424;SQUAMOUS CELL CANCER#0.6298;EPITHELIAL CELL#0.6202;ESOPHAGEAL CANCER#0.6141;CERVICAL CANCER#0.6107
101805492	CELL PROLIFERATION#1.0785;CELL GROWTH#1.0391;CANCER CELL#1.0334;SQUAMOUS CELL CARCINOMA#1.0330;APOPTOSIS#1.0285;CELL MIGRATION#0.9293;BREAST CANCER#0.8919;LYMPH NODE#0.8445;LYMPH NODE METASTASIS#0.7907;ESOPHAGEAL CANCER#0.7887;POLYMERASE CHAIN REACTION#0.7266;CELL CYCLE#0.7146;ONCOGENIC#0.7121;GENE EXPRESSION#0.6513;RNA BINDING PROTEIN#0.6464;AKT SIGNALING#0.6447;RNA BINDING#0.6444;BREAST CANCER CELL#0.6401;TRANSCRIPTION FACTOR#0.6348
10180	RNA BINDING#1.0353;TUMOR SUPPRESSOR#0.9316;LUNG CANCER#0.9312;RNA BINDING PROTEIN#0.7581;SPLICING SPECKLE#0.6652;CANCER CELL#0.6382
10181	TUMOR SUPPRESSOR#1.0823;CANCER CELL#1.0818;CELL CYCLE#1.0778;LUNG CANCER#1.0732;RNA BINDING#1.0728;APOPTOSIS#1.0678;RNA BINDING PROTEIN#1.0579;CELL PROLIFERATION#1.0508;CELL GROWTH#1.0437;APOPTOTIC#1.0219;ADENOCARCINOMA#1.0117;LUNG ADENOCARCINOMA#0.9991;POLYMERASE CHAIN REACTION#0.9352;PROSTATE CANCER#0.9123;T CELL#0.8782;TUMOR TISSUES#0.8695;RNA RECOGNITION MOTIF#0.8474;CELL CYCLE ARREST#0.8311;MRNA SPLICING#0.8302;GENE EXPRESSION#0.8225;MYOBLAST DIFFERENTIATION#0.7952;GROWTH FACTOR#0.7807;PRE-MRNA SPLICING#0.7746;PANCREATIC CANCER#0.7724;REVERSE TRANSCRIPTION#0.7374;BREAST CANCER#0.7010;CELL DEATH#0.6601;QUANTITATIVE REVERSE TRANSCRIPTION#0.6442;EPIDERMAL GROWTH FACTOR#0.6186
101867536	PROSTATE CANCER#1.1037;CANCER CELL#0.9267;ANDROGEN RECEPTOR#0.9077;COLORECTAL CANCER#0.7895;COLORECTAL#0.7233;CELL CYCLE#0.6383;APOPTOSIS#0.6300;CELL PROLIFERATION#0.6016
10186	LIPOMA#0.8215
10188	RECEPTOR TYROSINE KINASE#1.0655;KINASE ACTIVITY#1.0524;EPIDERMAL GROWTH FACTOR#1.0421;PROSTATE CANCER#1.0366;CANCER CELL#1.0300;GROWTH FACTOR#1.0275;BREAST CANCER#1.0201;ANDROGEN RECEPTOR#1.0064;GROWTH FACTOR RECEPTOR#0.9898;PROTEIN KINASE#0.9861;SIGNALING PATHWAY#0.9587;ONCOGENIC#0.9435;UBIQUITIN#0.9360;APOPTOSIS#0.8970;TUMOR SUPPRESSOR#0.8901;CELL MIGRATION#0.8869;CELL PROLIFERATION#0.8790;GENE EXPRESSION#0.8549;DASATINIB#0.8512;DORSAL CLOSURE#0.8047;HEPATOCELLULAR CARCINOMA#0.7998;AKT SIGNALING#0.7958;CELL GROWTH#0.7826;KINASE INHIBITOR#0.7735;PROTEIN TYROSINE KINASE#0.7685;ENDOCYTOSIS#0.7568;BREAST CANCER CELL#0.7507;CELL DIVISION#0.7479;1 REPETITION MAXIMUM#0.7406;LUNG CANCER#0.7310;WISKOTT ALDRICH SYNDROME#0.7248;CELL CYCLE#0.7227;SRC FAMILY KINASE#0.7190;MAP KINASE#0.6803;RNA INTERFERENCE#0.6797;CELL ADHESION#0.6778;FOCAL ADHESION#0.6566;TYROSINE KINASE 1#0.6433;GTP BINDING#0.6401;SIGNAL TRANSDUCTION#0.6396;NUCLEOTIDE EXCHANGE FACTOR#0.6080
10189	TREX COMPLEX#1.0904;THO COMPLEX#1.0717;RNA BINDING#1.0282;NUCLEAR EXPORT#1.0282;CYTOPLASM#0.9844;EXON JUNCTION COMPLEX#0.9821;RNA BINDING PROTEIN#0.9752;GENE EXPRESSION#0.9749;MRNA SPLICING#0.9706;PRE-MRNA SPLICING#0.9512;MRNA PROCESSING#0.9496;HERPES SIMPLEX VIRUS#0.9263;HERPES SIMPLEX#0.9259;T CELL#0.8613;RNA HELICASE#0.8471;DNA BINDING#0.7782;NUCLEAR SPECKLE#0.7767;NUCLEAR PORE#0.7748;RNA EXPORT FACTOR#0.7681;ARGININE#0.7530;SPLICEOSOME#0.7408;EXON-EXON JUNCTION COMPLEX#0.7262;CELL PROLIFERATION#0.7108;TRANSCRIPTION FACTOR#0.6916;COMPLEX I#0.6853;PI3K SIGNALING#0.6100
1018	BREAST CANCER#1.0500;CYCLIN DEPENDENT KINASE#1.0384;CANCER CELL#1.0208;CELL CYCLE#1.0154;CELL PROLIFERATION#0.9821;BREAST CANCER CELL#0.9649;S PHASE#0.9046;KINASE ACTIVITY#0.8752;APOPTOSIS#0.8513;CELL GROWTH#0.8287;KINASE INHIBITOR#0.8181;TAMOXIFEN#0.8181;CYCLIN DEPENDENT KINASE INHIBITOR#0.8106;CDK INHIBITOR#0.8057;G1 PHASE#0.7765;GENE EXPRESSION#0.7601;TRANSCRIPTION FACTOR#0.7600;PROTEIN KINASE#0.7390;TUMOR SUPPRESSOR#0.7353;CELL DIVISION#0.6946;EPITHELIAL CELL#0.6683;CELL CYCLE REGULATOR#0.6415;CELL CYCLE TRANSITION#0.6181;M PHASE#0.6067;CELL CYCLE ARREST#0.6041
10190	TUBULIN FOLDING#0.6467;BREAST CANCER#0.6458;GERMINAL VESICLE#0.6003
101926885	OCULOCUTANEOUS ALBINISM#0.6249
101927003	SPINAL NERVE LIGATION#1.2165
101927034	CELL MIGRATION#1.0787;COLORECTAL CANCER#1.0439;OVERALL SURVIVAL TIME#0.9239;EPITHELIAL MESENCHYMAL TRANSITION#0.9067;SIGNALING PATHWAY#0.8952;COLORECTAL#0.8387;CELL GROWTH#0.7837;POLYMERASE CHAIN REACTION#0.6955;LUNG ADENOCARCINOMA#0.6670;CANCER CELL#0.6537
101927152	HEPATOCELLULAR CARCINOMA#0.6398
101927174	ENDOMETRIOSIS#0.8576;ENDOMETRIUM#0.8544;OVARIAN#0.8479
101927193	CELL PROLIFERATION#0.8960;ENDOMETRIOSIS#0.6857;OVARIAN#0.6774
101927423	DNA DEMETHYLATION#0.7711;HISTONE MODIFICATION#0.7603;TUMOR SUPPRESSOR#0.7468
101927525	HYPERTROPHIC SCAR FIBROBLASTS#0.8748
101927597	CANCER CELL#1.0378;CERVICAL CANCER#0.9767;CELL PROLIFERATION#0.9015;CERVICAL#0.7831;CELL CYCLE#0.7079;OVARIAN CANCER#0.6619;CELL MIGRATION#0.6601;PROSTATE CANCER#0.6597
101927703	LYMPH NODE#0.6931;CELL PROLIFERATION#0.6831;GASTRIC ADENOCARCINOMA#0.6556;LYMPH NODE METASTASIS#0.6440;PROSTATE CANCER#0.6395
101927813	ANTISENSE RNA#0.7978;EPITHELIAL OVARIAN CANCER#0.7609;LUNG ADENOCARCINOMA#0.7552;OVARIAN CANCER#0.7501;BREAST CANCER CELL#0.7487;BREAST CANCER#0.7435;CANCER CELL#0.7420
101927953	CANCER CELL#0.9840;SQUAMOUS CELL CARCINOMA#0.7776;CERVICAL CANCER#0.7008;GASTRIC CARDIA ADENOCARCINOMA#0.6997;NULL CELL#0.6562;ESOPHAGEAL CANCER#0.6519
101928099	CELL PROLIFERATION#0.7520;PROSTATE CANCER#0.6430
101928243	CANCER CELL#0.9511;THYROID CANCER#0.7230;APOPTOTIC CELL DEATH#0.7204;TUMOR TISSUES#0.7200;OVARIAN CANCER#0.7166;CELL DEATH#0.7103;CELL PROLIFERATION#0.6213
101928337	THYROID CANCER#0.7464
101928353	ADENOCARCINOMA#0.8483
101928483	T CELL#0.8022;ACUTE LYMPHOBLASTIC LEUKEMIA#0.7167;NOTCH SIGNALING PATHWAY#0.6792;GOBLET CELL#0.6723;SIGNALING PATHWAY#0.6542
101928601	TRANSCRIPTION FACTOR#1.0876;MEIOSIS#1.0279;DOUBLE STRAND BREAK#0.9439;MEIOSIS I#0.8559;PROPHASE#0.7848;SPORULATION#0.7404;DNA REPLICATION#0.7247;NUCLEAR MOVEMENT#0.6672;MEIOTIC CHROMOSOME#0.6611;DNA SYNTHESIS#0.6573;DNA BINDING#0.6205
101928607	APOPTOSIS#0.9092;CELL PROLIFERATION#0.8284;LUNG CANCER#0.7628;PROSTATE CANCER#0.6736;HEPATOCELLULAR CARCINOMA#0.6320
101928931	CANCER CELL#0.9856;GASTRIC CARDIA ADENOCARCINOMA#0.8320;TUMOR SUPPRESSOR#0.7822;HEPATOCELLULAR CARCINOMA CELL#0.7606;ESOPHAGEAL CANCER#0.7604;HEPATOCELLULAR CARCINOMA#0.7483
101928941	X CHROMOSOME#1.1934;PROGENITOR CELL#1.1842;TROPHECTODERM#0.8665
101929110	NEURAL CELL#0.9098
101929222	MAJOR PSYCHIATRIC DISORDERS#0.7964;PROTEIN TRANSLATION#0.7697;OXIDOREDUCTASE ACTIVITY#0.7465;MITOCHONDRIA#0.6947
101929328	EPITHELIAL OVARIAN CANCER#1.1970;OVARIAN CANCER#1.1862;CANCER CELL#1.1780;OVARIAN#0.8479;APOPTOSIS#0.8439
101929639	COLON CANCER#0.7510
101929665	APOPTOSIS#0.6411
10193	RECEPTOR DEGRADATION#1.1112;UBIQUITIN#1.0735;APOPTOSIS#1.0640;BREAST CANCER#0.9749;CELL GROWTH#0.9668;GROWTH FACTOR#0.9601;CANCER CELL#0.9424;CYTOKINE RECEPTOR#0.9411;GROWTH FACTOR RECEPTOR#0.9089;EPIDERMAL GROWTH FACTOR#0.8930;PROTEASOME#0.8823;RECEPTOR TYROSINE KINASE#0.8743;MITOPHAGY#0.8284;CARDIOMYOCYTE#0.7797;DEUBIQUITINATING ENZYME#0.7783;CELL SURFACE#0.7747;COLORECTAL CANCER#0.7605;CELL CYCLE#0.7119;CELL PROLIFERATION#0.7044;HEPATOCELLULAR CARCINOMA#0.6938;PARKINSON'S DISEASE#0.6918;EPITHELIAL CELL#0.6871;TRANSCRIPTION FACTOR#0.6324;CELL POLARITY#0.6151;HEMATOPOIETIC STEM CELL#0.6139;RNA INTERFERENCE#0.6133;RETINOIC ACID#0.6125;HEART DISEASE#0.6114;CELL MIGRATION#0.6056;PROGENITOR CELL#0.6054;T CELL#0.6044;STEM CELL#0.6020;COLORECTAL#0.6014
10194	TRANSCRIPTION FACTOR#0.8818;SPINAL CORD#0.8118;GLUTAMINE#0.7707;MIDDLE EAR#0.6313
10195	N GLYCAN#1.0284;GLYCOSYLATION#1.0255;ENDOPLASMIC RETICULUM#0.9180;GLCNAC#0.9105;CONGENITAL DISORDER#0.9018;APOPTOSIS#0.8831;ALZHEIMER'S DISEASE#0.8727;CONGENITAL DISORDER OF GLYCOSYLATION#0.8398;ASPARAGINE#0.6451
10196	RIBOSOMAL PROTEIN#1.0486;ARGININE#1.0470;N METHYLTRANSFERASE#1.0318;RIBOSOMAL SUBUNIT#0.8486;PANCREATIC CANCER#0.7828;RIBOSOME#0.7709;L-METHIONINE#0.7518;GENE EXPRESSION#0.7212;METHYLTRANSFERASE ACTIVITY#0.7126;S-ADENOSYL-L-METHIONINE#0.7087;CANCER CELL#0.6930;METHIONINE#0.6751;ASYMMETRIC DIMETHYLARGININE#0.6645;POLY-A BINDING#0.6445;RRNA PROCESSING#0.6385;GLYCINE#0.6315;FATTY LIVER#0.6195;TUMOR SUPPRESSOR#0.6064
101978785	PROSTATE CANCER#0.9967;HEPATOCELLULAR CARCINOMA#0.6600;CELL CYCLE#0.6555
10197	20S PROTEASOME#1.0601;PROTEASOME#1.0538;CELL CYCLE#1.0502;UBIQUITIN#1.0108;HCV CORE PROTEIN#0.9992;CANCER CELL#0.9973;HEPATITIS C VIRUS#0.8731;HEPATITIS C#0.8721;BREAST CANCER#0.8529;APOPTOSIS#0.8457;CELL GROWTH#0.8201;CELL PROLIFERATION#0.8085;T CELL#0.7773;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7607;LUPUS ERYTHEMATOSUS#0.7604;PROTEIN DEGRADATION#0.7494;STEROID RECEPTOR COACTIVATOR#0.7032;IFN-GAMMA#0.6952;GENE EXPRESSION#0.6594;TUMOR SUPPRESSOR#0.6391;CYCLIN DEPENDENT KINASE INHIBITOR#0.6271;CYTOPLASM#0.6246;RNA INTERFERENCE#0.6229;CYCLIN DEPENDENT KINASE#0.6229;KINASE INHIBITOR#0.6202;M PHASE#0.6130;PANCREATIC CANCER#0.6109;LUNG CANCER#0.6057;S PHASE#0.6049
10198	TYPE 2 DIABETES#0.8049;M PHASE#0.7214;MULTIPLE SCLEROSIS#0.6462;GROWTH FACTOR#0.6375;MOTHER CENTRIOLE#0.6197
10199	SMALL NUCLEOLAR RIBONUCLEOPROTEIN#1.1468;SSU PROCESSOME#1.0948;SNORNP#1.0797;RRNA PROCESSING#1.0278;RIBOSOME#0.9548;RIBOSOME BIOGENESIS#0.9062;M PHASE#0.7846;SMALL NUCLEOLAR RNA#0.7456;NUCLEOLUS#0.7251;RIBOSOMAL PROTEIN#0.6609;SMALL SUBUNIT PROCESSOME#0.6148;RIBONUCLEOPROTEIN COMPLEX#0.6008
1019	CYCLIN D1-CDK4 COMPLEX#1.0846;MURINE DOUBLE MINUTE#1.0615;BETA CELL#1.0355;FLAVOPIRIDOL#1.0268;TELOMERASE REVERSE TRANSCRIPTASE#1.0223;FAMILIAL MELANOMA#1.0195;ANTI HER2#1.0181;ATYPICAL LIPOMATOUS TUMOR#1.0165;LUNG FIBROBLASTS#1.0137;COMPLEX I#1.0123;CELL DIVISION CYCLE#1.0111;ESTROGEN-RECEPTOR POSITIVE BREAST CANCER#1.0087;CELL CYCLE PATHWAY#1.0084;MULTIPLE PRIMARY MELANOMA#1.0062;CYCLIN DEPENDENT KINASE#1.0051;PROTEIN PHOSPHORYLATION#1.0049;CARDIOMYOCYTE#1.0027;ADVANCED BREAST CANCER#1.0027;FULVESTRANT#1.0010;CELL CYCLE TRANSITION#1.0005;MYOTUBE#0.9998;MELANOMA CELL LINES#0.9986;LETROZOLE#0.9984;CLEAVED CASPASE 3#0.9973;METASTATIC BREAST CANCER#0.9964;DEPHOSPHORYLATION#0.9962;SMOOTH MUSCLE ACTIN#0.9961;EVEROLIMUS#0.9956;KINASE INHIBITOR P27#0.9952;LIPOSARCOMA#0.9947;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9939;MYOBLAST#0.9932;HYPERPHOSPHORYLATION#0.9923;MALIGNANT GLIOMA#0.9915;KINASE ACTIVITY#0.9915;B CELL LYMPHOMA#0.9900;METASTATIC MELANOMA#0.9891;HYPOXIA#0.9890;QUIESCENCE#0.9887;LUMINAL#0.9882;LIPOMA#0.9874;CELL CYCLE PHASE#0.9870;COPY NUMBER VARIATION#0.9866;NUCLEAR IMPORT#0.9866;ENDOMETRIAL CANCER#0.9864;RETINOBLASTOMA#0.9861;SENESCENCE#0.9861;MAMMARY EPITHELIAL CELL#0.9860;TELOMERASE ACTIVITY#0.9860;GRANULOSA CELL#0.9860;TRANSCRIPTASE#0.9858;NEUROBLASTOMA#0.9857;CATALYTIC ACTIVITY#0.9857;ASTROCYTOMA#0.9854;MESANGIAL CELL#0.9847;G2 PHASE#0.9841;CELLULAR SENESCENCE#0.9834;RAPAMYCIN#0.9833;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9828;BREAST CANCER PATIENTS#0.9824;MULTIPLE MYELOMA#0.9821;PROTEIN KINASE B#0.9821;OVARIAN CARCINOMA#0.9817;REGULATION OF CELL CYCLE#0.9807;INSULIN-LIKE GROWTH FACTOR#0.9805;MOUSE EMBRYONIC FIBROBLAST#0.9802;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9802;ATP BINDING#0.9801;CELL CYCLE REGULATOR#0.9801;DNA REPAIR#0.9798;STANDARD OF CARE#0.9798;CDK INHIBITOR#0.9797;TARGET OF RAPAMYCIN#0.9793;ORAL SQUAMOUS CELL CARCINOMA#0.9792;TERMINAL DIFFERENTIATION#0.9792;MELANOCYTE#0.9790;LUNG CARCINOMA#0.9783;CELL DIVISION#0.9782;BREAST CARCINOMA#0.9773;HEMATOPOIETIC CELL#0.9767;KERATINOCYTE#0.9767;PROTEIN KINASE C#0.9765;STRUCTURE ACTIVITY RELATIONSHIP#0.9760;REVERSE TRANSCRIPTION#0.9758;GROWTH FACTOR RECEPTOR#0.9754;BREAST CANCER#0.9754;ESOPHAGEAL CANCER#0.9753;PANCREATIC CANCER#0.9751;PACLITAXEL#0.9751;CERVICAL CANCER#0.9751;REPLICATIVE SENESCENCE#0.9749;HEPATOCYTE GROWTH FACTOR#0.9749;STROMAL CELL#0.9749;MAPK SIGNALING#0.9749;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9749;MANTLE CELL LYMPHOMA#0.9747;ENDOTHELIAL GROWTH FACTOR#0.9746;EPITHELIAL MESENCHYMAL TRANSITION#0.9744;INHIBITION OF CELL PROLIFERATION#0.9743;ARGININE#0.9740;B CELL#0.9739;MAP KINASE#0.9739;CELL CYCLE CONTROL#0.9737;CELL CYCLE#0.9737;G1 PHASE#0.9737;RHABDOMYOSARCOMA#0.9737;CYCLIN DEPENDENT KINASE INHIBITOR#0.9736;CHROMOSOMAL REGION#0.9735;GLYCOGEN SYNTHASE KINASE#0.9735;RECEPTOR TYROSINE KINASE#0.9734;MITOSIS#0.9733;COPY NUMBER ALTERATION#0.9732;FIBROBLAST GROWTH FACTOR#0.9731;OVARIAN CANCER#0.9730;CHONDROSARCOMA#0.9730;GLIOBLASTOMA MULTIFORME#0.9727;EMBRYONIC LUNG#0.9726;PROTEASOME#0.9726;SIGNALING CASCADE#0.9726;DOXORUBICIN#0.9725;ESTROGEN RECEPTOR#0.9725;CYTOPLASM#0.9725;RIBOSOMAL PROTEIN#0.9719;PLATELET-DERIVED GROWTH FACTOR#0.9717;VSMC PROLIFERATION#0.9715;AUTOPHAGY#0.9714;CDK ACTIVITY#0.9714;CELL CYCLE CHECKPOINT#0.9713;CERVICAL#0.9710;QUANTITATIVE REVERSE TRANSCRIPTION#0.9709;COMPARATIVE GENOMIC HYBRIDIZATION#0.9708;TRANSFORMING GROWTH FACTOR BETA#0.9708;PROGESTERONE#0.9705;DRUG RESISTANCE#0.9702;ESTRADIOL#0.9696;RNA INTERFERENCE#0.9695;PROTEIN PROTEIN INTERACTION#0.9693;QUANTITATIVE REAL TIME#0.9693;LUNG ADENOCARCINOMA#0.9691;EPIDERMAL GROWTH FACTOR#0.9687;SOFT TISSUE SARCOMA#0.9687;SIGNALING MOLECULE#0.9686;MYXOID LIPOSARCOMA#0.9682;ASTROCYTE#0.9682;PROGENITOR CELL#0.9681;UBIQUITIN#0.9681;BONE MARROW#0.9674;LIVER CANCER#0.9672;POLYMERASE CHAIN REACTION#0.9672;TRANSACTIVATION#0.9672;PERIPHERAL BLOOD#0.9670;MACROPHAGE#0.9668;HEPATOCYTE PROLIFERATION#0.9668;S PHASE#0.9663;KINASE INHIBITOR#0.9660;OVARIAN#0.9659;CELL CYCLE ARREST#0.9659;T CELL#0.9659;PROTEIN SYNTHESIS#0.9658;MECHANISM OF ACTION#0.9657;SQUAMOUS CELL CARCINOMA#0.9656;LYMPH NODE#0.9654;SKIN CANCER#0.9653;CENTRAL NERVOUS SYSTEM#0.9650;ENDOTHELIAL CELL#0.9650;MYELOID LEUKEMIA#0.9649;FLOW CYTOMETRY ANALYSIS#0.9647;T LYMPHOCYTE#0.9644;DNA BINDING#0.9644;TYROSINE KINASE INHIBITOR#0.9644;ACUTE MYELOID LEUKEMIA#0.9643;PROTEIN COMPLEX#0.9639;AKT SIGNALING#0.9636;M PHASE#0.9635;ONCOGENIC#0.9633;TUMOR SUPPRESSOR#0.9632;POLY ADP RIBOSE#0.9632;ONCOGENESIS#0.9632;ADIPOSE TISSUE#0.9632;COLORECTAL CANCER#0.9631;RIBOSE#0.9630;CELL CYCLE REGULATION#0.9629;NEUTROPENIA#0.9629;DOMINANT NEGATIVE MUTANT#0.9628;CELL DIFFERENTIATION#0.9624;TRANSFORMING GROWTH FACTOR#0.9624;COLORECTAL CARCINOMA#0.9623;TUMOR TISSUES#0.9620;DNA REPLICATION#0.9620;CELLULAR GROWTH#0.9620;NERVOUS SYSTEM#0.9618;PANCREATIC ISLET#0.9617;ISCHEMIA#0.9614;ANCHORAGE INDEPENDENT GROWTH#0.9614;HEAT SHOCK PROTEIN#0.9613;CISPLATIN#0.9611;COLONY FORMATION ASSAY#0.9609;CYTOCHROME C#0.9605;COLON CANCER#0.9603;SIGNALLING PATHWAY#0.9602;RETINOIC ACID#0.9599;STEM CELL#0.9598;EPITHELIAL CELL#0.9598;COLORECTAL#0.9598;STAUROSPORINE#0.9593;SKELETAL MUSCLE#0.9593;HEPATOCELLULAR CARCINOMA CELL#0.9592;REGENERATION#0.9591;PROTEIN KINASE#0.9590;APOPTOTIC CELL DEATH#0.9588;NUCLEAR EXPORT#0.9587;BREAST CANCER CELL#0.9586;CYCLIC AMP#0.9580;LYMPH NODE METASTASIS#0.9578;DNA SYNTHESIS#0.9577;UVEAL MELANOMA#0.9577;THYMIDINE#0.9577;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9577;HISTONE DEACETYLASE#0.9570;MAMMARY GLAND#0.9564;TUMOR CELLS#0.9562;GROWTH FACTOR#0.9561;WOUND HEALING#0.9560;PROPIDIUM#0.9558;CARCINOGEN#0.9557;MECHANISMS OF ACTION#0.9556;LUNG CANCER#0.9553;MITOCHONDRIAL MEMBRANE#0.9552;CANCER STEM CELL#0.9552;DNA FRAGMENTATION#0.9550;MITOCHONDRIA#0.9549;ANDROGEN RECEPTOR#0.9546;RESVERATROL#0.9543;SIGNAL TRANSDUCER#0.9542;HUMAN BREAST CANCER#0.9537;TUMOR NECROSIS FACTOR#0.9537;MITOGEN ACTIVATED PROTEIN#0.9532;CELL MIGRATION#0.9532;TOXICITY#0.9528;TRANSCRIPTION FACTOR#0.9528;ADIPOCYTE#0.9528;INHIBITION OF CELL GROWTH#0.9527;HISTONE DEACETYLASE INHIBITOR#0.9525;ANGIOGENESIS#0.9524;GENE EXPRESSION#0.9524;SIGNAL TRANSDUCTION#0.9521;ADENOCARCINOMA#0.9521;CELL GROWTH#0.9511;REACTIVE OXYGEN SPECIES#0.9510;SMOOTH MUSCLE#0.9509;PROSTATE CANCER#0.9509;INDUCTION OF APOPTOSIS#0.9507;DNA DAMAGE RESPONSE#0.9505;ADENOSINE#0.9504;CYTOTOXICITY#0.9503;CELL PROLIFERATION#0.9502;TAMOXIFEN#0.9502;VASCULAR SMOOTH MUSCLE CELL#0.9501;INTESTINAL EPITHELIAL CELL#0.9499;LOVASTATIN#0.9492;APOPTOTIC#0.9491;HEPATOCELLULAR CARCINOMA#0.9490;BETA CELL MASS#0.9488;PROSTATE CARCINOMA#0.9484;MESENCHYMAL STEM CELL#0.9483;CONTACT INHIBITION#0.9482;SIGNALING PATHWAY#0.9482;CANCER CELL#0.9477;SMOOTH MUSCLE CELL#0.9472;APOPTOSIS#0.9472;MUSCLE CELL#0.9468;CELL DEATH#0.9468;EXTRACELLULAR MATRIX#0.9468;TELOMERE#0.9465;DISEASE FREE SURVIVAL#0.9464;PEROXISOME#0.9463;LIVER REGENERATION#0.9459;ARTERY#0.9457;COLON CARCINOMA#0.9455;RENAL CELL CARCINOMA#0.9454;ALZHEIMER'S DISEASE#0.9451;FACTOR I#0.9450;2'-DEOXYURIDINE#0.9445;ROS GENERATION#0.9444;PROTEIN DEGRADATION#0.9434;LYMPHOCYTIC LEUKEMIA#0.9427;OOCYTE#0.9421;CELL ACTIVATION#0.9416;BINDING PROTEIN 1#0.9403;MYELOID CELL#0.9399;DUAL LUCIFERASE REPORTER#0.9399;GENE SILENCING#0.9397;CASPASE-3 ACTIVITY#0.9382;CHONDROCYTE#0.9377;EMBRYONIC STEM CELL#0.9372;DNA METHYLATION#0.9364;DEDIFFERENTIATION#0.9361;CELL ADHESION#0.9341;MONONUCLEAR CELLS#0.9341;NON-SMALL CELL LUNG CARCINOMA#0.9336;PROGRAMMED CELL DEATH#0.9333;GERM CELL#0.9330;T-CELL LEUKEMIA#0.9328;METFORMIN#0.9321;ENZYME ACTIVITY#0.9314;PITUITARY ADENOMA#0.9308;GENOTOXIC#0.9306;5 FLUOROURACIL#0.9305;UMBILICAL VEIN#0.9289;NITRIC OXIDE#0.9287;TYPE 2 DIABETES#0.9287;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9287;KERATINOCYTE PROLIFERATION#0.9277;GLUTATHIONE#0.9267;MUTAGENESIS#0.9259;HUMAN UMBILICAL VEIN#0.9258;SEQUESTERING#0.9248;MUSCLE CELL PROLIFERATION#0.9247;ATHEROSCLEROSIS#0.9246;ALL TRANS RETINOIC ACID#0.9246;THYROID CANCER#0.9200;INTERPHASE#0.9199;PLEOMORPHIC LIPOSARCOMA#0.9191;ENDOMETRIAL CARCINOMA#0.9190;CASPASE INHIBITOR#0.9182;MOLECULAR DYNAMICS SIMULATION#0.9181;IMMUNE RESPONSE#0.9171;B LYMPHOCYTE#0.9167;DEXAMETHASONE#0.9164;HUMAN BRONCHIAL EPITHELIAL#0.9152;TRADITIONAL CHINESE MEDICINE#0.9139;OSTEOBLAST#0.9130;SMOOTH MUSCLE CELL PROLIFERATION#0.9130;CYTOCHROME C RELEASE#0.9128;CANCER RELATED DEATH#0.9108;HYPOXIC#0.9100;HYPOXIA INDUCIBLE FACTOR#0.9097;PHOSPHATASE AND TENSIN HOMOLOG#0.9095;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.9054;CELL COUNTING KIT#0.9052;BLOOD BRAIN BARRIER#0.9050;LEIOMYOSARCOMA#0.9043;ENDOPLASMIC RETICULUM#0.9016;CELL SURFACE#0.9011;GELDANAMYCIN#0.9005;ALANINE#0.9002;DIARRHEA#0.8995;HEPATOMA CELLS#0.8993;HUMAN MAMMARY EPITHELIAL#0.8993;MOUSE EMBRYONIC STEM#0.8975;G0 PHASE#0.8975;ADJACENT NORMAL TISSUE#0.8971;ANTI APOPTOSIS#0.8963;PANCREATIC DUCTAL ADENOCARCINOMA#0.8952;IMMUNE SYSTEM#0.8930;FLUOROURACIL#0.8927;MYOGENESIS#0.8921;UMBILICAL VEIN ENDOTHELIAL CELLS#0.8915;EARLY BREAST CANCER#0.8909;PRECURSOR CELL#0.8894;GLUCOSE METABOLISM#0.8893;OLIGODENDROGLIOMA#0.8887;IMATINIB#0.8883;RECURRENCE FREE SURVIVAL#0.8866;TRASTUZUMAB#0.8864;SORAFENIB#0.8848;MUCOSAL MELANOMA#0.8846;ACTIVATED T-CELLS#0.8822;ACTIVATED T CELL#0.8819;BLOOD VESSEL#0.8801;GEMCITABINE#0.8784;MYOGENIC CELL#0.8775;CELL EXPANSION#0.8766;CELL MEMBRANE#0.8764;ESOPHAGEAL CARCINOMA#0.8746;FOCAL ADHESION#0.8744;MEDULLOBLASTOMA#0.8744;FIBROUS HISTIOCYTOMA#0.8740;ETHANOL#0.8739;GENISTEIN#0.8737;CEREBRAL ISCHEMIA#0.8726;HODGKIN'S LYMPHOMA#0.8697;NEURONAL CELL DEATH#0.8695;BERBERINE#0.8691;LUNG EPITHELIAL CELL#0.8681;CASPASE ACTIVATION#0.8680;NEURAL STEM CELL#0.8670;TRANSCRIPTIONAL CONTROL#0.8669;MODE OF ACTION#0.8667;FORMALIN#0.8656;IMMUNE CELL#0.8649;STROMA#0.8630;BREAST CANCER MODEL#0.8630;EPSTEIN BARR VIRUS#0.8618;NITRIC OXIDE SYNTHASE#0.8614;EPITHELIAL CELL PROLIFERATION#0.8586;ENHANCER BINDING#0.8573;REPORTER GENE ASSAY#0.8561;CALCINEURIN#0.8548;CELL CYCLE DYSREGULATION#0.8543;SIMVASTATIN#0.8540;TUBE FORMATION#0.8532;CARDIOMYOCYTE PROLIFERATION#0.8525;NULL CELL#0.8505;DEGRADATION OF CYCLIN#0.8504;MELATONIN#0.8504;ACTIVE CASPASE 3#0.8479;ADULT T-CELL LEUKEMIA#0.8475;ENDOTHELIAL CELL PROLIFERATION#0.8459;HEMATOPOIETIC STEM CELL#0.8449;OLOMOUCINE#0.8446;INSULIN SECRETION#0.8445;ACUTE LEUKEMIA#0.8445;LYSINE#0.8444;PAPILLOMA#0.8421;EPIGALLOCATECHIN#0.8405;ANEMIA#0.8401;LYMPHOMA CELL LINES#0.8399;SUPEROXIDE DISMUTASE#0.8393;ACTIVATOR PROTEIN 1#0.8392;DEATH RECEPTOR#0.8378;HAIR FOLLICLE#0.8368;PROTEASOME PATHWAY#0.8368;PROTEIN KINASE A#0.8353;MITOTIC CELL CYCLE#0.8335;LINES OF EVIDENCE#0.8334;BORTEZOMIB#0.8329;BRONCHIAL EPITHELIAL CELLS#0.8327;RANDOMIZED CONTROLLED TRIAL#0.8324;G-CSF#0.8322;CYCLIN D2-CDK4 COMPLEX#0.8308;DOUBLE STRAND BREAK#0.8288;MULTIPLE MYELOMA CELLS#0.8282;OBJECTIVE RESPONSE RATE#0.8282;CHONDROCYTE PROLIFERATION#0.8280;TOPOISOMERASE#0.8266;ENHANCER BINDING PROTEIN#0.8257;TARGET OF RAPAMYCIN COMPLEX#0.8246;ARYL HYDROCARBON RECEPTOR#0.8246;CHROMOSOME REGION#0.8241;ALTERNATIVE READING FRAME#0.8235;PERIPHERAL NERVE#0.8234;PHOSPHOLIPASE C#0.8226;APOPTOTIC PROCESS#0.8217;HUMAN PANCREATIC CANCER#0.8215;DIFFUSE LARGE B-CELL LYMPHOMA#0.8210;URINARY BLADDER#0.8208;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8194;TUMOR ANTIGEN#0.8186;DIABETES MELLITUS#0.8186;RECEPTOR ANTAGONIST#0.8184;CYCLIN-DEPENDENT KINASE ACTIVITY#0.8174;PHOSPHATASE ACTIVITY#0.8171;IFN-GAMMA#0.8166;HYPERTENSION#0.8165;FLOW CYTOMETRY ASSAY#0.8165;ANASTROZOLE#0.8156;CEREBELLAR GRANULE NEURON#0.8138;GLIAL CELL#0.8138;IB-MECA#0.8110;WHOLE TISSUE SECTIONS#0.8106;VASCULAR ENDOTHELIAL CELL#0.8085;PRIMARY BREAST CANCER#0.8079;SMALL INTESTINE#0.8078;THYROID CARCINOMA#0.8077;AORTIC SMOOTH MUSCLE CELLS#0.8076;ESTROGENS#0.8069;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.8069;CHOLANGIOCARCINOMA#0.8058;C TERMINAL DOMAIN#0.8039;MOUSE EMBRYO FIBROBLASTS#0.8036;CYCLIN BINDING#0.8034;HEAD AND NECK CANCER#0.8033;NECK CANCER#0.8033;RANDOMIZED CLINICAL TRIAL#0.8029;EPITHELIAL TO MESENCHYMAL TRANSITION#0.8027;EPITHELIAL TO MESENCHYMAL#0.8025;OOCYTE MATURATION#0.8008;TUMOR GROWTH INHIBITION#0.8002;PI3K SIGNALING#0.8000;LEYDIG CELL#0.7977;COLONY-STIMULATING FACTOR#0.7976;ISOQUINOLINE#0.7975;MALIGNANT MESOTHELIOMA#0.7973;COPY NUMBER CHANGE#0.7968;INFLAMMATORY RESPONSE#0.7960;GRANULOCYTE#0.7947;CELL MOTILITY#0.7945;SRC FAMILY KINASE#0.7941;MAXIMUM TOLERATED DOSE#0.7925;HEPATITIS B#0.7922;METAPHASE#0.7918;GENE COPY NUMBER#0.7906;HEPATIC STELLATE CELL#0.7905;MALIGNANT PERIPHERAL NERVE SHEATH TUMOR#0.7884;HOMOLOGOUS RECOMBINATION#0.7880;CHRONIC MYELOID LEUKEMIA#0.7872;ARA-C#0.7859;BASAL CELL#0.7859;ALVEOLAR RHABDOMYOSARCOMA#0.7856;INSULIN RECEPTOR#0.7854;ACTIVATED CASPASE 3#0.7826;CORNEAL ENDOTHELIAL CELL#0.7796;INDOLE#0.7794;UBIQUITIN PROTEASOME PATHWAY#0.7787;ANAPLASTIC OLIGODENDROGLIOMA#0.7775;PLASMA CELL#0.7768;RNA BINDING#0.7766;VITAMIN C#0.7758;SPINDLE CELL LIPOMA#0.7749;INHIBITION OF GROWTH#0.7747;PLASMA MEMBRANE#0.7725;ESOPHAGUS#0.7719;CARCINOMA IN SITU#0.7709;LEUCINE#0.7705;HISTIOCYTOMA#0.7704;CERVICAL CANCER CELL LINES#0.7699;CELL DEVELOPMENT#0.7698;INFERTILITY#0.7695;NERVE GROWTH FACTOR#0.7656;ADIPOGENESIS#0.7635;CLINICAL BENEFIT RATE#0.7619;ORAL CAVITY#0.7604;LYMPHOID CELL#0.7592;HEPATITIS B VIRUS#0.7588;SALIVARY GLAND#0.7588;VASCULAR DISEASE#0.7587;PROTEIN BINDING#0.7583;HOST CELL#0.7573;REGULATION OF CELL PROLIFERATION#0.7553;NEUROENDOCRINE TUMOR#0.7545;YEAR SURVIVAL RATE#0.7535;EWING SARCOMA#0.7498;MYOBLAST DIFFERENTIATION#0.7489;HERPES SIMPLEX#0.7484;SKIN FIBROBLASTS#0.7477;ORAL LICHEN PLANUS#0.7454;PROGESTIN#0.7444;HISTONE ACETYLATION#0.7421;TETRACYCLINE#0.7417;LEUKOCYTE#0.7416;MEDIAN OVERALL SURVIVAL#0.7416;EPITHELIAL OVARIAN CANCER#0.7412;STEM CELL MARKER#0.7408;FOCAL ADHESION KINASE#0.7408;ELECTROPHORETIC MOBILITY SHIFT#0.7389;NEUTROPHIL#0.7386;LICHEN PLANUS#0.7386;POST-TRANSLATIONAL MODIFICATION#0.7379;PROTEIN KINASE ACTIVITY#0.7366;INDUCIBLE NITRIC OXIDE#0.7366;LIVER DISEASE#0.7348;DOSE LIMITING TOXICITIES#0.7338;PROTEIN KINASE INHIBITOR#0.7315;NODULAR#0.7312;OVERALL SURVIVAL RATE#0.7304;CELL KILLING#0.7298;LUCIFERASE ACTIVITY#0.7291;WORLD HEALTH ORGANIZATION#0.7288;ENDOPLASMIC RETICULUM STRESS#0.7280;PULMONARY ARTERY#0.7279;MONOCYTE#0.7278;HERPES SIMPLEX VIRUS#0.7275;COPY NUMBER GAIN#0.7272;BONE MARROW CELLS#0.7269;ADRENOCORTICAL CARCINOMA#0.7267;T CELL PROLIFERATION#0.7266;SYNOVIAL SARCOMA#0.7252;MEGAKARYOCYTE#0.7234;PODOCYTE#0.7232;THYMOCYTE#0.7206;ERYTHROCYTE#0.7201;ADIPOCYTE DIFFERENTIATION#0.7195;HIGH MOBILITY GROUP#0.7173;VITAMIN D RECEPTOR#0.7171;PROTEIN INTERACTION NETWORK#0.7170;GLUCOSE HOMEOSTASIS#0.7167;HYPERGLYCEMIA#0.7163;MICROTUBULE#0.7162;PANCREATIC BETA CELL PROLIFERATION#0.7150;CELL NUCLEUS#0.7149;RHEUMATOID ARTHRITIS#0.7137;METHYLATION SPECIFIC PCR#0.7123;CHROMATIN REMODELING#0.7105;TO TUMOR PROGRESSION#0.7104;LEIOMYOMA#0.7099;OLIGODENDROCYTE#0.7090;INHIBITION OF PHOSPHORYLATION#0.7070;ATAXIA TELANGIECTASIA#0.7066;VALPROIC ACID#0.7066;NEVUS#0.7051;GLUTAMINE#0.7032;THROMBOCYTOPENIA#0.7003;OVARIES#0.6997;QUERCETIN#0.6994;REACTIVE OXYGEN SPECIES GENERATION#0.6991;APOPTOSIS INDUCING FACTOR#0.6989;TESTOSTERONE#0.6979;INSULINOMA#0.6977;SPINAL CORD#0.6969;CENTROSOME#0.6962;KINASE INHIBITOR PROTEIN#0.6962;CELLULAR METABOLISM#0.6961;72-HOURS#0.6943;PROTEIN TYROSINE KINASE#0.6941;RNA BINDING PROTEIN#0.6936;DNA METHYLTRANSFERASE#0.6932;INFLAMMATORY CELL#0.6896;DOCETAXEL#0.6874;REPLICATION COMPARTMENT#0.6866;STEM CELL PROLIFERATION#0.6865;AGE AT DIAGNOSIS#0.6864;BIOTIN#0.6858;N-ACETYLCYSTEINE#0.6857;BETA GALACTOSIDASE#0.6848;BLADDER CARCINOMA#0.6842;TRANSDIFFERENTIATION#0.6839;REGULATION OF CELLULAR#0.6832;CAMPTOTHECIN#0.6813;AUTOIMMUNE DISEASE#0.6810;MELANOCYTE DIFFERENTIATION#0.6807;PREADIPOCYTE#0.6806;SERTOLI CELL#0.6799;EXEMESTANE#0.6797;PARATHYROID#0.6785;NEUROECTODERMAL TUMOR#0.6773;DNA DAMAGE CHECKPOINT#0.6762;SENSITIZATION#0.6760;DNA AMPLIFICATION#0.6758;ANTHRACENE#0.6756;NEOPLASTIC TISSUES#0.6754;CORD BLOOD#0.6751;MALIGNANT BRAIN TUMOR#0.6745;CORONARY ARTERY#0.6744;26S PROTEASOME#0.6727;EMBRYONAL CARCINOMA#0.6721;LUNG METASTASIS#0.6702;QUANTITATIVE REVERSE TRANSCRIPTASE#0.6702;NUCLEAR LOCALIZATION SIGNAL#0.6702;MYOSIN HEAVY CHAIN#0.6682;PROSTATE SPECIFIC ANTIGEN#0.6680;RESPONSE TO TREATMENT#0.6674;DIPHOSPHATE#0.6667;GASTROINTESTINAL TRACT#0.6656;EOSIN#0.6645;GROWTH HORMONE#0.6639;RB-E2F COMPLEX#0.6638;NEPHROPATHY#0.6630;CERVIX#0.6622;SOLITARY FIBROUS TUMOR#0.6617;FACTOR VIII#0.6595;MAPK ACTIVATION#0.6592;NEURON DEATH#0.6577;ETOPOSIDE#0.6577;COENZYME A#0.6564;ATAXIA TELANGIECTASIA MUTATED#0.6554;TRANSITIONAL CELL CARCINOMA#0.6544;ANTISENSE RNA#0.6543;NEURODEGENERATIVE DISEASE#0.6542;HEMATOPOIESIS#0.6532;FIBROSARCOMA#0.6521;ERLOTINIB#0.6502;MESOTHELIOMA CELL#0.6497;ORAL CANCER CELL#0.6492;UMBILICAL CORD#0.6490;MYOCYTES#0.6482;BLAST CELL#0.6478;CD8+ T CELL#0.6471;FORSKOLIN#0.6469;BONE FORMATION#0.6462;VEMURAFENIB#0.6460;GERM CELL TUMORS#0.6458;DNA COPY NUMBER#0.6447;SCHWANN CELL#0.6435;RETINOID X RECEPTOR#0.6423;TEMOZOLOMIDE#0.6418;CDC2 KINASE ACTIVITY#0.6415;EUKARYOTIC INITIATION FACTOR#0.6412;PERIPHERAL BLOOD LEUKOCYTE#0.6412;GROWTH PATTERN#0.6408;L-CYSTEINE#0.6401;GM-CSF#0.6398;HIGH RISK PATIENTS#0.6396;MISMATCH REPAIR#0.6388;GLIAL FIBRILLARY ACIDIC PROTEIN#0.6365;FIBROUS DYSPLASIA#0.6364;GALACTOSIDASE ACTIVITY#0.6338;OVARIAN SURFACE EPITHELIUM#0.6335;COLON ADENOCARCINOMA#0.6319;NERVE SHEATH TUMORS#0.6316;GENE EXPRESSION OMNIBUS#0.6312;GASTROINTESTINAL STROMAL TUMOR#0.6304;EMBRYONAL RHABDOMYOSARCOMA#0.6295;HSP90 BINDING#0.6284;CASEIN KINASE 1#0.6284;DIABETIC NEPHROPATHY#0.6264;SURFACE EPITHELIUM#0.6262;PROTEIN PHOSPHATASE 2A#0.6244;PHOSPHATASE 2A#0.6241;INVASIVE BREAST CANCER#0.6238;WNT SIGNALING PATHWAY#0.6232;TRAMETINIB#0.6222;UMBILICAL CORD BLOOD#0.6217;NEURITE OUTGROWTH#0.6211;SV40 T-ANTIGEN#0.6211;PIPERAZIN#0.6209;DEMETHYLATION#0.6203;VIRAL REPLICATION#0.6201;VASCULAR CELL#0.6198;PLEOMORPHIC ADENOMA#0.6193;ERYTHROLEUKEMIA#0.6191;UTERUS#0.6188;T CELL ACTIVATION#0.6186;LEUKOPENIA#0.6185;ENDOMETRIOSIS#0.6164;HUMAN PAPILLOMA VIRUS#0.6163;MAMMARY EPITHELIUM#0.6147;ICI 182,780#0.6129;OXIDATIVE METABOLISM#0.6122;GRANULOSA CELL PROLIFERATION#0.6122;ORNITHINE DECARBOXYLASE#0.6119;GESTATION#0.6114;CUGBP1-EIF2 COMPLEX#0.6110;GLYCOLYSIS#0.6109;CASPASE ACTIVITY#0.6109;VON HIPPEL LINDAU#0.6107;OESOPHAGEAL SQUAMOUS CELL#0.6105;LYMPH NODE INVOLVEMENT#0.6103;CYCLOSPORIN A#0.6101;MULTIPLE ENDOCRINE NEOPLASIA#0.6095;NEURAL CELL#0.6090;L-OHP#0.6086;HISTIDINE#0.6075;GLUCOCORTICOID RECEPTOR#0.6074;TRANSLATION INITIATION#0.6066;CORE NEEDLE BIOPSIES#0.6060;VORINOSTAT#0.6060;ATPASE ACTIVITY#0.6059;NEURONAL CELLS#0.6054;ENDOMETRIOID ENDOMETRIAL CARCINOMA#0.6052;CYTOTOXIC T-LYMPHOCYTE#0.6047;CETUXIMAB#0.6045;ENTEROCYTE#0.6043;HYPERGLYCEMIC#0.6041;PRIMARY CUTANEOUS MELANOMA#0.6039;CELL ADHESION MOLECULE#0.6033;SERUM ALBUMIN#0.6009;17-DMAG#0.6003
101	LEUKOCYTE DIFFERENTIATION#1.0804;PANCREATIC CANCER#1.0612;LEUKOCYTE#1.0404;CANCER CELL#1.0224;MACROPHAGE#1.0091;GROWTH FACTOR#1.0076;LUNG CANCER#1.0064;HEPATOCELLULAR CARCINOMA#0.9833;CELL ADHESION#0.9745;GENE EXPRESSION#0.9732;ENDOTHELIAL CELL#0.9700;B CELL#0.9597;EXTRACELLULAR MATRIX#0.9570;MYOCARDIAL INFARCTION#0.9516;POLYMERASE CHAIN REACTION#0.9481;BREAST CANCER#0.9471;CELL SURFACE#0.9469;T CELL#0.9444;OSTEOCLAST#0.9220;NEUTROPHIL#0.9206;PERIPHERAL BLOOD#0.9152;CELL MIGRATION#0.8936;INFLAMMATORY CELL#0.8837;EOSINOPHIL#0.8790;EPITHELIAL CELL#0.8697;EPIDERMAL GROWTH FACTOR#0.8608;MONOCYTE#0.8518;EOSINOPHILIC PNEUMONIA#0.8453;TUMOR NECROSIS FACTOR#0.8426;ALLERGEN#0.8269;APOPTOSIS#0.8209;CELL GROWTH#0.8191;MONONUCLEAR CELLS#0.8023;SIGNALING PATHWAY#0.7975;BREAST CANCER CELL#0.7944;BONE MARROW#0.7651;PERIODONTAL DISEASE#0.7642;BLOOD VESSEL#0.7630;AMNIOTIC FLUID#0.7621;SPINAL CORD#0.7500;SKELETAL MUSCLE#0.7488;SELECTIN#0.7434;ADENOCARCINOMA#0.7400;STEM CELL#0.7293;REVERSE TRANSCRIPTION#0.7242;CELL FUSION#0.7187;DENDRITIC CELL#0.7117;T LYMPHOCYTE#0.7108;PROTEIN KINASE#0.7084;TUMOR CELLS#0.7072;ANGIOGENESIS#0.7071;INFLAMMATORY RESPONSE#0.7061;SQUAMOUS CELL CARCINOMA#0.6930;PERIODONTITIS#0.6915;SMOOTH MUSCLE#0.6913;BATIMASTAT#0.6901;BLOOD CIRCULATION#0.6875;IMMUNE CELL#0.6779;CHONDROCYTE#0.6642;CATALYTIC ACTIVITY#0.6556;RHEUMATOID ARTHRITIS#0.6530;CELL PROLIFERATION#0.6503;HYPOXIA#0.6372;GROWTH FACTOR RECEPTOR#0.6316;PNEUMONIA#0.6310;ATHEROSCLEROTIC#0.6286;TOXICITY#0.6261;GINGIVAL CREVICULAR FLUID#0.6229;CCL22 PRODUCTION#0.6178;ALLERGIC AIRWAY INFLAMMATION#0.6089;CELL DEATH#0.6054
10200	M PHASE#0.8897;NERVE FIBER#0.6143;RNA BINDING#0.6116
10201	NUCLEOSIDE DIPHOSPHATE KINASE#0.6630;STEM CELL#0.6094
10202	CHOLINE BINDING#1.1024;HISTIDINE#1.0609;OUTER MEMBRANE#1.0310;GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE#1.0229;CHOLINE#1.0194;ACUTE OTITIS MEDIA#1.0073;PNEUMOCOCCAL CONJUGATE VACCINE#1.0062;DIPHTHERIA#0.9996;OTITIS MEDIA#0.9964;INVASIVE PNEUMOCOCCAL DISEASE#0.9956;VIRULENCE#0.9948;SURFACTANT PROTEIN D#0.9906;IMMUNE RESPONSE#0.9708;PNEUMONIA#0.9551;RESPIRATORY TRACT#0.9514;GENE EXPRESSION#0.9430;MIDDLE EAR#0.9256;HEPATITIS B#0.8947;SERIOUS ADVERSE EVENT#0.8938;PERTUSSIS#0.8884;POLYAMINE TRANSPORT#0.8839;RANDOMIZED CONTROLLED TRIAL#0.8783;PHOSPHODIESTERASE#0.8613;RESPIRATORY TRACT INFECTION#0.8543;HEPATOCELLULAR CARCINOMA#0.8379;T CELL#0.8213;CELL CYCLE#0.8040;LUNG DISEASE#0.8008;MACROPHAGE#0.7822;SODIUM DODECYL SULFATE#0.7815;DODECYL SULFATE#0.7814;CHLAMYDIA#0.7785;RANDOMISED CONTROLLED TRIAL#0.7698;HEPATITIS A#0.7590;APOPTOSIS#0.7581;SICKLE CELL DISEASE#0.7576;EPIDIDYMIS#0.7569;B CELL#0.7456;PROTEIN COMPLEX#0.7257;RESPIRATORY-BURST OXIDASE#0.7189;DICARBOXYLIC ACID TRANSPORT#0.7169;RESPIRATORY BURST#0.7128;EPITHELIAL CELL#0.7106;MONOCYTE#0.7051;HOST CELL#0.7039;CANCER CELL#0.7015;PROTEIN SYNTHESIS#0.6964;CLARA CELL#0.6840;RIBOSOME#0.6797;DNA SYNTHESIS#0.6733;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.6630;POLYMERASE CHAIN REACTION#0.6569;YERSINIA OUTER PROTEIN#0.6476;PARACETAMOL#0.6356;MEMBRANE PROTEIN COMPLEX#0.6321;IMMUNE SYSTEM#0.6288;CAPUT#0.6265;IGD BINDING#0.6247;CAUDA#0.6237;BREAST CANCER#0.6235;PROTEIN KINASE#0.6196;ASPARTATE#0.6163;CELL SURFACE#0.6162;LYSIS#0.6139;LECTIN#0.6113;HEPATOCELLULAR CARCINOMA CELL#0.6107;DICARBOXYLIC ACID#0.6041
10203	CALCITONIN RECEPTOR#1.0467;RECEPTOR ACTIVITY#1.0353;AM BINDING#1.0346;ADRENOMEDULLIN RECEPTOR#1.0300;POLYMERASE CHAIN REACTION#1.0244;CGRP RECEPTOR#1.0167;RECEPTOR COMPLEX#1.0149;GENE EXPRESSION#1.0127;ENDOTHELIAL CELL#1.0103;MUSCLE CELL#1.0061;SMOOTH MUSCLE CELL#1.0052;REVERSE TRANSCRIPTION#1.0049;CELL SURFACE#1.0018;PLASMA MEMBRANE#1.0015;SMOOTH MUSCLE#1.0001;VASCULAR SMOOTH MUSCLE CELL#0.9894;GLYCOSYLATION#0.9889;VASODILATOR#0.9761;ARTERY#0.9697;RECEPTOR ANTAGONIST#0.9641;ANGIOGENESIS#0.9637;GROWTH FACTOR#0.9564;SIGNALING PATHWAY#0.9462;ADRENOMEDULLIN BINDING#0.9443;ENDOTHELIUM#0.9428;MIGRAINE#0.9409;TRANSCRIPTASE#0.9376;HYPERTENSION#0.9312;PROTEIN KINASE#0.9287;BLOOD VESSEL#0.9285;NERVOUS SYSTEM#0.9111;NITRIC OXIDE#0.9057;APOPTOSIS#0.9033;EPITHELIAL CELL#0.9015;SIGNAL TRANSDUCTION#0.8925;HYPOTENSIVE#0.8841;CELL PROLIFERATION#0.8809;SPINAL CORD#0.8523;HYPOXIA#0.8500;MACROPHAGE#0.8433;PEPTIDE HORMONE#0.8309;UTERUS#0.8303;ADIPOSE TISSUE#0.8274;CARDIOMYOCYTE#0.8244;VASODILATION#0.8197;CELLULAR LOCALIZATION#0.8173;CELL MEMBRANE#0.7999;CANCER CELL#0.7944;ACUTE MYELOID LEUKEMIA#0.7932;MYELOID LEUKEMIA#0.7913;MYOCARDIUM#0.7867;PHEOCHROMOCYTOMA#0.7766;ADENYLATE CYCLASE#0.7709;PROTEIN KINASE A#0.7705;AMYLIN RECEPTOR#0.7676;CLASS B GPCR#0.7553;TROPHOBLAST#0.7531;GESTATION#0.7351;CENTRAL NERVOUS SYSTEM#0.7346;HYPOXIC#0.7321;MAST CELL#0.7275;COMPLEX I#0.7231;SUBSTANCE P#0.7201;HYDROPS FETALIS#0.6969;RECEPTOR INTERNALIZATION#0.6962;MUTAGENESIS#0.6897;ALANINE#0.6888;QUANTITATIVE REAL TIME#0.6871;ISCHEMIA#0.6848;APOPTOTIC#0.6835;PEPTIDE BINDING#0.6834;STEM CELL#0.6823;ADRENAL MEDULLA#0.6814;TROPHOBLAST CELL#0.6793;OSTEOBLAST#0.6778;ADRENAL GLAND#0.6758;PANCREATIC CANCER#0.6733;CONGESTIVE HEART FAILURE#0.6726;NERVE FIBER#0.6625;RECEPTOR BINDING#0.6612;ADENYLATE#0.6596;BONE MARROW#0.6570;HUMAN EMBRYONIC KIDNEY#0.6533;EMBRYONIC KIDNEY#0.6529;MYOCYTES#0.6517;NEUROPEPTIDE RECEPTOR#0.6510;OSTEOCLAST#0.6488;ENDOTHELIAL GROWTH FACTOR#0.6339;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6339;COTRANSLATIONAL MODIFICATION#0.6289;ANGLE-CLOSURE GLAUCOMA#0.6169;REPRODUCTIVE SYSTEM#0.6053;BASILAR ARTERY#0.6041;ADENOSINE#0.6014;PULMONARY HYPERTENSION#0.6009
10204	IMPORTIN#1.0457;NUCLEAR TRANSPORT#1.0439;NUCLEAR IMPORT#1.0392;PROTEIN IMPORT#1.0380;PORE COMPLEX#1.0058;NUCLEAR PORE COMPLEX#1.0043;NUCLEAR PORE#1.0034;MOLECULAR DYNAMICS SIMULATION#1.0025;NUCLEAR EXPORT#0.9900;NUCLEAR ENVELOPE#0.9856;CYTOPLASM#0.9731;MOLAR#0.9151;INSULIN RECEPTOR#0.8996;ADIPOCYTE#0.8996;NUCLEAR PORE COMPLEXES#0.8875;KARYOPHERIN#0.8610;LITHIUM#0.8253;NUCLEOCYTOPLASMIC TRANSPORT#0.8115;RECEPTOR TYROSINE KINASE#0.8107;NUCLEAR LOCALIZATION SIGNAL#0.7954;CELL CYCLE#0.7658;RNA BINDING#0.7641;ETHANOL#0.7403;SIGNAL TRANSDUCTION#0.7253;PROTEIN TRANSPORT#0.7203;SIGNAL TRANSMISSION#0.6857;CATALYTIC ACTIVITY#0.6825;NUCLEOTIDE EXCHANGE FACTOR#0.6793;GLUCOSE TRANSPORT#0.6767;TRANSPORTIN#0.6757;LIMITS OF DETECTION#0.6314;GUANINE#0.6228
10205	MYELIN PROTEIN ZERO#1.0075;EPITHELIAL CELL#0.9940;T CELL#0.9838;CELL ADHESION#0.9290;GENE EXPRESSION#0.7968;THYMOCYTE#0.7917;B LYMPHOCYTE#0.7898;CELL ADHESION MOLECULE#0.7016;ANTI-VLA4#0.6653;T LYMPHOCYTE#0.6534;CANCER CELL#0.6505;CHOROID PLEXUS#0.6327;INNER EAR#0.6311
102060282	TUMOR SUPPRESSOR#0.7133
10206	DIHYDROMORPHINE#1.0648;SUBSTANCE P#1.0309;ETORPHINE#1.0269;RECEPTOR AGONIST#1.0212;MU OPIOID RECEPTOR#1.0119;DELTA OPIOID RECEPTOR#1.0090;LEUCINE#1.0085;RECEPTOR BINDING#1.0050;UBIQUITIN#1.0024;OPIOID PEPTIDE#0.9932;DOPAMINE#0.9901;KAPPA OPIOID RECEPTOR#0.9834;OPIOID RECEPTOR#0.9828;NALOXONE#0.9772;SPINAL CORD#0.9768;ADENYLATE CYCLASE#0.9435;RECEPTOR ANTAGONIST#0.9405;NEUROBLASTOMA#0.9246;TUMOR SUPPRESSOR#0.9175;T CELL#0.9138;PLASMA MEMBRANE#0.9132;STRIATUM#0.9034;CYCLASE ACTIVITY#0.8976;METHIONINE#0.8908;FENTANYL#0.8889;ADENYLATE#0.8739;PERTUSSIS#0.8625;DIPRENORPHINE#0.8532;B CELL#0.8473;NALTREXONE#0.8428;PEPTIDASE INHIBITOR#0.8380;OPIOID RECEPTOR BINDING#0.8221;ADENYLATE CYCLASE ACTIVITY#0.8221;NORADRENALINE#0.8127;MORPHINE SULFATE#0.8118;NERVOUS SYSTEM#0.8065;ADRENAL MEDULLA#0.8047;CAPTOPRIL#0.7829;NITRIC OXIDE SYNTHASE#0.7803;NITRIC OXIDE#0.7783;MEMBRANE FRACTION#0.7714;CELL DEATH#0.7642;LIGASE ACTIVITY#0.7481;SUBSTANTIA NIGRA#0.7472;THIORPHAN#0.7339;BETA-ENDORPHIN BINDING#0.7304;RECEPTOR LIGAND#0.7280;STRUCTURE ACTIVITY RELATIONSHIP#0.7271;CHRONIC LYMPHOCYTIC LEUKEMIA#0.7221;LYMPHOCYTIC LEUKEMIA#0.7214;NERVE TERMINAL#0.7053;AXON TERMINAL#0.6992;ENDOPEPTIDASE 24.11#0.6950;ACETYLCHOLINE#0.6851;BLOOD BRAIN BARRIER#0.6759;SMOOTH MUSCLE#0.6561;ANGIOTENSIN CONVERTING ENZYME#0.6524;LEUCINE BIOSYNTHESIS#0.6476;GUANINE#0.6468;BESTATIN#0.6459;THALAMUS#0.6459;ENDOPLASMIC RETICULUM#0.6455;FORSKOLIN#0.6344;ISCHEMIA#0.6315;CEREBRAL CORTEX#0.6297;CYCLIC AMP#0.6295;VASOPRESSIN#0.6195;SUFENTANIL#0.6176;LEVORPHANOL#0.6132;NERVOUS TISSUE#0.6119;AMIDE BINDING#0.6119;CENTRAL NERVOUS SYSTEM#0.6115;ALANINE#0.6076;PYRAMIDAL CELL#0.6071;CHROMAFFIN CELL#0.6041;UBIQUITIN LIGASE ACTIVITY#0.6020;N-ETHYLMALEIMIDE#0.6013
10207	TIGHT JUNCTION PROTEIN#1.0653;TIGHT JUNCTION#1.0484;EPITHELIAL CELL#1.0065;PROTEIN KINASE C#1.0061;PROTEIN KINASE#1.0052;CELL POLARITY#1.0043;PLASMA MEMBRANE#0.9556;PDZ BINDING MOTIF#0.9168;PROTEIN COMPLEX#0.8956;ADHERENS JUNCTION#0.8806;GLUTAMATE RECEPTOR#0.8776;MORPHOGENESIS#0.7903;SIGNALING PATHWAY#0.7809;PDZ DOMAIN BINDING#0.7667;ION CHANNEL#0.7225;SYNAPSE ASSOCIATED PROTEIN#0.7106;CELL SURFACE#0.6927;SIGNAL TRANSDUCTION#0.6814;NERVOUS SYSTEM#0.6810;INSULIN RECEPTOR#0.6794;CELL JUNCTION#0.6753;PHOTORECEPTOR CELL#0.6746;ZONULA OCCLUDENS#0.6658;PROTEIN PROTEIN INTERACTION#0.6553;USHER SYNDROME#0.6428;POSTSYNAPTIC DENSITY#0.6416;COMPLEX I#0.6381;RECEPTOR TYROSINE KINASE#0.6272;GROWTH FACTOR#0.6049
10208	SNRNA TRANSCRIPTION#0.6730;CAJAL BODY#0.6660;CYTOCHROME C#0.6568
10209	CYTOCHROME C#1.0831;PREINITIATION COMPLEX#1.0479;40S RIBOSOMAL SUBUNIT#1.0339;TRANSLATION INITIATION FACTOR#1.0339;EUKARYOTIC INITIATION FACTOR#1.0228;RIBOSOMAL SUBUNIT#1.0153;TRANSLATION INITIATION#1.0152;RIBOSOME#1.0091;PROTEIN SYNTHESIS#1.0040;OVARIAN CARCINOMA#0.9826;OVARIAN#0.9761;GTP HYDROLYSIS#0.9668;BASE PAIRING#0.9490;C TERMINAL DOMAIN#0.9045;RIBOSOMAL PROTEIN#0.8436;MRNA BINDING#0.8299;RETICULOCYTE#0.8240;TRANSLATION INITIATION COMPLEX#0.8132;GENE EXPRESSION#0.7960;SMALL RIBOSOMAL SUBUNIT#0.7952;GROWTH FACTOR#0.7692;INTERNODE#0.7496;HEPATOCELLULAR CARCINOMA#0.7434;80S RIBOSOME#0.7323;CANCER CELL#0.7239;RIBOSOME BINDING#0.7131;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7065;ENDOTHELIAL GROWTH FACTOR#0.7064;COMPLEX I#0.6833;PROTEIN SYNTHESIS INITIATION#0.6550;CELL GROWTH#0.6003
1020	TAU PROTEIN KINASE#1.0834;OLOMOUCINE#1.0533;CAMKII#1.0481;BETA CELL#1.0459;PROSTATE CANCER#1.0390;INSULIN SECRETION#1.0378;SYNAPTIC TRANSMISSION#1.0363;MAP KINASE#1.0330;HYPERACTIVITY#1.0302;ISCHEMIA#1.0297;MYOCYTE ENHANCER FACTOR#1.0294;MITOCHONDRIAL FISSION#1.0274;NEURONAL MIGRATION#1.0259;PODOCYTE#1.0256;CYCLIN DEPENDENT KINASE#1.0254;CELL MIGRATION#1.0238;MITOGEN ACTIVATED PROTEIN#1.0232;BRAIN DEVELOPMENT#1.0220;ATP BINDING#1.0209;CALCINEURIN#1.0207;GLYCOGEN SYNTHASE KINASE#1.0202;KINASE ACTIVITY#1.0197;HYPOXIA#1.0196;NEUROFILAMENT#1.0196;DENDRITIC SPINE#1.0187;NMDA RECEPTOR#1.0182;NEURITE OUTGROWTH#1.0176;NEUROTRANSMISSION#1.0174;CYTOPLASM#1.0170;CEREBRAL ISCHEMIA#1.0169;ENDOTHELIAL CELL#1.0161;SYNAPTIC VESICLE#1.0155;NEUROGENESIS#1.0154;PROTEIN PHOSPHATASE 2A#1.0152;NEUROTOXIC#1.0146;LUNG CANCER#1.0144;NEURONAL CELL DEATH#1.0144;PHOSPHATASE 2A#1.0136;EXOCYTOSIS#1.0129;AUTOPHAGY#1.0129;NEUROTOXICITY#1.0128;NEURONAL CELLS#1.0127;CELL DIFFERENTIATION#1.0127;CELL CYCLE REGULATION#1.0119;EPITHELIAL CELL#1.0116;PURKINJE CELL#1.0114;ACTIN CYTOSKELETON#1.0107;OLIGODENDROCYTE#1.0104;AXONAL TRANSPORT#1.0102;NERVOUS SYSTEM DEVELOPMENT#1.0088;NEUROTRANSMITTER RELEASE#1.0082;AMYOTROPHIC LATERAL SCLEROSIS#1.0081;ENDOCYTOSIS#1.0077;PROTEIN KINASE A#1.0075;GROWTH CONE#1.0075;CENTRAL NERVOUS SYSTEM#1.0073;SYSTEM DEVELOPMENT#1.0064;LATERAL SCLEROSIS#1.0059;SPINAL CORD#1.0047;HYPERPHOSPHORYLATION#1.0046;NITRIC OXIDE#1.0045;CELL ADHESION#1.0044;CANCER CELL#1.0038;BREAST CANCER CELL#1.0035;NEUROLOGICAL DISORDER#1.0031;PROTEIN KINASE C#1.0029;CALPAIN ACTIVITY#1.0027;NERVOUS SYSTEM#1.0020;PROTEIN KINASE#1.0016;MORPHOGENESIS#1.0015;PRIMARY CORTICAL NEURON#1.0011;NEURITE#1.0006;PROTEASOME#1.0003;BREAST CANCER#0.9998;CELL GROWTH#0.9992;DEPHOSPHORYLATION#0.9991;T CELL#0.9982;NEUROPROTECTION#0.9980;SIGNALING CASCADE#0.9980;UBIQUITIN#0.9976;GLUTAMATE RECEPTOR#0.9974;DOPAMINE#0.9965;GROWTH CONE COLLAPSE#0.9965;CELL DEATH#0.9964;PARKINSON'S DISEASE#0.9961;APOPTOSIS#0.9946;TRANSCRIPTION FACTOR#0.9942;PANCREATIC CANCER#0.9940;CELL MOTILITY#0.9936;S PHASE#0.9927;PROTEIN PHOSPHATASE 1#0.9926;NERVE TERMINAL#0.9926;STRIATUM#0.9926;CDK INHIBITOR#0.9921;TOXICITY#0.9915;SENSITIZATION#0.9914;CEREBRAL CORTEX#0.9914;SIGNALING PATHWAY#0.9911;APOPTOTIC#0.9907;ASTROCYTE#0.9901;MOLECULAR DYNAMICS SIMULATION#0.9900;DOPAMINERGIC NEURON#0.9894;AMYLOID PRECURSOR PROTEIN#0.9888;CELL CYCLE#0.9882;CYCLIC AMP#0.9879;PROTEIN PHOSPHORYLATION#0.9872;POSTSYNAPTIC DENSITY#0.9869;NEURODEGENERATIVE DISEASE#0.9868;STEM CELL#0.9867;FOREBRAIN#0.9863;NEUROBLASTOMA#0.9858;CELL DIVISION#0.9857;TUMOR SUPPRESSOR#0.9845;ASPARTATE#0.9843;GROWTH FACTOR#0.9830;CELL CYCLE ARREST#0.9829;TYPE 2 DIABETES#0.9824;RETINOIC ACID#0.9817;COMPLEX I#0.9816;MICROTUBULE#0.9814;GENE EXPRESSION#0.9807;CNS DEVELOPMENT#0.9806;ANGIOGENESIS#0.9805;SIGNAL TRANSDUCTION#0.9802;CELL PROLIFERATION#0.9791;NEUROFIBRILLARY TANGLE#0.9790;MICROTUBULE ASSOCIATED PROTEIN#0.9738;PROTEIN PROTEIN INTERACTION#0.9732;DENTATE GYRUS#0.9729;KINASE INHIBITOR#0.9723;MORRIS WATER MAZE#0.9722;LYMPH NODE#0.9709;TAUOPATHY#0.9703;MEMORY IMPAIRMENT#0.9698;ALZHEIMER'S DISEASE#0.9694;LONG TERM POTENTIATION#0.9687;REACTIVE OXYGEN SPECIES#0.9685;DYNEIN#0.9678;ENDOPLASMIC RETICULUM#0.9675;FOCAL ADHESION#0.9659;MITOCHONDRIA#0.9655;PEROXISOME#0.9653;DOPAMINE RECEPTOR#0.9648;NEUROMUSCULAR JUNCTION#0.9644;LITHIUM#0.9632;SPATIAL LEARNING#0.9617;DEMENTIA#0.9613;STRUCTURE ACTIVITY RELATIONSHIP#0.9595;EPITHELIAL MESENCHYMAL TRANSITION#0.9594;SYNAPSE DEVELOPMENT#0.9587;LYMPH NODE METASTASIS#0.9581;OPIOID RECEPTOR#0.9567;POLYMERASE CHAIN REACTION#0.9567;CASEIN KINASE 1#0.9557;SYNAPTOGENESIS#0.9555;SRC FAMILY KINASE#0.9549;DIABETES MELLITUS#0.9525;TUMOR CELLS#0.9518;REGENERATION#0.9508;MICROTUBULE BINDING#0.9492;NITRIC OXIDE SYNTHASE#0.9491;SIGNALLING PATHWAY#0.9488;GLUCOSE UPTAKE#0.9480;AMPA RECEPTOR#0.9473;DENDRITIC SPINE DENSITY#0.9461;CELL CYCLE REGULATOR#0.9445;HUNTINGTON'S DISEASE#0.9432;SENESCENCE#0.9420;SUBSTANTIA NIGRA#0.9409;STRESS FIBER#0.9396;DENDRITE DEVELOPMENT#0.9393;RETINOBLASTOMA#0.9388;HISTONE DEACETYLASE#0.9384;NEURAL CELL#0.9375;ALANINE#0.9363;CYCLIN DEPENDENT KINASE INHIBITOR#0.9350;PLASMA MEMBRANE#0.9319;INFLAMMATORY RESPONSE#0.9313;ACTIN BINDING#0.9309;ADIPOSE TISSUE#0.9308;COGNITION#0.9292;NERVE GROWTH FACTOR#0.9282;CALCIUM CHANNEL#0.9272;CEREBELLAR GRANULE NEURON#0.9248;SCIATIC NERVE#0.9231;ACTIN POLYMERIZATION#0.9212;SKELETAL MUSCLE#0.9208;CLEAVED CASPASE 3#0.9190;GANGLION CELLS#0.9187;CORNEAL EPITHELIAL CELL#0.9185;MIDDLE CEREBRAL ARTERY#0.9182;DNA BINDING#0.9182;CEREBRAL ARTERY#0.9179;MYOGENESIS#0.9174;TUMOR NECROSIS FACTOR#0.9159;POST-TRANSLATIONAL MODIFICATION#0.9142;EPILEPSY#0.9110;ADIPOCYTE#0.9110;GLUCOCORTICOID RECEPTOR#0.9108;INTERMEDIATE FILAMENT#0.9102;AXON GUIDANCE#0.9099;NEURITE GROWTH#0.9080;AMYGDALA#0.9063;GINSENOSIDE RB1#0.9061;AKT SIGNALING#0.9056;CATALYTIC ACTIVITY#0.9046;ACTIN FILAMENT#0.9038;ACETYLCHOLINE RECEPTOR#0.9023;GLIAL CELL#0.9004;TRANSIENT RECEPTOR POTENTIAL#0.8998;INTERNEURON#0.8957;CERVICAL CANCER#0.8949;RETINAL GANGLION CELL#0.8920;CELL BODY#0.8912;HEPATOCELLULAR CARCINOMA#0.8909;WOUND HEALING#0.8907;DORSAL ROOT GANGLION#0.8899;ACETYLCHOLINE#0.8896;GLUTATHIONE#0.8873;SIGNAL TRANSDUCER#0.8862;CELL CYCLE CONTROL#0.8813;FRONTAL#0.8793;ETHANOL#0.8790;TPK II#0.8767;RNA INTERFERENCE#0.8758;RELATED PROTEIN 1#0.8748;MEMBRANE FRACTION#0.8736;CEREBRAL ARTERY OCCLUSION#0.8723;ARTERY#0.8706;PHOSPHATASE ACTIVITY#0.8679;RECEPTOR TYROSINE KINASE#0.8664;EPHRIN#0.8662;NEURAL STEM CELL#0.8657;ACTIN BINDING PROTEIN#0.8656;FRONTOTEMPORAL DEMENTIA#0.8656;PHOSPHATASE INHIBITOR#0.8627;CAMP RESPONSE ELEMENT#0.8625;NERVOUS TISSUE#0.8614;PIOGLITAZONE#0.8605;PROGENITOR CELL#0.8590;TYPE 2 DIABETES MELLITUS#0.8582;2 DIABETES MELLITUS#0.8581;APOPTOTIC CELL DEATH#0.8576;DNA REPAIR#0.8571;MYOTUBE#0.8565;CAMP RESPONSE ELEMENT BINDING#0.8530;CYTOSKELETAL ELEMENT#0.8502;PRECURSOR CELL#0.8495;HYPOXIC#0.8480;MOTOR LEARNING#0.8472;BLOOD BRAIN BARRIER#0.8470;MITOSIS#0.8463;NEURON DEVELOPMENT#0.8461;MUTAGENESIS#0.8456;SYNAPTIC VESICLE ENDOCYTOSIS#0.8454;SPECTRIN#0.8449;ORGANELLE#0.8433;VESICLE ENDOCYTOSIS#0.8427;SPINAL DORSAL HORN#0.8417;ADENOCARCINOMA#0.8404;CYTOTOXICITY#0.8373;DNA DAMAGE RESPONSE#0.8345;TRANSFORMING GROWTH FACTOR#0.8330;SUPEROXIDE DISMUTASE#0.8329;G1 PHASE#0.8327;DNA METHYLATION#0.8317;EMBRYONIC BRAIN#0.8315;MICROTUBULE DYNAMICS#0.8312;FIBRIL#0.8307;ENDOPLASMIC RETICULUM STRESS#0.8285;PODOCYTE APOPTOSIS#0.8273;ION CHANNEL#0.8217;KINESIN#0.8210;AMYLOID PROTEIN#0.8193;SIGNALING MOLECULE#0.8184;AXON GROWTH#0.8178;MACROPHAGE#0.8164;NEURON APOPTOSIS#0.8139;M PHASE#0.8137;OOCYTE#0.8135;LISSENCEPHALY#0.8103;MOTOR NEURON DISEASE#0.8077;MYOBLAST#0.8077;CHANNEL ACTIVITY#0.8072;GAP ACTIVITY#0.8059;NEUROTOXIN#0.8050;PRO-INFLAMMATORY#0.8039;QUANTITATIVE REAL TIME#0.8022;PROTEIN PROCESSING#0.8018;PROTEASOME PATHWAY#0.8016;CONDITIONED PLACE PREFERENCE#0.7979;METABOTROPIC GLUTAMATE RECEPTORS#0.7963;DOMINANT NEGATIVE MUTANT#0.7952;CENTRAL NERVOUS SYSTEM DEVELOPMENT#0.7944;EXTRACELLULAR MATRIX#0.7934;HISTONE ACETYLATION#0.7929;MYELINATION#0.7928;PROTEIN KINASE B#0.7924;NEURON SURVIVAL#0.7919;RECEPTOR ANTAGONIST#0.7916;PROTEIN SYNTHESIS#0.7898;MELATONIN#0.7897;LYMPHATIC VESSEL#0.7895;PROGRAMMED CELL DEATH#0.7882;COLCHICINE#0.7878;ANDROGEN RECEPTOR#0.7864;PROTEIN KINASE INHIBITOR#0.7862;GLIAL FIBRILLARY ACIDIC PROTEIN#0.7803;LIPID RAFT#0.7783;ACTION POTENTIAL#0.7782;LEYDIG CELL#0.7776;SERTOLI CELL#0.7768;MECHANISM OF ACTION#0.7768;HYPERACTIVE#0.7767;NUCLEAR EXPORT#0.7760;MOTOR NEURON DEGENERATION#0.7752;DNA REPLICATION#0.7737;ADENYLATE CYCLASE#0.7734;CERVICAL#0.7733;INNATE IMMUNITY#0.7726;STEERED MOLECULAR DYNAMICS#0.7719;ADENOSINE#0.7693;CALCINEURIN SIGNALING#0.7681;INSULIN-LIKE GROWTH FACTOR#0.7679;CELLULAR SENESCENCE#0.7675;OLIGODENDROCYTE LINEAGE CELLS#0.7658;NEURON DEATH#0.7656;SYNAPTOSOME#0.7648;NOCICEPTION#0.7638;DENDRITIC SPINE DEVELOPMENT#0.7633;SPERM TAIL#0.7632;TAXOL#0.7621;ENDOSOME#0.7599;GENOTOXIC#0.7573;EPIDERMAL GROWTH FACTOR#0.7553;POSTTRANSLATIONAL MODIFICATION#0.7543;NEURITE EXTENSION#0.7518;MUSCLE CELL#0.7513;HERPES SIMPLEX VIRUS#0.7494;HERPES SIMPLEX#0.7490;CENTROSOME#0.7476;DOPAMINE D1 RECEPTOR#0.7473;INDUCTION OF APOPTOSIS#0.7468;CORTICOGENESIS#0.7462;ENDOTHELIAL CELL MIGRATION#0.7437;LOCOMOTION#0.7385;HAIR CELL#0.7358;CELL MATURATION#0.7357;C TERMINAL DOMAIN#0.7357;MICROCEPHALY#0.7350;PITUITARY ADENOMA#0.7341;CASEIN KINASE 2#0.7317;ONCOGENIC#0.7317;ENZYME ACTIVITY#0.7309;STAUROSPORINE#0.7280;GUANINE#0.7252;REGULATION OF PHOSPHORYLATION#0.7243;NUCLEOTIDE EXCHANGE FACTOR#0.7231;HISTONE MODIFICATION#0.7225;DENDRITIC CELL#0.7217;MENTAL RETARDATION#0.7214;L-DOPA#0.7206;GABAERGIC NEURON#0.7199;NEURON MIGRATION#0.7196;DIABETIC NEPHROPATHY#0.7192;POLY ADP RIBOSE#0.7186;FOCAL ADHESION KINASE#0.7178;CELLULAR LOCALIZATION#0.7177;SEVOFLURANE#0.7161;REVERSE TRANSCRIPTION#0.7159;PHOSPHODIESTERASE#0.7123;IMMATURE NEURON#0.7116;AXONAL GROWTH CONE#0.7109;NEUROPATHY#0.7107;LYSINE#0.7106;CELL SURFACE#0.7077;MAP KINASE KINASE#0.7076;CISPLATIN#0.7076;MICROTUBULE ASSEMBLY#0.7069;PODOCYTE DIFFERENTIATION#0.7003;REGULATION OF CELL CYCLE#0.6996;RIBOSOMAL PROTEIN#0.6981;ATAXIA TELANGIECTASIA MUTATED#0.6959;ATAXIA TELANGIECTASIA#0.6937;DOUBLE TRANSGENIC MICE#0.6934;IN UTERO ELECTROPORATION#0.6894;CELL DIVISION CYCLE#0.6891;NEUROBLAST#0.6887;OLIGODENDROCYTE DEVELOPMENT#0.6872;SIGNALLING CASCADE#0.6867;PROTEIN KINASE ACTIVITY#0.6867;ENDOTHELIAL CELL PROLIFERATION#0.6859;LIGAND BINDING DOMAIN#0.6852;MAPK SIGNALING#0.6812;TRANSACTIVATION#0.6801;PROTEIN PHOSPHATASE INHIBITOR#0.6798;MEMORY LOSS#0.6792;OLIGODENDROCYTE PRECURSOR CELL#0.6792;MYOBLAST DIFFERENTIATION#0.6779;COGNITIVE DISORDER#0.6778;ACTIN BUNDLING#0.6760;LEWY BODY#0.6740;TAMOXIFEN#0.6724;PACLITAXEL#0.6723;CASPASE-3 ACTIVITY#0.6717;PERIPHERAL NERVE#0.6705;PROTEIN COMPLEX#0.6703;TARGET OF RAPAMYCIN#0.6690;ADENO ASSOCIATED VIRUS#0.6685;UBIQUITIN PROTEASOME PATHWAY#0.6675;CHROMAFFIN CELL#0.6658;ISCHEMIA REPERFUSION INJURY#0.6651;TPK I#0.6636;APOPTOSIS OF NEURONS#0.6612;SYNAPTIC SIGNALING#0.6593;SILDENAFIL#0.6571;CAMP SIGNALING#0.6543;PROLIFERATING CELL NUCLEAR ANTIGEN#0.6541;MEDIUM SPINY NEURONS#0.6520;OPTIC NERVE#0.6491;GTPASE ACTIVITY#0.6487;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.6476;NUCLEAR IMPORT#0.6465;TUMOR TISSUES#0.6457;HUMAN EMBRYONIC KIDNEY#0.6448;EMBRYONIC KIDNEY#0.6444;PERIPHERAL NERVOUS SYSTEM#0.6430;FLAVOPIRIDOL#0.6428;ACTIVATION OF GSK#0.6418;DNA SYNTHESIS#0.6395;RAPAMYCIN#0.6364;ENDOTHELIUM#0.6346;METHAMPHETAMINE#0.6343;PRIMARY MICROCEPHALY#0.6326;NEURONAL CELL BODIES#0.6323;INCLUSION BODY#0.6291;VESICLE FUSION#0.6284;INHIBITION OF GSK#0.6271;ROSIGLITAZONE#0.6264;BASAL GANGLIA#0.6264;ASPARTIC ACID#0.6263;BRAIN DAMAGE#0.6253;OVARIAN#0.6246;ADENYLATE#0.6245;CDK ACTIVITY#0.6228;PUROMYCIN#0.6218;PROTEIN DEGRADATION#0.6216;CELL POLARITY#0.6210;SUNITINIB#0.6205;SUMOYLATION#0.6203;MULTIPLE MYELOMA#0.6195;NEUTROPHIL#0.6195;THYROID CANCER#0.6180;NOVEL OBJECT RECOGNITION#0.6176;COLORECTAL CANCER#0.6158;SQUAMOUS CELL CARCINOMA#0.6157;TEMPORAL LOBE#0.6154;OUTER DENSE FIBER#0.6152;TRAUMATIC BRAIN INJURY#0.6142;ANTEROGRADE AXONAL TRANSPORT#0.6131;LUNG ADENOCARCINOMA#0.6127;INCLUSION BODY MYOSITIS#0.6119;NEURONAL CELL APOPTOSIS#0.6116;LINES OF EVIDENCE#0.6108;HEAT SHOCK PROTEIN#0.6068;TOPOISOMERASE#0.6058;RIBOSE#0.6050;HYPERSENSITIVITY#0.6048;NEPHROPATHY#0.6040;MEDIAL PREFRONTAL CORTEX#0.6024;PHOSPHATASE 2B#0.6014
10210	UBIQUITIN#1.0543;TOPOISOMERASE#1.0373;TUMOR SUPPRESSOR#0.9979;RETINITIS PIGMENTOSA#0.9879;SUMOYLATION#0.9427;RETINITIS#0.8711;LIGASE ACTIVITY#0.7879;SUMO LIGASE#0.7397;GENE EXPRESSION#0.7328;P53 BINDING#0.7319;DNA TOPOISOMERASE#0.7152;BREAST CANCER#0.6549;SUMO LIGASE ACTIVITY#0.6418;CELL GROWTH#0.6326;PERICENTRIC HETEROCHROMATIN#0.6002
10211	MEMBRANE RAFT#1.0351;CELL PROLIFERATION#1.0304;MEMBRANE MICRODOMAIN#1.0295;LIPID RAFT#1.0287;EXOSOME#1.0252;ENDOCYTOSIS#1.0164;CAVEOLAE#1.0098;CANCER CELL#1.0074;GROWTH FACTOR#1.0047;SUCROSE#1.0004;T CELL#0.9954;DETERGENT RESISTANT MEMBRANE#0.9941;PLASMA MEMBRANE#0.9904;SIGNAL TRANSDUCTION#0.9791;BREAST CANCER#0.9787;SIGNALING PATHWAY#0.9607;EPITHELIAL CELL#0.9602;CELL MEMBRANE#0.9594;LYMPH NODE#0.9563;CELL ADHESION#0.9473;MACROPHAGE#0.9410;ENDOSOME#0.9398;PROTEIN KINASE#0.9351;ENDOPLASMIC RETICULUM#0.9252;UROPOD#0.9192;LYMPH NODE METASTASIS#0.9177;CELL GROWTH#0.9023;CELL SURFACE#0.9005;ALZHEIMER'S DISEASE#0.9004;GENE EXPRESSION#0.8976;BREAST CANCER CELL#0.8971;NEUTROPHIL#0.8876;LYSOSOME#0.8861;GROWTH FACTOR RECEPTOR#0.8857;SERTOLI CELL#0.8786;CELL MIGRATION#0.8650;ENDOTHELIAL CELL#0.8640;MEMBRANE FRACTION#0.8613;TRANSMISSION ELECTRON MICROSCOPY#0.8447;ACTIN CYTOSKELETON#0.8244;PERIPHERAL BLOOD#0.8137;LUNG CANCER#0.8118;APOPTOSIS#0.8024;RECEPTOR TYROSINE KINASE#0.7892;MITOGEN ACTIVATED PROTEIN#0.7862;CLATHRIN HEAVY CHAIN#0.7800;PHAGOSOME#0.7742;HOST CELL#0.7716;CELL CYCLE#0.7687;REGENERATION#0.7667;EXTRACELLULAR VESICLE#0.7589;MUSCLE CELL#0.7563;OVERALL SURVIVAL TIME#0.7552;PHAGOCYTOSIS#0.7548;ORGANELLE#0.7531;CLEAR CELL RENAL CELL CARCINOMA#0.7516;ASTROCYTE#0.7508;RENAL CELL CARCINOMA#0.7487;EPIDERMAL GROWTH FACTOR#0.7485;HEPATOCELLULAR CARCINOMA#0.7472;PROTEIN KINASE C#0.7276;TOTAL INTERNAL REFLECTION#0.7130;AKT SIGNALING#0.7115;SKELETAL MUSCLE#0.7067;LATE ENDOSOME#0.6871;INSULIN RECEPTOR#0.6716;POLYMERASE CHAIN REACTION#0.6702;ERYTHROCYTE#0.6668;ADIPOCYTE#0.6582;EPITHELIAL MESENCHYMAL TRANSITION#0.6516;RNA INTERFERENCE#0.6515;DOPAMINE#0.6505;PLASMA MEMBRANE RAFT#0.6444;HUMAN BREAST CANCER#0.6332;TRANSFERRIN RECEPTOR#0.6246;UROPOD FORMATION#0.6239;SEEDLING DEVELOPMENT#0.6212;CYTOPLASM#0.6207;CELL ACTIVATION#0.6202;AMYLOID PRECURSOR PROTEIN#0.6192
10212	RNA HELICASE#1.0998;NUCLEOCYTOPLASMIC SHUTTLING#0.8459;NUCLEAR EXPORT#0.8151;CANCER CELL#0.7831;RNA BINDING#0.7111;TREX COMPLEX#0.6817;DISEASE FREE SURVIVAL#0.6268;PROTEIN SYNTHESIS#0.6235
10213	DEUBIQUITINASE#1.0778;DEUBIQUITINATING ENZYME#1.0675;DEUBIQUITINATION#1.0469;PROTEASOME#1.0407;26S PROTEASOME#1.0371;UBIQUITIN#1.0051;CELL CYCLE#1.0036;GENE EXPRESSION#0.9311;COP9 SIGNALOSOME#0.9306;PROTEASOME ASSEMBLY#0.9094;20S PROTEASOME#0.9029;CANCER CELL#0.8902;SIGNALOSOME#0.8861;APOPTOSIS#0.8121;PROTEIN DEGRADATION#0.7967;TRANSCRIPTION FACTOR#0.7937;POLYUBIQUITIN#0.7885;CELL PROLIFERATION#0.7862;BREAST CANCER#0.7320;SIGNALING PATHWAY#0.7144;CELL GROWTH#0.6979;19S REGULATORY PARTICLE#0.6902;C TERMINAL DOMAIN#0.6900;ISOPEPTIDASE ACTIVITY#0.6684;DEUBIQUITINASE ACTIVITY#0.6507;SUPEROXIDE DISMUTASE#0.6334;MITOCHONDRIAL FISSION#0.6167;HEPATOCELLULAR CARCINOMA#0.6151;ESOPHAGEAL CANCER#0.6098
10214	SYNOVIAL SARCOMA#0.6777
102157401	CANCER CELL#1.0541;CELL MIGRATION#0.9014;CELL GROWTH#0.7837;CELL PROLIFERATION#0.7775;HEPATOCELLULAR CARCINOMA#0.6936;TONGUE SQUAMOUS CELL CARCINOMA#0.6892;PROSTATE CARCINOMA#0.6751;CERVICAL CANCER#0.6670;TUMOR TISSUES#0.6653;SQUAMOUS CELL CARCINOMA#0.6596;LUNG CANCER#0.6580
102157402	ADENYLATE KINASE#0.8973;ADENYLATE#0.7261;CDK INHIBITOR#0.7201;CYCLIN DEPENDENT KINASE#0.6576;ADRENAL GLAND#0.6354;TRANSCRIPTION FACTOR#0.6236
10215	TRANSCRIPTION FACTOR#1.0209;OLIGODENDROCYTE DEVELOPMENT#1.0168;OLIGODENDROCYTE DIFFERENTIATION#1.0153;TUMOR CELLS#1.0147;GROWTH FACTOR RECEPTOR#1.0147;OLIGODENDROGLIOMA#1.0143;GLIAL FIBRILLARY ACIDIC PROTEIN#1.0106;OLIGODENDROCYTE#1.0090;ASTROCYTOMA#1.0089;PLATELET-DERIVED GROWTH FACTOR#1.0085;OLIGODENDROCYTE LINEAGE CELLS#1.0045;INTERNEURON#1.0043;NEURAL CELL#1.0025;OLIGODENDROCYTE PRECURSOR CELL#1.0012;CEREBRAL CORTEX#1.0003;NEURAL TUBE#0.9994;CELL CYCLE#0.9980;NEURAL PROGENITOR CELL#0.9978;OLIGODENDROCYTE PROGENITOR CELL#0.9940;FOREBRAIN#0.9929;NEUROFILAMENT#0.9927;PRECURSOR CELL#0.9906;ASTROCYTE#0.9901;EPIDERMAL GROWTH FACTOR#0.9887;MYELINATION#0.9878;EMBRYONIC STEM CELL#0.9871;NEUROEPITHELIAL CELL#0.9869;SPINAL CORD#0.9849;T CELL#0.9843;MALIGNANT GLIOMA#0.9833;PROGENITOR CELL#0.9833;CELL PROLIFERATION#0.9791;GENE EXPRESSION#0.9790;NEUROGENESIS#0.9789;GROWTH FACTOR#0.9780;NEURAL STEM CELL#0.9763;GLIAL CELL#0.9760;RETINOIC ACID#0.9743;HUMAN EMBRYONIC STEM#0.9677;CELL DEATH#0.9671;FIBROBLAST GROWTH FACTOR#0.9665;STEM CELL#0.9661;SPINAL CORD INJURY#0.9650;TELENCEPHALON#0.9643;APOPTOSIS#0.9632;PLURIPOTENT STEM CELL#0.9627;MULTIPLE SCLEROSIS#0.9619;GLIOGENESIS#0.9586;STEM CELL MARKER#0.9584;CENTRAL NERVOUS SYSTEM#0.9576;SIGNALING PATHWAY#0.9575;NERVOUS SYSTEM#0.9549;DEMYELINATING DISEASE#0.9537;PHOSPHODIESTERASE#0.9536;POLYMERASE CHAIN REACTION#0.9530;HINDBRAIN#0.9529;DOWN SYNDROME#0.9512;CELL DIFFERENTIATION#0.9479;PILOCYTIC ASTROCYTOMA#0.9471;NEURAL PRECURSOR CELL#0.9422;MYELIN SHEATH#0.9378;MOUSE EMBRYONIC STEM#0.9321;MICROTUBULE ASSOCIATED PROTEIN#0.9310;NEURAL STEM PROGENITOR#0.9264;REGENERATION#0.9257;BRAIN DEVELOPMENT#0.9247;ASTROCYTE DIFFERENTIATION#0.9239;MAGNETIC RESONANCE IMAGING#0.9213;GABAERGIC NEURON#0.9198;CELL ADHESION#0.9121;REVERSE TRANSCRIPTION#0.9105;DNA METHYLATION#0.9092;WHITE MATTER INJURY#0.9056;NEURODEGENERATIVE DISEASE#0.9029;OLIGODENDROGLIAL CELLS#0.8959;BONE MORPHOGENETIC PROTEIN#0.8907;LATERAL VENTRICLE#0.8902;INDUCED PLURIPOTENT STEM CELL#0.8874;TERMINAL DIFFERENTIATION#0.8860;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.8860;CYTOPLASM#0.8847;ANAPLASTIC OLIGODENDROGLIOMA#0.8835;GLIOBLASTOMA MULTIFORME#0.8799;TEMPORAL LOBE#0.8769;PURKINJE CELL#0.8720;NEURON DIFFERENTIATION#0.8715;DNA BINDING#0.8701;OLFACTORY BULB#0.8695;MESENCHYMAL STEM CELL#0.8661;NEURONAL CELLS#0.8605;MICROTUBULE#0.8390;FRONTAL#0.8338;CANCER STEM CELL#0.8322;ASTROCYTE DEVELOPMENT#0.8322;CELL ADHESION MOLECULE#0.8242;PROTEOGLYCAN#0.8207;PARENCHYMA#0.8153;APOPTOTIC#0.8146;STROMAL CELL#0.8144;CNS DEVELOPMENT#0.8144;ENCEPHALOMYELITIS#0.8121;BONE MARROW#0.8114;NEUROBLAST#0.8093;FETAL BRAIN#0.8082;ONCOGENIC#0.8040;RETINAL PROGENITOR CELL#0.8037;MICROGLIAL CELL#0.8003;ISCHEMIA#0.7994;OBSESSIVE COMPULSIVE DISORDER#0.7959;TAMOXIFEN#0.7943;EPILEPSY#0.7941;PROTEIN KINASE#0.7896;DIFFUSE ASTROCYTOMA#0.7890;CELL FATE DETERMINATION#0.7864;2'-DEOXYURIDINE#0.7836;MACROPHAGE#0.7788;PROGESTERONE#0.7749;TUMOR SUPPRESSOR#0.7718;IMMATURE NEURON#0.7714;TUMOR INITIATING CELL#0.7710;HYPOXIA#0.7625;LOW GRADE GLIOMAS#0.7475;MYELIN OLIGODENDROCYTE GLYCOPROTEIN#0.7468;DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR#0.7387;STRIATUM#0.7370;CENTRAL NEUROCYTOMA#0.7368;NEURON DEVELOPMENT#0.7357;GESTATION#0.7276;OPTIC NERVE#0.7269;MEDULLOBLASTOMA#0.7204;OLIGODENDROGLIAL PROGENITOR CELLS#0.7174;CELL GROWTH#0.7126;ARTERY#0.7033;TEMOZOLOMIDE#0.7022;MYELIN FORMATION#0.7008;EXTRACELLULAR MATRIX#0.6966;FACTOR I#0.6919;HYPOXIC#0.6911;POST-TRANSLATIONAL MODIFICATION#0.6853;STEM CELL DIFFERENTIATION#0.6809;GENE REGULATORY NETWORK#0.6793;TOXICITY#0.6767;DENTATE GYRUS#0.6747;CELL DIVISION#0.6735;MEDIAL GANGLIONIC EMINENCE#0.6678;WORLD HEALTH ORGANIZATION#0.6662;SYSTEM DEVELOPMENT#0.6641;PERIPHERAL NERVOUS SYSTEM#0.6590;ADENOMATOUS POLYPOSIS COLI#0.6530;ANGIOGENESIS#0.6523;TRANSIT AMPLIFYING CELL#0.6477;EMBRYONIC BRAIN#0.6380;NERVOUS SYSTEM DEVELOPMENT#0.6354;THALAMUS#0.6346;MIDBRAIN#0.6344;ACTION POTENTIAL#0.6340;NEURITE#0.6325;DAYS POST INJURY#0.6300;SCHWANN CELL#0.6297;DOPAMINERGIC NEURON#0.6290;INTERMEDIATE FILAMENT#0.6285;ENDOTHELIAL GROWTH FACTOR#0.6238;MORRIS WATER MAZE#0.6154;QUANTITATIVE REAL TIME#0.6141;CELL MIGRATION#0.6100;CHOLINERGIC NEURON#0.6047;MIDLINE#0.6039;NEUROECTODERMAL TUMOR#0.6035;TRAUMATIC BRAIN INJURY#0.6026
10216	SUPERFICIAL ZONE PROTEIN#1.0928;COEFFICIENT OF FRICTION#1.0509;HYALURONAN#1.0466;PROTEOGLYCAN#1.0443;HYALURONIC ACID#1.0436;COLLAGEN TYPE I#1.0375;ANTERIOR CRUCIATE LIGAMENT#1.0356;SYNOVIAL FLUID#1.0298;CRUCIATE LIGAMENT#1.0274;COLLAGEN TYPE II#1.0234;TRANSFORMING GROWTH FACTOR#1.0160;CHONDROCYTE#1.0150;POLYMERASE CHAIN REACTION#1.0146;GENE EXPRESSION#1.0123;KNEE JOINT#1.0079;GROWTH FACTOR#1.0075;PROGENITOR CELL#1.0074;EXTRACELLULAR MATRIX#1.0035;ARTHROPATHY#0.9993;TRANSFORMING GROWTH FACTOR BETA#0.9957;BONE MORPHOGENETIC PROTEIN#0.9952;PERICARDITIS#0.9938;OSTEOARTHRITIS#0.9898;STEM CELL#0.9889;MESENCHYMAL STEM CELL#0.9833;MENISCUS#0.9817;RHEUMATOID ARTHRITIS#0.9761;MEGAKARYOCYTE#0.9715;SYNOVIUM#0.9658;PARATHYROID HORMONE#0.9343;BONE MARROW#0.9338;PHOSPHATE BUFFERED SALINE#0.9268;GLYCOSYLATION#0.9242;TUMOR NECROSIS FACTOR#0.9205;APOPTOSIS#0.9140;INTERVERTEBRAL DISC#0.9131;STROMAL CELL#0.9069;TRANSCRIPTION FACTOR#0.8886;ENDOTHELIAL CELL#0.8859;SMOOTH MUSCLE#0.8812;CHONDROGENESIS#0.8756;REGENERATION#0.8749;SIGNALING PATHWAY#0.8747;REVERSE TRANSCRIPTION#0.8650;DIGESTION#0.8600;NUCLEUS PULPOSUS#0.8499;CARTILAGE HOMEOSTASIS#0.8496;SMOOTH MUSCLE ACTIN#0.8475;CARTILAGE FORMATION#0.8462;SYNOVIOCYTE PROLIFERATION#0.8436;CELL ADHESION#0.8325;CELL PROLIFERATION#0.8251;MACROPHAGE#0.8160;FIBROBLAST GROWTH FACTOR#0.8125;PARATHYROID#0.7913;TOLL LIKE RECEPTOR#0.7907;FLEXOR DIGITORUM PROFUNDUS#0.7872;BREAST CANCER#0.7855;MATRIX METALLOPROTEINASE 13#0.7723;INFLAMMATORY RESPONSE#0.7677;EYELID#0.7673;NADPH OXIDASE#0.7594;QUANTITATIVE REAL TIME#0.7416;HYALURONAN SYNTHASE#0.7219;CONNECTIVE TISSUE#0.7211;CARTILAGE DEVELOPMENT#0.7198;OSTEOARTHRITIC CARTILAGE#0.7086;ADIPOSE TISSUE#0.7051;BONE FORMATION#0.7051;HYPOXIA#0.6879;AUTOLOGOUS CHONDROCYTE IMPLANTATION#0.6878;INSULIN-LIKE GROWTH FACTOR#0.6712;HYALURONATE#0.6708;TISSUE HOMEOSTASIS#0.6353;CHONDROITIN SULPHATE PROTEOGLYCAN#0.6296;SODIUM HYALURONATE#0.6230;MEDIAL COLLATERAL LIGAMENT#0.6187;O GLYCAN#0.6168;TISSUE CULTURE POLYSTYRENE#0.6164;DRY EYE DISEASE#0.6089
10217	TUMOR SUPPRESSOR#1.0613;CELL CYCLE#0.9952;CELL GROWTH#0.8790;LUNG CANCER#0.8571;CERVICAL#0.8088;DEPHOSPHORYLATION#0.7829;C TERMINAL DOMAIN#0.7757;TRANSCRIPTION FACTOR#0.7701;GENE EXPRESSION#0.7552;PHOSPHATIDYLSERINE#0.7090;CANCER CELL#0.6955;SQUAMOUS CELL CARCINOMA#0.6884;SIGNALING PATHWAY#0.6816;APOPTOSIS#0.6509;CERVICAL CANCER#0.6457;PLASMA MEMBRANE#0.6297
10218	EXTRACELLULAR MATRIX#0.9124;GENE EXPRESSION#0.8029;HUMAN TRABECULAR MESHWORK#0.7969;GROWTH FACTOR#0.7642;PROGENITOR CELL#0.7597;ANGIOGENESIS#0.7438;CELL PROLIFERATION#0.7143;STEM CELL#0.7098;DEXAMETHASONE#0.6577;SIGNALING PATHWAY#0.6119
102191832	ANGIOGENESIS#0.7469;NEURAL TUBE#0.6805;CAROTID ARTERY DISEASE#0.6574;AUTOPHAGY#0.6491;CAROTID ARTERY#0.6171;ARTERY DISEASE#0.6129;ENDOTHELIAL CELL#0.6054
10219	MAST CELL#1.0772;LECTIN#1.0512;CELL SURFACE#1.0368;EFFECTOR T CELL#1.0226;SENESCENCE#1.0197;T CELL#1.0192;CD8+ T CELL#1.0181;CD4+ T CELL#1.0086;MEMORY T CELL#1.0062;VIRAL INFECTION#1.0042;PERIPHERAL BLOOD#1.0027;T LYMPHOCYTE#0.9989;NATURAL KILLER CELL#0.9982;T CELL DIFFERENTIATION#0.9973;TRANSCRIPTION FACTOR#0.9951;CELL DIFFERENTIATION#0.9910;IMMUNE RESPONSE#0.9838;EFFECTOR MEMORY T CELL#0.9814;CYTOKINE PRODUCTION#0.9773;GENE EXPRESSION#0.9769;CYTOTOXICITY#0.9637;TERMINAL DIFFERENTIATION#0.9550;TREG CELL#0.9434;IMMUNE SYSTEM#0.9273;BONE MARROW#0.9245;CELL ACTIVATION#0.9105;TUBERCULOSIS#0.9084;REGULATORY T CELL#0.8912;IFN-GAMMA#0.8874;CELL PROLIFERATION#0.8847;DENDRITIC CELL#0.8671;CELL MATURATION#0.8501;IMMUNE CELL#0.8451;LYMPH NODE#0.8407;APOPTOSIS#0.8397;CELL DEATH#0.8321;CYTOKINE SECRETION#0.8234;LYMPHOCYTIC CHORIOMENINGITIS#0.8141;HEPATITIS B#0.8136;TELOMERE#0.8079;CHEMOKINE RECEPTOR#0.8008;CELL EXPANSION#0.7514;CHRONIC HEPATITIS B#0.7479;CELL CYCLE#0.7433;CADHERIN BINDING#0.7243;REPLICATIVE SENESCENCE#0.7208;SIGNALING PATHWAY#0.7188;TNF PRODUCTION#0.7001;PRECURSOR CELL#0.6942;T CELL ACTIVATION#0.6924;PROGRAMMED CELL DEATH#0.6848;CELL ADHESION#0.6781;HEPATITIS C VIRUS#0.6776;HEPATITIS C#0.6765;PRO-INFLAMMATORY#0.6619;LYMPHOID CELL#0.6527;CYTOTOXIC T-LYMPHOCYTE#0.6516;CELL DEVELOPMENT#0.6350;CELL DIVISION#0.6327;MONONUCLEAR CELLS#0.6314;B CELL#0.6300;STEM CELL#0.6144;TH1 CELL#0.6125;ACTIVATED CD8+ T CELL#0.6057;ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY#0.6045;T CELL PROLIFERATION#0.6024;EPSTEIN BARR VIRUS#0.6022;TRANSMEMBRANE RECEPTOR#0.6003
1021	ANTI HER2#1.0286;MEDULLOBLASTOMA#1.0082;FULVESTRANT#1.0061;CELL CYCLE TRANSITION#1.0049;LETROZOLE#1.0038;CELL CYCLE PATHWAY#1.0026;TARGET OF RAPAMYCIN#1.0025;ADVANCED BREAST CANCER#1.0015;LUMINAL#1.0014;CYCLIN DEPENDENT KINASE#0.9995;KINASE ACTIVITY#0.9986;RAPAMYCIN#0.9978;SENESCENCE#0.9948;METASTATIC BREAST CANCER#0.9947;OVARIAN CANCER#0.9946;CLEAVED CASPASE 3#0.9942;ESTROGEN-RECEPTOR POSITIVE BREAST CANCER#0.9942;CELL CYCLE REGULATOR#0.9932;KAPOSI'S SARCOMA#0.9928;CELLULAR SENESCENCE#0.9913;PANCREATIC CANCER#0.9890;COLON CANCER#0.9890;RETINOBLASTOMA#0.9879;CELL CYCLE CONTROL#0.9867;T CELL#0.9862;CDK INHIBITOR#0.9859;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9850;CELL DIVISION#0.9846;T LYMPHOCYTE#0.9843;PROTEIN PHOSPHORYLATION#0.9843;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9835;NEUROBLASTOMA#0.9833;OVARIAN#0.9828;B CELL LYMPHOMA#0.9827;DRUG RESISTANCE#0.9825;BREAST CANCER#0.9818;GROWTH FACTOR RECEPTOR#0.9813;SQUAMOUS CELL CARCINOMA#0.9803;TRANSFORMING GROWTH FACTOR#0.9802;BREAST CANCER PATIENTS#0.9801;MAPK SIGNALING#0.9799;G1 PHASE#0.9795;CHONDROCYTE#0.9790;CYCLIN DEPENDENT KINASE INHIBITOR#0.9790;CELL CYCLE#0.9785;S PHASE#0.9784;B CELL#0.9783;PROGENITOR CELL#0.9780;ONCOGENIC#0.9778;QUANTITATIVE REAL TIME#0.9778;ESTROGEN RECEPTOR#0.9775;REVERSE TRANSCRIPTION#0.9768;EPIDERMAL GROWTH FACTOR#0.9768;TUMOR TISSUES#0.9754;CELL CYCLE ARREST#0.9741;MECHANISM OF ACTION#0.9740;MYELOID LEUKEMIA#0.9738;BONE MARROW#0.9726;STEM CELL#0.9725;PROTEIN KINASE#0.9725;COLORECTAL#0.9724;COLORECTAL CANCER#0.9720;POLYMERASE CHAIN REACTION#0.9716;DNA SYNTHESIS#0.9713;CELL CYCLE REGULATION#0.9711;CISPLATIN#0.9705;KINASE INHIBITOR#0.9705;TUMOR CELLS#0.9698;BREAST CANCER CELL#0.9696;ACUTE MYELOID LEUKEMIA#0.9696;HEPATOCELLULAR CARCINOMA#0.9685;CERVICAL#0.9682;G2 PHASE#0.9673;GROWTH FACTOR#0.9673;TOXICITY#0.9670;REGULATION OF CELL CYCLE#0.9664;CELL DIFFERENTIATION#0.9658;TYROSINE KINASE INHIBITOR#0.9653;PROSTATE CANCER#0.9650;TUMOR SUPPRESSOR#0.9647;POLY ADP RIBOSE#0.9645;HUMAN BREAST CANCER#0.9644;LUNG CANCER#0.9641;CELL GROWTH#0.9636;INDUCTION OF APOPTOSIS#0.9635;EVEROLIMUS#0.9632;M PHASE#0.9631;SIGNAL TRANSDUCTION#0.9622;CYTOTOXICITY#0.9621;MULTIPLE MYELOMA#0.9615;FLOW CYTOMETRY ANALYSIS#0.9612;CDK ACTIVITY#0.9610;TRANSCRIPTION FACTOR#0.9608;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9605;CYTOPLASM#0.9605;CELL MIGRATION#0.9603;SIGNALING PATHWAY#0.9602;CELL ACTIVATION#0.9601;MITOSIS#0.9599;RIBOSE#0.9599;HISTONE DEACETYLASE#0.9597;EPITHELIAL CELL#0.9596;RNA INTERFERENCE#0.9590;GENE EXPRESSION#0.9572;MITOGEN ACTIVATED PROTEIN#0.9569;ADENOCARCINOMA#0.9568;CELL PROLIFERATION#0.9566;DNA REPAIR#0.9562;CELL DEATH#0.9545;ANGIOGENESIS#0.9544;APOPTOTIC#0.9541;CANCER CELL#0.9540;KERATINOCYTE#0.9538;EPITHELIAL MESENCHYMAL TRANSITION#0.9533;APOPTOSIS#0.9532;REACTIVE OXYGEN SPECIES#0.9532;NEUTROPENIA#0.9526;CELL DIVISION CYCLE#0.9508;STANDARD OF CARE#0.9494;ORAL SQUAMOUS CELL CARCINOMA#0.9481;SMOOTH MUSCLE#0.9480;CERVICAL CANCER#0.9479;MUSCLE CELL#0.9467;COLONY FORMATION ASSAY#0.9461;DNA METHYLATION#0.9419;CYTOCHROME C#0.9412;AKT SIGNALING#0.9403;NERVOUS SYSTEM#0.9402;WOUND HEALING#0.9389;LYMPH NODE#0.9386;SMOOTH MUSCLE CELL#0.9381;COMPLEX I#0.9375;PACLITAXEL#0.9350;UBIQUITIN#0.9350;APOPTOTIC CELL DEATH#0.9332;DEPHOSPHORYLATION#0.9299;TRANSFORMING GROWTH FACTOR BETA#0.9293;DNA BINDING#0.9249;ANDROGEN RECEPTOR#0.9244;DUAL LUCIFERASE REPORTER#0.9232;CENTRAL NERVOUS SYSTEM#0.9225;GLIOBLASTOMA MULTIFORME#0.9218;DNA REPLICATION#0.9182;ESOPHAGEAL CANCER#0.9173;HYPOXIA#0.9154;ENDOTHELIAL GROWTH FACTOR#0.9150;AUTOPHAGY#0.9145;MITOCHONDRIAL MEMBRANE#0.9134;PROTEASOME#0.9123;MECHANISMS OF ACTION#0.9113;PROTEIN KINASE C#0.9106;HEMATOPOIETIC CELL#0.9094;QUIESCENCE#0.9074;COMPARATIVE GENOMIC HYBRIDIZATION#0.9071;TUMOR NECROSIS FACTOR#0.9016;MACROPHAGE#0.9009;CELL CYCLE CHECKPOINT#0.8996;CATALYTIC ACTIVITY#0.8989;PERIPHERAL BLOOD#0.8976;TAMOXIFEN#0.8953;LUNG CARCINOMA#0.8950;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8942;INHIBITION OF CELL PROLIFERATION#0.8912;DOXORUBICIN#0.8906;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8893;OSTEOBLAST#0.8888;DNA FRAGMENTATION#0.8876;INDOLE#0.8861;ENDOTHELIAL CELL#0.8771;EXTRACELLULAR MATRIX#0.8761;STROMAL CELL#0.8647;VASCULAR SMOOTH MUSCLE CELL#0.8644;MANTLE CELL LYMPHOMA#0.8632;CELL COUNTING KIT#0.8630;CELLULAR GROWTH#0.8612;MAMMARY EPITHELIAL CELL#0.8607;SIGNALLING PATHWAY#0.8582;MITOCHONDRIA#0.8569;HEMATOPOIETIC STEM CELL#0.8557;BETA CELL#0.8521;ANCHORAGE INDEPENDENT GROWTH#0.8512;DNA DAMAGE RESPONSE#0.8489;RENAL CELL CARCINOMA#0.8463;REPLICATIVE SENESCENCE#0.8448;FLAVOPIRIDOL#0.8418;MELANOMA CELL LINES#0.8390;THYMIDINE#0.8379;TERMINAL DIFFERENTIATION#0.8374;RHEUMATOID ARTHRITIS#0.8366;CANCER RELATED DEATH#0.8365;CELL CYCLE PHASE#0.8348;IMMUNE RESPONSE#0.8292;MYELOID CELL#0.8267;EARLY BREAST CANCER#0.8254;QUANTITATIVE REVERSE TRANSCRIPTION#0.8233;CELL DEVELOPMENT#0.8188;SIGNALING CASCADE#0.8181;CELL ADHESION#0.8180;RECEPTOR TYROSINE KINASE#0.8175;HEPATOCELLULAR CARCINOMA CELL#0.8160;INSULIN-LIKE GROWTH FACTOR#0.8153;HYPERPHOSPHORYLATION#0.8138;CANCER STEM CELL#0.8133;RETINOIC ACID#0.8102;LYMPHOBLAST#0.8083;COPY NUMBER ALTERATION#0.8048;ACTIVATED T-CELLS#0.8047;ACTIVATED T CELL#0.8044;PLATELET-DERIVED GROWTH FACTOR#0.8036;SIGNAL TRANSDUCER#0.8034;FIBROBLAST GROWTH FACTOR#0.8011;T-CELL LEUKEMIA#0.8005;LYMPHOID CELL#0.7979;PROTEIN PROTEIN INTERACTION#0.7962;LUNG ADENOCARCINOMA#0.7962;METASTATIC MELANOMA#0.7947;5-AZA-2'-DEOXYCYTIDINE#0.7936;2'-DEOXYCYTIDINE#0.7932;THYROID CANCER#0.7926;TRASTUZUMAB#0.7921;BLOOD BRAIN BARRIER#0.7912;LYMPHOID LEUKEMIA#0.7905;ENDOPLASMIC RETICULUM#0.7876;REGENERATION#0.7859;THYMOCYTE#0.7830;B LYMPHOCYTE#0.7794;PANCREATIC DUCTAL ADENOCARCINOMA#0.7742;NEUROGENESIS#0.7736;GLYCOGEN SYNTHASE KINASE#0.7721;IMMUNE SYSTEM#0.7698;KINASE INHIBITOR P27#0.7684;HISTONE DEACETYLASE INHIBITOR#0.7652;BREAST CANCER MODEL#0.7638;DIARRHEA#0.7614;MAP KINASE#0.7608;SIGNALING MOLECULE#0.7607;HEAT SHOCK PROTEIN#0.7598;ANEMIA#0.7564;ATP BINDING#0.7543;LIVER CANCER#0.7527;TOPOISOMERASE II#0.7518;INHIBITION OF CELL GROWTH#0.7497;REGULATION OF CELL PROLIFERATION#0.7494;HEPATOCYTE GROWTH FACTOR#0.7480;MOLECULAR DYNAMICS SIMULATION#0.7452;TOPOISOMERASE#0.7443;DISEASE FREE SURVIVAL#0.7415;CELLULAR METABOLISM#0.7392;LUCIFERASE ACTIVITY#0.7374;CASPASE INHIBITOR#0.7371;ASTROCYTE#0.7361;EPSTEIN BARR VIRUS#0.7343;MALIGNANT GLIOMA#0.7342;PROTEIN KINASE B#0.7310;FOCAL ADHESION#0.7301;GERM CELL#0.7295;HUMAN MAMMARY EPITHELIAL#0.7292;APOPTOTIC PROCESS#0.7265;CHONDROCYTE DIFFERENTIATION#0.7258;B CELL PROLIFERATION#0.7226;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7222;EPITHELIAL TO MESENCHYMAL#0.7220;NEURAL STEM CELL#0.7207;CELL CYCLE DYSREGULATION#0.7200;MODE OF ACTION#0.7191;DEXAMETHASONE#0.7163;NEUTROPHIL#0.7033;MONONUCLEAR CELLS#0.7030;PROPIDIUM#0.7019;PRIMARY BREAST CANCER#0.6998;RESVERATROL#0.6983;TRANSCRIPTASE#0.6976;ONCOGENESIS#0.6953;FACTOR I#0.6937;GEMCITABINE#0.6935;HUMAN PANCREATIC CANCER#0.6920;SEQUESTERING#0.6882;CENTROSOME#0.6859;OSTEOCLAST DIFFERENTIATION#0.6844;ERYTHROID CELL#0.6841;ENDOMETRIAL CANCER#0.6840;PLASMA CELL#0.6817;COLORECTAL CARCINOMA#0.6808;MESENCHYMAL STEM CELL#0.6795;CYCLIN BINDING#0.6794;MONOCYTE#0.6788;LYMPHOMA CELL LINES#0.6776;P53 SIGNALING PATHWAY#0.6771;CELL EXPANSION#0.6730;CHOLANGIOCARCINOMA#0.6716;ANASTROZOLE#0.6714;ROS GENERATION#0.6708;ESTRADIOL#0.6706;PROTEIN KINASE ACTIVITY#0.6703;BREAST CARCINOMA#0.6691;HOST CELL#0.6684;LIPOSARCOMA#0.6674;SORAFENIB#0.6672;TRANSACTIVATION#0.6671;INTERPHASE#0.6659;ADULT T-CELL LEUKEMIA#0.6659;T CELL ACTIVATION#0.6637;SKIN CANCER#0.6626;ADENOSINE#0.6565;CELL SURFACE#0.6548;LYMPHOCYTIC LEUKEMIA#0.6543;GENE SILENCING#0.6542;IMMUNE CELL#0.6508;OSTEOBLAST DIFFERENTIATION#0.6495;OOCYTE#0.6482;PROSTATE SPECIFIC ANTIGEN#0.6480;MAXIMUM TOLERATED DOSE#0.6465;COPY NUMBER VARIATION#0.6452;MOUSE EMBRYONIC FIBROBLAST#0.6450;ADIPOCYTE#0.6408;EMBRYONIC STEM CELL#0.6399;EXEMESTANE#0.6383;PRIMARY EFFUSION LYMPHOMA#0.6359;PROGESTERONE#0.6343;VSMC PROLIFERATION#0.6315;MYOBLAST#0.6294;EWING SARCOMA#0.6292;PROGRAMMED CELL DEATH#0.6291;NON-SMALL CELL LUNG CARCINOMA#0.6286;OBJECTIVE RESPONSE RATE#0.6283;CHROMOSOMAL REGION#0.6269;GRANULOCYTE#0.6259;RANDOMIZED CLINICAL TRIAL#0.6258;1α,25-DIHYDROXYVITAMIN D3#0.6245;5 FLUOROURACIL#0.6240;T CELL PROLIFERATION#0.6235;MAMMARY GLAND#0.6222;CLINICAL BENEFIT RATE#0.6220;PROTEIN DEGRADATION#0.6210;INFLAMMATORY RESPONSE#0.6188;TUMOR GROWTH INHIBITION#0.6152;EPITHELIAL OVARIAN CANCER#0.6152;CHRONIC MYELOID LEUKEMIA#0.6111;CASPASE ACTIVATION#0.6110;OLOMOUCINE#0.6097;TEMOZOLOMIDE#0.6084;CETUXIMAB#0.6083;LYMPH NODE METASTASIS#0.6077;IMATINIB#0.6072;METFORMIN#0.6064;MALIGNANT BRAIN TUMOR#0.6044;OSTEOCLAST#0.6044;FAMILIAL MELANOMA#0.6017;TRAMETINIB#0.6009;PROSTATE CARCINOMA#0.6009;HYPERTENSION#0.6004
10220	GROWTH DIFFERENTIATION FACTOR#1.0561;TRANSFORMING GROWTH FACTOR BETA#1.0537;NEUROGENESIS#1.0523;TRANSFORMING GROWTH FACTOR#1.0405;PROGENITOR CELL#1.0393;BONE MORPHOGENETIC PROTEIN#1.0282;GROWTH FACTOR#1.0278;SIGNALING PATHWAY#1.0276;SKELETAL MUSCLE#1.0231;STEM CELL#1.0224;REGENERATION#1.0220;TAIL BUD#1.0077;CARDIOMYOCYTE#0.9860;GENE EXPRESSION#0.9852;ENDOTHELIAL CELL#0.9847;CELL PROLIFERATION#0.9828;BONE FORMATION#0.9750;SKELETON#0.9712;AXIAL SKELETON#0.9697;APOPTOSIS#0.9683;ISCHEMIA#0.9620;ACTIVIN RECEPTOR#0.9497;SKELETAL MUSCLE MASS#0.9339;VERTEBRAE#0.9145;NERVOUS SYSTEM#0.9140;AGEING#0.9075;SPINAL CORD#0.8940;BONE MARROW#0.8856;ANGIOGENESIS#0.8851;CANCER CELL#0.8772;NEURAL STEM CELL#0.8562;POLYMERASE CHAIN REACTION#0.8525;CELL CYCLE#0.8517;HYPOXIA#0.8285;ERYTHROPOIESIS#0.8199;RETINOIC ACID#0.8083;ANEMIA#0.8053;CACHEXIA#0.8035;REACTIVE OXYGEN SPECIES#0.8026;MUSCLE WASTING#0.7814;MYELODYSPLASTIC SYNDROME#0.7807;MYOCARDIAL INFARCTION#0.7743;MUSCLE ATROPHY#0.7739;CENTRAL NERVOUS SYSTEM#0.7727;HINDLIMB#0.7670;LIVER REGENERATION#0.7608;CEREBRAL ISCHEMIA#0.7538;DENTAL PULP#0.7537;ISCHEMIA REPERFUSION INJURY#0.7516;ENDOTHELIAL PROGENITOR CELL#0.7510;CELL DIFFERENTIATION#0.7498;TRANSCRIPTION FACTOR#0.7483;INSULIN-LIKE GROWTH FACTOR#0.7448;REVERSE TRANSCRIPTION#0.7441;ADIPOCYTE#0.7433;MYOTUBE#0.7407;TUMOR SUPPRESSOR#0.7405;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7335;EPITHELIAL TO MESENCHYMAL#0.7332;EMBRYONIC STEM CELL#0.7325;MUSCLE CELL#0.7290;MESENCHYME#0.7193;MYOBLAST#0.7137;SKELETAL MUSCLE REGENERATION#0.7109;URETERIC BUD#0.6973;PRO-INFLAMMATORY#0.6904;CARDIAC MUSCLE#0.6798;HEART DISEASE#0.6766;CELL MIGRATION#0.6758;COLORECTAL CANCER#0.6707;AUTOPHAGY#0.6691;DIABETES MELLITUS#0.6559;MESENCHYMAL STEM CELL#0.6529;URETERIC BUD FORMATION#0.6380;SMOOTH MUSCLE#0.6289;PERIPHERAL BLOOD#0.6280;PRIMITIVE STREAK#0.6260;CELL GROWTH#0.6254;PANCREAS DEVELOPMENT#0.6178;ADENO ASSOCIATED VIRUS#0.6143;ARTERY#0.6124;SMOOTH MUSCLE CELL#0.6060;ADIPOSE TISSUE#0.6060;TYPE 2 DIABETES#0.6052;HYPERTROPHIC CARDIOMYOPATHY#0.6036;ZINC FINGER PROTEIN#0.6002;OSTEOPOROSIS#0.6001
10221	LIPID METABOLISM#1.0519;MACROPHAGE#1.0349;ACUTE MYELOID LEUKEMIA#1.0115;MYELOID LEUKEMIA#1.0088;TRANSCRIPTION FACTOR#1.0020;GENE EXPRESSION#0.9944;CORONARY ARTERY DISEASE#0.9904;ARTERY DISEASE#0.9903;CORONARY ARTERY#0.9895;LOW DENSITY LIPOPROTEIN#0.9802;HEART DISEASE#0.9378;SIGNALING PATHWAY#0.9327;BONE MARROW#0.9321;ARTERY#0.9191;POLYMERASE CHAIN REACTION#0.9115;ENHANCER BINDING PROTEIN#0.8910;ENHANCER BINDING#0.8905;CELL PROLIFERATION#0.8880;APOPTOSIS#0.8778;LIVER DISEASE#0.8752;FATTY LIVER DISEASE#0.8585;FATTY LIVER#0.8573;CORONARY HEART DISEASE#0.8455;CELL CYCLE#0.8339;LIPOGENESIS#0.8082;ADIPOSE TISSUE#0.8060;HIGH DENSITY LIPOPROTEIN#0.8011;PROSTATE CANCER#0.7965;T CELL#0.7871;CANCER CELL#0.7866;LIPOPROTEIN METABOLISM#0.7699;ANTIBODY MEDIATED REJECTION#0.7695;PROTEIN KINASE#0.7645;MYOCARDIAL INFARCTION#0.7492;UBIQUITIN#0.7473;MYELOID CELL#0.7182;MITOGEN ACTIVATED PROTEIN#0.7032;ALCOHOLIC FATTY LIVER#0.6868;RETINOIC ACID#0.6781;STEM CELL#0.6641;M2 MACROPHAGE#0.6406;BONE MARROW CELLS#0.6352;MAP KINASE#0.6135;FOAM CELL FORMATION#0.6114;LIGASE ACTIVITY#0.6107;TUMOR SUPPRESSOR#0.6096;DOWN SYNDROME#0.6073
10223	COLORECTAL CANCER#1.0750;COLORECTAL#1.0497;COLON CANCER#1.0423;VACCINIA#1.0017;EPITHELIAL CELL#0.9666;VIRION#0.9606;CANCER CELL#0.9318;CELL SURFACE#0.9126;INTESTINAL EPITHELIAL CELL#0.8425;EXOSOME#0.7370;COLORECTAL CARCINOMA#0.7175;TUMOR CELLS#0.6478;T CELL#0.6453;TRANSCRIPTION FACTOR#0.6414;VIRION MEMBRANE#0.6338
10224	ZINC FINGER PROTEIN#0.9219
10225	T CELL#1.0584;STEM CELL#1.0319;ACUTE MYELOID LEUKEMIA#0.9966;MYELOID LEUKEMIA#0.9954;CELL SURFACE#0.9650;BONE MARROW#0.9567;CELL ADHESION#0.9194;NATURAL KILLER CELL#0.9034;LEUKEMIA STEM CELL#0.8611;IMMUNE RESPONSE#0.8562;CELL ACTIVATION#0.8422;GENE EXPRESSION#0.7889;T CELL ACTIVATION#0.7780;ACUTE LEUKEMIA#0.7557;MYELODYSPLASTIC SYNDROME#0.7537;HEMATOPOIETIC STEM CELL#0.7388;LEUKEMIC STEM CELL#0.7356;MONONUCLEAR CELLS#0.6705;IMMUNE CELL#0.6122
10226	LIPID DROPLET PROTEIN#1.0535;ENDOSOME#1.0378;LIPID DROPLET#1.0115;SKELETAL MUSCLE#1.0038;ADIPOCYTE#1.0009;ADIPOCYTE DIFFERENTIATION#0.9912;LIPID METABOLISM#0.9855;TRANS GOLGI NETWORK#0.9814;MACROPHAGE#0.9767;LIPID STORAGE#0.9740;LIPOLYSIS#0.9651;LATE ENDOSOME#0.9515;ADIPOSE TISSUE#0.9498;ENDOPLASMIC RETICULUM#0.9160;CARGO SELECTION#0.9135;RECEPTOR BINDING#0.8774;LIPID DROPLET FORMATION#0.8549;CELL DEATH#0.8402;MITOCHONDRIA#0.8254;OLEIC ACID#0.8237;CYTOPLASM#0.8224;ORGANELLE#0.8198;TRIGLYCERIDE LIPASE#0.8003;HEPATITIS C#0.7944;LIVER DISEASE#0.7754;GENE EXPRESSION#0.7601;MITOCHONDRIAL MEMBRANE#0.7554;BINDING PROTEIN 1#0.7337;CERVICAL#0.7254;FATTY LIVER#0.7119;COATOMER#0.7090;EPITHELIAL CELL#0.7061;HEPATITIS C VIRUS#0.7054;HORMONE SENSITIVE LIPASE#0.6468;FATTY LIVER DISEASE#0.6399;MAMMARY GLAND#0.6393;APOPTOSIS#0.6366;PALMITATE#0.6362;LOW DENSITY LIPOPROTEIN#0.6192;CERVICAL CANCER#0.6143;VIRION#0.6060
10227	EOSINOPHIL#0.6421
10228	TRANS GOLGI NETWORK#1.0353;ENDOSOME#1.0214;PLASMA MEMBRANE#1.0090;SNARE COMPLEX#1.0051;CELL SURFACE#0.9955;N-ETHYLMALEIMIDE#0.9895;EARLY ENDOSOME#0.9771;EXOCYTOSIS#0.9407;RECYCLING ENDOSOME#0.9314;MEMBRANE FUSION#0.9023;SECRETORY GRANULE#0.8954;VESICLE TRAFFICKING#0.8913;SECRETORY PATHWAY#0.8632;INTRACELLULAR MEMBRANE#0.8251;CELL MIGRATION#0.8153;GOLGI APPARATUS#0.7933;LYSOSOME#0.7530;MICROTUBULE#0.7464;LATE ENDOSOME#0.7459;COATED VESICLE#0.7318;ORGANELLE#0.7244;CLATHRIN COATED VESICLE#0.7182;ENDOPLASMIC RETICULUM#0.7117;GOLGI MEMBRANE#0.6964;ENDOCYTOSIS#0.6892;GROWTH FACTOR#0.6787;COG COMPLEX#0.6767;TRANSFERRIN RECEPTOR#0.6632;TRANSPORT VESICLE#0.6541;PROGRESSIVE SUPRANUCLEAR PALSY#0.6510;VESICULAR TRANSPORT#0.6509;GOLGI COMPLEX#0.6383;ADIPOCYTE#0.6333;CLATHRIN ADAPTOR#0.6195;MACROPHAGE#0.6114;ENDOTHELIAL CELL#0.6112
10229	UBIQUINONE BIOSYNTHESIS#1.1087;MITOCHONDRIA#1.0165;RESPIRATION#1.0114;RESPIRATORY CHAIN#0.9686;COENZYME Q BIOSYNTHESIS#0.9258;ELECTRON TRANSPORT#0.8501;COMPLEX I#0.8310;PLASMA MEMBRANE#0.7994;MITOCHONDRIAL RESPIRATORY CHAIN#0.7489;RHYTHMIC BEHAVIOR#0.7411;DEFECATION#0.7215;MITOCHONDRIAL DNA#0.7072;GLYCOLYSIS#0.6420;REACTIVE OXYGEN SPECIES#0.6400;INHIBITION OF GLYCOLYSIS#0.6340;ELECTRON CARRIER#0.6306;ELECTRON TRANSPORT CHAIN#0.6214
1022	CAK COMPLEX#1.0878;BUDDING#1.0270;C TERMINAL DOMAIN#1.0140;KINASE ACTIVITY#1.0104;PROTEIN KINASE#1.0102;BREAST CANCER#1.0099;CELL CYCLE CONTROL#1.0033;CELL DEATH#1.0032;CTD KINASE ACTIVITY#0.9999;TRANSCRIPTION FACTOR#0.9978;CELL PROLIFERATION#0.9948;DNA REPAIR#0.9944;CYCLIN DEPENDENT KINASE#0.9941;CELL CYCLE ARREST#0.9934;M PHASE#0.9914;CELL CYCLE REGULATION#0.9902;CELL CYCLE#0.9900;CDK INHIBITOR#0.9871;CELL DIVISION#0.9871;CANCER CELL#0.9828;NECROPTOSIS#0.9809;CELL GROWTH#0.9791;APOPTOSIS#0.9779;TRANSACTIVATION#0.9761;GENE EXPRESSION#0.9725;KINASE INHIBITOR#0.9702;SIGNALING PATHWAY#0.9658;NUCLEOTIDE EXCISION REPAIR#0.9613;ONCOGENIC#0.9588;OOCYTE#0.9586;SQUAMOUS CELL CARCINOMA#0.9575;APOPTOTIC#0.9557;GROWTH FACTOR#0.9541;PROSTATE CANCER#0.9539;S PHASE#0.9539;LUNG CANCER#0.9499;CYCLIN DEPENDENT KINASE INHIBITOR#0.9433;FLAVOPIRIDOL#0.9260;BREAST CANCER CELL#0.9259;TUMOR CELLS#0.9218;COMPLEX I#0.9090;MITOSIS#0.8908;T CELL#0.8854;OVARIAN CANCER#0.8816;ESTROGEN RECEPTOR#0.8716;XERODERMA PIGMENTOSUM#0.8624;PREINITIATION COMPLEX#0.8605;TUMOR NECROSIS FACTOR#0.8602;CYCLIN BINDING#0.8550;MIXED LINEAGE KINASE#0.8547;HEPATOCELLULAR CARCINOMA#0.8393;GROWTH FACTOR RECEPTOR#0.8355;RNA SYNTHESIS#0.8325;G1 PHASE#0.8265;MITOGEN ACTIVATED PROTEIN#0.8160;MEIOSIS#0.8140;RETINOBLASTOMA#0.8131;OVARIAN#0.8057;DEPHOSPHORYLATION#0.7933;STEM CELL#0.7930;CISPLATIN#0.7860;MECHANISM OF ACTION#0.7848;CYTOTOXICITY#0.7828;APOPTOTIC CELL DEATH#0.7622;HUMAN GASTRIC CARCINOMA#0.7621;TRANSCRIPTIONAL CONTROL#0.7596;DNA BINDING#0.7547;RETINOIC ACID#0.7468;MAP KINASE#0.7408;ENDOTHELIAL CELL#0.7396;NEUROBLASTOMA#0.7395;HUMAN IMMUNODEFICIENCY VIRUS#0.7390;SIGNAL TRANSDUCTION#0.7328;RETINOIC ACID RECEPTOR#0.7299;HYPERPHOSPHORYLATION#0.7278;PROTEIN KINASE ACTIVITY#0.7261;GLUTATHIONE#0.7149;TRANSCRIPTION INITIATION FACTOR#0.7138;CDK ACTIVITY#0.7125;POLYMERASE CHAIN REACTION#0.7077;ANDROGEN RECEPTOR#0.7048;CATALYTIC ACTIVITY#0.7021;B CELL#0.6977;CELL MIGRATION#0.6933;ATP BINDING#0.6877;SIGNALLING PATHWAY#0.6848;MRNA SYNTHESIS#0.6827;COLORECTAL CANCER#0.6756;CDK-ACTIVATING KINASE COMPLEX#0.6574;MYELOID LEUKEMIA#0.6569;HISTIDINE#0.6470;COLON CANCER#0.6468;COLORECTAL#0.6463;TUMOR SUPPRESSOR#0.6445;SPORE WALL#0.6436;MEDIATOR COMPLEX#0.6435;DRUG RESISTANCE#0.6285;CELL DIVISION CYCLE#0.6268;CYTOPLASM#0.6170;FACTOR I#0.6166;PROTEIN KINASE C#0.6122;EPITHELIAL CELL#0.6099;OOCYTE MATURATION#0.6088;ISCHEMIA#0.6069;INDUCTION OF APOPTOSIS#0.6021
10230	CANCER CELL#1.0856;BREAST CANCER#0.8696;BREAST CANCER CELL#0.8043;COLORECTAL CANCER#0.8036;OVARIAN CANCER#0.6934;ADENOSINE MONOPHOSPHATE#0.6422;PROTEIN KINASE#0.6389;CELL PROLIFERATION#0.6228;COLORECTAL#0.6122;OVARIAN#0.6116
10231	CALCINEURIN#1.0583;STATIONARY PHASE#1.0081;THYROID HORMONE RECEPTOR#0.9947;TRANSCRIPTION FACTOR#0.9807;GENE EXPRESSION#0.9771;TRIIODOTHYRONINE#0.9696;GROWTH HORMONE#0.9651;RETINOIC ACID#0.9550;POLYMERASE CHAIN REACTION#0.9366;MALIC ENZYME#0.9267;DNA BINDING#0.8923;CEREBRAL CORTEX#0.8861;RETINOID X RECEPTOR#0.8744;SKELETAL MUSCLE#0.8547;NERVOUS SYSTEM#0.8533;FATTY ACID SYNTHASE#0.8423;ADIPOSE TISSUE#0.8122;BRAIN DEVELOPMENT#0.8010;GROWTH FACTOR#0.7962;DOWN SYNDROME#0.7960;3,5,3'-TRIIODOTHYRONINE#0.7879;HYPOTHYROIDISM#0.7848;MYOSIN HEAVY CHAIN#0.7688;COMPETENCE STIMULATING PEPTIDE#0.7596;LIPOGENESIS#0.7547;STEROL REGULATORY ELEMENT#0.7501;RETINOIC ACID RECEPTOR#0.7476;METAMORPHOSIS#0.7471;HORMONE BINDING#0.7418;REVERSE TRANSCRIPTION#0.7417;CENTRAL NERVOUS SYSTEM#0.7020;ELECTROPHORETIC MOBILITY SHIFT#0.6809;SKIN FIBROBLASTS#0.6806;DIET INDUCED OBESITY#0.6775;T CELL#0.6755;9-CIS-RETINOIC ACID#0.6709;THYROID HORMONE BINDING#0.6518;SIGNALING PATHWAY#0.6446;STEAROYL COA DESATURASE#0.6369;APOPTOSIS#0.6316;PROTEIN KINASE#0.6276;RECEPTOR BINDING#0.6176;ACTIVATED T-CELLS#0.6078;ACTIVATED T CELL#0.6074;INSULIN-LIKE GROWTH FACTOR#0.6030;MAMMARY GLAND#0.6011;NEURONAL CELLS#0.6010
10232	MEGAKARYOCYTE POTENTIATING FACTOR#1.1125;MEGAKARYOCYTE#1.0700;LUNG ADENOCARCINOMA#1.0532;TUMOR ASSOCIATED ANTIGEN#1.0529;IMMUNOTOXIN#1.0481;CELL ADHESION#1.0451;OOCYTE#1.0433;PLEURAL DISEASE#1.0396;MESOTHELIAL CELL#1.0382;PANCREATIC ADENOCARCINOMA#1.0351;PANCREATIC CANCER#1.0327;MESOTHELIOMA CELL#1.0324;CELL SURFACE#1.0312;PROSTATE STEM CELL#1.0302;T CELL#1.0282;LYMPH NODE#1.0258;BREAST CANCER#1.0256;EPITHELIAL OVARIAN CANCER#1.0248;STEM CELL ANTIGEN#1.0243;OVARIAN CARCINOMA#1.0236;OVARIAN#1.0231;CD8+ T CELL#1.0224;LUNG CANCER#1.0213;GROWTH FACTOR#1.0209;OVARIAN CANCER#1.0201;TUMOR CELLS#1.0183;CANCER CELL#1.0183;TUMOR ANTIGEN#1.0168;CHIMERIC ANTIGEN RECEPTOR#1.0152;MALIGNANT MESOTHELIOMA#1.0123;CELL PROLIFERATION#1.0097;ADENOCARCINOMA#1.0091;PLEURA#1.0065;MALIGNANT PLEURAL MESOTHELIOMA#1.0044;PANCREATIC DUCTAL ADENOCARCINOMA#1.0040;STEM CELL#1.0039;CYTOTOXICITY#1.0034;IMMUNE RESPONSE#0.9992;APOPTOSIS#0.9988;EPITHELIAL CELL#0.9955;PERIPHERAL BLOOD#0.9944;SQUAMOUS CELL CARCINOMA#0.9917;GENE EXPRESSION#0.9835;T LYMPHOCYTE#0.9818;BILE DUCT#0.9809;COLORECTAL#0.9809;ENDOTHELIAL GROWTH FACTOR#0.9796;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9796;PERITONEUM#0.9788;PROTEIN KINASE#0.9784;PANCREATIC CARCINOMA#0.9734;LUMINAL#0.9602;EPIDERMAL GROWTH FACTOR#0.9577;DENDRITIC CELL#0.9544;SIGNALING PATHWAY#0.9539;TRANSCRIPTION FACTOR#0.9521;TOXICITY#0.9513;GROWTH FACTOR RECEPTOR#0.9439;COLORECTAL CANCER#0.9257;CELL CYCLE#0.9235;MESOTHELIUM#0.9221;HUMAN PANCREATIC CANCER#0.9213;ASCITES#0.9146;BREAST CANCER CELL#0.9079;PERITONEAL MESOTHELIOMA#0.9043;BREAST CARCINOMA#0.9030;B CELL#0.8948;MACROPHAGE#0.8947;FINE NEEDLE ASPIRATION#0.8914;THYROID TRANSCRIPTION FACTOR#0.8845;POLYMERASE CHAIN REACTION#0.8769;FOLATE RECEPTOR ALPHA#0.8722;REVERSE TRANSCRIPTION#0.8694;THYMIC CARCINOMA#0.8661;DISEASE FREE SURVIVAL#0.8640;CELL ADHESION MOLECULE#0.8639;FOLATE#0.8632;CELL SURFACE ANTIGEN#0.8602;PANCREATITIS#0.8566;INSULIN-LIKE GROWTH FACTOR#0.8554;CHOLANGIOCARCINOMA#0.8473;NEGATIVE PREDICTIVE VALUE#0.8471;GASTRIC ADENOCARCINOMA#0.8461;EPIDIDYMIS#0.8461;CYTOTOXIC T-LYMPHOCYTE#0.8440;POSITRON EMISSION TOMOGRAPHY#0.8415;WILMS TUMOR 1#0.8274;ESTROGEN RECEPTOR#0.8181;FORMALIN#0.8119;EPITHELIAL OVARIAN CARCINOMA#0.8028;M PHASE#0.8004;LYMPH NODE METASTASIS#0.8004;GALECTIN#0.7982;ASBESTOSIS#0.7972;RESPONSE TO TREATMENT#0.7966;POSITIVE PREDICTIVE VALUE#0.7828;CELL MEMBRANE#0.7749;CISPLATIN#0.7658;METASTATIC PANCREATIC ADENOCARCINOMA#0.7658;CERVICAL CANCER#0.7648;PACLITAXEL#0.7613;PROTEIN SYNTHESIS#0.7585;GLOMERULAR FILTRATION RATE#0.7585;MUCINOUS NEOPLASM#0.7581;GLOMERULAR FILTRATION#0.7581;RENAL CARCINOMA#0.7519;PEMETREXED#0.7396;LIVER CANCER#0.7384;PERICARDIUM#0.7360;RENAL CELL CARCINOMA#0.7352;RECEIVER OPERATOR CHARACTERISTIC#0.7352;CERVICAL#0.7310;CYTOKINE SECRETION#0.7211;CELL DEATH#0.7200;IFN-GAMMA#0.7171;COLONY-STIMULATING FACTOR#0.7160;PROGESTERONE#0.7156;CELL GROWTH#0.7142;MECHANISM OF ACTION#0.7024;MITOGEN ACTIVATED PROTEIN#0.6986;TUMOR TISSUES#0.6954;MAXIMUM TOLERATED DOSE#0.6923;GROWTH FACTOR BINDING#0.6892;PLATELET-DERIVED GROWTH FACTOR#0.6858;CYTOPLASM#0.6844;IMMUNE SYSTEM#0.6837;CLEAR CELL CARCINOMA#0.6816;COLORECTAL ADENOCARCINOMA#0.6749;TRANSITIONAL CELL CARCINOMA#0.6748;DOXORUBICIN#0.6742;SIGNAL TRANSDUCTION#0.6715;GEMCITABINE#0.6709;MITOSIS#0.6683;HEAT SHOCK PROTEIN#0.6678;TUMOR SUPPRESSOR#0.6672;PERIPHERAL BLOOD LYMPHOCYTES#0.6672;TUMOR NECROSIS FACTOR#0.6654;COLON CANCER#0.6631;PERITONEAL CAVITY#0.6521;GM-CSF#0.6465;REGULATORY T CELL#0.6464;CD4+ T CELL#0.6445;MONONUCLEAR CELLS#0.6426;MALIGNANT PLEURAL EFFUSION#0.6412;CELL KILLING#0.6327;MULTIPLE LINEAR REGRESSION#0.6262;MAP KINASE#0.6255;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6199;BILE DUCT CANCER#0.6096;OVARIAN SEROUS CARCINOMA#0.6086;HUMORAL IMMUNE RESPONSE#0.6052
10234	LEUCINE RICH REPEAT#0.9204;LEUCINE#0.7391;OSTEOCLAST DIFFERENTIATION#0.6747
10235	NUCLEOTIDE EXCHANGE FACTOR#1.0764;GUANINE#1.0653;ENDOTHELIAL CELL#0.9994;FACTOR I#0.9861;PROTEIN KINASE#0.9252;INTEGRIN ACTIVATION#0.8952;PLATELET AGGREGATION#0.7940;VASCULAR ENDOTHELIAL CELL#0.7044;PROTEIN KINASE C#0.7036;NEUTROPHIL#0.6917;SIGNALING PATHWAY#0.6488;APOPTOSIS#0.6425;PROTEIN KINASE A#0.6221;LEUKOCYTE#0.6078
10236	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#1.1242;RNA BINDING#0.7150;RNA BINDING PROTEIN#0.6883;SPINAL MUSCULAR ATROPHY#0.6798;MUSCULAR ATROPHY#0.6778
10237	UDP GALACTOSE#0.7109;ER MEMBRANE#0.6588
10238	CRANIOFACIAL DEVELOPMENT#0.9687;PROTEIN KINASE#0.9024;TRANSCRIPTION FACTOR#0.7840;ANTHOCYANIN SYNTHESIS#0.6577;ANTHOCYANIN BIOSYNTHESIS#0.6100;CYTOPLASM#0.6090
10239	TYPE 2 DIABETES#0.7121
10240	T CELL#0.8218
10241	NUCLEAR DOT#1.0864;SELECTIVE AUTOPHAGY#1.0539;AUTOPHAGY#1.0474;UBIQUITIN#1.0462;UBIQUITIN BINDING#1.0264;AUTOPHAGOSOME#1.0166;GALECTIN#1.0058;MITOPHAGY#1.0020;MITOCHONDRIA#0.9813;XENOPHAGY#0.9718;AUTOPHAGOSOME MATURATION#0.8434;TOLL LIKE RECEPTOR#0.8128;INNATE IMMUNITY#0.7839;LIGHT CHAIN 3#0.7823;MICROTUBULE ASSOCIATED PROTEIN#0.7759;MICROTUBULE#0.7699;LYSOSOME#0.7659;PHAGOPHORE#0.7393;IMMUNE RESPONSE#0.7359;VACUOLE#0.7016;TRANSCRIPTION FACTOR#0.6854;TANK BINDING KINASE#0.6187;ULK1 COMPLEX#0.6064;TARGET OF RAPAMYCIN#0.6019
10243	MOCO BIOSYNTHESIS#1.0674;RECEPTOR CLUSTERING#1.0656;PERIPHERAL MEMBRANE PROTEIN#1.0618;TUBULIN BINDING#1.0576;MOLYBDENUM COFACTOR#1.0569;POSTSYNAPTIC MEMBRANE#1.0531;ANCHORING#1.0421;GLYCINE RECEPTOR#1.0377;GABA A RECEPTOR#1.0322;GLYCINE#1.0304;NEUROLIGIN#1.0276;POSTSYNAPTIC DENSITY#1.0262;MICROTUBULE#1.0213;INHIBITORY SYNAPSE#1.0210;NUCLEOTIDE EXCHANGE FACTOR#1.0194;NEUROTRANSMITTER RECEPTOR#1.0161;CELL SURFACE#1.0160;PLASMA MEMBRANE#1.0146;COFACTOR BIOSYNTHESIS#1.0056;PRESYNAPTIC TERMINAL#1.0027;GLYCINERGIC SYNAPSE#0.9993;BOUTON#0.9978;SPINAL CORD#0.9972;NEUROTRANSMISSION#0.9900;EXCITATORY SYNAPSE#0.9881;CENTRAL NERVOUS SYSTEM#0.9855;INTERNEURON#0.9853;GLUTAMIC ACID#0.9847;NERVOUS SYSTEM#0.9834;SYNAPTIC TRANSMISSION#0.9814;SYNAPTOGENESIS#0.9768;GUANINE#0.9711;EPILEPSY#0.9698;PYRAMIDAL CELL#0.9692;MOLYBDENUM COFACTOR DEFICIENCY#0.9653;INHIBITORY SYNAPSE FORMATION#0.9604;GLUTAMATE RECEPTOR#0.9603;AMYGDALA#0.9598;DENTATE GYRUS#0.9589;PROTEIN KINASE#0.9578;POSTSYNAPSE#0.9547;GLUTAMATERGIC SYNAPSE#0.9462;C TERMINAL DOMAIN#0.9450;AMPA RECEPTOR#0.9319;ION CHANNEL#0.9296;RECEPTOR BINDING#0.9269;SINGLE PARTICLE TRACKING#0.9256;OLFACTORY BULB#0.9187;INNERVATION#0.9173;GENE EXPRESSION#0.9122;TEMPORAL LOBE EPILEPSY#0.8974;TEMPORAL LOBE#0.8933;NMDA RECEPTOR#0.8855;SYNAPSE DEVELOPMENT#0.8737;SYNAPTIC VESICLE#0.8713;RECEPTOR COMPLEX#0.8707;HYPEREKPLEXIA#0.8429;GANGLION CELLS#0.8324;CELL ADHESION#0.8314;BIPOLAR CELL#0.8254;AXON TERMINAL#0.8193;PROTEIN KINASE C#0.8180;AMACRINE CELL#0.8121;DENDRITIC SPINE#0.8093;POST SYNAPTIC DENSITY#0.7937;CYCLIN DEPENDENT KINASE#0.7916;LASER SCANNING MICROSCOPY#0.7914;ERGIC#0.7874;SIGNALING PATHWAY#0.7759;POSTSYNAPTIC SPECIALIZATION#0.7703;CEREBRAL CORTEX#0.7629;SIGNALING MOLECULE#0.7610;PROXIMAL DENDRITE#0.7584;CELL ADHESION MOLECULE#0.7577;INITIAL SEGMENT#0.7568;AUTISM SPECTRUM DISORDER#0.7541;PURKINJE CELL#0.7534;NEURONAL CELLS#0.7436;NITRIC OXIDE#0.7417;SULFITE OXIDASE#0.7375;BETA-2#0.7369;CYTOPLASM#0.7328;INTELLECTUAL DISABILITY#0.7313;THALAMUS#0.7230;ASPARTATE#0.7224;LONG TERM POTENTIATION#0.7176;SIGNAL TRANSDUCTION#0.7170;MENTAL RETARDATION#0.7163;FOREBRAIN#0.7155;NITRIC OXIDE SYNTHASE#0.7038;ALZHEIMER'S DISEASE#0.6997;POST-TRANSLATIONAL MODIFICATION#0.6894;CHOLINE#0.6758;CELL MEMBRANE#0.6753;COFACTOR SYNTHESIS#0.6726;PRESYNAPTIC BOUTON#0.6722;AXON INITIAL SEGMENT#0.6669;PROTEIN COMPLEX#0.6555;CAMKII#0.6548;POSTTRANSLATIONAL MODIFICATION#0.6517;GLYCOGEN SYNTHASE KINASE#0.6506;MICROTUBULE ASSOCIATED PROTEIN#0.6500;XANTHINE#0.6466;DYNEIN#0.6400;GABAERGIC NEURON#0.6374;CHLORIDE CHANNEL#0.6354;MUTAGENESIS#0.6319;MICROFILAMENT#0.6297;ACTIN CYTOSKELETON#0.6293;NERVE TERMINAL#0.6184;MEDIAL PREFRONTAL CORTEX#0.6121;XANTHINE DEHYDROGENASE#0.6079;DISTAL DENDRITE#0.6075
10244	IFN-GAMMA#1.0310;T CELL#1.0152;MACROPHAGE#0.9762;CD8+ T CELL#0.9290;IMMUNE RESPONSE#0.9281;CD4+ T CELL#0.8951;LYMPH NODE#0.8727;DENDRITIC CELL#0.8591;LYSOSOMAL MEMBRANE#0.7937;GENE EXPRESSION#0.7096;LATE ENDOSOME#0.7054;ENDOSOME#0.6317;DRAINING LYMPH NODE#0.6223;MONONUCLEAR CELLS#0.6120;DNA BINDING#0.6043
10245	INNER MITOCHONDRIAL MEMBRANE#0.8005;MITOCHONDRIAL MEMBRANE#0.7880;HOST MITOCHONDRIA#0.7578;MITOCHONDRIAL MATRIX#0.6800;HOST CELL#0.6639
102465513	FERROPTOSIS#0.6715
102465753	TRANSCRIPTION FACTOR#1.1783;GLUTATHIONE#0.8473
102465858	MALARIA#0.6515
102466081	ENDOTHELIAL CELL#1.1798
102466519	UMBILICAL VEIN ENDOTHELIAL CELLS#0.7653;HUMAN UMBILICAL VEIN#0.7647;UMBILICAL VEIN#0.7644;ENDOTHELIAL CELL#0.7579;APOPTOSIS#0.6411
102466854	BLADDER UROTHELIAL CARCINOMA#1.2270
102467146	T CELL DIFFERENTIATION#0.8164;CELL DIFFERENTIATION#0.8019;T CELL#0.7940
10247	PROTEIN SYNTHESIS#1.0276;PYRIDOXAL 5-PHOSPHATE#0.9992;RNASE P#0.9374;PYRIDOXAL#0.9224;C REACTIVE PROTEIN#0.9016;CELL PROLIFERATION#0.8618;RETICULOCYTE#0.8360;CANCER CELL#0.8056;TUMOR ANTIGEN#0.7598;POST-TRANSLATIONAL MODIFICATION#0.7107;MACROPHAGE#0.7100;REGULATION OF CELLULAR#0.7094;DEAMINASE ACTIVITY#0.6999;MITOCHONDRIA#0.6658;OTHER ORGANISM#0.6454;PYRUVATE#0.6448;CELLULAR GROWTH#0.6234;ENDOPLASMIC RETICULUM#0.6139;INFLAMMATORY RESPONSE#0.6127
10248	RNASE P#1.1148;RNASE MRP#1.1100;RIBONUCLEASE P#0.6767;RNA BINDING#0.6361
10249	GLYCINE N ACYLTRANSFERASE#1.1240;N ACYLTRANSFERASE#1.1000;ASPARTIC ACID#1.0758;N-ACYLTRANSFERASE ACTIVITY#1.0673;N ACETYLTRANSFERASE#1.0565;GLYCINE#1.0504;GENTAMICIN#1.0324;ACYLTRANSFERASE ACTIVITY#1.0134;AMIKACIN#1.0030;POLYMERASE CHAIN REACTION#0.9792;CIPROFLOXACIN#0.9786;CONJUGATION#0.9776;COENZYME A#0.9449;STREPTOMYCIN#0.9117;TETRACYCLINE#0.9063;TOBRAMYCIN#0.9045;MITOCHONDRIA#0.8997;KANAMYCIN#0.8896;ALANINE#0.8634;NALIDIXIC ACID#0.8563;DETOXIFICATION#0.8485;IMMUNE RESPONSE#0.8375;ENZYME ACTIVITY#0.7882;NETILMICIN#0.7455;GLUTAMIC ACID#0.7292;DNA BINDING#0.7290;TRIMETHOPRIM#0.7210;AMPICILLIN#0.7062;ADIPOSE TISSUE#0.6497;THYMIDINE#0.6496;ASPARAGINE#0.6189;BENZOIC ACID#0.6186;VIRULENCE#0.6063;CHLORAMPHENICOL#0.6033;TUMOR CELLS#0.6028
1024	CDK8 KINASE MODULE#1.1593;COLON CANCER#1.0531;KINASE ACTIVITY#1.0521;BREAST CANCER#1.0460;COLORECTAL CANCER#1.0406;CYCLIN DEPENDENT KINASE#1.0391;MEDIATOR COMPLEX#1.0296;COLORECTAL#1.0238;CANCER CELL#1.0194;PROTEIN KINASE#1.0162;CELL CYCLE#1.0038;SIGNALING PATHWAY#1.0002;TRANSCRIPTION FACTOR#0.9969;GENE EXPRESSION#0.9924;CELL PROLIFERATION#0.9872;COMPLEX I#0.9506;APOPTOSIS#0.9416;ONCOGENIC#0.9254;CELL GROWTH#0.8961;DNA BINDING#0.8791;GROWTH FACTOR#0.8646;PROSTATE CANCER#0.8578;BREAST CANCER CELL#0.8420;PROTEIN COMPLEX#0.8181;KINASE INHIBITOR#0.8153;UBIQUITIN#0.8145;C TERMINAL DOMAIN#0.8027;TUMOR SUPPRESSOR#0.7829;G1 PHASE#0.7714;STEM CELL#0.7647;PANCREATIC CANCER#0.7501;T CELL#0.7468;RNA INTERFERENCE#0.7465;CELL DIFFERENTIATION#0.7295;TRANSACTIVATION#0.7286;POLYMERASE CHAIN REACTION#0.7132;LIPOGENESIS#0.6869;TRANSCRIPTIONAL CONTROL#0.6830;CELL DEATH#0.6762;LYMPH NODE#0.6733;CTD KINASE ACTIVITY#0.6701;TUMOR TISSUES#0.6532;LIPID METABOLISM#0.6516;LEIOMYOMA#0.6424;ADJACENT NORMAL TISSUE#0.6385;CELL CYCLE ARREST#0.6335;EMBRYONIC STEM CELL#0.6333;GLYCOLYSIS#0.6285;CELL CYCLE CONTROL#0.6283;MITOSIS#0.6248;TUMOR CELLS#0.6243;S PHASE#0.6227;APOPTOTIC#0.6206;DEVELOPMENTAL TIMING#0.6160;DE NOVO LIPOGENESIS#0.6099;CDK INHIBITOR#0.6071;LUNG CANCER#0.6055
10250	NUCLEAR MATRIX#1.0975;EXON JUNCTION COMPLEX#0.9288;GENE EXPRESSION#0.8113;MRNA PROCESSING#0.7968;PRE-MRNA SPLICING#0.7661;MRNA SPLICING#0.7635;SPLICEOSOME#0.7449;ARGININE#0.7331;NUCLEIC ACID BINDING#0.6715;NUCLEIC ACID#0.6590;NUCLEAR SPECKLE#0.6579;RNA BINDING#0.6421
10251	X CHROMOSOME#0.7556;GROWTH FACTOR#0.6313
10252	CELL PROLIFERATION#1.0230;GROWTH FACTOR#1.0085;CANCER CELL#0.9969;RECEPTOR TYROSINE KINASE#0.9934;SIGNALING PATHWAY#0.9923;BREAST CANCER#0.9822;EPITHELIAL CELL#0.9658;STEM CELL#0.9564;T CELL#0.9421;APOPTOSIS#0.9419;ENDOTHELIAL CELL#0.9400;URETERIC BUD#0.9223;GENE EXPRESSION#0.9200;OVARIAN CANCER#0.9197;FIBROBLAST GROWTH FACTOR#0.9106;MAP KINASE#0.8951;TUMOR SUPPRESSOR#0.8858;CELL DEATH#0.8735;TRANSCRIPTION FACTOR#0.8698;MORPHOGENESIS#0.8516;QUIESCENCE#0.8280;CELL CYCLE#0.8220;AKT SIGNALING#0.8184;OTIC PLACODE#0.8096;INFLAMMATORY RESPONSE#0.8039;PROGENITOR CELL#0.7926;ANGIOGENESIS#0.7858;OVARIAN#0.7822;MAPK SIGNALING#0.7723;BRANCHING MORPHOGENESIS#0.7722;RHEUMATOID ARTHRITIS#0.7583;KIDNEY DEVELOPMENT#0.7517;HYPOXIA#0.7407;SIGNALLING PATHWAY#0.6870;MITOGEN ACTIVATED PROTEIN#0.6811;SENESCENCE#0.6602;MUSCLE STEM CELL#0.6579;LENS VESICLE#0.6496;ARSENITE#0.6462;ATRIAL FIBRILLATION#0.6436;ADIPOCYTE#0.6331;PROTEIN KINASE#0.6244;PHOSPHATASE AND TENSIN HOMOLOG#0.6233;ENDOTHELIAL CELL DEVELOPMENT#0.6187;ADIPOSE TISSUE#0.6130;TISSUE REMODELING#0.6094;EPITHELIAL OVARIAN CANCER#0.6039;CELL DEVELOPMENT#0.6030;S PHASE#0.6004
10253	COLON CANCER#1.0632;CANCER CELL#1.0370;TUMOR SUPPRESSOR#1.0338;PROTEIN KINASE#1.0291;EPIDERMAL GROWTH FACTOR#1.0242;MITOGEN ACTIVATED PROTEIN#1.0207;EPITHELIAL CELL#1.0167;CELL PROLIFERATION#1.0120;GROWTH FACTOR RECEPTOR#1.0110;RECEPTOR TYROSINE KINASE#1.0095;CELL MIGRATION#1.0071;FIBROBLAST GROWTH FACTOR#1.0022;SIGNALING PATHWAY#0.9984;GROWTH FACTOR#0.9964;GENE EXPRESSION#0.9830;MAP KINASE#0.9822;HYPOXIA#0.9803;TRANSCRIPTION FACTOR#0.9697;APOPTOSIS#0.9664;MAPK SIGNALING#0.9549;CELL DEATH#0.9284;PROSTATE CANCER#0.9222;KINASE ACTIVITY#0.9197;UBIQUITIN#0.9182;OVARIAN CANCER#0.8860;ANGIOGENESIS#0.8828;B CELL#0.8655;WOUND HEALING#0.8620;T CELL#0.8614;HEPATOCELLULAR CARCINOMA#0.8605;CELL GROWTH#0.8587;OVARIAN#0.8527;CELL CYCLE#0.8411;MORPHOGENESIS#0.8383;OSTEOBLAST#0.8335;ENDOTHELIAL CELL#0.8132;SIGNALLING PATHWAY#0.8066;ONCOGENIC#0.8062;REGENERATION#0.8014;OTIC PLACODE#0.7996;PHOSPHATASE AND TENSIN HOMOLOG#0.7974;POLYMERASE CHAIN REACTION#0.7879;LUNG DEVELOPMENT#0.7429;CLEFT PALATE#0.7409;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7367;EPITHELIAL TO MESENCHYMAL#0.7364;MAMMARY GLAND#0.7346;EPITHELIAL MESENCHYMAL TRANSITION#0.7266;BRANCHING MORPHOGENESIS#0.7222;STEM CELL#0.7032;GINGIVAL EPITHELIAL CELLS#0.6997;C TERMINAL DOMAIN#0.6965;MESENCHYME#0.6791;GLUCOSE UPTAKE#0.6770;TYPE 2 DIABETES#0.6755;NEURITE#0.6628;GRANULOSA CELL#0.6625;APOPTOTIC#0.6513;TISSUE REGENERATION#0.6396;NEURITE OUTGROWTH#0.6328;INHIBITION OF CELL MIGRATION#0.6284;TUMOR TISSUES#0.6251;ENDOCYTOSIS#0.6171;CLEFT LIP#0.6122;AXON GROWTH#0.6083;AXON REGENERATION#0.6054;INTRACELLULAR LOCALIZATION#0.6021
10254	GROWTH FACTOR#1.0503;ENDOSOME#0.9800;GROWTH FACTOR RECEPTOR#0.9767;EARLY ENDOSOME#0.9708;UBIQUITIN#0.9221;EPIDERMAL GROWTH FACTOR#0.8406;HEPATOCYTE GROWTH FACTOR#0.8013;NERVOUS SYSTEM#0.7617;DEUBIQUITINATING ENZYME#0.6750;EXOCYTOSIS#0.6649;GALACTOSIDASE ACTIVITY#0.6450;UBIQUITIN BINDING#0.6382;INTERSTITIAL CELL#0.6376;SECRETORY GRANULE#0.6376;MAST CELL#0.6298;ENDOSOME MEMBRANE#0.6163
10255	MAJOR HISTOCOMPATIBILITY COMPLEX#0.8792;BIPOLAR DISORDER#0.7228;HUMAN LEUKOCYTE ANTIGEN#0.6653
10256	CELL PROLIFERATION#0.9881;PROTEIN KINASE#0.9850;SIGNALING PATHWAY#0.9684;MITOGEN ACTIVATED PROTEIN#0.9217;CANCER CELL#0.9022;PLASMA MEMBRANE#0.8855;ONCOGENIC#0.8422;GROWTH FACTOR#0.8196;STERILE ALPHA MOTIF#0.7362;ERK CASCADE#0.7102;NUCLEOTIDE EXCHANGE FACTOR#0.7061;RECEPTOR TYROSINE KINASE#0.6955;CELL MIGRATION#0.6948;SIGNAL TRANSMISSION#0.6521;MAP KINASE CASCADE#0.6379;SIGNAL TRANSDUCTION#0.6377;MAP KINASE#0.6295;BREAST CANCER#0.6234;GENE EXPRESSION#0.6216;MAPK CASCADE#0.6184
102578074	PROSTATE CANCER#0.9014
10257	CGMP TRANSPORT#1.0540;MULTI DRUG RESISTANCE#1.0400;ADEFOVIR#1.0337;ORGANIC ANION TRANSPORTER#1.0300;URIC ACID#1.0293;6-MERCAPTOPURINE#1.0250;CISPLATIN#1.0228;EFFLUX PUMP#1.0218;MERCAPTOPURINE#1.0217;TENOFOVIR#1.0179;MULTIDRUG RESISTANCE PROTEIN#1.0167;ORGANIC CATION TRANSPORTER#1.0150;ATP BINDING CASSETTE TRANSPORTER#1.0120;METHOTREXATE#1.0102;CIPROFLOXACIN#1.0086;HUMAN EMBRYONIC KIDNEY#1.0085;EMBRYONIC KIDNEY#1.0080;PROSTATE CANCER#1.0079;CELL PROLIFERATION#1.0049;LUNG CANCER#1.0045;DRUG RESISTANCE#1.0017;PLATELET AGGREGATION#1.0016;BREAST CANCER#0.9990;ABC TRANSPORTER#0.9988;PLASMA MEMBRANE#0.9987;URATE#0.9984;POLYMERASE CHAIN REACTION#0.9971;EXCRETION#0.9945;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9943;ADENOSINE#0.9937;ATP BINDING CASSETTE#0.9928;ASPIRIN#0.9928;ATP BINDING#0.9919;PROSTAGLANDIN E2#0.9918;CANCER CELL#0.9912;ADENINE#0.9904;CHOLESTASIS#0.9890;ENDOTHELIAL CELL#0.9883;CYTOTOXICITY#0.9881;EPITHELIAL CELL#0.9873;ADENOSINE TRIPHOSPHATE#0.9870;PROBENECID#0.9870;RNA INTERFERENCE#0.9869;BLOOD BRAIN BARRIER#0.9850;TAUROCHOLATE#0.9836;GENE EXPRESSION#0.9791;GLUTATHIONE#0.9791;TOXICITY#0.9776;DETOXIFICATION#0.9736;BILE DUCT#0.9690;LUMINAL#0.9670;ADEFOVIR DIPIVOXIL#0.9643;CYTOCHROME P450#0.9636;REVERSE TRANSCRIPTION#0.9636;TUMOR CELLS#0.9635;IRINOTECAN#0.9581;ERYTHROCYTE#0.9579;COLORECTAL#0.9579;ESTRADIOL#0.9565;CELL MEMBRANE#0.9520;SIGNALING PATHWAY#0.9517;PHOSPHODIESTERASE#0.9468;DRUG TRANSPORT#0.9419;REGULATION OF FIBROBLAST MIGRATION#0.9412;PROXIMAL TUBULE CELL#0.9403;APOPTOSIS#0.9354;TRANSCRIPTION FACTOR#0.9324;HEPATOTOXICITY#0.9274;MULTIDRUG RESISTANT PROTEIN#0.9271;CPT-11#0.9271;CYSTIC FIBROSIS#0.9269;ADENOSINE MONOPHOSPHATE#0.9235;DUBIN-JOHNSON SYNDROME#0.9232;GLOMERULAR FILTRATION#0.9173;VESICULAR TRANSPORT#0.9172;SMOOTH MUSCLE#0.9156;CELL CYCLE#0.9147;BILE DUCT LIGATION#0.9134;CHOROID PLEXUS#0.9119;PLATELET ACTIVATION#0.9117;BILE ACID SYNTHESIS#0.9108;SMOOTH MUSCLE CELL#0.9093;MUSCLE CELL#0.9085;TIGHT JUNCTION#0.9068;LIVER DISEASE#0.9049;SIGNALING MOLECULE#0.9034;QUANTITATIVE REAL TIME#0.9031;STEM CELL#0.8999;EMBRYO IMPLANTATION#0.8968;COLORECTAL CANCER#0.8966;ENDOMETRIUM#0.8959;PREGNANE X RECEPTOR#0.8923;PROTEIN KINASE#0.8917;CYCLIC ADENOSINE MONOPHOSPHATE#0.8917;KUPFFER CELL#0.8882;HEPATITIS B#0.8857;T CELL#0.8843;FARNESOID X RECEPTOR#0.8833;CELECOXIB#0.8794;CELL GROWTH#0.8778;CELL MIGRATION#0.8770;NEUROBLASTOMA#0.8747;ASTROCYTE#0.8746;MEMBRANE TRANSPORT#0.8693;ACETAMINOPHEN#0.8668;MACROPHAGE#0.8667;URATE TRANSPORT#0.8615;HUMAN IMMUNODEFICIENCY VIRUS#0.8614;DOXORUBICIN#0.8577;CELL SURFACE#0.8564;ANTI INFLAMMATORY DRUGS#0.8556;6-THIOGUANINE#0.8512;GLOMERULAR FILTRATION RATE#0.8487;ORGANIC SOLUTE TRANSPORTER#0.8449;DIPYRIDAMOLE#0.8415;INDOMETHACIN#0.8411;PANCREATIC CANCER#0.8399;OVARIAN#0.8331;B CELL#0.8251;DICLOFENAC#0.8147;FIBROBLAST MIGRATION#0.8131;BRUSH BORDER#0.8125;PACLITAXEL#0.8083;CYCLIC AMP#0.8079;TRANSCRIPTASE#0.8072;CAMPTOTHECIN#0.8038;BONE MARROW#0.8032;ADENOCARCINOMA#0.8024;5 FLUOROURACIL#0.7987;TOPOTECAN#0.7979;CENTRAL NERVOUS SYSTEM#0.7973;NERVOUS SYSTEM#0.7963;CONSTITUTIVE ANDROSTANE RECEPTOR#0.7956;THIOGUANINE#0.7939;PROGENITOR CELL#0.7939;VINCRISTINE#0.7927;VERAPAMIL#0.7916;PULMONARY HYPERTENSION#0.7908;PERIPHERAL BLOOD#0.7869;IMMUNE RESPONSE#0.7853;VASCULAR ENDOTHELIAL CELL#0.7829;RITONAVIR#0.7821;ANION TRANSPORT#0.7789;ETOPOSIDE#0.7704;MEGAKARYOCYTE#0.7695;GUANOSINE#0.7694;AZIDOTHYMIDINE#0.7678;ORGANIC ANION TRANSPORT#0.7674;INTESTINAL ABSORPTION#0.7661;INTRAHEPATIC CHOLESTASIS#0.7656;MYELOID LEUKEMIA#0.7634;RECEPTOR ANTAGONIST#0.7572;CYCLOPHOSPHAMIDE#0.7532;BREAST CANCER CELL#0.7491;MEMBRANE FRACTION#0.7485;ESTROUS CYCLE#0.7459;BRUSH BORDER MEMBRANE#0.7458;ACUTE MYELOID LEUKEMIA#0.7448;FOLATE#0.7402;ATPASE ACTIVITY#0.7401;CYCLOSPORINE#0.7393;ALANINE#0.7361;NEUTROPENIA#0.7336;OOCYTE#0.7311;ARYL HYDROCARBON RECEPTOR#0.7267;JEJUNUM#0.7248;THIOPURINE S METHYLTRANSFERASE#0.7233;ESTRADIOL-17BETA#0.7217;TIGHT JUNCTION PROTEIN#0.7216;S METHYLTRANSFERASE#0.7204;CELL DIFFERENTIATION#0.7200;RIBOSOMAL PROTEIN#0.7180;KIDNEY DISEASE#0.7137;ARTERY#0.7128;FUROSEMIDE#0.7126;SMALL INTESTINE#0.7103;SERUM URIC ACID#0.7076;CELL DEATH#0.7056;DRUG METABOLISM#0.7039;ISOPROTERENOL#0.7025;FLUORESCEIN#0.7013;CORONARY ARTERY#0.6971;REACTIVE OXYGEN SPECIES#0.6959;TESTOSTERONE#0.6952;PROTEIN KINASE A#0.6936;KIDNEY PROXIMAL TUBULE#0.6931;DOCETAXEL#0.6896;LEYDIG CELL#0.6877;SERTOLI CELL#0.6871;FORSKOLIN#0.6868;UREMIC TOXIN#0.6838;PEROXISOME#0.6825;PDZ BINDING MOTIF#0.6812;ENDOMETRIOSIS#0.6802;GUT GRANULE#0.6795;HYPERTENSION#0.6751;BILE ACID TRANSPORT#0.6746;BLOOD VESSEL#0.6715;SPHINGOSINE 1 PHOSPHATE#0.6684;FLUOROURACIL#0.6678;CHRONIC HEPATITIS B#0.6671;TRANSMEMBRANE TRANSPORT#0.6632;LEUKOPENIA#0.6597;ANTIOXIDANT RESPONSE ELEMENT#0.6545;ZIDOVUDINE#0.6531;REVERSE TRANSCRIPTASE INHIBITOR#0.6525;CYCLIC GUANOSINE MONOPHOSPHATE#0.6522;VITAMIN D RECEPTOR#0.6476;MICROVASCULAR ENDOTHELIAL CELL#0.6469;MYOCYTES#0.6446;OVARIAN CANCER#0.6437;ACTIVE TRANSPORTER#0.6376;CHOLIC ACID#0.6373;PRAVASTATIN#0.6365;COLITIS#0.6315;NAPROXEN#0.6307;CYTOPLASM#0.6293;HYPERURICEMIA#0.6284;NEUTROPHIL#0.6280;SIGNAL TRANSDUCTION#0.6235;SPHINGOSINE#0.6219;URSODEOXYCHOLIC ACID#0.6209;GROWTH FACTOR#0.6201;GLUCURONATE#0.6182;NUCLEOTIDE BINDING#0.6173;GLYCOSYLATION#0.6168;HEPATITIS B VIRUS#0.6166;CELLULAR DETOXIFICATION#0.6155;BREAST CANCER PATIENTS#0.6151;GLIAL CELL#0.6148;LIVER DAMAGE#0.6143;GAMMA-GLUTAMYLCYSTEINE#0.6127;DUODENUM#0.6098;TOPOISOMERASE#0.6096;CEFAZOLIN#0.6041;COLORECTAL CARCINOMA#0.6015;ADVERSE DRUG REACTION#0.6015
1025	P-TEFB COMPLEX#1.0470;FLAVOPIRIDOL#1.0374;COMPLEX I#1.0257;CD4+ T CELL#1.0177;KINASE ACTIVITY#1.0160;CYCLIN DEPENDENT KINASE#1.0061;TRANSACTIVATION#1.0041;C TERMINAL DOMAIN#1.0026;PROTEIN KINASE#0.9979;T CELL#0.9964;BREAST CANCER#0.9955;VIRAL TRANSCRIPTION#0.9953;MACROPHAGE#0.9948;CANCER CELL#0.9940;B CELL#0.9932;MONOCYTE#0.9931;CELL GROWTH#0.9881;CELL PROLIFERATION#0.9868;HUMAN IMMUNODEFICIENCY VIRUS#0.9857;APOPTOTIC#0.9847;CDK INHIBITOR#0.9828;KINASE INHIBITOR#0.9817;APOPTOSIS#0.9815;DEPHOSPHORYLATION#0.9800;MYELOID LEUKEMIA#0.9782;PROTEIN PHOSPHATASE 1#0.9770;RNA INTERFERENCE#0.9767;TRANSCRIPTION FACTOR#0.9753;GENE EXPRESSION#0.9753;CELL CYCLE#0.9736;CELL DEATH#0.9727;CYCLIN DEPENDENT KINASE INHIBITOR#0.9712;RNA SYNTHESIS#0.9711;T LYMPHOCYTE#0.9676;VIRAL REPLICATION#0.9667;ACUTE MYELOID LEUKEMIA#0.9650;INDUCTION OF APOPTOSIS#0.9646;SMALL NUCLEAR RNA#0.9644;MECHANISM OF ACTION#0.9628;NUCLEAR SPECKLE#0.9601;HOST CELL#0.9586;VIRAL GENE EXPRESSION#0.9586;PERIPHERAL BLOOD#0.9578;CELL CYCLE ARREST#0.9563;SIGNALING PATHWAY#0.9561;TUMOR SUPPRESSOR#0.9524;UBIQUITIN#0.9524;CTD KINASE ACTIVITY#0.9468;CARDIOMYOCYTE#0.9463;RETINOBLASTOMA#0.9431;B CELL LYMPHOMA#0.9417;MRNA PROCESSING#0.9413;CELL DIVISION#0.9400;CELLULAR TRANSCRIPTION#0.9376;CELL DIFFERENTIATION#0.9365;PERIPHERAL BLOOD LYMPHOCYTES#0.9365;HISTONE ACETYLTRANSFERASE#0.9353;STEM CELL#0.9345;MUSCLE CELL#0.9257;LYSINE#0.9254;LUNG CANCER#0.9235;MULTIPLE MYELOMA#0.9115;PROVIRUS#0.9092;CELL ACTIVATION#0.9091;ATP BINDING#0.9075;ONCOGENIC#0.9071;T CELL ACTIVATION#0.9052;CHROMATIN REMODELING#0.9007;PROSTATE CANCER#0.8960;M PHASE#0.8921;TOXICITY#0.8909;INDIRUBIN-3'-MONOXIME#0.8906;RNA BINDING#0.8830;MRNA SYNTHESIS#0.8809;CYTOTOXICITY#0.8797;HERPES SIMPLEX VIRUS#0.8759;HERPES SIMPLEX#0.8756;HISTONE MODIFICATION#0.8660;DIFFUSE LARGE B-CELL LYMPHOMA#0.8630;DNA REPAIR#0.8595;DNA BINDING#0.8580;TUMOR NECROSIS FACTOR#0.8475;OOCYTE#0.8467;MRNA 3' END PROCESSING#0.8423;HISTONE DEACETYLASE#0.8363;HYPERPHOSPHORYLATION#0.8359;S PHASE#0.8354;PROTEASOME#0.8343;PREINITIATION COMPLEX#0.8253;CYTOPLASM#0.8241;EPITHELIAL CELL#0.8208;ADENOCARCINOMA#0.8202;PROTEIN KINASE ACTIVITY#0.8171;DNA REPLICATION#0.8116;GROWTH FACTOR#0.8015;PROTEIN CODING GENE#0.7989;ALVOCIDIB#0.7988;REVERSE TRANSCRIPTION#0.7980;CELL CYCLE REGULATION#0.7958;LYMPHOCYTIC LEUKEMIA#0.7940;IMMUNE RESPONSE#0.7901;CHRONIC LYMPHOCYTIC LEUKEMIA#0.7770;HEPATOCELLULAR CARCINOMA#0.7769;PROTEIN COMPLEX#0.7767;TUMOR CELLS#0.7736;INFLAMMATORY RESPONSE#0.7730;NEUROBLASTOMA#0.7730;SIGNAL TRANSDUCTION#0.7712;CELL DIVISION CYCLE#0.7669;BREAST CANCER CELL#0.7627;RNA PROCESSING#0.7614;PAF1 COMPLEX#0.7570;EMBRYONIC STEM CELL#0.7555;PROTEIN SYNTHESIS#0.7550;LYMPHOID TISSUE#0.7547;OVARIAN CANCER#0.7468;PROTEIN PROTEIN INTERACTION#0.7456;DOMINANT NEGATIVE MUTANT#0.7431;TRANSCRIPTIONAL CONTROL#0.7426;TRANSCRIPTION ELONGATION COMPLEX#0.7412;RNA BINDING PROTEIN#0.7409;MEDIATOR COMPLEX#0.7322;ADIPOSE TISSUE#0.7306;CELL CYCLE REGULATOR#0.7284;STRUCTURE ACTIVITY RELATIONSHIP#0.7243;HOST CELL FACTOR#0.7241;HEMATOPOIETIC CELL#0.7234;CATALYTIC ACTIVITY#0.7194;NUCLEOSOME#0.7188;HISTONE METHYLATION#0.7136;CHROMATIN MODIFICATION#0.7113;MITOSIS#0.7037;FACTOR I#0.6981;VIRAL LIFE CYCLE#0.6972;MACROPHAGE DIFFERENTIATION#0.6832;BONE MARROW#0.6808;VIRAL GENOME#0.6793;CTD PHOSPHATASE#0.6779;CERVICAL#0.6778;OVARIAN#0.6762;DNA DAMAGE RESPONSE#0.6753;ACTINOMYCIN D#0.6720;SPECKLE DOMAIN#0.6664;5 FLUOROURACIL#0.6647;ARGININE#0.6636;CERVICAL CANCER#0.6517;PEROXISOME#0.6516;MECHANISMS OF ACTION#0.6461;CHROMATIN BINDING#0.6384;NUT MIDLINE CARCINOMA#0.6333;CELL CYCLE CONTROL#0.6316;MYOBLAST#0.6313;OLOMOUCINE#0.6305;COLON CANCER#0.6262;MYOGENESIS#0.6239;MRNA TRANSCRIPTION#0.6238;PANCREATIC CANCER#0.6237;POSTTRANSLATIONAL MODIFICATION#0.6191;EMBRYONIC GENOME ACTIVATION#0.6189;MONONUCLEAR CELLS#0.6127;GERMINAL VESICLE#0.6107;ASTROCYTE#0.6072;NEUTROPHIL#0.6043;GERMINAL CENTER#0.6032
10260	PROMOTER BINDING#1.1288;BINDING PROTEIN 1#1.1056;TRANSCRIPTION FACTOR#0.6840;HUMAN CERVICAL CARCINOMA#0.6642
10261	PROTEIN KINASE#0.8917;PROTEIN KINASE C#0.8232;INFLAMMATORY BOWEL DISEASE#0.6406
10262	RNA BINDING#1.0214;U2 SNRNP#1.0162;SPLICEOSOME#0.9992;MRNA SPLICING#0.9981;ACROFACIAL DYSOSTOSIS#0.9893;PRE-MRNA SPLICING#0.9432;DYSOSTOSIS#0.8700;HEPATOCELLULAR CARCINOMA#0.8602;SMALL NUCLEAR RIBONUCLEOPROTEIN#0.8257;CELL CYCLE#0.8256;RNA RECOGNITION MOTIF#0.7699;GENE EXPRESSION#0.7496;RNA SPLICING#0.7245;PROTEIN COMPLEX#0.6883;RNA BINDING PROTEIN#0.6646
10263	TUMOR SUPPRESSOR#0.8284;GENE EXPRESSION#0.6301
102659353	TUMOR NECROSIS FACTOR#0.6482
10265	TRANSCRIPTION FACTOR#0.8411;POTASSIUM CHANNEL#0.6535
10266	ADRENOMEDULLIN RECEPTOR#1.0316;AM BINDING#1.0304;POLYMERASE CHAIN REACTION#1.0227;CGRP RECEPTOR#1.0124;CALCITONIN RECEPTOR#1.0116;GENE EXPRESSION#1.0106;RECEPTOR ACTIVITY#1.0105;ENDOTHELIAL CELL#1.0100;CELL SURFACE#1.0038;SMOOTH MUSCLE#1.0023;VASCULAR SMOOTH MUSCLE CELL#0.9993;SMOOTH MUSCLE CELL#0.9918;MUSCLE CELL#0.9912;ANGIOGENESIS#0.9584;REVERSE TRANSCRIPTION#0.9481;RECEPTOR ANTAGONIST#0.9383;CARDIOMYOCYTE#0.9371;VASODILATOR#0.9365;HYPERTENSION#0.9322;PLASMA MEMBRANE#0.8859;MYOCARDIUM#0.8816;RECEPTOR COMPLEX#0.8723;AMYLIN RECEPTOR#0.8626;CALCITONIN LIKE RECEPTOR#0.8571;SIGNALING PATHWAY#0.8543;EPITHELIAL CELL#0.8535;ARTERY#0.8431;CELL PROLIFERATION#0.8422;TRANSCRIPTASE#0.8374;HYPOXIA#0.8285;HYPOXIC#0.8244;GROWTH FACTOR#0.8179;GLUCAGON RECEPTOR#0.8120;NITRIC OXIDE#0.8120;CANCER CELL#0.8071;CELL DEATH#0.8030;PHEOCHROMOCYTOMA#0.7659;VASCULAR ENDOTHELIAL CELL#0.7635;HYPOTENSIVE#0.7568;UTERUS#0.7563;ADRENOMEDULLIN RECEPTOR ACTIVITY#0.7426;BLOOD VESSEL#0.7263;PEPTIDE HORMONE#0.7224;ISCHEMIA#0.7180;PROTEIN KINASE#0.7023;ADRENOMEDULLIN BINDING#0.6975;ADRENAL GLAND#0.6962;DILATED CARDIOMYOPATHY#0.6800;GESTATION#0.6744;MACROPHAGE#0.6655;ADIPOSE TISSUE#0.6565;COMPLEX I#0.6524;APOPTOSIS#0.6457;SYSTOLIC BLOOD PRESSURE#0.6293;NERVOUS SYSTEM#0.6279;APOPTOTIC#0.6107;CARDIOVASCULAR SYSTEM#0.6047;VENTRICULAR CARDIOMYOCYTE#0.6042;ADRENAL MEDULLA#0.6019
10267	CALCITONIN LIKE RECEPTOR#1.1068;AMYLIN RECEPTOR#1.0467;POLYMERASE CHAIN REACTION#1.0275;ADRENOMEDULLIN RECEPTOR#1.0273;ENDOTHELIAL CELL#1.0273;CGRP RECEPTOR#1.0254;SMOOTH MUSCLE CELL#1.0243;SMOOTH MUSCLE#1.0237;MUSCLE CELL#1.0236;CELL SURFACE#1.0207;RECEPTOR ACTIVITY#1.0198;CALCITONIN RECEPTOR#1.0177;GENE EXPRESSION#1.0160;PLASMA MEMBRANE#1.0080;NERVOUS SYSTEM#0.9957;MIGRAINE#0.9913;RECEPTOR ANTAGONIST#0.9788;RECEPTOR COMPLEX#0.9626;VASCULAR SMOOTH MUSCLE CELL#0.9597;GROWTH FACTOR#0.9536;HYPERTENSION#0.9525;VASODILATOR#0.9271;ARTERY#0.9164;BONE MARROW#0.8969;NITRIC OXIDE#0.8941;MACROPHAGE#0.8912;REVERSE TRANSCRIPTION#0.8908;STEM CELL#0.8884;IMMUNE CELL#0.8862;VASODILATION#0.8811;AMYLIN BINDING#0.8707;CARDIOMYOCYTE#0.8655;PEPTIDE BINDING#0.8369;MAST CELL#0.8354;MUTAGENESIS#0.8340;PROTEIN KINASE#0.8269;LYMPHATIC VESSEL#0.8072;T CELL#0.8040;PURKINJE CELL#0.8034;MESENCHYMAL STEM CELL#0.8001;ALANINE#0.7991;BLOOD VESSEL#0.7975;GROWTH FACTOR RECEPTOR#0.7909;AM BINDING#0.7909;MYOCARDIAL INFARCTION#0.7888;NERVE FIBER#0.7742;ENDOTHELIUM#0.7720;SIGNALING PATHWAY#0.7665;TRANSCRIPTASE#0.7658;SUBSTANCE P#0.7631;ENDOTHELIAL GROWTH FACTOR#0.7559;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7559;PLATELET-DERIVED GROWTH FACTOR#0.7473;PROSTATE CANCER#0.7423;CELLULAR LOCALIZATION#0.7296;OSTEOBLAST#0.7242;SPINAL CORD#0.7208;LYMPHANGIOGENESIS#0.7183;CELL PROLIFERATION#0.7176;ANGIOGENESIS#0.7168;CANCER CELL#0.7161;HYPOXIA#0.7078;SIGNAL TRANSDUCTION#0.7024;CENTRAL NERVOUS SYSTEM#0.6879;ENDOSOME#0.6819;C TERMINAL DOMAIN#0.6782;GLIAL CELL#0.6752;CYTOKINE PRODUCTION#0.6742;TRANSCRIPTION FACTOR#0.6741;HYPOXIC#0.6524;CELL MEMBRANE#0.6491;PRO-INFLAMMATORY#0.6479;VENTRICULAR CARDIOMYOCYTE#0.6399;GLYCOSYLATION#0.6376;NITRIC OXIDE SYNTHASE#0.6305;EPITHELIAL CELL#0.6255;ADENYLATE CYCLASE#0.6189;EXTRACELLULAR REGION#0.6175;TUMOR NECROSIS FACTOR#0.6172;RECEPTOR AGONIST#0.6166;TRYPTOPHAN#0.6145;BRAIN NATRIURETIC PEPTIDE#0.6119;SYSTOLIC BLOOD PRESSURE#0.6077;ALDOSTERONE#0.6072;WOUND HEALING#0.6050
10268	ADRENOMEDULLIN RECEPTOR#1.0364;AMYLIN RECEPTOR#1.0179;CGRP RECEPTOR#1.0128;POLYMERASE CHAIN REACTION#1.0124;CALCITONIN RECEPTOR#1.0115;GENE EXPRESSION#1.0115;RECEPTOR ACTIVITY#1.0046;AM BINDING#0.9890;CELL SURFACE#0.9862;ENDOTHELIAL CELL#0.9319;REVERSE TRANSCRIPTION#0.9317;SMOOTH MUSCLE#0.8966;CARDIOMYOCYTE#0.8872;HYPERTENSION#0.8634;EPITHELIAL CELL#0.8598;PLASMA MEMBRANE#0.8445;RECEPTOR ANTAGONIST#0.8366;SMOOTH MUSCLE CELL#0.8200;MUSCLE CELL#0.8193;ANGIOGENESIS#0.8095;VASODILATOR#0.8039;SIGNALING PATHWAY#0.7507;NITRIC OXIDE#0.7168;GROWTH FACTOR#0.7144;ESTROGEN RECEPTOR#0.7128;ADRENAL GLAND#0.6994;RECEPTOR COMPLEX#0.6984;VASCULAR SMOOTH MUSCLE CELL#0.6841;UTERUS#0.6781;ADENYLATE CYCLASE#0.6571;CANCER CELL#0.6556;MYOCARDIUM#0.6553;GLYCOSYLATION#0.6417;COTRANSLATIONAL MODIFICATION#0.6412;SYSTOLIC BLOOD PRESSURE#0.6321;PROTEIN KINASE#0.6321;TRANSCRIPTASE#0.6171;APOPTOSIS#0.6036;BLOOD VESSEL#0.6028;HYPOTENSIVE#0.6020;GESTATION#0.6011
10269	SENESCENCE#1.0250;PROGERIA#1.0215;ANGIOTENSIN CONVERTING ENZYME#1.0121;NUCLEAR LAMINA#1.0111;NUCLEAR ENVELOPE#1.0062;LIPODYSTROPHY#1.0007;METALLOPROTEINASE INHIBITOR#0.9978;FARNESYL#0.9373;MOUSE EMBRYONIC FIBROBLAST#0.9268;ENDOPLASMIC RETICULUM#0.9153;GROWTH FACTOR#0.8977;STEM CELL#0.8888;CELL PROLIFERATION#0.8634;CELL SURFACE#0.8541;CELLULAR SENESCENCE#0.8106;DNA REPAIR#0.8033;ADIPOSE TISSUE#0.8021;HEMORRHAGIC#0.7871;SMOOTH MUSCLE#0.7851;HIV PROTEASE INHIBITOR#0.7792;AGEING#0.7723;GENE EXPRESSION#0.7659;NUCLEAR MORPHOLOGY#0.7645;PLASMA PROTEIN#0.7616;TOXICITY#0.7487;WOUND HEALING#0.7456;SMOOTH MUSCLE CELL#0.7276;MUSCLE CELL#0.7269;POST-TRANSLATIONAL MODIFICATION#0.7249;DNA DAMAGE RESPONSE#0.7131;BONE MARROW#0.7051;MUTAGENESIS#0.7015;VASCULAR SMOOTH MUSCLE CELL#0.6916;ER MEMBRANE#0.6868;MUSCLE WEAKNESS#0.6825;PROTEIN KINASE#0.6702;NUCLEAR MEMBRANE#0.6589;FRUITING BODY DEVELOPMENT#0.6499;TRANSCRIPTION FACTOR#0.6464;AMYLOID PRECURSOR PROTEIN#0.6344;CLAVICLE#0.6305;TUMOUR NECROSIS FACTOR#0.6273;PARTIAL LIPODYSTROPHY#0.6226;ENDOPLASMIC RETICULUM MEMBRANE#0.6212;GENETIC DISORDER#0.6211;INSULIN-LIKE GROWTH FACTOR#0.6198;EXTRACELLULAR MATRIX#0.6153;ZINC BINDING#0.6133;PRENYLATION#0.6093;ABNORMAL NUCLEAR MORPHOLOGY#0.6092;L-PROLINE#0.6089;BASEMENT MEMBRANE#0.6070;PROGENITOR CELL#0.6037
1026	KINASE INHIBITOR PROTEIN#1.0518;CYCLE INHIBITOR P21#1.0468;SULINDAC#1.0383;MELATONIN#1.0336;CYCLIN BINDING#1.0333;P21 ACTIVATED KINASE#1.0311;CYCLIN-DEPENDENT KINASE ACTIVITY#1.0309;CYTOSINE ARABINOSIDE#1.0303;MRNA STABILIZATION#1.0303;HCV CORE PROTEIN#1.0296;LOVASTATIN#1.0271;HISTONE H3 ACETYLATION#1.0260;PKCDELTA#1.0243;CDC2 KINASE ACTIVITY#1.0212;PCNA COMPLEX#1.0206;INVERTED PAPILLOMA#1.0199;RESPONSE TO UV#1.0186;CELECOXIB#1.0173;METFORMIN#1.0158;FLAVOPIRIDOL#1.0151;OOCYTE MATURATION#1.0146;HYDROXYUREA#1.0145;CYCLIN DEPENDENT KINASE INHIBITOR#1.0145;CDK INHIBITOR#1.0134;CENTROSOME DUPLICATION#1.0124;ARSENITE#1.0120;DEGRADATION OF CYCLIN#1.0120;BERBERINE#1.0113;GASTRIC ADENOCARCINOMA#1.0108;GTPASE ACTIVITY#1.0106;PODOCYTE#1.0104;SALIVARY GLAND#1.0100;KINASE INHIBITOR P27#1.0096;SIMVASTATIN#1.0090;IFN-GAMMA#1.0088;S-PHASE CHECKPOINT#1.0082;PROTEIN KINASE INHIBITOR#1.0079;THYMIDINE KINASE#1.0073;LEIOMYOMA#1.0070;QUERCETIN#1.0068;ARA-C#1.0067;BETA CELL#1.0049;CYCLIN D1-CDK4 COMPLEX#1.0042;BETA-GALACTOSIDASE ACTIVITY#1.0041;KINASE INHIBITOR#1.0040;CONTACT INHIBITION#1.0038;GM-CSF#1.0036;CDK ACTIVITY#1.0035;TROGLITAZONE#1.0028;CYCLIN DEPENDENT KINASE#1.0023;GTP HYDROLYSIS#1.0016;UBIQUITIN LIGASE COMPLEX#1.0015;ENDOMETRIAL CARCINOMA#1.0013;THYMIDYLATE SYNTHASE#1.0012;G0 PHASE#1.0011;LARYNGEAL SQUAMOUS CELL CARCINOMA#1.0005;EMODIN#1.0005;KERATINOCYTE DIFFERENTIATION#0.9999;MOUSE EMBRYO FIBROBLASTS#0.9991;GENISTEIN#0.9989;ACTIVE CASPASE 3#0.9988;RESPONSE TO RADIATION#0.9987;VORINOSTAT#0.9986;BILE DUCT#0.9976;NUCLEOTIDE BINDING#0.9973;DENTATE GYRUS#0.9972;THYMIDYLATE#0.9968;CLEAVED CASPASE 3#0.9967;PITUITARY ADENOMA#0.9965;GTP BINDING#0.9964;OOCYTE#0.9957;RESPONSE TO IONIZING RADIATION#0.9957;TRANSITIONAL CELL CARCINOMA#0.9956;ASTROCYTOMA#0.9950;MITOTIC EXIT#0.9946;ESOPHAGUS#0.9944;HAIR FOLLICLE#0.9941;PROTEIN PHOSPHORYLATION#0.9940;GALACTOSIDASE ACTIVITY#0.9939;SENESCENCE#0.9937;SCHWANN CELL#0.9936;CELL CYCLE TRANSITION#0.9936;LUCIFERASE ACTIVITY#0.9934;NULL CELL#0.9932;INTESTINAL CRYPT#0.9931;HEPATOCYTE PROLIFERATION#0.9930;FATTY ACID SYNTHASE#0.9928;NUCLEOTIDE EXCISION REPAIR#0.9928;GRANULOSA CELL#0.9925;CHONDROCYTE#0.9925;MITOMYCIN#0.9923;MITOMYCIN C#0.9921;P53 BINDING#0.9920;HEME OXYGENASE 1#0.9920;PHOSPHATASE AND TENSIN HOMOLOG#0.9914;CENTROSOME#0.9913;MURINE DOUBLE MINUTE#0.9913;ADRIAMYCIN#0.9910;ACTIVATED CASPASE 3#0.9910;BINDING PROTEIN 3#0.9906;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9906;ENHANCER BINDING PROTEIN#0.9896;MESOTHELIOMA CELL#0.9895;ONCOGENE INDUCED SENESCENCE#0.9893;KERATINOCYTE PROLIFERATION#0.9891;RESVERATROL#0.9887;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9886;HETEROCHROMATIN#0.9883;LYMPH NODE METASTASES#0.9883;CELL CYCLE DYSREGULATION#0.9882;CELL CYCLE REGULATOR#0.9882;ENHANCER BINDING#0.9879;EXTRACELLULAR REGULATED KINASE#0.9879;CELL DIVISION CYCLE#0.9879;ZINC FINGER PROTEIN#0.9878;BIOTIN#0.9877;RETINOIC ACID RECEPTOR#0.9876;MITOTIC CATASTROPHE#0.9873;BLADDER CARCINOMA#0.9872;C TERMINAL DOMAIN#0.9872;PANCREATIC ADENOCARCINOMA#0.9871;ENDOMETRIAL CANCER#0.9869;DNA DAMAGE CHECKPOINT#0.9868;MESANGIAL CELL#0.9867;GUANOSINE#0.9863;PREADIPOCYTE#0.9861;MYOCYTES#0.9861;CYTOCHROME P450#0.9860;PROTEIN BINDING#0.9859;COLORECTAL ADENOCARCINOMA#0.9857;ALVEOLAR EPITHELIAL CELL#0.9857;BORTEZOMIB#0.9855;BETA GALACTOSIDASE#0.9854;MYOSIN HEAVY CHAIN#0.9853;NEURITE OUTGROWTH#0.9853;TRANSCRIPTIONAL CONTROL#0.9851;ESOPHAGEAL CARCINOMA#0.9851;PROTEIN STABILIZATION#0.9850;ACINAR CELL#0.9850;MAST CELL#0.9846;STRESS-INDUCED PREMATURE SENESCENCE#0.9845;FORMALIN#0.9843;STEM CELL PROLIFERATION#0.9842;DEPHOSPHORYLATION#0.9841;UBIQUITIN PROTEASOME PATHWAY#0.9841;OXYGENASE#0.9840;INDUCIBLE NITRIC OXIDE#0.9840;RECURRENCE FREE SURVIVAL#0.9839;DNA LIGASE#0.9839;BLEOMYCIN#0.9838;ESOPHAGEAL CANCER#0.9838;TAXOL#0.9835;VITAMIN D3#0.9835;HYPERPHOSPHORYLATION#0.9834;ACTINOMYCIN D#0.9833;STAUROSPORINE#0.9830;HUMAN PAPILLOMA VIRUS#0.9830;CREB BINDING#0.9829;GASTRIC MUCOSA#0.9829;TUBULAR EPITHELIAL CELL#0.9829;ARSENIC TRIOXIDE#0.9828;MALIGNANT PLEURAL MESOTHELIOMA#0.9827;EPITHELIAL OVARIAN CANCER#0.9827;ACTIVATION OF APOPTOSIS#0.9826;NUCLEAR LOCALIZATION SIGNAL#0.9824;GROWTH FACTOR BINDING#0.9823;HUMAN IMMUNODEFICIENCY VIRUS#0.9822;TETRACYCLINE#0.9822;ATAXIA TELANGIECTASIA MUTATED#0.9821;METHYLATION SPECIFIC PCR#0.9821;PROTEASOME PATHWAY#0.9819;YEAR SURVIVAL RATE#0.9819;PANCREATIC CARCINOMA#0.9818;VSMC PROLIFERATION#0.9818;FARNESYL#0.9818;ANTI APOPTOSIS#0.9817;GROWTH REGULATOR#0.9816;MAPK ACTIVATION#0.9816;DISEASE SPECIFIC SURVIVAL#0.9816;NON-SMALL CELL LUNG CARCINOMA#0.9815;VITAMIN D RECEPTOR#0.9814;PARATHYROID#0.9814;PULMONARY ARTERY#0.9813;HODGKIN'S LYMPHOMA#0.9813;APOPTOSIS INDUCING FACTOR#0.9813;FRAGMENT LENGTH POLYMORPHISM#0.9813;DNA TOPOISOMERASE#0.9812;PROSTATE SPECIFIC ANTIGEN#0.9811;CD4+ T CELL#0.9811;HISTONE ACETYLATION#0.9811;MYELOID CELL#0.9810;PAPILLOMA#0.9807;ENTEROCYTE#0.9806;MYOBLAST#0.9804;ACTIVIN RECEPTOR#0.9802;CARDIOMYOCYTE#0.9801;REPORTER GENE ASSAY#0.9801;HOMOLOGOUS RECOMBINATION#0.9800;B CELL LYMPHOMA#0.9799;HEPATOCYTE GROWTH FACTOR#0.9799;SMALL INTESTINE#0.9797;ORAL CANCER CELL#0.9796;ISCHEMIA REPERFUSION INJURY#0.9795;RETINOBLASTOMA#0.9794;TOPOISOMERASE II#0.9794;EPITHELIAL CELL PROLIFERATION#0.9793;INTESTINAL EPITHELIAL CELL#0.9792;HEPATITIS C#0.9792;REGULATION OF APOPTOSIS#0.9790;ROSIGLITAZONE#0.9790;QUANTITATIVE REVERSE TRANSCRIPTION#0.9788;RESPONSE TO GENOTOXIC STRESS#0.9788;RESPONSE TO TREATMENT#0.9787;TRANSACTIVATION#0.9787;T CELL PROLIFERATION#0.9786;HUMAN MAMMARY EPITHELIAL#0.9786;COLONY-STIMULATING FACTOR#0.9786;CAFFEINE#0.9786;PROTEIN DEGRADATION#0.9784;DEMETHYLATION#0.9784;QUIESCENCE#0.9783;AORTIC SMOOTH MUSCLE CELLS#0.9781;CYCLIC AMP#0.9781;LUNG FIBROBLASTS#0.9781;DIABETIC NEPHROPATHY#0.9780;SMOOTH MUSCLE ACTIN#0.9779;HYPOXIA INDUCIBLE FACTOR#0.9778;NUCLEOTIDE EXCHANGE FACTOR#0.9778;DNA SYNTHESIS#0.9778;ANTIGEN BINDING#0.9778;MEGAKARYOCYTE#0.9778;BONE MARROW CELLS#0.9777;1α,25-DIHYDROXYVITAMIN D3#0.9777;ETOPOSIDE#0.9777;COLORECTAL CARCINOMA#0.9776;MIMOSINE#0.9776;MISMATCH REPAIR#0.9775;COLON CARCINOMA#0.9775;TELOMERE#0.9774;APOPTOTIC PROCESS#0.9774;BASAL CELL#0.9774;ELLAGIC ACID#0.9773;CELLULAR LOCALIZATION#0.9773;INTERFERON REGULATORY FACTOR#0.9773;NEURITE#0.9773;METAPLASIA#0.9771;HEPATITIS C VIRUS#0.9770;GALECTIN#0.9768;INTRACELLULAR LOCALIZATION#0.9768;MAP KINASE CASCADE#0.9766;MYOBLAST DIFFERENTIATION#0.9764;HEPATOMA CELLS#0.9763;ESTROGEN RECEPTOR ALPHA#0.9763;VASCULAR CELL#0.9763;ENDOMETRIUM#0.9762;HYPOXIA#0.9762;MOUSE EMBRYONIC FIBROBLAST#0.9762;PROGESTERONE#0.9761;LIVER REGENERATION#0.9761;PROTEIN KINASE B#0.9760;DOMINANT NEGATIVE MUTANT#0.9760;INTRINSIC APOPTOSIS#0.9758;RESPONSE TO STRESS#0.9756;CELL CYCLE CHECKPOINT#0.9754;OXALIPLATIN#0.9754;DECITABINE#0.9753;REGULATION OF CELL CYCLE#0.9751;INTERSTITIAL CELL#0.9751;INHIBITION OF APOPTOSIS#0.9751;BRONCHIAL EPITHELIAL CELLS#0.9751;RHABDOMYOSARCOMA#0.9750;GUANINE#0.9750;ANDROGEN RECEPTOR#0.9750;TERMINAL DIFFERENTIATION#0.9750;TELOMERASE ACTIVITY#0.9749;DOCETAXEL#0.9749;HISTONE ACETYLTRANSFERASE#0.9747;CELL CYCLE#0.9745;PULMONARY HYPERTENSION#0.9745;CAMPTOTHECIN#0.9744;MAP KINASE#0.9744;GEMCITABINE#0.9744;RNA BINDING#0.9743;NF-KAPPAB ACTIVATION#0.9743;INHIBITION OF DNA REPLICATION#0.9742;G2 PHASE#0.9741;NEURAL CELL#0.9741;DEXAMETHASONE#0.9741;CELL ADHESION MOLECULE#0.9741;GLYCINE#0.9740;POSTTRANSLATIONAL MODIFICATION#0.9739;CARCINOMA IN SITU#0.9739;HYPERSENSITIVITY#0.9739;NEUROGENESIS#0.9738;MYOTUBE#0.9737;OVARIAN CARCINOMA#0.9737;INVASIVE CARCINOMA#0.9736;REPLICATIVE SENESCENCE#0.9735;BINDING PROTEIN 1#0.9735;KAPOSI'S SARCOMA#0.9735;CPT-11#0.9735;OSTEOBLAST#0.9733;P53 SIGNALING PATHWAY#0.9733;RNA BINDING PROTEIN#0.9732;NEPHROPATHY#0.9732;GLUCOCORTICOID RECEPTOR#0.9732;OSTEOCLAST#0.9731;NOCODAZOLE#0.9731;PROTEIN COMPLEX#0.9731;CELL CYCLE PATHWAY#0.9730;CELL CYCLE PHASE#0.9728;MELANOCYTE#0.9727;COLON ADENOCARCINOMA#0.9726;SMC PROLIFERATION#0.9726;MYOGENESIS#0.9725;ARGININE#0.9725;REPLICATION FORK#0.9725;ATAXIA TELANGIECTASIA#0.9723;COMPLEX I#0.9723;TELOMERASE REVERSE TRANSCRIPTASE#0.9722;PROXIMAL TUBULAR CELL#0.9722;NEURAL STEM CELL#0.9722;INTRINSIC APOPTOTIC PATHWAY#0.9720;SORAFENIB#0.9720;DNA REPLICATION#0.9719;FOCAL ADHESION KINASE#0.9719;LIGHT CHAIN 3#0.9719;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9719;CELL ACTIVATION#0.9718;NUCLEAR EXPORT#0.9718;HISTONE DEACETYLATION#0.9718;LOCALISATION#0.9718;LYMPH NODE METASTASIS#0.9718;HUMAN BRONCHIAL EPITHELIAL#0.9718;HUMAN CERVICAL CARCINOMA#0.9717;B CELL#0.9716;HISTONE MODIFICATION#0.9716;CELL QUIESCENCE#0.9716;OSTEOBLAST DIFFERENTIATION#0.9715;MESENCHYMAL CELL#0.9715;DISEASE FREE SURVIVAL#0.9714;LINES OF EVIDENCE#0.9714;ORAL SQUAMOUS CELL CARCINOMA#0.9713;METHIONINE#0.9713;INHIBITION OF CELL PROLIFERATION#0.9713;MAPK SIGNALLING#0.9712;DUAL LUCIFERASE REPORTER#0.9711;ASTROCYTE#0.9710;INHIBITION OF GROWTH#0.9710;HEMATOPOIETIC PROGENITOR CELL#0.9709;TOPOISOMERASE#0.9708;ULCERATIVE COLITIS#0.9708;GASTROINTESTINAL TRACT#0.9708;CERVIX#0.9706;MICROTUBULE ASSOCIATED PROTEIN#0.9706;THYROID CANCER#0.9705;SMOOTH MUSCLE CELL PROLIFERATION#0.9703;GERM CELL#0.9703;LEUKOCYTE#0.9702;MYOFIBROBLAST#0.9701;CELL CYCLE ARREST#0.9700;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9700;HEPATITIS B VIRUS#0.9699;CELL NUCLEUS#0.9699;KINASE ACTIVITY#0.9698;COLITIS#0.9697;ANAPLASTIC THYROID CARCINOMA#0.9696;MUSCLE CELL PROLIFERATION#0.9696;ENDOTHELIAL GROWTH FACTOR#0.9696;CELLULAR GROWTH#0.9695;DNA REPAIR PROTEIN#0.9695;REGULATION OF CELLULAR#0.9695;GLYCOGEN SYNTHASE KINASE#0.9695;INHIBITION OF CELL GROWTH#0.9694;CATALYTIC ACTIVITY#0.9694;PROTEIN KINASE C#0.9693;GERMINAL CENTER#0.9692;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9692;ETHANOL#0.9692;BASE EXCISION REPAIR#0.9690;METASTATIC MELANOMA#0.9690;ALKALINE PHOSPHATASE#0.9689;CASPASE-3 ACTIVITY#0.9689;CELLULAR SENESCENCE#0.9689;72-HOURS#0.9688;MONOCYTE#0.9688;KERATINOCYTE#0.9687;MUTAGENESIS#0.9687;HYPOXIC#0.9686;EARLY GROWTH RESPONSE#0.9686;PROTEIN KINASE A#0.9685;LYMPHOCYTIC LEUKEMIA#0.9685;THYROID CARCINOMA#0.9685;NADPH OXIDASE#0.9684;FIBROSARCOMA#0.9684;HEAD AND NECK CANCER#0.9683;NECK CANCER#0.9683;DEACETYLASE ACTIVITY#0.9683;GASTRITIS#0.9683;HEMATOPOIETIC CELL#0.9682;MAMMARY GLAND#0.9682;ADIPOCYTE#0.9682;CELL MOTILITY#0.9681;PLURIPOTENT STEM CELL#0.9681;G1 PHASE#0.9680;CELL KILLING#0.9680;DIGESTION#0.9680;PHOSPHOLIPASE C#0.9679;TESTOSTERONE#0.9678;HEAT SHOCK PROTEIN#0.9677;VASCULAR ENDOTHELIAL CELL#0.9677;5-AZA-2'-DEOXYCYTIDINE#0.9675;TAMOXIFEN#0.9675;RIBOSOMAL PROTEIN#0.9674;NITRIC OXIDE SYNTHASE#0.9674;DNA DAMAGE RESPONSE#0.9674;CELL CYCLE CONTROL#0.9673;HEPATITIS B#0.9673;TUBE FORMATION#0.9671;MALIGNANT GLIOMA#0.9670;PRECURSOR CELL#0.9670;ENDOTHELIAL CELL PROLIFERATION#0.9670;QUANTITATIVE REVERSE TRANSCRIPTASE#0.9670;CASPASE ACTIVATION#0.9670;DEATH RECEPTOR#0.9668;2'-DEOXYCYTIDINE#0.9668;REVERSE TRANSCRIPTION#0.9668;CYTOKINESIS#0.9667;STRESS FIBER#0.9666;ADJACENT NORMAL TISSUE#0.9666;L-CYSTEINE#0.9665;HIGH MOBILITY GROUP#0.9665;OXIDATIVE DNA DAMAGE#0.9663;S PHASE#0.9662;MAMMARY EPITHELIAL CELL#0.9661;EPSTEIN BARR VIRUS#0.9661;VITAMIN C#0.9661;BREAST CANCER PATIENTS#0.9661;PROTEIN SYNTHESIS#0.9660;PKC ACTIVITY#0.9659;PACLITAXEL#0.9658;TRANSCRIPTASE#0.9658;PROTEASOME#0.9658;PROTEIN PROTEIN INTERACTION#0.9657;NERVE GROWTH FACTOR#0.9657;NEUTROPHIL#0.9656;ISCHEMIA#0.9656;BUDDING#0.9655;GLUTATHIONE PEROXIDASE#0.9655;PROSTATE EPITHELIAL CELL#0.9655;CELLULAR QUIESCENCE#0.9654;MITOTIC SPINDLE#0.9653;ACTIN POLYMERIZATION#0.9653;SUMOYLATION#0.9653;THYMOCYTE#0.9652;MRNA DECAY#0.9652;ADVANCED BREAST CANCER#0.9652;REGULATION OF CELL PROLIFERATION#0.9651;VIRAL REPLICATION#0.9650;COLORECTAL ADENOMA#0.9650;INDUCED PLURIPOTENT STEM CELL#0.9649;HUMAN MESENCHYMAL STEM#0.9649;LYMPH NODE#0.9649;ALZHEIMER'S DISEASE#0.9648;PLASMA MEMBRANE#0.9648;LUNG ADENOCARCINOMA#0.9648;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.9647;STEM CELL MARKER#0.9647;LUNG CARCINOMA#0.9647;GEFITINIB#0.9646;GRANULOCYTE#0.9646;AGEING#0.9645;HEPATIC STELLATE CELL#0.9644;BREAST CARCINOMA#0.9643;UBIQUITIN#0.9642;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9642;DNA METHYLTRANSFERASE#0.9641;GROWTH FACTOR RECEPTOR#0.9641;EPIGALLOCATECHIN#0.9640;PROSTATE CARCINOMA#0.9640;CERVICAL CANCER CELL LINES#0.9639;ADENOSINE MONOPHOSPHATE#0.9639;LYSINE#0.9639;M PHASE#0.9639;BLOOD VESSEL#0.9639;RAPAMYCIN#0.9639;SEQUENCE SPECIFIC DNA BINDING#0.9639;ADENOSINE#0.9639;MITOTIC ENTRY#0.9639;DOXORUBICIN#0.9638;TUMOR TISSUES#0.9638;APOPTOSIS SIGNALING#0.9638;CASPASE ACTIVITY#0.9637;EPIDERMAL GROWTH FACTOR#0.9637;OVARIAN CANCER#0.9636;GLIAL CELL#0.9635;ADIPOCYTE DIFFERENTIATION#0.9634;SUBEROYLANILIDE HYDROXAMIC ACID#0.9634;FOCAL ADHESION#0.9634;SPINDLE CHECKPOINT#0.9634;BONE MORPHOGENETIC PROTEIN#0.9633;REACTIVE OXYGEN SPECIES GENERATION#0.9632;FIBROBLAST GROWTH FACTOR#0.9632;CISPLATIN#0.9630;EMBRYONAL CARCINOMA#0.9629;ELECTROPHORETIC MOBILITY SHIFT#0.9629;T CELL#0.9628;VINCRISTINE#0.9627;RNA INTERFERENCE#0.9626;T-CELL LEUKEMIA#0.9626;TROPHOBLAST#0.9625;EPITHELIAL TO MESENCHYMAL#0.9624;MELANOMA CELL LINES#0.9624;MEDULLOBLASTOMA#0.9624;TRANSFORMING GROWTH FACTOR BETA#0.9623;CORD BLOOD#0.9623;TRANSFORMING GROWTH FACTOR ALPHA#0.9623;PANCREATIC DUCTAL ADENOCARCINOMA#0.9623;CELL DEVELOPMENT#0.9622;OVARIAN#0.9622;ACTIN CYTOSKELETON#0.9622;RHEUMATOID ARTHRITIS#0.9622;LUNG EPITHELIAL CELL#0.9621;GESTATION#0.9621;SIGNAL TRANSDUCER#0.9620;HEMATOPOIETIC STEM CELL#0.9618;SENSITIZATION#0.9618;CHRONIC MYELOID LEUKEMIA#0.9617;ANAPHASE#0.9616;DNA REPAIR#0.9616;REGULATION OF CELL GROWTH#0.9616;MYELODYSPLASTIC SYNDROME#0.9615;LIVER DISEASE#0.9615;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9614;GENE SILENCING#0.9614;ENDOMETRIAL ADENOCARCINOMA#0.9614;POST-TRANSLATIONAL MODIFICATION#0.9613;RENAL CELL CARCINOMA#0.9612;SERTOLI CELL#0.9612;ALANINE#0.9611;CERVICAL#0.9611;PHOSPHATASE ACTIVITY#0.9611;SUPEROXIDE DISMUTASE#0.9611;PROGESTIN#0.9610;POLYMERASE CHAIN REACTION#0.9610;DERMAL FIBROBLAST#0.9610;HUMAN DERMAL FIBROBLAST#0.9609;SIGNALLING PATHWAY#0.9609;CELL DIVISION#0.9609;MACROPHAGE#0.9608;LEUCINE#0.9608;EPITHELIAL CELL DIFFERENTIATION#0.9608;SKIN FIBROBLASTS#0.9607;ADIPOSE TISSUE#0.9606;VALPROIC ACID#0.9605;MICROTUBULE#0.9605;DOUBLE STRAND BREAK#0.9604;SIGNALING CASCADE#0.9604;PROGRAMMED CELL DEATH#0.9603;BETA-2#0.9603;DNA METHYLATION#0.9603;FLOW CYTOMETRY ASSAY#0.9603;HISTONE METHYLTRANSFERASE#0.9603;MESENCHYMAL STROMAL CELL#0.9602;GINSENOSIDE RG1#0.9602;CELL CYCLE REGULATION#0.9602;CONNECTIVE TISSUE#0.9602;REGULATION OF GENE EXPRESSION#0.9602;AUTOPHAGY#0.9602;CHROMATIN REMODELING#0.9602;TO TUMOR PROGRESSION#0.9601;MITOCHONDRIAL DNA#0.9601;PLASMA CELL#0.9601;T LYMPHOCYTE#0.9600;RETINOID X RECEPTOR#0.9600;QUANTITATIVE REAL TIME#0.9600;PANCREATIC CANCER#0.9599;INVASIVE DUCTAL CARCINOMA#0.9599;CELL MEMBRANE#0.9599;MAPK SIGNALING#0.9598;ENDOPLASMIC RETICULUM STRESS#0.9597;PROTEIN KINASE ACTIVITY#0.9597;ENZYME ACTIVITY#0.9595;URINARY BLADDER#0.9594;IMATINIB#0.9594;MODE OF ACTION#0.9594;2'-DEOXYURIDINE#0.9593;NEURONAL CELLS#0.9593;CERVICAL CANCER#0.9593;PLATELET-DERIVED GROWTH FACTOR#0.9593;NITRIC OXIDE#0.9592;NOTCH SIGNALING PATHWAY#0.9592;CELL ADHESION#0.9591;VASCULAR DISEASE#0.9591;HYPERGLYCEMIA#0.9590;N-ACETYLCYSTEINE#0.9590;TARGET OF RAPAMYCIN#0.9589;PROTEIN KINASE#0.9589;ACTIN FILAMENT#0.9588;ESTRADIOL#0.9587;COLON CANCER#0.9586;GENOTOXIC#0.9586;SIGNALING MOLECULE#0.9585;IMMUNE CELL#0.9585;CELL DIFFERENTIATION#0.9584;ACETYLCYSTEINE#0.9584;ACUTE PROMYELOCYTIC LEUKEMIA#0.9584;MUTAGENIC#0.9583;POLY ADP RIBOSE#0.9583;PRIMARY BREAST CANCER#0.9583;NEUROBLASTOMA#0.9583;COLORECTAL#0.9582;RETINOIC ACID#0.9581;CYTOCHROME C RELEASE#0.9581;PULMONARY FIBROSIS#0.9581;MYOBLAST PROLIFERATION#0.9580;ALL TRANS RETINOIC ACID#0.9580;HYPERTENSION#0.9579;PROTEIN TYROSINE KINASE#0.9579;THYMIDINE#0.9579;ADENOCARCINOMA#0.9579;EPITHELIAL MESENCHYMAL TRANSITION#0.9578;ENDOPLASMIC RETICULUM#0.9577;INSULIN-LIKE GROWTH FACTOR#0.9577;MORPHOGENESIS#0.9577;MANTLE CELL LYMPHOMA#0.9577;STROMAL CELL#0.9576;MONONUCLEAR CELLS#0.9576;SKELETAL MUSCLE#0.9575;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9575;INVASIVE BREAST CANCER#0.9575;SQUAMOUS CELL CANCER#0.9574;STROMA#0.9574;HEMATOPOIESIS#0.9574;RECEPTOR TYROSINE KINASE#0.9573;INTERPHASE#0.9573;MYOGENIC REGULATORY FACTOR#0.9572;SQUAMOUS CELL CARCINOMA#0.9571;TUMOR SUPPRESSOR#0.9570;VIRAL INFECTION#0.9570;EMBRYONIC KIDNEY#0.9568;LUMINAL#0.9568;CANCER STEM CELL#0.9567;RIBOSE#0.9567;ANCHORAGE INDEPENDENT GROWTH#0.9566;MITOSIS#0.9566;DIFFUSE LARGE B-CELL LYMPHOMA#0.9566;GENOTOXICITY#0.9565;APOPTOSIS#0.9565;PRO-INFLAMMATORY#0.9565;METHOTREXATE#0.9565;MITOGEN ACTIVATED PROTEIN#0.9564;NUCLEOSOME#0.9563;CANCER SPECIFIC SURVIVAL#0.9563;GLIOBLASTOMA MULTIFORME#0.9563;INFLAMMATORY RESPONSE#0.9561;ENDOMETRIOSIS#0.9561;TUMOR NECROSIS FACTOR#0.9561;PERIPHERAL BLOOD#0.9560;CYTOPLASM#0.9560;ATHEROSCLEROTIC#0.9560;HOST CELL#0.9559;TRANSFORMING GROWTH FACTOR#0.9559;ACUTE LEUKEMIA#0.9558;INSULIN RECEPTOR#0.9557;FIBROBLAST PROLIFERATION#0.9557;PEROXISOME#0.9557;ENDOTHELIAL NITRIC OXIDE#0.9556;DOXYCYCLINE#0.9556;REGENERATION#0.9556;FACTOR I#0.9556;LIVER CIRRHOSIS#0.9555;MOLAR#0.9554;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9554;ACTIVATING TRANSCRIPTION FACTOR#0.9554;COLORECTAL CANCER#0.9552;SMOOTH MUSCLE#0.9552;TUMOUR NECROSIS FACTOR#0.9552;PI3K SIGNALING#0.9551;ROS GENERATION#0.9551;BONE FORMATION#0.9551;LIVER CANCER#0.9550;ADVANCED GLYCATION END#0.9550;CELL COUNTING KIT#0.9550;PROGENITOR CELL#0.9549;HISTONE METHYLATION#0.9549;AKT SIGNALING#0.9549;ESTROGEN RECEPTOR#0.9548;DEDIFFERENTIATION#0.9548;CELL POLARITY#0.9548;HUMAN UMBILICAL VEIN#0.9548;INDOLE#0.9547;NECROTIC#0.9547;UMBILICAL CORD#0.9545;CYTOCHROME C#0.9545;OXIDATIVE STRESS RESPONSE#0.9544;UMBILICAL VEIN#0.9544;HUMAN EMBRYONIC STEM#0.9544;ACUTE MYELOID LEUKEMIA#0.9543;SKIN CANCER#0.9542;OSTEOSARCOMA CELL LINES#0.9541;TONGUE CANCER#0.9540;CARCINOGEN#0.9540;GLUTATHIONE#0.9540;ABERRANT CRYPT FOCI#0.9540;GAP JUNCTION#0.9540;ENDOTHELIAL CELL#0.9540;ONCOGENIC#0.9539;DNA BINDING#0.9538;ONCOGENESIS#0.9538;HEPATOCELLULAR CARCINOMA CELL#0.9537;TYROSINE KINASE INHIBITOR#0.9537;26S PROTEASOME#0.9536;ARTERY#0.9536;WNT SIGNALING PATHWAY#0.9535;PROSTATE CANCER#0.9535;THYMINE#0.9534;B LYMPHOCYTE#0.9534;CHOLANGIOCARCINOMA#0.9533;VASCULAR SMOOTH MUSCLE CELL#0.9533;SIGNAL TRANSDUCTION#0.9531;EMBRYONIC STEM CELL#0.9530;5 FLUOROURACIL#0.9530;SMOOTH MUSCLE CELL#0.9529;HUMAN PANCREATIC CANCER#0.9529;COLONY FORMATION ASSAY#0.9528;MITOCHONDRIAL TRANSMEMBRANE POTENTIAL#0.9528;MUSCLE CELL#0.9527;FLUOROURACIL#0.9526;KIDNEY DISEASE#0.9525;APOPTOTIC#0.9523;ANAPLASTIC THYROID CANCER#0.9522;MYELOID LEUKEMIA#0.9521;CELL MATURATION#0.9521;CHROMOSOME SEGREGATION#0.9521;HUMAN GASTRIC CARCINOMA#0.9520;APOPTOTIC SIGNALING PATHWAY#0.9520;CERVICAL ADENOCARCINOMA#0.9517;ADIPOGENESIS#0.9516;GROWTH HORMONE#0.9515;MITOCHONDRIAL DAMAGE#0.9514;CELL PROLIFERATION#0.9513;DIABETES MELLITUS#0.9512;TOPICAL#0.9511;SPINAL CORD#0.9510;APOPTOTIC CELL DEATH#0.9509;ENDOTHELIUM#0.9508;GENE EXPRESSION#0.9508;RESPONSE TO OXIDATIVE STRESS#0.9508;BREAST CANCER#0.9508;DENDRITIC CELL#0.9508;MULTIPLE MYELOMA#0.9507;KIDNEY CANCER#0.9507;STREPTOZOTOCIN#0.9505;CREATINE KINASE#0.9505;GLYCOLYSIS#0.9505;BREAST CANCER CELL#0.9504;GROWTH FACTOR#0.9504;IMMUNE SYSTEM#0.9503;CELL MIGRATION#0.9503;BONE MARROW#0.9502;FLOW CYTOMETRY ANALYSIS#0.9501;AIRWAY EPITHELIAL CELL#0.9501;TRADITIONAL CHINESE MEDICINE#0.9500;NUCLEIC ACID#0.9499;HIGH FAT DIET#0.9499;CANCER RELATED DEATH#0.9498;RECEPTOR ANTAGONIST#0.9498;CENTRAL NERVOUS SYSTEM#0.9497;LUNG CANCER#0.9497;HISTONE DEACETYLASE INHIBITOR#0.9497;CELL GROWTH#0.9496;PHOSPHATIDYLSERINE#0.9496;LUNG DISEASE#0.9496;ACETYLTRANSFERASE ACTIVITY#0.9495;EPITHELIAL CELL#0.9494;NUCLEOLUS#0.9494;IMMUNE RESPONSE#0.9492;LYMPHOID CELL#0.9492;GALLBLADDER CANCER#0.9491;ANAPHASE PROMOTING COMPLEX#0.9491;CASPASE INHIBITOR#0.9489;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9489;DRUG RESISTANCE#0.9488;COMPARATIVE GENOMIC HYBRIDIZATION#0.9488;BREAST ADENOCARCINOMA#0.9487;BONE MARROW STROMAL#0.9487;ADULT T-CELL LEUKEMIA#0.9485;MESENCHYMAL STEM CELL#0.9485;TRANSMISSION ELECTRON MICROSCOPY#0.9484;NEURAL CREST#0.9483;HISTONE DEACETYLASE#0.9483;TUMOR CELLS#0.9482;GDP DISSOCIATION INHIBITOR#0.9482;HUMAN BREAST CANCER#0.9481;ADVANCED PROSTATE CANCER#0.9480;ASPARTATE#0.9480;T CELL ACTIVATION#0.9479;TUMOR GROWTH INHIBITION#0.9479;HUMAN HEPATOMA CELL LINES#0.9478;PROTEOGLYCAN#0.9477;ORAL CAVITY#0.9477;CPG ISLAND METHYLATION#0.9476;INDUCTION OF APOPTOSIS#0.9474;MYOGENIC CELL#0.9474;SOFT TISSUE SARCOMA#0.9474;OBESE#0.9473;MITOCHONDRIAL MEMBRANE#0.9472;PROTEIN TYROSINE PHOSPHATASE#0.9472;EOSIN#0.9471;CELL EXPANSION#0.9471;ANGIOGENESIS#0.9470;MRNA SYNTHESIS#0.9470;CELL SURFACE#0.9469;SKELETAL MUSCLE CELLS#0.9469;INTRACELLULAR SIGNALING PATHWAY#0.9467;CHRONIC LIVER DISEASE#0.9467;MITOCHONDRIA#0.9465;TRANSCRIPTION FACTOR#0.9464;ATHEROSCLEROSIS#0.9463;SIGNALING PATHWAY#0.9463;LIPID METABOLISM#0.9462;MAPK CASCADE#0.9460;CANCER CELL#0.9457;DNA FRAGMENTATION#0.9456;REACTIVE OXYGEN SPECIES#0.9456;PROPIDIUM#0.9456;XERODERMA PIGMENTOSUM#0.9455;CELL DEATH#0.9454;HERPES SIMPLEX#0.9454;STEM CELL#0.9451;TYPE 2 DIABETES#0.9450;HEPATOCELLULAR CARCINOMA#0.9449;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9449;BASEMENT MEMBRANE#0.9447;ANEMIA#0.9446;TUMOR ANTIGEN#0.9445;SIGNALLING CASCADE#0.9443;DNASE#0.9443;ANTISENSE RNA#0.9442;DNA DEMETHYLATION#0.9441;NICOTINAMIDE#0.9440;ARYL HYDROCARBON RECEPTOR#0.9439;WOUND HEALING#0.9439;RENAL FIBROSIS#0.9438;MOUSE EMBRYONIC STEM#0.9438;CYTOTOXICITY#0.9436;LYMPH NODE INVOLVEMENT#0.9436;EXTRACELLULAR MATRIX#0.9436;HIGH GRADE DYSPLASIA#0.9433;NERVOUS SYSTEM#0.9432;RNA SYNTHESIS#0.9432;PHEOCHROMOCYTOMA#0.9432;LIGASE ACTIVITY#0.9431;NUCLEUS PULPOSUS#0.9428;METAPHASE#0.9426;MECHANISM OF ACTION#0.9426;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9424;NEURODEGENERATIVE DISEASE#0.9423;SPINDLE ASSEMBLY#0.9420;GALLBLADDER#0.9420;MULTIPLE MYELOMA CELLS#0.9419;BONE MARROW STROMAL CELL#0.9419;FLUORESCEIN#0.9418;MEMBRANE DEPOLARIZATION#0.9417;STRUCTURE ACTIVITY RELATIONSHIP#0.9417;HERPES SIMPLEX VIRUS#0.9415;ANTIOXIDANT ACTIVITY#0.9414;SEQUESTERING#0.9414;STOMACH CANCER#0.9411;MECHANISMS OF ACTION#0.9409;GLUTAMINE#0.9407;OLIGODENDROCYTE#0.9406;SPHINGOSINE#0.9403;ORNITHINE DECARBOXYLASE#0.9401;PHOSPHATASE 2A#0.9399;FLUDARABINE#0.9398;MARROW STROMAL CELLS#0.9395;ESTROGENS#0.9394;GROWTH OF CELL#0.9392;RENAL CARCINOMA#0.9391;CANCER STEM-LIKE CELL#0.9390;MICROVASCULAR ENDOTHELIAL CELL#0.9388;TOXICITY#0.9386;PERIPHERAL BLOOD LYMPHOCYTES#0.9386;OLIGODENDROGLIOMA#0.9384;APOPTOTIC PROGRAM#0.9383;CHEMOKINE RECEPTOR#0.9383;CYCLIN E KINASE ACTIVITY#0.9382;20S PROTEASOME#0.9381;PRIMARY OPEN ANGLE GLAUCOMA#0.9381;STEM CELL LIKE#0.9381;UNFOLDED PROTEIN RESPONSE#0.9380;HEPARIN#0.9373;GLYCERALDEHYDE-3-PHOSPHATE#0.9371;LYMPHOCYTE PROLIFERATION#0.9370;CAMKII#0.9370;PROTEIN PHOSPHATASE 2A#0.9368;SINGLE STRAND BREAK#0.9368;CARDIOMYOCYTE PROLIFERATION#0.9368;CORONARY ARTERY#0.9367;PLEOMORPHIC ADENOMA#0.9367;ACT D#0.9367;OPEN ANGLE GLAUCOMA#0.9365;UBIQUITIN PROTEASOME SYSTEM#0.9362;AZACYTIDINE#0.9360;TEMOZOLOMIDE#0.9360;IRINOTECAN#0.9359;CALCITRIOL#0.9358;UROKINASE#0.9357;TO THE PROGRESSION#0.9357;INFLAMMATORY CELL#0.9357;SV40 T-ANTIGEN#0.9355;REGULATION OF GROWTH#0.9354;GINSENG#0.9354;HAIR CELL#0.9352;CAROTID ARTERY#0.9351;LARYNGEAL CARCINOMA#0.9350;ARECOLINE#0.9350;CALCIUM CHANNEL#0.9349;ANTHRACENE#0.9346;ENTRY INTO MITOSIS#0.9344;CHLORAMPHENICOL#0.9344;PROSTATE ADENOCARCINOMA#0.9341;KINASE BINDING#0.9338;LARYNX#0.9335;SMOOTH MUSCLE TUMOR#0.9335;PARATHYROID HORMONE#0.9334;MYOCARDIUM#0.9332;LEIOMYOSARCOMA#0.9331;AUTOIMMUNE DISEASE#0.9330;NUCLEAR MATRIX#0.9328;TISSUE REGENERATION#0.9325;MICROTUBULE DYNAMICS#0.9325;LYMPHOMA CELL LINES#0.9325;METHYLATION SPECIFIC POLYMERASE#0.9324;NON HODGKIN LYMPHOMA#0.9321;ADENINE#0.9318;LOW DENSITY LIPOPROTEIN#0.9317;TISSUE HOMEOSTASIS#0.9315;NUCLEAR MORPHOLOGY#0.9314;ANTI INFLAMMATORY DRUGS#0.9314;DIPHOSPHATE#0.9310;OVERALL SURVIVAL RATE#0.9309;POLYCYCLIC AROMATIC HYDROCARBON#0.9305;ACTIVATION OF NF-KAPPAB#0.9305;CELL FUSION#0.9304;P38 MAPK SIGNALING#0.9302;LUPUS ERYTHEMATOSUS#0.9300;PHAGOCYTOSIS#0.9297;HUMAN EPIDERMAL KERATINOCYTES#0.9295;ACTIVATOR PROTEIN 1#0.9293;COENZYME A#0.9293;ERYTHROLEUKEMIA#0.9293;ORAL MUCOSA#0.9290;CARRIE#0.9287;PAPILLARY THYROID CARCINOMA#0.9286;BURKITT LYMPHOMA#0.9286;VINBLASTINE#0.9281;CERVICAL INTRAEPITHELIAL NEOPLASIA#0.9276;PAPILLARY THYROID CANCER#0.9273;MITOTIC CHECKPOINT#0.9271;VACUOLE#0.9270;RESPONSE TO HYPOXIA#0.9268;METASTATIC BREAST CANCER#0.9268;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9266;HISTONE DEMETHYLASE#0.9263;FOLATE#0.9262;MACROPHAGE DIFFERENTIATION#0.9261;DIFFERENTIAL GENE EXPRESSION#0.9260;RECEPTOR AGONIST#0.9257;DNA REPLICATION FACTOR#0.9253;GLIAL FIBRILLARY ACIDIC PROTEIN#0.9253;OSTEOARTHRITIS#0.9253;SPERMATOGENESIS#0.9250;MAP KINASE KINASE#0.9248;CARBOPLATIN#0.9244;IDIOPATHIC PULMONARY FIBROSIS#0.9242;ERYTHROID CELL#0.9237;CHONDROSARCOMA#0.9236;SURFACE PLASMON RESONANCE#0.9232;ADENOMATOUS POLYPOSIS COLI#0.9232;SLIDING CLAMP#0.9231;MICRONUCLEUS#0.9231;ADULT STEM CELL#0.9220;FOREBRAIN#0.9217;DOPAMINERGIC NEURON#0.9216;NEUROBLAST#0.9216;CD8+ T CELL#0.9216;HISTONE DEACETYLASE ACTIVITY#0.9215;DIHYDROFOLATE REDUCTASE#0.9215;NUCLEAR IMPORT#0.9215;OVARIES#0.9212;CORNEAL ENDOTHELIAL CELL#0.9212;SENESCENCE-ASSOCIATED HETEROCHROMATIN FOCI#0.9207;EUKARYOTIC INITIATION FACTOR#0.9205;POLYCYSTIC KIDNEY DISEASE#0.9204;PKC ACTIVATION#0.9201;17β-ESTRADIOL#0.9195;FACTOR S#0.9195;DNA REPAIR ENZYME#0.9188;ATP BINDING#0.9185;ORNITHINE#0.9182;GUANYLATE CYCLASE#0.9180;ASPIRIN#0.9179;HUMAN EMBRYONIC KIDNEY#0.9178;LUNG METASTASIS#0.9178;NORMAL BREAST TISSUE#0.9177;UTERUS#0.9175;LUNG DEVELOPMENT#0.9175;NEUROTOXICITY#0.9172;MALIGNANT MESOTHELIOMA#0.9170;CELL AGING#0.9165;CELLULAR HOMEOSTASIS#0.9164;AUTOPHAGIC CELL DEATH#0.9163;ALDOSTERONE#0.9160;FIBROSARCOMA CELLS#0.9158;AGGRESSIVE BEHAVIOR#0.9157;MRNA TRANSCRIPTION#0.9153;CANCER SPECIFIC MORTALITY#0.9151;CYCLOSPORINE#0.9149;DETOXIFICATION#0.9143;GASTRIC EPITHELIAL CELLS#0.9142;ENDOTHELIAL PROGENITOR CELL#0.9142;FRONTAL#0.9130;ACTIVATED B CELL#0.9128;TRANSLATION INITIATION#0.9122;LI-FRAUMENI SYNDROME#0.9116;GTPASE BINDING#0.9114;MEDROXYPROGESTERONE ACETATE#0.9112;FATTY LIVER#0.9110;MOLECULAR FUNCTION#0.9110;ACTIVATED T CELL#0.9109;INSULIN SECRETION#0.9108;GENE COPY NUMBER#0.9106;DENDRITIC SPINE#0.9106;CHRONIC KIDNEY DISEASE#0.9103;HEXANE#0.9099;WISKOTT ALDRICH SYNDROME#0.9092;MITOTIC CELL CYCLE#0.9090;NUCLEUS PULPOSUS CELL#0.9087;PARKINSON'S DISEASE#0.9086;SPINDLE ASSEMBLY CHECKPOINT#0.9085;MEMBRANE FRACTION#0.9083;TOLL LIKE RECEPTOR#0.9079;MATRIX METALLOPROTEINASE 1#0.9077;MYOCARDIAL INFARCTION#0.9076;ACUTE KIDNEY INJURY#0.9075;MINERALIZATION#0.9072;G-CSF#0.9069;ACTIVATED T-CELLS#0.9063;CHLOROQUINE#0.9062;CREATINE#0.9054;PROSTAGLANDIN E2#0.9052;PROTEIN TRANSLATION#0.9046;NEUROENDOCRINE TUMOR#0.9032;POLYCOMB REPRESSIVE COMPLEX#0.9026;JUN KINASE#0.9025;TELOMERE MAINTENANCE#0.9025;MURINE EMBRYONIC FIBROBLASTS#0.9017;FORSKOLIN#0.9014;NOTCH RECEPTOR#0.9012;MYOEPITHELIAL CELL#0.9012;CEREBRAL CORTEX#0.8995;ADRENERGIC RECEPTOR#0.8989;MAJOR HISTOCOMPATIBILITY COMPLEX#0.8987;GENE EXPRESSION OMNIBUS#0.8984;EXTRINSIC APOPTOTIC PATHWAY#0.8984;CLEAR CELL RENAL CELL CARCINOMA#0.8983;OSTEOCLAST DIFFERENTIATION#0.8982;PARENCHYMA#0.8974;TRYPTOPHAN#0.8973;RIBOSOME#0.8970;GLOMERULONEPHRITIS#0.8969;INTERVERTEBRAL DISC#0.8969;SENSITIZER#0.8969;AUTOPHAGOSOME#0.8967;ADENO ASSOCIATED VIRUS#0.8964;PARATHYROID GLAND#0.8956;RENAL ISCHEMIA REPERFUSION#0.8954;MAP KINASE ACTIVITY#0.8954;BRAIN DEVELOPMENT#0.8953;RETINAL PIGMENT EPITHELIAL#0.8948;ENDOCYTOSIS#0.8942;DNA DAMAGE FOCI#0.8940;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.8937;HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#0.8937;VON HIPPEL LINDAU#0.8936;CYTARABINE#0.8934;COLLAGENASE#0.8934;GLUCOSE UPTAKE#0.8934;TRANSCRIPTION FACTOR ACTIVITY#0.8934;CELL CYCLE MODULATION#0.8930;AU RICH ELEMENT#0.8927;MUSCULAR DYSTROPHY#0.8925;MITOCHONDRIAL MEMBRANE DEPOLARIZATION#0.8925;RECEPTOR BINDING#0.8918;HUMAN PROXIMAL TUBULAR#0.8909;ICI 182,780#0.8909;HISTONE H4 ACETYLATION#0.8903;CHROMATID#0.8901;IGF BINDING#0.8900;CIGARETTE SMOKE EXTRACT#0.8897;VP-16#0.8891;MALIGNANT BRAIN TUMOR#0.8890;MESENCHYME#0.8889;INGENUITY PATHWAY ANALYSIS#0.8888;PANCREATITIS#0.8883;HEPATOCYTE APOPTOSIS#0.8870;EARLY TIME POINT#0.8862;POST NATAL DAY#0.8860;FORESKIN#0.8859;CIS-DIAMMINEDICHLOROPLATINUM#0.8859;OSTEOPOROSIS#0.8856;TH1 CELL#0.8851;DUCTAL CARCINOMA IN SITU#0.8849;HEPATOTOXICITY#0.8849;LYMPHOBLAST#0.8847;LECTIN#0.8847;EMBRYONIC LUNG#0.8839;VITAMIN E#0.8839;HISTIDINE#0.8838;PRIMARY EFFUSION LYMPHOMA#0.8837;ERYTHROPOIESIS#0.8835;SERUM ALBUMIN#0.8833;DEATH RECEPTOR 5#0.8828;NEUROPROTECTION#0.8827;MAMMARY GLAND DEVELOPMENT#0.8824;BARRETT'S ESOPHAGUS#0.8824;PIGMENT EPITHELIAL CELL#0.8821;ACTIVATION OF MAP KINASE#0.8814;WORLD HEALTH ORGANIZATION#0.8813;PROTEIN KINASE ACTIVATION#0.8812;ASCITES#0.8811;WEIGHT LOSS#0.8811;SEVERE COMBINED IMMUNODEFICIENCY#0.8810;GLAND DEVELOPMENT#0.8808;CAMP RESPONSE ELEMENT#0.8808;ASPARTIC ACID#0.8804;INTERMEDIATE FILAMENT#0.8804;VIRULENCE#0.8802;NODULAR#0.8800;CHROMATIN MODIFICATION#0.8797;TISSUE REMODELING#0.8792;DUAL SPECIFICITY PHOSPHATASE#0.8790;PHOSPHOLIPASE A2#0.8788;VELCADE#0.8787;FANCONI ANEMIA#0.8786;COLONIC EPITHELIAL CELLS#0.8784;PHOSPHATASE INHIBITOR#0.8782;DNA TOPOISOMERASE II#0.8779;IFN-BETA#0.8779;PIOGLITAZONE#0.8778;LYSOSOME#0.8777;ORGANELLE#0.8774;DOUBLE-STRAND BREAK REPAIR#0.8774;VALINE#0.8769;ERYTHROID PROGENITOR#0.8766;MITHRAMYCIN#0.8763;MYOSIN LIGHT-CHAIN KINASE#0.8760;OLOMOUCINE#0.8760;LENALIDOMIDE#0.8754;CONNEXIN#0.8751;LITHIUM#0.8747;TRANSLATION INITIATION FACTOR#0.8745;ARACHIDONIC ACID#0.8742;3-METHYLADENINE#0.8736;TISSUE GROWTH FACTOR#0.8729;GROWTH PATTERN#0.8728;PROMOTER BINDING#0.8727;CALCINEURIN#0.8727;HEART DISEASE#0.8725;SRC FAMILY KINASE#0.8719;KERATOSIS#0.8717;INTRACELLULAR SIGNAL TRANSDUCTION#0.8714;MYELOID PROGENITOR CELL#0.8712;BRONCHOPULMONARY DYSPLASIA#0.8705;TISSUE DAMAGE#0.8702;PANCREATIC ISLET#0.8699;HISTONE ACETYLTRANSFERASE ACTIVITY#0.8699;PROTEIN INTERACTION NETWORK#0.8694;PROXIMAL TUBULAR EPITHELIAL#0.8691;ADENYLATE CYCLASE#0.8688;VIRAL GENOME#0.8687;GLUTAMATE RECEPTOR#0.8685;DODECYL SULFATE#0.8683;CHEMOTAXIS#0.8682;ADENYLATE#0.8680;BREAST CELL LINES#0.8666;REGIONAL LYMPH NODE#0.8664;VIRAL HEPATITIS#0.8659;EXOSOME#0.8657;CAMP RESPONSE ELEMENT BINDING#0.8641;ERK CASCADE#0.8637;CYCLOSPORIN A#0.8633;GLUCOSE METABOLISM#0.8630;INHIBITION OF ANGIOGENESIS#0.8630;PARATHYROID ADENOMA#0.8624;INDOMETHACIN#0.8614;MUSCLE CELL DIFFERENTIATION#0.8609;NEDD8 ACTIVATING ENZYME#0.8602;HYPERTHERMIA#0.8599;PERIPHERAL NERVE#0.8594;RAD001#0.8594;REGULATION OF CELLULAR SENESCENCE#0.8592;NORMAL PROSTATE EPITHELIAL#0.8592;CAROTENOID#0.8586;SURFACE EPITHELIUM#0.8581;DERMIS#0.8576;THYMIDINE KINASE 1#0.8576;STEROID HORMONE RECEPTOR#0.8563;STEM CELL DIFFERENTIATION#0.8559;MAMMARY EPITHELIUM#0.8558;ROS FORMATION#0.8557;TRANSCRIPTION FACTOR BINDING#0.8554;LACTATION#0.8548;PROTEIN KINASE CASCADE#0.8546;TRANSFERASE INHIBITOR#0.8543;HIGH RISK PATIENTS#0.8538;ERLOTINIB#0.8536;LEYDIG CELL#0.8533;L-ARGININE#0.8529;CHORIOCARCINOMA#0.8520;RESPONSE TO CISPLATIN#0.8518;CELL CELL ADHESION#0.8513;PCNA INTERACTING PROTEIN#0.8511;MEIOSIS#0.8508;ALKALINE PHOSPHATASE ACTIVITY#0.8508;SPHINGOSINE 1 PHOSPHATE#0.8508;X CHROMOSOME#0.8502;GREEN TEA POLYPHENOL#0.8502;CEREBRAL ISCHEMIA#0.8502;ADRENAL GLAND#0.8500;SYNOVIAL SARCOMA#0.8500;7-HYDROXYSTAUROSPORINE#0.8497;DENTAL PULP#0.8490;MITOCHONDRION#0.8483;MTDNA#0.8476;WHITE BLOOD CELL#0.8473;UMBILICAL CORD BLOOD#0.8472;GROWTH DIFFERENTIATION FACTOR#0.8471;8-HYDROXY-2'-DEOXYGUANOSINE#0.8468;NEGATIVE CONTROL GROUP#0.8467;TRANSCRIPTION ACTIVATOR#0.8464;SCHWANN CELL PROLIFERATION#0.8464;CHROMOSOMAL REGION#0.8457;CELL FRACTION#0.8448;MENTAL RETARDATION#0.8447;SKIN DISEASE#0.8442;DAUNORUBICIN#0.8442;RESPONSE TO GROWTH FACTOR#0.8441;CYCLOPHOSPHAMIDE#0.8438;COLCHICINE#0.8438;PRIMARY BILIARY CIRRHOSIS#0.8437;AGE AT DIAGNOSIS#0.8433;CRYSTAL VIOLET#0.8420;STEM CELL TRANSPLANTATION#0.8420;COLLAGEN TYPE I#0.8420;INFERTILITY#0.8411;EXTRINSIC APOPTOSIS#0.8408;LEUCINE RICH REPEAT#0.8402;FERMENTATION#0.8400;PERTUSSIS#0.8399;CYTOKINE PRODUCTION#0.8397;EPITHELIAL OVARIAN CARCINOMA#0.8396;FIBROBLAST LIKE SYNOVIOCYTES#0.8393;MDM2 BINDING#0.8388;PROTEASOME DEGRADATION#0.8385;GERM CELL TUMORS#0.8382;AUTOIMMUNITY#0.8382;RETINAL PIGMENT EPITHELIUM#0.8380;ANAPLASTIC LARGE CELL LYMPHOMA#0.8380;SODIUM DODECYL SULFATE#0.8370;NUCLEOPLASM#0.8366;TRANSCRIPTIONAL TRANSACTIVATION#0.8365;CHOLINE#0.8364;TRANSDIFFERENTIATION#0.8350;CYTOKINE RECEPTOR#0.8350;REGULATION OF MRNA#0.8347;URETERAL OBSTRUCTION#0.8344;RESPONSE TO DOXORUBICIN#0.8344;PML NB#0.8340;LOW DOSE RATE#0.8336;VDR BINDING#0.8335;CLEAR CELL CARCINOMA#0.8330;TYPE 2 DIABETIC#0.8326;NATIONAL CANCER INSTITUTE#0.8315;MEMBRANE RUFFLING#0.8313;SINONASAL INVERTED PAPILLOMA#0.8312;TUMOR REGRESSION GRADE#0.8311;POTASSIUM CHANNEL#0.8309;HETEROTRIMERIC G-PROTEIN#0.8307;SPINDLE FORMATION#0.8299;DEOXYADENOSINE#0.8296;CHONDROGENESIS#0.8294;MITOCHONDRIAL DEPOLARIZATION#0.8292;GENOTOXINS#0.8286;SOMATOSTATIN RECEPTOR#0.8285;FERTILIZATION#0.8285;NEURONAL CELL DEATH#0.8285;GAP ACTIVITY#0.8279;FETAL LIVER#0.8278;HEPATOBLASTOMA#0.8275;INVASIVE BREAST CARCINOMA#0.8275;ENZYME INHIBITOR#0.8274;CELL FATE DETERMINATION#0.8273;LOW DOSE RADIATION#0.8263;EPITHELIAL TISSUES#0.8259;RECEPTOR LIGAND#0.8255;ARABINOFURANOSYLCYTOSINE#0.8251;SPECIFICITY PROTEIN 1#0.8248;EPITHELIAL CARCINOMA#0.8244;BIOLUMINESCENCE#0.8243;SYSTEM DEVELOPMENT#0.8242;ACETYL COA CARBOXYLASE#0.8238;NEURAL PRECURSOR CELL#0.8235;MITOTIC CLONAL EXPANSION#0.8235;MTOR COMPLEX#0.8235;INTESTINAL EPITHELIAL CELL DIFFERENTIATION#0.8231;TUMOR GROWTH DELAY#0.8230;SPERMATOCYTES#0.8229;NUCLEAR TRANSPORT#0.8226;MRNA SPLICING#0.8219;CORNEAL EPITHELIAL CELL#0.8218;LIPID DROPLET#0.8217;CIRCADIAN RHYTHM#0.8208;IFN REGULATORY FACTOR#0.8205;MEAN TELOMERE LENGTH#0.8203;PAPILLARY CARCINOMA#0.8200;FILAMENTOUS ACTIN#0.8200;CELL COMMUNICATION#0.8199;RNA HELICASE#0.8197;BREAST CARCINOMA CELL LINES#0.8195;PERIPHERAL NERVOUS SYSTEM#0.8194;HIGH POWER FIELD#0.8190;LUNG CARCINOMA CELL LINES#0.8189;LEUKEMIA INHIBITORY FACTOR#0.8177;DNASE I#0.8176;RECTUM#0.8173;MEDROXYPROGESTERONE#0.8171;PURKINJE CELL#0.8171;MUSCLE CONTRACTION#0.8165;PKCALPHA#0.8164;MELPHALAN#0.8161;MITOTIC CELL DEATH#0.8157;UBIQUITIN LIGASE ACTIVITY#0.8156;STEM CELL MAINTENANCE#0.8154;HEPARIN BINDING#0.8153;VITAMIN A#0.8152;DNA HYPERMETHYLATION#0.8145;IONOPHORE#0.8141;ACETYLCHOLINE#0.8140;T CELL ANERGY#0.8138;DEFEROXAMINE#0.8135;CHRONIC HEPATITIS C#0.8128;TUMOR NODE METASTASIS#0.8127;LYMPHOBLASTOID CELLS#0.8127;MEMBRANE BLEBBING#0.8127;STATUS EPILEPTICUS#0.8126;RETINAL PIGMENT EPITHELIAL CELLS#0.8124;INTESTINAL STEM CELL#0.8117;CELL CYCLE PROCESS#0.8116;SQUAMOUS INTRAEPITHELIAL LESION#0.8114;CHONDROCYTE PROLIFERATION#0.8114;AMLODIPINE#0.8107;DECIDUALIZATION#0.8103;HYPERCALCEMIA#0.8099;HISTONE ACETYL TRANSFERASE#0.8088;CARDIAC DEVELOPMENT#0.8085;OSSIFICATION#0.8084;CHROMATIN REMODELING COMPLEX#0.8084;SKIN PAPILLOMA#0.8083;HYPERACTIVE#0.8082;STEROIDOGENESIS#0.8078;MRNA DEGRADATION#0.8077;PROXIMAL TUBULE CELL#0.8073;PYRUVATE#0.8072;ADRENAL CORTEX#0.8070;SMOOTH MUSCLE CONTRACTION#0.8069;CARCINOGENICITY#0.8063;UBIQUITIN PROTEIN LIGASE#0.8061;TIGHT JUNCTION#0.8052;HEPATOCYTE NUCLEAR FACTOR#0.8050;LIVER METASTASIS#0.8042;T CELL DEVELOPMENT#0.8040;ALPHA-DIFLUOROMETHYLORNITHINE#0.8040;MUSCLE STEM CELL#0.8037;PUROMYCIN#0.8036;PROTEIN PHOSPHATASE 1#0.8035;RED BLOOD CELL#0.8033;MEMBRANE RUFFLE#0.8030;URACIL#0.8029;CATABOLISM#0.8027;TERATOMA#0.8026;BILE DUCT CARCINOMA#0.8021;DIHYDROTESTOSTERONE#0.8018;RECEPTOR ACTIVATOR#0.8012;CYTOKINE SECRETION#0.8011;NEURAL STEM PROGENITOR#0.8011;INTERVERTEBRAL DISC DEGENERATION#0.8009;ENDOCHONDRAL OSSIFICATION#0.8002;LIVER DAMAGE#0.8000;AUTOPHAGIC VACUOLE#0.7998;INVASIVE GROWTH#0.7996;GASTROINTESTINAL STROMAL TUMOR#0.7987;JNK SIGNALING PATHWAY#0.7982;INFLAMMATORY BOWEL DISEASE#0.7982;BONE MARROW FAILURE#0.7979;MOLECULAR DYNAMICS SIMULATION#0.7973;GLUTAMIC ACID#0.7973;SINGLE CELL GEL#0.7968;MITOGENIC ACTIVITY#0.7965;MESOTHELIAL CELL#0.7955;ACETAMINOPHEN#0.7953;AIRWAY SMOOTH MUSCLE#0.7949;LUMINAL CELL#0.7948;MONOCYTIC LEUKEMIA#0.7944;RENAL CANCER CELLS#0.7943;CHONDROCYTE DIFFERENTIATION#0.7942;CARDIOMYOPATHY#0.7937;ADENOID CYSTIC CARCINOMA#0.7932;MUTAGEN#0.7930;RELAPSE FREE SURVIVAL#0.7929;STEM CELL FACTOR#0.7922;RUFFLE#0.7921;9-CIS-RETINOIC ACID#0.7919;HYPERPARATHYROIDISM#0.7915;FAILURE FREE SURVIVAL#0.7905;ESTROGEN-RECEPTOR POSITIVE BREAST CANCER#0.7900;EXIT FROM MITOSIS#0.7896;GDP BINDING#0.7895;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE#0.7892;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY#0.7891;ACUTE MYELOID LEUKAEMIA#0.7879;CYCLOSPORIN#0.7878;COLORECTUM#0.7878;MITOCHONDRIAL TRANSLOCATION#0.7862;NEPHRITIS#0.7862;PULMONARY ARTERIAL HYPERTENSION#0.7857;PHOSPHODIESTERASE#0.7855;SKELETAL MUSCLE REGENERATION#0.7855;GANGLION CELLS#0.7854;TROPHOBLAST CELL#0.7851;CHROMATIN REMODELLING#0.7843;FLUVASTATIN#0.7842;SECONDARY HYPERPARATHYROIDISM#0.7841;GANCICLOVIR#0.7838;VIRION#0.7835;FOLLICULAR LYMPHOMA#0.7832;BRAIN CANCER#0.7830;GASTROESOPHAGEAL REFLUX DISEASE#0.7826;RESPIRATION#0.7824;DIPEPTIDYL PEPTIDASE#0.7823;BETA CELL MASS#0.7823;ORGANOGENESIS#0.7820;FEMALE BREAST CANCER#0.7819;TELOMERASE INHIBITOR#0.7819;HETEROCHROMATIN PROTEIN 1#0.7817;ORAL SQUAMOUS CARCINOMA#0.7817;ERYTHROBLAST#0.7816;CENTRIOLE#0.7813;MONOCYTE DIFFERENTIATION#0.7810;SEBACEOUS GLAND#0.7803;METASTATIC MELANOMA CELLS#0.7799;PSORIASIS#0.7798;DIAMMINEDICHLOROPLATINUM#0.7797;WEIGHT GAIN#0.7796;MOTHERS AGAINST DECAPENTAPLEGIC#0.7792;ISOTHERMAL TITRATION CALORIMETRY#0.7792;RU486#0.7790;PROTEIN MODIFICATION#0.7789;MYELOID CELL LEUKEMIA#0.7780;INSULIN GROWTH FACTOR#0.7779;DIMETHYL SULFOXIDE#0.7778;2-METHOXYESTRADIOL#0.7777;OVARIAN SURFACE EPITHELIAL#0.7776;BASAL CELL CARCINOMA#0.7776;CELLULAR COMPONENT#0.7770;SWISS ALBINO MICE#0.7768;MELATONIN RECEPTOR#0.7764;TYROSINE KINASE RECEPTOR#0.7762;ANCHORING#0.7757;OUABAIN#0.7754;ERYTHROCYTE#0.7753;GENETIC DISORDER#0.7749;ADENOSINE TRIPHOSPHATE#0.7746;CONSTITUTIVELY ACTIVE MUTANT#0.7741;TRANSFERRIN RECEPTOR#0.7740;FATTY LIVER DISEASE#0.7739;DNA REPLICATION LICENSING#0.7738;LYSIS#0.7737;BAFILOMYCIN A1#0.7732;SIGNAL PEPTIDE#0.7724;MALIGNANT LYMPHOMA#0.7721;SERUM RESPONSE FACTOR#0.7716;HUMAN PROSTATE EPITHELIAL#0.7715;CHOLESTEROL SYNTHESIS#0.7708;ENDOTHELIAL CELL MIGRATION#0.7708;RELATED PROTEIN 1#0.7706;LASER CAPTURE MICRODISSECTION#0.7704;OSTEOGENESIS#0.7702;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.7701;GOBLET CELL#0.7693;LYSINE SPECIFIC DEMETHYLASE#0.7683;SCIATIC NERVE#0.7682;FATTY ACID METABOLISM#0.7680;EDEMA#0.7671;ETHYL ACETATE EXTRACT#0.7671;GASTRIC EPITHELIUM#0.7669;NORMAL LIVER TISSUES#0.7667;GLOBIN#0.7661;CARDIAC MUSCLE#0.7659;ACTINIC KERATOSIS#0.7651;PALMITATE#0.7644;PRENYLATION#0.7644;PATHOLOGIC COMPLETE RESPONSE#0.7643;FIBRILLAR COLLAGEN#0.7639;ACETYLCHOLINE RECEPTOR#0.7638;NEPHROTOXICITY#0.7634;IN SITU CARCINOMA#0.7634;UVEAL MELANOMA#0.7632;OVERALL SURVIVAL TIME#0.7630;NATURAL KILLER CELL#0.7627;EPITHELIAL CELL APOPTOSIS#0.7623;BIOLOGICAL PROCESS#0.7619;ANAL CARCINOMA#0.7617;ATORVASTATIN#0.7615;UROKINASE PLASMINOGEN ACTIVATOR#0.7604;LARGE INTESTINE#0.7600;MUSCLE ATROPHY#0.7594;KINETOCHORE#0.7593;ADENINE DINUCLEOTIDE PHOSPHATE#0.7590;PALMITIC ACID#0.7585;B CELL DEVELOPMENT#0.7585;GASTRIC LYMPHOMA#0.7578;NEURAL TUBE#0.7578;RIBOSOMAL S6 KINASE#0.7576;JUN PHOSPHORYLATION#0.7575;LEUKEMIA STEM CELL#0.7572;DECIDUAL CELL#0.7571;OXIDATIVE PHOSPHORYLATION#0.7569;METASTASIS FREE SURVIVAL#0.7565;SCANNING ELECTRON MICROSCOPY#0.7562;DENSITY FUNCTIONAL THEORY#0.7547;INTRACELLULAR SIGNALING CASCADE#0.7547;TRAUMATIC BRAIN INJURY#0.7545;OXYGEN INDUCED RETINOPATHY#0.7545;INNATE IMMUNE RESPONSE#0.7544;CYTOSKELETON ORGANIZATION#0.7543;INO80 COMPLEX#0.7541;NUCLEAR EXPORT SIGNAL#0.7539;PITUITARY GLAND#0.7539;CAMP-RESPONSIVE ELEMENT BINDING#0.7538;OPIOID GROWTH FACTOR#0.7534;BONE RESORPTION#0.7534;REGULATORY T CELL#0.7534;GLUCOSE REGULATED PROTEIN#0.7531;NEURAL PROGENITOR CELL#0.7529;NEUROENDOCRINE CARCINOMA#0.7526;THYROID HORMONE RECEPTOR#0.7523;FOLLICULAR ADENOMA#0.7522;T CELL FACTOR#0.7521;LEWIS LUNG CARCINOMA#0.7521;TOXICANT#0.7520;HEART DEVELOPMENT#0.7518;SMAD BINDING#0.7511;GRANULOSA CELL PROLIFERATION#0.7508;SIGNET RING CELL#0.7505;BODY WEIGHT RATIO#0.7504;AGE RELATED MACULAR DEGENERATION#0.7503;SWELLING#0.7502;NEUROECTODERMAL TUMOR#0.7500;MACULAR DEGENERATION#0.7499;SUCROSE#0.7498;STRESS FIBRE#0.7496;MICROTUBULE POLYMERIZATION#0.7489;PRINCIPAL COMPONENT ANALYSIS#0.7487;TRANSCRIPTION REPRESSOR#0.7482;QUINACRINE#0.7481;EVEROLIMUS#0.7480;PROTEINASE INHIBITOR#0.7479;AMNIOTIC FLUID#0.7477;DNA HYPOMETHYLATION#0.7453;TESTICULAR CANCER#0.7450;O CELL#0.7440;ENTEROCYTE DIFFERENTIATION#0.7439;B CELL ACTIVATION#0.7437;TOTAL ANTIOXIDANT CAPACITY#0.7437;MELANOMA DIFFERENTIATION ASSOCIATED#0.7435;ADVANCED OVARIAN CANCER#0.7434;ANOIKIS#0.7432;LARGE CELL CARCINOMA#0.7429;CELL POLARIZATION#0.7429;NERVOUS SYSTEM DEVELOPMENT#0.7423;LAMINAR SHEAR STRESS#0.7422;METASTATIC PROSTATE CANCER#0.7418;ADIPOSE-DERIVED STEM CELL#0.7413;MYELOID-DERIVED SUPPRESSOR CELL#0.7413;CAMP SIGNALING#0.7408;CASPASE-INDEPENDENT APOPTOSIS#0.7399;ADVANCED GASTRIC CANCER#0.7393;SALICYLATE#0.7391;CELLULAR METABOLISM#0.7390;FOCAL SEGMENTAL GLOMERULOSCLEROSIS#0.7380;TRASTUZUMAB#0.7379;RISK OF DEATH#0.7377;EPITHELIAL STEM CELL#0.7374;BLEBBING#0.7372;PHENOBARBITAL#0.7369;PROSTATE EPITHELIUM#0.7367;INTESTINAL MUCOSA#0.7365;AIRWAY EPITHELIUM#0.7363;MUSCLE SATELLITE CELL#0.7355;NORMAL ORAL MUCOSA#0.7350;VIRAL DNA REPLICATION#0.7347;MITOTIC SPINDLE CHECKPOINT#0.7345;OUTER MEMBRANE#0.7345;BONE REGENERATION#0.7344;CELLULAR TRANSCRIPTION#0.7343;ALPHA CELL#0.7342;KERATOACANTHOMA#0.7338;SEBACEOUS CARCINOMA#0.7333;GRANULOCYTE COLONY STIMULATING FACTOR#0.7332;SKELETON#0.7332;CELLULAR RESPONSE TO STRESS#0.7331;E BOX BINDING#0.7329;EPHRIN#0.7327;TRANSCRIPTION REGULATOR#0.7326;SPERMINE#0.7326;SKIN CARCINOMA#0.7326;TIME TO PROGRESSION#0.7321;TRANSMEMBRANE RECEPTOR#0.7315;RELATIVE TELOMERE LENGTH#0.7303;ENDOTHELIAL CELL APOPTOSIS#0.7299;ADJUSTED ODDS RATIO#0.7295;RESPIRATORY CHAIN#0.7294;HYALURONIC ACID#0.7293;FRUCTOSE#0.7292;TOPOTECAN#0.7283;HYPERACTIVITY#0.7278;RNA PROCESSING#0.7277;OVARIAN SURFACE EPITHELIUM#0.7271;NUCLEAR ENVELOPE#0.7266;SAHF FORMATION#0.7264;STEROL REGULATORY ELEMENT#0.7263;AMYOTROPHIC LATERAL SCLEROSIS#0.7261;DRUG METABOLISM#0.7261;ION CHANNEL#0.7261;LATERAL SCLEROSIS#0.7260;CYTOCHROME C OXIDASE#0.7252;DNA METABOLISM#0.7244;LIVER DEVELOPMENT#0.7242;POLYAMINE BIOSYNTHESIS#0.7235;ENDOCRINE DISRUPTING CHEMICAL#0.7234;UBIQUITIN SPECIFIC PROTEASE#0.7234;CELL WALL#0.7229;THYROID GLAND#0.7226;LASER DESORPTION IONIZATION#0.7224;YES ASSOCIATED PROTEIN#0.7219;CENTROMERE#0.7216;NEURITE EXTENSION#0.7215;CEREBELLAR GRANULE NEURON#0.7213;CELL PERIPHERY#0.7212;INHIBITION OF PHOSPHORYLATION#0.7205;SUCCINATE#0.7202;CONJUGATION#0.7191;CUTANEOUS T CELL LYMPHOMA#0.7187;CYTIDINE#0.7185;GRAPE SEED EXTRACT#0.7183;PROPHASE#0.7177;NEUROTROPHIN RECEPTOR#0.7176;B CELL RECEPTOR#0.7163;SUNITINIB#0.7161;CYCLIC ADENOSINE MONOPHOSPHATE#0.7160;MAGNETIC RESONANCE SPECTROSCOPY#0.7159;CASPASE-9 ACTIVITY#0.7157;METHYL THIAZOLYL TETRAZOLIUM#0.7153;INHIBITION OF DNA REPAIR#0.7151;CHOLESTEATOMA#0.7147;PHOSPHATE BUFFERED SALINE#0.7147;STEARIC ACID#0.7144;MUSCLE FIBER#0.7142;VACCINIA#0.7141;ACTIN DEPOLYMERIZATION#0.7141;GLUCOSE HOMEOSTASIS#0.7139;NF-KAPPAB INHIBITOR#0.7134;ALVEOLAR MACROPHAGE#0.7131;FAMILIAL ADENOMATOUS POLYPOSIS#0.7123;BENZIMIDAZOLE#0.7107;INHIBITION OF TELOMERASE ACTIVITY#0.7103;ALTERNATIVE READING FRAME#0.7097;REPLICATION PROTEIN A#0.7097;GLYCOSYLASE#0.7093;PROTEIN KINASE C SIGNALING#0.7091;BILE DUCT LIGATION#0.7090;NEURONAL PROGENITOR CELL#0.7082;DASATINIB#0.7080;GERMINAL CENTER B CELL#0.7077;GERMINAL CENTER B#0.7075;MYOMETRIUM#0.7075;BILIARY TRACT#0.7072;ARA-A#0.7070;PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY#0.7068;CARDIOVASCULAR SYSTEM#0.7064;RIBOSOMAL RNA#0.7036;HYALURONAN#0.7035;HUMAN CORNEAL ENDOTHELIAL#0.7034;AORTIC ANEURYSM#0.7034;TYPE 2 DIABETES MELLITUS#0.7033;2 DIABETES MELLITUS#0.7033;TO TUMOR RECURRENCE#0.7031;PROTEASE ACTIVITY#0.7026;DEMETHYLASE ACTIVITY#0.7025;HDAC COMPLEX#0.7023;NALIDIXIC ACID#0.7020;ENDOMETRIAL EPITHELIAL CELLS#0.7019;SILENT INFORMATION REGULATOR#0.7014;CYCLOSOME#0.7012;FILAMENTOUS GROWTH#0.7005;VERRUCOUS CARCINOMA#0.7003;MYCOPHENOLIC ACID#0.6988;DNA DEGRADATION#0.6987;BREAST CANCER MODEL#0.6982;TOOTH DEVELOPMENT#0.6981;ANGIOTENSIN CONVERTING ENZYME#0.6976;ALA-PDT#0.6975;RESPONSE TO TPA#0.6969;THROMBIN RECEPTOR#0.6969;NECROTIC CELL DEATH#0.6967;DIARRHEA#0.6967;CELLULAR DNA DAMAGE RESPONSE#0.6965;SEMINAL VESICLE#0.6964;CHROMOSOME REGION#0.6964;LYMPH NODE DISSECTION#0.6955;RETICULOCYTE#0.6954;FAT PAD#0.6941;ENCAPSULATED THYMOMA#0.6936;PERIODONTAL LIGAMENT#0.6935;URINARY BLADDER CANCER#0.6935;MULTIPLE ENDOCRINE NEOPLASIA#0.6933;ESOPHAGEAL EPITHELIAL CELLS#0.6931;ADHERENS JUNCTION#0.6929;MACROPHAGE MIGRATION#0.6928;GROWTH CONE#0.6927;RESPONSE TO CURCUMIN#0.6926;INNER EAR#0.6925;PUTRESCINE#0.6915;OLFACTORY BULB#0.6904;GELDANAMYCIN#0.6903;MEMORY T CELL#0.6902;FOLLICLE STEM CELL#0.6897;TUMOR INITIATING CELL#0.6895;ASCORBIC ACID#0.6894;MEVASTATIN#0.6893;GALLBLADDER ADENOCARCINOMA#0.6891;TARGET OF RAPAMYCIN COMPLEX#0.6884;CYCLIC GUANOSINE MONOPHOSPHATE#0.6883;RIBOSOME BIOGENESIS#0.6872;L-OHP#0.6872;ARTERY DISEASE#0.6871;AMELOBLASTOMA#0.6862;IMATINIB MESYLATE#0.6861;FALSE DISCOVERY RATE#0.6853;CELLULAR RESPONSE TO UV#0.6851;ESOPHAGEAL SQUAMOUS CARCINOMA#0.6851;HESPERETIN#0.6846;POLYCYSTIN#0.6838;EPIRUBICIN#0.6820;CELL PROLIFERATION INDEX#0.6820;METHYLTRANSFERASE ACTIVITY#0.6819;AUTOPHAGOSOME FORMATION#0.6817;IKAPPAB KINASE#0.6812;CELL MORPHOGENESIS#0.6805;GLYCOSYLATION#0.6804;NB1011#0.6803;PROTEIN KINASE B SIGNALING#0.6802;PROTEASOMAL PATHWAY#0.6802;PHOSPHATIDYLINOSITOL 3-KINASE SIGNALING#0.6800;NEOMYCIN#0.6795;APOPTOTIC BODY#0.6795;FATTY ACID SYNTHESIS#0.6792;ORAL EPITHELIAL DYSPLASIA#0.6791;OVARIAN SURFACE EPITHELIAL CELL#0.6791;ORAL EPITHELIAL CELLS#0.6790;LASER SCANNING MICROSCOPY#0.6789;PROTEIN CODING GENE#0.6787;CALMODULIN BINDING#0.6785;PHOSPHOLIPASE A#0.6784;DNA DAMAGE BINDING#0.6782;MULTIPLE SCLEROSIS#0.6781;CROSS SECTIONAL AREA#0.6780;PILOCYTIC ASTROCYTOMA#0.6776;INSULIN RECEPTOR SUBSTRATE#0.6769;PLASMACYTOMA#0.6766;NASAL MUCOSA#0.6766;ELECTRON TRANSPORT#0.6765;FATTY ACID BINDING#0.6764;RESONANCE ENERGY TRANSFER#0.6764;COPY NUMBER VARIATION#0.6762;NEUROTOXIC#0.6752;RESPONSE TO DRUG#0.6749;PRIMARY BREAST TUMORS#0.6745;PROTEIN FOLDING#0.6739;ANDRO#0.6738;MITOCHONDRIAL LOCALIZATION#0.6730;MICROTUBULE ASSEMBLY#0.6725;MIDDLE CEREBRAL ARTERY#0.6720;ESTROGEN RESPONSE ELEMENT#0.6718;CEREBRAL ARTERY#0.6717;MITOCHONDRIAL FISSION#0.6716;SPERMIDINE#0.6711;NEVUS#0.6709;GENE REGULATORY NETWORK#0.6706;RENAL CELL CANCER#0.6706;CORTICAL CELL#0.6702;INDUCES CANCER#0.6699;TOCOPHEROL#0.6690;TYPE II PNEUMOCYTE#0.6684;CYTOTROPHOBLAST#0.6684;DOWN SYNDROME#0.6683;SYNCYTIOTROPHOBLAST#0.6678;MALE INFERTILITY#0.6672;DUCHENNE MUSCULAR DYSTROPHY#0.6670;LICHEN PLANUS#0.6668;COLUMNAR#0.6662;CELL SURFACE ANTIGEN#0.6661;LUMINAL EPITHELIAL CELL#0.6646;PORTAL VEIN#0.6644;COLON ADENOMA#0.6639;HEARING LOSS#0.6638;TYPE 1 DIABETES#0.6618;FILOPODIA FORMATION#0.6617;INNATE IMMUNITY#0.6617;ZEBULARINE#0.6616;K-252A#0.6613;GASTRULATION#0.6613;SCF COMPLEX#0.6605;REGULATION OF TELOMERASE ACTIVITY#0.6594;CELL DEDIFFERENTIATION#0.6587;RESPONSE TO PACLITAXEL#0.6583;VIRAL TRANSCRIPTION#0.6583;PRE-MRNA SPLICING#0.6582;TIME TO RECURRENCE#0.6576;PTERYGIUM#0.6576;RETINOL#0.6575;REPRODUCTIVE SYSTEM#0.6575;S-ADENOSYLMETHIONINE#0.6575;PROLIFERATIVE GLOMERULONEPHRITIS#0.6572;MAXIMUM TOLERATED DOSE#0.6570;BELINOSTAT#0.6568;ACID PHOSPHATASE#0.6567;HYPERGLYCEMIC#0.6559;PROSTATIC INTRAEPITHELIAL NEOPLASIA#0.6552;ACE INHIBITOR#0.6547;MRNA BINDING#0.6547;NOTCH LIGAND#0.6545;COAGULATION#0.6545;VASCULAR ENDOTHELIUM#0.6542;DNA FRAGMENTATION FACTOR#0.6540;CORNEAL EPITHELIUM#0.6536;DOPAMINE#0.6534;NURD COMPLEX#0.6530;B CELL PROLIFERATION#0.6530;RESPONSE TO PLATINUM#0.6523;TUMOR ASSOCIATED ANTIGEN#0.6512;LINEAR ENERGY TRANSFER#0.6509;MAGNETIC RESONANCE IMAGING#0.6507;CELLULAR MEMBRANE#0.6506;EXCRETION#0.6503;ZD1694#0.6498;ACTOMYOSIN#0.6495;GENETIC DISEASE#0.6493;APOPTOTIC DNA FRAGMENTATION#0.6493;CASPASE-8 ACTIVITY#0.6491;MUSCULAR ATROPHY#0.6487;CELL ASSOCIATED#0.6485;TERATOCARCINOMA#0.6480;HIGH RISK NEUROBLASTOMA#0.6476;CASPASE-INDEPENDENT CELL DEATH#0.6476;LIPOGENESIS#0.6475;IMMUNOGLOBULIN G#0.6473;INHIBITION OF CELL MIGRATION#0.6473;ATP BINDING CASSETTE#0.6469;MYELOID CELL LINES#0.6468;CERVICAL SQUAMOUS CELL CARCINOMA#0.6466;FTASE ACTIVITY#0.6466;R115777#0.6464;NUCLEOCYTOPLASMIC SHUTTLING#0.6455;4-HYDROXYTAMOXIFEN#0.6448;STEROID RECEPTOR COACTIVATOR#0.6446;CANCER TESTIS ANTIGEN#0.6443;INTEGRIN LINKED KINASE#0.6440;NEOPLASTIC TISSUES#0.6435;ISOQUINOLINE#0.6433;PERIPHERAL T-CELL LYMPHOMA#0.6433;XENOBIOTIC METABOLISM#0.6431;ORAL PREMALIGNANT LESIONS#0.6430;COLLAGEN TYPE IV#0.6429;CELL PENETRATING PEPTIDE#0.6428;PRIMORDIAL GERM CELL#0.6426;DESFERRIOXAMINE#0.6423;AMPK ACTIVITY#0.6421;DNA POLYMERASE BETA#0.6418;GASTRIC TISSUE#0.6417;ANDROGEN DEPRIVATION THERAPY#0.6412;DNA COPY NUMBER#0.6410;CORTISOL#0.6408;OTHER ORGANISM#0.6406;CYCLOPHILIN#0.6405;BONE DEVELOPMENT#0.6404;CLEFT PALATE#0.6402;DUCT CELL#0.6401;CELL MOVEMENT#0.6401;DORSAL ROOT GANGLION#0.6398;WHITE ADIPOSE TISSUE#0.6398;TREG CELL#0.6396;FORESKIN KERATINOCYTES#0.6395;LYMPHATIC VESSEL#0.6391;INOSINE#0.6390;NUCLEAR MEMBRANE#0.6387;PROTEINURIA#0.6383;CALCIUM SIGNALING#0.6377;EMBRYO DEVELOPMENT#0.6376;MONOCYTE CHEMOTACTIC PROTEIN#0.6375;TRADITIONAL CHINESE MEDICINAL#0.6371;FOLIC ACID#0.6369;UROTHELIAL CELL CARCINOMA#0.6362;LDL RECEPTOR#0.6355;TERATOGEN#0.6353;RECEPTOR COMPLEX#0.6351;REGULATION OF PHOSPHORYLATION#0.6344;POSITRON EMISSION TOMOGRAPHY#0.6336;TRANSCRIPTION COFACTOR#0.6331;URIDINE#0.6330;NMDA RECEPTOR#0.6330;FURAN#0.6321;NEUROFILAMENT#0.6320;ZOLEDRONIC ACID#0.6319;PRIMARY EPITHELIAL CELLS#0.6312;HUMAN LENS EPITHELIAL#0.6302;BMP SIGNALING PATHWAY#0.6299;CETRORELIX#0.6299;BIRTH DEFECT#0.6296;ETHANE#0.6294;BENIGN PROSTATE HYPERPLASIA#0.6290;MULTIPOTENT STEM CELL#0.6284;NEURITE FORMATION#0.6281;GROWTH ARREST SPECIFIC#0.6276;THYMIC CARCINOMA#0.6273;LOW GRADE GLIOMAS#0.6273;PULMONARY VASCULAR REMODELING#0.6273;VIRAL LIFE CYCLE#0.6268;BETA-ESTRADIOL#0.6268;INTERNATIONAL PROGNOSTIC INDEX#0.6265;PROTEIN DEPHOSPHORYLATION#0.6264;ANAPLASTIC CARCINOMA#0.6260;HYPOXANTHINE#0.6259;ADRENOCORTICAL CARCINOMA#0.6259;NEUROPATHY#0.6256;DAUNOMYCIN#0.6256;HUMAN INTESTINAL EPITHELIAL#0.6256;DNA AMPLIFICATION#0.6255;DEUBIQUITINATING ENZYME#0.6249;MUCOEPIDERMOID CARCINOMA#0.6245;DOUBLE TRANSGENIC MICE#0.6239;PROTEIN LOCALIZATION#0.6235;ATP SYNTHESIS#0.6232;OPIOID RECEPTOR#0.6229;COLONY-FORMING CELL#0.6228;BONE GROWTH#0.6223;COMBINED TREATMENT GROUP#0.6220;MGI-114#0.6219;MITOXANTRONE#0.6219;PITAVASTATIN#0.6211;DEXTRAN SULFATE SODIUM#0.6209;C-TERMINAL BINDING#0.6208;MONOCYTE DERIVED MACROPHAGE#0.6200;VINORELBINE#0.6197;NUCLEOCAPSID#0.6195;IL-6 PRODUCTION#0.6192;GLCNAC#0.6191;ACTIN BINDING#0.6188;HUMAN PULMONARY ARTERY#0.6187;EXTRAHEPATIC BILE DUCT CARCINOMA#0.6186;GREEN TEA CATECHIN#0.6185;SEPTUM#0.6175;NITRO-L-ARGININE#0.6170;WERNER SYNDROME#0.6163;PHENOXODIOL#0.6162;CEREBRAL ARTERY OCCLUSION#0.6160;PROTEIN ACETYLATION#0.6159;MENSTRUAL CYCLE#0.6157;OSTEOBLAST PROLIFERATION#0.6154;SPERMATOGENIC CELLS#0.6150;SWI-SNF COMPLEX#0.6149;IN STENT RESTENOSIS#0.6135;DNA POLYMERASE ALPHA#0.6135;IMIPRAMINE#0.6132;CALYCULIN A#0.6130;GERMINAL VESICLE#0.6129;ANESTHETIC#0.6126;VEGF PRODUCTION#0.6126;DENTAL PULP CELL#0.6126;ABC TRANSPORTER#0.6125;CARNITINE#0.6124;TERBINAFINE#0.6111;DIFFUSE ALVEOLAR DAMAGE#0.6106;MULTIPLE ENDOCRINE NEOPLASIA TYPE 1#0.6102;HISTONE LYSINE METHYLATION#0.6102;MYOCYTE PROLIFERATION#0.6098;CANCER ASSOCIATED FIBROBLASTS#0.6097;TRANSMISSION ELECTRON MICROSCOPE#0.6089;CELL BODY#0.6088;MYELOBLAST#0.6086;SUBSTANCE P#0.6080;RB-E2F COMPLEX#0.6077;MULTIDRUG RESISTANCE PROTEIN#0.6075;MUSCLE WASTING#0.6071;YOLK SAC#0.6064;PHOSPHOLIPASE D#0.6062;C-LEVEL#0.6048;MITOCHONDRIA MEMBRANE POTENTIAL#0.6047;GLUCOSE INTOLERANCE#0.6045;DNA DEMETHYLASE ACTIVITY#0.6044;BONE DISEASE#0.6044;MEDIAN OVERALL SURVIVAL#0.6044;RECEPTOR ACTIVITY#0.6041;APC ACTIVATION#0.6033;EXTRAMEDULLARY PLASMACYTOMA#0.6032;PEUTZ-JEGHERS SYNDROME#0.6028;DECIDUA#0.6024;ATPASE ACTIVITY#0.6022;UBIQUITIN-DEPENDENT PROTEOLYSIS#0.6019;PODOCYTE APOPTOSIS#0.6016;MSC PROLIFERATION#0.6014;CHOLESTEROL BIOSYNTHETIC#0.6005;FOLLICULAR THYROID CANCER#0.6004;CORONARY ARTERY DISEASE#0.6001
10270	ANCHORING#1.0632;PROTEIN KINASE#1.0276;PROTEIN KINASE A#1.0186;NUCLEAR MATRIX#1.0056;CELL CYCLE#0.9970;MITOSIS#0.9740;LUNG CANCER#0.9093;INTERPHASE#0.8677;CHROMOSOME CONDENSATION#0.7869;BREAST CANCER#0.7750;LYMPH NODE METASTASIS#0.7529;LYMPH NODE#0.7486;METAPHASE#0.7375;CONDENSIN COMPLEX#0.6722;PKA BINDING#0.6648;ESOPHAGEAL CANCER#0.6188;DNA REPLICATION#0.6136
102723099	CANCER CELL#1.1145;CELL PROLIFERATION#1.1141;CELL CYCLE#1.0071;EPITHELIAL MESENCHYMAL TRANSITION#0.9700;APOPTOSIS#0.9471;LYMPH NODE#0.9445;SIGNALING PATHWAY#0.8821;LYMPH NODE METASTASIS#0.8674;CERVICAL CANCER#0.8147;BREAST CANCER#0.8026;G1 PHASE#0.7321;CELL CYCLE ARREST#0.7297;ADJACENT NORMAL TISSUE#0.7262;POLYMERASE CHAIN REACTION#0.6400;BREAST CANCER CELL#0.6379;HEPATOCELLULAR CARCINOMA#0.6375;COLORECTAL CANCER#0.6373;CELL GROWTH#0.6354;ONCOGENIC#0.6317;CERVICAL#0.6166
102723100	OTOSCLEROSIS#0.6880
102723356	ANTISENSE RNA#0.7972;RENAL CELL CANCER#0.6826;APOPTOSIS#0.6815;GASTRIC TISSUE#0.6808;TUMOR TISSUES#0.6653;CANCER CELL#0.6537
102723508	INTERNAL SPHINCTER#1.0746;SPHINCTER OF ODDI#1.0517;METHYLERGOMETRINE#1.0490;DOBUTAMINE STRESS ECHOCARDIOGRAPHY#1.0486;ERGOMETRINE#1.0395;PRINZMETAL ANGINA#1.0393;SUCCINYLCHOLINE#1.0370;MASSETER#1.0364;CERVICAL DYSTONIA#1.0352;TRIGEMINAL NEURALGIA#1.0346;BELL'S PALSY#1.0337;ACOUSTIC NEUROMA#1.0324;NEURALGIA#1.0315;MODIFIED ASHWORTH SCALE#1.0315;SUXAMETHONIUM#1.0312;MITRAL VALVE PROLAPSE#1.0285;ARACHNOID CYST#1.0277;BLEPHAROSPASM#1.0268;VERTIGO#1.0257;ACHALASIA#1.0234;CORONARY THROMBOSIS#1.0230;BTX-A#1.0215;ERGOTAMINE#1.0206;HEPATIC ARTERY#1.0205;DOBUTAMINE#1.0199;MYOCARDIAL STUNNING#1.0194;FOCAL DYSTONIA#1.0192;TINNITUS#1.0187;FACIAL PARALYSIS#1.0180;SCLERODERMA#1.0180;NIMODIPINE#1.0166;HYPERHIDROSIS#1.0152;HAMSTRING#1.0150;ERGONOVINE#1.0144;THYROTOXICOSIS#1.0135;IMPLANTABLE CARDIOVERTER DEFIBRILLATOR#1.0131;RENAL ARTERY#1.0125;BONT/A#1.0111;CONVULSION#1.0092;NICARDIPINE#1.0090;MITRAL VALVE#1.0089;NITROGLYCERINE#1.0080;OPHTHALMIC ARTERY#1.0074;EMBOLISM#1.0073;OESOPHAGUS#1.0069;BILE DUCT#1.0068;ALLERGIC REACTION#1.0063;HYPERACTIVE#1.0054;RAYNAUD’S#1.0048;BOTOX#1.0046;BOTULINUM TOXIN A#1.0037;AORTIC VALVE#1.0030;PULMONARY EDEMA#1.0028;FACIAL NUCLEUS#1.0026;DYSTONIA#1.0025;MALIGNANT HYPERTHERMIA#1.0008;CORONARY ARTERY#0.9997;KINASE INHIBITOR#0.9997;DYSKINESIA#0.9995;LOW BACK PAIN#0.9993;ESOPHAGUS#0.9991;IRRITATION#0.9989;PAPAVERINE#0.9984;TUBEROUS SCLEROSIS#0.9983;EYELID#0.9983;PLATELET ACTIVATION#0.9981;ARTERIOVENOUS MALFORMATION#0.9980;MAGNETIC RESONANCE ANGIOGRAPHY#0.9979;DOXORUBICIN#0.9977;DIAZEPAM#0.9976;BOTULINUM TOXIN TYPE A#0.9975;BASILAR ARTERY#0.9975;THROMBOSIS#0.9975;MYOCARDITIS#0.9974;ENDOTHELIAL NITRIC OXIDE#0.9972;DIZZINESS#0.9971;ESOTROPIA#0.9969;HYPERACTIVITY#0.9968;CONSTIPATION#0.9967;AORTIC VALVE REPLACEMENT#0.9966;HYDROCEPHALUS#0.9965;PERISTALSIS#0.9965;CORONARY FLOW RESERVE#0.9964;HISTAMINE#0.9964;ARTERIOLE#0.9959;CARDIAC ARREST#0.9954;MAST CELL#0.9953;ADRENOCORTICOTROPIC HORMONE#0.9952;ESOPHAGITIS#0.9952;SYNCOPE#0.9948;NEUROPATHY#0.9947;HYPOXIA#0.9946;VERTEBRAL ARTERY#0.9937;ANAPHYLAXIS#0.9937;LOSS OF CONSCIOUSNESS#0.9937;METHYLERGONOVINE#0.9935;RANGE OF MOTION#0.9934;DIARRHEA#0.9929;CEREBRAL PALSY#0.9929;VIGABATRIN#0.9927;CORONARY STENOSIS#0.9926;SKELETAL MUSCLE#0.9924;CHRONIC PELVIC PAIN#0.9922;INDOMETHACIN#0.9921;POLIOMYELITIS#0.9920;OPTICAL COHERENCE TOMOGRAPHY#0.9917;GLYCERYL TRINITRATE#0.9917;ARTERY#0.9915;GASTROESOPHAGEAL REFLUX DISEASE#0.9914;VOMITING#0.9912;ATRIOVENTRICULAR BLOCK#0.9898;NEUROMA#0.9896;NUMBNESS#0.9895;ISOSORBIDE DINITRATE#0.9893;ANAPHYLACTIC#0.9892;HYOSCINE#0.9887;NITRIC OXIDE SYNTHASE#0.9882;BACLOFEN#0.9881;DIAGNOSTIC CORONARY ANGIOGRAPHY#0.9881;HYPERTHERMIA#0.9878;SWELLING#0.9877;FLUOROURACIL#0.9876;5 FLUOROURACIL#0.9875;MUSCLE WEAKNESS#0.9875;NARCOTIC#0.9874;INTERNAL CAROTID ARTERY#0.9872;CORONARY MICROVASCULAR DYSFUNCTION#0.9869;CORONARY ARTERY STENOSIS#0.9869;SUBSTANCE P#0.9868;VISUAL ANALOGUE SCALE#0.9863;EDEMA#0.9862;SEVERE PAIN#0.9862;BRADYCARDIA#0.9857;PARALYSIS#0.9856;WEST SYNDROME#0.9855;LEVATOR ANI#0.9854;ACETYLCHOLINE#0.9852;HYPERTROPHIC CARDIOMYOPATHY#0.9851;ISCHEMIC HEART DISEASE#0.9843;INTRACRANIAL ANEURYSM#0.9843;GALLBLADDER#0.9842;SUDDEN CARDIAC DEATH#0.9841;SCOLIOSIS#0.9840;CONNECTIVE TISSUE#0.9838;SUBARACHNOID SPACE#0.9835;TRANSPOSITION#0.9834;PLATELET AGGREGATION#0.9831;NIFEDIPINE#0.9828;PANCREATITIS#0.9828;NITROGLYCERIN#0.9826;PARKINSON'S DISEASE#0.9820;SMOOTH MUSCLE CONTRACTION#0.9819;ATRIAL FIBRILLATION#0.9819;COAGULATION#0.9818;SODIUM NITROPRUSSIDE#0.9816;ARRHYTHMIA#0.9816;FENTANYL#0.9815;BILIARY TRACT#0.9814;CORONARY ARTERY VASOSPASM#0.9812;MUSCLE CONTRACTION#0.9811;CERVICAL#0.9808;CEREBRAL INFARCTION#0.9807;EPINEPHRINE#0.9806;ANGINAL#0.9804;TRACHEA#0.9804;VASOMOTION#0.9803;ATHEROSCLEROSIS#0.9797;MIGRAINE#0.9796;MULTIPLE SCLEROSIS#0.9794;TOPICAL#0.9792;DYSPNEA#0.9791;ADRENERGIC RECEPTOR#0.9791;PROSTACYCLIN#0.9791;LARYNX#0.9783;VASODILATION#0.9783;DILTIAZEM#0.9783;PEDICLE#0.9782;BLOOD VESSEL#0.9782;AGE AT ONSET#0.9781;CEREBRAL ARTERY#0.9780;HEARING LOSS#0.9780;GASTRO#0.9777;DANTROLENE#0.9775;ATHEROSCLEROTIC#0.9775;DIPLOPIA#0.9774;PARESTHESIA#0.9772;MIDDLE CEREBRAL ARTERY#0.9770;CEREBRAL ISCHEMIA#0.9769;CORONARY ARTERY BYPASS#0.9768;PROPRANOLOL#0.9767;LEFT ANTERIOR DESCENDING#0.9766;METHACHOLINE#0.9766;CONSTRICTION#0.9766;VISUAL ANALOG SCALE#0.9762;CORONARY HEART DISEASE#0.9762;PROPOFOL#0.9761;VASODILATATION#0.9760;BLOOD CLOT#0.9757;NEUROLOGICAL DISORDER#0.9756;HALOTHANE#0.9755;LIDOCAINE#0.9754;STIFF PERSON SYNDROME#0.9754;EPILEPSY#0.9753;VASOPRESSIN#0.9752;MENTAL RETARDATION#0.9752;VASCULITIS#0.9748;VERAPAMIL#0.9745;SEDATION#0.9744;CAROTID ARTERY#0.9743;RECEPTOR ANTAGONIST#0.9738;VASCULAR SMOOTH MUSCLE CELL#0.9736;NITROPRUSSIDE#0.9735;INTRACRANIAL HYPERTENSION#0.9734;HYPERTHYROIDISM#0.9734;HYPOTENSION#0.9733;BLOOD BRAIN BARRIER#0.9732;HEART RATE VARIABILITY#0.9732;ISCHEMIA#0.9731;ASPIRIN#0.9731;CARDIOMYOPATHY#0.9728;BUPIVACAINE#0.9726;VASCULAR DISEASE#0.9726;ACUTE MYOCARDIAL INFARCTION#0.9724;PTOSIS#0.9722;TACHYCARDIA#0.9721;LUMINAL#0.9721;ADENOSINE#0.9720;ABDOMINAL PAIN#0.9719;HYPERSENSITIVITY#0.9718;NORADRENALINE#0.9713;SMOOTH MUSCLE#0.9710;NEUROTOXIN#0.9709;FOREARM#0.9709;HEART DISEASE#0.9703;VASODILATOR#0.9702;ACUTE CORONARY SYNDROME#0.9700;CONGESTIVE HEART FAILURE#0.9698;ANAESTHETIC#0.9695;MYOCARDIAL INFARCTION#0.9694;SPINAL CORD INJURY#0.9694;ATROPINE#0.9694;DIABETES MELLITUS#0.9694;ARACHIDONIC ACID#0.9694;NITRIC OXIDE#0.9693;CAROTID SINUS#0.9692;DIPYRIDAMOLE#0.9686;VASOCONSTRICTOR#0.9686;BLOOD CIRCULATION#0.9684;HEPARIN#0.9683;RESPIRATION#0.9682;FRONTAL#0.9681;CARBAMAZEPINE#0.9678;HYPERTENSION#0.9678;HYPOTENSIVE#0.9678;HEMORRHAGE#0.9676;VASOCONSTRICTION#0.9670;CALCIUM CHANNEL#0.9670;PREDNISOLONE#0.9670;NERVE FIBER#0.9668;INCONTINENCE#0.9665;ISOPROTERENOL#0.9663;ENDOTHELIAL CELL#0.9660;ACTION POTENTIAL#0.9659;MECHANISM OF ACTION#0.9658;PHENTOLAMINE#0.9653;INNERVATION#0.9648;MESENTERIC ARTERY#0.9646;ADVENTITIA#0.9643;MYOCARDIUM#0.9642;SPINAL CORD#0.9638;POTASSIUM CHLORIDE#0.9637;NERVOUS SYSTEM#0.9635;MOTOR ACTIVITY#0.9632;ANESTHETIC#0.9631;POLYMORPHIC VENTRICULAR TACHYCARDIA#0.9629;INFLAMMATORY RESPONSE#0.9626;PERCUTANEOUS CORONARY INTERVENTION#0.9625;SMOOTH MUSCLE CELL#0.9622;TOXICITY#0.9622;ESOPHAGEAL DISEASE#0.9621;MUSCLE CELL#0.9620;SUDDEN CARDIAC ARREST#0.9619;CORONARY ARTERY DISEASE#0.9614;DRUG ELUTING STENT#0.9614;MYOFASCIAL PAIN SYNDROME#0.9613;ENDOTHELIUM#0.9611;EMISSION COMPUTED TOMOGRAPHY#0.9606;ARTERY DISEASE#0.9606;PERIPHERAL NERVE#0.9603;UTERUS#0.9602;RANDOMIZED CONTROLLED TRIAL#0.9599;ASPHYXIA#0.9597;DOPAMINE#0.9596;VASCULAR ENDOTHELIUM#0.9593;PARALYTIC#0.9592;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9592;ARTERIOSCLEROSIS#0.9591;PHENOXYBENZAMINE#0.9590;PERIPHERAL VASCULAR DISEASE#0.9586;RESPIRATORY FAILURE#0.9586;HEMORRHAGIC#0.9584;COMPARTMENT SYNDROME#0.9576;CENTRAL NERVOUS SYSTEM#0.9569;COMMUNICATING ARTERY#0.9569;PNEUMONIA#0.9567;PROTEIN KINASE#0.9564;CREATINE#0.9561;RHEUMATOID ARTHRITIS#0.9556;STRUCTURAL HEART DISEASE#0.9548;IRRITABLE BOWEL SYNDROME#0.9545;C REACTIVE PROTEIN#0.9541;ERYTHROCYTE#0.9540;INTENSIVE CARE UNIT#0.9537;L-ARGININE#0.9530;MOTOR EVOKED POTENTIAL#0.9529;REGENERATION#0.9527;NOREPINEPHRINE#0.9525;PHENYLEPHRINE#0.9524;MAGNETIC RESONANCE IMAGING#0.9522;ANTI INFLAMMATORY DRUGS#0.9521;BASAL GANGLIA#0.9519;HEARING IMPAIRMENT#0.9519;ETHANOL#0.9518;CREATINE KINASE#0.9517;RESPONSE TO TREATMENT#0.9508;HYPOXIC#0.9507;SCALP#0.9497;MULTIPLE LOGISTIC REGRESSION#0.9492;AMINOPHYLLINE#0.9475;ALOPECIA#0.9473;SYSTOLIC BLOOD PRESSURE#0.9471;CARDIOVASCULAR SYSTEM#0.9468;LEUKOCYTE#0.9465;LARGE ARTERIES#0.9464;ARGININE#0.9464;GASTROINTESTINAL TRACT#0.9461;URINARY TRACT INFECTION#0.9459;RECEPTOR AGONIST#0.9457;SENSORINEURAL HEARING LOSS#0.9443;URETER#0.9438;URETHRA#0.9430;POSITRON EMISSION TOMOGRAPHY#0.9421;METHYSERGIDE#0.9420;STATUS EPILEPTICUS#0.9420;ADRENALINE#0.9418;ESSENTIAL HYPERTENSION#0.9417;72-HOURS#0.9415;NALOXONE#0.9414;TOPIRAMATE#0.9409;LIPOMA#0.9398;PENTAGASTRIN#0.9392;BRAIN DAMAGE#0.9385;HEMIPLEGIA#0.9361;POTASSIUM CHANNEL#0.9359;VENULE#0.9357;RED BLOOD CELL#0.9343;DUODENUM#0.9338;SALBUTAMOL#0.9337;CLONAZEPAM#0.9337;MEDULLA OBLONGATA#0.9335;MYOCARDIAL PERFUSION SCINTIGRAPHY#0.9334;TRANSCRANIAL MAGNETIC STIMULATION#0.9333;ANAL CANAL#0.9332;NERVE DAMAGE#0.9315;INFLAMMATORY CELL#0.9308;CARDIOVASCULAR RISK FACTOR#0.9306;PROTEIN KINASE C#0.9296;MIDDLE EAR#0.9293;HEMOSTASIS#0.9291;PROTON PUMP#0.9284;CELL MEMBRANE#0.9269;CAFFEINE#0.9268;PULMONARY HYPERTENSION#0.9255;CROSS SECTIONAL AREA#0.9253;SCIATIC NERVE#0.9250;INFERIOR MYOCARDIAL INFARCTION#0.9249;ACUTE PANCREATITIS#0.9231;MECHANISMS OF ACTION#0.9229;ESSENTIAL TREMOR#0.9227;PARAPLEGIA#0.9224;CORONARY ARTERY LESIONS#0.9224;SIGNALING PATHWAY#0.9224;BRUGADA SYNDROME#0.9223;RESPONSE TO ACETYLCHOLINE#0.9221;CARISOPRODOL#0.9220;LIMB ISCHEMIA#0.9206;APOPTOSIS#0.9198;COMMON CAROTID ARTERY#0.9197;DURA MATER#0.9197;SMALL INTESTINE#0.9194;PROTON PUMP INHIBITOR#0.9191;NECROTIC#0.9187;BRUXISM#0.9177;FIBROMYALGIA#0.9176;SENSITIZATION#0.9174;TRAPEZIUS#0.9173;URINARY BLADDER#0.9157;TETRAETHYLAMMONIUM#0.9157;ADENOSINE TRIPHOSPHATE#0.9153;HEMATURIA#0.9153;FACTOR I#0.9152;TEMPORAL BONE#0.9151;HIGH RISK PATIENTS#0.9150;LOW DENSITY LIPOPROTEIN#0.9148;PULMONARY ARTERY#0.9137;AIRWAY SMOOTH MUSCLE#0.9124;HYPERCHOLESTEROLEMIA#0.9123;MENINGITIS#0.9116;PERIPHERAL BLOOD#0.9113;WHITE BLOOD CELL#0.9109;QUANTITATIVE CORONARY ANGIOGRAPHY#0.9106;PARENTERAL#0.9103;GABAPENTIN#0.9080;COCAINE ABUSE#0.9062;DIAPHRAGM#0.9055;PALPITATION#0.9047;RANDOMIZED CLINICAL TRIAL#0.9038;TUBEROUS SCLEROSIS COMPLEX#0.9035;NEUROMUSCULAR JUNCTION#0.9021;CYSTIC DUCT#0.9012;VOCAL FOLD#0.9005;RANDOMISED CONTROLLED TRIAL#0.9004;STABLE ANGINA PECTORIS#0.9002;BLINDNESS#0.9002;DROWSINESS#0.8998;COUGHING#0.8998;PHOSPHODIESTERASE#0.8998;BLURRED VISION#0.8995;PHEOCHROMOCYTOMA#0.8989;ENDOTHELIUM-DERIVED RELAXING FACTOR#0.8987;MUCOUS#0.8976;LYSIS#0.8974;RESPIRATORY TRACT#0.8966;JOINT PAIN#0.8964;SUBCLAVIAN ARTERY#0.8947;MIDAZOLAM#0.8939;IN STENT RESTENOSIS#0.8927;RECURRENT LARYNGEAL NERVE#0.8918;AMLODIPINE#0.8915;PROSTAGLANDIN E2#0.8904;LENNOX-GASTAUT SYNDROME#0.8900;SLEEP APNEA#0.8893;ECLAMPSIA#0.8878;DELAYED CEREBRAL ISCHEMIA#0.8868;POLYMERASE CHAIN REACTION#0.8867;EXCRETION#0.8859;RESPONSE TO EXERCISE#0.8851;ILIAC ARTERY#0.8839;TIZANIDINE#0.8836;PHARYNX#0.8833;WEIGHT LOSS#0.8826;SEPTUM#0.8822;THEOPHYLLINE#0.8816;GROWTH FACTOR#0.8816;HYPERKINETIC#0.8816;RESPIRATORY DISTRESS#0.8815;FLUSHING#0.8809;CLONIDINE#0.8801;PROSTAGLANDIN E1#0.8799;MAGNESIUM SULFATE#0.8798;FIBROMUSCULAR DYSPLASIA#0.8755;DILATED CARDIOMYOPATHY#0.8738;MODE OF ACTION#0.8727;ANGIOTENSIN CONVERTING ENZYME#0.8725;ARTERIAL SYSTEM#0.8721;BRONCHITIS#0.8711;PULMONARY EMBOLISM#0.8707;WOUND HEALING#0.8698;NEUTROPHIL#0.8694;PYLORIC STENOSIS#0.8681;SALIVATION#0.8679;CLOTTING#0.8675;DEVELOPMENTAL DELAY#0.8662;STREPTOKINASE#0.8654;DUCTUS ARTERIOSUS#0.8648;SEVOFLURANE#0.8647;MUSCLE FIBER#0.8646;CEREBRAL CORTEX#0.8645;INSOMNIA#0.8641;OPTIC NERVE#0.8634;BOTULINUM TOXIN TYPE B#0.8632;CARDIAC MAGNETIC RESONANCE#0.8616;EDROPHONIUM#0.8615;SERIOUS ADVERSE EVENT#0.8595;ISOFLURANE#0.8584;CARRIE#0.8577;ANEMIA#0.8561;POSITIVE PREDICTIVE VALUE#0.8560;LUNG CANCER#0.8558;PLATELET ACTIVATING FACTOR#0.8554;OXYBUTYNIN#0.8553;BLOOD LOSS#0.8549;PREDNISONE#0.8530;CORONARY FLOW VELOCITY#0.8529;TISSUE DAMAGE#0.8526;SHORTNESS OF BREATH#0.8521;DEFECATION#0.8521;COLORECTAL#0.8520;HIGH DENSITY LIPOPROTEIN#0.8516;METABOLIC ACIDOSIS#0.8515;CERVIX#0.8509;APHASIA#0.8506;GLASGOW COMA SCALE#0.8500;COLITIS#0.8475;NEGATIVE PREDICTIVE VALUE#0.8470;BASAL CISTERN#0.8468;CHAGAS DISEASE#0.8468;MAGNESIUM DEFICIENCY#0.8457;BRACHIAL PLEXUS#0.8451;PNEUMOTHORAX#0.8450;OSTEOARTHRITIS#0.8447;STRIATED MUSCLE#0.8446;INTRACTABLE EPILEPSY#0.8432;ACUTE MYOCARDITIS#0.8430;VENOUS BLOOD#0.8426;NERVE TRUNK#0.8424;NEOSTIGMINE#0.8421;LEVETIRACETAM#0.8416;IRRITABILITY#0.8416;DANTROLENE SODIUM#0.8410;MASTICATION#0.8410;PARACETAMOL#0.8402;TRANSIENT ISCHEMIC ATTACK#0.8394;REMIFENTANIL#0.8382;CYCLIC AMP#0.8375;PERIPHERAL ARTERIAL DISEASE#0.8369;GLOMERULAR FILTRATION#0.8365;CARDIOMYOCYTE#0.8363;ASTIGMATISM#0.8360;HERPES ZOSTER#0.8357;ASPIRATION PNEUMONIA#0.8346;CONNECTIVE TISSUE DISEASE#0.8339;CEREBROVASCULAR DISEASE#0.8310;VITAMIN E#0.8298;MIDLINE#0.8277;INTERVERTEBRAL DISC#0.8264;ISOPRENALINE#0.8262;MILRINONE#0.8260;CARDIAC TAMPONADE#0.8252;SEXUAL DYSFUNCTION#0.8241;BETA ADRENOCEPTOR#0.8240;DIHYDROERGOTAMINE#0.8239;SPINAL CORD INJURED#0.8237;ORPHENADRINE#0.8234;MACROPHAGE#0.8217;ALLERGEN#0.8209;CARBACHOL#0.8204;METAIODOBENZYLGUANIDINE#0.8200;ADVERSE DRUG REACTION#0.8200;GASTRIC ULCER#0.8192;CARDIAC SYNDROME X#0.8171;MOYAMOYA DISEASE#0.8153;ALPHA ADRENOCEPTOR#0.8149;QUADRICEPS#0.8143;SPASTIC CEREBRAL PALSY#0.8142;TENSION TYPE HEADACHE#0.8124;BETA-2#0.8114;URTICARIA#0.8109;FIBRINOLYSIS#0.8108;RADICULOPATHY#0.8107;MUSCLE HYPERTROPHY#0.8096;ILOPROST#0.8095;CRAMPING#0.8083;PILOCARPINE#0.8083;NEUROMUSCULAR DISEASE#0.8074;DYSPEPSIA#0.8071;GLUTAMIC ACID#0.8070;PARENCHYMA#0.8053;HYPOKALEMIA#0.8051;TRADITIONAL CHINESE MEDICINE#0.8036;MYASTHENIA GRAVIS#0.8033;AUDITORY BRAINSTEM RESPONSE#0.8031;GASTRIC EMPTYING#0.8028;GESTATION#0.8020;NEUROMYELITIS OPTICA#0.8015;IPRATROPIUM BROMIDE#0.8013;UPPER MOTOR NEURON#0.8012;CHOLESTEATOMA#0.8011;LOWER URINARY TRACT#0.8005;AICARDI SYNDROME#0.8004;LYMPH NODE#0.7995;ERYTHROCYTE SEDIMENTATION RATE#0.7991;CIMETIDINE#0.7991;OSTEOPOROSIS#0.7987;PROCAINE#0.7970;SEROTONIN RECEPTOR#0.7967;TETRODOTOXIN#0.7959;DICLOFENAC#0.7947;EOSINOPHIL#0.7944;CAPECITABINE#0.7935;MAGNESIUM SULPHATE#0.7923;HEART MUSCLE#0.7923;KAWASAKI DISEASE#0.7915;PRAZOSIN#0.7912;ERYTHEMA#0.7902;COMPUTED TOMOGRAPHY ANGIOGRAPHY#0.7902;WHEEZING#0.7901;CEREBRAL BLOOD VOLUME#0.7889;LIGNOCAINE#0.7888;THALAMUS#0.7877;FLUORESCEIN#0.7865;VARICOSE VEINS#0.7856;MANDIBLE#0.7852;GINKGO BILOBA#0.7841;BARE METAL STENT#0.7840;MEDIAN NERVE#0.7815;PELVIS#0.7815;PULMONARY VEIN#0.7805;PAROXYSMAL ATRIAL FIBRILLATION#0.7803;OUTFLOW TRACT#0.7775;BRAIN EDEMA#0.7773;NERVE TERMINAL#0.7765;SCANNING ELECTRON MICROSCOPY#0.7759;VECURONIUM#0.7755;BARRETT'S ESOPHAGUS#0.7752;CORONARY ENDOTHELIAL DYSFUNCTION#0.7726;KETAMINE#0.7718;MYOCYTES#0.7698;CHEWING#0.7680;JOINT DISORDER#0.7677;HYDROCORTISONE#0.7669;CORTICOTROPIN#0.7667;HEALTHY CONTROL SUBJECTS#0.7665;LUPUS ERYTHEMATOSUS#0.7665;EOSINOPHILIC ESOPHAGITIS#0.7655;DEXAMETHASONE#0.7641;TEAR SECRETION#0.7638;FALLOPIAN TUBES#0.7630;INTESTINAL OBSTRUCTION#0.7627;DUODENAL ULCER#0.7623;HEMOLYSIS#0.7614;INTENTION TO TREAT#0.7614;VITAMIN D DEFICIENCY#0.7575;VALPROIC ACID#0.7568;LENGTH OF STAY#0.7546;NERVE ENDING#0.7542;EPIGASTRIC ARTERY#0.7521;VERTEBRA#0.7501;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.7496;OTITIS MEDIA#0.7496;OBESE#0.7490;BILIARY DYSKINESIA#0.7486;RESPONSE TO NITROGLYCERIN#0.7479;INCREASED INTRACRANIAL PRESSURE#0.7478;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7478;KIDNEY DISEASE#0.7459;TIMI FRAME COUNT#0.7450;METHYLPREDNISOLONE#0.7449;ADIPOSE TISSUE#0.7449;HEMANGIOMA#0.7447;TUBERCULOSIS#0.7445;FLOW MEDIATED DILATION#0.7421;LUMBAR DISC HERNIATION#0.7417;MEATUS#0.7416;MYOPATHY#0.7403;MUSCLE ATROPHY#0.7394;FIBRINOGEN#0.7391;MYOCARDIAL PERFUSION IMAGING#0.7386;TRAUMATIC BRAIN INJURY#0.7381;CURARE#0.7379;CYSTITIS#0.7377;MIDBRAIN#0.7375;SLEEP DISORDER#0.7375;SPONDYLOLISTHESIS#0.7365;ENZYME INHIBITOR#0.7362;TRADITIONAL RISK FACTORS#0.7357;PURE TONE AUDIOMETRY#0.7355;OPTIMAL MEDICAL THERAPY#0.7343;PENICILLIN#0.7340;DEHYDRATION#0.7328;PERICARDITIS#0.7326;PLASMA MEMBRANE#0.7320;ESOPHAGEAL CANCER#0.7314;DUODENAL PAPILLA#0.7309;VENOUS SYSTEM#0.7309;MULTIPLE REGRESSION ANALYSIS#0.7308;KETOROLAC#0.7305;CHLORPROMAZINE#0.7303;SPINAL CORD INJURIES#0.7296;AS MYOCARDIAL INFARCTION#0.7291;AORTIC ANEURYSM#0.7282;CISPLATIN#0.7281;PHOSPHOLIPASE C#0.7277;LATERAL WALL#0.7275;ASPARTATE#0.7269;BRAIN INFARCTION#0.7267;METHOXAMINE#0.7255;MUSCULAR DYSTROPHY#0.7244;INTERNEURON#0.7207;IPRATROPIUM#0.7206;MUCUS SECRETION#0.7206;RECTUM#0.7205;PANIC DISORDER#0.7205;TEMPOROMANDIBULAR JOINT DISORDER#0.7204;LOWER LEG#0.7199;ALVERINE CITRATE#0.7198;RESERPINE#0.7194;SOMNOLENCE#0.7193;GLIBENCLAMIDE#0.7192;JEJUNUM#0.7185;GUANYLATE CYCLASE#0.7184;MEPERIDINE#0.7175;FENOTEROL#0.7174;MICROCEPHALY#0.7174;UROKINASE#0.7171;THIOPENTAL#0.7168;GENE EXPRESSION#0.7166;INFERTILITY#0.7165;PORTAL VEIN#0.7159;CILIARY BODY#0.7157;MYOSITIS#0.7151;ULCERATIVE COLITIS#0.7151;VITAMIN C#0.7146;MUSCLE DAMAGE#0.7139;THROMBOCYTOPENIA#0.7126;PROSTAGLANDIN SYNTHESIS#0.7124;SELECTIN#0.7116;PECTORALIS MAJOR#0.7115;INCOORDINATION#0.7102;PATENT DUCTUS ARTERIOSUS#0.7100;ASTROCYTOMA#0.7091;OVARIAN#0.7086;TUBOCURARINE#0.7085;SARCOPLASMIC RETICULUM#0.7085;CELL PROLIFERATION#0.7081;VERTEBRAE#0.7080;SULCUS#0.7079;MONOCYTE#0.7073;GLASGOW OUTCOME SCALE#0.7052;TEMPORAL LOBE#0.7038;AGITATION#0.7035;SINUSITIS#0.7032;COLORECTAL CANCER#0.7026;RETINAL DETACHMENT#0.7009;BECK DEPRESSION INVENTORY#0.7002;PROSTATITIS#0.7000;ILEUS#0.6985;LEVOSIMENDAN#0.6981;HIP JOINT#0.6971;RHINITIS#0.6968;PAROTID GLAND#0.6966;HYPOTHYROIDISM#0.6956;CRANIAL NERVE PALSY#0.6953;CEREBRAL HEMORRHAGE#0.6952;ULNAR NERVE#0.6935;AMNESIA#0.6932;ALDOSTERONE#0.6930;FUNCTIONAL INDEPENDENCE MEASURE#0.6929;DEMENTIA#0.6927;PERIPHERAL NERVOUS SYSTEM#0.6915;RESTLESS#0.6896;CONTROLLED CLINICAL TRIALS#0.6888;CAROTID ARTERY STENTING#0.6884;COGNITION#0.6884;APRAXIA#0.6880;APPENDICITIS#0.6866;GASTRITIS#0.6865;FEMORAL VEIN#0.6863;LETHARGY#0.6858;HEAD AND NECK CANCER#0.6856;BRIEF PAIN INVENTORY#0.6856;NECK CANCER#0.6855;TORSADE DE POINTES#0.6852;EPHEDRINE#0.6851;TUMOR NECROSIS FACTOR#0.6847;MITOCHONDRIA#0.6845;ACETIC ACID#0.6844;L-THYROXINE#0.6842;ACUTE HEART FAILURE#0.6842;CARDIAC MUSCLE#0.6838;VASCULAR SMOOTH MUSCLE CONTRACTION#0.6836;ANURIA#0.6824;NITRO-L-ARGININE#0.6822;PRE-ECLAMPSIA#0.6807;BETA ADRENERGIC RECEPTOR#0.6802;ANXIETY DISORDER#0.6789;CELIAC DISEASE#0.6780;MEPYRAMINE#0.6775;METRIZAMIDE#0.6766;CACL2#0.6753;GINKGO BILOBA EXTRACT#0.6752;VIRAL INFECTION#0.6742;PHOTOSENSITIVE EPILEPSY#0.6717;SUMATRIPTAN#0.6714;DEPRESSANT#0.6707;TENDINITIS#0.6699;OXALIPLATIN#0.6696;PHOSPHODIESTERASE INHIBITOR#0.6695;PHENYTOIN#0.6694;ENDOMETRIOSIS#0.6681;T LYMPHOCYTE#0.6680;MARFAN SYNDROME#0.6677;MAST CELL DEGRANULATION#0.6671;COMPLEX REGIONAL PAIN SYNDROME#0.6668;CLEFT LIP#0.6667;ANOREXIA#0.6661;ADENOSINE MONOPHOSPHATE#0.6653;GASTRIC MUCOSA#0.6652;UMBILICAL CORD#0.6645;NEPHROPATHY#0.6619;METHERGINE#0.6598;ANAEMIA#0.6587;CELL DEATH#0.6583;LEVODOPA#0.6579;METHERGIN#0.6577;RIGHT ATRIUM#0.6573;T CELL#0.6568;ACE INHIBITOR#0.6552;4-AMINOPYRIDINE#0.6546;LIPOPROTEIN METABOLISM#0.6530;BICEPS#0.6530;NEUROTRANSMITTER RELEASE#0.6520;DEPRESSIVE SYMPTOMS#0.6518;GRAVES' DISEASE#0.6511;STANDARD OF CARE#0.6504;IBUPROFEN#0.6502;ALLERGAN#0.6497;RESPONSE TO COLD#0.6497;SODIUM CHANNEL#0.6495;BROMOCRIPTINE#0.6490;BREAST CANCER#0.6484;HEART ATTACK#0.6481;LUNG DISEASE#0.6480;L-TYPE CALCIUM CHANNEL#0.6477;WEIGHT GAIN#0.6465;AMAUROSIS#0.6459;SODIUM BICARBONATE#0.6454;RHEUMATIC DISEASE#0.6454;CELL ACTIVATION#0.6447;IODOPHENYL#0.6446;ACETYLSALICYLIC ACID#0.6422;OBSTRUCTIVE SLEEP APNEA#0.6417;IMMUNE RESPONSE#0.6417;EVERY OTHER DAY#0.6412;HEROIN#0.6410;SMOOTH MUSCLE CELL PROLIFERATION#0.6406;RESPONSE TO SEROTONIN#0.6405;MUSCLE CELL PROLIFERATION#0.6404;JUGULAR VEIN#0.6402;HYOSCYAMINE#0.6397;NEURITIS#0.6396;DRY MOUTH#0.6374;VALPROATE#0.6350;SPINAL CORD ISCHEMIA#0.6344;UMBILICAL VEIN#0.6343;URIC ACID#0.6341;TERBUTALINE#0.6336;LACRIMATION#0.6331;INSTITUTIONAL REVIEW BOARD#0.6325;EPILEPSIA PARTIALIS CONTINUA#0.6296;NECROTIZING#0.6273;NEUROGENIC BLADDER#0.6266;LEFT ATRIUM#0.6266;CRUCIATE LIGAMENT#0.6265;RIGHT UPPER QUADRANT#0.6257;TRANSMISSION ELECTRON MICROSCOPY#0.6240;IRRITANT#0.6233;VENA CAVA#0.6230;KNEE JOINT#0.6223;DEHISCENCE#0.6213;CAUDATE NUCLEUS#0.6199;FATALITY#0.6193;SPONDYLOSIS#0.6193;BONE MARROW#0.6190;NAPROXEN#0.6179;HIRSCHSPRUNG'S DISEASE#0.6174;PRESSURE PAIN THRESHOLD#0.6174;EOSINOPHILIA-MYALGIA SYNDROME#0.6170;OBSESSIVE COMPULSIVE DISORDER#0.6163;TIMOLOL#0.6150;QUADRATUS LUMBORUM#0.6143;CONDUCTIVE HEARING LOSS#0.6143;INFERTILE#0.6142;PERIPHERAL ARTERY DISEASE#0.6129;BRAIN ISCHEMIA#0.6123;PERITONITIS#0.6120;MENIERE'S DISEASE#0.6117;DISSEMINATED INTRAVASCULAR COAGULATION#0.6109;ERECTOR SPINAE#0.6094;ALLERGIC RHINITIS#0.6093;BODY SURFACE AREA#0.6083;ZONISAMIDE#0.6080;PAIN DISORDER#0.6079;CHRONIC HEART FAILURE#0.6066;CYCLIC ADENOSINE MONOPHOSPHATE#0.6060;INTELLECTUAL DISABILITY#0.6059;PITRESSIN#0.6057;CORONARY ATHEROSCLEROTIC PLAQUE#0.6051;CARCINOID SYNDROME#0.6048;ENURESIS#0.6045;CORONAL#0.6045;NOXIOUS#0.6029;SARCOGLYCAN COMPLEX#0.6024;CALCIUM CHLORIDE#0.6017;BUSCOPAN#0.6016;DIABETIC KETOACIDOSIS#0.6015;CHOLECYSTITIS#0.6013;AMIODARONE#0.6012;PHENOBARBITAL#0.6011;HYPEREKPLEXIA#0.6003
102723547	TAXOL#1.0743;CANCER TESTIS ANTIGEN#1.0402;T CELL#0.9351;BREAST CANCER#0.9317;IMMUNE RESPONSE#0.8474;CANCER CELL#0.7921;PACLITAXEL#0.7323;OVARIAN CARCINOMA#0.7314;NON-SMALL CELL LUNG CARCINOMA#0.6594;LUNG CARCINOMA#0.6521;CYTOTOXIC T-LYMPHOCYTE#0.6504;DENDRITIC CELL#0.6456;IFN-GAMMA#0.6451;T LYMPHOCYTE#0.6446;OVARIAN#0.6268
102724047	OVARIAN#0.6451
102724362	SQUAMOUS CELL CARCINOMA#0.9013;CANCER CELL#0.8953;LAPATINIB#0.6604
10272	ACTIVIN BINDING#1.0930;BONE MORPHOGENETIC PROTEIN#1.0180;GROWTH FACTOR#1.0103;SKELETAL MUSCLE#0.9950;TRANSFORMING GROWTH FACTOR#0.9938;GENE EXPRESSION#0.9785;CELL PROLIFERATION#0.9610;TRANSFORMING GROWTH FACTOR BETA#0.9357;ACTIVIN RECEPTOR#0.9331;GESTATIONAL DIABETES#0.9245;RELATED PROTEIN 1#0.9082;INHIBIN#0.9048;TROPHOBLAST#0.8923;ENDOMETRIUM#0.8918;STROMAL CELL#0.8639;RHEUMATOID ARTHRITIS#0.8463;OBESE#0.8268;GESTATIONAL DIABETES MELLITUS#0.8211;POLYMERASE CHAIN REACTION#0.8165;DIABETES MELLITUS#0.8165;PRE-ECLAMPSIA#0.8101;OVARIAN#0.7928;CELL SURFACE#0.7923;B CELL#0.7899;GESTATION#0.7716;GLUCOSE HOMEOSTASIS#0.7707;TUMOR NECROSIS FACTOR#0.7280;GROWTH DIFFERENTIATION FACTOR#0.7241;HEMATOPOIESIS#0.7225;INSULIN-LIKE GROWTH FACTOR#0.7121;DECIDUA#0.6989;HEPARIN BINDING#0.6893;EXTRACELLULAR MATRIX#0.6831;BONE FORMATION#0.6800;EPITHELIAL CELL#0.6776;SIGNALING PATHWAY#0.6644;BREAST CANCER#0.6527;ECLAMPSIA#0.6504;SMAD BINDING ELEMENT#0.6249;SMAD BINDING#0.6202;GROWTH FACTOR BINDING#0.6185;HORMONE BINDING#0.6172;HEMATOPOIETIC CELL#0.6150;HEART DEVELOPMENT#0.6135;HEPARIN#0.6034;GLUCOCORTICOID RECEPTOR#0.6004
10273	UBIQUITIN LIGASE ACTIVITY#1.0783;HSC70 INTERACTING PROTEIN#1.0728;HSP70 INTERACTING PROTEIN#1.0687;LIGASE ACTIVITY#1.0621;PROTEIN QUALITY CONTROL#1.0255;UBIQUITIN#1.0183;HEMATOPOIESIS#1.0076;NEURODEGENERATIVE DISEASE#1.0037;PROTEIN DEGRADATION#1.0023;HISTONE MODIFICATION#1.0000;DNA BINDING#0.9950;UBIQUITIN PROTEASOME SYSTEM#0.9943;PROTEASOME#0.9937;CELL DEATH#0.9929;HEAT SHOCK PROTEIN#0.9925;PROTEASOME PATHWAY#0.9895;PROSTATE CANCER#0.9894;T CELL#0.9889;AUTOPHAGY#0.9879;LYSINE#0.9868;TRANSCRIPTION FACTOR BINDING#0.9866;CELL GROWTH#0.9853;TUMOR SUPPRESSOR#0.9811;ONCOGENIC#0.9811;BREAST CANCER CELL#0.9795;UBIQUITIN PROTEASOME PATHWAY#0.9785;ENDOPLASMIC RETICULUM#0.9782;BREAST CANCER#0.9781;CELL CYCLE#0.9734;LUNG CANCER#0.9722;EPITHELIAL CELL#0.9717;PROTEIN KINASE#0.9691;TRANSACTIVATION#0.9691;APOPTOSIS#0.9683;STEM CELL#0.9669;CANCER CELL#0.9665;PROTEIN FOLDING#0.9655;GENE EXPRESSION#0.9654;COLORECTAL CANCER#0.9641;TRANSCRIPTION FACTOR#0.9618;HYPOXIA#0.9612;COLON CANCER#0.9604;MACROPHAGE#0.9595;ALZHEIMER'S DISEASE#0.9588;GROWTH FACTOR#0.9588;SIGNALING PATHWAY#0.9588;CELL PROLIFERATION#0.9581;OSTEOBLAST DIFFERENTIATION#0.9554;ESTROGEN RECEPTOR#0.9547;DNA METHYLATION#0.9540;CYTOPLASM#0.9511;B CELL#0.9480;ENDOTHELIAL CELL#0.9478;CELL DIFFERENTIATION#0.9471;SENESCENCE#0.9441;COLORECTAL#0.9440;IMMUNE RESPONSE#0.9431;PARKINSON'S DISEASE#0.9417;ANDROGEN RECEPTOR#0.9415;HISTONE DEACETYLASE#0.9413;APOPTOTIC#0.9411;GELDANAMYCIN#0.9357;MYOCARDIAL INFARCTION#0.9348;NITRIC OXIDE#0.9325;CELL MIGRATION#0.9311;CARDIOMYOCYTE#0.9280;CELL SURFACE#0.9250;TOXICITY#0.9248;PROTEIN UBIQUITINATION#0.9225;PERIPHERAL BLOOD#0.9198;ANGIOGENESIS#0.9195;NUCLEOSOME#0.9179;MUTAGENESIS#0.9130;OSTEOBLAST#0.9106;AKT SIGNALING#0.9097;NITRIC OXIDE SYNTHASE#0.9064;NERVOUS SYSTEM#0.9059;EXOSOME#0.9047;EMBRYONIC STEM CELL#0.9042;RNA INTERFERENCE#0.8966;TRANSFORMING GROWTH FACTOR#0.8936;MOUSE EMBRYONIC FIBROBLAST#0.8919;CHAPERONE ACTIVITY#0.8902;HUMAN BREAST CANCER#0.8891;PROTEASOME DEGRADATION#0.8870;CYTOCHROME P450#0.8797;TUMOR CELLS#0.8785;OVARIAN#0.8759;PROTEIN PROTEIN INTERACTION#0.8697;MYELOID LEUKEMIA#0.8667;REPORTER GENE ASSAY#0.8635;CYSTIC FIBROSIS#0.8633;TF BINDING#0.8590;TRANSCRIPTIONAL CONTROL#0.8540;POST-TRANSLATIONAL MODIFICATION#0.8531;OVARIAN CANCER#0.8488;LUCIFERASE ACTIVITY#0.8418;TOLL LIKE RECEPTOR#0.8347;DNASE#0.8340;BONE MARROW#0.8326;CEREBELLAR ATAXIA#0.8323;ENDOCYTOSIS#0.8318;HISTONE ACETYLATION#0.8293;INSULIN RECEPTOR#0.8286;CHAPERONE BINDING#0.8270;PROGENITOR CELL#0.8251;DNA REPAIR#0.8178;EPITHELIAL MESENCHYMAL TRANSITION#0.8149;HYPOXIC#0.8117;REGULATORY T CELL#0.8094;SIGNAL TRANSDUCTION#0.8064;FACTOR I#0.8055;UNFOLDED PROTEIN RESPONSE#0.8030;SMOOTH MUSCLE#0.8029;26S PROTEASOME#0.8021;MONOCYTE#0.7968;OXYGEN GLUCOSE DEPRIVATION#0.7953;QUALITY CONTROL SYSTEM#0.7907;MUSCLE CELL#0.7877;UBIQUITIN PROTEIN LIGASE#0.7851;MITOCHONDRIA#0.7847;CANCER STEM CELL#0.7843;HEAT SHOCK FACTOR#0.7828;TREG CELL#0.7814;DUAL LUCIFERASE REPORTER#0.7787;HYPOXIA INDUCIBLE FACTOR#0.7761;HYPOGONADISM#0.7743;HYPOXIA RESPONSE ELEMENT#0.7721;CHROMATIN REMODELING#0.7677;ISCHEMIA#0.7655;HEMATOPOIETIC STEM CELL#0.7646;LYSOSOME#0.7614;ACUTE MYELOID LEUKEMIA#0.7571;HEPATOCELLULAR CARCINOMA#0.7548;POLYMERASE CHAIN REACTION#0.7520;REACTIVE OXYGEN SPECIES#0.7500;PANCREATIC CANCER#0.7435;POLYUBIQUITIN#0.7416;LYMPH NODE#0.7366;MICROTUBULE#0.7308;SMOOTH MUSCLE CELL#0.7301;OSTEOCLAST#0.7299;ARGININE#0.7248;GENE EXPRESSION OMNIBUS#0.7246;MECHANISM OF ACTION#0.7202;ADENOCARCINOMA#0.7180;TUMOR NECROSIS FACTOR#0.7154;ZINC FINGER PROTEIN#0.7139;DRUG RESISTANCE#0.7132;NECROPTOSIS#0.7093;NEURONAL CELL DEATH#0.7062;ERYTHROID CELL#0.6975;ESTRADIOL#0.6844;DNA REPLICATION#0.6839;COMPLEX I#0.6833;KINASE INHIBITOR#0.6810;ENHANCER BINDING PROTEIN#0.6756;ENHANCER BINDING#0.6752;COLON CARCINOMA#0.6751;PROTEIN BINDING#0.6732;S PHASE#0.6710;CENTRAL NERVOUS SYSTEM#0.6704;SURFACE PLASMON RESONANCE#0.6701;DENDRITIC CELL#0.6692;CYTOTOXICITY#0.6625;MOUSE EMBRYONIC STEM#0.6610;CELL CYCLE ARREST#0.6607;CELL ADHESION#0.6592;PROTEIN COMPLEX#0.6571;RNA BINDING#0.6567;QUANTITATIVE REAL TIME#0.6545;TELOMERE#0.6544;KINASE ACTIVITY#0.6543;DEUBIQUITINATING ENZYME#0.6538;LEUCINE#0.6531;ADIPOCYTE#0.6512;HOST CELL#0.6480;CD4+ T CELL#0.6456;AMYLOID PRECURSOR PROTEIN#0.6438;BONE MORPHOGENETIC PROTEIN#0.6430;AR BINDING#0.6380;SELECTIVE AUTOPHAGY#0.6288;INFLAMMATORY RESPONSE#0.6285;RESPONSE TO STRESS#0.6277;INNATE IMMUNITY#0.6260;MITOSIS#0.6259;CELLULAR SENESCENCE#0.6242;AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA#0.6234;MESENCHYMAL STEM CELL#0.6233;PRO-INFLAMMATORY#0.6229;HEART DISEASE#0.6226;GROWTH FACTOR RECEPTOR#0.6223;LYMPH NODE METASTASIS#0.6219;CORONARY ARTERY#0.6161;C TERMINAL DOMAIN#0.6158;CEREBRAL CORTEX#0.6142;CYCLIN DEPENDENT KINASE#0.6138;GRANULOSA CELL#0.6127;ARTERY#0.6126;GERM CELL#0.6112;BREAST CANCER PATIENTS#0.6107;RECEPTOR TYROSINE KINASE#0.6105;SIGNALLING PATHWAY#0.6102;IMMUNE SYSTEM#0.6081;INTESTINAL TRACT#0.6074;ATHEROSCLEROSIS#0.6048;HUMAN EMBRYONIC STEM#0.6046;VALOSIN CONTAINING PROTEIN#0.6020;HEAD AND NECK CANCER#0.6013;NECK CANCER#0.6013;BINDING PROTEIN 1#0.6003
10274	TELOMERE#1.0212;COHESIN COMPLEX#1.0168;SISTER CHROMATID COHESION#0.9991;CHROMATID#0.9975;FIBROSARCOMA#0.9417;TUMOR CELLS#0.9067;GENE EXPRESSION#0.9054;CANCER CELL#0.8422;CISPLATIN#0.8407;T CELL#0.8255;MITOSIS#0.8248;CENTROMERE#0.8139;CYSTATIN#0.8101;DNA REPAIR#0.8077;CELL DIVISION#0.7561;CHROMOSOME SEGREGATION#0.7507;CYTOTOXICITY#0.7293;BLEOMYCIN#0.7002;TUMOR GROWTH DELAY#0.7002;PROTEIN COMPLEX#0.6864;DNA REPLICATION#0.6854;MEIOSIS#0.6309;OVARIAN#0.6276;COMPLEX I#0.6047
10276	NUCLEOTIDE EXCHANGE FACTOR#1.0751;CANCER CELL#1.0698;GUANINE#1.0692;BREAST CANCER#1.0641;CELL MOTILITY#1.0378;SQUAMOUS CELL CARCINOMA#1.0075;SKIN SQUAMOUS CELL CARCINOMA#0.9710;BREAST CANCER CELL#0.9708;NEUROEPITHELIAL CELL#0.9669;HEPATOCELLULAR CARCINOMA#0.9565;FOCAL ADHESION#0.9531;STRESS FIBER#0.9485;CELL PROLIFERATION#0.9435;SIGNALING PATHWAY#0.9396;GENE EXPRESSION#0.8993;RHOGEF#0.8935;CELL MIGRATION#0.8808;GROWTH FACTOR#0.8503;ONCOGENIC#0.8159;PLASMA MEMBRANE#0.8062;MAMMARY GLAND#0.7828;EPITHELIAL CELL#0.7594;EXTRACELLULAR MATRIX#0.7236;PROTEASOME#0.7012;HUMAN BREAST CANCER#0.6960;TUMOR SUPPRESSOR#0.6915;POLYMERASE CHAIN REACTION#0.6887;APOPTOSIS#0.6714;TRANSFORMING GROWTH FACTOR#0.6427;ADENOCARCINOMA#0.6292;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.6190;BREAST CANCER PATIENTS#0.6158;CATALYTIC ACTIVITY#0.6111;CELL ADHESION#0.6068;CELL DEATH#0.6043
10277	UBIQUITIN#1.0453;NICOTINAMIDE MONONUCLEOTIDE#1.0215;APOPTOSIS#0.9813;PROTEASOME#0.9413;NICOTINAMIDE#0.9265;NEUROBLASTOMA#0.9186;TUMOR SUPPRESSOR#0.8611;CELL PROLIFERATION#0.8120;PROTEIN DEGRADATION#0.7887;NEURODEGENERATIVE DISEASE#0.7651;EPIDERMAL GROWTH FACTOR#0.7408;GROWTH FACTOR RECEPTOR#0.7408;GROWTH FACTOR#0.7382;CELL CYCLE#0.7202;GENE EXPRESSION#0.7150;CISPLATIN#0.6959;ENDOPLASMIC RETICULUM#0.6692;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.6689;PROTEASOME PATHWAY#0.6419;PROTEIN QUALITY CONTROL#0.6195;CELL MIGRATION#0.6062;CELL GROWTH#0.6040;BREAST CANCER#0.6022;MUSCLE CELL#0.6010
10278	SIGNAL TRANSDUCTION#1.0410;CRISPR-CAS SYSTEM#1.0151;APOPTOSIS#1.0050;GROWTH FACTOR#1.0042;PROTEIN KINASE#1.0035;DNA DEGRADATION#1.0000;T CELL#0.9866;TRANSCRIPTION FACTOR#0.9829;GENE EXPRESSION#0.9710;IMMUNE SYSTEM#0.9573;GLUTAMINE#0.9160;CHEMOTAXIS#0.9066;T LYMPHOCYTE#0.8985;CELL CYCLE#0.8965;APOPTOTIC#0.8952;SIGNALING PATHWAY#0.8853;PHOSPHATASE ACTIVITY#0.8796;CANCER CELL#0.8704;NITROGEN FIXATION#0.8418;DNA BINDING#0.8247;NUCLEIC ACID#0.8205;ARGININE#0.8154;ADAPTIVE IMMUNE SYSTEM#0.8122;PROTEIN KINASE C#0.8118;PROTEIN PROTEIN INTERACTION#0.7813;CELL PROLIFERATION#0.7733;NUCLEASE ACTIVITY#0.7630;MITOGEN ACTIVATED PROTEIN#0.7605;HISTIDINE#0.7496;LYMPH NODE#0.7391;TUMOR NECROSIS FACTOR#0.7380;STEM CELL#0.7330;POLYMERASE CHAIN REACTION#0.7223;REACTIVE OXYGEN SPECIES#0.7172;INTRACELLULAR SIGNAL TRANSDUCTION#0.7148;AMP BINDING#0.7034;KINASE ACTIVITY#0.7023;TOXICITY#0.6874;REVERSE TRANSCRIPTION#0.6745;GTP BINDING#0.6732;DOCKING PROTEIN#0.6650;RIBONUCLEOPROTEIN COMPLEX#0.6644;NUCLEOTIDE BINDING#0.6634;EPITHELIAL CELL#0.6568;CELL ADHESION#0.6468;BASE PAIRING#0.6417;BIOFILM FORMATION#0.6378;N-ACETYL-L-GLUTAMATE#0.6354;VIRULENCE#0.6289;CELL GROWTH#0.6274;FOCAL ADHESION#0.6170;CATALYTIC ACTIVITY#0.6043;CELL MIGRATION#0.6017
10279	T CELL#1.0773;CD4+ T CELL#1.0702;EPITHELIAL CELL#0.9993;THYMIC EPITHELIAL CELLS#0.9448;T CELL DEVELOPMENT#0.8955;CELL DEVELOPMENT#0.8886;THYMOCYTE#0.7397;TYPE 1 DIABETES#0.6243
1027	MULTIPLE ENDOCRINE NEOPLASIA TYPE 4#1.0674;NUCLEAR EXPORT#1.0376;SERTOLI CELL#1.0319;BINDING PROTEIN 1#1.0242;PAPILLARY THYROID CARCINOMA#1.0206;MESANGIAL CELL#1.0160;CYCLIN DEPENDENT KINASE INHIBITOR#1.0117;CDK INHIBITOR#1.0093;CDK ACTIVITY#1.0068;KINASE INHIBITOR#1.0057;PITUITARY ADENOMA#1.0049;LYMPH NODE METASTASES#1.0045;CONTACT INHIBITION#1.0039;DISEASE FREE SURVIVAL#1.0035;COLORECTAL CARCINOMA#1.0033;SENESCENCE#1.0028;QUIESCENCE#1.0024;ANDROGEN RECEPTOR#1.0020;MULTIPLE ENDOCRINE NEOPLASIA TYPE 1#1.0019;ORAL SQUAMOUS CELL CARCINOMA#1.0014;MULTIPLE ENDOCRINE NEOPLASIA#1.0012;THYROID CARCINOMA#1.0012;HODGKIN'S LYMPHOMA#1.0011;CYCLIN DEPENDENT KINASE#0.9992;RAPAMYCIN#0.9978;OVARIAN CANCER#0.9975;PROGESTERONE#0.9971;NEUROBLASTOMA#0.9963;KINASE INHIBITOR P27#0.9951;RETINOIC ACID#0.9945;INHIBITION OF CELL PROLIFERATION#0.9934;REGULATION OF CELL CYCLE#0.9929;TRANSFORMING GROWTH FACTOR BETA#0.9928;BASAL CELL#0.9923;BREAST CARCINOMA#0.9921;TELOMERASE ACTIVITY#0.9920;UBIQUITIN#0.9909;BREAST CANCER PATIENTS#0.9908;DEPHOSPHORYLATION#0.9907;CELL ADHESION#0.9903;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9901;T LYMPHOCYTE#0.9899;CERVICAL#0.9899;B CELL LYMPHOMA#0.9889;LYMPH NODE METASTASIS#0.9888;COLORECTAL CANCER#0.9886;CORNEAL ENDOTHELIAL CELL#0.9879;SQUAMOUS CELL CARCINOMA#0.9876;COLON CANCER#0.9875;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9868;RNA INTERFERENCE#0.9864;RENAL CELL CARCINOMA#0.9864;HEPATOCELLULAR CARCINOMA#0.9862;PROTEASOME#0.9861;PROSTATE CARCINOMA#0.9857;M PHASE#0.9855;COLORECTAL#0.9855;CYCLIC AMP#0.9850;AUTOPHAGY#0.9842;PARATHYROID#0.9841;ENDOTHELIAL CELL#0.9838;T CELL#0.9837;CELL CYCLE REGULATOR#0.9836;NEUROENDOCRINE TUMOR#0.9832;B CELL#0.9825;MYELOID LEUKEMIA#0.9824;DNA REPLICATION#0.9824;OVARIAN#0.9815;PROSTATE CANCER#0.9815;HYPERPARATHYROIDISM#0.9806;VASCULAR SMOOTH MUSCLE CELL#0.9804;CYTOPLASM#0.9802;PRECURSOR CELL#0.9800;PROGENITOR CELL#0.9800;LYMPH NODE#0.9800;CELL CYCLE TRANSITION#0.9798;TRANSFORMING GROWTH FACTOR#0.9797;PROTEIN KINASE B#0.9797;SMOOTH MUSCLE#0.9792;ASTROCYTOMA#0.9791;PROTEASOME PATHWAY#0.9791;BREAST CANCER#0.9790;ACUTE MYELOID LEUKEMIA#0.9787;SMOOTH MUSCLE ACTIN#0.9786;CELL CYCLE#0.9785;CELL CYCLE CONTROL#0.9784;IFN-GAMMA#0.9784;PROTEIN SYNTHESIS#0.9780;TUMOR SUPPRESSOR#0.9778;KINASE ACTIVITY#0.9777;RETINOBLASTOMA#0.9774;CELL MIGRATION#0.9773;MAMMARY EPITHELIAL CELL#0.9769;NEUROGENESIS#0.9767;S PHASE#0.9763;SMOOTH MUSCLE CELL#0.9761;CELL CYCLE ARREST#0.9760;CELL DIFFERENTIATION#0.9754;CELL CYCLE REGULATION#0.9752;MUSCLE CELL#0.9749;CELL DIVISION#0.9744;BREAST CANCER CELL#0.9743;MAP KINASE#0.9743;MEDULLOBLASTOMA#0.9743;G1 PHASE#0.9742;ENDOTHELIAL GROWTH FACTOR#0.9742;ADENOCARCINOMA#0.9738;PLATELET-DERIVED GROWTH FACTOR#0.9737;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9737;REVERSE TRANSCRIPTION#0.9734;LUNG CANCER#0.9732;MITOGEN ACTIVATED PROTEIN#0.9725;KERATINOCYTE#0.9725;POLYMERASE CHAIN REACTION#0.9724;HUMAN BREAST CANCER#0.9723;ESTROGEN RECEPTOR#0.9721;CYTOCHROME C#0.9720;ONCOGENIC#0.9716;OVARIAN CARCINOMA#0.9714;INDUCTION OF APOPTOSIS#0.9710;EPIDERMAL GROWTH FACTOR#0.9708;UBIQUITIN PROTEASOME PATHWAY#0.9707;GROWTH FACTOR RECEPTOR#0.9706;PANCREATIC CANCER#0.9702;TUMOR CELLS#0.9700;INHIBITION OF CELL GROWTH#0.9699;NERVOUS SYSTEM#0.9691;PROTEIN DEGRADATION#0.9688;AKT SIGNALING#0.9688;THYROID CANCER#0.9685;DNA SYNTHESIS#0.9684;HYPOXIA#0.9674;MULTIPLE MYELOMA#0.9672;APOPTOTIC CELL DEATH#0.9667;REGENERATION#0.9664;VSMC PROLIFERATION#0.9663;SPINAL CORD#0.9663;STEM CELL#0.9661;HEPATOCELLULAR CARCINOMA CELL#0.9655;EPITHELIAL CELL#0.9653;APOPTOTIC#0.9646;MACROPHAGE#0.9644;CELL PROLIFERATION#0.9640;CANCER CELL#0.9638;MUSCLE CELL PROLIFERATION#0.9638;DNA FRAGMENTATION#0.9637;APOPTOSIS#0.9637;PROTEIN KINASE#0.9637;HISTONE DEACETYLASE#0.9634;THYMIDINE#0.9624;BONE MARROW#0.9620;CENTRAL NERVOUS SYSTEM#0.9614;ANCHORAGE INDEPENDENT GROWTH#0.9599;GROWTH FACTOR#0.9596;POLY ADP RIBOSE#0.9594;CYTOTOXICITY#0.9590;CELL GROWTH#0.9587;OLIGODENDROCYTE#0.9581;TRANSCRIPTION FACTOR#0.9577;GENE EXPRESSION#0.9575;DNA REPAIR#0.9574;CISPLATIN#0.9571;SIGNALING PATHWAY#0.9564;TUMOR TISSUES#0.9553;EXTRACELLULAR MATRIX#0.9551;CELL DEATH#0.9545;PRIMARY HYPERPARATHYROIDISM#0.9545;DEXAMETHASONE#0.9542;SMOOTH MUSCLE CELL PROLIFERATION#0.9541;TARGET OF RAPAMYCIN#0.9538;SIGNAL TRANSDUCTION#0.9532;CHOLANGIOCARCINOMA#0.9521;TERMINAL DIFFERENTIATION#0.9517;PERIPHERAL BLOOD#0.9514;HYPERPHOSPHORYLATION#0.9502;CELL DIVISION CYCLE#0.9502;REACTIVE OXYGEN SPECIES#0.9500;CARNEY COMPLEX#0.9496;MITOSIS#0.9494;GRANULOSA CELL#0.9488;INSULIN-LIKE GROWTH FACTOR#0.9472;BORTEZOMIB#0.9468;CELL SURFACE#0.9462;ANGIOGENESIS#0.9461;DNA BINDING#0.9440;FORMALIN#0.9439;STROMAL CELL#0.9434;DRUG RESISTANCE#0.9406;RIBOSE#0.9402;TRASTUZUMAB#0.9354;RECEPTOR TYROSINE KINASE#0.9352;CD4+ T CELL#0.9347;MECHANISM OF ACTION#0.9342;CERVICAL CANCER#0.9311;SKELETAL MUSCLE#0.9288;RESVERATROL#0.9266;DIFFUSE LARGE B-CELL LYMPHOMA#0.9245;PROTEIN KINASE C#0.9241;SCIATIC NERVE#0.9227;CELLULAR SENESCENCE#0.9226;1α,25-DIHYDROXYVITAMIN D3#0.9223;CELL DEVELOPMENT#0.9221;T CELL PROLIFERATION#0.9217;DNA METHYLATION#0.9208;VITAMIN D3#0.9195;GERM CELL#0.9189;ASTROCYTE#0.9183;B LYMPHOCYTE#0.9159;ATHEROSCLEROSIS#0.9136;PAPILLARY CARCINOMA#0.9117;ONCOGENESIS#0.9108;ESTRADIOL#0.9104;INVASIVE CARCINOMA#0.9100;ARYL HYDROCARBON RECEPTOR#0.9099;ENDOTHELIAL CELL PROLIFERATION#0.9097;MITOCHONDRIAL MEMBRANE#0.9072;OOCYTE#0.9056;TYROSINE KINASE INHIBITOR#0.9056;CELL CYCLE CHECKPOINT#0.9054;TOXICITY#0.9034;COLON CARCINOMA#0.9023;RNA BINDING#0.8995;CELL MOTILITY#0.8981;LUNG CARCINOMA#0.8942;PARATHYROID ADENOMA#0.8928;PHEOCHROMOCYTOMA#0.8902;TUMOR NECROSIS FACTOR#0.8884;MOUSE EMBRYONIC FIBROBLAST#0.8883;LYMPHOCYTIC LEUKEMIA#0.8867;CELL CYCLE PATHWAY#0.8865;GLYCOGEN SYNTHASE KINASE#0.8863;EPSTEIN BARR VIRUS#0.8857;CELL CYCLE PHASE#0.8855;EPITHELIAL CELL PROLIFERATION#0.8854;HEMATOPOIETIC CELL#0.8852;HISTONE DEACETYLASE INHIBITOR#0.8850;MITOCHONDRIA#0.8842;QUANTITATIVE REAL TIME#0.8834;ARTERY#0.8827;LYMPHOID TISSUE#0.8817;MECHANISMS OF ACTION#0.8816;SIGNAL TRANSDUCER#0.8810;PROSTATE SPECIFIC ANTIGEN#0.8784;5 FLUOROURACIL#0.8781;SIGNALLING PATHWAY#0.8778;UBIQUITIN LIGASE COMPLEX#0.8773;TAMOXIFEN#0.8771;FIBROBLAST GROWTH FACTOR#0.8767;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8766;MALIGNANT GLIOMA#0.8753;TRANSCRIPTASE#0.8736;LUMINAL#0.8732;PRIMARY BREAST CANCER#0.8700;PROSTATIC INTRAEPITHELIAL NEOPLASIA#0.8699;PAPILLOMA#0.8694;LUNG ADENOCARCINOMA#0.8684;PROTEIN KINASE A#0.8659;GENISTEIN#0.8652;TRANSACTIVATION#0.8640;HAIR CELL#0.8618;HEMATOPOIETIC STEM CELL#0.8601;FLOW CYTOMETRY ANALYSIS#0.8564;DENDRITIC CELL#0.8515;HYPOXIC#0.8470;MAMMARY GLAND#0.8464;CARCINOGEN#0.8458;SIGNALING MOLECULE#0.8457;GLIAL CELL#0.8454;FLUOROURACIL#0.8452;G2 PHASE#0.8449;MALIGNANT LYMPHOMA#0.8427;DIABETES MELLITUS#0.8427;CARDIOMYOCYTE#0.8418;RECEPTOR INTERACTING PROTEIN#0.8386;CANCER SPECIFIC SURVIVAL#0.8376;MELANOCYTE#0.8370;LYMPHOID CELL#0.8356;GM-CSF#0.8329;CYCLIN-DEPENDENT KINASE ACTIVITY#0.8320;MICROTUBULE#0.8287;MANTLE CELL LYMPHOMA#0.8275;CHRONIC LYMPHOCYTIC LEUKEMIA#0.8274;RNA BINDING PROTEIN#0.8263;CARCINOMA IN SITU#0.8247;NEURAL PROGENITOR CELL#0.8247;DOXORUBICIN#0.8243;PHOSPHATASE AND TENSIN HOMOLOG#0.8240;GEFITINIB#0.8232;HEPATOMA CELLS#0.8229;MAPK ACTIVATION#0.8217;CELL ACTIVATION#0.8181;OVARIES#0.8149;CASPASE INHIBITOR#0.8142;VASCULAR CELL#0.8135;CYTOCHROME C RELEASE#0.8133;ENDOMETRIUM#0.8125;IMMUNE RESPONSE#0.8122;BETA CELL#0.8121;CELL EXPANSION#0.8105;KINASE INHIBITOR PROTEIN#0.8103;LIVER CANCER#0.8080;GENE SILENCING#0.8070;ALL TRANS RETINOIC ACID#0.8058;TOPOISOMERASE#0.8054;FOCAL ADHESION#0.8033;FIBROBLAST PROLIFERATION#0.7996;OSTEOBLAST#0.7992;WOUND HEALING#0.7989;PITUITARY GLAND#0.7978;PANCREATIC ADENOCARCINOMA#0.7977;ACTIVATED T CELL#0.7966;CHROMOSOMAL REGION#0.7952;ANAPLASTIC LARGE CELL LYMPHOMA#0.7944;OXIDATIVE DNA DAMAGE#0.7941;HYPERTENSION#0.7933;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.7932;ENDOMETRIAL CANCER#0.7927;CLEAVED CASPASE 3#0.7924;RECURRENCE FREE SURVIVAL#0.7915;PANCREATIC ISLET#0.7914;POST-TRANSLATIONAL MODIFICATION#0.7913;HUMAN UMBILICAL VEIN#0.7897;UMBILICAL VEIN#0.7895;SIGNALING CASCADE#0.7888;PROSTATE ADENOCARCINOMA#0.7884;SEQUESTERING#0.7882;MYOCARDIAL INFARCTION#0.7880;ENDOPLASMIC RETICULUM#0.7875;COLONY-STIMULATING FACTOR#0.7873;SERTOLI CELL PROLIFERATION#0.7853;NITRIC OXIDE#0.7849;PACLITAXEL#0.7848;DOMINANT NEGATIVE MUTANT#0.7829;CELL MATURATION#0.7821;MITOTIC SPINDLE#0.7819;LEYDIG CELL#0.7802;URINARY BLADDER#0.7799;LYMPH NODE INVOLVEMENT#0.7789;SPINAL CORD INJURY#0.7788;DENTATE GYRUS#0.7772;HUMAN PANCREATIC CANCER#0.7753;G0 PHASE#0.7726;PROGRAMMED CELL DEATH#0.7721;FAMILIAL ISOLATED HYPERPARATHYROIDISM#0.7715;DIABETIC NEPHROPATHY#0.7702;CD8+ T CELL#0.7700;PROTEIN PROTEIN INTERACTION#0.7689;LYSINE#0.7688;ACTIVE CASPASE 3#0.7687;MOUSE EMBRYO FIBROBLASTS#0.7677;EPITHELIAL OVARIAN CANCER#0.7653;UBIQUITIN PROTEASOME SYSTEM#0.7652;INNER EAR#0.7649;TRANSCRIPTIONAL CONTROL#0.7637;COPY NUMBER CHANGE#0.7635;LEUCINE#0.7625;ADENOSINE#0.7611;LOCALIZED PROSTATE CANCER#0.7609;TOPOISOMERASE II#0.7603;FACTOR I#0.7586;REGULATION OF CELL PROLIFERATION#0.7582;EPITHELIAL MESENCHYMAL TRANSITION#0.7536;PROPIDIUM#0.7520;ACTIVATED T-CELLS#0.7510;GROWTH HORMONE#0.7509;NORMAL ORAL MUCOSA#0.7506;MYELOID CELL#0.7504;TASTE BUD#0.7496;COP9 SIGNALOSOME#0.7492;LOVASTATIN#0.7491;ORGAN OF CORTI#0.7488;COPY NUMBER ALTERATION#0.7487;COMPARATIVE GENOMIC HYBRIDIZATION#0.7454;METHYLATION SPECIFIC PCR#0.7452;NEPHROPATHY#0.7440;YEAR SURVIVAL RATE#0.7432;COMPLEX I#0.7392;ACROMEGALY#0.7385;HEAT SHOCK PROTEIN#0.7381;BIOTIN#0.7350;CYCLIN E KINASE ACTIVITY#0.7341;PLASMA CELL#0.7338;T CELL ANERGY#0.7330;METFORMIN#0.7315;DEGRADATION OF CYCLIN#0.7309;MONOCYTE#0.7292;PROSTATE EPITHELIAL CELL#0.7273;ESOPHAGEAL CARCINOMA#0.7270;VASCULAR DISEASE#0.7269;THYMOCYTE#0.7266;ADVANCED PROSTATE CANCER#0.7260;ANTI HER2#0.7257;PROTEASOME DEGRADATION#0.7257;METASTATIC MELANOMA#0.7213;CASPASE ACTIVATION#0.7213;MYELODYSPLASTIC SYNDROME#0.7210;ORAL MUCOSA#0.7210;FATTY ACID SYNTHASE#0.7208;RIBOSOMAL PROTEIN#0.7197;GASTRIC MUCOSA#0.7195;CELL QUIESCENCE#0.7178;CEREBRAL CORTEX#0.7162;ESOPHAGEAL CANCER#0.7151;PODOCYTE#0.7146;NULL CELL#0.7115;CATALYTIC ACTIVITY#0.7111;CELLULAR GROWTH#0.7102;CONNEXIN#0.7101;CYCLIN D1-CDK4 COMPLEX#0.7078;IMMUNE SYSTEM#0.7072;DNA DAMAGE RESPONSE#0.7072;ENDOTHELIUM#0.7057;PANCREATIC CARCINOMA#0.7041;MESENCHYMAL STEM CELL#0.7041;TO TUMOR PROGRESSION#0.7033;PARATHYROID HORMONE#0.7033;26S PROTEASOME#0.7031;TRANSITIONAL CELL CARCINOMA#0.7025;VON HIPPEL LINDAU#0.7017;ACTIVATED CASPASE 3#0.7008;EVEROLIMUS#0.7006;TESTOSTERONE#0.6993;UBIQUITIN PROTEIN LIGASE#0.6985;PULMONARY HYPERTENSION#0.6977;NODULAR#0.6974;ENHANCER BINDING#0.6969;MAPK SIGNALING#0.6963;VASCULAR ENDOTHELIAL CELL#0.6955;CYCLIN BINDING#0.6954;PROTEIN STABILIZATION#0.6944;MYOBLAST#0.6914;LYMPHOCYTE PROLIFERATION#0.6912;LINES OF EVIDENCE#0.6903;REPLICATIVE SENESCENCE#0.6900;CANCER RELATED DEATH#0.6899;SIGNALOSOME#0.6893;EMBRYONIC STEM CELL#0.6855;RETINAL PROGENITOR CELL#0.6846;PROTEIN PHOSPHORYLATION#0.6830;OLIGODENDROCYTE DIFFERENTIATION#0.6823;CORNEAL ENDOTHELIUM#0.6822;ACUTE PROMYELOCYTIC LEUKEMIA#0.6806;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6803;SMALL INTESTINE#0.6796;GLUTATHIONE#0.6781;LYMPHOMA CELL LINES#0.6768;PLASMA MEMBRANE#0.6763;LIVER REGENERATION#0.6752;POSTTRANSLATIONAL MODIFICATION#0.6734;BERBERINE#0.6709;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.6704;BETA GALACTOSIDASE#0.6702;PARAGANGLIOMA#0.6701;CELL ADHESION MOLECULE#0.6666;ZD1839#0.6664;PERIPHERAL NERVE#0.6645;FAMILIAL HYPOCALCIURIC HYPERCALCEMIA#0.6631;MCCUNE ALBRIGHT SYNDROME#0.6598;GRANULOSA CELL PROLIFERATION#0.6596;DIFFERENTIAL GENE EXPRESSION#0.6571;MELANOMA CELL LINES#0.6555;GERMINAL CENTER#0.6554;QUANTITATIVE REVERSE TRANSCRIPTION#0.6540;HYPERCALCEMIA#0.6536;CAROTID ARTERY#0.6533;PRIMARY EFFUSION LYMPHOMA#0.6532;NUCLEAR IMPORT#0.6509;SMC PROLIFERATION#0.6502;INFLAMMATORY RESPONSE#0.6483;HEAD AND NECK CANCER#0.6478;NOTCH SIGNALING PATHWAY#0.6478;NECK CANCER#0.6477;INVASIVE DUCTAL CARCINOMA#0.6468;ATHEROSCLEROTIC#0.6459;RELAPSE FREE SURVIVAL#0.6458;COLON ADENOCARCINOMA#0.6457;B CELL RECEPTOR#0.6454;COLONY FORMATION ASSAY#0.6438;CELLULAR LOCALIZATION#0.6430;STAUROSPORINE#0.6423;ALANINE#0.6418;HEMATOPOIESIS#0.6409;FLAVOPIRIDOL#0.6400;PEROXISOME#0.6384;T CELL DEVELOPMENT#0.6330;ORAL CANCER CELL#0.6316;HEPATOCYTE PROLIFERATION#0.6307;CERVIX#0.6302;BLADDER CARCINOMA#0.6280;PROXIMAL TUBULAR CELL#0.6280;CENTROSOME#0.6277;ENDOMETRIAL CARCINOMA#0.6271;ADIPOCYTE#0.6260;GRANULOCYTE#0.6252;LOCALISATION#0.6248;CHROMOSOME REGION#0.6240;CANCER STEM CELL#0.6231;DNA TOPOISOMERASE#0.6226;GLOMERULONEPHRITIS#0.6225;PANCREATIC DUCTAL ADENOCARCINOMA#0.6223;INTERNATIONAL PROGNOSTIC INDEX#0.6221;T CELL ACTIVATION#0.6215;HEPATITIS B#0.6214;MONONUCLEAR CELLS#0.6188;HAIR FOLLICLE#0.6187;ARGININE#0.6180;NON-SMALL CELL LUNG CARCINOMA#0.6165;ORAL SQUAMOUS CARCINOMA#0.6159;ENTEROCYTE DIFFERENTIATION#0.6158;T CELL DIFFERENTIATION#0.6157;MORPHOGENESIS#0.6154;SIMVASTATIN#0.6154;TYROSINE KINASE RECEPTOR#0.6143;FOCAL ADHESION KINASE#0.6132;ACTINOMYCIN D#0.6131;INTESTINAL EPITHELIAL CELL#0.6126;CELL CYCLE DYSREGULATION#0.6126;COPY NUMBER VARIATION#0.6125;NUCLEAR LOCALIZATION SIGNAL#0.6120;SOMATOSTATIN RECEPTOR#0.6114;ADVANCED OVARIAN CANCER#0.6080;HOST CELL#0.6067;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.6049;CORONARY ARTERY#0.6048;PROTEINURIA#0.6035;PERIPHERAL NERVE INJURY#0.6033;IN VIVO ELECTROPORATION#0.6033;PARATHYROID GLAND#0.6000
102800310	AUTOPHAGY#1.0678;APOPTOSIS#0.9911;SIGNALING PATHWAY#0.6739;LYMPHOMA CELL LINES#0.6407;MANTLE CELL LYMPHOMA#0.6370;LUNG CARCINOMA#0.6270;DISEASE FREE SURVIVAL#0.6244;OVARIAN CANCER#0.6214;HEPATOCELLULAR CARCINOMA#0.6196
102800311	CANCER CELL#1.0680;CELL PROLIFERATION#1.0653;APOPTOSIS#1.0581;SIGNALING PATHWAY#1.0189;SMOOTH MUSCLE#1.0167;SMOOTH MUSCLE CELL#1.0023;MUSCLE CELL#1.0015;CELL CYCLE#0.9852;HEPATOCELLULAR CARCINOMA#0.9473;VASCULAR SMOOTH MUSCLE CELL#0.9079;COLORECTAL CANCER#0.8912;TUMOR SUPPRESSOR#0.8552;POLYMERASE CHAIN REACTION#0.8521;GENE EXPRESSION#0.8451;PROSTATE CANCER#0.8105;LIVER CANCER#0.7848;ENDOTHELIAL CELL#0.7449;COLORECTAL#0.7305;AORTIC ANEURYSM#0.7034;HEPATIC STELLATE CELL#0.7015;CORONARY ARTERY#0.6957;CELL GROWTH#0.6906;DNA DAMAGE RESPONSE#0.6487;HYPOXIC#0.6480;GLYCOLYSIS#0.6477;REVERSE TRANSCRIPTION#0.6429;ARTERY#0.6413;GINKGO BILOBA EXTRACT#0.6411;GINKGO BILOBA#0.6339;HYPOXIA#0.6295;CELL MIGRATION#0.6248;VASCULAR ENDOTHELIAL CELL#0.6177;EPITHELIAL MESENCHYMAL TRANSITION#0.6168;HEPATITIS B#0.6159;COLON CANCER#0.6148;GLUTAMINE CATABOLISM#0.6093
10280	LATERAL SCLEROSIS#1.0448;AMYOTROPHIC LATERAL SCLEROSIS#1.0406;PENTAZOCINE#1.0292;ENDOPLASMIC RETICULUM#1.0236;ION CHANNEL#1.0034;MITOCHONDRIA#0.9930;NEUROPROTECTION#0.9900;CELL DEATH#0.9879;SPINAL CORD#0.9846;NEURODEGENERATIVE DISEASE#0.9660;NEUROPATHY#0.9528;FLUVOXAMINE#0.9506;ER MEMBRANE#0.9363;ALZHEIMER'S DISEASE#0.9149;HEREDITARY MOTOR NEUROPATHY#0.8998;PROTEIN KINASE#0.8960;APOPTOSIS#0.8768;GANGLION CELLS#0.8736;NMDA RECEPTOR#0.8690;PLASMA MEMBRANE#0.8530;NEURITE#0.8064;RETINAL GANGLION CELL#0.8041;DOPAMINE#0.7964;GENE EXPRESSION#0.7879;NERVOUS SYSTEM#0.7847;ETHANOL#0.7662;NEURITE OUTGROWTH#0.7648;PARKINSON'S DISEASE#0.7363;SIGNALING PATHWAY#0.7311;ASTROCYTE#0.7184;HALOPERIDOL#0.7158;NUCLEAR ENVELOPE#0.7053;CENTRAL NERVOUS SYSTEM#0.7036;METHAMPHETAMINE#0.6995;ER STRESS RESPONSE#0.6971;AUTOPHAGY#0.6954;HUNTINGTON'S DISEASE#0.6910;CARDIOMYOCYTE#0.6877;CANCER CELL#0.6768;MOTOR NEURON DISEASE#0.6731;OPIOID RECEPTOR#0.6665;CAMKIV#0.6611;PROTEASOME#0.6554;TOXICITY#0.6539;RECEPTOR ANTAGONIST#0.6531;RECEPTOR AGONIST#0.6382;ASPARTATE#0.6382;ENDOPLASMIC RETICULUM STRESS#0.6315;CHRONIC NEUROPATHIC PAIN#0.6258;UBIQUITIN PROTEASOME PATHWAY#0.6120;PROTEASOME PATHWAY#0.6100;RECEPTOR LIGAND#0.6083;MAJOR DEPRESSIVE DISORDER#0.6077;OPTIC NERVE#0.6054;DEMENTIA#0.6041;DENDRITIC SPINE#0.6034;PROTEIN KINASE B#0.6030;CYTOPLASM#0.6019;PROTEIN PROTEIN INTERACTION#0.6002
10281	DOWN SYNDROME#0.9127;PERIPHERAL BLOOD CELLS#0.6416;PERIPHERAL BLOOD#0.6210
10282	PHOSPHORAMIDON#0.9452;ENDOPLASMIC RETICULUM#0.9407;SNARE COMPLEX#0.9368;CARDIAC ARREST#0.8320;TRANEXAMIC ACID#0.7830;GOLGI COMPLEX#0.7649;GOLGI APPARATUS#0.7615;CELL WALL#0.7608;ER TO GOLGI TRANSPORT#0.7578;VESICULAR TRANSPORT#0.7454;PULMONARY EMBOLISM#0.7054;TOPICAL#0.6262;TRANSPORT VESICLE#0.6224
10283	RETINAL DEGENERATION#0.7141;SPLICEOSOME#0.6143
10284	HISTONE DEACETYLASE#1.0231;HDAC COMPLEX#0.9575;HISTONE DEACETYLASE COMPLEX#0.9286;TRANSCRIPTION FACTOR#0.8424;UBIQUITIN#0.7613;GENE EXPRESSION#0.7098;TRANSCRIPTIONAL REPRESSOR COMPLEX#0.6250
10285	SKIN CANCER#0.7810;SPLICEOSOME#0.7296;SURVIVAL MOTOR NEURON#0.7267;TOPICAL#0.7243;PHOTOPROTECTION#0.6922
10286	DASH COMPLEX#1.1406;DAM1 COMPLEX#1.1232;COMPLEX I#1.0712;KINETOCHORE#1.0578;BREAST CANCER#1.0465;MICROTUBULE#1.0410;CANCER CELL#1.0325;KINETOCHORE MICROTUBULE#1.0308;MICROTUBULE BINDING#1.0220;CHROMOSOME SEGREGATION#1.0215;BUDDING#1.0199;MITOSIS#0.9795;BREAST CANCER CELL#0.9623;SPINDLE MICROTUBULE#0.9560;MRNA SPLICING#0.9514;MICROTUBULE DEPOLYMERIZATION#0.9402;CELL CYCLE#0.9188;PRE-MRNA SPLICING#0.9151;NDC80 COMPLEX#0.9084;CENTROMERE#0.8775;KINETOCHORE-MICROTUBULE ATTACHMENT#0.8760;MITOTIC SPINDLE#0.8748;PROTEIN COMPLEX#0.8120;ESTROGEN RECEPTOR#0.8109;SPINDLE POLE#0.8108;METAPHASE#0.8069;ANAPHASE#0.7984;MICROTUBULE PLUS END#0.7753;BREAST CARCINOMA#0.7736;MICROTUBULE END#0.7443;APOPTOSIS#0.7382;SPINDLE ASSEMBLY#0.6979;CHROMATID#0.6937;CENTROMERE CLUSTERING#0.6889;PROTEIN PROTEIN INTERACTION#0.6871;SPINDLE ASSEMBLY CHECKPOINT#0.6730;MICROTUBULE DYNAMICS#0.6718;BIPOLAR ATTACHMENT#0.6457;KINETOCHORE LOCALIZATION#0.6447;SPLICEOSOME#0.6441;PROTEIN KINASE#0.6382
10287	GROWTH FACTOR#0.9783;GTPASE ACTIVITY#0.9703;CELL PROLIFERATION#0.9676;OPIOID RECEPTOR#0.9634;SIGNALING PATHWAY#0.9600;PROTEIN KINASE#0.9382;GAP ACTIVITY#0.9239;HETEROTRIMERIC G-PROTEIN#0.9230;GTP HYDROLYSIS#0.9129;CANCER CELL#0.9094;CLATHRIN COATED VESICLE#0.8829;COATED VESICLE#0.8783;RECEPTOR TYROSINE KINASE#0.8654;AUTOPHAGY#0.7787;COLON CANCER#0.7612;EPITHELIAL CELL#0.7591;PROTEIN KINASE C#0.7404;PLASMA MEMBRANE#0.7136;TRANS GOLGI NETWORK#0.6968;WNT RECEPTOR#0.6621;CELL MEMBRANE#0.6610;SIGNAL TRANSDUCTION#0.6596;MITOGEN ACTIVATED PROTEIN#0.6407;PDZ BINDING MOTIF#0.6365;MACROAUTOPHAGY#0.6196;OVARIAN CANCER#0.6182;CELL CYCLE#0.6140;DORSAL ROOT GANGLION#0.6070
10288	ENDOTHELIAL CELL#1.0404;MONOCYTE#1.0270;CELL SURFACE#1.0139;LEUKOCYTE#1.0133;DENDRITIC CELL#1.0119;HUMAN LEUKOCYTE ANTIGEN#1.0077;CANCER CELL#1.0046;ANTIGEN PRESENTING CELLS#1.0032;MACROPHAGE#0.9943;T CELL#0.9931;IMMUNE CELL#0.9882;GENE EXPRESSION#0.9875;IMMUNE RESPONSE#0.9854;PERIPHERAL BLOOD#0.9732;LUNG CANCER#0.9646;CELL PROLIFERATION#0.9384;SIGNALING PATHWAY#0.9343;POLYMERASE CHAIN REACTION#0.8962;TOLEROGENIC DENDRITIC CELLS#0.8951;MAJOR HISTOCOMPATIBILITY COMPLEX#0.8909;STEM CELL#0.8856;LYMPH NODE#0.8690;IMMUNE SYSTEM#0.8618;CD8+ T CELL#0.8448;REGULATORY T CELL#0.8258;GROWTH FACTOR#0.8223;B CELL#0.8176;TUMOR CELLS#0.8175;CELL ACTIVATION#0.8080;TUMOR TISSUES#0.7936;CYTOKINE PRODUCTION#0.7841;CD4+ T CELL#0.7622;APOPTOSIS#0.7563;MYELOID CELL#0.7545;STROMAL CELL#0.7443;SMOOTH MUSCLE#0.7409;IFN-GAMMA#0.7303;HEPATOCELLULAR CARCINOMA#0.7266;CYTOTOXICITY#0.7103;T CELL PROLIFERATION#0.7102;PERIPHERAL BLOOD MONOCYTES#0.6927;IL-10 PRODUCTION#0.6863;AUTOIMMUNE DISEASE#0.6814;MONONUCLEAR CELLS#0.6638;TROPHOBLAST#0.6423;TRYPTOPHAN#0.6303;BREAST CANCER#0.6290;CELL DIFFERENTIATION#0.6231;CYTOKINE SECRETION#0.6136;TROPHOBLAST CELL#0.6084;MYELOID DENDRITIC CELL#0.6047;DUAL LUCIFERASE REPORTER#0.6017
1028	IMAGE SYNDROME#1.1366;VILLOUS CYTOTROPHOBLAST#1.0547;CYTOTROPHOBLAST#1.0508;LOSS OF METHYLATION#1.0380;STROMAL CELL#1.0353;PANCREATIC CANCER#1.0332;CDK INHIBITOR#1.0322;CYCLIN DEPENDENT KINASE INHIBITOR#1.0272;PODOCYTE#1.0267;IMPRINTING CONTROL REGION#1.0223;PROLIFERATING CELL NUCLEAR ANTIGEN#1.0215;KINASE INHIBITOR#1.0205;HEPATOCELLULAR CARCINOMA#1.0196;CYCLIN DEPENDENT KINASE#1.0166;MOLAR#1.0162;BECKWITH-WIEDEMANN SYNDROME#1.0142;PARTIAL HYDATIDIFORM MOLE#1.0139;INSULIN-LIKE GROWTH FACTOR#1.0103;PROTEIN KINASE#1.0088;TROPHOBLAST#1.0076;TUMOR SUPPRESSOR#1.0069;POLYMERASE CHAIN REACTION#1.0033;CELL CYCLE REGULATOR#1.0027;TRANSFORMING GROWTH FACTOR#1.0016;SKELETAL MUSCLE#1.0008;HISTONE DEACETYLASE#1.0004;CELL DIFFERENTIATION#0.9999;CELL CYCLE CONTROL#0.9986;TUMOR CELLS#0.9974;REVERSE TRANSCRIPTION#0.9972;DNA METHYLATION#0.9968;CELL CYCLE ARREST#0.9954;BREAST CANCER#0.9948;CELL CYCLE#0.9947;LYMPH NODE#0.9944;CELL CYCLE REGULATION#0.9922;G1 PHASE#0.9911;CELL GROWTH#0.9907;SENESCENCE#0.9891;S PHASE#0.9882;MUSCLE CELL#0.9875;APOPTOTIC#0.9867;CANCER CELL#0.9862;QUIESCENCE#0.9855;PROGENITOR CELL#0.9849;GROWTH FACTOR#0.9835;RETINOBLASTOMA#0.9829;OVARIAN#0.9827;CELL DEATH#0.9819;APOPTOSIS#0.9786;SIGNALING PATHWAY#0.9773;T CELL#0.9772;CHONDROCYTE#0.9766;EPITHELIAL CELL#0.9764;KINASE ACTIVITY#0.9745;STEM CELL#0.9740;5-AZA-2'-DEOXYCYTIDINE#0.9736;BONE MARROW#0.9736;2'-DEOXYCYTIDINE#0.9732;GESTATION#0.9730;CELL PROLIFERATION#0.9722;ONCOGENIC#0.9721;HISTONE DEACETYLASE INHIBITOR#0.9711;PLACENTAL DEVELOPMENT#0.9708;LUNG CANCER#0.9690;TRANSCRIPTION FACTOR#0.9673;CELL MIGRATION#0.9661;B CELL#0.9656;GENE EXPRESSION#0.9656;SMOOTH MUSCLE#0.9644;MYOBLAST#0.9636;DIFFERENTIALLY METHYLATED REGION#0.9632;UBIQUITIN#0.9595;SHORT TANDEM REPEAT#0.9589;TUMOR TISSUES#0.9587;PROTEASOME#0.9558;BREAST CANCER CELL#0.9476;HUMAN PANCREATIC CANCER#0.9469;COLORECTAL#0.9459;PRECURSOR CELL#0.9428;SCHWANN CELL#0.9412;NEUROGENESIS#0.9398;OVARIAN CANCER#0.9383;VILLOUS STROMAL CELL#0.9382;NERVOUS SYSTEM#0.9355;HEMATOPOIETIC STEM CELL#0.9347;DEXAMETHASONE#0.9338;CELL DIVISION#0.9299;BETA CELL#0.9280;SQUAMOUS CELL CARCINOMA#0.9276;CYTOPLASM#0.9265;SMOOTH MUSCLE CELL#0.9197;TRANSFORMING GROWTH FACTOR BETA#0.9178;TERMINAL DIFFERENTIATION#0.9176;SILVER RUSSELL SYNDROME#0.9151;DNA REPLICATION#0.9110;QUANTITATIVE REAL TIME#0.9110;KERATINOCYTE#0.9051;EMBRYONIC STEM CELL#0.9033;ENDOTHELIAL CELL#0.8976;DECIDUA#0.8956;PROSTATE CANCER#0.8943;NEURAL STEM CELL#0.8941;PROTEASOME PATHWAY#0.8930;DEMETHYLATION#0.8914;REGENERATION#0.8878;HYPOXIA#0.8870;OLIGODENDROCYTE#0.8844;HISTONE MODIFICATION#0.8822;METAPHYSEAL DYSPLASIA#0.8799;INDUCTION OF APOPTOSIS#0.8795;ACTIN CYTOSKELETON#0.8723;LYMPH NODE METASTASIS#0.8696;RNA INTERFERENCE#0.8693;B CELL LYMPHOMA#0.8605;CHORIOCARCINOMA#0.8599;GREEN TEA POLYPHENOL#0.8522;DNA SYNTHESIS#0.8497;VASCULAR SMOOTH MUSCLE CELL#0.8488;OVARIAN CARCINOMA#0.8429;CARDIOMYOCYTE#0.8391;SIGNAL TRANSDUCTION#0.8388;CENTRAL NERVOUS SYSTEM#0.8387;MYELOID LEUKEMIA#0.8342;CLEFT PALATE#0.8313;CHROMOSOMAL REGION#0.8296;ADENOCARCINOMA#0.8255;QUANTITATIVE REVERSE TRANSCRIPTION#0.8241;OSTEOBLAST#0.8220;DECIDUALIZATION#0.8219;PERIPHERAL BLOOD#0.8198;CELL ADHESION#0.8140;RETINAL PROGENITOR CELL#0.8132;UBIQUITIN PROTEASOME PATHWAY#0.8126;M PHASE#0.8115;FORMALIN#0.8098;DNA BINDING#0.8072;HYPOXIC#0.8062;DIFFUSE LARGE B-CELL LYMPHOMA#0.8018;MYELODYSPLASTIC SYNDROME#0.7993;ADRENAL CORTEX#0.7976;COLORECTAL CARCINOMA#0.7943;HYPERTENSION#0.7929;LIPID RAFT#0.7910;SPINAL CORD#0.7909;REGULATION OF CELL CYCLE#0.7872;MITOSIS#0.7849;TRANSCRIPTASE#0.7831;INHIBITION OF CELL PROLIFERATION#0.7830;HUMAN BREAST CANCER#0.7818;APOPTOTIC CELL DEATH#0.7813;CYCLIN BINDING#0.7726;FIBROBLAST GROWTH FACTOR#0.7689;TRANSACTIVATION#0.7670;GENE SILENCING#0.7574;MAMMARY EPITHELIAL CELL#0.7477;HISTONE DEACETYLATION#0.7466;TROPHOBLAST GIANT CELLS#0.7458;MOUSE EMBRYONIC STEM#0.7448;METHYLATION SPECIFIC PCR#0.7428;TROPHOBLAST CELL#0.7428;FACTOR I#0.7423;ADRENOCORTICAL CARCINOMA#0.7422;PATERNALLY EXPRESSED GENE#0.7417;EPITHELIAL CELL PROLIFERATION#0.7405;TYPE 2 DIABETES#0.7404;C TERMINAL DOMAIN#0.7401;DNA METHYLTRANSFERASE#0.7399;COLORECTAL CANCER#0.7382;MORPHOGENESIS#0.7378;DISEASE FREE SURVIVAL#0.7375;RHABDOMYOSARCOMA#0.7352;BLADDER CARCINOMA#0.7253;ANGIOGENESIS#0.7246;ONCOGENESIS#0.7234;CEREBRAL CORTEX#0.7213;LEYDIG CELL#0.7190;CORTICOGENESIS#0.7176;POLYPYRIMIDINE TRACT BINDING#0.7161;ACUTE MYELOID LEUKEMIA#0.7153;CDK ACTIVITY#0.7141;OOCYTE#0.7122;FETAL GROWTH RESTRICTION#0.7113;PROTEIN KINASE INHIBITOR#0.7058;DOPAMINERGIC NEURON#0.7036;THYROID CARCINOMA#0.7028;DNA DAMAGE RESPONSE#0.7015;MESENCHYME#0.7000;ACUTE LYMPHOCYTIC LEUKEMIA#0.6955;DIABETES MELLITUS#0.6948;SYNCYTIOTROPHOBLAST#0.6909;MACROPHAGE#0.6883;CELL MOTILITY#0.6848;LYMPHOCYTIC LEUKEMIA#0.6841;NEUROBLASTOMA#0.6826;ENDOTHELIAL GROWTH FACTOR#0.6778;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6778;INTERNEURON#0.6770;ALLELE SPECIFIC EXPRESSION#0.6737;LENS DEVELOPMENT#0.6733;PROTEIN SYNTHESIS#0.6701;MONONUCLEAR CELLS#0.6691;NEURAL CELL#0.6688;DNASE#0.6636;LYSINE#0.6605;CELL ADHESION MOLECULE#0.6591;DOPAMINE#0.6572;PRE-ECLAMPSIA#0.6497;GLUCOCORTICOID RECEPTOR#0.6491;WOUND HEALING#0.6473;BONE MORPHOGENETIC PROTEIN#0.6443;PROTEIN PROTEIN INTERACTION#0.6442;DNA REPAIR#0.6428;HYPERINSULINISM#0.6405;CHONDROCYTE DIFFERENTIATION#0.6368;REPLICATIVE SENESCENCE#0.6360;PODOCYTE DIFFERENTIATION#0.6341;ASTROCYTOMA#0.6314;GROWTH FACTOR RECEPTOR#0.6287;BRAIN DEVELOPMENT#0.6285;PAPILLARY THYROID CARCINOMA#0.6283;MESENCHYMAL CELL#0.6280;DNASE I#0.6274;HEMATOPOIESIS#0.6258;COLONY FORMATION ASSAY#0.6247;TO THE PROGRESSION#0.6246;METHYLATION SPECIFIC POLYMERASE#0.6239;KINASE INHIBITOR PROTEIN#0.6205;ADIPOSE TISSUE#0.6193;MOUSE EMBRYONIC FIBROBLAST#0.6151;FETAL KIDNEY#0.6145;CLEAVED CASPASE 3#0.6136;SOMATIC TISSUE#0.6121;CELL QUIESCENCE#0.6103;OMPHALOCELE#0.6035;HUMAN MAMMARY EPITHELIAL#0.6032
10290	STRIATED MUSCLE#1.0762;PROTEIN KINASE#1.0282;SMOOTH MUSCLE#0.9983;DILATED CARDIOMYOPATHY#0.9938;CARDIOMYOPATHY#0.9637;MUSCLE CELL#0.8709;SMOOTH MUSCLE CELL#0.8610;CARDIOMYOCYTE#0.8001;SKELETAL MUSCLE#0.7836;CENTRONUCLEAR MYOPATHY#0.7561;MYOPATHY#0.6953;TRANSVERSE TUBULE#0.6685;VASCULAR SMOOTH MUSCLE CELL#0.6214
10291	U2 SNRNP#1.0827;SPLICEOSOME#0.8982;GENE EXPRESSION#0.8040;MRNA SPLICING#0.7820;PRE-MRNA SPLICING#0.6478;17S U2 SNRNP#0.6365;SMALL NUCLEAR RIBONUCLEOPROTEIN#0.6168;SPLICEOSOME ASSEMBLY#0.6038
10293	UBIQUITIN#1.0383;DNA DAMAGE RESPONSE#0.9614;TUMOR NECROSIS FACTOR#0.9006;CELL CYCLE#0.8431;MITOSIS#0.7729;DNA REPLICATION#0.7612;REPLICATION FORK#0.7486;CELL PROLIFERATION#0.7173;TRAF SIGNALING#0.7158;LIGASE ACTIVITY#0.6881;REPLISOME#0.6786;SECKEL SYNDROME#0.6254
10294	HEAT SHOCK PROTEIN#1.0239;ATPASE ACTIVITY#1.0195;PROTEIN FOLDING#1.0075;ATP HYDROLYSIS#0.9948;CHAPERONE ACTIVITY#0.9299;ENDOPLASMIC RETICULUM#0.8376;NUCLEOTIDE EXCHANGE FACTOR#0.8135;CYCLOPHILIN#0.7887;SUBSTRATE BINDING DOMAIN#0.7336;C TERMINAL DOMAIN#0.7204;MITOCHONDRIAL PROTEIN IMPORT#0.7121;GENE EXPRESSION#0.7064;PROTEIN IMPORT#0.6986;IMMUNE RESPONSE#0.6817;TUMOR SUPPRESSOR#0.6798;CELL CYCLE#0.6352;T CELL#0.6318;TRANSCRIPTION FACTOR#0.6234;ISOMERASE ACTIVITY#0.6206
10295	ALPHA KETOACID DEHYDROGENASE#1.1161;DEHYDROGENASE COMPLEX#1.0636;CATABOLISM#1.0237;KINASE ACTIVITY#0.9583;PROTEIN KINASE#0.9108;PYRUVATE DEHYDROGENASE KINASE#0.8915;PYRUVATE#0.8332;SKELETAL MUSCLE#0.8231;INTELLECTUAL DISABILITY#0.7049;COMPLEX I#0.6711;LEUCINE#0.6399;MITOCHONDRIA#0.6254
10296	ERYTHROBLAST#1.0698;MACROPHAGE#1.0519;TETRAHYDROCANNABINOL#1.0125;CELL WALL#1.0082;ETHANOL#1.0063;BONE MARROW#0.9821;ERYTHROID CELL#0.9558;MULTIPLE SCLEROSIS#0.9007;DELTA-9-TETRAHYDROCANNABINOL#0.8926;GENE EXPRESSION#0.8441;ANTIOXIDANT ACTIVITY#0.8354;SECONDARY CELL WALL#0.8304;FERMENTATION#0.8242;YOLK SAC#0.8182;TOXICITY#0.7998;LUNG DISEASE#0.7987;GERMINATION#0.7904;FETAL LIVER#0.7894;SCANNING ELECTRON MICROSCOPY#0.7871;SOY PROTEIN ISOLATE#0.7720;SUCCINIC ACID#0.7708;FLOWERING#0.7673;ERYTHROPOIESIS#0.7514;APOPTOSIS#0.7384;DIGESTION#0.7331;LUNG CANCER#0.7007;GROWTH REGULATOR#0.7000;HEMATOPOIESIS#0.6872;FRAGMENT LENGTH POLYMORPHISM#0.6858;SEX CHROMOSOME#0.6837;ERYTHROCYTE#0.6830;DIABETES MELLITUS#0.6818;TYPE 2 DIABETES MELLITUS#0.6700;2 DIABETES MELLITUS#0.6700;CELL MOTILITY#0.6679;TYPE 2 DIABETES#0.6663;FORCED EXPIRATORY VOLUME#0.6540;NERVOUS SYSTEM#0.6530;DRONABINOL#0.6522;DELTA-9-THC#0.6519;CANNABINOID RECEPTOR#0.6501;HISTAMINE#0.6499;INTERNAL TRANSCRIBED SPACER#0.6442;CHRONIC RESPIRATORY DISEASE#0.6430;SWELLING#0.6296;CELL MIGRATION#0.6231;ENUCLEATION#0.6214;RAPAMYCIN#0.6189;PERIPHERAL BLOOD#0.6127
10297	ADENOMATOUS POLYPOSIS COLI#1.0535;MICROTUBULE#1.0385;TUMOR SUPPRESSOR#1.0340;SIGNALING PATHWAY#1.0115;CANCER CELL#0.9935;5 AZC#0.9533;NERVOUS SYSTEM#0.9393;ADENOMATOSIS POLYPOSIS COLI#0.9261;WNT SIGNALING PATHWAY#0.9205;CELL PROLIFERATION#0.8901;COLORECTAL CANCER#0.8320;COLORECTAL#0.7797;OVARIAN CANCER#0.7516;OVARIAN#0.7278;COLON CANCER#0.7229;CENTRAL NERVOUS SYSTEM#0.6916;BREAST CANCER#0.6895;DENDRITE BRANCH#0.6664;STEM CELL#0.6453;CENTROSOME#0.6419;CELL CYCLE#0.6351;GENE EXPRESSION#0.6335;MITOTIC SPINDLE#0.6250;LUNG CANCER#0.6115
10298	BREAST CANCER#1.0718;BREAST CANCER CELL#1.0643;KINASE ACTIVITY#1.0498;CELL MIGRATION#1.0375;CANCER CELL#1.0344;ONCOGENIC#1.0334;P21 ACTIVATED KINASE#1.0325;CELL CYCLE#1.0320;EPITHELIAL CELL#1.0316;CELL PROLIFERATION#1.0302;PANCREATIC CANCER#1.0301;LUNG CANCER#1.0265;SIGNALING PATHWAY#1.0192;PROTEIN KINASE#1.0178;APOPTOSIS#1.0177;CELL GROWTH#1.0148;CELL MOTILITY#0.9934;GROWTH FACTOR#0.9928;CELL ADHESION#0.9911;PROSTATE CANCER#0.9849;ANCHORAGE INDEPENDENT GROWTH#0.9834;ACTIN CYTOSKELETON#0.9611;GENE EXPRESSION#0.9581;FOCAL ADHESION#0.9517;HUMAN BREAST CANCER#0.9215;KINASE INHIBITOR#0.9015;CELL DEATH#0.8750;SIGNALING CASCADE#0.8706;MAMMARY EPITHELIAL CELL#0.8590;TRANSCRIPTION FACTOR#0.8562;TUMOR NECROSIS FACTOR#0.8520;SIGNALLING PATHWAY#0.8513;COLON CANCER#0.8511;APICAL JUNCTION#0.8445;COLORECTAL CANCER#0.8394;TUMOR SUPPRESSOR#0.8296;ENDOMETRIUM#0.8296;ADENOCARCINOMA#0.8288;MITOGEN ACTIVATED PROTEIN#0.8261;LYMPH NODE#0.8254;ENDOTHELIAL CELL#0.8193;AKT SIGNALING#0.8111;EPITHELIAL MESENCHYMAL TRANSITION#0.8015;ACINAR CELL#0.8007;CISPLATIN#0.7988;CYTOPLASM#0.7728;PANCREATIC DUCTAL ADENOCARCINOMA#0.7576;MORPHOGENESIS#0.7554;STRESS FIBER#0.7519;ENDOMETRIAL CANCER#0.7501;CELL CYCLE ARREST#0.7494;STEM CELL#0.7443;COLORECTAL#0.7330;RNA INTERFERENCE#0.7281;SENESCENCE#0.7115;NERVOUS SYSTEM#0.7076;MICROTUBULE#0.7073;ENDOTHELIAL MICROPARTICLE#0.7014;MOLECULAR DYNAMICS SIMULATION#0.6969;CELL JUNCTION#0.6928;TOXICITY#0.6878;PROTEIN KINASE A#0.6798;FOCAL ADHESION KINASE#0.6791;MAMMARY GLAND#0.6764;HEPATOCELLULAR CARCINOMA#0.6756;INFLAMMATORY RESPONSE#0.6744;CYCLIN DEPENDENT KINASE#0.6741;OVARIAN#0.6729;CELL CELL JUNCTION#0.6717;NICOTINAMIDE#0.6641;OVARIAN CANCER#0.6583;G1 PHASE#0.6543;GROWTH FACTOR RECEPTOR#0.6497;NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE#0.6460;PODOSOME RING#0.6439;ACTIN POLYMERIZATION#0.6391;SPINDLE POSITIONING#0.6293;GUANINE EXCHANGE FACTOR#0.6226;METASTATIC GASTRIC CANCER#0.6215;STRESS FIBRE#0.6185;DISEASE FREE SURVIVAL#0.6104;S PHASE#0.6092;RHOGEF#0.6083;CLEAR CELL RENAL CELL CARCINOMA#0.6037
102997063	INTELLECTUAL DISABILITY#1.1965
10299	UBIQUITIN#1.0592;ER MEMBRANE#1.0225;ENDOPLASMIC RETICULUM#1.0110;PROTEASOME#0.9517;PROTEIN DEGRADATION#0.9275;CHOLESTEROL SYNTHESIS#0.9111;PROTEIN QUALITY CONTROL#0.8361;NUCLEAR ENVELOPE#0.8273;TRANSCRIPTION FACTOR#0.8215;ERAD PATHWAY#0.8077;INNER NUCLEAR MEMBRANE#0.7862;NUCLEAR MEMBRANE#0.7770;COENZYME A#0.7320;CHOLESTEROL BIOSYNTHESIS#0.6598;ENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION#0.6320;GENE EXPRESSION#0.6101
1029	ARF BINDING#1.0803;OROPHARYNX CANCER#1.0609;ALTERNATIVE READING FRAME#1.0516;VAGINAL CANCER#1.0495;ORAL EPITHELIAL DYSPLASIA#1.0475;HYBRID CAPTURE 2#1.0456;MURINE DOUBLE MINUTE#1.0419;INTRAEPITHELIAL NEOPLASM#1.0391;ANAL INTRAEPITHELIAL NEOPLASIA#1.0378;ACTINIC KERATOSIS#1.0373;PHOSPHATASE AND TENSIN HOMOLOG#1.0348;NORMAL CERVICAL TISSUE#1.0346;PERITONEAL MESOTHELIOMA#1.0345;EMBRYONAL CARCINOMA#1.0317;ADENOMATOUS POLYPOSIS COLI#1.0314;SUMOYLATION#1.0304;SPUTUM#1.0298;ASCUS#1.0278;MULTIPLE PRIMARY MELANOMA#1.0262;NUCLEOPLASM#1.0256;FAMILIAL MELANOMA#1.0248;NULL CELL#1.0247;GALLBLADDER CARCINOMA#1.0244;PLEOMORPHIC ADENOMA#1.0241;RIBOSOME BIOGENESIS#1.0232;NUCLEOLUS#1.0227;HIGH GRADE LESION#1.0219;BETA-GALACTOSIDASE ACTIVITY#1.0218;INVERTED PAPILLOMA#1.0217;LIQUID BASED CYTOLOGY#1.0214;PENILE CANCER#1.0214;EYE DEVELOPMENT#1.0212;NUCLEOTIDE EXCHANGE FACTOR#1.0201;ANAPLASTIC OLIGODENDROGLIOMA#1.0201;SMOOTH MUSCLE TUMOR#1.0191;P53 SIGNALING PATHWAY#1.0178;CDK ACTIVITY#1.0163;RETINOIC ACID RECEPTOR#1.0153;LARYNGEAL SQUAMOUS CELL CARCINOMA#1.0152;ATYPICAL SQUAMOUS CELLS#1.0146;NEUROFIBROMA#1.0145;MDM2 BINDING#1.0141;NEURAL CELL#1.0139;COLON CARCINOMA#1.0136;ENDOMETRIAL ADENOCARCINOMA#1.0136;LEIOMYOMA#1.0129;CYCLIN DEPENDENT KINASE INHIBITOR#1.0129;CERVICAL ADENOCARCINOMA#1.0128;BETA-2#1.0127;MOUSE EMBRYO FIBROBLASTS#1.0120;ENDOCERVICAL ADENOCARCINOMA#1.0118;QUANTITATIVE METHYLATION SPECIFIC#1.0114;LARYNGEAL CARCINOMA#1.0113;MALT LYMPHOMA#1.0112;CDK INHIBITOR#1.0109;KERATOSIS#1.0108;FOLLICULAR ADENOMA#1.0106;LICHEN PLANUS#1.0100;GASTRIC TISSUE#1.0094;METHYLATION SPECIFIC POLYMERASE#1.0093;HISTIDINE#1.0090;ESOPHAGEAL CARCINOMA#1.0087;METASTATIC LYMPH NODE#1.0084;ACUTE LYMPHOCYTIC LEUKEMIA#1.0082;TONGUE CANCER#1.0078;COLORECTAL ADENOCARCINOMA#1.0076;INTERPHASE#1.0074;CERVICAL CANCER SCREENING#1.0073;LYNCH SYNDROME#1.0072;UVEAL MELANOMA#1.0072;LIVER CIRRHOSIS#1.0072;NON-SMALL CELL LUNG CARCINOMA#1.0071;BIOTIN#1.0068;LYMPHOCYTIC CHORIOMENINGITIS#1.0067;RETINOIC ACID#1.0065;MESOTHELIOMA CELL#1.0063;CLEAVED CASPASE 3#1.0062;HUMAN MAMMARY EPITHELIAL#1.0059;BLADDER CARCINOMA#1.0058;HODGKIN'S LYMPHOMA#1.0056;FAMILIAL PANCREATIC CANCER#1.0056;EWING SARCOMA#1.0055;GASTRIC ADENOCARCINOMA#1.0055;COLORECTAL ADENOMA#1.0055;LIGASE ACTIVITY#1.0053;PROSTATE CARCINOMA#1.0051;CHROMOSOME REGION#1.0049;STRESS-INDUCED PREMATURE SENESCENCE#1.0048;LEIOMYOSARCOMA#1.0047;GALECTIN#1.0042;CANCER SPECIFIC SURVIVAL#1.0042;HUMAN PANCREATIC CANCER#1.0041;LIPOSARCOMA#1.0040;GALLBLADDER#1.0035;CERVICAL SQUAMOUS CELL CARCINOMA#1.0033;KINASE INHIBITOR#1.0033;EVENT FREE SURVIVAL#1.0028;MYCOSIS FUNGOIDES#1.0024;SCALP#1.0021;GALACTOSIDASE ACTIVITY#1.0020;SENESCENCE#1.0020;CYCLIN D1-CDK4 COMPLEX#1.0019;ALL TRANS RETINOIC ACID#1.0017;VON HIPPEL LINDAU#1.0016;PITUITARY ADENOMA#1.0015;SMOOTH MUSCLE ACTIN#1.0011;PILOCYTIC ASTROCYTOMA#1.0011;CYCLIN DEPENDENT KINASE#1.0009;MEDULLOBLASTOMA#1.0009;GTP BINDING#1.0007;POSITIVE PREDICTIVE VALUE#1.0006;MELANOMA CELL LINES#1.0006;VERRUCOUS CARCINOMA#1.0005;INVASIVE CERVICAL CANCER#1.0004;ESOPHAGEAL CANCER#1.0003;DEMETHYLATION#1.0003;PROLIFERATING CELL NUCLEAR ANTIGEN#1.0002;RIBOSOME#1.0000;ONCOGENE INDUCED SENESCENCE#0.9998;NORMAL BREAST TISSUE#0.9998;GENE COPY NUMBER#0.9995;ESTROGEN RECEPTOR#0.9992;LI-FRAUMENI SYNDROME#0.9991;CONTACT INHIBITION#0.9991;THYMOCYTE#0.9990;PROGESTERONE#0.9988;TOPOISOMERASE#0.9987;DEPHOSPHORYLATION#0.9987;CHONDROSARCOMA#0.9986;PANCREATIC CARCINOMA#0.9983;AMELOBLASTOMA#0.9982;CERVICITIS#0.9979;ARSENIC TRIOXIDE#0.9976;BILE DUCT#0.9975;COPY NUMBER GAIN#0.9975;MYOCYTES#0.9974;GENETICALLY ENGINEERED MOUSE#0.9974;OVARIAN CARCINOMA#0.9973;CELL CYCLE DYSREGULATION#0.9972;QUANTITATIVE REVERSE TRANSCRIPTION#0.9972;ANDROGEN RECEPTOR#0.9972;SMALL CELL CARCINOMA#0.9971;HYPOXIA INDUCIBLE FACTOR#0.9970;IMATINIB#0.9970;RNA BINDING PROTEIN#0.9969;ASTROCYTE#0.9969;ADJACENT NORMAL TISSUE#0.9969;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9968;METHYLATION SPECIFIC PCR#0.9967;BARRETT'S ESOPHAGUS#0.9964;ORAL MUCOSA#0.9963;MALIGNANT LYMPHOMA#0.9961;MALIGNANT GLIOMA#0.9957;CERVICAL INTRAEPITHELIAL NEOPLASIA#0.9956;RELAPSE FREE SURVIVAL#0.9956;SQUAMOUS INTRAEPITHELIAL LESION#0.9955;TO TUMOR PROGRESSION#0.9953;COLORECTAL CARCINOMA#0.9953;BASAL CELL CARCINOMA#0.9953;GUANINE#0.9953;AZACYTIDINE#0.9952;CELL CYCLE TRANSITION#0.9950;GASTROINTESTINAL STROMAL TUMOR#0.9947;COLITIS#0.9945;CERVICAL LYMPH NODE#0.9945;ULCERATIVE COLITIS#0.9945;VIRION#0.9945;CD8+ T CELL#0.9945;NEUROBLASTOMA#0.9945;HYPERMETHYLATION OF CPG ISLAND#0.9945;LUNG CARCINOMA#0.9941;MALIGNANT PLEURAL MESOTHELIOMA#0.9941;TO THE PROGRESSION#0.9939;BETA GALACTOSIDASE#0.9938;NERVE SHEATH TUMORS#0.9937;TOPOISOMERASE II#0.9936;INHIBITION OF CELL GROWTH#0.9935;LIVER METASTASIS#0.9935;MAMMARY EPITHELIAL CELL#0.9933;CELL DIVISION CYCLE#0.9932;DIFFUSE ASTROCYTOMA#0.9931;CELL CYCLE PATHWAY#0.9931;NEURAL STEM CELL#0.9931;TUMOR SUPPRESSOR#0.9930;HISTONE METHYLATION#0.9930;ANAL CANAL#0.9930;FOLLICULAR LYMPHOMA#0.9929;RHABDOMYOSARCOMA#0.9928;REGULATION OF CELL CYCLE#0.9924;NEGATIVE PREDICTIVE VALUE#0.9923;MEDIAN NERVE#0.9923;MOUSE EMBRYONIC FIBROBLAST#0.9923;DYSPLASTIC NEVUS#0.9922;LARGE CELL CARCINOMA#0.9922;DUCTAL CARCINOMA IN SITU#0.9922;MULTIPLE MYELOMA#0.9921;RETINOBLASTOMA#0.9921;CARDIOMYOCYTE#0.9920;FOLATE#0.9919;IFN-GAMMA#0.9919;BRONCHIAL EPITHELIAL CELLS#0.9919;CHONDROCYTE#0.9918;ADENOCARCINOMA IN SITU#0.9918;PLASMA CELL#0.9918;MAMMARY GLAND#0.9917;TELOMERASE ACTIVITY#0.9913;RIBOSOMAL RNA#0.9913;RIBOSOMAL PROTEIN#0.9912;MESOTHELIAL CELL#0.9909;LYMPHOCYTIC LEUKEMIA#0.9908;FOCAL ADHESION#0.9906;RNA BINDING#0.9905;LINES OF EVIDENCE#0.9905;URINARY BLADDER#0.9904;BETA CELL#0.9904;BREAST CARCINOMA#0.9903;5-AZA-2'-DEOXYCYTIDINE#0.9903;PANCREATIC ADENOCARCINOMA#0.9903;CELL AGING#0.9901;AUTOPHAGY#0.9899;2'-DEOXYCYTIDINE#0.9899;CENTROSOME#0.9897;MAP KINASE#0.9897;OVERALL SURVIVAL RATE#0.9896;TETRACYCLINE#0.9896;ENDOMETRIAL CARCINOMA#0.9895;MALIGNANT PERIPHERAL NERVE SHEATH TUMOR#0.9894;EOSIN#0.9892;ORAL SQUAMOUS CELL CARCINOMA#0.9892;CERVICAL#0.9892;CELL CYCLE PHASE#0.9892;URINARY BLADDER CANCER#0.9891;ANOIKIS#0.9890;GASTRIC MUCOSA#0.9889;OLIGODENDROGLIOMA#0.9886;CYTOCHROME C#0.9886;PRIMARY BREAST CANCER#0.9885;CELL CYCLE REGULATOR#0.9885;THYROID CARCINOMA#0.9883;ADENOID CYSTIC CARCINOMA#0.9882;CHOLANGIOCARCINOMA#0.9882;BONE MARROW CELLS#0.9881;MYOGENESIS#0.9881;REPLICATIVE SENESCENCE#0.9878;THYROID CANCER#0.9878;HEPATITIS B VIRUS#0.9875;SALIVARY GLAND#0.9874;CPG ISLAND METHYLATION#0.9873;GERM CELL#0.9873;LYMPH NODE INVOLVEMENT#0.9870;TELOMERE MAINTENANCE#0.9870;DNA METHYLTRANSFERASE#0.9868;HEPATITIS C VIRUS#0.9867;NUCLEAR EXPORT#0.9866;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9864;CERVICAL CANCER CELL LINES#0.9863;HIGH GRADE DYSPLASIA#0.9862;NEVUS#0.9861;TRANSACTIVATION#0.9861;MALIGNANT MESOTHELIOMA#0.9858;SQUAMOUS CELL CANCER#0.9857;ENDOMETRIAL CANCER#0.9857;SCHWANN CELL#0.9856;PLATELET-DERIVED GROWTH FACTOR#0.9855;NEUROENDOCRINE TUMOR#0.9854;LARYNX#0.9852;GLUTATHIONE#0.9851;HEPATOCELLULAR CARCINOMA CELL#0.9850;QUIESCENCE#0.9850;MELANOCYTE#0.9850;MISMATCH REPAIR#0.9845;INSULIN-LIKE GROWTH FACTOR#0.9845;INVASIVE CARCINOMA#0.9844;CARDIAC MUSCLE#0.9844;CELL CYCLE CHECKPOINT#0.9844;NEUROENDOCRINE CARCINOMA#0.9843;ASTROCYTOMA#0.9842;MONONUCLEAR CELLS#0.9842;VESICLE TRAFFICKING#0.9841;MAPK SIGNALING#0.9838;PAPILLARY CARCINOMA#0.9836;ATAXIA TELANGIECTASIA MUTATED#0.9834;INTRAHEPATIC CHOLANGIOCARCINOMA#0.9832;HIGH FAT DIET#0.9831;CORONARY ARTERY DISEASE#0.9830;LUNG CANCER#0.9830;ADULT T-CELL LEUKEMIA#0.9829;ARTERY DISEASE#0.9828;ESOPHAGUS#0.9828;TIME TO PROGRESSION#0.9828;EPIDERMAL GROWTH FACTOR#0.9827;CENTROMERE#0.9827;DOUBLE STRAND BREAK#0.9826;VULVA#0.9825;MUCINOUS ADENOCARCINOMA#0.9824;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9824;CERVICAL CANCER#0.9823;LYMPH NODE METASTASES#0.9822;PARATHYROID ADENOMA#0.9822;NORMAL ORAL MUCOSA#0.9820;INHIBITION OF CELL PROLIFERATION#0.9820;HEMATOPOIETIC CELL#0.9819;POLYCOMB REPRESSIVE COMPLEX#0.9819;BILIARY TRACT#0.9818;RISK OF DEATH#0.9818;PANCREATIC CANCER#0.9817;SOFT TISSUE SARCOMA#0.9816;PERIPHERAL NERVE#0.9815;CETUXIMAB#0.9813;HEPATITIS C#0.9813;ANAPLASTIC MENINGIOMA#0.9811;LYMPH NODE METASTASIS#0.9810;HOST CELL#0.9809;HETEROCHROMATIN#0.9809;DNA HYPERMETHYLATION#0.9809;METASTATIC MELANOMA#0.9807;PROTEIN PROTEIN INTERACTION#0.9807;CHRONIC MYELOID LEUKEMIA#0.9806;WHITE BLOOD CELL#0.9806;UBIQUITIN#0.9806;PROTEASOME#0.9806;TELOMERASE REVERSE TRANSCRIPTASE#0.9805;POLYMERASE CHAIN REACTION#0.9805;ACUTE LEUKEMIA#0.9804;BASAL CELL#0.9803;ARGININE#0.9802;TELOMERE#0.9800;SIGNALLING PATHWAY#0.9800;GROWTH FACTOR RECEPTOR#0.9799;AGE AT DIAGNOSIS#0.9798;OVARIAN CANCER#0.9797;MALIGNANT PLEURAL EFFUSION#0.9797;CELL CYCLE CONTROL#0.9796;NEURONAL CELLS#0.9795;ATAXIA TELANGIECTASIA#0.9794;TERMINAL DIFFERENTIATION#0.9793;AGEING#0.9792;HEPATITIS B#0.9791;LEUKOCYTE#0.9790;CERVIX#0.9789;HEPATOCYTE GROWTH FACTOR#0.9788;PROTEIN SYNTHESIS#0.9787;DIFFUSE LARGE B-CELL LYMPHOMA#0.9787;PROTEIN COMPLEX#0.9787;DISEASE SPECIFIC SURVIVAL#0.9786;OVARIAN#0.9785;CELLULAR SENESCENCE#0.9785;RECURRENCE FREE SURVIVAL#0.9784;RNA INTERFERENCE#0.9784;TRANSITIONAL CELL CARCINOMA#0.9784;ANCHORAGE INDEPENDENT GROWTH#0.9784;QUANTITATIVE REAL TIME#0.9783;MYELODYSPLASTIC SYNDROME#0.9782;VSMC PROLIFERATION#0.9781;CHROMOSOMAL REGION#0.9780;ADIPOSE TISSUE#0.9780;INVASIVE BREAST CANCER#0.9780;DNA FRAGMENTATION#0.9779;TUMOR TISSUES#0.9779;HEAT SHOCK PROTEIN#0.9779;CORONARY ARTERY#0.9779;INVASIVE DUCTAL CARCINOMA#0.9779;EPITHELIAL OVARIAN CANCER#0.9779;PANCREATITIS#0.9779;MANTLE CELL LYMPHOMA#0.9778;PHOSPHOLIPASE D#0.9776;STEM CELL MARKER#0.9774;AGGRESSIVE BEHAVIOR#0.9774;GALLBLADDER CANCER#0.9773;COPY NUMBER CHANGE#0.9773;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9772;AKT SIGNALING#0.9771;TRANSCRIPTASE#0.9770;DNA HYPOMETHYLATION#0.9770;OSTEOBLAST#0.9769;KERATINOCYTE#0.9769;HUMAN PAPILLOMA VIRUS#0.9769;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9769;CELL CYCLE#0.9768;THYMIC CARCINOMA#0.9768;ACUTE MYELOID LEUKEMIA#0.9767;ENDOTHELIAL GROWTH FACTOR#0.9766;HISTONE MODIFICATION#0.9764;NITRIC OXIDE SYNTHASE#0.9764;BURKITT LYMPHOMA#0.9764;ADIPOCYTE#0.9764;ORAL CAVITY#0.9763;NUCLEIC ACID#0.9763;HUMAN BREAST CANCER#0.9763;TONSIL#0.9760;NODULAR#0.9760;HYPERPHOSPHORYLATION#0.9760;GENE SILENCING#0.9759;HYPOXIA#0.9757;NEUROGENESIS#0.9756;POLYCOMB REPRESSIVE COMPLEX 1#0.9756;LUNG ADENOCARCINOMA#0.9756;METHIONINE#0.9755;T-CELL LEUKEMIA#0.9755;REVERSE TRANSCRIPTION#0.9754;ONCOGENESIS#0.9754;DERMAL FIBROBLAST#0.9753;FIBROBLAST GROWTH FACTOR#0.9753;MESANGIAL CELL#0.9753;ATHEROSCLEROSIS#0.9752;BREAST CANCER PATIENTS#0.9749;PROTEIN KINASE C#0.9749;PROTEIN PHOSPHORYLATION#0.9748;COLORECTAL#0.9748;G2 PHASE#0.9747;LUMINAL#0.9746;HEAD AND NECK CARCINOMA#0.9745;G1 PHASE#0.9745;CELL ADHESION MOLECULE#0.9745;DNA SYNTHESIS#0.9744;ENDOMETRIUM#0.9744;TRANSFORMING GROWTH FACTOR BETA#0.9744;YEAR SURVIVAL RATE#0.9744;LYSINE#0.9743;CELL CYCLE ARREST#0.9742;MICROTUBULE#0.9742;ALZHEIMER'S DISEASE#0.9741;SUPEROXIDE DISMUTASE#0.9741;DNA DAMAGE RESPONSE#0.9741;CELL DEVELOPMENT#0.9740;TONGUE SQUAMOUS CELL CARCINOMA#0.9739;TRANSCRIPTIONAL CONTROL#0.9738;SKELETAL MUSCLE#0.9737;COLORECTAL CANCER#0.9736;MYELOID LEUKEMIA#0.9735;ORAL LICHEN PLANUS#0.9734;KINASE ACTIVITY#0.9734;HISTONE ACETYLATION#0.9731;CANCER STEM CELL#0.9730;IMMUNE CELL#0.9729;TYPE 2 DIABETES MELLITUS#0.9729;2 DIABETES MELLITUS#0.9729;TYPE 2 DIABETES#0.9729;PAPILLOMA#0.9729;CELL ADHESION#0.9727;DENDRITIC CELL#0.9725;B LYMPHOCYTE#0.9723;FINE NEEDLE ASPIRATION#0.9722;CELL CYCLE REGULATION#0.9722;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9722;PROSTATE CANCER#0.9720;ATHEROSCLEROTIC#0.9720;LYMPHOMA CELL LINES#0.9720;EPITHELIAL TO MESENCHYMAL#0.9719;CARCINOMA IN SITU#0.9719;SEQUESTERING#0.9718;MUTAGENESIS#0.9717;B CELL LYMPHOMA#0.9716;COLON CANCER#0.9715;METASTATIC SQUAMOUS CELL CARCINOMA#0.9715;RAPAMYCIN#0.9715;MITOCHONDRIA#0.9714;HYPOXIC#0.9713;SMOOTH MUSCLE#0.9713;METAPLASIA#0.9711;EPSTEIN BARR VIRUS#0.9710;COPY NUMBER VARIATION#0.9710;HUMAN BRONCHIAL EPITHELIAL#0.9710;DIGESTION#0.9710;MUCINOUS NEOPLASM#0.9709;HIGH RISK PATIENTS#0.9709;BREAST CANCER#0.9709;INFLUENZA A VIRUS#0.9708;PANCREATIC DUCTAL ADENOCARCINOMA#0.9708;BREAST CANCER CELL#0.9707;CELL MIGRATION#0.9706;SPINAL CORD#0.9706;T CELL#0.9705;5 FLUOROURACIL#0.9701;PROTEIN KINASE B#0.9701;FORMALIN#0.9701;MRNA BINDING#0.9701;RISK OF RELAPSE#0.9700;NITRIC OXIDE#0.9698;ARTERY#0.9698;EMBRYONIC STEM CELL#0.9697;BINDING PROTEIN 3#0.9695;ISCHEMIA#0.9694;THYROID TRANSCRIPTION FACTOR#0.9693;REGULATION OF CELLULAR#0.9693;VASCULAR SMOOTH MUSCLE CELL#0.9693;TRANSFORMING GROWTH FACTOR#0.9692;REGENERATION#0.9692;DNA COPY NUMBER#0.9692;T LYMPHOCYTE#0.9690;PROTEIN KINASE#0.9690;PLURIPOTENT STEM CELL#0.9690;COMPLEX I#0.9690;LIVER DISEASE#0.9690;PRO-INFLAMMATORY#0.9689;SKIN CANCER#0.9689;PLASMA MEMBRANE#0.9689;RESPONSE TO TREATMENT#0.9688;CHROMATIN REMODELING#0.9688;LOW GRADE GLIOMAS#0.9688;MACROPHAGE#0.9687;PHARYNX#0.9686;POLYCOMB REPRESSIVE COMPLEXES#0.9685;COLUMNAR#0.9685;DISEASE FREE SURVIVAL#0.9685;GASTRITIS#0.9685;LIVER CANCER#0.9684;HISTONE DEACETYLASE INHIBITOR#0.9683;MITOCHONDRIAL MEMBRANE#0.9682;GLIAL CELL#0.9682;NASOPHARYNX#0.9681;ENDOMETRIOSIS#0.9681;ONCOGENIC#0.9680;S PHASE#0.9680;APOPTOTIC CELL DEATH#0.9676;EPITHELIAL MESENCHYMAL TRANSITION#0.9676;DOXORUBICIN#0.9675;SEBACEOUS CARCINOMA#0.9673;B CELL#0.9671;M PHASE#0.9671;TUMOR NECROSIS FACTOR#0.9670;DNA BINDING#0.9669;CELL MEMBRANE#0.9669;DNA METHYLATION#0.9668;HISTONE DEACETYLASE#0.9668;ADENOCARCINOMA#0.9668;XERODERMA PIGMENTOSUM#0.9668;LYMPH NODE#0.9666;DRUG RESISTANCE#0.9665;MYOCARDIAL INFARCTION#0.9664;COPY NUMBER ALTERATION#0.9664;GLIOBLASTOMA MULTIFORME#0.9664;CYTOPLASM#0.9664;GLIAL FIBRILLARY ACIDIC PROTEIN#0.9664;GENOTOXIC#0.9663;POLY ADP RIBOSE#0.9662;PERIPHERAL BLOOD#0.9661;MONOCYTE#0.9660;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9655;CELL GROWTH#0.9653;FLUOROURACIL#0.9653;LIPOMA#0.9653;INDUCTION OF APOPTOSIS#0.9652;PROGENITOR CELL#0.9652;PSORIASIS#0.9651;SMOOTH MUSCLE CELL#0.9651;HEAD AND NECK CANCER#0.9651;LEUCINE#0.9651;GROWTH FACTOR#0.9651;HEPATOCELLULAR CARCINOMA#0.9650;DENTATE GYRUS#0.9650;DNA REPAIR#0.9648;HEMATOPOIETIC STEM CELL#0.9648;DNA DEMETHYLATION#0.9648;NECK CANCER#0.9648;FRONTAL#0.9648;ACTIN CYTOSKELETON#0.9647;GROWTH PATTERN#0.9646;UBIQUITIN LIGASE ACTIVITY#0.9646;PACLITAXEL#0.9646;CELL DIVISION#0.9645;SQUAMOUS CELL CARCINOMA#0.9645;FACTOR I#0.9644;TUMOR CELLS#0.9642;DNA REPLICATION#0.9642;VIRAL INFECTION#0.9642;SIGNALING CASCADE#0.9642;RECEPTOR TYROSINE KINASE#0.9641;KERATINIZING SQUAMOUS CELL CARCINOMA#0.9641;RENAL CELL CARCINOMA#0.9641;TARGET OF RAPAMYCIN#0.9638;CD4+ T CELL#0.9638;BONE MORPHOGENETIC PROTEIN#0.9637;PRECURSOR CELL#0.9635;INFLAMMATORY RESPONSE#0.9632;SENESCENCE-ASSOCIATED HETEROCHROMATIN FOCI#0.9632;CELL PROLIFERATION#0.9632;RENAL CARCINOMA#0.9631;CYTOTOXICITY#0.9631;CLEAR CELL CARCINOMA#0.9631;CELL DIFFERENTIATION#0.9631;EPITHELIAL CELL#0.9630;DIABETES MELLITUS#0.9629;HEMATOPOIESIS#0.9629;MITOGEN ACTIVATED PROTEIN#0.9628;POSITRON EMISSION TOMOGRAPHY#0.9627;SKIN CARCINOMA#0.9627;THYMIDINE#0.9626;PERIPHERAL BLOOD LYMPHOCYTES#0.9624;MESENCHYMAL STEM CELL#0.9623;STROMAL CELL#0.9622;CISPLATIN#0.9621;MUSCLE CELL#0.9620;CANCER CELL#0.9620;APOPTOSIS#0.9618;THYMIDYLATE SYNTHASE#0.9618;CELL SURFACE#0.9614;FLAVOPIRIDOL#0.9613;ENDOTHELIAL CELL#0.9612;PEUTZ-JEGHERS SYNDROME#0.9611;HAIR FOLLICLE#0.9610;HEPATOMA CELLS#0.9609;MYELOID CELL#0.9609;PRIMARY CUTANEOUS MELANOMA#0.9609;PROGRAMMED CELL DEATH#0.9608;SIGNAL TRANSDUCTION#0.9608;ORAL CAVITY CANCER#0.9607;ANGIOGENESIS#0.9605;FIBROSARCOMA#0.9604;OVARIAN SEROUS CARCINOMA#0.9602;LYMPHOID TISSUE#0.9602;BONE MARROW#0.9602;APOPTOTIC#0.9600;ENDOPLASMIC RETICULUM#0.9600;SIGNET RING CELL#0.9599;ADULT STEM CELL#0.9599;HOMOLOGOUS RECOMBINATION#0.9598;STEM CELL TRANSPLANTATION#0.9598;WORLD HEALTH ORGANIZATION#0.9597;OXYGEN INDUCED RETINOPATHY#0.9596;STROMA#0.9596;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9596;TYROSINE KINASE INHIBITOR#0.9596;HIGH MOBILITY GROUP#0.9595;RIBOSE#0.9595;ACRAL LENTIGINOUS MELANOMA#0.9594;OXIDATIVE DNA DAMAGE#0.9594;WOUND HEALING#0.9594;SIGNAL TRANSDUCER#0.9591;REACTIVE OXYGEN SPECIES#0.9591;SPORADIC BREAST CANCER#0.9591;FRAGMENT LENGTH POLYMORPHISM#0.9591;DOMINANT NEGATIVE MUTANT#0.9590;CARCINOGEN#0.9586;REGIONAL LYMPH NODE#0.9585;COMPARATIVE GENOMIC HYBRIDIZATION#0.9584;ADENINE#0.9582;PARATHYROID#0.9580;IMMUNE SYSTEM#0.9579;STEM CELL#0.9576;MULTIPLE SCLEROSIS#0.9576;CANCER RELATED DEATH#0.9576;NUCLEUS PULPOSUS#0.9575;IMMUNE RESPONSE#0.9574;CARRIE#0.9574;P53 BINDING#0.9573;UNCERTAIN MALIGNANT POTENTIAL#0.9571;CORD BLOOD#0.9571;ENHANCER BINDING#0.9569;MITOSIS#0.9568;MEDIAN OVERALL SURVIVAL#0.9568;MECHANISM OF ACTION#0.9564;DIMETHYL SULFOXIDE#0.9561;SIGNALING PATHWAY#0.9561;HISTONE METHYLTRANSFERASE#0.9561;SPITZ NEVUS#0.9559;GASTROINTESTINAL TRACT#0.9559;TRANSCRIPTION FACTOR#0.9558;MUCOEPIDERMOID CARCINOMA#0.9557;GENE EXPRESSION#0.9556;ANAL SQUAMOUS CELL CARCINOMA#0.9554;FOCAL ADHESION KINASE#0.9554;SYNOVIAL SARCOMA#0.9554;CELL DEATH#0.9553;EXTRACELLULAR MATRIX#0.9550;GERM CELL TUMORS#0.9543;WHOLE GENOME SEQUENCING#0.9543;CELLULAR GROWTH#0.9542;HISTONE DEMETHYLASE#0.9542;HUMAN IMMUNODEFICIENCY VIRUS#0.9540;BINDING PROTEIN 1#0.9539;CELL MOTILITY#0.9537;TUMOR ASSOCIATED ANTIGEN#0.9532;CALCIUM CHANNEL#0.9523;UMBILICAL VEIN#0.9521;RESPONSE TO UV#0.9520;SIGNALING MOLECULE#0.9516;ANEMIA#0.9516;LASER CAPTURE MICRODISSECTION#0.9511;TERATOCARCINOMA#0.9509;CEREBRAL CORTEX#0.9508;MAGNETIC RESONANCE IMAGING#0.9508;DECITABINE#0.9507;GESTATION#0.9507;OVARIES#0.9506;HUMAN UMBILICAL VEIN#0.9506;CENTRAL NERVOUS SYSTEM#0.9503;NERVOUS SYSTEM#0.9499;NEOPLASTIC TISSUES#0.9493;INDUCED PLURIPOTENT STEM CELL#0.9479;ADJUSTED ODDS RATIO#0.9478;INVASIVE UROTHELIAL CARCINOMA#0.9478;ADENO ASSOCIATED VIRUS#0.9477;DOXYCYCLINE#0.9475;MYOFIBROBLAST#0.9473;METHYL CPG BINDING#0.9473;ENDOSOME#0.9472;POST-TRANSLATIONAL MODIFICATION#0.9470;ENHANCER BINDING PROTEIN#0.9465;ADENOSINE#0.9455;RESVERATROL#0.9450;TOXICITY#0.9450;MYOBLAST#0.9449;STANDARD OF CARE#0.9448;VIRAL REPLICATION#0.9443;NMDA RECEPTOR#0.9443;DEDIFFERENTIATION#0.9442;INCREASED COPY NUMBER#0.9439;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9435;INTERNATIONAL PROGNOSTIC INDEX#0.9434;INTERVERTEBRAL DISC#0.9433;MOUSE EMBRYONIC STEM#0.9432;ATP BINDING#0.9431;CHEWING#0.9428;HUMAN MESENCHYMAL STEM#0.9428;ELECTROPHORETIC MOBILITY SHIFT#0.9424;UMBILICAL CORD#0.9423;INFLAMMATORY CELL#0.9422;ACUTE MYELOID LEUKAEMIA#0.9421;PEROXISOME#0.9421;VASCULAR ENDOTHELIAL CELL#0.9420;OPTIC NERVE#0.9420;QUERCETIN#0.9418;NECROTIC#0.9418;COLONY FORMATION ASSAY#0.9418;DNA TOPOISOMERASE#0.9416;OESOPHAGUS#0.9414;PAPILLARY THYROID CARCINOMA#0.9399;MESENCHYMAL CELL#0.9399;NADPH OXIDASE#0.9398;GINSENOSIDE RG1#0.9398;CELL EXPANSION#0.9388;ALKALINE PHOSPHATASE#0.9386;GLUCOSE HOMEOSTASIS#0.9381;NATIONAL CANCER INSTITUTE#0.9372;CYTOCHROME C RELEASE#0.9370;LOCALISATION#0.9369;IN SITU CARCINOMA#0.9365;MINIMAL RESIDUAL DISEASE#0.9358;NEUROECTODERMAL TUMOR#0.9355;PLEOMORPHIC XANTHOASTROCYTOMA#0.9349;ROS GENERATION#0.9347;GEMCITABINE#0.9347;NEURITE#0.9347;ENDOTHELIUM#0.9346;UTERUS#0.9345;HYPERTENSION#0.9344;HUMAN DERMAL FIBROBLAST#0.9339;GLYCOGEN SYNTHASE KINASE#0.9336;LANGERHANS CELL#0.9332;N-ACETYLCYSTEINE#0.9331;ETOPOSIDE#0.9329;NEURAL CREST#0.9327;HISTONE DEACETYLATION#0.9325;CUNEATE NUCLEUS#0.9322;BASALOID SQUAMOUS CELL CARCINOMA#0.9321;HIGH RESOLUTION MELTING#0.9320;FLOW CYTOMETRY ANALYSIS#0.9312;NEPHROPATHY#0.9311;FIBROUS HISTIOCYTOMA#0.9307;CATALYTIC ACTIVITY#0.9307;ANION EXCHANGER 1#0.9306;MRNA TRANSCRIPTION#0.9299;ADJUSTED HAZARD RATIO#0.9299;ANAL CARCINOMA#0.9296;RETINOID X RECEPTOR#0.9291;PLASMACYTOMA#0.9290;CARCINOSARCOMA#0.9288;GERMINAL CENTER#0.9287;RIBOZYME#0.9286;TYROSINE KINASE RECEPTOR#0.9284;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.9282;UROTHELIAL CELL CARCINOMA#0.9275;CUTANEOUS T CELL LYMPHOMA#0.9265;GALLBLADDER ADENOCARCINOMA#0.9261;REGULATION OF GENE EXPRESSION#0.9260;DNA DAMAGE CHECKPOINT#0.9258;HEART DISEASE#0.9258;PROSTATE EPITHELIAL CELL#0.9257;COLON MUCOSA#0.9244;PROSTATE SPECIFIC ANTIGEN#0.9244;MYOMETRIUM#0.9244;DOCETAXEL#0.9240;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.9237;LARGE CELL NEUROENDOCRINE CARCINOMA#0.9235;REGULATION OF CELL PROLIFERATION#0.9233;MORPHOGENESIS#0.9229;METAPHASE#0.9228;ANGIOSARCOMA#0.9226;LYMPHOBLASTIC LYMPHOMA#0.9226;CENTRAL NERVOUS SYSTEM LYMPHOMA#0.9222;QUANTITATIVE REVERSE TRANSCRIPTASE#0.9217;LYMPHOID CELL#0.9210;PATHOLOGIC COMPLETE RESPONSE#0.9209;DESMOPLASTIC MELANOMA#0.9203;LUNG DISEASE#0.9203;GESTATIONAL DIABETES#0.9200;THYMIDINE KINASE#0.9196;CELL ACTIVATION#0.9194;ANAPLASTIC LARGE CELL LYMPHOMA#0.9194;TONSIL CANCER#0.9191;HEPATOCYTE NUCLEAR FACTOR#0.9190;NON HODGKIN LYMPHOMA#0.9189;INTERVERTEBRAL DISC DEGENERATION#0.9189;X CHROMOSOME#0.9176;PAROTID GLAND#0.9172;REGULATION OF CELLULAR SENESCENCE#0.9172;C TERMINAL DOMAIN#0.9172;MERKEL CELL#0.9168;ORGANELLE#0.9167;CARCINOMA OF UNKNOWN PRIMARY#0.9162;BILE DUCT CARCINOMA#0.9155;ESTROGEN RECEPTOR ALPHA#0.9148;ALANINE#0.9147;GEFITINIB#0.9140;ADENOSQUAMOUS CARCINOMA#0.9139;STEM CELL LIKE#0.9139;TOLL LIKE RECEPTOR#0.9138;MUCOSAL MELANOMA#0.9135;NORMAL LIVER TISSUES#0.9133;CAUSE SPECIFIC SURVIVAL#0.9130;SMALL INTESTINE#0.9127;SKIN MELANOMA#0.9126;CELLULAR LOCALIZATION#0.9125;PERIPHERAL BLOOD LEUKOCYTE#0.9120;BILE DUCT CANCER#0.9107;NEUTROPHIL#0.9106;GENISTEIN#0.9106;INDUCIBLE NITRIC OXIDE#0.9105;PURKINJE CELL#0.9101;BUDDING#0.9089;LECTIN#0.9086;AMERICAN CANCER SOCIETY#0.9084;POSITIVE FAMILY HISTORY#0.9083;GRANULOCYTE#0.9083;GUANOSINE#0.9070;GROWTH OF CELL#0.9061;TUMOR ANTIGEN#0.9057;SORAFENIB#0.9057;MUTAGENIC#0.9056;LUNG EPITHELIAL CELL#0.9054;HISTONE ACETYLTRANSFERASE#0.9054;CAROTID ARTERY#0.9050;ZINC FINGER PROTEIN#0.9047;BLOOD VESSEL#0.9046;SERPIN#0.9039;TAMOXIFEN#0.9037;ACTINOMYCIN D#0.9028;FLUORESCEIN#0.9025;GROWTH FACTOR BINDING#0.9024;HYPERSENSITIVITY#0.9024;METASTASIS FREE SURVIVAL#0.9021;TUMOR NODE METASTASIS#0.9020;CARBOPLATIN#0.9019;CHROMATIN MODIFICATION#0.9019;TERATOMA#0.9012;HAIR CELL#0.9009;RHEUMATOID ARTHRITIS#0.9000;GOBLET CELL#0.8984;HIGH POWER FIELD#0.8977;KIDNEY CANCER#0.8970;MAPK SIGNALLING#0.8968;CYTOKINESIS#0.8968;ASPARTATE#0.8968;SENSITIZATION#0.8952;BILIARY TRACT CANCER#0.8950;PHEOCHROMOCYTOMA#0.8950;CARCINOGENICITY#0.8943;SURFACE EPITHELIUM#0.8939;ATYPICAL MENINGIOMA#0.8934;CARDIOMYOCYTE DIFFERENTIATION#0.8925;FINE NEEDLE ASPIRATE#0.8925;OSTEOSARCOMA CELL LINES#0.8922;DIGESTIVE TRACT#0.8916;HERPES SIMPLEX#0.8908;DIED OF DISEASE#0.8906;CAMPTOTHECIN#0.8906;MESENCHYMAL STROMAL CELL#0.8903;HEMATOPOIETIC PROGENITOR CELL#0.8896;RETINOIC ACID BINDING#0.8895;PLEURA#0.8894;CONJUGATION#0.8892;VASCULAR CELL#0.8887;BONE MARROW STROMAL#0.8884;NEURODEGENERATIVE DISEASE#0.8881;CHRONIC CERVICITIS#0.8873;PROTEIN BINDING#0.8867;COOH-TERMINAL BINDING#0.8866;GROWTH HORMONE#0.8864;THYMIDYLATE#0.8864;TRANS GOLGI NETWORK#0.8862;CONNECTIVE TISSUE#0.8859;ENDOCYTOSIS#0.8856;PANCREATIC NEUROENDOCRINE TUMOR#0.8855;BONE FORMATION#0.8854;RNA SYNTHESIS#0.8849;CHANGES IN DNA METHYLATION#0.8847;ACETYLCYSTEINE#0.8841;FOLIC ACID#0.8838;LUNG FIBROBLASTS#0.8834;LUNG SQUAMOUS CELL CARCINOMA#0.8833;PRIMARY BILIARY CIRRHOSIS#0.8821;ENDOTHELIAL PROGENITOR CELL#0.8820;C-TERMINAL BINDING#0.8817;LOW DENSITY LIPOPROTEIN#0.8814;DERMIS#0.8811;UTERINE SEROUS CARCINOMA#0.8808;MYOSIN HEAVY CHAIN#0.8807;PROTEIN TYROSINE PHOSPHATASE#0.8807;DNA AMPLIFICATION#0.8798;UBIQUITIN PROTEIN LIGASE#0.8787;ETHANOL#0.8787;INSULIN SECRETION#0.8784;DODECYL SULFATE#0.8782;ACTION POTENTIAL#0.8782;NEURITE OUTGROWTH#0.8778;INHIBITION OF GROWTH#0.8776;PROTEIN KINASE INHIBITOR#0.8767;TISSUE HOMEOSTASIS#0.8756;ESTRADIOL#0.8740;BRAIN DEVELOPMENT#0.8732;DNA REPAIR CAPACITY#0.8724;VIRAL GENOME#0.8723;CHRONIC LIVER DISEASE#0.8720;PITUITARY GLAND#0.8717;TRANSDIFFERENTIATION#0.8715;GRANULOSA CELL#0.8714;PRIMARY SCLEROSING CHOLANGITIS#0.8713;PROTEIN DEGRADATION#0.8711;NUCLEOSOME#0.8706;SCLEROSING CHOLANGITIS#0.8701;OBESE#0.8700;MODE OF ACTION#0.8700;MALIGNANT BRAIN TUMOR#0.8697;SODIUM DODECYL SULFATE#0.8695;VASCULAR DISEASE#0.8694;SIRNA BINDING#0.8692;CORONARY HEART DISEASE#0.8690;RECEPTOR ANTAGONIST#0.8688;NOT OTHERWISE SPECIFIED#0.8686;RETINOPATHY OF PREMATURITY#0.8683;NUCLEUS PULPOSUS CELL#0.8679;CHOLANGITIS#0.8675;VACUOLE#0.8674;MEDIAN SURVIVAL TIME#0.8671;PERIPHERAL BLOOD CELLS#0.8670;OLFACTORY BULB#0.8662;IFN-BETA#0.8661;DIHYDROFOLATE REDUCTASE#0.8657;HEARING LOSS#0.8648;LUCIFERASE ACTIVITY#0.8646;TUBULAR EPITHELIAL CELL#0.8642;MARROW STROMAL CELLS#0.8637;BONE MARROW STROMAL CELL#0.8637;AGE AT ONSET#0.8635;ULNAR-MAMMARY SYNDROME#0.8629;PRIMARY BREAST TUMORS#0.8628;POSTTRANSLATIONAL MODIFICATION#0.8625;ARSENITE#0.8624;NORMAL SQUAMOUS EPITHELIUM#0.8622;GERMINAL CENTER B CELL#0.8618;BASEMENT MEMBRANE#0.8616;GERMINAL CENTER B#0.8615;DYSPLASTIC NEVUS SYNDROME#0.8614;EPIGALLOCATECHIN#0.8612;ENZYME ACTIVITY#0.8612;HUMAN GASTRIC CARCINOMA#0.8608;MICROTUBULE ASSOCIATED PROTEIN#0.8608;NEURAL PROGENITOR CELL#0.8608;PARENCHYMA#0.8600;ASCITES#0.8599;COENZYME A#0.8595;TYPE 1 DIABETES#0.8592;TISSUE REGENERATION#0.8586;CELL COUNTING KIT#0.8580;UTERINE CERVICAL CANCER#0.8571;DNA INTEGRATION#0.8567;LARYNX CANCER#0.8560;GASTRINOMA#0.8557;OLIGODENDROCYTE#0.8557;CELL CELL ADHESION#0.8552;UROKINASE#0.8551;CELL KILLING#0.8549;METHOTREXATE#0.8547;GLYCINE#0.8544;SKIN FIBROBLASTS#0.8544;LUNG METASTASIS#0.8543;METASTATIC CARCINOMA#0.8542;TUBE FORMATION#0.8538;THALAMUS#0.8532;CHOLANGIOLOCELLULAR CARCINOMA#0.8532;HEPATIC STELLATE CELL#0.8526;ACINAR CELL#0.8525;HERPES SIMPLEX VIRUS#0.8523;T CELL PROLIFERATION#0.8518;TYPE 2 DIABETIC#0.8513;CORNEAL ENDOTHELIAL CELL#0.8511;CHROMATIN REMODELLING#0.8503;LYMPHOID LEUKEMIA#0.8501;WEIGHT LOSS#0.8499;PANCREATIC ISLET#0.8497;MIDLINE#0.8497;EYELID#0.8497;THYMINE#0.8496;INVASIVE GROWTH#0.8494;HISTIOCYTOMA#0.8494;GLUTAMATE RECEPTOR#0.8490;ACTIVATED B CELL#0.8489;TRADITIONAL CHINESE MEDICINE#0.8486;DUCTAL CELL#0.8483;ADRIAMYCIN#0.8473;INVASIVE BREAST CARCINOMA#0.8470;SINONASAL INVERTED PAPILLOMA#0.8463;OESOPHAGEAL SQUAMOUS CELL#0.8461;EPITHELIAL TISSUES#0.8459;ENDOMETRIAL STROMAL SARCOMA#0.8458;PHOTORECEPTOR CELL#0.8455;HUMAN PROSTATE EPITHELIAL#0.8454;ORAL PREMALIGNANT LESIONS#0.8450;STROMAL SARCOMA#0.8445;HISTOGENESIS#0.8442;CELL FUSION#0.8439;ABERRANT CRYPT FOCI#0.8438;TEMOZOLOMIDE#0.8438;SALIVARY GLAND CARCINOMA#0.8435;MRNA DECAY#0.8433;FETAL LIVER#0.8430;G0 PHASE#0.8430;2'-DEOXYURIDINE#0.8425;UMBILICAL CORD BLOOD#0.8422;STREPTOZOTOCIN#0.8421;GOLGI APPARATUS#0.8407;AUTOIMMUNE DISEASE#0.8402;TAXOL#0.8394;DASATINIB#0.8391;MITOTIC CHECKPOINT#0.8386;PANCREATIC DUCTAL CARCINOMA#0.8371;KERATOACANTHOMA#0.8371;SINGLE NUCLEOTIDE VARIANTS#0.8369;METHYLTRANSFERASE ACTIVITY#0.8367;FOLATE METABOLISM#0.8365;GESTATIONAL DIABETES MELLITUS#0.8354;ENDOMETRIOID ENDOMETRIAL CARCINOMA#0.8352;KIDNEY DISEASE#0.8351;GOLGI COMPLEX#0.8342;TROPICAL SPASTIC PARAPARESIS#0.8334;COLORECTUM#0.8330;GLYCOLYSIS#0.8329;TIME TO RECURRENCE#0.8317;NUCLEOTIDE EXCISION REPAIR#0.8314;SKIN DISEASE#0.8309;MITOTIC CATASTROPHE#0.8308;ATYPICAL NEUROFIBROMA#0.8308;CASPASE ACTIVATION#0.8307;YOLK SAC#0.8306;COLONY-STIMULATING FACTOR#0.8294;BETA CELL MASS#0.8291;DIPHOSPHATE#0.8290;ANTI EGFR#0.8287;PROPIDIUM#0.8284;EXTRAHEPATIC BILE DUCT CARCINOMA#0.8283;CYSTADENOMA#0.8279;MURINE EMBRYONIC FIBROBLASTS#0.8277;ENDOTHELIAL NITRIC OXIDE#0.8276;HEALTHY CONTROL GROUP#0.8276;HUMAN UROTHELIAL CELLS#0.8274;ISCHEMIA REPERFUSION INJURY#0.8269;SESSILE SERRATED ADENOMA#0.8264;INSULINOMA#0.8264;CYCLIN-DEPENDENT KINASE ACTIVITY#0.8256;TRANSMISSION ELECTRON MICROSCOPY#0.8254;MAST CELL#0.8253;PROTEASOME PATHWAY#0.8253;RESPONSE TO RADIATION#0.8249;OXIDATIVE STRESS RESPONSE#0.8241;PREMATURITY#0.8240;LYMPHOBLAST#0.8238;PRIMARY BRAIN TUMORS#0.8226;OSTEOCLAST#0.8220;FALSE DISCOVERY RATE#0.8210;B CELL DEVELOPMENT#0.8205;SENTINEL LYMPH NODE#0.8204;QUANTITATIVE TRAIT LOCI#0.8203;MITOMYCIN C#0.8193;RECTUM#0.8191;SMOOTH MUSCLE CELL PROLIFERATION#0.8185;MUSCLE CELL PROLIFERATION#0.8182;MESENCHYME#0.8180;DIABETIC NEPHROPATHY#0.8180;MERKEL CELL CARCINOMA#0.8177;RETINAL GANGLION CELL#0.8177;KINASE INHIBITOR PROTEIN#0.8177;FAILURE FREE SURVIVAL#0.8176;PULMONARY FIBROSIS#0.8170;POSTNATAL DAY 7#0.8164;GANGLION CELLS#0.8163;MULTIPLE LOGISTIC REGRESSION#0.8160;CROHN'S DISEASE#0.8158;ACUTE PROMYELOCYTIC LEUKEMIA#0.8158;WNT SIGNALING PATHWAY#0.8157;KERATINIZATION#0.8143;BARRETT'S ADENOCARCINOMA#0.8143;PROTEIN KINASE A#0.8142;STANDARDIZED UPTAKE VALUE#0.8140;DEATH RECEPTOR#0.8136;ESOPHAGITIS#0.8134;NUCLEOTIDE BINDING#0.8125;DEXAMETHASONE#0.8125;SWI-SNF COMPLEX#0.8121;MARGINAL ZONE B CELL#0.8119;MECHANISMS OF ACTION#0.8117;MARGINAL ZONE B#0.8116;PROSTATIC INTRAEPITHELIAL NEOPLASIA#0.8116;CLEAR CELL RENAL CELL CARCINOMA#0.8115;CELLULAR HOMEOSTASIS#0.8107;MICROPHTHALMIA#0.8105;PLEXIFORM NEUROFIBROMA#0.8101;FOREBRAIN#0.8100;PERICYTE#0.8099;RETINAL DEGENERATION#0.8094;VILLOUS ADENOMA#0.8092;ZEBULARINE#0.8090;INFLAMMATORY BOWEL DISEASE#0.8086;MYOEPITHELIAL CELL#0.8085;GENE EXPRESSION SIGNATURES#0.8084;STAUROSPORINE#0.8083;LASER DESORPTION IONIZATION#0.8083;OXYGENASE#0.8079;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.8077;IMATINIB MESYLATE#0.8070;ORAL SQUAMOUS CARCINOMA#0.8064;ADVANCED GASTRIC CANCER#0.8053;ENDOTHELIAL CELL PROLIFERATION#0.8052;CHOLINE#0.8048;GLUTATHIONE PEROXIDASE#0.8034;LYSOSOME#0.8026;MULTIPLE LINEAR REGRESSION#0.8026;HUMORAL IMMUNE RESPONSE#0.8025;GENETIC DISEASE#0.8022;PULMONARY ARTERY#0.8013;MAPK ACTIVATION#0.8011;MUCINOUS CYSTIC NEOPLASM#0.8002;RANDOMIZED CONTROLLED TRIAL#0.7995;INNATE IMMUNITY#0.7994;INNATE IMMUNE RESPONSE#0.7993;POST NATAL DAY#0.7991;TRANSLATION INITIATION#0.7989;ATP BINDING CASSETTE#0.7983;VESICLE FORMATION#0.7979;CYCLIC AMP#0.7979;OSTEOARTHRITIS#0.7973;BENIGN MENINGIOMA#0.7969;CLASSICAL HODGKIN LYMPHOMA#0.7968;STEM CELL DIFFERENTIATION#0.7967;NUCLEAR LAYER#0.7963;MORTAL#0.7963;IRINOTECAN#0.7962;LYSIS#0.7952;MAMMARY EPITHELIUM#0.7947;CELLULAR COMPONENT#0.7943;ERLOTINIB#0.7942;STEROID HORMONE RECEPTOR#0.7940;CHORIOCARCINOMA#0.7935;ORAL CANCER CELL#0.7932;VEMURAFENIB#0.7927;RNA HELICASE#0.7921;PROTEIN TRANSLATION#0.7911;ANTISENSE RNA#0.7906;ANTI APOPTOSIS#0.7903;GROWTH CONE#0.7902;CELL FRACTION#0.7896;MITOMYCIN#0.7896;RECEIVER OPERATOR CHARACTERISTIC#0.7895;DNA DAMAGE FOCI#0.7894;TRANSCRIPTION FACTOR BINDING#0.7894;T CELL ACTIVATION#0.7889;SAHF FORMATION#0.7887;LIPID METABOLISM#0.7881;RESPONSE TO STRESS#0.7880;PI3K SIGNALING#0.7878;VITAMIN A#0.7873;CHRONIC HEPATITIS B#0.7871;SERTOLI CELL#0.7870;MATRIX METALLOPROTEINASE 1#0.7868;CYCLOPHOSPHAMIDE#0.7867;PROTEIN CODING GENE#0.7860;SOLITARY FIBROUS TUMOR#0.7855;OVAL CELL#0.7849;GROWTH REGULATOR#0.7838;OSTEOPOROSIS#0.7838;HUMAN EPIDERMAL KERATINOCYTES#0.7834;MITOTIC SPINDLE#0.7833;FORESKIN#0.7817;RRNA PROCESSING#0.7814;NEOPLASTIC DISEASE#0.7805;LANGERHANS CELL HISTIOCYTOSIS#0.7800;AZACITIDINE#0.7799;MARGINAL ZONE LYMPHOMA#0.7794;B CELL DIFFERENTIATION#0.7791;IDIOPATHIC PULMONARY FIBROSIS#0.7789;NUCLEAR TRANSPORT#0.7771;OOCYTE#0.7770;NICOTINAMIDE#0.7766;METFORMIN#0.7764;CELL AGGREGATION#0.7763;BLAST CELL#0.7758;CYTIDINE#0.7757;UBIQUITIN SPECIFIC PROTEASE#0.7754;MARGINAL ZONE B-CELL LYMPHOMA#0.7748;TUMOR INITIATING CELL#0.7741;METASTATIC PROSTATE CANCER#0.7741;TIGHT JUNCTION#0.7739;VIRAL HEPATITIS#0.7729;NATURAL KILLER CELL#0.7728;VINCRISTINE#0.7722;RELATIVE TELOMERE LENGTH#0.7720;CELLULAR MEMBRANE#0.7714;NEUTROPENIA#0.7713;ACTIVATOR PROTEIN 1#0.7701;SECRETORY PATHWAY#0.7700;COLON ADENOMA#0.7699;GAP ACTIVITY#0.7697;ORGANOGENESIS#0.7692;GLUCOSE UPTAKE#0.7686;HETEROCHROMATIN PROTEIN 1#0.7684;RELATED PROTEIN 1#0.7683;INTERSTITIAL CELL#0.7673;CAMP RESPONSE ELEMENT#0.7661;RECEPTOR BINDING#0.7660;STEM CELL MAINTENANCE#0.7658;ANTHRACENE#0.7656;GENES OF INTEREST#0.7654;ACETIC ACID#0.7651;BRACHIAL PLEXUS#0.7648;GLUCOSE TOLERANCE TEST#0.7645;MALIGNANT PERITONEAL MESOTHELIOMA#0.7644;ANAPLASTIC EPENDYMOMA#0.7642;MOLECULAR DYNAMICS SIMULATION#0.7640;GASTRIC EPITHELIAL CELLS#0.7632;MUCOSITIS#0.7632;ERYTHROCYTE#0.7626;TOPICAL#0.7622;EPITHELIAL CELL PROLIFERATION#0.7617;KAPOSI'S SARCOMA#0.7604;RNA SILENCING SUPPRESSOR#0.7600;ORAL SUBMUCOUS FIBROSIS#0.7598;OCULAR MELANOMA#0.7598;SEBORRHEIC KERATOSIS#0.7595;CELL POLARITY#0.7592;HEDGEHOG SIGNALING PATHWAY#0.7583;CHROMATIN REMODELING COMPLEX#0.7580;GOLGI MEMBRANE#0.7577;GENETIC DISORDER#0.7566;PKCALPHA#0.7561;HYDROXYUREA#0.7558;INHIBITION OF DNA METHYLATION#0.7553;LYMPHANGIOGENESIS#0.7543;3-OST-2#0.7536;EPITHELIAL OVARIAN CARCINOMA#0.7531;RNA PROCESSING#0.7531;MOLECULAR FUNCTION#0.7531;RESPONSE TO OXIDATIVE STRESS#0.7529;TISSUE REMODELING#0.7520;LINEAR REGRESSION ANALYSIS#0.7518;ADVANCED COLORECTAL CANCER#0.7511;RRNA TRANSCRIPTION#0.7505;DENTAL PULP#0.7498;INHIBITION OF APOPTOSIS#0.7498;UROKINASE-TYPE PLASMINOGEN ACTIVATOR#0.7497;TESTICULAR CANCER#0.7492;UROTHELIAL BLADDER CANCER#0.7491;TISSUE INVASION#0.7486;IMPORTIN#0.7485;DERMAL PAPILLA CELL#0.7484;CASPASE INHIBITOR#0.7473;STEM CELL FACTOR#0.7471;MAMMARY GLAND DEVELOPMENT#0.7470;REGULATORY T CELL#0.7461;PROTEIN STABILIZATION#0.7457;DETOXIFICATION#0.7454;CYTOSINE METHYLATION#0.7451;GLAND DEVELOPMENT#0.7450;CANCER SPECIFIC MORTALITY#0.7444;MURAL CELL#0.7444;ADVANCED OVARIAN CANCER#0.7442;RRNA SYNTHESIS#0.7441;SUCROSE#0.7441;DSRNA BINDING#0.7437;FAMILIAL ADENOMATOUS POLYPOSIS#0.7428;8-HYDROXY-2'-DEOXYGUANOSINE#0.7428;ATYPICAL LIPOMATOUS TUMOR#0.7426;GLUTAMINE#0.7425;GLYCOSYLATION#0.7422;CORNEAL ENDOTHELIUM#0.7410;COLON ADENOCARCINOMA#0.7407;VALINE#0.7397;MYOTUBE#0.7392;HIERARCHICAL CLUSTERING ANALYSIS#0.7388;DIABETIC RETINOPATHY#0.7376;MYOGENIC CELL#0.7372;INTERMEDIATE FILAMENT#0.7369;OVERALL SURVIVAL TIME#0.7361;CASPASE-3 ACTIVITY#0.7360;VITAMIN D RECEPTOR#0.7359;PRIMARY EFFUSION LYMPHOMA#0.7357;P38 MAPK SIGNALING#0.7354;MITOCHONDRIAL DNA#0.7353;CYTOTOXIC T-LYMPHOCYTE#0.7349;IRON OVERLOAD#0.7345;DUCT CELL#0.7337;SOFT PALATE#0.7333;ESOPHAGEAL SQUAMOUS CARCINOMA#0.7327;PARATHYROID HORMONE#0.7327;Y CHROMOSOME#0.7321;STEM CELL PROLIFERATION#0.7320;PARKINSON'S DISEASE#0.7319;CYTOKINE PRODUCTION#0.7319;NUCLEAR LOCALIZATION SIGNAL#0.7318;SEMINOMA#0.7312;AMELANOTIC MELANOMA#0.7309;OSTEOGENESIS#0.7304;LASER CAPTURE MICRODISSECTED#0.7299;NF-KAPPAB ACTIVATION#0.7285;MYOCARDIUM#0.7279;POLYCYCLIC AROMATIC HYDROCARBON#0.7277;CELLULAR METABOLISM#0.7275;SARCOMATOID MESOTHELIOMA#0.7267;BLOOD BRAIN BARRIER#0.7264;LEUKEMIA STEM CELL#0.7262;AFRICAN SWINE FEVER#0.7258;GM-CSF#0.7257;ORAL GLUCOSE TOLERANCE#0.7250;72-HOURS#0.7250;INTESTINAL EPITHELIAL CELL#0.7247;SOMATIC TISSUE#0.7238;UNCONDITIONAL LOGISTIC REGRESSION#0.7235;WILCOXON RANK SUM#0.7235;METASTATIC MELANOMA CELLS#0.7231;ORGAN OF CORTI#0.7225;C REACTIVE PROTEIN#0.7222;ION CHANNEL#0.7222;CPT-11#0.7221;LEUKEMIA INITIATING CELLS#0.7219;RESPONSE TO GENOTOXIC STRESS#0.7212;ARF GAP ACTIVITY#0.7198;CYCLE INHIBITOR P21#0.7186;SEVERE COMBINED IMMUNODEFICIENCY#0.7183;ADENINE DINUCLEOTIDE PHOSPHATE#0.7177;INTRACELLULAR SIGNALING PATHWAY#0.7161;TIRAPAZAMINE#0.7157;CIRCULATING CELL FREE#0.7156;VACCINIA#0.7148;CHOLECYSTITIS#0.7145;BENIGN NEOPLASM#0.7144;SIGNAL PEPTIDE#0.7134;UNDIFFERENTIATED PLEOMORPHIC SARCOMA#0.7133;MAPK CASCADE#0.7132;JOHNS HOPKINS HOSPITAL#0.7130;ENDOTHELIN RECEPTOR#0.7127;SPERMATOGENESIS#0.7127;PAPILLARY RENAL CELL CARCINOMA#0.7122;INTRACRANIAL ANEURYSM#0.7122;MINERALIZATION#0.7121;EMBRYO DEVELOPMENT#0.7100;ATROPHIC GASTRITIS#0.7095;APOPTOSIS SIGNALING#0.7094;SUNITINIB#0.7093;PERIPHERAL T-CELL LYMPHOMA#0.7092;ASPARTIC ACID#0.7079;OUTER MEMBRANE#0.7076;OSTEOCYTE#0.7066;RITUXIMAB#0.7048;INFERTILITY#0.7038;LOW BIRTH WEIGHT#0.7036;GLIOSARCOMA#0.7035;SKELETAL MUSCLE CELLS#0.7029;SKELETON#0.7028;PNEUMONIA#0.7027;ARYL HYDROCARBON RECEPTOR#0.7024;REPLICATION FORK#0.7019;METASTATIC BREAST CANCER#0.7015;CELL AGEING#0.7010;RICHTER'S SYNDROME#0.7009;SWEAT GLAND#0.7002;MIXED LINEAGE LEUKEMIA#0.6996;MELANOCYTIC NEVUS#0.6992;PELVIS#0.6991;TROPHOBLAST#0.6970;ADVANCED PROSTATE CANCER#0.6967;CHROMOSOME INACTIVATION#0.6967;AUXIN EFFLUX#0.6962;TO TUMOR RECURRENCE#0.6957;NUCLEOCYTOPLASMIC SHUTTLING#0.6957;THYROID HORMONE RECEPTOR#0.6957;DOUBLE-STRAND BREAK REPAIR#0.6953;HYPERACTIVITY#0.6947;NEUROFILAMENT#0.6946;MAP KINASE CASCADE#0.6944;RETINITIS PIGMENTOSA#0.6936;REPORTER GENE ASSAY#0.6924;GANGLIOGLIOMA#0.6920;CYTOTOXIC T CELL#0.6911;ADVANCED GLYCATION END#0.6904;CENTROSOME DUPLICATION#0.6904;AREA UNDER CURVE#0.6902;HUMAN LEUKOCYTE ANTIGEN#0.6900;BEVACIZUMAB#0.6895;EYE DISEASE#0.6893;DUODENUM#0.6889;KINASE INHIBITOR P27#0.6883;LACTATION#0.6881;WEIGHT GAIN#0.6872;TUMOUR NECROSIS FACTOR#0.6871;ANGIOTENSIN CONVERTING ENZYME#0.6867;FOLLICULAR THYROID CARCINOMA#0.6865;DE NOVO DNA METHYLATION#0.6860;GRANULAR COMPONENT#0.6856;CAMP RESPONSE ELEMENT BINDING#0.6855;COPY NUMBER VARIANTS#0.6855;VESICLE TRANSPORT#0.6852;LIPID DROPLET#0.6847;OUTER NUCLEAR LAYER#0.6844;TRANSCRIPTION TERMINATION FACTOR#0.6837;HUMAN CORNEAL ENDOTHELIAL#0.6836;HEPATOBLASTOMA#0.6834;CANCER ASSOCIATED FIBROBLASTS#0.6832;COMPARATIVE GENOMIC HYBRIDISATION#0.6820;GLUCOCORTICOID RECEPTOR#0.6813;VIRULENCE#0.6812;INSULIN RECEPTOR#0.6809;LYMPHOBLASTOID CELLS#0.6804;TISSUE DAMAGE#0.6804;LEUKOCYTE TELOMERE LENGTH#0.6804;PANCREATIC LESIONS#0.6801;RETINAL PIGMENT EPITHELIAL#0.6798;OBJECTIVE RESPONSE RATE#0.6796;INTERNEURON#0.6792;ADVANCED BREAST CANCER#0.6791;ONE CARBON METABOLISM#0.6790;DIFFERENTIAL GENE EXPRESSION#0.6788;IN UTERO EXPOSURE#0.6786;BLADDER UROTHELIAL CARCINOMA#0.6784;METASTATIC ADENOCARCINOMA#0.6782;RECEPTOR INTERACTING PROTEIN#0.6780;RESPIRATION#0.6773;OPIOID GROWTH FACTOR#0.6772;LYMPHOEPITHELIOMA-LIKE CARCINOMA#0.6771;MUSCLE STEM CELL#0.6766;ARTIFICIAL NEURAL NETWORK#0.6761;ANAPLASTIC OLIGOASTROCYTOMA#0.6758;SYNAPTIC TRANSMISSION#0.6758;NEGATIVE LIKELIHOOD RATIO#0.6755;ADRENERGIC RECEPTOR#0.6748;KINASE BINDING#0.6743;GASTRO#0.6725;CYCLIN BINDING#0.6724;CYTOCHROME P450#0.6721;RECEPTOR AGONIST#0.6720;CELL FATE DETERMINATION#0.6717;HISTONE H3 ACETYLATION#0.6715;X CHROMOSOME INACTIVATION#0.6705;AORTIC SMOOTH MUSCLE CELLS#0.6699;THYROID ADENOMA#0.6696;TYPE 1 DIABETIC#0.6694;LIGHT CHAIN 3#0.6686;CIRCULATING TUMOR CELL#0.6685;MYOFIBROBLAST DIFFERENTIATION#0.6684;MULTIPLE ENDOCRINE NEOPLASIA#0.6674;T CELL DIFFERENTIATION#0.6674;FIBROSARCOMA CELLS#0.6672;SEROUS BORDERLINE TUMORS#0.6669;DUAL LUCIFERASE REPORTER#0.6664;ACTIN POLYMERIZATION#0.6660;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6651;SKIN SQUAMOUS CELL CARCINOMA#0.6644;GASTRIC LYMPHOMA#0.6644;ACTIN FILAMENT#0.6644;LIVER FLUKE-RELATED CHOLANGIOCARCINOMA#0.6636;HETEROTRIMERIC G-PROTEIN#0.6636;ARA-C#0.6634;PROSTAGLANDIN E2#0.6633;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6629;LUPUS ERYTHEMATOSUS#0.6627;BRAIN CANCER#0.6626;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6619;PERITONEUM#0.6618;DNASE I#0.6611;HYPERGLYCEMIA#0.6608;BORTEZOMIB#0.6607;HEMORRHAGE#0.6606;CYTOCHROME C OXIDASE#0.6603;LUNG ADENOMA#0.6598;EPITHELIAL CARCINOMA#0.6595;MELANOCYTE DIFFERENTIATION#0.6588;EPITHELIAL STEM CELL#0.6574;NUCLEAR EXPORT SIGNAL#0.6567;PANCREATIC DUCTAL CELL#0.6567;V-D-J RECOMBINATION#0.6561;ACETYLCHOLINE#0.6552;OLOMOUCINE#0.6547;PROTEIN INTERACTION NETWORK#0.6544;HEPARIN#0.6540;COLONY-FORMING CELL#0.6537;SWELLING#0.6534;REGULATION OF APOPTOSIS#0.6526;MALIGNANT EYELID TUMOR#0.6526;TUBEROUS SCLEROSIS#0.6525;SIGNALLING CASCADE#0.6524;CHRONIC KIDNEY DISEASE#0.6521;NERVE GROWTH FACTOR#0.6519;HISTIOCYTOSIS#0.6517;FIBROBLAST PROLIFERATION#0.6513;HUMAN EMBRYONIC STEM#0.6508;NORMAL HUMAN UROTHELIAL#0.6505;5'-DEOXY-5'-METHYLTHIOADENOSINE#0.6505;MRNA SPLICING#0.6504;TISSUE MICROARRAY ANALYSIS#0.6500;ADENOMATOID TUMOR#0.6496;NORMAL ADJACENT TISSUE#0.6493;EMBRYONIC KIDNEY#0.6490;THYMIC EPITHELIAL CELLS#0.6486;RESPIRATORY TRACT#0.6482;TRASTUZUMAB#0.6473;EMBRYOID BODY#0.6471;OPEN ANGLE GLAUCOMA#0.6466;SYNCYTIUM FORMATION#0.6462;NEURAL STEM PROGENITOR#0.6460;POTASSIUM CHANNEL#0.6458;INNERVATION#0.6438;IMIQUIMOD#0.6436;HYDRALAZINE#0.6435;CELL PENETRATING PEPTIDE#0.6434;BIZARRE LEIOMYOMA#0.6434;TRANSCRIPTION ACTIVATOR#0.6433;HAEMATOPOIETIC STEM CELL#0.6423;MEMORY IMPAIRMENT#0.6415;DNA REPAIR PROTEIN#0.6413;SPINDLE ASSEMBLY#0.6408;PROLACTINOMA#0.6403;DERMATITIS#0.6402;MELANOCYTE PROLIFERATION#0.6401;APOPTOTIC PROCESS#0.6400;ACTIVE CASPASE 3#0.6398;NEUROENDOCRINE CELL#0.6394;INTRACELLULAR LOCALIZATION#0.6390;T CELL DEVELOPMENT#0.6390;AUTOIMMUNITY#0.6390;MICRONUCLEUS#0.6390;ATPASE ACTIVITY#0.6385;MTDNA#0.6384;ADIPOCYTE DIFFERENTIATION#0.6382;REGULATION OF RIBOSOME BIOGENESIS#0.6382;CHROMOSOME SEGREGATION#0.6380;PORTAL VEIN#0.6371;ATYPICAL DUCTAL HYPERPLASIA#0.6365;MEMORY T CELL#0.6363;TH17 CELL#0.6357;PELVIC LYMPH NODE#0.6356;CELL WALL#0.6349;SPINDLE CELL CARCINOMA#0.6341;POLYCOMB REPRESSOR COMPLEX#0.6341;DIDEOXYCYTIDINE#0.6338;APPARENT DIFFUSION COEFFICIENT#0.6336;CELL QUIESCENCE#0.6332;GLUCOSE METABOLISM#0.6331;GINSENG#0.6324;HEPATOCELLULAR ADENOMA#0.6317;GRANULOSA CELL TUMOR#0.6308;DIGITAL IMAGE ANALYSIS#0.6299;MITOTIC ENTRY#0.6291;CYSTITIS#0.6286;GENE EXPRESSION OMNIBUS#0.6282;PRINCIPAL COMPONENT ANALYSIS#0.6278;B CELL RECEPTOR#0.6274;URETHANE#0.6273;GIANT CELL GLIOBLASTOMA#0.6272;LUMINAL CELL#0.6272;NEOMYCIN#0.6269;RETINAL ISCHEMIA#0.6269;PRIMARY EPITHELIAL CELLS#0.6263;ERYTHROLEUKEMIA#0.6262;DNA METHYLTRANSFERASE ACTIVITY#0.6261;BILE DUCT ADENOMA#0.6257;OMENTUM#0.6256;PTERYGIUM#0.6238;ACTIVATION OF MAP KINASE#0.6236;STANDARD UPTAKE VALUE#0.6236;LITHIUM#0.6232;MIDBRAIN#0.6230;COPY NUMBER INCREASE#0.6230;EPHRIN#0.6228;EARLY BREAST CANCER#0.6226;MOLAR#0.6221;PROTEIN KINASE ACTIVITY#0.6220;PRIMARY OPEN ANGLE GLAUCOMA#0.6215;RENAL CELL CANCER#0.6213;SPERMATOCYTES#0.6211;DIFFERENTIATED THYROID CARCINOMA#0.6211;RANDOMISED CONTROLLED TRIAL#0.6208;RESPIRATORY FAILURE#0.6206;ALVEOLAR EPITHELIAL CELL#0.6198;L-CYSTEINE#0.6197;SIMVASTATIN#0.6194;DOPAMINE#0.6192;HUMAN EMBRYONIC KIDNEY#0.6191;MEGAKARYOCYTE#0.6191;FIBROMA#0.6190;TESTOSTERONE#0.6188;HEALTHY CONTROL SUBJECTS#0.6184;BILE TRACT#0.6180;DNA METABOLISM#0.6173;MATURE CYSTIC TERATOMA#0.6170;FATTY LIVER#0.6165;PEDIATRIC OSTEOSARCOMA#0.6165;CHEMOKINE RECEPTOR#0.6159;TENOFOVIR#0.6157;AUTOPHAGIC CELL DEATH#0.6150;DEACETYLASE ACTIVITY#0.6150;CARDIOVASCULAR RISK FACTOR#0.6145;EDEMA#0.6145;SPINDLE ASSEMBLY CHECKPOINT#0.6142;FATTY ACID BINDING#0.6140;BONE RESORPTION#0.6138;RECURSIVE PARTITIONING ANALYSIS#0.6136;CYSTIC TERATOMA#0.6132;ATP BINDING CASSETTE TRANSPORTER#0.6129;CORNEAL EPITHELIAL CELL#0.6125;GRADIENT GEL ELECTROPHORESIS#0.6119;INSULIN RECEPTOR SUBSTRATE#0.6118;KERATINOCYTE DIFFERENTIATION#0.6104;RESPONSE TO HYPOXIA#0.6103;GLOBIN#0.6086;HYPERTHERMIA#0.6081;MICROGLIAL CELL#0.6074;TRYPTOPHAN#0.6070;PARAGANGLIOMA#0.6063;SOLID CARCINOMA#0.6062;T-TYPE CALCIUM CHANNEL#0.6059;ACTIVATION OF NF-KAPPAB#0.6055;INHIBITION OF TELOMERASE ACTIVITY#0.6052;PYRAMIDAL CELL#0.6051;ECTODERM DEVELOPMENT#0.6046;PHOSPHOLIPASE C#0.6043;EXTRAMEDULLARY PLASMACYTOMA#0.6042;ACUTE KIDNEY INJURY#0.6040;SEROUS CYSTADENOMA#0.6030;APOPTOTIC SIGNALLING PATHWAY#0.6022;BLEOMYCIN#0.6013;MOUSE LUNG EPITHELIAL#0.6008
102	RNA INTERFERENCE#1.0446;SQUAMOUS CELL CARCINOMA#1.0411;HEPATOCELLULAR CARCINOMA#1.0394;RETINOIC ACID#1.0338;B CELL#1.0320;GERM CELL#1.0305;BREAST CANCER#1.0283;NOTCH RECEPTOR#1.0280;BREAST CANCER CELL#1.0277;METALLOPROTEINASE INHIBITOR#1.0223;EXOSOME#1.0203;LYMPH NODE#1.0130;CELL GROWTH#1.0126;MEPRIN#1.0122;POLYMERASE CHAIN REACTION#1.0079;TUMOR CELLS#1.0066;CELL MEMBRANE#1.0058;CELL CELL ADHESION#1.0043;APOPTOSIS#1.0030;CELL MIGRATION#1.0015;PLASMA MEMBRANE#0.9999;ENDOPLASMIC RETICULUM#0.9997;NEUROBLASTOMA#0.9993;CELL PROLIFERATION#0.9982;EPITHELIAL CELL#0.9975;CANCER CELL#0.9949;LEUKOCYTE#0.9937;ENDOTHELIAL CELL#0.9935;T CELL#0.9917;AMYLOID PROTEIN#0.9899;MONOCYTE#0.9894;GENE EXPRESSION#0.9887;TUMOR NECROSIS FACTOR#0.9885;PROGENITOR CELL#0.9881;CELL ADHESION MOLECULE#0.9875;CELL SURFACE#0.9874;MACROPHAGE#0.9873;EPHRIN#0.9865;NERVOUS SYSTEM#0.9858;PERIPHERAL BLOOD#0.9847;SIGNALING PATHWAY#0.9841;TRANSCRIPTION FACTOR#0.9838;CELL ADHESION#0.9831;APP METABOLISM#0.9815;EPIDERMAL GROWTH FACTOR#0.9814;PROTEIN KINASE C#0.9800;CELL DEATH#0.9785;STEM CELL#0.9779;AMYLOID PRECURSOR PROTEIN#0.9776;GROWTH FACTOR RECEPTOR#0.9767;PROTEIN KINASE#0.9762;EXTRACELLULAR MATRIX#0.9756;GROWTH FACTOR#0.9732;NEURODEGENERATIVE DISEASE#0.9689;ANGIOGENESIS#0.9681;SYNAPSE ASSOCIATED PROTEIN#0.9679;ALZHEIMER'S DISEASE#0.9640;CENTRAL NERVOUS SYSTEM#0.9636;IMMUNE RESPONSE#0.9611;ENZYME ACTIVITY#0.9578;REVERSE TRANSCRIPTION#0.9578;NOTCH SIGNALING PATHWAY#0.9578;METALLOPROTEASE INHIBITOR#0.9563;ECTODOMAIN CLEAVAGE#0.9559;REGULATED INTRAMEMBRANE PROTEOLYSIS#0.9553;NEUTROPHIL#0.9517;PROTEIN PROCESSING#0.9503;ASTROCYTE#0.9498;DEMENTIA#0.9481;NEURONAL CELLS#0.9474;GENE SILENCING#0.9471;PRO-INFLAMMATORY#0.9467;ACITRETIN#0.9460;MITOGEN ACTIVATED PROTEIN#0.9459;PRION DISEASE#0.9418;SMOOTH MUSCLE#0.9414;TUMOR SUPPRESSOR#0.9412;CYTOTOXICITY#0.9342;ORAL SQUAMOUS CELL CARCINOMA#0.9300;NEUROGENESIS#0.9266;RECEPTOR TYROSINE KINASE#0.9259;TUMOUR NECROSIS FACTOR#0.9219;ENDOCYTOSIS#0.9194;INFLAMMATORY RESPONSE#0.9179;CATALYTIC ACTIVITY#0.9165;ATHEROSCLEROSIS#0.9157;TOXICITY#0.9157;MURINE EMBRYONIC FIBROBLASTS#0.9137;ATHEROSCLEROTIC#0.9113;CELL DEVELOPMENT#0.9094;HEPARIN BINDING#0.9077;TRANSFORMING GROWTH FACTOR#0.9073;LIPID RAFT#0.9071;CELL DIFFERENTIATION#0.9054;APOPTOTIC#0.9051;T LYMPHOCYTE#0.9038;NEUROTOXIC#0.9032;ENDOTHELIUM#0.8976;BONE MARROW#0.8923;HEPARIN#0.8922;ADVANCED GLYCATION END#0.8916;TRASTUZUMAB#0.8898;METALLOPROTEASE ACTIVITY#0.8892;NEURITE#0.8889;REGENERATION#0.8859;RHEUMATOID ARTHRITIS#0.8859;MUSCLE CELL#0.8850;KERATINOCYTE#0.8828;GM6001#0.8820;COLORECTAL CANCER#0.8798;MYELOID CELL#0.8784;LONG TERM POTENTIATION#0.8758;TRANSACTIVATION#0.8756;SMOOTH MUSCLE CELL#0.8681;ADHERENS JUNCTION#0.8681;ZINC BINDING#0.8670;EXTRACELLULAR REGION#0.8634;SYNAPTIC MEMBRANE#0.8612;ESTROGEN RECEPTOR#0.8611;RETINOIC ACID RECEPTOR#0.8602;SIGNALING MOLECULE#0.8591;CELL JUNCTION#0.8590;MYELINATION#0.8585;EXCITATORY SYNAPSE#0.8568;HYPOXIA#0.8541;CHONDROCYTE#0.8537;TUMOR TISSUES#0.8530;PANCREATIC CANCER#0.8477;DENDRITIC SPINE#0.8461;MORRIS WATER MAZE#0.8458;CELL MOTILITY#0.8392;IMMUNE SYSTEM#0.8392;REACTIVE OXYGEN SPECIES#0.8372;CELL ACTIVATION#0.8334;GANGLION CELLS#0.8324;NEUROPROTECTION#0.8292;IMMUNE CELL#0.8275;NMDA RECEPTOR#0.8230;KIDNEY DISEASE#0.8157;MAST CELL#0.8139;NOTCH INTRACELLULAR DOMAIN#0.8126;CD8+ T CELL#0.8124;DOUBLE TRANSGENIC MICE#0.8105;PROSTATE CANCER#0.8074;CELL CYCLE#0.8050;DENTATE GYRUS#0.7991;INTESTINAL STEM CELL#0.7988;SECRETORY PATHWAY#0.7985;COLON CANCER#0.7976;NEURITE OUTGROWTH#0.7976;INSULIN DEGRADING ENZYME#0.7939;SIGNALLING PATHWAY#0.7933;SYNAPTOGENESIS#0.7928;PODOCYTE#0.7910;COLORECTAL#0.7901;QUANTITATIVE REAL TIME#0.7895;SIGNAL TRANSDUCTION#0.7876;STROMAL CELL#0.7870;B CELL DEVELOPMENT#0.7865;GROWTH CONE#0.7856;AKT SIGNALING#0.7826;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7814;CALCIUM CHANNEL#0.7814;EPITHELIAL TO MESENCHYMAL#0.7812;HOST CELL#0.7777;DENDRITIC CELL#0.7773;BRAIN DEVELOPMENT#0.7770;NOTCH LIGAND#0.7769;LUNG CANCER#0.7742;ONCOGENIC#0.7737;CYTOPLASM#0.7726;MORPHOGENESIS#0.7692;OVARIAN#0.7664;TISSUE HOMEOSTASIS#0.7663;PROTEASE ACTIVITY#0.7624;INSULIN-LIKE GROWTH FACTOR#0.7622;CARDIOMYOCYTE#0.7599;MICROVASCULAR ENDOTHELIAL CELL#0.7589;GLIAL CELL#0.7572;VIRULENCE#0.7537;MONONUCLEAR CELLS#0.7526;MULTIPLE MYELOMA#0.7479;STATUS EPILEPTICUS#0.7466;EPILEPSY#0.7454;TOLL LIKE RECEPTOR#0.7423;KINASE INHIBITOR#0.7413;LOW DENSITY LIPOPROTEIN#0.7403;PITUITARY ADENOMA#0.7399;5ALPHA DIHYDROTESTOSTERONE#0.7397;SYNAPTIC VESICLE#0.7393;BRUSH BORDER#0.7373;EPITHELIAL MESENCHYMAL TRANSITION#0.7373;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7348;HEMATOPOIETIC CELL#0.7323;AUTOPHAGY#0.7298;FACTOR I#0.7292;NEURAL PROGENITOR CELL#0.7291;TRANSMEMBRANE RECEPTOR#0.7280;DUAL LUCIFERASE REPORTER#0.7267;RESONANCE ENERGY TRANSFER#0.7257;RECEPTOR LIGAND#0.7240;TRANSFORMING GROWTH FACTOR ALPHA#0.7209;MEMBRANE FRACTION#0.7208;DOXORUBICIN#0.7200;CORONARY ARTERY#0.7197;ENDOTHELIAL GROWTH FACTOR#0.7188;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7188;SPINAL CORD#0.7185;PRIMARY CORTICAL NEURON#0.7086;JUXTAMEMBRANE#0.7048;ARTERY#0.7012;BREAST CANCER PATIENTS#0.7009;MUTAGENESIS#0.7008;TIGHT JUNCTION#0.7006;NEURAL CELL#0.7002;OVARIAN CANCER#0.6995;BASEMENT MEMBRANE#0.6994;OSTEOBLAST#0.6950;SENESCENCE#0.6936;DRUG RESISTANCE#0.6913;NEUROFIBRILLARY TANGLE#0.6875;CELL FATE SPECIFICATION#0.6843;MAP KINASE#0.6840;INTERLEUKIN 6 RECEPTOR#0.6830;WOUND HEALING#0.6828;VASCULAR ENDOTHELIAL CADHERIN#0.6820;CELL FUSION#0.6814;L-TYPE CALCIUM CHANNEL#0.6779;BATIMASTAT#0.6778;MARGINAL ZONE B CELL#0.6777;IGE RECEPTOR#0.6775;MARGINAL ZONE B#0.6772;MELATONIN#0.6771;CELL FATE DETERMINATION#0.6751;BRAIN ENDOTHELIAL CELL#0.6740;GOLGI APPARATUS#0.6712;CARDIOMYOPATHY#0.6711;GERMINAL CENTER#0.6710;RECEPTOR SHEDDING#0.6698;BASAL CELL#0.6692;PERIPHERAL NERVE#0.6626;SPERMATOGENESIS#0.6625;ARGININE#0.6625;GASTROINTESTINAL TRACT#0.6613;VASCULAR SMOOTH MUSCLE CELL#0.6561;BLOOD BRAIN BARRIER#0.6559;CELLULAR LOCALIZATION#0.6523;NEURAL CREST#0.6520;SCRAPIE#0.6500;HEPATOCYTE GROWTH FACTOR#0.6457;GLUTAMATE RECEPTOR#0.6448;CEREBRAL CORTEX#0.6443;NEUROTOXICITY#0.6437;NITRIC OXIDE#0.6436;RECEPTOR AGONIST#0.6426;SIGNAL PEPTIDE PEPTIDASE#0.6386;MEMBRANE TYPE 1#0.6346;GAMMA SECRETASE COMPLEX#0.6343;HUPERZINE A#0.6334;MILD COGNITIVE IMPAIRMENT#0.6305;GLYCOSYLATION#0.6303;OSTEOCLAST#0.6297;EMBRYONIC KIDNEY#0.6290;VITAMIN A#0.6267;EPITHELIAL CELL-CELL ADHESION#0.6259;CELL CELL JUNCTION#0.6245;TYPE 1 DIABETES#0.6228;RENAL CELL CARCINOMA#0.6227;ETOPOSIDE#0.6196;CELL ASSOCIATED#0.6179;RENAL CANCER CELLS#0.6177;EXTRACELLULAR VESICLE#0.6175;CHEMOTAXIS#0.6174;CELL COMMUNICATION#0.6172;SIGNAL PEPTIDE#0.6169;GOLGI OUTPOST#0.6112;BRAIN CORTEX#0.6106;MELATONIN RECEPTOR#0.6106;TRANSITIONAL B CELL#0.6093;POSTSYNAPTIC DENSITY#0.6063;1α,25-DIHYDROXYVITAMIN D3#0.6053;GRANULOCYTE#0.6053;APOPTOTIC VESICLE#0.6011;MESENCHYMAL CELL#0.6000
10300	KATANIN COMPLEX#1.1598;MICROTUBULE SEVERING ACTIVITY#1.0949;MEIOTIC SPINDLE#1.0887;MICROTUBULE SEVERING#1.0613;SPINDLE POLE#1.0523;CORTICAL MICROTUBULE#1.0499;MICROTUBULE#1.0356;MEIOSIS#1.0262;MITOSIS#1.0252;MITOTIC SPINDLE#1.0136;CENTROSOME#1.0126;MICROTUBULE DYNAMICS#1.0039;CELL DIVISION#0.9924;MICROTUBULE MINUS END#0.9911;MICROTUBULE DISASSEMBLY#0.9850;CELL WALL#0.9643;MICROTUBULE BINDING#0.9544;CELL CYCLE#0.9366;MICROTUBULE ASSOCIATED PROTEIN#0.9364;CELL ELONGATION#0.9129;BASAL BODY#0.9087;BREAST CANCER#0.9082;CYTOKINESIS#0.9064;LYMPH NODE#0.8737;INTERPHASE#0.8687;ATPASE ACTIVITY#0.8559;ATP HYDROLYSIS#0.8381;KINESIN#0.8367;MORPHOGENESIS#0.8366;TUBULIN COMPLEX#0.8351;SPINDLE FORMATION#0.8202;LYMPH NODE METASTASIS#0.8037;SPINDLE ASSEMBLY#0.7966;C TERMINAL DOMAIN#0.7799;M PHASE#0.7578;UBIQUITIN#0.7565;OOCYTE#0.7539;TRANSITION FIBER#0.7370;COMPLEX I#0.7117;HEREDITARY SPASTIC PARAPLEGIA#0.6957;SPERMATOGENESIS#0.6907;PHRAGMOPLAST#0.6888;CELL PROLIFERATION#0.6816;SPINDLE MICROTUBULE#0.6693;CANCER CELL#0.6690;GERM CELL#0.6559;GENE EXPRESSION#0.6547;MICROTUBULE CYTOSKELETON#0.6505;MICROCEPHALY#0.6381;PARAPLEGIA#0.6342;CELL EXPANSION#0.6309;SPERM HEAD#0.6277;DYNEIN#0.6242;CELL MIGRATION#0.6239;CENTRAL SPINDLE#0.6222;PROTEASOME#0.6176;CENTRIOLE#0.6157;PROSTATE CANCER#0.6084;MEIOTIC SPINDLE ASSEMBLY#0.6051
10301	CELL PROLIFERATION#1.0560;SMALL INTESTINE#1.0258;LEUCINE#1.0230;T CELL#1.0179;LYMPHOCYTIC LEUKEMIA#1.0122;CHRONIC LYMPHOCYTIC LEUKEMIA#1.0082;B CELL#1.0034;APOPTOSIS#0.9956;TUMOR SUPPRESSOR#0.9937;T LYMPHOCYTE#0.9930;B LYMPHOCYTE#0.9875;PERIPHERAL BLOOD#0.9722;BONE MARROW#0.9713;T-CELL LEUKEMIA#0.9267;CELL DIFFERENTIATION#0.9250;LYMPHOID CELL#0.9044;CELL SURFACE#0.9038;GENE EXPRESSION#0.8740;B CELL LYMPHOMA#0.8738;MULTIPLE SCLEROSIS#0.8705;B CELL DIFFERENTIATION#0.8412;THYMOCYTE#0.8398;MONONUCLEAR CELLS#0.8296;EPITHELIAL CELL#0.8282;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8268;LYMPH NODE#0.8219;PLASMA CELL#0.8034;ERYTHROCYTE#0.7964;ONCOGENIC#0.7739;ADULT T-CELL LEUKEMIA#0.7625;RENAL CELL CARCINOMA#0.7529;MUTAGEN#0.7203;LYMPHOBLASTIC LYMPHOMA#0.6926;TUMOR CELLS#0.6898;DUAL LUCIFERASE REPORTER#0.6816;REPORTER GENE ASSAY#0.6809;POLYMERASE CHAIN REACTION#0.6771;LUNG CANCER#0.6751;CANCER CELL#0.6721;MUTAGENESIS#0.6475;LEUCINE BIOSYNTHESIS#0.6432;HODGKIN'S LYMPHOMA#0.6384;HAIRY CELL LEUKEMIA#0.6356;SUPPRESSOR T CELL#0.6352;STEM CELL#0.6307;O CELL#0.6204;PANCREATIC DUCTAL ADENOCARCINOMA#0.6006
103021165	COLORECTAL CANCER#0.8458;NON-SMALL CELL LUNG CARCINOMA#0.6764;LUNG CARCINOMA#0.6674;COLORECTAL#0.6608
103021294	TYPE 2 DIABETIC#0.6012
10306	CELL ENVELOPE#0.6299
10307	AMYLOID PRECURSOR PROTEIN#1.0370;HUMAN LENS EPITHELIAL#0.8976;EPITHELIAL CELL#0.7883;ALZHEIMER'S DISEASE#0.6392;MAPK SIGNALLING#0.6134
10308	ZINC FINGER PROTEIN#1.1210;TRANSCRIPTION FACTOR#0.7916;GENE EXPRESSION#0.7904;LIVER DISEASE#0.7235;HEPATOCELLULAR CARCINOMA#0.7227
10309	KINASE ACTIVITY#0.8217;MOTILE CILIA#0.7813;APOPTOSIS#0.7236;LYMPHOID CELL#0.6537;CENTRIOLE#0.6453;CELL CYCLE#0.6269
1030	ANTISENSE RNA#1.0439;DEMETHYLATION#1.0273;METHYLATION SPECIFIC POLYMERASE#1.0200;DECITABINE#1.0196;CYCLIN DEPENDENT KINASE INHIBITOR#1.0185;MULTIPLE MYELOMA#1.0156;CDK INHIBITOR#1.0156;KINASE INHIBITOR#1.0115;METHYLATION SPECIFIC PCR#1.0092;CYCLIN DEPENDENT KINASE#1.0078;ACUTE LEUKEMIA#1.0058;MYELODYSPLASTIC SYNDROME#1.0053;SENESCENCE#1.0043;PANCREATIC CANCER#1.0033;5-AZA-2'-DEOXYCYTIDINE#1.0007;DNA METHYLTRANSFERASE#1.0003;ESTROGEN RECEPTOR#1.0003;2'-DEOXYCYTIDINE#0.9996;ACUTE MYELOID LEUKEMIA#0.9978;MYELOID LEUKEMIA#0.9961;PERIPHERAL BLOOD#0.9957;PROSTATE CANCER#0.9946;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.9942;CHROMOSOMAL REGION#0.9937;TUMOR SUPPRESSOR#0.9926;LYMPHOCYTIC LEUKEMIA#0.9925;ASTROCYTOMA#0.9920;CPG ISLAND METHYLATION#0.9919;RETINOBLASTOMA#0.9912;B CELL LYMPHOMA#0.9909;DISEASE FREE SURVIVAL#0.9908;ATHEROSCLEROSIS#0.9907;SMOOTH MUSCLE#0.9906;CELL CYCLE REGULATOR#0.9902;LUNG ADENOCARCINOMA#0.9893;OVARIAN#0.9887;T CELL#0.9874;MUSCLE CELL#0.9870;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9868;BONE MARROW#0.9867;SMOOTH MUSCLE CELL#0.9858;TYPE 2 DIABETES#0.9853;COLORECTAL CANCER#0.9847;OVARIAN CANCER#0.9846;PROGENITOR CELL#0.9846;CELL CYCLE CONTROL#0.9844;PROTEIN KINASE#0.9842;POLYMERASE CHAIN REACTION#0.9841;CELL CYCLE REGULATION#0.9839;LUNG CANCER#0.9828;CELL CYCLE ARREST#0.9826;TRANSFORMING GROWTH FACTOR BETA#0.9823;REVERSE TRANSCRIPTION#0.9821;CORONARY ARTERY DISEASE#0.9816;COPY NUMBER ALTERATION#0.9812;ARTERY DISEASE#0.9809;CELL CYCLE#0.9806;S PHASE#0.9803;ACUTE LYMPHOCYTIC LEUKEMIA#0.9784;SQUAMOUS CELL CARCINOMA#0.9781;APOPTOTIC#0.9779;MYOCARDIAL INFARCTION#0.9779;COLORECTAL#0.9772;TRANSCRIPTASE#0.9771;CORONARY ARTERY#0.9770;MYELOID CELL#0.9769;G1 PHASE#0.9769;CELLULAR SENESCENCE#0.9765;ONCOGENIC#0.9757;BREAST CANCER#0.9757;HEPATOCELLULAR CARCINOMA#0.9754;TRANSCRIPTION FACTOR#0.9749;EPITHELIAL CELL#0.9749;TRANSFORMING GROWTH FACTOR#0.9747;DNA METHYLATION#0.9744;ARTERY#0.9742;CELL DIFFERENTIATION#0.9741;TUMOR CELLS#0.9733;OPEN ANGLE GLAUCOMA#0.9730;BREAST CANCER CELL#0.9730;ADENOCARCINOMA#0.9725;SIGNALING PATHWAY#0.9718;KINASE ACTIVITY#0.9715;COMPARATIVE GENOMIC HYBRIDIZATION#0.9707;B CELL#0.9703;CANCER CELL#0.9693;CELL GROWTH#0.9686;GROWTH FACTOR RECEPTOR#0.9685;PRIMARY OPEN ANGLE GLAUCOMA#0.9682;GROWTH FACTOR#0.9668;CELL PROLIFERATION#0.9666;REPLICATIVE SENESCENCE#0.9646;APOPTOSIS#0.9643;STEM CELL#0.9637;MALIGNANT MESOTHELIOMA#0.9633;EVENT FREE SURVIVAL#0.9624;GENE EXPRESSION#0.9621;DIABETES MELLITUS#0.9618;REGULATION OF CELL CYCLE#0.9604;BETA CELL#0.9583;GENE SILENCING#0.9564;MITOGEN ACTIVATED PROTEIN#0.9552;CHRONIC MYELOID LEUKEMIA#0.9552;CELL DEATH#0.9550;CERVICAL#0.9534;DIFFUSE LARGE B-CELL LYMPHOMA#0.9529;DNA REPAIR#0.9498;LYMPH NODE#0.9480;COLON CANCER#0.9451;NERVOUS SYSTEM#0.9443;ESOPHAGEAL CANCER#0.9440;COPY NUMBER CHANGE#0.9439;HODGKIN'S LYMPHOMA#0.9424;TELOMERASE ACTIVITY#0.9410;KERATINOCYTE#0.9400;HISTONE DEACETYLASE#0.9399;DNA HYPERMETHYLATION#0.9397;EPIDERMAL GROWTH FACTOR#0.9386;DNA SYNTHESIS#0.9346;PLASMA CELL#0.9343;CELL DIVISION#0.9319;T-CELL LEUKEMIA#0.9314;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9273;CELL CYCLE PATHWAY#0.9257;TYPE 2 DIABETES MELLITUS#0.9210;2 DIABETES MELLITUS#0.9209;TUMOR TISSUES#0.9199;MELANOMA CELL LINES#0.9165;ATHEROSCLEROTIC#0.9113;COMMON MYELOID PROGENITOR#0.9109;ENDOTHELIAL CELL#0.9088;COPY NUMBER VARIATION#0.9086;HEMATOPOIETIC CELL#0.9083;CENTRAL NERVOUS SYSTEM#0.9080;PARATHYROID ADENOMA#0.9064;QUANTITATIVE REAL TIME#0.9056;INSULIN SECRETION#0.8996;MONONUCLEAR CELLS#0.8994;RETINOIC ACID#0.8987;ORAL SQUAMOUS CELL CARCINOMA#0.8960;MALIGNANT GLIOMA#0.8958;M PHASE#0.8941;ADULT T-CELL LEUKEMIA#0.8911;CERVICAL CANCER#0.8890;HUMAN BREAST CANCER#0.8871;EXTRACELLULAR MATRIX#0.8791;BREAST CARCINOMA#0.8781;BONE MARROW CELLS#0.8756;NEUROBLASTOMA#0.8752;FOLLICULAR LYMPHOMA#0.8739;PARATHYROID#0.8721;GLIOBLASTOMA MULTIFORME#0.8718;HYPOXIA#0.8715;UBIQUITIN#0.8705;MONOCYTE#0.8683;HEART DISEASE#0.8668;LYSINE#0.8650;LEUKOCYTE#0.8649;DNA COPY NUMBER#0.8632;CELL ADHESION#0.8533;ACUTE PROMYELOCYTIC LEUKEMIA#0.8528;FORMALIN#0.8508;CHRONIC LYMPHOCYTIC LEUKEMIA#0.8491;ONCOGENESIS#0.8481;CORONARY HEART DISEASE#0.8477;MYCOSIS FUNGOIDES#0.8464;SIGNAL TRANSDUCTION#0.8459;VON HIPPEL LINDAU#0.8448;OLIGODENDROGLIOMA#0.8424;LYMPHOBLASTIC LYMPHOMA#0.8412;GESTATIONAL DIABETES#0.8392;MACROPHAGE#0.8359;VASCULAR SMOOTH MUSCLE CELL#0.8349;ARSENIC TRIOXIDE#0.8348;QUANTITATIVE REVERSE TRANSCRIPTION#0.8346;DRUG RESISTANCE#0.8342;PERIPHERAL NERVE#0.8337;GRANULOCYTE#0.8312;FAMILIAL MELANOMA#0.8298;DNA BINDING#0.8293;CYTOPLASM#0.8279;INDUCTION OF APOPTOSIS#0.8264;HISTONE METHYLATION#0.8249;CELL MIGRATION#0.8231;GERM CELL#0.8217;HYPERMETHYLATION OF CPG ISLAND#0.8206;LYMPH NODE METASTASIS#0.8185;CELL CYCLE CHECKPOINT#0.8133;CARCINOGEN#0.8112;PROTEASOME#0.8093;REGENERATION#0.8027;CELL DIVISION CYCLE#0.8001;ADENOMATOUS POLYPOSIS COLI#0.7995;SOFT TISSUE SARCOMA#0.7991;GENE COPY NUMBER#0.7982;PROTEIN KINASE INHIBITOR#0.7972;ACUTE MYELOID LEUKAEMIA#0.7967;HEMATOPOIETIC STEM CELL#0.7966;CUTANEOUS T CELL LYMPHOMA#0.7962;PANCREATIC CARCINOMA#0.7959;ALTERNATIVE READING FRAME#0.7953;DNA REPLICATION#0.7911;TYROSINE KINASE INHIBITOR#0.7874;HEMATOPOIESIS#0.7867;POLYCOMB REPRESSIVE COMPLEX#0.7843;PLEOMORPHIC XANTHOASTROCYTOMA#0.7843;ADIPOSE TISSUE#0.7835;MANTLE CELL LYMPHOMA#0.7826;RENAL CELL CARCINOMA#0.7802;WHITE BLOOD CELL#0.7791;PITUITARY ADENOMA#0.7789;CDK ACTIVITY#0.7711;ANAPLASTIC MENINGIOMA#0.7696;HUMAN PANCREATIC CANCER#0.7693;PROSTATE CARCINOMA#0.7685;ESOPHAGEAL CARCINOMA#0.7673;RELAPSE FREE SURVIVAL#0.7635;THYROID CANCER#0.7624;TYPE 1 DIABETES#0.7621;LUNG CARCINOMA#0.7618;GLUTATHIONE#0.7604;MINIMAL RESIDUAL DISEASE#0.7569;HISTONE DEACETYLASE INHIBITOR#0.7549;RNA INTERFERENCE#0.7541;ORAL GLUCOSE TOLERANCE#0.7537;WOUND HEALING#0.7534;GLUCOSE TOLERANCE TEST#0.7527;AZACYTIDINE#0.7434;BASAL CELL#0.7434;QUIESCENCE#0.7405;MAPK SIGNALING#0.7400;HISTONE MODIFICATION#0.7380;STROMAL CELL#0.7282;PROGESTERONE#0.7274;TRANSITIONAL CELL CARCINOMA#0.7271;NERVE SHEATH TUMORS#0.7263;HYPERTENSION#0.7259;PERIPHERAL BLOOD CELLS#0.7252;LUNG EPITHELIAL CELL#0.7250;HISTONE ACETYLATION#0.7231;METASTATIC MELANOMA#0.7225;OVARIAN CARCINOMA#0.7210;STRIATUM#0.7205;HEMATOPOIETIC PROGENITOR CELL#0.7195;PROTEIN PHOSPHORYLATION#0.7158;ONCOGENE INDUCED SENESCENCE#0.7141;INHIBITION OF CELL PROLIFERATION#0.7125;OPTIC NERVE#0.7098;TERMINAL DIFFERENTIATION#0.7097;MISMATCH REPAIR#0.7093;MITOSIS#0.7075;VSMC PROLIFERATION#0.7063;MOUSE EMBRYO FIBROBLASTS#0.7062;CHONDROSARCOMA#0.7062;AORTIC ANEURYSM#0.7038;DNA HYPOMETHYLATION#0.7014;ANGIOGENESIS#0.7003;CELL ADHESION MOLECULE#0.6940;INFLAMMATORY RESPONSE#0.6913;RNA BINDING#0.6897;GESTATIONAL DIABETES MELLITUS#0.6893;AGEING#0.6846;ADJACENT NORMAL TISSUE#0.6837;PROLIFERATING CELL NUCLEAR ANTIGEN#0.6819;TELOMERE#0.6818;COPY NUMBER GAIN#0.6816;CHOLANGIOCARCINOMA#0.6807;HISTONE DEMETHYLASE#0.6792;MALIGNANT PERIPHERAL NERVE SHEATH TUMOR#0.6780;RNASE P#0.6779;LIVER FLUKE-RELATED CHOLANGIOCARCINOMA#0.6777;CARCINOMA IN SITU#0.6741;COLORECTAL CARCINOMA#0.6740;EPITHELIAL OVARIAN CANCER#0.6736;INTERPHASE#0.6727;THYROID CARCINOMA#0.6727;PHOSPHATASE AND TENSIN HOMOLOG#0.6709;ASTROCYTE#0.6691;MECHANISM OF ACTION#0.6676;PILOCYTIC ASTROCYTOMA#0.6668;WORLD HEALTH ORGANIZATION#0.6623;RECURRENCE FREE SURVIVAL#0.6578;MUTAGENESIS#0.6577;EPSTEIN BARR VIRUS#0.6542;CELL CYCLE TRANSITION#0.6539;MALIGNANT LYMPHOMA#0.6531;DENTATE GYRUS#0.6528;GASTRIC ADENOCARCINOMA#0.6522;INSULIN-LIKE GROWTH FACTOR#0.6508;HYPOXIC#0.6491;BLAST CELL#0.6479;PROTEIN CODING GENE#0.6472;CAROTID ARTERY#0.6469;HEAD AND NECK CANCER#0.6448;ENDOMETRIAL CANCER#0.6448;NECK CANCER#0.6447;DIDEOXYCYTIDINE#0.6430;SYPHILIS#0.6360;3-OST-2#0.6321;EPITHELIAL CELL PROLIFERATION#0.6306;DEPHOSPHORYLATION#0.6278;MOUSE EMBRYONIC FIBROBLAST#0.6271;GASTRIC MUCOSA#0.6245;STEM CELL TRANSPLANTATION#0.6238;CELL DEVELOPMENT#0.6237;MESENCHYMAL STEM CELL#0.6219;DNA DEMETHYLATION#0.6214;PROTEIN SYNTHESIS#0.6210;GENOTOXIC#0.6185;MELANOCYTE#0.6181;ANAPLASTIC OLIGODENDROGLIOMA#0.6180;ATYPICAL MENINGIOMA#0.6178;T LYMPHOCYTE#0.6177;BASAL CELL CARCINOMA#0.6174;MICROTUBULE#0.6169;WNT SIGNALING PATHWAY#0.6160;DOUBLE STRAND BREAK#0.6125;FIBROBLAST GROWTH FACTOR#0.6065;CISPLATIN#0.6042;IMMUNE RESPONSE#0.6036
10311	DOWN SYNDROME#0.8430
10312	PROTON PUMP#1.0672;AUTOSOMAL RECESSIVE OSTEOPETROSIS#1.0638;T CELL#1.0632;IMMUNE RESPONSE#1.0559;OSTEOPETROSIS#1.0320;OSTEOCLAST#1.0201;BONE RESORPTION#0.9960;ACIDIFICATION#0.9852;BONE MARROW#0.9802;CELL ACTIVATION#0.9773;STEM CELL#0.9683;CHLORIDE CHANNEL#0.9648;GENE EXPRESSION#0.9517;T CELL ACTIVATION#0.9405;PERIPHERAL BLOOD#0.8958;HEMATOPOIETIC STEM CELL#0.8698;STEM CELL TRANSPLANTATION#0.8515;OSTEOCLAST DIFFERENTIATION#0.8215;B CELL#0.8118;BONE DISEASE#0.8107;VACUOLE#0.7930;CELL PROLIFERATION#0.7777;T CELL PROLIFERATION#0.7549;ACTIVATED T CELL#0.7410;ATPASE COMPLEX#0.7248;ACID PHOSPHATASE#0.7151;T LYMPHOCYTE#0.7129;MONOCYTE#0.6850;VACUOLAR ACIDIFICATION#0.6744;MACROPHAGE#0.6634;THROMBOCYTOPENIA#0.6467;ACTIVATED T-CELLS#0.6317;OSTEOCLAST PRECURSOR CELL#0.6313;POLYMERASE CHAIN REACTION#0.6304;OPTIC NERVE#0.6133;COLLAGEN INDUCED ARTHRITIS#0.6117;LYMPHOCYTE ACTIVATION#0.6045;INDUCED PLURIPOTENT STEM CELL#0.6028;PLURIPOTENT STEM CELL#0.6010;PRECURSOR CELL#0.6002
10313	APOPTOSIS#1.0524;ENDOPLASMIC RETICULUM#1.0477;NEURITE#0.9950;ALZHEIMER'S DISEASE#0.9739;APOPTOTIC#0.9270;AMYLOID PRECURSOR PROTEIN#0.8952;VIRAL REPLICATION#0.8251;AUTOPHAGY#0.8191;CEREBRAL CORTEX#0.8137;ER MEMBRANE#0.7783;CYTOCHROME C#0.7612;CELL DEATH#0.7045;AXONAL TRANSPORT#0.7029;MITOCHONDRIA#0.6981;PLASMA MEMBRANE#0.6883;CENTRAL NERVOUS SYSTEM#0.6639;NERVOUS SYSTEM#0.6629;NEURODEGENERATIVE DISEASE#0.6429;REGENERATION#0.6274
10314	NADPH OXIDASE#0.9623;ERYTHROCYTE#0.9110;GLUTATHIONE#0.7967;PROTEIN TYROSINE KINASE#0.7058;MAURER'S CLEFT#0.6466
103164619	MACROPHAGE#0.8847;IFN-GAMMA#0.8083;PRINCIPAL COMPONENT ANALYSIS#0.7808;PURKINJE CELL#0.7752;ATPASE ACTIVITY#0.7374;VIRULENCE#0.7007;GENE EXPRESSION#0.6936;PARATHYROID HORMONE#0.6151
10316	NEUROMEDIN U RECEPTOR#1.0572;NERVOUS SYSTEM#0.9770;CENTRAL NERVOUS SYSTEM#0.9441;POLYMERASE CHAIN REACTION#0.8127;GASTROINTESTINAL TRACT#0.7203;REVERSE TRANSCRIPTION#0.7048;PITUITARY GLAND#0.6692;STRUCTURE ACTIVITY RELATIONSHIP#0.6677;GROWTH HORMONE#0.6644;INSULIN SECRETION#0.6431;MAST CELL#0.6425;GENE EXPRESSION#0.6414;ENERGY HOMEOSTASIS#0.6216;ANORECTIC#0.6081
10317	PANCREATIC CANCER#0.7304;COLON CANCER#0.7292;TRANSCRIPTION FACTOR#0.6734;N GLYCAN#0.6619
10318	VAN DER WOUDE SYNDROME#1.1183;VAN DER WAALS#1.0829;UBIQUITIN BINDING#1.0504;PSORIASIS#1.0299;UBIQUITIN#1.0286;SYSTEMIC LUPUS ERYTHEMATOSUS#1.0176;LUPUS ERYTHEMATOSUS#1.0174;T CELL#1.0064;APOPTOSIS#1.0042;TUMOR NECROSIS FACTOR#0.9892;GENE EXPRESSION#0.9889;SIGNALING PATHWAY#0.9808;PROTEIN KINASE#0.9753;KERATINOCYTE#0.9733;AUTOIMMUNE DISEASE#0.9705;NF-KAPPAB ACTIVATION#0.9700;TRANSCRIPTION FACTOR#0.9419;IMMUNE RESPONSE#0.9388;PERIPHERAL BLOOD#0.9120;HUMAN IMMUNODEFICIENCY VIRUS#0.9011;GROWTH FACTOR#0.8954;RETINOIC ACID#0.8845;EOSIN#0.8798;EPITHELIAL CELL#0.8725;KINASE ACTIVITY#0.8544;RETINOIC ACID RECEPTOR#0.8455;B CELL#0.8391;CELL DEATH#0.8376;NEPHRITIS#0.8328;TOLL LIKE RECEPTOR#0.8284;MITOGEN ACTIVATED PROTEIN#0.8269;CLEFT LIP#0.8255;POLYMERASE CHAIN REACTION#0.8248;PLANAR CELL POLARITY#0.8160;CELL POLARITY#0.8076;CANCER CELL#0.7943;APOPTOTIC#0.7855;IMMUNE CELL#0.7846;IMMUNE SYSTEM#0.7808;CELL PROLIFERATION#0.7780;PSORIATIC ARTHRITIS#0.7777;CLEFT PALATE#0.7707;INNATE IMMUNE RESPONSE#0.7670;LUPUS NEPHRITIS#0.7532;CELL SURFACE#0.7527;INFLAMMATORY RESPONSE#0.7391;CELL GROWTH#0.7390;AUTOIMMUNITY#0.7367;RHEUMATOID ARTHRITIS#0.7360;POPLITEAL PTERYGIUM SYNDROME#0.7344;NEURAL TUBE#0.7253;SPINA BIFIDA#0.7215;SIGNAL TRANSDUCTION#0.7005;REVERSE TRANSCRIPTION#0.6944;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6891;MACROPHAGE#0.6827;ENHANCER BINDING PROTEIN#0.6780;ENHANCER BINDING#0.6774;TUMOUR NECROSIS FACTOR#0.6732;DNA BINDING#0.6704;DENDRITIC CELL#0.6697;LEUKOCYTE#0.6635;INTERFERON REGULATORY FACTOR#0.6542;VIRION#0.6537;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6526;MONONUCLEAR CELLS#0.6514;PROTEIN KINASE C#0.6473;POLYUBIQUITIN#0.6229;MYASTHENIA GRAVIS#0.6124;CARCINOMA IN SITU#0.6027
10319	BASEMENT MEMBRANE#0.8342;APICAL ES#0.6805;ANTISENSE MORPHOLINO OLIGONUCLEOTIDE#0.6058
1031	BREAST CANCER#1.0378;CDK INHIBITOR#1.0271;B CELL#1.0260;CYCLIN DEPENDENT KINASE INHIBITOR#1.0174;KINASE INHIBITOR#1.0109;CELL CYCLE ARREST#1.0102;CELL CYCLE REGULATOR#1.0068;TUMOR SUPPRESSOR#1.0063;CELL GROWTH#1.0051;CYCLIN DEPENDENT KINASE#1.0043;T CELL#0.9978;CANCER CELL#0.9976;CELL CYCLE#0.9945;STEM CELL#0.9943;CELL PROLIFERATION#0.9930;TUMOR CELLS#0.9920;G1 PHASE#0.9893;POLYMERASE CHAIN REACTION#0.9886;RETINOBLASTOMA#0.9859;MULTIPLE MYELOMA#0.9843;APOPTOSIS#0.9816;APOPTOTIC#0.9783;GENE EXPRESSION#0.9780;TRANSCRIPTION FACTOR#0.9750;CELL DIVISION#0.9696;CELL DIFFERENTIATION#0.9614;CELL CYCLE REGULATION#0.9596;BONE MARROW#0.9592;CELL CYCLE CONTROL#0.9591;BREAST CANCER CELL#0.9584;PITUITARY ADENOMA#0.9523;MULTIPLE ENDOCRINE NEOPLASIA#0.9518;CELL DEATH#0.9436;PLASMA CELL#0.9380;HEMATOPOIETIC STEM CELL#0.9366;PROGENITOR CELL#0.9281;S PHASE#0.9210;PARATHYROID ADENOMA#0.9207;PROTEIN KINASE#0.9205;SIGNALING PATHWAY#0.9107;PARATHYROID#0.9089;OLIGODENDROGLIOMA#0.8876;LUNG CANCER#0.8839;CELL DIVISION CYCLE#0.8788;KINASE ACTIVITY#0.8787;CISPLATIN#0.8595;PROSTATE CANCER#0.8517;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8474;B LYMPHOCYTE#0.8406;REVERSE TRANSCRIPTION#0.8386;THYROID CARCINOMA#0.8381;MULTIPLE ENDOCRINE NEOPLASIA TYPE 1#0.8320;GROWTH FACTOR#0.8286;LUMINAL PROGENITOR CELL#0.8142;SENESCENCE#0.8112;LUMINAL PROGENITOR#0.7947;PANCREATIC ISLET#0.7825;MEDULLOBLASTOMA#0.7705;NEUROBLASTOMA#0.7652;CELL EXPANSION#0.7639;LEYDIG CELL#0.7450;SPERMATOGENESIS#0.7343;LUMINAL#0.7270;BETA CELL#0.7083;EPITHELIAL CELL#0.6994;HEPATOCELLULAR CARCINOMA#0.6876;HUMAN BREAST CANCER#0.6813;CELL CYCLE PATHWAY#0.6789;SQUAMOUS CELL CARCINOMA#0.6754;MANTLE CELL LYMPHOMA#0.6574;COMPARATIVE GENOMIC HYBRIDIZATION#0.6534;ONCOGENIC#0.6437;TERMINAL DIFFERENTIATION#0.6332;DNA REPLICATION#0.6319;HYPOXIA#0.6292;QUIESCENCE#0.6191;OVARIAN CANCER#0.6191;OVARIAN#0.6189;INDUCTION OF APOPTOSIS#0.6167;B CELL LYMPHOMA#0.6046
10320	ZINC FINGER PROTEIN#1.0594;LYMPHOCYTE DEVELOPMENT#1.0537;CHROMATIN REMODELING#1.0470;LYMPHOCYTE DIFFERENTIATION#1.0446;HETEROCHROMATIN#1.0403;T CELL DEVELOPMENT#1.0333;T CELL DIFFERENTIATION#1.0332;DNA BINDING#1.0308;THYMOCYTE#1.0304;LENALIDOMIDE#1.0298;HISTONE DEACETYLASE#1.0284;HEMATOPOIETIC CELL#1.0283;TUMOR SUPPRESSOR#1.0272;CD4+ T CELL#1.0268;POMALIDOMIDE#1.0250;EVENT FREE SURVIVAL#1.0239;HEMATOPOIESIS#1.0224;LYMPHOID CELL#1.0220;TRANSCRIPTION FACTOR#1.0190;B CELL DIFFERENTIATION#1.0185;B CELL DEVELOPMENT#1.0178;CELL DIFFERENTIATION#1.0122;CELL DEVELOPMENT#1.0115;CELL CYCLE#1.0099;T LYMPHOCYTE#1.0098;UBIQUITIN#1.0088;MINIMAL RESIDUAL DISEASE#1.0074;SYSTEMIC LUPUS ERYTHEMATOSUS#1.0071;LUPUS ERYTHEMATOSUS#1.0069;T CELL#1.0039;ONCOGENIC#1.0031;ACUTE MYELOID LEUKEMIA#1.0029;B CELL RECEPTOR#1.0026;COPY NUMBER ALTERATION#1.0012;CYTOKINE RECEPTOR#1.0012;HEMATOPOIETIC STEM CELL#1.0010;ACUTE LYMPHOBLASTIC LEUKEMIA#1.0005;SIGNALING PATHWAY#0.9979;MYELOID LEUKEMIA#0.9973;B CELL#0.9961;B LYMPHOCYTE#0.9953;MULTIPLE MYELOMA#0.9951;POLYMERASE CHAIN REACTION#0.9945;GENE EXPRESSION#0.9910;IMMUNE SYSTEM#0.9909;STEM CELL#0.9900;CELL PROLIFERATION#0.9898;PROGENITOR CELL#0.9896;APOPTOSIS#0.9866;THALIDOMIDE#0.9847;KINASE INHIBITOR#0.9810;BONE MARROW#0.9797;NURD COMPLEX#0.9779;PERIPHERAL BLOOD#0.9740;MACROPHAGE#0.9714;DENDRITIC CELL#0.9692;THYMOCYTE DIFFERENTIATION#0.9691;MYELOID CELL#0.9678;T-CELL LEUKEMIA#0.9674;REVERSE TRANSCRIPTION#0.9670;PROTEIN PHOSPHATASE 1#0.9667;TYROSINE KINASE INHIBITOR#0.9647;ACUTE LEUKEMIA#0.9644;WHITE BLOOD CELL#0.9626;CELL ACTIVATION#0.9622;FACTOR I#0.9606;CASEIN KINASE 2#0.9582;UBIQUITIN LIGASE COMPLEX#0.9552;IMMUNE RESPONSE#0.9516;AUTOIMMUNITY#0.9440;PROTEASOME#0.9404;ERYTHROID CELL#0.9379;PROTEIN KINASE#0.9271;CELL SURFACE#0.9182;DISEASE FREE SURVIVAL#0.9153;DEXAMETHASONE#0.9133;CANCER CELL#0.9117;CELL GROWTH#0.9096;MULTIPLE MYELOMA CELLS#0.9081;MYELODYSPLASTIC SYNDROME#0.9011;PLASMA CELL#0.8986;STEM CELL TRANSPLANTATION#0.8977;REGULATORY T CELL#0.8940;PRE-B CELL DIFFERENTIATION#0.8933;CD8+ T CELL#0.8931;GROWTH FACTOR#0.8904;AUTOIMMUNE DISEASE#0.8874;SIGNAL TRANSDUCTION#0.8868;GLOBIN#0.8841;CELL DEATH#0.8767;RISK OF RELAPSE#0.8706;CELL ADHESION#0.8697;CHRONIC MYELOID LEUKEMIA#0.8641;MYELOPROLIFERATIVE NEOPLASM#0.8588;MECHANISM OF ACTION#0.8496;HISTONE ACETYLATION#0.8484;DRUG RESISTANCE#0.8482;COLORECTAL CANCER#0.8472;LYMPHOID LEUKEMIA#0.8455;MONONUCLEAR CELLS#0.8452;IFN-GAMMA#0.8450;IMATINIB#0.8397;ELECTROPHORETIC MOBILITY SHIFT#0.8379;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8312;C-TERMINAL BINDING#0.8299;TRANSCRIPTION FACTOR BINDING#0.8285;CELL MATURATION#0.8283;COLORECTAL#0.8233;RELAPSE FREE SURVIVAL#0.8224;T CELL ACTIVATION#0.8185;CELL CYCLE ARREST#0.8145;LYMPHOBLAST#0.8130;HISTONE DEACETYLATION#0.8072;NUCLEOSOME#0.8052;DNA METHYLATION#0.7991;CASEIN KINASE 1#0.7982;IMMUNE CELL#0.7900;STROMAL CELL#0.7880;PANCREATIC CANCER#0.7857;MONOCYTE#0.7857;B CELL LYMPHOMA#0.7840;ACTIVATED T CELL#0.7830;MUTAGENESIS#0.7820;COMPARATIVE GENOMIC HYBRIDIZATION#0.7792;PLASMA MEMBRANE#0.7776;SEQUENCE SPECIFIC DNA BINDING#0.7691;LYMPHOID TISSUE#0.7591;T CELL HOMEOSTASIS#0.7575;POLYCOMB REPRESSIVE COMPLEX#0.7543;TRANSCRIPTION REPRESSOR#0.7538;TRANSCRIPTION REGULATOR#0.7503;MOLECULAR FUNCTION#0.7494;CYTOPLASM#0.7449;POTASSIUM CHANNEL#0.7449;LEUCINE#0.7448;INTERFERON REGULATORY FACTOR#0.7438;CYTOTOXICITY#0.7420;PRECURSOR CELL#0.7393;CORD BLOOD#0.7389;T HELPER CELL#0.7376;INFLAMMATORY RESPONSE#0.7347;S PHASE#0.7312;FETAL LIVER#0.7275;LYMPHOCYTIC LEUKEMIA#0.7249;CYCLIN DEPENDENT KINASE#0.7182;LYSINE#0.7154;PROTEIN DEGRADATION#0.7128;B CELL ACTIVATION#0.7092;QUANTITATIVE REAL TIME#0.7089;STEM CELL DIFFERENTIATION#0.7085;TH2 CELL#0.7064;GERMINAL CENTER#0.7030;TRANSCRIPTIONAL CONTROL#0.7029;HISTIDINE#0.6959;NATURAL KILLER CELL#0.6938;LEUKEMIA FREE SURVIVAL#0.6935;GROWTH FACTOR RECEPTOR#0.6894;ACTIVATED T-CELLS#0.6849;PROTEIN PROTEIN INTERACTION#0.6849;ALKALINE PHOSPHATASE#0.6800;CHANNEL ACTIVITY#0.6796;CHROMATIN MODIFICATION#0.6790;SYSTEM DEVELOPMENT#0.6767;PLASMACYTOID DENDRITIC CELL#0.6765;CHRONIC LYMPHOCYTIC LEUKEMIA#0.6756;REGULATION OF GENE EXPRESSION#0.6726;ONCOGENESIS#0.6693;NERVOUS SYSTEM#0.6686;DIFFUSE LARGE B-CELL LYMPHOMA#0.6489;ERYTHROPOIESIS#0.6470;PROTEIN KINASE A#0.6444;GENE REGULATORY NETWORK#0.6361;BONE MARROW STROMAL#0.6311;SUMOYLATION#0.6251;C TERMINAL DOMAIN#0.6217;DNA COPY NUMBER#0.6204;CENTROMERIC HETEROCHROMATIN#0.6167;HIGH RISK PATIENTS#0.6155;SIGNAL TRANSDUCER#0.6152;NK CELL DIFFERENTIATION#0.6151;ADENOCARCINOMA#0.6136;EPITHELIAL CELL#0.6075;HYPOXIA#0.6049;V-D-J RECOMBINATION#0.6039;CYCLIN DEPENDENT KINASE INHIBITOR#0.6039;AGE AT DIAGNOSIS#0.6035;NATIONAL CANCER INSTITUTE#0.6013;ACTIVATED CD8+ T CELL#0.6006
10321	SPECIFIC GRANULE#1.1115;SEMINAL PLASMA#1.0730;PROSTATE CANCER#1.0614;SALIVARY GLAND#1.0529;NEUTROPHIL#1.0123;GENE EXPRESSION#0.9338;SEMEN#0.8917;PLASMA PROTEIN#0.8912;CANCER CELL#0.8907;B CELL#0.8554;EPIDIDYMIS#0.7884;GRANULOCYTE#0.7482;EPITHELIAL CELL#0.7381;EOSINOPHIL#0.7155;PERIPHERAL BLOOD#0.7152;ACINAR CELL#0.7106;ACIDIC EPIDIDYMAL GLYCOPROTEIN#0.7034;REVERSE TRANSCRIPTION#0.6602;ANDROGEN RECEPTOR#0.6395;ENDOMETRIAL EPITHELIAL CELLS#0.6281;POLYMERASE CHAIN REACTION#0.6062
10322	HETEROCHROMATIN#0.6398
10324	SKELETAL MUSCLE#0.9817;CELL CYCLE#0.9217;CYCLIN DEPENDENT KINASE#0.8961;MYOFIBRIL#0.8507;CYCLIN DEPENDENT KINASE INHIBITOR#0.8397;KINASE INHIBITOR#0.8317;NEMALINE MYOPATHY#0.7433;MYOPATHY#0.6587
10325	GTP BINDING#0.9878;TARGET OF RAPAMYCIN#0.9480;TARGET OF RAPAMYCIN COMPLEX#0.9206;RAPAMYCIN#0.8811;GAP ACTIVITY#0.8565;CELL GROWTH#0.8112;LYSOSOME#0.7682;LYSOSOME LOCALIZATION#0.7135;LEUCINE#0.6599;MTOR COMPLEX#0.6367
10326	CELL PROLIFERATION#0.6599;MYELOID CELL#0.6569;QUANTITATIVE TRAIT LOCUS#0.6231;COLONY FORMATION ASSAY#0.6163;PROSTATE CANCER#0.6018
10327	ALDO KETO REDUCTASE#1.0342;DAUNORUBICIN#0.6461
10329	LECTIN#1.0119;ENDOPLASMIC RETICULUM#0.9938;GLYCOSYLATION#0.9899;APOPTOSIS#0.9785;CELL SURFACE#0.9777;T CELL#0.9692;GOLGI APPARATUS#0.9605;TUMOR NECROSIS FACTOR#0.9472;PLASMA MEMBRANE#0.9361;LOW DENSITY LIPOPROTEIN#0.9016;VIRION#0.8506;B CELL#0.8410;CELL WALL#0.8363;SIGNAL PEPTIDE#0.8042;HERPES SIMPLEX VIRUS#0.8038;HERPES SIMPLEX#0.8035;POLYMERASE CHAIN REACTION#0.7409;GLCNAC#0.7402;ACTIVATED T-CELLS#0.7334;ACTIVATED T CELL#0.7331;ENDOTHELIAL CELL#0.7274;DENDRITIC CELL#0.7227;ENZYME ACTIVITY#0.7167;LUMINAL#0.7150;NEUTRAL ENDOPEPTIDASE 24.11#0.6993;ENDOPEPTIDASE 24.11#0.6946;CYTOPLASMIC REGION#0.6891;N GLYCAN#0.6870;TRANSFERRIN RECEPTOR#0.6845;TUMOUR NECROSIS FACTOR#0.6778;PSEUDORABIES#0.6770;GLUCAN SYNTHESIS#0.6653;MACROPHAGE#0.6518;CELL DEATH#0.6491;PROSTATE-SPECIFIC MEMBRANE ANTIGEN#0.6332;O GLYCAN#0.6295;T LYMPHOCYTE#0.6169;ENDOCYTOSIS#0.6164
1032	KINASE INHIBITOR#1.0382;CYCLIN DEPENDENT KINASE#1.0340;CELL CYCLE#1.0338;CYCLIN DEPENDENT KINASE INHIBITOR#1.0313;CDK INHIBITOR#0.9962;GENE EXPRESSION#0.9402;APOPTOSIS#0.9365;CELL PROLIFERATION#0.9228;TUMOR SUPPRESSOR#0.9102;GERM CELL#0.7916;CANCER CELL#0.7805;HEARING LOSS#0.7784;POLYMERASE CHAIN REACTION#0.7543;LUNG CANCER#0.7440;CELL GROWTH#0.7400;OVARIAN#0.7365;SIGNALING PATHWAY#0.7167;CELL CYCLE CONTROL#0.7142;OVARIAN CANCER#0.6346;OVARIAN CARCINOMA#0.6149;RETINOIC ACID#0.6046
10330	GROWTH FACTOR#0.8985;CELL PROLIFERATION#0.8900;ENDOPLASMIC RETICULUM#0.8864;NEURITE OUTGROWTH#0.7239;ANGIOGENESIS#0.7207;APOPTOSIS#0.7171;REGULATORY LIGHT CHAIN#0.6644;SAPOSIN#0.6450;CELL GROWTH#0.6441;SIGNALING PATHWAY#0.6420;POLYMERASE CHAIN REACTION#0.6408;CELL MIGRATION#0.6387;PROSTATE CANCER#0.6383;SMOOTH MUSCLE#0.6362;GENE EXPRESSION#0.6325
10331	LEUCINE#0.6422;LYMPH NODE METASTASIS#0.6258;LYMPH NODE#0.6142
10332	ENDOTHELIAL CELL#1.0581;LYMPH NODE#1.0570;LECTIN#1.0422;HEPATITIS C VIRUS#1.0371;HEPATITIS C#1.0362;CARBOHYDRATE RECOGNITION DOMAIN#1.0323;DENDRITIC CELL#1.0211;HUMAN IMMUNODEFICIENCY VIRUS#1.0199;CELL SURFACE#1.0046;T CELL#0.9571;SEVERE ACUTE RESPIRATORY SYNDROME#0.9250;MACROPHAGE#0.9069;PERIPHERAL BLOOD#0.8974;CELL ADHESION#0.8608;VIRAL INFECTION#0.8514;IMMUNE RESPONSE#0.8508;IMMUNE SYSTEM#0.8483;VIRION#0.8371;GLYCOSYLATION#0.8325;TUBERCULOSIS#0.7953;HOST CELL#0.7896;GLCNAC#0.7896;ENDOTHELIUM#0.7788;LIVER METASTASIS#0.7715;MICROVASCULAR ENDOTHELIAL CELL#0.7663;CARBOHYDRATE BINDING#0.7640;CD4+ T CELL#0.7357;PATHOGEN RECOGNITION RECEPTOR#0.7354;T LYMPHOCYTE#0.7313;ENDOCYTOSIS#0.7282;VIRAL ENVELOPE#0.7250;N GLYCAN#0.6898;COLON CANCER#0.6801;MANNOSE BINDING#0.6677;INNATE IMMUNE SYSTEM#0.6615;ANGIOTENSIN CONVERTING ENZYME#0.6580;VIRAL GLYCOPROTEIN#0.6549;MANNOSE RECEPTOR#0.6268;HUMAN DENDRITIC CELL#0.6148;SIMIAN IMMUNODEFICIENCY VIRUS#0.6052
10333	CELL SURFACE#1.0043;MONONUCLEAR CELLS#0.9962;CYTOKINE PRODUCTION#0.9949;MACROPHAGE#0.9931;TUMOR NECROSIS FACTOR#0.9901;BONE MARROW#0.9879;MONOCYTE#0.9874;PRO-INFLAMMATORY#0.9873;PEPTIDOGLYCAN#0.9867;TOLL LIKE RECEPTOR#0.9848;TUBERCULOSIS#0.9841;EPITHELIAL CELL#0.9822;SIGNALING PATHWAY#0.9801;T CELL#0.9797;PERIPHERAL BLOOD#0.9781;INFLAMMATORY RESPONSE#0.9774;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9753;GENE EXPRESSION#0.9745;PATTERN RECOGNITION RECEPTOR#0.9730;INNATE IMMUNE RESPONSE#0.9725;DENDRITIC CELL#0.9721;INNATE IMMUNE SYSTEM#0.9714;IMMUNE SYSTEM#0.9698;B CELL#0.9695;APOPTOSIS#0.9690;IMMUNE RESPONSE#0.9599;IMMUNE CELL#0.9590;INNATE IMMUNITY#0.9581;HUMAN EMBRYONIC KIDNEY#0.9579;EMBRYONIC KIDNEY#0.9574;NEUTROPHIL#0.9564;POLYMERASE CHAIN REACTION#0.9522;NF-KAPPAB ACTIVATION#0.9327;CELL WALL#0.9265;TLR2:TLR6 HETERODIMER#0.9215;GRANULOCYTE#0.9191;PROTEIN KINASE#0.9094;MITOGEN ACTIVATED PROTEIN#0.9057;CELL ACTIVATION#0.8991;TRANSCRIPTION FACTOR#0.8884;CYTOKINE SECRETION#0.8844;ALVEOLAR MACROPHAGE#0.8830;SIGNALING MOLECULE#0.8770;GROWTH FACTOR#0.8703;NITRIC OXIDE#0.8648;PHAGOCYTOSIS#0.8540;CANCER CELL#0.8485;ENDOTHELIAL CELL#0.8478;IFN-GAMMA#0.8439;KERATINOCYTE#0.8316;NUCLEOTIDE BINDING#0.7982;LEUCINE RICH REPEAT#0.7823;BREAST CANCER#0.7802;SIGNALING CASCADE#0.7791;CELL PROLIFERATION#0.7725;LYMPH NODE#0.7653;ADAPTIVE IMMUNE RESPONSE#0.7643;MALARIA#0.7636;LEUKOCYTE#0.7497;CELL DEATH#0.7437;LIPID RAFT#0.7437;QUANTITATIVE REAL TIME#0.7407;STEM CELL#0.7216;INTERLEUKIN 1 RECEPTOR#0.7178;TNF PRODUCTION#0.7138;SIGNALLING PATHWAY#0.7132;DNA METHYLATION#0.7061;MYELOID CELL#0.7037;HOST CELL#0.7028;PLASMA MEMBRANE#0.7027;REGULATORY T CELL#0.7024;LEUCINE#0.6940;COLITIS#0.6891;T LYMPHOCYTE#0.6852;RESPONSE TO PHENOL#0.6809;ACTIVATION OF NF-KAPPAB#0.6784;CORD BLOOD#0.6778;ANTIGEN PRESENTING CELLS#0.6773;SIGNAL TRANSDUCTION#0.6733;MAST CELL#0.6719;PALMITOYL#0.6710;COLORECTAL CANCER#0.6691;ATOPIC DERMATITIS#0.6636;MAP KINASE#0.6607;LYMPHOID TISSUE#0.6563;APOPTOTIC#0.6528;RECEPTOR COMPLEX#0.6509;COLONY-STIMULATING FACTOR#0.6454;TNF-ALPHA PRODUCTION#0.6350;GM-CSF#0.6299;B LYMPHOCYTE#0.6190;BOVINE TUBERCULOSIS#0.6159;ALLERGEN#0.6126;RESPIRATORY TRACT#0.6059;CONNECTIVE TISSUE#0.6025
103344718	TUMOR SUPPRESSOR#1.1829
103344929	BETA GLUCOSIDASE#0.8851;GLOBIN#0.6970
10335	SMOOTH MUSCLE#0.9988;PROTEIN KINASE#0.8451;PLATELET AGGREGATION#0.8408;NITRIC OXIDE#0.8239;SMOOTH MUSCLE CELL#0.7882;MUSCLE CELL#0.7874
1033	KINASE INHIBITOR PROTEIN#1.0776;KINASE INHIBITOR P27#1.0540;FLAVOPIRIDOL#1.0448;CYCLIN DEPENDENT KINASE INHIBITOR#1.0281;CYCLIN DEPENDENT KINASE#1.0262;KINASE INHIBITOR#1.0247;CDK INHIBITOR#1.0135;CHRONIC LYMPHOCYTIC LEUKEMIA#1.0007;OLOMOUCINE#0.9975;HISTONE DEACETYLASE#0.9952;LYMPHOCYTIC LEUKEMIA#0.9945;SENESCENCE#0.9932;HISTONE DEACETYLASE INHIBITOR#0.9881;CELL CYCLE CHECKPOINT#0.9879;OVARIAN CANCER#0.9862;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9849;MULTIPLE MYELOMA#0.9848;DNA REPLICATION#0.9837;OVARIAN#0.9820;PROSTATE CANCER#0.9820;TERMINAL DIFFERENTIATION#0.9817;CERVICAL CANCER#0.9808;CDK ACTIVITY#0.9800;TUMOR SUPPRESSOR#0.9797;CELLULAR SENESCENCE#0.9796;CELL CYCLE REGULATOR#0.9793;RETINOIC ACID#0.9789;CERVICAL#0.9783;QUIESCENCE#0.9773;PROTEASOME#0.9771;UBIQUITIN#0.9770;KERATINOCYTE#0.9764;RETINOBLASTOMA#0.9761;VASCULAR SMOOTH MUSCLE CELL#0.9757;COLORECTAL#0.9756;TRANSFORMING GROWTH FACTOR BETA#0.9755;T CELL#0.9755;GROWTH FACTOR RECEPTOR#0.9752;B CELL#0.9749;G1 PHASE#0.9742;EPIDERMAL GROWTH FACTOR#0.9742;DNA REPAIR#0.9734;COLORECTAL CANCER#0.9728;CELL DIVISION#0.9728;CELL CYCLE REGULATION#0.9724;BREAST CANCER CELL#0.9723;HEPATOCELLULAR CARCINOMA#0.9720;DEPHOSPHORYLATION#0.9720;MITOSIS#0.9717;CISPLATIN#0.9715;STEM CELL#0.9710;TRANSFORMING GROWTH FACTOR#0.9710;LUNG CANCER#0.9705;SMOOTH MUSCLE CELL#0.9702;SMOOTH MUSCLE#0.9700;S PHASE#0.9698;CELL CYCLE ARREST#0.9697;SQUAMOUS CELL CARCINOMA#0.9689;HUMAN BREAST CANCER#0.9683;ENDOTHELIAL CELL#0.9683;MYELOID LEUKEMIA#0.9681;BREAST CANCER#0.9678;DNA SYNTHESIS#0.9676;COLON CANCER#0.9674;INDUCTION OF APOPTOSIS#0.9671;CELL CYCLE#0.9666;MUSCLE CELL#0.9665;CELL CYCLE CONTROL#0.9660;CELL DIFFERENTIATION#0.9659;M PHASE#0.9657;MECHANISM OF ACTION#0.9650;PROGENITOR CELL#0.9646;B CELL LYMPHOMA#0.9645;CYTOTOXICITY#0.9638;ADENOCARCINOMA#0.9636;HYPOXIA#0.9633;REVERSE TRANSCRIPTION#0.9632;ESTROGEN RECEPTOR#0.9631;APOPTOTIC CELL DEATH#0.9621;PANCREATIC CANCER#0.9614;CELL MIGRATION#0.9613;BREAST CARCINOMA#0.9612;ONCOGENIC#0.9612;POLYMERASE CHAIN REACTION#0.9604;TUMOR CELLS#0.9601;APOPTOSIS#0.9601;PROTEIN KINASE C#0.9601;MITOGEN ACTIVATED PROTEIN#0.9600;KINASE ACTIVITY#0.9598;EPITHELIAL CELL#0.9591;INSULIN-LIKE GROWTH FACTOR#0.9583;MAP KINASE#0.9577;NERVOUS SYSTEM#0.9575;OVARIAN CARCINOMA#0.9574;G2 PHASE#0.9571;CANCER CELL#0.9566;PROTEIN KINASE#0.9566;CELL GROWTH#0.9563;SIGNALING PATHWAY#0.9559;CYTOPLASM#0.9558;DNA METHYLATION#0.9556;SIGNAL TRANSDUCTION#0.9555;MACROPHAGE#0.9553;GROWTH FACTOR#0.9551;BONE MARROW#0.9551;DNA BINDING#0.9549;CELL PROLIFERATION#0.9537;TOXICITY#0.9532;APOPTOTIC#0.9529;DRUG RESISTANCE#0.9524;GENE EXPRESSION#0.9524;POLY ADP RIBOSE#0.9522;TRANSCRIPTION FACTOR#0.9507;CELL DEATH#0.9476;LYMPH NODE#0.9475;TRANSACTIVATION#0.9441;CELL ADHESION#0.9424;PERIPHERAL BLOOD#0.9414;RAPAMYCIN#0.9410;MULTIPLE ENDOCRINE NEOPLASIA#0.9361;PROTEASOME PATHWAY#0.9348;LUNG ADENOCARCINOMA#0.9347;THYMIDINE#0.9324;DOXORUBICIN#0.9321;ANGIOGENESIS#0.9317;RIBOSE#0.9304;COLON CARCINOMA#0.9299;NEUTROPHIL APOPTOSIS#0.9293;DNA DAMAGE RESPONSE#0.9290;CYTOCHROME C#0.9288;VSMC PROLIFERATION#0.9283;MYOBLAST#0.9279;LUNG CARCINOMA#0.9275;SKELETAL MUSCLE#0.9267;DNA FRAGMENTATION#0.9252;MYELOID CELL#0.9233;CELLULAR GROWTH#0.9227;CENTRAL NERVOUS SYSTEM#0.9225;REACTIVE OXYGEN SPECIES#0.9212;TUMOR NECROSIS FACTOR#0.9187;PROTEIN PROTEIN INTERACTION#0.9171;NEUROBLASTOMA#0.9169;CASPASE INHIBITOR#0.9168;PROTEIN PHOSPHORYLATION#0.9165;SIGNAL TRANSDUCER#0.9155;BECKWITH-WIEDEMANN SYNDROME#0.9154;UBIQUITIN PROTEASOME PATHWAY#0.9149;PROGRAMMED CELL DEATH#0.9135;RNA INTERFERENCE#0.9127;ACUTE MYELOID LEUKEMIA#0.9121;PROTEIN SYNTHESIS#0.9056;MOUSE EMBRYONIC FIBROBLAST#0.9040;REPLICATIVE SENESCENCE#0.9037;FAMILIAL MELANOMA#0.8987;EXTRACELLULAR MATRIX#0.8975;MAMMARY EPITHELIAL CELL#0.8960;NITRIC OXIDE#0.8953;CELL DIVISION CYCLE#0.8943;TARGET OF RAPAMYCIN#0.8929;ISCHEMIA#0.8925;REGENERATION#0.8919;PACLITAXEL#0.8917;HEAT SHOCK PROTEIN#0.8912;CELL CYCLE TRANSITION#0.8888;UBIQUITIN LIGASE COMPLEX#0.8874;NEUTROPHIL#0.8858;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8854;INHIBITION OF CELL PROLIFERATION#0.8852;THYROID CANCER#0.8850;HEMATOPOIETIC CELL#0.8849;BETA GALACTOSIDASE#0.8839;CASPASE-3 ACTIVITY#0.8795;MAXIMUM TOLERATED DOSE#0.8761;TRANSCRIPTASE#0.8703;PLATELET-DERIVED GROWTH FACTOR#0.8680;MUSCLE CELL PROLIFERATION#0.8676;NEUROGENESIS#0.8667;CELL SURFACE#0.8638;HEAD AND NECK CANCER#0.8612;NECK CANCER#0.8612;REGULATION OF CELL CYCLE#0.8602;ESTRADIOL#0.8588;SMOOTH MUSCLE CELL PROLIFERATION#0.8573;BINDING PROTEIN 1#0.8572;AKT SIGNALING#0.8571;DISEASE FREE SURVIVAL#0.8544;HEMATOPOIETIC STEM CELL#0.8541;CHROMOSOMAL REGION#0.8512;ARTERY#0.8508;DUAL SPECIFICITY PHOSPHATASE#0.8486;MITOCHONDRIAL MEMBRANE#0.8476;CELL CYCLE PHASE#0.8472;PROGESTERONE#0.8460;GRANULOCYTE#0.8460;TYROSINE KINASE INHIBITOR#0.8457;ANAPHASE#0.8450;T LYMPHOCYTE#0.8450;PARATHYROID#0.8434;GENOTOXIC#0.8434;ORAL SQUAMOUS CELL CARCINOMA#0.8415;MITOCHONDRIA#0.8386;PRECURSOR CELL#0.8382;COLORECTAL CARCINOMA#0.8367;PROTEIN DEGRADATION#0.8366;BUDDING#0.8363;ANDROGEN RECEPTOR#0.8329;DOSE LIMITING TOXICITIES#0.8328;HUMAN IMMUNODEFICIENCY VIRUS#0.8322;PROSTATE CARCINOMA#0.8313;MELANOMA CELL LINES#0.8309;CASPASE ACTIVATION#0.8279;C TERMINAL DOMAIN#0.8270;GENE SILENCING#0.8260;TELOMERASE ACTIVITY#0.8257;QUANTITATIVE REAL TIME#0.8240;OOCYTE#0.8232;IMMUNE RESPONSE#0.8203;LYMPH NODE METASTASIS#0.8185;ASTROCYTE#0.8180;ANAPHASE PROMOTING COMPLEX#0.8162;ALZHEIMER'S DISEASE#0.8159;TUMOR TISSUES#0.8102;STROMAL CELL#0.8093;ATHEROSCLEROSIS#0.8088;DNA METHYLTRANSFERASE#0.8086;LIVER CANCER#0.8084;PURVALANOL#0.8054;MONOCYTE#0.8051;COLONY-STIMULATING FACTOR#0.8038;LYSINE#0.8033;LYSIS#0.8031;METHYLATION SPECIFIC PCR#0.8014;TETRACYCLINE#0.8004;SKIN CANCER#0.8002;DIFFUSE LARGE B-CELL LYMPHOMA#0.7997;ALL TRANS RETINOIC ACID#0.7991;MANTLE CELL LYMPHOMA#0.7972;RETINOIC ACID RECEPTOR#0.7943;HYPERPHOSPHORYLATION#0.7923;CELL QUIESCENCE#0.7917;TOPOISOMERASE#0.7917;DOUBLE STRAND BREAK#0.7882;FIBROBLAST GROWTH FACTOR#0.7880;ONCOGENESIS#0.7866;CARDIOMYOCYTE#0.7841;PROPIDIUM#0.7833;ARA-C#0.7831;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE#0.7817;DIARRHEA#0.7815;PURVALANOL A#0.7809;MITOCHONDRIAL MEMBRANE POTENTIAL#0.7798;SIGNALLING PATHWAY#0.7781;INHIBITION OF CELL GROWTH#0.7780;DEXAMETHASONE#0.7780;METASTATIC MELANOMA#0.7775;APOPTOTIC PROCESS#0.7767;MONONUCLEAR CELLS#0.7763;PHOSPHATASE AND TENSIN HOMOLOG#0.7762;CYTOCHROME C RELEASE#0.7758;NEURAL STEM CELL#0.7757;PHOSPHATASE ACTIVITY#0.7757;THYROID CARCINOMA#0.7753;DUAL-SPECIFICITY PROTEIN PHOSPHATASE#0.7750;PLASMA MEMBRANE#0.7740;MICROTUBULE#0.7732;TELOMERE#0.7725;TAMOXIFEN#0.7720;GENISTEIN#0.7666;NEUTROPENIA#0.7657;ENDOMETRIAL CARCINOMA#0.7655;MULTIPLE ENDOCRINE NEOPLASIA TYPE 1#0.7645;1α,25-DIHYDROXYVITAMIN D3#0.7620;UBIQUITIN PROTEASOME SYSTEM#0.7597;FACTOR I#0.7596;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7571;ENDOTHELIAL GROWTH FACTOR#0.7570;PROTEIN KINASE B#0.7556;2'-DEOXYURIDINE#0.7554;ACUTE LEUKEMIA#0.7536;HODGKIN'S LYMPHOMA#0.7529;CONTACT INHIBITION#0.7520;RENAL CELL CARCINOMA#0.7504;RECEPTOR TYROSINE KINASE#0.7496;PAPILLOMA#0.7457;VITAMIN D3#0.7453;PEROXISOME#0.7440;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.7438;TUMOR LYSIS SYNDROME#0.7414;INDIRUBIN-3'-MONOXIME#0.7412;AUTOPHAGY#0.7407;EMBRYONIC STEM CELL#0.7405;ATP BINDING#0.7405;GALACTOSIDASE ACTIVITY#0.7381;INFLAMMATORY RESPONSE#0.7365;HOST CELL#0.7327;ADIPOCYTE#0.7321;RNA BINDING#0.7295;BREAST CANCER PATIENTS#0.7285;HYPOXIC#0.7281;PARATHYROID ADENOMA#0.7268;ENDOPLASMIC RETICULUM#0.7261;GLUTATHIONE#0.7253;MALIGNANT GLIOMA#0.7239;PROSTATE ADENOCARCINOMA#0.7229;HUMAN MAMMARY EPITHELIAL#0.7216;EPSTEIN BARR VIRUS#0.7199;CENTROSOME#0.7183;ESOPHAGEAL CANCER#0.7156;ADENOSINE#0.7148;CALCIUM CHANNEL#0.7120;NON-SMALL CELL LUNG CARCINOMA#0.7119;DEGRADATION OF CYCLIN#0.7081;MELANOCYTE#0.7078;FLUOROURACIL#0.7077;RNA BINDING PROTEIN#0.7076;GERM CELL#0.7059;RENAL ISCHEMIA REPERFUSION#0.7052;PROTEIN KINASE INHIBITOR#0.7004;NUCLEAR EXPORT#0.6995;CELL EXPANSION#0.6988;HERPES SIMPLEX#0.6986;T-CELL LEUKEMIA#0.6986;HEPATOCELLULAR CARCINOMA CELL#0.6984;NEPHROPATHY#0.6984;NF-KAPPAB ACTIVATION#0.6964;PLASMA CELL#0.6960;MECHANISMS OF ACTION#0.6954;MITOTIC CELL CYCLE#0.6953;ETOPOSIDE#0.6948;CYCLIN-DEPENDENT KINASE ACTIVITY#0.6925;SPINAL CORD#0.6917;HUMAN PAPILLOMA VIRUS#0.6892;CATALYTIC ACTIVITY#0.6883;5 FLUOROURACIL#0.6871;HUMAN PANCREATIC CANCER#0.6864;MYOTUBE#0.6820;HOMOLOGOUS RECOMBINATION#0.6816;EPITHELIAL MESENCHYMAL TRANSITION#0.6805;FORMALIN#0.6799;HERPES SIMPLEX VIRUS#0.6797;BETA-GALACTOSIDASE ACTIVITY#0.6797;IFN-GAMMA#0.6771;MYOGENESIS#0.6769;EPITHELIAL CELL PROLIFERATION#0.6759;MEIOSIS#0.6751;MULTIPLE MYELOMA CELLS#0.6748;ISCHEMIA REPERFUSION INJURY#0.6688;EPITHELIAL OVARIAN CANCER#0.6682;TYROSINE KINASE RECEPTOR#0.6681;SERTOLI CELL#0.6669;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6666;PRO-INFLAMMATORY#0.6653;NULL CELL#0.6643;COLONY FORMATION ASSAY#0.6633;ALTERNATIVE READING FRAME#0.6630;DOMINANT NEGATIVE MUTANT#0.6624;HYPERTENSION#0.6587;TUBULAR EPITHELIAL CELL#0.6567;CELL MOTILITY#0.6543;DNA DAMAGE CHECKPOINT#0.6542;ASTROCYTOMA#0.6525;CELL ADHESION MOLECULE#0.6513;CELL ACTIVATION#0.6504;ADIPOCYTE DIFFERENTIATION#0.6495;OLIGODENDROCYTE#0.6485;P53 BINDING#0.6481;CELL CYCLE DYSREGULATION#0.6461;RNA SYNTHESIS#0.6460;5-AZA-2'-DEOXYCYTIDINE#0.6451;2'-DEOXYCYTIDINE#0.6447;ANCHORAGE INDEPENDENT GROWTH#0.6439;METASTATIC BREAST CANCER#0.6429;ENDOMETRIAL CANCER#0.6427;ACTINOMYCIN D#0.6422;T CELL PROLIFERATION#0.6414;MAMMARY GLAND#0.6405;VASCULAR ENDOTHELIAL CELL#0.6403;GM-CSF#0.6398;BONE MORPHOGENETIC PROTEIN#0.6395;NITRIC OXIDE SYNTHASE#0.6368;LEUKOCYTE#0.6367;CERVIX#0.6306;26S PROTEASOME#0.6296;PROTEIN BINDING#0.6296;INHIBITION OF APOPTOSIS#0.6283;MESENCHYMAL STEM CELL#0.6275;NUCLEAR IMPORT#0.6251;HEPATOMA CELLS#0.6247;DOXYCYCLINE#0.6213;RHEUMATOID ARTHRITIS#0.6201;CD8+ T CELL#0.6154;GENE EXPRESSION OMNIBUS#0.6135;PROTEIN TYROSINE PHOSPHATASE#0.6126;CDC2 KINASE ACTIVITY#0.6116;7-HYDROXYSTAUROSPORINE#0.6106;ROS GENERATION#0.6095;BLOOD VESSEL#0.6088;INTRINSICALLY DISORDERED PROTEIN#0.6086;FOCAL ADHESION#0.6083;SIGNALING MOLECULE#0.6073;B LYMPHOCYTE#0.6073;ALVOCIDIB#0.6071;EXIT FROM MITOSIS#0.6062;IMATINIB#0.6057;CORONARY ARTERY#0.6052;ADIPOSE TISSUE#0.6052;MITOTIC EXIT#0.6018;MITOCHONDRIAL DAMAGE#0.6016;SMC PROLIFERATION#0.6007
10342	ENDOPLASMIC RETICULUM#1.0244;NEUROPATHY#1.0059;TROPOMYOSIN RECEPTOR KINASE#0.9682;ONCOGENIC#0.8876;EXTRASKELETAL MYXOID CHONDROSARCOMA#0.8530;MYXOID CHONDROSARCOMA#0.8512;PROTEIN SECRETION#0.8345;HEREDITARY SPASTIC PARAPLEGIA#0.8056;ANAPLASTIC LARGE CELL LYMPHOMA#0.7892;PARAPLEGIA#0.7860;CHONDROSARCOMA#0.7789;ENDOPLASMIC RETICULUM EXIT SITE#0.7559;CHARCOT MARIE TOOTH#0.7205;ER EXIT#0.7137;THYROID CARCINOMA#0.7133;ERGIC#0.7122;POLYMERASE CHAIN REACTION#0.7118;ER EXIT SITE#0.6949;DNA BINDING#0.6421;TRANSCRIPTION FACTOR#0.6389;CHARCOT-MARIE-TOOTH DISEASE#0.6373;TOOTH DISEASE#0.6372;TRANSITIONAL ER#0.6365;ONCOGENESIS#0.6341;MOTOR NEURON DEGENERATION#0.6314;TYROSINE KINASE DOMAIN#0.6160;UBIQUITIN#0.6057;CANCER CELL#0.6015
10343	POLYCYSTIN#0.7303;SPERM COMPETITION#0.6946;ACROSOME REACTION#0.6309;POLYCYSTIC KIDNEY DISEASE#0.6276;KIDNEY DISEASE#0.6197
10344	IFN-GAMMA#1.0461;DERMAL FIBROBLAST#1.0409;BRONCHIAL EPITHELIAL CELLS#1.0336;CC CHEMOKINE RECEPTOR#1.0303;AIRWAY EPITHELIAL CELL#1.0229;MAST CELL#1.0218;ALVEOLAR EPITHELIAL CELL#1.0207;MONOCYTE#1.0167;EPITHELIAL CELL#1.0164;CHEMOKINE RECEPTOR#1.0153;TUMOR NECROSIS FACTOR#1.0149;MACROPHAGE#1.0097;POLYMERASE CHAIN REACTION#1.0096;EOSINOPHIL#1.0087;GROWTH FACTOR#1.0050;CHEMOTAXIS#0.9973;EOSINOPHILIC ESOPHAGITIS#0.9957;GENE EXPRESSION#0.9942;ENDOTHELIAL CELL#0.9897;ESOPHAGITIS#0.9890;TRANSFORMING GROWTH FACTOR#0.9853;T CELL#0.9817;ATOPIC DERMATITIS#0.9752;PROTON PUMP INHIBITOR#0.9729;PROTON PUMP#0.9727;SIGNAL TRANSDUCER#0.9720;MACROPHAGE INFLAMMATORY PROTEIN#0.9664;ALLERGEN#0.9639;PRO-INFLAMMATORY#0.9629;IMMUNE RESPONSE#0.9545;KERATINOCYTE#0.9534;DERMATITIS#0.9530;MONOCYTE CHEMOATTRACTANT PROTEIN#0.9468;CANCER CELL#0.9378;MONOCYTE CHEMOTACTIC PROTEIN#0.9327;PERIPHERAL BLOOD#0.9228;INFLAMMATORY RESPONSE#0.9133;LEUKOCYTE#0.9021;ALLERGIC ASTHMA#0.9010;BASOPHIL#0.8899;LUNG EPITHELIAL CELL#0.8811;OMEPRAZOLE#0.8638;CC CHEMOKINE LIGAND#0.8538;ALLERGIC RHINITIS#0.8528;SIGNALING PATHWAY#0.8517;PROTEIN SECRETION#0.8460;DENDRITIC CELL#0.8399;GASTROESOPHAGEAL REFLUX DISEASE#0.8391;CHURG STRAUSS SYNDROME#0.8270;TOPICAL#0.8138;ESOPHAGEAL EPITHELIAL CELLS#0.8133;ESOPHAGUS#0.8112;CELL SURFACE#0.7987;HUMAN BRONCHIAL EPITHELIAL#0.7877;SELECTIN#0.7848;RHEUMATOID ARTHRITIS#0.7839;REVERSE TRANSCRIPTION#0.7823;APOPTOSIS#0.7682;RHINITIS#0.7675;NEUTROPHIL#0.7627;SMOOTH MUSCLE#0.7608;EOSINOPHIL MIGRATION#0.7438;SKIN DISEASE#0.7328;TH2 CELL#0.7326;HIGH POWER FIELD#0.7288;SPUTUM#0.7265;TSC1 TSC2 COMPLEX#0.7162;ANGIOGENESIS#0.7057;INFLAMMATORY CELL#0.7041;INTERLEUKIN 4 RECEPTOR#0.6957;COLITIS#0.6912;TUMOUR NECROSIS FACTOR#0.6902;TRANSFORMING GROWTH FACTOR BETA#0.6889;HUMAN DERMAL FIBROBLAST#0.6850;ULCERATIVE COLITIS#0.6842;TRANSCRIPTION FACTOR#0.6832;NEUROTOXIN#0.6768;TARGET OF RAPAMYCIN#0.6749;TRANSCRIPTASE#0.6707;CELL CYCLE#0.6634;AIRWAY EPITHELIUM#0.6583;EOSINOPHIL CHEMOTAXIS#0.6518;VASCULAR ENDOTHELIAL CELL#0.6513;MUSCLE CELL#0.6480;COLONY-STIMULATING FACTOR#0.6480;QUANTITATIVE REAL TIME#0.6480;LUNG FIBROBLASTS#0.6371;CD8+ T CELL#0.6298;ALLERGIC REACTION#0.6264;GM-CSF#0.6209;GRANULOCYTE#0.6205;HEPATOCELLULAR CARCINOMA#0.6189;EXTRACELLULAR MATRIX#0.6179;T LYMPHOCYTE#0.6142;GRANULOMATOSIS WITH POLYANGIITIS#0.6070
10345	LUMINAL#1.0462;RYANODINE RECEPTOR#1.0285;MYOTUBE#1.0257;SKELETAL MUSCLE#1.0128;T TUBULE#1.0120;SARCOPLASMIC RETICULUM#1.0055;CARDIAC MUSCLE#1.0043;MUSCLE CELL#0.9982;ARRHYTHMIA#0.9937;SARCOPLASMIC RETICULUM MEMBRANE#0.9753;HISTIDINE#0.9733;MYOCYTES#0.9401;CARDIOMYOCYTE#0.9161;POLYMORPHIC VENTRICULAR TACHYCARDIA#0.9103;PROTEIN KINASE#0.9059;CAFFEINE#0.9053;MUSCLE FIBER#0.9037;STRIATED MUSCLE#0.8901;TACHYCARDIA#0.8823;CALCIUM RELEASE CHANNEL#0.8656;CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA#0.8379;ENDOPLASMIC RETICULUM#0.8322;PROTEIN PROTEIN INTERACTION#0.8125;ANCHORING#0.7891;CHANNEL ACTIVITY#0.7745;SKELETAL MUSCLE CELLS#0.7644;CARDIAC ARREST#0.7642;MUSCLE CONTRACTION#0.7387;CALCIUM CHANNEL#0.7354;TRIAD JUNCTION#0.7013;RYANODINE RECEPTOR COMPLEX#0.6955;GLUTATHIONE#0.6606;COMPLEX I#0.6562;MYOCARDIUM#0.6466;MYOBLAST#0.6406;RECEPTOR COMPLEX#0.6356;PROTEIN COMPLEX#0.6338;TRANSVERSE TUBULE#0.6245;RECEPTOR ACTIVITY#0.6173;SUDDEN CARDIAC DEATH#0.6118;GLYCOSYLATION#0.6026
10346	T CELL#1.0084;HEPATITIS B#0.9370;HEPATITIS C#0.9360;SIGNALING PATHWAY#0.9354;UBIQUITIN#0.9283;HUMAN IMMUNODEFICIENCY VIRUS#0.9042;UBIQUITIN LIGASE ACTIVITY#0.8843;LIGASE ACTIVITY#0.8787;MONONUCLEAR CELLS#0.8727;GENE EXPRESSION#0.8577;CELL CYCLE#0.8381;PERIPHERAL BLOOD#0.8272;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8161;CHRONIC HEPATITIS C#0.8130;VIRAL REPLICATION#0.8079;LUNG CANCER#0.8041;MACROPHAGE#0.7903;HEPATITIS B VIRUS#0.7791;HEPATITIS C VIRUS#0.7659;IMMUNE RESPONSE#0.7548;INNATE IMMUNE RESPONSE#0.6915;T LYMPHOCYTE#0.6900;CANCER CELL#0.6408;TUMOR NECROSIS FACTOR#0.6374;CD4+ T CELL#0.6338;CELL PROLIFERATION#0.6307;TRANSCRIPTION FACTOR#0.6305;NUCLEAR LOCALIZATION SIGNAL#0.6193
10347	ATP BINDING CASSETTE TRANSPORTER#1.0403;ATP BINDING CASSETTE#1.0317;ATP BINDING#1.0304;ABC TRANSPORTER#1.0289;MACROPHAGE#1.0238;CHOLESTEROL EFFLUX#1.0192;ALZHEIMER'S DISEASE#1.0041;HIGH DENSITY LIPOPROTEIN#0.9658;PHAGOCYTOSIS#0.9521;GENE EXPRESSION#0.8785;DEMENTIA#0.8657;LIPID METABOLISM#0.8555;NEURODEGENERATIVE DISEASE#0.8512;AMYLOID PRECURSOR PROTEIN#0.7901;CELL SURFACE#0.7506;CHOLESTEROL HOMEOSTASIS#0.7226;LIPID TRANSPORT#0.7173;PREMATURE TERMINATION CODON#0.7111;BONE MARROW#0.6783;TRANSCRIPTION FACTOR#0.6524;PHOSPHOLIPID EFFLUX#0.6515;DNA METHYLATION#0.6388;MINOR ALLELE FREQUENCY#0.6381;LIPID HOMEOSTASIS#0.6357;MINI MENTAL STATE#0.6348;IMMUNE RESPONSE#0.6324;LOW DENSITY LIPOPROTEIN#0.6244;MINOR HISTOCOMPATIBILITY ANTIGEN#0.6232;COMPLEMENT RECEPTOR#0.6219;ENDOCYTOSIS#0.6208;ADENOSINE TRIPHOSPHATE#0.6181;MAMMARY GLAND#0.6155;PERIPHERAL BLOOD#0.6082;WHITE ADIPOSE TISSUE#0.6046;AGE AT ONSET#0.6020
10349	ABC TRANSPORTER#0.7845
10350	ABC TRANSPORTER#0.8059;ATP BINDING CASSETTE#0.8047;ATP BINDING#0.8032;GENE EXPRESSION#0.7913;MONOCYTE DIFFERENTIATION#0.6288
10351	ATP BINDING#1.0586;ATP BINDING CASSETTE#1.0345;ABC TRANSPORTER#0.9847;ATP BINDING CASSETTE TRANSPORTER#0.8210;GENE EXPRESSION#0.7793;CHOROID PLEXUS#0.6491;CHOLESTEROL EFFLUX#0.6486;OVARIAN CANCER#0.6454;OLIGODENDROCYTE#0.6081;ALDEHYDE REDUCTASE#0.6070
10352	INTELLECTUAL DISABILITY#0.7469;LACTIC ACIDOSIS#0.6551
10360	CHROMATIN REMODELING#0.6840;HISTONE CHAPERONE#0.6742;RRNA SYNTHESIS#0.6196
103611090	CANCER CELL#1.0629;APOPTOSIS#1.0367;CELL PROLIFERATION#1.0067;SIGNALING PATHWAY#0.9669;LUNG CANCER#0.9467;HEPATOCELLULAR CARCINOMA#0.9088;SQUAMOUS CELL CARCINOMA#0.9085;BREAST CANCER#0.9050;LYMPH NODE#0.8820;STEM CELL#0.8587;RELATED PROTEIN 1#0.8552;CISPLATIN#0.8505;CELL MIGRATION#0.7773;TUMOR TISSUES#0.7676;COLORECTAL CANCER#0.7635;TUMOR SUPPRESSOR#0.7626;OVARIAN CANCER#0.7522;GENE EXPRESSION#0.7414;ALZHEIMER'S DISEASE#0.7280;PERIODONTAL LIGAMENT STEM CELL#0.6439;POLYMERASE CHAIN REACTION#0.6413;QUANTITATIVE REVERSE TRANSCRIPTION#0.6306;LYMPH NODE METASTASIS#0.6280;PERIODONTAL LIGAMENT#0.6262;REVERSE TRANSCRIPTION#0.6246;ADJACENT NORMAL TISSUE#0.6244;INSULIN SECRETION#0.6171;MYOCARDIAL INFARCTION#0.6139;COLORECTAL#0.6038
103611155	GLYCOSIDE HYDROLASE FAMILY#0.9506
103611157	AUTOPHAGY#0.6918;HUMAN EMBRYONIC STEM#0.6628;EMBRYONIC STEM CELL#0.6540;STEM CELL#0.6439;VASCULAR ENDOTHELIAL CELL#0.6383;ENDOTHELIAL CELL#0.6324
10361	OOCYTE#1.0603;CHROMATIN REMODELING#0.8670;GENE EXPRESSION#0.6751;HISTONE CHAPERONE#0.6747;FERTILIZATION#0.6647
10362	HIGH MOBILITY GROUP#0.9551;DNA BINDING#0.9528;HISTONE DEACETYLASE#0.6529;PROSTATE CANCER#0.6490;KINESIN#0.6467;CELL DIVISION#0.6427
10363	TYPE 2 DIABETES#0.9115;TRANSCRIPTION FACTOR#0.6636;HIGH MOBILITY GROUP#0.6543
10365	SIMVASTATIN#1.0773;ENDOTHELIAL NITRIC OXIDE#1.0448;NITRIC OXIDE SYNTHASE#1.0423;CANCER CELL#1.0271;NITRIC OXIDE#1.0247;TRANSCRIPTION FACTOR#1.0216;PRO-INFLAMMATORY#1.0200;T CELL#1.0182;QUIESCENCE#1.0087;PROTEIN KINASE#1.0026;B CELL#1.0020;CELL ACTIVATION#1.0011;ENDOTHELIUM#1.0007;SIGNALING PATHWAY#1.0007;SMOOTH MUSCLE#1.0003;GROWTH FACTOR#1.0003;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9996;UMBILICAL VEIN#0.9981;CELL ADHESION#0.9979;ANGIOGENESIS#0.9975;MUSCLE CELL#0.9975;CELL PROLIFERATION#0.9970;MONOCYTE#0.9952;HUMAN UMBILICAL VEIN#0.9943;ENDOTHELIAL CELL#0.9937;APOPTOSIS#0.9932;MACROPHAGE#0.9903;STEM CELL#0.9893;BLOOD VESSEL#0.9882;TUMOR SUPPRESSOR#0.9833;GENE EXPRESSION#0.9819;NAIVE T CELL#0.9792;INFLAMMATORY RESPONSE#0.9785;ATHEROSCLEROSIS#0.9763;SMOOTH MUSCLE CELL#0.9754;CELL MIGRATION#0.9702;POLYMERASE CHAIN REACTION#0.9685;LUNG DEVELOPMENT#0.9685;CELL CYCLE#0.9681;CHEMOKINE RECEPTOR#0.9616;ATHEROSCLEROTIC#0.9608;ARTERY#0.9594;CD8+ T CELL#0.9581;TUMOR NECROSIS FACTOR#0.9556;EMBRYONIC STEM CELL#0.9550;VASCULAR ENDOTHELIUM#0.9510;BONE MARROW#0.9461;ENDOTHELIAL GROWTH FACTOR#0.9397;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9397;ADIPOCYTE DIFFERENTIATION#0.9364;CELL ADHESION MOLECULE#0.9325;SELECTIN#0.9306;ADIPOGENESIS#0.9306;ENHANCER BINDING PROTEIN#0.9214;ENHANCER BINDING#0.9209;PLURIPOTENT STEM CELL#0.9177;SPHINGOSINE 1 PHOSPHATE#0.9167;CELL DIFFERENTIATION#0.9149;ADIPOCYTE#0.9140;IMMUNE RESPONSE#0.9113;LYMPHOID ORGANS#0.9050;LUNG CANCER#0.8974;FLUID SHEAR STRESS#0.8972;LAMINAR SHEAR STRESS#0.8967;LOW DENSITY LIPOPROTEIN#0.8903;LYMPH NODE#0.8848;VASCULAR CELL#0.8769;DNA BINDING#0.8752;CELL GROWTH#0.8739;VASCULAR ENDOTHELIAL CELL#0.8696;THYMOCYTE#0.8655;PERIPHERAL BLOOD#0.8624;CD4+ T CELL#0.8606;INDUCED PLURIPOTENT STEM CELL#0.8573;EPITHELIAL CELL#0.8509;HEME OXYGENASE 1#0.8489;QUANTITATIVE REAL TIME#0.8424;MYELOID CELL#0.8423;FACTOR I#0.8340;MARGINAL ZONE LYMPHOMA#0.8310;ISCHEMIA#0.8305;T CELL ACTIVATION#0.8242;MEMORY T CELL#0.8203;OXYGENASE#0.8147;ONCOGENIC#0.8133;T LYMPHOCYTE#0.8127;HEPATOCELLULAR CARCINOMA#0.8118;SPLENIC MARGINAL ZONE LYMPHOMA#0.8096;LEUKOCYTE#0.8084;CELL QUIESCENCE#0.8062;ACTIVATED T CELL#0.8058;INTRACRANIAL ANEURYSM#0.8054;ELECTROPHORETIC MOBILITY SHIFT#0.8006;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.7969;SPHINGOSINE#0.7962;ALZHEIMER'S DISEASE#0.7939;GLOBIN#0.7939;TRANSACTIVATION#0.7919;HISTONE DEACETYLASE#0.7871;MOUSE EMBRYONIC STEM#0.7840;SKELETAL MUSCLE#0.7835;ERYTHROID CELL#0.7770;MITOGEN ACTIVATED PROTEIN#0.7769;LUCIFERASE ACTIVITY#0.7751;THROMBOSIS#0.7721;HYPOXIA#0.7721;IMMUNE SYSTEM#0.7671;BASILAR ARTERY#0.7654;VASCULAR DISEASE#0.7647;AUTOPHAGY#0.7629;ACTIVATED T-CELLS#0.7593;MORPHOGENESIS#0.7512;ADIPOSE TISSUE#0.7472;CYCLIN DEPENDENT KINASE#0.7426;PREADIPOCYTE#0.7419;LYSINE#0.7350;PEROXISOME#0.7318;CELL SURFACE#0.7168;EXTRACELLULAR MATRIX#0.7116;REACTIVE OXYGEN SPECIES#0.7112;TUBE FORMATION#0.7088;RAPAMYCIN#0.7012;TRANSFORMING GROWTH FACTOR#0.7004;B CELL LYMPHOMA#0.6980;T CELL DIFFERENTIATION#0.6959;HYPERTENSION#0.6949;REVERSE TRANSCRIPTION#0.6947;LYSINE SPECIFIC DEMETHYLASE#0.6932;CELL DEATH#0.6754;CEREBRAL CAVERNOUS MALFORMATION#0.6679;CAROTID ARTERY#0.6630;PORTAL HYPERTENSION#0.6629;CELL DEVELOPMENT#0.6623;MYOCYTE ENHANCER FACTOR#0.6623;CYTOKINE PRODUCTION#0.6533;PROGENITOR CELL#0.6473;TYPE I PNEUMOCYTE#0.6392;CORONARY ARTERY#0.6289;DENDRITIC CELL#0.6221;EPIBLAST#0.6212;TOLL LIKE RECEPTOR#0.6181;COLORECTAL CANCER#0.6174;LYMPH NODE METASTASIS#0.6161;LEUKOCYTE ADHESION#0.6106;SMOOTH MUSCLE CELL MIGRATION#0.6086;MUSCLE CELL MIGRATION#0.6082;ACTIVATED CD8+ T CELL#0.6075;VASCULOGENESIS#0.6040;PANCREATIC CANCER#0.6039;STROMAL CELL#0.6021;CARDIOVASCULAR SYSTEM#0.6019;MYOCARDIAL INFARCTION#0.6013
10367	MITOCHONDRIAL CALCIUM UPTAKE#1.0991;MITOCHONDRIAL MEMBRANE#1.0036;MITOCHONDRIA#1.0003;CELL DEATH#0.9068;APOPTOSIS#0.8970;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8459;INNER MITOCHONDRIAL MEMBRANE#0.8068;CANCER CELL#0.8022;MITOCHONDRIAL MATRIX#0.7609;OXIDATIVE METABOLISM#0.7035;CELL CYCLE#0.7016;MUSCLE WEAKNESS#0.6965;CYTOCHROME C#0.6882;CRISTAE JUNCTION#0.6347;ORGANELLE#0.6244;SKELETAL MUSCLE#0.6190;NEUROLOGICAL DISORDER#0.6130;REACTIVE OXYGEN SPECIES#0.6091
103689915	OVARIAN CANCER#1.1862;OVARIAN#0.8479
10369	CALCIUM CHANNEL#1.0590;AMPA RECEPTOR#1.0373;POSTSYNAPTIC DENSITY#1.0138;PLASMA MEMBRANE#1.0125;GLUTAMATE RECEPTOR#0.9998;SYNAPTIC TRANSMISSION#0.9893;ABSENCE EPILEPSY#0.9656;EPILEPSY#0.9586;ION CHANNEL#0.9466;POSTSYNAPTIC MEMBRANE#0.9090;PROTEIN KINASE#0.8848;NMDA RECEPTOR#0.8789;OOCYTE#0.8781;CELL SURFACE#0.8779;BIPOLAR DISORDER#0.8495;EXCITATORY SYNAPSE#0.8387;CEREBELLAR ATAXIA#0.8344;NERVOUS SYSTEM#0.7928;CAMKII#0.7909;ENDOPLASMIC RETICULUM#0.7494;RECEPTOR ACTIVITY#0.7422;PDZ BINDING MOTIF#0.7305;SKELETAL MUSCLE#0.7299;DEPHOSPHORYLATION#0.7185;ANCHORING#0.7013;CENTRAL NERVOUS SYSTEM#0.6943;PROTEIN KINASE A#0.6853;AMPA RECEPTOR ACTIVITY#0.6582;PURKINJE CELL#0.6439;LONG TERM POTENTIATION#0.6428;IONOTROPIC GLUTAMATE RECEPTOR#0.6199;LIGAND BINDING DOMAIN#0.6126;GLUTAMATERGIC SYNAPSE#0.6085;RECEPTOR COMPLEX#0.6001
1036	CYSTEINE DIOXYGENASE#1.1032;DNA METHYLATION#1.0570;BREAST CANCER#0.9938;METHYLATION SPECIFIC PCR#0.9754;GENE EXPRESSION#0.9613;CANCER CELL#0.8919;COLORECTAL CANCER#0.8686;QUANTITATIVE METHYLATION SPECIFIC#0.8675;TUMOR SUPPRESSOR#0.8437;POLYMERASE CHAIN REACTION#0.7781;TUMOR TISSUES#0.7708;COLORECTAL#0.7360;PRIMARY BREAST CANCER#0.7029;TAURINE BIOSYNTHESIS#0.6835;DNA HYPERMETHYLATION#0.6387;TAURINE SYNTHESIS#0.6271;ENDOMETRIAL CANCER#0.6211;BONE MARROW#0.6088
10370	CONGENITAL HEART DISEASE#1.0606;STEM CELL#1.0564;CANCER CELL#1.0557;NEURAL TUBE#1.0472;HEART DISEASE#1.0428;BREAST CANCER#1.0386;HYPOXIA#1.0313;HYPOXIA INDUCIBLE FACTOR#1.0282;TRANSCRIPTION FACTOR#1.0277;GROWTH FACTOR#1.0231;TRANSACTIVATION#1.0174;EMBRYONIC STEM CELL#1.0161;CREB BINDING#1.0102;APOPTOSIS#1.0098;HEMATOPOIETIC STEM CELL#1.0048;GENE EXPRESSION#1.0009;CARDIAC DEVELOPMENT#0.9874;BREAST CANCER CELL#0.9767;FETAL LIVER#0.9631;CELL PROLIFERATION#0.9557;HYPOXIC#0.9473;GLUTAMIC ACID#0.9456;VENTRICULAR SEPTAL DEFECT#0.9321;CELL CYCLE#0.9300;ASPARTIC ACID#0.9179;QUIESCENCE#0.9028;CONGENITAL HEART DEFECTS#0.8702;NEURAL CREST#0.8533;TRANSFORMING GROWTH FACTOR#0.8445;CHONDROCYTE#0.8411;MOUSE EMBRYONIC STEM#0.8292;ENDOTHELIAL GROWTH FACTOR#0.8176;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8176;SIGNALING PATHWAY#0.8141;CARDIOMYOCYTE#0.8008;BONE MARROW#0.7920;HEART DEVELOPMENT#0.7892;PEROXISOME#0.7697;TROPHOBLAST#0.7635;ENDOTHELIAL CELL#0.7597;MACROPHAGE#0.7524;ADRENAL GLAND#0.7380;ANGIOGENESIS#0.7293;PROGENITOR CELL#0.7256;MELANOCYTE#0.7195;MYELOID LEUKEMIA#0.7144;CELL GROWTH#0.7112;HISTONE ACETYLTRANSFERASE#0.7042;TUMOR SUPPRESSOR#0.7016;EMBRYONIC HEART#0.6994;POLYMERASE CHAIN REACTION#0.6993;OUTFLOW TRACT#0.6959;GONAD#0.6925;IL-11#0.6903;ADRENAL CORTEX#0.6850;FOLIC ACID#0.6846;ACUTE MYELOID LEUKEMIA#0.6821;HUMAN BREAST CANCER#0.6821;HEMATOPOIESIS#0.6582;CELL MIGRATION#0.6534;MOUSE EMBRYONIC FIBROBLAST#0.6370;SEPTUM#0.6349;PROTEIN BINDING#0.6337;AKT SIGNALING#0.6333;PRO-INFLAMMATORY#0.6331;MORPHOGENESIS#0.6322;CISPLATIN#0.6312;NEURAL TUBE CLOSURE#0.6311;TUBE CLOSURE#0.6309;CYTOCHROME C#0.6307;TETRALOGY OF FALLOT#0.6111;CELL ADHESION#0.6095;TROPHOBLAST CELL#0.6050;SEX DETERMINATION#0.6048;INDUCED PLURIPOTENT STEM CELL#0.6017
10371	GROWTH CONE COLLAPSE#1.0525;RECEPTOR COMPLEX#1.0474;NERVE FIBER#1.0335;T CELL#1.0302;GROWTH CONE#1.0278;AXON GROWTH#1.0258;DORSAL ROOT GANGLION#1.0253;ACUTE KIDNEY INJURY#1.0245;APOPTOSIS#1.0235;OLFACTORY BULB#1.0226;TUMOR CELLS#1.0212;ALKALINE PHOSPHATASE#1.0212;PERIPHERAL NERVE#1.0199;NERVE GROWTH FACTOR#1.0192;BONE FORMATION#1.0190;OSTEOBLAST#1.0189;EPITHELIAL CELL#1.0176;POLYMERASE CHAIN REACTION#1.0175;NEURITE OUTGROWTH#1.0174;CELL PROLIFERATION#1.0165;PODOCYTE#1.0115;PROTEIN SYNTHESIS#1.0104;PROTEIN KINASE#1.0095;INNERVATION#1.0093;CHEMOREPULSION#1.0092;REGENERATION#1.0090;NEURITE#1.0089;IMMUNE RESPONSE#1.0086;ENDOTHELIAL CELL#1.0084;STEM CELL#1.0065;CELL SURFACE#1.0050;ENDOTHELIAL GROWTH FACTOR#1.0044;SPINAL CORD#1.0044;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0044;B CELL#1.0042;AXONAL TRANSPORT#1.0042;MUSCLE FIBER#1.0039;CANCER CELL#1.0033;SIGNALING PATHWAY#1.0025;AXON GUIDANCE#1.0003;MACROPHAGE#0.9996;CELL MIGRATION#0.9989;GROWTH FACTOR#0.9988;ANGIOGENESIS#0.9985;NEURAL CREST#0.9939;AXONAL GROWTH CONE#0.9934;BONE MARROW#0.9931;MESENCHYMAL STEM CELL#0.9923;KERATINOCYTE#0.9902;GENE EXPRESSION#0.9876;BLOOD VESSEL#0.9854;OSTEOBLAST DIFFERENTIATION#0.9853;MORPHOGENESIS#0.9823;CELL ADHESION#0.9818;REVERSE TRANSCRIPTION#0.9809;MULTIPLE SCLEROSIS#0.9785;CELL DEATH#0.9777;ISCHEMIA#0.9776;EXTRACELLULAR MATRIX#0.9770;NERVOUS SYSTEM#0.9732;FOCAL ADHESION#0.9732;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9723;LUPUS ERYTHEMATOSUS#0.9720;PURKINJE CELL#0.9700;ENDOCYTOSIS#0.9700;INTERNEURON#0.9692;TRANSCRIPTION FACTOR#0.9688;RETINAL GANGLION CELL#0.9670;NEURAL CREST CELL#0.9631;CENTRAL NERVOUS SYSTEM#0.9619;CELL ADHESION MOLECULE#0.9601;BONE RESORPTION#0.9576;QUANTITATIVE REAL TIME#0.9555;SIGNAL TRANSDUCTION#0.9554;NEURONAL MIGRATION#0.9486;MESENCHYME#0.9477;CEREBRAL CORTEX#0.9466;HEPATOCYTE GROWTH FACTOR#0.9406;KALLMANN SYNDROME#0.9395;OXYGEN GLUCOSE DEPRIVATION#0.9376;OSTEOCLAST#0.9374;TUMOR SUPPRESSOR#0.9346;MICROTUBULE#0.9333;GANGLION CELLS#0.9321;CHONDROCYTE#0.9321;OPTIC NERVE#0.9310;AUTOIMMUNE DISEASE#0.9295;BRANCHING MORPHOGENESIS#0.9271;BONE REMODELING#0.9269;GLYCOGEN SYNTHASE KINASE#0.9264;SYSTEM DEVELOPMENT#0.9259;CORNEAL EPITHELIAL CELL#0.9241;BONE REGENERATION#0.9239;BREAST CANCER#0.9210;FOCAL ADHESION KINASE#0.9175;HYPOXIA#0.9163;RHEUMATOID ARTHRITIS#0.9156;PROGENITOR CELL#0.9146;CARDIOMYOCYTE#0.9103;DENDRITIC CELL#0.9086;DENTAL PULP#0.9064;TRANSFORMING GROWTH FACTOR#0.9047;CYCLIN DEPENDENT KINASE#0.9033;ATOPIC DERMATITIS#0.9014;APICAL DENDRITE#0.9001;ACTIN CYTOSKELETON#0.8996;NERVOUS SYSTEM DEVELOPMENT#0.8991;OSTEOGENESIS#0.8934;SIGNALLING PATHWAY#0.8921;OLIGODENDROCYTE#0.8912;SCHWANN CELL#0.8904;PROTEOGLYCAN#0.8839;CELL BODY#0.8822;SEMAPHORIN RECEPTOR#0.8814;MYOCARDIAL INFARCTION#0.8781;CD4+ T CELL#0.8706;ARRHYTHMIA#0.8682;TRAUMATIC BRAIN INJURY#0.8679;ASTROCYTE#0.8679;SMOOTH MUSCLE#0.8675;SPINAL CORD INJURY#0.8647;SIGNALING CASCADE#0.8645;IMMUNE SYSTEM#0.8632;MIDDLE CEREBRAL ARTERY#0.8611;CEREBRAL ARTERY#0.8608;IMMUNE CELL#0.8592;GLOMERULAR FILTRATION BARRIER#0.8548;DERMATITIS#0.8523;ARTERY#0.8497;ADIPOSE-DERIVED STEM CELL#0.8468;CORNEAL EPITHELIUM#0.8438;MONOCYTE#0.8425;GLOMERULAR FILTRATION#0.8406;EPHRIN#0.8390;SIGNALING MOLECULE#0.8370;NEURITE EXTENSION#0.8357;SCIATIC NERVE#0.8339;PROSTATE CANCER#0.8280;MITOGEN ACTIVATED PROTEIN#0.8277;TUBE FORMATION#0.8233;DISTAL AXON#0.8223;RETROGRADE AXONAL TRANSPORT#0.8221;VASCULAR ENDOTHELIAL CELL#0.8208;NEURONAL CELLS#0.8183;OSTEOPOROSIS#0.8087;FIBROBLAST GROWTH FACTOR#0.8079;STRIATUM#0.8067;CEREBRAL ISCHEMIA#0.8064;TOLL LIKE RECEPTOR#0.8062;C FIBER#0.8061;AXON PATHFINDING#0.8054;PERIPHERAL NERVOUS SYSTEM#0.8048;PERINEURONAL NET#0.8035;GLIAL CELL#0.7970;WOUND HEALING#0.7954;INFLAMMATORY RESPONSE#0.7933;TREG CELL#0.7925;MYOBLAST#0.7917;LYMPHATIC VESSEL#0.7884;AXOPLASMIC TRANSPORT#0.7868;CEREBRAL ARTERY OCCLUSION#0.7862;PANCREATIC CANCER#0.7834;MUSCLE CELL#0.7815;DIABETES MELLITUS#0.7785;AXON COLLATERAL#0.7764;CLIMBING FIBER#0.7760;PLASMA MEMBRANE#0.7748;SYNAPSE ELIMINATION#0.7680;CHONDROITIN SULFATE PROTEOGLYCAN#0.7672;AMYOTROPHIC LATERAL SCLEROSIS#0.7594;LATERAL SCLEROSIS#0.7594;BONE DISEASE#0.7576;FACTOR I#0.7561;DENTATE GYRUS#0.7545;BASAL DENDRITE#0.7534;BONE CELLS#0.7503;HUMAN EPIDERMAL KERATINOCYTES#0.7490;RAPAMYCIN#0.7461;OSTEOCLAST DIFFERENTIATION#0.7447;MOLAR#0.7438;OSTEOCYTE#0.7426;NEUROGENESIS#0.7400;PRO-INFLAMMATORY#0.7397;AXON GROWTH CONE#0.7353;APOPTOTIC#0.7351;TYPE 2 DIABETES MELLITUS#0.7334;2 DIABETES MELLITUS#0.7334;MOTOR NEURON DISEASE#0.7307;TYPE 2 DIABETES#0.7295;OVARIAN#0.7223;BONE MINERAL DENSITY#0.7201;ACTIN FILAMENT#0.7197;NEURAL CELL#0.7192;RNA INTERFERENCE#0.7189;NEURAL TUBE#0.7150;PERIPHERAL BLOOD#0.7140;OVARIAN CANCER#0.7136;SOMITE#0.7113;SMOOTH MUSCLE CELL#0.7086;URETERIC BUD BRANCHING#0.7075;DIABETIC RETINOPATHY#0.7070;EXOSOME#0.7050;CELL CYCLE#0.6973;SKELETAL MUSCLE#0.6966;PERIPHERAL NERVE INJURY#0.6940;NEURAL PROGENITOR CELL#0.6922;CELL ACTIVATION#0.6917;KINASE INHIBITOR#0.6908;URETERIC BUD#0.6868;NEURITE GROWTH#0.6844;MYOCARDIUM#0.6841;MESENCHYMAL CELL#0.6761;PRECURSOR CELL#0.6751;ALLERGIC RHINITIS#0.6746;AMPA RECEPTOR#0.6739;KINASE ACTIVITY#0.6721;CELL DIFFERENTIATION#0.6717;COLLAGEN INDUCED ARTHRITIS#0.6717;ADIPOCYTE#0.6708;GUANYLATE CYCLASE#0.6703;GROWTH FACTOR RECEPTOR#0.6702;HINDBRAIN#0.6687;PROTEINURIA#0.6678;OXYGEN INDUCED RETINOPATHY#0.6665;BASAL CELL#0.6661;CELL GROWTH#0.6653;ALZHEIMER'S DISEASE#0.6545;LUNG CANCER#0.6543;TUMOR ASSOCIATED MACROPHAGE#0.6520;REPULSIVE GUIDANCE MOLECULE#0.6480;TIBIA#0.6479;CELL MOTILITY#0.6467;FILOPODIA FORMATION#0.6440;NEPHROPATHY#0.6438;BREAST CANCER CELL#0.6437;CERVICAL#0.6427;CHEMOTAXIS#0.6423;ALIZARIN RED S#0.6400;AXON EXTENSION#0.6376;SUDDEN CARDIAC DEATH#0.6345;DENDRITIC SPINE#0.6301;EOSINOPHIL#0.6272;AXON REGENERATION#0.6270;NEURAL CREST CELL MIGRATION#0.6265;HYPOGONADOTROPIC HYPOGONADISM#0.6260;OCULAR DOMINANCE PLASTICITY#0.6252;MICROTUBULE ASSOCIATED PROTEIN#0.6227;THYMOCYTE#0.6199;BONE REMODELLING#0.6147;AXON BRANCHING#0.6145;GALECTIN#0.6126;STROMAL CELL#0.6112;TOPICAL#0.6101;SENSITIZATION#0.6092;HISTAMINE#0.6083;HYPOXIC#0.6076;PERIODONTAL LIGAMENT#0.6064;KERATINOCYTE MIGRATION#0.6061;COLLAGEN TYPE I#0.6055;PHOSPHATE BUFFERED SALINE#0.6054;NERVE TERMINAL#0.6043;OLFACTORY EPITHELIUM#0.6038;MUSCLE SATELLITE CELL#0.6023;BRUGADA SYNDROME#0.6014
103752554	TUMOR TISSUES#0.7535;BREAST CANCER CELL#0.7487;BREAST CANCER#0.7435;CANCER CELL#0.7420
103752587	DOXORUBICIN#0.8545;ERYTHROID CELL#0.6463;SMOOTH MUSCLE CELL#0.6319;PROSTATE CANCER#0.6318;MUSCLE CELL#0.6308;SMOOTH MUSCLE#0.6291;BREAST CANCER#0.6273;TRANSCRIPTION FACTOR#0.6260;CANCER CELL#0.6257
103752588	AUTOPHAGY#0.8125;HOPS COMPLEX#0.7970;AUTOPHAGOSOME MATURATION#0.7873;LIPID METABOLISM#0.6084
103753528	LOCALISATION#0.6539
10376	MICROTUBULE#1.0141;GENE EXPRESSION#0.9607;NERVOUS SYSTEM#0.8461;HEAT SHOCK PROTEIN#0.7914;TUBULIN TYROSINE LIGASE#0.7813;POST-TRANSLATIONAL MODIFICATION#0.7660;EPITHELIAL CELL#0.7483;TRANSCRIPTION FACTOR#0.7446;CENTRAL NERVOUS SYSTEM#0.7092;GLYCERALDEHYDE-3-PHOSPHATE#0.7024;LUNG TRANSPLANT RECIPIENTS#0.7016;GROWTH FACTOR#0.6981;CYTOPLASM#0.6941;CELL CYCLE#0.6915;POSTTRANSLATIONAL MODIFICATION#0.6601;BETA-2#0.6558;CANCER CELL#0.6510;RIBOSOMAL PROTEIN#0.6349;IMMUNE RESPONSE#0.6330;TUBULIN BINDING#0.6160
10379	ISGF3 COMPLEX#1.0884;TRANSCRIPTION FACTOR COMPLEX#1.0786;INTERFERON STIMULATED GENE#1.0320;IFN REGULATORY FACTOR#1.0299;INTERFERON REGULATORY FACTOR#1.0254;IFN-BETA#1.0199;DNA BINDING#1.0174;IFN STIMULATED GENES#1.0060;IFN-GAMMA#1.0033;TRANSCRIPTION FACTOR#1.0026;SIGNAL TRANSDUCER#1.0011;ANTIVIRAL RESPONSE#1.0011;T CELL#0.9994;MACROPHAGE#0.9884;PROTEIN KINASE#0.9874;VIRAL INFECTION#0.9817;SIGNALING PATHWAY#0.9802;SIGNAL TRANSDUCTION#0.9789;CYTOPLASM#0.9784;INNATE IMMUNE RESPONSE#0.9764;GENE EXPRESSION#0.9741;IMMUNE RESPONSE#0.9738;RETINOIC ACID#0.9728;TRANSACTIVATION#0.9649;ELECTROPHORETIC MOBILITY SHIFT#0.9644;MONOCYTE#0.9627;APOPTOSIS#0.9624;CANCER CELL#0.9570;CELL SURFACE#0.9556;PROTEIN SYNTHESIS#0.9450;VIRAL REPLICATION#0.9379;INNATE IMMUNITY#0.9365;HEPATOMA CELLS#0.9204;CELL GROWTH#0.9174;HEPATITIS C#0.9101;IMMUNE SYSTEM#0.9052;INTERFERON RECEPTOR#0.9000;SIGNALING MOLECULE#0.8860;EPITHELIAL CELL#0.8804;PERIPHERAL BLOOD#0.8793;GROWTH FACTOR#0.8783;HEPATITIS C VIRUS#0.8758;TUMOR CELLS#0.8621;B CELL#0.8618;TUMOR NECROSIS FACTOR#0.8601;POLYMERASE CHAIN REACTION#0.8469;HEPATITIS B#0.8424;DAMAGED DNA BINDING#0.8300;TUMOR SUPPRESSOR#0.8258;NUCLEAR LOCALIZATION SIGNAL#0.8015;PROTEIN PROTEIN INTERACTION#0.7995;DENDRITIC CELL#0.7965;SIGNALING CASCADE#0.7874;INFLAMMATORY RESPONSE#0.7836;COMPLEX I#0.7806;SIGNALLING PATHWAY#0.7803;ACINAR CELL#0.7752;PROTEIN COMPLEX#0.7635;MAJOR HISTOCOMPATIBILITY COMPLEX#0.7483;IMMUNE CELL#0.7470;CELL CYCLE#0.7442;CELL DEATH#0.7436;ENDOTHELIAL CELL#0.7436;TOLL LIKE RECEPTOR#0.7350;MONONUCLEAR CELLS#0.7340;CELL PROLIFERATION#0.7216;MYELOID LEUKEMIA#0.7049;HEPATITIS B VIRUS#0.7037;HOST CELL#0.7024;PROTEIN KINASE C#0.7013;GENISTEIN#0.6903;GLIAL CELL#0.6866;REVERSE TRANSCRIPTION#0.6838;CELL DIFFERENTIATION#0.6743;VESICULAR STOMATITIS VIRUS#0.6671;PROTEIN KINASE R#0.6628;JAK-STAT SIGNAL TRANSDUCTION#0.6601;PERIPHERAL BLOOD MONOCYTES#0.6597;NUCLEAR IMPORT#0.6550;BINDING PROTEIN 1#0.6493;HISTONE DEACETYLASE#0.6474;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6452;PRO-INFLAMMATORY#0.6443;BREAST CANCER#0.6423;LYMPHOCYTIC CHORIOMENINGITIS#0.6351;PROTEIN TYROSINE KINASE#0.6324;FACTOR I#0.6286;KINASE INHIBITOR#0.6272;NERVOUS SYSTEM#0.6256;MUSCLE CELL#0.6236;ENHANCER BINDING PROTEIN#0.6223;ENHANCER BINDING#0.6219;STOMATITIS#0.6149;HEPATOCELLULAR CARCINOMA#0.6128;PROTEASOME#0.6095
10380	PLASMA MEMBRANE#0.8353;PHOSPHOLIPASE C#0.7729;LITHIUM#0.6539
10381	NEUROFILAMENT#1.0379;ADVANCED GASTRIC CANCER#1.0343;OVARIAN CANCER#1.0341;GLIAL FIBRILLARY ACIDIC PROTEIN#1.0300;BETA-2#1.0294;CONGENITAL FIBROSIS OF THE EXTRAOCULAR MUSCLES#1.0281;OVARIAN#1.0269;THYMIDYLATE SYNTHASE#1.0261;MICROTUBULE ASSOCIATED PROTEIN#1.0259;PACLITAXEL#1.0239;DOCETAXEL#1.0239;BREAST CANCER#1.0179;ADENOCARCINOMA#1.0173;COMPLEMENTATION GROUP 1#1.0160;CISPLATIN#1.0146;AXON GUIDANCE#1.0119;LUNG CANCER#1.0094;THYMIDYLATE#1.0086;DRUG RESISTANCE#1.0031;MICROTUBULE#1.0023;CANCER CELL#0.9989;POLYMERASE CHAIN REACTION#0.9986;NEURITE OUTGROWTH#0.9974;TUMOR CELLS#0.9927;CELL PROLIFERATION#0.9862;SQUAMOUS CELL CARCINOMA#0.9862;GENE EXPRESSION#0.9851;APOPTOSIS#0.9849;RETINOIC ACID#0.9847;NERVOUS SYSTEM#0.9847;REVERSE TRANSCRIPTION#0.9841;TRANSCRIPTION FACTOR#0.9833;COLORECTAL#0.9832;GROWTH FACTOR#0.9819;NEURITE#0.9795;ASTROCYTE#0.9767;PROGENITOR CELL#0.9761;VINORELBINE#0.9748;SKELETAL MUSCLE#0.9744;CENTRAL NERVOUS SYSTEM#0.9737;NEUROGENESIS#0.9672;SPINAL CORD#0.9660;STEM CELL#0.9654;SIGNALING PATHWAY#0.9645;NEURAL STEM CELL#0.9611;EPIDERMAL GROWTH FACTOR#0.9606;CELL CYCLE#0.9583;MICROTUBULE DYNAMICS#0.9578;NEURONAL CELLS#0.9564;GROWTH FACTOR RECEPTOR#0.9564;EPITHELIAL CELL#0.9542;REGENERATION#0.9493;CELL ADHESION#0.9480;TAXOL#0.9406;NEURAL CELL#0.9330;OLIGODENDROCYTE#0.9303;COLORECTAL CANCER#0.9257;HYPOXIA#0.9202;CELL DIFFERENTIATION#0.9115;PROTEIN KINASE#0.9109;NEURAL CREST#0.9107;EMBRYONIC STEM CELL#0.9087;CELL DEATH#0.9073;SEQUESTERING#0.9070;GLIAL CELL#0.9064;EMBRYONAL CARCINOMA#0.9036;NEURONAL MIGRATION#0.9024;MEDULLOBLASTOMA#0.9009;LYMPH NODE#0.8996;LUNG CARCINOMA#0.8984;SCHWANN CELL#0.8980;GEMCITABINE#0.8980;CELL MIGRATION#0.8885;TUBULIN BINDING#0.8808;GROWTH CONE#0.8793;BREAST CANCER PATIENTS#0.8749;MELANOCYTE#0.8729;BREAST CANCER CELL#0.8725;CELL ADHESION MOLECULE#0.8709;HEPATIC STELLATE CELL#0.8696;QUANTITATIVE REAL TIME#0.8635;NERVE FIBER#0.8573;NEUROBLASTOMA#0.8532;MESENCHYMAL STEM CELL#0.8484;OLFACTORY BULB#0.8448;POSTTRANSLATIONAL MODIFICATION#0.8377;NEUROBLAST#0.8336;PERIPHERAL NERVE#0.8287;TOPOISOMERASE II#0.8170;CALCIUM CHANNEL#0.8141;PRECURSOR CELL#0.8110;DISEASE FREE SURVIVAL#0.8101;GANGLION CELLS#0.8042;5 FLUOROURACIL#0.7996;BASEMENT MEMBRANE#0.7942;HAIR CELL#0.7916;NEURAL TUBE#0.7857;AKT SIGNALING#0.7849;PTOSIS#0.7837;KINESIN#0.7829;PLURIPOTENT STEM CELL#0.7693;DORSAL ROOT GANGLION#0.7673;RETINAL PIGMENT EPITHELIAL#0.7619;OPTIC NERVE#0.7601;BRAIN DEVELOPMENT#0.7594;TOXICITY#0.7583;BONE MARROW#0.7556;LYMPH NODE METASTASIS#0.7538;CELL GROWTH#0.7455;OPHTHALMOPLEGIA#0.7420;FLUOROURACIL#0.7414;TUMOR TISSUES#0.7407;CEREBRAL CORTEX#0.7354;MAGNETIC RESONANCE IMAGING#0.7244;PERIPHERAL NERVOUS SYSTEM#0.7216;PLASMA MEMBRANE#0.7216;PROSTATE CANCER#0.7215;CYTOPLASM#0.7204;BLOOD VESSEL#0.7084;ENDOTHELIAL CELL#0.7073;FORMALIN#0.6987;INNER EAR#0.6914;DOXORUBICIN#0.6885;PATUPILONE#0.6818;NEOPLASTIC TISSUES#0.6795;MEDIAN OVERALL SURVIVAL#0.6791;ACTIN BINDING#0.6790;STEM CELL MARKER#0.6789;TOPOISOMERASE#0.6743;WOUND HEALING#0.6738;DNA REPAIR#0.6736;NEUROLOGICAL DISORDER#0.6729;FIBROBLAST GROWTH FACTOR#0.6729;CAPECITABINE#0.6718;EXTRACELLULAR MATRIX#0.6715;PANCREATIC CANCER#0.6698;NEUROPATHY#0.6680;PROLIFERATING CELL NUCLEAR ANTIGEN#0.6658;APOPTOTIC#0.6634;MITOTIC SPINDLE#0.6632;RESPONSE TO DOCETAXEL#0.6548;DESMOPLASTIC MEDULLOBLASTOMA#0.6482;CYTOTOXICITY#0.6474;ENDOTHELIAL GROWTH FACTOR#0.6436;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6436;MITOSIS#0.6337;NETRIN RECEPTOR#0.6319;NEUROBLASTIC TUMOR#0.6317;TUMOR SUPPRESSOR#0.6254;CARBOPLATIN#0.6254;B CELL#0.6228;NEURAL PROGENITOR CELL#0.6197;COLON CANCER#0.6162;SUBSTANCE P#0.6162;LAMININ RECEPTOR#0.6156;CAROTID BODY#0.6146;GLOMUS CELL#0.6133;RESPONSE TO PACLITAXEL#0.6118;THYMIC CARCINOMA#0.6111;PROTEASOME#0.6093;OOCYTE#0.6079;IMMATURE NEURON#0.6067;KALLMANN SYNDROME#0.6047;QUANTITATIVE REVERSE TRANSCRIPTION#0.6046;SCIATIC NERVE#0.6035;ADRENAL GLAND#0.6031;DENTATE GYRUS#0.6027;LUNG ADENOCARCINOMA#0.6021
10382	DYSTONIA#1.0723;BASAL GANGLIA#1.0598;BETA-2#1.0202;MICROTUBULE#1.0037;HYPOMYELINATING LEUKODYSTROPHY#0.9557;LEUKODYSTROPHY#0.8965;GENERALIZED DYSTONIA#0.8112;GENE EXPRESSION#0.7770;PARAPLEGIA#0.7338;MITOCHONDRIAL TRANSPORT#0.6362;MICROTUBULE ASSEMBLY#0.6177;HEREDITARY SPASTIC PARAPLEGIA#0.6174
10383	BETA2 ADRENOCEPTOR#1.1056;EOSINOPHIL#1.0484;BETA-2#1.0434;AXONEME#1.0304;SALBUTAMOL#1.0126;NEUTROPHIL#1.0049;MAST CELL#1.0003;MICROTUBULE#1.0001;FIBRIL#0.9775;GENE EXPRESSION#0.9392;CELL SURFACE#0.9376;MAST CELL DEGRANULATION#0.9355;SPERMATOGENESIS#0.9210;MITOTIC SPINDLE#0.8975;SALMETEROL#0.8738;EOSINOPHIL DEGRANULATION#0.8561;LEUKOCYTE#0.8519;CELL CYCLE#0.8419;GM-CSF#0.8277;MACROPHAGE#0.8095;SIGNALING PATHWAY#0.8020;CANCER CELL#0.7981;PROTEIN KINASE#0.7942;PLATELET ACTIVATING FACTOR#0.7772;BETA ADRENOCEPTOR#0.7762;SELECTIN#0.7716;NEUTROPHIL DEGRANULATION#0.7527;FENOTEROL#0.7488;TRYPTOPHAN#0.7438;GRANULOCYTE#0.7435;SIGNAL TRANSDUCTION#0.7429;AMYLOIDOSIS#0.7386;ADRENERGIC RECEPTOR#0.7330;PROPRANOLOL#0.7173;CELL ADHESION#0.7151;CYTOPLASMIC MICROTUBULE#0.7089;PLASMA MEMBRANE#0.7075;HEAT SHOCK PROTEIN#0.7070;MICROTUBULE ASSEMBLY#0.6894;TAXOL#0.6767;T LYMPHOCYTE#0.6732;NEUTROPHIL ACTIVATION#0.6718;GROWTH FACTOR#0.6697;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6521;COLONY-STIMULATING FACTOR#0.6509;GUANIDINE#0.6355;GERM CELL#0.6329;MITOSIS#0.6308;MICROTUBULE ASSOCIATED PROTEIN#0.6249;ISOPROTERENOL#0.6182;PROTEIN KINASE C#0.6170;ALBUTEROL#0.6122;CELL ACTIVATION#0.6054
10384	T CELL#0.9614
10385	T CELL#1.0684;T LYMPHOCYTE#0.6893
10388	SYNAPTONEMAL COMPLEX#1.0695;MEIOSIS#0.9379;AXIAL ELEMENT#0.8850;PROPHASE#0.7854;MEIOTIC CHROMOSOME#0.7718;SYNAPSIS#0.7574;LATERAL ELEMENT#0.7112;CHROMOSOMAL SYNAPSIS#0.6855;SPERMATOCYTES#0.6793;OOCYTE#0.6776;CENTROMERE#0.6636;BREAST CANCER#0.6211;METAPHASE#0.6016
10389	POLYCOMB REPRESSIVE COMPLEX 1#0.7929;POLYCOMB REPRESSIVE COMPLEX#0.7811;SPERMATOGENESIS#0.7789;GENE EXPRESSION#0.7679;SEX CHROMOSOME#0.7634;MEIOSIS#0.7583;HETEROCHROMATIN ORGANIZATION#0.6523;XY BODY#0.6459;DNA BINDING#0.6441;MALE MEIOSIS#0.6226
1038	ABC TRANSPORTER#1.0433;EFFLUX PUMP#1.0311;RHODAMINE 6G#1.0241;ATP BINDING CASSETTE#1.0138;CLINICAL DEMENTIA RATING#1.0127;ATP BINDING#1.0106;MILD COGNITIVE IMPAIRMENT#1.0083;DEMENTIA#1.0074;ANTIGEN BINDING#1.0055;ATP BINDING CASSETTE TRANSPORTER#1.0026;FLUCONAZOLE#1.0000;DRUG RESISTANCE#0.9980;TRANSCRIPTION FACTOR#0.9976;PROTEIN KINASE#0.9974;ERGOSTEROL#0.9962;GENE EXPRESSION#0.9953;POLYMERASE CHAIN REACTION#0.9929;REVERSE TRANSCRIPTION#0.9871;RELATED PROTEIN 1#0.9849;T CELL#0.9779;ALZHEIMER'S DISEASE#0.9663;B CELL#0.9563;ITRACONAZOLE#0.9510;ERGOSTEROL BIOSYNTHESIS#0.9481;CANDIDIASIS#0.9345;AMPHOTERICIN B#0.9291;CELL CYCLE#0.9089;PLASMA MEMBRANE#0.9043;MUTAGENESIS#0.9043;AMPHOTERICIN#0.8809;PUMP ACTIVITY#0.8717;MINI MENTAL STATE#0.8620;VIRULENCE#0.8613;KETOCONAZOLE#0.8345;VERY MILD DEMENTIA#0.8334;QUANTITATIVE REAL TIME#0.8317;MITOTIC ENTRY#0.8287;MITOSIS#0.8236;FLUPHENAZINE#0.8187;EPITHELIAL CELL#0.8090;CANCER CELL#0.8078;BIOFILM FORMATION#0.8075;DISEASE RESISTANCE#0.8070;ALANINE#0.7941;NUCLEOTIDE BINDING#0.7852;VORICONAZOLE#0.7827;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7686;LUPUS ERYTHEMATOSUS#0.7684;IMMUNE RESPONSE#0.7634;MAJOR FACILITATOR SUPERFAMILY#0.7554;PURKINJE CELL#0.7480;NUCLEOTIDE BINDING DOMAIN#0.7304;CELL WALL#0.7277;MAJOR HISTOCOMPATIBILITY COMPLEX#0.7257;DEMENTIA RATING SCALE#0.7245;TERBINAFINE#0.6852;ASPARTIC ACID#0.6757;PERIPHERAL BLOOD#0.6610;OROPHARYNGEAL CANDIDIASIS#0.6606;MINIMUM INHIBITORY CONCENTRATION#0.6555;LANOSTEROL#0.6463;ASPARAGINE#0.6357;HUMAN IMMUNODEFICIENCY VIRUS#0.6343;AUTOIMMUNE DISEASE#0.6338;INTERNATIONAL WORKING GROUP#0.6265;HYPERACTIVE#0.6258;CELL GROWTH#0.6142;CALYCULIN A#0.6042;CELL ACTIVATION#0.6004
10390	CHOLINE#1.0532;ETHANOLAMINE#0.9257
103910	REGULATORY LIGHT CHAIN#1.0708;MYOSIN LIGHT-CHAIN KINASE#1.0401;MUSCLE CONTRACTION#1.0227;MYOSIN PHOSPHATASE#1.0203;SMOOTH MUSCLE CONTRACTION#1.0195;SMOOTH MUSCLE#1.0155;MUSCLE CELL#1.0130;SMOOTH MUSCLE CELL#1.0100;ATPASE ACTIVITY#1.0013;PROTEIN KINASE#0.9994;DEPHOSPHORYLATION#0.9762;PROTEIN KINASE C#0.9640;ARTERY#0.9321;SENSITIZATION#0.8694;PHOSPHATASE ACTIVITY#0.8393;SIGNALING PATHWAY#0.8307;KINASE INHIBITOR#0.8058;MYOSIN HEAVY CHAIN#0.7973;MYOSIN ATPASE ACTIVITY#0.7946;VASCULAR SMOOTH MUSCLE CELL#0.7702;KINASE ACTIVITY#0.7582;ACTOMYOSIN#0.7565;AIRWAY SMOOTH MUSCLE#0.7454;ACTIN FILAMENT#0.7239;CARBACHOL#0.7105;GENE EXPRESSION#0.6938;BLADDER SMOOTH MUSCLE#0.6606;BETA-ESCIN#0.6304;PHENYLEPHRINE#0.6268;TIGHT JUNCTION#0.6188;MESENTERIC ARTERY#0.6133;AORTIC SMOOTH MUSCLE CELLS#0.6132;ACTIN POLYMERIZATION#0.6055;PORTAL VEIN#0.6042
10391	ACTIN CYTOSKELETON#0.9644;FOOT PROCESS EFFACEMENT#0.7519;PODOCYTE#0.7392
10392	ADIPOCYTE#1.0457;RECEPTOR INTERACTING PROTEIN#1.0415;NUCLEOTIDE OLIGOMERIZATION DOMAIN#1.0372;NF-KAPPAB ACTIVATION#1.0326;INTESTINAL EPITHELIAL CELL#1.0299;ENDOTHELIAL CELL#1.0270;NEUTROPHIL#1.0238;POLYMERASE CHAIN REACTION#1.0205;PEPTIDOGLYCAN#1.0192;AUTOPHAGY#1.0183;GASTRIC EPITHELIAL CELLS#1.0158;T CELL#1.0122;PROTEIN KINASE#1.0115;DENDRITIC CELL#1.0094;EPITHELIAL CELL#1.0092;CELL WALL#1.0090;CYTOKINE PRODUCTION#1.0088;NUCLEOTIDE BINDING#1.0080;MONOCYTE#1.0066;LEUCINE RICH REPEAT#1.0040;MACROPHAGE#1.0039;MITOGEN ACTIVATED PROTEIN#1.0035;SIGNALLING PATHWAY#1.0030;COLITIS#1.0027;INFLAMMATORY BOWEL DISEASE#1.0026;TUMOR NECROSIS FACTOR#1.0012;GRAM NEGATIVE BACTERIAL#1.0008;SIGNALING PATHWAY#1.0000;PRO-INFLAMMATORY#0.9985;HOST CELL#0.9982;PATTERN RECOGNITION RECEPTOR#0.9967;LEUCINE#0.9963;INNATE IMMUNE RESPONSE#0.9957;TROPHOBLAST CELL#0.9952;TROPHOBLAST#0.9946;INNATE IMMUNITY#0.9941;APOPTOSIS#0.9907;INFLAMMATORY RESPONSE#0.9899;NUCLEOTIDE BINDING DOMAIN#0.9893;IMMUNE CELL#0.9888;GENE EXPRESSION#0.9876;TOLL LIKE RECEPTOR#0.9873;INNATE IMMUNE SYSTEM#0.9870;RNA INTERFERENCE#0.9863;TRANSCRIPTION FACTOR#0.9856;BONE MARROW#0.9820;IMMUNE RESPONSE#0.9816;PERIPHERAL BLOOD#0.9811;CROHN'S DISEASE#0.9802;IMMUNE SYSTEM#0.9796;ULCERATIVE COLITIS#0.9709;ALLERGIC RHINITIS#0.9626;MONONUCLEAR CELLS#0.9601;CELL ACTIVATION#0.9581;CYTOKINE SECRETION#0.9520;REVERSE TRANSCRIPTION#0.9511;CANCER CELL#0.9510;SIGNALING MOLECULE#0.9489;IFN-GAMMA#0.9453;SIGNAL TRANSDUCTION#0.9450;FRAGMENT LENGTH POLYMORPHISM#0.9443;GLUCOSE UPTAKE#0.9436;ADAPTIVE IMMUNE RESPONSE#0.9379;CASPASE ACTIVATION#0.9366;OUTER MEMBRANE#0.9273;QUANTITATIVE REAL TIME#0.9112;IL-8 SECRETION#0.9042;GASTRITIS#0.9022;MAMMARY GLAND#0.9008;CELL SURFACE#0.8957;CELL DEATH#0.8939;CHLAMYDIA#0.8932;PLASMA MEMBRANE#0.8905;DISEASE RESISTANCE#0.8904;AIRWAY EPITHELIAL CELL#0.8888;VIRULENCE#0.8862;SIGNALING CASCADE#0.8849;B CELL#0.8811;MYELOID CELL#0.8790;ACTIVATION OF NF-KAPPAB#0.8780;CELL PROLIFERATION#0.8694;RECEPTOR LIGAND#0.8584;PATHOGEN RECOGNITION RECEPTOR#0.8571;UBIQUITIN#0.8545;IL-8 PRODUCTION#0.8485;CARDIOMYOCYTE#0.8408;MAPK SIGNALING#0.8350;MAST CELL#0.8320;BREAST CANCER#0.8296;PATTERN RECOGNITION MOLECULES#0.8259;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8230;NOD2 SIGNALING PATHWAY#0.8156;RHINITIS#0.8142;APOPTOTIC#0.8114;HUMAN BETA DEFENSIN#0.8109;HOST CYTOSOL#0.8095;GROWTH FACTOR#0.8060;EARLY ENDOSOME#0.8008;LEUKOCYTE#0.8000;VIRAL INFECTION#0.7990;MONOCYTE CHEMOATTRACTANT PROTEIN#0.7960;ENDOPLASMIC RETICULUM#0.7951;CHEMOKINE PRODUCTION#0.7903;PHAGOCYTOSIS#0.7893;MAPK ACTIVATION#0.7862;REACTIVE OXYGEN SPECIES#0.7822;RECEPTOR AGONIST#0.7804;ADIPOSE TISSUE#0.7745;HUMAN EMBRYONIC KIDNEY#0.7720;EMBRYONIC KIDNEY#0.7716;CYTOPLASM#0.7687;ISCHEMIA#0.7684;TUMOUR NECROSIS FACTOR#0.7672;ORAL EPITHELIAL CELLS#0.7619;BLAU SYNDROME#0.7616;ALLERGEN#0.7606;PANCREATITIS#0.7550;HUMAN DENDRITIC CELL#0.7492;BEHCET'S DISEASE#0.7453;ISCHEMIA REPERFUSION INJURY#0.7429;LYMPH NODE#0.7429;MONOCYTE DERIVED MACROPHAGE#0.7429;TUBULAR EPITHELIAL CELL#0.7418;ANTIGEN PRESENTING CELLS#0.7413;TYPE 2 DIABETES#0.7372;CIGARETTE SMOKE EXTRACT#0.7367;EOSINOPHIL#0.7299;INFLAMMATORY CELL#0.7244;STROMAL CELL#0.7230;LIPOLYSIS#0.7149;HEPATOCELLULAR CARCINOMA#0.7142;ATHEROSCLEROSIS#0.6978;NEUTROPHIL MIGRATION#0.6967;STRUCTURE ACTIVITY RELATIONSHIP#0.6961;ENDOSOME#0.6895;MAP KINASE#0.6869;PERIODONTITIS#0.6846;DAP I#0.6845;ALLERGIC ASTHMA#0.6837;HEART DISEASE#0.6835;NOD SIGNALING PATHWAY#0.6752;SIGNAL TRANSDUCER#0.6750;MESOTHELIAL CELL#0.6746;LUNG EPITHELIAL CELL#0.6726;CELL CYCLE#0.6724;BONE RESORPTION#0.6707;HEAT SHOCK PROTEIN#0.6692;SQUAMOUS CELL CARCINOMA#0.6668;SARCOIDOSIS#0.6617;IL-6 PRODUCTION#0.6570;T CELL ACTIVATION#0.6518;IFN-BETA#0.6511;TH17 CELL#0.6491;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6471;PROTEASOME#0.6453;ALVEOLAR MACROPHAGE#0.6286;MOLECULAR DYNAMICS SIMULATION#0.6247;NITRIC OXIDE#0.6245;METAPLASIA#0.6243;ISOPROTERENOL#0.6232;GASTRIC EPITHELIUM#0.6178;ABSENT IN MELANOMA#0.6156;IL-1 SECRETION#0.6147;CHAPERONE COMPLEX#0.6108;DEFENSE RESPONSE#0.6027
10393	ANAPHASE PROMOTING COMPLEX#1.0480;ANAPHASE#1.0258;CELL CYCLE#0.9693;UBIQUITIN#0.9386;CYCLOSOME#0.8963;MITOSIS#0.7634;BUDDING#0.6117
10394	EOSINOPHIL#0.8750
10395	FOCAL ADHESION KINASE#1.0643;CELL GROWTH#1.0625;BREAST CANCER#1.0608;FOCAL ADHESION#1.0586;LIVER CANCER#1.0540;TUMOR SUPPRESSOR#1.0495;HEPATOCELLULAR CARCINOMA#1.0488;CELL MIGRATION#1.0417;APOPTOSIS#1.0410;CANCER CELL#1.0373;GENE EXPRESSION#1.0321;CELL PROLIFERATION#1.0305;BREAST CANCER CELL#1.0250;CELL CYCLE#1.0155;PROSTATE CANCER#1.0111;COLON CANCER#1.0084;CELL MOTILITY#1.0062;SIGNALING PATHWAY#0.9872;GAP ACTIVITY#0.9691;GROWTH FACTOR#0.9680;POLYMERASE CHAIN REACTION#0.9633;ENDOTHELIAL CELL#0.9628;REVERSE TRANSCRIPTION#0.9581;ACTIN CYTOSKELETON#0.9489;PROTEIN KINASE#0.9469;HEPATOCELLULAR CARCINOMA CELL#0.9463;NON-SMALL CELL LUNG CARCINOMA#0.9426;LUNG CARCINOMA#0.9343;LUNG CANCER#0.9316;EPITHELIAL CELL#0.8937;PROSTATE CARCINOMA#0.8764;DNA METHYLATION#0.8763;HISTONE DEACETYLASE#0.8590;STRESS FIBER#0.8555;MULTIPLE MYELOMA#0.8543;5-AZA-2'-DEOXYCYTIDINE#0.8525;2'-DEOXYCYTIDINE#0.8520;SQUAMOUS CELL CARCINOMA#0.8491;ONCOGENIC#0.8465;DYNEIN LIGHT CHAIN#0.8386;OVARIAN#0.8065;COLORECTAL#0.7884;SUBEROYLANILIDE HYDROXAMIC ACID#0.7829;CONTACT INHIBITION#0.7800;ANGIOGENESIS#0.7702;METHYLATION SPECIFIC PCR#0.7577;COLORECTAL CANCER#0.7523;TRANSCRIPTION FACTOR#0.7501;LYMPH NODE#0.7475;CYTOPLASM#0.7419;PANCREATIC CANCER#0.7374;PHOSPHOTYROSINE BINDING#0.7340;INHIBITION OF CELL PROLIFERATION#0.7053;STERILE ALPHA MOTIF#0.7027;BREAST CARCINOMA#0.6987;ANCHORAGE INDEPENDENT GROWTH#0.6872;DYNEIN#0.6726;LYMPH NODE METASTASIS#0.6572;OVARIAN CANCER#0.6558;TUMOR CELLS#0.6535;METHYLATION SPECIFIC POLYMERASE#0.6490;SIGNALING MOLECULE#0.6335;HISTONE DEACETYLASE INHIBITOR#0.6187;G1 PHASE#0.6151;PLASMA MEMBRANE#0.6093;PEPTIDE BINDING#0.6073;ADHERENS JUNCTION#0.6067;CELL POLARITY#0.6060;PROTEIN DEGRADATION#0.6024
10396	SCRAMBLASE#1.0539;FLIPPASE#1.0416;ERYTHROCYTE#1.0236;PLASMA MEMBRANE#1.0174;PHOSPHATIDYLETHANOLAMINE#1.0069;PHOSPHATIDYLSERINE#1.0013;PHOSPHOLIPID SCRAMBLASE#0.9961;APOPTOSIS#0.9862;N-ETHYLMALEIMIDE#0.9827;RED BLOOD CELL#0.9796;MEMBRANE LEAFLET#0.9547;CELL MEMBRANE#0.9086;CELL SURFACE#0.8985;ATPASE ACTIVITY#0.8887;APOPTOTIC#0.8468;CHROMAFFIN GRANULE#0.7961;ADENOSINE#0.7912;EXTERNALIZATION OF PHOSPHATIDYLSERINE#0.7562;MACROPHAGE#0.7305;DNA DEPENDENT ATPASE#0.7025;ADENOSINE TRIPHOSPHATE#0.6851;IONOPHORE#0.6789;ENDOTHELIAL CELL#0.6772;OUTER MEMBRANE#0.6570;FLIPPASE ACTIVITY#0.6447;PHOSPHOLIPID TRANSLOCATION#0.6153
10397	CHARCOT-MARIE-TOOTH DISEASE TYPE 4D#1.1039;PANCREATIC CANCER#1.0625;COLON CANCER#1.0582;CELL DIFFERENTIATION#1.0514;CELL MIGRATION#1.0471;COLORECTAL CANCER#1.0437;HYPOXIA#1.0338;LUNG CANCER#1.0310;COLORECTAL#1.0309;HEPATOCELLULAR CARCINOMA#1.0306;EPITHELIAL MESENCHYMAL TRANSITION#1.0279;EPITHELIAL CELL#1.0277;TOOTH DISEASE#1.0276;CHARCOT-MARIE-TOOTH DISEASE#1.0276;LYMPH NODE#1.0269;TUMOR SUPPRESSOR#1.0250;BREAST CANCER CELL#1.0248;HYPOXIC#1.0237;PROSTATE CANCER#1.0206;NEUROPATHY#1.0203;TUMOR CELLS#1.0180;BREAST CANCER#1.0176;GROWTH FACTOR#1.0174;CELL GROWTH#1.0160;ANGIOGENESIS#1.0154;LYMPH NODE METASTASIS#1.0144;CHARCOT MARIE TOOTH#1.0133;CANCER CELL#1.0126;APOPTOSIS#1.0125;SIGNALING PATHWAY#1.0110;HYPOXIA INDUCIBLE FACTOR#1.0106;SCHWANN CELL#1.0091;PROTEIN KINASE#1.0070;CELL PROLIFERATION#1.0061;ADENOCARCINOMA#1.0030;ONCOGENIC#1.0022;TRANSCRIPTION FACTOR#0.9999;CELL CYCLE#0.9994;SQUAMOUS CELL CARCINOMA#0.9947;POLYMERASE CHAIN REACTION#0.9927;HUMAN BREAST CANCER#0.9887;CELL DEATH#0.9882;CYTOPLASM#0.9871;GENE EXPRESSION#0.9860;CELL CYCLE ARREST#0.9775;MAST CELL#0.9774;PERIPHERAL NERVE#0.9718;APOPTOTIC#0.9678;TROPHOBLAST#0.9585;DISEASE RESISTANCE#0.9579;NERVOUS SYSTEM#0.9571;EPIDERMAL GROWTH FACTOR#0.9524;RETINOIC ACID#0.9444;MACROPHAGE#0.9404;DISEASE FREE SURVIVAL#0.9294;ENDOTHELIAL CELL#0.9293;ENDOTHELIAL GROWTH FACTOR#0.9179;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9179;DNA METHYLATION#0.9163;RNA INTERFERENCE#0.9095;PLASMA MEMBRANE#0.9091;NEUROBLASTOMA#0.8998;CERVICAL#0.8979;GROWTH FACTOR RECEPTOR#0.8922;BINDING PROTEIN 1#0.8904;REVERSE TRANSCRIPTION#0.8899;CPT-11#0.8867;AUTOPHAGY#0.8865;ESOPHAGEAL CANCER#0.8839;DRUG RESISTANCE#0.8791;BREAST CANCER PATIENTS#0.8668;POLYNEUROPATHY#0.8591;T CELL#0.8543;ACTIVATING TRANSCRIPTION FACTOR#0.8529;CELL MEMBRANE#0.8489;LIPID DROPLET#0.8449;HISTONE DEACETYLASE#0.8344;PROTEIN KINASE C#0.8316;CENTRAL NERVOUS SYSTEM#0.8252;ER STRESS RESPONSE#0.8099;UBIQUITIN#0.8097;TRANSFORMING GROWTH FACTOR#0.8094;TUMOR TISSUES#0.8088;LIPID METABOLISM#0.8070;CENTROSOME#0.7981;HEAT SHOCK PROTEIN#0.7969;DOXORUBICIN#0.7963;STEM CELL#0.7759;ENDOPLASMIC RETICULUM#0.7759;CENTROSOME DUPLICATION#0.7741;CERVICAL ADENOCARCINOMA#0.7728;LUNG ADENOCARCINOMA#0.7722;OVARIAN#0.7693;MECHANISM OF ACTION#0.7673;GENE SILENCING#0.7624;PROTEASOME#0.7622;KINASE INHIBITOR#0.7594;PANCREATIC DUCTAL ADENOCARCINOMA#0.7585;CELL ADHESION#0.7575;STROMAL CELL#0.7542;PROSTATE CARCINOMA#0.7528;OLIGODENDROCYTE#0.7523;SYSTEMIC ACQUIRED RESISTANCE#0.7513;DEATH RECEPTOR#0.7468;HUMAN PANCREATIC CANCER#0.7466;KINASE ACTIVITY#0.7444;METASTASIS SUPPRESSOR GENES#0.7422;MYELINATION#0.7406;CERVICAL CANCER#0.7396;IMMUNE RESPONSE#0.7366;ANDROGEN RECEPTOR#0.7366;EARLY GROWTH RESPONSE#0.7313;DNA METHYLTRANSFERASE#0.7254;COLORECTAL CARCINOMA#0.7245;MICROTUBULE#0.7235;QUANTITATIVE REAL TIME#0.7186;CISPLATIN#0.7163;TARGET OF RAPAMYCIN#0.7137;RAPAMYCIN#0.7136;SALICYLIC ACID#0.7093;S PHASE#0.7017;IRINOTECAN#0.6957;RESPONSE TO HYPOXIA#0.6956;DEFENSE RESPONSE#0.6877;MYELIN SHEATH#0.6779;SIGNALING CASCADE#0.6767;REACTIVE OXYGEN SPECIES#0.6729;MAMMARY EPITHELIAL CELL#0.6720;MITOGEN ACTIVATED PROTEIN#0.6694;B CELL#0.6677;ISCHEMIA#0.6667;PERIPHERAL NERVOUS SYSTEM#0.6519;MIMOSINE#0.6518;AKT SIGNALING#0.6487;TRANSACTIVATION#0.6479;PROTEIN PROTEIN INTERACTION#0.6473;CYTOTOXICITY#0.6442;TUMOR NECROSIS FACTOR#0.6425;COLON CARCINOMA#0.6311;G1 PHASE#0.6284;RIBOSOMAL PROTEIN#0.6260;OVARIAN CANCER#0.6258;ENDOMETRIUM#0.6233;HEPATOCELLULAR CARCINOMA CELL#0.6231;BREAST CARCINOMA#0.6193;NEUTROPHIL#0.6170;SIGNALLING PATHWAY#0.6145;NORMAL PROSTATE EPITHELIAL#0.6131;BONE MARROW#0.6110;CELLULAR LOCALIZATION#0.6077;GLYCOGEN SYNTHASE KINASE#0.6068;METAL BINDING#0.6038;FLAVOPIRIDOL#0.6008
10398	REGULATORY LIGHT CHAIN#1.0256;MYOSIN PHOSPHATASE#1.0200;SMOOTH MUSCLE CONTRACTION#1.0126;MUSCLE CONTRACTION#1.0094;MYOSIN LIGHT-CHAIN KINASE#1.0061;DEPHOSPHORYLATION#1.0027;MUSCLE CELL#0.9990;SMOOTH MUSCLE#0.9982;SMOOTH MUSCLE CELL#0.9968;PROTEIN KINASE C#0.9966;ACTOMYOSIN#0.9892;PROTEIN KINASE#0.9876;ATPASE ACTIVITY#0.9844;ARTERY#0.9818;TRANSCRIPTION FACTOR#0.9552;KINASE INHIBITOR#0.9500;SKELETAL MUSCLE#0.9380;AIRWAY SMOOTH MUSCLE#0.9321;PHOSPHATASE ACTIVITY#0.9264;CANCER CELL#0.9233;VASCULAR SMOOTH MUSCLE CELL#0.9209;SIGNALING PATHWAY#0.9181;GENE EXPRESSION#0.9167;MYOSIN HEAVY CHAIN#0.9077;TOXICITY#0.9023;SENSITIZATION#0.8786;CELL MIGRATION#0.8683;PHENYLEPHRINE#0.8669;STRESS FIBER#0.8640;VASCULAR SMOOTH MUSCLE CONTRACTION#0.8547;KINASE ACTIVITY#0.8545;PHOSPHATASE INHIBITOR#0.8248;BREAST CANCER#0.8184;BREAST CANCER CELL#0.8099;COLON CANCER#0.8006;T CELL#0.7989;BETA-ESCIN#0.7791;ENDOTHELIAL CELL#0.7609;ACTIN FILAMENT#0.7547;NOREPINEPHRINE#0.7446;MUSCLE FIBER#0.7262;MESENTERIC ARTERY#0.6981;GROWTH FACTOR#0.6731;SUPEROXIDE DISMUTASE#0.6476;HYPOXIA#0.6444;VASOCONSTRICTION#0.6399;CARDIOMYOPATHY#0.6386;ARTERIOLE#0.6374;ZIPPER INTERACTING PROTEIN#0.6373;HYPERTROPHIC CARDIOMYOPATHY#0.6294;APOPTOSIS#0.6256;DIGESTION#0.6239;PROTEIN PHOSPHORYLATION#0.6215;CARBACHOL#0.6184;RECEPTOR AGONIST#0.6169;CATION BINDING#0.6164;MAP KINASE#0.6080;PROTEIN PHOSPHATASE 1#0.6078;SIGNAL TRANSDUCTION#0.6029;CONSTRICTION#0.6013
10399	AUTOPHAGY#1.0561;PKC BINDING#1.0546;ACTIVATED PROTEIN C#1.0511;ANCHORING#1.0489;CELL MIGRATION#1.0466;PKC ACTIVATION#1.0423;FOCAL ADHESION#1.0394;LYMPH NODE#1.0381;RIBOSOMAL PROTEIN#1.0377;BREAST CANCER#1.0319;RIBOSOMAL SUBUNIT#1.0319;RIBOSOME#1.0310;CELL CYCLE#1.0277;CYTOKINE PRODUCTION#1.0276;PLASMA MEMBRANE#1.0244;CELL PROLIFERATION#1.0232;SMOOTH MUSCLE#1.0231;CELL ADHESION#1.0212;EPITHELIAL CELL#1.0210;KINASE ACTIVITY#1.0210;MITOGEN ACTIVATED PROTEIN#1.0202;CELL GROWTH#1.0197;CANCER CELL#1.0193;PROTEIN KINASE C#1.0158;BREAST CANCER CELL#1.0154;SIGNALING PATHWAY#1.0136;HETEROTRIMERIC G-PROTEIN#1.0129;T CELL#1.0128;SQUAMOUS CELL CARCINOMA#1.0128;SIGNALING MOLECULE#1.0118;APOPTOSIS#1.0118;PROTEIN KINASE#1.0114;PKCEPSILON#1.0098;GROWTH FACTOR#1.0071;INSULIN-LIKE GROWTH FACTOR#1.0061;SIGNAL TRANSDUCTION#1.0059;LYMPH NODE METASTASIS#1.0038;PROTEIN SYNTHESIS#1.0022;UBIQUITIN#1.0017;SIGNALING CASCADE#0.9997;NUCLEOTIDE BINDING#0.9988;APOPTOTIC#0.9938;ONCOGENIC#0.9868;COLON CANCER#0.9862;HEPATOCELLULAR CARCINOMA#0.9858;PHOSPHODIESTERASE#0.9839;ISCHEMIA#0.9828;TRANSCRIPTION FACTOR#0.9822;GENE EXPRESSION#0.9820;ETHANOL#0.9703;RNA INTERFERENCE#0.9640;SMOOTH MUSCLE CELL#0.9603;MUSCLE CELL#0.9598;40S RIBOSOMAL SUBUNIT#0.9597;CYTOPLASM#0.9579;MACROPHAGE#0.9574;HYPOXIA#0.9553;CORTISOL#0.9461;PKCDELTA#0.9454;PROTEASOME#0.9445;POLYMERASE CHAIN REACTION#0.9435;CELL SURFACE#0.9406;TRANSLATION INITIATION#0.9339;SIGNALLING PATHWAY#0.9316;PKCALPHA#0.9296;LEUKOCYTE#0.9257;GUANINE#0.9251;PROSTATE CANCER#0.9216;CELL DEATH#0.9203;LUNG CANCER#0.9146;PROTEIN PROTEIN INTERACTION#0.9141;ISCHEMIA REPERFUSION INJURY#0.9123;PKC ACTIVITY#0.9064;PROTEIN TRANSLATION#0.9032;ALVEOLAR MACROPHAGE#0.9027;NERVOUS SYSTEM#0.9026;ADENOCARCINOMA#0.8974;MAPK CASCADE#0.8912;TUMOR CELLS#0.8890;EUKARYOTIC INITIATION FACTOR#0.8887;IMMUNE RESPONSE#0.8863;BREAST CARCINOMA#0.8845;ENDOTHELIAL CELL#0.8790;BETA-2#0.8775;SMALL RIBOSOMAL SUBUNIT#0.8762;PHOSPHOLIPASE C#0.8734;FACTOR I#0.8678;ANGIOGENESIS#0.8661;HYPOXIA INDUCIBLE FACTOR#0.8631;AKT SIGNALING#0.8617;ASPARTATE#0.8605;FARNESYL#0.8583;CELLULAR LOCALIZATION#0.8536;ORAL SQUAMOUS CELL CARCINOMA#0.8535;CELL MEMBRANE#0.8531;TRANSFORMING GROWTH FACTOR#0.8520;RIBOSOME BINDING#0.8490;ENDOPLASMIC RETICULUM#0.8382;EPITHELIAL MESENCHYMAL TRANSITION#0.8372;TRYPTOPHAN#0.8224;PROTEIN PHOSPHATASE 2A#0.8177;PHOSPHATASE 2A#0.8174;FOCAL ADHESION KINASE#0.8144;DEHYDROEPIANDROSTERONE#0.8136;CELL DIFFERENTIATION#0.8114;S PHASE#0.8107;NMDA RECEPTOR#0.8074;CELL CELL ADHESION#0.8070;DRUG RESISTANCE#0.8055;ANCHORAGE INDEPENDENT GROWTH#0.7976;PANCREATIC DUCTAL ADENOCARCINOMA#0.7968;CARDIOMYOCYTE#0.7934;REACTIVE OXYGEN SPECIES#0.7934;TUMOR SUPPRESSOR#0.7909;RNA BINDING#0.7824;TUMOUR NECROSIS FACTOR#0.7810;PROTEIN DEGRADATION#0.7800;CHANNEL ACTIVITY#0.7733;PROTEIN TYROSINE KINASE#0.7709;ANDROGEN RECEPTOR#0.7673;PROTEASOME DEGRADATION#0.7655;CAMP SIGNALING#0.7644;IMMUNE CELL#0.7615;ADENOSINE#0.7591;POLYSOME#0.7581;INFLUENZA A VIRUS#0.7514;GLUTATHIONE#0.7458;TUMOR NECROSIS FACTOR#0.7424;RETINOIC ACID#0.7409;CD4+ T CELL#0.7391;CELL MOTILITY#0.7386;REVERSE TRANSCRIPTION#0.7373;CENTRAL NERVOUS SYSTEM#0.7369;VIRULENCE#0.7339;INSULIN RECEPTOR#0.7250;CERVICAL CANCER#0.7245;MICROTUBULE#0.7190;BETA CELL#0.7180;CENTROSOME#0.7176;CELL ACTIVATION#0.7150;EXTRACELLULAR MATRIX#0.7069;DEPHOSPHORYLATION#0.7063;RNA BINDING PROTEIN#0.7049;80S RIBOSOME#0.7028;MELANOCYTE#0.6997;RECEPTOR COMPLEX#0.6984;STRESS GRANULE#0.6983;HYPOXIC#0.6956;RECEPTOR TYROSINE KINASE#0.6949;HEAT SHOCK PROTEIN#0.6937;GROWTH CONE#0.6931;TYROSINE KINASE 2#0.6872;MIRNA BIOGENESIS#0.6843;RECYCLING ENDOSOME#0.6842;MUTAGENESIS#0.6836;SPECTRIN#0.6833;PROTEIN KINASE A#0.6785;FRONTAL#0.6785;CALCINEURIN#0.6771;GABA A RECEPTOR#0.6740;GLYCOGEN SYNTHASE KINASE#0.6735;NEURONAL CELLS#0.6719;ADENYLATE CYCLASE#0.6715;GLUCOCORTICOID RECEPTOR#0.6714;INNATE IMMUNITY#0.6713;WOUND HEALING#0.6698;CEREBRAL ISCHEMIA#0.6670;REGENERATION#0.6661;TANDEM AFFINITY PURIFICATION#0.6638;CELL WALL#0.6605;ION CHANNEL#0.6592;GERMINATION#0.6522;TRANSACTIVATION#0.6500;VIRAL REPLICATION#0.6487;ACTIN CYTOSKELETON#0.6474;DOPAMINE#0.6459;CERVICAL#0.6443;ALZHEIMER'S DISEASE#0.6440;RAPAMYCIN#0.6310;CYTOKINESIS#0.6252;MONONUCLEAR CELLS#0.6224;VASCULAR SMOOTH MUSCLE CELL#0.6222;RIBOSOME ASSEMBLY#0.6221;GLIAL CELL#0.6218;ENDOSOME#0.6215;MEMBRANE FRACTION#0.6204;ASTRAL MICROTUBULE#0.6173;PKC SIGNAL TRANSDUCTION#0.6166;HEPATITIS C#0.6165;UBIQUITIN LIGASE COMPLEX#0.6153;KINASE INHIBITOR#0.6146;BRAIN CORTEX#0.6133;BUDDING#0.6131;ORAL SQUAMOUS CARCINOMA#0.6129;NEURITE#0.6104;ENDOCYTOSIS#0.6099;ALANINE#0.6078;AIRWAY EPITHELIAL CELL#0.6078;OVARIAN#0.6074;MEMORY IMPAIRMENT#0.6062;TH2 CELL#0.6051;GENE SILENCING#0.6028;OOCYTE#0.6017;PANCREATIC CANCER#0.6009;CYTOCHROME C#0.6009;RNA REPLICATION#0.6004;RESPONSE TO STRESS#0.6004
1039	ABC TRANSPORTER#1.0544;EFFLUX PUMP#1.0399;ANTIGEN BINDING#1.0248;ATP BINDING#1.0189;ATP BINDING CASSETTE#1.0168;CLINICAL DEMENTIA RATING#1.0098;DEMENTIA#1.0093;FLUCONAZOLE#1.0064;GENE EXPRESSION#0.9962;DRUG RESISTANCE#0.9915;TRANSCRIPTION FACTOR#0.9887;T CELL#0.9866;OVARIAN#0.9827;MITOTIC ENTRY#0.9668;B CELL#0.9611;OVARIAN CANCER#0.9569;MUTAGENESIS#0.9476;CELL CYCLE#0.9470;ALZHEIMER'S DISEASE#0.9401;IMMUNE RESPONSE#0.9390;MULTIPLE SCLEROSIS#0.9341;RHODAMINE 6G#0.9311;POLYMERASE CHAIN REACTION#0.9249;PROTEIN KINASE#0.8859;MITOSIS#0.8844;ATP BINDING CASSETTE TRANSPORTER#0.8742;REVERSE TRANSCRIPTION#0.8544;TUMOR CELLS#0.8497;ERGOSTEROL#0.8413;CANDIDIASIS#0.8383;MILD COGNITIVE IMPAIRMENT#0.8338;CELL GROWTH#0.8244;PLASMA MEMBRANE#0.8243;KINASE ACTIVITY#0.8230;ENCEPHALOMYELITIS#0.7935;DEMENTIA RATING SCALE#0.7728;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.7657;REGULATORY T CELL#0.7571;ITRACONAZOLE#0.7565;CD8+ T CELL#0.7479;RENAL CELL CARCINOMA#0.7444;CELL TIP#0.7435;HUMAN IMMUNODEFICIENCY VIRUS#0.7373;CYTOKINESIS#0.7281;PURKINJE CELL#0.7256;MINI MENTAL STATE#0.7256;CELL SURFACE#0.7237;AMPHOTERICIN B#0.7135;TUMOR ANTIGEN#0.7101;PUMP ACTIVITY#0.7058;AUTOIMMUNE DISEASE#0.7026;PERIPHERAL BLOOD#0.6991;VORICONAZOLE#0.6980;DNA BINDING#0.6952;ARGININE#0.6869;MICAFUNGIN#0.6601;T LYMPHOCYTE#0.6584;GENE CONVERSION#0.6567;FLUPHENAZINE#0.6558;AMPHOTERICIN#0.6321;CELL DIVISION#0.6315;CELL POLARITY#0.6306;LYSINE#0.6301;CANCER CELL#0.6258;QUANTITATIVE REAL TIME#0.6237;BREAST CANCER#0.6232;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6163;PROLYL 4-HYDROXYLASE#0.6089;CYTOKINETIC RING#0.6027
103	DOUBLE-STRANDED RNA BINDING#1.0440;T CELL#1.0408;STEM CELL#1.0394;CELL DEATH#1.0379;MRNA EDITING#1.0351;DNA BINDING#1.0319;APOPTOSIS#1.0225;ADENOSINE DEAMINASE#1.0197;DEAMINASE ACTIVITY#1.0165;INTERFERON STIMULATED GENE#1.0162;CANCER CELL#1.0140;RNA EDITING#1.0135;RNA BINDING#1.0127;ADENOSINE#1.0127;PROTEIN KINASE#1.0120;IMMUNE RESPONSE#1.0112;VIRAL INFECTION#1.0104;DSRNA BINDING#1.0101;INNATE IMMUNE RESPONSE#1.0090;CELL PROLIFERATION#1.0054;RNA BINDING PROTEIN#1.0048;GLUTAMATE RECEPTOR#1.0044;POLYMERASE CHAIN REACTION#1.0010;INOSINE#0.9999;BREAST CANCER#0.9997;MACROPHAGE#0.9992;ADENOSINE TO INOSINE EDITING#0.9969;GENE EXPRESSION#0.9955;RNA INTERFERENCE#0.9833;CYTOPLASM#0.9789;NERVOUS SYSTEM#0.9768;INNATE IMMUNITY#0.9766;VIRAL REPLICATION#0.9755;NUCLEIC ACID#0.9682;GUANOSINE#0.9637;STRESS GRANULE#0.9543;CELL CYCLE#0.9464;MIRNA PROCESSING#0.9411;RNA MODIFICATION#0.9387;SIGNALING PATHWAY#0.9366;NALIDIXIC ACID#0.9294;PERIPHERAL BLOOD#0.9184;NUCLEAR LOCALIZATION SIGNAL#0.8990;MYELOID LEUKEMIA#0.8965;T LYMPHOCYTE#0.8937;PROTEIN SYNTHESIS#0.8931;BASE PAIRING#0.8928;ONCOGENIC#0.8839;TRANSCRIPTION FACTOR#0.8810;ION CHANNEL#0.8738;CENTRAL NERVOUS SYSTEM#0.8698;NUCLEAR EXPORT#0.8685;GENE SILENCING#0.8627;ANTIVIRAL RESPONSE#0.8561;AUTOIMMUNE DISEASE#0.8525;ALVEOLAR MACROPHAGE#0.8348;IMMUNE SYSTEM#0.8341;SQUAMOUS CELL CARCINOMA#0.8311;PROTEIN TRANSLATION#0.8278;MEASLES#0.8258;CYTIDINE DEAMINASE#0.8181;CYTIDINE#0.8046;DYSTONIA#0.8035;LEUKEMIA STEM CELL#0.8012;HEPATITIS B#0.7974;LUPUS ERYTHEMATOSUS#0.7959;LUNG ADENOCARCINOMA#0.7892;APOBEC#0.7891;CIPROFLOXACIN#0.7826;REVERSE TRANSCRIPTION#0.7815;SYSTEMIC LUPUS ERYTHEMATOSUS#0.7787;HOST CELL#0.7781;HEPATOCELLULAR CARCINOMA#0.7780;NUCLEAR EXPORT SIGNAL#0.7667;APOPTOTIC#0.7652;INTERFERON PRODUCTION#0.7642;MUTAGENESIS#0.7598;CHRONIC MYELOID LEUKEMIA#0.7571;MOUSE EMBRYO FIBROBLASTS#0.7571;SALMONELLOSIS#0.7553;VESICULAR STOMATITIS VIRUS#0.7496;METASTATIC MELANOMA#0.7448;MICRORNA PROCESSING#0.7431;HUMAN IMMUNODEFICIENCY VIRUS#0.7379;PROGENITOR CELL#0.7371;CELL DEVELOPMENT#0.7350;B CELL#0.7346;REGULATION OF GENE EXPRESSION#0.7276;ADENOCARCINOMA#0.7232;EMBRYONIC STEM CELL#0.7198;TUMOR CELLS#0.7183;IFN-GAMMA#0.7160;ADENOSINE DEAMINASE ACTIVITY#0.7116;HEPATITIS C#0.7101;RNA PROCESSING#0.7062;ASTROCYTE#0.7047;CHEMICAL SHIFT PERTURBATION#0.7040;AUTOIMMUNITY#0.6999;HYPOXIA#0.6965;NERVOUS TISSUE#0.6941;SEROTONIN RECEPTOR#0.6921;SIGNAL TRANSDUCTION#0.6903;MRNA SPLICING#0.6902;NUCLEOLUS#0.6839;ERYTHROPOIESIS#0.6761;ARGININE#0.6746;ADENINE#0.6734;GASTROENTERITIS#0.6715;DISEASE FREE SURVIVAL#0.6688;LIVER DAMAGE#0.6666;RNA REPLICATION#0.6575;HEMATOPOIESIS#0.6502;BONE MARROW#0.6398;NEUROTRANSMITTER RECEPTOR#0.6367;PROTEIN KINASE R#0.6363;VIRION#0.6302;NEUROLOGICAL DISORDER#0.6296;NUCLEAR IMPORT#0.6278;TYPE I IFN PRODUCTION#0.6209;SKIN DISEASE#0.6197;RNA DEGRADATION#0.6154;REGENERATION#0.6151;STEM CELL MAINTENANCE#0.6145;ENZYME ACTIVITY#0.6137;BINDING PROTEIN 1#0.6029;VIRAL GENOME#0.6000
10400	N-METHYLTRANSFERASE ACTIVITY#1.0836;PHOSPHATIDYLETHANOLAMINE N METHYLTRANSFERASE#1.0652;HEPATOMA CELLS#1.0612;CDP CHOLINE PATHWAY#1.0512;N METHYLTRANSFERASE#1.0505;METHYLTRANSFERASE ACTIVITY#1.0505;PHOSPHATIDYLETHANOLAMINE#1.0463;HIGH FAT DIET#1.0253;ADIPOCYTE#1.0235;FATTY LIVER#1.0215;LOW DENSITY LIPOPROTEIN#1.0189;S-ADENOSYLMETHIONINE#1.0179;CHOLINE#1.0158;PHENYLETHANOLAMINE N METHYLTRANSFERASE#1.0145;PHOSPHOCHOLINE#1.0139;LIVER DISEASE#1.0138;FATTY LIVER DISEASE#1.0056;CHOLINE METABOLISM#1.0007;CELL DIVISION#1.0002;METHIONINE#0.9960;PLASMA MEMBRANE#0.9933;VERY-LOW-DENSITY LIPOPROTEIN#0.9904;DIET INDUCED OBESITY#0.9897;LIVER DAMAGE#0.9867;PHOSPHATIDYLCHOLINE SYNTHESIS#0.9826;ENDOPLASMIC RETICULUM#0.9822;NONALCOHOLIC FATTY LIVER DISEASE#0.9692;GENE EXPRESSION#0.9659;PHOSPHATIDYLCHOLINE BIOSYNTHESIS#0.9647;ETHANOLAMINE#0.9527;ADOMET#0.9524;MITOCHONDRIA#0.9461;PROTEIN KINASE#0.9406;L-METHIONINE#0.9207;WEIGHT GAIN#0.9187;FOLATE#0.9120;APOPTOSIS#0.9112;CHOLINE DEHYDROGENASE#0.9094;CHOLINE DEFICIENT DIET#0.9091;ISOPROTERENOL#0.9067;MICROSOME#0.9020;S-ADENOSYL-L-METHIONINE#0.9011;CELL PROLIFERATION#0.8886;BREAST CANCER#0.8846;SKELETAL MUSCLE#0.8820;CHOLINE KINASE#0.8730;CYCLIC AMP#0.8612;MITOCHONDRIA-ASSOCIATED MEMBRANE#0.8499;EPINEPHRINE#0.8488;ADIPOSE TISSUE#0.8376;PHOSPHATIDYLSERINE#0.8349;ENZYME ACTIVITY#0.8278;ATHEROSCLEROSIS#0.8197;FETAL BRAIN#0.8116;LIPOLYSIS#0.8011;ETHANOL#0.7938;CELL DEATH#0.7865;OBESE#0.7759;PHOSPHATIDYLSERINE DECARBOXYLASE#0.7739;LIPID METABOLISM#0.7721;PHOSPHOLIPID METABOLISM#0.7665;BRUSH BORDER MEMBRANE#0.7585;BRUSH BORDER#0.7546;PHOSPHOLIPASE A2#0.7519;CELL MEMBRANE#0.7510;ADENYLATE CYCLASE#0.7504;HIGH DENSITY LIPOPROTEIN#0.7473;LIVER CANCER#0.7464;METHIONINE SYNTHASE#0.7372;GLYCINE#0.7354;CYTIDYLYLTRANSFERASE ACTIVITY#0.7277;ALZHEIMER'S DISEASE#0.7274;CELL GROWTH#0.7268;KENNEDY PATHWAY#0.7080;DNA METHYLATION#0.6918;HEPATOCYTE PROLIFERATION#0.6860;METHIONINE ADENOSYLTRANSFERASE#0.6707;SIGNALING PATHWAY#0.6648;S-ADENOSYL-L-HOMOCYSTEINE#0.6510;PROTEIN KINASE C#0.6295;HEPATOCELLULAR CARCINOMA#0.6294;NOREPINEPHRINE#0.6238;CATABOLISM#0.6162;BRAIN DEVELOPMENT#0.6109;FOLIC ACID#0.6056
10401	LUNG CANCER#1.0459;SUMOYLATION#1.0455;CANCER CELL#1.0356;DNA BINDING#1.0328;CELL GROWTH#1.0182;SIGNAL TRANSDUCER#1.0148;SUMO LIGASE#1.0127;GENE EXPRESSION#1.0073;SIGNALING PATHWAY#1.0013;UBIQUITIN#0.9985;TRANSCRIPTION FACTOR#0.9917;PROSTATE CANCER#0.9875;BREAST CANCER#0.9871;MAST CELL#0.9715;APOPTOSIS#0.9599;CELL PROLIFERATION#0.9387;T CELL#0.9210;GROWTH FACTOR#0.8670;CONJUGATION#0.8303;LIGASE ACTIVITY#0.8293;BREAST CANCER CELL#0.8108;TRANSACTIVATION#0.8100;EPITHELIAL CELL#0.8049;LYSINE#0.7930;CELL MIGRATION#0.7923;CELL CYCLE#0.7910;RESVERATROL#0.7696;MELANOCYTE#0.7608;OSTEOCLAST#0.7395;ONCOGENIC#0.7099;PERIPHERAL BLOOD#0.7062;MICROPHTHALMIA#0.7045;TH17 CELL#0.7013;SIGNAL TRANSDUCTION#0.6816;ANDROGEN RECEPTOR#0.6680;IMMUNE RESPONSE#0.6332;B CELL#0.6320;POST-TRANSLATIONAL MODIFICATION#0.6240;APOPTOTIC#0.6155;TUMOR TISSUES#0.6132;MALIGNANT MESOTHELIOMA#0.6108;OSTEOCLAST DIFFERENTIATION#0.6061
10402	SIALYLATION#0.9249;GLYCOSYLATION#0.7782;CELL PROLIFERATION#0.7067;SELECTIN#0.6841;ADJACENT NORMAL TISSUE#0.6429;HEPATOCELLULAR CARCINOMA#0.6321
10403	MIS12 COMPLEX#1.0992;NDC80 COMPLEX#1.0707;MICROTUBULE BINDING#1.0428;KINETOCHORE MICROTUBULE INTERACTION#1.0418;ENDOMETRIAL ADENOCARCINOMA#1.0393;KINETOCHORE#1.0365;KINETOCHORE-MICROTUBULE ATTACHMENT#1.0338;MICROTUBULE PLUS END#1.0320;COMPLEX I#1.0318;SPINDLE CHECKPOINT#1.0297;KINETOCHORE LOCALIZATION#1.0249;M PHASE#1.0238;KINETOCHORE MICROTUBULE#1.0235;ADENOCARCINOMA#1.0224;MICROTUBULE#1.0178;CELL DEATH#1.0168;CANCER CELL#1.0093;MITOTIC CHECKPOINT#1.0082;CENTROMERE#1.0078;CELL PROLIFERATION#1.0077;METAPHASE#1.0017;SPINDLE ASSEMBLY CHECKPOINT#1.0002;SPINDLE MICROTUBULE#0.9990;SPINDLE ASSEMBLY#0.9974;DAM1 COMPLEX#0.9945;SPINDLE POLE#0.9940;CELL CYCLE#0.9922;KINETOCHORE ASSEMBLY#0.9907;APOPTOSIS#0.9903;CELL DIVISION#0.9903;ENDOMETRIAL CANCER#0.9879;ANAPHASE#0.9878;CHROMOSOME CONGRESSION#0.9877;CHROMOSOME SEGREGATION#0.9871;BUDDING#0.9864;MITOSIS#0.9851;MITOTIC SPINDLE#0.9799;GENE EXPRESSION#0.9795;CHROMOSOME MOVEMENT#0.9704;NUCLEAR DIVISION#0.9661;BREAST CANCER#0.9565;MICROTUBULE DYNAMICS#0.9549;CELL GROWTH#0.9517;MEIOSIS#0.9509;RNA INTERFERENCE#0.9457;PROTEIN PROTEIN INTERACTION#0.9326;CHROMATID#0.9240;TRANSCRIPTION FACTOR#0.9224;PROTEIN COMPLEX#0.9167;DYNEIN#0.9057;OOCYTE#0.9016;CENTROSOME#0.8938;HEPATOCELLULAR CARCINOMA#0.8769;ENDOMETRIAL CARCINOMA#0.8657;EPITHELIAL CELL#0.8500;LUNG CANCER#0.8371;MICROTUBULE END#0.8220;CELL CYCLE ARREST#0.8168;MIND COMPLEX#0.8165;MICROTUBULE ASSOCIATED PROTEIN#0.8034;STEM CELL#0.7977;PROPHASE#0.7973;KINESIN#0.7921;POLYMERASE CHAIN REACTION#0.7790;MEIOSIS I#0.7764;SPINDLE POLE BODY#0.7657;GROWTH FACTOR#0.7637;CYCLIN DEPENDENT KINASE#0.7629;PROTEIN KINASE#0.7553;MITOTIC CHROMOSOME#0.7520;OVARIAN#0.7503;OVARIAN CANCER#0.7475;BREAST CANCER CELL#0.7275;PROTEASOME#0.7238;MICROTUBULE DEPOLYMERIZATION#0.7236;METAPHASE CHROMOSOME#0.7124;TUMOR TISSUES#0.7099;ANAPHASE PROMOTING COMPLEX#0.7026;DEPHOSPHORYLATION#0.6807;MITOTIC EXIT#0.6645;STROMAL CELL#0.6547;LEUCINE#0.6494;TUMOR CELLS#0.6455;SIGNALING PATHWAY#0.6442;INTERPHASE#0.6407;ENDOMETRIUM#0.6373;SPINDLE ORGANIZATION#0.6319;PLASMA MEMBRANE#0.6263;SPINDLE FORMATION#0.6107;NUCLEOSOME#0.6075
10404	BLOOD PLASMA#0.7894;DIPEPTIDASE ACTIVITY#0.6766;QUERCETIN#0.6640
10406	ENDOMETRIOSIS#1.0577;ENDOMETRIAL CANCER#1.0454;EPIDIDYMIS#1.0453;CANCER CELL#1.0348;OVARIAN CARCINOMA#1.0301;POSITIVE PREDICTIVE VALUE#1.0299;NEGATIVE PREDICTIVE VALUE#1.0260;OVARIAN#1.0255;EPITHELIAL OVARIAN CANCER#1.0226;OVARIAN CANCER#1.0201;BORDERLINE OVARIAN TUMOR#1.0176;ADENOCARCINOMA#1.0144;ENDOMETRIAL CARCINOMA#1.0068;LYMPH NODE#1.0055;STATISTICALLY SIGNIFICANT DIFFERENCE#1.0029;GENE EXPRESSION#0.9979;OVARIAN CYST#0.9761;RECEIVER OPERATOR CHARACTERISTIC#0.9397;GROWTH FACTOR#0.9270;ASCITES#0.9265;LYMPH NODE METASTASIS#0.9151;CELL PROLIFERATION#0.9123;LUNG CANCER#0.9067;OVARIAN DISEASE#0.9028;POSITIVE LIKELIHOOD RATIO#0.8848;MAGNETIC RESONANCE IMAGING#0.8545;EPITHELIAL CELL#0.8542;DISEASE FREE SURVIVAL#0.8413;APOPTOSIS#0.8370;PERITONEAL CARCINOMA#0.8337;ENDOMETRIOID ENDOMETRIAL CANCER#0.8243;CERVICAL#0.8184;UTERUS#0.8060;GLOMERULAR FILTRATION#0.7984;MENSTRUAL CYCLE#0.7942;LUNG ADENOCARCINOMA#0.7919;AREA UNDER CURVE#0.7724;EPITHELIAL OVARIAN CARCINOMA#0.7578;OVARIES#0.7536;TUMOR CELLS#0.7531;BREAST CANCER#0.7399;RECURRENT OVARIAN CANCER#0.7289;NEGATIVE LIKELIHOOD RATIO#0.7189;HIGH RISK PATIENTS#0.7103;GLOMERULAR FILTRATION RATE#0.7083;SIGNALING PATHWAY#0.7020;ADVANCED OVARIAN CANCER#0.6964;MICROPARTICLE#0.6957;UTERINE CANCER#0.6947;CLEAR CELL CARCINOMA#0.6862;CELL ADHESION#0.6861;CELL CYCLE#0.6834;RESPIRATORY TRACT#0.6730;SALIVARY GLAND#0.6721;OVARIAN CANCER SCREENING#0.6380;PELVIC INFLAMMATORY DISEASE#0.6185
10407	EPIDIDYMIS#1.0905;CAPUT#0.8488;POLYMERASE CHAIN REACTION#0.8158;VARICOCELE#0.6877;HUMAN BETA DEFENSIN#0.6801;SPERMATOZOA#0.6665;MRNA SPLICING#0.6420;GENE EXPRESSION#0.6398
10408	DNA BINDING#1.0938;NEUROBLASTOMA#0.9776;GENE EXPRESSION#0.9048;SEQUENCE SPECIFIC DNA BINDING#0.7337;TRANSCRIPTION FACTOR#0.6168
10409	CALMODULIN BINDING#1.0752;SYNAPTIC VESICLE#1.0383;PROTEIN KINASE C#1.0203;PROTEIN KINASE#1.0166;PLASMA MEMBRANE#0.9818;MEMBRANE MICRODOMAIN#0.9241;TUMOR SUPPRESSOR#0.9153;NEURITE OUTGROWTH#0.9040;AMYLOID PROTEIN#0.8998;GENE EXPRESSION#0.8914;APOPTOSIS#0.8824;NERVE TERMINAL#0.8173;CANCER CELL#0.8166;NEURITE#0.8144;LIPID RAFT#0.7887;REGENERATION#0.7864;INSOLUBLE FRACTION#0.7731;ACTIN CYTOSKELETON#0.7729;PHOSPHATASE ACTIVITY#0.7670;GROWTH CONE#0.7429;NERVOUS SYSTEM#0.7346;CELL CYCLE#0.6967;CELL MEMBRANE#0.6593;TRANSCRIPTION FACTOR#0.6554;CORTICAL CYTOSKELETON#0.6438;PRESYNAPTIC MEMBRANE#0.6389;PROTEIN SYNTHESIS#0.6151;MEMBRANE FRACTION#0.6116;ION CHANNEL#0.6038;CHROMATOID BODY#0.6011;PHOSPHATIDYLSERINE#0.6001
1040	PHOSPHATIDATE CYTIDYLYLTRANSFERASE#1.1631;PHOSPHOLIPASE C#0.8735;ENDOPLASMIC RETICULUM#0.8729;CARDIOLIPIN#0.7801;GENE EXPRESSION#0.7633;CYTIDYLYLTRANSFERASE ACTIVITY#0.7505;PROTEIN KINASE#0.6893;MITOCHONDRIA#0.6300;ER MEMBRANE#0.6291;PHOTOTRANSDUCTION#0.6281;PROTEIN KINASE C#0.6138;PHOSPHOLIPID BIOSYNTHESIS#0.6013
10410	GERM CELL#1.0634;ENDOSOME#1.0445;INFLUENZA A VIRUS#1.0366;INTERFERON STIMULATED GENE#1.0334;HEPATOCELLULAR CARCINOMA#1.0178;VIRAL INFECTION#1.0136;T CELL#1.0095;PLASMA MEMBRANE#0.9869;GENE EXPRESSION#0.9817;LATE ENDOSOME#0.9703;IMMUNE RESPONSE#0.9525;CELL PROLIFERATION#0.9492;CANCER CELL#0.9297;CELL SURFACE#0.9269;MEMBRANE FUSION#0.9155;EPITHELIAL CELL#0.9143;CELL GROWTH#0.9085;SQUAMOUS CELL CARCINOMA#0.9070;ANTIVIRAL RESPONSE#0.9061;VESICULAR STOMATITIS VIRUS#0.8915;HOST CELL#0.8824;IMMUNE SYSTEM#0.8797;VIRION#0.8792;MACROPHAGE#0.8778;VIRAL REPLICATION#0.8724;PRIMORDIAL GERM CELL#0.8639;ASTROCYTE#0.8500;AVIAN INFLUENZA#0.8465;ENDOCYTOSIS#0.8454;CELL CYCLE#0.8405;SIGNALING PATHWAY#0.8334;LYSOSOME#0.8257;INFLUENZA A VIRUSES#0.8122;WEST NILE VIRUS#0.8077;STEM CELL#0.7965;CELL ADHESION#0.7869;LYMPH NODE#0.7737;CYTOPLASM#0.7664;AMPHOTERICIN B#0.7649;STOMATITIS#0.7629;POLYMERASE CHAIN REACTION#0.7618;CELL DEATH#0.7580;COLON CANCER#0.7515;APOPTOSIS#0.7357;INNATE IMMUNE SYSTEM#0.7295;EARLY ENDOSOME#0.7190;HEPATITIS C#0.7100;COLITIS#0.7095;PERIPHERAL BLOOD#0.7042;AVIAN INFLUENZA VIRUS#0.6973;ENDOTHELIAL CELL#0.6893;ULCERATIVE COLITIS#0.6826;BONE MARROW#0.6743;CD8+ T CELL#0.6731;IFN STIMULATED GENES#0.6681;TOLL LIKE RECEPTOR#0.6532;CELL DEVELOPMENT#0.6370;INNATE IMMUNE RESPONSE#0.6368;HEPATITIS C VIRUS#0.6360;DENDRITIC CELL#0.6335;GROWTH FACTOR#0.6296;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6234;MONONUCLEAR CELLS#0.6223;CELL FUSION#0.6181;AMPHOTERICIN#0.6116
10411	CAMP BINDING DOMAIN#1.0746;CANCER CELL#1.0605;CAMKII#1.0569;CARDIOMYOCYTE#1.0473;CAMP BINDING#1.0393;SIGNALING CASCADE#1.0299;MACROPHAGE#1.0292;PLASMA MEMBRANE#1.0282;CELL MIGRATION#1.0280;NUCLEOTIDE EXCHANGE FACTOR#1.0277;RESONANCE ENERGY TRANSFER#1.0276;GUANINE#1.0225;CELL ADHESION#1.0189;FORSKOLIN#1.0184;INSULIN SECRETION#1.0181;PHOSPHOLIPASE C#1.0174;SIGNAL TRANSDUCTION#1.0136;SMOOTH MUSCLE#1.0115;ENDOTHELIAL CELL#1.0114;CYCLIC ADENOSINE MONOPHOSPHATE#1.0114;ADENOSINE MONOPHOSPHATE#1.0108;EXOCYTOSIS#1.0091;SMOOTH MUSCLE CELL#1.0073;MUSCLE CELL#1.0067;CAMP SIGNALING#1.0040;ISOPROTERENOL#1.0032;CYCLIC AMP#1.0009;CELL PROLIFERATION#1.0006;GROWTH FACTOR#0.9998;MYOCYTES#0.9988;SIGNALING PATHWAY#0.9987;APOPTOSIS#0.9984;GENE EXPRESSION#0.9980;PROTEIN KINASE A#0.9975;ADENOSINE#0.9958;CAMP SIGNALLING#0.9956;ADRENERGIC RECEPTOR#0.9939;PROTEIN KINASE#0.9929;PROSTAGLANDIN E2#0.9862;TRANSCRIPTION FACTOR#0.9822;PHOSPHODIESTERASE#0.9816;SIGNALLING PATHWAY#0.9738;LUNG CANCER#0.9738;ION CHANNEL#0.9712;RETINAL ENDOTHELIAL CELLS#0.9621;CAMP RESPONSE ELEMENT#0.9618;ACTIN CYTOSKELETON#0.9594;VASCULAR ENDOTHELIAL CELL#0.9580;SKELETAL MUSCLE#0.9567;RYANODINE RECEPTOR#0.9554;CELL JUNCTION#0.9541;CAMP RESPONSE ELEMENT BINDING#0.9427;MICROTUBULE#0.9382;HUMAN UMBILICAL VEIN#0.9335;PROTEIN KINASE C#0.9335;UMBILICAL VEIN#0.9333;STEM CELL#0.9328;HISTONE DEACETYLASE#0.9309;T CELL#0.9306;BETA CELL#0.9265;CELL CYCLE#0.9256;NUCLEOTIDE BINDING#0.9237;NUCLEAR EXPORT#0.9234;ADENYLATE CYCLASE#0.9217;SPINAL CORD#0.9107;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9088;CYCLIC NUCLEOTIDE BINDING#0.8901;SARCOPLASMIC RETICULUM#0.8885;ISCHEMIA#0.8878;TRANSFORMING GROWTH FACTOR#0.8793;RECEPTOR AGONIST#0.8752;CELL DEATH#0.8744;AIRWAY SMOOTH MUSCLE#0.8709;VASCULAR SMOOTH MUSCLE CELL#0.8676;ADENYLATE#0.8585;BONE MARROW#0.8520;NUCLEAR PORE#0.8518;ANGIOGENESIS#0.8509;RESPONSE TO CAMP#0.8470;HYPOXIA#0.8432;ARRHYTHMIA#0.8418;NUCLEOTIDE BINDING DOMAIN#0.8364;GUANINE EXCHANGE FACTOR#0.8355;RNA INTERFERENCE#0.8345;PROTEIN KINASE B#0.8319;CELL CELL JUNCTION#0.8251;SENSITIZATION#0.8200;EPITHELIAL CELL#0.8155;EXTRACELLULAR MATRIX#0.8121;ENDOTHELIAL GROWTH FACTOR#0.8101;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8101;MITOGEN ACTIVATED PROTEIN#0.8092;SIGNALING MOLECULE#0.8048;CHEMOTAXIS#0.8047;PRO-INFLAMMATORY#0.7972;ENHANCER BINDING PROTEIN#0.7934;ENHANCER BINDING#0.7928;PROSTATE CANCER#0.7882;MONOCYTE#0.7825;KINASE ACTIVITY#0.7801;CELL SURFACE#0.7748;FOCAL ADHESION#0.7669;SMOOTH MUSCLE CELL MIGRATION#0.7634;MUSCLE CELL MIGRATION#0.7631;ADIPOCYTE#0.7624;ENDOTHELIUM#0.7563;ACROSOME REACTION#0.7509;SECRETORY GRANULE#0.7473;NUCLEAR ENVELOPE#0.7455;MESENCHYMAL STEM CELL#0.7433;ADIPOSE TISSUE#0.7415;PHAGOCYTOSIS#0.7399;RECEPTOR ANTAGONIST#0.7388;INFLAMMATORY RESPONSE#0.7387;CILOSTAZOL#0.7364;ANCHORING#0.7281;NEURITE#0.7249;NEURITE OUTGROWTH#0.7232;TOLBUTAMIDE#0.7175;CYCLIC NUCLEOTIDE GATED#0.7146;HIGH FAT DIET#0.7065;ENDOPLASMIC RETICULUM#0.6945;5'-ADENOSINE MONOPHOSPHATE#0.6884;PROGENITOR CELL#0.6850;PHOSPHODIESTERASE INHIBITOR#0.6843;BREAST CANCER#0.6820;CELL FUSION#0.6763;BLOOD VESSEL#0.6756;ACROSOME#0.6734;HEPATIC STELLATE CELL#0.6732;ARTERY#0.6725;MITOCHONDRIA#0.6676;NEUTROPHIL#0.6667;ACTION POTENTIAL#0.6620;DORSAL ROOT GANGLION#0.6583;ADHERENS JUNCTION#0.6546;ROFLUMILAST#0.6496;TRANSENDOTHELIAL ELECTRICAL RESISTANCE#0.6456;NITRIC OXIDE#0.6448;TUMOR NECROSIS FACTOR#0.6444;RELATED PROTEIN 1#0.6304;PROTEIN SYNTHESIS#0.6257;LATE PHAGOSOME#0.6256;LEUKOCYTE#0.6207;UBIQUITIN#0.6198;ALZHEIMER'S DISEASE#0.6161;MECHANISM OF ACTION#0.6141;JUN PHOSPHORYLATION#0.6086;OXYGEN INDUCED RETINOPATHY#0.6073;MICROTUBULE ASSOCIATED PROTEIN#0.6067;CYCLIC NUCLEOTIDE PHOSPHODIESTERASE#0.6052;PLATELET-DERIVED GROWTH FACTOR#0.6034;MUSCLE HYPERTROPHY#0.6026;VASCULAR ENDOTHELIAL CADHERIN#0.6016
10412	MESANGIAL CELL#0.8426;DIABETIC NEPHROPATHY#0.8389;CELL PROLIFERATION#0.7891;CELL CYCLE#0.7308;RIBOSOMAL SUBUNIT#0.6687;RIBOSOME BIOGENESIS#0.6610;NEPHROPATHY#0.6368
10413	SWH PATHWAY#1.0779;TRANSCRIPTION REGULATOR#1.0691;HIPPO SIGNALING CASCADE#1.0661;CARDIOMYOCYTE PROLIFERATION#1.0657;TRANSCRIPTION COACTIVATOR#1.0655;LOCALISATION#1.0543;VERTEPORFIN#1.0531;PDZ BINDING MOTIF#1.0507;NUCLEAR EXPORT#1.0504;PODOCYTE#1.0487;KERATINOCYTE#1.0474;THYROID CANCER#1.0432;TRANSCRIPTION COFACTOR#1.0410;RESPONSE TO OXIDATIVE STRESS#1.0380;DEPHOSPHORYLATION#1.0374;LIVER REGENERATION#1.0374;YES ASSOCIATED PROTEIN#1.0357;AKT SIGNALING#1.0351;TISSUE GROWTH FACTOR#1.0331;CARDIOMYOCYTE#1.0327;COLON CANCER#1.0314;TRANSACTIVATION#1.0301;ACTOMYOSIN#1.0260;OVARIAN CANCER#1.0257;PANCREATIC CANCER#1.0236;MYOBLAST#1.0217;CONNECTIVE TISSUE#1.0212;ACTIN CYTOSKELETON#1.0210;ORGAN GROWTH#1.0207;LUNG ADENOCARCINOMA#1.0201;MYOFIBROBLAST#1.0199;LIVER CANCER#1.0194;HEPATOCELLULAR CARCINOMA CELL#1.0192;STROMAL CELL#1.0187;GLYCOLYSIS#1.0186;DNA BINDING#1.0184;STRESS FIBER#1.0184;DASATINIB#1.0167;OXIDATIVE STRESS RESPONSE#1.0160;CYTOPLASM#1.0159;HYPOXIA#1.0158;S PHASE#1.0155;SENESCENCE#1.0154;OVARIAN#1.0153;PROSTATE CANCER#1.0153;ANCHORAGE INDEPENDENT GROWTH#1.0150;GRANULOSA CELL#1.0148;CELL MOTILITY#1.0144;CONTACT INHIBITION#1.0141;AUTOPHAGY#1.0137;MITOGEN ACTIVATED PROTEIN#1.0128;DISEASE FREE SURVIVAL#1.0127;SKELETAL MUSCLE#1.0125;RNA INTERFERENCE#1.0124;CISPLATIN#1.0120;ORAL SQUAMOUS CELL CARCINOMA#1.0120;DUAL LUCIFERASE REPORTER#1.0116;SMOOTH MUSCLE CELL#1.0108;CHOLANGIOCARCINOMA#1.0094;CERVICAL CANCER#1.0090;FOCAL ADHESION#1.0089;CHONDROCYTE#1.0088;SQUAMOUS CELL CARCINOMA#1.0088;UVEAL MELANOMA#1.0086;NEURAL CREST#1.0078;TRANSCRIPTION ACTIVATOR#1.0077;RECEPTOR TYROSINE KINASE#1.0069;EPITHELIAL TO MESENCHYMAL TRANSITION#1.0068;HEPATIC STELLATE CELL#1.0063;LUNG CANCER#1.0060;FIBROBLAST ACTIVATION#1.0057;EPITHELIAL TO MESENCHYMAL#1.0057;ONCOGENIC#1.0053;TRANSCRIPTION FACTOR#1.0052;MACROPHAGE#1.0050;OSTEOGENESIS#1.0047;BREAST CANCER CELL#1.0046;ENDOTHELIAL CELL#1.0044;MUSCLE CELL#1.0043;ACTIN POLYMERIZATION#1.0043;ADHERENS JUNCTION#1.0042;PANCREATIC DUCTAL ADENOCARCINOMA#1.0036;MORPHOGENESIS#1.0034;KINASE ACTIVITY#1.0032;PROGENITOR CELL#1.0027;MAMMARY EPITHELIAL CELL#1.0024;DRUG RESISTANCE#1.0019;OSTEOBLAST#1.0010;SIGNALING MOLECULE#1.0006;RENAL CELL CARCINOMA#1.0006;EPITHELIAL MESENCHYMAL TRANSITION#1.0006;ANGIOGENESIS#1.0004;STEM CELL PROLIFERATION#1.0003;HIPPO SIGNALING#0.9998;UBIQUITIN#0.9998;CELLULAR LOCALIZATION#0.9996;HIPPO SIGNALING PATHWAY#0.9995;TUMOR TISSUES#0.9994;T CELL#0.9991;TISSUE REGENERATION#0.9989;ESOPHAGEAL CANCER#0.9988;POLYMERASE CHAIN REACTION#0.9981;COLORECTAL#0.9981;COLORECTAL CANCER#0.9980;QUANTITATIVE REAL TIME#0.9980;ADENOCARCINOMA#0.9977;CELL CYCLE ARREST#0.9975;TRANSFORMING GROWTH FACTOR#0.9973;SMOOTH MUSCLE#0.9973;SIGNALING CASCADE#0.9971;CELL DIFFERENTIATION#0.9965;HEPATOCELLULAR CARCINOMA#0.9963;BREAST CANCER#0.9958;CELL JUNCTION#0.9956;PROTEIN PROTEIN INTERACTION#0.9955;CANCER CELL#0.9951;EPITHELIAL CELL#0.9949;REVERSE TRANSCRIPTION#0.9946;REGENERATION#0.9945;HUMAN BREAST CANCER#0.9942;CANCER STEM CELL#0.9938;TIGHT JUNCTION#0.9933;EPIDERMAL GROWTH FACTOR#0.9931;APOPTOTIC#0.9927;TISSUE DEVELOPMENT#0.9927;CELL EXPANSION#0.9925;SIGNALLING PATHWAY#0.9919;CELL GROWTH#0.9918;KERATINOCYTE PROLIFERATION#0.9916;CELL POLARITY#0.9915;BREAST CANCER PATIENTS#0.9915;CELL MIGRATION#0.9915;HYPOXIC#0.9913;CELL ACTIVATION#0.9911;GROWTH FACTOR RECEPTOR#0.9906;CELL ADHESION#0.9897;MESENCHYMAL STEM CELL#0.9892;G1 PHASE#0.9890;GROWTH FACTOR#0.9890;CERVICAL#0.9888;TUMOR SUPPRESSOR#0.9887;SIGNALING PATHWAY#0.9884;GLUTATHIONE#0.9879;KINASE INHIBITOR#0.9878;CELL PROLIFERATION#0.9878;CLEAR CELL RENAL CELL CARCINOMA#0.9866;TISSUE HOMEOSTASIS#0.9860;TUMOR CELLS#0.9857;PLURIPOTENT STEM CELL#0.9857;APOPTOSIS#0.9855;PROTEIN KINASE#0.9849;SUPEROXIDE DISMUTASE#0.9849;PRO-INFLAMMATORY#0.9845;GENE EXPRESSION#0.9838;CELL CYCLE#0.9837;EMBRYONIC STEM CELL#0.9837;LYMPH NODE METASTASIS#0.9832;TYROSINE KINASE INHIBITOR#0.9832;STEM CELL#0.9830;CELL DEATH#0.9828;MAPK SIGNALING#0.9827;SCHWANN CELL#0.9825;LYMPH NODE#0.9823;ONCOGENESIS#0.9820;QUIESCENCE#0.9800;TRANSCRIPTIONAL CONTROL#0.9800;LIVER DEVELOPMENT#0.9796;CELL DIVISION#0.9789;CELL CYCLE REGULATOR#0.9781;B CELL#0.9772;MYOCARDIAL INFARCTION#0.9772;WOUND HEALING#0.9772;INTESTINAL STEM CELL#0.9765;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9763;EXTRACELLULAR MATRIX#0.9754;MITOCHONDRIAL FISSION#0.9741;PROTEASOME#0.9732;TOXICITY#0.9730;SIGNAL TRANSDUCTION#0.9722;THYROID CARCINOMA#0.9712;SRC FAMILY KINASE#0.9708;NUCLEAR IMPORT#0.9707;REACTIVE OXYGEN SPECIES#0.9692;TARGET OF RAPAMYCIN#0.9688;MUTAGENESIS#0.9680;BLOOD VESSEL#0.9676;LIVER DISEASE#0.9673;RAPAMYCIN#0.9668;CANCER STEM-LIKE CELL#0.9665;GASTRIC ADENOCARCINOMA#0.9650;GLUCOSE METABOLISM#0.9638;C TERMINAL DOMAIN#0.9636;MEDULLOBLASTOMA#0.9609;PODOCYTE APOPTOSIS#0.9607;NEURAL STEM CELL#0.9600;BASAL CELL#0.9599;CELL SURFACE#0.9586;STEM CELL MAINTENANCE#0.9568;RHABDOMYOSARCOMA#0.9545;MESOTHELIAL CELL#0.9540;NERVOUS SYSTEM#0.9536;EPIDERMAL STEM CELL#0.9532;IMMUNE RESPONSE#0.9530;SMOOTH MUSCLE ACTIN#0.9529;COMPLEX I#0.9505;METFORMIN#0.9499;SIGNALLING CASCADE#0.9481;GEMCITABINE#0.9479;MAMMARY GLAND#0.9471;REGULATION OF CELL PROLIFERATION#0.9463;STEM CELL LIKE#0.9461;INSULIN-LIKE GROWTH FACTOR#0.9455;LEUCINE#0.9443;PLASMA MEMBRANE#0.9436;HEPATOCYTE PROLIFERATION#0.9427;BUDDING#0.9420;ESTROGEN RECEPTOR#0.9417;ADIPOGENESIS#0.9409;STROMA#0.9406;DETOXIFICATION#0.9401;LYSINE#0.9400;BONE MARROW#0.9396;HYPOXIA INDUCIBLE FACTOR#0.9373;SPHINGOSINE 1 PHOSPHATE#0.9372;TRANSDIFFERENTIATION#0.9369;VASCULAR SMOOTH MUSCLE CELL#0.9356;OSTEOBLAST DIFFERENTIATION#0.9352;MAP KINASE#0.9320;STEM CELL MARKER#0.9290;WNT SIGNALING PATHWAY#0.9289;REPORTER GENE ASSAY#0.9288;EMBRYONAL RHABDOMYOSARCOMA#0.9269;PERIODONTAL LIGAMENT#0.9264;CYTOTOXICITY#0.9263;PROTEIN DEGRADATION#0.9253;INDUCTION OF APOPTOSIS#0.9234;ATHEROSCLEROSIS#0.9199;DEDIFFERENTIATION#0.9161;ORGAN DEVELOPMENT#0.9160;GENE SILENCING#0.9155;ERLOTINIB#0.9148;BRAIN DEVELOPMENT#0.9145;CYTOCHROME C#0.9140;DNA REPLICATION#0.9138;SIMVASTATIN#0.9137;INTESTINAL EPITHELIAL CELL#0.9133;GLUTATHIONE PEROXIDASE#0.9127;ISCHEMIA#0.9125;LUMINAL#0.9115;TROPHECTODERM#0.9109;PROTEASE ACTIVATED RECEPTOR#0.9098;TISSUE DAMAGE#0.9096;MALIGNANT MESOTHELIOMA#0.9088;HEART GROWTH#0.9080;PULMONARY FIBROSIS#0.9060;MESENCHYMAL CELL#0.9050;BONE FORMATION#0.9040;FACTOR I#0.9029;INNER CELL MASS#0.9022;CELLULAR SENESCENCE#0.9022;NUCLEOCYTOPLASMIC SHUTTLING#0.9018;SIGNAL TRANSDUCER#0.9007;CHROMATIN REMODELING#0.9004;OVARIAN FOLLICLE#0.8991;SPINAL CORD#0.8989;BILE DUCT#0.8981;SOFT TISSUE SARCOMA#0.8981;ADJACENT NORMAL TISSUE#0.8968;ENDOMETRIAL CANCER#0.8930;CELL COUNTING KIT#0.8923;COLONY FORMATION ASSAY#0.8900;MITOCHONDRIA#0.8897;ENDOTHELIAL GROWTH FACTOR#0.8897;NEURAL PROGENITOR CELL#0.8894;TERMINAL DIFFERENTIATION#0.8888;CENTRAL NERVOUS SYSTEM#0.8887;KIDNEY DISEASE#0.8848;OOCYTE#0.8839;HEPATOBLASTOMA#0.8836;DUCTAL CELL#0.8832;STEM CELL DIFFERENTIATION#0.8826;GLUTAMINE#0.8810;NEUROGENESIS#0.8789;PANCREATITIS#0.8789;SKIN CANCER#0.8783;PRECURSOR CELL#0.8759;MUSCLE FIBER#0.8759;LUNG FIBROBLASTS#0.8758;EPITHELIAL TISSUES#0.8741;MITOCHONDRIAL MEMBRANE#0.8737;DNA REPAIR#0.8736;VASCULAR CELL#0.8732;IMMUNE CELL#0.8730;NEUROBLASTOMA#0.8721;CHONDROCYTE DIFFERENTIATION#0.8717;SPHINGOSINE#0.8706;MITOSIS#0.8687;MAJOR FACILITATOR SUPERFAMILY#0.8686;ANOIKIS#0.8672;TO TUMOR PROGRESSION#0.8669;SERUM RESPONSE FACTOR#0.8660;ORGANOGENESIS#0.8660;PROTEIN KINASE A#0.8657;ANTI APOPTOSIS#0.8638;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8613;TUBE FORMATION#0.8603;NEURAL TUBE#0.8598;ETHANOL#0.8585;INDUCED PLURIPOTENT STEM CELL#0.8580;LUNG DEVELOPMENT#0.8570;PERIPHERAL NERVE#0.8565;DNA METHYLATION#0.8562;HYPERTENSION#0.8554;RNA BINDING#0.8550;ISCHEMIA REPERFUSION INJURY#0.8549;HISTONE DEACETYLASE#0.8542;CELL CELL JUNCTION#0.8538;HEPATOCYTE DIFFERENTIATION#0.8531;INFLAMMATORY RESPONSE#0.8525;O CELL#0.8525;VIRULENCE#0.8523;CYTOKINESIS#0.8522;DERMAL FIBROBLAST#0.8468;EPITHELIAL CELL PROLIFERATION#0.8442;GLUCOSE UPTAKE#0.8435;CANCER ASSOCIATED FIBROBLASTS#0.8410;OVERALL SURVIVAL RATE#0.8358;KINASE ACTIVATOR#0.8357;EPITHELIAL OVARIAN CANCER#0.8352;ACTIN BINDING#0.8347;MENADIONE#0.8345;DNA DAMAGE RESPONSE#0.8342;OSTEOARTHRITIS#0.8339;FOCAL ADHESION KINASE#0.8338;MALIGNANT PLEURAL MESOTHELIOMA#0.8314;PROTEIN SYNTHESIS#0.8313;MESOTHELIOMA CELL#0.8275;MYOFIBROBLAST DIFFERENTIATION#0.8268;HYPERSENSITIVITY#0.8265;BLASTOCYST FORMATION#0.8263;CELLULAR METABOLISM#0.8255;PRIMORDIAL FOLLICLE ACTIVATION#0.8224;PROTEIN KINASE C#0.8224;REGULATION OF HIPPO SIGNALING#0.8221;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8195;POST-TRANSLATIONAL MODIFICATION#0.8184;VSMC APOPTOSIS#0.8176;FERMENTATION#0.8167;TROPHOBLAST CELL#0.8158;CILIOGENESIS#0.8142;DEUBIQUITINASE#0.8139;PLATELET-DERIVED GROWTH FACTOR#0.8120;TUMOR NECROSIS FACTOR#0.8117;BONE DEVELOPMENT#0.8115;NOTCH SIGNALING PATHWAY#0.8107;SPROUTING ANGIOGENESIS#0.8106;OSTEOCLAST#0.8081;CELL CYCLE CONTROL#0.8066;BREAST CARCINOMA#0.8057;BASAL CELL CARCINOMA#0.8043;CYCLIC AMP#0.8029;CHONDROCYTE PROLIFERATION#0.8020;ADIPOCYTE#0.8006;BLOOD BRAIN BARRIER#0.8004;CELL NUCLEUS#0.8000;ARTERY#0.7999;NORMAL ORAL MUCOSA#0.7995;GRANULOSA CELL PROLIFERATION#0.7993;GLUTAMINE METABOLISM#0.7991;EYE DEVELOPMENT#0.7990;HYPERACTIVE#0.7982;INTERVERTEBRAL DISC DEGENERATION#0.7974;HUMAN MESENCHYMAL STEM#0.7952;CELLULAR GROWTH#0.7946;HYALURONIC ACID#0.7945;KIDNEY DEVELOPMENT#0.7941;OVARIAN SEROUS CYSTADENOCARCINOMA#0.7938;EFFLUX PUMP#0.7935;PROTEIN TYROSINE PHOSPHATASE#0.7928;PULMONARY HYPERTENSION#0.7918;PROTEIN COMPLEX#0.7917;LINES OF EVIDENCE#0.7915;GLIAL CELL#0.7897;TRANSFORMING GROWTH FACTOR BETA#0.7878;INTERVERTEBRAL DISC#0.7877;VEGF SIGNALING#0.7873;ORAL MUCOSA#0.7871;ENDOPLASMIC RETICULUM#0.7864;MYELINATION#0.7864;GAMMA-GLUTAMYLCYSTEINE#0.7864;INTRAHEPATIC CHOLANGIOCARCINOMA#0.7855;ADVANCED GASTRIC CANCER#0.7842;ASTROCYTE#0.7826;LIVER METASTASIS#0.7826;MYOGENESIS#0.7819;GASTRIC MUCOSA#0.7788;DOXORUBICIN#0.7784;MICROVASCULAR ENDOTHELIAL CELL#0.7784;SEQUESTERING#0.7783;PANCREATIC STELLATE CELL#0.7781;OVARIES#0.7780;ACTIN FILAMENT#0.7780;FIN REGENERATION#0.7777;HUMAN EMBRYONIC STEM#0.7771;INHIBITION OF CELL PROLIFERATION#0.7755;RECURRENCE FREE SURVIVAL#0.7741;VASCULAR ENDOTHELIAL CELL#0.7741;MINERALIZATION#0.7732;LUCIFERASE ACTIVITY#0.7729;RNA BINDING PROTEIN#0.7711;M PHASE#0.7704;OSSIFICATION#0.7686;SEROUS CYSTADENOCARCINOMA#0.7685;ANDROGEN RECEPTOR#0.7683;TOOTH MORPHOGENESIS#0.7679;MONOCYTE#0.7670;AGGRESSIVE BEHAVIOR#0.7669;MELANOCYTE#0.7647;HUMAN PERIODONTAL LIGAMENT#0.7620;GEFITINIB#0.7614;EMBRYO DEVELOPMENT#0.7612;CELL WALL#0.7602;EPITHELIAL PROGENITOR CELL#0.7588;BRANCHING MORPHOGENESIS#0.7580;TRANSLATION INITIATION#0.7577;CANCER RELATED DEATH#0.7576;POLYCYSTIC OVARY SYNDROME#0.7569;MYOCARDIUM#0.7569;TROPHOBLAST#0.7539;BONE RESORPTION#0.7512;BONE REMODELING#0.7504;ADENOSINE MONOPHOSPHATE#0.7489;ENDOMETRIOSIS#0.7466;CETUXIMAB#0.7456;ENDOTHELIUM#0.7455;NOTCH LIGAND#0.7447;INHIBITION OF GROWTH#0.7436;UBIQUITIN PROTEIN LIGASE#0.7432;MACROPHAGE POLARIZATION#0.7428;STATIONARY PHASE#0.7423;ENDOMETRIUM#0.7410;LUNG DISEASE#0.7402;PLANAR CELL POLARITY#0.7400;ALANINE#0.7396;LATRUNCULIN B#0.7393;MOUSE EMBRYONIC STEM#0.7389;MECHANISM OF ACTION#0.7386;PAPILLARY CARCINOMA#0.7385;BONE REGENERATION#0.7381;CELL MEMBRANE#0.7377;TIGHT JUNCTION PROTEIN#0.7376;LONGISSIMUS DORSI MUSCLE#0.7371;LIVER PROGENITOR CELL#0.7367;NUCLEOTIDE BIOSYNTHESIS#0.7365;LUNG GROWTH#0.7329;OSTEOCLAST DIFFERENTIATION#0.7328;NUCLEIC ACID#0.7328;HIGH FAT DIET#0.7319;RETINOIC ACID#0.7314;SWI-SNF COMPLEX#0.7310;MITOCHONDRIAL FUSION#0.7276;MICROTUBULE#0.7268;SKELETAL DEVELOPMENT#0.7266;COLITIS#0.7251;IMMUNE SYSTEM#0.7251;ADENOSINE#0.7247;NUCLEAR PORE#0.7246;CELLULAR HOMEOSTASIS#0.7241;REGULATION OF CELLULAR#0.7236;LIPOSARCOMA#0.7226;CELL FATE DETERMINATION#0.7213;NEPHROPATHY#0.7212;FILAMENTOUS ACTIN#0.7206;RENAL FIBROSIS#0.7202;NULL CELL#0.7196;NADPH OXIDASE#0.7184;PACLITAXEL#0.7174;CERIVASTATIN#0.7159;FEED FORWARD LOOP#0.7155;HEART DISEASE#0.7153;METAPLASIA#0.7145;MACULAR DEGENERATION#0.7142;HEPATOMA CELLS#0.7135;ADIPOSE TISSUE#0.7130;B CELL LYMPHOMA#0.7124;CELL ADHESION MOLECULE#0.7094;CD8+ T CELL#0.7086;5 FLUOROURACIL#0.7065;NUCLEAR EXPORT SIGNAL#0.7064;MECHANISMS OF ACTION#0.7054;BASEMENT MEMBRANE#0.7051;PEROXISOME#0.7046;IMMUNE EVASION#0.7025;NEPHRON#0.7014;COLUMNAR#0.7009;INTRACELLULAR LOCALIZATION#0.6998;MELANOMA CELL LINES#0.6989;HEPATIC STELLATE CELL ACTIVATION#0.6977;TRABECULAR MESHWORK CELLS#0.6970;FATTY LIVER DISEASE#0.6962;RESVERATROL#0.6957;FATTY LIVER#0.6951;MUSCULAR DYSTROPHY#0.6948;CARDIOMYOPATHY#0.6945;GERM CELL#0.6945;MIRNA BIOGENESIS#0.6931;GLOMERULAR FILTRATION#0.6929;GLUTATHIONE BIOSYNTHESIS#0.6911;ATP BINDING CASSETTE#0.6890;PROLIFERATING CELL NUCLEAR ANTIGEN#0.6882;COLOBOMA#0.6881;RESPIRATION#0.6880;ATP BINDING#0.6875;ORGAN REGENERATION#0.6874;CHONDROGENESIS#0.6863;BODY WEIGHT RATIO#0.6858;M2 MACROPHAGE#0.6841;YOLK SAC#0.6839;PERIODONTAL LIGAMENT STEM CELL#0.6833;MYOTUBE#0.6827;PRIMARY BREAST CANCER#0.6827;CYCLIC ADENOSINE MONOPHOSPHATE#0.6820;ACINAR CELL#0.6811;FORSKOLIN#0.6806;CELL DEVELOPMENT#0.6802;LIVER CIRRHOSIS#0.6791;RIBOSOMAL PROTEIN#0.6787;NUCLEUS PULPOSUS CELL#0.6785;PROGESTERONE#0.6777;DIABETIC NEPHROPATHY#0.6777;EMBRYONIC HEART#0.6776;CELL MATRIX ADHESION#0.6763;MIDGUT#0.6759;NUCLEUS PULPOSUS#0.6717;REGULATION OF GENE EXPRESSION#0.6712;MYELOID-DERIVED SUPPRESSOR CELL#0.6701;ACTIN BINDING PROTEIN#0.6693;ATP BINDING CASSETTE TRANSPORTER#0.6681;SUMOYLATION#0.6680;TAXOL#0.6679;COLLAGEN TYPE I#0.6671;ADRIAMYCIN#0.6660;ABC TRANSPORTER#0.6659;PROTEIN FOLDING#0.6651;ALKALINE PHOSPHATASE#0.6649;IMATINIB#0.6644;MITOCHONDRIAL DAMAGE#0.6639;TRAMETINIB#0.6612;INSULIN RECEPTOR#0.6604;DILATED CARDIOMYOPATHY#0.6602;ATHEROSCLEROTIC#0.6597;NEURITE OUTGROWTH#0.6575;UBIQUITIN LIGASE COMPLEX#0.6562;QUANTITATIVE REVERSE TRANSCRIPTION#0.6538;ANGIOSARCOMA#0.6523;LEUKEMIA INHIBITORY FACTOR#0.6498;FIBROBLAST GROWTH FACTOR#0.6498;PAPILLARY THYROID CARCINOMA#0.6493;INVASIVE BREAST CANCER#0.6493;DOBUTAMINE#0.6486;POSTTRANSLATIONAL MODIFICATION#0.6472;TRANSCRIPTASE#0.6468;IDIOPATHIC PULMONARY FIBROSIS#0.6448;HUMAN BRONCHIAL EPITHELIAL#0.6440;STEM CELL FACTOR#0.6433;BRONCHIAL EPITHELIAL CELLS#0.6430;PALMITATE#0.6425;OVARIAN FOLLICLE DEVELOPMENT#0.6423;COLORECTAL CARCINOMA#0.6421;PREADIPOCYTE#0.6408;BONE MORPHOGENETIC PROTEIN#0.6397;TUMOR-PROPAGATING CELL#0.6396;ENTEROCYTE#0.6390;HEPATOBLAST#0.6346;MUSCLE STEM CELL#0.6345;LEUKOCYTE#0.6338;ANKYRIN REPEAT DOMAIN#0.6332;OVAL CELL#0.6323;SPECTRIN#0.6299;SALIVARY GLAND CELL DEATH#0.6297;ADULT STEM CELL#0.6292;AXIS ELONGATION#0.6282;GENE EXPRESSION OMNIBUS#0.6276;CYCLIN DEPENDENT KINASE#0.6274;TISSUE REMODELING#0.6262;GERMLINE STEM CELL#0.6261;TUMOR ASSOCIATED MACROPHAGE#0.6249;EWING SARCOMA#0.6243;STEAROYL COA DESATURASE#0.6239;HEART DEVELOPMENT#0.6239;MESENCHYMAL STROMAL CELL#0.6237;PHOTORECEPTOR CELL#0.6237;PHOSPHATASE ACTIVITY#0.6226;GENETICALLY ENGINEERED MOUSE#0.6221;DISEASE SPECIFIC SURVIVAL#0.6219;EPITHELIAL STEM CELL#0.6217;FLUOROURACIL#0.6216;TUMOR INITIATING CELL#0.6213;GROWTH REGULATOR#0.6212;HEPATOCYTE NUCLEAR FACTOR#0.6212;INHIBITION OF APOPTOSIS#0.6210;ENDOTHELIAL CELL PROLIFERATION#0.6207;EMBRYONIC KIDNEY#0.6206;REGULATION OF CELL GROWTH#0.6204;HYDROCEPHALUS#0.6203;FERROPTOSIS#0.6189;OSTEOCYTE#0.6178;TARGET OF RAPAMYCIN COMPLEX#0.6176;NURD COMPLEX#0.6164;LIPOGENESIS#0.6149;GALECTIN#0.6146;MOUSE EMBRYONIC FIBROBLAST#0.6141;DRG DEVELOPMENT#0.6139;OVULATION#0.6127;LIVER DAMAGE#0.6123;MITOCHONDRIAL DNA#0.6116;NEURITE#0.6110;GLOMERULAR FILTRATION BARRIER#0.6103;PROTEIN STABILIZATION#0.6102;ERBB SIGNALING PATHWAY#0.6091;INTRINSICALLY DISORDERED PROTEIN#0.6088;MYELOID LEUKEMIA#0.6086;AUTOPHAGOSOME#0.6064;ENDOSOME#0.6046;UNDIFFERENTIATED PLEOMORPHIC SARCOMA#0.6042;SYNOVIAL SARCOMA#0.6037;AIRWAY SMOOTH MUSCLE#0.6010;FATTY ACID METABOLISM#0.6006;CARDINAL VEIN#0.6003
10415	MODE OF ACTION#0.8089;HUMAN BREAST CANCER#0.8058;BREAST CANCER CELL#0.8018;BREAST CANCER#0.7966;CANCER CELL#0.7951
10417	EXTRACELLULAR MATRIX#1.0655;IMMUNE RESPONSE#1.0250;PROSTATE CANCER#1.0071;MACROPHAGE#0.9765;DIABETIC NEPHROPATHY#0.9487;INNATE IMMUNE RESPONSE#0.8715;OVARIAN CANCER#0.8648;GENE EXPRESSION#0.8582;ANGIOGENESIS#0.8543;AKT SIGNALING#0.8230;HEPATOCELLULAR CARCINOMA#0.8064;FOAM CELL FORMATION#0.7911;REVERSE TRANSCRIPTION#0.7866;INTEGRIN LIGAND#0.7825;QUANTITATIVE REVERSE TRANSCRIPTION#0.7805;NEPHROPATHY#0.7777;POLYMERASE CHAIN REACTION#0.7715;APOPTOSIS#0.7695;INFLAMMATORY CELL#0.7606;CELL MIGRATION#0.7579;GROWTH FACTOR#0.7347;COLORECTAL#0.7020;PROSTATE SPECIFIC ANTIGEN#0.6945;OVARIAN#0.6943;COLON CANCER#0.6939;LYMPH NODE#0.6873;COLORECTAL CANCER#0.6710;ALLERGIC AIRWAYS DISEASE#0.6420;IMMUNE SYSTEM#0.6207;CELL PROLIFERATION#0.6179;CYTOKINE PRODUCTION#0.6097;T LYMPHOCYTE#0.6067;SMOOTH MUSCLE#0.6059;TUMOR CELLS#0.6055;ENDOTHELIAL CELL#0.6006
10418	FLOOR PLATE#1.0728;EXTRACELLULAR MATRIX#1.0305;GENE EXPRESSION#0.9561;SMOOTH MUSCLE#0.9360;NEURITE#0.9165;CELL MIGRATION#0.9058;NERVOUS SYSTEM#0.9055;OVARIAN#0.8792;VASCULAR SMOOTH MUSCLE CELL#0.8662;SMOOTH MUSCLE CELL#0.8631;MUSCLE CELL#0.8622;BASEMENT MEMBRANE#0.8622;AMYLOID PRECURSOR PROTEIN#0.8190;CELL GROWTH#0.8118;CELL ADHESION#0.7734;GROWTH FACTOR#0.7704;PERIODONTAL LIGAMENT#0.7309;SPINAL CORD#0.7209;CELL DEATH#0.6995;OVARIAN CARCINOMA#0.6945;RETINOIC ACID#0.6896;OVARIAN CANCER#0.6891;STEM CELL#0.6824;T CELL#0.6783;APOPTOSIS#0.6627;RETINOIC ACID BINDING#0.6284;NEURITE OUTGROWTH#0.6232;IL-6 PRODUCTION#0.6137;PERIPHERAL NERVE#0.6091;AKT SIGNALING#0.6085
10419	METHYLOSOME#1.1009;B CELL#1.0632;LUNG CANCER#1.0622;METHYLTRANSFERASE ACTIVITY#1.0573;BINDING PROTEIN 1#1.0558;BREAST CANCER#1.0543;HISTONE ARGININE METHYLATION#1.0500;GERM CELL#1.0446;CELL GROWTH#1.0362;CYTOPLASM#1.0359;ARGININE#1.0280;PROTEIN METHYLTRANSFERASE#1.0271;CANCER CELL#1.0270;CELL PROLIFERATION#1.0244;TUMOR SUPPRESSOR#1.0231;PROSTATE CANCER#1.0204;STEM CELL#1.0196;APOPTOSIS#1.0148;SIGNALING PATHWAY#1.0110;CELL CYCLE#1.0091;HEPATOCELLULAR CARCINOMA#1.0069;T CELL#1.0053;DNA BINDING#1.0020;GENE EXPRESSION#1.0013;SMALL NUCLEAR RIBONUCLEOPROTEIN#0.9977;TRANSCRIPTION FACTOR#0.9968;CELL DEATH#0.9940;CHROMATIN REMODELING#0.9907;S-ADENOSYLMETHIONINE#0.9833;PROGENITOR CELL#0.9825;ONCOGENIC#0.9814;LYSINE#0.9763;POST-TRANSLATIONAL MODIFICATION#0.9670;MRNA SPLICING#0.9518;N METHYLTRANSFERASE#0.9432;PROTEIN KINASE#0.9345;EPITHELIAL CELL#0.9339;GROWTH FACTOR#0.9274;HISTONE METHYLATION#0.9194;CELL DEVELOPMENT#0.9174;CELL CYCLE ARREST#0.9031;MANTLE CELL LYMPHOMA#0.9015;HISTONE MODIFICATION#0.8992;HISTONE DEACETYLASE#0.8964;DNA METHYLATION#0.8935;RNA PROCESSING#0.8922;CELL DIFFERENTIATION#0.8892;METHIONINE#0.8832;PRE-MRNA SPLICING#0.8766;DNA REPAIR#0.8749;KINASE BINDING#0.8743;POSTTRANSLATIONAL MODIFICATION#0.8712;UBIQUITIN#0.8649;THYMIDINE#0.8628;ANDROGEN RECEPTOR#0.8543;SIGNAL TRANSDUCTION#0.8527;RNA BINDING#0.8441;PANCREATIC CANCER#0.8409;ACUTE MYELOID LEUKEMIA#0.8401;MYELOID LEUKEMIA#0.8385;SQUAMOUS CELL CARCINOMA#0.8365;MYOGENESIS#0.8356;COMPLEX I#0.8351;GLOBIN#0.8349;SMN COMPLEX#0.8308;GERM CELL DEVELOPMENT#0.8305;OLIGODENDROCYTE DIFFERENTIATION#0.8177;PRIMORDIAL GERM CELL#0.8135;L-METHIONINE#0.8085;RNA SPLICING#0.8056;HISTONE METHYLTRANSFERASE#0.8051;B CELL LYMPHOMA#0.8044;SURVIVAL MOTOR NEURON#0.8002;DNA METHYLTRANSFERASE#0.7998;SKELETAL MUSCLE#0.7967;RNA INTERFERENCE#0.7966;PROTEIN METHYLTRANSFERASE ACTIVITY#0.7959;COLORECTAL CANCER#0.7954;B LYMPHOCYTE#0.7933;PROTEIN METHYLATION#0.7882;FLOWERING#0.7738;COLORECTAL#0.7718;CATALYTIC ACTIVITY#0.7623;CANCER STEM CELL#0.7594;BREAST CANCER CELL#0.7549;ENZYME ACTIVITY#0.7546;HYPOXIA#0.7487;CYCLIN DEPENDENT KINASE#0.7471;DEMETHYLATION#0.7433;LUNG ADENOCARCINOMA#0.7411;VIRAL GENE EXPRESSION#0.7387;APOPTOTIC#0.7327;REGULATION OF GENE EXPRESSION#0.7315;EPITHELIAL MESENCHYMAL TRANSITION#0.7283;GENE SILENCING#0.7255;MYELINATION#0.7214;CELL SURFACE#0.7201;S-ADENOSYL-L-METHIONINE#0.7109;EPSTEIN BARR VIRUS#0.7090;THYMINE#0.6952;LYMPHOMA CELL LINES#0.6853;SENESCENCE#0.6844;KERATINOCYTE DIFFERENTIATION#0.6825;IMMUNE RESPONSE#0.6824;ENDOTHELIAL CELL#0.6754;SIGNALING CASCADE#0.6737;BONE MARROW#0.6688;GLUTATHIONE#0.6672;EMBRYONIC STEM CELL#0.6619;SPLICEOSOME#0.6602;CHROMATIN MODIFICATION#0.6596;MITOSIS#0.6577;MITOGEN ACTIVATED PROTEIN#0.6573;ERYTHROID PROGENITOR#0.6565;TUMOR CELLS#0.6502;METHYLASE#0.6483;HISTONE BINDING#0.6393;CIRCADIAN RHYTHM#0.6320;OLIGODENDROCYTE#0.6249;KERATINOCYTE#0.6219;GROWTH FACTOR RECEPTOR#0.6212;PRMT ACTIVITY#0.6186;RETINOBLASTOMA#0.6148;GLYCINE#0.6124;ADJACENT NORMAL TISSUE#0.6108;OOCYTE#0.6104;ZINC FINGER PROTEIN#0.6097;ADENOCARCINOMA#0.6094;EPITHELIAL TO MESENCHYMAL TRANSITION#0.6076;EPITHELIAL TO MESENCHYMAL#0.6074;HOMOLOGOUS RECOMBINATION#0.6059;QUANTITATIVE REAL TIME#0.6037;COLON CANCER#0.6029;RESPONSE TO TNF#0.6028;LYMPH NODE#0.6011
1041	PEELING#1.0703;HAIR FOLLICLE#1.0523;SKIN DISEASE#1.0520;PSORIASIS#1.0507;DESMOSOME#1.0174;KERATINOCYTE#1.0108;HYPOTRICHOSIS#0.9845;PEELING SKIN SYNDROME#0.9818;SCALP#0.9514;MAJOR HISTOCOMPATIBILITY COMPLEX#0.8745;ATOPIC DERMATITIS#0.8682;LAYER BY LAYER#0.8283;DERMATITIS#0.7975;ROOT SHEATH#0.7948;CELL ADHESION#0.7148;HUMAN LEUKOCYTE ANTIGEN#0.7100;GENE EXPRESSION#0.7061;CELL CELL ADHESION#0.7054;GLYCINE#0.7006;CORNIFIED ENVELOPE#0.6454;CORNIFICATION#0.6382;TIGHT JUNCTION#0.6301;GROWTH FACTOR#0.6271;LEUKOCYTE#0.6014;PROTEIN PROTEIN INTERACTION#0.6001
10420	PROTEIN KINASE#0.9095;SERTOLI CELL#0.6840;KINASE ACTIVITY#0.6751
10421	TRANSCRIPTION FACTOR#1.0743;SIGNALING PATHWAY#1.0212;MAP KINASE#0.9940;T CELL#0.9633;U5 SNRNP#0.8672;PRECURSOR CELL#0.8176;RECEPTOR TYROSINE KINASE#0.7679;SIGNAL TRANSDUCTION#0.7212;CARCINOMA IN SITU#0.6978;VULVA#0.6865;VULVAL DEVELOPMENT#0.6836;DENDRITIC CELL#0.6038;SUMOYLATION#0.6020
10422	CEFTAZIDIME#1.0237;COLISTIN#1.0021;WHOLE GENOME SEQUENCING#0.9984;CLAVULANIC ACID#0.9982;IMIPENEM#0.9938;TIGECYCLINE#0.9925;MEROPENEM#0.9864;ERTAPENEM#0.9807;VIRULENCE#0.9704;POLYMERASE CHAIN REACTION#0.9647;METALLO BETA LACTAMASE#0.9633;CONJUGATION#0.9603;INTENSIVE CARE UNIT#0.9559;GENTAMICIN#0.9456;MINIMUM INHIBITORY CONCENTRATION#0.9403;DRUG RESISTANCE#0.9383;PNEUMONIA#0.9259;AMIKACIN#0.9162;AZTREONAM#0.9107;WASTEWATER TREATMENT PLANT#0.9089;FOSFOMYCIN#0.9017;CEFOTAXIME#0.9010;ANTIMICROBIAL SUSCEPTIBILITY TESTING#0.8947;TAZOBACTAM#0.8815;UBIQUITIN#0.8400;CLAVULANATE#0.8348;CEFEPIME#0.7928;METHYLASE#0.7671;OUTER MEMBRANE#0.7640;CYSTIC FIBROSIS#0.7227;CIPROFLOXACIN#0.7217;PENICILLIN#0.7204;AMPICILLIN#0.7168;URINARY TRACT INFECTION#0.7099;MOLECULAR DYNAMICS SIMULATION#0.6913;GENE EXPRESSION#0.6664;MINIMAL INHIBITORY CONCENTRATION#0.6300;RRNA METHYLTRANSFERASE#0.6265;CEFTRIAXONE#0.6219;CYTOPLASM#0.6189;PHENYL BORONIC ACID#0.6188;PIPERACILLIN#0.6178;RESPIRATORY TRACT#0.6003
10423	MYO-INOSITOL#1.0448;PHOSPHOLIPID BIOSYNTHETIC#1.0268;ENDOPLASMIC RETICULUM#1.0232;PHOSPHATIDYLSERINE#1.0170;PLASMA MEMBRANE#1.0015;ALPHA 1-ANTITRYPSIN#0.9855;PHOSPHOLIPASE C#0.9442;GENE EXPRESSION#0.9266;PHOSPHATIDYLINOSITOL SYNTHESIS#0.9255;CYTIDINE#0.8746;ALPHA 1-ANTITRYPSIN DEFICIENCY#0.8741;PHOSPHOLIPID SYNTHESIS#0.8684;CHOLINE#0.8409;PHOSPHATIDYLETHANOLAMINE#0.8285;CELL MEMBRANE#0.8224;PHOSPHOLIPID BIOSYNTHESIS#0.7866;AUTOPHAGOSOME FORMATION#0.7733;EPITHELIAL CELL#0.7729;ERYTHROCYTE#0.7700;MICROSOME#0.7576;LIVER DISEASE#0.7430;MEMBRANE FRACTION#0.7193;TRANSCRIPTION FACTOR#0.6905;L-SERINE#0.6683;SIGNAL TRANSDUCTION#0.6648;AUXIN TRANSPORT INHIBITOR#0.6537;AUTOPHAGY-INITIATION COMPLEX#0.6447;CARBACHOL#0.6422;POLAR AUXIN TRANSPORT#0.6366;CELL GROWTH#0.6340;ULK COMPLEX#0.6237;AUXIN TRANSPORT#0.6230;RETINAL PIGMENT EPITHELIAL#0.6067
10424	PROGESTERONE#1.0570;CELL CYCLE#1.0278;PROGESTIN#0.9870;ESTROUS CYCLE#0.9615;GRANULOSA CELL#0.9069;OVARIAN#0.8618;GENE EXPRESSION#0.8568;MRNA BINDING#0.7846;OOCYTE#0.7840;BINDING PROTEIN 1#0.7741;ENDOMETRIUM#0.7566;CYTOCHROME P450#0.6765;APOPTOSIS#0.6651;CELL PROLIFERATION#0.6649;OVIDUCT#0.6596;OOCYTE MATURATION#0.6596;STEROID BINDING#0.6584;ENDOMETRIOSIS#0.6555;CANCER CELL#0.6458;MITOTIC SPINDLE#0.6259;MITOSIS#0.6174;MEMBRANE PROGESTIN RECEPTOR#0.6163;OVARIAN CANCER#0.6100
10425	UBIQUITIN#1.0501;MYELOID CELL#0.8802;MYELOID PROGENITOR CELL#0.8543;LIGASE ACTIVITY#0.8461;PROGENITOR CELL#0.8178;BONE MARROW#0.8147;APOPTOSIS#0.6469;MYO-INOSITOL#0.6361;ELECTRON TRANSFER#0.6167;STEM CELL#0.6156;CANCER CELL#0.6146;PROTEASOME#0.6120
10426	GAMMA TUBULIN COMPLEX#1.0986;TUBULIN COMPLEX#1.0858;SPINDLE POLE BODY#1.0743;SPINDLE POLE#1.0640;MICROTUBULE#1.0258;MICROTUBULE NUCLEATION#1.0245;CENTROSOME#0.9228;CELL CYCLE#0.8608;MICROTUBULE ORGANIZING CENTER#0.8092;MITOTIC SPINDLE#0.7791;COMPLEX I#0.7062
10427	COPII VESICLE#1.0844;ENDOPLASMIC RETICULUM#0.9981;PROTEIN COMPLEX#0.9959;COMPLEX II#0.9815;NEURAL TUBE#0.9469;COATED VESICLE#0.8350;COPII-COATED VESICLE#0.7933;ER EXIT#0.7840;PROTEIN TRANSPORT#0.7801;CARGO SELECTION#0.7501;SECRETORY PATHWAY#0.7263;NEURAL TUBE CLOSURE#0.7190;TUBE CLOSURE#0.7188;VESICLE FORMATION#0.6833;TRANSPORT VESICLE#0.6824;PLASMA MEMBRANE#0.6629;BUDDING#0.6550;GOLGI APPARATUS#0.6532;ER TO GOLGI TRANSPORT#0.6399;CELL SURFACE#0.6124
10428	CRANIOFACIAL DEVELOPMENT#1.0055;CHROMATIN ORGANIZATION#0.7251;GENE EXPRESSION#0.7109;CORONARY ARTERY DISEASE#0.6378;ARTERY DISEASE#0.6376;CORONARY ARTERY#0.6356
10430	ENDOPLASMIC RETICULUM#0.7230;PLASMA MEMBRANE#0.6532;CELL PROLIFERATION#0.6294;COLON CANCER#0.6251
104326057	CELL GROWTH#0.7121
104326192	INFLAMMATORY CELL#0.9041;HEMORRHAGE#0.6492
10432	RNA BINDING#1.0445;RNA BINDING PROTEIN#1.0046;CELL DIFFERENTIATION#0.9101;STEM CELL#0.8188;TRANSCRIPTION FACTOR#0.7352;RNA SPLICING#0.7180;PARASPECKLES#0.6202;GENE EXPRESSION#0.6172;CELL PROLIFERATION#0.6125;MESODERM DEVELOPMENT#0.6037
10434	ACYL PROTEIN THIOESTERASE#1.1024;SYNAPTIC FACILITATION#1.0578;SENSITIZATION#1.0282;PALMITOYL#0.9067;TRANSCRIPTION FACTOR#0.8497;LYSOPHOSPHOLIPASE ACTIVITY#0.8375;SERINE HYDROLASE#0.7951;PALMITATE#0.6949;PLASMA MEMBRANE#0.6835;PROTEIN KINASE#0.6813;NITRIC OXIDE#0.6802;PROTEIN PALMITOYLATION#0.6680;ENZYME ACTIVITY#0.6304;DENDRITIC SPINE#0.6137;CHOLINERGIC NEURON#0.6135;OPIOID PEPTIDE#0.6135;LIPID DROPLET#0.6065
104355217	APOPTOSIS#0.6411
104355290	LUNG CANCER#0.8997
10435	MYOBLAST DIFFERENTIATION#0.6866
10436	RIBOSOME BIOGENESIS#1.0600;RIBOSOME#1.0435;CELL DEATH#1.0002;RIBOSOME ASSEMBLY#0.7895;VIRULENCE#0.7804;TRANSCRIPTION FACTOR#0.7682;GENE EXPRESSION#0.7318;RIBOSOMAL SUBUNIT#0.7316;RIBOSOMAL PROTEIN#0.7176;IMMUNE RESPONSE#0.7029;40S RIBOSOMAL SUBUNIT#0.6672;STOMATAL CLOSURE#0.6469;PROTEIN KINASE#0.6174;MITOGEN ACTIVATED PROTEIN#0.6030
10437	ANTIGEN PROCESSING#1.0594;T CELL#1.0439;IMMUNE RESPONSE#1.0165;MAJOR HISTOCOMPATIBILITY COMPLEX#1.0047;ANTIGEN PRESENTING CELLS#0.9507;B CELL#0.9287;ANTIGEN PRESENTATION#0.9192;CD4+ T CELL#0.8980;MACROPHAGE#0.8737;IFN-GAMMA#0.8733;LYSOSOME#0.8275;GENE EXPRESSION#0.8202;GLYCOSYLATION#0.8068;INNATE IMMUNE RESPONSE#0.7899;MELANOCYTE#0.7728;ANTIGEN PROCESSING AND PRESENTATION#0.7560;APOPTOSIS#0.7490;IMMUNE SYSTEM#0.7330;CELL PROLIFERATION#0.6996;SIGNAL PEPTIDE#0.6994;AUTOPHAGY#0.6935;METASTATIC MELANOMA#0.6933;SUPEROXIDE DISMUTASE#0.6604;CROSS PRESENTATION#0.6532;PHAGOSOME#0.6521;MELANOCYTE DIFFERENTIATION#0.6378;CELL RECOGNITION#0.6303;DISEASE FREE SURVIVAL#0.6084;NADPH OXIDASE#0.6049;SIGNAL TRANSDUCER#0.6035;MECHANISM OF ACTION#0.6014
10438	HIGH MOBILITY GROUP#1.0801;EXOSOME#1.0630;DNA BINDING#1.0613;RNA PROCESSING#0.9442;TRANSCRIPTION FACTOR#0.8338;POLY ADP RIBOSE#0.8296;GENE EXPRESSION#0.7876;DNA REPAIR#0.7584;INFLAMMATORY RESPONSE#0.7512;NUCLEAR MATRIX#0.6965;RIBOSE#0.6877;MACROPHAGE#0.6643;PROTEIN KINASE#0.6551;DOUBLE STRAND BREAK#0.6434;RRNA PROCESSING#0.6243;RNA BINDING#0.6186;RNA SURVEILLANCE#0.6057
10439	NEURAL CREST#1.0280;EPITHELIAL CELL#0.9565;NEURAL CREST CELL#0.8401;CELL DEATH#0.8338;NEURAL TUBE#0.8243;OPTIC NERVE#0.8219;CEREBRAL CORTEX#0.8186;NERVOUS SYSTEM#0.7800;NEUROBLASTOMA#0.7484;SIGNALING PATHWAY#0.7458;AMPA RECEPTOR#0.7066;RETINAL GANGLION CELL#0.7058;OLFACTORY BULB#0.7056;EMBRYO IMPLANTATION#0.6408;MEMBRANE FRACTION#0.6227
1043	CAMPATH#1.0499;ALEMTUZUMAB#1.0452;MONOCYTE#1.0450;CELL SURFACE#1.0371;B LYMPHOCYTE#1.0326;EPIDIDYMIS#1.0247;SPERMATOZOA#1.0235;IMMUNE CELL#1.0230;CD4+ T CELL#1.0221;T LYMPHOCYTE#1.0160;SEMINAL PLASMA#1.0127;LEUKOCYTE#1.0063;EOSINOPHIL#1.0061;RITUXIMAB#0.9997;GRAFT VERSUS HOST#0.9978;PLASMA CELL#0.9970;T CELL#0.9968;LYMPHOCYTIC LEUKEMIA#0.9964;B CELL#0.9963;MULTIPLE SCLEROSIS#0.9960;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9960;CYTOTOXICITY#0.9939;DENDRITIC CELL#0.9917;CELL ACTIVATION#0.9892;BONE MARROW#0.9877;STEM CELL#0.9876;FLUDARABINE#0.9873;STEM CELL TRANSPLANTATION#0.9838;RELAPSING-REMITTING MULTIPLE SCLEROSIS#0.9797;PERIPHERAL BLOOD#0.9790;T CELL ACTIVATION#0.9735;CELL SURFACE ANTIGEN#0.9717;IMMUNE SYSTEM#0.9716;RHEUMATOID ARTHRITIS#0.9661;MACROPHAGE#0.9649;GENE EXPRESSION#0.9640;AUTOIMMUNE DISEASE#0.9627;PROLYMPHOCYTIC LEUKEMIA#0.9593;NEUTROPHIL#0.9592;LYSIS#0.9587;HODGKIN'S LYMPHOMA#0.9585;TUMOR CELLS#0.9583;CD8+ T CELL#0.9563;MONONUCLEAR CELLS#0.9537;HEMATOPOIETIC STEM CELL#0.9498;CYCLOPHOSPHAMIDE#0.9348;APOPTOSIS#0.9296;ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY#0.9247;TOXICITY#0.9218;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9208;LYMPHOCYTE ANTIGEN#0.9185;B CELL LYMPHOMA#0.9146;PERIPHERAL T-CELL LYMPHOMA#0.9133;EPITHELIAL CELL#0.9052;MULTIPLE MYELOMA#0.9037;IMMUNE RESPONSE#0.8901;CELL DEATH#0.8889;GLYCOSYLATION#0.8829;MECHANISM OF ACTION#0.8752;LECTIN#0.8733;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8729;INFERTILITY#0.8708;LYMPHOPENIA#0.8670;MINIMAL RESIDUAL DISEASE#0.8643;POLYMERASE CHAIN REACTION#0.8605;CAUDA#0.8552;COMPLEMENT DEPENDENT CYTOTOXICITY#0.8543;PROGENITOR CELL#0.8237;GRANULOCYTE#0.8198;LYMPH NODE#0.8159;STEM CELL TRANSPLANT#0.8128;GROWTH FACTOR#0.8043;CYTOTOXIC T-LYMPHOCYTE#0.8032;O GLYCAN#0.7985;LARGE GRANULAR LYMPHOCYTE#0.7979;T-CELL LEUKEMIA#0.7919;AGGLUTINATION#0.7846;INFERTILE#0.7836;NON HODGKIN LYMPHOMA#0.7769;REGULATORY T CELL#0.7683;AUTOIMMUNITY#0.7640;N GLYCAN#0.7634;PHOSPHOLIPASE C#0.7612;NATALIZUMAB#0.7551;MYELOID LEUKEMIA#0.7474;NERVOUS SYSTEM#0.7446;CUTANEOUS T CELL LYMPHOMA#0.7439;LYMPHOID CELL#0.7434;ANTITHYMOCYTE GLOBULIN#0.7405;LYMPHOPROLIFERATIVE DISEASE#0.7368;TUMOR NECROSIS FACTOR#0.7368;CELL PROLIFERATION#0.7361;SEMEN#0.7348;ANEMIA#0.7303;ANTIGEN BINDING#0.7301;CENTRAL NERVOUS SYSTEM#0.7235;CELL MEMBRANE#0.7204;MACROGLOBULINEMIA#0.7167;EPRATUZUMAB#0.7140;LYMPHOPLASMACYTIC LYMPHOMA#0.7128;MYELOID CELL#0.7073;DACLIZUMAB#0.7052;INTERLEUKIN 2 RECEPTOR#0.7017;NATURAL KILLER CELL#0.6973;LANGERHANS CELL#0.6928;INTERFERON BETA-1A#0.6833;T CELL PROLIFERATION#0.6735;CLADRIBINE#0.6734;ANTI-CD33#0.6726;THROMBOCYTOPENIA#0.6665;MANTLE CELL LYMPHOMA#0.6664;HEMATOPOIETIC CELL#0.6609;ANAPLASTIC LARGE CELL LYMPHOMA#0.6551;ACTIVATED T-CELLS#0.6490;ACTIVATED T CELL#0.6487;ACUTE MYELOID LEUKEMIA#0.6485;MECHANISMS OF ACTION#0.6476;SIGNAL TRANSDUCTION#0.6439;GROWTH FACTOR RECEPTOR#0.6437;ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA#0.6436;LEUCOCYTE DIFFERENTIATION#0.6421;PAROXYSMAL NOCTURNAL HEMOGLOBINURIA#0.6420;NEUTROPENIA#0.6406;HAIRY CELL LEUKEMIA#0.6404;MATURE B-CELL NEOPLASM#0.6321;NOT OTHERWISE SPECIFIED#0.6300;TUMOUR NECROSIS FACTOR#0.6298;ERYTHROCYTE#0.6088;ADULT T-CELL LEUKEMIA#0.6044;METHOTREXATE#0.6039;FOLLICULAR LYMPHOMA#0.6029
10440	OUTER MITOCHONDRIAL MEMBRANE#1.0628;MITOCHONDRIAL OUTER MEMBRANE#1.0482;TOM COMPLEX#1.0435;MITOCHONDRIAL INNER MEMBRANE#1.0410;MITOCHONDRIAL MEMBRANE#1.0336;OUTER MEMBRANE#1.0268;INNER MITOCHONDRIAL MEMBRANE#1.0242;COMPLEX I#1.0089;MITOCHONDRIA#0.9984;PROTEIN IMPORT#0.9982;MITOCHONDRIAL PROTEIN IMPORT#0.9817;TIM23 COMPLEX#0.9785;BREAST CANCER#0.9530;BREAST CANCER CELL#0.9024;MEMBRANE OF MITOCHONDRIA#0.8986;CANCER CELL#0.8955;HEAT SHOCK PROTEIN#0.8373;PROTEIN TRANSPORT#0.6968;ATPASE ACTIVITY#0.6267;MITOCHONDRIAL DNA#0.6179;ORGANELLE#0.6055;HUMAN BREAST CANCER#0.6013
104457406	SMOOTH MUSCLE CELL#0.7409;MUSCLE CELL#0.7401;SMOOTH MUSCLE#0.7390;PULMONARY ARTERIAL HYPERTENSION#0.7303;CELL PROLIFERATION#0.6213
10445	CELL PROLIFERATION#1.0943;CELL CYCLE#1.0738;LUNG CANCER#0.9499;CANCER CELL#0.9406;ONCOGENIC#0.8545;NUCLEOLUS#0.8324;TELOMERASE ACTIVITY#0.7762;APOPTOSIS#0.7681;CELL CYCLE ARREST#0.7678;RRNA TRANSCRIPTION#0.7280;GENE EXPRESSION#0.7196;NSL COMPLEX#0.7078;COLORECTAL#0.7018;COLORECTAL CANCER#0.6960;S PHASE#0.6716;SPINDLE ASSEMBLY#0.6572;SIGNALING PATHWAY#0.6431;TRANSCRIPTION FACTOR#0.6238;EPITHELIAL MESENCHYMAL TRANSITION#0.6207;RENAL CELL CARCINOMA#0.6205;CYCLIN DEPENDENT KINASE#0.6194;HEPATOCELLULAR CARCINOMA#0.6164;PROTEIN KINASE#0.6118;CENTRIOLAR SATELLITE#0.6097
10446	LEUCINE RICH REPEAT#0.7128
104472713	PROSTATE CANCER#0.8544;TUMOR SUPPRESSOR#0.7040;SIGNALING PATHWAY#0.6542
104472715	CELL PROLIFERATION#1.1077;SMALL NUCLEOLAR RNA#1.0629;APOPTOSIS#1.0582;CANCER CELL#1.0462;POLYMERASE CHAIN REACTION#1.0100;COLORECTAL CANCER#0.9523;OVARIAN CANCER#0.9415;CELL CYCLE#0.8351;BREAST CANCER#0.8349;QUANTITATIVE REAL TIME#0.8176;COLORECTAL#0.8066;CERVICAL CANCER#0.8024;CELL MIGRATION#0.7597;OVARIAN#0.7538;DUAL LUCIFERASE REPORTER#0.7290;PANCREATIC CANCER#0.7103;LUNG CANCER#0.7055;ADENOCARCINOMA#0.6549;LUNG ADENOCARCINOMA#0.6335;TRASTUZUMAB#0.6140;CERVICAL#0.6073
104472848	BREAST CANCER#0.9407;TUMOR SUPPRESSOR#0.7215;ACUTE MYELOID LEUKEMIA#0.7064;MYELOID LEUKEMIA#0.7050;CELL PROLIFERATION#0.7037;MULTIPLE MYELOMA#0.6795;PANCREATIC CANCER#0.6781;BREAST CANCER CELL#0.6742;CANCER CELL#0.6674
10447	EPITHELIAL TO MESENCHYMAL TRANSITION#1.0255;EPITHELIAL TO MESENCHYMAL#1.0253;EPITHELIAL MESENCHYMAL TRANSITION#1.0066;BREAST CANCER#0.9680;CANCER CELL#0.9314;GROWTH FACTOR#0.7825;GENE EXPRESSION#0.7696;HUMAN BREAST CANCER#0.7631;LIPID METABOLISM#0.7616;SQUAMOUS CELL CARCINOMA#0.7590;BONE MINERAL DENSITY#0.7156;MELANOMA CELL LINES#0.7124;SIGNALING PATHWAY#0.6969;EPITHELIAL CELL#0.6959;TRANSFORMING GROWTH FACTOR#0.6723;GLUCONEOGENESIS#0.6628;PROTEIN KINASE#0.6281;CELL MIGRATION#0.6157;OBESE#0.6104
10449	COENZYME A#1.0718;FATTY ACID OXIDATION#0.9048;BETA-KETOTHIOLASE DEFICIENCY#0.7801;LIPID METABOLISM#0.7668;GENE EXPRESSION#0.7666;APOPTOSIS#0.6679
1044	INTESTINAL EPITHELIAL CELL#1.0638;INTESTINAL DEVELOPMENT#1.0597;COLON CANCER#1.0483;COLORECTAL#1.0396;CANCER CELL#1.0348;COLORECTAL CANCER#1.0322;TRANSCRIPTION FACTOR#1.0203;METAPLASIA#1.0197;COLORECTAL CARCINOMA#1.0168;EPITHELIAL CELL#1.0125;CELL PROLIFERATION#1.0116;GENE EXPRESSION#0.9975;STEM CELL#0.9959;RETINOIC ACID#0.9876;SMALL INTESTINE#0.9869;ADENOCARCINOMA#0.9791;SIGNALING PATHWAY#0.9784;POLYMERASE CHAIN REACTION#0.9718;CELL DIFFERENTIATION#0.9608;TUMOR SUPPRESSOR#0.9596;CELL GROWTH#0.9590;ENTEROCYTE#0.9461;PRIMITIVE STREAK#0.9257;DNA METHYLATION#0.9122;ELECTROPHORETIC MOBILITY SHIFT#0.8995;ESOPHAGUS#0.8967;ONCOGENIC#0.8713;APOPTOSIS#0.8508;BARRETT'S ESOPHAGUS#0.8481;CELL CYCLE#0.8220;GOBLET CELL#0.8130;GASTRIC MUCOSA#0.7932;CANCER STEM CELL#0.7739;GASTRULATION#0.7738;CELL ADHESION#0.7689;HYPOXIA#0.7553;REVERSE TRANSCRIPTION#0.7451;GUT DEVELOPMENT#0.7397;MORPHOGENESIS#0.7377;ENTEROCYTE DIFFERENTIATION#0.7290;GASTROINTESTINAL TRACT#0.7144;DNA BINDING#0.7079;HINDGUT#0.7002;ALKALINE PHOSPHATASE#0.6920;EMBRYONIC STEM CELL#0.6668;URORECTAL SEPTUM#0.6663;SOMITE#0.6554;CERVICAL#0.6373;GESTATION#0.6352;HEPATOCYTE NUCLEAR FACTOR#0.6318;TRANSACTIVATION#0.6260;SIGNALLING PATHWAY#0.6243;T CELL FACTOR#0.6216;TRANSCRIPTASE#0.6158;CELL CELL ADHESION#0.6156;MESENCHYME#0.6050;GASTRIC EPITHELIAL CELLS#0.6041;T CELL#0.6023;INTESTINAL TRACT#0.6017
10450	CYCLOPHILIN#1.0288;RNA BINDING#0.8174
10451	PROSTATE CANCER#1.0650;NUCLEOTIDE EXCHANGE FACTOR#1.0354;CANCER CELL#1.0326;GUANINE#1.0318;ANDROGEN RECEPTOR#1.0111;CELL PROLIFERATION#1.0100;SIGNALING PATHWAY#1.0074;T CELL#0.9999;BREAST CANCER#0.9923;B CELL#0.9895;GROWTH FACTOR#0.9850;CELL GROWTH#0.9818;GENE EXPRESSION#0.9638;APOPTOSIS#0.9584;OSTEOCLAST#0.9425;SIGNAL TRANSDUCTION#0.8800;CELL MIGRATION#0.8706;BREAST CANCER CELL#0.8701;BONE RESORPTION#0.8519;OVARIAN CANCER#0.8502;ACTIN CYTOSKELETON#0.8378;NEUTROPHIL#0.8237;AKT SIGNALING#0.8100;MACROPHAGE#0.8017;GUANOSINE#0.7597;CELL CYCLE#0.7503;FACTOR I#0.7496;PHAGOCYTOSIS#0.7161;HYPERTENSION#0.7143;PROTEIN KINASE#0.7056;CELL ACTIVATION#0.7036;SIGNALING MOLECULE#0.6973;IMMUNE RESPONSE#0.6916;OPEN ANGLE GLAUCOMA#0.6914;OVARIAN#0.6826;HEMATOPOIETIC CELL#0.6820;EPIDERMAL GROWTH FACTOR#0.6777;STEM CELL#0.6763;B CELL RECEPTOR#0.6628;HYPOXIA#0.6293;GROWTH FACTOR RECEPTOR#0.6292;ANGIOGENESIS#0.6250;MEMBRANE RUFFLE#0.6201;TARGET ORGAN DAMAGE#0.6168;PROTEIN TYROSINE KINASE#0.6160;MAPK SIGNALING#0.6153;PHOSPHOLIPASE C#0.6143;PRIMARY OPEN ANGLE GLAUCOMA#0.6131;DRUG RESISTANCE#0.6119;POLYMERASE CHAIN REACTION#0.6001
10452	GIP COMPLEX#1.1100;SAM COMPLEX#1.1079;POLY T#1.0881;TOM COMPLEX#1.0343;MITOCHONDRIAL OUTER MEMBRANE#1.0328;OUTER MEMBRANE#1.0283;ANION CHANNEL#1.0228;OUTER MITOCHONDRIAL MEMBRANE#1.0182;COMPLEX I#1.0128;GENE EXPRESSION#1.0099;PROTEIN IMPORT#1.0082;MITOCHONDRIAL MEMBRANE#1.0016;ALZHEIMER'S DISEASE#0.9988;MITOCHONDRIAL FUSION#0.9866;MITOCHONDRIA#0.9854;AGE AT ONSET#0.9854;MITOCHONDRIAL PROTEIN IMPORT#0.9777;ORGANELLE#0.9660;APOPTOSIS#0.9633;TOB COMPLEX#0.9536;DEMENTIA#0.9463;MITOCHONDRIAL FISSION#0.9353;MITOPHAGY#0.9277;CYTOCHROME C#0.9169;MITOCHONDRIAL INTERMEMBRANE SPACE#0.9149;AUTOPHAGY#0.9087;MITOCHONDRIAL DNA#0.8884;ENDOPLASMIC RETICULUM#0.8644;CELL DEATH#0.8587;MTDNA#0.8548;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8164;LOW DENSITY LIPOPROTEIN#0.8088;INNER MITOCHONDRIAL MEMBRANE#0.8082;MILD COGNITIVE IMPAIRMENT#0.8070;NEURODEGENERATIVE DISEASE#0.7953;APOPTOTIC#0.7818;PROTEIN COMPLEX#0.7712;MEDIAL TEMPORAL LOBE#0.7638;PARKINSON'S DISEASE#0.7619;MEMBRANE OF MITOCHONDRIA#0.7575;TEMPORAL LOBE#0.7506;UBIQUITIN#0.7476;MAGNETIC RESONANCE IMAGING#0.7420;CONTACT SITE#0.7379;MITOCHONDRIAL INNER MEMBRANE#0.7377;NERVOUS SYSTEM#0.7337;COGNITION#0.7222;AGEING#0.7215;LIPID METABOLISM#0.7065;CHANNEL ACTIVITY#0.7017;HIDDEN MARKOV MODEL#0.6992;TRANSCRIPTION FACTOR#0.6980;BENZODIAZEPINE RECEPTOR#0.6839;FALSE DISCOVERY RATE#0.6810;REACTIVE OXYGEN SPECIES#0.6737;PROTEIN TRANSPORT#0.6704;CHARCOT MARIE TOOTH#0.6571;DNA METHYLATION#0.6543;OXIDATIVE PHOSPHORYLATION#0.6529;AUTOPHAGOSOME#0.6392;CYTOPLASM#0.6333;PROTEIN PROTEIN INTERACTION#0.6312;MITOCHONDRION#0.6296;PROTEIN DEGRADATION#0.6224;CENTRAL NERVOUS SYSTEM#0.6129;AGE RELATED MACULAR DEGENERATION#0.6087;MACULAR DEGENERATION#0.6081;INCLUSION BODY MYOSITIS#0.6048
10454	BINDING PROTEIN 1#1.0675;TRANSFORMING GROWTH FACTOR BETA#1.0147;KINASE ACTIVITY#1.0070;TRANSFORMING GROWTH FACTOR#1.0046;GROWTH FACTOR#1.0000;PROTEIN KINASE#0.9997;MITOGEN ACTIVATED PROTEIN#0.9966;SIGNALING PATHWAY#0.9894;APOPTOSIS#0.9813;T CELL#0.9757;TUMOR NECROSIS FACTOR#0.9693;TOLL LIKE RECEPTOR#0.9645;GENE EXPRESSION#0.9585;PRO-INFLAMMATORY#0.9577;IMMUNE RESPONSE#0.9522;NF-KAPPAB ACTIVATION#0.9522;MAP KINASE#0.9512;CELL DEATH#0.9438;SIGNAL TRANSDUCTION#0.9340;MACROPHAGE#0.9334;INFLAMMATORY RESPONSE#0.9225;CANCER CELL#0.9100;TRANSCRIPTION FACTOR#0.9096;UBIQUITIN#0.8989;INNATE IMMUNITY#0.8852;MAPK SIGNALING#0.8563;STEM CELL#0.8313;ISCHEMIA#0.8153;BREAST CANCER#0.8033;BONE MARROW#0.8025;CELL PROLIFERATION#0.8005;CELL ADHESION#0.7986;IKAPPAB KINASE#0.7853;APOPTOTIC#0.7823;SIGNALING CASCADE#0.7792;MAPK ACTIVATION#0.7743;EPITHELIAL CELL#0.7585;NITRIC OXIDE#0.7301;INNATE IMMUNE RESPONSE#0.6958;APOPTOSIS SIGNALING#0.6919;MOUSE EMBRYONIC FIBROBLAST#0.6846;GLCNAC#0.6825;BREAST CANCER CELL#0.6529;BONE MORPHOGENETIC PROTEIN#0.6371;SIGNALLING PATHWAY#0.6252;P38 MAPK SIGNALING#0.6098;DNA BINDING#0.6012
10455	PEROXISOMAL#0.9179;PROSTATE CANCER#0.8085;PEROXISOME#0.7046;RELATED PROTEIN 1#0.6504
104564224	CELL PROLIFERATION#0.7181;TUBE FORMATION#0.6839
104564225	APOPTOSIS#0.8607;MYOSIN HEAVY CHAIN#0.8126;CARDIOMYOCYTE#0.8001;HYPERTENSION#0.7571;CARDIO VASCULAR DISEASE#0.6830;VASCULAR DISEASE#0.6374
10456	BREAST CANCER#1.0739;MITOCHONDRIA#1.0706;APOPTOTIC#1.0537;CANCER CELL#1.0522;SEVERE CONGENITAL NEUTROPENIA#1.0418;CELL DEATH#1.0388;APOPTOSIS#1.0358;NEUTROPENIA#1.0313;CELL MIGRATION#1.0175;MITOCHONDRIAL MEMBRANE#1.0151;REGULATION OF APOPTOSIS#1.0118;NEUTROPHIL#1.0010;CELL PROLIFERATION#0.9955;ENDOPLASMIC RETICULUM#0.9484;STEM CELL#0.9449;BONE MARROW#0.9443;MITOCHONDRIAL MEMBRANE POTENTIAL#0.9397;CELL MOTILITY#0.9393;B CELL#0.9378;SARCOPLASMIC RETICULUM#0.9152;G-CSF#0.9114;CARDIOMYOCYTE#0.9003;SPECIFIC PROTEIN 1#0.8985;HEMATOPOIETIC CELL#0.8941;ISCHEMIA#0.8910;CEREBRAL ISCHEMIA#0.8837;GRANULOCYTE COLONY STIMULATING FACTOR#0.8777;COLONY-STIMULATING FACTOR#0.8751;SIGNAL TRANSDUCTION#0.8622;BREAST CANCER CELL#0.8589;GRANULOCYTE#0.8487;SQUAMOUS CELL CARCINOMA#0.8461;CYTOPLASM#0.8242;ACTIN CYTOSKELETON#0.8072;LYMPH NODE#0.8032;EPITHELIAL CELL#0.7922;POLYMERASE CHAIN REACTION#0.7871;NERVOUS SYSTEM#0.7694;PERIPHERAL BLOOD#0.7521;CENTRAL NERVOUS SYSTEM#0.7516;PROGENITOR CELL#0.7513;C TERMINAL DOMAIN#0.7512;LYMPH NODE METASTASIS#0.7487;INFLUENZA A VIRUS#0.7441;NUCLEAR EXPORT#0.7412;INDUCED PLURIPOTENT STEM CELL#0.7386;PLURIPOTENT STEM CELL#0.7364;ISCHEMIA REPERFUSION INJURY#0.7344;FOCAL ADHESION#0.6987;TUMOR TISSUES#0.6833;HEAT SHOCK PROTEIN#0.6762;GENE EXPRESSION#0.6742;PROGRAMMED CELL DEATH#0.6568;CISPLATIN#0.6535;PROTEIN KINASE#0.6505;INNER MITOCHONDRIAL MEMBRANE#0.6415;MYELOID LEUKEMIA#0.6369;P BODY#0.6303;REVERSE TRANSCRIPTION#0.6293;CASPASE ACTIVATION#0.6171;RNA INTERFERENCE#0.6128;INDUCTION OF APOPTOSIS#0.6125;NEGATIVE CONTROL GROUP#0.6114;FOCAL CEREBRAL ISCHEMIA#0.6069;MRNA PROCESSING#0.6061;B CELL DEVELOPMENT#0.6029
10457	IRIS DISEASE#1.0812;METASTATIC MELANOMA#1.0558;CELL ADHESION MOLECULE#1.0539;EPITHELIAL CELL#1.0466;CELL ADHESION#1.0402;OSTEOBLAST DIFFERENTIATION#1.0368;OSTEOBLAST#1.0341;BREAST CANCER CELL#1.0301;MACROPHAGE#1.0216;GROWTH FACTOR#1.0166;BREAST CANCER#1.0159;EPIDERMAL GROWTH FACTOR#1.0139;CANCER CELL#1.0078;TRANSCRIPTION FACTOR#1.0068;SIGNALING PATHWAY#0.9989;STEM CELL#0.9988;CELL SURFACE#0.9946;CELL PROLIFERATION#0.9932;TUMOR CELLS#0.9920;ENDOTHELIAL CELL#0.9783;GENE EXPRESSION#0.9751;MELANOSOME#0.9750;T CELL#0.9721;GROWTH FACTOR RECEPTOR#0.9706;DENDRITIC CELL#0.9654;PROSTATE CANCER#0.9653;ANGIOGENESIS#0.9630;EXTRACELLULAR MATRIX#0.9617;HEMATOPOIETIC CELL#0.9601;OSTEOCLAST DIFFERENTIATION#0.9556;INFLAMMATORY RESPONSE#0.9541;OSTEOCLAST#0.9515;BONE MARROW#0.9504;MELANOCYTE#0.9462;REGENERATION#0.9444;APOPTOSIS#0.9415;PARKINSON'S DISEASE#0.9357;SKELETAL MUSCLE#0.9313;KINASE ACTIVITY#0.9219;BONE FORMATION#0.9206;MONOCYTE#0.9175;IMMUNE RESPONSE#0.9171;HUMAN BREAST CANCER#0.9038;AMYOTROPHIC LATERAL SCLEROSIS#0.8980;LATERAL SCLEROSIS#0.8980;CELL GROWTH#0.8979;CELL MIGRATION#0.8838;OSTEOGENESIS#0.8679;LYMPH NODE#0.8642;ADENOCARCINOMA#0.8608;PROTEIN KINASE#0.8604;PERIPHERAL BLOOD#0.8394;SIGNAL TRANSDUCTION#0.8278;MESENCHYMAL STEM CELL#0.8164;MINERALIZATION#0.8091;NERVOUS SYSTEM#0.8066;PANCREATIC CANCER#0.8052;COLORECTAL#0.7990;CELL ACTIVATION#0.7986;CELL DIFFERENTIATION#0.7956;CELL CELL ADHESION#0.7914;POLYMERASE CHAIN REACTION#0.7777;KIDNEY INJURY MOLECULE#0.7719;ALZHEIMER'S DISEASE#0.7689;MELANOMA CELL LINES#0.7686;SQUAMOUS CELL CARCINOMA#0.7644;CELL CYCLE#0.7618;TUMOR SUPPRESSOR#0.7611;APOPTOTIC#0.7580;ALKALINE PHOSPHATASE#0.7577;M2 MACROPHAGE#0.7570;ASTROCYTE#0.7494;CELL MEMBRANE#0.7488;SUBSTANCE P#0.7452;KINASE INHIBITOR#0.7452;GLYCOSYLATION#0.7433;ADIPOSE TISSUE#0.7414;MITOGEN ACTIVATED PROTEIN#0.7409;BONE REGENERATION#0.7350;METASTATIC BREAST CANCER#0.7317;NEURODEGENERATIVE DISEASE#0.7280;KIDNEY DISEASE#0.7270;COLORECTAL CANCER#0.7265;SUBSTANTIA NIGRA#0.7254;REVERSE TRANSCRIPTION#0.7254;TOXICITY#0.7250;CANCER STEM CELL#0.7237;RENAL CELL CARCINOMA#0.7092;PRO-INFLAMMATORY#0.7053;STROMAL CELL#0.7030;CELL DEATH#0.7030;BLOOD VESSEL#0.7030;IMMUNE CELL#0.6967;ENDOTHELIAL GROWTH FACTOR#0.6953;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.6953;MELANIN SYNTHESIS#0.6889;LECTIN#0.6771;NEUTROPHIL#0.6681;BONE RESORPTION#0.6627;PLASMA MEMBRANE#0.6590;CENTRAL NERVOUS SYSTEM#0.6574;LUNG CANCER#0.6519;KERATINOCYTE#0.6509;HEPATOCELLULAR CARCINOMA#0.6481;PROGENITOR CELL#0.6481;B CELL#0.6448;TUMOR ASSOCIATED ANTIGEN#0.6270;INSULIN RECEPTOR#0.6260;SMOOTH MUSCLE#0.6250;TRANSFORMING GROWTH FACTOR#0.6222;MICROPHTHALMIA#0.6211;UVEAL MELANOMA#0.6171;RECEPTOR TYROSINE KINASE#0.6165;DENTAL PULP#0.6127;ISCHEMIA#0.6101;BLOOD COAGULATION#0.6100;HUMAN DENTAL PULP#0.6037;INSULIN-LIKE GROWTH FACTOR#0.6034;ACUTE LIVER INJURY#0.6019
10458	FILOPODIA FORMATION#1.0823;FILOPODIUM FORMATION#1.0789;INSULIN RECEPTOR SUBSTRATE#1.0786;INSULIN RECEPTOR#1.0648;RECEPTOR TYROSINE KINASE#1.0489;ACTIN FILAMENT#1.0280;FILOPODIUM#1.0250;PLASMA MEMBRANE#1.0179;ACTIN CYTOSKELETON#1.0126;ACTIN BUNDLING#0.9897;POSTSYNAPTIC DENSITY#0.9619;LEUCINE#0.9476;CELL MIGRATION#0.9435;DENDRITIC SPINE#0.9323;NMDA RECEPTOR#0.9303;NEURITE#0.8881;WISKOTT ALDRICH SYNDROME#0.8862;ACTIN POLYMERIZATION#0.8832;MISSING IN METASTASIS#0.8785;GROWTH FACTOR#0.8744;SIGNALING PATHWAY#0.8693;ANGIOGENESIS#0.8421;EPITHELIAL CELL#0.8064;GENE EXPRESSION#0.7900;TRANSCRIPTION FACTOR#0.7874;CANCER CELL#0.7872;HOST CELL#0.7818;CELL ADHESION#0.7727;MEMBRANE RUFFLING#0.7172;NEURITE OUTGROWTH#0.7095;MEMBRANE CURVATURE#0.7050;LEADING EDGE OF CELL#0.6510;LOCALISATION#0.6369;CELL MOTILITY#0.6305;RESPONSE TO INSULIN#0.6103;LONG TERM POTENTIATION#0.6047;ACTIN BINDING#0.6012
10459	MITOTIC ARREST DEFICIENT#1.1234;CELL CYCLE#1.0378;DNA REPAIR#1.0327;DNA SYNTHESIS#1.0321;MITOTIC CHECKPOINT#1.0258;DOUBLE STRAND BREAK#1.0249;TRANSLESION SYNTHESIS#1.0206;MUTAGENESIS#1.0158;CELL CYCLE CONTROL#0.9849;ANAPHASE#0.9786;ANAPHASE PROMOTING COMPLEX#0.9694;CANCER CELL#0.9486;HOMOLOGOUS RECOMBINATION#0.9454;SPINDLE ASSEMBLY#0.9285;S PHASE#0.9146;DNA DAMAGE TOLERANCE#0.9132;SPINDLE ASSEMBLY CHECKPOINT#0.9073;MITOTIC SPINDLE#0.9019;CELL CYCLE REGULATION#0.9004;CELL PROLIFERATION#0.8968;DNA REPLICATION#0.8959;C TERMINAL DOMAIN#0.8952;GENE EXPRESSION#0.8448;GERM CELL#0.8257;CISPLATIN#0.8112;MUTAGENIC#0.8057;OVARIAN#0.7986;SPINDLE CHECKPOINT#0.7976;APOPTOSIS#0.7952;TRANSCRIPTION FACTOR#0.7841;DOUBLE-STRAND BREAK REPAIR#0.7786;RENAL CELL CARCINOMA#0.7526;EPITHELIAL CELL#0.7514;DNA DAMAGE RESPONSE#0.7183;OVARIAN CANCER#0.7143;CLASS SWITCH RECOMBINATION#0.7133;REPLICATION FORK#0.7041;BREAST CANCER#0.7027;PRIMORDIAL GERM CELL#0.6984;APC INHIBITOR#0.6739;M PHASE#0.6604;DNA DAMAGE CHECKPOINT#0.6500;PROTEIN PROTEIN INTERACTION#0.6404;CELL CYCLE ARREST#0.6383;CELL DEATH#0.6246;EPITHELIAL OVARIAN CANCER#0.6209;COLORECTAL CANCER#0.6131;SIGNAL TRANSDUCTION#0.6121;HISTONE METHYLTRANSFERASE#0.6121;LASER SCANNING MICROSCOPY#0.6102;COLORECTAL#0.6026
1045	GASTRIC INTESTINAL METAPLASIA#1.0534;INTESTINAL DEVELOPMENT#1.0533;THYROID TRANSCRIPTION FACTOR#1.0462;HEPATOCYTE NUCLEAR FACTOR#1.0385;SMOOTH MUSCLE ACTIN#1.0360;ESTROGEN RECEPTOR#1.0277;SMOOTH MUSCLE#1.0240;PROGESTERONE#1.0238;HINDGUT#1.0232;PROSTATE SPECIFIC ANTIGEN#1.0226;OVARIAN CARCINOMA#1.0218;MYELOID LEUKEMIA#1.0206;TUMOR SUPPRESSOR#1.0200;MIDGUT#1.0190;TROPHOBLAST STEM CELL#1.0180;ACUTE MYELOID LEUKEMIA#1.0173;PROSTATE CANCER#1.0159;REVERSE TRANSCRIPTION#1.0157;INTESTINAL EPITHELIAL CELL#1.0137;ENTEROCYTE#1.0125;ATROPHIC GASTRITIS#1.0111;GASTRIC MUCOSA#1.0110;GOBLET CELL#1.0099;COLON CARCINOMA#1.0097;GASTRITIS#1.0092;YOLK SAC#1.0091;CELL MIGRATION#1.0086;MISMATCH REPAIR#1.0083;BARRETT'S ESOPHAGUS#1.0081;POLYMERASE CHAIN REACTION#1.0075;METAPLASIA#1.0069;COLORECTAL ADENOCARCINOMA#1.0067;TRANSCRIPTION FACTOR#1.0064;LACTASE-PHLORIZIN HYDROLASE#1.0061;TROPHOBLAST#1.0058;NEUROENDOCRINE TUMOR#1.0048;TUMOR CELLS#1.0043;COLON CANCER#1.0043;CANCER CELL#1.0038;GROWTH FACTOR RECEPTOR#1.0038;LYMPH NODE METASTASIS#1.0028;TROPHECTODERM#1.0025;METASTATIC ADENOCARCINOMA#1.0023;BLASTOCYST FORMATION#1.0023;DNA BINDING#1.0019;ELECTROPHORETIC MOBILITY SHIFT#1.0005;BLASTOMERE#1.0002;EPIDERMAL GROWTH FACTOR#0.9992;MORPHOGENESIS#0.9989;COLORECTAL CARCINOMA#0.9978;QUANTITATIVE REAL TIME#0.9977;RECTUM#0.9975;ALKALINE PHOSPHATASE#0.9965;PANCREATIC ADENOCARCINOMA#0.9963;CELL PROLIFERATION#0.9963;ESOPHAGUS#0.9962;LUNG ADENOCARCINOMA#0.9961;RNA INTERFERENCE#0.9956;GASTROINTESTINAL TRACT#0.9940;CELL POLARITY#0.9936;SMALL INTESTINE#0.9936;GASTRIC ADENOCARCINOMA#0.9927;DNA REPAIR#0.9926;BREAST CANCER#0.9922;COLORECTAL CANCER#0.9918;CELL CYCLE#0.9915;GASTRIC EPITHELIAL CELLS#0.9913;SQUAMOUS CELL CARCINOMA#0.9908;GALLBLADDER#0.9905;COLORECTAL#0.9903;PYLORIC GLAND#0.9899;SIGNET RING CELL#0.9897;EPITHELIAL CELL#0.9893;CELL ADHESION#0.9881;ESOPHAGEAL EPITHELIAL CELLS#0.9881;CELL DIFFERENTIATION#0.9880;OVARIAN#0.9877;DNA METHYLATION#0.9875;TIGHT JUNCTION#0.9872;FORMALIN#0.9867;MUCINOUS ADENOCARCINOMA#0.9865;APOPTOSIS#0.9862;VITAMIN D RECEPTOR#0.9858;OVARIAN CANCER#0.9854;DISEASE FREE SURVIVAL#0.9844;URINARY BLADDER#0.9831;INNER CELL MASS#0.9822;TRANSCRIPTASE#0.9814;HIGH GRADE DYSPLASIA#0.9814;METASTATIC COLORECTAL ADENOCARCINOMA#0.9808;APOPTOTIC#0.9807;COLUMNAR#0.9799;GROWTH FACTOR#0.9789;EPIBLAST#0.9787;GERM CELL#0.9785;TROPHOBLAST CELL#0.9784;CERVICAL#0.9776;TERATOMA#0.9776;MUCINOUS NEOPLASM#0.9773;OOCYTE#0.9772;LUNG CANCER#0.9771;CERVICAL ADENOCARCINOMA#0.9770;DUODENUM#0.9770;ANDROGEN RECEPTOR#0.9766;BILE DUCT#0.9763;INTRAHEPATIC CHOLANGIOCARCINOMA#0.9761;GENE EXPRESSION#0.9759;ADENOCARCINOMA#0.9754;SIGNALING PATHWAY#0.9749;BONE MINERAL DENSITY#0.9744;TRANSACTIVATION#0.9743;CHOLANGIOCARCINOMA#0.9736;PLURIPOTENT STEM CELL#0.9735;CELL GROWTH#0.9718;MOUSE EMBRYONIC STEM#0.9711;LYMPH NODE#0.9683;EMBRYO DEVELOPMENT#0.9682;METASTATIC CARCINOMA#0.9678;QUANTITATIVE REVERSE TRANSCRIPTION#0.9674;LIVER METASTASIS#0.9654;TROPHECTODERM CELL#0.9652;PROTEIN KINASE#0.9650;FACTOR I#0.9635;PROGENITOR CELL#0.9634;STEM CELL#0.9629;INTESTINAL MUCOSA#0.9627;BLASTOCYST DEVELOPMENT#0.9604;EMBRYONIC STEM CELL#0.9601;CYTOPLASM#0.9570;EPITHELIAL CELL DIFFERENTIATION#0.9567;ONCOGENIC#0.9525;INTESTINAL CRYPT#0.9520;BONE MARROW#0.9515;GROWTH PATTERN#0.9512;INTESTINAL EPITHELIAL CELL DIFFERENTIATION#0.9486;T CELL#0.9484;BREAST CARCINOMA#0.9481;GI TRACT#0.9454;PANCREATIC DUCTAL ADENOCARCINOMA#0.9454;OESOPHAGUS#0.9452;INTESTINAL STEM CELL#0.9451;COLORECTAL ADENOMA#0.9447;STEM CELL MARKER#0.9431;GASTRIC EPITHELIUM#0.9409;HEPATOCELLULAR CARCINOMA#0.9399;METASTATIC COLORECTAL CARCINOMA#0.9394;FERTILIZATION#0.9379;HUMAN INTESTINAL EPITHELIAL#0.9379;FIBROBLAST GROWTH FACTOR#0.9374;SMALL CELL CARCINOMA#0.9351;NEUROENDOCRINE CARCINOMA#0.9340;BLADDER ADENOCARCINOMA#0.9307;FOREGUT#0.9302;GUT DEVELOPMENT#0.9287;SIGNALLING PATHWAY#0.9281;CELL CELL ADHESION#0.9278;PANCREATIC CANCER#0.9270;ALPHA CELL#0.9264;EOSIN#0.9250;COLON ADENOCARCINOMA#0.9234;LARGE INTESTINE#0.9213;GASTRIC TISSUE#0.9207;INTESTINAL TRACT#0.9192;RETINOIC ACID#0.9183;HISTONE MODIFICATION#0.9152;INVASIVE CARCINOMA#0.9138;STROMA#0.9138;DEOXYCHOLIC ACID#0.9138;CELL DEATH#0.9107;HIPPO SIGNALING#0.9078;ADVANCED GASTRIC CANCER#0.9058;HUMAN EMBRYONIC STEM#0.8992;METASTATIC COLORECTAL CANCER#0.8962;BONE MORPHOGENETIC PROTEIN#0.8943;GERM CELL TUMORS#0.8927;ENTEROCYTE DIFFERENTIATION#0.8921;MITOGEN ACTIVATED PROTEIN#0.8910;PSEUDOMYXOMA PERITONEI#0.8910;ENDOCRINE CELL#0.8910;LYMPH NODE METASTASES#0.8901;LUNG CARCINOMA#0.8868;GASTRO#0.8840;HISTONE ACETYLATION#0.8814;JEJUNUM#0.8799;WNT SIGNALING PATHWAY#0.8795;NEURAL TUBE#0.8789;BETA CELL#0.8777;DEMETHYLATION#0.8776;CERVIX#0.8758;KERATINOCYTE#0.8758;TRANSCRIPTION FACTOR BINDING#0.8748;TUMOR TISSUES#0.8746;COLORECTUM#0.8732;COLITIS#0.8722;ESOPHAGITIS#0.8672;CYCLIN DEPENDENT KINASE#0.8668;ACID PHOSPHATASE#0.8667;OSTEOPOROSIS#0.8627;ABDOMINAL PAIN#0.8576;TRANSDIFFERENTIATION#0.8575;KINASE INHIBITOR#0.8555;UTERUS#0.8548;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8544;FINE NEEDLE ASPIRATION#0.8542;HATCHING#0.8536;CELL DIVISION#0.8533;LYSINE#0.8532;CHROMATIN REMODELING#0.8522;CANCER STEM CELL#0.8490;PANCREATIC ISLET#0.8478;NEOPLASTIC TISSUES#0.8444;HISTONE DEACETYLASE#0.8443;PLACENTAL DEVELOPMENT#0.8416;COENZYME A#0.8372;THYROID CARCINOMA#0.8339;S PHASE#0.8313;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8312;GASTROESOPHAGEAL REFLUX DISEASE#0.8311;ENDOTHELIAL GROWTH FACTOR#0.8311;BRUSH BORDER#0.8307;LUCIFERASE ACTIVITY#0.8301;TUBERCULOSIS#0.8277;TWO-CELL STAGE#0.8276;OVARIES#0.8271;INFLAMMATORY BOWEL DISEASE#0.8268;TUBULAR ADENOCARCINOMA#0.8250;FARNESOID X RECEPTOR#0.8240;WORLD HEALTH ORGANIZATION#0.8229;POSITIVE PREDICTIVE VALUE#0.8226;TUMOR NECROSIS FACTOR#0.8218;PROTEASOME#0.8215;BASAL CELL#0.8212;POSITRON EMISSION TOMOGRAPHY#0.8209;FRAGMENT LENGTH POLYMORPHISM#0.8190;QUANTITATIVE REVERSE TRANSCRIPTASE#0.8113;METHYLATION SPECIFIC PCR#0.8111;ASCITES#0.8078;EARLY GASTRIC CANCER#0.8075;ENTEROENDOCRINE CELL#0.8068;GASTRIC GLAND#0.8059;ENDOMETRIUM#0.8025;HYPOXIA#0.7990;GALLBLADDER CARCINOMA#0.7980;5-AZA-2'-DEOXYCYTIDINE#0.7947;2'-DEOXYCYTIDINE#0.7942;INDUCED PLURIPOTENT STEM CELL#0.7933;GESTATION#0.7928;DNA METHYLTRANSFERASE#0.7907;IMMUNE RESPONSE#0.7864;ADENOSQUAMOUS CARCINOMA#0.7860;PULMONARY TUBERCULOSIS#0.7824;HAMARTOMA#0.7818;ESOPHAGEAL CANCER#0.7795;CAMP RESPONSE ELEMENT BINDING#0.7790;CAMP RESPONSE ELEMENT#0.7775;CELL MEMBRANE#0.7769;HUMAN GASTRIC CARCINOMA#0.7748;NITRIC OXIDE#0.7719;INVASIVE DUCTAL CARCINOMA#0.7703;ADENOMATOUS POLYPOSIS COLI#0.7699;BREAST CANCER CELL#0.7691;FATTY ACID BINDING#0.7651;MESENCHYME#0.7594;SIGNET RING CELL ADENOCARCINOMA#0.7583;EPITHELIAL MESENCHYMAL TRANSITION#0.7552;STATISTICALLY SIGNIFICANT DIFFERENCE#0.7543;IN VITRO FERTILIZED#0.7516;ACUTE LEUKEMIA#0.7515;SIGNAL TRANSDUCTION#0.7512;CISPLATIN#0.7495;CELL FATE SPECIFICATION#0.7489;DIGESTIVE TRACT#0.7480;ENDOMETRIAL ADENOCARCINOMA#0.7459;YEAR SURVIVAL RATE#0.7448;CYSTIC TERATOMA#0.7430;PROSTATE ADENOCARCINOMA#0.7428;TROPHOBLAST GIANT CELLS#0.7416;MEDULLARY CARCINOMA#0.7414;ENDOMETRIAL CARCINOMA#0.7403;DIGESTION#0.7361;INGUINAL LYMPH NODE#0.7353;HEPATOID ADENOCARCINOMA#0.7334;DIED OF DISEASE#0.7330;PANETH CELL#0.7327;GALLBLADDER CANCER#0.7325;LUMINAL#0.7250;MATURE CYSTIC TERATOMA#0.7216;PAPILLARY THYROID CARCINOMA#0.7179;RESPONSE TO BILE ACID#0.7169;ENDODERM CELL#0.7143;MUCOUS#0.7120;AXIS ELONGATION#0.7096;GASTRULATION#0.7064;CYSTADENOMA#0.7047;GOBLET CELL METAPLASIA#0.7037;PANCREATIC CARCINOMA#0.7036;EXTRACELLULAR MATRIX#0.7007;RNA BINDING#0.6987;MACROPHAGE#0.6950;OVARIAN MUCINOUS ADENOCARCINOMA#0.6949;HISTOGENESIS#0.6945;PERITONEUM#0.6937;NORMAL ESOPHAGEAL MUCOSA#0.6928;TYPE 2 DIABETES#0.6926;SESSILE SERRATED ADENOMA#0.6922;INFLAMMATORY RESPONSE#0.6915;PERIPHERAL BLOOD#0.6904;METHYLATION SPECIFIC POLYMERASE#0.6902;NOTCH SIGNALING PATHWAY#0.6883;CELL ADHESION MOLECULE#0.6879;STOMACH CANCER#0.6850;COLON EPITHELIUM#0.6846;B CELL#0.6844;PERIAMPULLARY ADENOCARCINOMA#0.6830;NEURAL TUBE CLOSURE#0.6829;TUBE CLOSURE#0.6828;EPITHELIAL CELL MIGRATION#0.6825;CELL POLARIZATION#0.6818;CARCINOMA OF UNKNOWN PRIMARY#0.6814;RNA BINDING PROTEIN#0.6810;CROHN'S DISEASE#0.6804;PROTEIN BINDING#0.6800;SURFACE EPITHELIUM#0.6782;CELL SURFACE#0.6770;INTESTINAL TYPE CARCINOMA#0.6748;ULCERATIVE COLITIS#0.6711;NEGATIVE PREDICTIVE VALUE#0.6678;ANTISENSE RNA#0.6669;INTESTINAL CANCER#0.6660;TAIL BUD#0.6643;LYMPH NODE INVOLVEMENT#0.6583;EMBRYONAL CARCINOMA#0.6538;GENE SILENCING#0.6530;EPITHELIAL CELL PROLIFERATION#0.6493;MESOTHELIAL CELL#0.6483;PELVIS#0.6463;REGENERATION#0.6462;URORECTAL SEPTUM#0.6461;TELOMERASE REVERSE TRANSCRIPTASE#0.6454;HOMOLOGOUS RECOMBINATION#0.6415;PHOSPHATASE ACTIVITY#0.6411;ASCENDING COLON#0.6400;MUTAGENESIS#0.6357;GENE REGULATORY NETWORK#0.6324;BILIARY TRACT#0.6312;EPIBLAST CELL#0.6292;WEIGHT LOSS#0.6288;MAGNETIC RESONANCE IMAGING#0.6285;BIOTIN#0.6282;5 FLUOROURACIL#0.6246;COLON MUCOSA#0.6240;ACINAR CELL#0.6236;FLUOROURACIL#0.6231;NOT OTHERWISE SPECIFIED#0.6227;IN VITRO PRODUCED#0.6224;EXTRAMAMMARY PAGET'S DISEASE#0.6218;HUMAN BREAST CANCER#0.6189;URETHRA#0.6183;RELAPSE FREE SURVIVAL#0.6175;EPITHELIUM DEVELOPMENT#0.6147;PRC2 COMPLEX#0.6108;CELL CYCLE ARREST#0.6103;INSULIN-LIKE GROWTH FACTOR#0.6090;MAINTENANCE OF PLURIPOTENCY#0.6089;RENAL CELL CARCINOMA#0.6088;BASEMENT MEMBRANE#0.6087;CHRONIC CHOLANGITIS#0.6082;BUDDING#0.6074;CYSTITIS#0.6069;T CELL FACTOR#0.6066;CARCINOGEN#0.6052;MEDIAN SURVIVAL TIME#0.6028;DISEASE SPECIFIC SURVIVAL#0.6026
10460	CELL DEATH#1.0557;SPINDLE ASSEMBLY#1.0500;CENTROSOME#1.0490;CANCER CELL#1.0454;MITOTIC SPINDLE#1.0439;MICROTUBULE#1.0368;ONCOGENIC#1.0255;CELL CYCLE#1.0167;SIGNALING PATHWAY#1.0028;MITOTIC SPINDLE ASSEMBLY#1.0000;MITOSIS#0.9966;CELL PROLIFERATION#0.9941;SPINDLE POLE#0.9903;KINETOCHORE#0.9898;LUNG CANCER#0.9517;GROWTH FACTOR#0.9271;MICROTUBULE DYNAMICS#0.9223;GENE EXPRESSION#0.9144;CELL ADHESION MOLECULE#0.9137;CELL ADHESION#0.9116;NEURAL CELL#0.9100;FIBROBLAST GROWTH FACTOR#0.9072;APOPTOSIS#0.9008;BREAST CANCER#0.8993;GROWTH FACTOR RECEPTOR#0.8976;EPITHELIAL MESENCHYMAL TRANSITION#0.8932;CERVICAL CANCER#0.8929;SQUAMOUS CELL CARCINOMA#0.8630;CLATHRIN COMPLEX#0.8426;STEM CELL#0.8394;CELL GROWTH#0.8392;CERVICAL#0.8389;CELL DIVISION#0.8242;MICROTUBULE PLUS END#0.8221;KINASE ACTIVITY#0.8203;CHROMOSOME SEGREGATION#0.8164;PACLITAXEL#0.8051;KINASE INHIBITOR#0.8041;CLATHRIN HEAVY CHAIN#0.7996;MICROTUBULE ASSEMBLY#0.7925;LUNG ADENOCARCINOMA#0.7820;SPINDLE MICROTUBULE#0.7714;DISEASE FREE SURVIVAL#0.7665;TRANSCRIPTION FACTOR#0.7633;OVARIAN#0.7550;OVARIAN CANCER#0.7526;KINETOCHORE MICROTUBULE#0.7309;ADENOCARCINOMA#0.7248;OOCYTE#0.7245;SPINDLE FORMATION#0.7177;MICROTUBULE NUCLEATION#0.7059;EPITHELIAL CELL#0.7002;POLYMERASE CHAIN REACTION#0.6996;PROGENITOR CELL#0.6857;NUCLEAR ENVELOPE#0.6855;AKT SIGNALING#0.6796;METAPHASE#0.6676;MULTIPLE MYELOMA#0.6636;MITOTIC SPINDLE ORGANIZATION#0.6441;URINARY BLADDER#0.6414;SPINDLE ORGANIZATION#0.6386;CELL CYCLE ARREST#0.6354;RNA INTERFERENCE#0.6321;MICROTUBULE ASSOCIATED PROTEIN#0.6287;SOFT TISSUE SARCOMA#0.6032;MESENCHYMAL CELL#0.6008;DNA DAMAGE RESPONSE#0.6005
10461	TYROSINE KINASE RECEPTOR#1.0586;APOPTOTIC CELL CLEARANCE#1.0493;EFFEROCYTOSIS#1.0447;PROTEIN TYROSINE KINASE#1.0361;B CELL#1.0349;RECEPTOR TYROSINE KINASE#1.0319;ACUTE LYMPHOBLASTIC LEUKEMIA#1.0295;TYROSINE KINASE INHIBITOR#1.0284;MER A#1.0282;PROTEIN KINASE#1.0227;RETINITIS PIGMENTOSA#1.0222;PHAGOCYTOSIS#1.0206;RETINITIS#1.0201;GROWTH ARREST SPECIFIC#1.0177;PHOTORECEPTOR OUTER SEGMENT#1.0147;ONCOGENIC#1.0143;INNATE IMMUNE RESPONSE#1.0142;RETINAL PIGMENT EPITHELIUM#1.0136;RETINAL DEGENERATION#1.0130;CANCER CELL#1.0127;KINASE INHIBITOR#1.0121;MONOCYTE#1.0120;APOPTOTIC#1.0108;MACROPHAGE#1.0100;RETINAL PIGMENT EPITHELIAL#1.0094;PHOSPHATIDYLSERINE#1.0081;BONE MARROW#1.0060;IMMUNE RESPONSE#1.0052;CELL PROLIFERATION#1.0025;EPITHELIAL CELL#1.0022;INFLAMMATORY RESPONSE#1.0003;PHOTORECEPTOR CELL#1.0003;T CELL#0.9991;GROWTH FACTOR#0.9990;VITAMIN K#0.9988;SIGNALING PATHWAY#0.9959;DENDRITIC CELL#0.9953;IMMUNE CELL#0.9946;APOPTOSIS#0.9934;STEM CELL#0.9931;CELL DEATH#0.9923;GENE EXPRESSION#0.9906;ATHEROSCLEROSIS#0.9903;TUMOR CELLS#0.9869;CELL ADHESION#0.9862;SIGNAL TRANSDUCTION#0.9804;LUNG CANCER#0.9791;NEUTROPHIL#0.9790;SERTOLI CELL#0.9777;PLATELET AGGREGATION#0.9680;CELL SURFACE#0.9650;ACUTE LUNG INJURY#0.9637;ENDOTHELIAL CELL#0.9623;AUTOIMMUNITY#0.9606;CONE DYSTROPHY#0.9596;CELL ACTIVATION#0.9556;PIGMENT EPITHELIAL CELL#0.9538;RETINAL PIGMENT EPITHELIAL CELLS#0.9508;TRANSCRIPTION FACTOR#0.9493;CYTOKINE PRODUCTION#0.9483;GLIOBLASTOMA MULTIFORME#0.9471;FOCAL ADHESION#0.9464;NERVOUS SYSTEM#0.9448;TOLL LIKE RECEPTOR#0.9439;BREAST CANCER#0.9422;THYMOCYTE#0.9415;ANGIOGENESIS#0.9405;PRO-INFLAMMATORY#0.9372;KINASE ACTIVITY#0.9354;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9342;MITOGEN ACTIVATED PROTEIN#0.9340;LUPUS ERYTHEMATOSUS#0.9340;NECROTIC#0.9309;FOCAL ADHESION KINASE#0.9274;AUTOIMMUNE DISEASE#0.9267;MULTIPLE SCLEROSIS#0.9244;LIVER DISEASE#0.9216;PLATELET ACTIVATION#0.9164;GROWTH FACTOR RECEPTOR#0.9081;CELL ADHESION MOLECULE#0.9022;THROMBOSIS#0.9019;CELL GROWTH#0.8983;TUMOR NECROSIS FACTOR#0.8891;CENTRAL NERVOUS SYSTEM#0.8798;MAP KINASE#0.8770;INNATE IMMUNITY#0.8766;ALVEOLAR MACROPHAGE#0.8763;PROTEIN KINASE C#0.8760;RETINAL DISEASE#0.8741;ATHEROSCLEROTIC#0.8671;EPIDERMAL GROWTH FACTOR#0.8623;ACUTE MYELOID LEUKEMIA#0.8570;MYELOID LEUKEMIA#0.8556;ENGULFMENT OF APOPTOTIC CELL#0.8555;FATTY LIVER DISEASE#0.8370;FATTY LIVER#0.8355;MONOCYTE DERIVED MACROPHAGE#0.8341;IMMUNE SYSTEM#0.8291;PROSTATE CANCER#0.8254;POLYMERASE CHAIN REACTION#0.8204;PERIPHERAL BLOOD#0.8090;ADENO ASSOCIATED VIRUS#0.8068;GERMINAL CENTER#0.8066;HEPATITIS C#0.8061;PLASMA MEMBRANE#0.8002;MYELOID CELL#0.7960;T CELL ACTIVATION#0.7956;LIVER X RECEPTOR#0.7930;MACULAR DEGENERATION#0.7862;WOUND HEALING#0.7810;SIGNALING MOLECULE#0.7804;TRANSFORMING GROWTH FACTOR#0.7743;GERM CELL#0.7701;AGE RELATED MACULAR DEGENERATION#0.7689;CELL MIGRATION#0.7617;RECEPTOR LIGAND#0.7498;INFLAMMATORY CELL#0.7468;TISSUE HOMEOSTASIS#0.7454;CELL CYCLE#0.7430;LEBER CONGENITAL AMAUROSIS#0.7424;ATP BINDING#0.7413;AUTOPHAGY#0.7322;SCAVENGER RECEPTOR#0.7299;SIGNALING CASCADE#0.7257;MACROPHAGE ACTIVATION#0.7235;MYOCARDIAL INFARCTION#0.7230;REVERSE TRANSCRIPTION#0.7220;RHEUMATOID ARTHRITIS#0.7171;MAMMARY GLAND#0.7071;CD8+ T CELL#0.7033;CYTOKINE SECRETION#0.6988;PHAGOSOME#0.6958;VIRAL INFECTION#0.6958;CELL MEMBRANE#0.6941;DEXAMETHASONE#0.6939;LEUKOCYTE#0.6935;PLURIPOTENT STEM CELL#0.6889;ASTROCYTE#0.6842;ANTI APOPTOSIS#0.6761;INDUCED PLURIPOTENT STEM CELL#0.6754;HEMATOPOIETIC CELL#0.6722;COAGULATION#0.6719;AMAUROSIS#0.6686;PROTEIN KINASE B#0.6686;ISCHEMIA#0.6667;EXTRACELLULAR REGION#0.6563;NEPHRITIS#0.6525;BLINDNESS#0.6500;OLIGODENDROCYTE#0.6442;MACROPHAGE POLARIZATION#0.6373;PATTERN RECOGNITION RECEPTOR#0.6320;FACTOR I#0.6271;HEPATITIS C VIRUS#0.6264;REACTIVE OXYGEN SPECIES#0.6258;NEURAL CELL#0.6252;DRUG RESISTANCE#0.6138;TUMOR ASSOCIATED MACROPHAGE#0.6101;B CELL ACTIVATION#0.6087;RNA INTERFERENCE#0.6027;M2 MACROPHAGE#0.6026;MARGINAL ZONE B CELL#0.6022;LIPID METABOLISM#0.6005
10462	LECTIN#1.0585;MACROPHAGE#1.0388;BREAST CANCER#1.0062;T CELL#1.0027;DENDRITIC CELL#0.9665;STEM CELL#0.9222;PERIPHERAL BLOOD#0.9068;TRANSCRIPTION FACTOR#0.8901;IMMUNE RESPONSE#0.8774;PROVIRUS#0.8454;GENE EXPRESSION#0.8100;BREAST CANCER PATIENTS#0.8010;M2 MACROPHAGE#0.7817;GERM CELL#0.7791;CANCER CELL#0.7414;MONOCYTE#0.7321;MONONUCLEAR CELLS#0.7141;ADIPOSE TISSUE#0.7123;CYTOKINE SECRETION#0.6911;TRANSCRIPTASE#0.6669;GLYCOSYLATION#0.6452;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6393;CYTOKINE PRODUCTION#0.6294;MANNOSE RECEPTOR#0.6286;PROSTATE CANCER#0.6140;TRANSCRIPTION FACTOR BINDING#0.6062;MYELOID CELL#0.6004
10463	ZINC HOMEOSTASIS#0.7404;CANCER CELL#0.6408;DNA BINDING#0.6370
10464	PROGESTERONE#1.0594;CYTOKINE PRODUCTION#1.0480;PERIPHERAL BLOOD#1.0359;TROPHOBLAST#1.0026;GESTATION#0.9898;MIFEPRISTONE#0.9714;SPONTANEOUS ABORTION#0.9708;IMMUNE RESPONSE#0.9578;T CELL#0.9226;IMMUNE SYSTEM#0.8785;DYDROGESTERONE#0.8673;IL-10 PRODUCTION#0.8371;CANCER CELL#0.7822;PRO-INFLAMMATORY#0.7717;B CELL#0.7697;FOLLICULAR PHASE#0.7557;MONONUCLEAR CELLS#0.7213;T LYMPHOCYTE#0.7207;NATURAL KILLER CELL#0.7188;JOUBERT SYNDROME#0.7153;DECIDUA#0.7105;BREAST CANCER#0.7003;CELL CYCLE REGULATION#0.6967;RECEPTOR ANTAGONIST#0.6886;CELL CYCLE#0.6857;CYTOTOXICITY#0.6832;CENTRIOLAR SATELLITE#0.6589;CHORIOCARCINOMA#0.6518;LEUKOCYTE#0.6374;IFN-GAMMA#0.6373;EXTRACELLULAR VESICLE#0.6292;SPINDLE POLE#0.6158;AKT SIGNALING#0.6098;CYTOTROPHOBLAST#0.6086;LUTEAL PHASE#0.6079;PERIPHERAL BLOOD LYMPHOCYTES#0.6063;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6014
10465	CYCLOPHILIN#1.0277;CYCLOSPORIN A#0.8244;PRE-MRNA SPLICING#0.7602;MRNA SPLICING#0.7571;SMALL NUCLEAR RIBONUCLEOPROTEIN#0.6810;CYCLOSPORIN#0.6669;SPLICEOSOME#0.6062
10466	COG COMPLEX#0.9841;CONSERVED OLIGOMERIC GOLGI#0.9396;GOLGI COMPLEX#0.9070;GLYCOSYLATION#0.8478;CONGENITAL DISORDER#0.7499;COMPLEX I#0.6961;CONSERVED OLIGOMERIC GOLGI COMPLEX#0.6768
10467	CELL PROLIFERATION#0.9096;LGR5+ STEM CELL#0.7379;STEM CELL MAINTENANCE#0.7004;CELL CYCLE#0.7001;STEM CELL#0.6686
10468	INHIBIN BETA-A#1.0668;HEPATOCYTE GROWTH FACTOR#1.0591;FSH-BETA#1.0546;ACTIVIN BINDING#1.0540;LIVER REGENERATION#1.0443;POLYCYSTIC OVARY SYNDROME#1.0348;HEPARIN BINDING#1.0329;COLONY-STIMULATING FACTOR#1.0323;ALPHA-2 MACROGLOBULIN#1.0323;AMNIOTIC FLUID#1.0276;ENDOMETRIUM#1.0236;INHIBIN#1.0232;EPIDERMAL GROWTH FACTOR#1.0223;HEPARIN#1.0221;MUSCLE HYPERTROPHY#1.0208;MYOBLAST#1.0207;PLATELET-DERIVED GROWTH FACTOR#1.0204;OOCYTE MATURATION#1.0203;FSH SECRETION#1.0191;GRANULOCYTE COLONY STIMULATING FACTOR#1.0190;FIBROBLAST GROWTH FACTOR#1.0172;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0170;INSULIN-LIKE GROWTH FACTOR#1.0169;MENSTRUAL CYCLE#1.0163;ENDOTHELIAL GROWTH FACTOR#1.0154;GROWTH DIFFERENTIATION FACTOR#1.0133;PROSTATE CANCER#1.0119;ACTIVIN RECEPTOR#1.0104;WOUND HEALING#1.0100;STROMAL CELL#1.0087;ESTROUS CYCLE#1.0086;OOCYTE#1.0074;GRANULOSA CELL#1.0066;DNA SYNTHESIS#1.0059;OBESE#1.0057;PRE-ECLAMPSIA#1.0056;SERTOLI CELL#1.0049;BONE MARROW#1.0033;REVERSE TRANSCRIPTION#1.0030;GONAD#1.0024;GESTATION#1.0024;ESTRADIOL#1.0016;GONADOTROPIN RELEASING HORMONE#1.0013;TESTOSTERONE#1.0006;ADIPOSE TISSUE#1.0003;MUSCLE WASTING#1.0002;G-CSF#0.9989;CELL SURFACE#0.9983;GERM CELL#0.9981;LUTEAL PHASE#0.9975;PROGENITOR CELL#0.9974;ANDROSTENEDIONE#0.9971;PROGESTERONE#0.9966;OVARIES#0.9963;REGENERATION#0.9962;ENDOTHELIAL CELL#0.9960;POLYMERASE CHAIN REACTION#0.9955;EPITHELIAL CELL#0.9951;FOLLICLE STIMULATING HORMONE#0.9951;MUSCLE CELL#0.9945;OVARIAN FOLLICLE#0.9942;TRANSCRIPTASE#0.9935;OVARIAN#0.9885;BONE MORPHOGENETIC PROTEIN#0.9871;SKELETAL MUSCLE MASS#0.9870;LIVER DISEASE#0.9860;CANCER CELL#0.9859;ANGIOGENESIS#0.9851;CELL GROWTH#0.9841;BREAST CANCER#0.9841;FORSKOLIN#0.9839;GENE EXPRESSION#0.9832;EXTRACELLULAR MATRIX#0.9828;MORPHOGENESIS#0.9815;MUSCLE ATROPHY#0.9815;SKELETAL MUSCLE#0.9810;MYOGENESIS#0.9807;TUMOR NECROSIS FACTOR#0.9806;CELL DIFFERENTIATION#0.9802;GROWTH FACTOR#0.9801;PROTEIN KINASE#0.9794;PROTEIN KINASE C#0.9791;TRANSFORMING GROWTH FACTOR BETA#0.9788;APOPTOSIS#0.9788;SOMITE#0.9785;INFLAMMATORY RESPONSE#0.9776;MUSCULAR DYSTROPHY#0.9774;PITUITARY GLAND#0.9774;TRANSCRIPTION FACTOR#0.9750;CELL PROLIFERATION#0.9749;CUMULUS OOCYTE COMPLEXES#0.9746;GRANULOCYTE#0.9745;SMOOTH MUSCLE#0.9740;PROTEIN KINASE A#0.9736;STEM CELL#0.9732;TRANSFORMING GROWTH FACTOR#0.9731;OVARIAN CANCER#0.9730;DECIDUA#0.9728;CELL CYCLE#0.9727;SIGNALING PATHWAY#0.9701;STEROIDOGENESIS#0.9700;TYPE 2 DIABETES#0.9689;NERVOUS SYSTEM#0.9685;QUANTITATIVE REAL TIME#0.9674;ENDOMETRIOSIS#0.9666;INHIBIN BETA-B#0.9637;GROWTH HORMONE#0.9636;CELL ADHESION#0.9630;OSTEOBLAST#0.9629;SIGNAL TRANSDUCTION#0.9627;PROTEIN SYNTHESIS#0.9616;OVULATION#0.9608;FERTILIZATION#0.9604;PROTEOGLYCAN#0.9567;ADIPOCYTE#0.9566;CORPUS LUTEUM#0.9563;FOLLICULAR PHASE#0.9539;GASTRULATION#0.9521;MYOTUBE#0.9512;ADENYLATE CYCLASE#0.9486;HORMONE SECRETION#0.9465;RETINOIC ACID#0.9431;HAIR FOLLICLE#0.9429;ESTRUS#0.9417;SPERMATOGENESIS#0.9398;UTERUS#0.9396;OESTRADIOL#0.9348;EPIDIDYMIS#0.9346;RECEPTOR BINDING#0.9340;SURFACE PLASMON RESONANCE#0.9339;CELL ADHESION MOLECULE#0.9336;MESANGIAL CELL#0.9304;HEPATITIS C#0.9243;GROWTH FACTOR BINDING#0.9237;SKELETAL MUSCLE HYPERTROPHY#0.9236;IN VITRO MATURATION#0.9227;C REACTIVE PROTEIN#0.9223;ANDROGEN RECEPTOR#0.9222;TUMOR SUPPRESSOR#0.9220;TUMOR CELLS#0.9186;PERIPHERAL BLOOD#0.9169;HEPATOCELLULAR CARCINOMA#0.9162;ECLAMPSIA#0.9137;DECIDUALIZATION#0.9135;GLYCOSYLATION#0.9102;MUSCLE FIBER#0.9100;CYTOPLASM#0.9079;MAMMARY GLAND#0.9076;PRIMITIVE STREAK#0.9073;LEYDIG CELL#0.9068;B CELL#0.9066;SEMINAL PLASMA#0.9061;TUMOUR NECROSIS FACTOR#0.9054;MACROPHAGE#0.9053;SIGNALLING PATHWAY#0.9032;ISCHEMIA#0.9030;HYPOXIA#0.8988;CACHEXIA#0.8986;CENTRAL NERVOUS SYSTEM#0.8974;POLYCYSTIC OVARIAN SYNDROME#0.8973;FACTOR I#0.8972;OVARIAN DEVELOPMENT#0.8943;CHONDROCYTE#0.8928;IMMUNE RESPONSE#0.8893;GONADOTROPIN SECRETION#0.8875;PROGESTERONE SECRETION#0.8834;HINDBRAIN#0.8824;TROPHOBLAST#0.8818;KERATINOCYTE#0.8817;LUNG CANCER#0.8817;PROESTRUS#0.8813;IGF BINDING#0.8812;WHITE ADIPOSE TISSUE#0.8811;REPRODUCTIVE SYSTEM#0.8770;NOTOCHORD#0.8760;ADENO ASSOCIATED VIRUS#0.8729;MONOCYTE#0.8722;ADENYLATE#0.8721;CELL DEATH#0.8706;PLACENTAL GROWTH FACTOR#0.8699;STROMA#0.8695;EMBRYO DEVELOPMENT#0.8613;ADENOCARCINOMA#0.8599;IMMUNE CELL#0.8559;PORTAL VEIN#0.8547;APOPTOTIC#0.8546;SIGNALING CASCADE#0.8486;SMOOTH MUSCLE CELL#0.8435;MESODERM FORMATION#0.8427;PITUITARY ADENOMA#0.8419;DIESTRUS#0.8419;NITRIC OXIDE#0.8415;BONE FORMATION#0.8400;CROSS SECTIONAL AREA#0.8391;MESENCHYMAL STEM CELL#0.8338;BONE MORPHOGENIC PROTEIN#0.8336;THYMIDINE#0.8262;MESENCHYMAL CELL#0.8253;THECAL CELL#0.8234;PUBERTY#0.8223;BREAST CANCER CELL#0.8222;DECIDUAL CELL#0.8205;NEURAL PLATE#0.8200;OVARIAN FOLLICLE DEVELOPMENT#0.8126;PEROXISOME#0.8080;QUADRICEPS#0.8071;BRANCHING MORPHOGENESIS#0.8060;EMBRYONIC MUSCLE#0.8044;OVARIAN CYST#0.8041;MESENCHYME#0.8029;GLUCOSE HOMEOSTASIS#0.8028;NEUROGENESIS#0.8000;SMOOTH MUSCLE ACTIN#0.7985;KIDNEY DISEASE#0.7983;SIGNALING MOLECULE#0.7979;PROTEIN BINDING#0.7964;SPINAL CORD#0.7956;FATTY LIVER#0.7947;HEMATOPOIETIC CELL#0.7942;PLASMA PROTEIN#0.7924;GERMINAL VESICLE#0.7900;PROSTAGLANDIN E2#0.7892;ENDOCRINE CELL#0.7834;LEUKOCYTE#0.7833;INTESTINAL EPITHELIAL CELL#0.7778;PRO-INFLAMMATORY#0.7718;ARTERY#0.7695;INFERTILITY#0.7683;AMNION#0.7669;RAPAMYCIN#0.7655;AMELOBLAST DIFFERENTIATION#0.7643;PANCREATIC ISLET#0.7635;HEPARAN SULFATE BINDING#0.7634;PREMATURE OVARIAN FAILURE#0.7632;MINERALIZATION#0.7616;OSTEOGENESIS#0.7590;SULFATE BINDING#0.7571;ORGANOGENESIS#0.7569;MOLAR#0.7562;CILIARY GANGLION#0.7545;TOOTH DEVELOPMENT#0.7520;HIGH FAT DIET#0.7477;DEXAMETHASONE#0.7461;INHIBIN BINDING#0.7431;COLITIS#0.7425;GONADOTROPHIN SECRETION#0.7410;KINASE INHIBITOR#0.7395;OVARIAN CARCINOMA#0.7394;UMBILICAL VEIN#0.7391;BETA CELL#0.7389;MYOBLAST PROLIFERATION#0.7376;HEMATOPOIESIS#0.7375;INCLUSION BODY MYOSITIS#0.7368;HISTONE DEACETYLASE#0.7349;MECHANISM OF ACTION#0.7336;CONNECTIVE TISSUE#0.7306;CORTISOL#0.7304;INCLUSION BODY#0.7296;ZONA PELLUCIDA#0.7275;HEART MUSCLE#0.7271;HEPATOCYTE APOPTOSIS#0.7262;TERMINAL DIFFERENTIATION#0.7240;ENDOTHELIUM#0.7239;ACUTE LIVER FAILURE#0.7237;FATTY LIVER DISEASE#0.7215;AROMATASE ACTIVITY#0.7209;OVIDUCT#0.7180;MYOCARDIAL INFARCTION#0.7180;DIABETES MELLITUS#0.7179;RECEPTOR ANTAGONIST#0.7167;ISCHEMIA REPERFUSION INJURY#0.7162;TARGET OF RAPAMYCIN#0.7154;PARTURITION#0.7151;LUTEINIZATION#0.7141;INSULIN SECRETION#0.7133;DUCHENNE MUSCULAR DYSTROPHY#0.7121;CELL ACTIVATION#0.7114;ALKALINE PHOSPHATASE#0.7052;HATCHING#0.7033;ANDROGEN SECRETION#0.7029;PULMONARY FIBROSIS#0.7007;LUNG DISEASE#0.7006;LATE PREGNANCY#0.6977;VASCULAR ENDOTHELIAL CELL#0.6974;SODIUM DODECYL SULFATE#0.6972;DODECYL SULFATE#0.6971;WEIGHT LOSS#0.6964;TUBULOGENESIS#0.6959;ADENOSINE#0.6944;IMMUNE SYSTEM#0.6939;OSTEOCLAST#0.6918;T CELL#0.6908;GRANULOSA CELL PROLIFERATION#0.6891;ATHEROSCLEROSIS#0.6890;BLOOD VESSEL#0.6862;BMP SIGNALING PATHWAY#0.6860;TESTICULAR DEVELOPMENT#0.6819;ECTOPIC PREGNANCY#0.6817;CERVICAL#0.6811;MYOBLAST FUSION#0.6805;MITOGEN ACTIVATED PROTEIN#0.6794;STREPTOZOTOCIN#0.6767;DNA BINDING#0.6763;BMP BINDING#0.6757;FOLLICLE STIMULATING HORMONE SECRETION#0.6757;EPIBLAST#0.6748;CILIARY BODY#0.6724;NONALCOHOLIC FATTY LIVER DISEASE#0.6702;GLIAL CELL#0.6698;QUANTITATIVE REVERSE TRANSCRIPTION#0.6681;72-HOURS#0.6677;GLAND MORPHOGENESIS#0.6662;INSULIN RECEPTOR#0.6658;HYPERGLYCEMIA#0.6642;CHRONIC HEPATITIS C#0.6615;HYPOXIC#0.6614;EMBRYONIC STEM CELL#0.6606;MYOGENIC REGULATORY FACTOR#0.6563;ROOT SHEATH#0.6535;MYOSITIS#0.6527;NEUROMUSCULAR DISEASE#0.6526;HEPATOCYTE PROLIFERATION#0.6519;TERATOCARCINOMA#0.6508;VENOUS BLOOD#0.6491;TISSUE GROWTH FACTOR#0.6475;PROTEIN SECRETION#0.6474;INCREASED MUSCLE MASS#0.6450;MYOFIBROBLAST#0.6437;ADRENAL GLAND#0.6433;MECHANISMS OF ACTION#0.6430;BINDING PROTEIN 1#0.6428;LYMPH NODE#0.6423;IN VITRO MATURED#0.6412;RHOMBOMERE#0.6394;ESTROGEN RECEPTOR#0.6385;SMAD BINDING ELEMENT#0.6345;ANTI MULLERIAN HORMONE#0.6344;SPERMATOGENIC CELLS#0.6340;SEX DETERMINATION#0.6322;SMAD BINDING#0.6308;CYTOTROPHOBLAST#0.6277;LUCIFERASE ACTIVITY#0.6276;DIHYDROTESTOSTERONE#0.6260;SPERMATOCYTES#0.6258;BROWN ADIPOSE TISSUE#0.6253;CELL DEVELOPMENT#0.6249;HEPATIC STELLATE CELL#0.6247;MYOSIN HEAVY CHAIN#0.6239;PATTERN FORMATION#0.6238;ADIPOCYTE DIFFERENTIATION#0.6222;TROPHECTODERM CELL#0.6219;S PHASE#0.6217;SQUAMOUS CELL CARCINOMA#0.6216;BREAST CARCINOMA#0.6206;CHRONIC KIDNEY DISEASE#0.6200;NEURAL TUBE#0.6167;NERVE GROWTH FACTOR#0.6166;GRANULOSA CELL DIFFERENTIATION#0.6143;VASCULAR SMOOTH MUSCLE CELL#0.6125;ERYTHROPOIESIS#0.6073;FLOOR PLATE#0.6060;LEAN BODY MASS#0.6043;RELATED PROTEIN 1#0.6032;GESTATIONAL DIABETES#0.6028;MYOGENIC CELL#0.6006
10469	INNER MITOCHONDRIAL MEMBRANE#1.0716;MITOCHONDRIAL MEMBRANE#1.0466;PROTEIN IMPORT#1.0383;MITOCHONDRIAL INNER MEMBRANE#1.0267;HEAT SHOCK PROTEIN#1.0170;TIM23 COMPLEX#1.0052;MITOCHONDRIA#1.0034;MITOCHONDRIAL PROTEIN IMPORT#0.9863;MITOCHONDRIAL MATRIX#0.9823;C TERMINAL DOMAIN#0.9745;PEPTIDE BINDING#0.9680;PERIPHERAL MEMBRANE PROTEIN#0.8933;NUCLEOTIDE EXCHANGE FACTOR#0.8515;GENE EXPRESSION#0.7107;OUTER MEMBRANE#0.7092;ATP HYDROLYSIS#0.6437;COMPLEX I#0.6381;MITOCHONDRIAL FUSION#0.6316;CELL PROLIFERATION#0.6198
1046	STEM CELL#1.0200;GENE EXPRESSION#1.0192;TRANSCRIPTION FACTOR#1.0153;SPINAL CORD#0.9934;HEMATOPOIESIS#0.9528;PROGENITOR CELL#0.9275;MYELOID LEUKEMIA#0.9191;RETINOIC ACID#0.8742;ACUTE MYELOID LEUKEMIA#0.8574;EMBRYONIC STEM CELL#0.8328;MYELOID PROGENITOR CELL#0.8306;HINDBRAIN#0.8267;HEMATOPOIETIC STEM CELL#0.8233;BONE MARROW#0.7437;HINDGUT#0.7179;SIGNALING PATHWAY#0.7113;URORECTAL SEPTUM#0.6861;PRIMITIVE HEMATOPOIESIS#0.6456;NEURAL TUBE#0.6226;MORPHOGENESIS#0.6008
10471	LIGASE INHIBITOR#0.6808;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6533
10472	CEREBRAL CORTEX#1.0468;TRANSCRIPTION FACTOR#1.0083;ZINC FINGER PROTEIN#0.9230;PROGENITOR CELL#0.9071;TELOMERE BINDING#0.8911;TRANSACTIVATION#0.8854;CELL CYCLE#0.8655;CREB BINDING#0.8575;GENE EXPRESSION#0.8413;TELOMERE#0.8343;DNA BINDING#0.8340;NEURONAL MIGRATION#0.8316;MICROCEPHALY#0.8058;ZINC BINDING#0.7908;INTELLECTUAL DISABILITY#0.7274;BRAIN DEVELOPMENT#0.6724;HETEROCHROMATIN#0.6559;TUMOR SUPPRESSOR#0.6361;GABAERGIC NEURON#0.6265;HYPOXIC#0.6150
10473	NUCLEOSOME BINDING#0.6567;HEART MUSCLE#0.6292;KINASE ACTIVITY#0.6113;DNA BINDING#0.6092
10474	HISTONE ACETYLTRANSFERASE#1.0554;CELL CYCLE#1.0098;TRANSACTIVATION#0.9911;CANCER CELL#0.9760;CELL PROLIFERATION#0.9477;TRANSCRIPTION FACTOR#0.9201;BREAST CANCER#0.9182;HISTONE ACETYLATION#0.8530;MAMMARY EPITHELIAL CELL#0.8253;SAGA COMPLEX#0.8123;EPITHELIAL CELL#0.8112;BREAST CANCER CELL#0.8050;GLUCOSE REPRESSION#0.8041;GENE EXPRESSION#0.7792;LYSINE#0.7623;APOPTOSIS#0.7461;ESTROGEN RECEPTOR#0.7236;DNA REPAIR#0.7063;HUMAN MAMMARY EPITHELIAL#0.7042;MOUSE EMBRYONIC FIBROBLAST#0.6964;CERVICAL CANCER#0.6922;CERVICAL#0.6414;RETINOIC ACID#0.6216;BREAST CANCER PATIENTS#0.6097
10475	INFLAMMATORY RESPONSE#0.7449;VIRAL INFECTION#0.6603;SIGNALING PATHWAY#0.6419;IFN REGULATORY FACTOR#0.6152;VESICULAR STOMATITIS VIRUS#0.6103;OSTEOBLAST DIFFERENTIATION#0.6053
10476	ATP SYNTHASE#0.9837;OXIDATIVE PHOSPHORYLATION#0.7229;APOPTOSIS#0.6468
10477	UBIQUITIN PROTEIN LIGASE#1.0855;UBIQUITIN#1.0699;TRANSCRIPTION FACTOR#0.8632;CELL PROLIFERATION#0.6168
10478	PEROXISOMAL MEMBRANE#1.0580;PEROXISOMAL#1.0523;ATP BINDING#1.0495;ATP BINDING CASSETTE#1.0438;PROTEIN IMPORT#1.0208;PEROXISOMAL MATRIX#1.0121;PEROXISOME#0.9975;ORGANELLE#0.9664;ZELLWEGER SYNDROME#0.9521;ENDOPLASMIC RETICULUM#0.9411;PEROXISOME PROLIFERATION#0.9366;ATP BINDING CASSETTE TRANSPORTER#0.9189;PEROXISOME MEMBRANE#0.8611;MITOCHONDRIA#0.8115;ACYL COA OXIDASE#0.8051;PTS1 RECEPTOR#0.7401;FATTY ACID OXIDATION#0.7375;PEXOPHAGY#0.7280;GENE EXPRESSION#0.7144;ABC TRANSPORTER#0.7128;SUPEROXIDE DISMUTASE#0.7081;NERVOUS SYSTEM#0.6908;CYTOPLASM#0.6617;MEMBRANE BIOGENESIS#0.6545;LIPID METABOLISM#0.6529;PROTEIN TARGETING#0.6472;UBIQUITIN#0.6250;COENZYME A#0.6127
104797537	CELL PROLIFERATION#1.0895;CANCER CELL#0.9506;BREAST CANCER#0.8791;APOPTOSIS#0.6827;COLORECTAL CANCER#0.6673;LUNG CANCER#0.6659;CELL GROWTH#0.6654;SIGNALING PATHWAY#0.6511;COLONY FORMATION ASSAY#0.6200;ADJACENT NORMAL TISSUE#0.6191
10479	CHRISTIANSON SYNDROME#1.1419;ENDOSOME#1.0596;PLASMA MEMBRANE#1.0250;RECYCLING ENDOSOME#1.0229;INTELLECTUAL DISABILITY#0.9947;ANGELMAN SYNDROME#0.9551;MICROCEPHALY#0.9480;EPILEPSY#0.9113;MENTAL RETARDATION#0.8706;SODIUM:HYDROGEN EXCHANGER#0.8497;TRANS GOLGI NETWORK#0.7810;STATUS EPILEPTICUS#0.7655;LUMINAL#0.7542;ACIDIFICATION#0.6989;ORGANELLE#0.6321;EARLY ENDOSOME#0.6274;CELL POLARITY#0.6243
1047	ENDOPLASMIC RETICULUM#0.9939;ZONA PELLUCIDA#0.9306;SPERMATOGENESIS#0.8714;GERM CELL#0.8706;OVIDUCT#0.7967;LECTIN#0.6502;ANGIOTENSIN CONVERTING ENZYME#0.6423;ACROSOME#0.6174
10480	TRANSLATION INITIATION#0.8706;TRANSLATION INITIATION FACTOR#0.8283;EUKARYOTIC INITIATION FACTOR#0.7755;CANCER CELL#0.7113;DENDRITIC CELL#0.6293;PROTEIN SYNTHESIS#0.6192
10481	TAMOXIFEN#1.0438;BREAST CANCER#1.0379;PROSTATE CANCER#1.0267;CANCER CELL#1.0263;ANDROGEN RECEPTOR#1.0244;TRANSCRIPTION FACTOR#1.0238;CELL PROLIFERATION#1.0232;CELL GROWTH#1.0219;GENE EXPRESSION#0.9972;BREAST CANCER PATIENTS#0.9858;PROSTATE SPECIFIC ANTIGEN#0.9494;TUMOR SUPPRESSOR#0.9491;LYMPH NODE#0.9483;ESTROGEN RECEPTOR#0.9431;EPITHELIAL CELL#0.9414;POLYMERASE CHAIN REACTION#0.9258;PROSTATE DEVELOPMENT#0.9153;COLORECTAL CANCER#0.8912;WOUND HEALING#0.8870;OVARIAN CANCER#0.8866;COLORECTAL#0.8422;ADENOCARCINOMA#0.8387;SPINAL CORD#0.8185;ANGIOGENESIS#0.8165;METASTATIC PROSTATE CANCER#0.8165;COLON CANCER#0.7967;REVERSE TRANSCRIPTION#0.7670;DISEASE FREE SURVIVAL#0.7503;OVARIAN#0.7436;DNA BINDING#0.7278;BREAST CANCER CELL#0.6941;CELL CYCLE#0.6907;PROSTATE EPITHELIAL CELL#0.6656;APOPTOSIS#0.6523;TUMOR TISSUES#0.6325;QUANTITATIVE REAL TIME#0.6304;LUMINAL#0.6187;TOXICITY#0.6145;RECURRENCE FREE SURVIVAL#0.6038;ENDOMETRIAL CANCER#0.6019
10482	RNA EXPORT FACTOR#1.0712;NUCLEAR PORE COMPLEX#1.0345;PORE COMPLEX#1.0338;RNA HELICASE#1.0313;NUCLEAR PORE#1.0240;TREX COMPLEX#1.0227;NUCLEAR EXPORT#1.0196;RNA BINDING#1.0179;NUCLEAR TRANSPORT#1.0046;CYTOPLASM#0.9860;RIBOSOMAL SUBUNIT#0.9809;NUCLEAR PORE COMPLEXES#0.9779;RNA BINDING PROTEIN#0.9748;GENE EXPRESSION#0.9721;HERPES SIMPLEX VIRUS#0.9698;HERPES SIMPLEX#0.9695;MRNA PROCESSING#0.9637;EXON JUNCTION COMPLEX#0.9405;ARGININE#0.9379;T CELL#0.9271;UBIQUITIN#0.9212;MRNA TRANSPORT#0.9169;NUCLEOCYTOPLASMIC TRANSPORT#0.9154;NUCLEAR ENVELOPE#0.9040;NUCLEOCYTOPLASMIC SHUTTLING#0.9027;RIBOSOME#0.8910;NUCLEAR EXPORT SIGNAL#0.8795;TRANSCRIPTION FACTOR#0.8612;VIRAL REPLICATION#0.8574;LEUCINE#0.8550;COMPLEX I#0.8454;NUCLEAR SPECKLE#0.8352;RNA HELICASE A#0.8238;PROTEIN SYNTHESIS#0.8209;OOCYTE#0.8136;LEUCINE RICH REPEAT#0.8071;C TERMINAL DOMAIN#0.8062;THO COMPLEX#0.8037;IFN-GAMMA#0.8008;IMMUNE RESPONSE#0.7975;NUCLEAR IMPORT#0.7936;MRNA METABOLISM#0.7893;INFLUENZA A VIRUS#0.7762;RNA TRANSPORT#0.7743;IMPORTIN#0.7603;PROTEIN KINASE#0.7598;RNA PROCESSING#0.7581;MRNA SPLICING#0.7565;TAP BINDING#0.7458;HUMAN IMMUNODEFICIENCY VIRUS#0.7286;HOST CELL#0.7164;MRNA BINDING#0.7104;NUCLEOPLASM#0.7074;KARYOPHERIN#0.6956;ANTIGEN PROCESSING#0.6823;NUP84 COMPLEX#0.6795;NEURONAL CELLS#0.6729;PRE-MRNA SPLICING#0.6704;RNA RECOGNITION MOTIF#0.6636;RNA INTERFERENCE#0.6326;EPITHELIAL CELL#0.6284;RESONANCE ENERGY TRANSFER#0.6255;POLYSOME#0.6228;PROTEASOME#0.6225;PROTEIN PROTEIN INTERACTION#0.6180;ANTIGEN PRESENTATION#0.6027;CELL SURFACE#0.6018;EPSTEIN BARR VIRUS#0.6010;GERM CELL#0.6004
10483	CONGENITAL DYSERYTHROPOIETIC ANEMIA#1.0568;ANEMIA#1.0361;ERYTHROCYTE#1.0344;ANAEMIA#0.9677;BONE MARROW#0.9640;ENDOPLASMIC RETICULUM#0.9332;ERYTHROBLAST#0.9192;PROTEIN COMPLEX#0.8817;ERYTHROPOIESIS#0.8427;COMPLEX II#0.8212;GLYCOSYLATION#0.7945;IRON OVERLOAD#0.7692;APOPTOSIS#0.7313;GOLGI APPARATUS#0.6678;RED BLOOD CELL#0.6634;CELL MEMBRANE#0.6622;RETINOIC ACID#0.6065
10484	ENDOPLASMIC RETICULUM#1.0161;PROTEIN COMPLEX#0.8818;COMPLEX II#0.7979;TRANSCRIPTION FACTOR#0.6688;CELL PROLIFERATION#0.6511;COPII VESICLE#0.6361;COLLAGEN SYNTHESIS#0.6312;EXTRACELLULAR MATRIX#0.6184
10485	HEPATOCELLULAR CARCINOMA#0.7116
10486	ACTIN CYTOSKELETON#0.8282;HEPATOCELLULAR CARCINOMA#0.8130;YEAR SURVIVAL RATE#0.8006;SKELETAL MUSCLE#0.7760;ADENYLATE CYCLASE#0.7216;WOUND HEALING#0.6253;BREAST CANCER#0.6195
10487	BREAST CANCER#1.0841;C TERMINAL DOMAIN#1.0732;ADENYLATE CYCLASE#1.0708;ADENYLATE#1.0688;CANCER CELL#1.0593;ACTIN FILAMENT#1.0569;ACTIN BINDING#1.0481;ACTIN CYTOSKELETON#1.0218;CELL ADHESION#1.0161;BREAST CANCER CELL#1.0025;CAMP SIGNALING#0.9646;SIGNALING PATHWAY#0.9463;ACTIN MONOMER BINDING#0.9178;GENE EXPRESSION#0.9044;CELL MOTILITY#0.9021;PANCREATIC CANCER#0.8900;SIGNAL TRANSDUCTION#0.8900;CYCLASE ACTIVITY#0.8900;LUNG CANCER#0.8880;CELL PROLIFERATION#0.8715;ACTIN BINDING PROTEIN#0.8564;ACTIN POLYMERIZATION#0.8500;CYCLIC AMP#0.8495;ADENYLYL CYCLASE ACTIVITY#0.8368;STRESS FIBER#0.8141;POLYMERASE CHAIN REACTION#0.8070;EPITHELIAL CELL#0.7927;MORPHOGENESIS#0.7718;PROTEIN KINASE#0.7451;PERIPHERAL BLOOD#0.7267;CELL GROWTH#0.7250;ENDOCYTOSIS#0.7120;CELL POLARITY#0.7033;CELL MIGRATION#0.6951;SEQUESTERING#0.6847;ACTIN FILAMENT DEPOLYMERIZATION#0.6705;VIRULENCE#0.6570;CAMP SYNTHESIS#0.6325;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6311;MONONUCLEAR CELLS#0.6299;SH3 DOMAIN BINDING#0.6275;FILAMENTOUS GROWTH#0.6269;GERM TUBE#0.6242;CELL CORTEX#0.6131;ACTIN DEPOLYMERIZATION#0.6123;TOLL LIKE RECEPTOR#0.6116;PLASMA MEMBRANE#0.6088;BONE DISEASE#0.6041;TRAUMATIC BRAIN INJURY#0.6023
10488	LEUCINE#1.0530;UNFOLDED PROTEIN RESPONSE#1.0325;CELL MIGRATION#1.0287;TRANSCRIPTION FACTOR#1.0242;ENDOPLASMIC RETICULUM#1.0214;DNA BINDING#1.0000;GENE EXPRESSION#0.9923;TRANSACTIVATION#0.9860;CANCER CELL#0.9767;HERPES SIMPLEX VIRUS#0.9562;HERPES SIMPLEX#0.9558;BREAST CANCER#0.9511;CELL PROLIFERATION#0.9259;T CELL#0.9207;CYTOPLASM#0.9006;HOST CELL#0.8936;HOST CELL FACTOR#0.8886;APOPTOSIS#0.8748;CAMP RESPONSE ELEMENT#0.8604;GLUCOCORTICOID RECEPTOR#0.8549;CELL CYCLE#0.8513;ENDOPLASMIC RETICULUM STRESS#0.8489;CAMP RESPONSE ELEMENT BINDING#0.8400;ACTIVATING TRANSCRIPTION FACTOR#0.8305;REGULATED INTRAMEMBRANE PROTEOLYSIS#0.8082;BREAST CANCER CELL#0.8041;CELLULAR TRANSCRIPTION#0.7959;ER STRESS RESPONSE#0.7935;T-CELL LEUKEMIA#0.7760;CERVICAL CANCER#0.7621;ENHANCER BINDING PROTEIN#0.7611;ENHANCER BINDING#0.7606;BINDING PROTEIN 3#0.7569;GRANULOSA CELL#0.7388;ER MEMBRANE#0.7385;ELECTROPHORETIC MOBILITY SHIFT#0.7083;CAMP-RESPONSIVE ELEMENT BINDING#0.6963;AXON GROWTH#0.6940;VIRAL TRANSCRIPTION#0.6725;DECIDUAL CELL#0.6157;CC CHEMOKINE RECEPTOR#0.6133;CELL BODY#0.6083;JUN DIMERIZATION PROTEIN#0.6044
10489	LEUCINE RICH REPEAT#0.9705;LEUCINE#0.7323;UBIQUITIN#0.6960
1048	FACTOR VIII#1.0465;GLIAL FIBRILLARY ACIDIC PROTEIN#1.0455;BETA-2#1.0451;PROSTATE SPECIFIC ANTIGEN#1.0342;GLASSY CARBON ELECTRODE#1.0330;ENDOMETRIAL ADENOCARCINOMA#1.0291;LOW DETECTION LIMIT#1.0286;ENDOCERVICAL ADENOCARCINOMA#1.0272;THYROID TRANSCRIPTION FACTOR#1.0271;C REACTIVE PROTEIN#1.0249;OVARIAN CYST#1.0231;ALPHA 1-ANTITRYPSIN#1.0200;BREAST DISEASE#1.0178;MALIGNANT PLEURAL EFFUSION#1.0165;CELL ADHESION MOLECULE#1.0153;SMOOTH MUSCLE ACTIN#1.0150;PERICARDIAL EFFUSION#1.0147;ESTROGEN RECEPTOR#1.0145;MUCINOUS CYSTADENOCARCINOMA#1.0141;LIMIT OF DETECTION#1.0138;ALKALINE PHOSPHATASE#1.0126;COLON CARCINOMA#1.0117;COLORECTAL ADENOCARCINOMA#1.0101;CERVICAL ADENOCARCINOMA#1.0088;PROGESTERONE#1.0084;IFN-GAMMA#1.0081;CYSTADENOCARCINOMA#1.0069;SWEAT GLAND#1.0061;MECONIUM#1.0055;OVARIAN CARCINOMA#1.0049;GM-CSF#1.0046;LUMINAL#1.0042;SMOOTH MUSCLE#1.0041;NEUROFILAMENT#1.0039;METASTATIC ADENOCARCINOMA#1.0037;CELL ADHESION#1.0036;LEUKOCYTE#1.0031;TRANSCRIPTION FACTOR#1.0031;TUMOR ANTIGEN#1.0027;MEDULLARY CARCINOMA#1.0022;ADVANCED BREAST CANCER#1.0021;LUNG DISEASE#1.0016;TUMOR ASSOCIATED ANTIGEN#1.0015;COLORECTAL CARCINOMA#1.0014;CERVICAL CANCER#1.0006;DENDRITIC CELL#0.9992;LIVER DISEASE#0.9990;CELL SURFACE#0.9983;METASTATIC CARCINOMA#0.9975;SIGNET RING CELL#0.9971;PANCREATIC LESIONS#0.9964;TUMOR TISSUES#0.9962;METASTATIC BREAST CANCER#0.9957;EPIDERMAL GROWTH FACTOR#0.9954;MESOTHELIAL CELL#0.9953;GASTRIC ADENOCARCINOMA#0.9948;LUNG ADENOCARCINOMA#0.9944;BILIARY TRACT#0.9929;PRIMARY BREAST CANCER#0.9929;ESOPHAGEAL CANCER#0.9929;COLORECTAL CANCER#0.9924;SQUAMOUS CELL CARCINOMA#0.9916;ENDOTHELIAL GROWTH FACTOR#0.9911;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9911;SMALL CELL CARCINOMA#0.9903;BIOTIN#0.9900;SERUM ALBUMIN#0.9899;PANCREATIC CARCINOMA#0.9895;BREAST CANCER PATIENTS#0.9895;T LYMPHOCYTE#0.9889;LECTIN#0.9888;PSEUDOMYXOMA PERITONEI#0.9884;TRANSCRIPTASE#0.9882;METAPLASIA#0.9881;CELL MEMBRANE#0.9880;MICROPARTICLE#0.9877;PANCREATIC CANCER#0.9872;LUNG CARCINOMA#0.9872;HEPATOCELLULAR CARCINOMA#0.9864;MYOEPITHELIAL CELL#0.9864;BREAST CANCER#0.9862;GROWTH FACTOR RECEPTOR#0.9861;MUCINOUS CYSTIC NEOPLASM#0.9860;ASCITES#0.9855;MUCINOUS ADENOCARCINOMA#0.9851;INTERMEDIATE FILAMENT#0.9850;LUNG CANCER#0.9850;TRANSITIONAL CELL CARCINOMA#0.9848;BONE MARROW#0.9846;CELL DIFFERENTIATION#0.9843;ADVANCED GASTRIC CANCER#0.9843;GALLBLADDER#0.9843;MUCINOUS NEOPLASM#0.9834;REVERSE TRANSCRIPTION#0.9834;LIVER METASTASIS#0.9832;LYMPH NODE INVOLVEMENT#0.9831;PERIPHERAL BLOOD#0.9827;COLORECTAL#0.9825;COLON CANCER#0.9822;BREAST CARCINOMA#0.9818;BLOOD GROUP ANTIGEN#0.9818;OVARIAN#0.9813;MALIGNANT MESOTHELIOMA#0.9812;CHOLANGIOCARCINOMA#0.9811;PANCREATIC ADENOCARCINOMA#0.9811;OVARIAN CANCER#0.9810;SURFACE PLASMON RESONANCE#0.9805;CERVIX#0.9805;FORMALIN#0.9804;CIRCULATING TUMOR CELL#0.9803;RECURRENCE FREE SURVIVAL#0.9801;EOSIN#0.9793;THYROID CARCINOMA#0.9792;WEIGHT LOSS#0.9788;NEUTROPHIL#0.9787;LYMPH NODE METASTASES#0.9787;PELVIS#0.9786;EPITHELIAL CELL#0.9786;CERVICAL#0.9784;STOMACH CANCER#0.9782;TUMOR CELLS#0.9780;GROWTH FACTOR#0.9779;CYSTADENOMA#0.9774;LYMPH NODE METASTASIS#0.9773;COLORECTAL LIVER METASTASES#0.9771;LARGE CELL CARCINOMA#0.9764;T CELL#0.9761;GASTROINTESTINAL TRACT#0.9761;MEDIAN SURVIVAL TIME#0.9752;EXTRAMAMMARY PAGET'S DISEASE#0.9747;BILE DUCT#0.9745;POSITIVE PREDICTIVE VALUE#0.9741;NEGATIVE PREDICTIVE VALUE#0.9737;ACID PHOSPHATASE#0.9734;ADENOSQUAMOUS CARCINOMA#0.9725;FINE NEEDLE ASPIRATE#0.9723;IMMUNE RESPONSE#0.9719;GERM CELL#0.9718;GENE EXPRESSION#0.9717;SALIVARY GLAND#0.9717;COLUMNAR#0.9713;AREA UNDER CURVE#0.9713;MACROPHAGE#0.9709;POLYMERASE CHAIN REACTION#0.9707;GRANULOCYTE#0.9703;ENDOMETRIAL CARCINOMA#0.9702;ADENOCARCINOMA#0.9699;COLON ADENOCARCINOMA#0.9694;DISEASE FREE SURVIVAL#0.9692;MUCINOUS CYSTADENOMA#0.9687;THYROID CANCER#0.9681;GALLBLADDER CANCER#0.9677;LYMPH NODE#0.9669;CANCER CELL#0.9666;SEROUS CYSTADENOMA#0.9655;BASAL CELL#0.9655;LYMPH NODE DISSECTION#0.9652;QUANTITATIVE REAL TIME#0.9646;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9645;YEAR SURVIVAL RATE#0.9644;LUMINAL CELL#0.9632;CYTOTOXIC T-LYMPHOCYTE#0.9632;PANCREATIC DUCTAL ADENOCARCINOMA#0.9632;INTRAHEPATIC CHOLANGIOCARCINOMA#0.9630;FINE NEEDLE ASPIRATION#0.9629;GROWTH PATTERN#0.9628;STEM CELL#0.9624;CYTOPLASM#0.9624;RECTUM#0.9622;URINARY BLADDER#0.9621;INVASIVE CARCINOMA#0.9618;BREAST CANCER CELL#0.9612;COLONY-STIMULATING FACTOR#0.9606;POSITRON EMISSION TOMOGRAPHY#0.9605;CELL PROLIFERATION#0.9601;ELECTRON TRANSFER#0.9590;LIMITS OF DETECTION#0.9588;PLEURA#0.9588;ENDOTHELIAL CELL#0.9574;CPT-11#0.9573;ABDOMINAL PAIN#0.9572;GOBLET CELL#0.9565;METASTATIC LYMPH NODE#0.9563;CLEAR CELL CARCINOMA#0.9561;NEUROENDOCRINE TUMOR#0.9561;MAGNETIC RESONANCE IMAGING#0.9557;DIFFERENTIAL PULSE VOLTAMMETRY#0.9554;STROMA#0.9549;CYTOTOXICITY#0.9546;CISPLATIN#0.9545;TOXICITY#0.9521;FALSE POSITIVE RATE#0.9520;REGIONAL LYMPH NODE#0.9519;HISTOGENESIS#0.9518;LIVER CANCER#0.9498;ADENOID CYSTIC CARCINOMA#0.9495;RENAL CELL CARCINOMA#0.9471;ANOIKIS#0.9456;GEMCITABINE#0.9453;5 FLUOROURACIL#0.9450;GLYCOSYLATION#0.9435;RESPONSE TO TREATMENT#0.9428;MEDIAN OVERALL SURVIVAL#0.9426;EARLY GASTRIC CANCER#0.9413;STROMAL CELL#0.9408;MONONUCLEAR CELLS#0.9403;PROSTATE CANCER#0.9397;POINT OF CARE#0.9381;TUMOR SUPPRESSOR#0.9342;PANCREATITIS#0.9334;FLUOROURACIL#0.9333;CD8+ T CELL#0.9302;ENDOMETRIUM#0.9288;G-CSF#0.9286;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9284;PACLITAXEL#0.9283;SEROUS CYSTADENOCARCINOMA#0.9283;CARCINOMA IN SITU#0.9281;MALIGNANT PLEURAL MESOTHELIOMA#0.9278;DOCETAXEL#0.9259;ESOPHAGUS#0.9253;SWELLING#0.9246;ADENOCARCINOMA IN SITU#0.9242;OVERALL SURVIVAL RATE#0.9240;APOPTOSIS#0.9236;OXALIPLATIN#0.9235;MEDIASTINAL LYMPH NODE#0.9229;PERITONEUM#0.9215;EARLY BREAST CANCER#0.9209;HEALTHY CONTROL GROUP#0.9208;KINASE INHIBITOR#0.9186;UTERUS#0.9182;B CELL#0.9163;TUMOR NECROSIS FACTOR#0.9156;ADVANCED PANCREATIC CANCER#0.9133;TUBULAR ADENOCARCINOMA#0.9129;PULMONARY ALVEOLAR PROTEINOSIS#0.9115;BETA GLUCURONIDASE#0.9098;TUBERCULOSIS#0.9096;PAPILLARY ADENOCARCINOMA#0.9049;PAPILLOMA#0.9042;NODULAR#0.9034;INHIBIN#0.9027;APOCRINE GLAND#0.9003;GEFITINIB#0.8975;ESOPHAGEAL CARCINOMA#0.8972;ARTERY#0.8971;GERM CELL TUMORS#0.8968;PATHOLOGIC COMPLETE RESPONSE#0.8960;TRASTUZUMAB#0.8938;PERITONEAL CAVITY#0.8920;DUCT CELL#0.8916;WHITE BLOOD CELL#0.8907;MICROVILLI#0.8904;IRINOTECAN#0.8896;PORTAL VEIN#0.8855;LIVER CIRRHOSIS#0.8854;CELL CYCLE#0.8852;CAPECITABINE#0.8834;WIDE DYNAMIC RANGE#0.8832;DERMIS#0.8821;TYROSINE KINASE INHIBITOR#0.8816;ERLOTINIB#0.8815;MUCOUS#0.8806;GASTRITIS#0.8781;ANEMIA#0.8779;ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY#0.8744;BASAL CELL CARCINOMA#0.8717;TOTAL MESORECTAL EXCISION#0.8713;CYST WALL#0.8706;DIGESTIVE TRACT#0.8705;THYMIDINE KINASE#0.8694;GASTROINTESTINAL CARCINOMA#0.8683;PERICARDITIS#0.8673;MEDULLARY THYROID CANCER#0.8659;RISK OF DEATH#0.8644;SPUTUM#0.8620;GALLBLADDER CARCINOMA#0.8617;BORDERLINE OVARIAN TUMOR#0.8612;HIGH RISK PATIENTS#0.8593;AGE AT DIAGNOSIS#0.8588;PLEOMORPHIC ADENOMA#0.8574;DISEASE CONTROL RATE#0.8571;HEPATITIS B#0.8550;APOPTOTIC#0.8536;CONNECTIVE TISSUE#0.8518;THYROID GLAND#0.8501;TERATOMA#0.8494;PAPILLARY CARCINOMA#0.8487;OVARIES#0.8481;ATROPHIC GASTRITIS#0.8455;EXTRACELLULAR MATRIX#0.8445;FIBRINOGEN#0.8438;PATHOLOGICAL COMPLETE RESPONSE#0.8436;THYMIC CARCINOMA#0.8428;HMN-14#0.8419;ANTI HER2#0.8415;BILIARY TRACT CANCER#0.8397;CELL AGGREGATION#0.8391;DIABETES MELLITUS#0.8386;PNEUMONIA#0.8382;RESONANCE ENERGY TRANSFER#0.8376;NEUROENDOCRINE CARCINOMA#0.8373;BLADDER CARCINOMA#0.8371;BLOOD PLASMA#0.8358;NEURAL CELL#0.8358;THYMIDINE#0.8328;GASTRIC MUCOSA#0.8320;AMNIOTIC FLUID#0.8294;CARCINOSARCOMA#0.8259;DIARRHEA#0.8246;EXOSOME#0.8234;PROLIFERATING CELL NUCLEAR ANTIGEN#0.8233;BLOOD VESSEL#0.8218;ANDROGEN RECEPTOR#0.8216;TUMOR REGRESSION GRADE#0.8208;QUANTITATIVE REVERSE TRANSCRIPTION#0.8205;SPECIFIC SURFACE AREA#0.8177;HEPATOCYTE GROWTH FACTOR#0.8173;KERATINOCYTE#0.8169;TIME TO PROGRESSION#0.8156;ANGIOGENESIS#0.8147;ADENOSINE#0.8123;NEOPLASTIC DISEASE#0.8094;PERITONEAL MESOTHELIOMA#0.8071;IMMUNE SYSTEM#0.8062;OBSTRUCTIVE JAUNDICE#0.8055;LYMPH NODE RATIO#0.8051;PERITONITIS#0.8049;MELANOSOME#0.8044;EPITHELIAL OVARIAN CANCER#0.7983;MUCOEPIDERMOID CARCINOMA#0.7981;SENTINEL LYMPH NODE#0.7975;STANDARDIZED UPTAKE VALUE#0.7946;NON-SMALL CELL LUNG CARCINOMA#0.7914;SWEAT GLAND CARCINOMA#0.7857;BASEMENT MEMBRANE#0.7852;CELL GROWTH#0.7838;NERVOUS SYSTEM#0.7831;SQUAMOUS CELL CANCER#0.7830;EPITHELIAL OVARIAN CARCINOMA#0.7812;VOMITING#0.7811;NEUTROPENIA#0.7802;PLEURISY#0.7792;DERMOID CYST#0.7782;TRANSMISSION ELECTRON MICROSCOPY#0.7781;RECEIVER OPERATOR CHARACTERISTIC#0.7774;CELLULAR IMMUNE RESPONSE#0.7774;ENHANCED COMPUTED TOMOGRAPHY#0.7741;ENDOMETRIAL CANCER#0.7741;DOXORUBICIN#0.7728;BEVACIZUMAB#0.7680;TUBERCULOUS PERITONITIS#0.7676;DIGESTION#0.7676;PARENCHYMA#0.7671;MITOMYCIN C#0.7646;RELAPSE FREE SURVIVAL#0.7644;TYPE 2 DIABETES#0.7629;GALL BLADDER#0.7605;CARBOPLATIN#0.7602;SQUARE WAVE VOLTAMMETRY#0.7588;HUMAN PANCREATIC CANCER#0.7582;MODAL#0.7572;INDIUM TIN OXIDE#0.7551;CHONDROSARCOMA#0.7551;WORLD HEALTH ORGANIZATION#0.7550;SCANNING ELECTRON MICROSCOPY#0.7539;CERVICAL SQUAMOUS CELL CARCINOMA#0.7522;IMMUNOGLOBULIN G#0.7517;HEPATIC ARTERY#0.7484;SYNOVIAL SARCOMA#0.7481;NECK CANCER#0.7475;LEUCOVORIN#0.7449;LOCALISATION#0.7442;HYALURONIC ACID#0.7418;HUMAN PAPILLOMA VIRUS#0.7405;VENOUS BLOOD#0.7397;MONOCYTE#0.7397;SMALL INTESTINE#0.7380;CELL MIGRATION#0.7357;ORAL SQUAMOUS CELL CARCINOMA#0.7345;HUMAN LEUKOCYTE ANTIGEN#0.7331;HEMORRHAGE#0.7322;ANAPLASTIC CARCINOMA#0.7308;S PHASE#0.7301;VULVA#0.7293;SIGMOID COLON CANCER#0.7264;METHOTREXATE#0.7238;CONJUGATION#0.7235;RECEIVER OPERATING CURVE#0.7232;AGGRESSIVE BEHAVIOR#0.7228;PULMONARY TUBERCULOSIS#0.7221;CELL DEATH#0.7220;RELATIVE STANDARD DEVIATION#0.7195;ADENOSINE DEAMINASE#0.7169;LARGE INTESTINE#0.7164;BILE DUCT CARCINOMA#0.7144;METASTATIC COLORECTAL CARCINOMA#0.7133;PARAGANGLIOMA#0.7131;CREATINE KINASE#0.7124;ERYTHROCYTE#0.7118;PAROTID GLAND#0.7116;ALANINE#0.7114;TRANSVERSE COLON#0.7110;INVASIVE DUCTAL CARCINOMA#0.7104;TRICOM#0.7089;ONCOGENIC#0.7078;DUCTAL CELL#0.7070;LAYER BY LAYER#0.7059;DYSPNEA#0.7054;DESMOSOME#0.7042;DUODENUM#0.7031;VACUOLE#0.7024;NEGATIVE LIKELIHOOD RATIO#0.7008;HEMATURIA#0.7007;PLEURAL DISEASE#0.6994;YOLK SAC#0.6983;BILE DUCT CANCER#0.6983;INGUINAL LYMPH NODE#0.6974;HYPOXIA#0.6945;CATALYTIC ACTIVITY#0.6924;INFLAMMATORY CELL#0.6918;WILMS TUMOR 1#0.6918;NUCLEOSOME#0.6915;ANAL CANAL#0.6904;LUNG SQUAMOUS CELL CARCINOMA#0.6901;MEDIASTINUM#0.6898;TRANSFORMING GROWTH FACTOR#0.6886;CENTRAL NERVOUS SYSTEM#0.6885;SECRETORY GRANULE#0.6879;OVERALL SURVIVAL TIME#0.6873;CIRCULATING TUMOUR CELLS#0.6866;PROTEIN KINASE#0.6865;MITOMYCIN#0.6862;HEAT SHOCK PROTEIN#0.6840;MYOBLAST#0.6811;METASTATIC COLORECTAL CANCER#0.6810;PELVIC LYMPH NODE#0.6808;LUNG LESIONS#0.6800;ENDOCRINE CELL#0.6800;GALECTIN#0.6796;BRUSH BORDER#0.6796;HEAD AND NECK CANCER#0.6790;PRIMARY BRAIN TUMORS#0.6765;ENDOPLASMIC RETICULUM#0.6755;SYRINGOMA#0.6755;BILIARY TRACT DISEASE#0.6754;ASCENDING COLON#0.6724;MELANOCYTE#0.6717;COLLAGEN TYPE IV#0.6715;ORAL CAVITY#0.6705;CANCER SPECIFIC SURVIVAL#0.6700;PERITONEAL CARCINOMA#0.6683;HIGH GRADE DYSPLASIA#0.6674;HEPATOCYTE NUCLEAR FACTOR#0.6672;GRANULOCYTE COLONY STIMULATING FACTOR#0.6665;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.6650;CELL MATURATION#0.6644;BLADDER ADENOCARCINOMA#0.6639;MALIGNANT LYMPHOMA#0.6629;FOLATE#0.6618;SIGNALING PATHWAY#0.6611;EDEMA#0.6597;OVARIAN MUCINOUS CYSTADENOCARCINOMA#0.6570;CHOLANGITIS#0.6555;ETOPOSIDE#0.6553;SECRETORY CELL#0.6514;EPSTEIN BARR VIRUS#0.6513;UMBILICAL CORD#0.6504;FOWLPOX#0.6475;CHONDROID CHORDOMA#0.6435;ERYTHEMA#0.6427;LUNG METASTASIS#0.6424;CREATINE#0.6419;DETECTION OF TUMOR CELL#0.6403;ADRENAL GLAND#0.6394;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.6393;ERYTHROCYTE SEDIMENTATION RATE#0.6390;MESOTHELIUM#0.6384;PLATELET-DERIVED GROWTH FACTOR#0.6382;CHOLECYSTITIS#0.6370;LYSIS#0.6347;HYPERTENSION#0.6346;DISEASE SPECIFIC SURVIVAL#0.6271;OVERALL RESPONSE RATE#0.6248;BOWEL OBSTRUCTION#0.6244;ASCORBIC ACID#0.6226;INTESTINAL EPITHELIAL CELL#0.6225;OVARIAN SEROUS TUMOR#0.6222;GLUTATHIONE#0.6205;HOST CELL#0.6197;REGULATORY T CELL#0.6196;HIDRADENOMA#0.6190;MUTAGENESIS#0.6181;CERVICAL INTRAEPITHELIAL NEOPLASIA#0.6171;ALVEOLAR MACROPHAGE#0.6151;CYSTIC TERATOMA#0.6148;TUMOR NODE METASTASIS#0.6136;CELL SURFACE ANTIGEN#0.6134;PHOSPHOLIPASE C#0.6131;INVASIVE BREAST CANCER#0.6104;RESPIRATORY FAILURE#0.6103;INSULIN-LIKE GROWTH FACTOR#0.6097;METASTATIC GASTRIC CANCER#0.6062;DIED OF DISEASE#0.6056;SIGNAL TRANSDUCTION#0.6049;UROTHELIAL CELL CARCINOMA#0.6044;FLUORESCEIN#0.6035
10490	SYNAPTIC VESICLE#1.0212;SNARE COMPLEX#1.0193;LATE ENDOSOME#1.0109;SECRETORY VESICLE#1.0105;ENDOSOME#1.0078;TRANSPORT VESICLE#1.0026;EXOCYTOSIS#0.9973;VACUOLE#0.9946;LYSOSOME#0.9883;N-ETHYLMALEIMIDE#0.9881;VESICLE FUSION#0.9871;MEMBRANE FUSION#0.9858;PLASMA MEMBRANE#0.9852;ENDOPLASMIC RETICULUM#0.9790;SNARE BINDING#0.9732;CELL SURFACE#0.9653;TRANS GOLGI NETWORK#0.9639;COPII VESICLE#0.9403;PROTEIN COMPLEX#0.9376;VESICLE TRANSPORT#0.9350;EARLY ENDOSOME#0.9271;VESICLE DOCKING#0.9230;SNAP RECEPTOR#0.9128;ORGANELLE#0.9127;NEUROTRANSMITTER RELEASE#0.9107;ENDOCYTOSIS#0.9082;RECYCLING ENDOSOME#0.9007;COATED VESICLE#0.8597;COMPLEX I#0.8500;SECRETORY PATHWAY#0.8420;ADIPOCYTE#0.8418;GOLGI APPARATUS#0.8415;INTRACELLULAR MEMBRANE#0.7991;GOLGI MEMBRANE#0.7834;VESICULAR TRANSPORT#0.7763;NEUROTOXIN#0.7707;AUTOPHAGY#0.7680;GENE EXPRESSION#0.7661;BUDDING#0.7584;VESICLE EXOCYTOSIS#0.7411;CONSTITUTIVE EXOCYTOSIS#0.7403;MICROTUBULE#0.7267;TOTAL INTERNAL REFLECTION#0.7185;MACROPHAGE#0.7152;LATE GOLGI#0.7109;AUTOPHAGOSOME#0.7105;RNA INTERFERENCE#0.7077;VACUOLE FUSION#0.7070;CLATHRIN COATED VESICLE#0.6763;VESICLE FORMATION#0.6762;PHAGOCYTOSIS#0.6749;NERVE TERMINAL#0.6670;CELL WALL#0.6645;SYNAPTIC VESICLE FUSION#0.6560;EPITHELIAL CELL#0.6475;DENSE CORE VESICLE#0.6466;GOLGI STACK#0.6406;SNARE COMPLEX ASSEMBLY#0.6396;EXOCYST#0.6314;PHAGOSOME#0.6305;NEUROTRANSMISSION#0.6147
10491	CYCLOPHILIN#1.0445;OSTEOGENESIS IMPERFECTA#1.0265;OSTEOGENESIS#1.0175;ENDOPLASMIC RETICULUM#0.9832;COLLAGEN TYPE I#0.8285;POST-TRANSLATIONAL MODIFICATION#0.8014;CONNECTIVE TISSUE#0.7069;EXTRACELLULAR MATRIX#0.6651;OSTEOPOROSIS#0.6518;COLE-CARPENTER SYNDROME#0.6447;COMPLEX I#0.6381
10492	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#1.1056;RNA BINDING#1.0547;RNA BINDING PROTEIN#1.0545;GAIT COMPLEX#0.9911;RIBOSOMAL PROTEIN#0.8993;GLYCERALDEHYDE-3-PHOSPHATE#0.8410;GENE EXPRESSION#0.7804;STEM CELL#0.7415;MRNA BINDING#0.7263;RNA EDITING#0.7052;INSULIN RECEPTOR#0.6925;RNA RECOGNITION MOTIF#0.6798;APOBEC#0.6615;MRNA TRANSPORT#0.6318;T CELL#0.6305;RNA REPLICATION#0.6297;NEUROMUSCULAR JUNCTION#0.6194;SPINAL MUSCULAR ATROPHY#0.6171;MUSCULAR ATROPHY#0.6149
10493	SYNAPTIC VESICLE#1.0894;VESICLE MEMBRANE#0.9705;SYNAPTIC VESICLE MEMBRANE#0.8928;CANCER CELL#0.8592;ATPASE ACTIVITY#0.6572;PLASMA MEMBRANE#0.6494;CELL PROLIFERATION#0.6369
10494	PROTEIN KINASE#1.0443;HIGH FAT DIET#0.9949;CELL DEATH#0.9760;GERMINAL CENTER#0.9204;LIPID DROPLET#0.9148;SIGNALING PATHWAY#0.8890;GENE EXPRESSION#0.8783;APOPTOSIS#0.8753;SKELETAL MUSCLE#0.8608;CELL PROLIFERATION#0.8448;LIPID METABOLISM#0.8223;CELL MIGRATION#0.8195;CANCER CELL#0.8166;MYOBLAST#0.7842;TYPE 2 DIABETES#0.7650;KINASE ACTIVITY#0.7155;TUMOR SUPPRESSOR#0.7074;LIPID OXIDATION#0.7049;GLUCOSE UPTAKE#0.6961;SIGNAL TRANSDUCTION#0.6648;GOLGI APPARATUS#0.6544;CEREBRAL CAVERNOUS MALFORMATION#0.6497;LIPID STORAGE#0.6367;APOPTOTIC CELL DEATH#0.6153;PANCREAS DISEASE#0.6136
10495	PHENOXODIOL#1.0776;CELL SURFACE#1.0623;PLASMA MEMBRANE#1.0536;CANCER CELL#1.0497;APOPTOSIS#0.9835;CELL GROWTH#0.8980;GREEN TEA CATECHIN#0.8463;ELECTRON TRANSPORT#0.8228;CELL PROLIFERATION#0.8208;EPIGALLOCATECHIN#0.7325;HUMAN CERVICAL CARCINOMA#0.6451;ADENINE#0.6388;MALIGNANT MESOTHELIOMA#0.6321;CERVICAL#0.6086;PROTEIN KINASE#0.6060
10497	SYNAPTIC VESICLE PRIMING#1.0890;VESICLE EXOCYTOSIS#1.0575;SNARE COMPLEX ASSEMBLY#1.0539;SNARE COMPLEX#1.0389;CAM BINDING#1.0293;EXOCYTOSIS#1.0230;NEUROTRANSMITTER RELEASE#1.0226;SYNAPTIC TRANSMISSION#1.0201;SYNAPTIC VESICLE#1.0177;VESICLE FUSION#1.0168;SYNAPTIC VESICLE EXOCYTOSIS#1.0152;PROTEIN KINASE C#1.0131;PROTEIN KINASE#1.0129;MAST CELL#1.0042;MEMBRANE FUSION#1.0036;PLASMA MEMBRANE#0.9905;PRESYNAPTIC ACTIVE ZONE#0.9794;DENSE CORE VESICLE#0.9724;NERVOUS SYSTEM#0.9700;VESICLE DOCKING#0.9696;NEUROMUSCULAR JUNCTION#0.9637;NERVE TERMINAL#0.9400;SECRETORY GRANULE#0.9329;N-ETHYLMALEIMIDE#0.9327;SYNAPTIC VESICLE FUSION#0.8460;RIBBON SYNAPSE#0.8401;SNARE BINDING#0.8341;NEUROENDOCRINE CELL#0.8293;PHOTORECEPTOR RIBBON SYNAPSE#0.7919;MAST CELL DEGRANULATION#0.7703;PRESYNAPTIC TERMINAL#0.7419;ACETYLCHOLINE#0.7403;LYSOSOME#0.7372;REGULATED EXOCYTOSIS#0.7334;HYPERGLYCEMIA#0.7327;NEUROTRANSMISSION#0.7309;CALCIUM CHANNEL#0.6958;CHROMAFFIN CELL#0.6937;SECRETORY CELL#0.6878;ETHANOL#0.6854;GOBLET CELL#0.6654;CALMODULIN BINDING#0.6633;READILY RELEASABLE POOL#0.6608;SYNAPTOGENESIS#0.6605;FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS#0.6549;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS#0.6448;SYNAPTIC VESICLE PROTEIN#0.6445;SECRETORY PATHWAY#0.6351;SIGNALING PATHWAY#0.6305;SYNAPTIC VESICLE CYCLE#0.6281;ACTION POTENTIAL#0.6260;PARALLEL FIBER#0.6129;GLUTAMATERGIC SYNAPSE#0.6048;PURKINJE CELL#0.6002
10498	METHYLTRANSFERASE ACTIVITY#1.0700;STEM CELL#1.0429;BREAST CANCER#1.0370;ARGININE#1.0303;CANCER CELL#1.0276;TRANSCRIPTION FACTOR#1.0191;AUTOPHAGY#1.0180;CELL CYCLE#1.0176;HISTONE METHYLATION#1.0167;ESTROGEN RECEPTOR#1.0138;GENE EXPRESSION#1.0082;CHROMATIN REMODELING#1.0042;CELL PROLIFERATION#0.9975;PROTEIN METHYLTRANSFERASE#0.9973;STEROID RECEPTOR COACTIVATOR#0.9962;SIGNALING PATHWAY#0.9923;APOPTOSIS#0.9884;BREAST CANCER CELL#0.9830;HISTONE METHYLTRANSFERASE#0.9822;EPITHELIAL CELL#0.9557;LYSINE#0.9517;HISTONE ACETYLTRANSFERASE#0.9507;SKELETAL MUSCLE#0.9492;OVARIAN CANCER#0.9491;CREB BINDING#0.9457;TRANSACTIVATION#0.9437;CELL PENETRATING PEPTIDE#0.9434;EMBRYONIC STEM CELL#0.9311;ONCOGENIC#0.9288;GLUCOCORTICOID RECEPTOR#0.9276;COLORECTAL CANCER#0.9201;POST-TRANSLATIONAL MODIFICATION#0.9013;HISTONE MODIFICATION#0.8779;LUNG CANCER#0.8700;RNA BINDING#0.8585;RECEPTOR INTERACTING PROTEIN#0.8485;ANDROGEN RECEPTOR#0.8467;LIPID METABOLISM#0.8407;PROTEIN KINASE#0.8286;POSTTRANSLATIONAL MODIFICATION#0.8282;NUCLEAR HORMONE RECEPTOR#0.8265;T CELL#0.8135;TUMOR SUPPRESSOR#0.8027;CELL GROWTH#0.8020;PROTEIN METHYLTRANSFERASE ACTIVITY#0.8010;OVARIAN#0.7978;ADIPOCYTE DIFFERENTIATION#0.7976;COLORECTAL#0.7950;LIVER CANCER#0.7940;N METHYLTRANSFERASE#0.7937;GLUCOSE METABOLISM#0.7906;ESTROGEN RECEPTOR ALPHA#0.7905;CELL DIFFERENTIATION#0.7870;CAMP RESPONSE ELEMENT BINDING#0.7802;CAMP RESPONSE ELEMENT#0.7791;PROTEIN PROTEIN INTERACTION#0.7708;UBIQUITIN#0.7695;MUSCULAR ATROPHY#0.7694;C TERMINAL DOMAIN#0.7641;PROSTATE CANCER#0.7588;HEMATOPOIESIS#0.7377;CYTOPLASM#0.7376;SENESCENCE#0.7354;DNA BINDING#0.7294;HISTONE ARGININE METHYLATION#0.7261;POLYMERASE CHAIN REACTION#0.7195;BLASTOMERE#0.7076;SPINAL MUSCULAR ATROPHY#0.7027;PRE-MRNA SPLICING#0.7022;MRNA SPLICING#0.6991;RNA BINDING PROTEIN#0.6950;INNER CELL MASS#0.6919;MYOGENESIS#0.6914;ADENOSINE#0.6907;HUMAN EMBRYONIC STEM#0.6849;HUMAN BREAST CANCER#0.6782;PROTEIN METHYLATION#0.6772;REGULATION OF GENE EXPRESSION#0.6686;GROWTH FACTOR#0.6584;L-METHIONINE#0.6426;ADIPOCYTE#0.6361;ADIPOGENESIS#0.6322;MAINTENANCE OF PLURIPOTENCY#0.6316;PROTEIN BINDING#0.6304;S-ADENOSYLMETHIONINE#0.6301;PEROXISOME#0.6236;S PHASE#0.6227;ACETYLTRANSFERASE ACTIVITY#0.6172;MUSCLE STEM CELL#0.6151;MYOCYTE ENHANCER FACTOR#0.6112
10499	MESENCHYMAL CHONDROSARCOMA#1.0758;RECEPTOR INTERACTING PROTEIN#1.0551;STEROID RECEPTOR COACTIVATOR#1.0269;GLUCOCORTICOID RECEPTOR#1.0208;HISTONE ACETYLTRANSFERASE#1.0203;CREB BINDING#1.0194;CHONDROSARCOMA#1.0142;ACUTE MYELOID LEUKEMIA#1.0130;MYELOID LEUKEMIA#1.0118;PROTEIN PROTEIN INTERACTION#1.0118;MAMMARY GLAND#1.0118;RETINOIC ACID#1.0060;PROTEIN KINASE#1.0025;THYROID HORMONE RECEPTOR#1.0020;BREAST CANCER#1.0008;ESTROGEN RECEPTOR ALPHA#0.9994;TRANSACTIVATION#0.9973;NUCLEAR HORMONE RECEPTOR#0.9948;PROSTATE CANCER#0.9920;BREAST CANCER CELL#0.9887;CELL PROLIFERATION#0.9870;DNA BINDING#0.9866;ANDROGEN RECEPTOR#0.9864;PROGESTERONE#0.9853;ARGININE#0.9842;VITAMIN D RECEPTOR#0.9841;LIGAND BINDING DOMAIN#0.9841;STROMAL CELL#0.9815;CANCER CELL#0.9815;CELL CYCLE#0.9800;HORMONE BINDING#0.9796;RETINOID X RECEPTOR#0.9794;ENDOMETRIUM#0.9772;ESTROGEN RECEPTOR#0.9766;CAMP RESPONSE ELEMENT BINDING#0.9766;POLYMERASE CHAIN REACTION#0.9765;ESTRADIOL#0.9763;CAMP RESPONSE ELEMENT#0.9754;GROWTH FACTOR#0.9752;UTERUS#0.9728;GENE EXPRESSION#0.9672;TRANSCRIPTION FACTOR#0.9670;SIGNALING PATHWAY#0.9667;PROTEIN BINDING#0.9634;SERTOLI CELL#0.9627;SKELETAL MUSCLE#0.9594;STEROID HORMONE RECEPTOR#0.9545;GLUTATHIONE#0.9504;TUMOR NECROSIS FACTOR#0.9326;RETINOIC ACID RECEPTOR#0.9237;PEROXISOME#0.9233;EPITHELIAL CELL#0.9224;ESTROGEN RESPONSE ELEMENT#0.9105;HISTONE ACETYLATION#0.9092;RECEPTOR BINDING#0.9086;APOPTOSIS#0.9046;REVERSE TRANSCRIPTION#0.9038;TAMOXIFEN#0.8986;LIVER CANCER#0.8790;CONSTITUTIVE ANDROSTANE RECEPTOR#0.8746;DECIDUALIZATION#0.8724;STEM CELL#0.8693;MACROPHAGE#0.8632;MUTAGENESIS#0.8577;RHABDOMYOSARCOMA#0.8557;DEXAMETHASONE#0.8539;NUCLEAR RECEPTOR SUPERFAMILY#0.8537;NUCLEAR RECEPTOR BINDING#0.8518;CELL GROWTH#0.8461;DIHYDROTESTOSTERONE#0.8445;BICALUTAMIDE#0.8425;TUMOR SUPPRESSOR#0.8385;CYTOPLASM#0.8355;SMOOTH MUSCLE#0.8277;SIGNAL TRANSDUCTION#0.8211;OVARIAN#0.8192;RECEPTOR LIGAND#0.8192;C TERMINAL DOMAIN#0.8120;RECEPTOR ACTIVITY#0.7975;ADIPOSE TISSUE#0.7961;HYPOXIA#0.7907;COLORECTAL#0.7905;EPIDERMAL GROWTH FACTOR#0.7903;RU486#0.7857;ZINC FINGER PROTEIN#0.7822;BONE MARROW#0.7785;CHROMATIN REMODELING#0.7708;METHYLTRANSFERASE ACTIVITY#0.7704;MITOGEN ACTIVATED PROTEIN#0.7644;ADIPOCYTE#0.7577;HISTONE DEACETYLASE#0.7567;MONOCYTIC LEUKEMIA#0.7518;ESTROGENS#0.7483;KUPFFER CELL#0.7468;ACTIVATOR PROTEIN 1#0.7449;PROTEIN KINASE A#0.7405;REPORTER GENE ASSAY#0.7396;4-HYDROXYTAMOXIFEN#0.7385;HEPATOCYTE NUCLEAR FACTOR#0.7318;EMBRYO IMPLANTATION#0.7309;ONCOGENIC#0.7287;RESONANCE ENERGY TRANSFER#0.7247;COMPLEX I#0.7202;MUSCLE CELL#0.7173;UBIQUITIN#0.7162;PROTEASOME#0.7145;ICI 182,780#0.7127;SUMOYLATION#0.7081;ACETYLTRANSFERASE ACTIVITY#0.7079;LIVER X RECEPTOR#0.7079;HISTONE MODIFICATION#0.7068;PROSTATE SPECIFIC ANTIGEN#0.7042;SMOOTH MUSCLE CELL#0.6993;LEUCINE#0.6976;SIGNALING CASCADE#0.6952;PEPTIDE BINDING#0.6925;HISTONE ACETYL TRANSFERASE#0.6921;TUMOR CELLS#0.6906;ACUTE LEUKEMIA#0.6899;ARYL HYDROCARBON RECEPTOR#0.6886;LIPID METABOLISM#0.6858;MECHANISM OF ACTION#0.6851;LYSINE#0.6839;HISTONE ACETYLTRANSFERASE ACTIVITY#0.6654;GROWTH FACTOR RECEPTOR#0.6435;ANDROGEN INSENSITIVITY SYNDROME#0.6429;MYOBLAST#0.6337;SPINDLE CELL RHABDOMYOSARCOMA#0.6321;RECEPTOR TRANSACTIVATION#0.6282;GERM CELL#0.6260;TRANSFORMING GROWTH FACTOR#0.6253;PREGNANE X RECEPTOR#0.6214;ENERGY HOMEOSTASIS#0.6205;INFERTILITY#0.6202;MORPHOGENESIS#0.6153;ACUTE MYELOID LEUKAEMIA#0.6107;TRANSCRIPTASE#0.6087;APOPTOTIC#0.6061;EMBRYONAL RHABDOMYOSARCOMA#0.6038;17β-ESTRADIOL#0.6015
104	AXIAL ELEMENT#1.0608;MEIOSIS#1.0244;AMPA RECEPTOR#1.0226;GLUTAMATE RECEPTOR#1.0133;RNA BINDING#1.0108;RNA EDITING#1.0103;ADENOSINE DEAMINASE#1.0011;ADENOSINE#0.9974;AMYOTROPHIC LATERAL SCLEROSIS#0.9960;LATERAL SCLEROSIS#0.9959;MRNA EDITING#0.9937;INOSINE#0.9855;SYNAPTONEMAL COMPLEX#0.9830;MEIOTIC CHROMOSOME#0.9798;GENE EXPRESSION#0.9790;DOUBLE-STRANDED RNA BINDING#0.9750;ARGININE#0.9716;DOUBLE STRAND BREAK#0.9497;GLUTAMINE#0.9228;DEAMINASE ACTIVITY#0.9163;SYNAPSIS#0.9066;DSRNA BINDING#0.9048;ASTROCYTE#0.8834;NERVOUS SYSTEM#0.8827;BUDDING#0.8817;PACHYTENE#0.8510;CHROMATID#0.8362;PROPHASE#0.8268;DNA BINDING#0.8147;LATERAL ELEMENT#0.8104;MEIOSIS I#0.7955;DNA DAMAGE CHECKPOINT#0.7846;SPINAL CORD#0.7791;PROTEIN KINASE#0.7784;ASTROCYTOMA#0.7633;TUMOR SUPPRESSOR#0.7602;TRANSCRIPTION FACTOR#0.7593;NEUROTRANSMITTER RECEPTOR#0.7550;ION CHANNEL#0.7449;SPORULATION#0.7321;NUCLEOLUS#0.7262;CELL CYCLE#0.7245;RNA INTERFERENCE#0.7160;KINASE ACTIVITY#0.7053;RNA BINDING PROTEIN#0.6930;IMMUNE RESPONSE#0.6841;MEIOTIC RECOMBINATION CHECKPOINT#0.6838;CANCER CELL#0.6735;CYTOPLASM#0.6657;FLUOXETINE#0.6657;CHROMOSOME SEGREGATION#0.6628;EXOSOME#0.6564;SEROTONIN RECEPTOR#0.6559;GENE SILENCING#0.6511;CATALYTIC ACTIVITY#0.6509;GUANOSINE#0.6506;CELL DEATH#0.6466;MUTAGENESIS#0.6447;ADENOSINE TO INOSINE EDITING#0.6387;FOREBRAIN#0.6364;BIPOLAR DISORDER#0.6356;INNATE IMMUNE RESPONSE#0.6329;EPILEPSY#0.6231;POLYMERASE CHAIN REACTION#0.6128;ZINC FINGER PROTEIN#0.6125;DNA REPAIR#0.6057;CYTOPLASMIC INCLUSION#0.6048
10500	GROWTH CONE#0.8275;PRIMORDIAL FOLLICLE ACTIVATION#0.6790;SKELETAL MUSCLE#0.6698;RETINAL DEVELOPMENT#0.6362;CELL JUNCTION#0.6263
10501	AXON GUIDANCE#0.8953;BREAST CANCER#0.8291;GENE EXPRESSION#0.7794;RETINOIC ACID#0.7752;CANCER CELL#0.7104;FENOFIBRATE#0.6287
105031671	SYNCOPE#1.0516;LOSS OF CONSCIOUSNESS#1.0478;BRADYCARDIA#1.0393;TACHYCARDIA#1.0297;HYPOTENSION#1.0170;METOPROLOL#0.9909;CAROTID SINUS#0.9602;NITROGLYCERIN#0.9523;SYSTOLIC BLOOD PRESSURE#0.9245;HEART RATE VARIABILITY#0.9169;NERVOUS SYSTEM#0.9150;RANDOMIZED CONTROLLED TRIAL#0.8752;VASOCONSTRICTION#0.8597;NOREPINEPHRINE#0.7828;ADENOSINE#0.7563;NITRIC OXIDE#0.7468;MIDODRINE#0.7443;MIDODRINE HYDROCHLORIDE#0.7388;HEART DISEASE#0.7019;EPINEPHRINE#0.6997;VENOUS BLOOD#0.6794;HYPERSENSITIVITY#0.6632;FLUOXETINE#0.6388;ARGININE VASOPRESSIN#0.6371;STRUCTURAL HEART DISEASE#0.6354;PROPRANOLOL#0.6345;ADRENERGIC RECEPTOR#0.6325;ABDOMINAL PAIN#0.6000
10505	PROSTATE CANCER#0.6672;CANCER CELL#0.6508;POST SYNAPTIC DENSITY#0.6446;BREAST CANCER#0.6010
10507	GROWTH CONE COLLAPSE#1.0705;GROWTH CONE#1.0598;OLIGODENDROCYTE#1.0589;ENDOTHELIAL CELL#1.0485;ANGIOGENESIS#1.0443;DENDRITIC CELL#1.0422;PERIPHERAL BLOOD#1.0399;GROWTH FACTOR#1.0398;B CELL#1.0382;T CELL#1.0377;T LYMPHOCYTE#1.0366;CELL PROLIFERATION#1.0358;OSTEOCLAST#1.0354;MACROPHAGE#1.0345;BONE FORMATION#1.0344;OSTEOBLAST#1.0318;IMMUNE SYSTEM#1.0278;CANCER CELL#1.0268;CELL ACTIVATION#1.0243;CELL SURFACE#1.0238;SQUAMOUS CELL CARCINOMA#1.0224;BREAST CANCER#1.0223;IMMUNE RESPONSE#1.0199;AXON GUIDANCE#1.0148;SIGNALING PATHWAY#1.0124;GAP ACTIVITY#1.0083;CELL MIGRATION#1.0083;MONOCYTE#1.0022;NERVOUS SYSTEM#1.0018;APOPTOSIS#0.9961;IMMUNE CELL#0.9863;TUMOR CELLS#0.9849;RAS GAP ACTIVITY#0.9754;OVARIAN CANCER#0.9610;B LYMPHOCYTE#0.9467;INHIBITORY SYNAPSE#0.9458;INFLAMMATORY RESPONSE#0.9353;OVARIAN#0.9337;LYMPH NODE#0.9277;NEURITE#0.9274;HYPOXIA#0.9225;SPINAL CORD#0.9199;EPITHELIAL CELL#0.9129;HEPATITIS C#0.9103;MULTIPLE SCLEROSIS#0.9073;BONE RESORPTION#0.9029;KERATINOCYTE#0.8810;RHOGEF#0.8809;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8774;ENDOTHELIAL GROWTH FACTOR#0.8773;HEPATITIS C VIRUS#0.8753;T CELL ACTIVATION#0.8714;INVASIVE GROWTH#0.8679;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.8617;TUMOR ASSOCIATED MACROPHAGE#0.8573;ENDOTHELIAL CELL MIGRATION#0.8547;NEURITE OUTGROWTH#0.8545;PROTEIN TYROSINE PHOSPHATASE#0.8541;LYMPH NODE METASTASIS#0.8530;BONE MARROW#0.8527;LEUKOCYTE#0.8515;PLATELET ACTIVATION#0.8500;MIDDLE CEREBRAL ARTERY#0.8494;CEREBRAL ARTERY#0.8490;OSTEOBLAST DIFFERENTIATION#0.8483;COLORECTAL#0.8462;GENE EXPRESSION#0.8449;CD8+ T CELL#0.8433;CELL ADHESION#0.8422;AXONAL GROWTH CONE#0.8359;HYPOXIA INDUCIBLE FACTOR#0.8182;SYNAPSE DEVELOPMENT#0.8166;BONE REMODELING#0.8090;T CELL PROLIFERATION#0.8051;CEREBRAL ARTERY OCCLUSION#0.8047;COLORECTAL CARCINOMA#0.8037;PROSTATE CANCER#0.8000;STEM CELL#0.7992;COLON CANCER#0.7978;CENTRAL NERVOUS SYSTEM#0.7970;SIGNALING MOLECULE#0.7911;REGENERATION#0.7884;COLORECTAL CANCER#0.7865;PROGENITOR CELL#0.7865;SIGNAL TRANSDUCTION#0.7698;ATHEROSCLEROSIS#0.7532;OSTEOPOROSIS#0.7514;WOUND HEALING#0.7485;BONE MINERAL DENSITY#0.7450;BREAST CANCER PATIENTS#0.7308;ANTIGEN PRESENTING CELLS#0.7286;RHEUMATOID ARTHRITIS#0.7282;PERICYTE#0.7174;SPINAL CORD INJURY#0.7152;NUCLEOTIDE EXCHANGE FACTOR#0.7114;BREAST CANCER CELL#0.7094;RECEPTOR TYROSINE KINASE#0.7069;EPITHELIAL OVARIAN CANCER#0.6986;LYMPHOID TISSUE#0.6954;CEREBRAL ISCHEMIA#0.6949;BLOOD BRAIN BARRIER#0.6928;OLIGODENDROCYTE PROGENITOR CELL#0.6925;KINASE ACTIVITY#0.6911;LUNG CANCER#0.6889;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6823;BONE DISEASE#0.6817;ATHEROSCLEROTIC#0.6806;RECEPTOR ACTIVATOR#0.6803;ARTERY#0.6801;EPITHELIAL MESENCHYMAL TRANSITION#0.6786;HEMATOPOIETIC CELL#0.6779;DEPHOSPHORYLATION#0.6767;NEURAL CELL#0.6763;MORPHOGENESIS#0.6745;DISEASE FREE SURVIVAL#0.6737;GROWTH FACTOR RECEPTOR#0.6488;SERINE KINASE ACTIVITY#0.6486;EXTRACELLULAR REGION#0.6385;ISCHEMIA#0.6340;TUBE FORMATION#0.6323;APOPTOTIC#0.6304;CELL DIFFERENTIATION#0.6304;PRESYNAPTIC BOUTON#0.6267;AXON REGENERATION#0.6214;GUANINE#0.6146;DENTAL PULP STEM CELL#0.6109;BRANCHING MORPHOGENESIS#0.6082;CELL AGGREGATION#0.6079;CD4+ T CELL#0.6066;CELL DEATH#0.6039;SOFT TISSUE SARCOMA#0.6026;CELL CYCLE#0.6023;DENTAL PULP#0.6018
10509	LUNG CANCER#1.0111;BONE MARROW#0.7705;SIGNALING PATHWAY#0.7098
1050	GRANULOCYTE DIFFERENTIATION#1.0600;FETAL LIVER#1.0318;CAAT ENHANCER BINDING#1.0285;LIVER DEVELOPMENT#1.0252;INTERNAL TANDEM DUPLICATION#1.0246;STEROL REGULATORY ELEMENT#1.0245;LIPOPROTEIN LIPASE#1.0230;FATTY ACID SYNTHASE#1.0209;BINDING PROTEIN 1#1.0206;FATTY ACID BINDING#1.0188;G-CSF#1.0185;HEPATOCYTE NUCLEAR FACTOR#1.0163;CELL CYCLE ARREST#1.0162;HEPATOCYTE PROLIFERATION#1.0162;PROTEIN PROTEIN INTERACTION#1.0150;PEROXISOME#1.0146;ENHANCER BINDING PROTEIN#1.0138;ENHANCER BINDING#1.0135;GRANULOCYTE COLONY STIMULATING FACTOR#1.0132;S PHASE#1.0103;TRANSCRIPTION FACTOR BINDING#1.0097;WHITE BLOOD CELL#1.0076;TUMOR SUPPRESSOR#1.0072;HYPOXIA#1.0072;KERATINOCYTE#1.0069;ACUTE MYELOID LEUKAEMIA#1.0049;GRANULOCYTE#1.0048;CAMP RESPONSE ELEMENT#1.0042;LUNG CANCER#1.0039;GLUCOCORTICOID RECEPTOR#1.0039;ELECTROPHORETIC MOBILITY SHIFT#1.0026;B CELL#1.0015;FACTOR I#1.0013;TRANSACTIVATION#1.0004;HEPATOMA CELLS#1.0003;LUNG DEVELOPMENT#0.9993;MITOTIC CLONAL EXPANSION#0.9991;LIPOGENESIS#0.9989;PROSTATE CANCER#0.9977;HEMATOPOIETIC CELL#0.9971;COLONY-STIMULATING FACTOR#0.9968;CANCER CELL#0.9967;ACETYL COA CARBOXYLASE#0.9951;TERMINAL DIFFERENTIATION#0.9949;NEUTROPHIL#0.9948;ACUTE PHASE RESPONSE#0.9943;LEUCINE#0.9942;HISTONE ACETYLATION#0.9942;EVENT FREE SURVIVAL#0.9940;MYELOID CELL#0.9940;LIVER REGENERATION#0.9937;DNA BINDING#0.9929;REVERSE TRANSCRIPTION#0.9926;STEAROYL COA DESATURASE#0.9916;FAT CELL#0.9913;BRM COMPLEX#0.9910;CORE BINDING FACTOR#0.9909;TRANSCRIPTION FACTOR#0.9906;PHOSPHOENOLPYRUVATE CARBOXYKINASE#0.9906;ADIPOCYTE#0.9894;CELL CYCLE#0.9891;DISEASE FREE SURVIVAL#0.9891;HEPATOCELLULAR CARCINOMA#0.9890;ACUTE LEUKEMIA#0.9883;BREAST CANCER#0.9878;MYELODYSPLASTIC SYNDROME#0.9875;MUTAGENESIS#0.9872;CYTOCHROME P450#0.9870;DNA METHYLATION#0.9869;RETINOIC ACID#0.9861;MACROPHAGE#0.9860;CLARA CELL#0.9860;POLYMERASE CHAIN REACTION#0.9847;CAMP RESPONSE ELEMENT BINDING#0.9844;HEMATOPOIESIS#0.9838;ONCOGENIC#0.9837;HYPOXIA INDUCIBLE FACTOR#0.9834;LIPID DROPLET#0.9829;T CELL#0.9822;INSULIN-LIKE GROWTH FACTOR#0.9820;REPORTER GENE ASSAY#0.9817;CELL GROWTH#0.9815;MONOCYTE#0.9815;ADIPOCYTE DIFFERENTIATION#0.9797;ADIPOGENESIS#0.9796;EPITHELIAL CELL#0.9795;REGENERATION#0.9793;ALL TRANS RETINOIC ACID#0.9786;DNA SYNTHESIS#0.9785;HISTONE DEACETYLASE#0.9785;GLUCOSE UPTAKE#0.9785;ACUTE MYELOID LEUKEMIA#0.9782;MYELOID LEUKEMIA#0.9781;CYCLIN DEPENDENT KINASE#0.9780;CELL DIFFERENTIATION#0.9779;HEPATIC NUCLEAR FACTOR#0.9773;PREADIPOCYTE#0.9770;CREB BINDING#0.9767;TUMOR NECROSIS FACTOR#0.9757;QUANTITATIVE REAL TIME#0.9756;PROGENITOR CELL#0.9751;CELL PROLIFERATION#0.9735;DEXAMETHASONE#0.9732;SIGNAL TRANSDUCER#0.9731;TRANSDIFFERENTIATION#0.9731;BROWN ADIPOSE TISSUE#0.9725;PHOSPHOENOLPYRUVATE#0.9722;HEMATOPOIETIC STEM CELL#0.9718;HORMONE SENSITIVE LIPASE#0.9716;OSTEOBLAST#0.9715;DNASE I#0.9713;SMOOTH MUSCLE#0.9710;LIPID METABOLISM#0.9705;WHITE ADIPOSE TISSUE#0.9701;STROMAL CELL#0.9697;GROWTH FACTOR#0.9685;RETINOID X RECEPTOR#0.9678;CELL DEVELOPMENT#0.9655;GROWTH HORMONE#0.9655;KINASE INHIBITOR#0.9654;STEM CELL TRANSPLANTATION#0.9646;ACTIVATOR PROTEIN 1#0.9643;OBESE#0.9642;GENE EXPRESSION#0.9640;GLUCONEOGENESIS#0.9637;ESTROGEN RECEPTOR#0.9630;PROTEIN BINDING#0.9623;SUBCUTANEOUS ADIPOSE TISSUE#0.9621;PRECURSOR CELL#0.9619;HIGH FAT DIET#0.9619;DEPHOSPHORYLATION#0.9606;ACUTE PROMYELOCYTIC LEUKEMIA#0.9605;APOPTOSIS#0.9604;PROTEIN KINASE#0.9604;BONE MARROW#0.9600;MITOGEN ACTIVATED PROTEIN#0.9598;ADIPOSE TISSUE#0.9598;PERIPHERAL BLOOD#0.9585;SIGNALING PATHWAY#0.9582;PROTEASOME#0.9579;SIGNAL TRANSDUCTION#0.9574;LIPOLYSIS#0.9567;MESENCHYMAL STEM CELL#0.9563;HEMATOPOIETIC PROGENITOR CELL#0.9560;MUSCLE CELL#0.9555;APOPTOTIC#0.9541;STEM CELL#0.9541;CELL DEATH#0.9517;GLUCOSE TRANSPORT#0.9509;INFLAMMATORY RESPONSE#0.9495;INSULIN RECEPTOR#0.9480;BREAST CANCER CELL#0.9474;CYCLIC AMP#0.9473;DNASE#0.9464;ESTRADIOL#0.9463;TYPE 2 DIABETES#0.9461;CHLORAMPHENICOL#0.9457;GLUCOSE METABOLISM#0.9455;REGULATION OF ADIPOGENESIS#0.9442;ALKALINE PHOSPHATASE#0.9426;WORLD HEALTH ORGANIZATION#0.9422;FOR ADIPOCYTE DIFFERENTIATION#0.9420;PROTEIN COMPLEX#0.9399;HEPATOCYTE DIFFERENTIATION#0.9395;CYTOPLASM#0.9392;TRANSFORMING GROWTH FACTOR#0.9386;RETINOBLASTOMA#0.9382;RELAPSE FREE SURVIVAL#0.9358;EXTRACELLULAR MATRIX#0.9333;GESTATION#0.9315;ENERGY HOMEOSTASIS#0.9296;TROGLITAZONE#0.9277;WEIGHT GAIN#0.9249;LUCIFERASE ACTIVITY#0.9248;LIPID BINDING PROTEIN#0.9218;TUMOR CELLS#0.9210;SQUAMOUS CELL CARCINOMA#0.9207;CHRONIC MYELOID LEUKEMIA#0.9197;TRANSCRIPTASE#0.9180;EPIDERMAL GROWTH FACTOR#0.9174;LIPID BINDING#0.9149;INHIBITION OF ADIPOGENESIS#0.9130;RETINOIC ACID RECEPTOR#0.9082;SUMOYLATION#0.9070;COENZYME A#0.9069;ALANINE#0.9068;ENDOTHELIAL CELL#0.9064;GM-CSF#0.9051;MAMMARY GLAND#0.9020;NEUTROPHIL DIFFERENTIATION#0.9014;SKELETAL MUSCLE#0.9005;MYELOBLAST#0.8999;MYELOID PROGENITOR CELL#0.8987;PROTEIN SYNTHESIS#0.8981;MOUSE EMBRYONIC FIBROBLAST#0.8980;TRANSCRIPTIONAL CONTROL#0.8964;CHROMATIN REMODELING#0.8961;ACUTE LYMPHOBLASTIC LEUKEMIA#0.8949;UBIQUITIN#0.8942;TRANSFORMING GROWTH FACTOR BETA#0.8913;MALIC ENZYME#0.8905;MAST CELL#0.8901;SMOOTH MUSCLE CELL#0.8894;TRANSLATION INITIATION#0.8890;PRO-INFLAMMATORY#0.8890;VASCULAR CELL#0.8867;OVARIAN#0.8866;ENDOPLASMIC RETICULUM#0.8866;DNA REPLICATION#0.8866;LIVER DISEASE#0.8837;TISSUE DEVELOPMENT#0.8777;FATTY LIVER#0.8768;LIVER X RECEPTOR#0.8756;GLUTATHIONE#0.8744;ROSIGLITAZONE#0.8711;BONE MARROW CELLS#0.8677;REACTIVE OXYGEN SPECIES#0.8648;MARROW STROMAL CELLS#0.8620;BONE MARROW STROMAL CELL#0.8620;BONE MARROW STROMAL#0.8616;CELLULAR TRANSCRIPTION#0.8596;GLUCOSE HOMEOSTASIS#0.8583;RNA INTERFERENCE#0.8573;A-GEL#0.8567;CELL NUCLEUS#0.8565;ADIPOSE TISSUE DEVELOPMENT#0.8562;ANDROGEN RECEPTOR#0.8515;LIGAND BINDING DOMAIN#0.8487;DEMETHYLATION#0.8483;SERUM ALBUMIN#0.8476;HETEROCHROMATIN#0.8471;LIPID HOMEOSTASIS#0.8448;FACTOR S#0.8423;LOW DENSITY LIPOPROTEIN#0.8396;SEBACEOUS GLAND#0.8396;RESONANCE ENERGY TRANSFER#0.8387;HISTONE DEACETYLASE INHIBITOR#0.8385;MAMMARY EPITHELIAL CELL#0.8376;LIVER CANCER#0.8375;KINASE ACTIVITY#0.8369;MYELOID NEOPLASM#0.8362;THYMIDINE#0.8354;MESENCHYMAL CELL#0.8336;MYOBLAST#0.8333;EPIDIDYMAL ADIPOSE TISSUE#0.8332;PROLIFERATING CELL NUCLEAR ANTIGEN#0.8324;IMMUNE RESPONSE#0.8323;MYELOPROLIFERATIVE NEOPLASM#0.8317;DENDRITIC CELL#0.8308;MECHANISM OF ACTION#0.8296;DIET INDUCED OBESITY#0.8293;GLUCOSE 6 PHOSPHATASE#0.8275;PROTEIN KINASE A#0.8262;BONE MORPHOGENETIC PROTEIN#0.8259;BASOPHIL#0.8257;ETHANOL#0.8254;MINIMAL RESIDUAL DISEASE#0.8240;CELL CYCLE CONTROL#0.8233;INSULIN RECEPTOR SUBSTRATE#0.8221;FATTY ACID OXIDATION#0.8216;CENTROMERIC HETEROCHROMATIN#0.8189;KAPOSI'S SARCOMA#0.8185;FAT PAD#0.8183;MORPHOGENESIS#0.8162;OSTEOBLAST DIFFERENTIATION#0.8160;GLYCOGEN SYNTHASE KINASE#0.8140;LEUKOCYTE#0.8123;OSTEOGENESIS#0.8117;GRANULOCYTE-MONOCYTE PROGENITOR#0.8045;BLAST CELL#0.8029;KERATINOCYTE DIFFERENTIATION#0.8029;ADENOSINE#0.8006;DIABETES MELLITUS#0.8001;HEPATOBLAST#0.7999;TYROSINE KINASE DOMAIN#0.7994;VITAMIN D RECEPTOR#0.7987;UNFOLDED PROTEIN RESPONSE#0.7986;3-ISOBUTYL-1-METHYLXANTHINE#0.7980;FATTY ACID SYNTHESIS#0.7940;TOXICITY#0.7927;REGULATION OF ADIPOCYTE DIFFERENTIATION#0.7921;STROMAL VASCULAR CELLS#0.7921;SIGNALING MOLECULE#0.7901;RNA BINDING PROTEIN#0.7893;REGULATION OF GENE EXPRESSION#0.7886;ADIPOGENIC DIFFERENTIATION MEDIUM#0.7880;RNA BINDING#0.7879;DNA HYPERMETHYLATION#0.7866;CELL SURFACE#0.7831;HAIR FOLLICLE#0.7820;HEPATOCYTE GROWTH FACTOR#0.7808;RAPAMYCIN#0.7802;SIGNALING CASCADE#0.7793;HUMAN ADIPOSE TISSUE#0.7783;LYSINE#0.7778;MONONUCLEAR CELLS#0.7766;MYELOID CELL DEVELOPMENT#0.7748;COMPLEX I#0.7692;GENE SILENCING#0.7623;POST-TRANSLATIONAL MODIFICATION#0.7619;MONOCYTE CHEMOATTRACTANT PROTEIN#0.7615;HYPOGLYCEMIA#0.7603;METHYLATION SPECIFIC POLYMERASE#0.7583;2'-DEOXYCYTIDINE#0.7581;LUNG EPITHELIAL CELL#0.7578;BODY WEIGHT GAIN#0.7577;QUANTITATIVE REVERSE TRANSCRIPTION#0.7562;CARNITINE#0.7535;MONOCYTE DIFFERENTIATION#0.7529;MAP KINASE#0.7518;NEUTROPENIA#0.7517;MITOCHONDRIA#0.7505;TYROSINE KINASE INHIBITOR#0.7497;ANEMIA#0.7491;FIBROBLAST GROWTH FACTOR#0.7484;VISCERAL ADIPOSE TISSUE#0.7449;HISTONE MODIFICATION#0.7446;BONE MARROW FAILURE#0.7434;5-AZA-2'-DEOXYCYTIDINE#0.7397;GRANULOSA CELL#0.7392;LYMPHOID CELL#0.7388;ALKALINE PHOSPHATASE ACTIVITY#0.7377;PHOSPHATASE ACTIVITY#0.7348;MYELOID CELL DIFFERENTIATION#0.7330;LIPID STORAGE#0.7282;PLASMA MEMBRANE#0.7257;MIXED LINEAGE LEUKEMIA#0.7243;PROMOTER BINDING#0.7240;OLEIC ACID#0.7228;DOMINANT NEGATIVE MUTANT#0.7228;ADIPOSE TISSUE MASS#0.7227;HEPATIC STELLATE CELL#0.7224;GROWTH FACTOR BINDING#0.7217;COMMON MYELOID PROGENITOR#0.7194;EOSINOPHIL#0.7170;CELL CYCLE REGULATOR#0.7167;BETA-2#0.7163;HUMAN MESENCHYMAL STEM#0.7161;MICROGLIAL CELL#0.7134;ATP BINDING#0.7118;HYPOXIC#0.7108;ERYTHROID PROGENITOR#0.7052;GROWTH FACTOR RECEPTOR#0.7023;NITRIC OXIDE#0.7015;NICOTINAMIDE#0.7014;ACTIVATING TRANSCRIPTION FACTOR#0.7003;SEVERE CONGENITAL NEUTROPENIA#0.6981;DNA METHYLTRANSFERASE#0.6970;PEROXISOME PROLIFERATION#0.6938;TYROSINE KINASE RECEPTOR#0.6927;IFN-GAMMA#0.6913;HEMATOPOIETIC CELL TRANSPLANTATION#0.6905;CELL DIVISION#0.6883;THYMIDINE KINASE#0.6853;CYCLIN DEPENDENT KINASE INHIBITOR#0.6836;TROPHOBLAST#0.6829;EPSTEIN BARR VIRUS#0.6787;PROGESTERONE#0.6772;TOLL LIKE RECEPTOR#0.6761;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.6744;DEDIFFERENTIATION#0.6723;MULTIPLE MYELOMA#0.6712;LEUKEMIA INITIATING CELLS#0.6710;HEPATITIS B VIRUS#0.6698;ADENOCARCINOMA#0.6698;DNA DEMETHYLATION#0.6695;HEPATITIS B#0.6684;SMALL INTESTINE#0.6684;STANDARD OF CARE#0.6679;SUPEROXIDE DISMUTASE#0.6650;NORMAL CONTROL GROUP#0.6623;OSTEOPOROSIS#0.6617;ORNITHINE CYCLE#0.6610;LACTATION#0.6604;HODGKIN'S LYMPHOMA#0.6595;ADENOSINE MONOPHOSPHATE#0.6551;TRANSCRIPTION REGULATOR#0.6518;TETRACYCLINE#0.6517;CHONDROCYTE#0.6513;CHROMATIN REMODELING COMPLEX#0.6511;TRANSCRIPTION ACTIVATOR#0.6503;ORNITHINE#0.6501;HEPATOCELLULAR CARCINOMA CELL#0.6435;CELL CYCLE REGULATION#0.6428;RECEPTOR LIGAND#0.6423;ATP BINDING CASSETTE#0.6423;MYOTUBE#0.6393;TUMOUR NECROSIS FACTOR#0.6393;PROTEIN KINASE C#0.6382;DYSKERATOSIS CONGENITA#0.6339;BROWN ADIPOCYTE DIFFERENTIATION#0.6333;UREA CYCLE#0.6312;MINERALIZATION#0.6296;AIRWAY SMOOTH MUSCLE#0.6285;NUCLEAR MATRIX#0.6279;PKCDELTA#0.6270;MYOGENESIS#0.6256;LIPODYSTROPHY#0.6236;EARLY GROWTH RESPONSE#0.6235;PYRUVATE#0.6213;BERBERINE#0.6212;IMMUNE CELL#0.6204;INHIBITION OF CELL PROLIFERATION#0.6169;INSULIN SIGNALING PATHWAY#0.6160;THYROID HORMONE RECEPTOR#0.6133;PROSTATE EPITHELIUM#0.6123;RESPONSE TO TREATMENT#0.6099;ERYTHROPOIESIS#0.6068;MLL1 COMPLEX#0.6066;CALCINEURIN#0.6052;11BETA-HYDROXYSTEROID DEHYDROGENASE#0.6028;ASTROCYTE#0.6025;CRE BINDING#0.6023;REGULATION OF 'MALIC' ENZYME#0.6019;CORTISOL#0.6019;COMMON LYMPHOID PROGENITOR#0.6017;PROTEIN PHOSPHATASE 2A#0.6015;PHOSPHATASE 2A#0.6012;ENAMEL FORMATION#0.6003
10512	BREAST CANCER#1.0216;CANCER CELL#1.0183;ENDOTHELIAL CELL#1.0123;GENE EXPRESSION#0.9885;ANGIOGENESIS#0.9707;NEURAL CREST#0.9600;CELL PROLIFERATION#0.9565;PROSTATE CANCER#0.9560;GROWTH CONE#0.9264;OUTFLOW TRACT#0.9173;SIGNALING PATHWAY#0.8735;BREAST CANCER CELL#0.8500;EPITHELIAL CELL#0.8321;AXON GUIDANCE#0.8239;GROWTH FACTOR#0.8044;MORPHOGENESIS#0.7779;NERVOUS SYSTEM#0.7769;CELL MIGRATION#0.7728;SIGNAL TRANSDUCTION#0.7172;EXTRACELLULAR MATRIX#0.7141;CARDIAC NEURAL CREST#0.7114;NEURAL CREST CELL#0.6958;POLYMERASE CHAIN REACTION#0.6837;TRANSCRIPTION FACTOR#0.6834;INNERVATION#0.6560;ADENOCARCINOMA#0.6429;APOPTOSIS#0.6257;GROWTH CONE COLLAPSE#0.6238;WOUND HEALING#0.6020
10513	CELL SURFACE#0.9669;AMYLOID PRECURSOR PROTEIN#0.8779;KINESIN LIGHT CHAIN#0.8341;KINESIN#0.6367;CELL DEATH#0.6348;PRIMARY CORTICAL NEURON#0.6051
10514	STEROID RECEPTOR COACTIVATOR#1.0513;TRANSCRIPTION FACTOR#1.0118;TUMOR SUPPRESSOR#0.9959;GENE EXPRESSION#0.9949;CREB BINDING#0.9751;CELL CYCLE#0.9537;ANTHOCYANIN BIOSYNTHESIS#0.9342;NUCLEOLUS#0.9335;BREAST CANCER#0.9300;GLUCOCORTICOID RECEPTOR#0.9169;HISTONE ACETYLTRANSFERASE#0.9150;TRANSACTIVATION#0.8567;CANCER CELL#0.8493;HISTONE DEACETYLASE#0.8251;NUCLEOPLASM#0.8133;CAMP RESPONSE ELEMENT BINDING#0.7970;CAMP RESPONSE ELEMENT#0.7959;PROTEIN BINDING#0.7756;LEUCINE#0.7440;APOPTOSIS#0.7258;PROTEIN METHYLTRANSFERASE#0.7209;BREAST CANCER CELL#0.7187;LIGAND BINDING DOMAIN#0.7046;ANDROGEN RECEPTOR#0.6999;THYROID HORMONE RECEPTOR#0.6784;DNA BINDING#0.6698;RETINOIC ACID#0.6601;ESTROGEN RECEPTOR#0.6589;GROWTH FACTOR#0.6542;SIGNALING PATHWAY#0.6366;CELL CYCLE ARREST#0.6161;ACETYLTRANSFERASE ACTIVITY#0.6155;PROTEIN INTERACTION NETWORK#0.6114;RIBOSOME BIOGENESIS#0.6091;MITOSIS#0.6078
10516	ELASTIC FIBRE#1.0744;ELASTIC FIBER ASSEMBLY#1.0705;CUTIS LAXA#1.0643;FIBRILLIN#1.0528;CEREBRAL PALSY#1.0522;ENDOTHELIAL CELL#1.0479;PARKINSON'S DISEASE#1.0474;PELVIC ORGAN PROLAPSE#1.0397;CELL PROLIFERATION#1.0372;ELASTIC FIBER#1.0304;ANGIOGENESIS#1.0285;MICROFIBRIL#1.0274;RANGE OF MOTION#1.0232;CANCER CELL#1.0166;DEMENTIA#1.0159;SMOOTH MUSCLE CELL#1.0141;MUSCLE CELL#1.0135;AGE RELATED MACULAR DEGENERATION#1.0129;MACULAR DEGENERATION#1.0124;GROWTH FACTOR#1.0099;SMOOTH MUSCLE#1.0063;EPIDERMAL GROWTH FACTOR#1.0039;RANDOMIZED CONTROLLED TRIAL#1.0015;INTEGRIN BINDING#0.9997;EXTRACELLULAR MATRIX#0.9992;TRANSFORMING GROWTH FACTOR#0.9916;CELL ADHESION#0.9897;GENE EXPRESSION#0.9892;BREAST CANCER#0.9806;COGNITION#0.9801;VASCULAR SMOOTH MUSCLE CELL#0.9797;CELL MIGRATION#0.9683;CONNECTIVE TISSUE#0.9526;RANDOMISED CONTROLLED TRIAL#0.9458;QUANTITATIVE REAL TIME#0.9378;POLYMERASE CHAIN REACTION#0.9237;WOUND HEALING#0.9120;ARTERY#0.9065;DERMAL FIBROBLAST#0.8980;ELASTIC FIBRE ASSEMBLY#0.8939;NEURAL CREST#0.8885;PEOPLE WITH DEMENTIA#0.8829;DERMIS#0.8716;HUNTINGTON'S DISEASE#0.8709;AUTISM SPECTRUM DISORDER#0.8383;EXTRACELLULAR MATRIX GLYCOPROTEIN#0.8293;EPITHELIAL CELL#0.8255;LUNG FIBROBLASTS#0.8121;CELL SURFACE#0.8074;BASEMENT MEMBRANE#0.7979;DOWN SYNDROME#0.7966;OBESE#0.7948;ENDOTHELIAL GROWTH FACTOR#0.7918;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7918;TRANSFORMING GROWTH FACTOR BETA#0.7914;TRANSCRIPTION FACTOR#0.7911;AORTIC ANEURYSM#0.7858;LUNG CANCER#0.7811;PROTEOGLYCAN#0.7808;APOPTOSIS#0.7708;CELL MOTILITY#0.7697;ELASTIN FIBER#0.7547;TUMOR SUPPRESSOR#0.7496;LEUCINE RICH REPEAT#0.7443;PERIODONTAL LIGAMENT#0.7421;MILD COGNITIVE IMPAIRMENT#0.7415;BONE RESORPTION#0.7368;OVARIAN CANCER#0.7333;BREAST CANCER CELL#0.7319;FIBROMYALGIA#0.7271;VASCULAR CELL#0.7206;HEPATOCELLULAR CARCINOMA#0.7121;AGEING#0.7030;PHYSICAL ACTIVITY LEVEL#0.7010;TERIPARATIDE#0.6931;CELL GROWTH#0.6898;LONG TERM CARE#0.6875;CERVICAL#0.6821;ECSTASY#0.6803;CHARCOT MARIE TOOTH#0.6781;THORACIC AORTA#0.6765;RETINAL PIGMENT EPITHELIAL#0.6721;RHEUMATOID ARTHRITIS#0.6658;STROMAL CELL#0.6609;ABDOMINAL AORTIC ANEURYSM#0.6587;HUMAN DERMAL FIBROBLAST#0.6535;PLASMA MEMBRANE#0.6466;BLOOD VESSEL#0.6431;ALZHEIMER'S DISEASE#0.6204;CAROTID ARTERY#0.6176;HEPARIN#0.6165;NEUTROPHIL#0.6136;HUMAN PERIODONTAL LIGAMENT#0.6126;MOTOR LEARNING#0.6095;HYPERTENSION#0.6055;PROTEASE ACTIVITY#0.6046;AEROBIC EXERCISE TRAINING#0.6008
10518	INTEGRIN BINDING#1.0936;HAIR CELL#1.0760;HEARING LOSS#1.0612;USHER SYNDROME#1.0554;NONSYNDROMIC DEAFNESS#0.8135;SKELETAL MUSCLE#0.7087
10519	BINDING PROTEIN 1#1.0737;CDK INHIBITOR#1.0671;INTEGRIN BINDING#1.0671;CYCLIN DEPENDENT KINASE INHIBITOR#1.0400;CYCLIN DEPENDENT KINASE#1.0273;KINASE INHIBITOR#1.0268;CALCINEURIN#1.0253;CELL MIGRATION#1.0057;CELL CYCLE#1.0056;CELL DEATH#1.0019;PROTEIN KINASE#0.9990;CELL PROLIFERATION#0.9886;APOPTOSIS#0.9784;CANCER CELL#0.9768;SIGNALING PATHWAY#0.9752;DNA BINDING#0.9608;BREAST CANCER#0.9207;G1 PHASE#0.9184;ENDOTHELIAL CELL#0.9004;GENE EXPRESSION#0.8939;CELL CYCLE REGULATOR#0.8868;KINASE ACTIVITY#0.8798;FIBRINOGEN#0.8757;ANGIOGENESIS#0.8749;S PHASE#0.8711;CELL CYCLE ARREST#0.8677;APOPTOTIC#0.8534;MEGAKARYOCYTE#0.8407;PROTEIN PROTEIN INTERACTION#0.8363;ALZHEIMER'S DISEASE#0.8269;CELL CYCLE REGULATION#0.8245;PLASMA MEMBRANE#0.8167;TRANSCRIPTION FACTOR#0.8156;C TERMINAL DOMAIN#0.7990;PLATELET AGGREGATION#0.7919;GROWTH FACTOR#0.7871;CELL GROWTH#0.7653;BREAST CANCER CELL#0.7616;SPINAL CORD#0.7491;FOCAL ADHESION#0.7472;CELL ADHESION#0.7427;P21 ACTIVATED KINASE#0.7256;FILOPODIA FORMATION#0.7001;STEM CELL#0.6810;RESPONSE TO BLUE LIGHT#0.6574;PROTEIN COMPLEX#0.6559;ONCOGENIC#0.6558;RNA INTERFERENCE#0.6542;CELL DIVISION#0.6534;TUMOR SUPPRESSOR#0.6521;CYTOPLASM#0.6470;HEMOSTASIS#0.6429;DNA DAMAGE RESPONSE#0.6376;TELOMERE#0.6331;SENESCENCE#0.6182;MACROPINOCYTOSIS#0.6147;CALCIUM SIGNALING#0.6036
1051	IL-6 BINDING#1.0841;BETA-NF#1.0459;MITOTIC CLONAL EXPANSION#1.0408;ALKALINE PHOSPHATASE#1.0339;ACTIVATION OF NF-KAPPAB#1.0304;CAAT ENHANCER BINDING#1.0289;CAMP RESPONSE ELEMENT BINDING#1.0258;CREB BINDING#1.0243;NF KAPPAB BINDING#1.0225;G-CSF#1.0214;ACTIVATING TRANSCRIPTION FACTOR#1.0213;ACTIVATOR PROTEIN 1#1.0200;MAMMARY GLAND#1.0198;HYPOXIA#1.0197;DOMINANT NEGATIVE MUTANT#1.0188;GRANULOSA CELL#1.0176;MAMMARY EPITHELIAL CELL#1.0139;S PHASE#1.0133;LEUCINE#1.0130;IFN-GAMMA#1.0124;HEPATOCYTE NUCLEAR FACTOR#1.0119;BINDING PROTEIN 1#1.0113;GLUCOCORTICOID RECEPTOR#1.0104;ASTROCYTE#1.0092;CAMP RESPONSE ELEMENT#1.0085;CRE BINDING#1.0085;STROMAL CELL#1.0069;ENHANCER BINDING#1.0065;ENHANCER BINDING PROTEIN#1.0064;TRANSACTIVATION#1.0059;TRANSCRIPTION FACTOR BINDING#1.0052;PROTEIN PROTEIN INTERACTION#1.0045;LIVER REGENERATION#1.0040;CYCLIC AMP#1.0017;CHONDROCYTE#1.0015;TRANSLATION INITIATION#1.0013;OSTEOBLAST#1.0012;FACTOR I#1.0007;MAP KINASE#1.0004;CAMP-RESPONSIVE ELEMENT BINDING#1.0001;KERATINOCYTE#0.9994;SIGNAL TRANSDUCER#0.9990;PROTEIN KINASE A#0.9985;ACUTE PHASE RESPONSE#0.9984;B CELL#0.9981;GLUTATHIONE#0.9974;LUCIFERASE ACTIVITY#0.9973;NF-KAPPAB ACTIVATION#0.9969;PHOSPHOENOLPYRUVATE CARBOXYKINASE#0.9968;DNA BINDING#0.9967;IL-6 PRODUCTION#0.9963;MYELOID CELL#0.9949;BREAST CANCER#0.9947;TERMINAL DIFFERENTIATION#0.9938;PEROXISOME#0.9938;ESTROGEN RECEPTOR#0.9917;ELECTROPHORETIC MOBILITY SHIFT#0.9910;TRANSCRIPTION FACTOR#0.9907;ADIPOGENESIS#0.9906;RETINOIC ACID#0.9899;PREADIPOCYTE#0.9898;PROTEIN COMPLEX#0.9892;MUTAGENESIS#0.9891;ADIPOCYTE DIFFERENTIATION#0.9888;REGENERATION#0.9888;RNA INTERFERENCE#0.9880;MUSCLE CELL#0.9879;SKELETAL MUSCLE#0.9878;OVARIAN#0.9876;T CELL#0.9869;MACROPHAGE#0.9866;SMOOTH MUSCLE#0.9861;INSULIN-LIKE GROWTH FACTOR#0.9859;PROTEIN BINDING#0.9855;COLONY-STIMULATING FACTOR#0.9853;BREAST CANCER CELL#0.9853;SMOOTH MUSCLE CELL#0.9850;ENDOTHELIAL CELL#0.9850;ONCOGENIC#0.9844;TUMOR SUPPRESSOR#0.9838;ADIPOCYTE#0.9835;CELL PROLIFERATION#0.9833;DEXAMETHASONE#0.9831;CELL DEATH#0.9821;MOUSE EMBRYONIC FIBROBLAST#0.9818;SENESCENCE#0.9816;TUMOR CELLS#0.9815;PRO-INFLAMMATORY#0.9809;SIGNAL TRANSDUCTION#0.9803;C REACTIVE PROTEIN#0.9803;GRANULOCYTE#0.9802;GROWTH HORMONE#0.9802;BETA CELL#0.9801;ALANINE#0.9793;ENDOPLASMIC RETICULUM#0.9792;CELL CYCLE#0.9791;NITRIC OXIDE SYNTHASE#0.9791;MONOCYTE#0.9791;BONE MARROW#0.9783;HEPATOMA CELLS#0.9780;NITRIC OXIDE#0.9778;CANCER CELL#0.9777;PROTEIN KINASE C#0.9776;LIVER DEVELOPMENT#0.9775;PROTEIN SYNTHESIS#0.9767;DNASE I#0.9765;CHLORAMPHENICOL#0.9765;EPITHELIAL CELL#0.9764;CELL DIFFERENTIATION#0.9758;INDUCIBLE NITRIC OXIDE#0.9753;PERIPHERAL BLOOD#0.9747;DNASE#0.9746;OSTEOBLAST DIFFERENTIATION#0.9744;PROGESTERONE#0.9735;APOPTOSIS#0.9725;STEROL REGULATORY ELEMENT#0.9724;PROGENITOR CELL#0.9723;INFLAMMATORY RESPONSE#0.9720;STEM CELL#0.9720;PHOSPHOENOLPYRUVATE#0.9718;FATTY ACID BINDING#0.9711;MITOGEN ACTIVATED PROTEIN#0.9703;APOPTOTIC#0.9696;NEUTROPHIL#0.9695;KINASE INHIBITOR#0.9690;CELL GROWTH#0.9687;SIGNALING PATHWAY#0.9687;GLYCOGEN SYNTHASE KINASE#0.9684;PROTEIN KINASE#0.9682;PROTEASOME#0.9680;GLIAL CELL#0.9677;ADIPOSE TISSUE#0.9661;SALICYLATE#0.9658;GENE EXPRESSION#0.9656;TUMOR NECROSIS FACTOR#0.9654;BETA-2#0.9649;RNA BINDING#0.9648;RESPONSE TO LPS#0.9640;POLYMERASE CHAIN REACTION#0.9637;IMMUNE RESPONSE#0.9631;IFN-BETA#0.9630;TRANSFORMING GROWTH FACTOR#0.9627;ADENOSINE#0.9627;EXTRACELLULAR MATRIX#0.9610;ALL TRANS RETINOIC ACID#0.9602;TUBERCULOSIS#0.9599;REPORTER GENE ASSAY#0.9597;VIRAL REPLICATION#0.9592;PROSTATE CANCER#0.9592;REVERSE TRANSCRIPTION#0.9589;GROWTH FACTOR#0.9578;MESENCHYMAL STEM CELL#0.9569;FORSKOLIN#0.9566;GRANULOCYTE COLONY STIMULATING FACTOR#0.9559;TRANSCRIPTIONAL CONTROL#0.9555;CYTOPLASM#0.9554;ENZYME ACTIVITY#0.9533;POST-TRANSLATIONAL MODIFICATION#0.9515;DEPHOSPHORYLATION#0.9514;SIGNALLING PATHWAY#0.9480;LIPOPROTEIN LIPASE#0.9474;AUTOPHAGY#0.9471;AIRWAY EPITHELIAL CELL#0.9470;PROMOTER BINDING#0.9463;MICROGLIAL CELL#0.9454;MAMMARY GLAND DEVELOPMENT#0.9451;HEPATOCYTE PROLIFERATION#0.9448;GLAND DEVELOPMENT#0.9432;RETINOIC ACID RECEPTOR#0.9423;ENDOPLASMIC RETICULUM STRESS#0.9412;LIPID DROPLET#0.9383;WHITE ADIPOSE TISSUE#0.9381;EPIDERMAL GROWTH FACTOR#0.9373;HUMAN IMMUNODEFICIENCY VIRUS#0.9367;CELL ACTIVATION#0.9364;REACTIVE OXYGEN SPECIES#0.9358;INSULIN RECEPTOR#0.9354;TOLL LIKE RECEPTOR#0.9326;PROSTAGLANDIN E2#0.9309;VIRAL INFECTION#0.9303;VITAMIN D RECEPTOR#0.9283;FATTY ACID SYNTHASE#0.9279;RNA BINDING PROTEIN#0.9258;HISTONE ACETYLATION#0.9233;DNA-PROTEIN COMPLEX#0.9231;EARLY GROWTH RESPONSE#0.9212;LUNG EPITHELIAL CELL#0.9187;ALVEOLAR MACROPHAGE#0.9177;HISTONE DEACETYLASE#0.9172;RHEUMATOID ARTHRITIS#0.9161;TRANSFORMING GROWTH FACTOR BETA#0.9158;OSTEOCLAST#0.9157;CELL CYCLE ARREST#0.9143;ADENOCARCINOMA#0.9140;HEPATOCELLULAR CARCINOMA#0.9133;RAPAMYCIN#0.9131;HYPOXIA INDUCIBLE FACTOR#0.9122;LIPID METABOLISM#0.9112;CYTOKINE PRODUCTION#0.9098;INTESTINAL EPITHELIAL CELL#0.9096;VASCULAR SMOOTH MUSCLE CELL#0.9085;LYSINE#0.9060;CYTOCHROME P450#0.9049;HEPATIC STELLATE CELL#0.9048;MYELOID LEUKEMIA#0.9042;T LYMPHOCYTE#0.9033;LEUKOCYTE#0.9017;LIVER DISEASE#0.8991;QUANTITATIVE REAL TIME#0.8986;RETINOID X RECEPTOR#0.8984;ESTRADIOL#0.8967;CYCLIN DEPENDENT KINASE#0.8940;SIGNALING CASCADE#0.8925;SIGNALING MOLECULE#0.8923;FAT CELL#0.8914;TYPE 2 DIABETES#0.8913;KINASE ACTIVITY#0.8909;HEMATOPOIESIS#0.8881;RESPONSE TO TNF#0.8876;IL-8 PRODUCTION#0.8865;MONOCYTE CHEMOATTRACTANT PROTEIN#0.8861;DECIDUALIZATION#0.8860;IMMUNE CELL#0.8852;NUCLEAR MATRIX#0.8850;GM-CSF#0.8848;FIBROBLAST GROWTH FACTOR#0.8832;FETAL LIVER#0.8802;ADENOSINE MONOPHOSPHATE#0.8797;HEPATOCYTE GROWTH FACTOR#0.8786;RIBOSOMAL S6 KINASE#0.8778;DNA SYNTHESIS#0.8764;ISCHEMIA#0.8759;HUMAN BREAST CANCER#0.8754;FOR ADIPOCYTE DIFFERENTIATION#0.8729;BROWN ADIPOSE TISSUE#0.8709;TRANSCRIPTASE#0.8703;STEROIDOGENIC FACTOR 1#0.8694;CELL SURFACE#0.8692;GLUCONEOGENESIS#0.8641;PLASMA MEMBRANE#0.8637;UNFOLDED PROTEIN RESPONSE#0.8628;CYCLIC ADENOSINE MONOPHOSPHATE#0.8626;GROWTH FACTOR RECEPTOR#0.8624;STEAROYL COA DESATURASE#0.8577;MYOTUBE#0.8576;PLASMA PROTEIN#0.8574;TARGET OF RAPAMYCIN#0.8550;TETRACYCLINE#0.8539;ANGIOGENESIS#0.8538;ONCOGENE INDUCED SENESCENCE#0.8537;COLORECTAL CANCER#0.8524;CELL ADHESION#0.8520;REGULATION OF GENE EXPRESSION#0.8503;MAPK ACTIVATION#0.8495;BILE DUCT#0.8472;HYPOXIC#0.8471;B LYMPHOCYTE#0.8470;MAPK SIGNALING#0.8461;COMPLEX I#0.8435;COLORECTAL#0.8416;MECHANISM OF ACTION#0.8416;HUMAN BRONCHIAL EPITHELIAL#0.8375;BRONCHIAL EPITHELIAL CELLS#0.8365;MONONUCLEAR CELLS#0.8354;IMMUNE SYSTEM#0.8342;MORPHOGENESIS#0.8331;UBIQUITIN#0.8327;OBESE#0.8322;COLON CANCER#0.8317;IL-6 SECRETION#0.8297;LIVER DAMAGE#0.8282;EOSINOPHIL#0.8267;HIGH FAT DIET#0.8234;INTERFERON REGULATORY FACTOR#0.8233;DENDRITIC CELL#0.8228;MYOBLAST#0.8225;CYTOTOXICITY#0.8176;FACTOR S#0.8153;CHROMATIN REMODELING#0.8150;GLUCOSE 6 PHOSPHATASE#0.8130;PRECURSOR CELL#0.8128;AMINO ACID RESPONSE#0.8107;RECEPTOR TYROSINE KINASE#0.8095;GLUCOSE HOMEOSTASIS#0.8083;HEMATOPOIETIC CELL#0.8067;MACROPHAGE INFLAMMATORY PROTEIN#0.8067;NERVOUS SYSTEM#0.8066;BONE MORPHOGENETIC PROTEIN#0.8063;DNA REPLICATION#0.8063;HEPATITIS B#0.8059;METHIONINE#0.8054;INNATE IMMUNITY#0.8036;SUPEROXIDE DISMUTASE#0.8025;LUNG CANCER#0.8023;MOUSE EMBRYO FIBROBLASTS#0.8018;MACROPHAGE DIFFERENTIATION#0.8012;RETINOBLASTOMA#0.7996;KERATINOCYTE DIFFERENTIATION#0.7976;ANAPLASTIC LARGE CELL LYMPHOMA#0.7952;TROPHOBLAST#0.7940;OSTEOCLAST DIFFERENTIATION#0.7931;NUCLEAR EXPORT#0.7923;MACROPHAGE ACTIVATION#0.7913;DNA METHYLATION#0.7896;SERUM RESPONSE FACTOR#0.7887;ARGININE#0.7879;CARCINOGEN#0.7870;SERUM AMYLOID A#0.7847;CYCLIN DEPENDENT KINASE INHIBITOR#0.7826;LIPOGENESIS#0.7815;TOXICITY#0.7802;ETHANOL#0.7800;HEAT SHOCK PROTEIN#0.7775;MITOCHONDRIA#0.7764;ACETYL COA CARBOXYLASE#0.7761;GESTATION#0.7760;MESENCHYMAL CELL#0.7751;FATTY LIVER#0.7749;OSTEOARTHRITIS#0.7732;HUMAN AIRWAY EPITHELIAL#0.7728;UTERUS#0.7726;SUBCUTANEOUS ADIPOSE TISSUE#0.7671;BONE FORMATION#0.7665;HYPERGLYCEMIA#0.7640;1α,25-DIHYDROXYVITAMIN D3#0.7621;THYMIDINE#0.7601;IL-8 SECRETION#0.7599;ACUTE PROMYELOCYTIC LEUKEMIA#0.7596;TRANSLATION INITIATION FACTOR#0.7590;GROWTH FACTOR BINDING#0.7550;ENDOMETRIUM#0.7538;LUMINAL#0.7524;ACUTE MYELOID LEUKEMIA#0.7501;C TERMINAL DOMAIN#0.7486;HEAT SHOCK FACTOR#0.7479;SUMOYLATION#0.7475;PULMONARY TUBERCULOSIS#0.7444;INNATE IMMUNE RESPONSE#0.7417;HYPERTENSION#0.7416;ACETYLTRANSFERASE ACTIVITY#0.7402;LYMPHOID CELL#0.7386;ANDROGEN RECEPTOR#0.7362;ACID PHOSPHATASE#0.7346;HEPATITIS B VIRUS#0.7346;ATHEROSCLEROSIS#0.7316;LEYDIG CELL#0.7309;STEROIDOGENESIS#0.7302;TYROSINE KINASE INHIBITOR#0.7284;CEREBRAL ISCHEMIA#0.7278;SQUAMOUS CELL CARCINOMA#0.7263;LOW DENSITY LIPOPROTEIN#0.7251;ENDOCHONDRAL OSSIFICATION#0.7224;YOLK SAC#0.7216;BONE RESORPTION#0.7195;CELL DEVELOPMENT#0.7122;TROGLITAZONE#0.7078;MAMMARY EPITHELIUM#0.7073;PHOSPHODIESTERASE#0.7069;TUMOUR NECROSIS FACTOR#0.7055;AIRWAY EPITHELIUM#0.7015;MESANGIAL CELL#0.6984;CIRCADIAN RHYTHM#0.6980;ACTINOMYCIN D#0.6979;CERVICAL#0.6976;CALCIUM CHANNEL#0.6974;EXCRETION#0.6965;SWI-SNF COMPLEX#0.6963;MAST CELL#0.6958;NUCLEAR LOCALIZATION SIGNAL#0.6938;STROMA#0.6920;REGULATION OF ADIPOGENESIS#0.6915;LEUKEMIA INHIBITORY FACTOR#0.6910;RESPONSE TO CAMP#0.6874;CELL ADHESION MOLECULE#0.6869;FUNCTIONAL DIFFERENTIATION#0.6834;HERPES SIMPLEX VIRUS#0.6823;HERPES SIMPLEX#0.6820;XANTHINE#0.6818;VASCULAR CELL#0.6813;EPITHELIAL TO MESENCHYMAL TRANSITION#0.6809;EPITHELIAL TO MESENCHYMAL#0.6807;TRANSCRIPTION REGULATOR#0.6796;PROSTAGLANDIN ENDOPEROXIDE SYNTHASE#0.6795;TRANSDIFFERENTIATION#0.6784;RECEPTOR ANTAGONIST#0.6768;MATRIX METALLOPROTEINASE 13#0.6766;EPITHELIAL CELL PROLIFERATION#0.6763;MARROW STROMAL CELLS#0.6757;BONE MARROW STROMAL CELL#0.6757;BONE MARROW STROMAL#0.6753;IFN REGULATORY FACTOR#0.6740;HUMAN MESENCHYMAL STEM#0.6740;THYMIDINE KINASE#0.6734;LIGAND BINDING DOMAIN#0.6727;SEBACEOUS GLAND#0.6709;ENDOMETRIOSIS#0.6708;PHOSPHOLIPASE A2#0.6704;GALECTIN#0.6702;UMBILICAL VEIN#0.6702;BREAST CARCINOMA#0.6687;INSULIN RECEPTOR SUBSTRATE#0.6667;DIABETES MELLITUS#0.6666;PALMITATE#0.6663;CHLORAMPHENICOL ACETYLTRANSFERASE ACTIVITY#0.6661;11BETA-HYDROXYSTEROID DEHYDROGENASE#0.6660;CD4+ T CELL#0.6659;PANCREATIC ISLET#0.6655;EPITHELIAL CELL DIFFERENTIATION#0.6646;INHIBITION OF ADIPOGENESIS#0.6621;CHOLINE#0.6620;CARDIOMYOCYTE#0.6609;HUMAN INTESTINAL EPITHELIAL#0.6568;CACHEXIA#0.6551;TRANSLATIONAL INITIATION#0.6541;OXYGENASE#0.6493;CELL MIGRATION#0.6479;ARTERY#0.6471;NUCLEAR HORMONE RECEPTOR#0.6464;HISTONE ACETYLTRANSFERASE#0.6462;ACTIVATED T-CELLS#0.6459;ACTIVATED T CELL#0.6456;UMBILICAL VEIN ENDOTHELIAL CELLS#0.6450;EUKARYOTIC INITIATION FACTOR#0.6446;HUMAN UMBILICAL VEIN#0.6445;CUGBP1-EIF2 COMPLEX#0.6417;QUANTITATIVE REVERSE TRANSCRIPTION#0.6415;ASPARTATE#0.6413;G1 PHASE#0.6411;SMOOTH MUSCLE ACTIN#0.6408;HEPATIC NUCLEAR FACTOR#0.6394;LECTIN#0.6390;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6377;ALZHEIMER'S DISEASE#0.6363;GROWTH ARREST SPECIFIC#0.6332;MYOCYTES#0.6326;ER STRESS RESPONSE#0.6311;GENISTEIN#0.6305;CAMP SIGNALING#0.6299;LUNG DISEASE#0.6298;FOCAL ADHESION#0.6294;NUTRIENT SENSING#0.6290;OVARIES#0.6285;LYMPHOBLAST#0.6279;GLUTAMINE#0.6260;CENTRAL NERVOUS SYSTEM#0.6253;ORNITHINE#0.6244;GAMMA GLUTAMYLTRANSFERASE#0.6238;LUNG CARCINOMA#0.6237;COLLAGEN SYNTHESIS#0.6236;AMNION#0.6225;ESTROGENS#0.6223;MULTIPLE MYELOMA#0.6213;BLOOD VESSEL#0.6207;CELL MEMBRANE#0.6204;LYMPHOID TISSUE#0.6202;PROLACTIN RECEPTOR#0.6198;BINDING PROTEIN 3#0.6196;PLASMA CELL#0.6193;LYMPH NODE#0.6185;OVULATION#0.6179;FAT PAD#0.6171;NF-KAPPAB INHIBITOR#0.6163;ESTROGEN RECEPTOR ALPHA#0.6146;METFORMIN#0.6144;BLOOD BRAIN BARRIER#0.6103;OVARIAN CANCER#0.6091;MAMMARY GLAND INVOLUTION#0.6091;PLATELET-DERIVED GROWTH FACTOR#0.6076;INFLAMMATORY CELL#0.6065;CALCINEURIN#0.6061;ACTIVATED MONOCYTES#0.6054;LACTATION#0.6049;ASPIRIN#0.6047;THYMOCYTE#0.6042;HYPERSENSITIVITY#0.6040;MONOCYTE DIFFERENTIATION#0.6035;FIBRINOGEN#0.6033;VILLOUS CYTOTROPHOBLAST#0.6014;RESPONSE TO IL-6#0.6007
10521	RNA HELICASE#1.0702;GENE EXPRESSION#1.0100;ESTROGEN RECEPTOR#1.0076;TRANSCRIPTION FACTOR#0.9251;MIRNA BIOGENESIS#0.8796;RNA BINDING#0.8456;CELL PROLIFERATION#0.8022;BREAST CANCER#0.7697;CANCER CELL#0.7074;HISTONE DEACETYLASE#0.7062;MIRNA PROCESSING#0.7052;ATPASE ACTIVITY#0.6918;RNA METABOLISM#0.6746;REGULATION OF MIRNA BIOGENESIS#0.6343;SIGNALING PATHWAY#0.6151;TRANSACTIVATION#0.6113;COLON CANCER#0.6077;ESTROGEN RECEPTOR ALPHA#0.6076;APOPTOSIS#0.6046;CELL DIFFERENTIATION#0.6017
105221694	PAPILLARY CARCINOMA#0.7669;HEPATITIS E VIRUS#0.7473;HEPATITIS E#0.7455
10522	TRANSCRIPTION FACTOR#1.0537;INTELLECTUAL DISABILITY#1.0513;DNA BINDING#1.0350;LYMPH NODE#0.9773;GENE EXPRESSION#0.9608;PANCREATIC LYMPH NODE#0.8973;TYPE 1 DIABETES#0.8951;CELL PROLIFERATION#0.8949;IMMUNE RESPONSE#0.7696;CELL CYCLE#0.7196;STROMAL CELL#0.6907;POLYMERASE CHAIN REACTION#0.6657;NUCLEOSOME#0.6471;PROTEIN PROTEIN INTERACTION#0.6463;NUCLEAR EXPORT SIGNAL#0.6260;RETINOIC ACID#0.6207;THYMIDINE KINASE#0.6166;NUCLEAR EXPORT#0.6164;MAMMARY EPITHELIAL CELL#0.6144;INNATE IMMUNE RESPONSE#0.6100;EPITHELIAL CELL#0.6018;DNA-PK COMPLEX#0.6006
10523	ENDOPLASMIC RETICULUM#1.1111;CELL PROLIFERATION#0.7431;ER MEMBRANE#0.6289;CELLULAR GROWTH#0.6239;ACTIVATED T-CELLS#0.6169;ACTIVATED T CELL#0.6164;T LYMPHOCYTE#0.6080;CELL SURFACE#0.6065;T CELL#0.6025
10524	HISTONE ACETYL TRANSFERASE#1.0795;HISTONE ACETYLTRANSFERASE ACTIVITY#1.0572;ACETYLTRANSFERASE COMPLEX#1.0467;ACETYLTRANSFERASE ACTIVITY#1.0464;HISTONE ACETYLTRANSFERASE COMPLEX#1.0446;PHOSPHOLIPASE A2#1.0322;TRANSACTIVATION#1.0256;TUMOR SUPPRESSOR#1.0230;HISTONE ACETYLTRANSFERASE#1.0213;CHROMATIN REMODELING#1.0179;PROSTATE CANCER#1.0178;BREAST CANCER#1.0146;TIP60 HISTONE ACETYLTRANSFERASE COMPLEX#1.0129;ATAXIA TELANGIECTASIA#1.0122;APOPTOSIS#1.0069;COMPLEX I#1.0068;DNA DAMAGE RESPONSE#1.0068;LYSINE#1.0052;T CELL#1.0047;SIGNALING PATHWAY#1.0037;APOPTOTIC#1.0031;CELL CYCLE#1.0019;AMYLOID PRECURSOR PROTEIN#1.0012;DNA REPAIR#0.9964;ATAXIA TELANGIECTASIA MUTATED#0.9959;HISTONE DEACETYLASE#0.9958;KINASE ACTIVITY#0.9924;CELL CYCLE ARREST#0.9920;CELL PROLIFERATION#0.9919;HISTONE ACETYLATION#0.9917;APP INTRACELLULAR DOMAIN#0.9917;PROTEIN KINASE#0.9913;UBIQUITIN#0.9913;CANCER CELL#0.9912;DOUBLE STRAND BREAK#0.9898;GENE EXPRESSION#0.9891;CELL GROWTH#0.9879;CELL DEATH#0.9871;NUCLEOSOME#0.9869;HOMOLOGOUS RECOMBINATION#0.9867;DNA BINDING#0.9828;TRANSCRIPTION FACTOR#0.9805;ANDROGEN RECEPTOR#0.9785;STEM CELL#0.9758;AUTOPHAGY#0.9731;HISTONE H4 ACETYLATION#0.9703;ALZHEIMER'S DISEASE#0.9653;CHROMATIN REMODELING COMPLEX#0.9579;PROTEASOME#0.9560;POST-TRANSLATIONAL MODIFICATION#0.9489;HISTONE MODIFICATION#0.9431;CELL MIGRATION#0.9414;GENOTOXIC#0.9281;POSTTRANSLATIONAL MODIFICATION#0.9273;CISPLATIN#0.9211;GROWTH FACTOR#0.9108;EMBRYONIC STEM CELL#0.9004;CHROMATIN MODIFICATION#0.8943;DNA REPLICATION#0.8850;ONCOGENIC#0.8833;RNA INTERFERENCE#0.8753;CATALYTIC ACTIVITY#0.8750;COLORECTAL CANCER#0.8668;MITOSIS#0.8563;HETEROCHROMATIN#0.8556;S PHASE#0.8545;COLORECTAL#0.8457;LUNG CANCER#0.8323;CHROMOSOME SEGREGATION#0.8282;NERVOUS SYSTEM#0.8258;ZINC FINGER PROTEIN#0.8181;NUCLEAR HORMONE RECEPTOR#0.8161;EPITHELIAL CELL#0.8088;HUMAN IMMUNODEFICIENCY VIRUS#0.7963;G1 PHASE#0.7912;CYTOPLASM#0.7891;SIGNAL TRANSDUCTION#0.7830;ESTROGEN RECEPTOR#0.7820;SENESCENCE#0.7790;MRN COMPLEX#0.7782;POLYMERASE CHAIN REACTION#0.7719;PROTEIN PROTEIN INTERACTION#0.7680;DNA METHYLATION#0.7668;HISTONE EXCHANGE#0.7631;MYOBLAST DIFFERENTIATION#0.7621;MESANGIAL CELL#0.7453;DNA METHYLTRANSFERASE#0.7435;COENZYME A#0.7422;REGULATORY T CELL#0.7404;SUMOYLATION#0.7361;CYCLIN DEPENDENT KINASE#0.7252;THYROID CARCINOMA#0.7230;SET3 COMPLEX#0.7211;AKT SIGNALING#0.7203;ARACHIDONIC ACID#0.7190;MONOCYTIC LEUKEMIA#0.7152;MACROPHAGE#0.6968;RESPONSE TO UV#0.6902;DOUBLE-STRAND BREAK REPAIR#0.6835;FANCONI ANEMIA#0.6824;B CELL#0.6807;THYROID CANCER#0.6778;SIGNALING CASCADE#0.6757;HYPOXIA#0.6751;GLYCOGEN SYNTHASE KINASE#0.6739;ADIPOCYTE#0.6732;MITOGEN ACTIVATED PROTEIN#0.6727;ADIPOCYTE DIFFERENTIATION#0.6722;GERM CELL#0.6717;BREAST CANCER CELL#0.6691;ADIPOSE TISSUE#0.6676;HISTONE METHYLTRANSFERASE#0.6667;ATP-DEPENDENT CHROMATIN REMODELING#0.6658;CELL CYCLE CONTROL#0.6579;TUMOR CELLS#0.6554;MUTAGENESIS#0.6527;ENDOPLASMIC RETICULUM#0.6495;ACUTE MYELOID LEUKEMIA#0.6477;EPITHELIAL MESENCHYMAL TRANSITION#0.6470;MYELOID LEUKEMIA#0.6465;BUDDING#0.6452;QUANTITATIVE REAL TIME#0.6450;XPF-ERCC1 COMPLEX#0.6394;HISTONE METHYLATION#0.6379;HISTONE DEMETHYLASE#0.6337;ACETYLASE ACTIVITY#0.6329;ACETYL-COA BINDING#0.6313;CERVICAL CANCER#0.6279;POLY ADP RIBOSE#0.6272;PEROXISOMAL#0.6253;MOLECULAR FUNCTION#0.6242;PERICENTRIC HETEROCHROMATIN#0.6190;PROGRAMMED CELL DEATH#0.6182;SIGNALLING PATHWAY#0.6170;MOUSE EMBRYONIC STEM#0.6076;HISTONE BINDING#0.6059;M PHASE#0.6045
105259599	LOSS OF METHYLATION#1.0575;IMPRINTING CONTROL REGION#1.0554;DNA METHYLATION#1.0388;SILVER RUSSELL SYNDROME#1.0200;BECKWITH-WIEDEMANN SYNDROME#1.0063;DIFFERENTIALLY METHYLATED REGION#0.9826;GROWTH FACTOR#0.8458;GENE EXPRESSION#0.8318;DEMETHYLATION#0.7824;INSULIN-LIKE GROWTH FACTOR#0.7364;MACROCEPHALY#0.6735;ZINC FINGER PROTEIN#0.6359;DNA HYPOMETHYLATION#0.6311;MALE INFERTILITY#0.6248;GROWTH PATTERN#0.6235;HISTONE MODIFICATION#0.6049
105259600	GIGANTISM#0.7096;PITUITARY ADENOMA#0.6068
10525	NUCLEOTIDE EXCHANGE FACTOR#1.0854;GLUCOSE REGULATED PROTEIN#1.0619;HYPOXIA#1.0460;HEAT SHOCK PROTEIN#1.0337;CELL DEATH#1.0277;CANCER CELL#1.0155;ISCHEMIA#1.0120;ENDOPLASMIC RETICULUM#1.0074;APOPTOSIS#1.0021;ENDOPLASMIC RETICULUM STRESS#1.0006;T CELL#0.9835;HYPOXIC#0.9823;IMMUNE RESPONSE#0.9783;APOPTOTIC#0.9712;GROWTH FACTOR#0.9640;BREAST CANCER#0.9640;TRANSCRIPTION FACTOR#0.9551;ENDOTHELIAL CELL#0.9488;ENDOTHELIAL GROWTH FACTOR#0.9299;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9299;GENE EXPRESSION#0.9212;PROTEIN DISULFIDE ISOMERASE#0.9151;DENDRITIC CELL#0.9111;PROSTATE CANCER#0.8910;BETA CELL#0.8714;EPITHELIAL CELL#0.8678;UNFOLDED PROTEIN RESPONSE#0.8580;CROSS PRESENTATION#0.8570;ANGIOGENESIS#0.8466;TUMOR CELLS#0.8364;MACROPHAGE#0.8361;CHAPERONE COMPLEX#0.8314;PROTEIN FOLDING#0.8312;CD8+ T CELL#0.8217;INSULIN SECRETION#0.8038;ASTROCYTE#0.7879;THYROID CANCER#0.7594;PROTEASOME#0.7390;ANTIGEN PRESENTING CELLS#0.7318;APOPTOTIC CELL DEATH#0.7162;PROTEIN TRANSPORT#0.6937;SCAVENGER RECEPTOR#0.6865;TYPE 2 DIABETES#0.6843;ISCHEMIA REPERFUSION INJURY#0.6826;HIGH FAT DIET#0.6811;PRO-INFLAMMATORY#0.6773;LYMPH NODE#0.6768;POLYMERASE CHAIN REACTION#0.6747;ATHEROSCLEROTIC#0.6547;2-DEOXYGLUCOSE#0.6207;PEPTIDE BINDING#0.6186;TOXICITY#0.6149;CALPAIN ACTIVITY#0.6141;MIDDLE CEREBRAL ARTERY#0.6140;CEREBRAL ARTERY#0.6137;PROLIFERATIVE DIABETIC RETINOPATHY#0.6120;ER STRESS RESPONSE#0.6045;INVASIVE BREAST CANCER#0.6043;BRAIN ISCHEMIA#0.6035;NEURONAL CELL DEATH#0.6030;DIABETIC RETINOPATHY#0.6012
10526	IMPORTIN#1.0989;GENE EXPRESSION#1.0121;NUCLEAR IMPORT#0.9367;OSTEOBLAST DIFFERENTIATION#0.6307;GENE SILENCING#0.6265;REVERSE TRANSCRIPTION#0.6233;OSTEOBLAST#0.6012
105274375	MOOD DISORDER#0.8455
10527	IMPORTIN#1.0693;NUCLEAR IMPORT#1.0511;NUCLEAR LOCALIZATION SIGNAL#0.9213;NUCLEAR PORE#0.9014;NUCLEAR TRANSPORT#0.8896;TRANSPORTIN#0.8862;TRANSCRIPTION FACTOR#0.8852;RIBOSOMAL PROTEIN#0.8540;CYTOPLASM#0.8502;GENE EXPRESSION#0.8271;METALLO BETA LACTAMASE#0.7622;PROTEIN KINASE#0.7514;CANCER CELL#0.7015;SIGNALING PATHWAY#0.6742;GROWTH FACTOR#0.6542;CELL CYCLE#0.6240;APOPTOSIS#0.6222;HUMAN IMMUNODEFICIENCY VIRUS#0.6188;SIMIAN IMMUNODEFICIENCY VIRUS#0.6178;MITOGEN ACTIVATED PROTEIN#0.6082
10528	SNORNP#1.0715;RIBOSOMAL RNA#0.8898;SMALL NUCLEOLAR RNA#0.8873;RRNA METHYLATION#0.8798;RIBOSOME BIOGENESIS#0.8599;CEREBELLAR ATAXIA#0.8317;RIBOSOME#0.8183;SMALL NUCLEOLAR RIBONUCLEOPROTEIN#0.7248;AMYOTROPHIC LATERAL SCLEROSIS#0.7169;LATERAL SCLEROSIS#0.7169;RNA PROCESSING#0.7049;RNA BINDING#0.6491
10529	Z LINE#1.1238;FOCAL ADHESION#1.0769;ACTIN BINDING#1.0631;ACTIN BINDING PROTEIN#1.0255;CARDIAC MUSCLE#0.9245;DILATED CARDIOMYOPATHY#0.9176;CANCER CELL#0.9071;ACTIN FILAMENT#0.9030;Z DISC#0.8967;STRIATED MUSCLE#0.8916;Z DISK#0.8661;MYOFIBRIL#0.8613;SARCOMERE#0.8472;COLORECTAL CANCER#0.8269;SKELETAL MUSCLE#0.8201;CARDIOMYOPATHY#0.8020;CARDIOMYOCYTE#0.7614;POLYMERASE CHAIN REACTION#0.7247;GENE EXPRESSION#0.7087;CELL MIGRATION#0.6969;SIGNALING PATHWAY#0.6924;ENDOCARDIAL FIBROELASTOSIS#0.6703;CARDIAC MYOFIBRIL#0.6669;COLORECTAL#0.6492;LYMPH NODE METASTASIS#0.6205;LYMPH NODE#0.6096
1052	MAMMARY EPITHELIAL CELL#1.0672;TUMOR SUPPRESSOR#1.0629;BREAST CANCER#1.0257;ACUTE PHASE RESPONSE#1.0204;EPITHELIAL CELL#1.0190;MAMMARY GLAND#1.0184;ASTROCYTE#1.0167;CANCER CELL#1.0164;OSTEOBLAST#1.0136;APOPTOSIS#1.0116;ADIPOCYTE DIFFERENTIATION#1.0101;ENHANCER BINDING#1.0082;ENHANCER BINDING PROTEIN#1.0079;FACTOR I#1.0059;GROWTH FACTOR#1.0055;CELL CYCLE#1.0046;DNA BINDING#1.0040;ELECTROPHORETIC MOBILITY SHIFT#1.0034;LEUCINE#1.0029;PEROXISOME#1.0026;MACROPHAGE#0.9987;ADIPOCYTE#0.9985;CELL GROWTH#0.9974;CELL PROLIFERATION#0.9973;ADIPOGENESIS#0.9960;PREADIPOCYTE#0.9933;TRANSACTIVATION#0.9933;SIGNALING PATHWAY#0.9905;INFLAMMATORY RESPONSE#0.9904;DEXAMETHASONE#0.9887;PROTEIN KINASE#0.9877;TRANSCRIPTION FACTOR#0.9874;TUMOR NECROSIS FACTOR#0.9776;GENE EXPRESSION#0.9772;ADIPOSE TISSUE#0.9753;SIGNAL TRANSDUCTION#0.9594;INSULIN-LIKE GROWTH FACTOR#0.9554;SMOOTH MUSCLE#0.9511;CAAT ENHANCER BINDING#0.9396;PROSTATE CANCER#0.9296;BREAST CANCER CELL#0.9278;ALZHEIMER'S DISEASE#0.9044;MUSCLE CELL#0.9009;CAMP RESPONSE ELEMENT#0.8993;HUMAN BREAST CANCER#0.8978;CELL DIFFERENTIATION#0.8919;SIGNAL TRANSDUCER#0.8853;SMOOTH MUSCLE CELL#0.8848;VASCULAR SMOOTH MUSCLE CELL#0.8781;CELL DEATH#0.8729;STEROL REGULATORY ELEMENT#0.8704;BONE MARROW#0.8605;CYCLIC AMP#0.8411;POLYMERASE CHAIN REACTION#0.8356;MAMMARY GLAND INVOLUTION#0.8338;PROTEIN COMPLEX#0.8296;PLATELET-DERIVED GROWTH FACTOR#0.8284;PRO-INFLAMMATORY#0.8275;STEM CELL#0.8249;APOPTOTIC#0.8218;INTESTINAL EPITHELIAL CELL#0.8195;ACTIVATOR PROTEIN 1#0.8192;TERMINAL DIFFERENTIATION#0.8192;PROTEIN BINDING#0.8158;ESTROGEN RECEPTOR#0.8106;TRANSFORMING GROWTH FACTOR#0.8093;FAT CELL#0.8082;MITOTIC CLONAL EXPANSION#0.8069;STROMAL CELL#0.8003;MYELOID LEUKEMIA#0.7957;IMMUNE RESPONSE#0.7945;PROTEIN SYNTHESIS#0.7944;MITOGEN ACTIVATED PROTEIN#0.7671;CAMP RESPONSE ELEMENT BINDING#0.7666;HUMAN MAMMARY EPITHELIAL#0.7619;HEPATOCELLULAR CARCINOMA#0.7544;MAP KINASE#0.7541;PROSTAGLANDIN E2#0.7481;PROTEIN KINASE A#0.7436;PROGENITOR CELL#0.7401;SKELETAL MUSCLE#0.7398;MUTAGENESIS#0.7358;T CELL#0.7318;KERATINOCYTE#0.7249;MYELOID CELL#0.7221;ACUTE MYELOID LEUKEMIA#0.7211;SUPEROXIDE DISMUTASE#0.7175;CELL ADHESION#0.7119;KINASE INHIBITOR#0.7008;GLIAL CELL#0.6881;UBIQUITIN#0.6881;EXTRACELLULAR MATRIX#0.6861;NITRIC OXIDE#0.6731;CERVICAL CANCER#0.6703;RNA BINDING#0.6694;DNA-PROTEIN COMPLEX#0.6661;LIPID DROPLET#0.6650;NERVOUS SYSTEM#0.6571;FOR ADIPOCYTE DIFFERENTIATION#0.6558;LUCIFERASE ACTIVITY#0.6527;HEPATOMA CELLS#0.6526;MONOCYTE#0.6494;IFN-GAMMA#0.6454;INTESTINAL CRYPT#0.6427;SUMOYLATION#0.6409;FATTY ACID BINDING#0.6345;PROLACTINOMA#0.6342;MOUSE EMBRYONIC FIBROBLAST#0.6337;HISTONE DEACETYLASE#0.6287;B CELL#0.6268;ENDOTHELIAL CELL#0.6264;MONOCYTE CHEMOATTRACTANT PROTEIN#0.6177;PROTEIN PROTEIN INTERACTION#0.6161;MESANGIAL CELL#0.6077;GLUCOCORTICOID RECEPTOR#0.6042;TOLL LIKE RECEPTOR#0.6031;RETINOIC ACID#0.6026;AU RICH ELEMENT#0.6015;WHITE ADIPOSE TISSUE#0.6015
10531	GROWTH FACTOR#1.0165;MITOCHONDRIA#0.9450;TRANSFORMING GROWTH FACTOR#0.9285;EXTRACELLULAR MATRIX#0.8620;TUMOR NECROSIS FACTOR#0.8449;TUBERCULOSIS#0.7897;ALZHEIMER'S DISEASE#0.7693;MACROPHAGE#0.7555;GENE EXPRESSION#0.7444;TRANSFORMING GROWTH FACTOR BETA#0.7333;MITOCHONDRIAL MATRIX#0.7331;POLYMERASE CHAIN REACTION#0.7291;ENDOTHELIAL GROWTH FACTOR#0.7000;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7000;CHLOROPLAST#0.6648;APOPTOSIS#0.6190
10533	CONJUGATION#1.0269;BAFILOMYCIN A1#1.0162;AUTOPHAGY#1.0103;CHLOROQUINE#1.0086;SENESCENCE#1.0059;3-METHYLADENINE#1.0049;POLYMERASE CHAIN REACTION#1.0028;BETA CELL#1.0012;CLEAVED CASPASE 3#1.0002;RNA INTERFERENCE#0.9997;MACROPHAGE#0.9993;T CELL#0.9981;LIGHT CHAIN 3#0.9979;CISPLATIN#0.9971;MICROTUBULE ASSOCIATED PROTEIN#0.9969;MOUSE EMBRYONIC FIBROBLAST#0.9960;GERM CELL#0.9932;MICROTUBULE#0.9926;AUTOPHAGOSOME FORMATION#0.9908;AUTOLYSOSOME#0.9901;ADIPOSE TISSUE#0.9899;MITOPHAGY#0.9891;AUTOPHAGIC CELL DEATH#0.9872;UBIQUITIN#0.9864;KERATINOCYTE#0.9853;AUTOPHAGIC VACUOLE#0.9834;ENDOTHELIAL CELL#0.9818;CELL PROLIFERATION#0.9806;EPITHELIAL CELL#0.9805;OVARIAN#0.9803;LUNG CANCER#0.9801;BREAST CANCER#0.9795;REGULATION OF AUTOPHAGY#0.9793;BREAST CANCER CELL#0.9792;MACROAUTOPHAGY#0.9789;CYTOTOXICITY#0.9788;APOPTOTIC CELL DEATH#0.9786;GENE EXPRESSION#0.9778;BONE MARROW#0.9778;SKELETAL MUSCLE#0.9776;CARDIOMYOCYTE#0.9773;AUTOPHAGOSOME#0.9772;HYPOXIA#0.9766;CELL DEATH#0.9764;VACUOLE#0.9764;TARGET OF RAPAMYCIN#0.9752;RAPAMYCIN#0.9740;PROTEIN DEGRADATION#0.9733;CYTOPLASM#0.9721;CELL CYCLE#0.9719;APOPTOTIC#0.9716;TRANSCRIPTION FACTOR#0.9701;TOXICITY#0.9684;B CELL#0.9683;TRANSMISSION ELECTRON MICROSCOPY#0.9680;STEM CELL#0.9678;PROTEASOME#0.9673;TUMOR NECROSIS FACTOR#0.9670;CELLULAR HOMEOSTASIS#0.9653;APOPTOSIS#0.9652;PRO-INFLAMMATORY#0.9645;MITOCHONDRIA#0.9642;HEPATOCELLULAR CARCINOMA#0.9642;PROTEIN KINASE#0.9642;ENDOPLASMIC RETICULUM#0.9641;GROWTH FACTOR#0.9636;INFLAMMATORY RESPONSE#0.9633;CELL GROWTH#0.9628;REACTIVE OXYGEN SPECIES#0.9627;ISCHEMIA#0.9620;LYSOSOME#0.9610;CANCER CELL#0.9595;PHOSPHATIDYLETHANOLAMINE#0.9593;CELL CYCLE ARREST#0.9586;SIGNALING PATHWAY#0.9567;IMMUNE RESPONSE#0.9551;TUMOR CELLS#0.9544;CYTOCHROME C#0.9516;ORGANELLE#0.9506;QUANTITATIVE REAL TIME#0.9503;ADIPOCYTE#0.9498;DNA FRAGMENTATION#0.9421;HIGH FAT DIET#0.9418;MYELOID LEUKEMIA#0.9395;TUMOR SUPPRESSOR#0.9392;FATTY LIVER#0.9385;DRUG RESISTANCE#0.9383;MYELOID CELL#0.9367;CATABOLIC PROCESS#0.9356;OVARIAN CANCER#0.9321;MITOCHONDRIAL MEMBRANE#0.9318;PROGRAMMED CELL DEATH#0.9315;PEROXISOME#0.9285;CASPASE INHIBITOR#0.9275;LIPID DROPLET#0.9269;COLORECTAL CANCER#0.9257;NEURODEGENERATIVE DISEASE#0.9229;ENDOPLASMIC RETICULUM STRESS#0.9224;MUSCLE ATROPHY#0.9218;SMOOTH MUSCLE#0.9207;ONCOGENIC#0.9205;TYPE 2 DIABETES#0.9124;OBESE#0.9091;HYPOXIC#0.9086;COLORECTAL#0.9082;KINASE INHIBITOR#0.9068;PROSTATE CANCER#0.9046;NERVOUS SYSTEM#0.9045;CHONDROCYTE#0.8983;SUPEROXIDE DISMUTASE#0.8917;ANGIOGENESIS#0.8899;DUAL LUCIFERASE REPORTER#0.8893;LIPID METABOLISM#0.8889;SELECTIVE AUTOPHAGY#0.8878;OSTEOCLAST#0.8875;MITOGEN ACTIVATED PROTEIN#0.8870;ROS GENERATION#0.8842;CENTRAL NERVOUS SYSTEM#0.8837;COLON CANCER#0.8834;LIVER DISEASE#0.8825;T LYMPHOCYTE#0.8805;REVERSE TRANSCRIPTION#0.8770;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8767;PROGENITOR CELL#0.8681;MUSCLE CELL#0.8640;HISTONE DEACETYLASE#0.8605;CELLULAR COMPONENT#0.8561;PERIPHERAL BLOOD#0.8556;EXTRACELLULAR MATRIX#0.8496;TRANSFORMING GROWTH FACTOR#0.8495;ACUTE MYELOID LEUKEMIA#0.8478;INSULIN SECRETION#0.8465;UBIQUITIN ACTIVATING ENZYME#0.8387;STROMAL CELL#0.8358;INDUCTION OF APOPTOSIS#0.8340;CYTOKINE PRODUCTION#0.8328;HYPERGLYCEMIA#0.8301;S PHASE#0.8268;OSTEOBLAST#0.8265;PROTEIN SYNTHESIS#0.8254;CELL DIFFERENTIATION#0.8246;MYOCARDIAL INFARCTION#0.8245;CANCER STEM CELL#0.8198;CELLULAR PROCESS#0.8173;TUBE FORMATION#0.8126;BINDING PROTEIN 1#0.8090;DENDRITIC CELL#0.8059;UNFOLDED PROTEIN RESPONSE#0.8022;HEPATIC STELLATE CELL#0.7990;C TERMINAL DOMAIN#0.7978;CELL MIGRATION#0.7965;N-ACETYLCYSTEINE#0.7953;NITRIC OXIDE#0.7944;PANCREATIC CANCER#0.7930;DOPAMINE#0.7919;VIRAL INFECTION#0.7898;ETHANOL#0.7866;DOPAMINERGIC NEURON#0.7818;SMOOTH MUSCLE CELL#0.7796;ENDOSOME#0.7785;PLASMA MEMBRANE#0.7784;CD4+ T CELL#0.7764;PHAGOCYTOSIS#0.7738;AUTOPHAGIC DEATH#0.7720;PARKINSON'S DISEASE#0.7708;PHAGOPHORE#0.7702;FATTY ACID OXIDATION#0.7670;LYSOSOMAL MEMBRANE#0.7661;HOST CELL#0.7635;NEUROPROTECTION#0.7599;EPITHELIAL MESENCHYMAL TRANSITION#0.7595;PALMITATE#0.7593;HEMATOPOIETIC STEM CELL#0.7590;TYROSINE KINASE INHIBITOR#0.7558;SIGNALLING PATHWAY#0.7521;KINASE ACTIVITY#0.7513;MONOCYTE#0.7493;CASPASE ACTIVATION#0.7471;ADENINE#0.7460;ADENOCARCINOMA#0.7450;ISCHEMIA REPERFUSION INJURY#0.7444;INNATE IMMUNITY#0.7441;PURKINJE CELL#0.7420;MITOCHONDRIAL DEPOLARIZATION#0.7409;HEPATOCELLULAR CARCINOMA CELL#0.7359;NEURON DEATH#0.7324;SIGNALING CASCADE#0.7318;REGENERATION#0.7292;SQUAMOUS CELL CARCINOMA#0.7291;RESPIRATION#0.7282;GLUTATHIONE#0.7279;INTESTINAL EPITHELIAL CELL#0.7237;ARTERY#0.7231;ACETYLCYSTEINE#0.7231;HYDROXYCHLOROQUINE#0.7219;CD8+ T CELL#0.7191;DIGESTION#0.7187;RIBOSOMAL PROTEIN#0.7164;ATHEROSCLEROSIS#0.7144;UBIQUITIN PROTEASOME SYSTEM#0.7142;RESVERATROL#0.7141;RED FLUORESCENT PROTEIN#0.7118;MECHANISM OF ACTION#0.7116;FATTY LIVER DISEASE#0.7103;PROTEIN KINASE B#0.7103;HYPERTENSION#0.7102;OOCYTE#0.7098;MESENCHYMAL STEM CELL#0.7074;UMBILICAL VEIN ENDOTHELIAL CELLS#0.7068;MIDBRAIN#0.7065;HUMAN UMBILICAL VEIN#0.7063;ESTROGEN RECEPTOR#0.7062;UMBILICAL VEIN#0.7061;CELL SURFACE#0.7042;MICROVASCULAR ENDOTHELIAL CELL#0.7034;ATHEROSCLEROTIC#0.7031;CELL KILLING#0.7016;WHITE ADIPOSE TISSUE#0.7007;PRECURSOR CELL#0.6995;GENE SILENCING#0.6986;RENAL CELL CARCINOMA#0.6984;INHIBITION OF CELL PROLIFERATION#0.6975;MELANIN DEGRADATION#0.6952;IMMUNE SYSTEM#0.6948;MONONUCLEAR CELLS#0.6948;ADENOSINE#0.6928;ACINAR CELL#0.6856;ALZHEIMER'S DISEASE#0.6853;DIABETES MELLITUS#0.6853;GROWTH FACTOR RECEPTOR#0.6851;SIGNALING MOLECULE#0.6828;PODOCYTE#0.6812;PANETH CELL#0.6811;MITOCHONDRIAL DAMAGE#0.6777;GLYCOLYSIS#0.6759;DNA DAMAGE RESPONSE#0.6733;MITOCHONDRIAL DNA#0.6729;RELATED PROTEIN 1#0.6724;TOLL LIKE RECEPTOR#0.6693;PHAGOSOME#0.6679;HUMAN BREAST CANCER#0.6666;DOXORUBICIN#0.6643;TRANSMISSION ELECTRON MICROSCOPE#0.6639;MYOBLAST#0.6631;AUTOPHAGOSOME-LYSOSOME FUSION#0.6613;SENSITIZATION#0.6610;VASCULAR SMOOTH MUSCLE CELL#0.6610;ASTROCYTE#0.6594;NUCLEUS PULPOSUS#0.6575;GLUCOSE HOMEOSTASIS#0.6571;NEURONAL CELLS#0.6563;BETA CELL MASS#0.6533;SWELLING#0.6506;PROTEIN COMPLEX#0.6488;G1 PHASE#0.6483;SYSTEMIC LUPUS ERYTHEMATOSUS#0.6478;TUBULAR EPITHELIAL CELL#0.6477;LUPUS ERYTHEMATOSUS#0.6475;CELL ACTIVATION#0.6452;HEAT SHOCK PROTEIN#0.6416;RETINOIC ACID#0.6411;SIGNAL TRANSDUCTION#0.6389;NEUROBLASTOMA#0.6383;ACUTE KIDNEY INJURY#0.6337;ANTIGEN PRESENTATION#0.6336;AKT SIGNALING#0.6319;MYOFIBROBLAST DIFFERENTIATION#0.6312;MYOFIBROBLAST#0.6310;INTRACELLULAR MEMBRANE#0.6308;PALMITIC ACID#0.6297;EPIDERMAL GROWTH FACTOR#0.6279;AUTOPHAGOLYSOSOME#0.6274;INNATE IMMUNE RESPONSE#0.6255;GLUCOSE METABOLISM#0.6249;SCHWANN CELL#0.6244;OVARIAN CARCINOMA#0.6243;NECROTIC#0.6193;MTDNA#0.6185;IMPAIRED GLUCOSE TOLERANCE#0.6182;NEURONAL CELL DEATH#0.6178;NEUROTOXICITY#0.6161;DIET INDUCED OBESITY#0.6144;LYSINE#0.6141;BORTEZOMIB#0.6120;NADPH OXIDASE#0.6110;BRAIN ENDOTHELIAL CELL#0.6075;MELANOCYTE#0.6073;LYSOSOMAL MEMBRANE PERMEABILIZATION#0.6034;PHOSPHATE BUFFERED SALINE#0.6024;RETICULOCYTE#0.6023;TRADITIONAL CHINESE MEDICINE#0.6012;ATPASE INHIBITOR#0.6011;ENERGY HOMEOSTASIS#0.6009
10534	CENTROMERE#0.6738;CYCLIN DEPENDENT KINASE#0.6601;GASTROINTESTINAL STROMAL TUMOR#0.6076;TRADITIONAL CHINESE MEDICINE#0.6038
10535	RNASE H ACTIVITY#1.0441;DNA POLYMERASE I#1.0368;EXONUCLEASE ACTIVITY#1.0279;DNA POLYMERASE ACTIVITY#1.0268;DIGESTION#1.0206;RIBONUCLEASE H#1.0144;DNA LIGASE#1.0076;REVERSE TRANSCRIPTASE INHIBITOR#1.0071;VIRAL GENOME#1.0058;RNA DEGRADATION#1.0053;HEPATITIS B VIRUS#1.0052;HEPATITIS B#1.0029;DRUG RESISTANCE#1.0026;TOPOISOMERASE#1.0004;TRANSCRIPTASE#0.9988;RNA BINDING#0.9955;VIRION#0.9950;MECHANISM OF ACTION#0.9934;DNASE#0.9928;VIRAL REPLICATION#0.9925;RIBOZYME#0.9905;DNA REPLICATION#0.9904;CATALYTIC ACTIVITY#0.9903;MUTAGENESIS#0.9881;DNA SYNTHESIS#0.9869;NUCLEASE ACTIVITY#0.9867;DNA BINDING#0.9864;C TERMINAL DOMAIN#0.9856;HUMAN IMMUNODEFICIENCY VIRUS#0.9840;REVERSE TRANSCRIPTASE ACTIVITY#0.9836;NUCLEOCAPSID#0.9817;BASE PAIRING#0.9817;PROTEIN SYNTHESIS#0.9787;NUCLEIC ACID#0.9765;MRNA CLEAVAGE#0.9753;LOCKED NUCLEIC ACID#0.9751;REVERSE TRANSCRIPTION#0.9746;POLYMERASE CHAIN REACTION#0.9719;RIBOSOME#0.9671;GENE EXPRESSION#0.9601;OOCYTE#0.9597;GLOBIN#0.9570;DNASE I#0.9561;DNA REPAIR#0.9551;SURFACE PLASMON RESONANCE#0.9547;ENDONUCLEASE ACTIVITY#0.9537;SPLICEOSOME#0.9518;NUCLEIC ACID BINDING#0.9510;ENZYME ACTIVITY#0.9495;RNA INTERFERENCE#0.9455;PROTEIN BINDING#0.9442;RETICULOCYTE#0.9433;THYMIDINE#0.9415;NEVIRAPINE#0.9374;DNA POLYMERASE ALPHA#0.9358;TRANSLATION INITIATION#0.9313;GENE SILENCING#0.9283;RIBOSOMAL SUBUNIT#0.9271;STRUCTURE ACTIVITY RELATIONSHIP#0.9255;HOST CELL#0.9232;MRNA SPLICING#0.9229;HISTIDINE#0.9207;RESONANCE ENERGY TRANSFER#0.9169;MRNA DEGRADATION#0.9164;SMALL NUCLEAR RNA#0.9139;N-ETHYLMALEIMIDE#0.9129;STRAND DISPLACEMENT#0.9118;STRAND TRANSFER REACTION#0.9103;FLAP ENDONUCLEASE#0.9086;T CELL#0.9071;RIBOSOMAL RNA#0.9057;PRE-MRNA SPLICING#0.9054;CANCER CELL#0.9003;RNA SYNTHESIS#0.8993;TRANSPOSITION#0.8972;MODE OF ACTION#0.8971;ALANINE#0.8891;HEPATITIS C VIRUS#0.8880;HEPATITIS C#0.8872;CELL PROLIFERATION#0.8840;EFAVIRENZ#0.8797;CELL GROWTH#0.8742;RNASE T1#0.8712;CYTOPLASM#0.8668;METAL BINDING#0.8658;PEPTIDE NUCLEIC ACID#0.8618;SINGLE-STRANDED DNA BINDING#0.8593;U2 SNRNP#0.8565;TOXICITY#0.8516;5'-EXONUCLEASE ACTIVITY#0.8503;ANTISENSE RNA#0.8427;REPLICATION FORK#0.8407;CYTOTOXICITY#0.8375;SUCROSE#0.8361;DNA PRIMASE#0.8310;ACTINOMYCIN D#0.8297;MITOCHONDRIA#0.8288;DNA TOPOISOMERASE#0.8243;SMALL NUCLEAR RIBONUCLEOPROTEIN#0.8238;MOLECULAR DYNAMICS SIMULATION#0.8212;APOPTOSIS#0.8187;DEOXYTHYMIDINE#0.8106;ASPARTIC ACID#0.8091;TRANSCRIPTION FACTOR#0.8067;RNA BINDING PROTEIN#0.7978;COMPLEX I#0.7965;RIBOSE#0.7932;CARRIE#0.7882;ADENOSINE#0.7865;RNA PROCESSING#0.7767;NUCLEOTIDE BINDING#0.7758;HOMOLOGOUS RECOMBINATION#0.7753;CELL CYCLE#0.7752;TUMOR CELLS#0.7663;DOUBLE STRAND BREAK#0.7628;CYTIDINE#0.7620;RIBONUCLEASE ACTIVITY#0.7568;SODIUM DODECYL SULFATE#0.7422;DODECYL SULFATE#0.7421;DSRNA BINDING#0.7377;SUBSTRATE BINDING DOMAIN#0.7328;GUANIDINIUM CHLORIDE#0.7327;U1 SNRNP#0.7245;VIRAL INFECTION#0.7199;TELOMERE#0.7198;PERIPHERAL BLOOD#0.7155;PROVIRUS#0.7152;ROLLING CIRCLE AMPLIFICATION#0.7061;URACIL#0.7048;DNA HELICASE#0.7045;LYSINE#0.7010;HERPES SIMPLEX VIRUS#0.6974;HERPES SIMPLEX#0.6971;U12 SNRNP#0.6934;RETROTRANSPOSITION#0.6874;SPLICEOSOME ASSEMBLY#0.6871;RNA-INDUCED SILENCING COMPLEX#0.6846;GUANINE#0.6679;30S RIBOSOMAL SUBUNIT#0.6677;IMMUNE RESPONSE#0.6646;DOUBLE-STRANDED RNA BINDING#0.6579;3'-5' EXONUCLEASE ACTIVITY#0.6497;MUTAGENIC#0.6490;CHLORAMPHENICOL#0.6490;ENZYME COMPLEX#0.6485;HEPARIN#0.6472;THYMINE#0.6436;RISC COMPLEX#0.6418;RNASE ACTIVITY#0.6409;ZIDOVUDINE#0.6373;DNA DEPENDENT ATPASE#0.6371;EQUINE INFECTIOUS ANEMIA#0.6339;MITOCHONDRIAL DNA#0.6311;CONJUGATION#0.6300;FURAN#0.6287;ASPARTATE#0.6241;GROWTH FACTOR#0.6232;PHOSPHODIESTERASE#0.6222;METHIONINE#0.6216;ENDOTHELIAL CELL#0.6184;MRNA DECAY#0.6151;POSTREPLICATION REPAIR#0.6136;DNA POLYMERASE III#0.6109;DNASE ACTIVITY#0.6012
10536	COLD SHOCK PROTEIN#1.0910;FIBRONECTIN BINDING#1.0898;METASTATIC MELANOMA#1.0886;HEAT SHOCK PROTEIN#1.0478;OUTER MEMBRANE#1.0339;RIBOSOME#1.0250;PROGESTERONE#1.0237;ESTRADIOL-17BETA#1.0214;AMYOTROPHIC LATERAL SCLEROSIS#1.0197;LATERAL SCLEROSIS#1.0197;GROWTH FACTOR#1.0157;POLYMERASE CHAIN REACTION#0.9995;VIRULENCE#0.9886;HOST CELL#0.9761;IMMUNE RESPONSE#0.9633;NERVE GROWTH FACTOR#0.9617;ENDOPLASMIC RETICULUM#0.9575;B CELL#0.9454;DNA BINDING#0.9445;GESTATION#0.9435;GENE EXPRESSION#0.9421;ESTRADIOL#0.9368;MACROPHAGE#0.9311;SIGNALING PATHWAY#0.9287;CELL WALL#0.9258;INSEMINATION#0.9212;SPHINGOLIPID ACTIVATOR PROTEIN#0.9186;CELL SURFACE#0.9135;TUBERCULOSIS#0.9073;PROSTAGLANDIN E2#0.9015;IRON ACQUISITION#0.8877;SPOTTED FEVER#0.8815;T CELL#0.8809;TRANSCRIPTION FACTOR#0.8774;RIBOSOMAL PROTEIN#0.8740;BIOFILM FORMATION#0.8625;MOTOR NEURON DISEASE#0.8576;BREAST CANCER#0.8566;PROTEIN KINASE#0.8561;HIGH MOBILITY GROUP#0.8513;DODECYL SULFATE#0.8509;SODIUM DODECYL SULFATE#0.8509;LYME DISEASE#0.8506;CELL PROLIFERATION#0.8486;DENTAL CARIES#0.8416;EPITHELIAL CELL#0.8393;LUNG CANCER#0.8302;PROTEIN SYNTHESIS#0.8246;PERIPHERAL BLOOD#0.8208;CANCER CELL#0.8203;ELECTRON TRANSFER#0.8143;CENTROMERE BINDING#0.8048;CENTROMERE#0.8043;FIBRINOGEN#0.8023;MICROTUBULE#0.8014;ESTRUS#0.7916;RENAL CELL CARCINOMA#0.7879;COLICIN#0.7876;APOPTOSIS#0.7873;PLASMA PROTEIN#0.7849;ESTROUS CYCLE#0.7814;RESPIRATORY DISTRESS#0.7691;TUBERCULOUS MENINGITIS#0.7638;REVERSE TRANSCRIPTION#0.7632;STEM CELL#0.7613;GLYCINE#0.7601;MUTAGENESIS#0.7446;MENINGITIS#0.7341;CELL DIVISION#0.7175;LYSINE#0.7124;CYTOPLASM#0.7090;CELL DEATH#0.7066;INTERFERON STIMULATED GENE#0.7042;UNFOLDED PROTEIN RESPONSE#0.7038;CHLAMYDIA#0.6903;IMMUNOGLOBULIN G#0.6880;TF BINDING#0.6867;METACHROMATIC LEUKODYSTROPHY#0.6864;QUANTITATIVE REAL TIME#0.6844;LEUKOCYTE#0.6812;DUODENAL ULCER#0.6787;C TERMINAL DOMAIN#0.6756;PROTEIN PROTEIN INTERACTION#0.6739;PEPTIDOGLYCAN#0.6544;HISTIDINE#0.6530;TYPHUS#0.6491;DIGESTION#0.6485;NUCLEIC ACID#0.6452;ENDOMETRIUM#0.6442;RIBONUCLEOPROTEIN COMPLEX#0.6370;AUTOPHAGY#0.6299;FIBRINOGEN BINDING#0.6292;ENHANCER BINDING PROTEIN#0.6250;ENHANCER BINDING#0.6245;SIGNAL TRANSDUCTION#0.6244;CELLULOSE BINDING#0.6187;PENICILLIN BINDING#0.6174;SURFACE PLASMON RESONANCE#0.6157;SAPOSIN#0.6112;Q FEVER#0.6062;ALPHA GALACTOSIDASE#0.6017;MICROTUBULE ASSOCIATED PROTEIN#0.6016;QUALITY CONTROL SYSTEM#0.6007
105371906	ORAL SQUAMOUS CELL CARCINOMA#0.9119;SQUAMOUS CELL CARCINOMA#0.9013
105373853	VSMC DIFFERENTIATION#0.7277;SERUM RESPONSE FACTOR#0.6950;TRANSFORMING GROWTH FACTOR#0.6719;GROWTH FACTOR#0.6655
105375355	MESOTHELIOMA CELL#0.6238;MESOTHELIAL CELL#0.6129
105377108	COLORECTAL CANCER#1.1841;SIGNALING PATHWAY#1.1785;COLORECTAL#0.8485
105377363	DNA METHYLATION#0.8293;STEM CELL#0.7963
10537	HEPATOCELLULAR CARCINOMA#1.0500;APOPTOSIS#1.0409;PROTEASOME#1.0233;UBIQUITIN#1.0220;26S PROTEASOME#1.0172;CONJUGATION#1.0144;UBIQUITIN BINDING#1.0058;CELL CYCLE#1.0028;POLYUBIQUITIN#0.9969;GENE EXPRESSION#0.9924;CANCER CELL#0.9850;DEUBIQUITINATING ENZYME#0.9662;DEUBIQUITINASE#0.9612;LYSINE#0.9588;TUMOR NECROSIS FACTOR#0.9426;SIGNALING PATHWAY#0.9358;CELL PROLIFERATION#0.9154;PROTEIN DEGRADATION#0.9104;IMMUNE RESPONSE#0.9031;DENDRITIC CELL#0.8986;PRO-INFLAMMATORY#0.8934;POST-TRANSLATIONAL MODIFICATION#0.8877;UBIQUITIN ACTIVATING ENZYME#0.8732;IFN-GAMMA#0.8666;CELL DEATH#0.8458;COLON CANCER#0.8456;EPITHELIAL CELL#0.8347;T CELL#0.8309;ANTIGEN PRESENTATION#0.8130;BREAST CANCER#0.7918;TUMOR SUPPRESSOR#0.7880;COLON CARCINOMA#0.7568;MITOSIS#0.7313;HUMAN LEUKOCYTE ANTIGEN#0.7311;LEUKOCYTE#0.7236;AUTOPHAGY#0.7069;DNA DAMAGE RESPONSE#0.6953;LYMPH NODE#0.6891;ONCOGENIC#0.6835;B CELL#0.6773;CELL SURFACE#0.6600;MAJOR HISTOCOMPATIBILITY COMPLEX#0.6593;DNA REPAIR#0.6507;CYTOPLASM#0.6501;ENDOPLASMIC RETICULUM#0.6324;QUANTITATIVE REAL TIME#0.6278;PROTEIN QUALITY CONTROL#0.6223;POLYMERASE CHAIN REACTION#0.6186;MUTAGENESIS#0.6133;VIRAL INFECTION#0.6086;SPINDLE ASSEMBLY#0.6038
10538	ACTIVATING TRANSCRIPTION FACTOR#1.0870;LEUCINE#1.0771;TH17 CELL#1.0558;TRANSCRIPTION FACTOR#1.0534;B CELL#1.0519;GENE EXPRESSION#1.0373;CD4+ T CELL#1.0351;T CELL#1.0301;ACTIVATOR PROTEIN 1#1.0273;CELL DIFFERENTIATION#1.0159;CELL DEVELOPMENT#1.0110;DNA BINDING#0.9809;TH9 CELL#0.9456;CD8+ T CELL#0.9231;GM-CSF#0.8887;RETINOIC ACID#0.8779;TH2 CELL#0.8665;IMMUNE RESPONSE#0.8318;INTERFERON REGULATORY FACTOR#0.8237;ALLERGIC ASTHMA#0.7974;HEPATITIS B#0.7730;T HELPER CELL#0.7695;CELL PROLIFERATION#0.7588;NKT CELL#0.7577;EFFECTOR T CELL#0.7312;RELATED ORPHAN RECEPTOR#0.7271;IL-9 PRODUCTION#0.6584;AUTOIMMUNE DISEASE#0.6499;T FOLLICULAR HELPER#0.6481;QUANTITATIVE REAL TIME#0.6407;DENDRITIC CELL#0.6393;EPSTEIN BARR VIRUS#0.6369;SIGNAL TRANSDUCER#0.6357;T CELL DIFFERENTIATION#0.6217;CLASS SWITCH RECOMBINATION#0.6194;CELLULAR GROWTH#0.6183;HISTONE ACETYLATION#0.6174;PERIPHERAL BLOOD#0.6173;HEPATITIS B VIRUS#0.6124;T CELL PROLIFERATION#0.6123;COLITIS#0.6122;CELL ACTIVATION#0.6113;MYELOID LEUKEMIA#0.6089;MACROPHAGE#0.6061
10539	IRON SULFUR CLUSTER#1.0228;GLUTATHIONE#1.0057;IRON HOMEOSTASIS#0.9970;PROTEIN KINASE#0.9947;CANCER CELL#0.9701;PROTEIN KINASE C#0.9604;T CELL#0.9193;SIGNALING PATHWAY#0.9113;TRANSCRIPTION FACTOR#0.9048;CELL GROWTH#0.8888;REACTIVE OXYGEN SPECIES#0.8697;OXIDATIVE STRESS RESPONSE#0.8067;ACTIN CYTOSKELETON#0.7607;RESPONSE TO IRON#0.7532;GENE EXPRESSION#0.7513;L-CYSTEINE#0.7416;CELL CYCLE#0.7313;LUNG CANCER#0.7292;CARDIOMYOCYTE#0.7185;IRON REGULATORY PROTEIN#0.7005;MITOCHONDRIA#0.6942;COLON CANCER#0.6826;BREAST CANCER#0.6726;CHAPERONE COMPLEX#0.6197;PROTEIN PROTEIN INTERACTION#0.6137;T LYMPHOCYTE#0.6094;PKC ACTIVITY#0.6043;HISTIDINE#0.6043
1053	G-CSF#1.0561;ACUTE LYMPHOBLASTIC LEUKEMIA#1.0453;ENHANCER BINDING PROTEIN#1.0361;MYELOID CELL#1.0360;ENHANCER BINDING#1.0359;NEUTROPHIL#1.0283;DNA BINDING#1.0270;GENE EXPRESSION#1.0244;TRANSCRIPTION FACTOR#1.0208;GRANULOCYTE#1.0178;SPECIFIC GRANULE#1.0147;RETINOIC ACID#1.0117;MACROPHAGE#1.0050;BONE MARROW#0.9927;SECONDARY GRANULE#0.9868;MYELOID LEUKEMIA#0.9507;COLONY-STIMULATING FACTOR#0.9366;B CELL#0.9321;CELL CYCLE#0.9225;T CELL#0.9206;MONOCYTE#0.9168;EOSINOPHIL#0.9148;ACUTE MYELOID LEUKEMIA#0.8969;TERMINAL DIFFERENTIATION#0.8932;PERIPHERAL BLOOD#0.8470;ALL TRANS RETINOIC ACID#0.8298;APOPTOSIS#0.8276;GRANULOCYTE COLONY STIMULATING FACTOR#0.8268;HEMATOPOIETIC CELL#0.8146;PROMYELOCYTE#0.8144;TRANSACTIVATION#0.8123;LEUCINE#0.8031;NEUTROPHIL DIFFERENTIATION#0.7992;STEM CELL#0.7932;ACUTE PROMYELOCYTIC LEUKEMIA#0.7727;HEMATOPOIETIC STEM CELL#0.7608;RETINOIC ACID RECEPTOR#0.7131;PROGENITOR CELL#0.7114;GRANULOCYTE DIFFERENTIATION#0.6951;CELL CYCLE ARREST#0.6867;BONE MARROW CELLS#0.6859;POLYMERASE CHAIN REACTION#0.6787;KINASE INHIBITOR#0.6372;CELL DIFFERENTIATION#0.6280;PROTEIN PROTEIN INTERACTION#0.6095;ELECTROPHORETIC MOBILITY SHIFT#0.6002
10540	DYNACTIN COMPLEX#1.0721;DYNEIN#1.0548;MICROTUBULE#0.9993;KINETOCHORE#0.8377;KINESIN#0.8250;CELL SURFACE#0.8177;ENDOPLASMIC RETICULUM#0.8099;CELL PERIPHERY#0.7686;NOCODAZOLE#0.7643;MICROTUBULE MOTOR#0.7574;CENTROSOME#0.7275;MITOTIC SPINDLE#0.7032;DYNEIN COMPLEX#0.6953;ORGANELLE#0.6836;ACTIN RELATED PROTEIN#0.6811;ENDOSOME#0.6428;MACROPHAGE#0.6354;PLASMA MEMBRANE#0.6265;BASAL CORTEX#0.6259;MICROTUBULE BASED#0.6246;GROWTH CONE#0.6177
105416157	BREAST CANCER#1.0850;APOPTOSIS#1.0497;SIGNALING PATHWAY#1.0084;CANCER CELL#0.9565;CELL PROLIFERATION#0.9525;EPITHELIAL MESENCHYMAL TRANSITION#0.9323;CELL DEATH#0.8408;LUNG CANCER#0.7694;TUMOR SUPPRESSOR#0.7107;INFLAMMATORY RESPONSE#0.7100;SQUAMOUS CELL CARCINOMA#0.6584;TUMOR TISSUES#0.6372;SIGNALLING PATHWAY#0.6354;AUTOPHAGY#0.6125
10541	STEM CELL#0.9891;BONE MARROW#0.9814;STEM CELL TRANSPLANTATION#0.9811;PERIPHERAL BLOOD#0.9742;HUMAN LEUKOCYTE ANTIGEN#0.9685;T CELL#0.9651;GRAFT VERSUS HOST#0.9566;LEUKOCYTE#0.9557;LEUCINE#0.9521;HEMATOPOIETIC STEM CELL#0.9449;MYELOID LEUKEMIA#0.9438;CYCLOPHOSPHAMIDE#0.9234;ANEMIA#0.8779;CORD BLOOD#0.8760;ACUTE MYELOID LEUKEMIA#0.8665;CYCLOSPORINE#0.8566;APLASTIC ANEMIA#0.8367;APOPTOSIS#0.8216;MYELODYSPLASTIC SYNDROME#0.8184;HISTONE CHAPERONE#0.8049;DISEASE FREE SURVIVAL#0.7880;MATCHED SIBLING DONOR#0.7855;CHRONIC MYELOID LEUKEMIA#0.7666;ACUTE LYMPHOBLASTIC LEUKEMIA#0.7502;UVEITIS#0.7469;ACUTE LEUKEMIA#0.7462;BUSULFAN#0.7357;STEM CELL TRANSPLANT#0.7294;UMBILICAL CORD#0.7293;METHOTREXATE#0.7082;T LYMPHOCYTE#0.6853;B CELL#0.6725;UMBILICAL CORD BLOOD#0.6653;ETOPOSIDE#0.6466;ANTERIOR UVEITIS#0.6309;APOPTOTIC#0.6276;IMMUNE RESPONSE#0.6244;GENE EXPRESSION#0.6243;DIABETES MELLITUS#0.6125;INFLUENZA A VIRUS#0.6113;POLYMERASE CHAIN REACTION#0.6107;FLUDARABINE#0.6102
10542	BREAST CANCER CELL#1.0932;BREAST CANCER#1.0862;CANCER CELL#1.0774;HEPATITIS B#1.0596;CELL PROLIFERATION#1.0592;HEPATITIS B VIRUS#1.0512;TRANSCRIPTION FACTOR#1.0466;LYMPH NODE#1.0209;LYMPH NODE METASTASIS#0.9706;APOPTOSIS#0.9456;CELL MIGRATION#0.9355;HEPATOMA CELLS#0.9163;HUMAN BREAST CANCER#0.9080;BREAST CANCER PATIENTS#0.8635;HEPATOCELLULAR CARCINOMA#0.8502;SIGNALING PATHWAY#0.8248;AKT SIGNALING#0.8241;QUANTITATIVE REAL TIME#0.8200;ONCOGENIC#0.8005;CELL GROWTH#0.7883;GLUCOSE METABOLISM#0.7765;TUMOR SUPPRESSOR#0.7751;OVARIAN CANCER#0.7736;REPORTER GENE ASSAY#0.7732;SQUAMOUS CELL CARCINOMA#0.7713;CELL CYCLE#0.7562;LIVER CANCER#0.7131;ACTIVATING TRANSCRIPTION FACTOR#0.7012;BREAST CARCINOMA#0.6935;GENE EXPRESSION#0.6887;CENTROSOME REPLICATION#0.6516;REVERSE TRANSCRIPTION#0.6406;SPINDLE FORMATION#0.6305
10544	RECEPTOR SHEDDING#1.0939;APC BINDING#1.0934;CEREBRAL MALARIA#1.0446;MALARIA#1.0434;HEMATOPOIETIC STEM CELL#1.0327;PROTEASE ACTIVATED RECEPTOR#1.0320;NEUTROPHIL#1.0241;CANCER CELL#1.0233;TUMOR NECROSIS FACTOR#1.0233;STEM CELL#1.0229;BREAST CANCER#1.0204;SELECTIN#1.0202;ENDOTHELIAL CELL#1.0174;MAP KINASE#1.0150;CELL SURFACE#1.0137;ENDOTHELIUM#1.0135;HUMAN UMBILICAL VEIN#1.0130;UMBILICAL VEIN ENDOTHELIAL CELLS#1.0118;ERYTHROCYTE#1.0105;UMBILICAL VEIN#1.0102;VASCULAR ENDOTHELIAL CELL#1.0065;POLYMERASE CHAIN REACTION#1.0024;ACTIVATED PROTEIN C#1.0016;SIGNALING PATHWAY#0.9979;FACTOR V LEIDEN#0.9962;GROWTH FACTOR#0.9960;ANTICOAGULANT ACTIVITY#0.9960;INFLAMMATORY RESPONSE#0.9954;LEUKOCYTE#0.9877;APOPTOSIS#0.9869;BLOOD VESSEL#0.9869;THROMBOSIS#0.9867;GENE EXPRESSION#0.9860;BLOOD COAGULATION#0.9857;ANTICOAGULANT PROTEIN C#0.9845;COAGULATION#0.9835;BONE MARROW#0.9810;LIPID RAFT#0.9763;T CELL#0.9756;CELL ADHESION#0.9742;BRAIN ENDOTHELIAL CELL#0.9732;THROMBIN RECEPTOR#0.9688;PROGENITOR CELL#0.9672;MACROPHAGE#0.9665;APOPTOTIC#0.9651;NITRIC OXIDE#0.9569;MONOCYTE#0.9559;HEMOSTASIS#0.9541;MYOCARDIAL INFARCTION#0.9457;CELL PROLIFERATION#0.9435;CLOTTING#0.9419;C-LEVEL#0.9397;MICROPARTICLE#0.9258;FIBRINOGEN#0.9200;MAJOR HISTOCOMPATIBILITY COMPLEX#0.9200;PROTEIN KINASE#0.9163;LUPUS ERYTHEMATOSUS#0.9115;REVERSE TRANSCRIPTION#0.9095;SMOOTH MUSCLE#0.9066;TUMOR CELLS#0.9065;CELL CYCLE#0.9057;EPITHELIAL CELL#0.9057;FIBRINOLYSIS#0.9033;FACTOR XA#0.9018;SMOOTH MUSCLE CELL#0.9015;MUSCLE CELL#0.9008;CELL ADHESION MOLECULE#0.9005;MITOGEN ACTIVATED PROTEIN#0.8985;LUNG CANCER#0.8982;VITAMIN K#0.8960;ECTODOMAIN CLEAVAGE#0.8955;IMMUNE CELL#0.8947;MICROVASCULAR ENDOTHELIAL CELL#0.8922;ARTERY#0.8903;BREAST CANCER CELL#0.8867;THROMBOPHILIA#0.8827;TROPHOBLAST#0.8770;HEMOPHILIA#0.8762;IMMUNE RESPONSE#0.8686;CELL MIGRATION#0.8628;KERATINOCYTE#0.8588;SURFACE PLASMON RESONANCE#0.8545;ANGIOGENESIS#0.8520;PLASMA PROTEIN#0.8519;STEM CELL MARKER#0.8504;SPHINGOSINE 1 PHOSPHATE#0.8436;VASCULAR ENDOTHELIUM#0.8417;OVARIAN CANCER#0.8415;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8330;PLATELET ACTIVATION#0.8275;CANCER STEM CELL#0.8231;PRO-INFLAMMATORY#0.8155;TRANSCRIPTION FACTOR#0.8127;VASCULAR CELL#0.8114;FACTOR VIII#0.8092;NITRIC OXIDE SYNTHASE#0.8086;PLASMA MEMBRANE#0.8078;HEMATOPOIETIC CELL#0.7988;DISSEMINATED INTRAVASCULAR COAGULATION#0.7983;PERIPHERAL BLOOD#0.7968;CELL GROWTH#0.7961;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7908;ENDOTHELIAL GROWTH FACTOR#0.7907;OVARIAN#0.7852;SPHINGOSINE#0.7818;ATHEROSCLEROSIS#0.7817;CHEMOTAXIS#0.7736;BREAST CANCER PATIENTS#0.7686;NEPHRITIS#0.7563;EXTRACELLULAR REGULATED KINASE#0.7477;WOUND HEALING#0.7461;C REACTIVE PROTEIN#0.7431;HEART DISEASE#0.7427;ENDOTHELIAL MICROPARTICLE#0.7421;VASCULAR SMOOTH MUSCLE CELL#0.7420;DENDRITIC CELL#0.7415;ISCHEMIA#0.7323;INTENSIVE CARE UNIT#0.7269;TRANSCRIPTASE#0.7265;HEPARIN#0.7137;ACTIVATION OF COAGULATION#0.7130;HEMATOPOIESIS#0.7011;GROWTH FACTOR RECEPTOR#0.7006;LEUKOCYTE ADHESION#0.6923;CIRCULATING ENDOTHELIAL CELL#0.6905;ACUTE LUNG INJURY#0.6899;RECEPTOR COMPLEX#0.6894;EPIDERMAL GROWTH FACTOR#0.6814;ENDOCYTOSIS#0.6778;ANTIPHOSPHOLIPID SYNDROME#0.6775;RHEUMATOID ARTHRITIS#0.6756;HIGH MOBILITY GROUP#0.6737;LUPUS NEPHRITIS#0.6737;CORONARY ARTERY#0.6728;TROPHOBLAST CELL#0.6726;MAMMARY GLAND#0.6723;CORONARY HEART DISEASE#0.6708;HEME OXYGENASE 1#0.6675;LUNG CARCINOMA#0.6672;INNATE IMMUNE RESPONSE#0.6528;PURPURA FULMINANS#0.6485;SIGNAL TRANSDUCTION#0.6483;ENDOTHELIAL NITRIC OXIDE#0.6475;PNEUMONIA#0.6472;CELL DEATH#0.6466;EXTRACELLULAR MATRIX#0.6439;RESPONSE TO ENDOTOXIN#0.6325;TIGHT JUNCTION#0.6273;CELL ACTIVATION#0.6269;IMMUNE SYSTEM#0.6259;MONONUCLEAR CELLS#0.6259;RESPIRATORY DISTRESS#0.6257;RECEPTOR BINDING#0.6221;DIABETES MELLITUS#0.6220;ANGIOTENSIN CONVERTING ENZYME#0.6216;INNATE IMMUNITY#0.6178;METALLOPROTEINASE INHIBITOR#0.6146;HEMORRHAGE#0.6104;PNEUMOCOCCAL PNEUMONIA#0.6091;EPIDERMAL STEM CELL#0.6088;PROTEIN C DEFICIENCY#0.6074;T- PA#0.6071;TUBE FORMATION#0.6047;72-HOURS#0.6044;PHOSPHOLIPASE A2#0.6034;INFLAMMATORY BOWEL DISEASE#0.6012
105463123	X CHROMOSOME#0.9328
105463127	PROGRESSIVE FAMILIAL HEART BLOCK#1.0887
10547	PSORIASIS#1.0272;EPIDERMAL DIFFERENTIATION COMPLEX#0.9513;LATE CORNIFIED ENVELOPE#0.6055
10548	AUTOPHAGY#0.8725;ENDOPLASMIC RETICULUM#0.8575;AUTOPHAGOSOME FORMATION#0.7569;AUTOPHAGOSOME#0.7178;IMMUNE RESPONSE#0.6518;INNATE IMMUNE RESPONSE#0.6184
10549	THIOREDOXIN PEROXIDASE ACTIVITY#1.1517;OXIDATIVE PROTEIN FOLDING#1.0780;THIOREDOXIN PEROXIDASE#1.0593;PROTEIN FOLDING#1.0446;SUPEROXIDE DISMUTASE#1.0410;GLUTATHIONE PEROXIDASE#1.0311;PEROXIDASE ACTIVITY#1.0185;GLUTATHIONE#1.0138;ENDOPLASMIC RETICULUM#1.0078;APOPTOSIS#1.0040;PROTEIN DISULFIDE ISOMERASE#0.9915;CELL DEATH#0.9763;HEAT SHOCK PROTEIN#0.9725;SIGNAL TRANSDUCTION#0.9723;REACTIVE OXYGEN SPECIES#0.9692;GENE EXPRESSION#0.9566;MITOCHONDRIA#0.9435;ANTIOXIDANT ACTIVITY#0.9432;IMMUNE RESPONSE#0.9394;TRANSCRIPTION FACTOR#0.9294;CANCER CELL#0.9162;INFLAMMATORY RESPONSE#0.9045;DETOXIFICATION#0.8907;SIGNALING PATHWAY#0.8833;MACROPHAGE#0.8761;LUNG CANCER#0.8752;GLYCERALDEHYDE-3-PHOSPHATE#0.8732;GROWTH FACTOR#0.8394;SIGNAL PEPTIDE#0.8391;POLYMERASE CHAIN REACTION#0.8388;ATP SYNTHASE#0.8365;QUANTITATIVE REAL TIME#0.8340;UBIQUITIN#0.8328;CELL PROLIFERATION#0.8253;LASER DESORPTION IONIZATION#0.8177;TYPE 2 DIABETES#0.8062;TOXICITY#0.8028;GALECTIN#0.8018;EPITHELIAL CELL#0.8010;DIABETES MELLITUS#0.7939;CELL GROWTH#0.7934;ADENOCARCINOMA#0.7931;SQUAMOUS CELL CARCINOMA#0.7859;OXYGENASE#0.7791;OXIDATIVE STRESS RESPONSE#0.7708;COLORECTAL CANCER#0.7640;THIOREDOXIN REDUCTASE 1#0.7635;ENDOTHELIAL CELL#0.7453;MYELOID LEUKEMIA#0.7444;RNA INTERFERENCE#0.7429;ASCORBATE#0.7121;PROTEIN KINASE#0.7099;PROSTATE CANCER#0.7052;HYPOXIA#0.7020;COLORECTAL#0.6993;PANCREATIC ISLET#0.6915;HEPATOCELLULAR CARCINOMA#0.6785;PROTEASOME#0.6765;LUNG ADENOCARCINOMA#0.6758;AKT SIGNALING#0.6753;ACUTE MYELOID LEUKEMIA#0.6740;CELL CYCLE#0.6731;BREAST CANCER#0.6731;STREPTOZOTOCIN#0.6343;HUMAN CARDIAC FIBROBLASTS#0.6273;LIVER DISEASE#0.6270;APOPTOTIC#0.6255;ALLOGRAFT INFLAMMATORY FACTOR#0.6231;LYMPH NODE#0.6213;FRUCTOSE#0.6148;GLUCOSE REGULATED PROTEIN#0.6135;NITRIC OXIDE#0.6125;SPERMATOGENIC CELLS#0.6053;ATHEROSCLEROSIS#0.6029
1054	ENHANCER BINDING PROTEIN#1.0625;ENHANCER BINDING#1.0621;TRANSCRIPTION FACTOR#1.0106;B CELL#0.9505;DNA BINDING#0.9381;LEUCINE#0.8897;GENE EXPRESSION#0.8041;BRONCHIAL EPITHELIAL CELLS#0.7808;DNA REPAIR#0.7729;EPITHELIAL CELL#0.7684;GLOBIN#0.6555;ELECTROPHORETIC MOBILITY SHIFT#0.6440;FETAL LIVER#0.6366;HUMAN BRONCHIAL EPITHELIAL#0.6293;LUNG CANCER#0.6271;IFN-GAMMA#0.6105
10550	APOPTOSIS#1.0727;CELL MIGRATION#1.0554;CANCER CELL#1.0342;SIGNALING PATHWAY#0.9875;ENDOPLASMIC RETICULUM#0.9858;PLASMA MEMBRANE#0.9621;SQUAMOUS CELL CARCINOMA#0.9435;TRANSCRIPTION FACTOR#0.8976;MAPK SIGNALING#0.8713;RETINOIC ACID#0.8704;GLUTATHIONE#0.8546;HEAT SHOCK PROTEIN#0.8203;HUMAN BRONCHIAL EPITHELIAL#0.7874;PROTEIN KINASE#0.7724;POLYMERASE CHAIN REACTION#0.7373;ANGIOGENESIS#0.7354;BASE EXCISION REPAIR#0.7034;TUBE FORMATION#0.6975;CELL DIFFERENTIATION#0.6935;DNA REPAIR#0.6913;EPITHELIAL CELL#0.6863;CELL PROLIFERATION#0.6619;MICROTUBULE#0.6496;CISPLATIN#0.6430;ER EXIT#0.6421;CELL SURFACE#0.6395;SINGLE STRAND BREAK#0.6277;MICROTUBULE ASSOCIATED PROTEIN#0.6270;MAPK CASCADE#0.6259;MITOGEN ACTIVATED PROTEIN#0.6217;ACTIN CYTOSKELETON#0.6149;BREAST CARCINOMA#0.6137;BREAST CANCER#0.6056
10551	PROTEIN DISULFIDE ISOMERASE#1.0778;GOBLET CELL#1.0660;PANCREATIC CANCER#1.0526;ENDOPLASMIC RETICULUM#1.0524;PROSTATE CANCER#1.0522;CELL PROLIFERATION#1.0418;BREAST CANCER CELL#1.0399;ESTROGEN RECEPTOR#1.0375;ONCOGENIC#1.0326;CANCER CELL#1.0268;ADENOCARCINOMA#1.0252;BREAST CANCER#1.0213;EPITHELIAL CELL#1.0132;COLORECTAL CANCER#1.0115;TAMOXIFEN#1.0106;OVARIAN CANCER#1.0091;TUMOR CELLS#1.0007;LUNG CANCER#0.9928;LUNG ADENOCARCINOMA#0.9907;STEM CELL#0.9829;CELL CYCLE#0.9828;TRANSCRIPTION FACTOR#0.9816;GENE EXPRESSION#0.9784;LYMPH NODE#0.9718;OVARIAN#0.9712;DRUG RESISTANCE#0.9660;COLORECTAL#0.9642;SQUAMOUS CELL CARCINOMA#0.9585;GROWTH FACTOR#0.9545;REGENERATION#0.9528;BREAST CANCER PATIENTS#0.9516;APOPTOSIS#0.9406;CELL SURFACE#0.9251;SIGNALING PATHWAY#0.9179;PANCREATIC DUCTAL ADENOCARCINOMA#0.9089;INFLAMMATORY BOWEL DISEASE#0.9072;CELL MIGRATION#0.8889;CIRCULATING TUMOR CELL#0.8696;PROTEIN FOLDING#0.8685;CELL GROWTH#0.8680;ANGIOGENESIS#0.8634;EPITHELIAL MESENCHYMAL TRANSITION#0.8578;CELL DEATH#0.8350;QUANTITATIVE REAL TIME#0.8269;POLYMERASE CHAIN REACTION#0.8145;IMMUNE RESPONSE#0.7993;BILIARY TRACT CANCER#0.7827;T CELL#0.7769;BILIARY TRACT#0.7673;ANDROGEN RECEPTOR#0.7613;COLON CANCER#0.7607;MAMMARY EPITHELIAL CELL#0.7569;METASTATIC PROSTATE CANCER#0.7554;HYPOXIA#0.7519;UNFOLDED PROTEIN RESPONSE#0.7510;SIGNALLING PATHWAY#0.7490;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.7489;HUMAN BREAST CANCER#0.7468;ESOPHAGUS#0.7440;LYMPH NODE METASTASIS#0.7090;BREAST CARCINOMA#0.6932;TUMOR SUPPRESSOR#0.6781;STROMAL CELL#0.6761;MAMMARY GLAND#0.6753;MECHANISM OF ACTION#0.6508;REVERSE TRANSCRIPTION#0.6493;GROWTH FACTOR RECEPTOR#0.6488;BEVACIZUMAB#0.6313;PANCREATITIS#0.6296;KINASE INHIBITOR#0.6295;DISEASE FREE SURVIVAL#0.6291;ADJUVANT HORMONAL THERAPY#0.6268;PEPTIDE BINDING#0.6152;TUMOR TISSUES#0.6098;RNA INTERFERENCE#0.6088;TYROSINE KINASE INHIBITOR#0.6075
10553	HEPATOCELLULAR CARCINOMA#1.0767;TUMOR SUPPRESSOR#1.0631;APOPTOSIS#1.0414;CANCER CELL#1.0401;TUMOR CELLS#1.0205;GENE EXPRESSION#0.9645;CELL PROLIFERATION#0.9611;TUMOR TISSUES#0.9439;BREAST CANCER#0.9276;LYMPH NODE#0.9059;GROWTH FACTOR#0.8958;CELL DEATH#0.8944;SORAFENIB#0.8784;TRANSCRIPTION FACTOR#0.8379;LIPID METABOLISM#0.8157;SQUAMOUS CELL CARCINOMA#0.8139;LUNG CANCER#0.8127;APOPTOTIC#0.8118;HISTONE ACETYLTRANSFERASE#0.8082;ANGIOGENESIS#0.8038;ADENOCARCINOMA#0.7782;GENE SILENCING#0.7734;LUNG ADENOCARCINOMA#0.7730;BREAST CARCINOMA#0.7712;CELL GROWTH#0.7705;SIGNALING PATHWAY#0.7683;IMPORTIN#0.7485;PROTEIN COMPLEX#0.7468;LYMPH NODE METASTASIS#0.7212;COLORECTAL#0.7208;NUCLEAR IMPORT#0.7131;ESTROGEN RECEPTOR#0.7030;CELL CYCLE#0.7004;EARLY ENDOSOME#0.6984;HYPOXIA INDUCIBLE FACTOR#0.6924;PANCREATIC CANCER#0.6920;MAMMARY GLAND#0.6904;COLORECTAL CANCER#0.6888;HUMAN IMMUNODEFICIENCY VIRUS#0.6630;DNA METHYLATION#0.6448;NUCLEOCYTOPLASMIC TRANSPORT#0.6370;CLEAVED CASPASE 3#0.6245;EXTRACELLULAR MATRIX#0.6176;OVERALL SURVIVAL RATE#0.6158;ADJACENT NORMAL TISSUE#0.6155;HEPATOCELLULAR CARCINOMA CELL#0.6147;HEPATOMA CELLS#0.6125;EPITHELIAL MESENCHYMAL TRANSITION#0.6122;DISEASE FREE SURVIVAL#0.6086;KINASE ACTIVITY#0.6016;PROSTATE CANCER#0.6004
10554	ACYLTRANSFERASE ACTIVITY#1.0687;PHOSPHOLIPASE A2#0.9222;O ACYLTRANSFERASE#0.8995;PHOSPHATIDYLETHANOLAMINE#0.7882;LIPID METABOLISM#0.7859;LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE#0.7788;ARACHIDONIC ACID#0.7445;ACYL COA HYDROLASE#0.7399;ENDOPLASMIC RETICULUM#0.7285;COA HYDROLASE#0.7247;HORMONE SENSITIVE LIPASE#0.7047;GOLGI COMPLEX#0.7045;PHOSPHOLIPASE A#0.6546;PHOSPHOLIPASE A1#0.6444;TRIGLYCERIDE LIPASE#0.6266;SKELETAL MUSCLE#0.6022
10555	LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE#1.1121;O ACYLTRANSFERASE#1.0876;CONGENITAL GENERALIZED LIPODYSTROPHY#1.0534;LIPODYSTROPHY#1.0333;ADIPOCYTE#1.0201;ADIPOSE TISSUE#1.0030;APOPTOSIS#0.9575;LIPID DROPLET#0.9336;PARTIAL LIPODYSTROPHY#0.9194;ADIPOGENESIS#0.9066;DIABETES MELLITUS#0.8690;OVARIAN CANCER#0.8585;TRIGLYCERIDE SYNTHESIS#0.8090;PEROXISOME#0.8025;CANCER CELL#0.7986;LIPID METABOLISM#0.7926;GENE EXPRESSION#0.7889;OVARIAN#0.7684;BROWN ADIPOSE TISSUE#0.7675;CELL DEATH#0.7672;PREADIPOCYTE#0.7603;ADIPOCYTE DIFFERENTIATION#0.7480;FAMILIAL PARTIAL LIPODYSTROPHY#0.6959;ACANTHOSIS NIGRICANS#0.6935;TRIGLYCERIDE BIOSYNTHESIS#0.6529;PHOSPHOLIPID SYNTHESIS#0.6313
10556	RNASE P#1.0767;RIBONUCLEASE P#0.9587;TUMOR CELLS#0.7016;RNASE MRP#0.6189;TRNA PROCESSING#0.6135
10557	RNASE P#1.0843;RNASE MRP#0.9329;RNASE MRP COMPLEX#0.7645;RIBONUCLEASE P#0.7604;TRNA PROCESSING#0.6265
10558	HEREDITARY SENSORY NEUROPATHY#1.0971;HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 1#1.0859;AUTONOMIC NEUROPATHY#1.0511;NEUROPATHY#1.0509;SPHINGOLIPID SYNTHESIS#1.0412;SERINE PALMITOYLTRANSFERASE#1.0389;SPHINGOLIPID BIOSYNTHESIS#1.0137;L-SERINE#1.0022;PALMITOYLTRANSFERASE ACTIVITY#0.9758;B CELL#0.9424;CERAMIDE SYNTHESIS#0.9365;PALMITOYL#0.9184;ENDOPLASMIC RETICULUM#0.9082;SPHINGOLIPID METABOLISM#0.8700;INHERITED NEUROPATHY#0.8447;SERINE PALMITOYL TRANSFERASE#0.7473;NEUROTOXIC#0.7185;LYMPHOBLAST#0.7069;CELL DEATH#0.6927;GENE EXPRESSION#0.6910;LIPID METABOLISM#0.6888;NERVOUS SYSTEM#0.6815;ALANINE#0.6497;CHARCOT MARIE TOOTH#0.6462;DEMENTIA#0.6421;SPHINGOSINE#0.6214;HEARING LOSS#0.6170;DIABETIC NEUROPATHY#0.6077;FOCAL ADHESION#0.6006
10559	UDP GALACTOSE#0.8644;GLYCOSYLATION#0.7394;NUCLEOTIDE SUGAR TRANSPORTER#0.6994;SUGAR TRANSPORTER#0.6823;UDP-GAL#0.6686;SIALYLATION#0.6564;CST COMPLEX#0.6526;TELOMERE#0.6185;GOLGI MEMBRANE#0.6016
10560	THIAMINE#1.0590;MEGALOBLASTIC ANEMIA#1.0571;ANEMIA#1.0363;ACINAR CELL#1.0267;T CELL#1.0252;THIAMINE TRANSPORT#1.0209;FOLATE#1.0176;DIABETES MELLITUS#1.0081;ANAEMIA#0.9902;REDUCED FOLATE CARRIER#0.9809;IFN-GAMMA#0.9790;CD8+ T CELL#0.9742;T LYMPHOCYTE#0.9301;HEARING LOSS#0.9149;VITAMIN B1#0.8854;GENE EXPRESSION#0.8546;PLASMA MEMBRANE#0.8289;EPITHELIAL CELL#0.7524;TH1 CELL#0.7177;BREAST CANCER#0.7105;TRANSCRIPTION FACTOR#0.6996;GLYCOSYLATION#0.6987;CELL DEATH#0.6918;IMMUNE RESPONSE#0.6900;TYPE 2 DIABETES#0.6853;TUMOR CELLS#0.6774;CELL SURFACE#0.6768;SENSORINEURAL HEARING LOSS#0.6759;NEONATAL DIABETES MELLITUS#0.6591;BONE MARROW#0.6525;TH17 CELL#0.6162;DOWN SYNDROME#0.6018
10561	MAP KINASE#1.0722;MITOGEN ACTIVATED PROTEIN#1.0613;PROTEIN KINASE#1.0536;SIGNALING PATHWAY#0.9993;IFN-GAMMA#0.9938;GENE EXPRESSION#0.9840;IMMUNE RESPONSE#0.9390;PERIPHERAL BLOOD#0.9154;MICROTUBULE#0.8861;HEPATITIS C#0.8771;GROWTH FACTOR#0.8579;MACROPHAGE#0.8492;TRANSCRIPTION FACTOR#0.8052;IFN STIMULATED GENES#0.7862;T CELL#0.7831;PROTEIN KINASE C#0.7821;MICROTUBULE ASSOCIATED PROTEIN#0.7756;INTERFERON STIMULATED GENE#0.7644;KINASE INHIBITOR#0.7514;POLYMERASE CHAIN REACTION#0.7488;MONONUCLEAR CELLS#0.7459;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7236;CELL CYCLE#0.7206;HEPATITIS C VIRUS#0.7145;APOPTOSIS#0.7114;SIGNAL TRANSDUCER#0.6849;PHOSPHOLIPASE C#0.6845;VIRAL INFECTION#0.6715;EPITHELIAL CELL#0.6368;MONOCYTE#0.6349;TUMOR NECROSIS FACTOR#0.6217;INNATE IMMUNE RESPONSE#0.6108
10562	NEUTROPHIL#1.0642;STEM CELL MARKER#1.0434;INTESTINAL STEM CELL#1.0389;CANCER CELL#1.0385;STEM CELL#1.0267;APOPTOSIS#1.0190;COLORECTAL CANCER#1.0158;COLORECTAL#1.0065;ADENOCARCINOMA#0.9954;PROSTATE CANCER#0.9936;GENE EXPRESSION#0.9874;BREAST CANCER#0.9731;EPITHELIAL CELL#0.9469;CELL PROLIFERATION#0.9469;PANCREATIC CANCER#0.9440;SMALL INTESTINE#0.9394;CELL ADHESION#0.9207;PERIPHERAL BLOOD#0.9183;LYMPH NODE#0.9112;SIGNALING PATHWAY#0.8960;G-CSF#0.8906;TRANSCRIPTION FACTOR#0.8785;LUNG CANCER#0.8713;INTESTINAL CRYPT#0.8620;GROWTH FACTOR#0.8586;CELL GROWTH#0.8288;TUMOR SUPPRESSOR#0.8071;BONE MARROW#0.8032;POLYMERASE CHAIN REACTION#0.8021;EPITHELIAL MESENCHYMAL TRANSITION#0.7969;ESTROGEN RECEPTOR#0.7929;IMMUNE RESPONSE#0.7849;CELL CYCLE#0.7647;INFLAMMATORY BOWEL DISEASE#0.7582;LYMPH NODE METASTASIS#0.7549;GASTRIC MUCOSA#0.7353;PROGENITOR CELL#0.7328;APOPTOTIC#0.7104;INNATE IMMUNITY#0.6836;BREAST CANCER PATIENTS#0.6786;GROWTH FACTOR RECEPTOR#0.6786;TUMOR CELLS#0.6586;GOBLET CELL#0.6424;GASTROINTESTINAL TRACT#0.6380;LGR5+ STEM CELL#0.6372;RETINOIC ACID#0.6363;CATHEPSIN C ACTIVITY#0.6334;SPECIFIC GRANULE#0.6208;GRANULOCYTE COLONY STIMULATING FACTOR#0.6143;COLONY-STIMULATING FACTOR#0.6113;EPIDERMAL GROWTH FACTOR#0.6087;INTESTINAL EPITHELIAL CELL#0.6078;5-AZA-2'-DEOXYCYTIDINE#0.6074;PANCREATIC ADENOCARCINOMA#0.6072;TUMOR TISSUES#0.6071;2'-DEOXYCYTIDINE#0.6068;COLON CANCER#0.6056;CASPASE-3 ACTIVITY#0.6019;CERVICAL CANCER#0.6001
10563	CXCL13 PRODUCTION#1.1290;B1 CELL#1.0397;LUPUS NEPHRITIS#1.0385;SYSTEMIC LUPUS ERYTHEMATOSUS#1.0256;B LYMPHOCYTE#1.0219;FOLLICULAR HELPER T CELL#1.0201;LUPUS ERYTHEMATOSUS#1.0191;CANCER CELL#1.0177;CC CHEMOKINE LIGAND#1.0173;ENDOTHELIAL CELL#1.0143;CHEMOTAXIS#1.0135;MACROPHAGE INFLAMMATORY PROTEIN#1.0117;PROSTATE CANCER#1.0114;NEPHRITIS#1.0098;ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA#1.0062;TUMOR CELLS#1.0053;STROMAL CELL#1.0049;BREAST CANCER#1.0045;MONOCYTE#1.0041;B CELL#1.0038;PRO-INFLAMMATORY#1.0023;CELL MIGRATION#1.0023;CELL ADHESION#1.0019;SALIVARY GLAND#1.0016;TUMOR NECROSIS FACTOR#0.9976;FOLLICULAR DENDRITIC CELL#0.9964;LYMPHOID TISSUE#0.9956;B CELL ACTIVATION#0.9954;TOLL LIKE RECEPTOR#0.9935;SECONDARY LYMPHOID ORGANS#0.9930;GROWTH FACTOR#0.9917;SIGNALING PATHWAY#0.9914;EPITHELIAL CELL#0.9910;MACROPHAGE#0.9908;SPINAL CORD#0.9899;T LYMPHOCYTE#0.9893;LYMPHOID ORGANS#0.9884;CD8+ T CELL#0.9884;GERMINAL CENTER#0.9880;POLYMERASE CHAIN REACTION#0.9878;CHEMOKINE RECEPTOR#0.9874;G-CSF#0.9859;GERMINAL CENTER FORMATION#0.9859;B CELL LYMPHOMA#0.9857;MEMORY B CELL#0.9856;CELL ACTIVATION#0.9837;CENTRAL NERVOUS SYSTEM#0.9836;VENULE#0.9836;NEUROFILAMENT#0.9834;MENINGITIS#0.9832;AUTOIMMUNE DISEASE#0.9830;RHEUMATOID ARTHRITIS#0.9810;DENDRITIC CELL#0.9810;NERVOUS SYSTEM#0.9808;APOPTOSIS#0.9800;MULTIPLE SCLEROSIS#0.9798;LEUKOCYTE#0.9794;CELL PROLIFERATION#0.9794;T FOLLICULAR HELPER#0.9792;LYMPH NODE#0.9792;ANTIBODY PRODUCTION#0.9790;CD4+ T CELL#0.9786;TRANSCRIPTION FACTOR#0.9776;STEM CELL#0.9775;PERIPHERAL T-CELL LYMPHOMA#0.9775;REVERSE TRANSCRIPTION#0.9775;T HELPER CELL#0.9766;BONE MARROW#0.9765;T CELL#0.9761;PLASMA CELL#0.9758;PERIPHERAL BLOOD#0.9739;CLINICALLY ISOLATED SYNDROME#0.9733;INFLAMMATORY RESPONSE#0.9722;NEUTROPHIL#0.9721;IMMUNE CELL#0.9689;GENE EXPRESSION#0.9682;LYMPHOCYTIC LEUKEMIA#0.9616;IMMUNE RESPONSE#0.9609;ORGANOGENESIS#0.9605;CELL ADHESION MOLECULE#0.9598;IMMUNE SYSTEM#0.9588;SYNOVIUM#0.9584;MONONUCLEAR CELLS#0.9540;RITUXIMAB#0.9528;MESENCHYMAL STEM CELL#0.9469;CELL DIFFERENTIATION#0.9460;IFN-GAMMA#0.9450;GM-CSF#0.9402;CHRONIC LYMPHOCYTIC LEUKEMIA#0.9395;TRANSFORMING GROWTH FACTOR#0.9370;TONSIL#0.9369;INFLAMMATORY CELL#0.9324;LYMPHOID TISSUE INDUCER#0.9294;ENCEPHALOMYELITIS#0.9293;QUANTITATIVE REAL TIME#0.9259;C REACTIVE PROTEIN#0.9234;SELECTIN#0.9233;MYASTHENIA GRAVIS#0.9219;SPHINGOSINE 1 PHOSPHATE#0.9173;NOT OTHERWISE SPECIFIED#0.9149;LYMPH NODE METASTASIS#0.9147;EPSTEIN BARR VIRUS#0.9110;NEOPTERIN#0.9033;DRAINING LYMPH NODE#0.9021;HUMORAL IMMUNE RESPONSE#0.8998;HEPATITIS B#0.8975;DISEASE ACTIVITY INDEX#0.8943;COLONY-STIMULATING FACTOR#0.8908;EXTRACELLULAR MATRIX#0.8858;ACTIVATED T-CELLS#0.8829;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.8828;ACTIVATED T CELL#0.8826;EPIDERMAL GROWTH FACTOR#0.8813;TUMOUR NECROSIS FACTOR#0.8811;LUNG CANCER#0.8804;DISEASE ACTIVITY SCORE#0.8793;AUTOIMMUNITY#0.8786;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.8774;PROTEIN KINASE#0.8753;GROWTH FACTOR RECEPTOR#0.8731;OSTEOBLAST#0.8671;CELL SURFACE#0.8570;PERITONEAL CAVITY#0.8532;TREG CELL#0.8525;SYNOVIAL FLUID#0.8523;COLORECTAL CANCER#0.8469;LYMPHOID CELL#0.8437;CELL DEVELOPMENT#0.8429;EOSINOPHIL#0.8428;OSTEOARTHRITIS#0.8427;CELL DEATH#0.8372;SQUAMOUS CELL CARCINOMA#0.8339;RECEPTOR LIGAND#0.8310;REGULATORY T CELL#0.8288;STROMA#0.8283;SPHINGOSINE#0.8272;CYTOKINE PRODUCTION#0.8262;BREAST CANCER PATIENTS#0.8237;LYMPHOCYTE HOMING#0.8233;ATTRACTANT#0.8223;MAGNETIC RESONANCE IMAGING#0.8205;MALT LYMPHOMA#0.8181;TRANSCRIPTASE#0.8162;MARGINAL ZONE B CELL#0.8113;MARGINAL ZONE B#0.8110;TUBERCULOSIS#0.8065;FOLLICULAR LYMPHOMA#0.8060;C CHEMOKINE RECEPTOR#0.8051;CELL CYCLE#0.8045;ASEPTIC MENINGITIS#0.8031;TH17 CELL#0.8015;VIRULENCE#0.8007;SYPHILIS#0.8001;LYMPHOTOXIN BETA RECEPTOR#0.7987;SYNOVITIS#0.7980;PLASMABLAST#0.7965;RETINOIC ACID#0.7955;VASCULAR CELL#0.7947;GRANULOCYTE#0.7916;B CELL PROLIFERATION#0.7910;B CELL RECEPTOR#0.7884;GASTRIC MUCOSA#0.7837;ACTIVATED B CELL#0.7824;TICK-BORNE ENCEPHALITIS#0.7815;HEPATOCELLULAR CARCINOMA#0.7798;B CELL DEPLETION#0.7744;HEMATOPOIETIC CELL#0.7737;ASTROCYTE#0.7735;SMOOTH MUSCLE#0.7723;COLORECTAL#0.7716;SYSTEMIC AUTOIMMUNE DISEASE#0.7680;SMALL INTESTINE#0.7649;MAST CELL#0.7635;CELL ASSOCIATED#0.7594;ATHEROSCLEROSIS#0.7584;GERMINAL CENTER B#0.7535;BREAST CANCER CELL#0.7533;B CELL DEVELOPMENT#0.7509;ORGAN DEVELOPMENT#0.7481;COLON CANCER#0.7455;CD3+ T CELL#0.7444;NODULAR#0.7433;HYPERTENSION#0.7402;B CELL DIFFERENTIATION#0.7393;CORD BLOOD#0.7391;WHITE BLOOD CELL#0.7376;ANTIGEN PRESENTATION#0.7352;RESPONSE TO TREATMENT#0.7349;NEUROMYELITIS OPTICA#0.7316;DISABILITY STATUS SCALE#0.7314;CELL CHEMOTAXIS#0.7297;NKT CELL#0.7267;NEUROLOGICAL DISORDER#0.7245;RELAPSING-REMITTING MULTIPLE SCLEROSIS#0.7191;GERMINAL CENTER B CELL#0.7187;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.7174;INNATE IMMUNITY#0.7155;SJOGREN'S SYNDROME#0.7124;CENTRAL NERVOUS SYSTEM LYMPHOMA#0.7110;BLOOD VESSEL#0.7077;CHEMOKINE PRODUCTION#0.7060;COLLAGEN INDUCED ARTHRITIS#0.7059;HUMAN MESENCHYMAL STEM#0.7053;CUTANEOUS T CELL LYMPHOMA#0.7052;KINASE INHIBITOR#0.6951;DISEASE FREE SURVIVAL#0.6921;NON HODGKIN LYMPHOMA#0.6890;PLASMACYTOID DENDRITIC CELL#0.6889;NAIVE B CELL#0.6872;ORAL SQUAMOUS CELL CARCINOMA#0.6857;GASTRITIS#0.6829;COLITIS#0.6825;ERYTHROCYTE#0.6822;MYCOSIS FUNGOIDES#0.6807;TISSUE DEVELOPMENT#0.6807;CYTOTOXICITY#0.6795;FOLLICULAR T CELL#0.6788;METHOTREXATE#0.6770;ADAPTIVE IMMUNE RESPONSE#0.6744;BETA-2#0.6737;FOLLICULAR B CELL#0.6734;LYME DISEASE#0.6732;ALKALINE PHOSPHATASE#0.6715;GLIAL CELL#0.6715;IL-1RA#0.6711;EARLY BREAST CANCER#0.6707;SIGNAL TRANSDUCTION#0.6687;LUNG FIBROBLASTS#0.6686;ENDOTHELIUM#0.6630;ANAPLASTIC LARGE CELL LYMPHOMA#0.6628;SPINAL NERVE LIGATION#0.6588;HEPATITIS B VIRUS#0.6572;LYMPHOCYTE MIGRATION#0.6559;T CELL ACTIVATION#0.6558;CYTOPLASM#0.6514;APOPTOTIC#0.6500;ADJACENT NORMAL TISSUE#0.6478;ERYTHROCYTE SEDIMENTATION RATE#0.6465;POSITIVE PREDICTIVE VALUE#0.6461;MEMORY T CELL#0.6461;MONOCYTE CHEMOATTRACTANT PROTEIN#0.6444;BLOOD BRAIN BARRIER#0.6438;GLIAL FIBRILLARY ACIDIC PROTEIN#0.6431;MECHANISM OF ACTION#0.6412;B CELL CHEMOTAXIS#0.6411;FORMALIN#0.6400;MENINGES#0.6371;THYMIC EPITHELIAL CELLS#0.6344;CELL LOCALIZATION#0.6324;LUMINAL#0.6302;EMETIC#0.6298;CYTOKINE RECEPTOR#0.6296;DIFFUSE LARGE B-CELL LYMPHOMA#0.6292;PULMONARY FIBROSIS#0.6287;CHRONIC HEPATITIS B#0.6283;LYMPH NODE DEVELOPMENT#0.6282;HODGKIN'S LYMPHOMA#0.6275;TUMOR TISSUES#0.6261;NEUROBLAST#0.6253;B CELL ADHESION#0.6251;FIBROBLASTIC RETICULAR CELLS#0.6239;HYPOXIA#0.6238;PROGENITOR CELL#0.6232;HUMAN BREAST CANCER#0.6220;ESTROGEN RECEPTOR#0.6194;MESENCHYMAL CELL#0.6165;LUNG DISEASE#0.6156;EARLY RHEUMATOID ARTHRITIS#0.6138;VIRAL INFECTION#0.6108;COMPARATIVE GENOMIC HYBRIDISATION#0.6100;LACRIMAL GLAND#0.6093;ADULT-ONSET STILL'S DISEASE#0.6090;TNF-R2#0.6056;IMMUNOGLOBULIN PRODUCTION#0.6042;MARROW STROMAL CELLS#0.6028;BONE MARROW STROMAL CELL#0.6028;BONE MARROW STROMAL#0.6024;EFFECTOR T CELL#0.6022;EPITHELIAL TO MESENCHYMAL TRANSITION#0.6006;EPITHELIAL TO MESENCHYMAL#0.6004
10564	RECYCLING ENDOSOME#1.0652;TRANS GOLGI NETWORK#1.0615;NUCLEOTIDE EXCHANGE FACTOR#1.0564;GUANINE#1.0512;ENDOSOME#1.0456;GUANINE EXCHANGE FACTOR#0.9722;VESICLE TRAFFICKING#0.9559;MICROCEPHALY#0.9397;NEURONAL MIGRATION#0.9319;PERIVENTRICULAR NODULAR HETEROTOPIA#0.9106;GOLGI MEMBRANE#0.8999;ANCHORING#0.8295;PROTEIN KINASE#0.8015;PROTEIN KINASE A#0.7800;MEMBRANE TUBULATION#0.7420;NODULAR#0.7408;ENDOMEMBRANE ORGANIZATION#0.6982;ENDOTHELIAL CELL#0.6901;CELL MIGRATION#0.6900;CELL SURFACE#0.6878;ACTIN BINDING#0.6721;CELL ADHESION#0.6646;PLASMA MEMBRANE#0.6641;CLATHRIN ADAPTOR#0.6612;LATERAL VENTRICLE#0.6380;ENDOSOMAL MEMBRANE#0.6264;CEREBRAL CORTEX#0.6252;GOLGI APPARATUS#0.6102;SIGNALING PATHWAY#0.6008
10565	GUANINE#1.0480;NUCLEOTIDE EXCHANGE FACTOR#1.0463;GOLGI MEMBRANE#1.0321;TRANS GOLGI NETWORK#1.0053;RECYCLING ENDOSOME#0.9488;ENDOSOME#0.9137;GOLGI COMPLEX#0.8573;CLATHRIN ADAPTOR#0.8455;SCHWANN CELL#0.7800;PROTEIN KINASE#0.7405;MICROTUBULE#0.7370;CELL SURFACE#0.7223;PLASMA MEMBRANE#0.7169;CELL WALL#0.7109;VESICLE TRAFFICKING#0.7047;ENDOMEMBRANE ORGANIZATION#0.6964;CELL MIGRATION#0.6883;TUMOR SUPPRESSOR#0.6871;PROTEIN KINASE A#0.6741;ANCHORING#0.6323;SIGNALING PATHWAY#0.6171;EXOSOME PRODUCTION#0.6079
105664404	COLORECTAL CANCER#0.8193;STEM CELL#0.7086;EPITHELIAL CELL#0.6709;COLORECTAL#0.6479;COLONIC EPITHELIAL CELLS#0.6375;REPORTER GENE ASSAY#0.6265;HEPATOCELLULAR CARCINOMA#0.6159
10566	ANCHORING#1.0615;PROTEIN KINASE#0.9877;PROTEIN KINASE A#0.9644;SPERMATOZOA#0.9298;SPERM TAIL#0.9146;SPERM MOTILITY#0.9033;SPERM CAPACITATION#0.8533;OVARIAN CANCER#0.7874;FLAGELLUM#0.7745;GENE EXPRESSION#0.7695;SPERM FLAGELLUM#0.7144;PKA BINDING#0.6844;SPERMATOGENESIS#0.6491;POLYMERASE CHAIN REACTION#0.6461;T CELL ACTIVATION#0.6235;CELL ACTIVATION#0.6208;T CELL#0.6141
10567	GOLGI COMPLEX#0.9481;VESICLE TRAFFICKING#0.7980;PLASMA MEMBRANE#0.7962;ENDOPLASMIC RETICULUM#0.7923;CELL WALL#0.7594;T CELL#0.7343;GOLGI APPARATUS#0.7109;CELL SURFACE#0.7084;ZINC BINDING#0.7025;IMMUNE EVASION#0.6993;VIRULENCE#0.6795;BIOFILM FORMATION#0.6137;EPSTEIN BARR VIRUS#0.6048;CELL MIGRATION#0.6045
105682749	CELL PROLIFERATION#1.0959;CANCER CELL#1.0889;CERVICAL#1.0224;CERVICAL CANCER#0.9191;METASTATIC PANCREATIC ADENOCARCINOMA#0.6663;ADENOCARCINOMA#0.6437;COLON ADENOCARCINOMA#0.6236;PANCREATIC ADENOCARCINOMA#0.6215
10568	PULMONARY ALVEOLAR MICROLITHIASIS#1.0673;SMALL INTESTINE#1.0539;LUNG CANCER#1.0121;GENE EXPRESSION#1.0114;PHOSPHATE TRANSPORT#1.0066;DUODENUM#0.9952;OOCYTE#0.9909;EPITHELIAL CELL#0.9770;JEJUNUM#0.9702;BRUSH BORDER#0.9528;CANCER CELL#0.9426;BRUSH BORDER MEMBRANE#0.9133;SIGNALING PATHWAY#0.9118;BREAST CANCER#0.9116;STEM CELL#0.8860;STEM CELL LIKE#0.8605;GROWTH FACTOR#0.8555;CELL PROLIFERATION#0.8254;LUNG ADENOCARCINOMA#0.8222;POLYMERASE CHAIN REACTION#0.8191;EXCRETION#0.8123;ADENOCARCINOMA#0.8047;PLASMA MEMBRANE#0.7721;INTESTINAL ABSORPTION#0.7600;ALVEOLAR EPITHELIAL CELL#0.7453;VITAMIN D RECEPTOR#0.7404;CANCER STEM CELL#0.7164;AKT SIGNALING#0.6817;REVERSE TRANSCRIPTION#0.6551;PARATHYROID HORMONE#0.6543;CELL GROWTH#0.6538;APOPTOSIS#0.6512;KINASE INHIBITOR#0.6365;PARATHYROID#0.6292;OVARIAN#0.6176;ED-71#0.6117;COLORECTAL CANCER#0.6111;HYPERPHOSPHATEMIA#0.6005
10569	SPLICEOSOME#1.0309;PRE-MRNA SPLICING#1.0206;MRNA SPLICING#1.0179
1056	CHOLESTEROL ESTERASE ACTIVITY#1.0711;MAMMARY GLAND#1.0579;TRIGLYCERIDE LIPASE#1.0456;PHOSPHOLIPASE A2#1.0424;GLYCOSYLATION#1.0400;ESTERASE ACTIVITY#1.0395;LIPOPROTEIN LIPASE#1.0372;PANCREATITIS#1.0346;ESTERASE A#1.0345;ACINAR CELL#1.0345;MATURITY-ONSET DIABETES OF THE YOUNG#1.0245;HORMONE SENSITIVE LIPASE#1.0149;INTESTINAL MUCOSA#1.0138;PROTEIN KINASE#1.0106;MACROPHAGE#1.0081;LIPASE ACTIVITY#1.0067;GENE EXPRESSION#1.0057;ADIPOSE TISSUE#1.0049;DIGESTION#1.0025;TAUROCHOLATE#0.9996;PANCREATIC CANCER#0.9987;MONOCYTE#0.9952;ATHEROSCLEROSIS#0.9936;HEPARIN#0.9917;CYCLIC AMP#0.9902;LOW DENSITY LIPOPROTEIN#0.9885;OLEIC ACID#0.9880;URETHANE#0.9870;SMALL INTESTINE#0.9819;ENZYME ACTIVITY#0.9815;T CELL#0.9808;MICROSOME#0.9744;LIPID METABOLISM#0.9721;HIGH DENSITY LIPOPROTEIN#0.9709;ACID PHOSPHATASE#0.9615;ATHEROSCLEROTIC#0.9579;LIPOLYSIS#0.9545;ADENOCARCINOMA#0.9535;HIGH CHOLESTEROL DIET#0.9528;CATALYTIC ACTIVITY#0.9463;ENTEROCYTE#0.9421;ADRENAL GLAND#0.9289;ETHANOL#0.9271;DUODENUM#0.9209;CHOLESTEROL METABOLISM#0.9186;MONOCYTE DERIVED MACROPHAGE#0.9170;COENZYME A#0.9156;PHOSPHOLIPASE A#0.9149;ENDOPLASMIC RETICULUM#0.9050;REVERSE TRANSCRIPTION#0.9046;2,3-DIMERCAPTOPROPANOL#0.9020;INTESTINAL ABSORPTION#0.9019;EPITHELIAL CELL#0.8935;PANCREATIC ADENOCARCINOMA#0.8929;PERIPHERAL BLOOD#0.8924;VERY-LOW-DENSITY LIPOPROTEIN#0.8903;MOLAR#0.8860;LIPID DIGESTION#0.8790;SERINE HYDROLASE#0.8785;PLASMA MEMBRANE#0.8762;CHYLOMICRON#0.8754;CELL SURFACE#0.8660;LACTATION#0.8628;APOPTOSIS#0.8619;GESTATION#0.8583;POLYMERASE CHAIN REACTION#0.8543;PANCREATIC DUCTAL ADENOCARCINOMA#0.8539;HUMAN IMMUNODEFICIENCY VIRUS#0.8514;ACUTE PANCREATITIS#0.8444;O GLYCAN#0.8441;ESTRADIOL#0.8439;ENDOTHELIAL CELL#0.8420;ALVEOLAR MACROPHAGE#0.8401;SCANNING ELECTRON MICROSCOPY#0.8378;KINASE ACTIVITY#0.8376;MILK PROTEIN#0.8363;ADIPOCYTE#0.8270;SMOOTH MUSCLE#0.8200;ACAT ACTIVITY#0.8191;CHOLESTEROL UPTAKE#0.8099;HEART DISEASE#0.8087;GASTROINTESTINAL TRACT#0.8079;INTRACELLULAR MEMBRANE#0.8030;LIPID DROPLET#0.8029;ADRENAL CORTEX#0.7998;BETA-HYDROXYSTEROID DEHYDROGENASE#0.7983;CHOLESTEROL ACYLTRANSFERASE ACTIVITY#0.7930;STEROIDOGENESIS#0.7908;ACYLTRANSFERASE ACTIVITY#0.7885;BRUSH BORDER#0.7858;CHOLESTEROL TRANSPORT#0.7802;MUSCLE CELL#0.7751;LYSOSOME#0.7748;LDL PARTICLE#0.7724;LYSINE#0.7717;INFLAMMATORY RESPONSE#0.7700;CHEMOKINE RECEPTOR#0.7654;BRUSH BORDER MEMBRANE#0.7599;SMOOTH MUSCLE CELL#0.7578;GROWTH FACTOR#0.7578;DODECYL SULFATE#0.7571;SODIUM DODECYL SULFATE#0.7571;TUMOR CELLS#0.7558;TESTOSTERONE#0.7553;MONONUCLEAR CELLS#0.7550;HYDROLASE ACTIVITY#0.7544;HYPERTENSION#0.7452;CELL MEMBRANE#0.7427;CALCIUM MOBILIZATION#0.7400;DIMERCAPTOSUCCINIC ACID#0.7400;SIGNALING PATHWAY#0.7389;LIPID RAFT#0.7377;PALMITATE#0.7317;DIABETES MELLITUS#0.7298;PHOSPHATASE ACTIVITY#0.7232;DENDRITIC CELL#0.7205;SERUM ALBUMIN#0.7188;BETA CELL#0.7156;LECTIN#0.7100;CHOLESTEROL O ACYLTRANSFERASE#0.7099;CANCER CELL#0.7096;PROTEIN SYNTHESIS#0.7078;TRANSCRIPTION FACTOR#0.7042;WEIGHT GAIN#0.7014;OVARIAN#0.7001;ACID PHOSPHATASE ACTIVITY#0.6974;ARACHIDONIC ACID#0.6924;LIPOPROTEIN METABOLISM#0.6878;ACYL-COA:CHOLESTEROL ACYLTRANSFERASE ACTIVITY#0.6839;O ACYLTRANSFERASE#0.6819;TOXICITY#0.6796;CORONARY HEART DISEASE#0.6753;BETA-ESTRADIOL#0.6741;MUTAGENESIS#0.6724;C TERMINAL DOMAIN#0.6687;EXCRETION#0.6683;CHOLINE#0.6661;HISTIDINE#0.6660;CAROTENOID#0.6587;EPIDIDYMAL ADIPOSE TISSUE#0.6586;NEUTROPHIL#0.6479;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6427;LEUKOCYTE#0.6369;FOAM CELL FORMATION#0.6340;SCAVENGER RECEPTOR#0.6289;VITAMIN E#0.6283;IMMUNE RESPONSE#0.6277;LYMPHOID CELL#0.6246;T LYMPHOCYTE#0.6229;B CELL#0.6219;PHOSPHATE BUFFER SOLUTION#0.6203;PROTEIN KINASE C#0.6200;ENDOCYTOSIS#0.6167;ENZYME INHIBITOR#0.6122;COLLAGENASE#0.6090;N GLYCAN#0.6049;PHOSPHOLIPASE ACTIVITY#0.6016;HOMOLOGOUS RECOMBINATION#0.6012;SIGNAL PEPTIDE#0.6006
10570	NEURITE#0.7043;NERVOUS SYSTEM#0.6804;APOPTOSIS#0.6609;NEURITE OUTGROWTH#0.6493;CEREBRAL ISCHEMIA#0.6413;GENE EXPRESSION#0.6291;MORPHOGENESIS#0.6229;ISCHEMIA#0.6128
10572	APOPTOSIS#1.0548;APOPTOTIC#1.0539;T CELL#1.0291;CANCER CELL#1.0274;CELL DEATH#0.9551;SIGNALING PATHWAY#0.9076;GENE EXPRESSION#0.8681;BREAST CANCER#0.8613;TUMOR NECROSIS FACTOR#0.8149;UBIQUITIN#0.7959;CELL CYCLE#0.7632;TRANSCRIPTION FACTOR#0.7617;CELL PROLIFERATION#0.7425;CISPLATIN#0.7314;INDUCTION OF APOPTOSIS#0.7294;TUMOR SUPPRESSOR#0.7256;CYTOCHROME C#0.7093;LUNG CANCER#0.7068;BREAST CANCER CELL#0.6909;PROTEIN KINASE#0.6388;LYMPHOID CELL#0.6164;WOUND HEALING#0.6123;CELL MIGRATION#0.6056;SKELETAL MUSCLE#0.6047;T LYMPHOCYTE#0.6042
10573	CYCLIN DEPENDENT KINASE#1.0270;CELL CYCLE#1.0139;TUMOR SUPPRESSOR#1.0131;T CELL#0.9877;CYCLIN DEPENDENT KINASE INHIBITOR#0.9806;KINASE INHIBITOR#0.9735;T LYMPHOCYTE#0.9357;CELL CYCLE ARREST#0.8749;RETINOBLASTOMA#0.8270;PERIPHERAL BLOOD#0.8055;APOPTOSIS#0.8043;POLYMERASE CHAIN REACTION#0.8023;IMMUNE RESPONSE#0.7934;MELANOCYTE#0.7894;BONE MARROW#0.7788;CDK INHIBITOR#0.7770;CYTOTOXIC T-LYMPHOCYTE#0.7604;CELL SURFACE#0.7494;B CELL#0.7096;MELANOMA CELL LINES#0.6767;SENESCENCE#0.6622;VIRION#0.6244;CELL SURFACE ANTIGEN#0.6126;BREAST CANCER#0.6102;PERIPHERAL BLOOD LYMPHOCYTES#0.6098;RIBOSOMAL PROTEIN#0.6052;APOPTOTIC#0.6048
10574	CHAPERONIN-CONTAINING T-COMPLEX#0.9954;CHAPERONIN#0.9449;WOUND HEALING#0.7124;SOLUBLE GUANYLYL CYCLASE#0.6500;SMOOTH MUSCLE ACTIN#0.6408;SMOOTH MUSCLE#0.6358
10575	CHAPERONIN#1.0482;CHAPERONIN-CONTAINING T-COMPLEX#0.9456;CELL CYCLE#0.6060
105761008	REGULATION OF MACROPHAGE ACTIVATION#0.8786;EXTRACELLULAR VESICLE#0.8186;MACROPHAGE ACTIVATION#0.8132
10576	CHAPERONIN#1.0243;CELL CYCLE#0.8670;BREAST CANCER#0.8080;CANCER CELL#0.7894;GENE EXPRESSION#0.6904;LEBER CONGENITAL AMAUROSIS#0.6392;BREAST CANCER CELL#0.6088;CELL DEATH#0.6053
10577	CHOLESTEROL BINDING#1.0522;LYSOSOMAL STORAGE DISORDER#1.0371;CHOLESTEROL TRANSPORT#1.0319;LATE ENDOSOME#1.0241;NIEMANN-PICK DISEASE#1.0217;LIPID STORAGE#1.0138;CHOLESTEROL HOMEOSTASIS#1.0136;ENDOSOME#1.0111;STEROL BINDING#1.0106;LYSOSOME#1.0077;LYSOSOMAL STORAGE DISEASE#0.9948;EPIDIDYMIS#0.9925;LOW DENSITY LIPOPROTEIN#0.9908;CHOLESTEROL STORAGE#0.9877;CHOLESTEROL EFFLUX#0.9815;PLASMA MEMBRANE#0.9801;LIPID TRANSPORT#0.9771;NEURODEGENERATIVE DISEASE#0.9692;MACROPHAGE#0.9632;CHOLESTEROL METABOLISM#0.9553;GENE EXPRESSION#0.9549;ENDOPLASMIC RETICULUM#0.9432;ORGANELLE#0.9153;STEROL TRANSPORT#0.8995;INTRACELLULAR CHOLESTEROL TRANSPORT#0.8860;BONE MARROW#0.8630;MIGLUSTAT#0.8604;LYSOSOMAL MEMBRANE#0.8533;ASTROCYTE#0.8468;PURKINJE CELL#0.8408;LIPID METABOLISM#0.8313;CELL DEATH#0.8305;LIPID STORAGE DISEASE#0.8256;CHOLESTEROL EXPORT#0.8173;DEMENTIA#0.8075;SKIN FIBROBLASTS#0.7937;BREAST CANCER#0.7880;GALLSTONE FORMATION#0.7777;ODORANT BINDING PROTEIN#0.7645;ODORANT BINDING#0.7641;LUMINAL#0.7603;ADIPOSE TISSUE#0.7566;INTESTINAL CHOLESTEROL ABSORPTION#0.7539;SEMINAL PLASMA#0.7515;LIVER CANCER#0.7510;GROWTH FACTOR#0.7387;AUTOPHAGY#0.7175;ALLERGEN#0.7131;ADIPOCYTE#0.7098;AUTOSOMAL RECESSIVE DISEASE#0.7085;SAPOSIN#0.7048;CHOLESTEROL ESTERIFICATION#0.7026;SPERMATOZOA#0.6962;RESPIRATORY DISTRESS#0.6948;PROTEIN KINASE#0.6940;CANCER CELL#0.6838;ENDOCYTOSIS#0.6718;ALZHEIMER'S DISEASE#0.6657;LUNG DISEASE#0.6521;NIEMANN-PICK DISEASE TYPE C1#0.6469;NERVOUS SYSTEM#0.6456;INTRACELLULAR LIPID TRANSPORT#0.6396;CHOLESTEROL UPTAKE#0.6357;ACID SPHINGOMYELINASE#0.6329;HEPATOCELLULAR CARCINOMA#0.6298;LIPID BINDING#0.6291;ENZYME ACTIVITY#0.6280;STEM CELL#0.6279;CHOLESTEROL TRANSPORTER#0.6266;GLYCOSYLATION#0.6143;GARP COMPLEX#0.6071;DYSTONIA#0.6038
10578	CYTOLYTIC GRANULE#1.0814;GRANULYSIN PRODUCTION#1.0761;NOTCH RECEPTOR#1.0361;NATURAL KILLER CELL#1.0341;CD8+ T CELL#1.0327;CD4+ T CELL#1.0313;CYTOTOXIC T CELL#1.0293;CELL DEATH#1.0235;APOPTOSIS#1.0180;CYTOTOXICITY#1.0157;CYTOTOXIC T-LYMPHOCYTE#1.0149;TUBERCULOSIS#1.0143;PERIPHERAL BLOOD#1.0102;T CELL#1.0094;T LYMPHOCYTE#1.0075;TUMOR CELLS#1.0034;STEVENS-JOHNSON SYNDROME#0.9932;GENE EXPRESSION#0.9899;MACROPHAGE#0.9889;KERATINOCYTE#0.9875;TOXIC EPIDERMAL NECROLYSIS#0.9854;EXOCYTOSIS#0.9832;LYSIS#0.9816;IMMUNE RESPONSE#0.9773;IFN-GAMMA#0.9757;DENDRITIC CELL#0.9739;APOPTOTIC#0.9736;MONONUCLEAR CELLS#0.9708;POLYMERASE CHAIN REACTION#0.9692;IMMUNE SYSTEM#0.9643;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9598;IMMUNE CELL#0.9555;MONOCYTE#0.9548;TUMOR NECROSIS FACTOR#0.9414;LEUKOCYTE#0.9346;NOTCH LIGAND#0.9314;PERIPHERAL BLOOD LYMPHOCYTES#0.9290;CELL SURFACE#0.9278;SIGNALING PATHWAY#0.9264;TRANSCRIPTION FACTOR#0.9155;CELL ACTIVATION#0.8988;ADRENALINE#0.8943;PRECURSOR CELL#0.8922;REGULATORY T CELL#0.8763;NKT CELL#0.8733;B CELL#0.8620;CYTOCHROME C#0.8561;STEM CELL#0.8492;CELL-MEDIATED IMMUNITY#0.8395;LYSOSOME#0.8368;GROWTH FACTOR#0.8325;PRO-INFLAMMATORY#0.8289;HOST CELL#0.8113;ACTIVATED T LYMPHOCYTES#0.8088;ENDOTHELIAL CELL#0.8059;ANTIGEN PRESENTING CELLS#0.7996;ACTIVATOR PROTEIN 1#0.7987;CELL PROLIFERATION#0.7975;PSORIASIS#0.7948;ENDOMETRIUM#0.7938;LIPID RAFT#0.7894;T CELL ACTIVATION#0.7873;MITOCHONDRIA#0.7860;HUMAN LEUKOCYTE ANTIGEN#0.7608;ARGININE#0.7465;CELL MEMBRANE#0.7400;RED BLOOD CELL#0.7257;SAPOSIN#0.7219;CANCER CELL#0.7196;TROPHOBLAST#0.7103;MEMORY T CELL#0.7079;REACTIVE OXYGEN SPECIES#0.7019;ACTIVATED T CELL#0.6979;APOPTOTIC CELL DEATH#0.6884;SIGNAL TRANSDUCTION#0.6849;ADVERSE DRUG REACTION#0.6839;LYMPHOCYTE ACTIVATION#0.6779;INNATE IMMUNITY#0.6769;ACTIVATED T-CELLS#0.6739;B CELL LYMPHOMA#0.6669;GM-CSF#0.6662;DECIDUA#0.6612;ALLOPURINOL#0.6573;NERVOUS SYSTEM#0.6560;HEPATITIS B#0.6484;EPIDERMAL GROWTH FACTOR#0.6438;CORD BLOOD#0.6284;HYPERSENSITIVITY#0.6280;MYOCARDIAL INFARCTION#0.6269;GONAD#0.6264;LEPROSY#0.6199;LYSINE#0.6194;KERATINOCYTE APOPTOSIS#0.6179;APOPTOSIS INDUCING FACTOR#0.6118;TRANSCRIPTASE#0.6101;CASPASE INHIBITOR#0.6073;OXYPURINOL#0.6025
10579	BREAST CANCER#1.0019;TUMOR SUPPRESSOR#0.9153;CENTROSOME#0.8877;CELL CYCLE#0.8031;MICROTUBULE#0.7940;CANCER CELL#0.7721;EPITHELIAL CELL#0.6588;BREAST CANCER CELL#0.6296;CELL PROLIFERATION#0.6246;GENE EXPRESSION#0.6031
10580	PROSTATE CANCER#1.0605;INSULIN RECEPTOR#1.0574;GLUCOSE UPTAKE#1.0211;SKELETAL MUSCLE#1.0104;ADIPOCYTE#1.0098;LIPID RAFT#1.0082;ADIPOSE TISSUE#1.0072;GLUCOSE TRANSPORT#1.0054;FOCAL ADHESION#1.0008;SIGNALING PATHWAY#0.9798;ANDROGEN RECEPTOR#0.9767;PLASMA MEMBRANE#0.9479;GENE EXPRESSION#0.9464;EPITHELIAL CELL#0.9456;SIGNALING CASCADE#0.9249;CANCER CELL#0.8979;GROWTH FACTOR#0.8947;APOPTOSIS#0.8926;MUSCLE CELL#0.8915;STRESS FIBER#0.8599;CELL PROLIFERATION#0.8571;CELL ADHESION#0.8332;STROMAL CELL#0.8289;SIGNAL TRANSDUCTION#0.8188;PROTEIN KINASE#0.8177;HIGH FAT DIET#0.8079;AGE AT ONSET#0.7660;TRANSCRIPTION FACTOR#0.7652;INSULIN SIGNALING PATHWAY#0.7383;EXTRACELLULAR MATRIX#0.7021;POLYMERASE CHAIN REACTION#0.7000;TYPE 2 DIABETES#0.6921;DNA BINDING#0.6857;PEROXISOME#0.6847;COSTAMERE#0.6648;SIGNALLING PATHWAY#0.6558;MACROPHAGE#0.6511;VINCULIN BINDING#0.6435;METASTATIC PROSTATE CANCER#0.6419;BONE MARROW#0.6280;CELL CYCLE#0.6276;SH3 DOMAIN BINDING#0.6274;HIGH FAT FEEDING#0.6155
10581	GENE EXPRESSION#0.8634;MEMBRANE FUSION#0.7596;INTERFERON STIMULATED GENE#0.6814;ENDOSOME#0.6657;T CELL#0.6653;VIRAL INFECTION#0.6520;DENDRITIC CELL#0.6272;IMMUNE RESPONSE#0.6188
10584	LECTIN#1.0414;MANNAN BINDING LECTIN#0.9619;MANNAN BINDING#0.9602;PATTERN RECOGNITION MOLECULES#0.9022;MANNOSE BINDING LECTIN#0.8344;MANNOSE BINDING#0.8329
10585	WALKER-WARBURG SYNDROME#1.0381;LIMB-GIRDLE MUSCULAR DYSTROPHY#1.0275;MENTAL RETARDATION#1.0274;MANNOSYLATION#1.0252;GLYCOSYLATION#1.0247;CONGENITAL MUSCULAR DYSTROPHY#1.0071;CONGENITAL MUSCULAR DYSTROPHIES#1.0059;MANNOSYLTRANSFERASE ACTIVITY#1.0053;MUSCULAR DYSTROPHY#1.0038;BRAIN DISEASE#0.9752;PROTEIN O-MANNOSYLTRANSFERASE ACTIVITY#0.9175;EXTRACELLULAR MATRIX#0.8868;NEURONAL MIGRATION#0.8477;LISSENCEPHALY#0.8134;ENDOPLASMIC RETICULUM#0.7977;LAMININ BINDING#0.7936;ENZYME ACTIVITY#0.7714;BASEMENT MEMBRANE#0.7439;NERVOUS SYSTEM#0.7238;CENTRAL NERVOUS SYSTEM#0.6992;SKELETAL MUSCLE#0.6884;MICROCEPHALY#0.6551;MUSCLE WEAKNESS#0.6535;POLYMERASE CHAIN REACTION#0.6283;FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY#0.6021
10586	CELL PROLIFERATION#0.8017;EYE DEVELOPMENT#0.7638;OPTIC CUP#0.7480;COLOBOMA#0.7436;MORPHOGENESIS#0.6960;CHOROID FISSURE#0.6691;MICROPHTHALMIA#0.6424;TECTUM#0.6357;NEURAL TUBE#0.6087
10587	BETA-2#1.0584;THYROID CARCINOMA#1.0262;FOLLICULAR THYROID CARCINOMA#1.0249;GLUTATHIONE PEROXIDASE#1.0204;LIGAND BINDING DOMAIN#1.0149;THYROID CANCER#1.0149;MITOCHONDRIA#1.0137;TRANSACTIVATION#1.0096;POLYMERASE CHAIN REACTION#1.0051;METAMORPHOSIS#1.0017;HORMONE BINDING#1.0003;GLUTATHIONE#0.9999;RETINOID X RECEPTOR#0.9973;DNA BINDING#0.9949;THIOREDOXIN REDUCTASE 1#0.9922;THYROID HORMONE RECEPTOR#0.9902;APOPTOSIS#0.9877;REACTIVE OXYGEN SPECIES#0.9876;SIGNALING PATHWAY#0.9842;STEROID RECEPTOR COACTIVATOR#0.9827;SELENOCYSTEINE#0.9821;HYPOTHYROIDISM#0.9809;RETINOIC ACID#0.9805;NUCLEAR HORMONE RECEPTOR#0.9804;CELL PROLIFERATION#0.9800;GENE EXPRESSION#0.9789;TRANSCRIPTION FACTOR#0.9781;TRIIODOTHYRONINE#0.9758;CELL DEATH#0.9606;ESTROGEN RECEPTOR#0.9559;SKELETAL MUSCLE#0.9487;CANCER CELL#0.9443;HAIR CELL#0.9353;GROWTH FACTOR#0.9337;3,5,3'-TRIIODOTHYRONINE#0.9336;GLUCOCORTICOID RECEPTOR#0.9321;GC-24#0.9287;TACHYCARDIA#0.9262;MALIC ENZYME#0.9237;RETINOIC ACID RECEPTOR#0.9175;SUPEROXIDE DISMUTASE#0.9152;BREAST CANCER#0.9106;GOITER#0.9040;ELECTROPHORETIC MOBILITY SHIFT#0.8942;THYROTROPIN RELEASING HORMONE#0.8770;MYOSIN HEAVY CHAIN#0.8757;ONCOGENIC#0.8722;NERVOUS SYSTEM#0.8720;HYPERTHYROIDISM#0.8691;THYROID HORMONE RESISTANCE SYNDROME#0.8688;CARDIOMYOCYTE#0.8678;METHIONINE#0.8592;ENDOTHELIAL CELL#0.8591;AURANOFIN#0.8556;PITUITARY GLAND#0.8456;3,5,3'-TRIIODO-L-THYRONINE#0.8349;GROWTH HORMONE#0.8296;LIPID METABOLISM#0.8255;TSH SECRETION#0.8214;DILATED CARDIOMYOPATHY#0.8056;EPITHELIAL CELL#0.8045;PROTEIN PROTEIN INTERACTION#0.7964;TUMOR SUPPRESSOR#0.7946;THYROTOXICOSIS#0.7943;THYROID GLAND#0.7890;INNER EAR#0.7890;PEROXISOME#0.7885;CHOLESTEROL METABOLISM#0.7879;APOPTOTIC#0.7824;TOXICITY#0.7794;BRAIN DEVELOPMENT#0.7783;CELL GROWTH#0.7750;OPSIN#0.7703;PROSTATE CANCER#0.7648;HYPERCHOLESTEROLEMIA#0.7648;ARGININE#0.7608;QUANTITATIVE REAL TIME#0.7586;HYPERACTIVITY#0.7580;GENETIC DISEASE#0.7440;CENTRAL NERVOUS SYSTEM#0.7436;THYROID HORMONE BINDING#0.7421;FOLLICULAR THYROID CANCER#0.7380;TUMOR TISSUES#0.7379;CELL DIFFERENTIATION#0.7375;SKELETAL DEVELOPMENT#0.7347;LEUCINE#0.7322;ALANINE#0.7308;PROTEIN KINASE#0.7295;COCHLEA#0.7212;REVERSE TRANSCRIPTION#0.7212;CHONDROCYTE#0.7151;RESPONSE TO THYROID HORMONE#0.7100;HYPOXIA#0.7096;ADIPOSE TISSUE#0.7092;FAMILIAL GLUCOCORTICOID DEFICIENCY#0.7028;RECEPTOR LIGAND#0.7025;ISCHEMIA#0.7022;PROTEIN SYNTHESIS#0.7015;CARDIOMYOPATHY#0.7015;OSTEOBLAST#0.6990;STEM CELL#0.6955;STRUCTURE ACTIVITY RELATIONSHIP#0.6954;INSULIN-LIKE GROWTH FACTOR#0.6837;CYTOPLASM#0.6821;LIVER X RECEPTOR#0.6773;PURKINJE CELL#0.6743;CHROMATIN REMODELING#0.6737;3,3',5-TRIIODO-L-THYRONINE#0.6729;TUMOR CELLS#0.6701;ANDROGEN RECEPTOR#0.6695;HATCHING#0.6608;NUCLEAR RECEPTOR SUPERFAMILY#0.6547;DOMINANT NEGATIVE MUTANT#0.6509;CEREBRAL CORTEX#0.6465;MYOCARDIUM#0.6450;CELL CYCLE#0.6405;CYTOCHROME C#0.6232;DIABETES MELLITUS#0.6210;ESTROGEN RECEPTOR ALPHA#0.6207;THYMIDINE#0.6181;PROTEASOME#0.6179;HYPOXIA INDUCIBLE FACTOR#0.6169;ALTERNATIVE SPLICING VARIANT#0.6159;OUTER HAIR CELL#0.6127;OLIGODENDROCYTE#0.6109;GUANINE#0.6098;ADIPOCYTE#0.6083;SERTOLI CELL#0.6038
10588	FOLATE#1.0394;SYNTHETASE ACTIVITY#0.7819;ONE CARBON METABOLISM#0.7520;NEUROBLASTOMA#0.7083;TETRAHYDROFOLATE#0.6676;FOLATE METABOLISM#0.6647;FOLINIC ACID#0.6343
1058	CENP-A LOADING#1.1348;MIS18 COMPLEX#1.1104;CENP-A DEPOSITION#1.0963;INNER KINETOCHORE PLATE#1.0846;CENTROMERE SPECIFIC NUCLEOSOME#1.0726;CENTROMERE ASSEMBLY#1.0533;NUCLEOSOME ASSEMBLY#1.0515;CENTROMERIC NUCLEOSOME#1.0486;KINETOCHORE FORMATION#1.0464;CHROMATIN ASSEMBLY#1.0420;CENTROMERE LOCALIZATION#1.0418;HISTONE CHAPERONE#1.0398;NUCLEOSOME#1.0320;CENTROMERE#1.0270;KINETOCHORE ASSEMBLY#1.0268;INTERPHASE#1.0110;KINETOCHORE#1.0081;BUDDING#1.0059;DNA REPLICATION#1.0053;HETEROCHROMATIN#1.0034;S PHASE#1.0027;MITOTIC CHROMOSOME#1.0022;DNA BINDING#0.9992;POSTTRANSLATIONAL MODIFICATION#0.9966;CELL CYCLE#0.9960;RNA INTERFERENCE#0.9942;CHROMOSOMAL REGION#0.9937;HISTONE MODIFICATION#0.9929;G1 PHASE#0.9901;SPINDLE MICROTUBULE#0.9897;CHROMOSOME SEGREGATION#0.9887;MEIOSIS#0.9883;MITOTIC SPINDLE#0.9877;METAPHASE#0.9870;PROPHASE#0.9856;ANAPHASE#0.9845;COMPLEX I#0.9831;MITOTIC EXIT#0.9830;LYSINE#0.9805;MICROTUBULE#0.9788;CELL DIVISION#0.9773;CONSTRICTION#0.9765;KINETOCHORE MICROTUBULE#0.9761;MITOSIS#0.9754;GENE EXPRESSION#0.9709;CHROMATID#0.9709;CENTROMERIC HETEROCHROMATIN#0.9704;CHROMATIN ORGANIZATION#0.9552;TRANSCRIPTION FACTOR#0.9451;CANCER CELL#0.9446;MITOTIC CHECKPOINT#0.9427;HUMAN ARTIFICIAL CHROMOSOME#0.9409;APOPTOSIS#0.9398;UBIQUITIN#0.9302;BREAST CANCER#0.9265;TOPOISOMERASE#0.9209;CYTOKINESIS#0.9195;KINETOCHORE LOCALIZATION#0.9194;MICROTUBULE BINDING#0.9168;CELL DEATH#0.9132;EUCHROMATIN#0.9123;TELOPHASE#0.9070;OOCYTE#0.9009;PROTEIN COMPLEX#0.9007;PERICENTRIC HETEROCHROMATIN#0.8855;CENTROMERE BINDING#0.8842;SPINDLE ASSEMBLY#0.8815;CELL PROLIFERATION#0.8809;CELL CYCLE ARREST#0.8798;SISTER CHROMATID COHESION#0.8745;MEIOTIC CHROMOSOME#0.8738;METAPHASE CHROMOSOME#0.8677;HISTONE DEACETYLASE#0.8609;ARGININE#0.8591;POST-TRANSLATIONAL MODIFICATION#0.8408;NDC80 COMPLEX#0.8395;LUNG ADENOCARCINOMA#0.8327;NUCLEAR DIVISION#0.8272;TOPOISOMERASE II#0.8248;CELL CYCLE REGULATION#0.8236;HEPATOCELLULAR CARCINOMA#0.8229;MEIOSIS I#0.8228;CHROMATIN REMODELING#0.8122;DNA REPAIR#0.8071;CHROMATIN MODIFICATION#0.8061;PROTEIN PROTEIN INTERACTION#0.8013;TELOMERE#0.7999;SCLERODERMA#0.7908;STEM CELL#0.7906;MEIOTIC CHROMOSOME SEGREGATION#0.7756;G2 PHASE#0.7729;CHROMOSOME CONGRESSION#0.7680;HISTONE ACETYLATION#0.7669;C TERMINAL DOMAIN#0.7590;SPINDLE ASSEMBLY CHECKPOINT#0.7562;POLYMERASE CHAIN REACTION#0.7515;CELL DIVISION CYCLE#0.7481;LIGASE ACTIVITY#0.7444;CELL GROWTH#0.7417;COLORECTAL CANCER#0.7367;MITOTIC CELL CYCLE#0.7365;SPINDLE CHECKPOINT#0.7352;CHROMOSOME CONDENSATION#0.7304;NUCLEOSOME POSITIONING#0.7262;DNA METHYLATION#0.7236;CHROMOSOME MOVEMENT#0.7211;CYCLIN DEPENDENT KINASE#0.7164;KINETOCHORE-MICROTUBULE ATTACHMENT#0.7147;SPINDLE POLE#0.7089;CHROMOSOME TRANSMISSION#0.7061;PROTEASOME#0.7037;TUMOR CELLS#0.6977;COLORECTAL#0.6828;ADENOCARCINOMA#0.6826;HETEROCHROMATIN DOMAIN#0.6773;RSF COMPLEX#0.6749;M PHASE#0.6749;HETEROCHROMATIN FORMATION#0.6687;CHROMOSOMAL PASSENGER COMPLEX#0.6497;LINES OF EVIDENCE#0.6483;AUTOIMMUNE DISEASE#0.6428;NUCLEAR PERIPHERY#0.6416;GERM CELL#0.6161;HISTONE ACETYLTRANSFERASE#0.6059;SENESCENCE#0.6013;RHEUMATIC DISEASE#0.6009
10590	INSULIN SECRETION#0.9520;INTERNEURON#0.8936;NEUROENDOCRINE TUMOR#0.7088;NEUROENDOCRINE CELL#0.6591;STRIATUM#0.6553;VOMERONASAL ORGAN#0.6542
10591	ANCHORAGE INDEPENDENT GROWTH#0.6603;CANCER CELL#0.6349;NUCLEOTIDE METABOLISM#0.6135
10592	CONDENSIN COMPLEX#1.0704;CHROMOSOME CONDENSATION#0.9948;MITOTIC CHROMOSOME#0.9802;CHROMATID#0.9469;SISTER CHROMATID COHESION#0.9417;MITOSIS#0.9194;CELL CYCLE#0.8837;TUBERCULOSIS#0.8534;CHROMOSOME SEGREGATION#0.8405;DNA REPAIR#0.7845;COMPLEX I#0.7649;HEALTH CARE PROVIDER#0.7644;INTERPHASE#0.7221;SEXUALLY TRANSMITTED INFECTION#0.7125;CELL DIVISION#0.7072;TOPOISOMERASE#0.6936;BREAST CANCER#0.6713;CENTROMERE#0.6352;TOPOISOMERASE II#0.6278;DNA LIGASE#0.6069
10594	INTEIN#1.1073;U5 SNRNP#1.0716;SPLICEOSOME ASSEMBLY#1.0354;RETINITIS PIGMENTOSA#1.0270;RETINITIS#1.0261;MRNA PROCESSING#1.0256;SPLICEOSOME#1.0206;SMALL NUCLEAR RIBONUCLEOPROTEIN#1.0157;PRE-MRNA SPLICING#1.0048;MRNA SPLICING#1.0020;RNA HELICASE#0.9998;SMALL NUCLEAR RNA#0.9882;RNA SPLICING#0.9770;PROTEIN SPLICING#0.9595;PROTEIN SYNTHESIS#0.9247;CELL CYCLE#0.9195;GENE EXPRESSION#0.8998;PROTEIN COMPLEX#0.8984;TRANSCRIPTASE#0.8657;SPLICE SITE SELECTION#0.8308;T CELL#0.7959;C TERMINAL DOMAIN#0.7791;RNA PROCESSING#0.7784;RNA BINDING#0.7329;CANCER CELL#0.7260;COMPLEX I#0.7253;MUTAGENESIS#0.7235;PROTEIN PROTEIN INTERACTION#0.7176;CAP BINDING COMPLEX#0.7097;DNA DAMAGE RESPONSE#0.6776;HOST CELL#0.6531;APOPTOSIS#0.6491;PROTEIN KINASE#0.6476;BREAST CANCER#0.6280;NINETEEN COMPLEX#0.6150;RETINAL DEGENERATION#0.6073;U2 SNRNP#0.6039
10595	ENDOPLASMIC RETICULUM#0.9919;TRANSCRIPTION FACTOR#0.9061;UNFOLDED PROTEIN RESPONSE#0.8966;PROTEIN KINASE#0.8152;SIGNALING PATHWAY#0.8151;AUTOPHAGY#0.7483;RNASE ACTIVITY#0.6525;NODULE DEVELOPMENT#0.6181;MESODERM FORMATION#0.6018
10598	ATPASE ACTIVITY#1.0781;HEAT SHOCK PROTEIN#0.8304;ATPASE ACTIVATOR#0.7165;CANCER CELL#0.7033;CYSTIC FIBROSIS#0.6269
10599	REPAGLINIDE#1.0540;GEMFIBROZIL#1.0524;FLUVASTATIN#1.0497;PITAVASTATIN#1.0417;HUMAN EMBRYONIC KIDNEY#1.0398;EMBRYONIC KIDNEY#1.0396;IRINOTECAN#1.0372;DIGOXIN#1.0342;ESTRADIOL-17BETA#1.0329;PRAVASTATIN#1.0319;OOCYTE#1.0300;ROSUVASTATIN#1.0275;SIMVASTATIN#1.0269;ATORVASTATIN#1.0261;MYOPATHY#1.0260;RIFAMPIN#1.0256;PRIMARY HUMAN HEPATOCYTES#1.0204;ESTRONE#1.0201;MULTIDRUG RESISTANCE PROTEIN#1.0200;ORGANIC ANION TRANSPORTER#1.0151;ESTRADIOL#1.0146;CYCLOSPORINE#1.0135;RIFAMPICIN#1.0115;METHOTREXATE#1.0109;RITONAVIR#1.0101;ORGANIC CATION TRANSPORTER#1.0098;LOPINAVIR#1.0084;TAUROCHOLATE#1.0037;CYCLOSPORIN A#1.0026;BREAST CANCER#0.9953;PLASMA MEMBRANE#0.9946;FRAGMENT LENGTH POLYMORPHISM#0.9932;POLYMERASE CHAIN REACTION#0.9914;URSODEOXYCHOLIC ACID#0.9904;PREGNANE X RECEPTOR#0.9904;CYCLOSPORIN#0.9898;DRUG TRANSPORT#0.9894;ATP BINDING CASSETTE#0.9884;ATP BINDING#0.9870;CYTOCHROME P450#0.9867;ORGANIC ANION TRANSPORT#0.9815;TOXICITY#0.9794;CHOLESTASIS#0.9787;GENE EXPRESSION#0.9783;HEPATOTOXICITY#0.9781;DRUG METABOLISM#0.9766;RIFAMYCIN#0.9765;ANION TRANSPORT#0.9749;LOW DENSITY LIPOPROTEIN#0.9743;NATEGLINIDE#0.9727;PACLITAXEL#0.9693;TAUROCHOLIC ACID#0.9691;DOCETAXEL#0.9677;EXCRETION#0.9673;OLMESARTAN#0.9666;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9639;ADVERSE DRUG REACTION#0.9634;CONSTITUTIVE ANDROSTANE RECEPTOR#0.9626;TUBERCULOSIS#0.9570;NEUTROPENIA#0.9554;BLOOD BRAIN BARRIER#0.9540;LIVER DISEASE#0.9530;CANCER CELL#0.9528;BOSENTAN#0.9524;REVERSE TRANSCRIPTION#0.9521;VALSARTAN#0.9511;CYTOTOXICITY#0.9461;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9400;KINASE INHIBITOR#0.9400;FLUORESCEIN#0.9363;SULFATE TRANSPORT#0.9359;CHOLESTEROL SYNTHESIS#0.9344;TRANSPORTER ACTIVITY#0.9340;RESPONSE TO STATIN#0.9335;UREMIC TOXIN#0.9268;HEPATOCELLULAR CARCINOMA#0.9227;RECEPTOR ANTAGONIST#0.9224;MIDAZOLAM#0.9203;COLORECTAL CANCER#0.9176;ABC TRANSPORTER#0.9153;METFORMIN#0.9149;FEXOFENADINE#0.9139;CHOROID PLEXUS#0.9138;COENZYME A#0.9114;HYPERCHOLESTEROLEMIA#0.9107;ESTRONE SULFATE#0.9035;TYROSINE KINASE INHIBITOR#0.9026;HEPATOCYTE NUCLEAR FACTOR#0.9021;CLOPIDOGREL#0.9013;MICROSOME#0.9006;HEPATITIS C#0.8967;EFFLUX PUMP#0.8956;TELMISARTAN#0.8949;LOVASTATIN#0.8947;QUERCETIN#0.8941;CERIVASTATIN#0.8882;BILE ACID SYNTHESIS#0.8876;CHOLIC ACID#0.8837;PHENOBARBITAL#0.8822;TRANSCRIPTION FACTOR#0.8818;GLUCOSE-6-PHOSPHATE#0.8787;TACROLIMUS#0.8748;URIDINE#0.8687;COPROPORPHYRIN I#0.8676;EFAVIRENZ#0.8666;CLARITHROMYCIN#0.8639;PROBENECID#0.8614;COLORECTAL#0.8570;DEHYDROEPIANDROSTERONE SULFATE#0.8557;WARFARIN#0.8540;TYPE 2 DIABETES#0.8504;DEOXYCHOLIC ACID#0.8490;EZETIMIBE#0.8488;FARNESOID X RECEPTOR#0.8488;PIOGLITAZONE#0.8434;ALANINE#0.8356;DETOXIFICATION#0.8348;EPITHELIAL CELL#0.8320;SORAFENIB#0.8186;GLUCURONIDE TRANSPORT#0.8156;QUINIDINE#0.8055;HYPERTENSION#0.8043;KETOCONAZOLE#0.8039;ROSIGLITAZONE#0.8034;ATAZANAVIR#0.8022;METASTATIC COLORECTAL CANCER#0.8013;RENAL TRANSPLANT RECIPIENTS#0.7990;TRANSMEMBRANE TRANSPORT#0.7977;SIROLIMUS#0.7951;RESPONSE TO SIMVASTATIN#0.7937;DEHYDROEPIANDROSTERONE#0.7919;RECEPTOR AGONIST#0.7889;MYCOPHENOLIC ACID#0.7887;ENDOTHELIAL CELL#0.7885;TAMOXIFEN#0.7874;VERAPAMIL#0.7845;INTESTINAL ABSORPTION#0.7811;REGORAFENIB#0.7730;CELL MEMBRANE#0.7711;CHENODEOXYCHOLIC ACID#0.7697;SAQUINAVIR#0.7631;BILE ACID TRANSPORT#0.7598;SMALL INTESTINE#0.7552;INTRAHEPATIC CHOLESTASIS#0.7551;GEOMETRIC MEAN RATIO#0.7544;GLUTATHIONE#0.7448;CORONARY ARTERY DISEASE#0.7426;ARTERY DISEASE#0.7425;CORONARY ARTERY#0.7407;DEXAMETHASONE#0.7402;GLIBENCLAMIDE#0.7396;RECEPTOR LIGAND#0.7353;GLYCINE#0.7306;HARDY WEINBERG EQUILIBRIUM#0.7278;ASPIRIN#0.7259;HEPATOMA CELLS#0.7249;CREATINE#0.7209;SKELETAL MUSCLE#0.7194;APOPTOSIS#0.7140;PAZOPANIB#0.7129;PROTEIN KINASE#0.7091;GD-EOB-DTPA#0.7060;GLIMEPIRIDE#0.7024;ARTERY#0.7008;CREATINE KINASE#0.6991;ENTEROCYTE#0.6936;DIPHOSPHATE#0.6928;MEMBRANE TRANSPORT#0.6917;DRUG RESISTANCE#0.6908;EPIGALLOCATECHIN#0.6897;CPT-11#0.6866;LIVER DAMAGE#0.6841;ENALAPRIL#0.6816;TRANSCRIPTASE#0.6809;FUROSEMIDE#0.6712;DIABETES MELLITUS#0.6685;PERIPHERAL BLOOD#0.6669;BILE DUCT#0.6636;ERYTHROMYCIN METABOLISM#0.6624;DIARRHEA#0.6622;ITRACONAZOLE#0.6618;TORASEMIDE#0.6616;ERYTHROMYCIN#0.6594;TROGLITAZONE#0.6550;ENZYME ACTIVITY#0.6534;ENDOTHELIN RECEPTOR#0.6501;ROCURONIUM#0.6501;DOXORUBICIN#0.6426;MAGNETIC RESONANCE IMAGING#0.6416;GLICLAZIDE#0.6402;MERCAPTOPURINE#0.6398;THERAPEUTIC DRUG MONITORING#0.6373;POPULATION PHARMACOKINETIC MODEL#0.6345;ISONIAZID#0.6336;TICAGRELOR#0.6312;CICLOSPORIN#0.6311;IRBESARTAN#0.6304;ATP BINDING CASSETTE TRANSPORTER#0.6303;HIV PROTEASE INHIBITOR#0.6294;DASATINIB#0.6274;ACETIC ACID#0.6247;NAFCILLIN#0.6245;HUMAN IMMUNODEFICIENCY VIRUS#0.6243;CELL SURFACE#0.6213;MYELOID LEUKEMIA#0.6204;ENZYME INHIBITOR#0.6195;MYOCARDIAL INFARCTION#0.6191;GROWTH FACTOR#0.6188;NEONATAL JAUNDICE#0.6169;IBUPROFEN#0.6141;TESTOSTERONE#0.6090;GADOXETATE DISODIUM#0.6059;LIVER X RECEPTOR#0.6049
1059	DNA BINDING#1.0392;CENTROMERE#1.0324;CENTROMERIC HETEROCHROMATIN#1.0277;HETEROCHROMATIN#1.0199;NUCLEOSOME#1.0087;KINETOCHORE#1.0064;CENTROMERE BINDING#1.0055;SCLERODERMA#1.0002;CELL CYCLE#0.9877;TOPOISOMERASE#0.9812;HUMAN ARTIFICIAL CHROMOSOME#0.9798;MITOSIS#0.9539;METAPHASE#0.9309;CENTROMERE ASSEMBLY#0.9217;CHROMOSOME SEGREGATION#0.9184;AUTOIMMUNE DISEASE#0.9140;CONNECTIVE TISSUE DISEASE#0.8989;CONNECTIVE TISSUE#0.8901;INTERPHASE#0.8894;RAYNAUD’S#0.8871;MITOTIC CHROMOSOME#0.8609;SYSTEMIC LUPUS ERYTHEMATOSUS#0.8347;LUPUS ERYTHEMATOSUS#0.8344;RHEUMATIC DISEASE#0.8319;KINETOCHORE ASSEMBLY#0.8272;GROWTH FACTOR#0.8002;MICROTUBULE#0.7829;PRIMARY BILIARY CIRRHOSIS#0.7818;CONSTRICTION#0.7710;HETEROCHROMATIN FORMATION#0.7651;Y CHROMOSOME#0.7535;GENE EXPRESSION#0.7506;PROTEIN BINDING#0.7484;SMOOTH MUSCLE CELL#0.7457;MUSCLE CELL#0.7445;SMOOTH MUSCLE#0.7428;CELL PROLIFERATION#0.6961;AUTOIMMUNE HEPATITIS#0.6948;CELL DIVISION#0.6932;MEIOSIS#0.6856;S PHASE#0.6839;RHEUMATOID ARTHRITIS#0.6632;CENTROMERE LOCALIZATION#0.6605;ANAPHASE#0.6512;CHROMATIN ASSEMBLY#0.6493;METAPHASE CHROMOSOME#0.6466;TELOMERE#0.6400;DIGESTION#0.6153;COMPLEX I#0.6090;CENTROMERE SPECIFIC NUCLEOSOME#0.6072;CHROMATID#0.6053;SPINDLE CHECKPOINT#0.6041
105	ADENOSINE DEAMINASE#1.0379;RNA EDITING#1.0334;ADENOSINE#0.9909;RNA BINDING#0.8627;GENE EXPRESSION#0.8217;GLUTAMATE RECEPTOR#0.6433
10600	CELL CYCLE#0.9679;UBIQUITIN#0.9370;DEUBIQUITINASE#0.9351;DEUBIQUITINATION#0.8422;GENE EXPRESSION#0.8106;STEM CELL#0.7304;NUCLEAR EXPORT#0.6679;KINETOCHORE LOCALIZATION#0.6479;MITOSIS#0.6385;MITOTIC CHROMOSOME#0.6235;DNA DAMAGE RESPONSE#0.6012
10602	CENTROMERE#0.8751;KINETOCHORE#0.7972;DNA BINDING#0.7038;CANCER ASSOCIATED FIBROBLASTS#0.6407
10603	INSULIN RECEPTOR#1.0746;ADIPOCYTE#1.0023;GROWTH FACTOR#0.9381;PLASMA MEMBRANE#0.8749;SIGNALING PATHWAY#0.8422;PROTEIN KINASE#0.7984;GLUCOSE TRANSPORT#0.7972;ACTIN CYTOSKELETON#0.7126;B CELL#0.6912;ACTIN CYTOSKELETON ORGANISATION#0.6725;INSULIN RECEPTOR SUBSTRATE#0.6721;HIGH FAT FEEDING#0.6316;CYTOSKELETON ORGANISATION#0.6311;SKELETAL MUSCLE#0.6221;CELL PROLIFERATION#0.6193;GLUCOSE UPTAKE#0.6083;ADIPOSE TISSUE#0.6044
10605	POLY-A BINDING#1.0248;TRANSLATION INITIATION#0.8741;CELL CYCLE#0.8324;SIGNALING PATHWAY#0.7049;TRANSLATION INITIATION FACTOR#0.6692
10606	ADENINE#1.0192;GENE CONVERSION#0.9941;MITOTIC RECOMBINATION#0.9778;MUTAGENESIS#0.9598;MITOTIC GENE CONVERSION#0.9417;GENE EXPRESSION#0.9332;HOMOLOGOUS RECOMBINATION#0.9222;MUTAGENIC#0.8781;TRANSCRIPTION FACTOR#0.8629;MUTAGEN#0.8223;BREAST CANCER#0.8197;VACUOLE#0.8194;CANCER CELL#0.8186;CELL PROLIFERATION#0.7959;CENTROMERE#0.7853;LUNG ADENOCARCINOMA#0.7522;ADENOSINE#0.7378;PROSTATE CANCER#0.7087;CELL CYCLE#0.6759;NUCLEOTIDE SYNTHESIS#0.6694;PURINE NUCLEOTIDE SYNTHESIS#0.6605;CARRIE#0.6577;MEIOSIS#0.6091
10607	L-RHAMNOSE#0.6493
10608	TRANSCRIPTION FACTOR#0.9600;CELL CYCLE#0.8161;REPLICATIVE SENESCENCE#0.8023;GENE EXPRESSION#0.7415;PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY#0.7290;B CELL#0.6906;CELL PROLIFERATION#0.6300;T CELL#0.6210;LEUKOENCEPHALOPATHY#0.6167;CELL DEATH#0.6055
106099130	CD8+ T CELL#0.7491;T CELL#0.7409
10609	SYNAPTONEMAL COMPLEX#1.0184;ENDOPLASMIC RETICULUM#0.8560;GRANULAR COMPONENT#0.6345
1060	CENTROMERE LOCALIZATION#1.0895;MIS12 COMPLEX#1.0825;INNER KINETOCHORE PLATE#1.0666;DNA BINDING#1.0397;KINETOCHORE ASSEMBLY#1.0385;KINETOCHORE#1.0277;CENTROMERE#1.0260;NUCLEOSOME#1.0238;INTERPHASE#1.0236;METAPHASE#0.9979;CELL CYCLE#0.9940;MITOSIS#0.9929;NDC80 COMPLEX#0.9889;CHROMOSOME SEGREGATION#0.9872;ANAPHASE#0.9864;MICROTUBULE#0.9793;CELL DIVISION#0.9695;MEIOSIS#0.9571;HETEROCHROMATIN#0.9386;SPINDLE MICROTUBULE#0.9100;CENTROMERIC NUCLEOSOME#0.9099;KINETOCHORE FORMATION#0.8973;MITOTIC SPINDLE#0.8964;MITOTIC CHROMOSOME#0.8946;CENTROMERE ASSEMBLY#0.8820;CHROMATID#0.8639;BUDDING#0.8502;KINETOCHORE MICROTUBULE#0.8487;SPINDLE CHECKPOINT#0.8322;SCLERODERMA#0.8178;MICROTUBULE BINDING#0.8135;CHROMATIN ASSEMBLY#0.7869;MITOTIC CHECKPOINT#0.7796;MEIOSIS I#0.7793;CONSTRICTION#0.7481;KINETOCHORE LOCALIZATION#0.7385;MIS18 COMPLEX#0.7264;UBIQUITIN#0.7173;PROTEIN COMPLEX#0.6831;C TERMINAL DOMAIN#0.6764;PROPHASE#0.6697;SPINDLE ASSEMBLY#0.6422;PROTEASOME#0.6378;APOPTOSIS#0.6338;METAPHASE CHROMOSOME#0.6138;C-LEVEL#0.6119;G1 PHASE#0.6099;NUCLEAR IMPORT#0.6027;HUMAN ARTIFICIAL CHROMOSOME#0.6021
10610	BREAST CANCER#0.9702;CANCER CELL#0.8799;SIGNALING PATHWAY#0.8435;CELL SURFACE#0.7451;AKT SIGNALING#0.7199;GLYCOSYLATION#0.6987;SIALYLATION#0.6145;FOLLICULAR THYROID CANCER#0.6076;LEUKOCYTE#0.6027
10611	BIPOLAR DISORDER#1.0869;PROTEIN KINASE#1.0084;GENE EXPRESSION#0.9781;Z LINE#0.9714;PROTEIN KINASE C#0.9598;TRANSCRIPTION FACTOR#0.9381;DILATED CARDIOMYOPATHY#0.8282;HEPATITIS B VIRUS#0.8227;HEPATITIS B#0.8210;CELL PROLIFERATION#0.8118;SKELETAL MUSCLE#0.7881;CARDIOMYOCYTE#0.7801;PROSTATE CANCER#0.7720;MAJOR DEPRESSIVE DISORDER#0.7571;STRIATED MUSCLE#0.7352;HEART DEVELOPMENT#0.7067;LEUKOCYTE#0.7055;MUSCLE CELL#0.7053;POSTSYNAPTIC DENSITY#0.7022;SMOOTH MUSCLE CELL#0.6881;SMOOTH MUSCLE#0.6860;CARDIOMYOPATHY#0.6430;CANCER CELL#0.6411;PKCEPSILON#0.6114;PULMONARY HYPERTENSION#0.6105;CELL MIGRATION#0.6080
10612	CELL PROLIFERATION#1.0352;TUMOR SUPPRESSOR#0.9533;CANCER CELL#0.9459;STEM CELL#0.8814;UBIQUITIN#0.8305;CERVICAL CANCER#0.8050;CELL CYCLE#0.7212;APOPTOSIS#0.6525;NEURITE OUTGROWTH#0.6372;HEPATOCELLULAR CARCINOMA#0.6299;CERVICAL#0.6092
10613	COMPLEX I#0.9056;ER MEMBRANE#0.8589;ENDOPLASMIC RETICULUM#0.7843;PHOSPHATIDYLINOSITOL 3-PHOSPHATE BINDING#0.6879;PHOSPHATE BINDING#0.6065
106144538	BREAST CANCER PATIENTS#0.7148;BREAST CANCER#0.7077;CANCER CELL#0.6892;PANCREATIC CANCER#0.6644
10614	SMALL NUCLEAR RNA#1.0513;P-TEFB COMPLEX#1.0503;RNA BINDING#1.0488;ACETAMIDE#1.0466;BREAST CANCER#1.0260;KINASE ACTIVITY#1.0247;TRANSCRIPTION FACTOR#1.0188;GENE EXPRESSION#1.0080;GROWTH FACTOR#0.9747;CYCLIN DEPENDENT KINASE#0.9429;SMALL NUCLEAR RIBONUCLEOPROTEIN#0.9367;ENDOTHELIAL GROWTH FACTOR#0.9266;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9266;TUMOR SUPPRESSOR#0.8985;HUMAN IMMUNODEFICIENCY VIRUS#0.8970;CANCER CELL#0.8805;RIBONUCLEOPROTEIN COMPLEX#0.8723;HYPOXIA#0.8606;C TERMINAL DOMAIN#0.8557;T CELL#0.8511;CARDIOMYOCYTE#0.8437;CELL PROLIFERATION#0.8410;SKELETAL MUSCLE#0.8048;TRANSACTIVATION#0.8011;PROSTATE CANCER#0.7993;CELL GROWTH#0.7699;ANGIOGENESIS#0.7645;KINASE INHIBITOR#0.7507;GLUCOCORTICOID RECEPTOR#0.7386;CELL DIFFERENTIATION#0.6984;RNA BINDING PROTEIN#0.6853;HYPOXIA INDUCIBLE FACTOR#0.6828;ACUTE MYELOID LEUKEMIA#0.6597;MYELOID LEUKEMIA#0.6586;CELL CYCLE#0.6542;CYTOPLASM#0.6541;SPECKLE DOMAIN#0.6477;ARGININE#0.6195;CELL PENETRATING PEPTIDE#0.6184;MUSCLE CELL#0.6122;NUCLEAR LOCALIZATION SIGNAL#0.6099;STEM CELL#0.6097;METASTATIC BREAST CANCER#0.6056;APOPTOSIS#0.6006
10615	MITOTIC SPINDLE#1.0854;MICROTUBULE#1.0679;KINETOCHORE#1.0587;BREAST CANCER#1.0351;CELL CYCLE#1.0316;MICROTUBULE ASSOCIATED PROTEIN#1.0078;HEPATOCELLULAR CARCINOMA#0.9976;SPINDLE POLE#0.9825;CANCER CELL#0.9778;APOPTOSIS#0.9761;CELL PROLIFERATION#0.9628;MITOSIS#0.9380;LYMPH NODE#0.9149;CHROMOSOME SEGREGATION#0.9065;CERVICAL CANCER#0.9050;CELL DEATH#0.9041;SERTOLI CELL#0.8980;CENTROSOME#0.8480;AMNIOTIC FLUID#0.8232;SIGNALING PATHWAY#0.8150;GENE EXPRESSION#0.8092;SPINDLE MICROTUBULE#0.7804;CELL DIVISION#0.7750;AKT SIGNALING#0.7476;CERVICAL#0.7416;SPINDLE ASSEMBLY#0.7331;SPERM TAIL#0.7297;ONCOGENIC#0.7238;DISEASE FREE SURVIVAL#0.7212;LYMPH NODE METASTASIS#0.7208;BLADDER UROTHELIAL CARCINOMA#0.7172;LUNG CANCER#0.7170;CHROMATID#0.7039;T CELL#0.6790;MICROTUBULE BINDING#0.6733;CELL GROWTH#0.6597;MICROTUBULE PLUS END#0.6410;QUANTITATIVE REAL TIME#0.6386;SPINDLE ASSEMBLY CHECKPOINT#0.6335;METAPHASE#0.6293;DYNEIN#0.6169;LUNG ADENOCARCINOMA#0.6097;OVARIAN CANCER#0.6056;APOPTOTIC#0.6051;ENDOPLASMIC RETICULUM#0.6037
10616	PROTEIN KINASE#1.0581;UBIQUITIN#1.0540;PROTEIN KINASE C#0.9383;SIGNALING PATHWAY#0.8704;ESTROGEN RECEPTOR#0.8677;DNA BINDING#0.8257;TRANSCRIPTION FACTOR#0.8141;BREAST CANCER#0.8092;CELL DEATH#0.7829;POLYUBIQUITIN#0.7821;MYOPATHY#0.7658;IRON REGULATORY PROTEIN#0.7079;CANCER CELL#0.7055;PROTEIN KINASE C BINDING#0.6926;TUMOR NECROSIS FACTOR#0.6346;PKCBETA#0.6238;NUCLEAR EXPORT#0.6168;BREAST CANCER CELL#0.6076;T CELL#0.6020
10617	DEUBIQUITINATING ENZYME#1.0870;ENDOSOME#1.0457;UBIQUITIN#1.0406;DEUBIQUITINATION#1.0368;CELL SURFACE#0.9956;GROWTH FACTOR#0.9437;POLYUBIQUITIN#0.9093;MICROCEPHALY#0.8581;GROWTH FACTOR RECEPTOR#0.8479;EARLY ENDOSOME#0.8274;EPIDERMAL GROWTH FACTOR#0.8199;DEUBIQUITINASE#0.7921;LYSOSOME#0.7620;SIGNAL TRANSDUCTION#0.7486;LATE ENDOSOME#0.7416;ENDOCYTOSIS#0.7350;ESCRT III COMPLEX#0.6771;SIGNALING PATHWAY#0.6470;INTRACELLULAR SIGNAL TRANSDUCTION#0.6315
106182249	LUNG CANCER#0.7463;CELL CYCLE#0.7437
10618	TRANS GOLGI NETWORK#1.0282;RECYCLING ENDOSOME#1.0226;EARLY ENDOSOME#1.0197;LATE ENDOSOME#1.0155;ENDOSOME#1.0135;CELL SURFACE#1.0092;GOLGI APPARATUS#1.0072;GOLGI COMPLEX#1.0070;TRANSFERRIN RECEPTOR#1.0029;PLASMA MEMBRANE#1.0003;ENDOPLASMIC RETICULUM#0.9876;SECRETORY PATHWAY#0.9752;ORGANELLE#0.9687;LYSOSOME#0.9402;CYTOPLASM#0.9285;GOLGI STACK#0.9101;MICROTUBULE#0.9031;EXOCYTIC VESICLE#0.8410;ENDOCYTOSIS#0.8326;BUDDING#0.8191;NOCODAZOLE#0.8173;EPITHELIAL CELL#0.8169;GOLGI MEMBRANE#0.8128;PROTEIN TRANSPORT#0.7651;ENDOCYTIC RECYCLING#0.7446;ADAPTIN#0.7433;GOLGI CISTERNAE#0.7379;ALPHA-MANNOSIDASE II#0.7302;INTRACELLULAR MEMBRANE#0.7288;SECRETORY GRANULE#0.7250;CLATHRIN ADAPTOR#0.7205;CELL BODY#0.7181;ALPHA MANNOSIDASE#0.7110;COATED VESICLE#0.7085;TRANSPORT VESICLE#0.7076;VESICULAR STOMATITIS VIRUS#0.7020;LUMINAL#0.6936;INTRACELLULAR VESICLE#0.6908;GTP BINDING#0.6834;PROTEIN COMPLEX#0.6683;VIRION#0.6640;MEMBRANE TRANSPORT#0.6615;NEUROENDOCRINE CELL#0.6279;CELL DIVISION#0.6112;CELL JUNCTION#0.6053
10620	OVARIAN CANCER#1.0561;CANCER CELL#1.0104;OVARIAN#0.9161;TRANSCRIPTION FACTOR#0.9139;BREAST CANCER CELL#0.7983;BREAST CANCER#0.7637;DNA BINDING#0.7554;GENE EXPRESSION#0.7472;NEUROBLASTOMA#0.6640;APOPTOSIS#0.6617;B CELL#0.6598;STEM CELL#0.6581;MOUSE EMBRYONIC FIBROBLAST#0.6400;CELL DEATH#0.6263
10622	PLURIPOTENT STEM CELL#0.9812;STEM CELL#0.9729
10623	DNA UNWINDING#0.6391
10625	PLASMACYTOMA#0.9920;B CELL#0.9907;CELL SURFACE#0.9686;INFLUENZA A VIRUS#0.9678;LYMPH NODE#0.9669;PERIPHERAL BLOOD#0.9628;T CELL#0.9351;CELL FUSION#0.9169;GROWTH FACTOR#0.8949;TUMOR CELLS#0.8923;NEURITE OUTGROWTH#0.8848;GENE EXPRESSION#0.8694;T LYMPHOCYTE#0.8630;CYTOTOXICITY#0.8432;DNA REPLICATION#0.8420;NERVOUS SYSTEM#0.8416;B LYMPHOCYTE#0.8289;MACROPHAGE#0.8249;ASCITES#0.8232;BONE MARROW#0.8169;NEURITE#0.7954;APOPTOSIS#0.7936;SERUM ALBUMIN#0.7593;POLYMERASE CHAIN REACTION#0.7593;CANCER CELL#0.7588;CELL GROWTH#0.7446;IGM ANTIBODY#0.7404;PERIPHERAL BLOOD LYMPHOCYTES#0.7310;CELL SURFACE ANTIGEN#0.7253;MYELOMAS#0.7128;SQUAMOUS CELL CARCINOMA#0.7062;MONOCYTE#0.7021;IMMUNE RESPONSE#0.7002;B CELL LYMPHOMA#0.6905;MRNA SPLICING#0.6812;DODECYL SULFATE#0.6793;SODIUM DODECYL SULFATE#0.6793;LOW DENSITY LIPOPROTEIN#0.6648;CELL PROLIFERATION#0.6502;EPSTEIN BARR VIRUS#0.6333;ADENOCARCINOMA#0.6330;VIRAL GENOME#0.6327;RETINOIC ACID#0.6290;NERVE GROWTH FACTOR#0.6260;VIRAL DNA REPLICATION#0.6218;PLASMA MEMBRANE#0.6178;CYTOPLASM#0.6098;RNA BINDING#0.6064;HOST CELL#0.6050;S PHASE#0.6044;LYMPHOID CELL#0.6009
10626	CANCER CELL#1.0773;CELL MIGRATION#0.9523;AUTOPHAGY#0.9424;NEUROBLASTOMA#0.9144;CELL GROWTH#0.8522;BREAST CANCER#0.8196;GENE EXPRESSION#0.7840;SQUAMOUS CELL CARCINOMA#0.7766;BREAST CANCER CELL#0.7613;KERATINOCYTE#0.7526;CELL CYCLE#0.7158;DNA BINDING#0.7022;UBIQUITIN#0.6837;CELL PROLIFERATION#0.6717;SIGNALING PATHWAY#0.6534;LUNG CANCER#0.6504;CASPASE-2 ACTIVITY#0.6387;EPITHELIAL MESENCHYMAL TRANSITION#0.6359;VEMURAFENIB#0.6203;LYMPH NODE METASTASIS#0.6199;GALECTIN#0.6178;LYMPH NODE#0.6151
10627	REGULATORY LIGHT CHAIN#0.9426;T CELL#0.6449
10628	THIOREDOXIN ACTIVITY#1.0941;CARBOHYDRATE RESPONSE ELEMENT BINDING#1.0820;VITAMIN D3#1.0625;MESANGIAL CELL#1.0535;BETA CELL#1.0445;GLUCOSE UPTAKE#1.0426;NADPH OXIDASE#1.0387;VERAPAMIL#1.0340;TUMOR SUPPRESSOR#1.0338;NLRP3 INFLAMMASOME ACTIVATION#1.0325;DIABETIC RETINOPATHY#1.0301;GLUCOSE METABOLISM#1.0281;AUTOPHAGY#1.0259;CARDIOMYOCYTE#1.0243;ENDOPLASMIC RETICULUM STRESS#1.0237;BREAST CANCER#1.0214;DIABETIC NEPHROPATHY#1.0201;HEPATOCELLULAR CARCINOMA#1.0196;MACROPHAGE#1.0193;CELL GROWTH#1.0167;INSULIN SECRETION#1.0156;HYPOXIA#1.0155;ENDOTHELIAL CELL#1.0140;PODOCYTE#1.0139;NEPHROPATHY#1.0136;PALMITATE#1.0130;ISCHEMIA#1.0121;LIPID METABOLISM#1.0120;PROTEIN KINASE#1.0110;CELL PROLIFERATION#1.0106;HYPERGLYCEMIA#1.0094;GLYCOLYSIS#1.0094;SKELETAL MUSCLE#1.0093;CELLULAR OXIDATIVE STRESS#1.0082;ANGIOGENESIS#1.0078;CELL CYCLE#1.0068;CANCER CELL#1.0054;ENDOPLASMIC RETICULUM#1.0024;STREPTOZOTOCIN#1.0022;APOPTOSIS#1.0017;POLYMERASE CHAIN REACTION#1.0015;APOPTOTIC#1.0011;MITOGEN ACTIVATED PROTEIN#1.0005;GLUCOSE HOMEOSTASIS#1.0003;REVERSE TRANSCRIPTION#0.9997;EPITHELIAL CELL#0.9980;INFLAMMATORY RESPONSE#0.9977;FRUCTOSE#0.9977;GROWTH FACTOR#0.9970;CELL DEATH#0.9957;RESVERATROL#0.9951;HISTONE DEACETYLASE#0.9951;HUMAN UMBILICAL VEIN#0.9949;UMBILICAL VEIN#0.9947;ROS GENERATION#0.9943;SENESCENCE#0.9938;SIGNALING PATHWAY#0.9934;ISCHEMIA REPERFUSION INJURY#0.9932;NITRIC OXIDE#0.9924;PRO-INFLAMMATORY#0.9924;HIGH FAT DIET#0.9924;DIABETES MELLITUS#0.9906;CELL CYCLE ARREST#0.9905;MITOCHONDRIA#0.9901;TRANSCRIPTION FACTOR#0.9899;TYPE 1 DIABETES#0.9894;ADIPOSE TISSUE#0.9892;REACTIVE OXYGEN SPECIES#0.9887;GLUTATHIONE#0.9873;SUPEROXIDE DISMUTASE#0.9863;TYPE 2 DIABETES#0.9842;GENE EXPRESSION#0.9826;UBIQUITIN#0.9826;T CELL#0.9771;TUMOR NECROSIS FACTOR#0.9700;IL-1 SECRETION#0.9692;PROTEASOME#0.9661;DNA METHYLATION#0.9632;QUANTITATIVE REAL TIME#0.9531;BREAST CANCER CELL#0.9521;ARTERY#0.9499;LIVER DISEASE#0.9483;IL-1 PRODUCTION#0.9475;METFORMIN#0.9465;CLEAVED CASPASE 3#0.9460;NUCLEOTIDE BINDING#0.9458;STEM CELL#0.9456;PERIPHERAL BLOOD#0.9451;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9408;ENDOTHELIAL GROWTH FACTOR#0.9407;HYPOXIA INDUCIBLE FACTOR#0.9403;RNA INTERFERENCE#0.9383;N-ACETYLCYSTEINE#0.9382;UMBILICAL VEIN ENDOTHELIAL CELLS#0.9351;PANCREATIC CANCER#0.9308;TYPE 2 DIABETES MELLITUS#0.9290;2 DIABETES MELLITUS#0.9290;PLASMA MEMBRANE#0.9257;CALCIUM CHANNEL#0.9211;RESPONSE TO GLUCOSE#0.9186;HEPATOCELLULAR CARCINOMA CELL#0.9153;PEROXISOME#0.9153;PROTEIN SYNTHESIS#0.9134;NEURODEGENERATIVE DISEASE#0.9082;NEURONAL CELLS#0.9068;PANCREATIC ISLET#0.9010;B CELL#0.8954;BETA CELL MASS#0.8951;IMMUNE RESPONSE#0.8895;LUNG CANCER#0.8885;TOXICITY#0.8855;QUERCETIN#0.8854;GENE SILENCING#0.8826;FATTY LIVER#0.8823;CASPASE-1 ACTIVITY#0.8753;HIGH GLUCOSE LEVEL#0.8739;MAPK SIGNALING#0.8733;CELL ADHESION#0.8705;MYOCARDIAL INFARCTION#0.8696;CYTOPLASM#0.8694;CYTOTOXICITY#0.8666;PYROPTOSIS#0.8661;ATHEROSCLEROSIS#0.8652;HEME OXYGENASE 1#0.8647;SIGNALING MOLECULE#0.8638;TRANSFORMING GROWTH FACTOR#0.8584;HYPERGLYCEMIC#0.8584;SIGNAL TRANSDUCTION#0.8577;ACETYLCYSTEINE#0.8554;ADIPOCYTE#0.8517;PROSTATE CANCER#0.8505;MAP KINASE#0.8499;IMPAIRED GLUCOSE TOLERANCE#0.8481;ADENOCARCINOMA#0.8452;CEREBRAL ARTERY OCCLUSION#0.8424;FATTY LIVER DISEASE#0.8419;HISTONE DEACETYLASE INHIBITOR#0.8416;MIDDLE CEREBRAL ARTERY#0.8410;TYPE 2 DIABETIC#0.8408;CEREBRAL ARTERY#0.8407;KIDNEY DISEASE#0.8372;MUSCLE CELL#0.8339;TARGET OF RAPAMYCIN#0.8309;CELL MIGRATION#0.8238;DNA BINDING#0.8234;ALZHEIMER'S DISEASE#0.8228;NERVOUS SYSTEM#0.8209;BONE MARROW#0.8208;GLUCOCORTICOID RECEPTOR#0.8201;RAPAMYCIN#0.8106;CARDIOMYOPATHY#0.8093;PYRUVATE#0.8075;REGULATION OF AMPK#0.8073;KINASE INHIBITOR#0.8069;EXTRACELLULAR MATRIX#0.8052;ADENOSINE#0.8037;PROTEASOME PATHWAY#0.8024;MITOPHAGY#0.8019;NEUROTOXICITY#0.8002;MYOCARDIUM#0.7986;GLUTAMINE#0.7972;POLY ADP RIBOSE#0.7964;PROTEIN COMPLEX#0.7951;HEAT SHOCK PROTEIN#0.7949;MONONUCLEAR CELLS#0.7922;TUMOR CELLS#0.7907;GANGLION CELLS#0.7871;ENERGY HOMEOSTASIS#0.7817;CASPASE-3 ACTIVITY#0.7811;AMPK ACTIVITY#0.7798;IMMUNE CELL#0.7796;ADVANCED GLYCATION END#0.7779;MITOCHONDRIAL MEMBRANE#0.7742;SMOOTH MUSCLE#0.7742;GLUCOSE SENSING#0.7691;PROTEIN DEFICIENCY#0.7683;ACUTE LUNG INJURY#0.7654;CORONARY ARTERY#0.7593;GLUTATHIONE PEROXIDASE#0.7583;PROTEASOME DEGRADATION#0.7534;OBESE#0.7524;OXYGENASE#0.7466;LIVER REGENERATION#0.7455;LEUKOCYTE#0.7426;ASCORBIC ACID#0.7410;HUMAN BREAST CANCER#0.7403;UNFOLDED PROTEIN RESPONSE#0.7380;TOLL LIKE RECEPTOR#0.7371;ADENINE#0.7331;CYTOCHROME C#0.7329;HISTONE ACETYLATION#0.7285;2-DEOXYGLUCOSE#0.7277;OOCYTE#0.7253;FATTY ACID SYNTHASE#0.7238;CELL ADHESION MOLECULE#0.7220;NITRIC OXIDE SYNTHASE#0.7211;CELL DIFFERENTIATION#0.7208;MICROVASCULAR ENDOTHELIAL CELL#0.7201;HEMATOPOIETIC CELL#0.7168;SMOOTH MUSCLE CELL#0.7145;ESTRADIOL#0.7116;MONOCYTE#0.7099;L-CYSTEINE#0.7082;TUBE FORMATION#0.7069;THIOREDOXIN REDUCTASE 1#0.7065;CEREBRAL ISCHEMIA#0.7048;DIABETIC KIDNEY DISEASE#0.7045;NEUROBLASTOMA#0.7045;RIBOSE#0.7041;ATHEROSCLEROTIC#0.7036;HEMATOPOIETIC STEM CELL#0.7031;MOUSE MESANGIAL CELLS#0.7010;GLUCOSE-6-PHOSPHATE#0.7001;ALLOPURINOL#0.6964;AKT SIGNALING#0.6948;PROTEIN PROTEIN INTERACTION#0.6941;EARLY BRAIN INJURY#0.6922;ONCOGENIC#0.6913;LIPOGENESIS#0.6908;CELLULAR SENESCENCE#0.6901;NEUTROPHIL#0.6889;TELMISARTAN#0.6862;VASCULAR CELL#0.6853;OXIDATIVE STRESS RESPONSE#0.6836;ALANINE#0.6835;CYTOKINE PRODUCTION#0.6822;OXIDATIVE PHOSPHORYLATION#0.6799;REACTIVE OXYGEN SPECIES GENERATION#0.6783;LACTIC ACIDOSIS#0.6781;LYSOSOME#0.6753;CELLULAR METABOLISM#0.6752;NUCLEAR EXPORT#0.6748;FATTY ACID OXIDATION#0.6733;GESTATIONAL DIABETES#0.6720;RENAL CELL CARCINOMA#0.6689;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.6675;NEUROPATHY#0.6674;BREAST CANCER PATIENTS#0.6626;ENDOTHELIUM#0.6614;NUCLEIC ACID#0.6510;ALCOHOLIC FATTY LIVER#0.6505;BLOOD GLUCOSE LEVEL#0.6470;VASCULAR DISEASE#0.6470;BINDING PROTEIN 1#0.6465;TUMOR TISSUES#0.6451;MITOCHONDRIAL MEMBRANE POTENTIAL#0.6451;SIGNALING CASCADE#0.6447;CYCLIN DEPENDENT KINASE#0.6442;ESTROGEN RECEPTOR#0.6422;QUIESCENCE#0.6359;FAMILIAL COMBINED HYPERLIPIDEMIA#0.6340;HYPOXIC#0.6304;LYSINE#0.6296;DIET INDUCED OBESITY#0.6296;FENOFIBRATE#0.6282;STEROL REGULATORY ELEMENT#0.6261;HEART DISEASE#0.6257;RESPONSE TO OXIDATIVE STRESS#0.6241;EPITHELIAL TO MESENCHYMAL TRANSITION#0.6240;EPITHELIAL TO MESENCHYMAL#0.6238;GLIAL CELL#0.6236;CORONARY ARTERY DISEASE#0.6235;ARTERY DISEASE#0.6233;OF DIABETIC RATS#0.6224;MELATONIN#0.6209;COMPLEX I#0.6202;NICOTINAMIDE ADENINE DINUCLEOTIDE#0.6195;KINASE ACTIVITY#0.6190;OSTEOCLAST#0.6182;HYPERTENSION#0.6173;NUTRIENT SENSING#0.6150;GLUCONEOGENESIS#0.6127;REDOX ACTIVITY#0.6071;PYRUVATE KINASE#0.6063;1α,25-DIHYDROXYVITAMIN D3#0.6060;SCIATIC NERVE#0.6022;VASCULAR ENDOTHELIAL CADHERIN#0.6012;REGULATION OF CELLULAR#0.6008
1062	MICROTUBULE CAPTURE#1.1091;CHROMOSOME CONGRESSION#1.0634;KINESIN#1.0559;DYNEIN#1.0472;KINETOCHORE#1.0415;CENTROMERE#1.0402;KINETOCHORE MICROTUBULE#1.0394;MITOTIC CHECKPOINT#1.0223;SPINDLE CHECKPOINT#1.0152;METAPHASE#1.0133;SPINDLE MICROTUBULE#1.0122;MICROTUBULE MOTOR#1.0095;KINETOCHORE LOCALIZATION#1.0064;MICROTUBULE#1.0059;CELL CYCLE#1.0044;ANAPHASE#0.9996;SPINDLE ASSEMBLY#0.9960;CHROMOSOME MOVEMENT#0.9960;MITOSIS#0.9915;KINETOCHORE-MICROTUBULE ATTACHMENT#0.9899;CHROMOSOME SEGREGATION#0.9895;MICROTUBULE PLUS END#0.9854;MITOTIC SPINDLE#0.9812;SPINDLE EQUATOR#0.9788;CANCER CELL#0.9722;CELL DIVISION#0.9664;SPINDLE POLE#0.9628;SPINDLE ASSEMBLY CHECKPOINT#0.9609;SPINDLE MIDZONE#0.9510;MICROTUBULE END#0.9266;MICROTUBULE BINDING#0.9266;GENE EXPRESSION#0.9145;KINASE ACTIVITY#0.8908;KINETOCHORE BINDING#0.8807;PROTEIN KINASE#0.8646;CHROMATID#0.8630;MITOTIC CHROMOSOME#0.8447;CYTOKINESIS#0.8321;KINETOCHORE ASSEMBLY#0.8284;CENTRAL SPINDLE#0.8271;MOTOR ACTIVITY#0.8186;METAPHASE PLATE#0.8148;RNA INTERFERENCE#0.8101;MEIOSIS#0.8095;METAPHASE CHROMOSOME#0.7987;INTERPHASE#0.7961;OOCYTE#0.7894;KINETOCHORE MICROTUBULE INTERACTION#0.7478;BREAST CANCER#0.7474;MEIOSIS I#0.7462;CENTROSOME#0.7420;MICROTUBULE DYNAMICS#0.7417;APOPTOSIS#0.7415;SPINDLE FORMATION#0.7388;TELOPHASE#0.7269;LUNG CANCER#0.7095;TRANSFERASE INHIBITOR#0.6967;PROPHASE#0.6923;CELL CYCLE ARREST#0.6783;SPINDLE ELONGATION#0.6426;FARNESYL#0.6383;MEIOSIS II#0.6327;MIDBODY#0.6320;ADENOCARCINOMA#0.6250;TUMOR SUPPRESSOR#0.6217;PROTEIN PROTEIN INTERACTION#0.6083;MRNA SPLICING#0.6013
10630	FIBROBLASTIC RETICULAR CELLS#1.0649;GERM CELL#1.0522;PROLYL 4-HYDROXYLASE#1.0506;GERM CELL TUMORS#1.0503;HYALURONAN#1.0444;PODOCYTE#1.0425;O GLYCAN#1.0413;BASAL CELL#1.0406;PLATELET AGGREGATION#1.0400;CELL MOTILITY#1.0378;KERATINOCYTE#1.0334;ORAL SQUAMOUS CELL CARCINOMA#1.0331;PLATELET ACTIVATION#1.0320;SMOOTH MUSCLE ACTIN#1.0297;MYOEPITHELIAL CELL#1.0294;BREAST CARCINOMA#1.0277;CANCER ASSOCIATED FIBROBLASTS#1.0271;SALIVARY GLAND#1.0271;AMELOBLASTOMA#1.0261;CELL MIGRATION#1.0246;LUNG ADENOCARCINOMA#1.0238;LUNG SQUAMOUS CELL CARCINOMA#1.0227;EPIDERMAL GROWTH FACTOR#1.0215;STEM CELL MARKER#1.0212;MESOTHELIAL CELL#1.0189;LECTIN#1.0186;CELL SURFACE#1.0179;GROWTH FACTOR RECEPTOR#1.0170;FACTOR VIII#1.0169;OSTEOCYTE#1.0168;LYMPHATIC ENDOTHELIAL CELL#1.0159;FOLLICULAR DENDRITIC CELL#1.0146;PLASMA MEMBRANE#1.0146;ENDOTHELIUM#1.0133;ORAL CAVITY#1.0132;VASCULAR ENDOTHELIAL CELL#1.0112;LYMPHATIC VESSEL DENSITY#1.0111;SMOOTH MUSCLE#1.0100;EPITHELIAL MESENCHYMAL TRANSITION#1.0067;GLYCOSYLATION#1.0064;LYMPH NODE METASTASES#1.0062;EXTRACELLULAR MATRIX#1.0051;CARDINAL VEIN#1.0051;STROMAL CELL#1.0035;LYMPHATIC VESSEL#1.0030;CELL ADHESION#1.0029;CELL MEMBRANE#1.0029;EPITHELIAL CELL#1.0022;SQUAMOUS CELL CARCINOMA#1.0022;ALVEOLAR TYPE I#1.0005;OVARIAN#1.0002;ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY#0.9999;ENDOTHELIAL CELL#0.9999;CANCER CELL#0.9982;ENDOTHELIAL GROWTH FACTOR#0.9979;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9979;STROMA#0.9976;BREAST CANCER#0.9972;TRANSCRIPTION FACTOR#0.9965;CELL PROLIFERATION#0.9960;MALIGNANT MESOTHELIOMA#0.9958;OSTEOBLAST#0.9951;MACROPHAGE#0.9942;DENDRITIC CELL#0.9939;SEMINOMA#0.9938;CERVICAL#0.9937;ADENOCARCINOMA#0.9934;TUMOR CELLS#0.9932;MESENCHYMAL CELL#0.9927;NERVOUS SYSTEM#0.9924;COLORECTAL#0.9920;LYMPHATIC SYSTEM#0.9913;LYMPHOID ORGANS#0.9913;CANCER STEM CELL#0.9896;HUMAN IMMUNODEFICIENCY VIRUS#0.9893;GROWTH FACTOR#0.9887;POLYMERASE CHAIN REACTION#0.9877;THYROID TRANSCRIPTION FACTOR#0.9872;SIGNALING PATHWAY#0.9868;STEM CELL#0.9866;DISEASE FREE SURVIVAL#0.9863;TUMOR TISSUES#0.9856;HEAD AND NECK SQUAMOUS CELL CARCINOMA#0.9851;VASCULAR ENDOTHELIUM#0.9846;LYMPHATIC MICROVESSEL DENSITY#0.9832;CHOROID PLEXUS#0.9826;BLOOD VESSEL#0.9824;THROMBOSIS#0.9819;TRANSFORMING GROWTH FACTOR#0.9818;T CELL#0.9813;WOUND HEALING#0.9804;LYMPH NODE METASTASIS#0.9798;MYOFIBROBLAST#0.9797;PROGENITOR CELL#0.9791;REGIONAL LYMPH NODE#0.9790;APOPTOSIS#0.9762;GENE EXPRESSION#0.9759;LYMPHANGIOGENESIS#0.9752;TUMOR ASSOCIATED MACROPHAGE#0.9747;RENAL CELL CARCINOMA#0.9738;LUNG CANCER#0.9734;ANGIOGENESIS#0.9727;COLORECTAL CANCER#0.9725;B CELL#0.9717;CELL GROWTH#0.9699;LYMPHANGIOMA#0.9697;LYMPH NODE#0.9691;IMMUNE CELL#0.9674;TUBE FORMATION#0.9650;LUNG METASTASIS#0.9650;CELL DIFFERENTIATION#0.9631;BONE MARROW#0.9605;QUANTITATIVE REAL TIME#0.9599;AGGRESSIVE BEHAVIOR#0.9580;CYTOPLASM#0.9573;CONNECTIVE TISSUE#0.9569;CELL ADHESION MOLECULE#0.9552;IMMUNE RESPONSE#0.9547;ALVEOLAR EPITHELIAL CELL#0.9538;EOSIN#0.9524;VIRION#0.9490;ANGIOSARCOMA#0.9482;PLATELET-DERIVED GROWTH FACTOR#0.9477;ESTROGEN RECEPTOR#0.9464;FORMALIN#0.9455;LYMPHEDEMA#0.9443;DISEASE SPECIFIC SURVIVAL#0.9431;FIBROBLAST GROWTH FACTOR#0.9385;CENTRAL NERVOUS SYSTEM#0.9376;RHEUMATOID ARTHRITIS#0.9301;HEMANGIOMA#0.9299;TH17 CELL#0.9283;OVARIAN CARCINOMA#0.9282;CYTOTOXICITY#0.9257;GLOMERULAR EPITHELIAL CELL#0.9247;STATISTICALLY SIGNIFICANT DIFFERENCE#0.9227;REVERSE TRANSCRIPTION#0.9223;CERVICAL CANCER#0.9193;LUNG CARCINOMA#0.9166;FIBROBLAST ACTIVATION#0.9149;MONOCYTE#0.9133;KAPOSI'S SARCOMA#0.9095;INFLAMMATORY CELL#0.9095;RENAL GLOMERULUS#0.9083;LUMINAL#0.9060;CLEAR CELL RENAL CELL CARCINOMA#0.9056;PARENCHYMA#0.9032;PERICYTE#0.9010;COMPLEMENT DEPENDENT CYTOTOXICITY#0.8995;DERMIS#0.8991;LEUKOCYTE#0.8989;LYMPHOID TISSUE#0.8971;SURFACE PLASMON RESONANCE#0.8917;MUSCLE CELL#0.8906;LUNG DEVELOPMENT#0.8865;CHEMOKINE RECEPTOR#0.8864;RECURRENCE FREE SURVIVAL#0.8839;SMOOTH MUSCLE CELL#0.8835;MICROVASCULAR ENDOTHELIAL CELL#0.8826;MALIGNANT PLEURAL MESOTHELIOMA#0.8803;LYMPH NODE INVOLVEMENT#0.8789;CILIARY BODY#0.8789;LYMPH NODE DISSECTION#0.8772;BASAL CELL CARCINOMA#0.8740;PROTEINURIA#0.8736;INVASIVE BREAST CANCER#0.8730;ALKALINE PHOSPHATASE#0.8723;PROTEIN KINASE#0.8717;INVASIVE CARCINOMA#0.8714;MYOCARDIUM#0.8714;OVARIAN CANCER#0.8706;PERIPHERAL NERVE#0.8635;GLOMERULUS#0.8634;PROGESTERONE#0.8613;EPITHELIAL TO MESENCHYMAL#0.8611;GESTATION#0.8585;ADENOCARCINOMA IN SITU#0.8559;PANCREATIC CANCER#0.8543;TUMOR NECROSIS FACTOR#0.8525;CARCINOMA IN SITU#0.8513;SYNOVIUM#0.8495;HEAD AND NECK CANCER#0.8478;NECK CANCER#0.8477;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.8461;TUMOR NODE METASTASIS#0.8446;PLEURA#0.8413;PERITONEUM#0.8381;BLOOD VESSEL INVASION#0.8369;EMBRYONAL CARCINOMA#0.8368;CANCER SPECIFIC SURVIVAL#0.8314;PERIPHERAL BLOOD#0.8313;OVERALL SURVIVAL RATE#0.8312;HYPOXIA#0.8309;BASEMENT MEMBRANE#0.8278;LARYNGEAL CARCINOMA#0.8270;NEUROFIBROMA#0.8265;METASTATIC CARCINOMA#0.8207;NODULAR#0.8206;IL-17 SECRETION#0.8194;EDEMA#0.8169;POSITRON EMISSION TOMOGRAPHY#0.8148;CELL SURFACE ANTIGEN#0.8105;AQUAPORIN#0.8102;BREAST CANCER CELL#0.8059;HEMATOPOIETIC CELL#0.8056;FOLATE#0.8024;TONGUE CANCER#0.8013;INSULIN-LIKE GROWTH FACTOR#0.8011;ESOPHAGEAL CANCER#0.7983;SENTINEL LYMPH NODE#0.7906;TRANSMEMBRANE RECEPTOR#0.7833;TRANSMISSION ELECTRON MICROSCOPY#0.7821;ALVEOLAR MACROPHAGE#0.7775;INFLAMMATORY RESPONSE#0.7773;GROWTH PATTERN#0.7765;BREAST CANCER PATIENTS#0.7757;YEAR SURVIVAL RATE#0.7749;METASTATIC LYMPH NODE#0.7728;SUBLINGUAL GLAND#0.7667;METASTATIC ADENOCARCINOMA#0.7656;RESPIRATORY FAILURE#0.7612;MONONUCLEAR CELLS#0.7596;MYELOID CELL#0.7590;ORAL MUCOSA#0.7562;MALIGNANT GLIOMA#0.7546;MESOTHELIOMA CELL#0.7537;SKIN CANCER#0.7535;SEBACEOUS GLAND#0.7504;BLOOD VESSEL ENDOTHELIUM#0.7476;BACTERIAL ARTIFICIAL CHROMOSOME#0.7468;FETAL LIVER#0.7466;TRANSFORMING GROWTH FACTOR BETA#0.7465;HEMOSTASIS#0.7459;EPITHELIAL TO MESENCHYMAL TRANSITION#0.7453;VIRAL ENVELOPE#0.7444;ATHEROSCLEROTIC#0.7438;SARCOMATOID MESOTHELIOMA#0.7416;COLORECTAL CARCINOMA#0.7381;BUDDING#0.7379;URINARY BLADDER#0.7366;CELL CYCLE#0.7365;FIBROBLAST ACTIVATION PROTEIN#0.7345;LYMPH VESSEL DENSITY#0.7338;DENTATE GYRUS#0.7321;THYROID CANCER#0.7314;WILMS TUMOR 1#0.7311;SYNOVIAL SARCOMA#0.7308;BLOOD VESSEL DENSITY#0.7303;IMMUNE SYSTEM#0.7279;GALECTIN#0.7267;EFFECTOR T CELL#0.7236;LUNG EPITHELIAL CELL#0.7216;REGENERATION#0.7192;CD4+ T CELL#0.7178;HEPATITIS B#0.7153;HUMAN BREAST CANCER#0.7134;METASTASIS TO LYMPH NODE#0.7099;NEUTROPHIL#0.7098;ERYTHROCYTE#0.7081;UMBILICAL VEIN#0.7076;SINUS VENOSUS#0.6995;PULMONARY VEIN#0.6963;VENULE#0.6951;ASTROCYTE#0.6951;OPTIC NERVE#0.6938;TUMOR SUPPRESSOR#0.6930;CHONDROCYTE#0.6929;CERVICAL LYMPH NODE#0.6884;EPITHELIOID SARCOMA#0.6862;FOLATE BINDING#0.6851;FLOW CYTOMETRY ANALYSIS#0.6840;MEDIASTINAL LYMPH NODE#0.6814;SECONDARY LYMPHOID ORGANS#0.6798;APICAL PLASMA MEMBRANE#0.6788;DERMAL FIBROBLAST#0.6768;MRNA BINDING#0.6767;GLUTATHIONE#0.6763;ADENOID CYSTIC CARCINOMA#0.6762;MEGAKARYOCYTE#0.6756;EPENDYMAL CELL#0.6736;INVASIVE DUCTAL CARCINOMA#0.6732;REGULATORY T CELL#0.6719;B LYMPHOCYTE#0.6701;HOST CELL#0.6700;HYALURONIC ACID#0.6696;PRO-INFLAMMATORY#0.6676;DIGESTION#0.6673;T LYMPHOCYTE#0.6671;ACTIN CYTOSKELETON#0.6670;CERVIX#0.6669;KNEE JOINT#0.6666;HEPATOCELLULAR CARCINOMA#0.6608;ATYPICAL NEUROFIBROMA#0.6602;PAROTID GLAND#0.6559;HUMAN UMBILICAL VEIN#0.6545;CIRCULATING TUMOR CELL#0.6544;PROTEOGLYCAN#0.6494;COAGULATION#0.6494;CRIMEAN-CONGO HEMORRHAGIC FEVER#0.6484;DRAINING LYMPH NODE#0.6456;BINDING PROTEIN 1#0.6427;PNEUMONIA#0.6421;LIP CANCER#0.6396;CHRONIC MAXILLARY SINUSITIS#0.6396;SIGNAL TRANSDUCTION#0.6372;CHONDROSARCOMA#0.6356;TRANSDIFFERENTIATION#0.6341;MYCOSIS FUNGOIDES#0.6326;FIBROSARCOMA#0.6309;TUMOR INITIATING CELL#0.6295;MUCOUS#0.6289;ADENOMATOID TUMOR#0.6269;HEPATOCYTE GROWTH FACTOR#0.6255;MORPHOGENESIS#0.6228;FACTOR I#0.6227;METASTASIS FREE SURVIVAL#0.6227;HAIR FOLLICLE#0.6215;ENCAPSULATING PERITONEAL SCLEROSIS#0.6203;SCHWANN CELL#0.6201;MESOTHELIUM#0.6195;TOXICITY#0.6190;SEPTUM#0.6181;HEMORRHAGE#0.6175;INTERSTITIAL CELL#0.6170;GENE SILENCING#0.6141;ORAL EPITHELIAL DYSPLASIA#0.6124;MATRIX PROTEIN 1#0.6118;NEVOID BASAL CELL CARCINOMA SYNDROME#0.6107;CHOLANGIOCARCINOMA#0.6103;PIA MATER#0.6102;TOOTH DEVELOPMENT#0.6097;MESENCHYME#0.6087;CELL ACTIVATION#0.6075;ADIPOSE TISSUE#0.6071;STANDARDIZED UPTAKE VALUE#0.6056;ADIPOCYTE#0.6045;EXTRACELLULAR VESICLE#0.6033
10631	PROSTATE CANCER#1.0573;PERIOSTEUM#1.0533;COLORECTAL CANCER#1.0510;DERMAL FIBROBLAST#1.0454;LUNG CANCER#1.0454;AIRWAY EPITHELIAL CELL#1.0442;EXHALED NITRIC OXIDE#1.0393;LUNG FIBROBLASTS#1.0390;MYOFIBROBLAST DIFFERENTIATION#1.0388;CANCER ASSOCIATED FIBROBLASTS#1.0370;OVARIAN CANCER#1.0352;COLON CANCER#1.0337;BONE TURNOVER MARKER#1.0336;OSTEOBLAST DIFFERENTIATION#1.0317;CELL ADHESION MOLECULE#1.0312;LYMPH NODE METASTASIS#1.0311;KERATINOCYTE#1.0311;TISSUE REMODELING#1.0306;TISSUE GROWTH FACTOR#1.0294;COLLAGEN TYPE I#1.0276;CANCER STEM CELL#1.0264;OVARIAN#1.0262;ENDOTHELIAL GROWTH FACTOR#1.0251;VASCULAR ENDOTHELIAL GROWTH FACTOR#1.0251;LYMPH NODE#1.0249;CELL MIGRATION#1.0243;NITRIC OXIDE#1.0239;FOCAL ADHESION#1.0238;PULMONARY FIBROSIS#1.0238;WOUND HEALING#1.0237;BASEMENT MEMBRANE#1.0232;STROMA#1.0231;FOCAL ADHESION KINASE#1.0230;SMOOTH MUSCLE ACTIN#1.0227;SPUTUM#1.0227;KIDNEY DISEASE#1.0223;COLORECTAL#1.0219;MESENCHYMAL CELL#1.0215;OSTEOBLAST#1.0213;QUANTITATIVE REAL TIME#1.0211;MYOFIBROBLAST#1.0203;MACROPHAGE#1.0197;EOSINOPHIL#1.0196;TUMOR NECROSIS FACTOR#1.0190;HYPOXIA#1.0184;PANCREATIC CANCER#1.0183;EPITHELIAL MESENCHYMAL TRANSITION#1.0172;CONNECTIVE TISSUE#1.0163;SMOOTH MUSCLE CELL#1.0158;BREAST CANCER#1.0157;MUSCLE CELL#1.0146;ATOPIC DERMATITIS#1.0145;EPITHELIAL CELL#1.0140;PERIPHERAL BLOOD#1.0136;ANGIOGENESIS#1.0125;MESENCHYMAL STEM CELL#1.0118;CELL ADHESION#1.0116;IDIOPATHIC PULMONARY FIBROSIS#1.0116;OSTEOGENESIS#1.0112;PERIODONTITIS#1.0108;TRANSFORMING GROWTH FACTOR BETA#1.0108;MYOCARDIAL INFARCTION#1.0097;SMOOTH MUSCLE#1.0094;TUMOR CELLS#1.0078;TRANSFORMING GROWTH FACTOR#1.0075;SQUAMOUS CELL CARCINOMA#1.0074;CANCER CELL#1.0071;PERIODONTAL LIGAMENT#1.0069;REVERSE TRANSCRIPTION#1.0069;CHOLANGIOCARCINOMA#1.0067;CELL SURFACE#1.0066;DERMATITIS#1.0064;HEPATOCELLULAR CARCINOMA#1.0062;MESENCHYME#1.0061;HUMAN PERIODONTAL LIGAMENT#1.0061;HYPOXIC#1.0053;BLEOMYCIN#1.0053;CELL GROWTH#1.0040;APOPTOSIS#1.0039;PERIODONTAL DISEASE#1.0038;STROMAL CELL#1.0032;CARDIOMYOCYTE#1.0026;FATTY LIVER#1.0025;TRANSCRIPTION FACTOR#1.0019;ENDOTHELIAL CELL#1.0017;CELL CYCLE#1.0013;MINERALIZATION#1.0013;INFLAMMATORY CELL#1.0011;SIGNALING PATHWAY#1.0011;BONE MORPHOGENETIC PROTEIN#1.0010;POLYMERASE CHAIN REACTION#0.9995;BONE FORMATION#0.9993;T CELL#0.9985;GROWTH FACTOR#0.9983;EXTRACELLULAR MATRIX#0.9973;EXTRACELLULAR MATRIX COMPONENT#0.9971;ALKALINE PHOSPHATASE#0.9969;MYOCARDIUM#0.9968;CELL PROLIFERATION#0.9943;EXHALED BREATH CONDENSATE#0.9926;HEPATIC STELLATE CELL#0.9924;EPITHELIAL TO MESENCHYMAL TRANSITION#0.9923;EPITHELIAL TO MESENCHYMAL#0.9920;CHONDROCYTE#0.9911;NEUTROPHIL#0.9900;REGENERATION#0.9899;ADENOCARCINOMA#0.9897;BRONCHIAL EPITHELIAL CELLS#0.9892;BONE MARROW#0.9882;STEM CELL#0.9880;LIVER DISEASE#0.9875;OMALIZUMAB#0.9874;GINGIVAL CREVICULAR FLUID#0.9871;IMMUNE RESPONSE#0.9864;TISSUE REGENERATION#0.9853;AKT SIGNALING#0.9848;ACUTE MYOCARDIAL INFARCTION#0.9838;CARDIAC DEVELOPMENT#0.9836;INFLAMMATORY RESPONSE#0.9835;PROTEIN KINASE#0.9817;BREAST CANCER CELL#0.9800;ADIPOSE TISSUE#0.9797;TUBE FORMATION#0.9779;VASCULAR SMOOTH MUSCLE CELL#0.9769;PROGENITOR CELL#0.9766;BLOOD VESSEL#0.9757;ALLERGIC RHINITIS#0.9738;GROWTH FACTOR RECEPTOR#0.9720;GENE EXPRESSION#0.9714;SKELETAL MUSCLE#0.9705;BONE REMODELING#0.9704;INTRAHEPATIC CHOLANGIOCARCINOMA#0.9688;MAST CELL#0.9675;TUMOR ASSOCIATED MACROPHAGE#0.9671;SYNOVIAL FLUID#0.9648;DERMIS#0.9617;MONOCYTE#0.9616;CHRONIC KIDNEY DISEASE#0.9599;FORCED EXPIRATORY VOLUME#0.9571;AORTIC VALVE#0.9544;BONE MINERAL DENSITY#0.9532;C REACTIVE PROTEIN#0.9530;CELL DIFFERENTIATION#0.9525;OSTEOARTHRITIS#0.9523;THYROID CARCINOMA#0.9513;EOSINOPHILIC ESOPHAGITIS#0.9512;ARTERY#0.9509;DIABETIC RETINOPATHY#0.9493;GALECTIN#0.9489;OSTEOPOROSIS#0.9488;MORPHOGENESIS#0.9467;ISCHEMIA#0.9467;M2 MACROPHAGE#0.9467;BONE REGENERATION#0.9465;SIGNALLING PATHWAY#0.9460;DENTAL PULP#0.9452;RHINITIS#0.9449;OSTEOCYTE#0.9422;INTERSTITIAL CELL#0.9410;ALLERGEN#0.9353;OSTEOCLAST#0.9339;TYPE 2 DIABETES#0.9316;FIBRIL#0.9287;PROTEOGLYCAN#0.9276;LUNG ADENOCARCINOMA#0.9273;RENAL FIBROSIS#0.9255;PARATHYROID HORMONE#0.9213;ACID PHOSPHATASE#0.9193;MESENCHYMAL STROMAL CELL#0.9174;ANCHORAGE INDEPENDENT GROWTH#0.9152;SCLERODERMA#0.9136;MATRIX GLA PROTEIN#0.9134;VITAMIN K#0.9117;APOPTOTIC#0.9076;ALLERGIC ASTHMA#0.9073;PANCREATIC DUCTAL ADENOCARCINOMA#0.9058;NEPHROPATHY#0.9039;CARDIOMYOPATHY#0.9035;DRUG RESISTANCE#0.9006;PRO-INFLAMMATORY#0.9001;ORTHODONTIC TOOTH MOVEMENT#0.8972;DISEASE FREE SURVIVAL#0.8940;ADIPOCYTE#0.8931;TUMOR TISSUES#0.8927;FATTY LIVER DISEASE#0.8912;COLLAGEN SYNTHESIS#0.8896;GOBLET CELL#0.8830;EPIDERMAL GROWTH FACTOR#0.8819;SCHWANN CELL#0.8813;HEAD AND NECK CANCER#0.8775;NECK CANCER#0.8775;ESOPHAGITIS#0.8760;RNA INTERFERENCE#0.8716;B CELL#0.8709;BREAST CARCINOMA#0.8708;TISSUE DEVELOPMENT#0.8706;ASPIRIN#0.8691;SKIN DISEASE#0.8687;SPINAL CORD#0.8686;ESTROGEN RECEPTOR#0.8684;MYOCYTES#0.8676;FIBROBLAST GROWTH FACTOR#0.8666;CISPLATIN#0.8646;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.8617;RENAL CELL CARCINOMA#0.8592;BONE DEVELOPMENT#0.8559;TUMOR SUPPRESSOR#0.8552;MYOSIN HEAVY CHAIN#0.8551;DENTIN MATRIX PROTEIN#0.8539;HEMORRHAGE#0.8519;VASCULAR CELL#0.8514;HEART DISEASE#0.8493;HUMAN UMBILICAL VEIN#0.8465;MATRIX PROTEIN 1#0.8463;UMBILICAL VEIN#0.8463;SPHINGOSINE 1 PHOSPHATE#0.8457;SENSITIZATION#0.8441;MOLAR#0.8425;TIBIA#0.8421;ENDOMETRIOSIS#0.8417;UMBILICAL VEIN ENDOTHELIAL CELLS#0.8387;PNEUMONIA#0.8369;SIGNAL TRANSDUCER#0.8342;BILE DUCT#0.8339;CORONARY ARTERY#0.8339;LIVER CANCER#0.8305;BASOPHIL#0.8295;CELL DEATH#0.8292;OUTFLOW TRACT#0.8291;HYPOXIA INDUCIBLE FACTOR#0.8282;QUANTITATIVE REVERSE TRANSCRIPTION#0.8230;FEMUR#0.8200;C TERMINAL DOMAIN#0.8182;PARATHYROID#0.8161;CELL MOTILITY#0.8159;HYPERTENSION#0.8129;DIFFERENTIAL GENE EXPRESSION#0.8113;DIPEPTIDYL PEPTIDASE#0.8084;DIABETES MELLITUS#0.8052;REACTIVE OXYGEN SPECIES#0.8050;IMMUNE CELL#0.8037;ATHEROSCLEROTIC#0.8030;COLITIS#0.8027;MITOGEN ACTIVATED PROTEIN#0.8027;ZOLEDRONIC ACID#0.8011;LIVER METASTASIS#0.8010;TYPE 2 IMMUNE RESPONSE#0.7993;NASAL MUCOSA#0.7992;DIPEPTIDYL PEPTIDASE 4#0.7968;PLATELET-DERIVED GROWTH FACTOR#0.7945;GM-CSF#0.7919;TARGET OF RAPAMYCIN#0.7896;PROLIFERATIVE DIABETIC RETINOPATHY#0.7895;PANCREATIC STELLATE CELL#0.7894;SKIN FIBROBLASTS#0.7836;PAPILLARY THYROID CARCINOMA#0.7829;NEURAL CREST#0.7810;ANNULUS#0.7805;GENE SILENCING#0.7793;TRANSCRIPTASE#0.7789;DIGESTION#0.7787;OBESE#0.7777;COLONY-STIMULATING FACTOR#0.7767;GINGIVA#0.7734;RECEPTOR ACTIVATOR#0.7672;CEREBRAL ISCHEMIA#0.7656;CORE BINDING FACTOR#0.7652;MUCUS PRODUCTION#0.7641;INTEGRIN LINKED KINASE#0.7634;LEUKOCYTE#0.7624;AGGRESSIVE PERIODONTITIS#0.7593;SIGNALING MOLECULE#0.7588;SKELETON#0.7579;DISCOIDIN DOMAIN RECEPTOR#0.7578;ENDOMETRIAL EPITHELIAL CELLS#0.7568;ESOPHAGEAL CANCER#0.7543;ENDOPLASMIC RETICULUM#0.7538;INSULIN-LIKE GROWTH FACTOR#0.7519;ENDOMETRIUM#0.7516;SIGNAL TRANSDUCTION#0.7509;DIABETIC NEPHROPATHY#0.7507;HUMAN BREAST CANCER#0.7492;BILE DUCT CARCINOMA#0.7468;BONE RESORPTION#0.7435;EPITHELIAL OVARIAN CANCER#0.7425;NORMAL BREAST TISSUE#0.7411;CYTOPLASM#0.7405;TRANSVERSE AORTIC CONSTRICTION#0.7339;CREATINE KINASE#0.7334;KERATINOCYTE PROLIFERATION#0.7318;ASTROCYTE#0.7305;HUMAN ADIPOSE TISSUE#0.7302;INTEGRIN BINDING#0.7271;ATHEROSCLEROSIS#0.7228;GROWTH DIFFERENTIATION FACTOR#0.7228;LUNG DISEASE#0.7224;INTERVERTEBRAL DISC#0.7223;POLYCYSTIC KIDNEY DISEASE#0.7210;NEURITE#0.7190;ISOPROTERENOL#0.7138;RAPAMYCIN#0.7028;ALKALINE PHOSPHATASE ACTIVITY#0.7014;PERIODONTAL LIGAMENT STEM CELL#0.7002;PHOSPHATASE ACTIVITY#0.6987;FACTOR I#0.6982;SPHINGOSINE#0.6972;HEART DEVELOPMENT#0.6918;CANCER SPECIFIC SURVIVAL#0.6908;BREAST CANCER PATIENTS#0.6906;EARLY BRAIN INJURY#0.6886;CHLORIDE CHANNEL#0.6872;TOOTH ERUPTION#0.6869;ADJACENT NORMAL TISSUE#0.6865;TOOTH DEVELOPMENT#0.6859;ALLERGIC CONJUNCTIVITIS#0.6854;PSORIASIS#0.6853;LINEAR REGRESSION ANALYSIS#0.6850;FIBROUS DYSPLASIA#0.6849;DEXAMETHASONE#0.6817;FIBROBLAST ACTIVATION#0.6816;BLOOD VESSEL DENSITY#0.6816;DNA SYNTHESIS#0.6798;HEAT SHOCK PROTEIN#0.6787;CONSTRICTION#0.6772;OSSIFICATION#0.6771;MACROPHAGE POLARIZATION#0.6755;TH2 CELL#0.6745;NIFEDIPINE#0.6744;HUMAN BRONCHIAL EPITHELIAL#0.6726;ALCOHOLIC FATTY LIVER#0.6708;HEPATOCELLULAR CARCINOMA CELL#0.6704;NEUROTOXIN#0.6679;CELL DEVELOPMENT#0.6659;BONE MARROW STROMAL#0.6651;TYPE 2 DIABETES MELLITUS#0.6645;2 DIABETES MELLITUS#0.6645;CELL ACTIVATION#0.6644;INGENUITY PATHWAY ANALYSIS#0.6640;NEURITE OUTGROWTH#0.6625;TRANSMISSION ELECTRON MICROSCOPY#0.6604;SUBSTANCE P#0.6578;VASCULAR ENDOTHELIAL CELL#0.6486;PROGESTERONE#0.6478;CORONARY ARTERY DISEASE#0.6467;ARTERY DISEASE#0.6465;HYDROXYPROLINE#0.6462;YEAR SURVIVAL RATE#0.6454;T HELPER CELL#0.6453;ENDOSCOPIC SINUS SURGERY#0.6446;GLYCOGEN SYNTHASE KINASE#0.6442;STATISTICALLY SIGNIFICANT DIFFERENCE#0.6412;HIGH FAT DIET#0.6411;GLOMERULAR FILTRATION#0.6410;NERVOUS SYSTEM#0.6386;KINASE INHIBITOR#0.6386;PIRFENIDONE#0.6384;GRANULOCYTE#0.6367;BONE MARROW STROMAL CELL#0.6354;LYMPHANGIOGENESIS#0.6345;FIBRILLIN#0.6341;MANDIBLE#0.6319;GEMCITABINE#0.6284;CONJUNCTIVITIS#0.6281;PHENYTOIN#0.6264;DISEASE SPECIFIC SURVIVAL#0.6258;SINUSITIS#0.6251;NONALCOHOLIC FATTY LIVER DISEASE#0.6230;HYPERTROPHIC SCAR FIBROBLASTS#0.6217;AIRWAY EPITHELIUM#0.6204;LIPID METABOLISM#0.6198;URETER DEVELOPMENT#0.6172;TUMOUR NECROSIS FACTOR#0.6131;CELL MEMBRANE#0.6115;LOSARTAN#0.6100;SMOOTH MUSCLE CELL DIFFERENTIATION#0.6098;EOSINOPHILIC PNEUMONIA#0.6090;CYSTATIN#0.6087;ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS#0.6082;TOPICAL#0.6075;HUMAN DERMAL FIBROBLAST#0.6063;STEM CELL LIKE#0.6055;LUMINAL#0.6053;ADIPOSE-DERIVED STEM CELL#0.6052;SKIN DEVELOPMENT#0.6051;INTRAMEMBRANOUS OSSIFICATION#0.6050;BODY SURFACE AREA#0.6040;ENDOTHELIUM#0.6036;EXCRETION#0.6031;HAIR FOLLICLE#0.6025;ADJUSTED ODDS RATIO#0.6022;LYMPH NODE METASTASES#0.6020
10633	TUMOR SUPPRESSOR#0.9535;HISTONE MODIFICATION#0.7267
10634	GROWTH ARREST SPECIFIC#0.7553;MICROTUBULE#0.7044;CELL DIFFERENTIATION#0.6201
10635	HOMOLOGOUS RECOMBINATION#1.0740;DNA REPAIR#1.0235;DNA BINDING#0.9486;CANCER CELL#0.8834;DOUBLE STRAND BREAK#0.7756;STRUCTURE SPECIFIC DNA BINDING#0.6855;CELL CYCLE#0.6748;LUNG CANCER#0.6263
10636	SIGNALING PATHWAY#1.0508;PLASMA MEMBRANE#0.9614;GUANINE#0.9551;GTPASE ACTIVITY#0.9528;HETEROTRIMERIC G-PROTEIN#0.9526;SIGNALLING PATHWAY#0.8795;GAP ACTIVITY#0.8624;RESONANCE ENERGY TRANSFER#0.8087;PROTEIN KINASE#0.7983;CENTROSOME#0.7469;MITOGEN ACTIVATED PROTEIN#0.7211;NEPHROLITHIASIS#0.7134;MITOTIC SPINDLE#0.7002;MAP KINASE#0.6924;PROTEIN BINDING#0.6383;CELL DIVISION#0.6371;NERVOUS SYSTEM#0.6325;NUCLEOTIDE BINDING#0.6269;MICROTUBULE ASSOCIATED PROTEIN#0.6149;BIOLUMINESCENCE#0.6126
10637	NODAL SIGNALING#1.0465;MIDLINE#1.0369;LATERAL PLATE MESODERM#1.0362;STEM CELL#1.0063;GROWTH FACTOR#0.9936;GENE EXPRESSION#0.9779;EMBRYONIC STEM CELL#0.9736;TRANSCRIPTION FACTOR#0.9551;TRANSFORMING GROWTH FACTOR#0.9315;SIGNALING PATHWAY#0.8861;PRIMITIVE STREAK#0.8541;MOUSE EMBRYONIC STEM#0.8497;FLOOR PLATE#0.8013;EPIBLAST#0.7755;TRANSFORMING GROWTH FACTOR BETA#0.7542;ENDODERM CELL#0.7268;NOTOCHORD#0.7074;PLURIPOTENT STEM CELL#0.7029;HEART LOOPING#0.7027;ACTIVIN RECEPTOR#0.6969;HUMAN EMBRYONIC STEM#0.6935;VISCERAL ENDODERM CELL#0.6591;TERATOCARCINOMA#0.6200;ANTERIOR VISCERAL ENDODERM#0.6026
10638	S PHASE#1.1420;DNA SYNTHESIS#0.7901
10639	HEPATOCELLULAR CARCINOMA#0.9916
1063	CENTROMERE#1.0658;KINETOCHORE#1.0572;PROSTATE CANCER#1.0567;CELL CYCLE#1.0085;MICROTUBULE#0.9782;MITOSIS#0.9741;GENE EXPRESSION#0.9531;CHROMOSOME SEGREGATION#0.9435;CANCER CELL#0.9420;CELL PROLIFERATION#0.9278;M PHASE#0.9166;BREAST CANCER#0.9166;HEPATOCELLULAR CARCINOMA#0.8657;MITOTIC CHECKPOINT#0.8511;ASTROCYTOMA#0.8468;TOPOISOMERASE#0.8431;SQUAMOUS CELL CARCINOMA#0.8140;CELL DIVISION#0.8106;DNA TOPOISOMERASE#0.8074;DNA TOPOISOMERASE II#0.7805;TOPOISOMERASE II#0.7713;PROTEIN PROTEIN INTERACTION#0.7697;DISEASE FREE SURVIVAL#0.7534;METAPHASE#0.7503;ANAPHASE#0.7361;DYNEIN#0.7286;TRANSCRIPTION FACTOR#0.7260;SPINDLE CHECKPOINT#0.7158;DIFFUSE ASTROCYTOMA#0.7106;CELL MIGRATION#0.6985;SPINDLE POLE#0.6770;APOPTOSIS#0.6597;ONCOGENIC#0.6595;REVERSE TRANSCRIPTION#0.6569;GENE EXPRESSION OMNIBUS#0.6522;RECURRENCE FREE SURVIVAL#0.6222;LEUCINE#0.6218;POLYMERASE CHAIN REACTION#0.6028
10640	EXOCYST#1.0872;EXOCYST COMPLEX#1.0837;PLASMA MEMBRANE#0.9993;CILIOGENESIS#0.8370;EXOCYTOSIS#0.8355;PROTEIN COMPLEX#0.7611;SECRETORY VESICLE#0.7571;COMPLEX I#0.6519;EPITHELIAL CELL#0.6478;SPIRAL GANGLION NEURONS#0.6434;RETINAL DEVELOPMENT#0.6378;EYE DEVELOPMENT#0.6362;HAIR CELL#0.6270;URETER#0.6119
10641	TUMOR SUPPRESSOR#1.0820;CANCER CELL#1.0623;LUNG CANCER#1.0482;APOPTOSIS#1.0176;CELL CYCLE#1.0084;AUTOPHAGY#1.0063;TARGET OF RAPAMYCIN#0.9951;RESPONSE TO AMINO ACID#0.9684;GATOR1 COMPLEX#0.9660;RAPAMYCIN#0.9504;FOCAL EPILEPSY#0.9441;EPILEPSY#0.9307;GAP ACTIVITY#0.8846;GENE EXPRESSION#0.8721;CELL GROWTH#0.8714;TARGET OF RAPAMYCIN COMPLEX#0.8706;COLORECTAL CANCER#0.8622;CELL PROLIFERATION#0.8510;L-OHP#0.8309;PROSTATE CANCER#0.8204;CISPLATIN#0.8182;DNA DAMAGE CHECKPOINT#0.7957;SIGNALING PATHWAY#0.7878;PROTEIN COMPLEX#0.7649;COLON CANCER#0.7636;MTOR COMPLEX#0.7252;COLORECTAL#0.7089;GTP HYDROLYSIS#0.7088;DRUG RESISTANCE#0.6937;FOCAL CORTICAL DYSPLASIA#0.6661;G1 PHASE#0.6463;RENAL CANCER CELLS#0.6402;REGULATION OF AUTOPHAGY#0.6395;TCA CYCLE#0.6275;SQUAMOUS CELL CARCINOMA#0.6234;BREAST CANCER#0.6206;5 FLUOROURACIL#0.6173;DNA REPAIR#0.6130;MITOPHAGY#0.6048;ADENOCARCINOMA#0.6019
10642	BINDING PROTEIN 1#1.0598;MRNA BINDING#1.0483;INSULIN-LIKE GROWTH FACTOR#1.0470;GROWTH FACTOR#1.0436;OVARIAN CANCER#1.0387;RNA BINDING PROTEIN#1.0287;RNA BINDING#1.0285;CANCER CELL#1.0278;BREAST CANCER#1.0267;ONCOGENIC#1.0220;CELL PROLIFERATION#1.0132;GROWTH CONE#1.0105;CELL MIGRATION#1.0088;OVARIAN#1.0034;BREAST CANCER CELL#1.0010;TRANSCRIPTION FACTOR#0.9965;APOPTOSIS#0.9947;STEM CELL#0.9910;CELL GROWTH#0.9893;HEPATOCELLULAR CARCINOMA#0.9831;GENE EXPRESSION#0.9810;PROTEIN SYNTHESIS#0.9523;COLORECTAL CANCER#0.9461;COLORECTAL#0.9429;TUMOR SUPPRESSOR#0.9317;SIGNALING PATHWAY#0.9257;CELL CYCLE#0.9178;MACROPHAGE#0.9007;LUNG CANCER#0.8988;TUMOR CELLS#0.8923;MRNA TRANSPORT#0.8879;CELL ADHESION#0.8834;CELL DEATH#0.8749;CELL MOTILITY#0.8748;ADENOCARCINOMA#0.8653;RIBOSOME#0.8608;LUNG ADENOCARCINOMA#0.8448;RNA LOCALIZATION#0.8214;CYTOPLASM#0.8077;METASTATIC MELANOMA#0.8062;BREAST CARCINOMA#0.8050;PRO-INFLAMMATORY#0.7956;EPITHELIAL CELL#0.7836;METALLO BETA LACTAMASE#0.7576;COLON CANCER#0.7496;SQUAMOUS CELL CARCINOMA#0.7474;RNA RECOGNITION MOTIF#0.7149;MICROPHTHALMIA#0.7147;BONE MARROW#0.7047;ACUTE LYMPHOBLASTIC LEUKEMIA#0.6952;DNA METHYLATION#0.6916;QUANTITATIVE REAL TIME#0.6765;CORD BLOOD#0.6756;PROTEIN KINASE#0.6718;POLYMERASE CHAIN REACTION#0.6486;NEURONAL CELLS#0.6309;MICROTUBULE#0.6238;CELL POLARITY#0.6149;INTESTINAL EPITHELIAL CELL#0.6122;COPY NUMBER GAIN#0.6118;AKT SIGNALING#0.6102;MRNA STABILIZATION#0.6068;MRNA DEGRADATION#0.6019
10643	HIGH GRADE DYSPLASIA#1.0812;RENAL CELL CARCINOMA#1.0592;BREAST CANCER#1.0569;BINDING PROTEIN 3#1.0514;MRNA BINDING#1.0488;LYMPH NODE#1.0446;LYMPH NODE METASTASIS#1.0433;LUNG CANCER#1.0420;CELL PROLIFERATION#1.0420;CANCER CELL#1.0418;ADENOCARCINOMA#1.0406;TUMOR CELLS#1.0405;INSULIN-LIKE GROWTH FACTOR#1.0401;GROWTH FACTOR#1.0364;SQUAMOUS CELL CARCINOMA#1.0363;RNA BINDING#1.0360;RNA BINDING PROTEIN#1.0346;DISEASE FREE SURVIVAL#1.0266;LUNG ADENOCARCINOMA#1.0213;BREAST CANCER CELL#1.0140;COLORECTAL CANCER#1.0109;PANCREATIC CANCER#1.0073;PANCREATIC DUCTAL ADENOCARCINOMA#1.0065;COLORECTAL#1.0056;OVARIAN#1.0020;MALIGNANT MESOTHELIOMA#0.9980;CLEAR CELL CARCINOMA#0.9913;GENE EXPRESSION#0.9889;HEPATOCELLULAR CARCINOMA#0.9881;CELL MIGRATION#0.9861;ENDOMETRIAL CARCINOMA#0.9705;STEM CELL#0.9673;MESOTHELIAL CELL#0.9578;CELL CYCLE#0.9500;BILE DUCT#0.9415;PROSTATE CANCER#0.9376;GASTRIC ADENOCARCINOMA#0.9340;OVERALL SURVIVAL RATE#0.9265;BREAST CARCINOMA#0.9242;CERVICAL#0.9233;POLYMERASE CHAIN REACTION#0.9132;ONCOGENIC#0.9082;VON HIPPEL LINDAU#0.8972;FINE NEEDLE ASPIRATION#0.8962;DISEASE SPECIFIC SURVIVAL#0.8957;NEUROENDOCRINE TUMOR#0.8917;IMMUNE RESPONSE#0.8850;INVASIVE UROTHELIAL CARCINOMA#0.8815;SIGNALING PATHWAY#0.8736;ANGIOGENESIS#0.8599;T CELL#0.8595;METASTATIC MELANOMA#0.8511;CELL GROWTH#0.8460;PROTEIN KINASE#0.8440;DRUG RESISTANCE#0.8247;GROWTH FACTOR RECEPTOR#0.8243;CANCER TESTIS ANTIGEN#0.8178;EPITHELIAL MESENCHYMAL TRANSITION#0.8089;ESOPHAGUS#0.8056;CERVICAL INTRAEPITHELIAL NEOPLASIA#0.8028;EPITHELIAL CELL#0.8021;PERIPHERAL BLOOD#0.7981;CORE NEEDLE BIOPSIES#0.7980;AGGRESSIVE BEHAVIOR#0.7957;ESOPHAGEAL CANCER#0.7955;RNA INTERFERENCE#0.7882;OVARIAN CANCER#0.7876;ORAL SQUAMOUS CELL CARCINOMA#0.7868;B CELL#0.7830;CANCER SPECIFIC MORTALITY#0.7827;TUMOR SUPPRESSOR#0.7799;APOPTOSIS#0.7777;METASTASIS FREE SURVIVAL#0.7740;EXTRACELLULAR MATRIX#0.7662;OVARIAN CARCINOMA#0.7648;CELL CYCLE ARREST#0.7598;RECURRENCE FREE SURVIVAL#0.7557;SALIVARY GLAND#0.7527;THYROID CARCINOMA#0.7513;ENDOTHELIAL GROWTH FACTOR#0.7451;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.7451;EPIDERMAL GROWTH FACTOR#0.7425;OOCYTE#0.7424;NEUROENDOCRINE CARCINOMA#0.7412;CERVICAL CANCER#0.7326;CELL ADHESION#0.7240;PANCREATIC LESIONS#0.6999;METASTATIC ADENOCARCINOMA#0.6925;INTRAHEPATIC CHOLANGIOCARCINOMA#0.6922;HYPOXIA#0.6780;CYTOTOXIC T-LYMPHOCYTE#0.6774;T LYMPHOCYTE#0.6733;SMALL INTESTINE#0.6727;PROGESTERONE#0.6716;TUMOR TISSUES#0.6527;ESTROGEN RECEPTOR#0.6498;CANCER SPECIFIC SURVIVAL#0.6375;ENDOMETRIAL CANCER#0.6366;BILE DUCT CARCINOMA#0.6346;LYMPH NODE METASTASES#0.6325;TUMOR ASSOCIATED ANTIGEN#0.6293;CANCER STEM CELL#0.6246;LYMPHOCYTE ANTIGEN#0.6171;SMALL CELL CARCINOMA#0.6169;LARGE CELL NEUROENDOCRINE CARCINOMA#0.6168;PANCREATITIS#0.6168;CARCINOMA IN SITU#0.6144;COLON CANCER#0.6066;CHOLANGIOCARCINOMA#0.6046;CLEAR CELL RENAL CELL CARCINOMA#0.6019;DIFFERENTIATED THYROID CARCINOMA#0.6019;TUMOR NODE METASTASIS#0.6006
10644	MRNA BINDING#1.0625;INSULIN-LIKE GROWTH FACTOR#1.0483;GROWTH FACTOR#1.0433;RNA BINDING#1.0389;RNA BINDING PROTEIN#1.0344;TYPE 2 DIABETES MELLITUS#1.0051;2 DIABETES MELLITUS#1.0051;TYPE 2 DIABETES#1.0042;BREAST CANCER#1.0016;DIABETES MELLITUS#0.9977;CELL PROLIFERATION#0.9927;INSULIN SECRETION#0.9884;GENE EXPRESSION#0.9823;HEPATOCELLULAR CARCINOMA#0.9796;CANCER CELL#0.9732;SIGNALING PATHWAY#0.9353;BETA CELL#0.9262;PANCREATIC CANCER#0.8996;STEM CELL#0.8647;CELL MIGRATION#0.8383;TRANSCRIPTION FACTOR#0.7975;ONCOGENIC#0.7948;OVARIAN#0.7777;ORAL GLUCOSE TOLERANCE#0.7587;COLON CANCER#0.7530;SKELETAL MUSCLE#0.7492;GLUCOSE TOLERANCE TEST#0.7357;GESTATIONAL DIABETES#0.7164;ADENOCARCINOMA#0.6910;COLORECTAL CANCER#0.6781;GESTATIONAL DIABETES MELLITUS#0.6756;TUMOR SUPPRESSOR#0.6527;POLYMERASE CHAIN REACTION#0.6496;COLORECTAL#0.6346;CYCLIN DEPENDENT KINASE#0.6312;CANCER STEM CELL#0.6131;TYPE 1 DIABETES#0.6127;PANCREATIC DUCTAL ADENOCARCINOMA#0.6026;FATTY ACID OXIDATION#0.6013
10645	CAMKIV#1.0811;PROSTATE CANCER#1.0453;SIGNALING CASCADE#1.0273;PROTEIN KINASE#1.0213;GLUCOSE UPTAKE#1.0198;SKELETAL MUSCLE#1.0153;SIGNALING PATHWAY#1.0030;CELL GROWTH#1.0004;ADENOSINE MONOPHOSPHATE#1.0002;CANCER CELL#0.9921;ENDOTHELIAL CELL#0.9862;ADENOSINE#0.9803;CAMKII#0.9789;TARGET OF RAPAMYCIN#0.9695;AMPK ACTIVITY#0.9681;CELL CYCLE#0.9442;MUSCLE CELL#0.9436;AUTOPHAGY#0.9371;5'-AMP#0.9369;INFLAMMATORY RESPONSE#0.9346;CELL PROLIFERATION#0.9292;GENE EXPRESSION#0.9237;APOPTOSIS#0.9128;RAPAMYCIN#0.9027;ACETYL COA CARBOXYLASE#0.8953;TRANSCRIPTION FACTOR#0.8835;GROWTH FACTOR#0.8822;MACROPHAGE#0.8762;KINASE INHIBITOR#0.8562;CAMKKBETA#0.8537;SKELETAL MUSCLE CELLS#0.8465;T CELL#0.8432;CELL DEATH#0.8403;HIGH FAT DIET#0.8313;PLASMA MEMBRANE#0.8168;GLUCOSE INTOLERANCE#0.8069;SIGNAL TRANSDUCTION#0.7829;REACTIVE OXYGEN SPECIES#0.7789;HYPOXIA#0.7757;CAM BINDING#0.7665;ENERGY HOMEOSTASIS#0.7664;CALCIUM SIGNALING#0.7602;CYTOPLASM#0.7523;RNA INTERFERENCE#0.7467;BETA CELL#0.7443;TUMOR SUPPRESSOR#0.7284;TYPE 2 DIABETES#0.7156;NITRIC OXIDE#0.7143;BLOOD BRAIN BARRIER#0.7092;NERVOUS SYSTEM#0.7070;GLUCOSE HOMEOSTASIS#0.7042;NMDA RECEPTOR#0.7027;KINASE ACTIVITY#0.7002;CAMP RESPONSE ELEMENT BINDING#0.6824;GROWTH CONE#0.6822;NEURITE OUTGROWTH#0.6817;CAMP RESPONSE ELEMENT#0.6813;LUNG CANCER#0.6811;PROTEIN KINASE A#0.6782;CENTRAL NERVOUS SYSTEM#0.6739;ANDROGEN RECEPTOR#0.6648;NEURITE#0.6621;CELL CYCLE ARREST#0.6579;CARBACHOL#0.6551;REGULATION OF AMPK#0.6471;FATTY ACID OXIDATION#0.6384;ADIPOCYTE#0.6363;INSULIN SECRETION#0.6291;OOCYTE#0.6269;CEREBRAL CORTEX#0.6097;IMMUNE CELL#0.6074;PRO-INFLAMMATORY#0.6051;BINDING PROTEIN 1#0.6035;COENZYME A#0.6030
106478911	CYSTATIN#0.6107
106478956	CELL PROLIFERATION#1.0410;CANCER CELL#1.0403;TUMOR SUPPRESSOR#0.7999
106478973	AUTISTIC#0.6291
106479023	APOPTOSIS#0.8439;CYTOPLASMIC NUCLEOSOME#0.6015
106479059	ASPIRIN#0.8547
10647	CANCER CELL#0.6249;PANCREATIC CANCER#0.6188
106480318	CELL PROLIFERATION#0.8960;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.7789;SQUAMOUS CELL CARCINOMA#0.7609;APOPTOSIS#0.6411
106480735	CANCER CELL#1.1436;COLON CANCER#0.9044;CELL CYCLE#0.8971;APOPTOSIS#0.6741
10648	OVARIAN CARCINOMA#0.6194
10651	METAXIN#0.9371;TOXICITY#0.8245;MITOCHONDRIA#0.6744;EPIBOLY#0.6399;METHOTREXATE#0.6270;CEREBRAL CORTEX#0.6261;APOPTOSIS#0.6177
10652	VACUOLE FUSION#1.0363;SNARE COMPLEX#1.0332;VACUOLE#1.0289;ENDOSOME#1.0240;AUTOPHAGOSOME#0.9998;N-ETHYLMALEIMIDE#0.9983;PLASMA MEMBRANE#0.9953;LYSOSOME#0.9943;MEMBRANE FUSION#0.9937;ENDOPLASMIC RETICULUM#0.9648;AUTOPHAGOSOME-LYSOSOME FUSION#0.9310;SECRETORY PATHWAY#0.9250;ORGANELLE#0.9243;LATE ENDOSOME#0.9089;EXOCYTOSIS#0.8833;RECYCLING ENDOSOME#0.7837;GOLGI APPARATUS#0.7824;INTRACELLULAR MEMBRANE#0.7688;SNARE COMPLEX ASSEMBLY#0.7654;COMPLEX I#0.7598;ARGININE#0.7222;VESICLE FUSION#0.7110;AUTOPHAGY#0.6885;VESICLE TRAFFICKING#0.6695;TRANS GOLGI NETWORK#0.6675;PROTEIN PALMITOYLATION#0.6643;SYNAPTIC VESICLE#0.6444;PRENYLATION#0.6089;EXOSOME#0.6001
10653	TUMOR SUPPRESSOR#1.0686;EPITHELIAL CELL#1.0481;CANCER CELL#1.0470;BREAST CANCER#1.0453;HEPATOCYTE GROWTH FACTOR#1.0439;GROWTH FACTOR#1.0374;CELL SURFACE#1.0294;CELL MOTILITY#1.0098;PROSTATE CANCER#0.9819;BREAST CANCER CELL#0.9654;DIARRHEA#0.9568;PEPTIDASE INHIBITOR#0.9538;GENE EXPRESSION#0.9489;METHYLATION SPECIFIC PCR#0.8974;ZYMOGEN ACTIVATION#0.8866;RENAL CELL CARCINOMA#0.8846;PROTEINASE INHIBITOR#0.8542;POLYMERASE CHAIN REACTION#0.8200;CELL PROLIFERATION#0.8126;PLASMA MEMBRANE#0.8095;SQUAMOUS CELL CARCINOMA#0.8020;APOPTOSIS#0.7735;CERVICAL CANCER#0.7685;5-AZA-2'-DEOXYCYTIDINE#0.7629;2'-DEOXYCYTIDINE#0.7625;MAMMARY EPITHELIAL CELL#0.7604;HEPATOCELLULAR CARCINOMA#0.7387;SIGNALING PATHWAY#0.7046;INVASIVE GROWTH#0.7033;CELL MIGRATION#0.6858;STROMAL CELL#0.6667;DNA METHYLATION#0.6612;PLACENTAL DEVELOPMENT#0.6299;OVARIAN CANCER#0.6166;NEURAL TUBE#0.6108;PANCREATIC CANCER#0.6006
10654	PHOSPHOMEVALONATE KINASE#1.0971;MEVALONATE KINASE#1.0883;DIPHOSPHATE#1.0600;DIPHOSPHOMEVALONATE DECARBOXYLASE#1.0269;PEROXISOMAL#0.9420;CHOLESTEROL BIOSYNTHESIS#0.8962;PEROXISOME#0.7964;ISOPENTENYL PYROPHOSPHATE#0.7874;ISOPRENOID BIOSYNTHESIS#0.7390;POROKERATOSIS#0.7221;FARNESYL DIPHOSPHATE#0.6920;FARNESYL#0.6576
10655	TRANSCRIPTION FACTOR#0.9278;SEX DETERMINATION#0.8793;SOMITE#0.8399;GONAD#0.7193;DERMOMYOTOME#0.6884;DNA BINDING#0.6854;GERM CELL#0.6214;SKELETAL MUSCLE#0.6169
10656	RNA BINDING#1.0542;RNA BINDING PROTEIN#1.0349;TELOMERASE ACTIVITY#0.8316;CALCINEURIN#0.7549;GENE EXPRESSION#0.7495;PLASMA MEMBRANE#0.7184;CANCER CELL#0.7038;SIGNAL TRANSDUCTION#0.6644
10657	STRESS GRANULE#1.0429;GERM CELL#1.0429;MITOSIS#1.0422;BREAST CANCER#1.0421;RNA METABOLISM#1.0401;RNA BINDING PROTEIN#1.0390;INSULIN RECEPTOR#1.0372;RNA BINDING#1.0350;CELL PROLIFERATION#1.0246;BREAST CANCER CELL#1.0203;T CELL#1.0194;CELL CYCLE#1.0166;EPITHELIAL CELL#1.0165;NUCLEAR EXPORT#1.0164;CYTOPLASM#1.0112;CANCER CELL#1.0106;PROTEIN KINASE#1.0059;APOPTOSIS#1.0056;GENE EXPRESSION#1.0055;SRC FAMILY KINASE#1.0036;SIGNALING PATHWAY#1.0034;SIGNAL TRANSDUCTION#1.0024;ARGININE#0.9951;PROSTATE CANCER#0.9926;EPIDERMAL GROWTH FACTOR#0.9922;GROWTH FACTOR#0.9919;KINASE ACTIVITY#0.9875;B CELL#0.9836;HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#0.9780;RNA PROCESSING#0.9737;PROTEIN TYROSINE KINASE#0.9715;APOPTOTIC#0.9704;SIGNALING MOLECULE#0.9640;SPERMATOGENESIS#0.9598;MRNA SPLICING#0.9597;RNA HELICASE#0.9546;CELL GROWTH#0.9533;TRANSCRIPTION FACTOR#0.9508;ONCOGENIC#0.9494;DOCKING PROTEIN#0.9459;MITOGEN ACTIVATED PROTEIN#0.9447;PLASMA MEMBRANE#0.9444;NUCLEIC ACID#0.9363;LYMPH NODE METASTASIS#0.9355;CELL DEATH#0.9346;PHOSPHOLIPASE C#0.9310;LYMPH NODE#0.9284;NERVOUS SYSTEM#0.9198;MRNA PROCESSING#0.9184;ADIPOCYTE#0.9160;HUMAN IMMUNODEFICIENCY VIRUS#0.9118;NUCLEAR LOCALIZATION SIGNAL#0.9100;PROTEIN PROTEIN INTERACTION#0.9092;SH3 DOMAIN BINDING#0.8984;GROWTH FACTOR RECEPTOR#0.8922;AUTOPHAGY#0.8921;REVERSE TRANSCRIPTION#0.8845;KINASE INHIBITOR#0.8817;ADIPOGENESIS#0.8774;STEM CELL#0.8741;RNA SPLICING#0.8728;RECEPTOR TYROSINE KINASE#0.8724;PRE-MRNA SPLICING#0.8722;SIGNALING ADAPTOR#0.8698;SIGNALLING PATHWAY#0.8415;MAP KINASE#0.8408;DOMINANT NEGATIVE MUTANT#0.8401;TRANSACTIVATION#0.8391;CELL CYCLE REGULATION#0.8390;ADIPOSE TISSUE#0.8357;BONE MARROW#0.8249;S PHASE#0.8224;CERVICAL CANCER#0.8105;POLYMERASE CHAIN REACTION#0.8077;MACROPHAGE#0.8040;PREADIPOCYTE#0.7997;CELL MIGRATION#0.7986;GENE SILENCING#0.7948;PROTEIN SYNTHESIS#0.7941;UBIQUITIN#0.7876;CELL ACTIVATION#0.7850;LUNG CANCER#0.7831;COLORECTAL CANCER#0.7801;SQUAMOUS CELL CARCINOMA#0.7800;T LYMPHOCYTE#0.7797;PROTEIN KINASE C#0.7793;PRIMARY OVARIAN INSUFFICIENCY#0.7792;PERIPHERAL BLOOD#0.7782;PELVIC LYMPH NODE#0.7697;MRNA METABOLISM#0.7616;KERATINOCYTE DIFFERENTIATION#0.7608;CELL DIFFERENTIATION#0.7606;GENOTOXIC#0.7578;COLORECTAL#0.7522;RECURRENCE FREE SURVIVAL#0.7511;M PHASE#0.7463;CELL ADHESION#0.7459;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.7446;MONONUCLEAR CELLS#0.7433;EPITHELIAL MESENCHYMAL TRANSITION#0.7428;KERATINOCYTE#0.7418;CYCLIN DEPENDENT KINASE#0.7418;PROTEIN KINASE ACTIVITY#0.7347;ENDOPLASMIC RETICULUM#0.7345;ADENOCARCINOMA#0.7327;CERVICAL#0.7304;T CELL ACTIVATION#0.7274;OVARIAN#0.7265;MEIOSIS#0.7258;TUMOR SUPPRESSOR#0.7238;SPLICE SITE SELECTION#0.7186;MAST CELL#0.7061;DEPHOSPHORYLATION#0.7048;RESPONSE TO INSULIN#0.7048;NUCLEIC ACID BINDING#0.7026;NUCLEAR BODY#0.6992;RNA INTERFERENCE#0.6967;CENTRAL NERVOUS SYSTEM#0.6935;VIRAL REPLICATION#0.6897;ANDROGEN RECEPTOR#0.6873;FOCAL ADHESION#0.6780;HUMAN BREAST CANCER#0.6728;TUMOR CELLS#0.6727;NUCLEAR STRESS GRANULE#0.6721;MUTAGENESIS#0.6686;HEAT SHOCK PROTEIN#0.6652;RHEUMATOID ARTHRITIS#0.6646;B LYMPHOCYTE#0.6540;INSULIN RECEPTOR SUBSTRATE#0.6525;FOCAL ADHESION KINASE#0.6523;DNA REPAIR#0.6467;PROGENITOR CELL#0.6465;NUCLEOPLASM#0.6404;SPERMATOCYTES#0.6395;SPINAL MUSCULAR ATROPHY#0.6378;MUSCULAR ATROPHY#0.6362;RNA GRANULE#0.6294;MYELOID CELL#0.6289;REGULATION OF GENE EXPRESSION#0.6283;DNA BINDING#0.6278;TUMOR TISSUES#0.6247;HEPATOCELLULAR CARCINOMA#0.6216;PROTEIN BINDING#0.6205;ASTROCYTE#0.6201;OVERALL SURVIVAL TIME#0.6152;TUMOR NECROSIS FACTOR#0.6144;GLYCINE#0.6115;RIBONUCLEOPROTEIN COMPLEX#0.6077;UNFERTILIZED EGG#0.6065;QUANTITATIVE REAL TIME#0.6029;FIBROBLAST LIKE SYNOVIOCYTES#0.6010;SMALL NUCLEAR RIBONUCLEOPROTEIN#0.6002
10658	CUGBP1-EIF2 COMPLEX#1.1943;MRNA DECAY#1.0920;BINDING PROTEIN 1#1.0672;CANCER CELL#1.0550;RNA BINDING#1.0340;RNA BINDING PROTEIN#1.0329;APOPTOSIS#1.0237;MYOBLAST#1.0197;RNA PROCESSING#1.0147;MYOTONIC DYSTROPHY TYPE 1#1.0095;SKELETAL MUSCLE#1.0092;CELL CYCLE#0.9986;GENE EXPRESSION#0.9864;EPITHELIAL CELL#0.9853;PROTEIN KINASE#0.9803;CELL GROWTH#0.9753;CELL PROLIFERATION#0.9667;LUNG CANCER#0.9601;TRANSCRIPTION FACTOR#0.9343;T CELL#0.9151;RNA RECOGNITION MOTIF#0.9122;TOXICITY#0.9007;ALZHEIMER'S DISEASE#0.8955;MYOGENESIS#0.8724;MUSCLE CELL#0.8613;ENHANCER BINDING PROTEIN#0.8218;ENHANCER BINDING#0.8214;STRESS GRANULE#0.8206;NERVOUS SYSTEM#0.8146;RNA METABOLISM#0.8127;CARDIOMYOCYTE#0.8087;CARDIOMYOPATHY#0.7859;RNA SPLICING#0.7831;CYTOPLASM#0.7806;INSULIN RECEPTOR#0.7749;HEART MUSCLE#0.7733;MRNA DEGRADATION#0.7579;PRE-MRNA SPLICING#0.7560;MRNA SPLICING#0.7533;T CELL ACTIVATION#0.7518;CELL ACTIVATION#0.7483;AU RICH ELEMENT#0.7480;MUSCLE WASTING#0.7396;PROTEIN TRANSLATION#0.7365;BLOOD VESSEL#0.7270;SIGNALING PATHWAY#0.7202;MRNA DEADENYLATION#0.7161;INTESTINAL EPITHELIAL CELL#0.7134;MUSCULAR DYSTROPHY#0.7098;GROWTH FACTOR#0.7051;NEUROMUSCULAR DISEASE#0.7039;MYOTUBE#0.6840;LIVER CANCER#0.6825;OOCYTE#0.6743;BREAST CANCER#0.6731;TUMOR SUPPRESSOR#0.6705;HYPERPHOSPHORYLATION#0.6570;APOPTOTIC#0.6513;SPERMIOGENESIS#0.6446;SOMITE#0.6384;EMBRYONIC HEART#0.6255;HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN#0.6210;FERTILIZATION#0.6180;TRANSLATION INITIATION#0.6133;ORAL CANCER CELL#0.6124;MYOBLAST DIFFERENTIATION#0.6118;DILATED CARDIOMYOPATHY#0.6068
10659	RNA BINDING PROTEIN#1.0548;T CELL#1.0525;RNA BINDING#1.0523;APOPTOSIS#1.0417;CANCER CELL#1.0167;MITOTIC CATASTROPHE#0.9644;RNA RECOGNITION MOTIF#0.9440;NERVOUS SYSTEM#0.9276;COLON CANCER#0.9118;RNA PROCESSING#0.8483;GENE EXPRESSION#0.8269;TUMOR SUPPRESSOR#0.8175;BREAST CANCER#0.8076;CELL DEATH#0.7824;PANCREATIC CANCER#0.7435;MYOTONIC DYSTROPHY TYPE 1#0.7334;BINDING PROTEIN 3#0.6936;HINDBRAIN#0.6491;NEUROBLASTOMA#0.6469;MRNA EDITING#0.6285;RNA EDITING#0.6207;T CELL DEVELOPMENT#0.6153;CELL CYCLE#0.6143;APOBEC#0.6083;CELL DEVELOPMENT#0.6082;BREAST CANCER CELL#0.6038;ALZHEIMER'S DISEASE#0.6021
10660	ADOLESCENT IDIOPATHIC SCOLIOSIS#1.0710;IDIOPATHIC SCOLIOSIS#1.0667;SPINAL CORD#1.0634;SCOLIOSIS#1.0466;TRANSCRIPTION FACTOR#1.0408;MUSCLE PRECURSOR CELL#1.0193;PRECURSOR CELL#1.0085;SOMITE#0.9621;SKELETAL MUSCLE#0.9613;INTERNEURON#0.9321;MYOBLAST#0.9034;NEURAL TUBE#0.8800;HINDBRAIN#0.8205;MUSCLE CELL#0.8139;DERMOMYOTOME#0.8006;MYOGENESIS#0.7447;GENE EXPRESSION#0.7369;FORELIMB#0.7312;NEURAL CREST#0.7298;CARDIAC NEURAL CREST#0.7249;CELL PROLIFERATION#0.6826;MYOGENIC PRECURSOR CELL#0.6618;PROGENITOR CELL#0.6438;CELL MIGRATION#0.6393;MYOBLAST MIGRATION#0.6030
10661	DEFINITIVE ERYTHROPOIESIS#1.0811;CONGENITAL DYSERYTHROPOIETIC ANEMIA#1.0582;FETAL LIVER#1.0346;CELL CYCLE#1.0268;GLOBIN#1.0248;DNA BINDING#1.0237;TRANSACTIVATION#1.0233;ERYTHROID PROGENITOR#1.0231;TRANSCRIPTION FACTOR#1.0213;ANEMIA#1.0129;THALASSEMIA#1.0116;ERYTHROID CELL#1.0105;ERYTHROPOIESIS#1.0073;GENE EXPRESSION#0.9995;ERYTHROBLAST#0.9991;PROGENITOR CELL#0.9982;RED BLOOD CELL#0.9979;MEGAKARYOCYTE#0.9903;BONE MARROW#0.9881;STEM CELL#0.9876;TERMINAL DIFFERENTIATION#0.9770;ERYTHROCYTE#0.9715;POLYMERASE CHAIN REACTION#0.9700;YOLK SAC#0.9698;SICKLE CELL DISEASE#0.9680;PRIMITIVE ERYTHROPOIESIS#0.9649;ERYTHROLEUKEMIA#0.9615;HEMATOPOIESIS#0.9581;BETA THALASSEMIA#0.9536;CHROMATIN REMODELING#0.9502;PLURIPOTENT STEM CELL#0.9263;ZINC FINGER PROTEIN#0.9164;ERYTHROID PRECURSOR#0.9045;HEMOLYTIC ANEMIA#0.9004;HEMATOPOIETIC STEM CELL#0.8979;SIGNALING PATHWAY#0.8951;CELL DIFFERENTIATION#0.8848;HYDROPS FETALIS#0.8750;CORD BLOOD#0.8711;MEGAKARYOCYTE-ERYTHROID PROGENITOR#0.8613;MACROPHAGE#0.8541;HEMATOPOIETIC CELL#0.8499;PRIMITIVE ERYTHROID CELL#0.8461;INDUCED PLURIPOTENT STEM CELL#0.8301;BINDING PROTEIN 1#0.8286;PERIPHERAL BLOOD#0.8242;ERYTHROPOIETIN RECEPTOR#0.8164;T CELL#0.8073;EMBRYONIC STEM CELL#0.7905;DNASE I#0.7887;DNA METHYLATION#0.7865;DNASE#0.7693;CELL DIVISION#0.7637;FACTOR I#0.7620;CELL DEVELOPMENT#0.7456;HISTONE DEACETYLASE#0.7447;TRANSCRIPTIONAL CONTROL#0.7267;CELL MEMBRANE#0.7234;BLOOD GROUP ANTIGEN#0.7209;HEMOGLOBINOPATHY#0.7158;APOPTOSIS#0.7105;RETICULOCYTE#0.7000;CELL PROLIFERATION#0.6998;HYDROXYUREA#0.6925;CHROMATIN REMODELING COMPLEX#0.6902;NUCLEAR IMPORT#0.6838;ANEMIC#0.6804;PROTEIN PROTEIN INTERACTION#0.6793;RESPONSE TO ERYTHROPOIETIN#0.6788;GROWTH FACTOR#0.6723;ENDOTHELIAL CELL#0.6692;APOPTOTIC#0.6679;MYELOID LEUKEMIA#0.6554;HEMOLYSIS#0.6545;LYSINE#0.6511;MEGAKARYOCYTE DIFFERENTIATION#0.6499;HEMATOPOIETIC PROGENITOR CELL#0.6372;MYELOID CELL#0.6334;ACUTE MYELOID LEUKEMIA#0.6305;PROTEIN KINASE#0.6263;ENUCLEATION#0.6252;HEMOGLOBIN METABOLISM#0.6241;ANAEMIA#0.6008
10663	CXCR6+ T CELL#1.1699;CC CHEMOKINE RECEPTOR#1.0779;C CHEMOKINE RECEPTOR#1.0671;NKT CELL#1.0619;PROSTATE CANCER#1.0502;CD8+ T CELL#1.0311;CHEMOKINE RECEPTOR#1.0238;NATURAL KILLER T#1.0219;CANCER CELL#1.0170;LYMPHOID TISSUE#1.0160;REVERSE TRANSCRIPTION#1.0125;T LYMPHOCYTE#1.0110;POLYMERASE CHAIN REACTION#1.0088;CD4+ T CELL#1.0077;T CELL#1.0042;CELL ACTIVATION#1.0027;CHEMOTAXIS#0.9989;MEMORY T CELL#0.9966;MONOCYTE#0.9961;LYMPH NODE#0.9957;STEM CELL#0.9916;BONE MARROW#0.9912;PERIPHERAL BLOOD#0.9909;MACROPHAGE#0.9901;CELL SURFACE#0.9901;DENDRITIC CELL#0.9895;EPITHELIAL CELL#0.9893;SIMIAN IMMUNODEFICIENCY VIRUS#0.9855;BREAST CANCER#0.9848;ENDOTHELIAL CELL#0.9840;SIGNALING PATHWAY#0.9838;IMMUNE CELL#0.9825;CELL MIGRATION#0.9821;STROMAL CELL#0.9789;IMMUNE RESPONSE#0.9777;B CELL#0.9766;TH17 CELL#0.9752;HUMAN IMMUNODEFICIENCY VIRUS#0.9739;LEUKOCYTE#0.9697;MONONUCLEAR CELLS#0.9651;CELL PROLIFERATION#0.9562;RHEUMATOID ARTHRITIS#0.9491;NEUTROPHIL#0.9489;HEPATOCELLULAR CARCINOMA#0.9476;CYTOKINE PRODUCTION#0.9383;LUNG CANCER#0.9355;ATHEROSCLEROSIS#0.9348;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9296;GENE EXPRESSION#0.9251;CELL ADHESION#0.9158;SCAVENGER RECEPTOR#0.9131;TUMOR NECROSIS FACTOR#0.9050;TROPHOBLAST#0.9042;TROPHOBLAST CELL#0.8937;TUMOR CELLS#0.8926;ACTIVATED T CELL#0.8893;LIVER DISEASE#0.8839;ACTIVATED T-CELLS#0.8803;NATURAL KILLER T CELL#0.8752;SMOOTH MUSCLE#0.8741;OVARIAN#0.8736;TROPISM#0.8724;INFLAMMATORY RESPONSE#0.8617;T CELL ACTIVATION#0.8473;GROWTH FACTOR#0.8470;LYMPH NODE METASTASIS#0.8404;BREAST CANCER CELL#0.8376;TH1 CELL#0.8330;APOPTOSIS#0.8293;PRO-INFLAMMATORY#0.8251;CC CHEMOKINE LIGAND#0.8226;ANGIOGENESIS#0.8219;LYMPHOID CELL#0.8186;IFN-GAMMA#0.8182;TRANSCRIPTION FACTOR#0.8156;EFFECTOR T CELL#0.7929;NATURAL KILLER CELL#0.7835;CELL DEATH#0.7794;LOW DENSITY LIPOPROTEIN#0.7788;MESENCHYMAL STEM CELL#0.7689;ATHEROSCLEROTIC#0.7576;OVARIAN CARCINOMA#0.7493;FLOW CYTOMETRY ANALYSIS#0.7472;SMOOTH MUSCLE CELL#0.7451;MUSCLE CELL#0.7444;T CELL MIGRATION#0.7275;COLORECTAL CANCER#0.7190;ENDOTHELIUM#0.7190;SIGNAL TRANSDUCTION#0.7181;COLITIS#0.7042;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.7018;PERIPHERAL BLOOD LYMPHOCYTES#0.6917;MULTIPLE SCLEROSIS#0.6774;CANCER STEM CELL#0.6760;CELL GROWTH#0.6743;RENAL CELL CARCINOMA#0.6695;COLORECTAL#0.6684;CHRONIC LIVER DISEASE#0.6595;VIRAL REPLICATION#0.6516;STROMA#0.6344;REGULATORY T CELL#0.6311;KERATINOCYTE#0.6307;B CELL LYMPHOMA#0.6292;CENTRAL NERVOUS SYSTEM#0.6282;NERVOUS SYSTEM#0.6272;SELECTIN#0.6222;TUMOUR NECROSIS FACTOR#0.6201;NKT CELL ACTIVATION#0.6186;INFLAMMATORY CELL#0.6155;PRECURSOR CELL#0.6059;MALT LYMPHOMA#0.6059;TUBERCULOSIS#0.6056;FATTY LIVER#0.6055;JUVENILE IDIOPATHIC ARTHRITIS#0.6022;SPINAL CORD#0.6015;ALVEOLAR MACROPHAGE#0.6009
10664	CORNEAL EPITHELIAL CELL#1.0848;COHESIN COMPLEX#1.0628;ZINC FINGER PROTEIN#1.0509;CHROMATIN LOOPING#1.0413;FACTOR I#1.0296;TUMOR SUPPRESSOR#1.0237;BREAST CANCER CELL#1.0224;DNA BINDING#1.0214;X CHROMOSOME#1.0201;X CHROMOSOME INACTIVATION#1.0198;CHROMOSOME INACTIVATION#1.0196;GLOBIN#1.0194;GERM CELL#1.0185;ERYTHROID CELL#1.0182;CELL PROLIFERATION#1.0171;CHROMATIN ORGANIZATION#1.0153;IMPRINTING CONTROL REGION#1.0149;ELECTROPHORETIC MOBILITY SHIFT#1.0145;VIRAL GENOME#1.0131;DEMETHYLATION#1.0110;NUCLEOSOME POSITIONING#1.0082;BREAST CANCER#1.0081;CELL GROWTH#1.0060;EPITHELIAL CELL#1.0054;NUCLEOSOME#1.0052;POLYCOMB REPRESSIVE COMPLEX#1.0028;PROSTATE CANCER#1.0012;CELL CYCLE#1.0009;B CELL#1.0002;APOPTOTIC#1.0001;HISTONE MODIFICATION#0.9998;DNASE I#0.9994;CHROMATIN REMODELING#0.9992;DIFFERENTIALLY METHYLATED REGION#0.9989;CELL DIFFERENTIATION#0.9988;HETEROCHROMATIN#0.9984;CANCER CELL#0.9969;DNASE#0.9968;NUCLEOLUS#0.9966;LYSINE#0.9945;APOPTOSIS#0.9936;T CELL#0.9932;TRANSCRIPTION FACTOR#0.9921;INTELLECTUAL DISABILITY#0.9914;DNA METHYLATION#0.9909;MITOSIS#0.9908;INSULIN-LIKE GROWTH FACTOR#0.9906;GROWTH FACTOR#0.9900;GENE SILENCING#0.9892;LUNG CANCER#0.9886;HISTONE DEACETYLASE#0.9879;NUCLEAR ORGANIZATION#0.9879;EMBRYONIC STEM CELL#0.9871;PROTEIN BINDING#0.9862;V-D-J RECOMBINATION#0.9831;OVARIAN#0.9819;TRANSCRIPTION REGULATOR#0.9808;STEM CELL#0.9774;ESTROGEN RECEPTOR#0.9771;TRANSCRIPTION FACTOR BINDING#0.9765;MOUSE EMBRYONIC STEM#0.9744;GENE EXPRESSION#0.9728;HOST CELL#0.9701;NUCLEAR MATRIX#0.9694;ENDOMETRIAL CANCER#0.9653;EPSTEIN BARR VIRUS#0.9649;CHROMATIN BINDING#0.9617;KAPOSI'S SARCOMA#0.9582;HISTONE ACETYLATION#0.9573;ONCOGENIC#0.9561;TRANSCRIPTIONAL CONTROL#0.9553;BECKWITH-WIEDEMANN SYNDROME#0.9550;DNA REPLICATION#0.9542;CHROMATIN MODIFICATION#0.9513;DNA METHYLTRANSFERASE#0.9510;PROTEIN COMPLEX#0.9491;HUMAN CORNEAL EPITHELIAL#0.9427;HYPERSENSITIVITY#0.9421;SPERMATOGENESIS#0.9413;COHESIN LOADING#0.9393;PROGENITOR CELL#0.9385;SIGNALING PATHWAY#0.9360;CELL DEVELOPMENT#0.9347;INTERPHASE#0.9336;TF BINDING#0.9335;POLY ADP RIBOSE#0.9335;REGULATION OF GENE EXPRESSION#0.9330;OVARIAN CANCER#0.9302;CELL DEATH#0.9287;CANCER TESTIS ANTIGEN#0.9012;DNA HYPOMETHYLATION#0.8989;POST-TRANSLATIONAL MODIFICATION#0.8981;RNA BINDING#0.8962;HEPATOCELLULAR CARCINOMA#0.8941;DOUBLE STRAND BREAK#0.8920;FERTILIZATION#0.8918;DNA DEMETHYLATION#0.8887;DNA REPAIR#0.8866;LOSS OF METHYLATION#0.8864;TELOMERE#0.8849;SISTER CHROMATID COHESION#0.8771;RIBOSE#0.8710;HISTONE METHYLATION#0.8705;CHROMATID#0.8658;HERPES SIMPLEX#0.8585;RNA INTERFERENCE#0.8505;POSTTRANSLATIONAL MODIFICATION#0.8494;MONOCYTE#0.8488;HOMOLOGOUS RECOMBINATION#0.8408;CARDIOMYOCYTE#0.8368;VIRAL TRANSCRIPTION#0.8336;SIGNALLING PATHWAY#0.8303;HUMAN EMBRYONIC STEM#0.8294;POLYMERASE CHAIN REACTION#0.8292;MAJOR HISTOCOMPATIBILITY COMPLEX#0.8286;CD4+ T CELL#0.8257;EUCHROMATIN#0.8146;PROTEIN CODING GENE#0.8130;LIVER CANCER#0.8050;CHROMOSOME SEGREGATION#0.8044;COLORECTAL#0.8039;OOCYTE#0.8038;HETEROCHROMATIN FORMATION#0.8035;HERPES SIMPLEX VIRUS#0.7977;CHROMOSOME ORGANIZATION#0.7976;IMMUNE RESPONSE#0.7943;MYELOID CELL#0.7919;MYELOID LEUKEMIA#0.7894;EPITHELIAL OVARIAN CANCER#0.7848;HUMAN BREAST CANCER#0.7807;SQUAMOUS CELL CARCINOMA#0.7770;CYSTIC FIBROSIS#0.7769;NERVOUS SYSTEM#0.7727;MACROPHAGE#0.7697;SEQUENCE SPECIFIC DNA BINDING#0.7676;PLURIPOTENT STEM CELL#0.7652;TRANSFORMING GROWTH FACTOR#0.7606;EPIDERMAL GROWTH FACTOR#0.7598;PROTEIN KINASE#0.7581;SUMOYLATION#0.7574;RETINOIC ACID#0.7563;EPISOME#0.7520;DNA DAMAGE RESPONSE#0.7492;AMYLOID PRECURSOR PROTEIN#0.7391;5-AZA-2'-DEOXYCYTIDINE#0.7384;2'-DEOXYCYTIDINE#0.7380;TUMOR CELLS#0.7324;TUMOR NECROSIS FACTOR#0.7311;COLORECTAL CANCER#0.7298;ALLELE SPECIFIC EXPRESSION#0.7269;THYMOCYTE#0.7215;SILVER RUSSELL SYNDROME#0.7206;CELL MOTILITY#0.7204;PANCREATIC ISLET#0.7201;GAMETOGENESIS#0.7191;PLASMA CELL#0.7163;NUCLEAR LAMINA#0.7161;TOPOISOMERASE#0.7108;NUCLEAR PERIPHERY#0.7078;SUBTELOMERE#0.7056;DNA HYPERMETHYLATION#0.7027;ANGIOGENESIS#0.7000;PRECURSOR CELL#0.6990;CELL DIVISION#0.6979;VIRAL GENE EXPRESSION#0.6943;ACUTE MYELOID LEUKEMIA#0.6916;ANTISENSE RNA#0.6907;HEPATOCYTE NUCLEAR FACTOR#0.6899;CHROMATIN REMODELLING#0.6882;CO BINDING#0.6874;HETEROCHROMATIN PROTEIN 1#0.6827;CLASS SWITCH RECOMBINATION#0.6816;MITOTIC CHROMOSOME#0.6808;DEACETYLASE ACTIVITY#0.6804;B CELL DEVELOPMENT#0.6784;HEMATOPOIESIS#0.6749;MUTAGENESIS#0.6698;VDR BINDING#0.6689;REVERSE TRANSCRIPTION#0.6639;VITAMIN D RECEPTOR#0.6581;B LYMPHOCYTE#0.6556;S PHASE#0.6549;EARLY GROWTH RESPONSE#0.6509;CELL NUCLEUS#0.6508;CORNELIA DE LANGE SYNDROME#0.6472;ENHANCER BINDING#0.6470;CHROMOSOMAL REGION#0.6470;BINDING PROTEIN 1#0.6443;CERVICAL#0.6435;COMPLEX I#0.6433;BREAST CELL LINES#0.6415;BONE MARROW#0.6384;SOMATIC TISSUE#0.6373;NUCLEAR CHROMATIN#0.6338;SPERMATOZOA#0.6331;CYTOSINE METHYLATION#0.6281;SENESCENCE#0.6257;B CELL LYMPHOMA#0.6255;KERATINOCYTE#0.6255;HEMATOPOIETIC STEM CELL#0.6254;BREAST CARCINOMA#0.6223;MOLECULAR FUNCTION#0.6203;THYROID HORMONE RECEPTOR#0.6201;ENDOTHELIAL CELL#0.6161;PROTEIN PROTEIN INTERACTION#0.6141;CELL CYCLE ARREST#0.6127;NEURONAL CELLS#0.6118;RNA SPLICING#0.6075;NORMAL BREAST TISSUE#0.6065;RESPONSE TO ESTROGEN#0.6022;OVARIAN CARCINOMA#0.6000
10666	LEUKOCYTE ADHESION#1.0636;NATURAL CYTOTOXICITY RECEPTOR#1.0486;CD8+ T CELL#1.0365;ENDOTHELIAL CELL#1.0333;LEUKOCYTE#1.0331;CELL ADHESION#1.0313;TYPE 1 DIABETES#1.0283;CELL DIFFERENTIATION#1.0283;T CELL DIFFERENTIATION#1.0242;T CELL ACTIVATION#1.0240;AUTOIMMUNE DISEASE#1.0181;T LYMPHOCYTE#1.0165;NK CELL ACTIVATION#1.0165;RHEUMATOID ARTHRITIS#1.0152;T CELL#1.0108;DENDRITIC CELL#1.0107;CELL ACTIVATION#1.0094;LYSIS#1.0074;CYTOTOXIC T-LYMPHOCYTE#1.0063;RECEPTOR LIGAND#1.0041;CELL SURFACE#1.0025;CD4+ T CELL#1.0013;MULTIPLE MYELOMA#1.0012;CELL CELL ADHESION#1.0012;MONOCYTE#1.0007;CYTOTOXICITY#1.0001;CELL RECOGNITION#1.0000;MULTIPLE SCLEROSIS#0.9942;PERIPHERAL BLOOD#0.9933;TUMOR CELLS#0.9906;NATURAL KILLER CELL#0.9880;NKT CELL#0.9855;MONONUCLEAR CELLS#0.9844;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9832;LUPUS ERYTHEMATOSUS#0.9829;CANCER CELL#0.9818;IMMUNE RESPONSE#0.9816;CELL ADHESION MOLECULE#0.9800;IMMUNE CELL#0.9729;PLATELET ACTIVATION#0.9718;TRANSCRIPTION FACTOR#0.9715;B CELL#0.9704;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9678;STEM CELL#0.9667;CYTOKINE PRODUCTION#0.9654;GENE EXPRESSION#0.9606;IMMUNE SYSTEM#0.9574;BONE MARROW#0.9485;NK CELL MEDIATED CYTOTOXICITY#0.9409;GRAFT VERSUS HOST#0.9372;REGULATORY T CELL#0.9366;EPITHELIAL CELL#0.9290;MYELOID LEUKEMIA#0.9284;ACUTE MYELOID LEUKEMIA#0.9243;CELL PROLIFERATION#0.9146;NEUTROPHIL#0.9052;EXTRACELLULAR REGION#0.8916;APOPTOSIS#0.8798;LYMPH NODE#0.8703;CELL KILLING#0.8684;DNA DAMAGE RESPONSE#0.8681;VIRAL INFECTION#0.8635;PROTEIN KINASE#0.8604;ACTIVATED T CELL#0.8573;TUMOR NECROSIS FACTOR#0.8470;OVARIAN#0.8459;LIPID RAFT#0.8451;MAJOR HISTOCOMPATIBILITY COMPLEX#0.8397;MACROPHAGE#0.8386;GLYCOPROTEIN COMPLEX#0.8368;UMBILICAL VEIN ENDOTHELIAL CELLS#0.8356;HUMAN UMBILICAL VEIN#0.8350;UMBILICAL VEIN#0.8347;AUTOIMMUNITY#0.8327;PROTEIN KINASE C#0.8197;ACTIVATED T-CELLS#0.8144;NAIVE T CELL#0.7958;IMMUNOLOGICAL SYNAPSE#0.7849;ENDOTHELIUM#0.7833;BREAST CANCER#0.7822;CD3+ T CELL#0.7786;INNATE IMMUNITY#0.7777;NEUROBLASTOMA#0.7707;CELL MATURATION#0.7700;INFLAMMATORY MONOCYTE#0.7651;EXTRACELLULAR MATRIX#0.7566;OVARIAN CARCINOMA#0.7457;MELANOMA CELL LINES#0.7439;CHEMOKINE RECEPTOR#0.7417;NERVOUS SYSTEM#0.7369;SIGNALING PATHWAY#0.7312;ANTIGEN PRESENTING CELLS#0.7277;HEMATOPOIETIC STEM CELL#0.7268;GROWTH FACTOR#0.7193;IMMUNE EVASION#0.7191;POLYMERASE CHAIN REACTION#0.7141;NK CELL DEGRANULATION#0.7054;CYTOKINE SECRETION#0.7050;STEM CELL TRANSPLANTATION#0.7032;CYTOLYSIS#0.6947;MULTIPLE MYELOMA CELLS#0.6870;IFN-GAMMA#0.6849;OVARIAN CANCER#0.6775;THYMOCYTE#0.6774;MYELOID CELL#0.6771;CELL DEATH#0.6737;TH17 CELL#0.6705;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.6508;HEPATOCELLULAR CARCINOMA#0.6446;NATURAL KILLER T#0.6347;EFFECTOR T CELL#0.6334;PLASMA CELL#0.6310;PROGENITOR CELL#0.6263;MAST CELL#0.6262;MEGAKARYOCYTE#0.6257;ARTERY#0.6164;T CELL PROLIFERATION#0.6159;CENTRAL NERVOUS SYSTEM#0.6150;TH1 CELL#0.6068;MEMORY T CELL#0.6064;PLATELET AGGREGATION#0.6038;IL-17 PRODUCTION#0.6006
10667	PARAPLEGIA#0.7244;TRNA CHARGING#0.6729;TRNA BINDING#0.6404;ADENYLATE#0.6251;PROTEIN SYNTHESIS#0.6224
10668	NORMAL BREAST TISSUE#0.6591;ENDOMETRIAL CANCER#0.6509;BREAST CANCER#0.6350
10669	CELL GROWTH#0.7683;CELL ADHESION#0.6389
1066	CHOLESTERYL ESTER HYDROLASE ACTIVITY#1.0887;CHOLESTEROL O ACYLTRANSFERASE#1.0834;CHOLESTEROL ACYLTRANSFERASE ACTIVITY#1.0615;O ACYLTRANSFERASE#1.0601;OSELTAMIVIR#1.0538;ACYLTRANSFERASE ACTIVITY#1.0507;BETA GLUCURONIDASE#1.0496;CLOPIDOGREL#1.0452;ACAT ACTIVITY#1.0356;COENZYME A#1.0340;ADIPOCYTE#1.0328;HYDROLASE ACTIVITY#1.0327;ACUTE LYMPHOBLASTIC LEUKEMIA#1.0326;B CELL#1.0314;TRIGLYCERIDE LIPASE#1.0297;CPT-11#1.0296;HORMONE SENSITIVE LIPASE#1.0270;METHYLPHENIDATE#1.0200;BILE ACID SYNTHESIS#1.0147;DRUG METABOLISM#1.0125;IRINOTECAN#1.0118;HMG-COA REDUCTASE ACTIVITY#1.0111;LIPOLYSIS#1.0099;SMALL INTESTINE#1.0098;CHOLESTEROL EFFLUX#1.0095;ETHANOL#1.0070;CHOLESTEROL ESTERIFICATION#1.0053;SERINE HYDROLASE#1.0051;ENDOPLASMIC RETICULUM#1.0038;RETINOL#1.0023;CYTOCHROME P450#1.0016;ADIPOSE TISSUE#1.0010;STRUCTURE ACTIVITY RELATIONSHIP#1.0002;FOAM CELL FORMATION#0.9993;LDL RECEPTOR#0.9978;MACROPHAGE#0.9973;HYPERCHOLESTEROLEMIA#0.9967;LIPOPROTEIN LIPASE#0.9966;VITAMIN A#0.9956;MICROSOME#0.9951;OLEIC ACID#0.9945;ESTERASE ACTIVITY#0.9935;LIPID DROPLET#0.9920;CHOLESTEROL TRANSPORT#0.9915;ANGIOTENSIN CONVERTING ENZYME#0.9913;LIPASE ACTIVITY#0.9909;SCAVENGER RECEPTOR#0.9904;MONOCYTE#0.9902;CHOLESTEROL HOMEOSTASIS#0.9896;CATALYTIC ACTIVITY#0.9881;PROTEIN KINASE#0.9877;PLASMA MEMBRANE#0.9875;VERY-LOW-DENSITY LIPOPROTEIN#0.9870;CHOLESTEROL SYNTHESIS#0.9867;SMOOTH MUSCLE#0.9850;CELL DEATH#0.9850;CYTOTOXICITY#0.9848;PALMITATE#0.9836;GENE EXPRESSION#0.9821;ENZYME ACTIVITY#0.9818;CHOLESTEROL METABOLISM#0.9814;ATHEROSCLEROTIC#0.9809;SMOOTH MUSCLE CELL#0.9802;LIVER DISEASE#0.9801;MUSCLE CELL#0.9796;ATP BINDING CASSETTE#0.9795;LIPID METABOLISM#0.9782;MAMMARY GLAND#0.9782;ATP BINDING#0.9779;ATHEROSCLEROSIS#0.9778;APOPTOSIS#0.9763;HIGH DENSITY LIPOPROTEIN#0.9734;ENZYME INHIBITOR#0.9727;HIGH CHOLESTEROL DIET#0.9726;TRANSCRIPTION FACTOR#0.9710;DABIGATRAN#0.9702;TOXICITY#0.9681;LOW DENSITY LIPOPROTEIN#0.9675;CHYLOMICRON#0.9602;LYSOSOME#0.9585;CANCER CELL#0.9539;HEROIN#0.9532;CELL SURFACE#0.9495;ENALAPRIL#0.9486;PROGESTERONE#0.9457;MONOCYTE DERIVED MACROPHAGE#0.9430;REVERSE CHOLESTEROL TRANSPORT#0.9414;STEROIDOGENESIS#0.9350;POLYMERASE CHAIN REACTION#0.9338;RETINOL BINDING#0.9320;HIGH FAT DIET#0.9308;CYCLIC AMP#0.9265;HEPATOMA CELLS#0.9208;ADRENAL GLAND#0.9154;CATABOLISM#0.9153;MONONUCLEAR CELLS#0.9151;COA HYDROLASE#0.9135;DABIGATRAN ETEXILATE#0.9133;FATTY LIVER#0.9102;CHOLESTEROL BIOSYNTHESIS#0.9037;INTESTINAL CHOLESTEROL ABSORPTION#0.8979;INTESTINAL ABSORPTION#0.8950;HEPARIN#0.8888;ACYL COA HYDROLASE#0.8877;RETINOIC ACID#0.8874;RETINAL PIGMENT EPITHELIUM#0.8873;SIGNALING PATHWAY#0.8860;TUMOR CELLS#0.8826;SIMVASTATIN#0.8807;IFN-GAMMA#0.8797;CORONARY HEART DISEASE#0.8787;CHOLESTEROL UPTAKE#0.8768;HEART DISEASE#0.8763;CELL PROLIFERATION#0.8745;ARTERY#0.8738;EXCRETION#0.8720;HYDROLASE INHIBITOR#0.8707;DETOXIFICATION#0.8687;VLDL ASSEMBLY#0.8687;CHOLESTYRAMINE#0.8656;INTESTINAL MUCOSA#0.8653;T CELL#0.8636;LIPOGENESIS#0.8634;FATTY LIVER DISEASE#0.8627;ESTRADIOL#0.8578;PROTEIN KINASE C#0.8565;ATP BINDING CASSETTE TRANSPORTER#0.8564;PERIPHERAL BLOOD#0.8538;OBESE#0.8519;VITAMIN A METABOLISM#0.8509;ACE INHIBITOR#0.8474;CELL GROWTH#0.8461;BRUSH BORDER#0.8436;LIPID SYNTHESIS#0.8428;CARBOXYLESTERASE ACTIVITY#0.8404;PLATELET AGGREGATION#0.8382;PEROXISOME#0.8366;ASPIRIN#0.8357;ACID PHOSPHATASE#0.8356;VITAMIN E#0.8307;TAUROCHOLATE#0.8300;CELL DIVISION#0.8277;EPITHELIAL CELL#0.8237;COLORECTAL#0.8142;LIPOPROTEIN METABOLISM#0.8137;CHOLESTEROL ESTERASE ACTIVITY#0.8125;ACUTE CORONARY SYNDROME#0.8121;CELL CYCLE#0.8076;CLOFIBRATE#0.8067;PROGRAMMED CELL DEATH#0.8059;LOVASTATIN#0.8027;BREAST CANCER#0.8017;MITOCHONDRIA#0.7970;COLORECTAL CANCER#0.7964;REVERSE TRANSCRIPTION#0.7899;GLUTATHIONE#0.7895;CELL MEMBRANE#0.7883;CONGESTIVE HEART FAILURE#0.7877;ENTEROCYTE#0.7876;TESTOSTERONE#0.7820;PROBUCOL#0.7817;B LYMPHOCYTE#0.7793;TRANDOLAPRIL#0.7784;STEROL REGULATORY ELEMENT#0.7783;PROTEIN KINASE A#0.7762;GROWTH FACTOR#0.7751;HEPATOCELLULAR CARCINOMA#0.7732;CHOLESTEROL STORAGE#0.7674;OVARIAN#0.7645;TOPOISOMERASE#0.7617;HYDROXYLASE ACTIVITY#0.7611;IRINOTECAN, CPT-11#0.7608;PRASUGREL#0.7584;BRUSH BORDER MEMBRANE#0.7584;CHYLOMICRON REMNANT#0.7579;5 FLUOROURACIL#0.7566;ELECTROPHORETIC MOBILITY SHIFT#0.7563;HYPERTENSION#0.7493;ENDOTHELIAL CELL#0.7455;ATORVASTATIN#0.7453;LEYDIG CELL#0.7443;MUTAGENESIS#0.7420;MYOCARDIAL INFARCTION#0.7418;CORONARY ARTERY#0.7416;CELL POLARITY#0.7403;CAPECITABINE#0.7383;JEJUNUM#0.7343;HEPATIC LIPASE#0.7305;LIPID BINDING#0.7247;CORPUS LUTEUM#0.7245;HEPATOCYTE NUCLEAR FACTOR#0.7226;OOCYTE#0.7223;ARACHIDONIC ACID#0.7212;FATTY ACID OXIDATION#0.7206;SIGNAL TRANSDUCTION#0.7178;PRIMARY HUMAN HEPATOCYTES#0.7135;BEZAFIBRATE#0.7114;FARNESOID X RECEPTOR#0.7071;ACYL-COA:CHOLESTEROL ACYLTRANSFERASE ACTIVITY#0.7070;HISTIDINE#0.7045;CELL DIFFERENTIATION#0.7040;BONE MARROW#0.7015;RECEPTOR ACTIVITY#0.7011;WHITE ADIPOSE TISSUE#0.7008;QUANTITATIVE REAL TIME#0.6958;FATTY ACID BINDING#0.6949;PHOSPHOLIPASE A2#0.6933;ADENOSINE#0.6929;GLYCOSYLATION#0.6903;AORTIC SMOOTH MUSCLE CELLS#0.6895;LIPID HOMEOSTASIS#0.6887;SUPEROXIDE DISMUTASE#0.6875;HDL RECEPTOR#0.6866;HEPATITIS C#0.6822;LIPID STORAGE#0.6810;ASYMMETRIC CELL DIVISION#0.6801;RETINOID METABOLISM#0.6775;HISTONE DEACETYLASE#0.6713;CORONARY ARTERY DISEASE#0.6707;ARTERY DISEASE#0.6705;T LYMPHOCYTE#0.6697;MECHANISM OF ACTION#0.6695;ALKALINE PHOSPHATASE#0.6688;ALZHEIMER'S DISEASE#0.6679;DEXAMETHASONE#0.6634;DIPHOSPHATE#0.6629;ATTENTION DEFICIT HYPERACTIVITY DISORDER#0.6615;HEPATITIS C VIRUS#0.6552;CHLOROQUINE#0.6546;FLUOROURACIL#0.6516;STEROL SYNTHESIS#0.6408;MYELOID LEUKEMIA#0.6407;KINASE INHIBITOR#0.6395;TEMOCAPRIL#0.6376;PREGNENOLONE#0.6355;NARCOTIC#0.6309;KUPFFER CELL#0.6293;BENZOIC ACID#0.6273;UBIQUITIN#0.6261;KERATINOCYTE#0.6239;FATTY ACID SYNTHASE#0.6223;SERUM ALBUMIN#0.6215;DIACYLGLYCEROL O ACYLTRANSFERASE#0.6199;FAMILIAL HYPERCHOLESTEROLEMIA#0.6193;VERAPAMIL#0.6192;HUMAN INTESTINAL MICROSOMES#0.6186;DIGESTION#0.6171;ABC TRANSPORTER#0.6165;INDOMETHACIN#0.6159;BREAST CANCER CELL#0.6156;SULFONAMIDE#0.6139;LOPERAMIDE#0.6011
10670	TARGET OF RAPAMYCIN#1.0019;GAP ACTIVITY#0.9955;LYSOSOME#0.9822;RAPAMYCIN#0.9814;GTP BINDING#0.9749;TARGET OF RAPAMYCIN COMPLEX#0.9509;RAGULATOR COMPLEX#0.9248;CELL GROWTH#0.8754;GROWTH FACTOR#0.7768;LYSOSOMAL MEMBRANE#0.7745;MTOR COMPLEX#0.7572;STEM CELL#0.7450;NUTRIENT SENSING#0.7412;AUTOPHAGY#0.7041;LYSOSOME LOCALIZATION#0.7015;PROTEIN COMPLEX#0.6707;SKELETAL MUSCLE#0.6479;AUTOSOMAL DOMINANT CATARACT#0.6184;TRANSCRIPTION FACTOR#0.6026
10671	KINASE INHIBITOR P27#1.0640;CDK INHIBITOR#1.0383;CELL CYCLE REGULATOR#1.0376;CYCLIN DEPENDENT KINASE INHIBITOR#1.0363;SENESCENCE#1.0216;CYCLIN DEPENDENT KINASE#1.0211;KINASE INHIBITOR#1.0204;RETINOBLASTOMA#1.0121;CELLULAR SENESCENCE#1.0100;UBIQUITIN#1.0067;KINASE ACTIVITY#1.0061;RAPAMYCIN#1.0060;PROTEASOME#1.0038;DNA SYNTHESIS#0.9971;G1 PHASE#0.9970;S PHASE#0.9965;CYTOPLASM#0.9943;CELL CYCLE#0.9937;M PHASE#0.9924;CELL CYCLE REGULATION#0.9922;CELL CYCLE ARREST#0.9921;CELL CYCLE CONTROL#0.9915;T CELL#0.9900;TUMOR SUPPRESSOR#0.9881;POLY ADP RIBOSE#0.9870;ENDOTHELIAL GROWTH FACTOR#0.9843;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.9843;OVARIAN#0.9841;AKT SIGNALING#0.9839;INDUCTION OF APOPTOSIS#0.9830;ENDOTHELIAL CELL#0.9816;SQUAMOUS CELL CARCINOMA#0.9810;PROTEIN KINASE#0.9808;SMOOTH MUSCLE#0.9806;HUMAN BREAST CANCER#0.9805;CELL MIGRATION#0.9805;TUMOR CELLS#0.9776;OVARIAN CANCER#0.9769;GROWTH FACTOR RECEPTOR#0.9769;COLORECTAL CANCER#0.9758;SMOOTH MUSCLE CELL#0.9753;PROSTATE CANCER#0.9751;CELL DIVISION#0.9748;ANGIOGENESIS#0.9744;ONCOGENIC#0.9744;MUSCLE CELL#0.9739;ADENOCARCINOMA#0.9739;BREAST CANCER#0.9735;APOPTOTIC#0.9725;RIBOSE#0.9723;BREAST CANCER CELL#0.9721;LUNG CANCER#0.9716;VASCULAR SMOOTH MUSCLE CELL#0.9716;STEM CELL#0.9706;PANCREATIC CANCER#0.9695;MITOGEN ACTIVATED PROTEIN#0.9695;EPITHELIAL CELL#0.9694;HEPATOCELLULAR CARCINOMA#0.9682;GENE EXPRESSION#0.9680;APOPTOSIS#0.9676;COLON CANCER#0.9673;DEPHOSPHORYLATION#0.9664;CELL PROLIFERATION#0.9663;TRANSCRIPTION FACTOR#0.9662;GROWTH FACTOR#0.9662;TARGET OF RAPAMYCIN#0.9655;COLORECTAL#0.9652;CELL ADHESION#0.9651;EPIDERMAL GROWTH FACTOR#0.9649;B CELL#0.9645;CELL GROWTH#0.9644;SIGNALING PATHWAY#0.9625;CYTOCHROME C#0.9615;HISTONE DEACETYLASE#0.9613;CYTOTOXICITY#0.9608;CELL DEATH#0.9601;CANCER CELL#0.9584;REVERSE TRANSCRIPTION#0.9541;ORAL SQUAMOUS CELL CARCINOMA#0.9535;RNA INTERFERENCE#0.9532;POLYMERASE CHAIN REACTION#0.9523;CENTROSOME#0.9480;CLEAVED CASPASE 3#0.9473;INHIBITION OF CELL PROLIFERATION#0.9457;MULTIPLE ENDOCRINE NEOPLASIA#0.9432;LYMPH NODE#0.9422;THYROID CARCINOMA#0.9400;ESTROGEN RECEPTOR#0.9375;VSMC PROLIFERATION#0.9350;SIGNAL TRANSDUCTION#0.9323;TUMOR TISSUES#0.9322;DNA BINDING#0.9316;DRUG RESISTANCE#0.9296;CERVICAL CANCER#0.9262;REACTIVE OXYGEN SPECIES#0.9247;CISPLATIN#0.9222;CELL MOTILITY#0.9213;PROTEIN KINASE B#0.9204;TRANSFORMING GROWTH FACTOR#0.9187;PROLIFERATING CELL NUCLEAR ANTIGEN#0.9167;CELL DIFFERENTIATION#0.9135;MITOCHONDRIAL MEMBRANE#0.9133;TOXICITY#0.9091;BONE MARROW#0.9057;BREAST CARCINOMA#0.9047;AUTOPHAGY#0.9006;CERVICAL#0.9004;QUIESCENCE#0.8948;MECHANISM OF ACTION#0.8888;MACROPHAGE#0.8868;MOUSE EMBRYONIC FIBROBLAST#0.8859;LUNG ADENOCARCINOMA#0.8820;MITOCHONDRIAL MEMBRANE POTENTIAL#0.8815;PLATELET-DERIVED GROWTH FACTOR#0.8793;ANDROGEN RECEPTOR#0.8786;APOPTOTIC CELL DEATH#0.8774;HISTONE DEACETYLASE INHIBITOR#0.8753;MICROTUBULE#0.8743;FOCAL ADHESION#0.8727;MITOSIS#0.8712;ANCHORAGE INDEPENDENT GROWTH#0.8691;COLONY FORMATION ASSAY#0.8620;B CELL LYMPHOMA#0.8612;MITOCHONDRIA#0.8605;SIGNAL TRANSDUCER#0.8575;MYELOID LEUKEMIA#0.8506;DISEASE FREE SURVIVAL#0.8487;SIMIAN IMMUNODEFICIENCY VIRUS#0.8485;REGULATION OF CELL CYCLE#0.8482;PROGENITOR CELL#0.8457;SMOOTH MUSCLE CELL PROLIFERATION#0.8452;MUSCLE CELL PROLIFERATION#0.8449;UBIQUITIN LIGASE COMPLEX#0.8418;NERVOUS SYSTEM#0.8355;SIGNALING CASCADE#0.8351;NUCLEAR EXPORT#0.8344;TYROSINE KINASE INHIBITOR#0.8342;GENE SILENCING#0.8339;TERMINAL DIFFERENTIATION#0.8325;EXTRACELLULAR MATRIX#0.8316;TETRACYCLINE#0.8295;MULTIPLE MYELOMA#0.8287;CELL SURFACE#0.8247;DNA REPLICATION#0.8245;HYPOXIA#0.8225;PROTEIN KINASE C#0.8219;PROTEIN DEGRADATION#0.8200;BINDING PROTEIN 1#0.8191;PROTEASOME PATHWAY#0.8136;RETINOIC ACID#0.8133;CELL CYCLE CHECKPOINT#0.8131;RNA BINDING#0.8074;QUANTITATIVE REAL TIME#0.8052;LUNG CARCINOMA#0.7999;DOXORUBICIN#0.7998;TRANSACTIVATION#0.7967;HEPATOCELLULAR CARCINOMA CELL#0.7948;HEAT SHOCK PROTEIN#0.7920;CELL CYCLE TRANSITION#0.7895;CELLULAR GROWTH#0.7878;TUMOR NECROSIS FACTOR#0.7857;FOCAL ADHESION KINASE#0.7820;SIGNALLING PATHWAY#0.7754;ARTERY#0.7661;UBIQUITIN PROTEASOME PATHWAY#0.7656;PROPIDIUM#0.7620;ENDOTHELIAL CELL PROLIFERATION#0.7578;DNA DAMAGE RESPONSE#0.7556;RECEPTOR TYROSINE KINASE#0.7531;MALIGNANT GLIOMA#0.7530;INTRINSIC APOPTOTIC PATHWAY#0.7485;QUANTITATIVE REVERSE TRANSCRIPTION#0.7432;INVASIVE CARCINOMA#0.7399;TRANSFORMING GROWTH FACTOR BETA#0.7354;MAPK SIGNALING#0.7342;TRANSITIONAL CELL CARCINOMA#0.7281;TELOMERASE ACTIVITY#0.7272;NUCLEAR LOCALIZATION SIGNAL#0.7207;PEROXISOME#0.7193;CENTROSOME DUPLICATION#0.7179;MELATONIN#0.7085;ENHANCER BINDING PROTEIN#0.7050;ENHANCER BINDING#0.7045;CELL QUIESCENCE#0.7041;CASPASE INHIBITOR#0.7020;CELL DIVISION CYCLE#0.7010;PITUITARY ADENOMA#0.6956;IMMUNE RESPONSE#0.6925;SIGNALING MOLECULE#0.6915;DYNEIN#0.6904;EPITHELIAL MESENCHYMAL TRANSITION#0.6893;CDK ACTIVITY#0.6876;THYROID CANCER#0.6856;PROSTATE EPITHELIAL CELL#0.6843;PROGESTERONE#0.6818;LARYNGEAL SQUAMOUS CELL CARCINOMA#0.6797;NEUROBLASTOMA#0.6791;LIVER CANCER#0.6739;RNA BINDING PROTEIN#0.6738;ONCOGENESIS#0.6723;CD4+ T CELL#0.6713;COLON CARCINOMA#0.6706;THYMIDINE#0.6693;MYELOID CELL#0.6681;HUMAN PANCREATIC CANCER#0.6675;CANCER RELATED DEATH#0.6662;RENAL CELL CARCINOMA#0.6619;ACUTE MYELOID LEUKEMIA#0.6616;WOUND HEALING#0.6606;CARDIOMYOCYTE#0.6591;STROMAL CELL#0.6543;MESANGIAL CELL#0.6517;HYPOXIC#0.6516;ACTIVATED CASPASE 3#0.6500;TRANSCRIPTASE#0.6463;PROTEIN PHOSPHORYLATION#0.6461;CELLULAR LOCALIZATION#0.6458;ATHEROSCLEROSIS#0.6452;VIRAL REPLICATION#0.6452;DYNACTIN COMPLEX#0.6444;PERIPHERAL BLOOD#0.6381;HYPERPHOSPHORYLATION#0.6337;5 FLUOROURACIL#0.6331;MECHANISMS OF ACTION#0.6321;SIMVASTATIN#0.6311;FLOW CYTOMETRY ANALYSIS#0.6288;C TERMINAL DOMAIN#0.6235;CENTRAL NERVOUS SYSTEM#0.6204;KINASE INHIBITOR PROTEIN#0.6201;PROTEIN KINASE A#0.6144;MAP KINASE#0.6140;MESOTHELIOMA CELL#0.6130;TRASTUZUMAB#0.6093;ENDOPLASMIC RETICULUM#0.6082;ASTROCYTE#0.6056;IMATINIB#0.6011;NEUROGENESIS#0.6005;JUN PHOSPHORYLATION#0.6003
10672	HETEROTRIMERIC G-PROTEIN#1.0375;CANCER CELL#1.0094;SIGNALING PATHWAY#1.0047;B CELL#0.9916;GUANINE#0.9851;RHOGEF#0.9482;NUCLEOTIDE EXCHANGE FACTOR#0.9469;GENE EXPRESSION#0.9360;NUCLEOTIDE BINDING#0.9214;CELL MIGRATION#0.9124;B CELL LYMPHOMA#0.8932;CELL PROLIFERATION#0.8785;PROTEIN KINASE#0.8683;SIGNAL TRANSDUCTION#0.8578;DIFFUSE LARGE B-CELL LYMPHOMA#0.8578;COLORECTAL CANCER#0.8462;PROSTATE CANCER#0.8433;THROMBIN RECEPTOR#0.8338;APOPTOSIS#0.8302;STRESS FIBER#0.8099;CELL CYCLE#0.8047;PERTUSSIS#0.8019;BREAST CANCER#0.8010;BREAST CANCER CELL#0.7959;CELL GROWTH#0.7734;TRANSCRIPTION FACTOR#0.7650;COLORECTAL#0.7449;GERMINAL CENTER#0.7401;KINASE INHIBITOR#0.7320;GTP BINDING#0.7252;PHOSPHOLIPASE C#0.7224;SMOOTH MUSCLE#0.7114;ONCOGENIC#0.7015;GROWTH FACTOR#0.6617;PLASMA MEMBRANE#0.6516;GUANOSINE#0.6436;TUMOR SUPPRESSOR#0.6239;PHOSPHOLIPASE D#0.6065;ACTIN CYTOSKELETON#0.6060;BURKITT LYMPHOMA#0.6049;METASTATIC BREAST CANCER#0.6014
10673	BELIMUMAB#1.0481;FACTOR I#1.0456;CLASS SWITCHING#1.0352;TUMOUR NECROSIS FACTOR#1.0332;IMMUNOGLOBULIN SECRETION#1.0325;B CELL HOMEOSTASIS#1.0285;TRANSFORMING GROWTH FACTOR#1.0281;HEPATITIS C#1.0260;SJOGREN'S SYNDROME#1.0256;IMMUNOGLOBULIN PRODUCTION#1.0256;B CELL#1.0202;B LYMPHOCYTE#1.0187;TUMOR NECROSIS FACTOR#1.0178;REGULATORY B CELL#1.0175;CELL MATURATION#1.0156;CYCLOPHILIN#1.0152;MYELOID CELL#1.0149;FREE LIGHT CHAIN#1.0144;TRANSITIONAL B CELL#1.0134;HEPATITIS C VIRUS#1.0132;B CELL DIFFERENTIATION#1.0123;B CELL PROLIFERATION#1.0109;B CELL DEVELOPMENT#1.0105;CELL EXPANSION#1.0104;COLLAGEN INDUCED ARTHRITIS#1.0093;LYMPHOCYTIC LEUKEMIA#1.0091;CHRONIC LYMPHOCYTIC LEUKEMIA#1.0090;MULTIPLE MYELOMA#1.0088;EPITHELIAL CELL#1.0084;CELL GROWTH#1.0068;B CELL SELECTION#1.0068;MONOCYTE#1.0053;NAIVE B CELL#1.0050;FOLLICULAR B CELL#1.0046;CELL DEVELOPMENT#1.0045;ANTIBODY PRODUCTION#1.0020;GROWTH FACTOR#1.0014;MYASTHENIA GRAVIS#1.0014;CELL SURFACE#1.0013;HUMORAL IMMUNE RESPONSE#1.0012;MULTIPLE MYELOMA CELLS#1.0002;CELL CYCLE#0.9997;B CELL RECEPTOR#0.9997;SALIVARY GLAND#0.9996;B CELL ACTIVATION#0.9991;B LYMPHOCYTE PROLIFERATION#0.9985;T CELL ACTIVATION#0.9984;NEUTROPHIL#0.9984;PLASMABLAST#0.9973;GM-CSF#0.9970;IL-10 PRODUCTION#0.9969;STROMAL CELL#0.9967;SIGNALING PATHWAY#0.9962;CELL DIFFERENTIATION#0.9960;CLASS SWITCH RECOMBINATION#0.9957;B CELL LYMPHOMA#0.9952;ACTIVATED B CELL#0.9952;MARGINAL ZONE B#0.9951;NON HODGKIN LYMPHOMA#0.9949;LUPUS NEPHRITIS#0.9948;B CELL DEPLETION#0.9945;APOPTOSIS#0.9931;GRAFT VERSUS HOST#0.9930;MARGINAL ZONE B CELL#0.9927;TOLL LIKE RECEPTOR#0.9925;SYSTEMIC AUTOIMMUNE DISEASE#0.9924;MACROPHAGE#0.9918;CELL DEATH#0.9914;TH17 CELL#0.9912;PERIPHERAL BLOOD MONONUCLEAR CELLS#0.9904;CELL PROLIFERATION#0.9903;DISEASE ACTIVITY INDEX#0.9901;POLYMERASE CHAIN REACTION#0.9899;PROTEIN KINASE#0.9899;APOPTOTIC#0.9888;RITUXIMAB#0.9887;MONONUCLEAR CELLS#0.9886;ANTIBODY MEDIATED REJECTION#0.9883;LYMPHOCYTE PROLIFERATION#0.9881;CELL ACTIVATION#0.9869;LYMPHOID CELL#0.9866;REVERSE TRANSCRIPTION#0.9864;IFN-GAMMA#0.9859;T LYMPHOCYTE#0.9856;VASCULITIS#0.9853;MEMORY B CELL#0.9846;DENDRITIC CELL#0.9844;MULTIPLE SCLEROSIS#0.9839;RHEUMATOID ARTHRITIS#0.9839;AUTOIMMUNITY#0.9832;STEM CELL#0.9831;AUTOIMMUNE DISEASE#0.9819;NEPHRITIS#0.9819;LYMPH NODE#0.9819;CENTRAL NERVOUS SYSTEM#0.9810;RHEUMATIC DISEASE#0.9807;CD4+ T CELL#0.9804;LEUKOCYTE#0.9799;LUPUS ERYTHEMATOSUS#0.9799;SYSTEMIC LUPUS ERYTHEMATOSUS#0.9799;GERMINAL CENTER#0.9798;NERVOUS SYSTEM#0.9795;IMMUNE CELL#0.9785;TREG CELL#0.9783;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9767;STEM CELL TRANSPLANTATION#0.9764;PLASMA CELL#0.9764;PERIPHERAL BLOOD#0.9760;LYMPHOCYTE ACTIVATION#0.9757;GENE EXPRESSION#0.9748;CD8+ T CELL#0.9740;T CELL#0.9739;PRO-INFLAMMATORY#0.9737;C REACTIVE PROTEIN#0.9733;LYMPHOID TISSUE#0.9732;CANCER CELL#0.9731;TRANSCRIPTION FACTOR#0.9724;INNATE IMMUNITY#0.9719;COMMON VARIABLE IMMUNODEFICIENCY#0.9717;IMMUNE SYSTEM#0.9712;MECHANISM OF ACTION#0.9698;BONE MARROW#0.9697;DONOR SPECIFIC ANTIBODIES#0.9695;PURPURA#0.9683;IMMUNE RESPONSE#0.9675;HODGKIN'S LYMPHOMA#0.9675;INFLAMMATORY RESPONSE#0.9667;PROTEINURIA#0.9664;REGULATORY T CELL#0.9663;THROMBOCYTOPENIA#0.9583;DIFFUSE LARGE B-CELL LYMPHOMA#0.9580;GERMINAL CENTER B#0.9562;ANTIGEN PRESENTING CELLS#0.9552;ADAPTIVE IMMUNE RESPONSE#0.9542;GERMINAL CENTER B CELL#0.9533;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS#0.9515;BORTEZOMIB#0.9485;LYMPHOID ORGANS#0.9481;ADIPOSE TISSUE#0.9480;CYTIDINE DEAMINASE#0.9425;RECEPTOR LIGAND#0.9399;IMMUNOGLOBULIN G#0.9394;STANDARD OF CARE#0.9384;GRAVES' DISEASE#0.9318;GRANULOCYTE#0.9313;SYNOVIAL FLUID#0.9306;CELL ADHESION#0.9305;RECEPTOR BINDING#0.9294;ADIPOCYTE#0.9294;ENCEPHALOMYELITIS#0.9287;MITOGEN ACTIVATED PROTEIN#0.9281;BREAST CANCER#0.9265;SIGNAL TRANSDUCTION#0.9180;ISOTYPE SWITCHING#0.9144;NEPHROPATHY#0.9139;DEXAMETHASONE#0.9083;CHRONIC HEPATITIS C#0.9074;CYTOKINE PRODUCTION#0.9049;PLASMACYTOID DENDRITIC CELL#0.9017;MANTLE CELL LYMPHOMA#0.9009;RESPONSE TO TREATMENT#0.9003;EOSINOPHIL#0.8991;DERMATOMYOSITIS#0.8959;RECEPTOR ACTIVATOR#0.8950;CHEMOKINE RECEPTOR#0.8939;HEMATOPOIETIC STEM CELL#0.8934;LUNG DISEASE#0.8934;LYMPHOCYTE HOMEOSTASIS#0.8924;ATHEROSCLEROSIS#0.8922;T HELPER CELL#0.8909;B CELL APOPTOSIS#0.8905;CYCLIC CITRULLINATED PEPTIDE#0.8903;BREAST CANCER CELL#0.8897;NF-KAPPAB ACTIVATION#0.8877;EPSTEIN BARR VIRUS#0.8874;VIRAL INFECTION#0.8863;HEPATITIS B#0.8861;HEMATOPOIETIC CELL#0.8860;CYTIDINE#0.8841;FOLLICULAR DENDRITIC CELL#0.8815;ENDOTHELIAL GROWTH FACTOR#0.8801;VASCULAR ENDOTHELIAL GROWTH FACTOR#0.8801;SIGNALLING PATHWAY#0.8747;HYPERGAMMAGLOBULINEMIA#0.8733;SPINAL CORD#0.8712;GLOMERULONEPHRITIS#0.8676;B LYMPHOCYTE HOMEOSTASIS#0.8674;IMMUNOSUPPRESSANT#0.8671;CONNECTIVE TISSUE#0.8667;NITRIC OXIDE#0.8621;ENDOTHELIAL CELL#0.8615;DNA BINDING#0.8589;HYPERACTIVITY#0.8584;FIBROBLAST LIKE SYNOVIOCYTES#0.8570;LIVER DISEASE#0.8567;INTERSTITIAL LUNG DISEASE#0.8565;LYMPHOCYTE DEVELOPMENT#0.8563;NEUROMYELITIS OPTICA#0.8545;TUMOR CELLS#0.8543;CYCLOPHOSPHAMIDE#0.8516;CYTOTOXICITY#0.8514;BULLOUS PEMPHIGOID#0.8491;SYNOVIUM#0.8484;CORD BLOOD#0.8452;MALARIA#0.8438;MARROW STROMAL CELLS#0.8413;BONE MARROW STROMAL CELL#0.8413;BONE MARROW STROMAL#0.8408;IFN-BETA#0.8349;REACTIVE OXYGEN SPECIES#0.8327;POLYMYOSITIS#0.8322;RETINOIC ACID#0.8314;INTRAVENOUS IMMUNOGLOBULIN#0.8288;PLASMA MEMBRANE#0.8285;OSTEOARTHRITIS#0.8262;PEMPHIGUS#0.8258;MEMORY T CELL#0.8254;ACETYLCHOLINE RECEPTOR#0.8234;CELL ASSOCIATED#0.8225;HUMAN IMMUNODEFICIENCY VIRUS#0.8176;AUTOIMMUNE HEPATITIS#0.8171;TRANSCRIPTASE#0.8163;KIDNEY TRANSPLANT RECIPIENTS#0.8158;GERMINAL CENTER FORMATION#0.8100;CHRONIC OBSTRUCTIVE PULMONARY DISEASE#0.8094;IL-11#0.8048;TONSIL#0.8039;G-CSF#0.8034;COLONY-STIMULATING FACTOR#0.8027;CELL MEMBRANE#0.8020;CONNECTIVE TISSUE DISEASE#0.7998;SKIN DISEASE#0.7957;B LYMPHOCYTE ACTIVATION#0.7945;METHOTREXATE#0.7945;TYPE 1 DIABETES#0.7930;CYTOKINE RECEPTOR#0.7924;T CELL PROLIFERATION#0.7923;HIGH FAT DIET#0.7918;MYOSITIS#0.7893;TRANSFORMING GROWTH FACTOR BETA#0.7889;MESENTERIC LYMPH NODE#0.7861;DISEASE ACTIVITY SCORE#0.7808;CYTOKINE SECRETION#0.7779;INFLAMMATORY BOWEL DISEASE#0.7740;ALLERGEN#0.7705;MACROGLOBULINEMIA#0.7686;ASTROCYTE#0.7681;FACTOR S#0.7663;INNATE IMMUNE SYSTEM#0.7642;ACTIVATION OF NF-KAPPAB#0.7578;PERIPHERAL BLOOD LYMPHOCYTES#0.7568;HEPATITIS B VIRUS#0.7561;MESENCHYMAL STEM CELL#0.7558;SWITCHED MEMORY B CELL#0.7527;IL-1RA#0.7518;LYMPHOPENIA#0.7505;PROTEASOME#0.7505;PERIODONTITIS#0.7499;TOXICITY#0.7490;ANEMIA#0.7414;PRIMARY BILIARY CIRRHOSIS#0.7381;RAPAMYCIN#0.7380;MAP KINASE#0.7379;PROTEOGLYCAN#0.7346;OSTEOCLAST#0.7337;ANTIGEN PRESENTATION#0.7326;INSULIN-LIKE GROWTH FACTOR#0.7309;MAJOR HISTOCOMPATIBILITY COMPLEX#0.7298;QUANTITATIVE REAL TIME#0.7284;ANTIPHOSPHOLIPID SYNDROME#0.7283;JUVENILE IDIOPATHIC ARTHRITIS#0.7282;BASOPHIL#0.7262;ACETYLCHOLINE#0.7255;SERIOUS ADVERSE EVENT#0.7247;T1 B CELL#0.7187;STEM CELL FACTOR#0.7186;INFLAMMATORY CELL#0.7181;OBESE#0.7157;SIGNAL TRANSDUCER#0.7123;PEMPHIGUS VULGARIS#0.7116;PLASMA CELL DIFFERENTIATION#0.7111;PROTEIN KINASE C#0.7100;HUMAN LEUKOCYTE ANTIGEN#0.7092;ALEMTUZUMAB#0.7092;ENDOMETRIOSIS#0.7074;ADAPTIVE IMMUNE SYSTEM#0.7027;ERYTHROCYTE SEDIMENTATION RATE#0.6977;BETA-2#0.6971;EPRATUZUMAB#0.6970;CELL ADHESION MOLECULE#0.6944;CHRONIC HEPATITIS B#0.6930;RESPONSE TO TNF#0.6915;MONOCYTE DERIVED DENDRITIC CELL#0.6879;IGG ANTIBODY#0.6872;CD3+ T CELL#0.6871;IMMUNE THROMBOCYTOPENIC PURPURA#0.6862;IL-6 PRODUCTION#0.6839;RHEUMATISM#0.6838;CRYOGLOBULINEMIA#0.6832;RANDOMIZED CONTROLLED TRIAL#0.6817;T FOLLICULAR HELPER#0.6816;GLYCOSYLATION#0.6815;OLIGODENDROCYTE#0.6812;STATISTICALLY SIGNIFICANT DIFFERENCE#0.6807;SECONDARY LYMPHOID ORGANS#0.6789;ERYTHROCYTE#0.6781;NITRIC OXIDE SYNTHASE#0.6760;HEPATOCELLULAR CARCINOMA#0.6755;HYPERSENSITIVITY#0.6709;GELONIN#0.6708;GINGIVAL CREVICULAR FLUID#0.6702;PROTEIN SYNTHESIS#0.6691;COMPLEMENT ACTIVATION#0.6678;HYDROXYCHLOROQUINE#0.6638;BONE MARROW MICROENVIRONMENT#0.6582;FOLLICULAR HELPER T CELL#0.6571;SIALADENITIS#0.6569;ALANINE#0.6569;INNATE IMMUNE RESPONSE#0.6540;TERMINAL DIFFERENTIATION#0.6434;HIGH MOBILITY GROUP#0.6426;AUTOIMMUNE BULLOUS DISEASES#0.6402;B1 CELL#0.6402;CELL CYCLE ARREST#0.6401;FRAGMENT LENGTH POLYMORPHISM#0.6398;STROMA#0.6396;TUMOR NECROSIS FACTOR RECEPTOR 2#0.6388;IL-35 PRODUCTION#0.6375;MEAN FLUORESCENCE INTENSITY#0.6329;MYELOID DENDRITIC CELL#0.6314;ETANERCEPT#0.6304;METHYLPREDNISOLONE#0.6286;ABATACEPT#0.6284;FOLLICULAR LYMPHOMA#0.6281;SENSITIZATION#0.6279;INTERLEUKIN 6 RECEPTOR#0.6276;HEALTHY CONTROL SUBJECTS#0.6259;ATOPIC DERMATITIS#0.6248;NATURAL KILLER CELL#0.6237;MUTAGENESIS#0.6213;AIRWAY EPITHELIAL CELL#0.6209;POLYNEUROPATHY#0.6198;PANCREATITIS#0.6198;SPUTUM#0.6178;TO FIRST TREATMENT#0.6146;QUANTITATIVE REVERSE TRANSCRIPTION#0.6137;UBIQUITIN#0.6122;AUTOIMMUNE PANCREATITIS#0.6120;ARTERY#0.6102;HYPOXIA#0.6093;SURFACTANT PROTEIN D#0.6082;GERMINAL CENTRE B#0.6046;MYCOPHENOLATE MOFETIL#0.6025;ANGIOGENESIS#0.6018;CYTOPLASM#0.6015
10675	CHONDROITIN SULFATE PROTEOGLYCAN#1.1140;PROTEOGLYCAN#1.1016;GROWTH FACTOR#1.0042;EPIDERMAL GROWTH FACTOR#0.9308;NERVOUS SYSTEM#0.9165;CENTRAL NERVOUS SYSTEM#0.8762;RETINAL DEGENERATION#0.8115;CELL SURFACE#0.7197;NEURITE OUTGROWTH#0.7165;NEURITE#0.7042;LEUCINE#0.6624;PROTEIN TYROSINE PHOSPHATASE#0.6422;NEURONAL MIGRATION#0.6405;RETINAL PIGMENT EPITHELIUM#0.6398;GENE EXPRESSION#0.6333;GLYCOSYLATION#0.6178;SOTOS SYNDROME#0.6102
10677	IBUPROFEN#0.9020;ACTIN BINDING#0.8832;ACTIN BINDING PROTEIN#0.7617;DORSAL ROOT GANGLION#0.6905
106783499	DOMINANT OPTIC ATROPHY#0.7687;OPTIC ATROPHY#0.7564
10678	O GLYCAN#1.0910;GLCNAC#1.0525;N GLYCAN#1.0494;GROWTH FACTOR#1.0243;TRANSFORMING GROWTH FACTOR#1.0095;GLYCOSYLATION#1.0048;BETA-2#0.9782;CELL SURFACE#0.9757;BETA GALACTOSIDASE#0.9408;CANCER CELL#0.9253;UDP-GAL#0.9240;LECTIN#0.9189;ASPARAGINE#0.9171;EPITHELIAL CELL#0.8871;CELL ADHESION#0.8315;UDP GALACTOSE#0.8162;ERYTHROCYTE#0.7909;DIGESTION#0.7843;MICROSOME#0.7828;TRANSFERASE ACTIVITY#0.7639;GLUCOSAMINE#0.7484;GLCNAC TRANSFERASE ACTIVITY#0.7456;SIALYLATION#0.7240;LEUKOCYTE#0.7072;EXTRACELLULAR MATRIX#0.7069;CELL GROWTH#0.7007;SMALL INTESTINE#0.6966;POLYMERASE CHAIN REACTION#0.6904;CHONDROCYTE#0.6413;WALKER-WARBURG SYNDROME#0.6306;CELL MIGRATION#0.6295;GENE EXPRESSION#0.6161;COLON CANCER#0.6106;TUMOR CELLS#0.6002
10681	BIPOLAR CELL#1.0192;PLASMA MEMBRANE#0.9769;HETEROTRIMERIC G-PROTEIN#0.8688;SIGNALING PATHWAY#0.8538;GTPASE ACTIVITY#0.8084;NUCLEOTIDE BINDING#0.8073;SIGNAL TRANSDUCTION#0.7584;NERVOUS SYSTEM#0.7428;GUANINE#0.7064;OPIOID RECEPTOR#0.6505;PROTEIN PROTEIN INTERACTION#0.6374;AKT SIGNALING#0.6259;SPINAL CORD#0.6093
10682	CHONDRODYSPLASIA PUNCTATA#1.0552;CHOLESTEROL BIOSYNTHESIS#1.0441;GLUCOSE REGULATED PROTEIN#1.0371;DOMINANT NEGATIVE MUTANT#1.0223;STEROL REGULATORY ELEMENT#1.0188;ENHANCER BINDING#1.0156;ACTIVATING TRANSCRIPTION FACTOR#1.0156;ENHANCER BINDING PROTEIN#1.0155;DNA BINDING#1.0069;TRANSCRIPTION FACTOR#0.9997;PROTEIN DISULFIDE ISOMERASE#0.9994;EPITHELIAL CELL#0.9988;ADIPOGENESIS#0.9977;TRANSACTIVATION#0.9966;ELECTROPHORETIC MOBILITY SHIFT#0.9956;ADIPOCYTE#0.9909;UNFOLDED PROTEIN RESPONSE#0.9851;SIGNALING PATHWAY#0.9841;MACROPHAGE#0.9837;LEUCINE#0.9835;ADIPOCYTE DIFFERENTIATION#0.9827;PROTEIN KINASE#0.9827;GENE EXPRESSION#0.9808;BINDING PROTEIN 1#0.9805;ADIPOSE TISSUE#0.9801;ENDOPLASMIC RETICULUM#0.9800;APOPTOSIS#0.9800;ENDOPLASMIC RETICULUM STRESS#0.9692;PROTEIN BINDING#0.9609;GROWTH FACTOR#0.9593;PEROXISOME#0.9514;PREADIPOCYTE#0.9506;CAAT ENHANCER BINDING#0.9357;APOPTOTIC#0.9344;CAMP RESPONSE ELEMENT#0.9331;TUMOR NECROSIS FACTOR#0.9296;TERMINAL DIFFERENTIATION#0.9293;CELL CYCLE#0.9251;EUKARYOTIC INITIATION FACTOR#0.9225;HEPATOMA CELLS#0.9224;INTESTINAL EPITHELIAL CELL#0.9181;CELL DEATH#0.9160;ACUTE PHASE RESPONSE#0.9158;CHOLINE#0.9142;SIGNAL TRANSDUCTION#0.9044;DEXAMETHASONE#0.9032;GLUCOCORTICOID RECEPTOR#0.8889;CELL PROLIFERATION#0.8887;POLYMERASE CHAIN REACTION#0.8809;MONOCYTE#0.8806;MUTAGENESIS#0.8684;SKELETAL MUSCLE#0.8639;CANCER CELL#0.8635;MUSCLE CELL#0.8556;MITOGEN ACTIVATED PROTEIN#0.8523;CELL GROWTH#0.8432;PHOSPHATIDYLCHOLINE SYNTHESIS#0.8088;ICHTHYOSIS#0.8081;PHOSPHATIDYLETHANOLAMINE#0.7979;REACTIVE OXYGEN SPECIES#0.7919;CYCLIC AMP#0.7833;FATTY LIVER#0.7698;FATTY ACID SYNTHASE#0.7669;FACTOR I#0.7573;PHOSPHOENOLPYRUVATE CARBOXYKINASE#0.7557;SMOOTH MUSCLE#0.7523;FATTY ACID BINDING#0.7461;PROTEIN FOLDING#0.7316;PHOSPHOLIPID BIOSYNTHETIC#0.7213;T CELL#0.7205;ALOPECIA#0.7205;SIGNAL TRANSDUCER#0.7203;MITOTIC CLONAL EXPANSION#0.7186;SUPEROXIDE DISMUTASE#0.7168;REGENERATION#0.7123;LIVER DISEASE#0.7123;HEPATOCYTE NUCLEAR FACTOR#0.7119;N METHYLTRANSFERASE#0.7046;ASTROCYTE#0.6992;CAMP RESPONSE ELEMENT BINDING#0.6929;LIPID METABOLISM#0.6928;WHITE ADIPOSE TISSUE#0.6921;CRE BINDING#0.6872;CELL DIFFERENTIATION#0.6866;RESPONSE TO LPS#0.6864;NITRIC OXIDE#0.6843;PROTEIN KINASE A#0.6774;MAP KINASE#0.6770;PHOSPHOLIPID BIOSYNTHESIS#0.6668;CAMP-RESPONSIVE ELEMENT BINDING#0.6600;ENDOTHELIAL CELL#0.6543;MYELOID CELL#0.6499;FATTY LIVER DISEASE#0.6493;PLASMA MEMBRANE#0.6455;PHOSPHOENOLPYRUVATE#0.6390;MYOTUBE#0.6337;IL-6 PRODUCTION#0.6330;X CHROMOSOME#0.6328;TAMOXIFEN#0.6321;GLUTATHIONE#0.6319;OUTER MEMBRANE#0.6299;MONOCYTE CHEMOATTRACTANT PROTEIN#0.6297;HUMAN IMMUNODEFICIENCY VIRUS#0.6265;REVERSE TRANSCRIPTION#0.6160;PROTEIN SYNTHESIS#0.6136;MITOTIC SPINDLE#0.6097;LUNG EPITHELIAL CELL#0.6097;ER STRESS RESPONSE#0.6063;LIVER DEVELOPMENT#0.6052;ACTIVATOR PROTEIN 1#0.6016;ISOMERASE ACTIVITY#0.6013;SMOOTH MUSCLE CELL#0.6010
10683	SPONDYLOCOSTAL DYSOSTOSIS#1.0705;NOTCH LIGAND#1.0471;DYSOSTOSIS#1.0220;NOTCH RECEPTOR#1.0155;LUNG CANCER#1.0105;GAMMA DELTA T CELL#1.0090;NOTCH SIGNALING PATHWAY#1.0059;ENOYL COA HYDRATASE#0.9961;T CELL#0.9930;SIGNALING PATHWAY#0.9909;POLYMERASE CHAIN REACTION#0.9908;SOMITOGENESIS#0.9904;BREAST CANCER#0.9902;PERIPHERAL BLOOD#0.9849;GENE EXPRESSION#0.9773;TUMOR CELLS#0.9724;STEM CELL#0.9579;TRANSCRIPTION FACTOR#0.9514;ISOMERASE ACTIVITY#0.9372;ACUTE LYMPHOBLASTIC LEUKEMIA#0.9360;SOMITE#0.9284;PEROXISOMAL#0.9222;CANCER CELL#0.9177;B CELL#0.9106;GROWTH FACTOR#0.9081;NERVOUS SYSTEM#0.8892;NEUROENDOCRINE TUMOR#0.8857;PHOSPHOLIPASE C#0.8628;CELL SURFACE#0.8370;PULMONARY NEUROENDOCRINE TUMOR#0.8324;APOPTOSIS#0.8236;ESTROGEN RECEPTOR#0.8125;BONE MARROW#0.7996;NEUROENDOCRINE CARCINOMA#0.7922;1,8-CINEOLE#0.7895;EPITHELIAL CELL#0.7824;PROTEIN KINASE#0.7818;BETA-HYDROXYSTEROID DEHYDROGENASE#0.7787;CELL DIFFERENTIATION#0.7666;PROGENITOR CELL#0.7662;CELL DEVELOPMENT#0.7659;NOTCH SIGNALLING PATHWAY#0.7638;SIGNALLING PATHWAY#0.7614;HEPATOCELLULAR CARCINOMA#0.7336;OVARIAN#0.7325;ELECTRON TRANSFER#0.7294;SCOLIOSIS#0.7265;DNA BINDING#0.7236;MULTIPLE SCLEROSIS#0.7189;PEROXISOME#0.7129;NEUROGENESIS#0.7018;EPIDERMAL GROWTH FACTOR#0.6989;VERTEBRAE#0.6968;MINIMAL RESIDUAL DISEASE#0.6940;GROWTH HORMONE#0.6769;REVERSE TRANSCRIPTION#0.6733;CELL PROLIFERATION#0.6732;T CELL DEVELOPMENT#0.6647;BREAST CANCER CELL#0.6636;PROSTATE CANCER#0.6630;T LYMPHOCYTE#0.6569;SKELETAL MUSCLE#0.6499;LYMPH NODE#0.6491;CELL CYCLE#0.6424;CINEOLE#0.6424;OCTAHYDROINDOLE-2-CARBOXYLIC ACID#0.6410;NEUROENDOCRINE CELL#0.6352;TRIFUNCTIONAL ENZYME#0.6349;PROGESTERONE#0.6181;HEAT SHOCK PROTEIN#0.6171;AXIAL SKELETON#0.6167
10686	TIGHT JUNCTION PROTEIN#1.0624;NEPHROCALCINOSIS#1.0489;TIGHT JUNCTION#1.0311;EPITHELIAL CELL#1.0138;EXCRETION#0.9459;GENE EXPRESSION#0.9195;LOOP OF HENLE#0.9136;BREAST CANCER#0.8956;MAGNESIUM TRANSPORT#0.8801;TRANSIENT RECEPTOR POTENTIAL#0.8782;PROTEIN KINASE#0.8714;NEPHROLITHIASIS#0.8640;NEPHRON#0.8617;PLASMA MEMBRANE#0.8534;PROTEIN KINASE A#0.8114;LYSOSOME#0.8084;CANCER CELL#0.7933;KIDNEY DISEASE#0.7776;AUTOSOMAL RECESSIVE DISEASE#0.7160;HUMAN BREAST CANCER#0.6809;ENDOCYTOSIS#0.6587;TRANSEPITHELIAL ELECTRICAL RESISTANCE#0.6456;ION TRANSPORT#0.6453;CALCIUM TRANSPORT#0.6173;PRE-MRNA SPLICING#0.6109;CELL SURFACE#0.6095;POLYURIA#0.6080;MRNA SPLICING#0.6072
10687	POTASSIUM CHANNEL#0.9099;NMDA RECEPTOR#0.8657;ASPARTATE#0.8197;PARANEOPLASTIC NEUROLOGICAL SYNDROME#0.8157;CEREBRAL CORTEX#0.8091;BREAST CANCER#0.7766;GERM CELL#0.7689;CELL MEMBRANE#0.7506;SPINAL CORD#0.6563;NEURONAL CELL BODIES#0.6263;T CELL#0.6184;GANGLION CELLS#0.6177;CREUTZFELDT JAKOB DISEASE#0.6047;CELL SURFACE ANTIGEN#0.6026
1068	BASAL BODY#1.0225;CENTROSOME#0.9341;CENTROMERE#0.9254;GENE EXPRESSION#0.6405;CANCER TESTIS ANTIGEN#0.6369;PANCREATIC CANCER#0.6178;CELL DIVISION#0.6096
10690	NEURITE OUTGROWTH#0.8286;CELL SURFACE#0.8202;FUCOSYLATION#0.8189;COLORECTAL CANCER#0.7874;STEM CELL#0.7518;GLYCOSYLATION#0.7426;NEURITE#0.6635;LEUKOCYTE#0.6189;CANCER CELL#0.6112
10691	BINDING PROTEIN 1#1.0620;GLUCOCORTICOID RECEPTOR#1.0524;APOPTOSIS#0.8669;TRANSACTIVATION#0.8152;DNA BINDING#0.6437;M LINE#0.6340;T CELL APOPTOSIS#0.6137;ZINC BINDING#0.6099
10692	OPSIN#1.0958;RETINAL PIGMENT EPITHELIUM#0.9812;RETINITIS PIGMENTOSA#0.8475;RETINITIS#0.6809;RETINAL VEIN OCCLUSION#0.6621
10694	CHAPERONIN#1.0326;CHAPERONIN-CONTAINING T-COMPLEX#0.6657;CELL PROLIFERATION#0.6158
10695	CELL SURFACE#1.1086;TOLL LIKE RECEPTOR#0.9559;ENDOPLASMIC RETICULUM#0.8515;IMMUNE RESPONSE#0.8204;CLASSICAL MONOCYTE#0.6262;PANETH CELL#0.6127
10699	HYPERTENSION#1.0549;CARDIOMYOCYTE#0.9617;ZYMOGEN ACTIVATION#0.9601;CELL SURFACE#0.9259;HEART DISEASE#0.9237;DILATED CARDIOMYOPATHY#0.8906;SYSTOLIC BLOOD PRESSURE#0.8141;ARTERY#0.8073;CARDIOMYOPATHY#0.7725;TOTAL HIP ARTHROPLASTY#0.7084;GENE EXPRESSION#0.7041;FLOOR PLATE#0.6776;DALLAS HEART STUDY#0.6503;MIDBRAIN#0.6273;PRE-ECLAMPSIA#0.6267;CORONARY ARTERY#0.6159;SIGNALING PATHWAY#0.6120;NEPHROTIC SYNDROME#0.6099;TRANSCRIPTION FACTOR#0.6045;CORONARY ARTERY DISEASE#0.6043;ARTERY DISEASE#0.6041
1069	CENTROMERE#1.0374;NUCLEOTIDE EXCISION REPAIR#1.0305;CENTROSOME#1.0300;XERODERMA PIGMENTOSUM GROUP C#1.0240;XERODERMA PIGMENTOSUM#1.0211;CENTRIOLE#0.9979;BASAL BODY#0.9440;C TERMINAL DOMAIN#0.9017;CENTROSOME DUPLICATION#0.8963;SPINDLE POLE#0.8810;GENE EXPRESSION#0.8739;DNA REPAIR#0.8625;CONNECTING CILIUM#0.7971;CELL CYCLE#0.7952;CILIOGENESIS#0.7667;MICROTUBULE#0.7627;CELL DIVISION#0.7552;CILIUM#0.7454;CENTRIOLE ASSEMBLY#0.7316;CENTRIOLE DUPLICATION#0.7173;EPITHELIAL CELL#0.6374;METAL BINDING#0.6143;PROTEIN COMPLEX#0.6013
106	HETEROCHROMATIN FORMATION#0.7827
1070	SPINDLE POLE BODY#1.0149;SPINDLE POLE#1.0061;CENTROMERE#1.0002;TREX-2 COMPLEX#0.9771;CENTROSOME#0.8775;NUCLEAR PORE#0.8509;NUCLEAR EXPORT#0.8116;BASAL BODY#0.7942;MICROTUBULE#0.7721;SPINDLE POLE BODY DUPLICATION#0.7643;GENE EXPRESSION#0.7593;CONNECTING CILIUM#0.7310;MICROTUBULE ORGANIZING CENTER#0.6807;MITOSIS#0.6733;CELL CYCLE#0.6417;CELL DIVISION#0.6360;CENTRIOLE#0.6245
107126360	ACYL COA OXIDASE#0.6292
10712	HEPATOCELLULAR CARCINOMA#0.7369
10713	CELL CYCLE#1.0938;CANCER CELL#1.0859;UBIQUITIN#1.0759;CELL PROLIFERATION#1.0648;APOPTOSIS#1.0244;M PHASE#1.0062;MRNA SPLICING#0.9908;UBIQUITIN SPECIFIC PROTEASE#0.9495;RNA INTERFERENCE#0.9182;HEPATOCELLULAR CARCINOMA#0.9153;CELL GROWTH#0.9093;CELL CYCLE ARREST#0.8970;ONCOGENIC#0.8362;PRE-MRNA SPLICING#0.8358;COLORECTAL CANCER#0.8303;BREAST CANCER#0.8253;SIGNALING PATHWAY#0.7929;OVARIAN CANCER#0.7874;BREAST CANCER CELL#0.7700;SPINDLE CHECKPOINT#0.7194;SPLICEOSOME#0.7026;PROTEIN KINASE#0.6954;COLORECTAL#0.6519;MRNA PROCESSING#0.6431;DEUBIQUITINASE#0.6234
10714	TRANSCRIPTASE#1.0196;DNA REPLICATION#1.0100;DNA SYNTHESIS#0.9986;HUMAN IMMUNODEFICIENCY VIRUS#0.9934;TELOMERE#0.9291;RNASE H ACTIVITY#0.9190;CELL CYCLE#0.9057;DNA REPAIR#0.8760;DNA DAMAGE RESPONSE#0.8704;VIRION#0.8653;MUTAGENESIS#0.8078;S PHASE#0.8069;TRANSLESION SYNTHESIS#0.7746;CANCER CELL#0.7541;RIBONUCLEASE H#0.7501;PROLIFERATING CELL NUCLEAR ANTIGEN#0.7490;HOMOLOGOUS RECOMBINATION#0.7395;REPLICATION FORK#0.6903;DNA BINDING#0.6813;PYRIMIDINE METABOLISM#0.6344;DNA POLYMERASE ACTIVITY#0.6204
10715	CERAMIDE SYNTHESIS#1.0044;CELL DEATH#1.0037;ENDOPLASMIC RETICULUM#0.9736;APOPTOSIS#0.9181;CERAMIDE SYNTHASE ACTIVITY#0.8749;SKELETAL MUSCLE#0.8352;SPHINGOSINE#0.7974;CANCER CELL#0.7568;GENE EXPRESSION#0.7222;APOPTOTIC#0.6996;ENZYME ACTIVITY#0.6377;SPHINGOLIPID BIOSYNTHESIS#0.6331;SPHINGOLIPID METABOLISM#0.6291;MITOCHONDRIA#0.6234;PROTEIN KINASE#0.6148;CELL GROWTH#0.6129
10716	TRANSCRIPTION FACTOR#1.0295;AUTISM SPECTRUM DISORDER#1.0256;CEREBRAL CORTEX#1.0033;PROGENITOR CELL#0.9932;NEUROGENESIS#0.9764;INTELLECTUAL DISABILITY#0.9730;GLUTAMATERGIC NEURON#0.9722;TELENCEPHALON#0.9712;OLFACTORY BULB#0.9690;GENE EXPRESSION#0.9671;STEM CELL#0.9609;FOREBRAIN#0.9563;INTERNEURON#0.9423;BRAIN DEVELOPMENT#0.9355;INTERMEDIATE PROGENITOR CELL#0.9059;AMYGDALA#0.9043;CAJAL-RETZIUS CELL#0.8611;CORTICOGENESIS#0.8408;NEURONAL MIGRATION#0.8294;NMDA RECEPTOR#0.8138;GROWTH FACTOR#0.8054;PLURIPOTENT STEM CELL#0.7274;NERVOUS SYSTEM#0.7215;AUTISTIC#0.7200;INDUCED PLURIPOTENT STEM CELL#0.7038;NEURAL STEM CELL#0.6980;ASTROCYTE#0.6929;PROTEIN KINASE#0.6749;FOREBRAIN DEVELOPMENT#0.6466;POLYMERASE CHAIN REACTION#0.6214;CELL ADHESION#0.6197;GUANYLATE KINASE#0.6100;CENTRAL NERVOUS SYSTEM#0.6067
10717	INTELLECTUAL DISABILITY#0.9230;PARAPLEGIA#0.9229;PROTEIN COMPLEX#0.8838;HEREDITARY SPASTIC PARAPLEGIA#0.8809;HEMIDESMOSOME#0.7303;GROWTH FACTOR#0.6988;SIGNAL TRANSDUCTION#0.6214
10718	GROWTH FACTOR#1.0089;MAMMARY GLAND#0.9374;EPIDERMAL GROWTH FACTOR#0.8973;NERVOUS SYSTEM#0.8804;BIPOLAR DISORDER#0.8647;BREAST CANCER#0.8274;CENTRAL NERVOUS SYSTEM#0.8007;RECEPTOR TYROSINE KINASE#0.7849;SIGNALING PATHWAY#0.7796;MAMMARY GLAND DEVELOPMENT#0.7386;GLAND DEVELOPMENT#0.7367;GENE EXPRESSION#0.7124;INTERNEURON#0.7106;MORPHOGENESIS#0.6508;CANCER CELL#0.6151
1071	PROTEIN DEFICIENCY#1.0569;PROBUCOL#1.0391;HDL REMODELING#1.0366;PLASMA PROTEIN#1.0305;HEPATIC LIPASE#1.0303;PRAVASTATIN#1.0302;MOLECULAR DYNAMICS SIMULATION#1.0261;OLEIC ACID#1.0258;FRAGMENT LENGTH POLYMORPHISM#1.0208;LIPID BINDING#1.0184;LIPOPOLYSACCHARIDE BINDING#1.0177;ALZHEIMER'S DISEASE#1.0171;TYPE 2 DIABETIC#1.0160;LCAT ACTIVITY#1.0157;PHOSPHOLIPASE A2#1.0146;ATP BINDING CASSETTE TRANSPORTER#1.0113;INTIMA MEDIA THICKNESS#1.0108;PEROXISOME#1.0106;TYPE 1 DIABETIC#1.0098;NIACIN#1.0091;LIPOPROTEIN LIPASE#1.0090;ADIPOCYTE#1.0082;CHOLESTEROL METABOLISM#1.0081;LIVER X RECEPTOR#1.0077;ALDOSTERONE#1.0070;C REACTIVE PROTEIN#1.0043;PALMITIC ACID#1.0042;SIMVASTATIN#1.0041;VASCULAR DISEASE#1.0038;HIGH CHOLESTEROL DIET#1.0037;ADIPOSE TISSUE#1.0034;HIGH FAT DIET#1.0034;ATP BINDING CASSETTE#1.0032;OBESE#1.0027;CHOLESTEROL ESTERIFICATION#1.0026;FAMILIAL HYPERCHOLESTEROLEMIA#1.0016;ATP BINDING#1.0005;ATORVASTATIN#1.0002;EZETIMIBE#0.9999;NICOTINIC ACID#0.9997;SCAVENGER RECEPTOR#0.9995;TYPE 2 DIABETES MELLITUS#0.9991;2 DIABETES MELLITUS#0.9991;TRIGLYCERIDE LIPASE#0.9989;COENZYME A#0.9985;LDL RECEPTOR#0.9978;POLYMERASE CHAIN REACTION#0.9977;CHOLESTEROL HOMEOSTASIS#0.9977;LIPASE ACTIVITY#0.9969;ACUTE CORONARY SYNDROME#0.9959;LIPOPROTEIN PARTICLE#0.9952;RECEPTOR AGONIST#0.9949;CATABOLISM#0.9946;C-LEVEL#0.9942;HDL PARTICLE#0.9921;LDL PARTICLE#0.9921;REVERSE CHOLESTEROL TRANSPORT#0.9907;HIGH CARDIOVASCULAR RISK#0.9901;HYPERCHOLESTEROLEMIA#0.9899;CHOLESTEROL TRANSPORT#0.9897;FENOFIBRATE#0.9896;MULTIPLE REGRESSION ANALYSIS#0.9894;MULTIPLE LINEAR REGRESSION#0.9875;STRUCTURE ACTIVITY RELATIONSHIP#0.9875;CHOLESTEROL EFFLUX#0.9872;LINEAR REGRESSION ANALYSIS#0.9871;CORONARY ARTERY DISEASE#0.9871;ARTERY DISEASE#0.9868;LIPOPROTEIN METABOLISM#0.9863;FIBRINOGEN#0.9859;NITRIC OXIDE#0.9855;WEIGHT LOSS#0.9840;CORONARY ARTERY#0.9835;DIABETES MELLITUS#0.9834;RESPONSE TO STATIN#0.9833;TYPE 2 DIABETES#0.9825;VERY-LOW-DENSITY LIPOPROTEIN#0.9823;GENE EXPRESSION#0.9816;B CELL#0.9812;MYOCARDIAL INFARCTION#0.9808;LIPID METABOLISM#0.9807;CHYLOMICRON#0.9803;ATHEROSCLEROSIS#0.9800;HYPERTENSION#0.9795;ARTERY#0.9794;MACROPHAGE#0.9777;ATHEROSCLEROTIC#0.9774;WESTERN TYPE DIET#0.9769;HIGH DENSITY LIPOPROTEIN#0.9767;CORONARY HEART DISEASE#0.9767;HEART DISEASE#0.9749;GRADIENT GEL ELECTROPHORESIS#0.9738;CARDIOVASCULAR RISK FACTOR#0.9729;EXCRETION#0.9725;FATTY LIVER#0.9711;LOW DENSITY LIPOPROTEIN#0.9694;PLASMA GLYCOPROTEIN#0.9689;LIPOLYSIS#0.9670;ENDOTHELIAL NITRIC OXIDE#0.9665;LIPID TRANSPORT#0.9651;TRANSCRIPTION FACTOR#0.9636;GLUCOSE METABOLISM#0.9634;AGE RELATED MACULAR DEGENERATION#0.9615;MACULAR DEGENERATION#0.9610;ISCHEMIC HEART DISEASE#0.9589;TOXICITY#0.9585;DOUBLE TRANSGENIC MICE#0.9511;TRANS FATTY ACID#0.9511;ENDOTHELIAL CELL#0.9504;NEPHROTIC SYNDROME#0.9497;PARTICLE SIZE DISTRIBUTION#0.9460;HEPARIN#0.9451;HIGH-DENSITY LIPOPROTEIN PARTICLE#0.9391;KUPFFER CELL#0.9373;LOW-DENSITY LIPOPROTEIN PARTICLE#0.9336;NITRIC OXIDE SYNTHASE#0.9320;CHOLESTEROL SYNTHESIS#0.9296;LPS BINDING#0.9295;ANGIOTENSIN CONVERTING ENZYME#0.9278;INCREASE BLOOD PRESSURE#0.9192;MUTAGENESIS#0.9183;LIPOPROTEIN LIPASE ACTIVITY#0.9149;FARNESOID X RECEPTOR#0.9144;HYPOTHYROIDISM#0.9142;SYSTOLIC BLOOD PRESSURE#0.9121;MECHANISM OF ACTION#0.9113;DEMENTIA#0.9101;ALPHA-TOCOPHEROL#0.9053;CAROTID ARTERY#0.9051;LIPID DROPLET#0.9028;ACYLTRANSFERASE ACTIVITY#0.9003;HEAT SHOCK PROTEIN#0.8997;LECITHIN:CHOLESTEROL ACYLTRANSFERASE ACTIVITY#0.8995;VLDL PARTICLE#0.8990;VITAMIN E#0.8990;PHOSPHOLIPASE A#0.8971;CHOLESTEROL ACYLTRANSFERASE ACTIVITY#0.8962;MONOCYTE#0.8934;SERUM AMYLOID A#0.8911;IMMUNE RESPONSE#0.8872;PARAOXONASE ACTIVITY#0.8869;WEIGHT GAIN#0.8862;STEROL REGULATORY ELEMENT#0.8822;LIPID LOWERING AGENT#0.8785;SERUM ALBUMIN#0.8770;ATRIAL FIBRILLATION#0.8702;GEMFIBROZIL#0.8663;DIGESTION#0.8662;SATURATED FATTY ACID#0.8614;HIGH RISK PATIENTS#0.8595;GROWTH HORMONE#0.8532;LIPID LOWERING THERAPY#0.8479;DISCOIDAL HDL#0.8473;INSULIN SECRETION#0.8427;C TERMINAL DOMAIN#0.8425;SMOOTH MUSCLE#0.8424;TUMOR NECROSIS FACTOR#0.8417;RESPONSE TO CHOLESTEROL#0.8412;ENZYME ACTIVITY#0.8411;TOCOPHEROL#0.8406;MAGNETIC RESONANCE SPECTROSCOPY#0.8395;TYPE 1 DIABETES#0.8366;INCREASED BLOOD PRESSURE#0.8359;CELL ADHESION#0.8312;LOW FAT DIET#0.8293;RANDOMIZED CLINICAL TRIAL#0.8245;BEZAFIBRATE#0.8216;GLYCOSYLATION#0.8208;MECHANISMS OF ACTION#0.8184;SMOOTH MUSCLE CELL#0.8182;MUSCLE CELL#0.8176;T CELL#0.8169;LIPID MODIFICATION#0.8118;THROMBOSIS#0.8083;RANDOMIZED CONTROLLED TRIAL#0.8066;SMALL INTESTINE#0.8060;CELL ADHESION MOLECULE#0.8050;BONE MARROW#0.8044;ETHANOL#0.8002;SIGNALING PATHWAY#0.7995;CEREBROVASCULAR DISEASE#0.7980;GROWTH FACTOR#0.7955;LIPOPROTEIN BINDING#0.7943;MICROSOMAL TRANSFER PROTEIN#0.7930;IMPAIRED GLUCOSE TOLERANCE#0.7922;ROSUVASTATIN#0.7882;VASCULAR CELL#0.7881;LEUKOCYTE#0.7879;CHYLOMICRON REMNANT#0.7877;LEUCINE#0.7870;HUMAN ADIPOSE TISSUE#0.7863;VALINE#0.7853;CHOLESTEROL BIOSYNTHESIS#0.7806;AORTIC ATHEROSCLEROSIS#0.7792;MOLAR#0.7781;SIGNAL PEPTIDE#0.7773;ISCHEMIA#0.7697;RETINOIC ACID#0.7694;CHOLESTYRAMINE#0.7689;CHOLESTERYL LINOLEATE#0.7671;CYCLOSPORINE#0.7667;HARDY WEINBERG EQUILIBRIUM#0.7667;MONOUNSATURATED FATTY ACIDS#0.7653;GLUCOSE HOMEOSTASIS#0.7631;STATISTICALLY SIGNIFICANT DIFFERENCE#0.7601;KIDNEY DISEASE#0.7579;MENOPAUSE#0.7572;ADENOSINE TRIPHOSPHATE#0.7550;TRIGLYCERIDE METABOLISM#0.7490;ENDOPLASMIC RETICULUM#0.7487;CAROTENOID#0.7473;REACTIVE OXYGEN SPECIES#0.7464;RECEPTOR ACTIVITY#0.7411;CHANGE FROM BASELINE#0.7399;ADJUSTED HAZARD RATIO#0.7397;BINDING PROTEIN 1#0.7388;STEARIC ACID#0.7295;LIVER DISEASE#0.7271;HDL RECEPTOR#0.7240;BREAST CANCER#0.7195;LIPID HOMEOSTASIS#0.7191;FASTING BLOOD GLUCOSE#0.7152;EXTENDED RELEASE NIACIN#0.7152;CORONARY STENOSIS#0.7128;SPHERICAL HDL#0.7113;HEPATITIS C#0.7112;COAGULATION#0.7069;ADENOSINE#0.6963;ACUTE MYOCARDIAL INFARCTION#0.6957;GESTATION#0.6935;LIPOPROTEIN OXIDATION#0.6921;SELECTIN#0.6903;PROTEINURIA#0.6898;FAMILIAL COMBINED HYPERLIPIDEMIA#0.6853;TESTOSTERONE#0.6781;TOTAL BODY FAT#0.6764;CELL MEMBRANE#0.6760;ADVERSE CLINICAL OUTCOME#0.6747;SIZE EXCLUSION CHROMATOGRAPHY#0.6739;APOPTOSIS#0.6703;AMPHOTERICIN B#0.6691;CYTOCHROME P450#0.6668;INFLAMMATORY RESPONSE#0.6661;URIC ACID#0.6654;PLASMA LIPOPROTEIN PARTICLE#0.6650;REMNANT LIKE PARTICLE#0.6620;MIPOMERSEN#0.6609;MONONUCLEAR CELLS#0.6605;SQUALENE SYNTHASE#0.6555;FATTY LIVER DISEASE#0.6543;CELL PROLIFERATION#0.6472;NASCENT HDL#0.6469;GLUCOSE UPTAKE#0.6459;TANGIER DISEASE#0.6397;INSULIN-LIKE GROWTH FACTOR#0.6361;POLYPOIDAL CHOROIDAL VASCULOPATHY#0.6300;APOBEC#0.6298;LIPOPROTEIN FORMATION#0.6292;ALCOHOLIC FATTY LIVER#0.6266;CHOLESTEROL UPTAKE#0.6245;FLUVASTATIN#0.6245;SODIUM DODECYL SULFATE#0.6230;DODECYL SULFATE#0.6229;FASTING PLASMA GLUCOSE#0.6221;ATHEROSCLEROTIC HEART DISEASE#0.6219;ESSENTIAL HYPERTENSION#0.6206;MULTIPLE LOGISTIC REGRESSION#0.6203;ENDOTHELIUM#0.6191;FATTY ACID BINDING#0.6187;RESPONSE TO SIMVASTATIN#0.6187;NEPHROPATHY#0.6168;ADULT TREATMENT PANEL#0.6161;ASPARAGINE#0.6158;TOLL LIKE RECEPTOR#0.6128;CORONARY ARTERY CALCIUM#0.6118;ESTRADIOL#0.6111;RED BLOOD CELL#0.6100;ANTIOXIDANT ACTIVITY#0.6096;PROTEIN SYNTHESIS#0.6085;PRO-INFLAMMATORY#0.6049;GENETIC ASSOCIATION STUDIES#0.6048;PROTHROMBINASE ACTIVITY#0.6047;BILE ACID SYNTHESIS#0.6001
10721	DOUBLE STRAND BREAK#1.0522;DNA REPAIR#0.9676;BREAST CANCER#0.9545;TRANSLESION SYNTHESIS#0.9162;DNA REPLICATION#0.8665;HOMOLOGOUS RECOMBINATION#0.8649;DNA SYNTHESIS#0.8625;REPLICATION FORK#0.8136;DOUBLE-STRAND BREAK REPAIR#0.7222;BREAST CANCER PATIENTS#0.6117;CANCER CELL#0.6036
10723	PROTEIN KINASE#0.9015;SWELLING#0.8729;ADRENOCORTICAL CARCINOMA#0.8428;OOCYTE#0.8422;POTASSIUM CHLORIDE#0.8282;CHOROID PLEXUS#0.8228;NERVOUS SYSTEM#0.7203;RENAL TUBULAR ACIDOSIS#0.7143;EPITHELIAL CELL#0.6877;POLYMERASE CHAIN REACTION#0.6328
10724	BETA-N-ACETYLGLUCOSAMINIDASE ACTIVITY#1.0820;BETA-HEXOSAMINIDASE ACTIVITY#1.0725;BETA MANNOSIDASE#1.0545;ALPHA L FUCOSIDASE#1.0535;HEXOSAMINIDASE ACTIVITY#1.0516;KIDNEY INJURY MOLECULE#1.0511;BETA N ACETYLHEXOSAMINIDASE#1.0497;GAMMA GLUTAMYLTRANSFERASE#1.0426;ALPHA GALACTOSIDASE#1.0393;SUCCINATE DEHYDROGENASE#1.0373;SOMATIC CELL COUNT#1.0372;HEXOSAMINIDASE A#1.0370;BETA N ACETYLGLUCOSAMINIDASE#1.0369;RETINOL BINDING#1.0351;RETINOL#1.0328;BETA GLUCOSIDASE#1.0314;ALPHA MANNOSIDASE#1.0312;CYSTATIN#1.0298;ALPHA GLUCOSIDASE#1.0293;IMMUNOGLOBULIN G#1.0266;BETA GLUCURONIDASE#1.0266;O-GLCNAC TRANSFERASE#1.0260;ALPHA N ACETYLGALACTOSAMINIDASE#1.0256;BETA GALACTOSIDASE#1.0233;HYALURONIDASE#1.0224;LEUCINE#1.0218;SANDHOFF DISEASE#1.0206;ALANINE#1.0202;AMNIOTIC FLUID#1.0195;ACID PHOSPHATASE#1.0193;SEMINAL PLASMA#1.0177;BETA-2#1.0175;PERIPHERAL BLOOD LYMPHOCYTES#1.0160;TAY-SACHS DISEASE#1.0158;MALATE DEHYDROGENASE#1.0147;URIC ACID#1.0147;ALKALINE PHOSPHATASE#1.0101;ASPARTATE#1.0093;BRUSH BORDER#1.0081;GLCNAC#1.0076;LIVER DISEASE#1.0068;HISTAMINE#1.0059;CYTOCHROME C#1.0059;SECRETORY GRANULE#1.0058;GANGLIOSIDOSIS#1.0046;BLOOD UREA NITROGEN#1.0042;LYSOSOMAL STORAGE DISORDER#1.0025;SKIN FIBROBLASTS#1.0019;URINARY TRACT INFECTION#0.9999;SUCCINATE#0.9995;STREPTOZOTOCIN#0.9977;EXCRETION#0.9977;NAG ACTIVITY#0.9969;LYSOSOMAL STORAGE DISEASE#0.9963;TUMOR NECROSIS FACTOR#0.9961;IONOPHORE#0.9957;MASTITIS#0.9956;PERIPHERAL BLOOD#0.9950;NEPHROTIC SYNDROME#0.9945;GLUCOSE 6 PHOSPHATASE#0.9930;CHLOROQUINE#0.9928;GENTAMICIN#0.9927;SPERMATOZOA#0.9926;RHEUMATOID ARTHRITIS#0.9918;N GLYCAN#0.9916;ETHANOL#0.9913;EXOCYTOSIS#0.9909;HYALURONIC ACID#0.9900;CISPLATIN#0.9899;URINARY PROTEIN#0.9891;SERUM ALBUMIN#0.9884;EPIDIDYMIS#0.9883;FRUCTOSE#0.9882;ALVEOLAR MACROPHAGE#0.9882;NEUTROPHIL#0.9876;BETA-N-ACETYLHEXOSAMINIDASE ACTIVITY#0.9872;ESSENTIAL HYPERTENSION#0.9862;CELL WALL#0.9856;PROXIMAL TUBULAR CELL#0.9853;PYELONEPHRITIS#0.9848;ADENOSINE#0.9844;ANGIOTENSIN CONVERTING ENZYME#0.9840;MYOCARDIAL INFARCTION#0.9835;TYPE 2 DIABETIC#0.9835;LYSOSOMAL MEMBRANE#0.9833;MAST CELL DEGRANULATION#0.9830;ACUTE KIDNEY INJURY#0.9828;GLUTAMINE#0.9827;PHOSPHODIESTERASE#0.9827;IGE RECEPTOR#0.9827;DIGESTION#0.9823;MAST CELL#0.9819;GLOMERULONEPHRITIS#0.9818;TYPE 1 DIABETES#0.9812;DIABETES MELLITUS#0.9810;GLUTATHIONE#0.9807;ACID PHOSPHATASE ACTIVITY#0.9802;NEURODEGENERATIVE DISEASE#0.9797;AMIKACIN#0.9792;GLYCOSIDASE ACTIVITY#0.9789;MONOCYTE#0.9788;MITOCHONDRIA#0.9782;CARBACHOL#0.9779;PROTEIN KINASE#0.9778;ARACHIDONIC ACID#0.9769;GALACTOSIDASE ACTIVITY#0.9768;ENDOCYTOSIS#0.9768;SOLUBLE FRACTION#0.9765;TYPE 2 DIABETES MELLITUS#0.9765;2 DIABETES MELLITUS#0.9765;SKELETAL MUSCLE#0.9762;HYPERTENSION#0.9760;SUPEROXIDE DISMUTASE#0.9760;TYPE 2 DIABETES#0.9759;GLUCOSIDASE ACTIVITY#0.9758;LEUKOCYTE#0.9757;GLUTATHIONE PEROXIDASE#0.9756;SYSTOLIC BLOOD PRESSURE#0.9753;N-ACETYLHEXOSAMINIDASE ACTIVITY#0.9746;T CELL#0.9745;LACRIMAL GLAND#0.9742;ALZHEIMER'S DISEASE#0.9737;N-ACETYL-D-GLUCOSAMINE#0.9737;PROTEIN MODIFICATION#0.9734;GLOMERULAR FILTRATION RATE#0.9732;MACROPHAGE#0.9724;PLASMA MEMBRANE#0.9720;APOPTOSIS#0.9719;PHOSPHATASE ACTIVITY#0.9719;GLUCOSAMINE#0.9718;ENDOTHELIAL CELL#0.9718;NERVOUS SYSTEM#0.9715;LECTIN#0.9714;BREAST CANCER#0.9711;CANCER CELL#0.9709;ENDOPLASMIC RETICULUM#0.9704;BONE MARROW#0.9704;PROTEINURIA#0.9702;GLOMERULAR FILTRATION#0.9699;ERYTHROCYTE#0.9699;POSTTRANSLATIONAL MODIFICATION#0.9696;KIDNEY DAMAGE#0.9693;KIDNEY DISEASE#0.9692;NITRIC OXIDE#0.9689;SMOOTH MUSCLE#0.9688;SUCROSE#0.9688;GENE EXPRESSION#0.9687;GROWTH FACTOR#0.9683;ORGANELLE#0.9681;LYSOSOME#0.9679;PYRUVATE KINASE#0.9675;SPINAL CORD#0.9674;CELL DEATH#0.9671;HEXOSAMINE BIOSYNTHETIC PATHWAY#0.9666;DIABETIC NEPHROPATHY#0.9662;GLYCOSYLATION#0.9658;CENTRAL NERVOUS SYSTEM#0.9657;REACTIVE OXYGEN SPECIES#0.9657;DIABETIC RETINOPATHY#0.9657;INULIN#0.9655;STEM CELL#0.9654;CONNECTIVE TISSUE#0.9651;CATABOLISM#0.9644;PROSTAGLANDIN E2#0.9638;ISCHEMIA#0.9635;L IDURONIDASE#0.9631;TISSUE DAMAGE#0.9629;LIVER CIRRHOSIS#0.9628;CYCLOSPORIN A#0.9627;GRANULOCYTE#0.9624;LITHIUM#0.9622;BRUSH BORDER MEMBRANE#0.9620;HISTONE ACETYLTRANSFERASE#0.9619;NEPHROTOXICITY#0.9618;SIGNALING PATHWAY#0.9618;ACINAR CELL#0.9612;PROTEIN KINASE C#0.9606;GLUTAMATE DEHYDROGENASE#0.9605;CELL MEMBRANE#0.9600;PEROXISOME#0.9599;CELL SURFACE#0.9596;CYTOPLASM#0.9594;OVARIAN#0.9588;POLYMERASE CHAIN REACTION#0.9587;TRANSCRIPTION FACTOR#0.9584;HYPOXIA#0.9584;POST-TRANSLATIONAL MODIFICATION#0.9580;MEMBRANE FRACTION#0.9577;CATALYTIC ACTIVITY#0.9573;NEPHROTOXIC#0.9569;EXTRACELLULAR MATRIX#0.9567;ARTERY#0.9567;ENZYME ACTIVITY#0.9562;ARGININE#0.9562;CELL CYCLE#0.9558;EPITHELIAL CELL#0.9554;INFLAMMATORY RESPONSE#0.9551;NEPHROPATHY#0.9550;CELL ACTIVATION#0.9548;SUBSTANCE P#0.9545;POLYMORPHONUCLEAR LEUKOCYTES#0.9540;TYPE 1 DIABETIC#0.9538;PHAGOCYTOSIS#0.9525;PARATHYROID HORMONE#0.9524;SUBMANDIBULAR GLAND#0.9519;CYCLOSPORIN#0.9512;ADENOCARCINOMA#0.9511;SIGNAL TRANSDUCTION#0.9506;TOXICITY#0.9501;B CELL#0.9500;PROTEIN SYNTHESIS#0.9490;TYPE 1 DIABETES MELLITUS#0.9488;DIURESIS#0.9483;SYNOVIAL FLUID#0.9477;BASEMENT MEMBRANE#0.9469;NEPHRITIS#0.9451;HYPERGLYCEMIA#0.9444;CELL PROLIFERATION#0.9436;DODECYL SULFATE#0.9434;SODIUM DODECYL SULFATE#0.9434;LUNG CANCER#0.9421;LACTATION#0.9420;MAST CELL ACTIVATION#0.9420;TUBULAR EPITHELIAL CELL#0.9408;CYSTIC FIBROSIS#0.9397;GLUCOSE-6-PHOSPHATE#0.9391;RENIN ACTIVITY#0.9389;RED BLOOD CELL#0.9385;MUSCLE CELL#0.9385;TRANSFORMING GROWTH FACTOR#0.9385;BETA CELL#0.9381;VACUOLE#0.9380;BASOPHIL#0.9379;ALPHA N ACETYLGLUCOSAMINIDASE#0.9362;CYTOCHROME C OXIDASE#0.9336;CREATINE#0.9333;BETA-GLUCOCEREBROSIDASE#0.9332;BETA-GALACTOSIDASE ACTIVITY#0.9331;LACTOSE#0.9331;CYCLOSPORINE#0.9323;L-ALANINE#0.9318;PHOSPHOLIPASE C#0.9313;CELL BOUND#0.9307;PERTUSSIS#0.9288;ACUTE PYELONEPHRITIS#0.9278;NEPHRON#0.9275;PHOSPHOLIPASE A2#0.9270;MULTIPLE REGRESSION ANALYSIS#0.9268;VALINE#0.9266;INTRACELLULAR LOCALIZATION#0.9265;ALBUMIN CREATININE RATIO#0.9258;DIPEPTIDYL-AMINOPEPTIDASE IV#0.9249;ASPARAGINE#0.9247;TOBRAMYCIN#0.9238;INTRACELLULAR TRANSPORT#0.9216;ANAPHYLAXIS#0.9188;EOSINOPHIL#0.9187;GOLGI APPARATUS#0.9186;SMOOTH MUSCLE CELL#0.9178;PYRUVATE#0.9169;ALLERGIC REACTION#0.9149;C REACTIVE PROTEIN#0.9136;LUMINAL#0.9128;PEROXIDASE ACTIVITY#0.9121;GLUCURONIDASE ACTIVITY#0.9101;CHRONIC KIDNEY DISEASE#0.9098;ALLERGEN#0.9083;BETA-GLUCOSIDASE ACTIVITY#0.9081;RECEPTOR ANTAGONIST#0.9072;FATTY ACID BINDING#0.9062;PHOSPHODIESTERASE I#0.9051;CYTOTOXICITY#0.9046;ACUTE MYOCARDIAL INFARCTION#0.9046;FERTILIZATION#0.9028;OBESE#0.8999;MUTAGENESIS#0.8996;CYCLIC AMP#0.8980;ENZYME INHIBITOR#0.8975;BETA-GLUCURONIDASE ACTIVITY#0.8972;SEVOFLURANE#0.8968;PARATHYROID#0.8968;HEPARIN#0.8956;FRUCTOSE -6-PHOSPHATE#0.8952;TUMOR CELLS#0.8940;ENDOTHELIUM#0.8940;P-NITROPHENOL#0.8934;AUTOPHAGY#0.8916;INTENSIVE CARE UNIT#0.8912;RNA INTERFERENCE#0.8908;DEXAMETHASONE#0.8897;CREATININE CLEARANCE RATE#0.8889;GLUTATHIONE TRANSFERASE#0.8878;CORONARY ARTERY#0.8873;TESTOSTERONE#0.8870;PROTEIN GLYCOSYLATION#0.8860;PLATELET ACTIVATING FACTOR#0.8855;MANNOSIDASE ACTIVITY#0.8851;CELL GROWTH#0.8849;MAMMARY GLAND#0.8838;ACROSOME#0.8838;CREATINE KINASE#0.8830;NITRIC OXIDE SYNTHASE#0.8817;CEREBRAL CORTEX#0.8815;IMMUNE RESPONSE#0.8814;MICROTUBULE#0.8810;ADENOSINE DEAMINASE#0.8802;T LYMPHOCYTE#0.8780;BLOOD PLASMA#0.8774;PROTEIN PHOSPHORYLATION#0.8772;SECRETION OF LYSOSOMAL ENZYMES#0.8752;INDUCED RENAL INJURY#0.8747;PROXIMAL TUBULE CELL#0.8746;CHRONIC LIVER DISEASE#0.8739;IOHEXOL#0.8728;D-GLCNAC#0.8722;MONONUCLEAR CELLS#0.8704;STATISTICALLY SIGNIFICANT DIFFERENCE#0.8702;PROTEIN DEGRADATION#0.8701;ENDOSOME#0.8674;IGE ANTIBODY#0.8659;ATPASE ACTIVITY#0.8650;INDOMETHACIN#0.8628;ADIPOCYTE#0.8626;SWELLING#0.8619;SECONDARY LYSOSOME#0.8604;EPIDERMAL GROWTH FACTOR#0.8595;GLUCOSE METABOLISM#0.8580;HYDROXYPROLINE#0.8580;GESTATION#0.8572;LYSINE#0.8570;CHITIN DEGRADATION#0.8564;ASCORBIC ACID#0.8554;SENSITIZATION#0.8552;PRO-INFLAMMATORY#0.8550;METHIONINE#0.8549;ALDOSTERONE#0.8548;INSULIN SECRETION#0.8546;HYDROLASE ACTIVITY#0.8501;VESICOURETERAL REFLUX#0.8496;RENAL TRANSPLANT RECIPIENTS#0.8489;RENAL ARTERY#0.8464;BONE RESORPTION#0.8461;CARDIOMYOCYTE#0.8430;PANCREATITIS#0.8410;HEMATURIA#0.8399;MOLAR#0.8390;MUCOPOLYSACCHARIDOSIS#0.8371;PHOSPHOLIPASE D#0.8348;GLYCOLYSIS#0.8341;MECHANISM OF ACTION#0.8339;CELL ADHESION#0.8327;LYSIS#0.8299;RECEPTOR MEDIATED ENDOCYTOSIS#0.8298;KIDNEY PROXIMAL TUBULE#0.8286;COLORECTAL CANCER#0.8279;MITOGEN ACTIVATED PROTEIN#0.8254;SIGNAL PEPTIDE#0.8253;COLORECTAL#0.8231;MANNITOL#0.8223;LYMPHOID CELL#0.8184;CHEMOTAXIS#0.8182;TRANSFERASE ACTIVITY#0.8166;DIPHOSPHATE#0.8147;TUMOUR NECROSIS FACTOR#0.8145;CYTOKINE PRODUCTION#0.8136;FLUORESCEIN#0.8131;MYOCARDIUM#0.8128;CELL DIFFERENTIATION#0.8125;OOCYTE#0.8074;MAST CELL GRANULE#0.8072;CELL ASSOCIATED#0.8068;MICROSOME#0.8068;ACUTE PANCREATITIS#0.8067;CHOLESTASIS#0.8050;LOW DENSITY LIPOPROTEIN#0.8047;PLATELET AGGREGATION#0.8046;SECRETORY PATHWAY#0.8045;ESTRADIOL#0.8044;ALKALINE PHOSPHATASE ACTIVITY#0.8044;OVARIAN CANCER#0.8011;ATHEROSCLEROSIS#0.7996;IFOSFAMIDE#0.7983;REVERSE TRANSCRIPTION#0.7974;IFN-GAMMA#0.7966;COLLAGENASE#0.7965;DIMERCAPTOSUCCINIC ACID#0.7963;METHOTREXATE#0.7961;EMBRYONIC STEM CELL#0.7935;APOPTOTIC#0.7934;BILE DUCT#0.7906;SMALL INTESTINE#0.7871;PROTEOGLYCAN#0.7867;SEMEN#0.7864;GROWTH HORMONE#0.7855;SECRETORY VESICLE#0.7845;VANCOMYCIN#0.7832;HEAT SHOCK PROTEIN#0.7828;HEART DISEASE#0.7827;SEMINAL VESICLE#0.7789;ALPHA-MANNOSIDASE ACTIVITY#0.7789;QUERCETIN#0.7781;GLUTATHIONE PEROXIDASE ACTIVITY#0.7764;PROSTAGLANDIN I2#0.7754;FASTING BLOOD GLUCOSE#0.7748;KUPFFER CELL#0.7745;REGENERATION#0.7743;CAUDA#0.7715;DIATRIZOATE#0.7713;HUMAN SERUM ALBUMIN#0.7703;RETINAL BINDING#0.7685;ADENINE#0.7683;TRANSFORMING GROWTH FACTOR BETA#0.7683;FOSFOMYCIN#0.7674;PROGESTERONE#0.7669;GOLGI COMPLEX#0.7652;HYALURONATE#0.7622;EDEMA#0.7614;CIS-DIAMMINEDICHLOROPLATINUM#0.7610;LARYNX#0.7595;AMPHOTERICIN B#0.7593;ISCHEMIA REPERFUSION INJURY#0.7590;PROXIMAL TUBULAR EPITHELIAL#0.7576;MULTIPLE MYELOMA#0.7562;UTERUS#0.7558;COLITIS#0.7548;BONE MARROW CELLS#0.7544;PARTURITION#0.7518;TRANSMISSION ELECTRON MICROSCOPY#0.7483;HOST CELL#0.7471;SODIUM DODECYL SULPHATE#0.7465;LOWER URINARY TRACT#0.7413;CLARA CELL#0.7411;ESTERASE ACTIVITY#0.7399;RENOVASCULAR HYPERTENSION#0.7397;MICROVILLI#0.7396;STRUCTURE ACTIVITY RELATIONSHIP#0.7384;RESPIRATORY BURST#0.7369;DNA SYNTHESIS#0.7368;CELL FRACTION#0.7366;MYELOPEROXIDASE ACTIVITY#0.7355;IRON OVERLOAD#0.7355;PROTEINASE INHIBITOR#0.7347;ALPHA 1-ANTITRYPSIN#0.7321;CHONDROCYTE#0.7312;ANAPHYLACTIC#0.7296;PINOCYTOSIS#0.7292;THYMIDINE#0.7259;FIBRINOGEN#0.7239;VIRAL HE